PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ogawa, K; Aitani, N; Hemuki, Y				Ogawa, K.; Aitani, N.; Hemuki, Y.			Quantitative Evaluation of Scattered Photons in a Myocardial Pinhole SPECT Imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ogawa, K.; Aitani, N.; Hemuki, Y.] Hosei Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P066	S372	S372				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202241		
J	Ogushi, G; Kudo, S; Matsuda, R; Tomiguchi, S; Shiraishi, S; Yamashita, Y				Ogushi, G.; Kudo, S.; Matsuda, R.; Tomiguchi, S.; Shiraishi, S.; Yamashita, Y.			Appropriate time interval of dynamic 201Tl SPECT-MPI data acquisition for quantitative myocardial blood flow analysis on cardiac dedicated ultrafast SPECT camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ogushi, G.; Kudo, S.; Matsuda, R.; Tomiguchi, S.; Shiraishi, S.; Yamashita, Y.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP096	S855	S855				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203580		
J	Ohno, K; Higashi, T; Okuyama, C; Nakamoto, Y; Endo, K				Ohno, K.; Higashi, T.; Okuyama, C.; Nakamoto, Y.; Endo, K.			Promotion of measures to counter radiation health concerns using the comic (manga)	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ohno, K.; Endo, K.] Kyoto Coll Med Sci, Nantan, Japan; [Higashi, T.] Shiga Med Ctr Res Inst, Moriyama, Japan; [Okuyama, C.] Image Communiat Corp, Kyoto, Japan; [Nakamoto, Y.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P027	S352	S353				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202202		
J	Okazawa, H; Ikawa, M; Tsujikawa, T; Mori, T; Makino, A; Kiyono, Y; Yoneda, M				Okazawa, H.; Ikawa, M.; Tsujikawa, T.; Mori, T.; Makino, A.; Kiyono, Y.; Yoneda, M.			Evaluation of nigrostriatal oxidative stress intensity in patients with Parkinson's disease using [Cu-62]ATSM PET and FP-CIT SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Okazawa, H.; Ikawa, M.; Tsujikawa, T.; Mori, T.; Makino, A.; Kiyono, Y.] Univ Fukui, Fukui 910, Japan; [Yoneda, M.] Fukui Prefectural Univ, Fukui, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP641	S273	S273				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202051		
J	Okumiya, S; Ofuji, A; Ito, S				Okumiya, S.; Ofuji, A.; Ito, S.			Development of a new quantification method of dopamine transporter density with 123I-ioflupane	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Okumiya, S.; Ofuji, A.; Ito, S.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP078	S847	S847				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203562		
J	Onishi, H; Nakamoto, K; Kenda, S; Kangai, Y; Yada, N; Saho, T; Sakai, T; Hasegawa, D; Fukunaga, M; Amijima, H				Onishi, H.; Nakamoto, K.; Kenda, S.; Kangai, Y.; Yada, N.; Saho, T.; Sakai, T.; Hasegawa, D.; Fukunaga, M.; Amijima, H.			Effects of mis-registration of CT attenuation-corrected on myocardial perfusion images acquired using multi-focus fan beam collimator SPECT/CT and conventional SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Onishi, H.; Kangai, Y.; Yada, N.; Saho, T.] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Program Biol Syst Sci, Shobara, Hiroshima, Japan; [Nakamoto, K.] Hiroshima Prefectural Hosp, Dept Radiol, Hiroshima, Japan; [Kenda, S.; Sakai, T.; Hasegawa, D.; Fukunaga, M.] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Program Hlth & Welfare Sci, Mihara, Hiroshima, Japan; [Amijima, H.] Hyogo Univ Hlth Sci, Grad Sch Nursing, Kobe, Hyogo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P039	S359	S359				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202214		
J	Otomi, Y; Otsuka, H; Shinya, T; Terazawa, K; Kubo, M; Harada, M				Otomi, Y.; Otsuka, H.; Shinya, T.; Terazawa, K.; Kubo, M.; Harada, M.			FDG-PET/CT of bone lesions	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Otomi, Y.; Shinya, T.; Terazawa, K.; Kubo, M.; Harada, M.] Tokushima Univ Hosp, Tokushima, Japan; [Otsuka, H.] Univ Tokushima, Tokushima 770, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P925	S781	S781				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203424		
J	Saga, T; Inubushi, M; Koizumi, M; Yoshikawa, K; Zhang, M; Obata, T; Harada, R; Uno, T				Saga, T.; Inubushi, M.; Koizumi, M.; Yoshikawa, K.; Zhang, M.; Obata, T.; Harada, R.; Uno, T.			Clinical Value of FAZA-PET/CT in Head and Neck Cancer Patients	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Saga, T.; Yoshikawa, K.; Zhang, M.; Obata, T.] Natl Inst Radiol Sci, Chiba 260, Japan; [Inubushi, M.] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Koizumi, M.] Canc Inst Hosp, Tokyo, Japan; [Harada, R.; Uno, T.] Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW086	S322	S322				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202144		
J	Saito, H; Yamane, A; Imai, S; Orita, E; Hakozaki, K; Akiyama, K; Ishihara, K; Kumita, S				Saito, H.; Yamane, A.; Imai, S.; Orita, E.; Hakozaki, K.; Akiyama, K.; Ishihara, K.; Kumita, S.			Diagnostic performance of time-of-flight system to detect neck small lymph node using 18F-FDG PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Saito, H.; Yamane, A.; Imai, S.; Orita, E.; Hakozaki, K.; Akiyama, K.; Ishihara, K.; Kumita, S.] Nippon Med Sch, Bunkyo Ku, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P559	S607	S607				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203062		
J	Sakamoto, F; Shiraishi, S; Tsuda, N; Yuki, H; Namimoto, T; Kitajima, M; Hashimoto, M; Tomiguchi, S; Ikeda, M; Yamashita, Y				Sakamoto, F.; Shiraishi, S.; Tsuda, N.; Yuki, H.; Namimoto, T.; Kitajima, M.; Hashimoto, M.; Tomiguchi, S.; Ikeda, M.; Yamashita, Y.			IMP and MIBG scintigraphy as an index comparable to the core symptoms for a diagnosis of dementia with Lewy bodies?	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sakamoto, F.; Shiraishi, S.; Tsuda, N.; Yuki, H.; Namimoto, T.; Kitajima, M.] Kumamoto Univ, Grad Sch Life Sci, Diagnost Radiol, Kumamoto, Japan; [Hashimoto, M.; Ikeda, M.] Kumamoto Univ, Grad Sch Life Sci, Dept Neuropsychiat, Kumamoto, Japan; [Tomiguchi, S.] Kumamoto Univ, Sch Hlth, Dept Diagnost Med Imaging, Fac Life Sci, Kumamoto, Japan; [Yamashita, Y.] Kumamoto Univ, Grad Sch Life Sci, Dept Diagnost Radiol, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P987	S809	S809				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203483		
J	Sekine, T; Barbosa, F; Kuhn, F; Burger, I; von Schulthess, G; Veit-Haibach, P; Huellner, M				Sekine, T.; Barbosa, F.; Kuhn, F.; Burger, I.; von Schulthess, G.; Veit-Haibach, P.; Huellner, M.			PET/MR versus PET/CT in the Initial Staging of Head and Neck Cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sekine, T.; Barbosa, F.; Kuhn, F.; Burger, I.; von Schulthess, G.; Veit-Haibach, P.; Huellner, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Sekine, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP600	S253	S254				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202014		
J	Shimizu, K; Hino, M; Matsumoto, K; Yamamoto, S				Shimizu, K.; Hino, M.; Matsumoto, K.; Yamamoto, S.			Comparison of capability of diagnosis supporting system between two deifferent gamma cameras for bone scintigraphic images in diagnosing bone metastasis of cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shimizu, K.; Hino, M.] Kobe City Med Ctr, Gen Hosp, Kobe, Hyogo, Japan; [Matsumoto, K.] Kyoto Coll Med Sci, Nantan, Japan; [Yamamoto, S.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP034	S826	S826				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203518		
J	Shinya, T; Otomi, Y; Tanaka, T; Inai, R; Kanazawa, S; Harada, M				Shinya, T.; Otomi, Y.; Tanaka, T.; Inai, R.; Kanazawa, S.; Harada, M.			The Evaluation of Dual-time-point F-18 FDG PET/CT and chest CT for the prediction of the WHO grade in thymic epithelial neoplasms	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shinya, T.; Otomi, Y.; Harada, M.] Univ Tokushima, Grad Sch, Tokushima 770, Japan; [Tanaka, T.; Inai, R.; Kanazawa, S.] Okayama Univ Hosp, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P789	S719	S720				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203291		
J	Shiraishi, S; Tsuda, N; Sakamoto, F; Yoshida, M; Tomiguchi, S; Yamashita, Y				Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Yoshida, M.; Tomiguchi, S.; Yamashita, Y.			Prediction of occult coronary artery disease in patients with normal myocardial perfusion scintigraphy using myocardial perfusion reserve on dynamic thallium-201 single-photon emission computed tomography with a semiconductor gamma camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Tomiguchi, S.; Yamashita, Y.] Kumamoto Univ, Kumamoto, Japan; [Yoshida, M.] Amakusa Med Ctr, Hondo City, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P348	S508	S508				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202519		
J	Shuke, N; Miyazaki, C; Ando, A; Onishi, T; Saito, K; Sato, J; Okizaki, A; Nishikawa, K				Shuke, N.; Miyazaki, C.; Ando, A.; Onishi, T.; Saito, K.; Sato, J.; Okizaki, A.; Nishikawa, K.			Proposal of a Method to Estimate Normal Threshold Values of Summed Z-scores in the Specified Regions for Z Sum Analysis for Diagnosing Alzheimer's Disease with Voxel-based Control Database of I-123 IMP SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shuke, N.; Miyazaki, C.; Ando, A.; Onishi, T.; Saito, K.] Kushiro Kojinkai Mem Hosp, Kushiro, Japan; [Sato, J.; Okizaki, A.] Asahikawa Med Coll, Asahikawa, Hokkaido 078, Japan; [Nishikawa, K.] Nihon Medi Phys Co Ltd, Imaging Informat Technol Ctr, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P434	S549	S549				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202604		
J	Sone, Y; Abe, M; Arakawa, C; Kato, I; Sobajima, A; Kawachi, T; Takeda, I; Kumada, T				Sone, Y.; Abe, M.; Arakawa, C.; Kato, I.; Sobajima, A.; Kawachi, T.; Takeda, I.; Kumada, T.			Diagnostic value of 18F-FDG PET/CT in whole body cancer screening	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sone, Y.; Abe, M.; Arakawa, C.] Ogaki Municipal Hosp, Dept Radiol, Ogaki, Japan; [Kato, I.; Sobajima, A.; Kawachi, T.] Ogaki Municipal Hosp, Dept Radiol Technol, Ogaki, Japan; [Takeda, I.; Kumada, T.] Ogaki Municipal Hosp, Hlth Management Ctr, Ogaki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P784	S717	S717				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203286		
J	Sugihara, Y; Fukushima, Y; Kumita, S				Sugihara, Y.; Fukushima, Y.; Kumita, S.			Diagnostic accuracy of 123I-MIBG SPECT-CT using semi-quantitative analysis in patients with adrenal pheochromocytoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sugihara, Y.; Fukushima, Y.; Kumita, S.] Nippon Med Coll Hosp, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P966	S800	S801				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203464		
J	Takanami, K; Umezawa, R; Kadoya, N; Arai, A; Jingu, K; Takase, K				Takanami, K.; Umezawa, R.; Kadoya, N.; Arai, A.; Jingu, K.; Takase, K.			Association between radiation dosimetry of the heart and the myocardial fatty acid metabolic impairment due to chemoradiation-therapy : Prospective study using I-123 BMIPP SPECT/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Takanami, K.; Arai, A.; Takase, K.] Tohoku Univ Hosp, Dept Diagnost Radiol, Sendai, Miyagi, Japan; [Umezawa, R.; Kadoya, N.; Jingu, K.] Tohoku Univ Hosp, Dept Radiat Oncol, Sendai, Miyagi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW014	S284	S285				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202072		
J	Takano, A; Stepanov, V; Nakao, R; Amini, N; Kimura, H; Halldin, C				Takano, A.; Stepanov, V.; Nakao, R.; Amini, N.; Kimura, H.; Halldin, C.			Comparative Evaluation of Two PET Radioligands for PDE10A, [11C]T-773 and [18F]FM-T-773-d2 in Nonhuman Primates	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Takano, A.; Stepanov, V.; Nakao, R.; Amini, N.; Halldin, C.] Karolinska Inst, Stockholm, Sweden; [Kimura, H.] Takeda Pharmaceut Co Ltd, Fujisawa, Kanagawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP287	S119	S120				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201207		
J	Tanaka, T; Sato, S; Inai, R; Tada, A; Kanazawa, S				Tanaka, T.; Sato, S.; Inai, R.; Tada, A.; Kanazawa, S.			Contralateral axillary sentinel lymph node in breast cancer patients: an uncommon lymphatic drainage	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Tanaka, T.; Sato, S.; Inai, R.; Tada, A.; Kanazawa, S.] Okayama Univ Hosp, Dept Radiol, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P581	S617	S617				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203084		
J	Toubaru, S; Ohashi, S; Tachibana, Y; Hasebe, M; Tanimoto, K; Zhang, M; Yamamoto, N; Nakajima, M; Karube, M; Obata, T; Saga, T; Ando, Y; Yoshikawa, K; Kamada, T				Toubaru, S.; Ohashi, S.; Tachibana, Y.; Hasebe, M.; Tanimoto, K.; Zhang, M.; Yamamoto, N.; Nakajima, M.; Karube, M.; Obata, T.; Saga, T.; Ando, Y.; Yoshikawa, K.; Kamada, T.			Efficacy of SUVmax and SUVpeak to predict distant metastasis of non-small cell lung cancer before treatment	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Toubaru, S.; Ohashi, S.; Tachibana, Y.; Hasebe, M.; Tanimoto, K.; Zhang, M.; Yamamoto, N.; Nakajima, M.; Karube, M.; Obata, T.; Saga, T.; Ando, Y.; Kamada, T.] Natl Inst Radiol Sci, Chiba 260, Japan; [Yoshikawa, K.] Tokyo Bay Adv Imaging & Radiat Oncol Clin MAKUHAR, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P637	S645	S645				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203140		
J	Toyohara, J; Okamoto, M; Aramaki, H; Zaitsu, Y; Shimizu, I; Hosokawa, S; Ishiwata, K				Toyohara, J.; Okamoto, M.; Aramaki, H.; Zaitsu, Y.; Shimizu, I.; Hosokawa, S.; Ishiwata, K.			Radiosynthesis and fundamental evaluation of (R)-[11C] mopamil as a novel tracer for imaging enhanced P-glycoprotein function in the brain	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Toyohara, J.; Okamoto, M.; Ishiwata, K.] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Okamoto, M.; Aramaki, H.; Zaitsu, Y.; Shimizu, I.; Hosokawa, S.] Waseda Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP284	S117	S118				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201204		
J	Tsuchiya, S; Abe, S; Fujita, N; Sakuragi, Y; Koshiba, Y; Odagawa, T; Kato, K				Tsuchiya, S.; Abe, S.; Fujita, N.; Sakuragi, Y.; Koshiba, Y.; Odagawa, T.; Kato, K.			Comparative study on recovery coefficients of SPECT-CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Tsuchiya, S.; Koshiba, Y.; Odagawa, T.; Kato, K.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Abe, S.; Fujita, N.; Sakuragi, Y.] Nagoya Univ Hosp, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP020	S820	S820				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203504		
J	Tsukimoto, S				Tsukimoto, S.			A new amyloid imaging probe 125I-EISB in PET/SPECT imaging of amyloid was developed for both brain and whole body for clinical use	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Tsukimoto, S.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP027	S823	S823				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203511		
J	Uchino, Y				Uchino, Y.			Calorie consumption and brain glucose metabolism in the patients with chronic severe brain injury - A study using brain 18F-FDGPET -	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Uchino, Y.] Chiba Ryogo Ctr, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P504	S581	S582				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203008		
J	Umeda, IO; Ito, K; Hamamichi, S; Asano, M; Iwata, M; Matsui, J; Hori, Y; Funahashi, Y; Fujii, H				Umeda, I. O.; Ito, K.; Hamamichi, S.; Asano, M.; Iwata, M.; Matsui, J.; Hori, Y.; Funahashi, Y.; Fujii, H.			SPECT/CT Imaging of Radionuclide-carrying Liposomes Predict Therapeutic Effects of Liposomal Anti-cancer Agents in Mouse Xenograft Models	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Umeda, I. O.; Hamamichi, S.; Fujii, H.] Natl Canc Ctr, Kashiwa, Chiba, Japan; [Ito, K.; Asano, M.; Iwata, M.; Matsui, J.; Hori, Y.; Funahashi, Y.] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P230	S450	S451				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202403		
J	Utsunomiya, K; Yasuda, K; Kono, Y; Ueno, Y; Hakawa, SK; Stundzia, A; Tanigawa, N				Utsunomiya, K.; Yasuda, K.; Kono, Y.; Ueno, Y.; Hakawa, S. K.; Stundzia, A.; Tanigawa, N.			The clinical efficacy of endometriosis diagnosis using I-123 MIBG SPECT and MRI image fusion	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Utsunomiya, K.] Kansai Med Univ, Takii Hosp, Dept Radiol, Moriguchi, Osaka 570, Japan; [Yasuda, K.] Kansai Med Univ, Takii Hosp, Dept Gynecol, Moriguchi, Osaka 570, Japan; [Kono, Y.; Ueno, Y.; Hakawa, S. K.; Tanigawa, N.] Kansai Med Univ, Dept Radiol, Hirakata, Osaka, Japan; [Stundzia, A.] Tomographix, Toronto, ON, Canada								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P196	S435	S435				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202370		
J	van den Berg, NS; KleinJan, GH; Miwa, M; Sato, T; Maeda, Y; Karakullukcu, B; Horenblas, S; van Leeuwen, FWB				van den Berg, N. S.; KleinJan, G. H.; Miwa, M.; Sato, T.; Maeda, Y.; Karakullukcu, B.; Horenblas, S.; van Leeuwen, F. W. B.			Intraoperative fluorescence guidance under ambient light conditions using a new modified fluorescence camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[van den Berg, N. S.; KleinJan, G. H.; van Leeuwen, F. W. B.] LUMC, Leiden, Netherlands; [van den Berg, N. S.; KleinJan, G. H.; Karakullukcu, B.; Horenblas, S.; van Leeuwen, F. W. B.] AVL NKI, Amsterdam, Netherlands; [Miwa, M.; Sato, T.; Maeda, Y.] Hamamatsu Photon KK, Hamamatsu, Shizuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P189	S431	S432				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202363		
J	Watanabe, S; Nakajima, K; Yaegashi, H; Mizokami, A; Noguchi, N; Kawashiri, S; Inokuchi, M; Kinuya, S				Watanabe, S.; Nakajima, K.; Yaegashi, H.; Mizokami, A.; Noguchi, N.; Kawashiri, S.; Inokuchi, M.; Kinuya, S.			Feasibility of bone scan index for the diagnosis and follow-up of medication-related osteonecrosis of the jaw	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Watanabe, S.; Nakajima, K.; Yaegashi, H.; Mizokami, A.; Noguchi, N.; Kawashiri, S.; Inokuchi, M.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P913	S775	S776				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203412		
J	Watanabe, S; Okamoto, S; Shiga, T; Inoue, T; Hirata, K; Magota, K; Nishijima, K; Kuge, Y; Shirato, H; Tamaki, N				Watanabe, S.; Okamoto, S.; Shiga, T.; Inoue, T.; Hirata, K.; Magota, K.; Nishijima, K.; Kuge, Y.; Shirato, H.; Tamaki, N.			Respiratory-gated FMISO-PET/CT detects tumor hypoxia with higher sensitivity in non-small cell lung cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Watanabe, S.; Okamoto, S.; Shiga, T.; Hirata, K.; Magota, K.; Tamaki, N.] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Inoue, T.; Shirato, H.] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan; [Nishijima, K.; Kuge, Y.] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP144	S61	S61				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201099		
J	Watanabe, S; Kato, H; Shimosegawa, E; Hatazawa, J				Watanabe, S.; Kato, H.; Shimosegawa, E.; Hatazawa, J.		Osaka Twin Res Grp	Genetic influences in FDG uptake in precuneus and posterior cingulate cortex: a PET study in non-demented twins	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Watanabe, S.; Kato, H.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Shimosegawa, E.] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP515	S216	S216				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201383		
J	Werner, RA; Maya, Y; Jahns, V; Wakabayashi, H; Nakajo, M; Fukushima, K; Javadi, M; Yanagisawa, T; Jahns, R; Higuchi, T				Werner, R. A.; Maya, Y.; Jahns, V.; Wakabayashi, H.; Nakajo, M.; Fukushima, K.; Javadi, M.; Yanagisawa, T.; Jahns, R.; Higuchi, T.			FDG PET Imaging of a Rat Model of Autoimmune Myocarditis: Comparison with Histological Analysis	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Werner, R. A.; Maya, Y.; Wakabayashi, H.; Nakajo, M.; Higuchi, T.] Univ Klinikum Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Werner, R. A.; Higuchi, T.] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Maya, Y.] Nihon Medi Phys Co Ltd, Res Ctr, Chiba, Japan; [Jahns, V.] Univ Klinikum Wurzburg, Dept Pharmacol, Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Javadi, M.] Johns Hopkins Univ, Div Nucl Med, Baltimore, MD 21218 USA; [Yanagisawa, T.] Kitazato Univ, Sch Med, Dept Cardioangiol, Tokyo, Japan; [Jahns, R.] Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP431	S176	S176				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201309		
J	Yamamoto, Y; Tanaka, K; Yamamoto, H; Kudomi, N; Hatakeyama, T; Toyohara, J; Nishiyama, Y				Yamamoto, Y.; Tanaka, K.; Yamamoto, H.; Kudomi, N.; Hatakeyama, T.; Toyohara, J.; Nishiyama, Y.			Correlation of 4 '-[Methyl-11C]-Thiothymidine Uptake with Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas: Comparison with 11C-Methionine Uptake	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yamamoto, Y.; Tanaka, K.; Yamamoto, H.; Kudomi, N.; Hatakeyama, T.; Nishiyama, Y.] Kagawa Univ, Takamatsu, Kagawa 760, Japan; [Toyohara, J.] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P549	S602	S602				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203052		
J	Yamane, T; Seto, A; Matsunari, I; Kuji, I				Yamane, T.; Seto, A.; Matsunari, I.; Kuji, I.			Role of F-18 FDG PET in the differential diagnosis between mediastinal malignant lymphoma and thymic epithelial tumors	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yamane, T.; Seto, A.; Matsunari, I.; Kuji, I.] Saitama Med Univ, Saitama Int Medicial Ctr, Hidaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P613	S633	S634				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203116		
J	Yokoyama, K; Imabayashi, E; Matsuda, H				Yokoyama, K.; Imabayashi, E.; Matsuda, H.			Application of CT based spatial normalization by DARTEL to quantitative assessment of 123I-FP-CIT SPECT.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yokoyama, K.; Imabayashi, E.; Matsuda, H.] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P465	S562	S562				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202633		
J	Yoshida, M; Shiraishi, S; Tsuda, N; Sakamoto, F; Tomiguchi, S; Beppu, T; Baba, H; Yamashita, Y				Yoshida, M.; Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Tomiguchi, S.; Beppu, T.; Baba, H.; Yamashita, Y.			Evaluating the risk of postoperative liver failure using preoperative 99mTc-GSA SPECT/CT fused imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yoshida, M.] Amakusa Med Ctr, Amakusa, Japan; [Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Yamashita, Y.] Kumamoto Univ, Grad Sch Life Sci, Dept Diagnost Radiol, Kumamoto, Japan; [Tomiguchi, S.] Kumamoto Univ, Sch Hlth, Dept Diagnost Med Imaging, Fac Life Sci, Kumamoto, Japan; [Beppu, T.; Baba, H.] Kumamoto Univ, Grad Sch Life Sci, Dept Gastroenterol Surg, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW034	S295	S295				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202092		
J	Zhou, X; de Vries, E; Ishiwata, K; Dierckx, R; Nishiyama, S; Tsukada, H; Elsinga, P				Zhou, X.; de Vries, E.; Ishiwata, K.; Dierckx, R.; Nishiyama, S.; Tsukada, H.; Elsinga, P.			In vivo evaluation of [C-11]preladenant for imaging of adenosine A(2A) receptors in the conscious monkey	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Zhou, X.; de Vries, E.; Dierckx, R.; Elsinga, P.] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Ishiwata, K.] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan; [Nishiyama, S.; Tsukada, H.] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP048	S19	S20				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201022		
J	Morishita, S; Kaida, K; Yamauchi, S; Wakasugi, T; Ikegame, K; Kodama, N; Ogawa, H; Domen, K				Morishita, Shinichiro; Kaida, Katsuji; Yamauchi, Shinya; Wakasugi, Tatsushi; Ikegame, Kazuhiro; Kodama, Norihiko; Ogawa, Hiroyasu; Domen, Kazuhisa			Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients	EUROPEAN JOURNAL OF ONCOLOGY NURSING			English	Article						Allogeneic haematopoietic stem cell transplantation; HLA-haploidentical donor; Health-related QOL; Psychological status; Physical function; Oncology	ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; MUSCLE STRENGTH MEASUREMENTS; HAND-HELD DYNAMOMETER; UMBILICAL-CORD BLOOD; UNRELATED DONOR; TRANSLATION; RELIABILITY; VALIDATION; SURVIVORS	Purpose: This study investigated the differences between allogeneic haematopoietic stem cell transplantation (allo-HSCT) patients receiving HSC from human leucocyte antigen (HLA)-haploidentical donors (HID) and other donors that included HLA-matched sibling, matched unrelated, and unrelated umbilical cord blood donors in the 6 weeks after HSCT with respect to quality of life (QOL), psychological status, and physical function. Methods: The study included 126 patients (HID group, n = 100; other donor group, n = 26) who underwent allo-HSCT between July 2007 and December 2012. Patients were evaluated for health-related QOL using the Medical Outcome Study 36-item Short Form Health Survey. Psychological status was measured by Hospital Anxiety and Depression Scale. Physical function was assessed using tests for handgrip strength, knee extensor strength, and the 6-min walk test. Results: After HSCT, the HID group showed significantly greater improvements in the general health subscale and Mental Component Summary (MCS) of QOL than the other donor group (P < 0.01). Multivariate analysis confirmed that complete remission and age were associated with changes in the general health subscale before and after HSCT (P < 0.05). With regard to physical function, the HID group showed significantly more decline than the other donor group with respect to handgrip strength and knee extensor muscle strength after HSCT (P < 0.05). Total corticosteroid dose was associated with decreased handgrip strength before and after HSCT (P < 0.05). Conclusions: The donor type affects QOL, psychological status, and physical function in allo-HSCT recipients; these findings may provide insights for customised rehabilitation strategies for HSCT recipients. (C) 2015 Elsevier Ltd. All rights reserved.	[Morishita, Shinichiro; Yamauchi, Shinya; Wakasugi, Tatsushi] Hyogo Coll Med Hosp, Dept Rehabil, Nishinomiya, Hyogo, Japan; [Kaida, Katsuji; Ikegame, Kazuhiro; Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Haematol, Nishinomiya, Hyogo 6638501, Japan; [Kodama, Norihiko; Domen, Kazuhisa] Hyogo Coll Med, Dept Rehabil Med, Nishinomiya, Hyogo 6638501, Japan	Morishita, S (reprint author), Hyogo Coll Med, Dept Rehabil, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ptmorishin@yahoo.co.jp; kaidak@hyo-med.ac.jp; yamashin5577@yahoo.co.jp; waka.t2s920@gmail.com; kame@hyo-med.ac.jp; norihiko@hyo-med.ac.jp; ogawah@hyo-med.ac.jp; domen@aqu.bekkoame.ne.jp			Japan Society for the Promotion of Science [25862173]	This study was partly supported by a Grant-in-Aid for Young Scientists (B) and the Japan Society for the Promotion of Science (KAKENHI [25862173]).	Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Morishita S, 2013, PSYCHO-ONCOLOGY, V22, P1159, DOI 10.1002/pon.3128; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Grulke N, 2012, BONE MARROW TRANSPL, V47, P473, DOI 10.1038/bmt.2011.107; Aversa F, 2012, SEMIN ONCOL, V39, P643, DOI 10.1053/j.seminoncol.2012.09.002; Syrjala KL, 2010, PSYCHO-ONCOLOGY, V19, P462, DOI 10.1002/pon.1572; Rischer J, 2009, BONE MARROW TRANSPL, V44, P121, DOI 10.1038/bmt.2008.430; Ballen KK, 2012, BLOOD, V119, P1972, DOI 10.1182/blood-2011-11-354563; Sun CL, 2011, BLOOD, V118, P4723, DOI 10.1182/blood-2011-04-348730; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Watson M, 2004, EUR J CANCER, V40, P971, DOI 10.1016/S0959-8049(03)00628-2; Mo XD, 2012, BONE MARROW TRANSPL, V47, P1201, DOI 10.1038/bmt.2011.250; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Morishita S, 2013, SUPPORT CARE CANCER, V21, P2161, DOI 10.1007/s00520-013-1778-7; Yoshimi A, 2010, BONE MARROW TRANSPL, V45, P1682, DOI 10.1038/bmt.2010.34; Lau AKL, 2002, BONE MARROW TRANSPL, V29, P41, DOI 10.1038/sj.bmt.1703313; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Reisner Y, 2011, BLOOD, V118, P6006, DOI 10.1182/blood-2011-07-338822; Bevans M, 2011, PSYCHO-ONCOLOGY, V20, P615, DOI 10.1002/pon.1906; Morishita S, 2012, SUPPORT CARE CANCER, V20, P821, DOI 10.1007/s00520-011-1156-2; Morishita S, 2012, SUPPORT CARE CANCER, V20, P3161, DOI 10.1007/s00520-012-1460-5; Doorduijn J, 2005, EUR J HAEMATOL, V75, P116, DOI 10.1111/j.1600-0609.2005.00438.x; Katoh M, 2009, J PHYS THER SCI, V21, P37; Ogawa H, 2006, BIOL BLOOD MARROW TR, V12, P1073, DOI 10.1016/j.bbmt.2006.06.007; Bieri S, 2008, BONE MARROW TRANSPL, V42, P819, DOI 10.1038/bmt.2008.253; Ballen KK, 2011, BONE MARROW TRANSPL, V46, P323, DOI 10.1038/bmt.2010.260; Morishita S, 2013, EUR J CANCER CARE, V22, P289, DOI 10.1111/ecc.12027; Luznik L, 2012, SEMIN ONCOL, V39, P683, DOI 10.1053/j.seminoncol.2012.09.005; Alibhai SMH, 2009, CRIT REV ONCOL HEMAT, V69, P168, DOI 10.1016/j.critrevonc.2008.07.015; Okamoto S, 2002, INT J HEMATOL, V76, P310; Ruggeri A, 2010, BEST PRACT RES CL HA, V23, P207, DOI 10.1016/j.beha.2010.06.002; Wolschke C, 2014, BONE MARROW TRANSPL, V49, P126, DOI 10.1038/bmt.2013.143; Koh LP, 2008, BONE MARROW TRANSPL, V42, pS60, DOI 10.1038/bmt.2008.117; Sciurba F, 2003, AM J RESP CRIT CARE, V167, P1522, DOI 10.1164/rccm.200203-166OC; Katoh M, 2009, J PHYS THER SCI, V21, P239; Fukuhara S., 2004, MANUAL SF 36V2 JAPAN; Guimaraes FAB, 2008, REV LAT-AM ENFERM, V16, P856, DOI 10.1590/S0104-11692008000500010; Kanda J, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.85; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Pidala J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008818.pub2; Piper B F, 1998, Oncol Nurs Forum, V25, P677; Van Haren LE., 2013, PHYS THER, V93, P514; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1462-3889	1532-2122		EUR J ONCOL NURS	Eur. J. Oncol. Nurs.	OCT	2015	19	5					443	450		10.1016/j.ejon.2015.02.002		8	Oncology; Nursing	Oncology; Nursing	CU2IR	WOS:000363347700001		
J	Kotani, S; Sakamoto, M; Osakama, K; Nakajima, M				Kotani, Shunsuke; Sakamoto, Midori; Osakama, Kazuki; Nakajima, Makoto			A Sterically Congested -Cyanoamine as a Cyanating Reagent: Cyanation of Acetals and Orthoesters	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Nucleophilic addition; Cyanation; Acetals; Cyanides	ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; ASYMMETRIC CYANOHYDRIN SYNTHESIS; CHIRAL PHOSPHINE OXIDE; TRANSFER HYDROGENATION; ALDOL REACTION; TRICHLOROSILYL TRIFLATE; TRIMETHYLSILYL CYANIDE; CONJUGATE REDUCTION; HYDRIDE DONOR; LITHIUM DIISOPROPYLAMIDE	The cyanation of acetals and orthoesters by using a sterically congested -cyanoamine as a cyanating reagent was investigated. The -cyanoamine effectively facilitated cyanation in the presence of trichlorosilyl triflate to produce a variety of cyanated adducts in excellent yields. Analysis of the reaction mixture by H-1 NMR spectroscopy revealed that trichlorosilyl triflate produced an oxocarbenium cation species as an intermediate.	[Kotani, Shunsuke] Kumamoto Univ, Prior Org Innovat & Excellence, Chuo Ku, Kumamoto 8620973, Japan; [Kotani, Shunsuke; Sakamoto, Midori; Osakama, Kazuki; Nakajima, Makoto] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan	Kotani, S (reprint author), Kumamoto Univ, Prior Org Innovat & Excellence, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	skotani@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through JSPS KAKENHI [25860008]	This work was partially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, through JSPS KAKENHI grant number 25860008.	Zhou GH, 2010, CHEM COMMUN, V46, P6593, DOI 10.1039/c0cc01946a; Zhang C, 2009, J ORG CHEM, V74, P419, DOI 10.1021/jo802325x; North M, 2003, TETRAHEDRON-ASYMMETR, V14, P147, DOI 10.1016/S0957-4166(02)00825-X; Clerici A, 2004, TETRAHEDRON LETT, V45, P1825, DOI 10.1016/j.tetlet.2004.01.025; Kotani S, 2011, ORG LETT, V13, P3968, DOI 10.1021/ol2014895; MAJEWSKI M, 1988, TETRAHEDRON LETT, V29, P4057, DOI 10.1016/S0040-4039(00)80416-5; OLAH GA, 1968, J AM CHEM SOC, V90, P4323, DOI 10.1021/ja01018a023; MAYR H, 1995, J AM CHEM SOC, V117, P7862, DOI 10.1021/ja00135a002; CHIKASHITA H, 1986, B CHEM SOC JPN, V59, P1747, DOI 10.1246/bcsj.59.1747; SCHREIBER SL, 1980, TETRAHEDRON LETT, V21, P1027, DOI 10.1016/S0040-4039(00)78830-7; North M, 2008, CHEM REV, V108, P5146, DOI 10.1021/cr800255k; Aoki S, 2012, CHEM COMMUN, V48, P5524, DOI 10.1039/c2cc31543b; Okajima M, 2005, J AM CHEM SOC, V127, P6930, DOI 10.1021/ja050414y; Zhu C, 2009, ORG LETT, V11, P4180, DOI 10.1021/ol901762g; Brunel JM, 2004, ANGEW CHEM INT EDIT, V43, P2752, DOI 10.1002/anie.200300604; TORII S, 1987, B CHEM SOC JPN, V60, P2173, DOI 10.1246/bcsj.60.2173; Zhang YB, 2009, HETEROCYCLES, V78, P1541, DOI 10.3987/COM-08-11603; Murarka S, 2009, J AM CHEM SOC, V131, P13226, DOI 10.1021/ja905213f; Haibach MC, 2011, J AM CHEM SOC, V133, P2100, DOI 10.1021/ja110713k; Cho CS, 2009, B KOREAN CHEM SOC, V30, P1931; HIYAMA T, 1987, B CHEM SOC JPN, V60, P2139, DOI 10.1246/bcsj.60.2139; NISHIGUCHI T, 1975, J ORG CHEM, V40, P237, DOI 10.1021/jo00890a019; Hasegawa E, 2009, HETEROCYCLES, V77, P1147, DOI 10.3987/COM-08-S(F)94; Kotani S, 2011, TETRAHEDRON LETT, V52, P2834, DOI 10.1016/j.tetlet.2011.03.095; Mori K, 2009, CHEM LETT, V38, P524, DOI 10.1246/cl.2009.524; BABLER JH, 1987, TETRAHEDRON LETT, V28, P4657, DOI 10.1016/S0040-4039(00)96589-4; Murarka S, 2009, ORG LETT, V11, P129, DOI 10.1021/ol802519r; Rueping M, 2011, GREEN CHEM, V13, P1084, DOI 10.1039/c1gc15027h; KOWALSKI C, 1978, J ORG CHEM, V43, P2601, DOI 10.1021/jo00407a011; Connon SJ, 2007, ORG BIOMOL CHEM, V5, P3407, DOI 10.1039/b711499k; Kotani S, 2014, ORG LETT, V16, P4802, DOI 10.1021/ol502269w; Cao WD, 2011, ORG LETT, V13, P600, DOI 10.1021/ol1028282; UTIMOTO K, 1981, TETRAHEDRON LETT, V22, P4279, DOI 10.1016/S0040-4039(01)82933-6; You SL, 2007, CHEM-ASIAN J, V2, P820, DOI 10.1002/asia.200700081; Osakama K, 2012, TETRAHEDRON LETT, V53, P4199, DOI 10.1016/j.tetlet.2012.05.147; Gregory RJH, 1999, CHEM REV, V99, P3649, DOI 10.1021/cr9902906; BASSINDALE AR, 1984, J ORGANOMET CHEM, V271, pC1, DOI 10.1016/0022-328X(84)85193-1; Brunel J.-M., 2004, ANGEW CHEM, V116, P2810, DOI 10.1002/ange.200300604; Chen FX, 2005, SYNLETT, P892, DOI 10.1055/s-2005-864831; Chikashita H., 1987, J CHEM SOC PERK T, P699; CHIKASHITA H, 1984, SYNTHESIS-STUTTGART, P308; ITO Y, 1984, CHEM LETT, P937, DOI 10.1246/cl.1984.937; KANTLEHNER W, 1981, LIEBIGS ANN CHEM, P70; KIRCHMEYER S, 1983, SYNTHESIS-STUTTGART, P498; Kumamoto K, 2006, SYNLETT, P1968, DOI 10.1055/s-2006-947347; Ma L., 2013, J AM CHEM SOC, V134, P15305; Matyus P, 2006, SYNTHESIS-STUTTGART, P2625, DOI 10.1055/s-2006-942490; MIURA T, 1994, J CHEM SOC PERK T 1, P1659, DOI 10.1039/p19940001659; MIURA T, 1995, J CHEM SOC PERK T 1, P2155, DOI 10.1039/p19950002155; Moberg C, 2010, SYNLETT, P355, DOI 10.1055/s-0029-1219154; MUKAIYAMA T, 1989, CHEM LETT, P997, DOI 10.1246/cl.1989.997; NORTH M, 1993, SYNLETT, P807; Ohishi Y., 1999, ORG LETT, V1, P237; Ouellet SG, 2007, ACCOUNTS CHEM RES, V40, P1327, DOI 10.1021/ar7001864; SCOTT LT, 1978, TETRAHEDRON LETT, P4637; Tokuyama H, 2000, SYNTHESIS-STUTTGART, P1299; TORII S, 1984, CHEM LETT, P897, DOI 10.1246/cl.1984.897; WOO EP, 1974, TETRAHEDRON LETT, P4095	58	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	OCT	2015		30					6606	6609		10.1002/ejoc.201501084		4	Chemistry, Organic	Chemistry	CU2FR	WOS:000363339600004		
J	Nagata, C; Wada, K; Tsuji, M; Hayashi, M; Takeda, N; Yasuda, K				Nagata, Chisato; Wada, Keiko; Tsuji, Michiko; Hayashi, Makoto; Takeda, Noriyuki; Yasuda, Keigo			Association of hair dye use with circulating levels of sex hormones in premenopausal Japanese women	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							POSTMENOPAUSAL WOMEN; STEROID-HORMONES; CANCER; CARCINOGENICITY; TESTOSTERONE; NUTRITION; ALCOHOL; RISK; RATS	Background: Substances identified as animal carcinogens are no longer used as ingredients of hair dyes. However, hair dyes are diverse groups of chemicals, and certain compounds may affect endogenous sex hormone levels. We examined the association between hair dye use and sex hormone levels among premenopausal women. Methods: Study subjects were 431 premenopausal Japanese women who had regular menstrual cycles less than 40 days long. Information on the use of hair dyes or hair bleach, the type of hair coloring used, the duration of use and the frequency of application was collected using a self-administered questionnaire. Fasting plasma samples were obtained to measure estradiol, testosterone, dehydroepiandrosterone sulfate, sex hormone-binding globulin, follicle-stimulating hormone and luteinizing hormone. Results: After controlling for covariates, the mean plasma total testosterone level was about 14% higher in women who had used hair dyes for 10 or more years than that among women who had never used them (P for trend = 0.02). A similar association was observed when the type of hair dye was restricted to permanent hair dyes. A higher frequency of applying non-permanent hair dyes was marginally significantly associated with higher total and free estradiol levels. Conclusions: Data suggest that long-term use of hair dyes may be associated with an increase in circulating testosterone levels. As this is, to our knowledge, the first study examining the association between hair dye use and sex hormone levels, replication of the results is required.	[Nagata, Chisato; Wada, Keiko] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu 5011194, Japan; [Tsuji, Michiko] Japan Womens Univ, Dept Food & Nutr, Tokyo 112, Japan; [Hayashi, Makoto; Yasuda, Keigo] Matsunami Gen Hosp, Dept Internal Med, Gifu, Japan; [Takeda, Noriyuki] Asahi Univ, Murakami Mem Hosp, Dept Endocrinol & Metab, Gifu, Japan	Nagata, C (reprint author), Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, 1-1 Yanagido, Gifu 5011194, Japan.	chisato@gifu-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [221S0001]	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (No. 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ames BN, 1975, P NATL ACAD SCI USA, V72, P423; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Woolcock JG, 2008, FERTIL STERIL, V90, P2269, DOI 10.1016/j.fertnstert.2007.10.060; Schmidt L, 2013, ANAL BIOANAL CHEM, V405, P2019, DOI 10.1007/s00216-012-6618-y; Nettleship JE, 2007, HORM METAB RES, V39, P366, DOI 10.1055/s-2007-976543; Verkasalo PK, 2001, CANCER CAUSE CONTROL, V12, P47, DOI 10.1023/A:1008929714862; Nagata C, 2009, BRIT J NUTR, V101, P1427, DOI 10.1017/S0007114508083566; Baan R, 2008, LANCET ONCOL, V9, P322, DOI 10.1016/S1470-2045(08)70089-5; Wang HX, 2013, ANAL BIOANAL CHEM, V405, P4313, DOI 10.1007/s00216-013-6779-3; Han Y, 2010, SCI TOTAL ENVIRON, V408, P768, DOI 10.1016/j.scitotenv.2009.11.021; Yazar K, 2009, CONTACT DERMATITIS, V61, P269, DOI 10.1111/j.1600-0536.2009.01612.x; Takkouche B, 2005, JAMA-J AM MED ASSOC, V293, P2516, DOI 10.1001/jama.293.20.2516; Rinaldi S, 2006, CANCER CAUSE CONTROL, V17, P1033, DOI 10.1007/s10552-006-0041-7; Boberg J, 2010, REPROD TOXICOL, V30, P301, DOI 10.1016/j.reprotox.2010.03.011; Nagata C, 2011, CANCER CAUSE CONTROL, V22, P581, DOI 10.1007/s10552-011-9731-x; van Meeuwen JA, 2008, TOXICOL APPL PHARM, V230, P372, DOI 10.1016/j.taap.2008.03.002; WEISBURGER EK, 1980, CARCINOGENESIS, V1, P495, DOI 10.1093/carcin/1.6.495; McFadden JP, 2011, CLIN DERMATOL, V29, P316, DOI 10.1016/j.clindermatol.2010.11.011; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422; Tsuji M, 2012, CANCER CAUSE CONTROL, V23, P683, DOI 10.1007/s10552-012-9935-8; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; CARDY RH, 1979, J NATL CANCER I, V62, P1107; Endogenous H, 2013, LANCET ONCOL, V14, P1009, DOI [10.1016/S1470-2045(13)70301-2, DOI 10.1016/S1470-2045(13)70301-2]; International Agency For Research On Cancer (IARC), 2010, IARC MON EV CARC RIS, V99; Japan Soap and Detergent Association, 2002, JAPAN SOAP DETERGENT, V16, P3; Mileva Zh, 1988, Vutr Boles, V27, P29; Pardeshi SK, 2009, J HAZARD MATER, V163, P403, DOI 10.1016/j.jhazmat.2008.06.111; Yazar K, 2011, CONTACT DERMATITIS, V66, P27	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262	1464-360X		EUR J PUBLIC HEALTH	Eur. J. Public Health	OCT	2015	25	5					895	899		10.1093/eurpub/ckv020		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CT7DB	WOS:000362972700031		
J	Ishikawa, T; Abe, S; Kojima, Y; Horigome, R; Sano, T; Iwanaga, A; Seki, K; Honma, T; Yoshida, T				Ishikawa, Toru; Abe, Satoshi; Kojima, Yuichi; Horigome, Ryoko; Sano, Tomoe; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Yoshida, Toshiaki			Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						partial splenic arterial embolization; telaprevir-based triple therapy; thrombocytopenia	OVERWHELMING POSTSPLENECTOMY INFECTION; CHRONIC HCV INFECTION; LIVER-CIRRHOSIS; RIBAVIRIN; PEGINTERFERON; HYPERSPLENISM; SPLENECTOMY; RETREATMENT; INTERFERON; PLATELETS	Thrombocytopenia in patients with chronic hepatitis C negatively impacts interferon (IFN)-based treatment. The aim of this study was to evaluate the efficacy and safety of telaprevir (TVR)-based triple therapy including IFN for patients who have undergone partial splenic arterial embolization (PSE). Ten patients with thrombocytopenia who were infected with hepatitis C virus (HCV) genotype 1b received 12 weeks of TVR in combination with 24 weeks of pegylated interferon (PEG-IFN)alpha 2b and ribavirin following PSE. A sustained virological response (SVR) was seen in 9 of the 10 patients who could be assessed. Early relapse was seen in 1 patient who had the IL-28B minor allele and a null response to pretreatment. The a-fetoprotein levels of the patients decreased from 17.94 +/- 7.30 ng/ml prior to PSE to 4.33 +/- 2.41 ng/ml at 6 months after triple therapy (P=0.08). Furthermore, serum albumin, levels improved significantly from 3.68 +/- 0.49 g/dl pre-PSE to 4.13 +/- 0.34 g/dl at 12 months after triple therapy (P=0.043). PSE contributed to the treatment success of triple therapy, particularly for patients who were either treatment-naive, had a history of relapse or the IL28B major allele. This strategy can reduce carcinogenesis and improve hepatic function reserve.	[Ishikawa, Toru; Abe, Satoshi; Kojima, Yuichi; Horigome, Ryoko; Sano, Tomoe; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Yoshida, Toshiaki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan	Ishikawa, T (reprint author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan.	toruishi@ngt.saiseikai.or.jp					GOLDSTONE J, 1978, AM J SURG, V135, P385, DOI 10.1016/0002-9610(78)90071-5; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; ASTER RH, 1966, J CLIN INVEST, V45, P645, DOI 10.1172/JCI105380; Yoshida H, 2008, HEPATOL RES, V38, P225, DOI 10.1111/j.1872-034X.2007.00302.x; Amin MA, 2009, WORLD J SURG, V33, P1702, DOI 10.1007/s00268-009-0095-2; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176; Nagamine T, 1996, J HEPATOL, V24, P135, DOI 10.1016/S0168-8278(96)80021-3; Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Shimizu H, 2009, INTERNAL MED, V48, P747, DOI 10.2169/internalmedicine.48.1649; MADDISON FE, 1973, INVEST RADIOL, V8, P280, DOI 10.1097/00004424-197307000-00054; Ishikawa T, 1998, J GASTROEN HEPATOL, V13, P907, DOI 10.1111/j.1440-1746.1998.tb00760.x; Ikeda N, 2014, HEPATOL RES, V44, P829, DOI 10.1111/hepr.12184; Shiffman ML, 2007, GASTROENTEROLOGY, V132, P103, DOI 10.1053/j.gastro.2006.11.011; LINTON RR, 1947, SURG CLIN N AM, V27, P1162; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; AOKI Y, 1993, EUR J NUCL MED, V20, P123; Ogawa E, 2013, J HEPATOL, V59, P667, DOI 10.1016/j.jhep.2013.05.017; Tahara H, 2011, J GASTROENTEROL, V46, P1010, DOI 10.1007/s00535-011-0407-9; Waghorn DJ, 1997, J INFECTION, V35, P289, DOI 10.1016/S0163-4453(97)93232-1; SPIGOS DG, 1979, AM J ROENTGENOL, V132, P777; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Miyake Y, 2008, HEPATOL RES, V38, P980, DOI 10.1111/j.1872-034X.2008.00357.x; Hayashi H, 2007, J GASTROEN HEPATOL, V22, P1638, DOI 10.1111/j.1440-1746.2007.05090.x; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; Hanafiah M, 2013, BMJ CASE REP; Ishikawa T, 2014, HEPATOL RES, V44, P1056, DOI 10.1111/hepr.12222; Shimizu H, 2014, INTERNAL MED, V53, P925, DOI 10.2169/internalmedicine.53.1842	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	OCT	2015	10	4					1334	1338		10.3892/etm.2015.2674		5	Medicine, Research & Experimental	Research & Experimental Medicine	CT7MS	WOS:000362999400016		
J	Furukawa, S; Kuwajima, Y; Chosa, N; Satoh, K; Ohtsuka, M; Miura, H; Kimura, M; Inoko, H; Ishisaki, A; Fujimura, A; Miura, H				Furukawa, Shinji; Kuwajima, Yukinori; Chosa, Naoyuki; Satoh, Kazuro; Ohtsuka, Masato; Miura, Hiromi; Kimura, Minoru; Inoko, Hidetoshi; Ishisaki, Akira; Fujimura, Akira; Miura, Hiroyuki			Establishment of immortalized mesenchymal stem cells derived from the submandibular glands of tdTomato transgenic mice	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						tdTomato transgenic mice; submandibular gland; mesenchymal stem cells; osteogenic differentiation; adipogenic differentiation	HUMAN SALIVARY-GLANDS; QUALITY-OF-LIFE; BONE-MARROW; T-ANTIGEN; ECTODERMAL DYSPLASIAS; PANCREATIC LINEAGES; PROGENITOR CELLS; SJOGREN SYNDROME; STROMAL CELLS; TRANSPLANTATION	Transgenic mice that overexpress the red fluorescent protein tdTomato (tdTomato mice) are well suited for use in regenerative medicine studies. Cultured cells from this murine model exhibit strong red fluorescence, enabling real-time in vivo imaging through the body surface of grafted animals. Mesenchymal stem cells (MSCs) have marked potential for use in cell therapy and regenerative medicine; however, the mechanisms that regulate their dynamics in vivo are poorly understood. In the present study, an MSC line was derived from the submandibular gland fibroblasts of tdTomato mice. The fluorescent signal from this cell line was observed in organs throughout the body, as well as in salivary glands. Primary culture cells derived from the submandibular gland were immortalized with SV40 large T antigen (GManSV cells); these cells exhibited increased migratory ability, as compared with those isolated from the sublingual gland. GManSV cells were tdTomato-positive and exhibited spindle-shaped fibroblastic morphology; they also robustly expressed mouse MSC markers: Stem cell antigen-1 (Sca-1), CD44, and CD90. This cell line retained multipotent stem cell characteristics, as evidenced by its ability to differentiate into both osteogenic and adipogenic lineages. These results indicate that Sca-1(+)/CD44(+)/CD90(+)-GManSV cells may be useful for kinetic studies of submandibular gland-derived MSCs in the context of in vitro co-culture with other types of salivary gland-derived cells. These cells may also be used for in vivo imaging studies, in order to identify novel cell therapy and regenerative medicine for the treatment of salivary gland diseases.	[Furukawa, Shinji; Kuwajima, Yukinori; Satoh, Kazuro; Miura, Hiroyuki] Iwate Med Univ, Sch Dent, Dept Dev Oral Hlth Sci, Div Orthodont, Morioka, Iwate 0208505, Japan; [Chosa, Naoyuki; Ishisaki, Akira] Iwate Med Univ, Dept Biochem, Div Cellular Biosignal Sci, Yahaba, Iwate 0283694, Japan; [Ohtsuka, Masato; Miura, Hiromi; Kimura, Minoru; Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 2591193, Japan; [Fujimura, Akira] Iwate Med Univ, Dept Anat, Div Funct Morphol, Yahaba, Iwate 0283694, Japan	Chosa, N (reprint author), Iwate Med Univ, Dept Biochem, Div Cellular Biosignal Sci, 2-1-1 Nshitokuta, Yahaba, Iwate 0283694, Japan.	nchosa@iwate-med.ac.jp			JSPS KAKENHI [25463053, 23592896]; Ministry of Education, Culture, Sports, Science and Technology of Japan	The present study was supported in part by JSPS KAKENHI (grant no. 25463053 to Dr Naoyuki Chosa and grant no. 23592896 to Professor Akira Ishisaki); and a Grant-in-aid for Strategic Medical Science Research Centre from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2014.	Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Kawakami M, 2013, HUM CELL, V26, P80, DOI 10.1007/s13577-013-0061-z; Sato A, 2007, CLONING STEM CELLS, V9, P191, DOI 10.1089/clo.2006.0054; Rotter N, 2008, STEM CELLS DEV, V17, P509, DOI 10.1089/scd.2007.0180; Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Carpenter GH, 2010, FRONT ORAL BIOL, V14, P107, DOI 10.1159/000313710; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Ohtsuka M, 2012, CELL TISSUE RES, V350, P251, DOI 10.1007/s00441-012-1470-0; KAHN P, 1983, VIROLOGY, V126, P348, DOI 10.1016/0042-6822(83)90484-1; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Taichman RS, 2010, STEM CELLS DEV, V19, P1557, DOI 10.1089/scd.2009.0445; KAWAMOTO T, 1990, J HISTOCHEM CYTOCHEM, V38, P1805; Nordgarden H, 2003, EUR J ORAL SCI, V111, P371, DOI 10.1034/j.1600-0722.2003.00058.x; Hisatomi Y, 2004, HEPATOLOGY, V39, P667, DOI 10.1002/hep.20063; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Clauss F, 2008, J DENT RES, V87, P1089; Xu JJ, 2012, BLOOD, V120, P3142, DOI 10.1182/blood-2011-11-391144; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Weigert R, 2013, J CELL BIOL, V201, P969, DOI 10.1083/jcb.201212130; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Maria OM, 2012, ORAL DIS, V18, P162, DOI 10.1111/j.1601-0825.2011.01858.x; Okumura K, 2003, HEPATOLOGY, V38, P104, DOI 10.1053/jhep.2003.50259; Lim JY, 2015, TISSUE ENG PART C-ME, V21, P447, DOI [10.1089/ten.TEC.2014.0204, 10.1089/ten.tec.2014.0204]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Scott J, 1999, J DENT RES, V78, P1711; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; HOWELL N, 1982, CYTOGENET CELL GENET, V34, P215, DOI 10.1159/000131809; Nelson J, 2013, ORAL DIS, V19, P236, DOI 10.1111/j.1601-0825.2012.01958.x; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Pillemer SR, 2001, MAYO CLIN PROC, V76, P593; Matsumoto S, 2007, CLONING STEM CELLS, V9, P176, DOI 10.1089/clo.2006.0022; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939093; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Berk L, 2008, EXPERT OPIN DRUG MET, V4, P1333, DOI [10.1517/17425255.4.10.1333 , 10.1517/17425250802404841]; Arlt VM, 2007, CARCINOGENESIS, V28, P2253, DOI 10.1093/carcin/bgm082; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; Chen XD, 1999, J BONE MINER RES, V14, P362, DOI 10.1359/jbmr.1999.14.3.362; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI [10.1016/j.biocel.2010.09.023, 10.1016/j.bioce1.2010.09.023]; GEE CJ, 1979, J CELL SCI, V36, P223; Aomatsu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03652; FRIEDENS.AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Holsinger FC, 2007, SALIVARY GLANDS DISO, V1, P1; Jeong J, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.121; Khalili S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038615; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112158; Sohni A., 2013, STEM CELLS INT, V2013; Thomson WM, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-86	56	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	OCT	2015	10	4					1380	1386		10.3892/etm.2015.2700		7	Medicine, Research & Experimental	Research & Experimental Medicine	CT7MS	WOS:000362999400022		
J	Tomizawa, M; Shinozaki, F; Fugo, K; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Kishimoto, T; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Fugo, Kazunori; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Kishimoto, Takashi; Ishige, Naoki			Anti-mitochondrial M2 antibody-positive autoimmune hepatitis	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						primary biliary cirrhosis; anti-nuclear antibody; anti-mitochondrial antibody; receiver operator characteristics; logistic regression model	PRIMARY BILIARY-CIRRHOSIS; CLINICAL-SIGNIFICANCE; SCORING SYSTEM; AUTOANTIBODIES; DIAGNOSIS; PROGNOSIS; PROGRESS; EPITOPE	Anti-mitochondrial M2 antibody (AMA-M2) is specific to primary biliary cirrhosis (PBC), but can also be found in certain patients with autoimmune hepatitis (AIH). Effective methods of differentiating between PBC and AIH are required, as their clinical course and management are different. Titers of AMA-M2 were analyzed before and after follow-up in patients with PBC or AIH. Patients who underwent liver biopsy and were diagnosed with either AIH (10 patients) or PBC (3 patients) were enrolled in the study. The AMA-M2 antibody titers of these patients were analyzed upon hospital admission. AMA-M2 reacted with the pyruvate dehydrogenase complex-E2, branched-chain 2-oxo acid dehydrogenase complex and 2-oxoglutaric acid dehydrogenase complex in the assay utilized for this study. The cut-off value for AMA-M2 was 5. Six AIH patients were AMA-M2(-) and 4 were AMA-M2(+). The titer for the AIH patients who were AMA-M2(+) was 24.8 +/- 14.8, compared with 324 174 in the patients with PBC (P=0.0138). Three AMA-M2(+) AIH patients were followed-up after liver biopsy. The AMA-M2 levels had decreased in all 3 patients, becoming undetectable in 2 of them. In conclusion, certain patients with AIH in this study were found to be AMA-M2(+), but the titers were significantly lower than those in the patients with PBC. At follow-up, the AIH patients exhibited decreased AMA-M2 titers.	[Tomizawa, Minoru] Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, Yotsukaido, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Natl Hosp Org, Dept Radiol, Yotsukaido, Chiba 2840003, Japan; [Fugo, Kazunori; Kishimoto, Takashi] Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba, Chiba 2608670, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Natl Hosp Org, Dept Neurol, Yotsukaido, Chiba 2840003, Japan; [Sugiyama, Takao] Shimoshizu Hosp, Natl Hosp Org, Dept Rheumatol, Yotsukaido, Chiba 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Natl Hosp Org, Dept Pediat, Yotsukaido, Chiba 2840003, Japan; [Ishige, Naoki] Shimoshizu Hosp, Natl Hosp Org, Dept Neurosurg, Yotsukaido, Chiba 2840003, Japan	Tomizawa, M (reprint author), Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp					Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Suzuki A, 2011, HEPATOLOGY, V54, P931, DOI 10.1002/hep.24481; Oketani M, 2013, HEPATOL RES, V43, P97, DOI 10.1111/j.1872-034X.2012.01105.x; Kakuda Y, 2013, HUM PATHOL, V44, P1107, DOI 10.1016/j.humpath.2012.09.017; Liberal R, 2013, J AUTOIMMUN, V41, P126, DOI 10.1016/j.jaut.2012.11.002; Roda A, 2000, FRESEN J ANAL CHEM, V366, P752, DOI 10.1007/s002160051569; Liberal R, 2013, J AUTOIMMUN, V46, P17, DOI 10.1016/j.jaut.2013.08.001; LEUNG PSC, 1995, HEPATOLOGY, V22, P505, DOI 10.1016/0270-9139(95)90572-3; Bowlus CL, 2014, AUTOIMMUN REV, V13, P441, DOI 10.1016/j.autrev.2014.01.041; Czaja AJ, 2013, DIGEST DIS SCI, V58, P897, DOI 10.1007/s10620-012-2445-4; CZAJA AJ, 1993, GASTROENTEROLOGY, V104, P1755; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Chantran Y, 2013, CLIN RES HEPATOL GAS, V37, P431, DOI 10.1016/j.clinre.2013.05.002; O'Brien C, 2008, HEPATOLOGY, V48, P550, DOI 10.1002/hep.22380; Verslype C, 2005, ALIMENT PHARM THERAP, V21, P695, DOI 10.1111/j.1365-2036.2005.02403.x; Farias AQ, 2006, J GASTROEN HEPATOL, V21, P887, DOI 10.1111/1440-1746.2006.04130.x; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Moteki S, 1996, HEPATOLOGY, V23, P436; Yamamoto K, 2003, J GASTROENTEROL, V38, P52, DOI 10.1007/s005350300006; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Miyakawa H, 2000, HEPATOL RES, V18, P1, DOI 10.1016/S1386-6346(99)00079-0; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Yamagiwa S, 2014, WORLD J GASTROENTERO, V20, P2606, DOI 10.3748/wjg.v20.i10.2606; Yanagawa T, 2003, HEPATOL RES, V26, P81, DOI 10.1016/S1386-6346(03)00014-7; Montano-Loza AJ, 2008, AM J GASTROENTEROL, V103, P1944, DOI 10.1111/j.1572-0241.2008.01922.x; Dellavance A, 2012, HEPATOL INT, V7, P775; Gershwin M E, 1992, Prog Liver Dis, V10, P47; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	OCT	2015	10	4					1419	1422		10.3892/etm.2015.2694		4	Medicine, Research & Experimental	Research & Experimental Medicine	CT7MS	WOS:000362999400028		
J	Nakamura, M; Haarmann-Stemmann, T; Krutmann, J				Nakamura, Motoki; Haarmann-Stemmann, Thomas; Krutmann, Jean			COX inhibition enhances inflammatory immune cell infiltration in UV-irradiated human skin: implications for the treatment of sunburn	EXPERIMENTAL DERMATOLOGY			English	Editorial Material						cyclooxygenase; lipoxygenase; non-steroidal anti-inflammatory drug; sunburn; ultraviolet radiation			[Nakamura, Motoki; Haarmann-Stemmann, Thomas; Krutmann, Jean] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Nakamura, Motoki] Nagoya City Univ, Dept Environm & Geriatr Dermatol, Nagoya, Aichi, Japan; [Krutmann, Jean] Univ Dusseldorf, Fac Med, Dusseldorf, Germany	Krutmann, J (reprint author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	jean.krutmann@iuf-duesseldorf.de					Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; BLACK AK, 1978, BRIT J CLIN PHARMACO, V5, P431; Rhodes LE, 2001, J INVEST DERMATOL, V117, P880, DOI 10.1046/j.0022-202x.2001.01514.x; Krutmann J, 2012, J INVEST DERMATOL, V132, P976, DOI 10.1038/jid.2011.394; Gresham A, 1996, AM J PHYSIOL-CELL PH, V270, pC1037; GILCHREST BA, 1981, J AM ACAD DERMATOL, V5, P411, DOI 10.1016/S0190-9622(81)70103-8; CUNNINGHAM FM, 1987, PROSTAGLANDINS, V34, P71, DOI 10.1016/0090-6980(87)90264-4; Pilkington SM, 2015, EXP DERMATOL, V24, P790, DOI 10.1111/exd.12734; Rossaint J, 2012, CRIT CARE, V16, DOI 10.1186/cc11518	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					734	735		10.1111/exd.12783		2	Dermatology	Dermatology	CT8FG	WOS:000363049800004		
J	Thandavarayan, RA; Garikipati, VNS; Joladarashi, D; Babu, SS; Jeyabal, P; Verma, SK; Mackie, AR; Khan, M; Arumugam, S; Watanabe, K; Kishore, R; Krishnamurthy, P				Thandavarayan, Rajarajan A.; Garikipati, Venkata Naga Srikanth; Joladarashi, Darukeshwara; Babu, Sahana Suresh; Jeyabal, Prince; Verma, Suresh K.; Mackie, Alexander R.; Khan, Mohsin; Arumugam, Somasundaram; Watanabe, Kenichi; Kishore, Raj; Krishnamurthy, Prasanna			Sirtuin-6 deficiency exacerbates diabetes-induced impairment of wound healing	EXPERIMENTAL DERMATOLOGY			English	Article						angiogenesis; diabetes; inflammation; sirtuin 6; wound healing	HISTONE DEACETYLASE SIRT6; LOWER-EXTREMITY ULCERS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; 14-3-3 PROTEIN; GROWTH-FACTOR; MICE; CARDIOMYOPATHY; DYSFUNCTION	Delayed wound healing is one of the major complications in diabetes and is characterized by chronic proinflammatory response, and abnormalities in angiogenesis and collagen deposition. Sirtuin family proteins regulate numerous pathophysiological processes, including those involved in promotion of longevity, DNA repair, glycolysis and inflammation. However, the role of sirtuin 6 (SIRT6), a NAD+-dependent nuclear deacetylase, in wound healing specifically under diabetic condition remains unclear. To analyse the role of SIRT6 in cutaneous wound healing, paired 6-mm stented wound was created in diabetic db/db mice and injected siRNA against SIRT6 in the wound margins (transfection agent alone and nonsense siRNA served as controls). Wound time to closure was assessed by digital planimetry, and wounds were harvested for histology, immunohistochemistry and Western blotting. SIRT6-siRNA-treated diabetic wound showed impaired healing, which was associated with reduced capillary density (CD31-staining vessels) when compared to control treatment. Interestingly, SIRT6 deficiency decreased vascular endothelial growth factor expression and proliferation markers in the wounds. Furthermore, SIRT6 ablation in diabetic wound promotes nuclear factor-kappa B (NF-kappa B) activation resulting in increased expression of proinflammatory markers (intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumor necrosis factor-alpha and interleukin-1 beta) and increased oxidative stress. Collectively, our findings demonstrate that loss of SIRT6 in cutaneous wound aggravates proinflammatory response by increasing NF-kappa B activation, oxidative stress and decrease in angiogenesis in the diabetic mice. Based on these findings, we speculate that the activation of SIRT6 signalling might be a potential therapeutic approach for promoting wound healing in diabetics.	[Thandavarayan, Rajarajan A.; Joladarashi, Darukeshwara; Babu, Sahana Suresh; Jeyabal, Prince; Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Ctr Cardiovasc Regenerat, Houston, TX 77030 USA; [Garikipati, Venkata Naga Srikanth; Verma, Suresh K.; Khan, Mohsin; Kishore, Raj] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Mackie, Alexander R.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Niigata, Japan; [Krishnamurthy, Prasanna] Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, Cell & Dev Biol, New York, NY 10021 USA	Krishnamurthy, P (reprint author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.	pkrishnamurthy@houstonmethodist.org			National Institutes of Health (NIH) [1R01HL116729, HL091983, HL053354, HL108795, HL108806]; American Heart Association National-The Davee Foundation SDG Grant [0530350N]; AHA post-doctoral fellowship [15POST25710392, 15POST22720022]	This work was supported, in part, by the National Institutes of Health (NIH) grants 1R01HL116729 (to P.K.), HL091983, HL053354, HL108795 and HL108806 (to R.K.); American Heart Association National-The Davee Foundation SDG Grant 0530350N (to P.K.), AHA post-doctoral fellowship 15POST25710392 (to R.A.T) and 15POST22720022 (V.N.S.G).	Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Watanabe K, 2009, ACTA PHYSIOL HUNG, V96, P277, DOI 10.1556/APhysiol.96.2009.3.3; Thandavarayan RA, 2008, BIOCHEM PHARMACOL, V75, P1797, DOI 10.1016/j.bcp.2008.02.003; Chan JCN, 2014, DIABETES RES CLIN PR, V103, P244, DOI 10.1016/j.diabres.2013.11.012; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Balestrieri ML, 2015, DIABETES, V64, P1395, DOI 10.2337/db14-1149; Bitar MS, 1996, J SURG RES, V61, P113, DOI 10.1006/jsre.1996.0090; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Etchegaray JP, 2013, CURR TOP MED CHEM, V13, P2991; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Tie L, 2009, AM J PHYSIOL-ENDOC M, V296, pE1423, DOI 10.1152/ajpendo.00150.2009; Hansen SL, 2003, AM J PATHOL, V163, P2421, DOI 10.1016/S0002-9440(10)63597-3; Thanik VD, 2007, GENE THER, V14, P1305, DOI 10.1038/sj.gt.3302986; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Niebuhr M, 2008, EXP DERMATOL, V17, P1052, DOI 10.1111/j.1600-0625.2008.00750.x; Thandavarayan Rajarajan A., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P225; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Dasu MR, 2010, LAB INVEST, V90, P1628, DOI 10.1038/labinvest.2010.158; Lan CCE, 2013, DIABETES, V62, P2530, DOI 10.2337/db12-1714; Harrington C, 2000, DIABETES CARE, V23, P1333, DOI 10.2337/diacare.23.9.1333; Xu JW, 2012, DIABETES, V61, P2906, DOI 10.2337/db12-0145; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Diegelmann RF, 2004, FRONT BIOSCI, V9, P283, DOI 10.2741/1184; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Thandavarayan RA, 2011, CELL PHYSIOL BIOCHEM, V28, P911, DOI 10.1159/000335805; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Etchegaray JP, 2015, NAT CELL BIOL, V17, P545, DOI 10.1038/ncb3147; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen Y, 2015, BIOMED RES INT, V2015; Lee Y H, 2012, EXP DIABETES RES, V2012, DOI [DOI 10.1155/2012/504693, 10.1155/2012/504693]; Lin YT, 2015, J INVEST DERMATOL, V135, P258, DOI 10.1038/jid.2014.288; Sreedhar R, 2015, CELL SIGNAL, V27, P770, DOI 10.1016/j.cellsig.2014.12.021; Watanabe Kenichi, 2010, Curr Cardiol Rev, V6, P280, DOI 10.2174/157340310793566145; Yu SS, 2013, BRIT J PHARMACOL, V168, P117, DOI 10.1111/j.1476-5381.2012.01903.x; YUE DK, 1986, DIABETIC MED, V3, P221	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					773	778		10.1111/exd.12762		6	Dermatology	Dermatology	CT8FG	WOS:000363049800013		
J	Yokoyama, S; Hiramoto, K; Koyama, M; Ooi, K				Yokoyama, Satoshi; Hiramoto, Keiichi; Koyama, Mayu; Ooi, Kazuya			Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model	EXPERIMENTAL DERMATOLOGY			English	Article						acetylcholine receptor; colitis; mast cell; skin hydration; transepidermal water loss	INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; MAST-CELL ACTIVATION; ATOPIC-DERMATITIS; NITRIC-OXIDE; INTESTINAL INFLAMMATION; STRATUM-CORNEUM; CROHNS-DISEASE; FACTOR TNF; MICE	Dry skin has been clinically associated with visceral diseases, including liver disease, as well as for our previously reported small intestinal injury mouse model, which have abnormalities in skin barrier function. To clarify this disease-induced skin disruption, we used a dextran sulphate sodium (DSS)-induced colitis mouse model. Following treatment with DSS, damage to the colon and skin was monitored using histological and protein analysis methods as well as the detection of inflammatory mediators in the plasma. Notably, transepidermal water loss was higher, and skin hydration was lower in DSS-treated mice compared to controls. Tumor necrosis factor-alpha (TNF-alpha), interleukin 6 and NO2-/NO3- levels were also upregulated in the plasma, and a decrease in body weight and colon length was observed in DSS-treated mice. However, when administered TNF-alpha antibody or an iNOS inhibitor, no change in skin condition was observed, indicating that another signalling mechanism is utilized. Interestingly, the number of tryptase-expressing mast cells, known for their role in immune function via cholinergic signal transduction, was elevated. To evaluate the function of cholinergic signalling in this context, atropine (a muscarinic cholinoceptor antagonist) or hexamethonium (a nicotinic cholinergic ganglion-blocking agent) was administered to DSS-treated mice. Our data indicate that muscarinic acetylcholine receptors (mAChRs) are the primary receptors functioning in colon-to-skin signal transduction, as DSS-induced skin disruption was suppressed by atropine. Thus, skin disruption is likely associated with DSS-induced colitis, and the activation of mast cells via mAChRs is critical to this association.	[Yokoyama, Satoshi; Hiramoto, Keiichi; Koyama, Mayu; Ooi, Kazuya] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan	Ooi, K (reprint author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, Minami Tamagakicho 3500-3, Suzuka, Mie, Japan.	zooi@suzuka-u.ac.jp					Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Radosa J, 2011, EXP DERMATOL, V20, P677, DOI 10.1111/j.1600-0625.2011.01283.x; Sakai S, 2005, BRIT J DERMATOL, V153, P319, DOI 10.1111/j.1365-2133.2005.06756.x; Wulff BC, 2013, EXP DERMATOL, V22, P507, DOI 10.1111/exd.12169; Koarai A, 2012, EUR RESPIR J, V39, P698, DOI 10.1183/09031936.00136710; BLANDINA P, 1980, J PHYSIOL-LONDON, V301, P281; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455; Mori L, 1996, J IMMUNOL, V157, P3178; Orita K, 2011, EXP DERMATOL, V20, P911, DOI 10.1111/j.1600-0625.2011.01360.x; Nishimura T, 2010, J CLIN BIOCHEM NUTR, V46, P105, DOI 10.3164/jcbn.09-72; BAREL AO, 1995, SKIN PHARMACOL, V8, P186; Kondo S, 1997, EUR J IMMUNOL, V27, P1713, DOI 10.1002/eji.1830270718; Niederau C, 2008, LIVER INT, V28, P659, DOI 10.1111/j.1478-3231.2008.01694.x; Imai A, 2001, EUR J PHARMACOL, V423, P63, DOI 10.1016/S0014-2999(01)01042-1; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Buchli R, 1999, J CELL BIOCHEM, V74, P264, DOI 10.1002/(SICI)1097-4644(19990801)74:2<264::AID-JCB11>3.0.CO;2-Z; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Murthy SK, 2011, AM J GASTROENTEROL, V106, P713, DOI 10.1038/ajg.2011.53; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Taniuchi S, 2001, ALLERGY, V56, P693, DOI 10.1034/j.1398-9995.2001.00131.x; Ormerod AD, 1998, ARCH DERMATOL RES, V290, P3, DOI 10.1007/s004030050268; Yokoyama S, 2014, EXP DERMATOL, V23, P659, DOI 10.1111/exd.12499; Kim DW, 2006, INT J DERMATOL, V45, P698, DOI 10.1111/j.1365-4632.2005.02644.x; Tanaka S, 2010, EXPERT OPIN THER TAR, V14, P31, DOI 10.1517/14728220903473186; Reimund JM, 1996, GUT, V39, P684, DOI 10.1136/gut.39.5.684; Schottelius AJG, 2004, EXP DERMATOL, V13, P193, DOI 10.1111/j.0906-6705.2004.00205.x; Twig G, 2005, ANN NY ACAD SCI, V1051, P166, DOI 10.1196/annals.1361.058; Park TH, 1995, NEPHROL DIAL TRANSPL, V10, P2269; CUMMINGS JH, 1975, GUT, V16, P323, DOI 10.1136/gut.16.4.323; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; Ito T, 2012, J IMMUNOL, V188, P5428, DOI 10.4049/jimmunol.1103366; Berardesca E, 1997, SKIN RES TECHNOL, V3, P126, DOI 10.1111/j.1600-0846.1997.tb00174.x; Fakhoury M, 2014, J INFLAMM RES, V23, P113; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Norman Robert A, 2003, Dermatol Ther, V16, P254, DOI 10.1046/j.1529-8019.2003.01635.x; Schreiber O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071843; Tagami Hachiro, 2006, J Cosmet Dermatol, V5, P140, DOI 10.1111/j.1473-2165.2006.00241.x; Williams Horace, 2008, Curr Gastroenterol Rep, V10, P597, DOI 10.1007/s11894-008-0108-6	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					779	784		10.1111/exd.12775		6	Dermatology	Dermatology	CT8FG	WOS:000363049800014		
J	Matsuda, M; Hamada, T; Numata, S; Teye, K; Ishii, N; Ohata, C; Furumura, M; Nakama, T; Hashimoto, T				Matsuda, Mitsuhiro; Hamada, Takahiro; Numata, Sanae; Teye, Kwesi; Ishii, Norito; Ohata, Chika; Furumura, Minao; Nakama, Takekuni; Hashimoto, Takashi			A three-dimensional in vitro culture model of Hailey-Hailey disease	EXPERIMENTAL DERMATOLOGY			English	Article						ATP2C1; Hailey-Hailey disease; SPCA1; 3D culture	ATP2C1 GENE; KERATINOCYTES; MUTATIONS; SPCA1		[Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants; Ministry of Health, Labour and Welfare of Japan	We gratefully appreciate the technical assistance of Ms. Ayumi Suzuki, and Ms. Sachiko Sakaguchi, and the secretarial work of Ms. Tomoko Tashima and Ms. Mami Nishida. This study was supported by Grants-in-Aid for Scientific Research and Strategic Research Basis Formation Supporting Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Health and Labour Sciences Research Grants and the grants for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan.	Hakuno M, 2000, BRIT J DERMATOL, V142, P702, DOI 10.1046/j.1365-2133.2000.03415.x; Matsuda M, 2014, EXP DERMATOL, V23, P514, DOI 10.1111/exd.12410; Bernards M, 2000, J INVEST DERMATOL, V114, P1058, DOI 10.1046/j.1523-1747.2000.00960-2.x; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Ikebe D, 2007, GENES CELLS, V12, P197, DOI 10.1111/j.1365-2443.2007.001043.x; Raiko L, 2012, EXP DERMATOL, V21, P586, DOI 10.1111/j.1600-0625.2012.01520.x; Cooley JE, 1996, J INVEST DERMATOL, V107, P877, DOI 10.1111/1523-1747.ep12331167; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Dobson-Stone C, 2002, J INVEST DERMATOL, V118, P338, DOI 10.1046/j.0022-202x.2001.01675.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					788	789		10.1111/exd.12777		2	Dermatology	Dermatology	CT8FG	WOS:000363049800016		
J	Fukuda, Y; Sone, T; Sakuraba, H; Araki, T; Ohshima, T; Shibata, T; Yoneda, K				Fukuda, Yudai; Sone, Takeki; Sakuraba, Haruhiko; Araki, Tomohiro; Ohshima, Toshihisa; Shibata, Takeshi; Yoneda, Kazunari			A novel NAD(P)H-dependent carbonyl reductase specifically expressed in the thyroidectomized chicken fatty liver: catalytic properties and crystal structure	FEBS JOURNAL			English	Article						crystal structure; enzyme kinetics; NAD(P)H-dependent carbonyl reductase; short-chain dehydrogenase; reductase family; thyroidectomized chicken fatty liver	PROTEIN; HYPOTHYROIDISM; DEHYDROGENASE; HYPERTHYRODISM; LIPOPROTEIN; BINDING; FAMILY	A gene encoding a functionally unknown protein that is specifically expressed in the thyroidectomized chicken fatty liver and has a predicted amino acid sequence similar to that of NAD(P)H-dependent carbonyl reductase was overexpressed in Escherichiacoli; its product was purified and characterized. The expressed enzyme was an NAD(P)H-dependent broad substrate specificity carbonyl reductase and was inhibited by arachidonic acid at 1.5m. Enzymological characterization indicated that the enzyme could be classified as a cytosolic-type carbonyl reductase. The enzyme's 3D structure was determined using the molecular replacement method at 1.98 angstrom resolution in the presence of NADPH and ethylene glycol. The asymmetric unit consisted of two subunits, and a noncrystallographic twofold axis generated the functional dimer. The structures of the subunits, A and B, differed from each other. In subunitA, the active site contained an ethylene glycol molecule absent in subunitB. Consequently, Tyr172 in subunitA rotated by 103.7 degrees in comparison with subunitB, which leads to active site closure in subunitA. In Y172A mutant, the K-m value for 9,10-phenanthrenequinone (model substrate) was 12.5times higher than that for the wild-type enzyme, indicating that Tyr172 plays a key role in substrate binding in this carbonyl reductase. Because the Tyr172-containing active site lid structure (Ile164-Gln174) is not conserved in all known carbonyl reductases, our results provide new insights into substrate binding of carbonyl reductase. The catalytic properties and crystal structure revealed that thyroidectomized chicken fatty liver carbonyl reductase is a novel enzyme.	[Fukuda, Yudai; Sone, Takeki; Araki, Tomohiro; Yoneda, Kazunari] Tokai Univ, Dept Biosci, Kumamoto 8691404, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Dept Appl Biol Sci, Kagawa, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan; [Shibata, Takeshi] Tokai Univ, Dept Anim Sci, Kumamoto 8691404, Japan	Yoneda, K (reprint author), Tokai Univ, Sch Agr, Dept Biosci, Kumamoto 8691404, Japan.	kyoneda@agri.u-tokai.ac.jp			Tokai University Educational System	We are grateful to the staff of the Photon Factory for their assistance with data collection, which was approved by the Photon Factory Program Advisory Committee (Proposal no. 2014G502). This study was supported in part by the Tokai University Educational System (to KY) and a grant for Young Scientists (B) (to KY).	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Yoneda K, 2012, ACTA CRYSTALLOGR F, V68, P1568, DOI 10.1107/S1744309112046453; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Imamura Y, 1999, BIOL PHARM BULL, V22, P731; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Tanaka N, 2008, STRUCTURE, V16, P388, DOI 10.1016/j.str.2007.12.022; LAKER ME, 1981, BIOCHEM J, V196, P247; MOORE GE, 1984, GEN COMP ENDOCR, V55, P195, DOI 10.1016/0016-6480(84)90101-1; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Shibata T, 2003, POULTRY SCI, V82, P207; NISHINAKA T, 1992, ENZYME, V46, P221; NAKANISHI M, 1995, EUR J BIOCHEM, V228, P381, DOI 10.1111/j.1432-1033.1995.tb20274.x; Nakanishi M, 1997, ADV EXP MED BIOL, V414, P555; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; KING DB, 1976, GEN COMP ENDOCR, V29, P473, DOI 10.1016/0016-6480(76)90030-7; Sgraja T, 2004, J MOL BIOL, V342, P1613, DOI 10.1016/j.jmb.2004.08.020; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; SCOTTOLINI AG, 1980, CLIN CHEM, V26, P584; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; OHSHIMA T, 1978, J BIOL CHEM, V253, P5719; BENNER SA, 1982, EXPERIENTIA, V38, P633, DOI 10.1007/BF02327092; LITHELL H, 1981, EUR J CLIN INVEST, V11, P3, DOI 10.1111/j.1365-2362.1981.tb01758.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikki Takahiro, 1994, Japanese Poultry Science, V31, P262; NIKKI T, 1989, Proceedings of School of Agriculture Kyushu Tokai University, V8, P47; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAHEJA K L, 1970, Comparative Biochemistry and Physiology, V37, P555; Sturkie PD, 1976, AVIAN PHYSL, V3, P348; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Wermuth B, 1985, ENZYMOLOGY CARBONYL, V2, P209	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					3918	3928		10.1111/febs.13385		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200005		
J	Uda, N; Matoba, Y; Oda, K; Kumagai, T; Sugiyama, M				Uda, Narutoshi; Matoba, Yasuyuki; Oda, Kosuke; Kumagai, Takanori; Sugiyama, Masanori			The structural and mutational analyses of O-ureido-l-serine synthase necessary for d-cycloserine biosynthesis	FEBS JOURNAL			English	Article						antibiotic; biosynthesis; crystal structure; d-cycloserine; Streptomyceslavendulae	ALANYL-D-ALANINE; ACETYLSERINE SULFHYDRYLASE; CYSTEINE SYNTHASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCES-GARYPHALUS; SALMONELLA-TYPHIMURIUM; ENZYMATIC-SYNTHESIS; AMINO-ACIDS; CRYSTAL-STRUCTURES	We have recently been successful in cloning a gene cluster necessary for the biosynthesis of d-cycloserine (d-CS) from d-CS-producing StreptomyceslavendulaeATCC11924. Although dcsD, one of the ORFs located on the gene cluster, encodes a protein homologous to O-acetylserine sulfhydrylase that synthesizes l-cysteine using O-acetyl-l-serine together with sulfide, it functions to form O-ureido-l-serine as a d-CS biosynthetic intermediate, using O-acetyl-l-serine together with hydroxyurea (HU). In the present study, using crystallographic and mutational studies, three amino acid residues in DcsD that are important for the substrate preference toward HU were determined. We showed that two of the three residues are important for the binding of HU into the substrate-binding pocket. The other residue contributes to the formation of a loose hydrogen-bond network during the catalytic reaction. Information regarding the amino acid residues will be very useful in the design of a new catalyst for synthesizing the -substituted-l-alanine derivatives.	[Uda, Narutoshi; Matoba, Yasuyuki; Oda, Kosuke; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed & Hlth Sci, Hiroshima 7348551, Japan	Sugiyama, M (reprint author), Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed & Hlth Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp			Japan Aerospace Exploration Agency (JAXA); Japan Society for the Promotion of Science [15K07997]; Institute for Fermentation, Osaka (IFO); Novozymes, Japan	DNA sequence determination was carried out at the Analysis Center of Life Science, Hiroshima University. We are grateful to the beamline staff at SPring-8, Japan, for their kind help with the X-ray data collection. We also thank the Japan Aerospace Exploration Agency (JAXA) for the crystallographic experiment and for financial support. This study was supported by a Grant-in-Aid for Scientific Research (15K07997 to YM) from the Japan Society for the Promotion of Science and by research funds from the Institute for Fermentation, Osaka (IFO) and Novozymes, Japan, given to YM.	LAMBERT MP, 1972, J BACTERIOL, V110, P978; Matsuo H, 2003, J ANTIBIOT, V56, P762; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; WEAVER JD, 1974, J MED CHEM, V17, P1033, DOI 10.1021/jm00255a034; Kumagai T, 2012, ANTIMICROB AGENTS CH, V56, P3682, DOI 10.1128/AAC.00614-12; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Drauz K, 1997, CHIMIA, V51, P310; SVENSSON ML, 1982, ARCH MICROBIOL, V131, P129, DOI 10.1007/BF01053994; IKEGAMI F, 1990, PHYTOCHEMISTRY, V29, P3461, DOI 10.1016/0031-9422(90)85258-H; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; Maier THP, 2003, NAT BIOTECHNOL, V21, P422, DOI 10.1038/nbt807; IKEGAMI F, 1988, PHYTOCHEMISTRY, V27, P3379, DOI 10.1016/0031-9422(88)80735-0; Mozzarelli A, 2011, BBA-PROTEINS PROTEOM, V1814, P1497, DOI 10.1016/j.bbapap.2011.04.011; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; COOK PF, 1992, BIOCHEMISTRY-US, V31, P2298, DOI 10.1021/bi00123a013; Heine A, 2004, PROTEINS, V56, P387, DOI 10.1002/prot.20003; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; SVENSSON ML, 1981, ARCH MICROBIOL, V129, P210, DOI 10.1007/BF00425252; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; HERBERG LJ, 1990, PHARMACOL BIOCHEM BE, V36, P735, DOI 10.1016/0091-3057(90)90069-T; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; IKEGAMI F, 1993, PHYTOCHEMISTRY, V32, P31, DOI 10.1016/0031-9422(92)80101-J; Zocher G, 2007, FEBS J, V274, P5382, DOI 10.1111/j.1742-4658.2007.06063.x; IKEGAMI F, 1988, PHYTOCHEMISTRY, V27, P697, DOI 10.1016/0031-9422(88)84078-0; Goff DC, 1999, ARCH GEN PSYCHIAT, V56, P21, DOI 10.1001/archpsyc.56.1.21; IKEGAMI F, 1992, PHYTOCHEMISTRY, V31, P1991, DOI 10.1016/0031-9422(92)80347-H; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; STAMMER CH, 1962, J ORG CHEM, V27, P2957, DOI 10.1021/jo01055a530; HIDY PH, 1955, J AM CHEM SOC, V77, P2345, DOI 10.1021/ja01613a106; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; Bruning JB, 2011, ANTIMICROB AGENTS CH, V55, P291, DOI 10.1128/AAC.00558-10; NEUHAUS FC, 1964, BIOCHEMISTRY-US, V3, P471, DOI 10.1021/bi00892a001; Noda M, 2004, J BIOL CHEM, V279, P46143, DOI 10.1074/jbc.M404603200; Uda N, 2013, ANTIMICROB AGENTS CH, V57, P2603, DOI 10.1128/AAC.02291-12; ASWAD DW, 1984, ANAL BIOCHEM, V137, P405, DOI 10.1016/0003-2697(84)90106-4; MURAKOSHI I, 1985, PHYTOCHEMISTRY, V24, P1907, DOI 10.1016/S0031-9422(00)83090-3; Dietrich D, 2012, ORG BIOMOL CHEM, V10, P2248, DOI 10.1039/c2ob06864h; Oda K, 2013, J BACTERIOL, V195, P1741, DOI 10.1128/JB.02085-12; Kumagai T, 2010, ANTIMICROB AGENTS CH, V54, P1132, DOI 10.1128/AAC.01226-09; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Gren D, 2009, FEBS LETT, V583, P330; Haydel SE, 2010, PHARMACEUTICALS, V3, P2268, DOI DOI 10.3390/PH3072268; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; McRee D. E., 1992, J MOL GRAPHICS, V10, P44, DOI 10.1016/0263-7855(92)80022-6; IKEGAMI F, 1994, PHYTOCHEMISTRY, V35, P1089, DOI 10.1016/S0031-9422(00)94805-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sashikata K, 1969, J GEN APPL MICROBIOL, V9, P409	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					3929	3944		10.1111/febs.13386		16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200006		
J	Kumagai, Y; Yamashita, K; Tagami, T; Uraji, M; Wan, K; Okuyama, M; Yao, M; Kimura, A; Hatanaka, T				Kumagai, Yuya; Yamashita, Keitaro; Tagami, Takayoshi; Uraji, Misugi; Wan, Kun; Okuyama, Masayuki; Yao, Min; Kimura, Atsuo; Hatanaka, Tadashi			The loop structure of Actinomycete glycoside hydrolase family 5 mannanases governs substrate recognition	FEBS JOURNAL			English	Article						Actinomycete; chimeric enzyme; galactosylmannooligosaccharide; glycoside hydrolase family 5; mannanase	CARBOHYDRATE-BINDING MODULES; ALPHA-GALACTOSIDASE; THERMAL-STABILITY; BETA-MANNANASE; POLYSACCHARIDE RECOGNITION; CRYSTAL-STRUCTURE; SPECIFICITY; BIOFUELS; SITE; OLIGOSACCHARIDES	Endo--1,4-mannanases from Streptomyces thermolilacinus (StMan) and Thermobifida fusca (TfMan) demonstrated different substrate specificities. StMan hydrolyzed galactosylmannooligosaccharide (GGM5; 6(III),6(IV)--d-galactosyl mannopentaose) to GGM3 and M2, whereas TfMan hydrolyzed GGM5 to GGM4 and M1. To determine the region involved in the substrate specificity, we constructed chimeric enzymes of StMan and TfMan and evaluated their substrate specificities. Moreover, the crystal structure of the catalytic domain of StMan (StMandC) and the complex structure of the inactive mutant StE273AdC with M6 were solved at resolutions of 1.60 and 1.50 angstrom, respectively. Structural comparisons of StMandC and the catalytic domain of TfMan lead to the identification of a subsite around -1 in StMandC that could accommodate a galactose branch. These findings demonstrate that the two loops (loop7 and loop8) are responsible for substrate recognition in GH5 actinomycete mannanases. In particular, Trp281 in loop7 of StMan, which is located in a narrow and deep cleft, plays an important role in its affinity toward linear substrates. Asp310 in loop8 of StMan specifically bound to the galactosyl unit in the -1 subsite.	[Kumagai, Yuya; Uraji, Misugi; Wan, Kun; Hatanaka, Tadashi] Okayama Prefectural Technol Ctr Agr Forestry & Fi, Res Inst Biol Sci, Okayama, Okayama 7161241, Japan; [Kumagai, Yuya; Tagami, Takayoshi; Okuyama, Masayuki; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Yamashita, Keitaro; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan	Hatanaka, T (reprint author), Okayama Prefectural Technol Ctr Agr Forestry & Fi, Res Inst Biol Sci, 7549-1 Kibichuo Cho, Okayama, Okayama 7161241, Japan.	hatanaka@bio-ribs.com	yao, min/F-5287-2011	yao, min/0000-0003-1687-5904			Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661; Puchart V, 2005, BBA-GEN SUBJECTS, V1726, P206, DOI 10.1016/j.bbagen.2005.07.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Hilge M, 1998, STRUCT FOLD DES, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Demirbas MF, 2009, APPL ENERG, V86, pS151, DOI 10.1016/j.apenergy.2009.04.043; Kumagai Y, 2011, BBA-PROTEINS PROTEOM, V1814, P1127, DOI 10.1016/j.bbapap.2011.04.017; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; BULPIN PV, 1990, CARBOHYD POLYM, V12, P155, DOI 10.1016/0144-8617(90)90016-L; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Rinaudo M, 2004, BIOMACROMOLECULES, V5, P1155, DOI 10.1021/bm030077q; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Boraston AB, 2004, BIOCHEM J, V382, P769; Ardevol A, 2010, J AM CHEM SOC, V132, P16058, DOI 10.1021/ja105520h; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Goncalves AMD, 2012, ACTA CRYSTALLOGR D, V68, P1468, DOI 10.1107/S0907444912034646; Kumagai Y, 2013, J MOL CATAL B-ENZYM, V94, P63, DOI 10.1016/j.molcatb.2013.05.001; Kim HW, 2011, BIOCHEM J, V437, P223, DOI 10.1042/BJ20110292; Daas PJH, 2000, CARBOHYD RES, V329, P609, DOI 10.1016/S0008-6215(00)00209-3; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Kumagai Y, 2013, BBA-PROTEINS PROTEOM, V1834, P301, DOI 10.1016/j.bbapap.2012.08.011; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mori K, 2005, APPL ENVIRON MICROB, V71, P754, DOI 10.1128/AEM.71.2.754-760.2005; Zhang XY, 2014, J BIOL CHEM, V289, P2002, DOI 10.1074/jbc.M113.527770; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; dasSilva VM, 2014, PLOS ONE, V9; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Santos CR, 2012, J STRUCT BIOL, V177, P469, DOI [10.1016/j.jsb.2011.11.021, DOI 10.1016/J.JSB.2011.11.021]; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Takasuka TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094166; WANG WT, 1984, ANAL BIOCHEM, V141, P366, DOI 10.1016/0003-2697(84)90057-5; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					4001	4014		10.1111/febs.13401		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200011		
J	Machiyama, H; Yamaguchi, T; Sawada, Y; Watanabe, TM; Fujita, H				Machiyama, Hiroaki; Yamaguchi, Tomoyuki; Sawada, Yasuhiro; Watanabe, Tomonobu M.; Fujita, Hideaki			SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane	FEBS JOURNAL			English	Article						focal adhesion; phosphorylation; SH3 domain; Src; TIRF microscopy	TYROSINE KINASE SRC; FAMILY KINASES; DASATINIB BMS-354825; SIGNAL-TRANSDUCTION; LIGAND-BINDING; LIVING CELLS; CANCER CELLS; V-SRC; PHOSPHORYLATION; INTEGRIN	We studied the role of the Src SH3 domain in its dynamics at the cell membrane using site-directed mutagenesis and live cell imaging. Physiologically, cell proliferation and migration require the expression of Src family kinases. Hyperactivation of Src molecules has been detected in various cancer cells. Although the activation mechanism of Src has been intensively studied, the dynamics of Src at the cell membrane are still unclear. Although Src molecules also exist at various cellular locations, we found that activated Src molecules are mainly localized at peripheral cell adhesion sites. Src phosphorylation status and subdomain conformations are thought to regulate Src activation and translocation. In this study, we analyzed the single-molecule dynamics of wild-type Src and SH2- and SH3-mutated Src at the cell membrane. Introducing mutations in the SH3 domain resulted in reduced Src motility at the cell membrane, both inside and outside of focal adhesions. Disruption of the actin cytoskeleton resulted in less diffusive Src movement at the cell membrane. We demonstrate that, inside focal adhesions, the SH3 domain enhanced dissociation of Src from the adhesion site and disruption of the SH3 domain altered the distribution of Src at the cell membrane. Inside focal adhesions, kinase activity of Src was essential for the Src mobility reduction by SH3 domain mutation, suggesting that rapid mobility of Src at focal adhesions mediated by the SH3 domain is catalytic-activity-dependent. These findings show that the SH3 domain of Src governs the dynamics of Src at the cell membrane and may be involved in rapid signal transduction in cells.	[Machiyama, Hiroaki; Yamaguchi, Tomoyuki; Watanabe, Tomonobu M.; Fujita, Hideaki] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650874, Japan; [Sawada, Yasuhiro] Natl Rehabil Ctr Persons Disabil, Res Inst, Saitama, Japan; [Watanabe, Tomonobu M.; Fujita, Hideaki] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan	Fujita, H (reprint author), Osaka Univ, Immunol Frontier Res Ctr, OLABB, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan.	fujita@ifrec.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24570191]	We thank Kazuki Matsuda and Miwa Fukami for technical assistance. This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology to HF (#24570191).	Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Martin DS, 2002, BIOPHYS J, V83, P2109; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772; Chiang GG, 2000, J BIOL CHEM, V275, P6055, DOI 10.1074/jbc.275.9.6055; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; BUSS JE, 1986, J VIROL, V58, P468; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Staley CA, 1997, CELL GROWTH DIFFER, V8, P269; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-17312; Machiyama H, 2014, J CELL SCI, V127, P3440, DOI 10.1242/jcs.143438; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Tugues S, 2013, J BIOL CHEM, V288, P19060, DOI 10.1074/jbc.M113.468199; Pan Q, 2011, CELL MOL LIFE SCI, V68, P3425, DOI 10.1007/s00018-011-0638-1; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Li LM, 2002, MOL CELL BIOL, V22, P1203, DOI 10.1128/MCB.22.4.1203-1217.2002; Chatterjee SJ, 2004, J PATHOL, V203, P762, DOI 10.1002/path.1567; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Spagnol ST, 2014, INTEGR BIOL-UK, V6, P523, DOI 10.1039/c3ib40226f; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Evans JV, 2012, J CELL SCI, V125, P6185, DOI 10.1242/jcs.121046; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; ERPEL T, 1995, EMBO J, V14, P963; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1093/jcb.200701133; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Ferrando IM, 2012, MOL CELL PROTEOMICS, V11, P355, DOI 10.1074/mcp.M111.015750; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					4034	4055		10.1111/febs.13404		22	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200013		
J	Reyes-Becerril, M; Ascencio-Valle, F; Alamillo, E; Hirono, I; Kondo, H; Jirapongpairoj, W; Angulo, C				Reyes-Becerril, Martha; Ascencio-Valle, Felipe; Alamillo, Erika; Hirono, Ikuo; Kondo, Hidehiro; Jirapongpairoj, Walissara; Angulo, Carlos			Molecular cloning and comparative responses of Toll-like receptor 22 following ligands stimulation and parasitic infection in yellowtail (Seriola lalandi)	FISH & SHELLFISH IMMUNOLOGY			English	Article						Yellowtail Seriola lalandi; TLR22; Expression modulation	ROHU LABEO-ROHITA; SPERMATOGONIAL CELLS; EXPRESSION ANALYSIS; SIGNALING PATHWAYS; GENE STRUCTURE; IDENTIFICATION; FAMILY; TLR22; FISH; CARP	TLR22 is exclusively present in teleosts and amphibians and is expected to play the distinctive role in innate immunity. In this study, we cloned the full-length cDNA sequence of yellowtail (Serbia lalandi) TLR22 (SlTLR22). The complete cDNA sequence of SlTLR22 was 4208 bp and encodes a polypeptide of 961 amino acids. Analysis of the deduced amino acid sequence indicated that SlTLR22 has typical structural features of proteins belonging to the TLR family. These included 17 LRR domains (residues 91-633) and one C-terminal LRR domain (LRR-CT, residues 693-744) in the extracellular region, and a TIR domain (residues 800-943) in the cytoplasmic region. Comparison with homologous proteins showed that the deduced SlTLR22 has the highest sequence identity to turbot TLR22 (76%). Quantitative real-time PCR (qPCR) analysis demonstrated the constitutive expression of SlTLR22 mRNA in all examined tissues with higher levels in the head kidney, intestine, skin and spleen. Further, SlTLR22 expression was significantly up-regulated following TLR ligands injection with lipopolysaccharide (LPS), CpG ODN2006 and polyinosinic: polycytidylic acid (poly I:C) in spleen and liver. Amyloodinium ocellatum infection also induced a high expression of SlTLR22 in spleen, intestine, muscle, skin and gill, with maximum increases ranging from 1000 to 100 fold upon different ligands and organs. Finally, histological examination in gill tissue confirmed infection by the parasite and histopathological lesion was observed also in spleen and skin. These findings suggest a possible role of SlTLR22 in the immune responses to the infections of a broad range of pathogens that include DNA and RNA viruses and parasites. (C) 2015 Elsevier Ltd. All rights reserved.	[Reyes-Becerril, Martha; Ascencio-Valle, Felipe; Alamillo, Erika; Angulo, Carlos] Inst Politecn Nacl, Ctr Invest Biol Noroeste CIBNOR, La Paz 23096, BCS, Mexico; [Hirono, Ikuo; Kondo, Hidehiro; Jirapongpairoj, Walissara] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo 1088477, Japan	Angulo, C (reprint author), Inst Politecn Nacl, Ctr Invest Biol Noroeste CIBNOR, 195 Playa Palo de Santa Rita, La Paz 23096, BCS, Mexico.	eangulo@cibnor.mx			SEP-CONACYT grant [CB-2010/155381, CONACYT-INFR-2014-01/225924]	The juvenile yellowtail Serbia lalandi used in this study was generously provided by Dr. Juan Carlos Perez Urbiola. The project was funded under SEP-CONACYT grant CB-2010/155381 and CONACYT-INFR-2014-01/225924.	Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Xiao XQ, 2011, FISH SHELLFISH IMMUN, V30, P224, DOI 10.1016/j.fsi.2010.10.014; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Munoz I, 2014, DEV COMP IMMUNOL, V44, P173, DOI 10.1016/j.dci.2013.12.003; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Saurabh S, 2011, VET PARASITOL, V175, P119, DOI 10.1016/j.vetpar.2010.10.001; Ding X, 2012, FISH SHELLFISH IMMUN, V33, P494, DOI 10.1016/j.fsi.2012.05.034; Byadgi O, 2014, FISH SHELLFISH IMMUN, V36, P417, DOI 10.1016/j.fsi.2013.12.017; Hirono I, 2004, IMMUNOGENETICS, V56, P38, DOI 10.1007/s00251-004-0657-2; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Samanta M, 2012, FISH SHELLFISH IMMUN, V32, P411, DOI 10.1016/j.fsi.2011.11.029; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Lv JJ, 2012, FISH SHELLFISH IMMUN, V32, P1022, DOI 10.1016/j.fsi.2012.02.024; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Hu GB, 2015, FISH SHELLFISH IMMUN, V44, P399, DOI 10.1016/j.fsi.2015.03.001; Rebl A, 2007, DEV COMP IMMUNOL, V31, P499, DOI 10.1016/j.dci.2006.08.007; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Stafford JL, 2003, DEV COMP IMMUNOL, V27, P685, DOI 10.1016/S0145-305X(03)00041-7; Mohapatra C, 2010, MAR GENOM, V3, P157, DOI 10.1016/j.margen.2010.09.002; Levy MG, 2007, DIS AQUAT ORGAN, V73, P219, DOI 10.3354/dao073219; Mohapatra C, 2014, MOL BIOL REP, V41, P4123, DOI 10.1007/s11033-014-3283-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Matsuo A, 2008, J IMMUNOL, V181, P3474; Betancur-R R., 2013, PLOS CURRENTS TREE L, V1, P1, DOI DOI 10.1371/CURRENTS.TOL.53BA26640DF0CCAEE75BB165C8C26288; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Noga E. J., 2006, FISH DIS DISORDERS, V1, P16; Panda RP, 2014, DEV COMP IMMUNOL, V47, P25, DOI 10.1016/j.dci.2014.06.016; Peter M., 2007, IMMUNOLOGY, V123, P118; Rodriguez-De la cruz M.C., 1994, ATLAS PEQUERO MAXICO, P234; Sharp N., FISH FARMING INT; Sharp N., 2000, P NZ MAR SCI SOC C; Takashi A., 2008, FISH BETHESDA, P263	36	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	OCT	2015	46	2					323	333		10.1016/j.fsi.2015.06.020		11	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CT8MR	WOS:000363071200020		
J	Sahashi, G; Morita, K; Ohnuki, T; Ohkuma, K				Sahashi, G.; Morita, K.; Ohnuki, T.; Ohkuma, K.			An evaluation of the contribution of hatchery stocking on population density and biomass: a lesson from masu salmon juveniles within a Japanese river system	FISHERIES MANAGEMENT AND ECOLOGY			English	Article						enhancement; replacement; salmonid fish; wild fish	TROUT ONCORHYNCHUS-MYKISS; NATURAL-POPULATIONS; ATLANTIC SALMON; REARED FISH; WILD FISH; SUPPLEMENTATION; PRODUCTIVITY; MANAGEMENT; PROGRAMS; HABITAT	Stocking is an important management tool for enhancing fisheries resources, but its actual contribution to fisheries resources is controversial, taking into consideration both the positive and negative effects. This study compared density and biomass of hatchery (otolith thermal marked) and wild masu salmon parr between stocked and unstocked rivers to evaluate the contribution of stocking with hatchery-reared fish. Density and biomass of all fish did not differ between stocked and unstocked rivers. Moreover, density and biomass of wild fish in the stocked rivers were lower than those of the unstocked rivers. Density and biomass of hatchery fish in a non-natural reproducing river were similar with those of all fish in natural reproducing rivers. These results indicate that hatchery stocking does not have positive effects on population density or biomass but replaces wild fish with hatchery fish and that non-natural reproducing areas are more suitable as stocking sites.	[Sahashi, G.] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Hakodate, Hokkaido 0400051, Japan; [Morita, K.; Ohnuki, T.; Ohkuma, K.] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Sapporo, Hokkaido, Japan	Sahashi, G (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, 20-5 Benten Cho, Hakodate, Hokkaido 0400051, Japan.	genki.sahashi@gmail.com	Morita, Kentaro/G-2578-2015	Morita, Kentaro/0000-0002-7803-2438	JSPS KAKENHI [15J01925]	We thank K. Miyashita for his support and encouragement, T. Nomoto for obtaining the sampling permit issued by the Governor of Hokkaido and the staff of the Shari Field Station, Hokkaido National Fisheries Research Institute for thermally marking the salmon otoliths and providing the Shari River system hatchery stocking information. This work was supported by JSPS KAKENHI Grant Number 15J01925.	Griffiths AM, 2011, BIOL CONSERV, V144, P2733, DOI 10.1016/j.biocon.2011.07.017; Sweeting RM, 2003, N AM J FISH MANAGE, V23, P492, DOI 10.1577/1548-8675(2003)023<0492:ROWCSB>2.0.CO;2; Morita K, 2014, J ANIM ECOL, V83, P1268, DOI 10.1111/1365-2656.12240; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Pess GR, 2014, REV FISH BIOL FISHER, V24, P881, DOI 10.1007/s11160-013-9339-1; McLean JE, 2003, CAN J FISH AQUAT SCI, V60, P433, DOI 10.1139/F03-040; Pearsons TN, 2010, T AM FISH SOC, V139, P502, DOI 10.1577/T08-094.1; Shimoda Kazutaka, 2012, Scientific Reports of Hokkaido Fisheries Research Institutes, V82, P41; Hilborn R, 2000, T AM FISH SOC, V129, P333, DOI 10.1577/1548-8659(2000)129<0333:AROTHP>2.0.CO;2; Anderson JH, 2015, CAN J FISH AQUAT SCI, V72, P454, DOI 10.1139/cjfas-2014-0180; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Buhle ER, 2009, BIOL CONSERV, V142, P2449, DOI 10.1016/j.biocon.2009.05.013; Kitada S, 2006, FISH RES, V80, P101, DOI 10.1016/j.fishres.2006.03.019; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Temple GM, 2012, ENVIRON BIOL FISH, V94, P67, DOI 10.1007/s10641-011-9811-5; Morita K, 2010, CAN J FISH AQUAT SCI, V67, P955, DOI 10.1139/F10-028; Hill MS, 2006, CAN J FISH AQUAT SCI, V63, P1627, DOI 10.1139/F06-061; Shimoda Kazutaka, 2012, Scientific Reports of Hokkaido Fisheries Research Institutes, V81, P145; Chilcote MW, 2011, CAN J FISH AQUAT SCI, V68, P511, DOI 10.1139/F10-168; Ando D, 2002, NIPPON SUISAN GAKK, V68, P52; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Chilcote MW, 2003, CAN J FISH AQUAT SCI, V60, P1057, DOI 10.1139/F03-092; Stottrup JG, 2002, FISH RES, V59, P161, DOI 10.1016/S0165-7836(01)00413-1; Aoyama T., 2014, SHIKEN KENKYU WA IMA; Burnham K.P., 1991, USERS GUIDE INTERACT; Kato F., 1991, PACIFIC SALMON LIFE, P448; Kawana M., 2002, NPAFC DOCUMENTS; Leber K.M., 2005, STOCK ENHANCEMENT SE, P1; Machidori S., 1984, INT N PAC FISH COMM, V43, P1; Obata Y., 2008, ENHANCEMENT CONSERVA, P66; Ohnuki T., 2012, NPAFC DOCUMENTS, V1387, P8; Sato S., 2011, NPAFC DOCUMENTS, V1312, P7; Shimoda K., 2014, SCI REPORT HOKKAIDO, V85, P41; Sugiwaka K., 1994, UOTOMIZU, V31, P171; Urabe H., 2013, SCI REPORT HOKKAIDO, V84, P34	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0969-997X	1365-2400		FISHERIES MANAG ECOL	Fisheries Manag. Ecol.	OCT	2015	22	5					371	378		10.1111/fme.12136		8	Fisheries	Fisheries	CT8GM	WOS:000363053000003		
J	Ueda, S; Ozawa, S; Mori, K; Asanuma, K; Yanagita, M; Uchida, S; Nakagawa, T				Ueda, Shuko; Ozawa, Shota; Mori, Kiyoshi; Asanuma, Katsuhiko; Yanagita, Motoko; Uchida, Shunya; Nakagawa, Takahiko			ENOS deficiency causes podocyte injury with mitochondrial abnormality	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Endothelial; Oxidative stress; Nitric oxide; NO; Glomerular; Podocyte	NITRIC-OXIDE SYNTHASE; ADVANCED DIABETIC-NEPHROPATHY; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; KNOCKOUT MICE; THROMBOTIC MICROANGIOPATHY; BLOOD-PRESSURE; RENAL INJURY; EXPRESSION; KIDNEY	The contribution of endothelial nitric oxide synthase (eNOS) to podocyte integrity remains unclear. This study therefore examined podocytes and mitochondrial abnormalities in eNOS deficient mice. Absence of eNOS caused glomerular hypertrophy, along with occasional glomerular sclerosis and mesangiolysis. While many glomeruli did not have such advanced lesions, ultrastructural analysis showed cellular hypertrophy, vacuolization, lysosomal enlargement, and microvillus formation in podocytes of eNOS knockout (KO) mice. Increased oxidative stress was associated with mitochondrial abnormalities, including an increase in number, coupled with a reduction in size, of mitochondria in podocytes of eN0S1(0 mice. While the levels of expression of several mitochondrial proteins were not altered, the D-17 mutation in mitochondrial DNA was significantly associated with the eNOS deficiency. Renal ATP level in the renal cortex and mitochondrial respiration in the primary podocytes were significantly lower in eN0S-K0 mice, suggesting that renal mitochondria may be functionally impaired. Podocytes cultured with endothelial conditioned medium lacking NO consistently showed a greater degree of mitochondrial fragmentation and an increase in mitochondrial oxidative stress, with these mitochondrial alterations rescued by an NO donor. In conclusion, eNOS may be necessary to maintain poclocyte integrity, especially mitochond rial function. (C) 2015 Published by Elsevier Inc.	[Ueda, Shuko; Ozawa, Shota; Mori, Kiyoshi; Asanuma, Katsuhiko; Yanagita, Motoko; Nakagawa, Takahiko] Kyoto Univ, TMK Project, Med Innovat Ctr, Kyoto 6068397, Japan; [Ueda, Shuko; Uchida, Shunya] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Ozawa, Shota] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 2, Saitama, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Nakagawa, T (reprint author), Kyoto Univ, TMK Project, Med Innovat Ctr, Sakyo Ku, 53 Shogoin,Kawahara Cho, Kyoto 6068397, Japan.	nakagawt@gmail.com			Mitsubishi Tanabe Pharma Corporation; Teikyo University; Uehara memorial foundation	This study was supported by a research fund from the Mitsubishi Tanabe Pharma Corporation, a financial support from Teikyo University, and a research grant from the Uehara memorial foundation.	Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Nakagawa T, 2006, J AM SOC NEPHROL, V17, P736, DOI 10.1681/ASN.2005070759; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Forbes MS, 2007, AM J PATHOL, V170, P87, DOI 10.2353/ajpath.2007.060610; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Thomas SE, 1998, J AM SOC NEPHROL, V9, P231; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Nakayama T, 2010, AM J PATHOL, V176, P2198, DOI 10.2353/ajpath.2010.090316; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; BACHMANN S, 1995, AM J PHYSIOL-RENAL, V268, pF885; Kosugi T, 2009, AM J PATHOL, V174, P1221, DOI 10.2353/ajpath.2009.080605; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Herrera M, 2006, HYPERTENSION, V47, P95, DOI 10.1161/01.HYP.0000196274.78603.85; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Tanabe K, 2012, AM J PHYSIOL-RENAL, V302, pF1151, DOI 10.1152/ajprenal.00596.2011; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Faria AM, 2012, DIABETES, V61, P1838, DOI [10.2337/db11-1241, 10.2337/db11-1241/-/DC1]; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Gilkeson GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064650; Gu Xin, 2010, Int J Nephrol Renovasc Dis, V3, P11; Li Q., 2010, INVEST OPHTHALMOL VI; Nakayama T., 2009, AM J PHYSIOL-RENAL, V296, P317; Steinkamp-Fenske Katja, 2007, Atherosclerosis, V195, pe104, DOI 10.1016/j.atherosclerosis.2007.03.028	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	OCT	2015	87						181	192		10.1016/j.freeradbiomed.2015.06.028		12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CU1JK	WOS:000363277100016		
J	Iida, R; Ueki, M; Yasuda, T				Iida, Reiko; Ueki, Misuzu; Yasuda, Toshihiro			Identification of interacting partners of Human Mpv17-like protein with a mitigating effect of mitochondrial dysfunction through mtDNA damage	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Mitochondrial dysfunction; Mitochondrial DNA; Mpv17 family; Oxidative stress	ENDOPLASMIC-RETICULUM ER; PEROXISOMAL MEMBRANE; DNA-DAMAGE; REGULATES EXPRESSION; M-LP; GENE; S3; ORGANIZATION; REPLICATION; APOPTOSIS	Human Mpv17-like protein (M-LPH) has been suggested to participate in mitochondrial function. In this study, we investigated the proteins that interact with M-LPH, and identified four: H2A histone family, member X (H2AX), ribosomal protein S14 (RPS14), ribosomal protein 53 (RPS3) and B-cell receptor-associated protein 31 (Bap31). Immunofluorescence and subcellular fractionation studies revealed that M-LPH is localized predominantly in the nucleus, to some extent in a subset of mitochondria, and marginally in the cytosol. Mitochondrial M-LPH appeared as punctate foci, and these were co-localized with a subset of mitochonclrial transcription factor A (TFAM) and mtDNA, indicating that M-LPH is localized in or in close proximity to mitochonclrial nucleoids. RNAi-mecliatecl knockdown of M-LPH resulted in an increase of mtDNA damage and reduced the expression of mtDNA-encoded genes. A ROS inducer, antimycin A, caused an increase in both the number and size of the mitochonclrial M-LPH foci, and these foci were co-localized with two enzymes, DNA polymerase gamma (POLG) and DNA ligase Ill (LIG3), both involved in mtDNA repair. Furthermore, knockdown of M-LPH hampered mitochonclrial localization of these enzymes. Taken together, these observations suggest that M-LPI-1 is involved in the maintenance of mtDNA and protects cells from mitochondrial dysfunction. (C) 2015 Elsevier Inc. All rights reserved	[Iida, Reiko] Univ Fukui, Fac Med Sci, Div Life Sci, Fukui 9101193, Japan; [Iida, Reiko; Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Org Life Sci Adv Programs, Fukui 9101193, Japan; [Ueki, Misuzu; Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Div Med Genet & Biochem, Fukui 9101193, Japan	Iida, R (reprint author), Univ Fukui, Fac Med Sci, Div Life Sci, Fukui 9101193, Japan.	riida@u-fukui.ac.jp			Japan Society for the Promotion of Science [26293162, 24659335, 22249023]	This work was supported in part by Grants-in-Aid for scientific research from Japan Society for the Promotion of Science (26293162 and 24659335 to R.I., 22249023 to T.Y.),	Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; KIM J, 1995, J BIOL CHEM, V270, P13620; Iida R, 2000, MECH AGEING DEV, V113, P135, DOI 10.1016/S0047-6374(99)00104-9; Deutsch WA, 1997, J BIOL CHEM, V272, P32857, DOI 10.1074/jbc.272.52.32857; Iida R, 2012, FREE RADICAL BIO MED, V52, P1413, DOI 10.1016/j.freeradbiomed.2012.01.003; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; ZIEMIECKI A, 1990, EMBO J, V9, P191; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Heath-Engel HM, 2012, BBA-MOL CELL RES, V1823, P335, DOI 10.1016/j.bbamcr.2011.11.020; Iida R, 2005, EXP CELL RES, V302, P22, DOI 10.1016/j.yexer.2004.08.027; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Iida R, 2006, BIOCHEM BIOPH RES CO, V344, P948, DOI 10.1016/j.bbrc.2006.04.008; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112; Iida R, 2001, BIOCHEM BIOPH RES CO, V283, P292, DOI 10.1006/bbrc.2001.4769; Hegde V, 2004, DNA REPAIR, V3, P121, DOI 10.1016/j.dnarep.2003.10.004; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Kim Y, 2013, BBA-MOL CELL RES, V1833, P2943, DOI 10.1016/j.bbamcr.2013.07.015; Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405; Brosius U, 2002, J BIOL CHEM, V277, P774, DOI 10.1074/jbc.M108155200; Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Dalla Rosa I., 2014, NUCLEIC ACIDS RES, V42, P8500; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Firsanov Denis V, 2011, Clin Epigenetics, V2, P283, DOI 10.1007/s13148-011-0044-4; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; lida R., 2013, OPEN ACCESS, V2, P440; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Zhou Xiang, 2012, Genes Cancer, V3, P298, DOI 10.1177/1947601912455200	52	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	OCT	2015	87						336	345		10.1016/j.freeradbiomed.2015.07.008		10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CU1JK	WOS:000363277100029		
J	Noguchi, N; Urano, Y; Takabe, W; Saito, Y				Noguchi, Noriko; Urano, Yasuomi; Takabe, Wakako; Saito, Yoshiro			New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death	FREE RADICAL BIOLOGY AND MEDICINE			English	Review						24(S)-Hydroxycholesterol; CYP46A1; Cholesterol homeostasis; Cell death; Neurodegenerative disease; Free radicals	AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; HUMAN NEUROBLASTOMA-CELLS; BLOOD-BRAIN-BARRIER; DIFFERENTIATED PC12 CELLS; MIXED LINEAGE KINASE; ALZHEIMERS-DISEASE; CHOLESTEROL 24-HYDROXYLASE; LIPID-PEROXIDATION; OXIDATIVE STRESS	24(5)-Hydroxycholesterol (24S-OHC), which is enzymatically produced in the brain, has been known to play an important role in maintaining cholesterol homeostasis in the brain and has been proposed as a possible biomarker of neurodegenerative disease. Recent studies have revealed diverse functions of 24SOHC and gained increased attention. For example, 24S-OHC at sublethal concentrations has been found to induce an adaptive response via activation of the liver X receptor signaling pathway, thereby protecting neuronal cells against subsequent oxidative stress. It has also been found that physiological concentrations of 24S-OHC suppress amyloid-beta production via downregulation of amyloid precursor protein trafficking in neuronal cells. On the other hand, high concentrations of 24S-OHC have been found to induce a type of nonapoptotic programmed cell death in neuronal cells expressing little caspase-8. Because neuronal cell death induced by 24S-OHC has been found to proceed by a unique mechanism, which is different from but in some ways similar to necroptosis necroptosis being a type of programmed necrosis induced by tumor necrosis factor alpha neuronal cell death induced by 24S-OHC has been called "necroptosis-like" cell death. 24S-OHC-induced cell death is dependent on the formation of 24S-OHC esters but not on oxidative stress. This review article discusses newly reported aspects of 24S-OHC in neuronal cell death and sheds light on the possible importance of controlling 24S-OHC levels in the brain for preventing neuroclegenerative disease. (C) 2015 Elsevier Inc. All rights reserved.	[Noguchi, Noriko; Urano, Yasuomi; Takabe, Wakako; Saito, Yoshiro] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, Kyoto 6100394, Japan	Noguchi, N (reprint author), Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, Kyoto 6100394, Japan.	nnoguchi@mail.doshisha.ac.jp			KAKENHI [25830041]; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST; Foundation of Cosmetology Research; MEXT	We thank Gerry Peters (JTT K.K., Takatsuki, Japan) for his careful editing of the manuscript. This work was supported in part by KAKENHI Grant-in-Aid for Young Scientists (B) 25830041 to Y.U., the Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST, to Y.U., the Foundation of Cosmetology Research to N.N,, and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan for the years 2012-2016.	Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Mitic T, 2013, BIOCHIMIE, V95, P548, DOI 10.1016/j.biochi.2012.08.007; Jang ER, 2011, NEUROCHEM INT, V58, P52, DOI 10.1016/j.neuint.2010.10.012; Saito Y, 2014, BIOCHEM BIOPH RES CO, V446, P741, DOI 10.1016/j.bbrc.2013.12.083; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Gosselet F, 2014, BIOCHEM BIOPH RES CO, V446, P687, DOI 10.1016/j.bbrc.2013.11.059; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843; Rao ML, 1999, ANN NY ACAD SCI, V893, P379, DOI 10.1111/j.1749-6632.1999.tb07860.x; Kristofikova Z, 2008, NEUROCHEM RES, V33, P412, DOI 10.1007/s11064-007-9443-5; Estus S, 1997, J NEUROSCI, V17, P7736; Halford RW, 2009, P NATL ACAD SCI USA, V106, P3502, DOI 10.1073/pnas.0813349106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iuliano L, 2011, CHEM PHYS LIPIDS, V164, P457, DOI 10.1016/j.chemphyslip.2011.06.006; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Noguchi N, 2014, BIOCHEM BIOPH RES CO, V446, P692, DOI 10.1016/j.bbrc.2014.02.010; Kolsch H, 2004, NEUROSCI LETT, V368, P303, DOI 10.1016/j.neulet.2004.07.031; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Saito Y, 2007, J NEUROCHEM, V102, P1625, DOI 10.1111/j.1471-4159.2007.04701.x; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Popp J, 2012, J NEUROCHEM, V123, P310, DOI 10.1111/j.1471-4159.2012.07893.x; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; Shafaati M, 2010, J LIPID RES, V51, P318, DOI [10.1194/jlr.M900174-JLR200, 10.1194/jlr.M900174]; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI [10.1194/jlr.r400004, 10.1194/jlr.r400004-JLR200]; Bjorkhem I, 2013, NEUROSCI LETT, V555, P102, DOI 10.1016/j.neulet.2013.09.003; Patte-Mensah C, 2008, BRAIN RES REV, V57, P454, DOI 10.1016/j.brainresrev.2007.05.007; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; Fourgeux C, 2014, BIOCHEM BIOPH RES CO, V446, P775, DOI 10.1016/j.bbrc.2014.01.118; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sottero B, 2009, CURR MED CHEM, V16, P685; Ferrera P, 2008, NEUROCHEM RES, V33, P1509, DOI 10.1007/s11064-008-9623-y; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Lee CYJ, 2009, ANTIOXID REDOX SIGN, V11, P407, DOI 10.1089/ARS.2008.2179; Yamanaka K, 2012, RSC ADV, V2, P7894, DOI 10.1039/c2ra20816d; Wang QM, 2014, CURR PHARM DESIGN, V20, P1223; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Kolsch H, 2001, J NEURAL TRANSM, V108, P475, DOI 10.1007/s007020170068; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Saeed AA, 2014, J BIOL CHEM, V289, P23712, DOI 10.1074/jbc.M114.556159; Shafaati M, 2007, NEUROSCI LETT, V425, P78, DOI 10.1016/j.neulet.2007.08.014; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Vo DKH, 2015, STEROIDS, V99, P230, DOI 10.1016/j.steroids.2015.02.007; Bjorkhem I, 1999, CURR OPIN LIPIDOL, V10, P161, DOI 10.1097/00041433-199904000-00010; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Gamba P, 2014, AGING CELL, V13, P561, DOI 10.1111/acel.12206; Ohtsuki S, 2007, J NEUROCHEM, V103, P1430, DOI 10.1111/j.1471-4159.2007.04901.x; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200; Cavallucci V, 2012, MOL NEUROBIOL, V45, P366, DOI 10.1007/s12035-012-8251-3; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Leoni V, 2013, NEUROBIOL DIS, V55, P37, DOI 10.1016/j.nbd.2013.03.013; Lutjohann D, 2000, J LIPID RES, V41, P195; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Kristofikova Z, 2012, NEUROCHEM RES, V37, P604, DOI 10.1007/s11064-011-0650-8; Kim DE, 2009, NEUROCHEM RES, V34, P1433, DOI 10.1007/s11064-009-9930-y; Bogdanovica N, 2001, NEUROSCI LETT, V314, P45, DOI 10.1016/S0304-3940(01)02277-7; Brown J., 2004, J BIOL CHEM, V279, P34674; Doodipala S. R., 2010, PROG BRAIN RES, V186, P113; Feoktistova M., 2011, MOL CELL, V43, P449; Huang Y, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-40; Marca V. L., 2014, J NEUROCHEM, V130, P97; Okabe Akishi, 2013, Redox Biol, V2, P28, DOI 10.1016/j.redox.2013.11.007; Poli G, 2013, REDOX BIOL, V1, P125, DOI 10.1016/j.redox.2012.12.001; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Sun M. Y., 2015, NEUROSCIENTIST, P1; Urano Y, 2013, FASEB J, V27, P4305, DOI 10.1096/fj.13-231456; Yamanaka K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.524; Zuliani G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-121	94	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	OCT	2015	87						366	372		10.1016/j.freeradbiomed.2015.06.036		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CU1JK	WOS:000363277100032		
J	Ferro, A; Gaio, E; Novello, L; Matsukawa, M; Shimada, K; Kawamata, Y; Takechi, M				Ferro, Alberto; Gaio, Elena; Novello, Luca; Matsukawa, Makoto; Shimada, Katsuhiro; Kawamata, Yoichi; Takechi, Manabu			Reference design of the power supply system for the resistive-wall-mode control in JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; RWM; Sector coil; Power supply		The mission of JT-60SA, the satellite Tokamak under construction in Naka (Japan), includes the attainment of steady-state high-beta plasmas. For this purpose, an active control system based on 18 in-vessel sector coils (SC) is foreseen to suppress the resistive wall modes (RWM). Each coil will be independently fed by a dedicated converter, rated for 300A and 240V, which has to produce the required current/voltage following in real time the reference provided by the JT-60SA MHD Controller. To minimize the current rating, these converters shall be sufficiently fast to avoid an excessive growth of the RWM. This requires a very high dynamic performance, largely beyond that of standard industrial applications. This paper firstly reports the latest results of the studies on the requirements of the RWM active control system. Then, the reference design of the power supply system is presented, including the ac/dc conversion stage, the fast converters and the control section. The advantages of the proposed scheme are discussed and the main electrical parameters are presented. (C) 2015 Consorzio RFX. Published by Elsevier B.V. All rights reserved.	[Ferro, Alberto; Gaio, Elena] Consorzio RFX, I-35127 Padua, Italy; [Novello, Luca] Fus Energy, Broader Dev Fus Dept, D-85748 Garching, Germany; [Matsukawa, Makoto; Shimada, Katsuhiro; Kawamata, Yoichi; Takechi, Manabu] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan	Ferro, A (reprint author), Consorzio RFX, Cso Stari Uniti 4, I-35127 Padua, Italy.	alberto.ferro@igi.cnr.it					Ferro A, 2011, FUSION ENG DES, V86, P1527, DOI 10.1016/j.fusengdes.2010.12.009; Ferro A, 2013, FUSION ENG DES, V88, P1509, DOI 10.1016/j.fusengdes.2013.01.094; Toigo V, 2003, FUSION ENG DES, V66-68, P1143, DOI 10.1016/S0920-3796(03)00293-X; JT-60SA Research Unit, 2013, JT 60SA RES PLAN RES; Mohan N., 2003, POWER ELECT CONVERTE; Takechi M., 2010, 37 EPS C PLASM PHYS; Takechi M., 2010, 23 IAEA FUS EN C DAE	7	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1053	1057		10.1016/j.fusengdes.2015.06.116		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900004		
J	Hishinuma, Y; Kikuchi, A; Shimada, Y; Kashiwai, T; Hata, S; Yamada, S; Muroga, T; Sagara, A				Hishinuma, Yoshimitsu; Kikuchi, Akihiro; Shimada, Yusuke; Kashiwai, Taro; Hata, Satoshi; Yamada, Shuichi; Muroga, Takeo; Sagara, Akio			Development of MgB2 superconducting wire for the low activation superconducting magnet system operated around core D-T plasma	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		MgB2; Cu addition; Solenoid coil; Excitation test; B-11 boron isotope	FUSION-REACTOR; MICROSTRUCTURE	MgB2 is one of the "low activation superconductors", because the half-life of the induced radio-activity on the MgB2 is much shorter than that of Nb-based superconductors such as NbTi, Nb3Sn and Nb3Al. MgB2 wire would become an alternative material for Nb-Ti wire for the Poloidal Field and correction feedback coils, if the critical current density (J(c)) around the magnetic field of 4T could be improved. We found that addition of Cu using the compound Mg2Cu was an effective method to enhancek and succeed to fabricate 100 m length of MgB2 wire with Cu addition. Jc of the 100 m long MgB2 with Cu addition was comparable to that of a NbTi wire, and the small solenoid coil using Cu added MgB2 wire reached a central magnetic field of 2.62T. We found that MgB2 wire is an alternative material to commercial NbTi wires under the hard neutron irradiation in a fusion reactor. Furthermore, we also fabricated a Cu added MgB2 wire using isotope pure boron-11 (B-11) powder as the boron source to reduce the radioactivity. The critical temperature (T-c) of the MgB2 wire using B-11 powder was found to be 37K, and T-c was found to be changed by different boron materials. (C) 2015 Published by Elsevier B.V.	[Hishinuma, Yoshimitsu; Yamada, Shuichi; Muroga, Takeo; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kikuchi, Akihiro] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Shimada, Yusuke] Kyushu Univ, HVEM Lab, Nishi Ku, Fukuoka 812, Japan; [Kashiwai, Taro; Hata, Satoshi] Kyushu Univ, Dept Mol & Mat Sci, Fukuoka 812, Japan	Hishinuma, Y (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	hishinuma.yoshimitsu@nifs.ac.jp					Hishinuma Y, 2006, SUPERCOND SCI TECH, V19, P1269, DOI 10.1088/0953-2048/19/12/008; DeFouw JD, 2008, ACTA MATER, V56, P5751, DOI 10.1016/j.actamat.2008.07.049; Finnemore DK, 2001, PHYS REV LETT, V86, P2420, DOI 10.1103/PhysRevLett.86.2420; Noda T, 2004, J NUCL MATER, V329, P1590, DOI 10.1016/j.jnucmat.2004.04.164; Hishinuma Y, 2007, SUPERCOND SCI TECH, V20, P1178, DOI 10.1088/0953-2048/20/12/017; Hishinuma Y, 2007, IEEE T APPL SUPERCON, V17, P2798, DOI 10.1109/TASC.2007.897453; Hishinuma Y., 2006, FUSION ENG DES, V20-22, P2467; Hishinuma Y., 2012, PHYS PROCEDIA, V36, P1485	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1076	1080		10.1016/j.fusengdes.2015.05.005		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900009		
J	Kizu, K; Murakami, H; Natsume, K; Tsuchiya, K; Koide, Y; Yoshida, K; Obana, T; Hamaguchi, S; Takahata, K				Kizu, Kaname; Murakami, Haruyuki; Natsume, Kyohei; Tsuchiya, Katsuhiko; Koide, Yoshihiko; Yoshida, Kiyoshi; Obana, Tetsuhiro; Hamaguchi, Shinji; Takahata, Kazuya			Manufacturing design and development of the current feeders and coil terminal boxes for JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Coil terminal box; Current feeder; Electrical joint; JT-60SA; NbTi		Feeders and coil terminal boxes (CTBs) of the superconducting magnets for JT-60SA have been designed. A small tool which can connect soldering joint with vertical direction in the cryostat has been developed. The joint resistance of the sample showed 1.7 n Omega at 2T, 4.2 K, 20 kA which is within the requirement of <5 n Omega. A prototype feeder in CTB with crank shape was manufactured. The maximum dimensional error was 3 mm being within the requirement of +/- 10 mm. Feeder insulation samples showed a shear strength >60 MPa which is much higher than the requirement of 10 MPa as derived from analysis. Since all the manufacturing processes concerned have been proof-tested, the production of feeders and CTBs has been released. (C) 2015 Elsevier B.V. All rights reserved.	[Kizu, Kaname; Murakami, Haruyuki; Natsume, Kyohei; Tsuchiya, Katsuhiko; Koide, Yoshihiko; Yoshida, Kiyoshi] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Obana, Tetsuhiro; Hamaguchi, Shinji; Takahata, Kazuya] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Kizu, K (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan.	kizu.kaname@jaea.go.jp					Song Y, 2010, IEEE T APPL SUPERCON, V20, P1710, DOI 10.1109/TASC.2010.2044566; Obana T, 2010, IEEE T APPL SUPERCON, V20, P1471, DOI 10.1109/TASC.2009.2039637; Fietz WH, 2009, IEEE T APPL SUPERCON, V19, P2202, DOI 10.1109/TASC.2009.2019550; Yoshida K, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2174545; Kizu K, 2011, FUSION ENG DES, V86, P1432, DOI 10.1016/j.fusengdes.2011.01.028; FAST RW, 1988, CRYOGENICS, V28, P7, DOI 10.1016/0011-2275(88)90223-8; KITAMURA K, 1994, IEEE T MAGN, V30, P1879, DOI 10.1109/20.305628; Yoshida K, 2013, FUSION ENG DES, V88, P1499, DOI 10.1016/j.fusengdes.2012.12.010; Zani L, 2013, FUSION ENG DES, V88, P555, DOI 10.1016/j.fusengdes.2012.12.032	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1094	1097		10.1016/j.fusengdes.2015.04.030		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900013		
J	Lampasi, A; Zito, P; Coletti, A; Novello, L; Matsukawa, M; Shimada, K; Burini, F; Fone, YK; Taddia, G; Tenconi, S				Lampasi, Alessandro; Zito, Pietro; Coletti, Alberto; Novello, Luca; Matsukawa, Makoto; Shimada, Katsuhiro; Burini, Filippo; Fone, Yannick Kuate; Taddia, Giuseppe; Tenconi, Sandro			First Switching Network Unit for the JT-60SA superconducting Central Solenoid	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Switching Network Unit (SNU); DC current interruption; Hybrid electromechanical-electronic switch; High current tests	DESIGN	This paper presents the main characteristics and test results of the first Switching Network Unit (SNU) of the Central Solenoid for plasma initiation in the international experiment JT-60SA. The SNU can interrupt a direct current up to 20 kA producing at its terminals a voltage up to 5 kV with a rise time shorter than 100 mu s. This is obtained by synchronizing the operation of a light electromechanical contactor with a static switch in order to combine the benefits of both devices. Even though the design was based on the JT-60SA specifications, the adopted solutions can be extended to many fusion and industrial applications. Due to the novelty of the developed solutions, an exhaustive set of tests were performed both on relevant single devices and on the complete SNU, even at full current, full voltage and full energy. The most relevant tests were performed using the Frascati Tokamak Upgrade (FTU) facilities reproducing the JT-60SA operating conditions. As the presented tests demonstrated the capabilities of the SNU to comply with the requirements, the manufacturing of the remaining three Central Solenoid SNUs can proceed and is expected to be completed by 2015. (C) 2015 Elsevier B.V. All rights reserved.	[Lampasi, Alessandro; Zito, Pietro] Natl Agcy New Technol Energy & Sustainable Econ D, Frascati, Italy; [Coletti, Alberto; Novello, Luca] Fus Energy F4E Broader Fus Dev Dept, Garching, Germany; [Matsukawa, Makoto; Shimada, Katsuhiro] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Burini, Filippo; Fone, Yannick Kuate; Taddia, Giuseppe; Tenconi, Sandro] OCEM Energy Technol, Valsamoggia, Italy	Lampasi, A (reprint author), Natl Agcy New Technol Energy & Sustainable Econ D, Frascati, Italy.	alessandro.lampasi@enea.it		Lampasi, Alessandro/0000-0003-4395-3496			Lampasi A, 2014, FUSION ENG DES, V89, P342, DOI 10.1016/j.fusengdes.2014.02.080; Yamauchi K, 2013, PLASMA SCI TECHNOL, V15, P148, DOI 10.1088/1009-0630/15/2/14; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Roshal A, 2011, FUSION ENG DES, V86, P1450, DOI 10.1016/j.fusengdes.2011.01.032; Neumeyer C., 2013, 2013 IEEE 25 S FUS E, P1; Novello L, 2015, FUSION ENG DES, V98-99, P1122, DOI 10.1016/j.fusengdes.2015.06.014	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1098	1102		10.1016/j.fusengdes.2015.06.177		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900014		
J	Maistrello, A; Gaio, E; Novello, L; Matsukawa, M; Yamauchi, K				Maistrello, Alberto; Gaio, Elena; Novello, Luca; Matsukawa, Makoto; Yamauchi, Kunihito			Analyses of the impact of connections' layout on the coil transient voltage at the Quench Protection Circuit intervention in JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Quench Protection Circuit; dc current interruption; Layout optimization		The transient overvoltages associated to the interruption of high direct currents with high current derivative, at the base of the operation of a Quench Protection System for Superconducting Coils, have been studied, with particular reference to the JT-60SA project, which adopt edge technology solutions for current interruption: a Hybrid mechanical-static Circuit Breaker as main circuit breaker in series with a PyroBreaker as backup protection. The paper reports in particular on the analyses of the intervention of the backup circuit breaker in the final circuital conditions, considering the actual power connections that will be implemented on Site. The key elements which influence the peak value of the voltage and the relation existing among the different stray impedances of the circuit are identified, thus giving general guidelines for the design of the layout of the power connections. The specific case of JT-60SA is considered, but general criteria can be derived. (C) 2015 Elsevier B.V. All rights reserved.	[Maistrello, Alberto; Gaio, Elena] Consorzio RFX, Padua, Italy; [Novello, Luca] Fus Energy, Broader Dev Fus Dept, Garching, Germany; [Matsukawa, Makoto; Yamauchi, Kunihito] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan	Maistrello, A (reprint author), Consorzio RFX, Padua, Italy.	alberto.maistrello@igi.cnr.it					Gaio E, 2013, FUSION ENG DES, V88, P563, DOI 10.1016/j.fusengdes.2013.02.083; Gaio E, 2012, IEEE T PLASMA SCI, V40, P557, DOI 10.1109/TPS.2011.2171008; Manzuk M, 2013, FUSION ENG DES, V88, P1537, DOI 10.1016/j.fusengdes.2013.01.006; Maistrello, 2014, IEEE T APPL SUPERCON, V24	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1109	1112		10.1016/j.fusengdes.2015.06.020		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900016		
J	Matsunaga, G; Takechi, M; Sakurai, S; Suzuki, Y; Ide, S; Urano, H				Matsunaga, G.; Takechi, M.; Sakurai, S.; Suzuki, Y.; Ide, S.; Urano, H.			In-vessel coils for magnetic error field correction in JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Error field; Resonant magnetic perturbation	SYSTEM	We have designed in-vessel coils for a correction of magnetic error fields in JT-60SA. In order to design the in-vessel coils, namely, error field correction coils (EFCCs), error fields from several sources such as manufacturing and assembly errors of superconducting coils are calculated by Monte-Carlo approach. Required EFCC currents to correct error fields are evaluated by a least square method. Additionally, by the field line tracing, it is found that resonant magnetic perturbations (RMPs) by the EFCC enable to produce stochastic magnetic structures at the edge region, that is applicable to an ELM control. (C) 2015 Elsevier B.V. All rights reserved.	[Matsunaga, G.; Takechi, M.; Sakurai, S.; Ide, S.; Urano, H.] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Suzuki, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Matsunaga, G (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki, Japan.	matsunaga.go@jaea.go.jp					Ikeda Y, 2007, FUSION ENG DES, V82, P791, DOI 10.1016/j.fusengdes.2007.05.077; Shimada M, 2007, NUCL FUSION, V47, pS1, DOI 10.1088/0029-5515/47/6/S01; Ishida S, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094018; Park JK, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/4/045006; Hender TC, 2007, NUCL FUSION, V47, pS128, DOI 10.1088/0029-5515/47/6/S03; Evans TE, 2005, NUCL FUSION, V45, P595, DOI 10.1088/0029-5515/45/7/007; Kamada Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073011; Knaster J, 2011, FUSION ENG DES, V86, P1053, DOI 10.1016/j.fusengdes.2011.02.045; Suzuki Y., 2014, P 25 IAEA FUS EN C 1	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1113	1117		10.1016/j.fusengdes.2015.06.024		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900017		
J	Novello, L; Baulaigue, O; Coletti, A; Dumas, N; Ferro, A; Gaio, E; Lampasi, A; Maistrello, A; Matsukawa, M; Shimada, K; Yamauchi, K; Zito, P				Novello, Luca; Baulaigue, Olivier; Coletti, Alberto; Dumas, Nicolas; Ferro, Alberto; Gaio, Elena; Lampasi, Alessandro; Maistrello, Alberto; Matsukawa, Makoto; Shimada, Katsuhiro; Yamauchi, Kunihito; Zito, Pietro			Overview of the new Magnet Power Supply Systems of JT-60SA procured by EU	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Power Supply; ac-dc converter; dc current interruption; Inverter	DESIGN	JT-60SA, the superconducting tokamak under construction in Japan, will be equipped with a mix of new and reused Power Supply Systems. Most of the new Power Supply Systems are procured by European Voluntary Contributors under the framework of Broader Approach agreement between Europe and Japan. For the toroidal circuit, the 25.7 kA steady state ac/dc converter is procured by CEA. For the poloidal circuits, the procurement of 10 ac/dc converters, almost all rated +/- 20 kA and about +/- 1 kV is shared between CEA and ENEA. The two in-vessel coils for fast control of plasma position are supplied with two independent thyristor converters procured by ENEA, each one rated +/- 5 kA and +/- 1 kV. The operation of four Switching Network Units procured by ENEA inserts settable resistors in series to each Central Solenoid module, producing up to 5 kV at the nominal current of 20 kA and allowing stable plasma initiation. The protection of toroidal and poloidal superconducting magnets is assured by thirteen Quench Protection Circuits procured by Consorzio RFX, rated +/- 20 kA and +/- 3.8 kV for poloidal coils and 25.7 kA and 2.8 kV for toroidal ones, inserting a discharge resistor in the related circuit for fast dissipation of the magnetic energy stored in the coil. Finally, the suppression of Resistive Wall Modes is actively performed by 18 in-vessel coils, independently supplied by a corresponding number of fast inverters procured by Consorzio RFX, each one rated for 300A and 240V. The key aspects of the design of the aforementioned Power Supply Systems are described in the paper, informing also about the present status of the procurement: their design was completed and some systems were already manufactured, tested and delivered to Japan. (C) 2015 Elsevier B.V. All rights reserved.	[Novello, Luca; Coletti, Alberto] Fus Energy, Garching, Germany; [Baulaigue, Olivier; Dumas, Nicolas] CEA Cadarache, IRFM, F-13108 St Paul Les Durance, France; [Ferro, Alberto; Gaio, Elena; Maistrello, Alberto] Consorzio RFX, Padua, Italy; [Lampasi, Alessandro; Zito, Pietro] ENEA, Frascati, Italy; [Matsukawa, Makoto; Shimada, Katsuhiro; Yamauchi, Kunihito] JAEA, Naka, Ibaraki, Japan	Novello, L (reprint author), Fus Energy, Garching, Germany.	luca.novello@jt60sa.org		Lampasi, Alessandro/0000-0003-4395-3496			Lampasi A, 2014, FUSION ENG DES, V89, P342, DOI 10.1016/j.fusengdes.2014.02.080; Gaio E, 2013, FUSION ENG DES, V88, P563, DOI 10.1016/j.fusengdes.2013.02.083; Ferro A, 2013, FUSION ENG DES, V88, P1509, DOI 10.1016/j.fusengdes.2013.01.094; Coletti A, 2011, FUSION ENG DES, V86, P1373, DOI 10.1016/j.fusengdes.2011.02.042; Gaio E, 2012, IEEE T PLASMA SCI, V40, P557, DOI 10.1109/TPS.2011.2171008; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Benfatto I., 1995, 16 S FUS ENG SOFE; Ferro A., 2014, 28 S FUS TECHN SOFT; Lampasi A., 2014, 28 S FUS TECHN SOFT; Zito P., 2014, 28 S FUS TECHN SOFT	10	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1122	1126		10.1016/j.fusengdes.2015.06.014		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900019		
J	Zito, P; Lampasi, A; Coletti, A; Novello, L; Matsukawa, M; Shimada, K; Cinarelli, D; Portesine, M; Dorronsoro, A; Vian, D				Zito, P.; Lampasi, A.; Coletti, A.; Novello, L.; Matsukawa, M.; Shimada, K.; Cinarelli, D.; Portesine, M.; Dorronsoro, A.; Vian, D.			Design and realization of JT-60SA Fast Plasma Position Control Coils power supplies	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Power supply; AC/DC converter; In vessel coil		Fast Plasma Position Control Coils (FPPCC) PSs control the vertical position of the plasma during a plasma shot, to prevent Vertical Displacement Event (VDE), using FPPC coils installed in vacuum vessel for JT-60SA. For this task, the FPPCC PSs have to be very fast for reacting to plasma movements. Further, an open loop feed forward voltage control is adopted in order to achieve a fast control of FPPCC PSs. The main characteristics are: 4-quadrant AC/DC converter 12-pulse with circulating current, DC load voltage +/- 1000 V and DC load current +/- 5 kA. The overvoltage induced by FPPC coil during a plasma disruption can reach 10 kV and it is protected by a nonlinear resistor in parallel to the crowbar up to its intervention. All these technical characteristics have strongly influenced the design of the FPPCC converter and transformers which have been validated by simulation model of FPPCC PS. The outcomes of the simulation allowed to finalize the performances and dynamic behavior of voltage response. (C) 2015 Elsevier B.V. All rights reserved.	[Zito, P.; Lampasi, A.] Natl Agcy New Technol Energy & Sustainable Econ D, I-00044 Frascati, Italy; [Coletti, A.; Novello, L.] Fus Energy F4E Broader Fus Dev Dept, Garching, Germany; [Matsukawa, M.; Shimada, K.] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Cinarelli, D.; Portesine, M.] POSEICO, I-16152 Genoa, Italy; [Dorronsoro, A.; Vian, D.] JEMA, Lasarte Oria Gipuzkoa 20160, Spain	Zito, P (reprint author), Natl Agcy New Technol Energy & Sustainable Econ D, Via E Fermi 45, I-00044 Frascati, Italy.	pietro.zito@enea.it		Lampasi, Alessandro/0000-0003-4395-3496			Shimada K, 2011, FUSION ENG DES, V86, P1427, DOI 10.1016/j.fusengdes.2011.02.097; Jin JK, 2013, IEEE T PLASMA SCI, V41, P1799, DOI 10.1109/TPS.2013.2263299; Huang H., 2013, IEEE T APPL SUPERCON, V23; Novello L., 2014, SOFT C; Novello L., 2011, FUSION ENG DES, V86; Song I., 2014, IEEE T APPL SUPERCON, V24	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1191	1196		10.1016/j.fusengdes.2015.05.069		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900033		
J	Ezato, K; Suzuki, S; Seki, Y; Mohri, K; Yokoyama, K; Escourbiac, F; Hirai, T; Kuznetcov, V				Ezato, K.; Suzuki, S.; Seki, Y.; Mohri, K.; Yokoyama, K.; Escourbiac, F.; Hirai, T.; Kuznetcov, V.			Progress of ITER full tungsten divertor technology qualification in Japan	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		ITER; Divertor; Outer target; Tungsten monoblock; High heat flux test		Japan Atomic Energy Agency (JAEA) is in progress for technology qualification toward full-tungsten (W) ITER divertor outer vertical target (OVT), especially, tungsten monoblock technology that needs to withstand the repetitive heat load as high as 20 MW/m(2). To demonstrate the armor heat sink bonding technology and heat removal capability, 6 small-scale W monoblock mock-ups manufactured by different bonding technologies using different W materials in addition to 4 full-scale prototype plasma-facing units (PFUs). After non-destructive test, the W components were tested under high heat flux (HHF) in ITER Divertor Test Facility (IDTF) at NIIEFA. Consequently, all of the W monoblocks endured the repetitive heat load at 20MW/m(2) for 1000 cycles (requirements 20 MW/m(2) for 300 cycles) without any failure. In addition to the armor to heat sink joints, the load carrying capability test on the W monoblock with a leg attachment was carried out. In uniaxial tensile test, all of the W monoblock attachments with different bonding technologies such as brazing and HIPping withstand the tensile load exceeding 20 kN that is the value more than twice the design value. The failures occurred at the leg attachments or the W monoblocks, rather than the bonding interface of the W monoblocks to the leg attachment. (C) 2015 Elsevier B.V. All rights reserved.	[Ezato, K.; Suzuki, S.; Seki, Y.; Mohri, K.; Yokoyama, K.] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Escourbiac, F.; Hirai, T.] ITER Org, F-13067 St Paul Les Durance, France; [Kuznetcov, V.] DV Efremov Sci Res Inst Electrophys Apparatus, St Petersburg 196641, Russia	Ezato, K (reprint author), Japan Atom Energy Agcy, 801-1 Mukoyma, Naka, Ibaraki, Japan.	ezato.koichiro@jaea.go.jp					Hirai T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014006; Hirai T, 2013, FUSION ENG DES, V88, P1798, DOI 10.1016/j.fusengdes.2013.05.010; Kuznetsov V, 2014, FUSION ENG DES, V89, P955, DOI 10.1016/j.fusengdes.2014.04.064; Pintuk G., CHARACTERIZATION ITE	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1281	1284		10.1016/j.fusengdes.2015.03.009		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900051		
J	Gwon, H; Matsuda, S; Kasada, R; Konishi, S				Gwon, Hyoseong; Matsuda, Shinzaburo; Kasada, Ryuta; Konishi, Satoshi			Evaluation of thermal structural behavior of divertor under ELM	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		ELM; Critical ELM energy flux; Thermal stress		In this study, a YAG laser was used to simulate the transient heat load like ELM for the tungsten target, and the experiment results were compared with the analysis results by using finite element method. Average of total heat flux, ELM energy flux, and pulse width of ELM was considered as parameters in the analysis. Based on the results the thermal structural behavior of tungsten target under ELM was evaluated. When approximately 0.25 MJ/m(2) of ELM energy flux was applied, crack, and plastic deformation occurred at the tungsten surface even though recrystallization was not confirmed. It implied that the tungsten target could be damaged by thermal stress even at below 0.5 MJ/m(2). In addition the crack propagation under ELM was also investigated in this study. (C) 2015 Elsevier B.V. All rights reserved.	[Gwon, Hyoseong; Matsuda, Shinzaburo; Kasada, Ryuta; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Kyoto, Japan; [Matsuda, Shinzaburo] Tokyo Inst Technol, Tokyo 152, Japan	Gwon, H (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto, Japan.	gwonhs0213@gmail.com					Pitts RA, 2011, J NUCL MATER, V415, pS957, DOI 10.1016/j.jnucmat.2011.01.114; Oyama N, 2007, PLASMA PHYS CONTR F, V49, P249, DOI 10.1088/0741-3335/49/3/005; Zhitlukhin A, 2007, J NUCL MATER, V363, P301, DOI 10.1016/j.jnucmat.2007.01.027; Eich T, 2013, J NUCL MATER, V438, pS72, DOI 10.1016/j.jnucmat.2013.01.011; Federici G., 2003, PLASMA PHYS CONTROL, V45; Gludovatz B., 2010, INT J REFRACT METALS, V28; Holman JP, 2011, HEAT TRANSFER; Kirk A., 2008, J PHYS C SER, V123; Linke J., 2011, NUCL FUSION, V51; Pleli I., 2006, ANN REPORT ASS FORSC; Raffray A. R., 1999, FUSION ENG DES, V45; Smid I., 1998, J NUCL MATER, V25, P258; Tada H., 1973, STRESS ANAL CRACKS H; van Eden G. G., 2014, NUCL FUSION, V54; Wirtz M., 2013, J NUCL MAT, V438; Zohm H, 1996, PLASMA PHYS CONTR F, V38, P105, DOI 10.1088/0741-3335/38/2/001	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1318	1322		10.1016/j.fusengdes.2015.02.015		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900059		
J	Uehara, K; Katayama, K; Date, H; Fukada, S				Uehara, Keiichiro; Katayama, Kazunari; Date, Hiroyuki; Fukada, Satoshi			Hydrogen gas driven permeation through tungsten deposition layer formed by hydrogen plasma sputtering	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		D-T fusion reactor; Tungsten deposition; Sputtering; Hydrogen permeation; Hydrogen isotope	DEUTERIUM; BEHAVIOR; ISOTOPES; NICKEL	It is important to evaluate the influence of deposition layers formed on plasma facing wall on tritium permeation and tritium retention in the vessel of a fusion reactor from a viewpoint of safety. In this work, tungsten deposition layers having different thickness and porosity were formed on circular nickel plates by hydrogen RF plasma sputtering. Hydrogen permeation experiment was carried out at the temperature range from 250 degrees C to 500 degrees C and at hydrogen pressure range from 1013 Pa to 101,300 Pa. The hydrogen permeation flux through the nickel plate with tungsten deposition layer was significantly smaller than that through a bare nickel plate. This indicates that a rate-controlling step in hydrogen permeation was not permeation through the nickel plate but permeation though the deposition layer. The pressure dependence on the permeation flux differed by temperature. Hydrogen permeation flux through tungsten deposition layer is larger than that through tungsten bulk. From analysis of the permeation curves, it was indicated that hydrogen diffusivity in tungsten deposition layer is smaller than that in tungsten bulk and the equilibrium hydrogen concentration in tungsten deposition layer is enormously larger than that in tungsten bulk at same hydrogen pressure. (C) 2015 Elsevier B.V. All rights reserved.	[Uehara, Keiichiro; Katayama, Kazunari; Date, Hiroyuki; Fukada, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Katayama, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp					Esteban GA, 2001, J NUCL MATER, V295, P49, DOI 10.1016/S0022-3115(01)00486-X; Katayama K, 2008, FUSION SCI TECHNOL, V54, P549; Nakamura H, 2001, J NUCL MATER, V297, P285, DOI 10.1016/S0022-3115(01)00635-3; Shiraishi T, 1998, J NUCL MATER, V254, P205, DOI 10.1016/S0022-3115(97)00362-0; Nemanic V, 2012, J NUCL MATER, V429, P92, DOI 10.1016/j.jnucmat.2012.05.031; Chikada T., 2011, NUCL FUSION, V9, P1; FRAUENFE.R, 1968, J CHEM PHYS, V48, P3955, DOI 10.1063/1.1669720; Ishikawa S, 2012, FUSION ENG DES, V87, P1390, DOI 10.1016/j.fusengdes.2012.03.021; Katayama K, 2013, J NUCL MATER, V438, pS1010, DOI 10.1016/j.jnucmat.2013.01.220; Nemanic V, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4898061; ROBERTSO.WM, 1973, Z METALLKD, V64, P436; Zakharov A.P., 1973, SOV MATER SCI, V9, P149	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1341	1344		10.1016/j.fusengdes.2015.01.027		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900064		
J	Tsuru, D; Sakurai, S; Nakamura, S; Ozaki, H; Seki, Y; Yokoyama, K; Suzuki, S				Tsuru, Daigo; Sakurai, Shinji; Nakamura, Shigetoshi; Ozaki, Hidetsugu; Seki, Yohji; Yokoyama, Kenji; Suzuki, Satoshi			Development of residual thermal stress-relieving structure of CFC monoblock target for JT-60SA divertor	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		CFC monoblock target; Vacuum brazing; Residual thermal stress; Numerical simulation; Infrared thermography inspection; High heat flux test		Carbon fibre-reinforced carbon composite (CFC) monoblock target for JT-60SA divertor is under development towards the mass-production. CFC monoblocks, WCu interlayers and a CuCrZr cooling tube at the centre of the monoblocks were bonded by vacuum brazing in a high temperature, to a target. If residual thermal stress due to difference of thermal expansions between CFC and CuCrZr exceeds the maximum allowable stress of the CFC after the bonding, cracks are generated in the CFC monoblock and heat removal capacity of the target degrades. In this paper, new structures of the targets were proposed, to reduce residual thermal stress and to mitigate the degradation of heat removal capacity of the targets. Some measures, including slitting of the CFC monoblock aside of the cooling tube, replacement of the interlayer material and shifting the position of the cooling tube, were implemented. The effectiveness of the measures was evaluated by numerical simulations. Target mock-ups with the proposed structures were manufactured. Infrared thermography inspection and high heat flux test were carried out on the mock-ups in order to evaluate the heat removal capacity. (C) 2015 Elsevier B.V. All rights reserved.	[Tsuru, Daigo; Sakurai, Shinji; Nakamura, Shigetoshi; Ozaki, Hidetsugu; Seki, Yohji; Yokoyama, Kenji; Suzuki, Satoshi] Japan Atom Energy Agcy, Tokyo, Japan	Tsuru, D (reprint author), Japan Atom Energy Agcy, Tokyo, Japan.	tsuru.daigo@jaea.go.jp					Nakamura S, 2014, FUSION ENG DES, V89, P1024, DOI 10.1016/j.fusengdes.2014.02.067; Masaki K, 2002, FUSION ENG DES, V61-62, P171, DOI 10.1016/S0920-3796(02)00115-1; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Seki Y, 2010, FUSION ENG DES, V85, P1451, DOI 10.1016/j.fusengdes.2010.04.010; Ezato K, 2012, FUSION ENG DES, V87, P1177, DOI 10.1016/j.fusengdes.2012.02.094; Sakurai S., 2010, P 23 INT C FUS EN	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1403	1406		10.1016/j.fusengdes.2015.02.052		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900078		
J	Kim, GH; Park, CK; Ahn, HJ; Kim, HS; Hong, KH; Jin, SW; Lee, HG; Fukanuma, H; Huang, R; Roh, BR; Kim, TS; Sung, HJ; Sa, JW; Choi, CH				Kim, G. H.; Park, C. K.; Ahn, H. J.; Kim, H. S.; Hong, K. H.; Jin, S. W.; Lee, H. G.; Fukanuma, H.; Huang, R.; Roh, B. R.; Kim, T. S.; Sung, H. J.; Sa, J. W.; Choi, C. H.			Fabrication feasibility study on copper cold spray in tokamak system	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tokamak; Copper coating; Cold spray; Overlay welding; Plasma stabilization		To improve the plasma vertical stabilization during tokamak operation, partial pure copper layer could be considered on the inner shell of vacuum vessel which is large complex component made of stainless steel. The copper cladding has been a great challenge due to the complicated configuration and difficulty of dissimilar metal joining. From an engineering point of view, there are several candidates for the copper cladding such as cold spray, overlay welding and explosive welding. In this paper, fabrication feasibility study for copper cladding has been carried out by using cold spray method, and a set of full scale mock-up of in-vessel component has been conducted to demonstrate applicability of copper cold spray and to verify copper layer. The results of copper cold spray on test specimens and mock-up showed good properties and no defects on the thick copper layer. Optimum conditions of copper cold spray have been developed based on these results. Accordingly, it can be concluded that cold spray is a feasible and practical method to achieve thick copper cladding on tokamak component. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, G. H.; Park, C. K.; Ahn, H. J.; Kim, H. S.; Hong, K. H.; Jin, S. W.; Lee, H. G.] ITER Korea, Natl Fus Res Inst, Daejeon 305333, South Korea; [Fukanuma, H.; Huang, R.] Plasma Giken Co Ltd, Saitama 3691214, Japan; [Roh, B. R.; Kim, T. S.; Sung, H. J.] Hyundai Heavy Ind Co Ltd, Ulsan 682792, South Korea; [Sa, J. W.; Choi, C. H.] ITER Org, F-13067 St Paul Les Durance, France	Park, CK (reprint author), ITER Korea, Natl Fus Res Inst, Daejeon 305333, South Korea.	ckpark@nfri.re.kr					Kim BC, 2013, FUSION ENG DES, V88, P1960, DOI 10.1016/j.fusengdes.2013.01.012; Karthikeyan J., 2013, ASM HDB, V5A, P54; loki K., 2009, FUS ENG DES, V84, P229; Portone A., COMMUNICATION	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1576	1579		10.1016/j.fusengdes.2015.06.134		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900116		
J	Shibama, Y; Okano, F; Yagyu, J; Kaminaga, A; Miyo, Y; Hayakawa, A; Sagawa, K; Mochida, T; Morimoto, T; Hamada, T; Minemura, T; Yoneta, D; Ogawa, H; Mizumaki, S; Okuyama, T; Nobuoka, Y; Asano, S; Masaki, K; Sakasai, A				Shibama, Yusuke; Okano, Fuminori; Yagyu, Junnichi; Kaminaga, Atsushi; Miyo, Yasuhiko; Hayakawa, Atsuro; Sagawa, Keiich; Mochida, Tsutomu; Morimoto, Tamotsu; Hamada, Takashi; Minemura, Toshiyuki; Yoneta, Daiki; Ogawa, Hiromichi; Mizumaki, Shoichi; Okuyama, Toshihisa; Nobuoka, Yoshishige; Asano, Shiro; Masaki, Kei; Sakasai, Akira			Welding technology on sector assembly of the JT-60SA vacuum vessel	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Vacuum vessel; Onsite assembly; Root gap; Linear misalignment; Plastic deformation; JT-60SA		Manufacturing of JT-60SA Vacuum Vessel (VV) is under the onsite sector assembly, where ten W sectors are to be welded together into a torus. The vessel is 6.6 m height and 5 m major radius and a double wall structure with the thickness of 18 mm and locally 30 mm, and total dimensional tolerance is designed to avoid any interference due to operational displacements. In this paper, two issues are focused: the onsite sector assembly concept and sector welding technology. The assembly concept is a contrivance to fulfil high precision as a large torus W and efficient procedure, and obtained with combination of the direct butt joint and splice plate joint. The welding technology is a method to realize the VV, and investigated on acceptable error sizes with the test pieces for the onsite manipulator welding. Correction method of sector edge is also confirmed by the mock-up. Moreover, application to the onsite sector assembly is discussed. The onsite assembly has been started by this concept with its welding technology. (C) 2015 Elsevier B.V. All rights reserved.	[Shibama, Yusuke; Okano, Fuminori; Yagyu, Junnichi; Kaminaga, Atsushi; Miyo, Yasuhiko; Masaki, Kei; Sakasai, Akira] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Hayakawa, Atsuro; Sagawa, Keiich; Mochida, Tsutomu; Morimoto, Tamotsu; Hamada, Takashi; Minemura, Toshiyuki; Mizumaki, Shoichi; Okuyama, Toshihisa; Asano, Shiro] Toshiba Co Ltd, Isogo Ku, Yokohama, Kanagawa, Japan; [Yoneta, Daiki; Ogawa, Hiromichi; Nobuoka, Yoshishige] Toshiba Plant Syst & Serv Corp, Isogo Ku, Yokohama, Kanagawa, Japan	Shibama, Y (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki, Japan.	shibama.yusuke@jaea.go.jp					Medrano M, 2013, FUSION ENG DES, V88, P711, DOI 10.1016/j.fusengdes.2013.01.028; Asano S, 2011, FUSION ENG DES, V86, P1816, DOI 10.1016/j.fusengdes.2011.03.024; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Shibanuma K, 2013, FUSION ENG DES, V88, P705, DOI 10.1016/j.fusengdes.2012.12.011; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Masaki K, 2012, FUSION ENG DES, V87, P742, DOI 10.1016/j.fusengdes.2012.02.014; Sakasai A., 2012, P 24 IAEA FUS EN C S	7	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1614	1619		10.1016/j.fusengdes.2015.06.072		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900125		
J	Tamura, H; Tanaka, T; Goto, T; Miyazawa, J; Masuzaki, S; Watanabe, T; Yanagi, N; Sagara, A; Ito, S; Hashizume, H				Tamura, Hitoshi; Tanaka, Teruya; Goto, Takuya; Miyazawa, Junich; Masuzaki, Suguru; Watanabe, Tsuguhiro; Yanagi, Nagato; Sagara, Akio; Ito, Satoshi; Hashizume, Hidetoshi			Novel divertor design to mitigate neutron irradiation in the helical reactor FFHR-d1	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Helical reactor; FFHR; Divertor; Irradiation; Superconducting magnet; Structural analysis	DEMO	The heat flux at the divertor in a fusion reactor is considered to have a peak of >10 MW/m(2). In a design study of the helical reactor FFHR-d1, the feasibility of employing a copper alloy for divertor cooling pipes was investigated; however, radiation in the divertor area would quickly damage the copper alloy. The neutron load on the divertor can be reduced by a blanket arrangement; nevertheless, in the present divertor structure, irradiation damage of materials on the inboard side of the torus remains relatively high. If the divertor could be moved to an area receiving much less radiation, then the lifetimes of divertor materials should increase. In this paper, a novel divertor structure is introduced in which the coil-support structure is modified to create a region receiving relatively low amounts of radiation without changing the geometry of the helical or vertical field coils. Using this proposed design would increase the lifetime of the copper alloy in divertor components to more than an estimated six years. In addition, the divertor could be accessed from either the upper or lower sides of the device, simplifying maintenance. (C) 2015 Elsevier B.V. All rights reserved.	[Tamura, Hitoshi; Tanaka, Teruya; Goto, Takuya; Miyazawa, Junich; Masuzaki, Suguru; Watanabe, Tsuguhiro; Yanagi, Nagato; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ito, Satoshi; Hashizume, Hidetoshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	Tamura, H (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	tamura@nifs.ac.jp					Tanaka T, 2014, FUSION ENG DES, V89, P1939, DOI 10.1016/j.fusengdes.2014.02.071; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Sagara A, 2012, FUSION ENG DES, V87, P594, DOI 10.1016/j.fusengdes.2012.01.030; Tamura H, 2014, FUSION ENG DES, V89, P2336, DOI 10.1016/j.fusengdes.2014.02.058; Yanagi N, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2292775; EDWARDS DJ, 1992, J NUCL MATER, V191, P416; Yanagi N, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103017; Chida Y, 2011, FUSION ENG DES, V86, P2900, DOI 10.1016/j.fusengdes.2011.06.004; Li-Puma A, 2013, FUSION ENG DES, V88, P1836, DOI 10.1016/j.fusengdes.2013.05.114; GOURDON C, 1971, NUCL FUSION, V11, P161; Ito S., 2014, APPL SUP C AUG 10 15; Yanagi N., 2012, 24 FUS EN C SAN DIEG	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1629	1633		10.1016/j.fusengdes.2015.01.025		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900128		
J	Tanigawa, H; Maruyama, T; Noguchi, Y; Takeda, N; Kakudate, S				Tanigawa, Hisashi; Maruyama, Takahito; Noguchi, Yuto; Takeda, Nobukazu; Kakudate, Satoshi			Laser welding to expand the allowable gap in bore welding for ITER blanket hydraulic connection	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Remote handling; Maintenance; Re-welding; Irradiated materials; Tool lifetime		For application to bore welding of hydraulic connection in the ITER blanket module, laser welding presents the following benefits: low weld heat input is preferred for re-welding of the irradiated material. Its contactless process can intrinsically avoid a failure mode of the tool sticking on the weld. The exact requirements for pipe alignment were assessed in comparison with the assembly tolerance. The groove geometry was modified to expand the allowable initial gap. The groove was machined to be partially thick to obviate the filler wire. First, plates with partially thick grooves were welded to elucidate the preferred groove geometry and welding conditions. With the modified groove, the plates were welded for the initial gap of 1.0 mm. Then the groove geometry and welding conditions were adjusted based on results of pipe welding tests. By application of the additional 0.5-mm-thick and 2.5-mm-wide metal in the groove, pipes with an initial gap of 0.7 mm were welded successfully. (C) 2015 Elsevier B.V. All rights reserved.	[Tanigawa, Hisashi; Maruyama, Takahito; Noguchi, Yuto; Takeda, Nobukazu; Kakudate, Satoshi] Japan Atom Energy Agcy, Naka, Ibaraki, Japan	Tanigawa, H (reprint author), Japan Atom Energy Agcy, 801-1 Mukoyama, Naka, Ibaraki, Japan.	tanigawa.hisashi@jaea.go.jp					Tanigawa H, 2012, FUSION ENG DES, V87, P999, DOI 10.1016/j.fusengdes.2012.02.055; Merola M, 2014, FUSION ENG DES, V89, P890, DOI 10.1016/j.fusengdes.2014.01.055	2	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1634	1637		10.1016/j.fusengdes.2015.06.155		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900129		
J	Utoh, H; Tobita, K; Someya, Y; Asakura, N; Sakamoto, Y; Hoshino, K; Nakamura, M				Utoh, Hiroyasu; Tobita, Kenji; Someya, Youji; Asakura, Nobuyuki; Sakamoto, Yoshiteru; Hoshino, Kazuo; Nakamura, Makoto			Comparative evaluation of remote maintenance schemes for fusion DEMO reactor	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Remote maintenance; DEMO; Segment; Sector transport; Fusion reactor	PLASMA VERTICAL POSITION; DESIGN	Maintenance schemes are one of the critical issues in DEMO design, significantly affecting the configuration of in-vessel components, the size of toroidal field (TF) coil, the arrangement of poloidal field (PF) coils, reactor building, hot cell and so forth. Therefore, the maintenance schemes should satisfy many design requirements and criteria to assure reliable and safe plant operation and to attain reasonable plant availability. The plant availability depends on reliability of remote maintenance scheme, inspection of pipe connection and plasma operation. In this paper, various remote maintenance schemes for DEMO were comparatively assessed based on requirements for DEMO remote maintenance. From the view points of the reliability of inspection on hot cell, TF coil size, stored energy of PF coil and portability of segment, the banana shape segment transport using all vertical maintenance ports would be more probable DEMO reactor maintenance scheme, and it has key engineering issues such as in-vessel transferring mechanism of segment, pipe connection and conducting shell design for plasma vertical stability. (C) 2015 Elsevier B.V. All rights reserved.	[Utoh, Hiroyasu; Tobita, Kenji; Someya, Youji; Asakura, Nobuyuki; Sakamoto, Yoshiteru; Hoshino, Kazuo; Nakamura, Makoto] Japan Atom Energy Agcy, Rokkasho, Japan	Utoh, H (reprint author), Japan Atom Energy Agcy, Rokkasho, Japan.	uto.hiroyasu@jaea.go.jp					Tobita K, 2011, FUSION ENG DES, V86, P2730, DOI 10.1016/j.fusengdes.2011.03.022; Maisonnier D, 2008, FUSION ENG DES, V83, P858, DOI 10.1016/j.fusengdes.2008.05.014; KASAI M, 1988, FUSION ENG DES, V5, P343; Ihli T, 2007, FUSION ENG DES, V82, P2705, DOI 10.1016/j.fusengdes.2007.02.034; NISHIO S, 1993, FUSION ENG DES, V23, P17, DOI 10.1016/0920-3796(93)90107-S; Utoh H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123005; KAMEARI A, 1985, NUCL ENG DES FUSION, V2, P365, DOI 10.1016/0167-899X(85)90024-2; Nagy D, 2008, FUSION ENG DES, V83, P1870, DOI 10.1016/j.fusengdes.2008.05.033; Tobita K, 2006, FUSION ENG DES, V81, P1151, DOI 10.1016/j.fusengdes.2005.08.058; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1648	1651		10.1016/j.fusengdes.2015.06.139		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900132		
J	Hoshino, T				Hoshino, Tsuyoshi			Optimization of sintering conditions of advanced tritium breeder pebbles fabricated by the emulsion method	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Advanced tritium breeder; Pebble fabrication technique; Mass production; Li2TiO3; Li2TiO3 with excess Li	LI2TIO3; BLANKET; ITER	Demonstration power plant (DEMO) reactors require advanced tritium breeders with high thermal stability. Li2TiO3 with excess Li (Li2+x TiO3+y) has been developed as a material for an advanced tritium breeder. Considering the tritium release characteristics and the packing factor of the blanket, the optimum pebble diameter and grain size after sintering were determined to be 1 mm and <5 mu m, respectively. Therefore, optimum sintering conditions were surveyed in-the present study to obtain these target values. The predominant factor affecting grain growth is assumed to be the presence of binder in the gel particles. This remaining binder reacts with the excess Li in the Li2+x TiO3+y and Li2CO3 is generated, which promotes grain growth. To inhibit the generation of Li2CO3, calcined Li2+xTiO3+y pebbles were sintered under vacuum and subsequent 1% H-2-He atmosphere conditions. The diameter of the sintered Li2+xTiO3+y pebbles was 1.07 mm, and the average grain size on the surfaces and cross sections was <5 mu m. The results presented show that Li2+xTiO3+y, pebbles with optimum characteristics were successfully fabricated using the emulsion method. (C) 2015 Elsevier B.V. All rights reserved.	Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Sector Fus Res & Dev, Rokkasho Fus Inst,Dept Blanket Syst Res, Rokkasho, Aomori 0393212, Japan	Hoshino, T (reprint author), Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Sector Fus Res & Dev, Rokkasho Fus Inst,Dept Blanket Syst Res, 2-166 Obuch, Rokkasho, Aomori 0393212, Japan.	hoshino.tsuyoshi@jaea.go.jp					Kleykamp H, 2002, FUSION ENG DES, V61-62, P361, DOI 10.1016/S0920-3796(02)00120-5; Hoshino T, 2011, FUSION ENG DES, V86, P2172, DOI 10.1016/j.fusengdes.2011.01.065; Tanigawa H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055021; KOPASZ JP, 1994, J NUCL MATER, V212, P927, DOI 10.1016/0022-3115(94)90971-7; Giancarli L, 2007, J NUCL MATER, V367, P1271, DOI 10.1016/j.jnucmat.2007.03.234; Hoshino T, 2009, FUSION ENG DES, V84, P956, DOI 10.1016/j.fusengdes.2008.12.049; Hoshino T, 2007, FUSION ENG DES, V82, P2269, DOI 10.1016/j.fusengdes.2007.07.005; Hanada T, 2011, J NUCL MATER, V417, P735, DOI 10.1016/j.jnucmat.2010.12.130; Hoshino T, 2012, FUSION ENG DES, V87, P486, DOI 10.1016/j.fusengdes.2012.01.005; Roux N, 1998, FUSION ENG DES, V41, P31, DOI 10.1016/S0920-3796(97)00140-3; Roux N, 1996, J NUCL MATER, V233, P1431, DOI 10.1016/S0022-3115(96)00136-5; Hoshino T, 2002, FUSION ENG DES, V61-62, P353, DOI 10.1016/S0920-3796(02)00216-8; [Anonymous], 330831 PDF MAT DAT I	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1788	1791		10.1016/j.fusengdes.2015.04.023		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900164		
J	Isobe, K; Kawamura, Y; Iwai, Y; Oyaidzu, M; Nakamura, H; Suzuki, T; Yamada, M; Edao, Y; Kurata, R; Hayashi, T; Yamanishi, T				Isobe, Kanetsugu; Kawamura, Yoshinori; Iwai, Yasunori; Oyaidzu, Makoto; Nakamura, Hirofumi; Suzuki, Takumi; Yamada, Masayuki; Edao, Yuki; Kurata, Rie; Hayashi, Takumi; Yamanishi, Toshihiko			R&D activities of tritium technologies on Broader Approach in Phase 2-2	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Broader Approach; Tritium technology; Tritium accountancy; Tritium safety; Tritium durability	TRITIATED-WATER; PERMEATION; BEHAVIOR	Activities on Broader Approach (BA) were started in 2007. In Phase 2-2, many R&Ds, development of tritium accountancy technology, development of basic tritium safety research and tritium durability test, were implemented successfully by JAEA and Japanese Universities. In Phase 2-3, new collaborative study for tritium measurement and new R&D activities for JET ILW are started. R&D activities on BA have continued in Phase 2-3 (2014-2016). (C) 2015 Elsevier B.V. All rights reserved.	[Isobe, Kanetsugu; Kawamura, Yoshinori; Iwai, Yasunori; Oyaidzu, Makoto; Nakamura, Hirofumi; Suzuki, Takumi; Yamada, Masayuki; Edao, Yuki; Kurata, Rie; Hayashi, Takumi; Yamanishi, Toshihiko] Japan Atom Energy Agcy, Directorates Fus Energy Res, Tritium Technol Grp, Tokyo, Japan	Isobe, K (reprint author), Japan Atom Energy Agcy, Directorates Fus Energy Res, Tritium Technol Grp, Tokyo, Japan.	isobe.kanetsugu@jaea.go.jp					Iwai Y, 2013, FUSION ENG DES, V88, P2319, DOI 10.1016/j.fusengdes.2013.05.051; Nishitani T, 2011, J NUCL MATER, V417, P1331, DOI 10.1016/j.jnucmat.2010.12.304; Fukada S, 2013, FUSION SCI TECHNOL, V64, P636; Mao W, 2014, J NUCL MATER, V455, P360, DOI 10.1016/j.jnucmat.2014.06.063; Mao W, 2014, FUSION ENG DES, V89, P1294, DOI 10.1016/j.fusengdes.2014.03.019; Iwai Y, 2014, FUSION ENG DES, V89, P1534, DOI 10.1016/j.fusengdes.2014.02.018; WENDEL J, 1995, FUSION TECHNOL, V28, P1090; Oyaidzu M, 2013, ECS TRANSACTIONS, V50, P63, DOI 10.1149/05050.0063ecst; Oya M, 2015, J NUCL MATER, V463, P1037, DOI 10.1016/j.jnucmat.2014.11.124; Kawamura Y, 2013, FUSION ENG DES, V88, P2255, DOI 10.1016/j.fusengdes.2013.05.021; Oyaidzu M, 2015, FUSION SCI TECHNOL, V67, P519; Yamanishi T, 2013, FUSION ENG DES, V88, P2272, DOI 10.1016/j.fusengdes.2013.04.046; Engelmann U., 1997, P 4 INT S FUS NUCL T, P240; Hashizume K, 2013, J NUCL MATER, V442, pS880, DOI 10.1016/j.jnucmat.2013.05.038; Isobe K., 2013, J PLASMA FUSION RES, V10, P81; Otuka T., 2013, J NUCL MATER, V438, pS1048; Yamanishi T., 2008, FUSION SCI TECHNOL, V273, P45	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1792	1795		10.1016/j.fusengdes.2015.06.075		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900165		
J	Iwai, Y				Iwai, Yasunori			Upgrade in catalytic activity of hydrophobic platinum catalysts by irradiation with electron beams	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium; Detritiation; Electron beams; Hydrophobic catalyst; Platinum; Reaction rate	OXIDATION; HYDROGEN; POLYMERS; OXYGEN	The development of hydrophobic platinum catalysts is important to realize the passive recombiner for fusion safety. The upgrade in catalytic activity of hydrophobic platinum catalysts is required since the catalysts generally decrease in catalytic activity with a decrease in temperature. To upgrade in catalytic activity of granular polymer supported hydrophobic platinum catalysts, application of irradiation with electron beams has demonstrated. After irradiation with electron beams, the catalytic activity was evaluated by means of assessing overall reaction rate constant for the oxidation of tritium. The overall reaction rate constant increased as increase in dose. The constant showed the peak value in the dose between 500 and 750 kGy. After the peak, the constant decreased as increase in dose. The overall reaction rate constant at the peak was 6 times larger than that evaluated with unirradiated. The mechanical strength of irradiated catalysts kept integrity until 1500 kGy. The irradiation is a promising method to the upgrading in catalytic activity of Pt/SDBC group catalysts. (C) 2015 Elsevier B.V. All rights reserved.	Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Iwai, Y (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	iwai.yasunori@jaea.go.jp					Oshima A, 1999, POLYM INT, V48, P996, DOI 10.1002/(SICI)1097-0126(199910)48:10<996::AID-PI260>3.0.CO;2-M; Uda T, 2012, FUSION ENG DES, V87, P900, DOI 10.1016/j.fusengdes.2012.02.040; SEGUCHI T, 1981, RADIAT PHYS CHEM, V17, P195, DOI 10.1016/0146-5724(81)90331-9; ARAKAWA K, 1983, J POLYM SCI POL CHEM, V21, P1173, DOI 10.1002/pol.1983.170210424; Iwai Y, 2011, J NUCL SCI TECHNOL, V48, P1184, DOI 10.3327/jnst.48.1184; NARUSE Y, 1990, FUSION ENG DES, V12, P293, DOI 10.1016/0920-3796(90)90003-O; Iwai Y, 2011, FUSION ENG DES, V86, P2164, DOI 10.1016/j.fusengdes.2011.04.028; Popescu I, 2005, FUSION SCI TECHNOL, V48, P108; Iwai Y, 2002, FUSION SCI TECHNOL, V41, P1126; Iwai Y., 2014, P 7 TOK C ADV CAT SC; lwai Y., 2010, J PLASMA FUSION RES, V9, P332	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1796	1799		10.1016/j.fusengdes.2015.03.024		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900166		
J	Kasada, R; Kwon, S; Konishi, S; Sakamoto, Y; Yamanishi, T; Tobita, K				Kasada, Ryuta; Kwon, Saerom; Konishi, Satoshi; Sakamoto, Yoshiteru; Yamanishi, Toshihiko; Tobita, Kenji			A system dynamics model for stock and flow of tritium in fusion power plant	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Fusion reactor; Tritium; Fuel cycle; System dynamics	REACTORS	In order to analyze self-efficiency of tritium fuel cycle (TFC) and share the systems thinking of TFC among researchers and engineers in the vast area of fusion reactor technology, we develop a system dynamics (SD) TFC model using a commercial software STELLA. The SD-TFC model is illustrated as a pipe diagram which consists of tritium stocks, such as plasma, fuel clean up, isotope separation, fueling with storage and blanket, and pipes connecting among them. By using this model, we survey a possibility of D-D start-up without initial loading of tritium on two kinds of fusion plant having different plasma parameters. The D-D start-up scenario can reduce the necessity of initial loading of tritium through the production in plasma by D-D reaction and in breeding blanket by D-D neutron. The model is also used for considering operation scenario to avoid excess stock of tritium which must be produced at tritium breeding ratio over unity. (C) 2015 Elsevier B.V. All rights reserved.	[Kasada, Ryuta; Kwon, Saerom; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Kwon, Saerom] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Sakamoto, Yoshiteru; Yamanishi, Toshihiko; Tobita, Kenji] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan	Kasada, R (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	r-kasada@iae.kyoto-u.ac.jp					BOSCH HS, 1992, NUCL FUSION, V32, P611, DOI 10.1088/0029-5515/32/4/I07; El-Guebaly LA, 2009, FUSION ENG DES, V84, P2072, DOI 10.1016/j.fusengdes.2008.12.098; ABDOU MA, 1986, FUSION TECHNOL, V9, P250; Sakamoto Y, 2014, FUSION ENG DES, V89, P2440, DOI 10.1016/j.fusengdes.2014.04.032; Kuan W, 1999, FUSION TECHNOL, V35, P309; Tobita K, 2014, FUSION ENG DES, V89, P1870, DOI 10.1016/j.fusengdes.2014.02.077; Asaoka Y., 2000, 18 IAEA FUS EN C; Hiwatari R., 2010, IAEA FUS EN C DAEJ R, P446; Konishi S., 2000, J PLASMA FUSION RES, V76, P1309; Kwon S., 2013, 2013 IEEE 25 S FUS E; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1804	1807		10.1016/j.fusengdes.2015.03.047		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900168		
J	Shimozori, M; Katayama, K; Hoshino, T; Ushida, H; Yamamoto, R; Fukada, S				Shimozori, Motoki; Katayama, Kazunari; Hoshino, Tsuyoshi; Ushida, Hiroki; Yamamoto, Ryotaro; Fukada, Satoshi			Water vapor concentration dependence and temperature dependence of Li mass loss from Li2TiO3 with excess Li and Li4SiO4	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		D-T fusion reactor; Tritium breeding ceramic; Li mass loss		In this study, weight reduction of Li2TiO3 with excess Li and Li4SiO4 at elevated temperatures under hydrogen atmosphere or water vapor atmosphere was investigated. The Li mass loss for the Li2TiO3 at 900 degrees C was 0.4 wt% under 1000 Pa H-2 atmosphere and 1.5 wt% under 50 Pa H2O atmosphere. The Li mass loss for the Li2TiO3 increased proportionally to the water vapor pressure in the range from 50 to 200 Pa at 900 degrees C and increased with increasing temperature from 700 to 900 degrees C although Li mass loss at 600 degrees C was significantly smaller than expected. It was found that water vapor concentration dependence and temperature dependence of Li mass loss for the Li2TiO3 and the Li4SiO4 used in this work were quite different. Water vapor is released from the ceramic breeder materials into the purge gas due to desorption of adsorbed water and water formation reaction. The released water vapor possibly promotes Li mass loss with the formation of LiOH on the surface. (C) 2015 Elsevier B.V. All rights reserved.	[Shimozori, Motoki; Katayama, Kazunari; Ushida, Hiroki; Yamamoto, Ryotaro; Fukada, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Hoshino, Tsuyoshi] Japan Atom Energy Agcy, Sect Fus Res & Dev, Breeding Funct Mat Dev Grp, Dept Blanket Syst Res,Rokkasho Fus Inst, Rokkasho, Aomori 0393212, Japan	Katayama, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasugakoen, Kasuga, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp					TERAI T, 1991, J NUCL MATER, V179, P808, DOI 10.1016/0022-3115(91)90211-O; Katayama K, 2012, FUSION ENG DES, V87, P927, DOI 10.1016/j.fusengdes.2012.02.050; Kashimura H., 2013, J PLASMA FUSION RES, V10, P18; Kashimura H., 2013, FUSION ENG DES, V88, P2022	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1808	1811		10.1016/j.fusengdes.2015.03.015		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900169		
J	Kim, JH; Nakamichi, M				Kim, Jae-Hwan; Nakamichi, Masaru			Effect of titanium content on mechanical properties and reactivity of titanium beryllide pebbles	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Beryllide; Pebble; Crush strength; Oxidation resistance	ADVANCED NEUTRON MULTIPLIER; INTERMETALLIC COMPOUNDS	A combinational process for the fabrication of beryllide pebbles, consisting of a plasma-sintering method and the rotating electrode method for fabrication of electrode rods and pebbles, respectively, is proposed. To investigate the effect of Ti content in titanium beryllide pebbles on the pebbles' crush strength and oxidation resistance, beryllide pebbles with 3-10.5 at.% Ti were fabricated. Scanning electron microscopy (SEM) observations demonstrated that the surfaces of Be 3 and 5 at.% Ti pebbles contained a Be phase, whereas the surfaces of Be - 7-10.5 at.% Ti pebbles did not. Moreover, according to cross-sectional SEM images, the area fraction of the Be phase decreased with increasing Ti content in beryllide pebbles with 3-9 at.% Ti, whereas the pebble with 10.5 at.% Ti consisted primarily of the Be17Ti2 phase. With regard to the mechanical properties of the pebbles, their strength and elongation decreased with increasing Ti content because of the brittleness of the Be phase. The weight gain and the amount of H-2 generated by the pebbles under reaction with 1% H2O/Ar decreased with increasing Ti content, whereas the stability of the pebbles was strongly dependent on the presence of the Be phase on their surface. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Jae-Hwan; Nakamichi, Masaru] Japan Atom Energy Agcy, Sect Fus Res & Dev, Breeding Funct Mat Dev Grp, Rokkasho, Aomori 0393212, Japan	Kim, JH (reprint author), Japan Atom Energy Agcy, Sect Fus Res & Dev, Breeding Funct Mat Dev Grp, 2-166 Oaza Obuchi Aza Omotedate, Rokkasho, Aomori 0393212, Japan.	kim.jaehwan@jaea.go.jp					Nakamichi M, 2013, FUSION ENG DES, V88, P611, DOI 10.1016/j.fusengdes.2013.02.077; Nakamichi M, 2014, FUSION ENG DES, V89, P1304, DOI 10.1016/j.fusengdes.2014.02.081; Kim JH, 2013, J ALLOY COMPD, V577, P90, DOI 10.1016/j.jallcom.2013.04.185; Kim JH, 2013, J NUCL MATER, V442, pS461, DOI 10.1016/j.jnucmat.2012.10.013; Kim JH, 2013, J NUCL MATER, V438, P218, DOI 10.1016/j.jnucmat.2013.02.066; Kim JH, 2014, J ALLOY COMPD, V585, P63, DOI 10.1016/j.jallcom.2013.09.103	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1812	1816		10.1016/j.fusengdes.2015.06.170		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900170		
J	Nakamichi, M; Kim, JH				Nakamichi, Masaru; Kim, Jae-Hwan			Fabrication and hydrogen generation reaction with water vapor of prototypic pebbles of binary beryllides as advanced neutron multiplier	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Beryllide; Beryllium; Intermetallic compound; Neutron multiplier; Plasma sintering synthesis; Rotating electrode granulation		Advanced neutron multipliers such as beryllides with high stability at high temperatures are desired for demonstration power plant (DEMO) reactors. Prototypic pebbles 1 mm in diameter of single phase Be12Ti beryllide were successfully fabricated by a combination process involving plasma sintering, a rotating electrode method, and a homogenization treatment. Relative to the non-treated, multi-phase pebbles, the homogenized Be12Ti pebbles demonstrated an increased reactivity because the homogenization treatment caused an increase in the specific surface area of the treated pebbles. To prevent increased hydrogen generation, prototypic Be17Ti2 pebbles were successfully fabricated without homogenization. The Be17Ti2 prototypic pebbles where shown to have a good oxidation resistance. (C) 2015 Elsevier B.V. All rights reserved.	[Nakamichi, Masaru; Kim, Jae-Hwan] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Breeding Funct Mat Grp, Tokyo, Japan	Nakamichi, M (reprint author), Japan Atom Energy Agcy, Fus Res & Dev Directorate, Breeding Funct Mat Grp, Tokyo, Japan.	nakamichi.masaru@jaea.go.jp					Nakamichi M, 2013, J NUCL MATER, V440, P530, DOI 10.1016/j.jnucmat.2013.02.070; Nakamichi M, 2011, J NUCL MATER, V417, P765, DOI 10.1016/j.jnucmat.2010.12.140; Nakamichi M, 2013, FUSION ENG DES, V88, P611, DOI 10.1016/j.fusengdes.2013.02.077; Nakamichi M, 2011, FUSION ENG DES, V86, P2262, DOI 10.1016/j.fusengdes.2011.03.009; Kim JH, 2013, J NUCL MATER, V438, P218, DOI 10.1016/j.jnucmat.2013.02.066	5	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1838	1842		10.1016/j.fusengdes.2015.04.026		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900176		
J	Ochiai, K; Edao, Y; Kawamura, Y; Hoshino, T; Ohta, M; Sato, S; Konno, C				Ochiai, Kentaro; Edao, Yuki; Kawamura, Yoshinori; Hoshino, Tsuyoshi; Ohta, Masayuki; Sato, Satoshi; Konno, Chikara			Experimental investigation on tritium release from lithium titanate pebble under high temperature of 1073 K	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium release; DT neutron; Blanket; Lithium titanate; Temperature; Purge gas	NEUTRON-IRRADIATION; BLANKET; BED	The temperature of Li2TiO3 pebble breeder in a fusion DEMO blanket is assumed to be more than 1000 K. For the investigation of tritium release from a Li2TiO3 pebble breeder blanket at such a high temperature, we have carried out a tritium release experiment with the DT neutron source at the JAEA-FNS. The Li2TiO3 pebble (1.0-1.2 mm in diameter) of 70g was put into a stainless steel container and installed into an assembly stratified with beryllium and Li2TiO3 layers. During the DT neutron irradiation, the temperature was kept at 1073 K with wire heaters in the blanket container. Helium gas including 1% hydrogen gas (H-2/He) mainly flowed inside the container as the purge gas. Two chemical forms, HT and HTO, of extracted tritium were separately collected during the DT neutron irradiation by using water bubblers and CuO bed. The tritium activity in the water bubbler was measured by a liquid scintillation counter. To investigate the effect of moisture in the purge gas, we also performed the same experiments with H2O/He gas (H2O content: 1%) or pure helium gas. From our experiment at 1073K, in the case of the purge gas includes H-2, it is indicated that the increasing tendency of HT release is similar to that of the dry H-2/He. (C) 2015 Elsevier B.V. All rights reserved.	[Ochiai, Kentaro; Edao, Yuki; Kawamura, Yoshinori; Ohta, Masayuki; Sato, Satoshi; Konno, Chikara] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan; [Hoshino, Tsuyoshi] Japan Atom Energy Agcy, Rokkasho, Aomori, Japan	Ochiai, K (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki, Japan.	howartre@onid.oregonstate.edu					Kawamura Y, 2012, FUSION ENG DES, V87, P1253, DOI 10.1016/j.fusengdes.2012.02.125; Ochiai K, 2014, FUSION ENG DES, V89, P1464, DOI 10.1016/j.fusengdes.2014.04.079; Batistoni P, 2007, FUSION ENG DES, V82, P2095, DOI 10.1016/j.fusengdes.2007.04.009; Tsuru D, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065024; Kondo K, 2010, FUSION ENG DES, V85, P1229, DOI 10.1016/j.fusengdes.2010.03.009; Kinjyo T, 2007, FUSION ENG DES, V82, P2147, DOI 10.1016/j.fusengdes.2007.07.002; Sato S, 2003, NUCL FUSION, V43, P527, DOI 10.1088/0029-5515/43/7/303; Enoeda M, 2003, NUCL FUSION, V43, P1837, DOI 10.1088/0029-5515/43/12/026; Brown F.B., 2002, T AM NUCL SOC, V87; Kobayashi K., 2002, JENDLD99 JAP AT EN R; Lopez Al-dama D., 2004, INDCNDS467 INT AT EN	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1843	1846		10.1016/j.fusengdes.2015.07.003		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900177		
J	Ohta, M; Sato, S; Ochiai, K; Konno, C				Ohta, Masayuki; Sato, Satoshi; Ochiai, Kentaro; Konno, Chikara			Integral test of International Reactor Dosimetry and Fusion File on graphite assembly with DT neutron at JAEA/FNS	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Integral experiment; IRDFF; Graphite; DT neutron; Dosimetry reaction		We perform an integral test of a new library of dosimetry cross section data, International Reactor Dosimetry and Fusion File release 1.0 (IRDFF 1.0), which has been released from the International Atomic Energy Agency recently. A pseudo-cylindrical graphite assembly is used with a DT neutron source at the fusion neutronics source facility of Japan Atomic Energy Agency. A lot of foils for measurements of dosimetry reaction rates are placed in the small space along the central axis in the assembly. After the DT neutron irradiation, forty dosimetry reaction rates are measured and are compared with calculated values, which are obtained by using a Monte Carlo neutron transport code MCNP5-1.40 and a nuclear data library ENDF/B-VII.1 with the IRDFF-v.1.03 as the response functions for the dosimetry reactions. The calculated results generally show good agreements with the experimental ones. The cross section data of the Zn-68(n,np)Cu-67 and Zn-68(n,d)Cu-67 reactions and the In reaction, which are not included in IRDFF-v1.03, are needed for the analysis of the Zn-67(n,p)Cu-67 reaction and the In-113(n,gamma)In-114m reaction as the competitive reactions, respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Ohta, Masayuki; Sato, Satoshi; Ochiai, Kentaro; Konno, Chikara] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan	Ohta, M (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki, Japan.	ohta.masayuki@jaea.go.jp					[Anonymous], 2013, MCNP61MCNP5MCNPX; Bersillon O., 2006, IAEA TECHNICAL REPOR, V452; Kobayashi K., 2002, JENDLD99; MacFarlane R.E., 1994, LA12740M; Maekawa H., 1988, JAERIM88034; MCNP Team, 2005, LAUR058617 MCNP TEAM; Sublet J.-C., 2010, CCFER1005; Zsolnay E. M., 2012, INDCNDS0616 IAEA	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1847	1850		10.1016/j.fusengdes.2015.03.032		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900178		
J	Ogawa, S; Masuko, Y; Kato, H; Yuyama, H; Sakai, Y; Niwa, E; Hashimoto, T; Mukai, K; Hosino, T; Sasaki, K				Ogawa, Seiya; Masuko, Yuki; Kato, Hirokazu; Yuyama, Hayato; Sakai, Yutaro; Niwa, Eiki; Hashimoto, Takuya; Mukai, Keisuke; Hosino, Tsuyoshi; Sasaki, Kazuya			Li vaporization property of two-phase material of Li2TiO3 and Li2SiO3 for tritium breeder	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium breeder; Two-phase material; Li2TiO3; Li2SiO3; Li vaporization; DEMO blanket	LITHIUM-ORTHOSILICATE PEBBLES; BLANKET	Li vaporization property of two-phase materials of Li2TiO3 and Li2SiO3 in a working condition for the solid tritium breeder used in the demonstration power plant of fusion reactor was investigated, and the suppression mechanism of the vaporization was considered. The Li vaporization rate from the specimen pellet was measured by gravimetric method, and the change of Li concentration distribution in the pellet was analyzed by time-of-flight secondary ion mass spectrometer. Li was vaporized only from the Li2SiO3 at the vicinity of the surface of the pellet. The remarkable vaporization of Li arose only in an early short time. The inhibition of the vaporization from the Li2SiO3 was successful by adding the small amount of the stable secondary phase of Li2TiO3. (C) 2015 Elsevier B.V. All rights reserved.	[Ogawa, Seiya; Sasaki, Kazuya] Tokai Univ, Grad Sch Engn, Course Mech Engn, Hiratsuka, Kanagawa 2591292, Japan; [Masuko, Yuki; Kato, Hirokazu; Yuyama, Hayato; Sakai, Yutaro; Sasaki, Kazuya] Tokai Univ, Sch Engn, Dept Prime Mover Engn, Hiratsuka, Kanagawa 2591292, Japan; [Sasaki, Kazuya] Tokai Univ, Grad Sch Sci & Technol, Course Mech Engn & Aeronaut & Astronaut, Hiratsuka, Kanagawa 2591292, Japan; [Niwa, Eiki; Hashimoto, Takuya] Nihon Univ, Coll Humanities & Sci, Dept Phys, Setagaya Ku, Tokyo 1568550, Japan; [Mukai, Keisuke] Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan; [Hosino, Tsuyoshi] Japan Atom Energy Agcy, Sect Fus Res & Dev, Rokkasho Fus Inst, Breeding Funct Mat Dev Grp,Dept Blanket Syst Res, Rokkasho, Aomori 0393212, Japan	Sasaki, K (reprint author), Tokai Univ, Sch Engn, Dept Prime Mover Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	k_sasaki@tokai-u.jp					HESSE KF, 1977, ACTA CRYSTALLOGR B, V33, P901, DOI 10.1107/S0567740877004932; Hoshino T, 2009, FUSION ENG DES, V84, P956, DOI 10.1016/j.fusengdes.2008.12.049; Hoshino T, 2007, FUSION ENG DES, V82, P2269, DOI 10.1016/j.fusengdes.2007.07.005; Knitter R, 2009, J NUCL MATER, V386-88, P1071, DOI 10.1016/j.jnucmat.2008.12.284; Knitter R, 2007, J NUCL MATER, V361, P104, DOI 10.1016/j.jnucmat.2006.11.005; Roux N, 1996, J NUCL MATER, V233, P1431, DOI 10.1016/S0022-3115(96)00136-5; Knitter R, 2013, J NUCL MATER, V442, pS433, DOI 10.1016/j.jnucmat.2012.10.034; Enoeda M, 2003, NUCL FUSION, V43, P1837, DOI 10.1088/0029-5515/43/12/026; Ying A, 2012, FUSION ENG DES, V87, P1130, DOI 10.1016/j.fusengdes.2012.02.090; SCHUMACHER G, 1991, FUSION ENG DES, V17, P31, DOI 10.1016/0920-3796(91)90032-L; Claverie J., 1966, B SOC CHIM FR, V244-246	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1859	1863		10.1016/j.fusengdes.2015.01.042		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900181		
J	Satake, S; Aoyagi, Y; Unno, N; Yuki, K; Seki, Y; Enoeda, M				Satake, Shin-ichi; Aoyagi, Yusuke; Unno, Noriyuki; Yuki, Kazuhisa; Seki, Yohji; Enoeda, Mikio			Three-dimensional flow measurement of a water flow in a sphere-packed pipe by digital holographic PTV	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Digital hologram; Pebble; Refractive matching method		A water cooled ceramic breeder for ITER and DEMO of a nuclear fusion reactor plays a significant role in the design of a blanket module. Pebbles of a ceramic tritium breeder are packed in a container of the blanket. Investigation of the flow behavior is necessary in an actual environment of a facility where pressure drop takes place under a complex flow such as in case of the container for the pebble bed. For the development of a facility, it is necessary to be able to monitor fluid motion of a basic flow such as a sphere-packed pipe (SPP). In the present study, to discern the complex flow structures in SPP, digital holographic PTV visualization is carried out by a refractive index-matching method using a water employed as a working fluid. The water is chosen to be able to adjust its refractive index to match to that of the MEXFLON pebble with an index of 1.33. Hologram fringe images of particles behind the spheres can be observed, and the particles' positions can be reconstructed by a digital hologram. Consequently, 3-D velocity-fields around the spheres are obtained by the reconstructed particles' positions. The velocity between pebbles is found to be convergence and divergence regions in the SPP. (C) 2015 Elsevier B.V. All rights reserved.	[Satake, Shin-ichi; Aoyagi, Yusuke; Unno, Noriyuki] Tokyo Univ Sci, Katsushika Ku, Tokyo 1258585, Japan; [Unno, Noriyuki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Yuki, Kazuhisa] Tokyo Univ Sci, Dept Mech Engn, Sanyo Onoda, Yamaguchi 7560884, Japan; [Seki, Yohji; Enoeda, Mikio] Japan Atom Energy Agcy, Blanket Technol Grp, Naka, Ibaraki 3110193, Japan	Satake, S (reprint author), Tokyo Univ Sci, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	satake@te.noda.tus.ac.jp					Yanagi Y, 2001, J NUCL SCI TECHNOL, V38, P1014; Satake SI, 2007, APPL OPTICS, V46, P538, DOI 10.1364/AO.46.000538; Someya S, 2010, APPL PHYS B-LASERS O, V99, P325, DOI 10.1007/s00340-010-3926-9; Yuki K, 2008, J THERMOPHYS HEAT TR, V22, P632, DOI 10.2514/1.30141; Satake S, 2014, FUSION ENG DES, V89, P1064, DOI 10.1016/j.fusengdes.2014.01.029; BUDWIG R, 1994, EXP FLUIDS, V17, P350, DOI 10.1007/BF01874416; Enoeda M., 2001, JAERI TECHNOL, P2001; Hendricks R. C., 1998, VIRTUAL EXPT VISUALI; Satake S., 2004, OPT REV, V11, pL162; Seki Y., 2007, S COD DEV INT SIM TR; Seki Y., 2011, JAEA TECHNOL, P2007	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1864	1867		10.1016/j.fusengdes.2015.03.023		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900182		
J	Someya, Y; Tobita, K; Utoh, H; Tokunaga, S; Hoshino, K; Asakura, N; Nakamura, M; Sakamoto, Y				Someya, Youji; Tobita, Kenji; Utoh, Hiroyasu; Tokunaga, Shinji; Hoshino, Kazuo; Asakura, Nobuyuki; Nakamura, Makoto; Sakamoto, Yoshiteru			Design study of blanket structure based on a water-cooled solid breeder for DEMO	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Breeding blanket; Water-cooled solid breeder; DEMO		Blanket concept with a simplified interior for mass production has been developed using a mixed bed of Li2TiO3 and Be12Ti pebbles, coolant conditions of 15.5 MPa and 290-325 degrees C and cooling pipes without any partitions. Considering the continuity with the ITER test blanket module option of Japan and the engineering feasibility in its fabrication, our design study focused on a water-cooled solid breeding blanket using the mixed pebbles bed. Herein, we propose blanket segmentation corresponding to the shape and dimension of the blanket and routing of the coolant flow. Moreover, we estimate the overall tritium breeding ratio (TBR) with a torus configuration, based on the segmentation using three-dimensional (3D) Monte Carlo N-particle calculations. As a result, the overall TBR is 1.15. Our 3D neutronics analysis for TBR ensures that the blanket concept can achieve a self-sufficient supply of tritium. (C) 2015 Elsevier B.V. All rights reserved.	[Someya, Youji; Tobita, Kenji; Utoh, Hiroyasu; Tokunaga, Shinji; Hoshino, Kazuo; Asakura, Nobuyuki; Nakamura, Makoto; Sakamoto, Yoshiteru] Japan Atom Energy Agcy, Rokkasho, Aomori, Japan	Someya, Y (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori, Japan.						Al-dama D. Lopez, 2004, INDCNDS46 IAEA; Someya Y, 2011, FUSION ENG DES, V86, P2269, DOI 10.1016/j.fusengdes.2011.01.141; Someya Y, 2013, PLASMA SCI TECHNOL, V15, P171, DOI 10.1088/1009-0630/15/2/19; Uchida M, 2003, FUSION ENG DES, V69, P499, DOI 10.1016/S0920-3796(03)00395-8; Billone M.C., 1993, ITER SOLID BREEDER B; Krikorian O. H., 1985, High Temperatures - High Pressures, V17; Utoh H., 2011, FUSION ENG DES, V9-11, P2378; X-5 Monte Carlo Team, 2005, LACP030245 LANL	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1872	1875		10.1016/j.fusengdes.2015.05.042		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900184		
J	Sugiyama, T; Takada, A; Morita, Y; Kotoh, K; Munakata, K; Taguchi, A; Kawano, T; Tanaka, M; Akata, N				Sugiyama, Takahiko; Takada, Akito; Morita, Youhei; Kotoh, Kenji; Munakata, Kenzo; Taguchi, Akira; Kawano, Takao; Tanaka, Masahiro; Akata, Naofumi			Dual temperature dual pressure water-hydrogen chemical exchange for water detritiation	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium; Water detritiation; Isotope separation; Water-hydrogen chemical exchange; Separative analysis	CECE PROCESS; TRITIUM; PLANT	Experimental and analytical studies on hydrogen-tritium isotope separation by a dual temperature dual pressure catalytic exchange (DTDP-CE) with liquid phase chemical exchange columns were carried out in order to apply it to a part of the water detritiation system for DEMO fuel cycle. A prototype DTDP-CE apparatus was successfully operated and it was confirmed that tritium was separated by the apparatus as significantly distinguishable. A calculation code was developed based on the channeling stage model. The values of separation factors and the effects of some operating parameters were well predicted by the separative analyses with the code. (C) 2015 Elsevier B.V. All rights reserved.	[Sugiyama, Takahiko; Takada, Akito; Morita, Youhei] Nagoya Univ, Fac Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kotoh, Kenji] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Munakata, Kenzo] Akita Univ, Fac Engn & Resource Sci, Akita 0108502, Japan; [Taguchi, Akira] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Kawano, Takao; Tanaka, Masahiro; Akata, Naofumi] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Sugiyama, T (reprint author), Nagoya Univ, Fac Engn, Chikusa Ku, Fro Cho 1, Nagoya, Aichi 4648603, Japan.	t-sugiyama@nucl.nagoya-u.ac.jp					Michling R, 2009, FUSION ENG DES, V84, P338, DOI 10.1016/j.fusengdes.2009.03.003; Miller JM, 2002, FUSION SCI TECHNOL, V41, P1077; Vasyanina TV, 2008, FUSION ENG DES, V83, P1451, DOI 10.1016/j.fusengdes.2008.07.027; Iwai Y, 2002, FUSION SCI TECHNOL, V41, P1126; Alekseev IA, 2003, FUSION ENG DES, V69, P33, DOI 10.1016/S0920-3796(03)00230-8; Sugiyama T, 2011, FUSION SCI TECHNOL, V60, P1323; Benedict M., 1987, NUCL CHEM ENG; Sugiyama T., 2000, J NUCL SCI TECHNOL, V37	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1876	1879		10.1016/j.fusengdes.2015.05.054		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900185		
J	Yagi, J; Sagara, A; Watanabe, T; Tanaka, T; Takayama, S; Muroga, T				Yagi, Juro; Sagara, Akio; Watanabe, Takashi; Tanaka, Teruya; Takayama, Sadatsugu; Muroga, Takeo			Hydrogen solubility in FLiNaK mixed with titanium powder	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Metal powder-mixed molten salt; FLiNaK; Hydrogen solubility; Vanadium alloy	HELICAL REACTOR	The hydrogen solubility in a FLiNaK molten salt mixed with Ti powder was investigated. A hydrogen-soluble metal powder mixed with a molten salt can increase the effective hydrogen solubility of the molten salt, which is currently a major disadvantage of molten salts. A significant increase in hydrogen solubility was observed, even with a mass fraction of Ti powder of only 0.1 wt%. The increase of hydrogen solubility was so large that a vanadium alloy would be compatible with the Ti powder/molten salt mixture, unlike typical molten salts that result in an unacceptably large tritium inventory in the vanadium alloy. In addition, contamination of the Ti powder by oxidation suppressed the hydrogen uptake and release capability. Controlling the purity of the molten salt was found to be one of the key issues for the metal powder mixture concept. (C) 2015 Elsevier B.V. All rights reserved.	[Yagi, Juro; Sagara, Akio; Tanaka, Teruya; Takayama, Sadatsugu; Muroga, Takeo] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Watanabe, Takashi] Shizuoka Univ, Shizuoka, Shizuoka 4228529, Japan	Yagi, J (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	yagi.juro@LHD.nifs.ac.jp					Buxbaum RE, 2002, J NUCL MATER, V307, P576, DOI 10.1016/S0022-3115(02)01215-1; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Muroga T, 2014, J NUCL MATER, V455, P263, DOI 10.1016/j.jnucmat.2014.06.025; Tanaka T, 2005, FUSION SCI TECHNOL, V47, P530; MALINAUS.AP, 1974, IND ENG CHEM FUND, V13, P242, DOI 10.1021/i160051a015; San-Martin A., 1987, B ALLOY PHASE DIAGRA, V8, P30, DOI 10.1007/BF02868888	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1907	1910		10.1016/j.fusengdes.2015.06.124		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900192		
J	Chen, DS; Kimura, A; Han, WT; Je, H				Chen, Dongsheng; Kimura, Akihiko; Han, Wentuo; Je, Hwanil			Age-hardening susceptibility of high-Cr ODS ferritic steels and SUS430 ferritic steel	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Phase decomposition; Age-hardening; Cr precipitates; TEM; ODS steel; SUS430 steel	ALLOYS; IRON	The effect of aging on high-Cr ferritic steels was investigated with focusing on the role of oxide particles in alpha/alpha' phase decomposition behavior. 12Cr-oxide dispersion strengthened (ODS) steel, 15Cr-ODS steel and commercial SUS430 steel were isothermally aged at 475 degrees C for up to 10,000 h. Thermal aging caused a larger hardening in SUS430 than 15Cr-ODS, while 12Cr-ODS showed almost no hardening. A characteristic of the ODS steels is that the hardening was not accompanied by the significant loss of ductility that was observed in SUS430 steel. After aging for 2000 h, SUS430 steel shows a larger ductile-brittle transition temperature (DBTF) shift than 15Cr-ODS steel, which suggests that the age-hardening susceptibility is lower in 15Cr-ODS steel than in conventional SUS430 steel. Thermal aging leaded to a large number of Cr-rich alpha' precipitates, which were confirmed by transmission electron microscopy (TEM). Correlation of age-hardening and phase decomposition was interpreted by Orowan type strengthening model. Results indicate that oxide particles cannot only suppress ductility loss, but also may influence a/a' phase decomposition kinetics. (C) 2015 Elsevier B.V. All rights reserved.	[Chen, Dongsheng] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan; [Kimura, Akihiko; Han, Wentuo; Je, Hwanil] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Chen, DS (reprint author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan.	chen.dongsheng85@gmail.com					Isselin J, 2011, J NUCL MATER, V417, P185, DOI 10.1016/j.jnucmat.2010.12.061; Cho HS, 2007, J NUCL MATER, V367, P1180, DOI 10.1016/j.jnucmat.2007.03.211; LUCAS GE, 1993, J NUCL MATER, V206, P287, DOI 10.1016/0022-3115(93)90129-M; Yoshitake T, 2002, J NUCL MATER, V307, P788, DOI 10.1016/S0022-3115(02)00947-9; Terentyev DA, 2008, ACTA MATER, V56, P3229, DOI 10.1016/j.actamat.2008.03.004; Haghighat SMH, 2014, ACTA MATER, V64, P24, DOI 10.1016/j.actamat.2013.11.037; Bonny G, 2009, J NUCL MATER, V385, P278, DOI 10.1016/j.jnucmat.2008.12.002; Chen DS, 2014, J NUCL MATER, V455, P436, DOI 10.1016/j.jnucmat.2014.07.069; Kimura A, 2011, J NUCL MATER, V417, P176, DOI 10.1016/j.jnucmat.2010.12.300; Ribis J, 2014, J NUCL MATER, V444, P314, DOI 10.1016/j.jnucmat.2013.10.010; Muroga T, 2014, FUSION ENG DES, V89, P1717, DOI 10.1016/j.fusengdes.2014.01.010; Okuda N, 2009, J NUCL MATER, V386-88, P974, DOI 10.1016/j.jnucmat.2008.12.265; Lee JS, 2007, J NUCL MATER, V367, P229, DOI 10.1016/j.jnucmat.2007.03.007; Cepdevila C., 2008, MAT SCI ENG A-STRUCT, V490, P277	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1945	1949		10.1016/j.fusengdes.2015.05.078		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900201		
J	Fu, HY; Nagasaka, T; Kometani, N; Muroga, T; Guan, WH; Nogami, S; Yabuuchi, K; Iwata, T; Hasegawa, A; Yamazaki, M; Kano, S; Satoh, Y; Abe, H; Tanigawa, H				Fu, Haiying; Nagasaka, Takuya; Kometani, Nobuyuki; Muroga, Takeo; Guan, Wenhai; Nogami, Shuhei; Yabuuchi, Kiyohiro; Iwata, Takuya; Hasegawa, Akira; Yamazaki, Masanori; Kano, Sho; Satoh, Yuhki; Abe, Hiroaki; Tanigawa, Hiroyasu			Effect of post-weld heat treatment and neutron irradiation on a dissimilar-metal joint between F82H steel and 316L stainless steel	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		F82H steel; 316L stainless steel; Electron beam welding; Post-weld heat treatment; Neutron irradiation	DESIGN	A dissimilar-metal joint between F82H steel and 316L stainless steel was fabricated by using electron beam welding (EBW). By microstructural analysis and hardness test, the heat-affected zone (HAZ) of F82H was classified into interlayer area, fine-grain area, and coarse-carbide area. Post-weld heat treatment (PWHT) was applied to control the hardness of HAZ. After PWHT at 680 degrees C for 1 h, neutron irradiation at 300 degrees C with a dose of 0.1 dpa was carried out for the joint in Belgian Reactor II (BR-II). Compared to the base metals (BMs) and weld metal (WM), significant irradiation hardening up to 450HV was found in the fine-grain HAZ of F82H. However, the impact property of F82H-HAZ specimens, which was machined with the root of the V-notch at HAZ of F82H, was not deteriorated obviously in spite of the significant irradiation hardening. (C) 2015 Elsevier B.V. All rights reserved.	[Fu, Haiying; Nagasaka, Takuya; Muroga, Takeo] SOKENDAI, Toki, Gifu, Japan; [Nagasaka, Takuya; Muroga, Takeo] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kometani, Nobuyuki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Guan, Wenhai; Nogami, Shuhei; Yabuuchi, Kiyohiro; Iwata, Takuya; Hasegawa, Akira] Tohoku Univ, Sendai, Miyagi 980, Japan; [Yamazaki, Masanori] Tohoku Univ, Inst Mat Res, Int Res Ctr Nucl Mat Sci, Sendai, Miyagi 980, Japan; [Kano, Sho; Satoh, Yuhki; Abe, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan; [Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Rokkasho, Japan	Fu, HY (reprint author), SOKENDAI, Toki, Gifu, Japan.	haigirl1983@gmail.com					El-Guebaly LA, 2006, FUSION ENG DES, V80, P99, DOI 10.1016/j.fusengdes.2005.06.355; Tavassoli AAF, 2014, J NUCL MATER, V455, P269, DOI 10.1016/j.jnucmat.2014.06.017; Kalinin G, 1996, J NUCL MATER, V233, P9, DOI 10.1016/S0022-3115(96)00316-9; Nogami S, 2011, FUSION SCI TECHNOL, V60, P334; Hara N, 2009, FUSION SCI TECHNOL, V56, P318; Furuya K, 2009, J NUCL MATER, V386-88, P963, DOI 10.1016/j.jnucmat.2008.12.259; Asaoka Y, 2000, FUSION ENG DES, V48, P397, DOI 10.1016/S0920-3796(00)00149-6; Ansara I., 1985, 9657IEN EUR; Suri A.K., 2010, J PHYS C SER, V208; Takanori H., 2011, J PLASMA FUSION RES, V87, P172	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1968	1972		10.1016/j.fusengdes.2015.06.079		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900206		
J	Hirose, T; Sakasegawa, H; Nakajima, M; Tanigawa, H				Hirose, Takanori; Sakasegawa, Hideo; Nakajima, Motoki; Tanigawa, Hiroyasu			Mechanical properties of TIG and EB weld joints of F82H	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Reduced activation ferritic/martensitic steel; Welding; Post weld heat treatment; Mechanical property	MICROSTRUCTURE; STEEL	This work investigates mechanical properties of weld joints of a reduced activation ferritic/martensitic steel, F82H and effects of post weld heat treatment on the welds. Vickers hardness, tensile and Charpy impact tests were conducted on F82H weld joints prepared using tungsten-inert-gas and electron beam after various heat treatments. Although narrow groove tungsten-inert-gas welding reduced volume of weld bead, significant embrittlement was observed in a heat affected zone transformed due to heat input. Post weld heat treatment above 993 K successfully moderated the brittle transformed region. The hardness of the brittle region strongly depends on the heat treatment temperature. Meanwhile, strength of base metal was slightly reduced by the treatment at temperature ranging from 993 to 1053 K. Moreover, softening due to double welding was observed only in the weld metal, but negligible in base metal. (C) 2015 Elsevier B.V. All rights reserved.	[Hirose, Takanori; Sakasegawa, Hideo; Nakajima, Motoki; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Aomori, Japan	Hirose, T (reprint author), Japan Atom Energy Agcy, Aomori, Japan.	hirose.takanori@jaea.go.jp					Hirose T, 2014, FUSION ENG DES, V89, P1595, DOI 10.1016/j.fusengdes.2013.12.005; Hirose T, 2013, J NUCL MATER, V442, pS557, DOI 10.1016/j.jnucmat.2013.05.063; Tanigawa H, 2008, FUSION ENG DES, V83, P1471, DOI 10.1016/j.fusengdes.2008.07.024; Sawai T, 2000, J NUCL MATER, V283, P657, DOI 10.1016/S0022-3115(00)00089-1; [Anonymous], 2013, Z3121 JIS; Shiba K, 2012, FUSION SCI TECHNOL, V62, P145; Tanigawa H, 2003, FUSION SCI TECHNOL, V44, P219; Nakata T, 2012, FUSION ENG DES, V87, P589, DOI 10.1016/j.fusengdes.2012.01.048; Tanigawa H, 2011, FUSION ENG DES, V86, P2549, DOI 10.1016/j.fusengdes.2011.04.047; Hirose T, 2010, PROCEEDINGS OF THE ASME PRESSURE VESSELS AND PIPING CONFERENCE 2010, VOL 1: CODES AND STANDARDS, P263; Hollomon J H, 1947, FERROUS METALLURGICA, P245	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1982	1985		10.1016/j.fusengdes.2015.06.133		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900209		
J	Kanemura, T; Kondo, H; Furukawa, T; Hirakawa, Y; Hoashi, E; Yoshihashi, S; Horiike, H; Wakai, E				Kanemura, Takuji; Kondo, Hiroo; Furukawa, Tomohiro; Hirakawa, Yasushi; Hoashi, Eiji; Yoshihashi, Sachiko; Horiike, Hiroshi; Wakai, Eiichi			Measurement of Li target thickness in the EVEDA Li Test Loop	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; EVEDA; Liquid lithium; Wall jet; Vacuum; Flow diagnostics	JET	A high-speed (nominal: 15 m/s, range: 10-16 m/s) liquid lithium wall jet is planned to serve as the target for two 40 MeV and 125 mA deuteron beams in the International Fusion Materials Irradiation Facility (IFMIF). The design requirement of target thickness stability is 25 +/- 1 mm under a vacuum of 10(-3) Pa. This paper presents the results of the target thickness measurement conducted in the EVEDA Li Test Loop under a wide range of conditions including the IFMIF condition (target speed of 10, 15, and 20 m/s; vacuum pressure of 10(-3) Pa; and Li temperature of 250 degrees C). For measurement, we use a laser probe method that we developed in advance; this method generates statistical measurements method using a laser distance meter. The measurement results obtained under the IFMIF nominal condition (15 m/s, 10(-3) Pa, 250 degrees C) at the IFMIF beam center are as follows: average target thickness = 26.08 +/- 0.09 mm (2 sigma), mean wave amplitude = 0.26 +/- 0.01 mm (2 sigma), and maximum wave amplitude = 1.46 +/- 0.25 mm (2 sigma.). Of the total wave components, 99.7% are within the design requirement. The analytically predicted target thickness is in excellent agreement with the experimental data, resulting in successful characterization of the Li target thickness. (C) 2015 Elsevier B.V. All rights reserved.	[Kanemura, Takuji; Kondo, Hiroo; Furukawa, Tomohiro; Hirakawa, Yasushi; Wakai, Eiichi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan; [Hoashi, Eiji; Yoshihashi, Sachiko; Horiike, Hiroshi] Osaka Univ, Suita, Osaka 5650871, Japan	Kanemura, T (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki 3111393, Japan.	kanemura.takuji@jaea.go.jp					Ida M, 2002, FUSION ENG DES, V63-64, P333, DOI 10.1016/S0920-3796(02)00122-9; Kondo H, 2014, FUSION ENG DES, V89, P1688, DOI 10.1016/j.fusengdes.2014.02.022; Nakamura H, 1998, J NUCL MATER, V258, P440, DOI 10.1016/S0022-3115(98)00235-9; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Kanemura T, 2014, FUSION ENG DES, V89, P1642, DOI 10.1016/j.fusengdes.2014.03.037; Kondo H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123008; Francesco Saverio N., 2010, TERMOFLUIDODINAMICA; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA; Kolowith R., 1985, 8429 HEDLTME; Kondo H., 2015, FUSION ENG DES; Rondo H., 2010, FUSION ENG DES, V85, P1102; The American Society of Mechanical Engineering Measurement Uncertainty, 1985, 1911985 ANSIASME P 1	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1991	1997		10.1016/j.fusengdes.2015.06.060		7	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900211		
J	Kondo, K; Arbeiter, F; Fischer, U; Lu, L; Qiu, YF; Tian, K				Kondo, Keitaro; Arbeiter, Frederik; Fischer, Ulrich; Lu, Lei; Qiu, Yuefeng; Tian, Kuo			Shielding performances analysis for the IFMIF test facility based on high-fidelity Monte Carlo neutronic calculations	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; Test cell; Neutronics; McDeLicious; McCad; Neutron streaming	REFERENCE TEST CELL	The IFMIF Test Cell (TC) design was developed and optimized in the EVEDA phase, and finally the reference TC design was proposed. The present study is devoted to further investigations of open issues on the reference TC design. In order to examine the neutron streaming effect caused by pipe penetrations and gaps around removable shielding plugs, a new geometry model for neutronic analyses has been prepared directly from engineering CAD data by utilizing the McCad conversion software. All removable shielding plugs are separately described in the model and a detailed description of pipes was incorporated into the model. The calculation result suggests that the streaming effect is mitigated if the pipe penetration is designed appropriately, while the gaps around the shielding plugs above the TC have large impact on the radiation dose in the access cell. The concept of the reference TC design has been basically validated from the neutronics point of view, although the streaming effect should be compensated by the shielding capability of the test cell cover plate so that occupational workers can access to the access cell during operation. (C) 2015 Karlsruhe Institute of Technology. Published by Elsevier B.V. All rights reserved.	[Kondo, Keitaro; Arbeiter, Frederik; Fischer, Ulrich; Lu, Lei; Qiu, Yuefeng; Tian, Kuo] KIT, Eggenstein Leopoldshafen, Germany	Kondo, K (reprint author), Japan Atom Energy Agcy, Rokkasho, Japan.	kondo.keitaro@jaea.go.jp					Kondo K, 2014, FUSION ENG DES, V89, P1758, DOI 10.1016/j.fusengdes.2013.12.008; Garin P, 2012, FUSION SCI TECHNOL, V62, P219; Qiu YF, 2014, FUSION ENG DES, V89, P1330, DOI 10.1016/j.fusengdes.2014.02.044; Simakov SP, 2012, FUSION SCI TECHNOL, V62, P233; Lu L, 2014, FUSION ENG DES, V89, P1885, DOI 10.1016/j.fusengdes.2014.05.015; Tian K, 2014, FUSION ENG DES, V89, P1694, DOI 10.1016/j.fusengdes.2014.02.008; Forrest R.A., 2012, INDCNDS0628 IAEA; Grage D., 2014, FUS ENG DES, V88, P2210; Tian K., 2014, FUS ENG DES, V88, P635; X-5 Monte Carlo Team, 2003, LAUR031987 LOS AL NA	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1998	2002		10.1016/j.fusengdes.2015.01.019		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900212		
J	Kondo, M; Ishii, M; Muroga, T				Kondo, Masatoshi; Ishii, Masaorni; Muroga, Takeo			Corrosion of steels in molten gallium (Ga), tin (Sn) and tin lithium alloy (Sn-20Li)	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Liquid breeder; Lithium tin alloy; Tin; Gallium; Corrosion; Reduced activation ferritic martensitic steel	LIQUID GALLIUM; JLF-1	The compatibility of steels in liquid gallium (Ga), tin (Sn) and tin lithium alloy (Sn-20Li) was investigated by means of static corrosion tests. The corrosion tests were performed for reduced activation ferritic martensitic steel JLF-1 (JOYO-HEAT, Fe-9Cr-2W-0.1C) and austenitic steel SUS316 (Fe-18Cr-12Ni-2Mo). The test temperature was 873 K, and the exposure time was 250 and 750 h. The corrosion of these steels in liquid Ga, Sn and Sn-20Li alloy was commonly caused by the formation of a reaction layer and the dissolution of the steel elements into the melts. The reaction layer formed in liquid Ga was identified as Fe3Ga from the results of metallurgical analysis and the phase diagram. The growth rate of the reaction layer on the JLF-1 steel showed a parabolic rate law, and this trend indicated that the corrosion could be controlled by the diffusion process through the layer. The reaction layer formed in liquid Sn and Sn-20Li was identified as FeSn. The growth rate had a linear function with exposure time. The corrosion in Sn and Sn-20Li could be controlled by the interface reaction on the layer. The growth rate of the layer formed in liquid Sn and Sn-20Li was much slower than that in liquid Ga. The weight change of the JLF-1 specimen immersed in Sn-20Li for 750 h was measured after the removal of the adherent Sn-20Li in a Li pool. The weight loss was 1.42 x 10(3) g/m(3), and this value was 1500 times larger than that tested in liquid lead lithium alloy (Pb-17Li) at the same conditions in the previous studies. (C) 2015 Elsevier B.V. All rights reserved.	[Kondo, Masatoshi] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Ishii, Masaorni] Tokai Univ, Sch Engn, Dept Nucl Engn, Hiratsuka, Kanagawa 2591292, Japan; [Muroga, Takeo] Natl Inst Fus Sci, Dept Helical Plasma Res, Gifu 5025292, Japan	Kondo, M (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.	kondo.masatoshi@nr.titech.acjp					Futterer MA, 2000, J NUCL MATER, V283, P1375, DOI 10.1016/S0022-3115(00)00124-0; Kondo M, 2012, FUSION ENG DES, V87, P1777, DOI 10.1016/j.fusengdes.2011.12.013; [Anonymous], 2001, NIGENGOUKIN JOUTAIZU; Kondo M, 2013, FUSION ENG DES, V88, P2556, DOI 10.1016/j.fusengdes.2013.05.049; Natesan K, 2002, J NUCL MATER, V307, P743, DOI 10.1016/S0022-3115(02)01221-7; Shin SH, 2014, J NUCL MATER, V450, P314, DOI 10.1016/j.jnucmat.2013.08.006; Xu Q, 2009, J NUCL MATER, V394, P20, DOI 10.1016/j.jnucmat.2009.08.005; Barbier F, 1999, J MATER RES, V14, P737, DOI 10.1557/JMR.1999.0099; Ono H, 2004, J NUCL MATER, V329, P1117, DOI 10.1016/j.jnucmat.2004.04.034; Nakajima Y., 2015, FUSION ENG IN PRESS; Rondo M., 2013, PLASMA FUSION RES RE, V8; Yeliseyeva OI, 2002, J NUCL MATER, V307, P1400, DOI 10.1016/S0022-3115(02)00989-3	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2003	2008		10.1016/j.fusengdes.2015.05.051		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900213		
J	Nakajima, Y; Kondo, M; Nozawa, T				Nakajima, Yuu; Kondo, Masatoshi; Nozawa, Takashi			Study on fabrication method of lithium alloys with metal grains	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Liquid breeder; Lithium; Lithium-lead alloy; Lithium-tin alloy; Fusion blanket		Fabrication methods of lead-lithium (Pb-Li) alloys and tin-lithium (Sn-Li) alloys were studied. The alloys at various Li concentration were fabricated by the melting and mixing of the small metal grains of Li, Pb and Sn. The concentration of Li in the fabricated alloy was evaluated by two methods, i.e. chemical analysis by ICP-AES and the evaluation of the melting point of the alloys with the phase diagram. The concentration of Li determined by these two methods agreed well each other. The Li concentration of the fabricated alloys was lower than that expected from the mass of the Li metal grains used. The depletion of Li metal was caused by the oxidation of Li with the oxides on the pure Pb or Sn grains in the fabrication process. The concentration of Li in the fabricated alloy was successfully adjusted by the addition of the Li alloy having different Li concentration. (C) 2015 Elsevier B.V. All rights reserved.	[Nakajima, Yuu] Tokai Univ, Dept Nucl Engn, Hiratsuka, Kanagawa 2591292, Japan; [Kondo, Masatoshi] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Nozawa, Takashi] Japan Atom Energy Agcy, Rokkasyo, Aomori 0393212, Japan	Kondo, M (reprint author), Tokyo Inst Technol, Tokyo, Japan.	kondo.masatoshi@nr.titech.ac.jp					NEUBERT A, 1979, J CHEM THERMODYN, V11, P971, DOI 10.1016/0021-9614(79)90046-6; Gasior W, 2001, J NUCL MATER, V294, P77, DOI 10.1016/S0022-3115(01)00440-8; BUXBAUM RE, 1984, J LESS-COMMON MET, V97, P27, DOI 10.1016/0022-5088(84)90005-5; Kondo M, 2013, FUSION ENG DES, V88, P2556, DOI 10.1016/j.fusengdes.2013.05.049; Natesan K, 2002, J NUCL MATER, V307, P743, DOI 10.1016/S0022-3115(02)01221-7; Conde E., 2013, FUSION ENG DES, V89, P1250; Jansen D.H., 1959, J NUCL MATER, V3, P249; Lyon R.N., 1952, LIQUID METALS HDB; Yokogawa H., 1993, NETSU BUSSEI, V7, P63	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2009	2014		10.1016/j.fusengdes.2015.06.184		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900214		
J	Nagasaka, T; Sakasegawa, H; Tanigawa, H; Ando, M; Tanaka, T; Muroga, T; Sagara, A				Nagasaka, Takuya; Sakasegawa, Hideo; Tanigawa, Hiroyasu; Ando, Masami; Tanaka, Teruya; Muroga, Takeo; Sagara, Akio			Tensile properties of F82H steel after aging at 400-650 degrees C for 100,000h	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Fusion blankets; Reduced-activation ferritic/martensitic steels; Tensile tests; Aging effect	FERRITIC/MARTENSITIC STEELS; MECHANICAL-PROPERTIES; ACTIVATION	The present study investigated tensile properties of F82H steel after aging at 400-650 degrees C for 100,000 h (100 kh), and discusses the mechanisms for change in tensile properties due to the long-term aging. Tensile strength was degraded during the aging. The degradation of yield strength and ultimate tensile strength was 50 MPa or less at 550 degrees C and below in both room temperature and high temperature tests. Above 550 degrees C, yield strength and ultimate tensile strength decreased with increasing aging temperature. On the other hand, no degradation of ductility was detected after the aging. Most of the degradation of the tensile strength could be attributed to loss of solid solution hardening by W due to precipitation of Laves phase (Fe2W) at 550 degrees C. However, other mechanisms, such as coarsening of martensite structure and recovery of dislocations, should be taken into account to explain additional degradation above 550 degrees C. (C) 2015 Published by Elsevier B.V.	[Nagasaka, Takuya; Tanaka, Teruya; Muroga, Takeo; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sakasegawa, Hideo; Tanigawa, Hiroyasu; Ando, Masami] Japan Atom Energy Agcy, Rokkasho, Japan	Nagasaka, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	nagasaka@nifs.ac.jp					Shiba K, 2006, FUSION ENG DES, V81, P1051, DOI 10.1016/j.fusengdes.2005.07.030; Nagasaka T, 2011, FUSION ENG DES, V86, P2581, DOI 10.1016/j.fusengdes.2010.11.006; Tavassoli AAF, 2014, J NUCL MATER, V455, P269, DOI 10.1016/j.jnucmat.2014.06.017; Tavassoli AAF, 2002, FUSION ENG DES, V61-62, P617, DOI 10.1016/S0920-3796(02)00255-7; Sasmal CS, 2013, PROCEDIA ENGINEER, V55, P277, DOI 10.1016/j.proeng.2013.03.254; Shiba K, 2011, FUSION ENG DES, V86, P2895, DOI 10.1016/j.fusengdes.2011.06.005; Jitsukawa S, 2004, J NUCL MATER, V329, P39, DOI [10.1016/j.jnucmat.2004.04.319, 10.1016/jnucmat.2004.04.319]; Nagasaka T, 2013, FUSION ENG DES, V88, P2565, DOI 10.1016/j.fusengdes.2013.05.037; Kohyama A, 1996, J NUCL MATER, V233, P138, DOI 10.1016/S0022-3115(96)00327-3; Shiba K., 1997, 97038 JAERI, P55; Tamura M, 2000, J NUCL MATER, V283, P667, DOI 10.1016/S0022-3115(00)00138-0; Tanigawa, 2011, J NUCL MAT, V417, P9	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2046	2049		10.1016/j.fusengdes.2015.06.190		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900222		
J	Okita, T; Hoashi, E; Yoshihashi, S; Kondo, H; Kanemura, T; Yamaoka, N; Horiike, H				Okita, Takafumi; Hoashi, Eiji; Yoshihashi, Sachiko; Kondo, Hiroo; Kanemura, Takuji; Yamaoka, Nobuo; Horiike, Hiroshi			Certification of contact probe measurement of surface wave of Li jet for IFMIF	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		International fusion materials irradiation facility (IFMIF); Electra-contact probe; Liquid Li; Droplet; Accuracy; Surface tension	TARGET	The international fusion material irradiation facility (IFMIF) is a neutron source for developing fusion reactor materials. A liquid lithium (Li) jet with free surface is planned as a target to generate intense neutron field. It is important to obtain information on the surface wave characteristic for safety of the facility and efficient neutron generation. Surface wave characteristics experiment using the liquid Li circulation facility is carried out at Osaka University. In our studies, measurement using an electro-contact probe apparatus is conducted and many data about surface wave height were taken. In this experiment, a liquid Li droplet was observed on the probe. To see effect due to droplets on the probe needle, images near the surface of the Li jet including the Li droplet were taken by HSV camera synchronized with probe contact signals, and correlation between the behavior of the Li droplet and signals was evaluated. From the results, when the droplet on the probe contacts of the droplet with the surface, signals obviously different from the regular signal were observed. The influence on the result of frequency was estimated and is approximately <1%. Accuracy of measurement using probe could be increased by carefully deleting false signals. (C) 2015 Elsevier B.V. All rights reserved.	[Okita, Takafumi; Hoashi, Eiji; Yoshihashi, Sachiko; Yamaoka, Nobuo; Horiike, Hiroshi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan; [Kondo, Hiroo; Kanemura, Takuji] Japan Atom Energy Agcy, Oarai, Ibaraki, Japan	Okita, T (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka, Japan.	okita@stu.nucl.eng.osaka-u.ac.jp					Knaster J, 2014, FUSION ENG DES, V89, P1709, DOI 10.1016/j.fusengdes.2014.01.011; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Ida M, 2004, FUSION ENG DES, V70, P95, DOI 10.1016/S0920-3796(03)00416-2; Sugiura H, 2011, FUSION ENG DES, V86, P2635, DOI 10.1016/j.fusengdes.2011.03.084; Okita T., 2013, P NURETH, P186; Yoshihashi-Suzuki S, 2012, FUSION ENG DES, V87, P1434, DOI 10.1016/j.fusengdes.2012.03.027	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2050	2053		10.1016/j.fusengdes.2015.04.035		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900223		
J	Ozawa, K; Tanigawa, H; Morisada, Y; Fujii, H				Ozawa, Kazumi; Tanigawa, Hiroyasu; Morisada, Yoshiaki; Fujii, Hidetoshi			Impacts of friction stir processing on irradiation effects in vacuum-plasma-spray coated tungsten	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tungsten; Vacuum plasma spray; Friction stir processing; Ion irradiation; Nano indentation	HARDNESS	In order to examine the impacts of friction stir processing (FSP) on irradiation effects in vacuum-plasmaspray (VPS) coated tungsten (W), nano indentation hardness was evaluated of three kinds of W materials after self-ion-irradiation to 5.0-5.4 dpa at 500 and 800 degrees C. The VPS-FSP clearly got grains refined and isotropic compared to bulk-W and the as-VPS-W. Nano indentation hardness remains unchanged for the as-VPS-W and VPS-FSP x 2-W irradiated to 5.4 dpa at 500 degrees C and it decreased from 1 dpa at 800 degrees C, while typical irradiation induced hardening was observed for the bulk-W irradiated at 500 degrees C. (C) 2015 Elsevier B.V. All rights reserved.	[Ozawa, Kazumi; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori 0393212, Japan; [Morisada, Yoshiaki; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Ozawa, K (reprint author), Japan Atom Energy Agcy, Fus Res & Dev Directorate, 2-166 Obuchi Omotedate, Aomori 0393212, Japan.	ozawa.kazumi@jaea.go.jp					Fukuda M, 2013, J NUCL MATER, V442, pS273, DOI 10.1016/j.jnucmat.2013.03.058; Hirose T, 2006, FUSION ENG DES, V81, P645, DOI 10.1016/j.fusengdes.2005.07.015; Morisada Y, 2010, SURF COAT TECH, V204, P2459, DOI 10.1016/j.surfcoat.2010.01.021; Sasaki K, 2013, FUSION ENG DES, V88, P1735, DOI 10.1016/j.fusengdes.2013.05.052; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Noh S, 2014, FUSION ENG DES, V89, P289, DOI 10.1016/j.fusengdes.2014.01.084; Tokunaga K, 2006, FUSION ENG DES, V81, P133, DOI 10.1016/j.fusengdes.2005.08.032; Zinkle SJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104024; Nagasaka T, 2009, FUSION SCI TECHNOL, V56, P1053; Bolt H, 2004, J NUCL MATER, V329, P66, DOI 10.1016/j.jnucmat.2004.04.005; Tanigawa H, 2015, FUSION ENG DES, V98-99, P2080, DOI 10.1016/j.fusengdes.2015.04.059; Ziegler J.F., 1985, STOPPING RANGE IONS, P109	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2054	2057		10.1016/j.fusengdes.2015.06.104		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900224		
J	Sakasegawa, H; Tanigawa, H; Kano, S; Abe, H				Sakasegawa, Hideo; Tanigawa, Hiroyasu; Kano, Sho; Abe, Hiroaki			Material properties of the F82H melted in an electric arc furnace	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Fusion DEMO reactor; Reduced activation ferritic/martensitic steel; Electric arc furnace; Mechanical property; Microstructure	STEEL; TOUGHNESS	Fusion DEMO reactor requires over 11,000 tons of reduced activation ferritic/martensitic steel. It is necessary to develop the manufacturing technology for fabricating such large-scale steel with appropriate mechanical properties. In this work, we focused fundamental mechanical properties and microstructures of F82H-BA12 heat which was melted using a 20 tons electric arc furnace followed by electroslag remelting process. Its raw material of iron was blast furnace iron, because the production volume of electrolytic iron which has been used in former heats, is limited. After melting and forging, this F82H-BA12 heat was heat-treated in four different conditions to consider their fluctuations and to optimize them, and tensile and Charpy impact tests were then performed. The result of these mechanical properties were comparable to those of former F82H heats less than 5 tons which were melted applying vacuum induction melting. (C) 2015 Elsevier B.V. All rights reserved.	[Sakasegawa, Hideo; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Aomori, Japan; [Kano, Sho; Abe, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan	Sakasegawa, H (reprint author), Japan Atom Energy Agcy, Aomori, Japan.	sakasegawa.hideo@jaea.go.jp					Kushima H, 1999, TETSU TO HAGANE, V85, P841; Tanigawa H, 2014, FUSION ENG DES, V89, P1573, DOI 10.1016/j.fusengdes.2014.02.052; Obara S, 2009, TETSU TO HAGANE, V95, P417; Sakasegawa H, 2014, FUSION ENG DES, V89, P1684, DOI 10.1016/j.fusengdes.2014.02.024; Shiba K, 2012, FUSION SCI TECHNOL, V62, P145; WILLIAMSON GK, 1956, PHILOS MAG, V1, P34, DOI 10.1080/14786435608238074; Sakasegawa H, 2011, FUSION ENG DES, V86, P2541, DOI 10.1016/j.fusengdes.2011.03.087; Tanigawa H, 2011, FUSION ENG DES, V86, P2549, DOI 10.1016/j.fusengdes.2011.04.047; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2068	2071		10.1016/j.fusengdes.2015.06.103		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900227		
J	Sukegawa, AM; Murakami, H; Matsunaga, G; Sakurai, S; Takechi, M; Yoshida, K; Ikeda, Y				Sukegawa, Atsuhiko M.; Murakami, Haruyuki; Matsunaga, Go; Sakurai, Shinji; Takechi, Manabu; Yoshida, Kiyoshi; Ikeda, Yoshitaka			Estimation of the lifetime of resin insulators against baking temperature for JT-60SA in-vessel coils	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Bismaleimides resin; Cyanate ester resin; Cyanate ester epoxy resin; Thermal endurance; Lifetime; JT-605A in-vessel coils		In the present study, the thermal endurance of epoxy-based, bismaleimides, and cyanate ester resins for the current design of the in-vessel coils was measured by performing acceleration tests to assess their insulation properties using the thermal endurance defined by the International Electrotechnical Commission (IEC-60216 Partl -Part 6) for a minimum of 5,000h in the 180-240 degrees C temperature range. It was found that none of the resin insulators could tolerate the baking conditions of 40,000 h at 200 degrees C in the JT-60SA vacuum vessel. Therefore, the design of the in-vessel coils, including the error field correction coils (EFCC), was changed from the type without water cooling to with water cooling on JT-60SA. (C) 2015 Elsevier B.V. All rights reserved.	[Sukegawa, Atsuhiko M.; Murakami, Haruyuki; Matsunaga, Go; Sakurai, Shinji; Takechi, Manabu; Yoshida, Kiyoshi; Ikeda, Yoshitaka] Japan Atom Energy Agcy, Naka, Ibaraki, Japan	Sukegawa, AM (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki, Japan.	morioka.atsuhiko@jaea.go.jp					Abernethy R. B., 2006, NEW WEIBULL HDB; Sukegawa AM, 2011, J NUCL MATER, V417, P850, DOI 10.1016/j.jnucmat.2010.12.291; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Sukegawa AM, 2007, FUSION ENG DES, V82, P2799, DOI 10.1016/j.fusengdes.2007.06.021; Ayano R, 1984, NETSUKOHKASEIJYUSHI, V5, P23; Delfa G.L., HIGH TEMPERATURE FLA; Matsunaga G., 2014, 28 SOFT 2014 S FUS T; Tavlet M., 1998, COMPILATION RAD DAMA; Weber H.W., 2013, IEEE T APPL SUPERCON	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2076	2079		10.1016/j.fusengdes.2015.06.018		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900229		
J	Tanigawa, H; Ozawa, K; Morisada, Y; Noh, S; Fujii, H				Tanigawa, Hiroyasu; Ozawa, Kazumi; Morisada, Yoshiaki; Noh, Sanghoon; Fujii, Hidetoshi			Modification of vacuum plasma sprayed tungsten coating on reduced activation ferritic/martensitic steels by friction stir processing	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tungsten; Vacuum plasma spray; Friction stir processing; Reduced activation ferritic/martensitic steel		Tungsten (W) is the primary candidate material as a plasma facing material in fusion devices, as for its high melting temperature, good thermal conductivity and low sputtering rate, and vacuum plasma spray (VPS) technique is preferred as it is applicable for large area without brittle interlayer, but the thermal conductivity of W layer is very poor, and easy to detach, mainly caused by its porous structure. W Friction stir processing (FSP) was applied on VPS-W to improve these poor properties, and it was suggested that FSP can contribute to significant improvement in both mechanical and thermal properties of the VPS-W coating. (C) 2015 Elsevier B.V. All rights reserved.	[Tanigawa, Hiroyasu; Ozawa, Kazumi; Noh, Sanghoon] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori, Japan; [Morisada, Yoshiaki; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka, Japan; [Noh, Sanghoon] Korea Atom Energy Res Inst, Nucl Mat Dev Div, Daejeon, South Korea	Tanigawa, H (reprint author), Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori, Japan.	tanigawa.hiroyasu@jaea.go.jp					Hirose T, 2006, FUSION ENG DES, V81, P645, DOI 10.1016/j.fusengdes.2005.07.015; Morisada Y, 2010, SURF COAT TECH, V204, P2459, DOI 10.1016/j.surfcoat.2010.01.021; Tokunaga K, 2006, FUSION ENG DES, V81, P133, DOI 10.1016/j.fusengdes.2005.08.032; Nagasaka T, 2009, FUSION SCI TECHNOL, V56, P1053; Bolt H, 2004, J NUCL MATER, V329, P66, DOI 10.1016/j.jnucmat.2004.04.005	5	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2080	2084		10.1016/j.fusengdes.2015.04.059		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900230		
J	Tian, K; Abou-Sena, A; Arbeiter, F; Garcia, A; Gouat, P; Heidinger, R; Heinzel, V; Ibarra, A; Leysen, W; Mas, A; Mittwollen, M; Moslang, A; Theile, J; Yamamoto, M; Yokomine, T				Tian, Kuo; Abou-Sena, Ali; Arbeiter, Frederik; Garcia, Angela; Gouat, Philippe; Heidinger, Roland; Heinzel, Volker; Ibarra, Angel; Leysen, Willem; Mas, Avelino; Mittwollen, Martin; Moeslang, Anton; Theile, Juergen; Yamamoto, Michiyoshi; Yokomine, Takehiko			Overview of the IFMIF test facility design in IFMIF/EVEDA phase	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; Test facility; Test modules; Test cell; Neutron irradiation; Fusion material	BREEDER VALIDATION MODULE; REFERENCE TEST CELL; ENGINEERING DESIGN; KEY COMPONENTS; TARGET	The test facility (TF) is one of the three major facilities of the International Fusion Material Irradiation Facility (IFMIF). Engineering designs of TF main systems and key components have been initiated and developed in the IFMIF EVEDA (Engineering Validation and Engineering Design Activities) phase since 2007. The related work covers the designs of a test cell which is the meeting point of the TF and accelerator facility and lithium facility, a series of test modules for experiments under different irradiation conditions, an access cell to accommodate remote handling systems, four test module handling cells for test module processing and assembling, and test facility ancillary systems for engineering support on energy, media, and control infrastructure. This paper summarizes the principle functions, brief specifications, and the current design status of the above mentioned IFMIF TF systems and key components. (C) 2015 Karlsruhe Institute of Technology. Published by Elsevier B.V. All rights reserved.	[Tian, Kuo; Abou-Sena, Ali; Arbeiter, Frederik; Heinzel, Volker; Mittwollen, Martin; Moeslang, Anton] KIT, Karlsruhe, Germany; [Garcia, Angela; Ibarra, Angel; Mas, Avelino] CIEMAT, E-28040 Madrid, Spain; [Gouat, Philippe; Leysen, Willem] CEN SCK, B-2400 Mol, Belgium; [Heidinger, Roland] F4E BFD, Garching, Germany; [Theile, Juergen] CRPP EPFL, Villigen, Switzerland; [Yamamoto, Michiyoshi] IFMIF EVEDA Project Team, Rokkasho, Japan; [Yokomine, Takehiko] Kyoto Univ, Kyoto, Japan	Tian, K (reprint author), KIT, Karlsruhe, Germany.	kuo.tian@kit.edu					Kondo K, 2014, FUSION ENG DES, V89, P1758, DOI 10.1016/j.fusengdes.2013.12.008; Heidinger R, 2013, FUSION ENG DES, V88, P631, DOI 10.1016/j.fusengdes.2013.01.066; Wakai E, 2012, FUSION SCI TECHNOL, V62, P246; Arbeiter F, 2011, FUSION ENG DES, V86, P607, DOI 10.1016/j.fusengdes.2011.01.031; Mas A, 2014, FUSION ENG DES, V89, P1728, DOI 10.1016/j.fusengdes.2013.12.029; Gouat P, 2013, FUSION ENG DES, V88, P729, DOI 10.1016/j.fusengdes.2013.02.057; Tian K, 2010, FUSION ENG DES, V85, P2282, DOI 10.1016/j.fusengdes.2010.09.007; Tian K, 2013, FUSION ENG DES, V88, P635, DOI 10.1016/j.fusengdes.2013.03.055; Garin P, 2008, FUSION ENG DES, V83, P971, DOI 10.1016/j.fusengdes.2008.05.028; Casal N, 2013, FUSION ENG DES, V88, P863, DOI 10.1016/j.fusengdes.2013.03.057; Tian K, 2011, NUCL ENG DES, V241, P4818, DOI 10.1016/j.nucengdes.2011.03.037; Moeslang A, 2006, FUSION ENG DES, V81, P863, DOI 10.1016/j.fusengdes.2005.07.044; Tian K, 2014, FUSION ENG DES, V89, P1694, DOI 10.1016/j.fusengdes.2014.02.008; Yamamoto M, 2013, FUSION ENG DES, V88, P746, DOI 10.1016/j.fusengdes.2013.03.062; Abou-Sena A, 2013, FUSION ENG DES, V88, P818, DOI 10.1016/j.fusengdes.2013.02.041; IFMIF International Team, 2003, IFMIF COMPR DES REP; Leysen W., 2012, SOFT27; Tian K., 2013, ICONE, V21	18	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2085	2088		10.1016/j.fusengdes.2015.05.041		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900231		
J	Wakai, E; Kikuchi, T; Kim, B; Kimura, A; Nogami, S; Hasegawa, A; Nishimura, A; Soldaini, M; Yamamoto, M; Knaster, J				Wakai, Eiichi; Kikuchi, Takayuki; Kim, Byung; Kimura, Akihiko; Nogami, Shuhei; Hasegawa, Akira; Nishimura, Arata; Soldaini, Michel; Yamamoto, Michiyoshi; Knaster, Juan			Overview on recent progress toward small specimen test technique	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Small specimen test technique; IFMIF; Master curve method; Ductile-brittle transition temperature; PIE	TEMPERED MARTENSITIC STEEL; MASTER-CURVE ANALYSIS; FERRITIC/MARTENSITIC STEEL; SWELLING BEHAVIOR; ION-BEAMS; F82H; IRRADIATION; HELIUM; EUROFER97; HYDROGEN	The present status of the small specimen test technique (SSTT) and the engineering design of the post irradiation examination (PIE) facility in the International Fusion Materials Irradiation Facility (IFMIF) were evaluated and summarized as parts of the IFMIF/engineering validation and engineering design activity (EVEDA). SSTT is very important to obtain data mainly for the design of fusion demonstration (DEMO) reactors using the high flux test module (HFTM) of IFMIF. The analysis of brittle-ductile transition behaviors of reduced-activation ferritic/martensitic (RAFM) steels is very important for evaluating the structural integrity of RAFM steels used in the fusion DEMO reactors, and it is necessary to develop new analyses combined with random inhomogeneity analysis and the modified master curve method. Further developed analysis and test equipment developing for small specimen tests are necessary in the establishment of SSTT. (C) 2015 Elsevier B.V. All rights reserved.	[Wakai, Eiichi; Kikuchi, Takayuki; Kim, Byung] JAEA, Tokai, Ibaraki, Japan; [Kimura, Akihiko] Kyoto Univ, Uji, Kyoto, Japan; [Nogami, Shuhei; Hasegawa, Akira] Tohoku Univ, Sendai, Miyagi 980, Japan; [Nishimura, Arata] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Soldaini, Michel] CEA, Paris, France; [Yamamoto, Michiyoshi; Knaster, Juan] IFMIF Project Team, Aomori, Japan	Wakai, E (reprint author), JAEA, Tokai, Ibaraki, Japan.	wakai.eiichi@jaea.go.jp					Kim BJ, 2013, J NUCL MATER, V442, pS38, DOI 10.1016/j.jnucmat.2013.03.079; Wakai E, 2011, FUSION ENG DES, V86, P712, DOI 10.1016/j.fusengdes.2011.04.061; Wakai E, 2003, J NUCL MATER, V318, P267, DOI 10.1016/S0022-3115(03)00122-3; Wakai E, 2004, MATER TRANS, V45, P2641, DOI 10.2320/matertrans.45.2641; Wakai E, 2006, J NUCL MATER, V356, P95, DOI 10.1016/j.jnucmat.2006.05.032; Wakai E, 2012, FUSION SCI TECHNOL, V62, P246; Nogami S, 2013, J NUCL MATER, V441, P125, DOI 10.1016/j.jnucmat.2013.05.051; Wakai E, 2002, J NUCL MATER, V307, P278, DOI 10.1016/S0022-3115(02)01076-0; Wakai E, 2005, J NUCL MATER, V343, P285, DOI 10.1016/j.jnucmat.2004.10.167; Wallin K, 2004, ENG FRACT MECH, V71, P2329, DOI [10.1016/j.engfracmech.2004.01.010, 10.1016/j.angfracmech.2004.01.010]; [Anonymous], 2004, IFMIF COMPR DES REP; Gaganidze E, 2011, J NUCL MATER, V417, P93, DOI 10.1016/j.jnucmat.2010.12.047; Wakai E, 2000, J NUCL MATER, V283, P799, DOI 10.1016/S0022-3115(00)00268-3; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Nogami S, 2011, J NUCL MATER, V417, P131, DOI 10.1016/j.jnucmat.2010.12.048; Tanaka T, 2004, J NUCL MATER, V329, P294, DOI 10.1016/j.jnucmat.2004.04.051; Morimura T, 1996, J NUCL MATER, V239, P118, DOI 10.1016/S0022-3115(96)00466-7; Wakai E, 2011, J NUCL MATER, V417, P1325, DOI 10.1016/j.jnucmat.2011.02.011; Spatig P, 2007, J NUCL MATER, V367, P527, DOI 10.1016/j.jnucmat.2007.03.038; Taguchi T, 2004, J NUCL MATER, V335, P508, DOI 10.1016/j.jnucmat.2004.08.014; Mueller P, 2009, J NUCL MATER, V386-88, P323, DOI 10.1016/j.jnucmat.2008.12.122; Kim BJ, 2011, FUSION ENG DES, V86, P2403, DOI 10.1016/j.fusengdes.2011.04.001; [Anonymous], 1995, IEA TECHN PLANN WORK; Bonade R, 2007, J NUCL MATER, V367, P581, DOI 10.1016/j.jnucmat.2007.03.031; IFMIF International Team, 2003, IFMIF KEP INT FUS MA; Ito Y., 2014, 1576 ASTM STP, P209; Ito Y., 2015, J PLASMA FUSION RES, V11, P73; Martone M., 1996, RTERGFUS9611 ENEA; Moeslang A., DEV REFERENCE TEST M; Sokojov MA, 2007, J NUCL MATER, V367, P587, DOI 10.1016/j.jnucmat.2007.03.105; Wakai E., 2015, INT C FUS REACT MAT; Wakai E., 2015, J PLASMA FUSION RES, V11, P104; Wakai E., 2012, 24 IAEA FUS EN C OCT, P7	33	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2089	2093		10.1016/j.fusengdes.2015.06.068		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900232		
J	Zhang, ZX; Chen, DS; Han, WT; Kimura, A				Zhang, Z. X.; Chen, D. S.; Han, W. T.; Kimura, A.			Irradiation hardening in pure tungsten before and after recrystallization	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tungsten; Recrystallization; Ion-irradiation; Nano-indentation; Hardening effect	ION-IRRADIATION; COOLED DIVERTOR; DAMAGE; DEMO	Ion-irradiation hardening of tungsten (W) before and after recrystallization was investigated in this paper. Three specimens were sampled from a rolled pure (99.95%) W plate. Two are from the as-received W and one was from the recrystallized W (annealed at 1400 degrees C for 1 h). Specimens were irradiated with 6.4 MeV Fe3+ at 300 degrees C, 700 degrees C and 1000 degrees C, respectively. The profile of displacement per atom (dpa) calculated by SRIM showed the average displacement damage is about 2 dpa at the depth of 600 nm. The hardness of irradiated area was measured by nano-indentation method with continuous stiffness measurement (CSM) and was calculated by Nix-Gao model for bulk-equivalent hardness. Irradiation hardening was defined as the difference between the hardness values of irradiated area and unirradiated area of a specimen. The result revealed that recrystallized specimens exhibited larger irradiation hardening than the as-received ones, and the amount of hardening was independent of irradiation temperature, while the hardening of as-received W increased with increasing irradiation temperature. There was no difference in the irradiation hardening between the specimens sampled from the different sides of the as-received W. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, Z. X.; Chen, D. S.] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan; [Han, W. T.; Kimura, A.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan	Zhang, ZX (reprint author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan.	zx-zhang@iae.kyoto-u.ac.jp					Alimov VK, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014037; Hasegawa A, 2013, MATER TRANS, V54, P466, DOI 10.2320/matertrans.MG201208; Cui MH, 2013, NUCL INSTRUM METH B, V307, P507, DOI 10.1016/j.nimb.2012.12.083; Rieth M, 2013, J NUCL MATER, V432, P482, DOI 10.1016/j.jnucmat.2012.08.018; Kasada R, 2011, FUSION ENG DES, V86, P2658, DOI 10.1016/j.fusengdes.2011.03.073; Xu Q, 2003, NUCL INSTRUM METH B, V206, P123, DOI 10.1016/S0168-583X(03)00697-9; Pharr GM, 2010, ANNU REV MATER RES, V40, P271, DOI 10.1146/annurev-matsci-070909-104456; [Anonymous], 2009, E521962009 ASTM; Armstrong DEJ, 2013, J NUCL MATER, V432, P428, DOI 10.1016/j.jnucmat.2012.07.044; Bolt H, 2002, J NUCL MATER, V307, P43, DOI 10.1016/S0022-3115(02)01175-3; Stoller RE, 2013, NUCL INSTRUM METH B, V310, P75, DOI 10.1016/j.nimb.2013.05.008; Yi X, 2013, PHILOS MAG, V93, P1715, DOI 10.1080/14786435.2012.754110; Hasegawa A, 2014, FUSION ENG DES, V89, P1568, DOI 10.1016/j.fusengdes.2014.04.035; NORGETT MJ, 1975, NUCL ENG DES, V33, P50, DOI 10.1016/0029-5493(75)90035-7; Rieth M, 2011, J NUCL MATER, V417, P463, DOI 10.1016/j.jnucmat.2011.01.075; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Himei Y, 2013, MATER TRANS, V54, P446, DOI 10.2320/matertrans.MG201212; Norajitra P, 2006, FUSION ENG DES, V81, P341, DOI 10.1016/j.fusengdes.2005.07.024; Wang HW, 2013, J NUCL MATER, V442, P189, DOI 10.1016/j.jnucmat.2013.08.036; Janeschitz G, 2006, FUSION ENG DES, V81, P2661, DOI 10.1016/j.fusengdes.2006.07.085; Nix WD, 1998, J MECH PHYS SOLIDS, V46, P411, DOI 10.1016/S0022-5096(97)00086-0; Norajitra P, 2007, J NUCL MATER, V367, P1416, DOI 10.1016/j.jnucmat.2007.04.027; SCATTERGOOD RO, 1982, ACTA METALL MATER, V30, P1665, DOI 10.1016/0001-6160(82)90188-2	23	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2103	2107		10.1016/j.fusengdes.2015.06.192		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900235		
J	Furukawa, T; Hirakawa, Y; Kondo, H; Kanemura, T; Wakai, E				Furukawa, Tomohiro; Hirakawa, Yasushi; Kondo, Hiroo; Kanemura, Takuji; Wakai, Eiichi			Chemical reaction of lithium with room temperature atmosphere of various humidities	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; EVEDA; Lithium; Safety handling; Chemical reaction		When replacing lithium target components in the International Fusion Materials Irradiation Facility, the lithium adhering on the surface of components will chemically react with the surrounding atmosphere. In this study, we investigate the chemical reaction of pure lithium in room temperature air, oxygen, nitrogen, and argon of various humidities. In air, oxygen, and argon, the weight gain increases with time and humidity, and no significant difference is observed in these gases. In nitrogen, except for the test with 75% relative humidity (RH), the weight gain accelerates with time, and the weight gain rate decreases with increasing RH. We attribute the weight gain increase observed in low humidity to the acceleration due to lithium nitride formation. Upon increasing the moisture content of the gas, the main lithium reaction becomes lithium hydroxide formation. (C) 2014 Elsevier B.V. All rights reserved.	[Furukawa, Tomohiro; Hirakawa, Yasushi; Kondo, Hiroo; Kanemura, Takuji; Wakai, Eiichi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan	Furukawa, T (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki 3111393, Japan.	furukawa.tomohiro@jaea.go.jp					Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Kondo H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123008; Furukawa T, 2013, FUSION ENG DES, V88, P2502, DOI 10.1016/j.fusengdes.2013.04.036; Furukawa T, 2011, FUSION ENG DES, V86, P2433, DOI 10.1016/j.fusengdes.2010.12.037; Kondo H, 2012, FUSION ENG DES, V87, P418, DOI 10.1016/j.fusengdes.2011.11.011; Furukawa T., 2012, P 2012 20 INT C NUCL; Furukawa T., 2014, P 2014 22 INT C NUCL; Furukawa T., 2010, P 18 INT C NUCL ENG; Matsumoto T., 1992, NETSU SOKUTEI, V19, P170; Moeslang A., 2002, P 19 FUS EN C	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2138	2141		10.1016/j.fusengdes.2014.11.019		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900243		
J	Namba, K; Kasada, R; Konishi, S; Yamamoto, Y				Namba, Kyosuke; Kasada, Ryuta; Konishi, Satoshi; Yamamoto, Yasushi			Evaluation of tritium transport in the biomass-fusion hybrid system and its environmental impact	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium; Biomass; Fusion reactor; Fuel cell; Environmental safety; System dynamics	HIGH-TEMPERATURE; NEUTRONICS; REACTOR; BLANKET	The behavior of tritium contained, in the biofuel produced by the fusion energy is analyzed. Hydrogen product is contaminated with tritium from breeding blanket of fusion plant within the regulation limit and released to atmosphere when used for fuel cell vehicles. In the model city, Osaka, seven-compartment model describes the behavior of exhausted tritium by adapting the environment water flow and its migration was analyzed with STELLA system dynamics code. Tritium (HTO) with a concentration of 5000 Bq//m(3) exhausted from the running vehicle increases decades and reaches steady state after about 50 years, at around 40 Bq/m(3) in atmosphere and 4Bq/L in surface soil water that does not deserve health hazard, however causes contamination of large populated area. (C) 2015 Elsevier B.V. All rights reserved.	[Namba, Kyosuke] Kyoto Univ, Grad Sch Energy Sci, Kyoto, Japan; [Kasada, Ryuta; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Kyoto, Japan; [Yamamoto, Yasushi] Kansai Univ, Fac Engn Sci, Osaka, Japan	Kasada, R (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto, Japan.	r-kasada@iae.kyoto-u.ac.jp					[Anonymous], 2009, DAT PREC JAP; Demange D, 2014, FUSION ENG DES, V89, P1219, DOI 10.1016/j.fusengdes.2014.04.028; Kwon S, 2013, FUSION SCI TECHNOL, V64, P599; Ibano K, 2011, FUSION ENG DES, V86, P2779, DOI 10.1016/j.fusengdes.2010.12.011; Ibano K, 2013, FUSION ENG DES, V88, P2881, DOI 10.1016/j.fusengdes.2013.05.088; Yamamoto Y, 2014, FUSION ENG DES, V89, P1392, DOI 10.1016/j.fusengdes.2014.01.039; [Anonymous], 2012, WHIT PAP LAND INFR T; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107; Marui A., 2010, REPORT AMOUNT AVAILA; Onaka H., 2010, INT SEM JHFC; Rascob W., 1990, 4605 KFK; Rascob W., 1990, 5364 KFK; Toshihiro S., 2009, 23 IEEE NPSS S 2009	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2162	2165		10.1016/j.fusengdes.2015.07.009		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900248		
J	Konno, C; Ochiai, K; Sato, S; Ohta, M				Konno, Chikara; Ochiai, Kentaro; Sato, Satoshi; Ohta, Masayuki			Analyses of iron and concrete shielding experiments at JAEA/TIARA with JENDL/HE-2007, ENDF/B-VII.1 and FENDL-3.0	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Iron; Concrete; TIARA; JENDL/HE-2007; ENDF/B-VII.1; FENDL-3.0	NUCLEAR-SCIENCE; TECHNOLOGY; LIBRARY	IAEA released a new Fusion Evaluated Nuclear Data Library, FENDL-3.0, in 2012. FENDL-3.0 extends the neutron energy range from 20 MeV to greater than 60 MeV. Now there is increasing interest in nuclear data above 20 MeV. Thus we have analyzed the iron and concrete shielding experiments with the 40 and 65 MeV neutron sources at TIARA in Japan Atomic Energy Agency with the latest high-energy nuclear data libraries, JENDL/HE-2007, ENDF/B-VII.1 and FENDL-3.0. The Monte Carlo code MCNP-5 and ACE files of JENDL/HE-2007, ENDF/B-VII.1 and FENDL-3.0, which are supplied from JAEA, LANL and IAEA, respectively, were used for this analysis. The collimated neutron beam and test shields were modeled in the analysis. The measured source neutron data were adopted in the analysis. The followings are found out from the results; (1) Iron experiments: The calculation result with FENDL-3.0 agrees with the measured one best. That with JENDL/HE-2007 fairly agrees with the measured one. On the contrary that with ENDF/BVII.1 drastically overestimates the measured one. It is confirmed that this overestimation is due to the smaller non-elastic scattering data of Fe-56 in ENDF/B-VII.1. (2) Concrete experiments: The calculation result with ENDL/HE-2007 agrees with the measured one best, while those with FENDL-3.0 and ENDF/BVII.1 drastically overestimate the measured one. It is confirmed that this overestimation is due to both the larger elastic and smaller non-elastic scattering data of 160 in FENDL-3.0 and ENDF/B-VII.1. (C) 2015 Elsevier B.V. All rights reserved.	[Konno, Chikara; Ochiai, Kentaro; Sato, Satoshi; Ohta, Masayuki] Japan Atom Energy Agcy, Sect Fus Res & Dev, Tokai, Ibaraki 3191195, Japan	Konno, C (reprint author), Japan Atom Energy Agcy, Sect Fus Res & Dev, Tokai, Ibaraki 3191195, Japan.	konno.chikara@jaea.go.jp					Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; [Anonymous], 2013, RSICC CODE PACKAGE C; Watanabe Y, 2011, J KOREAN PHYS SOC, V59, P1040, DOI 10.3938/jkps.59.1040; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Chadwick MB, 2006, NUCL DATA SHEETS, V107, P2931, DOI 10.1016/j.nds.2006.11.001; Chadwick M. B., 1999, LAUR991222; Forrest R.A, INDCNDS0628; Kondo K, 2014, PROG NUCL SCI TECHNO, V4, P322; MacFarlane R.E., 1994, LA12740M; Nakane Y., 1996, 96029 JAERIDATACODE; Santamarina A., 2009, 22 JEFF; Sasa T., 2008, 2008022 JAEADATACODE; X-5 Monte Carlo Team, 2005, LAUR031987	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2178	2181		10.1016/j.fusengdes.2014.12.034		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900251		
J	Yokota, SI; Konno, M; Fujiwara, SI; Toita, N; Takahashi, M; Yamamoto, S; Ogasawara, N; Shiraishi, T				Yokota, Shin-ichi; Konno, Mutsuko; Fujiwara, Shin-ichi; Toita, Nariaki; Takahashi, Michiko; Yamamoto, Soh; Ogasawara, Noriko; Shiraishi, Tsukasa			Intrafamilial, Preferentially Mother-to-Child and Intraspousal, Helicobacter pylori Infection in Japan Determined by Mutilocus Sequence Typing and Random Amplified Polymorphic DNA Fingerprinting	HELICOBACTER			English	Article						Intrafamilial infection; intraspousal infection; Helicobacter pylori; multilocus sequence typing; random amplified polymorphic DNA fingerprinting	MOLECULAR EPIDEMIOLOGY; FOLLOW-UP; TRANSMISSION; ERADICATION; POPULATION; PREVALENCE; FAMILIES; SPOUSES; CAMPYLOBACTER; REINFECTION	Background: The infection route of Helicobacter pylori has been recognized to be mainly intrafamilial, preferentially mother-to-child, especially in developed countries. To determine the transmission route, we examined whether multilocus sequence typing (MLST) was useful for analysis of intrafamilial infection. The possibility of intraspousal infection was also evaluated. Materials and Methods: Clonal relationships between strains derived from 35 index Japanese pediatric patients, and their family members were analyzed by two genetic typing procedures, MLST and random amplified polymorphic DNA (RAPD) fingerprinting. Results: Mostly coincident results were obtained by MLST and RAPD. By MLST, the allele of loci in the isolates mostly matched between the index child and both the father and mother for 9 (25.7%) of the 35 patients, between the index child and the mother for 25 (60.0%) of the 35 patients. Conclusions: MLST is useful for analyzing the infection route of H. pylori as a highly reproducible method. Intrafamilial, especially mother-to-children and sibling, infection is the dominant transmission route. Intraspousal infection is also thought to occur in about a quarter in the Japanese families.	[Yokota, Shin-ichi; Yamamoto, Soh; Ogasawara, Noriko; Shiraishi, Tsukasa] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan; [Konno, Mutsuko; Fujiwara, Shin-ichi; Toita, Nariaki; Takahashi, Michiko] Sapporo Kosei Gen Hosp, Dept Pediat, Sapporo, Hokkaido 0600033, Japan; [Ogasawara, Noriko] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan	Yokota, SI (reprint author), Sapporo Kosei Gen Hosp, Dept Pediat, Chuo Ku, North-3,East-8, Sapporo, Hokkaido 0600033, Japan.	mutsukon@ja-hokkaidoukouseiren.or.jp					Nomura H, 2000, J GASTROEN HEPATOL, V15, P1377, DOI 10.1046/j.1440-1746.2000.02228.x; Kamada T, 2007, DIGEST ENDOSC, V19, P32, DOI 10.1111/j.1443-1661.2007.00671.x; SCHUTZE K, 1995, GUT, V36, P831, DOI 10.1136/gut.36.6.831; Vale FF, 2010, INT J FOOD MICROBIOL, V138, P1, DOI 10.1016/j.ijfoodmicro.2010.01.016; Mourad-Baars P, 2010, HELICOBACTER, V15, P53, DOI 10.1111/j.1523-5378.2010.00776.x; Suzuki J, 1999, J CLIN MICROBIOL, V37, P4174; MIYAJI H, 1995, LANCET, V345, P464; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Toita N, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/721306; Osaki T, 2013, J MED MICROBIOL, V62, P761, DOI 10.1099/jmm.0.053140-0; Breurec S, 2013, HELICOBACTER, V18, P249, DOI 10.1111/hel.12037; Konno M, 2008, PEDIATR INFECT DIS J, V27, P999, DOI 10.1097/INF.0b013e31817d756e; Kivi M, 2006, SCAND J INFECT DIS, V38, P407, DOI 10.1080/00365540600585131; Konno M, 2005, J CLIN MICROBIOL, V43, P2246, DOI 10.1128/JCM.43.5.2246; Take S, 2012, J GASTROENTEROL, V47, P641, DOI 10.1007/s00535-012-0536-9; Lee JYH, 2001, GUT, V49, pA31; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; WEBB PM, 1994, BRIT MED J, V308, P750; Rowland M, 2006, GASTROENTEROLOGY, V130, P65, DOI 10.1053/j.gastro.2005.11.004; Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; GOODMAN KJ, 1995, INT J EPIDEMIOL, V24, P875, DOI 10.1093/ije/24.5.875; Leal-Herrera Y, 2003, AM J GASTROENTEROL, V98, P2395, DOI 10.1016/S0002-9270(03)00714-7; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; Kivi M, 2003, J CLIN MICROBIOL, V41, P5604, DOI 10.1128/JCM.41.12.5604-5608.2003; Blaser MJ, 1996, SCI AM, V274, P104; Luman W, 2002, EUR J GASTROEN HEPAT, V14, P521, DOI 10.1097/00042737-200205000-00009; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Kuo CH, 1999, J INFECT DIS, V180, P2064, DOI 10.1086/315130; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; BAMFORD KB, 1993, GUT, V34, P1348, DOI 10.1136/gut.34.10.1348; Roma-Giannikou E, 2003, HELICOBACTER, V8, P15, DOI 10.1046/j.1523-5378.2003.00126.x; Han SR, 2000, J CLIN MICROBIOL, V38, P3646; Georgopoulos SD, 1996, GUT, V39, P634, DOI 10.1136/gut.39.5.634; MORRIS AJ, 1991, ANN INTERN MED, V114, P662; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; GRAHAM DY, 1989, GASTROENTEROLOGY, V96, P615; Linz B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082187; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Ueda J, 2014, HELICOBACTER, V19, P105, DOI 10.1111/hel.12110	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	OCT	2015	20	5					334	342		10.1111/hel.12217		9	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CT8KD	WOS:000363064100003		
J	Zaidi, SF; Refaat, A; Zhou, Y; Muhammad, JS; Shin, MS; Saiki, I; Sakurai, H; Sugiyama, T				Zaidi, Syed Faisal; Refaat, Alaa; Zhou, Yue; Muhammad, Jibran Sualeh; Shin, Myoung-Sook; Saiki, Ikuo; Sakurai, Hiroaki; Sugiyama, Toshiro			Helicobacter pylori Induces Serine Phosphorylation of EGFR via Novel TAK1-p38 Activation Pathway in an HB-EGF-Independent Manner	HELICOBACTER			English	Article						Epidermal growth factor receptor; HB-EGF; Helicobacter pylori; p38; TAK1; transactivation	GASTRIC EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; VACUOLATING CYTOTOXIN; VIRULENCE FACTORS; INFECTION; CAGA; KINASE; TRANSACTIVATION; CANCER	Background: The interaction of Helicobacter pylori with gastric epithelial cells can result in the activation of transcription factor NF-kappa B via TGF-beta-activated kinase 1 (TAK1). In this study, we have demonstrated the role of H. pylori in the activation of EGFR via TAK1-mediated phosphorylation of p38. Materials and Methods: Gastric epithelial AGS or MKN-45 cells were co-cultured with wild-type or cagA(-) H. pylori strains. H. pylori was added to the cells, and the activation of EGFR, p65 (NF-kappa B) subunit, p38, ERK, and TAK1 was examined by Western blotting. Infected cells were pretreated with or without ligands, chemical inhibitors, anti-HB-EGF antibody, and siRNAs to evaluate the effects on phosphorylation of various EGFR residues. Fluorescence microscopy and flow cytometry were performed to detect the internalization of EGFR. Results: Incubating cells with wild-type and CagA(-) H. pylori strains resulted in the rapid and transient phosphorylation of serine residues of EGFR. RNAi experiments using siRNA against TAK1 and p38 pathways blocked the phosphorylation of serine residue. Immunofluorescence and flow cytometry revealed that EGFR was internalized in H. pylori-infected cells after EGFR phosphorylation in a p38-dependent manner. In contrast, pretreatment with gefitinib and anti-HB-EGF antibody did not block both the phosphorylation and internalization of EGFR. Conclusion: Helicobacter pylori induces internalization of EGFR via novel TAK1-p38-serine activation pathway which is independent of HB-EGF. The interaction between TAK1 and EGFR in H. pylori-infected cells might open new dimensions in understanding H. pylori-associated gastric carcinogenesis.	[Zaidi, Syed Faisal; Muhammad, Jibran Sualeh; Sugiyama, Toshiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol & Hematol, Toyama 9300194, Japan; [Zaidi, Syed Faisal] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Basic Med Sci, Jeddah, Saudi Arabia; [Zaidi, Syed Faisal] Aga Khan Univ, Fac Hlth Sci, Dept Biol & Biomed Sci, Karachi, Pakistan; [Refaat, Alaa; Shin, Myoung-Sook; Saiki, Ikuo] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Refaat, Alaa] Zewail City Sci & Technol, Ctr Aging & Associated Dis, Giza, Egypt; [Zhou, Yue; Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan	Sugiyama, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol, 2630 Sugitani, Toyama 9300194, Japan.	sfaisalhz@gmail.com; tsugi@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors would like to thank Mrs. Toyomi Kozawa (Department of Gastroenterology, University of Toyama) for providing technical support in experiments. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas and the Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; TSUDA M, 1993, MICROBIOL IMMUNOL, V37, P85; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Schweitzer K, 2010, EMBO REP, V11, P10, DOI 10.1038/embor.2009.263; Bauer B, 2009, CELL MICROBIOL, V11, P156, DOI 10.1111/j.1462-5822.2008.01246.x; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Dickson JH, 2006, CANCER RES, V66, P7524, DOI 10.1158/0008-5472-CAN-05-3246; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Prenzel N, 1999, NATURE, V402, P884; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823; Cover TL, 1996, MOL MICROBIOL, V20, P241, DOI 10.1111/j.1365-2958.1996.tb02612.x; Peek RM, 2002, J GASTROENTEROL, V37, P10, DOI 10.1007/BF02990093; BLASER MJ, 1995, CANCER RES, V55, P2111; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Zaidi SFH, 2009, HELICOBACTER, V14, P588, DOI 10.1111/j.1523-5378.2009.00724.x; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Ashktorab H, 2007, AM J GASTROENTEROL, V102, P2135, DOI 10.1111/j.1572-0241.2007.01400.x; Marchildon PA, 2003, J CLIN MICROBIOL, V41, P1480, DOI 10.1128/JCM.41.4.1480-1485.2003; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; Keates S, 1999, J IMMUNOL, V163, P5552; CORREA P, 1992, CANCER RES, V52, P6735; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, SCHIST LIV FLUK HEL; Nakakuki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001782; Schweitzer K, 2010, EMBO REP, V11, P11; Singhirunnusorn P, 2005, BIOL CHEM, V280, P7359; Sokolova O, 2014, BBA-MOL CELL RES, V1843, P715, DOI 10.1016/j.bbamcr.2014.01.006; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	OCT	2015	20	5					381	389		10.1111/hel.12215		9	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CT8KD	WOS:000363064100007		
J	Omata, M; Kanda, T; Yokosuka, O; Crawford, D; Al-Mahtab, M; Wei, L; Ibrahim, A; Lau, GKK; Sharma, BC; Hamid, SS; Chuang, WL; Dokmeci, AK				Omata, Masao; Kanda, Tatsuo; Yokosuka, Osamu; Crawford, Darrell; Al-Mahtab, Mamun; Wei, Lai; Ibrahim, Alaaeldin; Lau, George K. K.; Sharma, Barjesh C.; Hamid, Saeed S.; Chuang, Wan-Long; Dokmeci, A. Kadir			Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries	HEPATOLOGY INTERNATIONAL			English	Review						Asian Pacific countries; HCV; IL28B; Direct-acting antivirals	SUSTAINED VIROLOGICAL RESPONSE; RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE WORKERS; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; CHRONIC LIVER-DISEASES; CHRONIC-RENAL-FAILURE; LONG-TERM EFFICACY; CHRONIC GENOTYPE 2; BLOOD-DONORS; RISK-FACTORS	Estimated hepatitis C virus (HCV) infection rates in the general populations were 1.3, 0.9, 0.4-1.0, 14.7, 0.1-0.3, 0.9-1.9, 1.0-2.0, 5, 4.4-8.6 and 0.5-1.3 % in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. The main HCV genotypes (Gs) are G1, G3, G1b, G4, G1b, G3, G1b, G3, G1b and G2, and G1 in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. Of IL28B genotypes, favorable alleles are similar to 50 % in Australia and Turkey, but 60-70 % in most of the other Asian countries. Peginterferon plus ribavirin is available in all ten Asian Pasific countries. In addition, HCV NS3/4A protease inhibitors with peginterferon plus ribavirin are currently available in several countries. Clinical trials of interferon-free regimens for HCV are ongoing in most of the ten Asian Pacific countries.	[Omata, Masao] Yamanashi Hosp Cent & Kita Org, Kofu, Yamanashi 4008506, Japan; [Omata, Masao] Univ Tokyo, Bunkyo Ku, Tokyo 1138655, Japan; [Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608677, Japan; [Crawford, Darrell] Univ Queensland, Sch Med, Woolloongabba, Qld 4102, Australia; [Al-Mahtab, Mamun] Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka 1000, Bangladesh; [Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China; [Ibrahim, Alaaeldin] Benha Univ, Dept Internal Med, GI Liver Div, Banha, Egypt; [Lau, George K. K.] 302 Hosp, Hong Kong SAR China Inst Translat Hepatol, Humanity & Hlth Med Ctr, Beijing, Peoples R China; [Lau, George K. K.] 302 Hosp, Ctr Liver Fibrosis Diag & Treatment Ctr, Beijing, Peoples R China; [Sharma, Barjesh C.] GB Pant Hosp, Dept Gastroenterol, New Delhi, India; [Hamid, Saeed S.] Aga Khan Univ & Hosp, Dept Med, Karachi 74800, Pakistan; [Chuang, Wan-Long] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Dokmeci, A. Kadir] Ankara Univ, Sch Med, Dept Gastroenterol, TR-06100 Ankara, Turkey	Kanda, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	momata-tky@umin.ac.jp; kandat-cib@umin.ac.jp; yokosukao@faculty.chiba-u.jp; d.crawford@uq.edu.au; shwapnil@agni.com; weilai@pkuph.edu.cn; alaabkbs@yahoo.com; gkklau@vip.126.com; drbcsharma@hotmail.com; saeed.hamid@aku.edu; waloch@kmu.edu.tw; akdokmeci@hotmail.com			Chugai Pharmaceutical; MSD; Sumitomo Dainippon Pharma; Tanabe-Mitsubishi; Ajinomoto; Bristol-Myers Squibb; Daiichi-Sankyo; Janssen Pharmaceutical; Bayer; Abbvie; Gilead; GlaxoSmithKline	All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study. This article does not contain any studies with animal subjects. Masao Omata, Mamun Al-Mahtab, Alaaeldin Ibrahim, George K.K. Lau, Barjesh C. Sharma, Saeed S. Hamid and A. Kadir Dokmeci declare that they have no conflict of interest. Tatsuo Kanda has research grants from Chugai Pharmaceutical, MSD, Sumitomo Dainippon Pharma and Bristol-Myers Squibb, and reports receiving lecture fees from Chugai Pharmaceutical, MSD, Tanabe-Mitsubishi, Ajinomoto, Bristol-Myers Squibb, Daiichi-Sankyo, Janssen Pharmaceutical and GlaxoSmithKline. Osamu Yokosuka has research grants from Chugai Pharmaceutical, Bayer, MSD, Daiichi-Sankyo, Tanabe-Mitsubishi, Bristol-Myers Squibb and Gilead. Darrell Crawford is a member of the national and international advisory board of Abbvie and a national advisory board member of Gilead and Jansen Cilag. Lai Wei has research grants from Bristol-Myers Squibb and reports receiving consulting fees from Abbvie and Gilead. Wan-Long Chuang is a member of the advisory boards of Abbvie, BI, Gilead, Novartis and Roche and is a speaker for BMS, Gilead, MSD and Roche.	Abraham Rachel, 2009, Indian J Gastroenterol, V28, P53, DOI 10.1007/s12664-009-0018-z; Aceijas C, 2006, SEX TRANSM INFECT S3, V82; Agarwal M B, 1993, J Assoc Physicians India, V41, P195; Agarwal S K, 1999, J Assoc Physicians India, V47, P1139; Aliberch MRM, 2010, GAC SANIT, V24, P288; Amarapurkar D N, 1992, Indian J Gastroenterol, V11, P80; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Khan A, 2009, J MED VIROL, V81, P1189, DOI 10.1002/jmv.21466; Hung CH, 2005, J GASTROEN HEPATOL, V20, P727, DOI 10.1111/j.1400-1746.2005.03791.x; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Yu ML, 2006, LIVER INT, V26, P73, DOI 10.1111/j.1478-3231.2005.01196.x; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Saha MK, 2000, INDIAN J MED RES, V111, P37; Amarapurkar D, 2001, J Assoc Physicians India, V49, P983; Lee PL, 2004, T ROY SOC TROP MED H, V98, P367, DOI 10.1016/j.trstmh.2003.10.013; Nishiguchi S, 2014, LIVER INT, V34, P78, DOI 10.1111/liv.12254; Senturk H, 2003, DIGEST DIS SCI, V48, P1124, DOI 10.1023/A:1023725014751; Ahmed B, 2013, HEPATOL INT, V7, P500, DOI 10.1007/s12072-012-9417-9; Seto WK, 2010, J HEPATOL, V53, P444, DOI 10.1016/j.jhep.2010.04.009; Bowden DS, 2006, FUTURE MICROBIOL, V1, P103, DOI 10.2217/17460913.1.1.103; TANAKA H, 1994, CANCER CAUSE CONTROL, V5, P409, DOI 10.1007/BF01694754; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Lee SD, 2005, J VIRAL HEPATITIS, V12, P283, DOI 10.1111/j.1365-2893.2005.00590.x; BHATTACHARYA DK, 1991, INDIAN J MED RES-B, V94, P430; Fujiwara K, 2006, LIVER INT, V26, P520, DOI 10.1111/j.1478-3231.2006.01263.x; Roberts SK, 2009, HEPATOLOGY, V50, P1045, DOI 10.1002/hep.23130; Yu ML, 2000, J GASTROEN HEPATOL, V15, P1404, DOI 10.1046/j.1440-1746.2000.02359.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Singh S, 2004, INDIAN J MED RES, V119, P145; Yokosuka O, 2004, INTERVIROLOGY, V47, P328, DOI 10.1159/000080876; Wong HK, 2012, TRANSFUSION MED, V22, P133, DOI 10.1111/j.1365-3148.2011.01128.x; Chakravarti A, 2011, INDIAN J MED RES, V133, P326; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Abdelwahab S, 2012, T ROY SOC TROP MED H, V106, P98, DOI 10.1016/j.trstmh.2011.10.003; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Akhan SC, 2008, INFECTION, V36, P341, DOI 10.1007/s15010-008-7134-z; Janjua NZ, 2010, J VIRAL HEPATITIS, V17, P317, DOI 10.1111/j.1365-2893.2009.01230.x; Bozdayi AM, 2004, ARCH VIROL, V149, P2115, DOI 10.1007/s00705-004-0363-2; Takano S, 1996, HEPATOLOGY, V23, P708, DOI 10.1002/hep.510230408; Simsek H, 2012, EUR J GASTROEN HEPAT, V24, P1113, DOI 10.1097/MEG.0b013e3283554c41; Karaca C, 2006, DIGEST DIS SCI, V51, P365, DOI 10.1007/s10620-006-3139-6; Waheed Y, 2009, WORLD J GASTROENTERO, V15, P5647, DOI 10.3748/wjg.15.5647; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; HWANG SJ, 1995, J INTERF CYTOK RES, V15, P611, DOI 10.1089/jir.1995.15.611; Akbar SMF, 1997, HEPATOL RES, V7, P113, DOI 10.1016/S0928-4346(97)00027-3; Mumtaz K, 2008, SAUDI MED J, V29, P1671; Kanda T, 2011, DIGEST DIS SCI, V56, P3335, DOI 10.1007/s10620-011-1750-7; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Kumar D, 2003, MED J AUSTRALIA, V178, P267; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Morikawa H, 2013, HEPATOL RES, V43, P1013, DOI 10.1111/hepr.12066; Gurol E, 2006, EUR J EPIDEMIOL, V21, P299, DOI 10.1007/s10654-006-0001-2; Ochi H, 2011, J GEN VIROL, V92, P1071, DOI 10.1099/vir.0.029124-0; Huang JF, 2001, EPIDEMIOL INFECT, V127, P485; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Mukhopadhya A, 2008, J BIOSCIENCES, V33, P465, DOI 10.1007/s12038-008-0065-0; KHAN M, 1993, GASTROENTEROL JPN, V28, P28, DOI 10.1007/BF02989200; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Coban S, 2011, HEPATO-GASTROENTEROL, V58, P1301, DOI 10.5754/hge10625; Parthiban R, 2009, INT J INFECT DIS, V13, pE394, DOI 10.1016/j.ijid.2009.01.013; El-Ghitany EM, 2015, LIVER INT, V35, P489, DOI 10.1111/liv.12617; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Kim DY, 2013, LIVER INT, V33, P586, DOI 10.1111/liv.12108; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Lawitz E, 2013, J HEPATOL, V59, P11, DOI 10.1016/j.jhep.2013.02.008; Yu ML, 2004, ANTIVIR RES, V63, P25, DOI 10.1016/j.antiviral.2004.01.002; Huang CF, 2011, HEPATOLOGY, V53, P367, DOI 10.1002/hep.24049; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Akcam FZ, 2009, INT J INFECT DIS, V13, P274, DOI 10.1016/j.ijid.2008.07.005; Lai MY, 1996, GASTROENTEROLOGY, V111, P1307, DOI 10.1053/gast.1996.v111.pm8898645; Yu ML, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-27; Lu WP, 2012, J CLIN MICROBIOL, V50, P2142, DOI 10.1128/JCM.00273-12; Hissar SS, 2006, J MED VIROL, V78, P452, DOI 10.1002/jmv.20561; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Yu ML, 2001, J MED VIROL, V65, P58; Fukuda Y, 1998, HAEMOPHILIA, V4, P595, DOI 10.1046/j.1365-2516.1998.440595.x; Yu JW, 2007, J GASTROEN HEPATOL, V22, P832, DOI 10.1111/j.1440-1746.2007.04904.x; Yu ML, 2006, LIVER INT, V26, P1187, DOI 10.1111/j.1478-3231.2006.01358a.x; Murakami J, 2012, HEPATOL RES, V42, P648, DOI 10.1111/j.1872-034X.2012.00968.x; Jaiswal SB, 2002, DIALYSIS TRANSPLANT, V31, P234; Huang CF, 2008, T ROY SOC TROP MED H, V102, P929, DOI 10.1016/j.trstmh.2008.05.018; Khodabandehloo M, 2013, J RES MED SCI, V18, P674; Jazag A, 2012, KOREAN J INTERN MED, V27, P121, DOI 10.3904/kjim.2012.27.2.121; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148; Altuglu I, 2008, INT J INFECT DIS, V12, P239, DOI 10.1016/j.ijid.2007.07.003; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Zhou YQ, 2011, J VIRAL HEPATITIS, V18, P595, DOI 10.1111/j.1365-2893.2010.01373.x; Chandra M, 2004, INTERVIROLOGY, V47, P374, DOI 10.1159/000080883; Rodriguez-Torres M, 2014, CLIN GASTROENTEROL H, V12, P1029, DOI 10.1016/j.cgh.2013.09.067; Senturk H, 1997, DIGEST DIS SCI, V42, P1438, DOI 10.1023/A:1018854424403; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Zhao SH, 2009, INT J CLIN PRACT, V63, P1334, DOI 10.1111/j.1742-1241.2009.02082.x; Gupta AC, 2014, J MED VIROL, V86, P707, DOI 10.1002/jmv.23876; Uddin G, 2010, J VIRAL HEPATITIS, V17, P327, DOI 10.1111/j.1365-2893.2009.01240.x; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Dore GJ, 2003, J CLIN VIROL, V26, P171, DOI 10.1016/S1386-6532(02)00116-6; Jindal N, 2006, INDIAN J MED RES, V123, P179; Shirin T, 2000, J HEALTH POPUL NUTR, V18, P145; Wong VWS, 2014, J GASTROEN HEPATOL, V29, P116, DOI 10.1111/jgh.12355; Chiou SS, 2006, DIGESTION, V74, P208, DOI 10.1159/000100506; MITA E, 1994, DIGEST DIS SCI, V39, P977, DOI 10.1007/BF02087547; Roberts SK, 2014, J GASTROEN HEPATOL, V29, P179, DOI 10.1111/jgh.12424; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kogure T, 2006, WORLD J GASTROENTERO, V12, P4757; Huang CF, 2013, J GASTROEN HEPATOL, V28, P1515, DOI 10.1111/jgh.12211; Chang JM, 2014, INT J MED SCI, V11, P436, DOI 10.7150/ijms.8265; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Raghuraman S, 2003, J CLIN VIROL, V26, P61, DOI 10.1016/S1386-6532(02)00025-2; [Anonymous], CENS IND WEBS OFF RE; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Marx MA, 2003, CLIN INFECT DIS, V37, P514, DOI 10.1086/376639; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Abdelwahab SF, 2013, J CLIN VIROL, V57, P24, DOI 10.1016/j.jcv.2013.01.005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Barua P, 2012, INDIAN J MED RES, V136, P30; Simsek H, 1996, J INT MED RES, V24, P132; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Sarkar K, 2003, LANCET, V361, P1301, DOI 10.1016/S0140-6736(03)13006-1; Kanda T, 2004, J GASTROEN HEPATOL, V19, P717, DOI 10.1111/j.1440-1746.2004.03399.x; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Kuboki M, 2007, J GASTROEN HEPATOL, V22, P645, DOI 10.1111/j.1440-1746.2007.04834.x; Jain A, 1999, EUR J GASTROEN HEPAT, V11, P1231, DOI 10.1097/00042737-199911000-00008; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Nakayama H, 2005, J MED VIROL, V75, P258, DOI 10.1002/jmv.20265; Narahari S, 2009, INFECT GENET EVOL, V9, P643, DOI 10.1016/j.meegid.2009.04.001; TAKANO S, 1994, DIGEST DIS SCI, V39, P28, DOI 10.1007/BF02090056; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Chakrabarty P, 2014, Mymensingh Med J, V23, P235; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Choudhry V. P., 1995, Indian Journal of Pediatrics, V62, P655, DOI 10.1007/BF02825110; Chuang Wang-Long, 2006, Intervirology, V49, P99, DOI 10.1159/000087271; Cuadros DF, 2014, HEPATOLOGY, V60, P1150, DOI 10.1002/hep.27248; Dai ZC, 1995, SEROPREVALENCE SURVE, P60; Das B R, 2002, Indian J Pathol Microbiol, V45, P323; Duseja A, 2002, Trop Gastroenterol, V23, P125; Esmat G, 2013, LIVER INT S, V33, P141; Ferenci P, 2015, J HEPA IN PRESS 0102; Fouad YM, 2012, TROP GASTROENTEROL, V33, P111; Galal IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101264; Ganju Sunite A., 2000, Journal of Communicable Diseases, V32, P228; Gupta Nalini, 2004, Indian J Med Sci, V58, P255; Hassanein T, 2014, J HEPATOL, V60, pS472; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Hezode C, 2014, J HEPATOL, V60, pS24; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Huang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058882; Islam ASM., 2014, THESIS BS MUJIB MED; IWAMURA K, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P191; John GT, 1999, TRANSPLANT REV, V13, P183; Kalaskar A, 2012, INT RES J MICROBIOL, V3, P10; Kapoor D, 2000, Indian J Gastroenterol, V19, P64; Li Quan-run, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P353, DOI 10.3760/cma.j.issn.1007-3418.2012.05.010; Mahtab MA, 2008, J GASTROEN HEPATOL, V23, P27; Mahtab MA, 2011, J CLIN EXP HEPATOL, V1, P13; Mahtab MA, 2008, HUNGARIAN MED J, V2, P577; Mittal Garima, 2013, J Clin Exp Hepatol, V3, P24, DOI 10.1016/j.jceh.2013.02.003; Mizokami M, 2014, HEPATOLOGY, V60, p1130A; Moatter Tariq, 2002, International Journal of Infectious Diseases, V6, P272, DOI 10.1016/S1201-9712(02)90160-8; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Narhari S, 2009, INFECT GENET EVOL, V9, P643; Oi Y, HEPATITIS FREE GENER; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Pereira M, 2003, SEX TRANSM INFECT, V79, P424; Puri Pankaj, 2014, J Clin Exp Hepatol, V4, P106, DOI 10.1016/j.jceh.2014.05.006; Qureshi H, 2010, East Mediterr Health J, V16 Suppl, pS15; Rahman M Z, 2013, Bangladesh Med Res Counc Bull, V39, P11; Rahman M Z, 2014, Mymensingh Med J, V23, P335; Recker C, 2014, INT J INFECT DIS; Reddy A K, 2005, Indian J Med Microbiol, V23, P106; Ruane PJ, 2014, J HEPATOL, V60, pS503; Rudra S, 2010, Mymensingh Med J, V19, P515; Rudra S, 2011, Mymensingh Med J, V20, P183; Sereno Leandro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P311, DOI 10.1177/1545109712453939; Sood Ajit, 2014, Indian J Gastroenterol, V33, P343, DOI 10.1007/s12664-014-0451-5; Sood Ajit, 2012, Indian J Gastroenterol, V31, P27, DOI 10.1007/s12664-012-0163-7; Suoglu OD, 2002, J PEDIATR GASTR NUTR, V34, P199, DOI 10.1097/00005176-200202000-00018; Tourism Commisson, TOUR PERF; Toyoda H, 2014, EPIDEMIOL INFECT, V5, P1; Waheed Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-211; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Williams T N, 1992, Indian Pediatr, V29, P1119; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073615; Yenice Necati, 2006, Turk J Gastroenterol, V17, P94; Yu ML, 2014, J HEPATOL, V60, P253, DOI 10.1016/j.jhep.2013.09.023	191	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	OCT	2015	9	4					486	507		10.1007/s12072-015-9630-4		22	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT8DA	WOS:000363044000003		
J	Han, Y; Hazelett, DJ; Wiklund, F; Schumacher, FR; Stram, DO; Berndt, SI; Wang, ZM; Rand, KA; Hoover, RN; Machiela, MJ; Yeager, M; Burdette, L; Chung, CC; Hutchinson, A; Yu, K; Xu, JF; Travis, RC; Key, TJ; Siddiq, A; Canzian, F; Takahashi, A; Kubo, M; Stanford, JL; Kolb, S; Gapstur, SM; Diver, WR; Stevens, VL; Strom, SS; Pettaway, CA; Al Olama, AA; Kote-Jarai, Z; Eeles, RA; Yeboah, ED; Tettey, Y; Biritwum, RB; Adjei, AA; Tay, E; Truelove, A; Niwa, S; Chokkalingam, AP; Isaacs, WB; Chen, C; Lindstrom, S; Le Marchand, L; Giovannucci, EL; Pomerantz, M; Long, H; Li, FG; Ma, J; Stampfer, M; John, EM; Ingles, SA; Kittles, RA; Murphy, AB; Blot, WJ; Signorello, LB; Zheng, W; Albanes, D; Virtamo, J; Weinstein, S; Nemesure, B; Carpten, J; Leske, MC; Wu, SY; Hennis, AJM; Rybicki, BA; Neslund-Dudas, C; Hsing, AW; Chu, LS; Goodman, PJ; Klein, EA; Zheng, SL; Witte, JS; Casey, G; Riboli, E; Li, QY; Freedman, ML; Hunter, DJ; Gronberg, H; Cook, MB; Nakagawa, H; Kraft, P; Chanock, SJ; Easton, DF; Henderson, BE; Coetzee, GA; Conti, DV; Haiman, CA				Han, Ying; Hazelett, Dennis J.; Wiklund, Fredrik; Schumacher, Fredrick R.; Stram, Daniel O.; Berndt, Sonja I.; Wang, Zhaoming; Rand, Kristin A.; Hoover, Robert N.; Machiela, Mitchell J.; Yeager, Merideth; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Xu, Jianfeng; Travis, Ruth C.; Key, Timothy J.; Siddiq, Afshan; Canzian, Federico; Takahashi, Atsushi; Kubo, Michiaki; Stanford, Janet L.; Kolb, Suzanne; Gapstur, Susan M.; Diver, W. Ryan; Stevens, Victoria L.; Strom, Sara S.; Pettaway, Curtis A.; Al Olama, Ali Amin; Kote-Jarai, Zsofia; Eeles, Rosalind A.; Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn; Truelove, Ann; Niwa, Shelley; Chokkalingam, Anand P.; Isaacs, William B.; Chen, Constance; Lindstrom, Sara; Le Marchand, Loic; Giovannucci, Edward L.; Pomerantz, Mark; Long, Henry; Li, Fugen; Ma, Jing; Stampfer, Meir; John, Esther M.; Ingles, Sue A.; Kittles, Rick A.; Murphy, Adam B.; Blot, William J.; Signorello, Lisa B.; Zheng, Wei; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Nemesure, Barbara; Carpten, John; Leske, M. Cristina; Wu, Suh-Yuh; Hennis, Anselm J. M.; Rybicki, Benjamin A.; Neslund-Dudas, Christine; Hsing, Ann W.; Chu, Lisa; Goodman, Phyllis J.; Klein, Eric A.; Zheng, S. Lilly; Witte, John S.; Casey, Graham; Riboli, Elio; Li, Qiyuan; Freedman, Matthew L.; Hunter, David J.; Gronberg, Henrik; Cook, Michael B.; Nakagawa, Hidewaki; Kraft, Peter; Chanock, Stephen J.; Easton, Douglas F.; Henderson, Brian E.; Coetzee, Gerhard A.; Conti, David V.; Haiman, Christopher A.			Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions	HUMAN MOLECULAR GENETICS			English	Article							RISK-ASSOCIATED LOCI; WIDE ASSOCIATION; CAUSAL VARIANTS; TRANSETHNIC METAANALYSIS; SEQUENCE VARIANTS; GENE-EXPRESSION; ANALYSES REVEAL; COMMON VARIANT; MULTIPLE; IDENTIFICATION	Interpretation of biological mechanisms underlying genetic risk associations for prostate cancer is complicated by the relatively large number of risk variants (n = 100) and the thousands of surrogate SNPs in linkage disequilibrium. Here, we combined three distinct approaches: multiethnic fine-mapping, putative functional annotation (based upon epigenetic data and genome-encoded features), and expression quantitative trait loci (eQTL) analyses, in an attempt to reduce this complexity. We examined 67 risk regions using genotyping and imputation-based fine-mapping in populations of European (cases/controls: 8600/6946), African (cases/controls: 5327/5136), Japanese (cases/controls: 2563/4391) and Latino (cases/controls: 1034/1046) ancestry. Markers at 55 regions passed a region-specific significance threshold (P-value cutoff range: 3.9 x 10(-4)-5.6 x 10(-3)) and in 30 regions we identified markers that were more significantly associated with risk than the previously reported variants in the multiethnic sample. Novel secondary signals (P < 5.0 x 10(-6)) were also detected in two regions (rs13062436/3q21 and rs17181170/3p12). Among 666 variants in the 55 regions with P-values within one order of magnitude of the most-associated marker, 193 variants (29%) in 48 regions overlapped with epigenetic or other putative functional marks. In 11 of the 55 regions, cis-eQTLs were detected with nearby genes. For 12 of the 55 regions (22%), the most significant region-specific, prostate-cancer associated variant represented the strongest candidate functional variant based on our annotations; the number of regions increased to 20 (36%) and 27 (49%) when examining the 2 and 3 most significantly associated variants in each region, respectively. These results have prioritized subsets of candidate variants for downstream functional evaluation.	[Han, Ying; Hazelett, Dennis J.; Schumacher, Fredrick R.; Stram, Daniel O.; Rand, Kristin A.; Ingles, Sue A.; Casey, Graham; Henderson, Brian E.; Coetzee, Gerhard A.; Conti, David V.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Schumacher, Fredrick R.; Stram, Daniel O.; Ingles, Sue A.; Casey, Graham; Henderson, Brian E.; Coetzee, Gerhard A.; Conti, David V.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA; [Wiklund, Fredrik; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Berndt, Sonja I.; Wang, Zhaoming; Hoover, Robert N.; Machiela, Mitchell J.; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Albanes, Demetrius; Weinstein, Stephanie; Cook, Michael B.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Wang, Zhaoming; Yeager, Merideth; Burdette, Laurie; Hutchinson, Amy] SAIC Frederick Inc, NCI DCEG, Canc Genom Res Lab, Frederick, MD USA; [Xu, Jianfeng] NorthShore Univ HealthSyst, Program Personalized Canc Care, Evanston, IL USA; [Xu, Jianfeng] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA; [Travis, Ruth C.; Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Tokyo, Japan; [Nakagawa, Hidewaki] RIKEN Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Stanford, Janet L.; Kolb, Suzanne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Gapstur, Susan M.; Diver, W. Ryan; Stevens, Victoria L.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Pettaway, Curtis A.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Al Olama, Ali Amin; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Korle Bu Teaching Hosp, Accra, Ghana; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Univ Ghana, Sch Med, Accra, Ghana; [Truelove, Ann; Niwa, Shelley] WESTAT Corp, Rockville, MD 20850 USA; [Chokkalingam, Anand P.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Isaacs, William B.] Johns Hopkins Univ Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Isaacs, William B.] Inst Med, Baltimore, MD USA; [Chen, Constance; Lindstrom, Sara; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.; Stampfer, Meir] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward L.; Stampfer, Meir; Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Pomerantz, Mark; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Long, Henry; Li, Fugen] Dana Farber Canc Inst, Dept Med Oncol, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Ma, Jing] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Kittles, Rick A.] Univ Arizona, Coll Med, Tucson, AZ USA; [Kittles, Rick A.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Murphy, Adam B.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Blot, William J.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Nemesure, Barbara; Leske, M. Cristina; Wu, Suh-Yuh; Hennis, Anselm J. M.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Carpten, John] Translat Genom Res Inst, Phoenix, AZ USA; [Hennis, Anselm J. M.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Hennis, Anselm J. M.] Univ W Indies, Fac Med Sci, Bridgetown, Barbados; [Rybicki, Benjamin A.; Neslund-Dudas, Christine] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Goodman, Phyllis J.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, Seattle, WA 98104 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44106 USA; [Zheng, S. Lilly] Wake Forest Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Li, Qiyuan] Xiamen Univ, Coll Med, Xiamen 361102, Peoples R China	Haiman, CA (reprint author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	haiman@usc.edu	Cook, Michael/A-5641-2009	Cook, Michael/0000-0002-0533-7302	National Institutes of Health (NIH), National Cancer Institute (NCI) GAME-ON U19 initiative for prostate cancer (ELLIPSE) [CA148537]; NIH/NCI [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics; NIH; NCI; U.S. Public Health Service from the NCI, Department of Health and Human Services [N01-CN-45165, N01-RC-45035, N01-RC-37004, HHSN261201000006C]; Cancer Risk Prediction Center (CRisP); Linneus Centre - Swedish Research Council [70867902, K2010-70X-20430-04-3]; Swedish Cancer Foundation [09-0677]; Hedlund Foundation; Soderberg Foundation; Enqvist Foundation; Stockholm County Council; Stiftelsen Johanna Hagstrand och Sigfrid Linner's Minne; Karlsson's Fund for urological and surgical research; NIH [CA63464, CA54281, CA1326792, CA148085, HG004726, CA056678, CA082664, CA092579, ES011126, S06GM08016, CA092447, CA098758]; Division of Cancer Epidemiology and Genetics, NCI, NIH; Cancer Research Fund [99-00524V-10258]; Department of Health Services Cancer Research Program [97-12013, 98-00924V]; NCI, NIH, Department of Health and Human Services [N01-PC-35139]; California Department of Health Services [103885]; Centers for Disease Control and Prevention [1U58DP000807-3]; Fred Hutchinson Cancer Research Center; National Human Genome Research Institute; DOD [W81XWH-07-1-0122, DAMD W81XWH-07-1-0203, DAMD W81XWH-06-1-0066, W81XWH-10-1-0532]; American Cancer Society; Public Health Service from the National Cancer Institute [CA37429, 5UM1CA182883]; National Program of Cancer Registries, Centers for Disease Control and Prevention (CDC); NIH/National Human Genome Research Institute [U01 HG004726-01]; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation;  [CA136924];  [CA68578];  [ES007784];  [DAMD W81XWH-07-1-0645];  [CA140388];  [U01 HG004446];  [R01 CA136924];  [R01 GM107427]	This work was supported by the National Institutes of Health (NIH), National Cancer Institute (NCI) GAME-ON U19 initiative for prostate cancer (ELLIPSE, CA148537). The BPC3 was supported by NIH/NCI cooperative agreements U01-CA98233 to D.J.H., U01-CA98710 to S.M.G., U01-CA98216 to E.R., and U01-CA98758 to B.E.H., and Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics). ATBC, PEGASUS/PLCO and the Ghana Prostate Study were supported in part by the Intramural Research Program of the NIH and NCI. Additionally, this research was supported by U.S. Public Health Service contracts N01-CN-45165, N01-RC-45035, N01-RC-37004 and HHSN261201000006C from the NCI, Department of Health and Human Services. CAPS was supported by the Cancer Risk Prediction Center (CRisP; www.crispcenter.org), a Linneus Centre (Contract ID 70867902) financed by the Swedish Research Council (grant no. K2010-70X-20430-04-3), the Swedish Cancer Foundation (grant no. 09-0677), the Hedlund Foundation, the Soderberg Foundation, the Enqvist Foundation, ALF funds from the Stockholm County Council. Stiftelsen Johanna Hagstrand och Sigfrid Linner's Minne, Karlsson's Fund for urological and surgical research. The AAPC studies were supported as follows: The MEC and the genotyping in AAPC were supported by NIH grants CA63464, CA54281, CA1326792, CA148085 and HG004726. Functional annotation was supported by grant CA136924. Genotyping of the PLCO samples was funded by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, NCI, NIH. LAAPC was funded by grant 99-00524V-10258 from the Cancer Research Fund, under Interagency Agreement #97-12013 (University of California contract # 98-00924V) with the Department of Health Services Cancer Research Program. Cancer incidence data for the MEC and LAAPC studies have been collected by the Los Angeles Cancer Surveillance Program of the University of Southern California with Federal funds from the NCI, NIH, Department of Health and Human Services, under Contract No. N01-PC-35139, and the California Department of Health Services as part of the state-wide cancer reporting program mandated by California Health and Safety Code Section 103885, and grant number 1U58DP000807-3 from the Centers for Disease Control and Prevention. KCPCS was supported by NIH grants CA056678, CA082664 and CA092579, with additional support from the Fred Hutchinson Cancer Research Center and the Intramural Program of the National Human Genome Research Institute. MDA was support by grants, CA68578, ES007784, DAMD W81XWH-07-1-0645, and CA140388. GECAP was supported by NIH grant ES011126. CaP Genes was supported by CA88164 and CA127298. IPCG was support by DOD grant W81XWH-07-1-0122. DCPC was supported by NIH grant S06GM08016 and DOD grants DAMD W81XWH-07-1-0203, DAMD W81XWH-06-1-0066 and DOD W81XWH-10-1-0532. CPS-II is supported by the American Cancer Society. SELECT is funded by Public Health Service grants CA37429 and 5UM1CA182883 from the National Cancer Institute. SCCS is funded by NIH grant CA092447. SCCS sample preparation was conducted at the Epidemiology Biospecimen Core Lab that is supported in part by the Vanderbilt Ingram Cancer Center (CA68485).; Data on SCCS cancer cases used in this publication were provided by the Alabama Statewide Cancer Registry; Kentucky Cancer Registry; Tennessee Department of Health, Office of Cancer Surveillance; Florida Cancer Data System; North Carolina Central Cancer Registry, North Carolina Division of Public Health; Georgia Comprehensive Cancer Registry; Louisiana Tumor Registry; Mississippi Cancer Registry; South Carolina Central Cancer Registry; Virginia Department of Health, Virginia Cancer Registry; Arkansas Department of Health, Cancer Registry. The Arkansas Central Cancer Registry is fully funded by a grant from National Program of Cancer Registries, Centers for Disease Control and Prevention (CDC). Data on SCCS cancer cases from Mississippi were collected by the Mississippi Cancer Registry which participates in the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Mississippi Cancer Registry. JAPC and LAPC were supported by NIH grants CA63464, CA54281 and CA098758, the NIH/National Human Genome Research Institute by U01 HG004726-01 and the Genome Coordinating Center was supported by U01 HG004446. BBJ was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government, and this study was supported in part by the Princess Takamatsu Cancer Research Fund and Takeda Science Foundation Award (to H.N.). G.A. Coetzee was supported by grant R01 CA136924 and M.L. Freedman was supported by grant R01 GM107427. We should like to thank all of the men who took part in these studies.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Al Olama A.A., 2014, NAT GENET IN PRESS; Al Olama A.A., 2012, HUM MOL GEN IN PRESS; Al Olama A.A., HUM MOL GENET, V24, P5589; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Lou H, 2009, P NATL ACAD SCI USA, V106, P7933, DOI 10.1073/pnas.0902104106; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Zheng SL, 2009, CANCER EPIDEM BIOMAR, V18, P1815, DOI 10.1158/1055-9965.EPI-08-0983; Xu X, 2014, EUR J HUM GENET, V22, P558, DOI 10.1038/ejhg.2013.195; Liu CT, 2014, HUM MOL GENET, V23, P4738, DOI 10.1093/hmg/ddu183; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cook MB, 2014, HUM GENET, V133, P509, DOI 10.1007/s00439-013-1387-z; Akamatsu S, 2010, HUM MOL GENET, V19, P4265, DOI 10.1093/hmg/ddq350; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Parikh H, 2011, HUM GENET, V129, P675, DOI 10.1007/s00439-011-0953-5; Ong RTH, 2012, EUR J HUM GENET, V20, P1300, DOI 10.1038/ejhg.2012.88; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Duggan D, 2007, J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Coetzee GA, 2010, CELL CYCLE, V9, P256; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Chung CC, 2012, PROSTATE, V72, P476, DOI 10.1002/pros.21450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Berndt S.I., 2011, HUM MOL GEN IN PRESS; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Han Y., 2014, INT J CANC IN PRESS; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; Replication DIG, 2014, NAT GENET, V46, P234, DOI DOI 10.1038/NG.2897; Rhie SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-331; Takayama K.I., 2014, CANC RES IN PRESS; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2014, BBA-MOL BASIS DIS, V1842, P1896, DOI 10.1016/j.bbadis.2014.04.024; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379	78	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	OCT 1	2015	24	19					5603	5618		10.1093/hmg/ddv269		16	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CT7TT	WOS:000363018100018		
J	Dat, PT; Kanno, A; Yamamoto, N; Kawanishi, T				Pham Tien Dat; Kanno, Atsushi; Yamamoto, Naokatsu; Kawanishi, Testuya			WDM RoF-MMW and Linearly Located Distributed Antenna System for Future High-Speed Railway Communications	IEEE COMMUNICATIONS MAGAZINE			English	Article							USERS	In this article, we propose dual-hop network architecture capable of providing high-speed communications to high-speed trains (HSTs). The system uses a seamless fiber-millimeter-wave system for backhaul transmission from a central station to antennas on trains, and a highspeed in-train Wi-Fi network. The system can be combined with signal processing and network control technologies to compensate for interference and the Doppler effect, and to reduce the number of handovers. It can realize seamless connectivity between the inside and outside of trains to avoid penetration loss and help organize the in-train network optimally to increase coverage and data rate. We present and discuss the possible network architecture and technologies that can help realize the proposed network. We also present a proof-of-concept demonstration on a high-performance seamless fiber-MMW system that can be applied for applications in backhaul networks. The proposed network can be an attractive solution to provide broadband services such as video on demand and high-speed mobile signals to users on HSTs.	[Pham Tien Dat; Kanno, Atsushi; Yamamoto, Naokatsu; Kawanishi, Testuya] Natl Inst Informat & Commun Technol, Beijing, Peoples R China; [Kawanishi, Testuya] Waseda Univ, Tokyo, Japan	Dat, PT (reprint author), Natl Inst Informat & Commun Technol, Beijing, Peoples R China.	ptdat@nict.go.jp			Ministry of Internal Affairs and Communications (MIC), Japan	This work was conducted as a part of the "Research and development for expansion of radio wave resources," supported by the Ministry of Internal Affairs and Communications (MIC), Japan.	[Anonymous], 2012, 36836 3GPP TR; [Anonymous], 2014, APTASTAPREPT11; Ito H, 2002, ELECTRON LETT, V38, P1376, DOI 10.1049/el:20020951; Sui YT, 2013, IEEE COMMUN MAG, V51, P62; Kanno A, 2012, IEEE PHOTONICS J, V4, P2196, DOI 10.1109/JPHOT.2012.2228182; de Greve F, 2005, WIRELESS PERS COMMUN, V33, P281, DOI 10.1007/s11277-005-0573-2; [Anonymous], 2010, G9872 ITUT; Wang JZ, 2012, IEEE J SEL AREA COMM, V30, P675, DOI 10.1109/JSAC.2012.120502; Dat P. T., 2013, P IEEE OFC; Dat P. T., 2014, J LIGHTWAVE TECH, V32, P0733; Dat P. T., 2014, P IEEE IMS; Haruyyama S., 2011, P IEEE OFC; Kanno A., 2013, P IEEE GLOBECOM; Lannoo, 2007, IEEE COMMUN MAG, V45, P56; Thanh T. L., 2015, P IEEE ICC	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	OCT	2015	53	10					86	94				9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0YU	WOS:000363246200012		
J	Choi, JK; Nishida, S; Yokobiki, T; Kawaguchi, K				Choi, Jin-Kyu; Nishida, Shuhei; Yokobiki, Takashi; Kawaguchi, Katsuyoshi			Automated Cable-Laying System for Thin Optical-Fiber Submarine Cable Installation	IEEE JOURNAL OF OCEANIC ENGINEERING			English	Article						Automated cable-laying system; Dense Oceanfloor Network System for Earthquakes and Tsunamis (DONET); optical-fiber submarine cable; remotely operated vehicle (ROV)		We have installed the Dense Oceanfloor Network System for Earthquakes and Tsunamis (DONET) that includes 20 observatories at Kumanonada (called DONET1) for the purpose of monitoring the seismogenic zone around the Nankai Trough. During the construction of DONET1, a remotely operated vehicle (ROV) was successfully used to lay the optical-fiber submarine cables that connect the observatories with the science nodes; however, the cable-laying operation was onerous because it takes approximately 10 h and is manually performed by ROV operators. For this reason, the cable-laying operation is usually not performed on successive days, which makes it difficult to schedule the construction work. In this paper, we present an automated cable-laying system that can automatically pay out the optical-fiber submarine cable on the seafloor at a rate that keeps pace with the ground speed and also adjusts the cable tautness. The components and control strategies are first described, and the results of some experiments and the first mission are then presented. The experiments and the first mission demonstrate that the automated cable-laying system can reduce the physical and mental burdens on the ROV operator and speed up the installation of DONET2 in 31 observatories. DONET2 is planned to be deployed off the Kii Peninsula (on the western side of DONET1).	[Choi, Jin-Kyu; Nishida, Shuhei; Yokobiki, Takashi; Kawaguchi, Katsuyoshi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan	Choi, JK (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan.	jk-choi@jamstec.go.jp; shuheinishida@jamstec.go.jp; yokobikit@jamstec.go.jp; kawak@jam-stec.go.jp					Andres J. M., 1993, P IEEE OCEANS C VICT, V2, pII413; Ferguson J, 1999, SEA TECHNOL, V40, P65; Kawaguchi K, 2002, IEEE J OCEANIC ENG, V27, P182, DOI 10.1109/JOE.2002.1002472; ZAJAC EE, 1957, AT&T TECH J, V36, P1129; Bird L. E., 2002, P MTS IEEE OCEANS C, DOI [10.1109/OCEANS.2002.1191947, DOI 10.1109/0CEANS.2002.1191947]; Butler B., 1993, P IEEE OCEANS C VICT, DOI [10.1109/OCEANS.1993.326046, DOI 10.1109/OCEANS.1993.326046]; Choi J.-K., 2013, P INT S UND TECHN TO, DOI [10.1109/UT.2013.6519810, DOI 10.1109/UT.2013.6519810]; Grewal M. S., 2001, KALMAN FILTERING THE; Hartley P., 1991, P INT S UNM UNT SUBM, P20; Japan Agency for Marine-Earth Science and Technology (JAMSTEC), DENS OC NETW SYST EA; Kaneda Y., 2013, P INT S UND TECHN TO, DOI [10.1109/UT.2013.6519904, DOI 10.1109/UT.2013.6519904]; Kawaguchi K., 2012, P MTS IEEE OCEANS YE, DOI [10.1109/OCEANS-Yeosu.2012.6263447, DOI 10.1109/OCEANS-YEOSU.2012.6263447]; Kawaguchi K., 2009, P IEEE OCEANS EUR C, DOI [10.1109/OCEANSE.2009.5278322, DOI 10.1109/0CEANSE.2009.5278322]; Kitada K., 2013, P INT S UND TECHN TO, DOI [10.1109/UT.2013.6519882, DOI 10.1109/UT.2013.6519882]; Kojima J., 1990, J SOC NAVAL ARCHITEC, V168, P309; Shepherd K., 2007, P MTS IEEE OCEANS C, DOI [10.1109/OCEANS.2007.4449275, DOI 10.1109/OCEANS.2007.4449275]	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0364-9059	1558-1691		IEEE J OCEANIC ENG	IEEE J. Ocean. Eng.	OCT	2015	40	4					981	992		10.1109/JOE.2014.2363785		12	Engineering, Civil; Engineering, Ocean; Engineering, Electrical & Electronic; Oceanography	Engineering; Oceanography	CT9XZ	WOS:000363171200021		
J	Wang, H; Kousai, S; Onizuka, K; Hu, S				Wang, Hua; Kousai, Shouhei; Onizuka, Kohei; Hu, Song			The Wireless Workhorse	IEEE MICROWAVE MAGAZINE			English	Article							CMOS POWER-AMPLIFIER; EFFICIENCY IMPROVEMENT; BACK-OFF; DIGITAL PREDISTORTION; ENVELOPE ELIMINATION; MOBILE PHONES; BULK CMOS; NM CMOS; TRANSMITTER; TRANSFORMER		[Wang, Hua; Hu, Song] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Kousai, Shouhei; Onizuka, Kohei] Toshiba Co Ltd, Ctr Semicond R&D, Tokyo, Japan	Wang, H (reprint author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	hua.wang@ece.gatech.edu; shouhei.kousai@toshiba.co.jp; kohei.onizuka@toshiba.co.jp; husong@gatech.edu					Alavi MS, 2014, IEEE T MICROW THEORY, V62, P732, DOI 10.1109/TMTT.2014.2307876; Choi J, 2009, IEEE T MICROW THEORY, V57, P1675, DOI 10.1109/TMTT.2009.2021880; Staszewski RB, 2005, IEEE J SOLID-ST CIRC, V40, P2469, DOI 10.1109/JSSC.2005.857417; Hu S, 2015, IEEE J SOLID-ST CIRC, V50, P1094, DOI 10.1109/JSSC.2015.2415494; Li CH, 2009, IEEE T ANTENN PROPAG, V57, P2763, DOI 10.1109/TAP.2009.2027081; Doherty WH, 1936, P IRE, V24, P1163, DOI 10.1109/JRPROC.1936.228468; Carrubba V, 2010, EUR MICROW INTEGRAT, P432; Boumaiza S, 2002, IEEE T MICROW THEORY, V50, P3016, DOI 10.1109/TMTT.2002.805139; Kwak M, 2012, IEEE T MICROW THEORY, V60, P1850, DOI 10.1109/TMTT.2012.2184128; Jager H, 2002, IEEE MTT-S, P1035, DOI 10.1109/MWSYM.2002.1011812; Zhao DX, 2012, IEEE J SOLID-ST CIRC, V47, P3172, DOI 10.1109/JSSC.2012.2216692; [Anonymous], 2008, IEEE J SOLID-ST CIRC; Kim D, 2011, IEEE T MICROW THEORY, V59, P1787, DOI 10.1109/TMTT.2011.2140124; Chowdhury D, 2009, IEEE J SOLID-ST CIRC, V44, P3393, DOI 10.1109/JSSC.2009.2032277; Okazaki H, 2013, URSI INT SYM ELECT, P432; Morgan DR, 2006, IEEE T SIGNAL PROCES, V54, P3852, DOI 10.1109/TSP.2006.879264; Hassan M, 2012, IEEE T MICROW THEORY, V60, P1321, DOI 10.1109/TMTT.2012.2187537; Chowdhury D, 2011, IEEE J SOLID-ST CIRC, V46, P1796, DOI 10.1109/JSSC.2011.2155790; Chowdhury D, 2012, IEEE J SOLID-ST CIRC, V47, P1113, DOI 10.1109/JSSC.2012.2185555; [Anonymous], 2015, RADIO FREQUENCY DEVI; Yoo SM, 2011, IEEE J SOLID-ST CIRC, V46, P2977, DOI 10.1109/JSSC.2011.2163469; Staszewski RB, 2004, IEEE J SOLID-ST CIRC, V39, P2278, DOI 10.1109/JSSC.2004.836345; Dasgupta K, 2014, IEEE RAD FREQ INTEGR, P343, DOI 10.1109/RFIC.2014.6851737; Grebennikov A, 2012, P IEEE, V100, P3190, DOI 10.1109/JPROC.2012.2211091; [Anonymous], 2014, P IEEE RF INT CIRC S; Ye L, 2013, IEEE J SOLID-ST CIRC, V48, P3160, DOI 10.1109/JSSC.2013.2281142; Yoo SM, 2013, IEEE J SOLID-ST CIRC, V48, P1212, DOI 10.1109/JSSC.2013.2252754; Wang FP, 2006, IEEE T MICROW THEORY, V54, P4086, DOI 10.1109/TMTT.2006.885575; Chen CT, 2012, IEEE T MICROW THEORY, V60, P4117, DOI 10.1109/TMTT.2012.2223712; Kim N, 2009, IEEE J SOLID-ST CIRC, V44, P2126, DOI 10.1109/JSSC.2009.2022921; [Anonymous], 2014, P IEEE RFIC S JUN 20; Margomenos A, 2012, EUR MICROW INTEGRAT, P615; Hu S, 2015, ISSCC DIG TECH PAP I, V58, P44; Berretta G, 2006, IEEE RADIO WIRELESS, P523, DOI 10.1109/RWS.2006.1615209; Wang H, 2010, IEEE J SOLID-ST CIRC, V45, P2709, DOI 10.1109/JSSC.2010.2077171; Haldi P, 2006, ELECTRON LETT, V42, P1091, DOI 10.1049/el:20061585; Liu G, 2008, IEEE J SOLID-ST CIRC, V43, P600, DOI 10.1109/JSSC.2007.916585; Birafane A, 2004, IEEE T MICROW THEORY, V52, P1702, DOI 10.1109/TMTT.2004.830485; Walling JS, 2009, IEEE J SOLID-ST CIRC, V44, P2339, DOI 10.1109/JSSC.2009.2023191; Darraji R, 2012, IEEE T MICROW THEORY, V60, P2875, DOI 10.1109/TMTT.2012.2207910; Vasylyev A, 2005, ELECTRON LETT, V41, P1281, DOI 10.1049/el:20053261; Chen KL, 2012, IEEE T MICROW THEORY, V60, P4107, DOI 10.1109/TMTT.2012.2221142; Wu RL, 2013, IEEE J SOLID-ST CIRC, V48, P2030, DOI 10.1109/JSSC.2013.2265501; Kousai S, 2009, IEEE J SOLID-ST CIRC, V44, P3376, DOI 10.1109/JSSC.2009.2032271; Boyle KR, 2007, IEEE T ANTENN PROPAG, V55, P364, DOI 10.1109/TAP.2006.889834; Chakrabarti A, 2014, IEEE T MICROW THEORY, V62, P1686, DOI 10.1109/TMTT.2014.2327919; Reynaert P, 2005, IEEE J SOLID-ST CIRC, V40, P2598, DOI 10.1109/JSSC.2005.857425; Wang CZ, 2004, IEEE J SOLID-ST CIRC, V39, P1927, DOI 10.1109/JSSC.2004.835834; Bowers SM, 2013, IEEE T MICROW THEORY, V61, P1301, DOI 10.1109/TMTT.2013.2243750; Noh YS, 2004, IEEE J SOLID-ST CIRC, V39, P967, DOI 10.1109/JSSC.2004.827804; Pelosi M, 2010, IEEE ANTENN PROPAG M, V52, P15, DOI 10.1109/MAP.2010.5586570; Wang FP, 2005, IEEE MTT-S, P645; Aoki I, 2002, IEEE T MICROW THEORY, V50, P316, DOI 10.1109/22.981284; Sowlati T, 2004, IEEE J SOLID-ST CIRC, V39, P2179, DOI 10.1109/JSSC.2004.836335; Xu HT, 2011, IEEE J SOLID-ST CIRC, V46, P1596, DOI 10.1109/JSSC.2011.2143930; Agah A, 2014, IEEE J SOLID-ST CIRC, V49, P1148, DOI 10.1109/JSSC.2014.2308292; Tai W, 2012, IEEE J SOLID-ST CIRC, V47, P1646, DOI 10.1109/JSSC.2012.2191674; Hassan M, 2012, IEEE J SOLID-ST CIRC, V47, P1185, DOI 10.1109/JSSC.2012.2184639; Wang H, 2014, IEEE T CIRCUITS-I, V61, P1321, DOI 10.1109/TCSI.2014.2309811; Kousai S, 2012, IEEE J SOLID-ST CIRC, V47, P2964, DOI 10.1109/JSSC.2012.2217833; Bakalski W, 2003, BCTM PROC, P61; Chireix H, 1935, P IRE, V23, P1370, DOI 10.1109/JRPROC.1935.227299; Thian M, 2009, IEEE T MICROW THEORY, V57, P323, DOI 10.1109/TMTT.2008.2011164; Asbeck P., 2012, IEEE 12 TOP M SIRF, P1; Chen J., 2013, ISSCC, P232, DOI DOI 10.1109/ISSCC.2013.6487713; Chiriac V., 2004, P ASME IMECE T AN CA, P1; COX DC, 1974, IEEE T COMMUN, VCO22, P1942, DOI 10.1109/TCOM.1974.1092141; Cripps S., 2006, RF POWER AMPLIFIERS; Cripps SC, 2002, ADV TECHNIQUES RF PO; Fan X., 2008, P IEEE 10 EL PACK TE, P1, DOI DOI 10.1109/PIMRC.2008.4699508; Gaber W. M., 2011, P ESSCIRC SEP, P139; Gaber W. M., 2012, P ESSCIRC, P341; Hau G., 2008, P IEEE RAD FREQ INT, P409; Hu S, 2015, IEEE T MICROW THEORY, V63, P580, DOI 10.1109/TMTT.2014.2385860; Ishihara H., 2010, IEEE INT SOL STAT CI, P66; Kousai S, 2014, IEEE J SOLID-ST CIRC, V49, P2902, DOI 10.1109/JSSC.2014.2361322; Lee T. H., 2003, DESIGN CMOS RADIO FR; Onizuka Kohei, 2012, Proceedings of the 2012 IEEE Asian Solid State Circuits Conference (A-SSCC); Onizuka K., 2013, P IEEE INT SOL STAT, P90; Pham A., 2006, P IEEE RAD FREQ INT, P4; RAAB FH, 1985, IEEE T COMMUN, V33, P1094, DOI 10.1109/TCOM.1985.1096219; Razavi B., 2011, RF MICROELECTRONICS; Schaumann R., 2009, DESIGN ANALOG FILTER; SOKAL NO, 1975, IEEE J SOLID-ST CIRC, VSC10, P168, DOI 10.1109/JSSC.1975.1050582; Song H., 2009, P IEEE INT SOL STAT, P384; Tuffy N., 2011, Proceedings 2011 European Microwave Integrated Circuit Conference (EuMIC 2011); Zhou J, 2014, IEEE J SOLID-ST CIRC, V49, P3046, DOI 10.1109/JSSC.2014.2359914	87	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1527-3342	1557-9581		IEEE MICROW MAG	IEEE Microw. Mag.	OCT	2015	16	9					36	63		10.1109/MMM.2015.2453872		28	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0WZ	WOS:000363241000005		
J	Farghal, AE; Shalaby, HMH; Kato, K; Pokharel, RK				Farghal, Ahmed E.; Shalaby, Hossam M. H.; Kato, Kazutoshi; Pokharel, Ramesh K.			Optical Code-Division Multiplexing (OCDM) Networks Adopting Code-Shift Keying/Overlapping PPM Signaling: Proposal and Performance Analysis	IEEE TRANSACTIONS ON COMMUNICATIONS			English	Article						Optical code division multiplexing (OCDM); APD noise; intersymbol interference (ISI); code-shift keying (CSK); overlapping pulse-position modulation (OPPM)	PULSE-POSITION MODULATION; ACCESS SYSTEMS; CDMA SYSTEMS; DISPERSION; SECURITY; SCHEMES; IMPACT; OPPM; TIME; APDS	Optical code-division multiplexing (OCDM) systems use short pulses compared with bit-duration to achieve high transmission rate. The use of short pulses poses several problems as a result of group velocity dispersion (GVD), intersymbol interference (ISI) (due to avalanche photodiode (APD) buildup time), and receivers limited bandwidth. In this paper, an OCDM system employing code-shift keying (CSK) and overlapping pulse-position modulation (OPPM) signaling is proposed and theoretically investigated. By using CSK while maintaining same data rate, the chip duration can be increased to counteract the GVD effect in 2D OCDM systems. Moreover, by increasing the chip duration, the chip rate is decreased and the stringent requirement on receiver bandwidth is relaxed. In addition, using overlapping property in OPPM allows for further chip duration increase. We consider using correlation receivers with hard-limiters and APDs at the receiver side. The bit error probability (BEP) of the proposed system is derived taking into account the impacts of APD noise, thermal noise, GVD, ISI, and multiple-access interference (MAI). A performance comparison between OOK-, PPM-, OPPM-OCDM and the proposed system is carried out. Our results reveal that the use of CSK/OPPM-OCDM with data rate constraint allows the reduction of MAI, GVD and ISI effects with improved spectral efficiency.	[Farghal, Ahmed E.; Shalaby, Hossam M. H.] Egypt Japan Univ Sci & Technol E JUST, Dept Elect & Commun Engn, Alexandria 21934, Egypt; [Kato, Kazutoshi; Pokharel, Ramesh K.] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan	Farghal, AE (reprint author), Egypt Japan Univ Sci & Technol E JUST, Dept Elect & Commun Engn, Alexandria 21934, Egypt.	ahmed.farghal@ejust.edu.eg; shalaby@ieee.org; kato@ed.kyushu-u.ac.jp; pokharel@ed.kyushu-u.ac.jp			Egyptian Ministry of Higher Education	This work was supported by the Egyptian Ministry of Higher Education. The associate editor coordinating the review of this paper and approving it for publication was W. C. Kwong.	Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Agrawal G. P., 2002, FIBER OPTIC COMMUNIC, P164; Sun P, 2006, J LIGHTWAVE TECHNOL, V24, P755, DOI 10.1109/JLT.2005.862436; Manzacca G, 2007, IEEE PHOTONIC TECH L, V19, P559, DOI 10.1109/LPT.2007.894261; [Anonymous], 2015, SUPP VIRT 7 FAM OV; Campbell JC, 2007, J LIGHTWAVE TECHNOL, V25, P109, DOI 10.1109/JLT.2006.888481; Ong DSG, 2009, J LIGHTWAVE TECHNOL, V27, P3294, DOI 10.1109/JLT.2009.2020303; Dang NT, 2010, J OPT COMMUN NETW, V2, P967, DOI 10.1364/JOCN.2.000967; Galli S, 2008, IEEE T COMMUN, V56, P2133, DOI 10.1109/TCOMM.2008.050640; Yang GC, 1997, IEEE T COMMUN, V45, P1426, DOI 10.1109/26.649764; Shalaby HMH, 1999, J LIGHTWAVE TECHNOL, V17, P1158, DOI 10.1109/50.774248; Tancevski L, 1996, IEE P-OPTOELECTRON, V143, P161, DOI 10.1049/ip-opt:19960318; Wang TC, 2009, J LIGHTWAVE TECHNOL, V27, P2612, DOI 10.1109/JLT.2009.2013367; Shake TH, 2005, J LIGHTWAVE TECHNOL, V23, P655, DOI 10.1109/JLT.2004.838844; Narimanov E, 2005, IEEE T COMMUN, V53, P2150, DOI 10.1109/TCOMM.2005.860041; Lu LJ, 2014, OPT LETT, V39, P1633, DOI 10.1364/OL.39.001633; Shalaby HMH, 2000, J LIGHTWAVE TECHNOL, V18, P905, DOI 10.1109/50.850734; Dang NT, 2011, ASIA-PAC CONF COMMUN, P96; Tancevski L, 1996, J LIGHTWAVE TECHNOL, V14, P2636, DOI 10.1109/50.545782; Majumder SP, 2005, IEEE PHOTONIC TECH L, V17, P1340, DOI 10.1109/LPT.2005.846924; Smith EDJ, 1998, IEEE T COMMUN, V46, P1176, DOI 10.1109/26.718559; PAPOULIS A, 1971, J APPL PROBAB, V8, P118, DOI 10.2307/3211842; Mashhadi S, 2006, IEEE T COMMUN, V54, P1457, DOI 10.1109/TCOMM.2006.878835; SHALABY HMH, 1995, J LIGHTWAVE TECHNOL, V13, P2121, DOI 10.1109/50.482031; Ng EKH, 2002, IEEE T COMMUN, V50, P1811, DOI 10.1109/TCOMM.2002.805262; El-Howayek G, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2302792; Farghal AE, 2014, J LIGHTWAVE TECHNOL, V32, P2649, DOI 10.1109/JLT.2014.2331700; Gagliardi R., 1995, OPTICAL COMMUNICATIO; Kong W. C., 2005, IEEE T COMMUN, V53, P117; Kouketsu H., 2014, P OPT FIB COMM C SAN; Sabbagh AG, 2013, J LIGHTWAVE TECHNOL, V31, DOI 10.1109/JLT.2013.2271238; Sanches Anderson L, 2009, Journal of Lightwave Technology, V27, DOI 10.1109/JLT.2009.2030775; Shurong S., 2006, J LIGHTWAVE TECHNOL, V24, P1646	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0090-6778	1558-0857		IEEE T COMMUN	IEEE Trans. Commun.	OCT	2015	63	10					3779	3788		10.1109/TCOMM.2015.2467372		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU1CP	WOS:000363257200026		
J	Asada, T; Baba, Y; Nagaoka, N; Ametani, A				Asada, Takashi; Baba, Yoshihiro; Nagaoka, Naoto; Ametani, Akihiro			Representation of a Straight Thin Wire in a Lossy Medium and an Oblique Thin Wire in Air for FDTD Simulations	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Equivalent radius; finite-difference time-domain method; thin wire; transient	SURGE SIMULATION; BOUNDARY	An improved representation of a straight thin wire for a 3-D finite-difference time-domain simulation has been applied to the transient analysis of a straight thin wire in a lossy medium, and its validity has been shown. In this representation, a straight wire having a specified radius is simulated by a straight wire having the equivalent radius 0.199 Delta s, where Delta s is the lateral side length of cubic cells employed, embedded in an artificial parallelepiped medium having modified conductivity (only if it is in a lossy medium), modified relative permittivity, and modified relative permeability. Also, the equivalent radius of a staircase-approximated oblique wire in air has been evaluated, and its thin-wire representation has been discussed.	[Asada, Takashi; Baba, Yoshihiro; Nagaoka, Naoto; Ametani, Akihiro] Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan	Asada, T (reprint author), Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan.	dun0306@mail4.doshisha.ac.jp; ybaba@mail.doshisha.ac.jp; nnagaoka@mail.doshisha.ac.jp; aametani@mail.doshisha.ac.jp					LIAO ZP, 1984, SCI SIN A-MATH P A T, V27, P1063; Zhang G, 2007, IET MICROW ANTENNA P, V1, P381, DOI 10.1049/iet-map:20050305; Asada T, 2015, IEEE T ELECTROMAGN C, V57, P484, DOI 10.1109/TEMC.2014.2380815; Baba Y, 2014, IEEE T ELECTROMAGN C, V56, P1506, DOI 10.1109/TEMC.2014.2331323; Edelvik F, 2003, IEEE T ELECTROMAGN C, V45, P416, DOI 10.1109/TEMC.2003.811294; Noda T, 2002, IEEE T POWER DELIVER, V17, P840, DOI 10.1109/TPWRD.2002.1022813; Makinen RM, 2002, IEEE T MICROW THEORY, V50, P1245, DOI 10.1109/22.999136; Baba Y, 2005, IEEE T ELECTROMAGN C, V47, P54, DOI 10.1109/TEMC.2004.842115; Taniguchi Y, 2008, IEEE T ANTENN PROPAG, V56, P3248, DOI 10.1109/TAP.2008.929447; Railton CJ, 2006, IEEE T ELECTROMAGN C, V48, P654, DOI 10.1109/TEMC.2006.884452; Holland R., 1981, ELECTROMAGNETIC COMP, VEMC-23, P88; Noda T, 2004, IEEE T POWER DELIVER, V19, P1913, DOI 10.1109/TPWRD.2004.835396; UMASHANKAR KR, 1987, IEEE T ANTENN PROPAG, V35, P1248, DOI 10.1109/TAP.1987.1144000; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	OCT	2015	57	5					1164	1167		10.1109/TEMC.2015.2424976		4	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0EQ	WOS:000363189200029		
J	Paoletti, U; Suga, T				Paoletti, Umberto; Suga, Takashi			The Printed Reverberation Board and the Extraction of IC Noise Models Above 1 GHz	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Integrated circuit (IC) measurements; integrated circuit modeling; integrated circuit noise; power supplies	CHAOTIC MICROWAVE CAVITIES; SCATTERING MATRICES; IMPEDANCE; STATISTICS	A new approach to integrated circuit (IC) noise modeling using a single current source for the whole area below the IC on a printed circuit board (PCB) is proposed. This approach extends the frequency of application of similar models in the literature by focusing on the current and power injected into the region outside the IC perimeter. A new measurement equipment for IC electromagnetic compatibility tests above 1 GHz is proposed; the printed reverberation board (PRB). A statistical model for characterizing the PRB is presented and confirmed by measurement results. Limitations of the fabricated PRB prototype and possible improvements are discussed. Anew random IC model that includes the random properties of the IC noise is introduced. A methodology to extract the IC model by means of the PRB is presented. An active test PCB has been designed and fabricated to verify the feasibility of the modeling and measurement methods. Measurement results corroborated the validity of the new measurement and modeling approaches on one side, and on the other side showed that further studies are required.	[Paoletti, Umberto; Suga, Takashi] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan	Paoletti, U (reprint author), Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan.	umberto.paoletti.ff@hitachi.com; takashi.suga.pt@hitachi.com					Wang ZL, 2005, IEEE T ELECTROMAGN C, V47, P2, DOI 10.1109/TEMC.2004.842205; Zhang YJ, 2010, IEEE T MICROW THEORY, V58, P3780, DOI 10.1109/TMTT.2010.2083870; Hemmady S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056215; Zheng X, 2006, ELECTROMAGNETICS, V26, P37, DOI 10.1080/02726340500214902; Zheng X, 2006, ELECTROMAGNETICS, V26, P3, DOI 10.1080/02726340500214894; Li L, 2012, IEEE INT SYMP ELEC, P560; Gotoh K, 2005, IEICE T COMMUN, VE88B, P3235, DOI 10.1093/ietcom/e88-b.8.3235; Paoletti U, 2013, 2013 9TH INTERNATIONAL WORKSHOP ON ELECTROMAGNETIC COMPATIBILITY OF INTEGRATED CIRCUITS (EMC COMPO 2013), P21, DOI 10.1109/EMCCompo.2013.6735166; Hemmady S, 2012, IEEE T ELECTROMAGN C, V54, P758, DOI 10.1109/TEMC.2011.2177270; Hill DA, 1998, IEEE T ELECTROMAGN C, V40, P209, DOI 10.1109/15.709418; Fiori F, 2003, IEEE T INSTRUM MEAS, V52, P839, DOI 10.1109/TIM.2003.814685; [Anonymous], 2011, 624331 IEC; [Anonymous], 2002, 619671 IEC; Hart JA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041109; Antonini G., 2003, P C EL PERF EL PACK, P345; Chen RL, 2005, IEEE T ELECTROMAGN C, V47, P10, DOI 10.1109/TEMC.2004.842204; EMC, 2000, 61000421 IEC; Nakao T., 2012, P IEEE INT 3D SYST I, P1; Paoletti U., 2012, P EUR INT S EL COMP; Papoulis A., 2002, PROBABILITY RANDOM V; Wada O., 2006, P 17 INT ZUR S EL CO, P316	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	OCT	2015	57	5					1206	1215		10.1109/TEMC.2015.2423314		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0EQ	WOS:000363189200034		
J	Mashimo, T				Mashimo, Tomoaki			Performance Evaluation of a Micro Ultrasonic Motor Using a One-Cubic-Millimeter Stator	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article							TRANSDUCER; CONTACT	A piezoelectric ultrasonic motor has two significant advantages, high energy density and simple structure, and these advantages can help in the miniaturization of the motor. We build a prototype micro ultrasonic motor using a stator with a volume of approximately 1 cubic millimeter. To evaluate its representative performance values (torque, angular velocity, and energy efficiency), we built an experimental setup and operated the prototype motor by varying experimental conditions, such as the preload between the stator and rotor and the amplitude of voltages applied to motor. The performance values obtained at the millimeter to sub-millimeter scale are discussed analytically using the macro scale models of ultrasonic motors. Experimentally, the prototype motor has generated a torque of more than 10 mu Nm with a 1-cubic-millimeter stator. The motor described herein is now the smallest micro ultrasonic motor with a practical torque, although its efficiency is still low.	Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan	Mashimo, T (reprint author), Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.	mashimo@eiiris.tut.ac.jp					Mashimo T, 2014, SENSOR ACTUAT A-PHYS, V213, P102, DOI 10.1016/j.sna.2014.03.018; Inoue A, 2006, MATER TRANS, V47, P1275, DOI 10.2320/matertrans.47.1275; HAGOOD NW, 1995, IEEE T ULTRASON FERR, V42, P210, DOI 10.1109/58.365235; Uchino K, 2004, J ELECTROCERAM, V13, P393, DOI 10.1007/s10832-004-5131-x; FAN LS, 1989, SENSOR ACTUATOR, V20, P41, DOI 10.1016/0250-6874(89)87100-8; Watson B, 2009, SENSOR ACTUAT A-PHYS, V152, P219, DOI 10.1016/j.sna.2009.04.001; Cagatay S, 2003, IEEE T ULTRASON FERR, V50, P782, DOI 10.1109/TUFFC.2003.1214498; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P481, DOI 10.1109/58.84293; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P188, DOI 10.1109/58.79602; Morita T, 2003, SENSOR ACTUAT A-PHYS, V103, P291, DOI 10.1016/S0924-4247(02)00405-3; KUROSAWA M, 1989, IEEE T ULTRASON FERR, V36, P517, DOI 10.1109/58.31795; [Anonymous], 2014, INT ULTR S, DOI DOI 10.1109/ULTSYM.2014.0213; Kanda T, 2006, SENSOR ACTUAT A-PHYS, V127, P131, DOI 10.1016/j.sna.2005.10.056; Wallaschek J, 1998, SMART MATER STRUCT, V7, P369, DOI 10.1088/0964-1726/7/3/011; GUCKEL H, 1993, MICRO ELECTRO MECHANICAL SYSTEMS, PROCEEDINGS, P7; Iino A, 2000, ULTRASONICS, V38, P54, DOI 10.1016/S0041-624X(99)00192-4; Jacobsen S. C., 1989, P IEEE INT C ROB AUT, V3, P1536; lino A., 2002, JPN J PREC ENG, V68, P641; Liu Daniel Kuang-Chen, 2010, Acoustical Science and Technology, V31, DOI 10.1250/ast.31.115; MAENO T, 1992, IEEE T ULTRASON FERR, V39, P675, DOI 10.1109/58.165550; Morita T, 2000, SENSOR ACTUAT A-PHYS, V83, P225, DOI 10.1016/S0924-4247(99)00388-X; TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9; Watson B, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/022001; Watson B., 2009, IEEE INT C ROB AUT K, P2225	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	OCT	2015	62	10					1819	1826		10.1109/TUFFC.2014.006834		8	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CU0WW	WOS:000363240600009		
J	Sugiura, S; Hanzo, L				Sugiura, Shinya; Hanzo, Lajos			Single-RF Spatial Modulation Requires Single-Carrier Transmission: Frequency-Domain Turbo Equalization for Dispersive Channels	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Broadband transmissions; EXIT chart; frequency-domain equalization; iterative detection; minimum mean-square error; orthogonal frequency-division multiplexing; single-carrier transmission; space-shift keying; spatial modulation	PERFORMANCE ANALYSIS; INFORMATION; SYSTEMS; DESIGN; CODES; FDMA	In this paper, we propose a broadband single-carrier (SC) spatial modulation (SM)-based multiple-input-multiple-output (MIMO) architecture relying on a soft decision (SoD) frequency-domain equalization (FDE) receiver. We demonstrate that conventional orthogonal-frequency-division-multiplexing (OFDM)-based broadband transmissions are not readily suitable for the single-radio-frequency-assisted SM-MIMO schemes since this scheme exhibits no substantial performance advantage over single-antenna transmissions. To circumvent this limitation, a low-complexity SoD FDE algorithm based on the minimum mean square error (MMSE) criterion is invoked for our broadband SC-based SM-MIMO scheme, which is capable of operating in a strongly dispersive channel having a long channel impulse response at moderate decoding complexity. Furthermore, our SoD FDE attains a near-capacity performance with the aid of a three-stage concatenated SC-based SM architecture.	[Sugiura, Shinya] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan; [Hanzo, Lajos] Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	Sugiura, S (reprint author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan.	sugiura@ieee.org; lh@ecs.soton.ac.uk	Sugiura, Shinya/A-5358-2013		Japan Society for the Promotion of Science [26709028]	This work was supported by the Japan Society for the Promotion of Science Grants-in Aid for Scientific Research (KAKENHI) under Grant 26709028. The review of this paper was coordinated by Dr. C. Cozzo.	Myung HG, 2006, IEEE VEH TECHNOL MAG, V1, P30, DOI 10.1109/MVT.2006.307304; Alrabadi ON, 2012, IEEE T ANTENN PROPAG, V60, P654, DOI 10.1109/TAP.2011.2173429; Mesleh RY, 2008, IEEE T VEH TECHNOL, V57, P2228, DOI [10.1109/TVT.2007.912136, 10.1109/TVT.2008.912136]; Som P, 2012, UEEE INT SYM PERS IN, P1962, DOI 10.1109/PIMRC.2012.6362674; Kalis A, 2008, IEEE J SEL AREA COMM, V26, P972, DOI 10.1109/JSAC.2008.080813; Sugiura S, 2012, IEEE SIGNAL PROC LET, V19, P805, DOI 10.1109/LSP.2012.2221707; Jeganathan J, 2008, IEEE COMMUN LETT, V12, P545, DOI 10.1109/LCOMM.2008.080739; Kadir MI, 2013, IEEE T VEH TECHNOL, V62, P408, DOI 10.1109/TVT.2012.2220794; Di Renzo M, 2010, IEEE T COMMUN, V58, P2590, DOI 10.1109/TCOMM.2010.09.090565; ten Brink S, 2001, IEEE T COMMUN, V49, P1727, DOI 10.1109/26.957394; Di Renzo M, 2011, IEEE COMMUN MAG, V49, P182; Pancaldi F, 2008, IEEE SIGNAL PROC MAG, V25, P37, DOI 10.1109/MSP.2008.926657; Sugiura S, 2012, IEEE COMMUN SURV TUT, V14, P421, DOI 10.1109/SURV.2011.032511.00136; ten Brink S, 2004, IEEE T COMMUN, V52, P670, DOI 10.1109/TCOMM.2004.826370; Jeganathan J, 2009, IEEE T WIREL COMMUN, V8, P3692, DOI 10.1109/TWC.2009.080910; Rajashekar R, 2013, IEEE T COMMUN, V61, P2318, DOI 10.1109/TCOMM.2013.043013.130011; ten Brink S, 2000, AEU-INT J ELECTRON C, V54, P389; Sugiura S, 2012, IEEE COMMUN SURV TUT, V14, P401, DOI 10.1109/SURV.2011.041911.00105; Astely D, 2009, IEEE COMMUN MAG, V47, P44, DOI 10.1109/MCOM.2009.4907406; Sugiura S, 2010, IEEE T COMMUN, V58, P3219, DOI 10.1109/TCOMM.2010.093010.090730; Sugiura S, 2014, IEEE SIGNAL PROC LET, V21, P390, DOI 10.1109/LSP.2014.2303471; Di Renzo M, 2014, P IEEE, V102, P56, DOI 10.1109/JPROC.2013.2287851; Ganesan S., 2006, P 40 AS C SIGN SYST; Hanzo L., 2009, NEAR CAPACITY MULTIF; Hanzo L., 2011, TURBO CODING TURBO E; Hanzo L., 2003, OFDM MC CDMA BROADBA; Hanzo L., 2003, SINGLE MULTICARRIER; Ishibashi Koji, 2014, IEEE Wireless Communications Letters, V3, DOI 10.1109/LWC.2014.2315819; Ngo H. A., 2011, IEEE SIGNAL PROCESS, V18, P177, DOI 10.1109/LSP.2011.2106773; Tuchler M, 2002, IEEE T SIGNAL PROCES, V50, P673, DOI 10.1109/78.984761	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	OCT	2015	64	10					4870	4875		10.1109/TVT.2014.2370679		6	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CU0FI	WOS:000363191100043		
J	Yuhji, M; Kiho, T; Yasuo, I; Yoshifumi, U; Shinji, T				Yuhji, Marui; Kiho, Tanaka; Yasuo, Ishii; Yoshifumi, Ubara; Shinji, Tomikawa			IMPACT OF PRE-OPERATIVE TREATMENT FOR POLYCYSTIC KIDNEY IN RENAL TRANSPLANT RECIPIENTS FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	IMMUNOLOGY AND CELL BIOLOGY			English	Meeting Abstract	33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand	JUN 21-23, 2015	ANU Campus, Canberra, AUSTRALIA	Transplantat Soc Australia & New Zealand	ANU Campus				[Yuhji, Marui; Kiho, Tanaka; Yasuo, Ishii; Shinji, Tomikawa] Toranomon Hosp Kajigya, Dept Renal Transplantat Surg, Tokyo, Japan; [Yoshifumi, Ubara] Toranomon Hosp Kajigya, Dept Nephrol, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0818-9641	1440-1711		IMMUNOL CELL BIOL	Immunol. Cell Biol.	OCT	2015	93	9					A27	A28				2	Cell Biology; Immunology	Cell Biology; Immunology	CU1ZE	WOS:000363320100069		
J	Rajalakshmy, AR; Malathi, J; Madhavan, HN; Samuel, JKA				Rajalakshmy, A. R.; Malathi, J.; Madhavan, H. N.; Samuel, J. K. A.			Mebiolgel, a thermoreversible polymer as a scaffold for three dimensional culture of Huh7 cell line with improved hepatocyte differentiation marker expression and HCV replication	INDIAN JOURNAL OF MEDICAL MICROBIOLOGY			English	Article						Hepatitis C virus; hepatocyte; Huh7; mebiolgel; three dimensional culture	HEPATITIS-C VIRUS; GELATION POLYMER; STEM-CELLS; SYSTEM; CULTIVATION; GENOME; LIVER	Purpose: A novel three dimensional (3D) culture system purely synthesised from co-polymer which is free from biological contamination for Huh7 cell cultivation and hepatitis C virus (HCV) replication has been attempted. Materials and Methods: Mebiolgel, a thermo-reversible gelation polymer was used as a 3D scaffold for culturing Huh7, a liver carcinoma cell line used in our study. The 3D culture of the cells were infected with cell culture derived HCV. Result: The scaffold supported the cell growth as 3D spheroids for up to 63 days. Moreover mebiolgel was found to be improving the hepatocyte differentiation of Huh7 cells at the transcript level. Three dimensional culture was susceptible for HCV infection, and this was confirmed by detecting the HCV replication intermediate viral core antigen. Conclusion: Mebiolgel based culture system was proven to be suited for 3D culture of Huh7 cells by improvising liver specific genotypic expression and was susceptible for HCV replication. Since mebiolgel based Huh 7 express better hepatocyte differentiation markers genotypically, this can be implemented as an alternate for primary hepatocytes in studies such as viral isolation from patient serum.	[Rajalakshmy, A. R.] Sankara Nethralaya, Chennai, Tamil Nadu, India; [Rajalakshmy, A. R.] SASTRA, CENTAB, Thanjavur, Tamil Nadu, India; [Rajalakshmy, A. R.] Sankara Nethralaya, Vis Res Fdn, Chennai, Tamil Nadu, India; [Malathi, J.; Madhavan, H. N.] Yamanashi Univ, Fac Med, Chuo, Yamanashi 4093898, Japan; [Samuel, J. K. A.] NCRM, Mary Yoshio Translat Hexagon, Chennai, Tamil Nadu, India	Madhavan, HN (reprint author), Sankara Nethralaya, Chennai, Tamil Nadu, India.	drhnm@snmail.org					Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Tosh D, 2002, HEPATOLOGY, V36, P534, DOI 10.1053/jhep.2002.35060; Nagaya M, 2006, HEPATOLOGY, V43, P1053, DOI 10.1002/hep.21153; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Pilarek M, 2013, BIOTECHNOL LETT, V35, P1387, DOI 10.1007/s10529-013-1218-2; Wang ZY, 2010, FEBS J, V277, P4066, DOI 10.1111/j.1742-4658.2010.07802.x; Medina RJ, 2006, J CELL BIOCHEM, V98, P174, DOI 10.1002/jcb.20757; Matsuda Y, 2011, INT J ONCOL, V38, P1253, DOI 10.3892/ijo.2011.945; Yang XZ, 2009, TISSUE ENG PART C-ME, V15, P615, DOI 10.1089/ten.TEC.2008.0516; Shimizu S, 1996, ARTIF ORGANS, V20, P1232; Nagaya M, 2004, EUR SURG RES, V36, P95, DOI 10.1159/000076649; Sitalakshmi G, 2009, TISSUE ENG PT A, V15, P407, DOI 10.1089/ten.tea.2008.0041; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Sudha B, 2006, INDIAN J MED RES, V124, P655; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103	17	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0255-0857	1998-3646		INDIAN J MED MICROBI	Indian J. Med. Microbiol.	OCT-DEC	2015	33	4					554	559		10.4103/0255-0857.167330		6	Immunology	Immunology	CU1KK	WOS:000363279900014		
J	Furihata, T; Fu, ZG; Suzuki, Y; Matsumoto, S; Morio, H; Tsubota, A; Matsumoto, S; Chiba, K				Furihata, Tomomi; Fu, Zhongguo; Suzuki, Yuki; Matsumoto, Shogo; Morio, Hanae; Tsubota, Akihito; Matsumoto, Sayaka; Chiba, Kan			Differential inhibition features of direct-acting anti-hepatitis C virus agents against human organic anion transporting polypeptide 2B1	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Direct-acting antivirals; Organic anion transporting polypeptide 2B1; Transporter; Drug drug interaction; Hepatitis C virus; Long-lasting inhibition	DRUG-DRUG INTERACTIONS; GRAPEFRUIT JUICE; PLASMA-CONCENTRATIONS; SUBSTRATE ALISKIREN; FRUIT JUICES; APPLE JUICE; PHARMACOKINETICS; TELAPREVIR; FEXOFENADINE; ABSORPTION	Simeprevir (SMV), asunaprevir (ASV), daclatasvir (DCV) and sofosbuvir (SOF), which are direct-acting antiviral (DAA) agents, are expected to become essential pharmaceutical tools in the fight against the hepatitis C virus (HCV). However, because DAAs are taken orally, there is a potential risk of drug-drug interactions (DDIs) at the absorption step with co-administered drugs in the small intestine. Since it is known that organic anion transporting polypeptide 2B1 (OATP2B1) is one of the key transporters contributing to intestinal drug absorption, it is important to thoroughly understand the inhibition profiles of various DAAs in relation to OATP2B1 function in order to avoid unexpected DDIs. Therefore, using a cell-based transport assay, this study aimed at clarifying such DAA inhibition characteristics towards OATP2B1 function. The results of co-incubation inhibition assays showed that SMV and ASV strongly inhibited estrone sulfate (5 nM) uptake by OATP2B1, with half maximal inhibitory concentrations of 0.49 +/- 0.12 mu M and 0.16 +/- 0.06 mu M, respectively. Furthermore, it was found that SMV and ASV imposed long-lasting pre-incubation inhibitory effects on OATP2B1 function that enhanced their co-incubation inhibition potencies. On the other hand, no (or much less significant) inhibitory effects were observed for SOF or DCV. To summarise, these results show that SMV and ASV are co-incubation, as well as long-lasting pre-incubation, inhibitors of OATP2B1 function and therefore these inhibitions may lead to clinically relevant DDIs when used with OATP2B1 substrates. (C) 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.	[Furihata, Tomomi; Fu, Zhongguo; Suzuki, Yuki; Matsumoto, Shogo; Morio, Hanae; Matsumoto, Sayaka; Chiba, Kan] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chuo Ku, Chiba, Chiba 2608675, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Res Ctr Med Sci, Core Res Facil Basic Sci,Div Mol Cell Biol, Tokyo 1058461, Japan	Furihata, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.	tomomif@faculty.chiba-u.jp			Ministry of Health, Labor and Welfare, Japan	This work was funded by a Ministry of Health, Labor and Welfare Grant-in-Aid for Scientific Research (Emergency Research Project to Conquer Hepatitis), Japan.	Schiller C, 2005, ALIMENT PHARM THERAP, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Mougey EB, 2011, J CLIN PHARMACOL, V51, P751, DOI 10.1177/0091270010374472; Chu XY, 2013, DRUG METAB DISPOS, V41, P668, DOI 10.1124/dmd.112.049668; Kunze A, 2012, BIOCHEM PHARMACOL, V84, P1096, DOI 10.1016/j.bcp.2012.07.032; Suzuki K, 2012, J PHARM SCI-US, V101, P2606, DOI 10.1002/jps.23174; Tapaninen T, 2010, CLIN PHARMACOL THER, V88, P339, DOI 10.1038/clpt.2010.101; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Burger D, 2013, J HEPATOL, V58, P792, DOI 10.1016/j.jhep.2012.10.027; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Furihata T, 2014, ANTIMICROB AGENTS CH, V58, P4555, DOI 10.1128/AAC.02724-14; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; Tapaninen T, 2011, BRIT J CLIN PHARMACO, V71, P718, DOI 10.1111/j.1365-2125.2010.03898.x; Lee JE, 2011, ANTIMICROB AGENTS CH, V55, P4569, DOI 10.1128/AAC.00653-11; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; Garg V, 2012, J CLIN PHARMACOL, V52, P1566, DOI 10.1177/0091270011419850; Tweedie D, 2013, CLIN PHARMACOL THER, V94, P113, DOI 10.1038/clpt.2013.77; Tamai I, 2012, ADV DRUG DELIVER REV, V64, P508, DOI 10.1016/j.addr.2011.07.007; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Shitara Y, 2012, DRUG METAB PHARMACOK, V27, P368, DOI 10.2133/dmpk.DMPK-11-RG-096; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Shah N, 2013, EXPERT OPIN INV DRUG, V22, P1107, DOI 10.1517/13543784.2013.806482; Shirasaka Y, 2012, DRUG METAB PHARMACOK, V27, P360, DOI 10.2133/dmpk.DMPK-11-SH-080; Lilja JJ, 1999, CLIN PHARMACOL THER, V66, P118, DOI 10.1053/cp.1999.v66.100453001; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Shirasaka Y, 2014, PHARM RES-DORDR, V31, P2035, DOI 10.1007/s11095-014-1305-7; Tamai I, 2013, CURR OPIN PHARMACOL, V13, P859, DOI 10.1016/j.coph.2013.09.001; Eley T, 2014, CLIN DRUG INVEST, V34, P661, DOI 10.1007/s40261-014-0219-9; Eley T, 2015, CLIN PHARMACOL THER, V97, P159, DOI 10.1002/cpt.4; Tsubota A, 2013, CLIN INVESTIGATOR, V3, P1	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	OCT	2015	46	4					381	388		10.1016/j.ijantimicag.2015.05.013		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU4IN	WOS:000363491200005		
J	Kumagai, Y; Murakawa, Y; Hasunuma, T; Aso, M; Yuji, W; Sakurai, T; Noto, M; Oe, T; Kaneko, A				Kumagai, Yuji; Murakawa, Yuji; Hasunuma, Tomoko; Aso, Masako; Yuji, Wakako; Sakurai, Tsutomu; Noto, Masahiko; Oe, Tetsuya; Kaneko, Akiko			Lack of effect of favipiravir, a novel antiviral agent, on the QT interval in healthy Japanese adults	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Article						favipiravir; thorough QT study; crossover; Japanese subjects; Ebola viruses	CARDIAC REPOLARIZATION; THOROUGH QT; MOXIFLOXACIN; T-705	Objective: A thorough QT study of favipiravir, a novel antiviral agent, was conducted using a randomized, double-blind, 4-group, 4-period crossover, placebo and positive-controlled (open-label moxifloxacin) design. Materials and methods: 56 healthy Japanese adults of both sexes received single oral doses of favipiravir 1,200 and 2,400 mg (Avigan (R) Tablets, Toyama Chemical Co., Ltd.), moxifloxacin 400 mg, and a placebo. QT intervals after these treatments were measured under blinded conditions. The primary endpoint was the time-matched, placebo-adjusted change in corrected QT intervals using the Fridericia method (QTcF) from predose for favipiravir or moxifloxacin (Delta Delta QTcF). Results: Lower bounds of the two-sided 90% confidence interval of Delta Delta QTcF values for moxifloxacin exceeded 3 msec at all time points, and the maximum value was 14.0 (11.8 - 16.1, 90% confidence interval) msec at 3 hours after administration. Similarly, maximum Delta Delta QTcF values for favipiravir were 0.833 (-1.33 - 3.00) msec at 3 hours after administration of 1,200 mg, and 0.500 (-1.88 - 2.88) msec at 6 hours after administration of 2,400 mg. Calculation of the sample size using the Delta Delta QTcF value of moxifloxacin indicated that 25 subjects would be sufficient for detection at a power of 90% or higher, which meets the criteria for assuring assay sensitivity. Conclusions: It is possible to use a smaller number of subjects in thorough QT studies in Japan than in Europe and the US utilizing moxifloxacin as a positive control. There were no detectable effects of favipiravir on the QT/QTc interval.	[Kumagai, Yuji; Aso, Masako] Kitasato Univ Hosp, Clin Trial Ctr, Sagamihara, Kanagawa 2520375, Japan; [Murakawa, Yuji] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Internal Med 4, Yokohama, Kanagawa, Japan; [Hasunuma, Tomoko] Oita Univ Hosp, Clin Pharmacol Ctr, Oita, Japan; [Yuji, Wakako] Kitasato Inst Hosp, Biomed Res Ctr, Tokyo, Japan; [Sakurai, Tsutomu; Noto, Masahiko; Oe, Tetsuya] Toyama Chem Co Ltd, Clin Res Dept, Tokyo, Japan; [Kaneko, Akiko] Toyama Chem Co Ltd, Data Sci & Adm Dept, Tokyo, Japan	Kumagai, Y (reprint author), Kitasato Univ Hosp, Clin Trial Ctr, Minami Ku, 15-1 Kitazato,1 Chome, Sagamihara, Kanagawa 2520375, Japan.	kuma-guy@za2.so-net.ne.jp			Toyama Chemical Co., Ltd	Financial support was provided by Toyama Chemical Co., Ltd. Dr. Kumagai and Dr. Murakawa received honorarium from Toyama Chemical Co., Ltd. However, Dr. Kumagai, Dr. Murakawa, Dr. Hasunuma, Dr. Aso and Dr. Yuji have no employment relationship with Toyama Chemical Co., Ltd. Dr. Kumagai is an advisor for evaluation of QT/QTc, Dr. Murakawa is a medical expert of thorough QT study. Dr. Hasunuma is a principal investigator of thorough QT study, Dr. Aso and Dr. Yuji are sub-investigators of thorough QT study.	Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Morganroth J, 2004, AM J CARDIOL, V93, P1378, DOI 10.1016/j.amjcard.2004.02.034; Garnett CE, 2008, J CLIN PHARMACOL, V48, P13, DOI 10.1177/0091270007307881; Chen SG, 2012, PHARMACOTHERAPY, V32, P333, DOI 10.1002/j.1875-9114.2012.01033.x; Boni JP, 2012, CANCER CHEMOTH PHARM, V69, P1433, DOI 10.1007/s00280-012-1845-7; Linnebjerg H, 2011, INT J CLIN PHARM TH, V49, P594, DOI 10.5414/CP201462; [Anonymous], 2005, GUID IND E14 CLIN EV; Whellan DJ, 2009, CLIN PHARMACOL THER, V86, P101, DOI 10.1038/clpt.2009.70; Damle B, 2011, ANTIMICROB AGENTS CH, V55, P4302, DOI 10.1128/AAC.01723-10; Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06; Demolis JL, 2000, CLIN PHARMACOL THER, V68, P658, DOI 10.1067/mcp.2000.111482; Bloomfield DM, 2008, CLIN PHARMACOL THER, V84, P475, DOI 10.1038/clpt.2008.33; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Mansbach RS, 2011, CLIN THER, V33, P851, DOI 10.1016/j.clinthera.2011.05.092; del Corral A, 2012, CANCER CHEMOTH PHARM, V69, P1255, DOI 10.1007/s00280-012-1825-y; Dmitrienko A, 20080429 BIOPH NETW; Ebana R, 2007, JPN J CLIN PHARM THE, V38, P97; European Medicines Agency, 2005, ICH TOP E14 CLIN EV; Food and Drug Administration, 2005, INT C HARM GUID E14; Hayashi T, 2008, 9 WORLD C CLIN PHARM; Mendzelevski B, 2011, BR J CLIN PHARM, V73, P203; Ministry of Health Labor and Welfare, 2009, CLIN EV QT QTC INT P; Nakano M, 2013, JMAJ, V56, P115; Ohnishi A, 2005, JPN PHARMACOL THER, V33, P1029	24	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	OCT	2015	53	10					866	874		10.5414/CP202388		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU3PH	WOS:000363436800009		
J	Takahashi, N; Noda, S; Taniguchi, T; Adachi, M				Takahashi, Naomi; Noda, Shinji; Taniguchi, Takashi; Adachi, Makoto			Efficacy comparison of ustekinumab between anti-tumor necrosis factor-alpha drug-naiive and anti-tumor necrosis factor-alpha drug-resistant Japanese psoriasis cases	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							TO-SEVERE PSORIASIS; ARTHRITIS; TUBERCULOSIS; INHIBITORS; GUIDELINES; MANAGEMENT; SAFETY; CARE	Ustekinumab is highly efficacious for psoriasis; however, it has not been fully clarified whether previous failure in anti-tumor necrosis factor-alpha (TNF-alpha) therapy affects the treatment response with ustekinumab. Therefore, we evaluated the efficacy of ustekinumab in anti-TNF-alpha-naive and anti-TNF-alpha-resistant cases and compared the clinical efficacies of adalimumab and ustekinumab in biologic naive cases. Thirty-five patients with plaque psoriasis who showed resistance to conventional therapies were enrolled; 26 patients, who had never been treated with biologics, were allocated to ustekinumab or adalimumab; nine patients who failed to achieve psoriasis area and severity index (PASI) 50 at week 16 with one or two TNF-alpha antagonists were switched to ustekinumab. The end of the study was defined as 52 weeks after starting the first biologic for anti-TNF-alpha-naive patients and after switching to ustekinumab for anti-TNF-alpha-resistant patients. The primary outcome measurement was the percentage of patients achieving PASI75 at week 16. In patients treated with ustekinumab, 87.5% of anti-TNF-alpha-naive and 77.8% of anti-TNF-alpha-resistant cases achieved a PASI75 response at week 16, and no statistically significant difference was found between the treatment response rates (P = 0.60). When comparing the treatment efficacy of ustekinumab and adalimumab among anti-TNF-alpha-naive patients, there was also no statistically significant difference in PASI75 achievement rates (87.5 vs. 83.3%, P = 0.79). Our study suggests that ustekinumab can be considered as a first-line biologic for psoriasis and a rescue therapy for anti-TNF-alpha-resistant cases.	[Takahashi, Naomi; Noda, Shinji; Taniguchi, Takashi; Adachi, Makoto] Kanto Rosai Hosp, Dept Dermatol, Kawasaki, Kanagawa 2118510, Japan	Noda, S (reprint author), Kanto Rosai Hosp, Dept Dermatol, Nakahara Ku, 1-1 Kizukisumiyoshi Cho, Kawasaki, Kanagawa 2118510, Japan.	m31071@gmail.com					Piaserico S, 2014, J AM ACAD DERMATOL, V70, P257, DOI 10.1016/j.jaad.2013.10.019; Hernandez C, 2008, J AM ACAD DERMATOL, V59, P363, DOI 10.1016/j.jaad.2008.05.033; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Clemmensen A, 2011, J EUR ACAD DERMATOL, V25, P1037, DOI 10.1111/j.1468-3083.2010.03914.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Fagerli KM, 2013, ANN RHEUM DIS, V72, P1840, DOI 10.1136/annrheumdis-2012-203018; Menter A, 2011, J AM ACAD DERMATOL, V65, P137, DOI 10.1016/j.jaad.2010.11.055; Tsai TF, 2012, BRIT J DERMATOL, V167, P1145, DOI 10.1111/j.1365-2133.2012.11142.x; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Hernandez C, 2008, J AM ACAD DERMATOL, V59, P82	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	OCT	2015	54	10					1194	1198		10.1111/ijd.12859		5	Dermatology	Dermatology	CU3CQ	WOS:000363401700034		
J	Nakai, K; Yoneda, K; Moriue, J; Moriue, T; Koura, A; Yokoi, I; Ishikawa, E; Kubota, Y; Haba, R; Kushida, Y; Katsuki, N; Inoue, S				Nakai, Kozo; Yoneda, Kozo; Moriue, Junko; Moriue, Tetsuya; Koura, Ayako; Yokoi, Ikumi; Ishikawa, Emiko; Kubota, Yasuo; Haba, Reiji; Kushida, Yoshio; Katsuki, Naomi; Inoue, Shigeaki			beta Klotho expression is reduced in human non-melanoma skin cancer	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							GROWTH-FACTOR RECEPTORS		[Nakai, Kozo; Yoneda, Kozo; Moriue, Junko; Moriue, Tetsuya; Koura, Ayako; Yokoi, Ikumi; Ishikawa, Emiko; Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Takamatsu, Kagawa 760, Japan; [Haba, Reiji; Kushida, Yoshio; Katsuki, Naomi] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan; [Inoue, Shigeaki] Tokai Univ, Inst Innovat Sci & Technol, Hiratsuka, Kanagawa 25912, Japan	Nakai, K (reprint author), Kagawa Univ, Fac Med, Dept Dermatol, Takamatsu, Kagawa 760, Japan.	kozo@kms.ac.jp					Takenaka H, 2002, ARCH DERMATOL RES, V294, P331, DOI 10.1007/s00403-002-0333-z; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Nakai K, 2013, EXP DERMATOL, V22, P772, DOI 10.1111/exd.12258; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Kuro-o Makoto, 2011, Korean Journal of Internal Medicine, V26, P113, DOI 10.3904/kjim.2011.26.2.113; Nakai K, 2014, J DERMATOL, V41, P171, DOI 10.1111/1346-8138.12371; Ye XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055615	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	OCT	2015	54	10					E431	E433		10.1111/ijd.12924		4	Dermatology	Dermatology	CU3CQ	WOS:000363401700010		
J	Nakata, Y; Watanabe, Y; Otake, H; Nakamura, T; Oiso, G; Sawa, T				Nakata, Yoshinori; Watanabe, Yuichi; Otake, Hiroshi; Nakamura, Toshihito; Oiso, Giichiro; Sawa, Tomohiro			The Japanese Surgical Reimbursement System Fails to Reflect Resource Utilization	INTERNATIONAL JOURNAL OF HEALTH SERVICES			English	Article						efficiency; data envelopment analysis; surgical reimbursement system		The goal of this study was to examine the current Japanese surgical payment system from the viewpoint of resource utilization. We collected data from surgical records in Teikyo University's electronic medical record system from April 1 through September 30, 2013. We defined the decision-making unit as a surgeon with the highest academic rank in the surgery. Inputs were defined as: 1) the number of medical doctors who assisted surgery and 2) the time of operation from skin incision to closure. An output was defined as the surgical fee. We calculated each surgeon's efficiency score using the output-oriented Banker-Charnes-Cooper model of data envelopment analysis. We compared the efficiency scores of each surgical specialty using the Kruskal-Wallis and Steel methods. We analyzed 2,825 surgical procedures performed by 103 surgeons. The difference in efficiency scores was significant (P=0.0001). The thoracic surgeons were the most efficient and were more efficient than plastic, obstetric and gynecologic, urologic, otorhinolaryngologic, orthopedic, general, and emergency surgeons (P<0.05). We demonstrated that surgeons' efficiency in operating rooms was significantly different among surgical specialties. This suggests that the Japanese surgical reimbursement scales fails to reflect resource utilization.	[Nakata, Yoshinori; Watanabe, Yuichi] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 1738605, Japan; [Nakata, Yoshinori; Sawa, Tomohiro] Teikyo Univ, Med Informat & Syst Res Ctr, Tokyo 1738605, Japan; [Otake, Hiroshi] Showa Univ, Sch Med, Dept Anesthesia, Tokyo 142, Japan; [Nakamura, Toshihito] Chiba Univ Hosp, Dept Hlth Policy Aged Soc, Chiba, Japan; [Oiso, Giichiro] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan	Nakata, Y (reprint author), Teikyo Univ, Grad Sch Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ynakata@med.teikyo-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25670337]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant No. 25670337 to Dr Yoshinori Nakata.	American Medical Association, 2013, MED RBRVS 2013 PHYS; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Hayashida K, 2005, HEALTH POLICY, V74, P24, DOI 10.1016/j.healthpol.2004.12.005; Macario A, 2010, J CLIN ANESTH, V22, P233, DOI 10.1016/j.jclinane.2010.02.003; Cooper W., 2007, DATA ENVELOPMENT ANA; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Hollingsworth B, 2008, ROUT INT STUD HEALTH, P1, DOI 10.4324/9780203486566; Japanese Joint Committee of Social Insurance by the Multidisciplinary Group of Surgical Associations (GAIHOREN), 2012, PROP SURG PAYM SYST; Ozcan Y. A., 2008, HLTH CARE BENCHMARKI; Social Insurance Institute (Shakaihoken Kenkyuusho), 2012, INT MED REIMB SCAL A, P622; Thanassoulis E., 2008, MEASUREMENT PRODUCTI, P251	11	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7314	1541-4469		INT J HEALTH SERV	Int. J. Health Serv.	OCT	2015	45	4					801	809		10.1177/0020731415585989		9	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	CU1KD	WOS:000363279200013		
J	Kawakita, M				Kawakita, Masayuki			A connectedness theorem over the spectrum of a formal power series ring	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Connectedness lemma; formal power series ring; minimal log discrepancy	MINIMAL LOG DISCREPANCIES; ADIC SEMI-CONTINUITY; CANONICAL THRESHOLDS; CHARACTERISTIC ZERO; ALGEBRAIC VARIETY; IDEAL; DESINGULARIZATION; SINGULARITIES; RESOLUTION; TOPOLOGY	We study the connectedness of the non-klt locus over the spectrum of a formal power series ring. In dimension 3, we prove the existence and normality of the smallest lc center, and apply it to the ACC for minimal log discrepancies greater than 1 on smooth 3-folds.	Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Kawakita, M (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	masayuki@kurims.kyoto-u.ac.jp			JSPS [24684003]	I would like to thank Professors O. Fujino, Y. Gongyo, H. Kawanoue, J. Kollar, M. Mustata and N. Nakayama for discussions. The research was partially supported by JSPS Grant-in-Aid for Young Scientists (A) 24684003.	Abhyankar S., 1998, SPRINGER MONOGRAPHS; Kawakita M, 2013, MICH MATH J, V62, P443; VERMA JK, 1988, J ALGEBRA, V112, P416, DOI 10.1016/0021-8693(88)90099-3; Fujino O, 2011, PUBL RES I MATH SCI, V47, P727, DOI 10.2977/PRIMS/50; Ambro F, 1999, MATH RES LETT, V6, P573; COHEN IS, 1946, T AM MATH SOC, V59, P54; de Fernex T, 2010, DUKE MATH J, V152, P93, DOI 10.1215/00127094-2010-008; Kawakita M, 2007, INVENT MATH, V167, P129, DOI 10.1007/s00222-006-0008-z; KODAIRA K, 1953, P NATL ACAD SCI USA, V39, P1268, DOI 10.1073/pnas.39.12.1268; ALEXEEV V, 1993, DUKE MATH J, V69, P527, DOI 10.1215/S0012-7094-93-06922-0; LIPMAN J, 1978, ANN MATH, V107, P151, DOI 10.2307/1971141; RAYNAUD M, 1971, INVENT MATH, V13, P1, DOI 10.1007/BF01390094; VIEHWEG E, 1982, J REINE ANGEW MATH, V335, P1; Temkin M, 2008, ADV MATH, V219, P488, DOI 10.1016/j.aim.2008.05.006; SCHENZEL P, 1985, P AM MATH SOC, V93, P15, DOI 10.2307/2044544; de Fernex T, 2009, ANN SCI ECOLE NORM S, V42, P491; Kawakita M, 2013, MATH ANN, V356, P1359, DOI 10.1007/s00208-012-0885-y; Chatzistamatiou A, 2015, COMPOS MATH, V151, P2131, DOI 10.1112/S0010437X15007435; Fernex T. de, 2011, EMS SER C REP, P221; Grothendieck A., 1965, PUBL MATH-PARIS, V24, P231; Grothendieck A., 1966, PUBL MATH-PARIS, V28, P255; Grothendieck A., 1961, PUBL MATH-PARIS, V11, P167; Hartshorne R., 1977, GRADUATE TEXTS MATH, V52; HIRONAKA H, 1964, ANN MATH, V79, P109, DOI 10.2307/1970486; Kawakita M, 2014, J ALGEBRAIC GEOM, V23, P765; KAWAMATA Y, 1982, MATH ANN, V261, P43, DOI 10.1007/BF01456407; Kollar J., 2008, ARXIV08050756; Kollar J., 2013, CAMBRIDGE TRACTS MAT, V200; Kollar J., 1992, ASTERISQUE, V211; Liu Q., 2002, OXFORD GRADUATE TEXT, V6; McKernan J., 2013, MSRI WORKSH 6 MAY; Nakamura Y., J REINE ANG IN PRESS, DOI [10.1515/Crelle-2013-0112, DOI 10.1515/CRELLE-2013-0112]; Shokurov V., 1992, IZV MATH+, V56, P105; Shokurov V. V., 2004, P STEKLOV I MATH, V246, P315; Shokurov V. V., 1988, BIRATIONAL GEOMETRY, P30; Shokurov V.V., 1996, J MATH SCI, V81, P2667, DOI 10.1007/BF02362335; Temkin M., 2009, ARXIV09122570; Zariski O., 1951, MEMORIES AM MATH SOC, V5	38	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	OCT	2015	26	11							1550088	10.1142/S0129167X15500883		27	Mathematics	Mathematics	CU3IZ	WOS:000363419500002		
J	Sasaki, H; Maeda, T; Hara, Y; Osa, M; Imai, K; Moriguchi, K; Mikita, K; Fujikura, Y; Kaida, K; Kawana, A				Sasaki, Hiroaki; Maeda, Takuya; Hara, Yu; Osa, Morichika; Imai, Kazuo; Moriguchi, Kota; Mikita, Kei; Fujikura, Yuji; Kaida, Kenichi; Kawana, Akihiko			Human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient presenting with relapsing and remitting hyponatraemia	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						Multicentric Castleman disease; HIV; AIDS; human herpes virus-8; interleukin-6; hyponatraemia; sodium; central pontine myelinolysis; antidiuretic hormone	CENTRAL PONTINE MYELINOLYSIS; KAPOSIS-SARCOMA; INTERLEUKIN-6; AIDS	We report a case of human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient with hyponatraemia. A 65-year-old man was admitted with relapsing and remitting fever, scattered skin eruptions and hepatosplenomegaly following combination antiretroviral therapy for his HIV infection. Based on histopathological findings, he was diagnosed as having human herpes virus-8-associated multicentric Castleman's disease and was treated with four-weekly infusions of rituximab. Prior to receiving chemotherapy, we observed several suspected biomarkers of disease activity, positive correlations between plasma human herpes virus-8 viral load and the levels of plasma interleukin-6, C-reactive protein and soluble interleukin-2 receptor, and negative correlations between platelet count, albumin levels and especially serum sodium levels. We hypothesize that non-osmotic release of plasma antidiuretic hormone is a cause of hyponatraemia in human herpes virus-8-associated multicentric Castleman's disease and that relapsing and remitting hyponatraemia could be correlated with plasma human herpes virus-8 viral load.	[Sasaki, Hiroaki; Maeda, Takuya; Hara, Yu; Osa, Morichika; Imai, Kazuo; Mikita, Kei; Fujikura, Yuji; Kawana, Akihiko] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Pulm Med, Saitama 3598513, Japan; [Moriguchi, Kota; Kaida, Kenichi] Natl Def Med Coll, Dept Internal Med, Div Neurol, Saitama 3598513, Japan	Maeda, T (reprint author), Natl Def Med Coll, Dept Infect Dis & Pulm Med, Saitama 3598513, Japan.	tmaeda@ndmc.ac.jp					Katchanov J, 2013, INT J STD AIDS, V24, P583, DOI 10.1177/0956462413477557; YOSHIZAKI K, 1989, BLOOD, V74, P1360; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Apoola A, 2003, SEX TRANSM INFECT, V79, P179, DOI 10.1136/sti.79.3.179; Du MQ, 2001, BLOOD, V97, P2130, DOI 10.1182/blood.V97.7.2130; Swart RM, 2011, NEPHRON PHYSIOL, V118, P45, DOI 10.1159/000322238; Bower M, 2010, BLOOD, V116, P4415, DOI 10.1182/blood-2010-07-290213; Oksenhendler E, 2000, BLOOD, V96, P2069; Mori Y, 2000, J MED VIROL, V61, P332, DOI 10.1002/1096-9071(200007)61:3<332::AID-JMV8>3.0.CO;2-3; Stebbing J, 2011, BLOOD, V118, P271, DOI 10.1182/blood-2011-02-335620	10	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	OCT	2015	26	12					909	911		10.1177/0956462414562050		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CU0PD	WOS:000363218600011		
J	Sacco, RL; Sandercock, P; Endres, M; Feigin, V; Pandian, J; Shinohara, Y; Spence, JD				Sacco, Ralph L.; Sandercock, Peter; Endres, Matthias; Feigin, Valery; Pandian, Jeyaraj; Shinohara, Yukito; Spence, J. David			Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee	INTERNATIONAL JOURNAL OF STROKE			English	Editorial Material							SCIENCE WORKSHOP		[Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Evelyn McKnight Brain Inst, Miami, FL 33136 USA; [Sandercock, Peter] Univ Edinburgh, Western Gen Hosp, DCN, Edinburgh, Midlothian, Scotland; [Endres, Matthias] Charite, Klin & Hcsh Ambulanz Neurol, D-13353 Berlin, Germany; [Feigin, Valery] AUT Univ, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Pandian, Jeyaraj] Christian Med Coll & Hosp, Dept Neurol, Ludhiana, Punjab, India; [Shinohara, Yukito] Tachikawa Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan; [Spence, J. David] Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6A 5C1, Canada	Sacco, RL (reprint author), Univ Miami, Miller Sch Med, Dept Neurol, Evelyn McKnight Brain Inst, Miami, FL 33136 USA.						Rankin G, 2012, PHYSIOTHERAPY, V98, P260, DOI 10.1016/j.physio.2012.03.002; Hachinski V, 2010, INT J STROKE, V5, P238, DOI 10.1111/j.1747-4949.2010.00442.x; Mattle HP, 2012, CEREBROVASC DIS, V34, P95, DOI 10.1159/000341728; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Mattle HP, 2014, STROKE, V45, pE113, DOI 10.1161/STROKEAHA.114.005583; Lahiff-Jenkins C, 2014, WE INVITE YOU COMMEN; Pollock A, 2012, INT J STROKE	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	OCT	2015	10			A100	SI		4	9		10.1111/ijs.12625		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CU6QW	WOS:000363658700003		
J	Fukuhara, K; Ogata, T; Ouma, S; Tsugawa, J; Matsumoto, J; Abe, H; Higashi, T; Inoue, T; Tsuboi, Y				Fukuhara, Kousuke; Ogata, Toshiyasu; Ouma, Shinji; Tsugawa, Jun; Matsumoto, Juntaro; Abe, Hiroshi; Higashi, Toshio; Inoue, Tooru; Tsuboi, Yoshio			Impact of initial symptom for accurate diagnosis of vertebral artery dissection	INTERNATIONAL JOURNAL OF STROKE			English	Article						symptoms; unilateral headaches; vertebral artery dissection; vertigo	HEADACHE; PAIN	BackgroundIt has been recognized that spontaneous vertebral artery dissection without neurological symptoms is not rare and easily misdiagnosed. Clinical clue for diagnosis of vertebral artery dissection includes initial symptoms such as headache, neck pain, or dizziness. AimTo assess the role of initial symptoms for diagnosis of spontaneous vertebral artery dissection. MethodsBetween September 2007 and January 2014, we retrospectively reviewed clinical records of 83 patients with unilateral vertebral artery dissection without consciousness disturbance at admission. Based on the diagnostic criteria of the Spontaneous Cervicocephalic Arterial Dissections Study, the patients were divided into three groups: possible, probable, and definite cases of vertebral artery dissection. Initial symptoms were collected at the time of diagnosis from medical record for the presence or absence of headache, neck pain, tinnitus and vertigo, as well as the area of pain and its characteristics. ResultsThe numbers of definite, probable, and possible vertebral artery dissection were 39, 26, and 18, respectively. Out of 83 cases, unilateral or bilateral headache was the most commonly seen (in 60 cases), followed by neck pain (in 41 cases) and vertigo (in 20 cases). Statistically, unilateral headache and/or neck pain was more common in cases with definite vertebral artery dissection group compared with other classification of the Spontaneous Cervicocephalic Arterial Dissections Study (P=0040). Vertigo was also associated with the stratification of Spontaneous Cervicocephalic Arterial Dissections Study criteria (P=0012). ConclusionsIn our study, headache and/or neck pain, especially unilateral presentation, and vertigo were symptoms associated with the stratification of Spontaneous Cervicocephalic Arterial Dissections Study criteria. Physicians should carefully obtain clinical history for the presence of a unilateral headache and/or neck pain and vertigo when vertebral artery dissection is suspected in patients with or without objective neurological signs.	[Fukuhara, Kousuke; Ogata, Toshiyasu; Ouma, Shinji; Tsugawa, Jun; Tsuboi, Yoshio] Fukuoka Univ, Fac Med, Dept Neurol, Fukuoka 8140180, Japan; [Matsumoto, Juntaro; Abe, Hiroshi; Higashi, Toshio; Inoue, Tooru] Fukuoka Univ, Fac Med, Dept Neurosurg, Fukuoka 8140180, Japan	Tsuboi, Y (reprint author), Fukuoka Univ, Dept Neurol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	tsuboi@cis.fukuoka-u.ac.jp			Clinical Research Foundation in Japan	This study was partly supported by the Clinical Research Foundation in Japan.	Maruyama H, 2012, J HEADACHE PAIN, V13, P247, DOI 10.1007/s10194-012-0420-2; Gottesman RF, 2012, NEUROLOGIST, V18, P245, DOI 10.1097/NRL.0b013e31826754e1; SILBERT PL, 1995, NEUROLOGY, V45, P1517; Arnold M, 2006, STROKE, V37, P2499, DOI 10.1161/01.STR.0000240493.88473.39; Arnold M, 2006, J NEUROL NEUROSUR PS, V77, P1021, DOI 10.1136/jnnp.2006.094359; Matsumoto J, 2014, J STROKE CEREBROVASC, V23, P2857, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.013; Takemoto K, 2011, ACTA NEUROCHIR SUPPL, V112, P59, DOI 10.1007/978-3-7091-0661-7_11; NICHOLS FT, 1993, HEADACHE, V33, P87, DOI 10.1111/j.1526-4610.1993.hed3302087.x; Tsukahara T, 2010, ACT NEUR S, V107, P35, DOI 10.1007/978-3-211-99373-6_5; Echigo Tadashi, 2013, No Shinkei Geka, V41, P305; Saeed Abdullah Bin, 2000, Canadian Journal of Neurological Sciences, V27, P292	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	OCT	2015	10			A100	SI		30	33		10.1111/ijs.12546		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CU6QW	WOS:000363658700007		
J	Matsumoto, K; Ehara, S; Hasegawa, T; Sakaguchi, M; Otsuka, K; Yoshikawa, J; Shimada, K				Matsumoto, Kenji; Ehara, Shoichi; Hasegawa, Takao; Sakaguchi, Mikumo; Otsuka, Kenichiro; Yoshikawa, Junichi; Shimada, Kenei			Localization of Coronary High-Intensity Signals on T1-Weighted MR Imaging Relation to Plaque Morphology and Clinical Severity of Angina Pectoris	JACC-CARDIOVASCULAR IMAGING			English	Article						angina pectoris; atherosclerosis; intraplaque hemorrhage; magnetic resonance imaging; optical coherence tomography; thrombosis	OPTICAL COHERENCE TOMOGRAPHY; MAGNETIC-RESONANCE; INTRAPLAQUE HEMORRHAGE; ATHEROSCLEROTIC PLAQUES; INTRACORONARY THROMBUS; HYPERINTENSE PLAQUE; ARTERY-DISEASE; PROGRESSION; PATHOGENESIS; MECHANISMS	OBJECTIVES This study sought to investigate the relationship between Localization of high-intensity signals (HISs) on T1-weighted imaging (T1WI) with the noncontrast magnetic resonance technique and plaque morphology detected on optical coherence tomography, and the clinical severity of angina pectoris. BACKGROUND Since the introduction of the T1WI noncontrast magnetic resonance technique for plaque imaging, some groups have reported that HISs in the coronary artery on T1WI are associated with a vulnerable morphology and future cardiac events. However, the association between the localization of HISs, such as coronary intrawall or intraluminal, and plaque morphology has not been investigated. METHODS One hundred Lesions with either stable or unstable angina were included and divided into 3 groups according to the following criteria using T1WI. First, the plaques with the ratio between the signal intensities of coronary plaque and cardiac muscle <= 1.0 were classified as non-HISs (n = 39). Then, HISs with the ratio between the signal intensities of coronary plaque and cardiac muscle >1.0 were classified into 2 types by using cross-sectional T1WI. Those Localized within the coronary wall when the Lumen was identified were defined as intrawall HISs (n = 37), whereas those occupying the lumen when the Lumen was not, or even if only partly, identified, were defined as intraluminal HISs (n = 24). RESULTS Multivariate analysis revealed that intrawall HISs were associated with macrophage accumulation and the absence of calcification assessed by using optical coherence tomography. In contrast, thrombus and intimal vasculature were independent factors associated with intraluminal HISS. Furthermore, 50% of patients with intraluminal HISs experienced rest angina, such as Braunwald class II or III. CONCLUSIONS This study shows that intrawall and intraluminal HISs on T1WI in patients with angina are related to the different types of vulnerable plaque morphology and the clinical severity. (C) 2015 by the American College of Cardiology Foundation.	[Matsumoto, Kenji; Ehara, Shoichi; Hasegawa, Takao; Sakaguchi, Mikumo; Otsuka, Kenichiro; Shimada, Kenei] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 5458585, Japan; [Yoshikawa, Junichi] Nishinomiya Watanabe Cardiovasc Ctr, Nishinomiya, Hyogo, Japan	Ehara, S (reprint author), Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	ehara@med.osaka-cu.ac.jp			JSPS KAKENHI [23591057]	This work was supported by JSPS KAKENHI (23591057). All authors have reported that they have no relationships relevant to the contents of this paper to disclose.	Sun J, 2012, JACC-CARDIOVASC IMAG, V5, P798, DOI 10.1016/j.jcmg.2012.03.014; Ehara S, 2012, EUR HEART J-CARD IMG, V13, P394, DOI 10.1093/ehjci/jer305; Kawasaki T, 2009, JACC-CARDIOVASC IMAG, V2, P720, DOI 10.1016/j.jcmg.2009.01.016; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Takaya N, 2005, CIRCULATION, V111, P2768, DOI 10.1161/CIRCULATIONAHA.104.504167; Jansen CHP, 2011, CIRCULATION, V124, P416, DOI 10.1161/CIRCULATIONAHA.110.965442; [Anonymous], 2000, THROMB VASC BIOL; Rupprecht HJ, 1995, EUR HEART J, V16, P1526; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; FUSTER V, 1992, NEW ENGL J MED, V326, P242; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Habs M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-76; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44	18	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	OCT	2015	8	10					1143	1152		10.1016/j.jcmg.2015.06.013		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CT8VX	WOS:000363096100005		
J	Choi, G; Lee, JM; Kim, HJ; Park, JB; Sankaran, S; Otake, H; Doh, JH; Nam, CW; Shin, ES; Taylor, CA; Koo, BK				Choi, Gilwoo; Lee, Joo Myung; Kim, Hyun-Jin; Park, Jun-Bean; Sankaran, Sethuraman; Otake, Hiromasa; Doh, Joon-Hyung; Nam, Chang-Wook; Shin, Eun-Seok; Taylor, Charles A.; Koo, Bon-Kwon			Coronary Artery Axial Plaque Stress and its Relationship With Lesion Geometry Application of Computational Fluid Dynamics to Coronary CT Angiography	JACC-CARDIOVASCULAR IMAGING			English	Article						axial plaque stress; computational fluid dynamics; coronary artery disease; coronary computed tomography angiography; coronary plaque; pressure; walt shear stress	3-DIMENSIONAL INTRAVASCULAR ULTRASOUND; CARDIAC COMPUTED-TOMOGRAPHY; WALL SHEAR-STRESS; LOCALIZED ELEVATION; FLOW; MORPHOLOGY; RUPTURE; DISEASE; ATHEROSCLEROSIS	OBJECTIVES The purpose of this study was to characterize the hemodynamic force acting on plaque and to investigate its relationship with Lesion geometry. BACKGROUND Coronary plaque rupture occurs when plaque stress exceeds plaque strength. METHODS Computational fluid dynamics was applied to 114 Lesions (81 patients) from coronary computed tomography angiography. The axial plaque stress (APS) was computed by extracting the axial component of hemodynamic stress acting on stenotic lesions, and the axial Lesion asymmetry was assessed by the Luminal radius change over length (radius gradient ERG]). Lesions were divided into upstream-dominant (upstream RG > downstream RG) and downstream-dominant lesions (upstream RG < downstream RG) according to the RG. RESULTS Thirty-three Lesions (28.9%) showed net retrograde axial plaque force. Upstream APS Linearly increased as lesion severity increased, whereas downstream APS exhibited a concave function for lesion severity. There was a negative correlation (r = -0.274, p = 0.003) between APS and lesion Length. The pressure gradient, computed tomography-derived fractional flow reserve (FFRCT), and wall shear stress were consistently higher in upstream segments, regardless of the lesion asymmetry. However, APS was higher in the upstream segment of upstream-dominant lesions (11,371.96 +/- 5,575.14 dyne/cm(2) vs. 6,878.14 +/- 4,319.51 dyne/cm(2), p < 0.001), and in the downstream segment of downstream-dominant lesions (7,681.12 +/- 4,556.99 dyne/cm(2) vs. 11,990.55 +/- 5,556.64 dyne/cm(2), p < 0.001). Although there were no differences in FFRCT, % diameter stenosis, and wall shear stress pattern, the distribution of APS was different between upstream- and downstream-dominant Lesions. CONCLUSIONS APS uniquely characterizes the stenotic segment and has a strong relationship with Lesion geometry. Clinical application of these hemodynamic and geometric indices may be helpful to assess the future risk of plaque rupture and to determine treatment strategy for patients with coronary artery disease. (Evaluation of FFR, WSS, and TPF Using CCTA; NCT01857687) (C) 2015 by the American College of Cardiology Foundation.	[Choi, Gilwoo; Kim, Hyun-Jin; Sankaran, Sethuraman; Taylor, Charles A.] HeartFlow, Redwood City, CA USA; [Choi, Gilwoo] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA; [Lee, Joo Myung; Park, Jun-Bean; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Med, Seoul 110744, South Korea; [Otake, Hiromasa] Kobe Univ, Grad Sch Med, Dept Med, Kobe, Hyogo 657, Japan; [Doh, Joon-Hyung] Inje Univ, Dept Med, Ilsan Paik Hosp, Goyang, South Korea; [Nam, Chang-Wook] Keimyung Univ, Dept Med, Dongsan Med Ctr, Daegu, South Korea; [Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea; [Taylor, Charles A.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea	Koo, BK (reprint author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehang Ro, Seoul 110744, South Korea.	bkkoo@snu.ac.kr			HeartFlow; St. Jude Medical	This study was funded by HeartFlow. Drs. Choi, Kim, Sankaran, and Taylor are employees and shareholders of HeartFlow, which provided the FFR<INF>CT</INF> service. Dr. Koo has received an institutional research grant from St. Jude Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The first 2 authors contributed equally to this work.	[Anonymous], 2008, EUR HEART J, V29, P38; Li ZY, 2008, J AM COLL CARDIOL, V52, P1106, DOI 10.1016/j.jacc.2008.08.004; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tanaka A, 2008, CIRCULATION, V118, P2368, DOI 10.1161/CIRCULATIONAHA.108.782540; Otsuka F, 2014, NAT REV CARDIOL, V11, P379, DOI 10.1038/nrcardio.2014.62; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; De Bruyne B, 2014, NEW ENGL J MED, V371, P1465; Doriot PA, 2003, PHYS MED BIOL, V48, P127, DOI 10.1088/0031-9155/48/1/309; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005	15	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	OCT	2015	8	10					1156	1166		10.1016/j.jcmg.2015.04.024		11	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CT8VX	WOS:000363096100007		
J	Kubo, T; Shimamura, K; Ino, Y; Yamaguchi, T; Matsuo, Y; Shiono, Y; Taruya, A; Nishiguchi, T; Shimokado, A; Teraguchi, I; Orii, M; Yamano, T; Tanimoto, T; Kitabata, H; Hirata, K; Tanaka, A; Akasaka, T				Kubo, Takashi; Shimamura, Kunihiro; Ino, Yasushi; Yamaguchi, Tomoyuki; Matsuo, Yoshiki; Shiono, Yasutsugu; Taruya, Akira; Nishiguchi, Tsuyoshi; Shimokado, Aiko; Teraguchi, Ikuko; Orii, Makoto; Yamano, Takashi; Tanimoto, Takashi; Kitabata, Hironori; Hirata, Kumiko; Tanaka, Atsushi; Akasaka, Takashi			Superficial Calcium Fracture After PCI as Assessed by OCT	JACC-CARDIOVASCULAR IMAGING			English	Letter							CALCIFICATION; LESIONS		[Kubo, Takashi; Shimamura, Kunihiro; Ino, Yasushi; Yamaguchi, Tomoyuki; Matsuo, Yoshiki; Shiono, Yasutsugu; Taruya, Akira; Nishiguchi, Tsuyoshi; Shimokado, Aiko; Teraguchi, Ikuko; Orii, Makoto; Yamano, Takashi; Tanimoto, Takashi; Kitabata, Hironori; Hirata, Kumiko; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418509, Japan	Kubo, T (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	takakubo@wakayama-med.ac.jp					Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108; MINTZ GS, 1995, CIRCULATION, V91, P1959; Vaquerizo B, 2010, J INTERV CARDIOL, V23, P240, DOI 10.1111/j.1540-8183.2010.00547.x; Madhavan MV, 2014, J AM COLL CARDIOL, V63, P1703, DOI 10.1016/j.jacc.2014.01.017	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	OCT	2015	8	10					1228	1229		10.1016/j.jcmg.2014.11.012		2	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CT8VX	WOS:000363096100016		
J	Barbanti, M; Gulino, S; Capranzano, P; Imme, S; Sgroi, C; Tamburino, C; Ohno, Y; Attizzani, GF; Patane, M; Sicuso, R; Pilato, G; Di Landro, A; Todaro, D; Di Simone, E; Picci, A; Giannetto, G; Costa, G; Deste, W; Giannazzo, D; Grasso, C; Capodanno, D; Tamburino, C				Barbanti, Marco; Gulino, Simona; Capranzano, Piera; Imme, Sebastiano; Sgroi, Carmelo; Tamburino, Claudia; Ohno, Yohei; Attizzani, Guilherme F.; Patane, Martina; Sicuso, Rita; Pilato, Gerlando; Di Landro, Alessio; Todaro, Denise; Di Simone, Emanuela; Picci, Andrea; Giannetto, Giuliana; Costa, Giuliano; Deste, Wanda; Giannazzo, Daniela; Grasso, Carmelo; Capodanno, Davide; Tamburino, Corrado			Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)	JACC-CARDIOVASCULAR INTERVENTIONS			English	Article						AKI; RenalGuard; TAVR	CONTRAST-INDUCED NEPHROPATHY; ACADEMIC RESEARCH CONSORTIUM; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-OUTCOMES; SALINE HYDRATION; METAANALYSIS; FAILURE; RISK; INSUFFICIENCY; DEFINITIONS	OBJECTIVES The purpose of this study was to investigate the effect of the RenalGuard System (PLC Medical Systems, Milford, Massachusetts) on prevention of acute kidney injury (AKI) in patients undergoing transcatheter aortic valve replacement (TAVR). BACKGROUND TAVR is associated with varying degrees of post-procedural AKI. The RenalGuard System is a dedicated device designed for contrast-induced AKI prevention. Whether this device is also effective in patients with severe aortic stenosis undergoing TAVR is unexplored. METHODS The present is an investigator-driven, single-center, prospective, open-label, registry-based randomized study that used the TAVR institutional registry of the Ferrarotto Hospital in Catania, Italy, as the platform for randomization, data collection, and follow-up assessment. A total of 112 consecutive patients undergoing TAVR were randomly assigned to hydration with normal saline solution controlled by the RenalGuard system and furosemide (RenalGuard group) or normal saline solution (control group). The primary endpoint was the incidence of Valve Academic Research Consortium-defined AKI in the first 72 h after the procedure. RESULTS The AKI rate was lower in the RenalGuard group than in the control group (n = 3 [5.4%] vs. n = 14 [25.0%], respectively, p = 0.014). The majority of patients (5.4% vs. 23.2%) developed a mild AKI (stage 1); severe damage (stage 3) occurred only in 1 patient in the control group (0.0% vs. 1.8%). No case of in-hospital renal failure requiring dialysis was reported. No significant differences in terms of mortality, cerebrovascular events, bleeding, and hospitalization for heart failure were noted in both groups at 30 days. CONCLUSIONS Furosemide-induced diuresis with matched isotonic intravenous hydration using the RenalGuard system is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVR. (C) 2015 by the American College of Cardiology Foundation.	[Barbanti, Marco; Gulino, Simona; Capranzano, Piera; Imme, Sebastiano; Sgroi, Carmelo; Tamburino, Claudia; Ohno, Yohei; Attizzani, Guilherme F.; Patane, Martina; Sicuso, Rita; Pilato, Gerlando; Di Landro, Alessio; Todaro, Denise; Di Simone, Emanuela; Picci, Andrea; Giannetto, Giuliana; Costa, Giuliano; Deste, Wanda; Giannazzo, Daniela; Grasso, Carmelo; Capodanno, Davide; Tamburino, Corrado] Univ Catania, Div Cardiol, Ferrarotto Hosp, Catania, Italy; [Ohno, Yohei] Tokai Univ, Sch Med, Dept Cardiol, Isehara, Kanagawa 25911, Japan; [Attizzani, Guilherme F.] Univ Hosp Cleveland, Valve & Struct Heart Dis Intervent Ctr, Harrington Heart & Vasc Inst, Case Med Ctr, Cleveland, OH 44106 USA; [Tamburino, Corrado] ETNA Fdn, Catania, Italy	Barbanti, M (reprint author), Univ Catania, Div Cardiol, Ferrarotto Hosp, Catania, Italy.	mbarbanti83@gmail.com					Barbash IM, 2012, AM HEART J, V163, P1031, DOI 10.1016/j.ahj.2012.01.009; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Bagur R, 2010, EUR HEART J, V31, P865, DOI 10.1093/eurheartj/ehp552; Briguori C, 2011, CIRCULATION, V124, P1260, DOI 10.1161/CIRCULATIONAHA.111.030759; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Nuis RJ, 2012, CIRC-CARDIOVASC INTE, V5, P680, DOI 10.1161/CIRCINTERVENTIONS.112.971291; Genereux P, 2013, AM J CARDIOL, V111, P100, DOI [10.1016/j.amjcard.2012.08.057, 10.1016/j.amjcard.2012.08:057]; Marenzi G, 2012, JACC-CARDIOVASC INTE, V5, P90, DOI 10.1016/j.jcin.2011.08.017; Gargiulo G, 2015, CATHETER CARDIO INTE, V86, P518, DOI 10.1002/ccd.25867; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Zagler A, 2006, AM HEART J, V151, P140, DOI 10.1016/j.ahj.2005.01.055; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Khawaja MZ, 2012, EUROINTERVENTION, V8, P563, DOI 10.4244/EIJV8I5A87; WEINSTEIN JM, 1992, NEPHRON, V62, P413; DIKSHIT K, 1973, NEW ENGL J MED, V288, P1087, DOI 10.1056/NEJM197305242882102; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Barbanti M, 2014, EUROINTERVENTION, V10, P133, DOI 10.4244/EIJV10I1A20; Nuis RJM, 2011, CATHETER CARDIO INTE, V77, P881, DOI 10.1002/ccd.22874; Dussol B, 2006, NEPHROL DIAL TRANSPL, V21, P2120, DOI 10.1093/ndt/gfl133; Resnic FS, 2009, J AM COLL CARDIOL, V53, pA36; Stevens Melissa A., 1999, Journal of the American College of Cardiology, V33, P403, DOI 10.1016/S0735-1097(98)00574-9	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	OCT	2015	8	12					1595	1604		10.1016/j.jcin.2015.07.012		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU1GN	WOS:000363268600016		
J	Yamamoto, M; Kawarada, O; Sakamoto, S; Harada, K; Noguchi, T; Yasuda, S; Ogawa, H				Yamamoto, Masahiro; Kawarada, Osami; Sakamoto, Shingo; Harada, Koichiro; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao			Hybrid Therapy Consisting of Balloon Maceration and Subsequent Fogarty Thrombectomy for Subacute Lower Limb Ischemia	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						endovascular therapy; peripheral artery disease; subacute ischemia; surgery; thrombus			[Yamamoto, Masahiro; Kawarada, Osami; Sakamoto, Shingo; Harada, Koichiro; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan	Kawarada, O (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kawarada.osami.hp@ncvc.go.jp					Dosluoglu HH, 2008, SEMIN VASC SURG, V21, P167, DOI 10.1053/j.semvascsurg.2008.11.002	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	OCT	2015	8	12					1633	1634		10.1016/j.jcin.2015.05.025		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU1GN	WOS:000363268600022		
J	Maekawa, Y; Akita, K; Tsuruta, H; Yashima, F; Kimura, M; Yamada, Y; Kawakami, T; Kanazawa, H; Hayashida, K; Yuasa, S; Murata, M; Jinzaki, M; Fukuda, K				Maekawa, Yuichiro; Akita, Keitaro; Tsuruta, Hikaru; Yashima, Fumiaki; Kimura, Mai; Yamada, Yoshitake; Kawakami, Takashi; Kanazawa, Hideaki; Hayashida, Kentaro; Yuasa, Shinsuke; Murata, Mitsushige; Jinzaki, Masahiro; Fukuda, Keiichi			"Protruding Myocardium" as a Target for Percutaneous Transluminal Septal Myocardial Ablation in a Case of Hypertrophic Obstructive Cardiomyopathy	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						heart failure; hypertrophic obstructive cardiomyopathy; percutaneous transluminal septal myocardial ablation			[Maekawa, Yuichiro; Akita, Keitaro; Tsuruta, Hikaru; Yashima, Fumiaki; Kimura, Mai; Kawakami, Takashi; Kanazawa, Hideaki; Hayashida, Kentaro; Yuasa, Shinsuke; Murata, Mitsushige; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Sch Med, Tokyo 1608582, Japan; [Yamada, Yoshitake; Jinzaki, Masahiro] Keio Univ, Dept Diagnost Radiol, Sch Med, Tokyo 1608582, Japan	Maekawa, Y (reprint author), Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ymaekawa@a5.keio.jp					Maekawa Y, 2014, INT J CARDIOL, V176, pE131, DOI 10.1016/j.ijcard.2014.07.211	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	OCT	2015	8	12					E201	E202		10.1016/j.jcin.2015.05.029		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU1GN	WOS:000363268600004		
J	Yoshida, K; Hayashida, N; Fukushima, Y; Ohtsuru, A; Ohba, T; Hasegawa, A; Sato, H; Shishido, F; Yasui, K; Kumagai, A; Yusa, T; Kudo, T; Yamashita, S; Takamura, N				Yoshida, Koji; Hayashida, Naomi; Fukushima, Yoshiko; Ohtsuru, Akira; Ohba, Takashi; Hasegawa, Arifumi; Sato, Hisashi; Shishido, Fumio; Yasui, Kiyotaka; Kumagai, Atsushi; Yusa, Takeshi; Kudo, Takashi; Yamashita, Shunichi; Takamura, Noboru			Changes in radiological imaging frequencies in children before and after the accident at the Fukushima Daiichi Nuclear Power Plant in Fukushima Prefecture, Japan	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Radiological examination; Radiation exposure; Fukushima Daiichi Nuclear Power Plant accident; Fukushima Prefecture; Children	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CANCER INCIDENCE; SUBSEQUENT RISK; PEDIATRIC CT; COHORT; CHILDHOOD; SCANS	The accident at the Fukushima Daiichi Nuclear Power Plant has raised concerns about radiation exposure, including medical radiation exposure such as X-ray and CT, in residents of Fukushima. We compared the numbers and the ratio of outpatients less than 10 years old who underwent imaging examinations [e.g., CT, X-ray, MRI, ultrasonography (US), etc.] at Fukushima Medical University hospital in Fukushima, Japan before (April 1, 2008-March 31, 2011) and after (April 1, 2011-March 31, 2014) the accident. The number of outpatients less than 10 years old decreased after the accident. The number of outpatients less than 10 years old who underwent CT and X-ray examinations also significantly decreased after the accident (p < 0.001, p < 0.01, respectively). Our results suggest that the number of pediatric radiological examinations decreased after the accident in Fukushima. We should continue to communicate with patients and their families to ensure that they understand the risks and benefits of radiological imaging in order to overcome their concerns about the nuclear disaster.	[Yoshida, Koji] Nagasaki Univ, Dept Global Hlth Med & Welf, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Hayashida, Naomi] Nagasaki Univ, Atom Bomb Dis Inst, Div Promot Collaborat Res Radiat & Environm Hlth, Nagasaki 852, Japan; [Fukushima, Yoshiko] Natl Inst Radiol Sci, Chiba 260, Japan; [Ohtsuru, Akira; Ohba, Takashi] Fukushima Med Univ, Dept Radiat Hlth Management, Sch Med, Fukushima, Japan; [Hasegawa, Arifumi] Fukushima Med Univ, Dept Radiat Disaster Med, Sch Med, Fukushima, Japan; [Sato, Hisashi] Fukushima Med Univ, Dept Radiat Oncol, Sch Med, Fukushima, Japan; [Shishido, Fumio] Fukushima Med Univ, Dept Radiol, Sch Med, Fukushima, Japan; [Yoshida, Koji; Yasui, Kiyotaka; Kumagai, Atsushi] Fukushima Med Univ, Educ Ctr Disaster Med, Fukushima, Japan; [Yusa, Takeshi] Fukushima Med Univ Hosp, Dept Radiol Technol, Fukushima, Japan; [Kudo, Takashi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radioisotope Med, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 852, Japan; [Takamura, Noboru] Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Nagasaki 852, Japan	Takamura, N (reprint author), Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp					Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Hammer GP, 2009, RADIAT RES, V171, P504, DOI 10.1667/RR1575.1; Townsend BA, 2010, AM J ROENTGENOL, V194, P1194, DOI 10.2214/AJR.09.3682; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Berrington de Gonzales A, 2004, LANCET, V363, P345, DOI DOI 10.1016/S0140-6736; Berrington de Gonzalez A, 2007, ARCH INTERN MED, V169, P2071; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289; Fukushima Prefecture, REP AG 5 YEARS OLD R; Journy N, 2014, RADIAT ENVIRON BIOPH, V53, P39, DOI 10.1007/s00411-013-0491-8; Krille L, 2015, RADIAT ENVIRON BIOPH, V54, P1, DOI 10.1007/s00411-014-0580-3; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miyazaki O., 2015, PEDIATR RADIOL, P1; Nuclear Emergency Response Headquarters of Japanese Government, ADD REP JAP GOV IAEA; Nuclear Emergency Response Headquarters of Japanese Government, JAP GOV IAEA MIN C N; Pearce MS, 2012, RADIOL RES PRACT; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2013 REP, VI	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					619	626		10.1007/s11604-015-0464-8		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400002		
J	Nakamura, Y; Kimura, T; Higaki, T; Honda, Y; Komoto, D; Yamagami, T; Iida, M; Nagata, Y; Honda, Y; Aikata, H; Chayama, K; Awai, K				Nakamura, Yuko; Kimura, Tomoki; Higaki, Toru; Honda, Yukiko; Komoto, Daisuke; Yamagami, Takuji; Iida, Makoto; Nagata, Yasushi; Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki; Awai, Kazuo			Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Stereotactic body radiotherapy; Gadoxetate disodium; Magnetic resonance imaging	FOCAL LIVER REACTION; GD-EOB-DTPA; RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR RESPONSE; PHASE-III; IMAGES; CT; CIRRHOSIS; IRRADIATION	To investigate the utility of gadoxetate disodium-enhanced hepatic MRI (EOB-MRI) for stereotactic body radiotherapy (SBRT) to treat hepatocellular carcinoma (HCC). We divided 30 HCC patients who underwent SBRT into group A (no change in their Child-Pugh score 6 months post-SBRT) and group B (increased score 6 months post-SBRT). EOB-MRI was performed before and 6 months after SBRT. We calculated the liver-spleen contrast (LSC) ratio for each radiation dose area on hepatobiliary phase scans (LSCbefore using images obtained before SBRT and LSCafter using images acquired after SBRT) and the weighted LSC (W-LSC) as: [(mean LSCbefore (0-30 Gy) x liver volume (0-30 Gy) + mean LSCbefore (30 Gy-) x liver volume (30 Gy-))/total liver volume]. Then we compared the W-LSC, percentage of the liver volume exposed to > 20 Gy (V20), and mean liver dose in the two groups. The LSCafter at 48, 40, and 30 Gy to the liver was statistically lower than the unirradiated area of the liver (p < 0.01). Univariate analysis showed that only W-LSC was significantly associated with group B (p = 0.02). W-LSC was a useful parameter for predicting changes in hepatic function after SBRT.	[Nakamura, Yuko; Higaki, Toru; Honda, Yukiko; Komoto, Daisuke; Iida, Makoto; Awai, Kazuo] Hiroshima Univ, Diagnost Radiol, Minami Ku, Hiroshima 7348551, Japan; [Kimura, Tomoki; Nagata, Yasushi] Hiroshima Univ, Radiat Oncol, Hiroshima, Japan; [Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Hiroshima, Japan; [Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Liver Res Project Ctr, Hiroshima, Japan	Nakamura, Y (reprint author), Hiroshima Univ, Diagnost Radiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yukon@hiroshima-u.ac.jp; tkkimura@hiroshima-u.ac.jp; higaki@hiroshima-u.ac.jp; honday@hiroshima-u.ac.jp; komoto@hiroshima-u.ac.jp; yamagami@kouchi-u.ac.jp; edamako@hiroshima-u.ac.jp; nagat@hiroshima-u.ac.jp; hyohji@hiroshima-u.ac.jp; aikata@hiroshima-u.ac.jp; chayama@hiroshima-u.ac.jp; awai@hiroshima-u.ac.jp			Toshiba Medical Systems Co., Ltd	Kazuo Awai received a research grant from Toshiba Medical Systems Co., Ltd. The other authors declare that they have no conflict of interest.	Takeda A, 2008, HEPATOL RES, V38, P60, DOI 10.1111/j.1872-034X.2007.00084.x; Lau H, 1997, BRIT J SURG, V84, P1255; Shinagawa Y, 2012, AM J ROENTGENOL, V199, P1010, DOI 10.2214/AJR.11.8204; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Kimura T, 2013, HEPATOL RES, V43, P717, DOI 10.1111/hepr.12007; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334; Sanuki N, 2013, AM J ROENTGENOL, V201, pW812, DOI 10.2214/AJR.12.10169; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Takeda A, 2012, RADIOTHER ONCOL, V104, P374, DOI 10.1016/j.radonc.2011.12.008; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Morita K, 2011, MAGN RESON MED, V66, P213, DOI 10.1002/mrm.22770; Okamoto D, 2014, MAGN RESON IMAGING, V32, P660, DOI 10.1016/j.mri.2014.02.019; Takeda A, 2014, J GASTROEN HEPATOL, V29, P372, DOI 10.1111/jgh.12350; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; MATSUMATA T, 1987, WORLD J SURG, V11, P678; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Ryder S. D., 2003, Gut, V52, P1; Sanuki N, 2014, INT J RADIAT ONCOL, V88, P306, DOI 10.1016/j.ijrobp.2013.10.045; Sanuki-Fujimoto N, 2010, BRIT J RADIOL, V83, P1063, DOI 10.1259/bjr/74105551	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					627	635		10.1007/s11604-015-0465-7		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400003		
J	Itoh, T; Saito, M; Marugami, N; Hirai, T; Marugami, A; Takahama, J; Tanaka, T; Kichikawa, K				Itoh, Takahiro; Saito, Miho; Marugami, Nagaaki; Hirai, Toshiko; Marugami, Aki; Takahama, Junko; Tanaka, Toshihiro; Kichikawa, Kimihiko			Correlation between the ABC classification and radiological findings for assessing gastric cancer risk	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Helicobacter pylori; ABC classification; Gastric cancer; Radiological finding	HELICOBACTER-PYLORI INFECTION; CHRONIC ACTIVE GASTRITIS; PEPSINOGEN; ANTIBODY	To investigate the correlation between ABC risk assessment and radiological findings of gastric mucosa and to propose an improved method for gastric cancer screening. We evaluated 318 participants with Helicobacter pylori (Hp) antibody titers, serum pepsinogen (PG) and upper GI radiography and then classified them into three groups: A, double-negative; B, Hp-positive, PG-negative; C, PG-positive. Group A was subclassified as: A-1, Hp antibody titer < 3.0 U/ml; A-2, Hp antibody titer a parts per thousand yen3.0 U/ml. Results for group A and non-A (B or C) participants and radiological findings of gastric mucosa (fold and area gastricae) were analyzed retrospectively. Radiological findings differed significantly between the 207 A-1 and 98 non-A group. Odds ratios were 17.72 for fold distribution, 10.63 for fold thickness, 6.10 for fold characteristics, and 10.62 for area gastricae. Presence of a parts per thousand yen2 risk factors offered 90.3 % sensitivity, 94.7 % specificity, and 93.3 % accuracy. Nine (69.2 %) of the 13 A-2 group participants and 11 (5.3 %) A-1 group participants had a risk for gastric cancer according to radiological findings. A good correlation exists between ABC classifications and radiological findings for gastric cancer risk, but some discrepant cases exist. We recommend both methods as screening for gastric cancer.	[Itoh, Takahiro; Marugami, Aki; Takahama, Junko; Tanaka, Toshihiro; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348521, Japan; [Saito, Miho; Marugami, Nagaaki; Hirai, Toshiko] Nara Med Univ, Dept Endoscopy & Ultrasound, Kashihara, Nara 6348521, Japan	Itoh, T (reprint author), Nara Med Univ, Dept Radiol, 840 Shijocho, Kashihara, Nara 6348521, Japan.	titoh@naramed-u.ac.jp					Wang CC, 2007, AM J GASTROENTEROL, V102, P1789, DOI 10.1111/j.1572-0241.2007.01335.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; SOHN J, 1995, RADIOLOGY, V195, P763; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; FUKAO A, 1995, INT J CANCER, V60, P45, DOI 10.1002/ijc.2910600106; CROCKER JD, 1995, INVEST RADIOL, V30, P480, DOI 10.1097/00004424-199508000-00005; Dheer S, 2002, BRIT J RADIOL, V75, P805; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; Kudo T, 2011, WORLD J GASTROENTERO, V17, P4793, DOI 10.3748/wjg.v17.i43.4793; Goto H, 2012, J GASTROINTEST CANC, V50, P429; Itoh T, 2011, J GASTROINTEST CANC, V49, P493; Miyamoto A, 2009, J GASTROENTEROLOGICA, V47, P55; Mochizuki N, 2014, J GASTROINTEST CANC, V52, P545; Nakajima S, 2006, STOMACH INTESTINE, V41, P1001; Nakajima S, 2013, CLIN GASTROENTEROL, V28, P1137; Okuda J, 2002, HLTH EVALUATION PROM, V29, P894; Saito Y, 2014, J GASTROINTEST CANC, V52, P46; Yamamichi N, 2014, PLOS ONE, V9, DOI [10.1371/journal(Pone.0111359.eCollection2014), DOI 10.1371/JOURNAL(PONE.0111359.ECOLLECTION2014)]; Yasuda M, 2010, J GASTROINTEST CANC, V48, P344; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					636	644		10.1007/s11604-015-0469-3		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400004		
J	Kiguchi, T; Higuchi, T; Takahashi, N; Shimokoshi, T; Yamazaki, M; Yoshimura, N; Aoyama, H				Kiguchi, Takao; Higuchi, Takeshi; Takahashi, Naoya; Shimokoshi, Toshikazu; Yamazaki, Motohiko; Yoshimura, Norihiko; Aoyama, Hidefumi			CT measurement of splenic volume changes as a result of hypovolemic shock	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Spleen; Hypovolemic shock; Multidetector computed tomography; Emergencies	SPLEEN; STIMULATION; RESPONSES	To evaluate the changes in splenic volume during hypovolemic shock and after recovery by use of multidetector computed tomography (MDCT). We investigated 22 cases who underwent MDCT during hypovolemic shock up to 3 h after presentation, compared the splenic volume with that after recovery, and evaluated the volume difference. We compared the volume ratio (recovery/shock) for two age groups: under 60 years (n = 10) and 60 years and over (n = 12). For cases (n = 10) undergoing CT examination twice after treatment, we compared the volume ratios by using the initial recovery CT and the second CT images. The average spleen volume in shock was 63 cm(3); under normal conditions it was 132 cm(3) (P < 0.001). The average volume ratio for groups under 60 years old was 2.34; for groups 60 years and over it was 2.05 (P = 0.051). The average volume ratio obtained by use of the initial post-recovery CT was 2.11; the ratio obtained by use of the second post-recovery CT was 2.16 (P = 0.386). Our results revealed that splenic volume was reduced during hypovolemic shock and rapidly increased after recovery. Splenic contraction is an important CT finding in shock.	[Kiguchi, Takao; Higuchi, Takeshi; Shimokoshi, Toshikazu] Niigata City Gen Hosp, Dept Diagnost Radiol, Chuo Ku, Niigata 9501197, Japan; [Takahashi, Naoya] Niigata Univ, Dept Radiol Technol, Grad Sch Hlth Sci, Niigata, Japan; [Yamazaki, Motohiko; Yoshimura, Norihiko; Aoyama, Hidefumi] Niigata Univ, Dept Radiol, Grad Sch Med & Dent Sci, Niigata, Japan	Kiguchi, T (reprint author), Niigata City Gen Hosp, Dept Diagnost Radiol, Chuo Ku, 463-7 Shumoku, Niigata 9501197, Japan.	takakig+jo@gmail.com					Silagy C, 1998, LANCET, V352, P710, DOI 10.1016/S0140-6736(05)60828-8; GUNTHEROTH WG, 1963, AM J PHYSIOL, V204, P35; AYERS AB, 1972, BRIT J PHARMACOL, V44, P17; KNECHT H, 1988, EUR J HAEMATOL, V41, P382; Kanki A, 2011, AM J ROENTGENOL, V197, pW980, DOI 10.2214/AJR.10.5736; FISHER BM, 1990, CLIN SCI, V78, P469; Tarrant AM, 2008, BRIT J RADIOL, V81, P252, DOI 10.1259/bjr/40962054; HAFFNER HT, 1994, FORENSIC SCI INT, V66, P95, DOI 10.1016/0379-0738(94)90333-6; Kaufman MJ, 1998, J APPL PHYSIOL, V85, P1877; Borley NR, 2008, GRAYS ANATOMY, P1191; Corradi F, 2012, SHOCK, V38, P46; de Moya MA, 2013, SHOCK MERCK MANUALS; Goodman R, 1990, RADIOLOGY, V176, P629; Stewart IB, 2002, THESIS U BRIT COLUMB	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					645	649		10.1007/s11604-015-0470-x		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400005		
J	Hirata, K; Utsunomiya, D; Oda, S; Kidoh, M; Funama, Y; Yuki, H; Yoshida, M; Yamashita, Y				Hirata, Kenichiro; Utsunomiya, Daisuke; Oda, Seitaro; Kidoh, Masafumi; Funama, Yoshinori; Yuki, Hideaki; Yoshida, Morikatsu; Yamashita, Yasuyuki			Added value of a single-energy projection-based metal-artifact reduction algorithm for the computed tomography evaluation of oral cavity cancers	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Head/neck; CT; Adults; Technology assessment	SQUAMOUS-CELL CARCINOMA; DENTAL ARTIFACTS; F-18-FDG PET/CT; IMAGE QUALITY; CT; ANGIOGRAPHY; IMPACT; MRI	The purpose of our study was to investigate the added value of the single-energy projection-based metallic artifact reduction (SEMAR) technique on the visualization and diagnostic confidence of oral cavity cancers. Contrast-enhanced CT was performed on 40 patients with dental metalwork. Of these, 18 patients had pathologically confirmed oral cavity cancer, and the other 22 patients had no lesions. CT attenuation and noise in the oral cavity were compared between the conventional and SEMAR images. Two radiologists visually graded the diagnostic confidence on a 5-point scale from 1 (definitely absent) to 5 (definitely present). The value of the SEMAR was assessed in a receiver-operating characteristic curve analysis. The artifact of the SEMAR images was significantly lower than that of the conventional images (38.4 +/- A 18.0 HU vs. 187.7 +/- A 162.7 HU; P < 0.01). Reviewers 1 and 2 detected 10 and 7 more lesions with the SEMAR, respectively. Areas under the curve for the conventional and SEMAR reconstruction were 0.761 and 0.942, respectively, for reviewer 1 and 0.701 and 0.864, respectively, for reviewer 2. The SEMAR significantly improved the oral cavity cancer visualization and diagnostic confidence.	[Hirata, Kenichiro; Utsunomiya, Daisuke; Oda, Seitaro; Kidoh, Masafumi; Yuki, Hideaki; Yoshida, Morikatsu; Yamashita, Yasuyuki] Kumamoto Univ, Diagnost Radiol, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Funama, Yoshinori] Kumamoto Univ, Med Phys, Fac Life Sci, Chuo Ku, Kumamoto 8620976, Japan	Utsunomiya, D (reprint author), Kumamoto Univ, Diagnost Radiol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	utsunomi@kumamoto-u.ac.jp					Baek CH, 2008, J NUCL MED, V49, P1422, DOI 10.2967/jnumed.108.051649; Pessis E, 2013, RADIOGRAPHICS, V33, P573, DOI 10.1148/rg.332125124; Kidoh M, 2014, CLIN RADIOL, V69, pE11, DOI 10.1016/j.crad.2013.08.008; Moon SG, 2008, J COMPUT ASSIST TOMO, V32, P630, DOI 10.1097/RCT.0b013e3181568b27; Leslie A, 1999, J COMPUT ASSIST TOMO, V23, P43, DOI 10.1097/00004728-199901000-00010; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015; Chung NN, 2004, HEAD NECK-J SCI SPEC, V26, P241, DOI 10.1002/hed.10378; Arya S, 2014, CLIN RADIOL, V69, P916, DOI 10.1016/j.crad.2014.04.013; Li H, 2012, MED PHYS, V39, P7507, DOI 10.1118/1.4762814; Yu LF, 2011, MED PHYS, V38, P6371, DOI 10.1118/1.3658568; Shinohara Y, 2014, ACTA RADIOL, V55, P1015, DOI 10.1177/0284185113510492; Joemai RMS, 2013, AM J ROENTGENOL, V201, P1291, DOI 10.2214/AJR.12.9780; Morsbach F, 2013, EUR RADIOL, V23, P2687, DOI 10.1007/s00330-013-2885-z; Lell MM, 2012, INVEST RADIOL, V47, P415, DOI 10.1097/RLI.0b013e3182532f17; Teixeira PAG, 2014, SKELETAL RADIOL, V43, P1237, DOI 10.1007/s00256-014-1923-5; Dong J, 2013, OR SURG OR MED OR PA, V115, pE63, DOI 10.1016/j.oooo.2012.07.436; Funama Y, 2015, PHYS MEDICA, V31, P66, DOI 10.1016/j.ejmp.2014.10.003; Hong HR, 2014, J SURG ONCOL, V110, P696, DOI 10.1002/jso.23691; Pickering CR, 2013, AM J NEURORADIOL, V34, P1818, DOI 10.3174/ajnr.A3635; Winklhofer S, 2014, Clin Radiol, V69, pe199, DOI 10.1016/j.crad.2013.12.011	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					650	656		10.1007/s11604-015-0471-9		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400006		
J	Miyazawa, R; Morita, Y; Okajima, Y; Matsusako, M; Kurihara, Y				Miyazawa, Ryo; Morita, Yuka; Okajima, Yuka; Matsusako, Masaki; Kurihara, Yasuyuki			Marathon-induced pulmonary edema of a patient with transient dyspnea	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Pulmonary edema; Marathon-induced pulmonary edema; Exercise-induced pulmonary edema; Endurance sports; Chest CT	EXERCISE	We report a case of a 31-year-old healthy man with marathon-induced pulmonary edema. Chest radiograph revealed pulmonary edema without cardiomegaly. Contrast-enhanced chest computed tomography (CT) revealed transient pulmonary edema without filling-defect in pulmonary arteries. As marathon running increases in popularity, radiologists and emergency physicians should be familiar with diagnosis of this entity on chest radiograph, avoiding unnecessary CT examination without additional clinical information.	[Miyazawa, Ryo; Morita, Yuka; Okajima, Yuka; Matsusako, Masaki; Kurihara, Yasuyuki] St Lukes Int Hosp, Dept Radiol, Chuo Ku, Tokyo 1048560, Japan	Miyazawa, R (reprint author), St Lukes Int Hosp, Dept Radiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	miyaryo@luke.ac.jp					Zavorsky GS, 2014, RESP PHYSIOL NEUROBI, V190, P137, DOI 10.1016/j.resp.2013.10.007; IRVING MH, 1974, NATURE, V248, P531, DOI 10.1038/248531a0; YOUNG M, 1987, AM REV RESPIR DIS, V136, P737; MCKECHNIE JK, 1979, S AFR MED J, V56, P261; OHHASHI T, 1978, PFLUG ARCH EUR J PHY, V375, P183, DOI 10.1007/BF00584242; Bates ML, 2011, PULM MED, DOI [10.1155/2011/361931., DOI 10.1155/2011/361931]; Cadez-Schmidt A, 2014, IDEA FIT J, V11, P16; Claire MH, 2013, CIRCULATION, V128, pe469; Ma JLG, 2013, EMERG MED AUSTRALAS, V25, P368, DOI 10.1111/1742-6723.12101; Shirakawa T, 2013, ANN REP HLTH PHYS ED, V32, P127; Zavorsky GS, 2014, PHYSL REP, DOI 10.14814/phy2.12056.	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					675	677		10.1007/s11604-015-0474-6		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400011		
J	Asai, T				Asai, Takashi			Are video laryngoscopes useful for paramedics during cardiopulmonary resuscitation?	JOURNAL OF ANESTHESIA			English	Editorial Material							HOSPITAL CARDIAC-ARREST; CERVICAL-SPINE IMMOBILIZATION; MACINTOSH LARYNGOSCOPE; DIFFICULT-AIRWAYS; NASOTRACHEAL INTUBATION; TRACHEAL INTUBATION; ENDOTRACHEAL-TUBES; VIDEOLARYNGOSCOPES; SCOPE; METAANALYSIS		Dokkyo Med Univ, Koshigaya Hosp, Dept Anaesthesiol, Koshigaya, Saitama 3438555, Japan	Asai, T (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Anaesthesiol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	asaita@dokkyomed.ac.jp					Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Arima T, 2014, AM J EMERG MED, V32, P40, DOI 10.1016/j.ajem.2013.09.026; Enomoto Y, 2008, BRIT J ANAESTH, V100, P544, DOI 10.1093/bja/aen002; Konrad C, 1998, ANESTH ANALG, V86, P635; Liu EHC, 2009, BRIT J ANAESTH, V103, P446, DOI 10.1093/bja/aep164; Saito T, 2012, J ANESTH, V26, P617, DOI 10.1007/s00540-012-1380-z; Gupta N, 2013, J ANESTH, V27, P663, DOI 10.1007/s00540-013-1588-6; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Asai T, 2009, ANESTHESIOLOGY, V110, P898, DOI 10.1097/ALN.0b013e31819c45e5; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Asai T, 2012, ANESTHESIOLOGY, V116, P515, DOI 10.1097/ALN.0b013e318246e866; Aziz MF, 2012, ANESTHESIOLOGY, V116, P629, DOI 10.1097/ALN.0b013e318246ea34; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Asai T, 2014, J ANESTH, V28, P87, DOI 10.1007/s00540-013-1672-y; Fouche PF, 2014, PREHOSP EMERG CARE, V18, P244, DOI 10.3109/10903127.2013.831509; Shiga T, 2005, ANESTHESIOLOGY, V103, P429, DOI 10.1097/00000542-200508000-00027; Asai T, 2014, J ANESTH, V28, P647, DOI 10.1007/s00540-014-1808-8; Okazaki Yumiko, 2011, Masui, V60, P757; Ono K, 2014, J ANESTH, V28, P650, DOI 10.1007/s00540-013-1778-2; Ota K, 2014, J ANESTH, DOI [10.1007/s00540-014-1960-1, DOI 10.1007/S00540-014-1960-1]; Satoh Masaaki, 2008, Masui, V57, P1283	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					651	653		10.1007/s00540-015-1978-z		3	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600001		
J	Miyazaki, Y; Komasawa, N; Matsunami, S; Kusaka, Y; Minami, T				Miyazaki, Yu; Komasawa, Nobuyasu; Matsunami, Sayuri; Kusaka, Yusuke; Minami, Toshiaki			Laryngoscopy facilitates successful i-gel insertion by novice doctors: a prospective randomized controlled trial	JOURNAL OF ANESTHESIA			English	Article						i-gel (R); Laryngoscopy; Novice doctors; Insertion efficacy; Randomized controlled trial	LARYNGEAL MASK AIRWAY; SUPRAGLOTTIC AIRWAY; CARDIOPULMONARY-RESUSCITATION; PEDIATRIC-PATIENTS; ENDOTRACHEAL-TUBE; EFFICACY; PLACEMENT; PRESSURE; DEVICES	This study investigated the hypothesis that the efficacy of insertion of the supraglottic device i-gel(A (R)) (i-gel) can be improved by laryngoscopy and can provide better sealing pressure in anesthetized patients by novice doctors. Eighty-four adult patients were assigned to the laryngoscopy group (L group, 42 patients) or control group (i.e., conventional blind insertion; C group, 42 patients). Anesthesia was induced with propofol and remifentanil, and rocuronium 0.6-0.9 mg/kg was administered. The number of attempts until successful insertion, sealing pressure, vital sign changes upon insertion, and subjective difficulty of insertion by novice doctors were compared between the groups. The total number of insertion attempts was one (L group 36 cases, C group 23 cases), two (L group 6 cases, C group 18 cases), and three (L group 0 case, C group 1 case), with significant differences between groups (P = 0.007). The sealing pressure was significantly higher in the L group than in the C group (L group 22.3 +/- A 2.6 cmH(2)O, C group 19.5 +/- A 2.7 cmH(2)O, P < 0.001). Vital sign changes (heart rate and blood pressure) did not differ between the two groups. The subjective difficulty of insertion was significantly lower in the L group than in the C group (L group 26.8 +/- A 11.8 mm, C group 47.0 +/- A 15.1 mm, P < 0.001). The incidence of postoperative pharyngeal pain was significantly lower in the L group than in the C group (P < 0.001), while the incidence of hoarseness did not differ between the two groups (P = 1.00). Our results suggest that laryngoscopy facilitates i-gel insertion by novice doctors, as reflected in the rate of successful insertions, higher sealing pressure, and lower subjective difficulty of insertion in anesthetized patients.	[Miyazaki, Yu; Komasawa, Nobuyasu; Matsunami, Sayuri; Kusaka, Yusuke; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Hashimoto Y, 2014, ANAESTHESIA, V69, P878, DOI 10.1111/anae.12731; Haske D, 2013, RESUSCITATION, V84, P1229, DOI 10.1016/j.resuscitation.2013.04.025; Yih PSW, 1999, CAN J ANAESTH, V46, P617; Kim HC, 2014, ANAESTHESIA, V69, P729, DOI 10.1111/anae.12680; Elwood T, 1996, CAN J ANAESTH, V43, P435; Kohama H, 2011, J ANESTH, V25, P98, DOI 10.1007/s00540-010-1054-7; Ismail SA, 2011, EUR J ANAESTH, V28, P443, DOI 10.1097/EJA.0b013e328345a413; Komasawa N, 2011, J ANESTH, V25, P535, DOI 10.1007/s00540-011-1145-0; REINHART DJ, 1994, ANN EMERG MED, V24, P260, DOI 10.1016/S0196-0644(94)70139-3; Abukawa Y, 2012, J ANESTH, V26, P357, DOI 10.1007/s00540-011-1322-1; Gabbott DA, 2007, RESUSCITATION, V73, P161, DOI 10.1016/j.resuscitation.2006.10.026; Asai T, 2009, ANESTHESIOLOGY, V110, P898, DOI 10.1097/ALN.0b013e31819c45e5; Asai T, 2002, RESUSCITATION, V55, P171, DOI 10.1016/S0300-9572(02)00170-3; Fujiwara A, 2015, J ANESTH, V29, P580, DOI 10.1007/s00540-015-1982-3; Wharton NM, 2008, ANAESTHESIA, V63, P991, DOI 10.1111/j.1365-2044.2008.05542.x; Janakiraman C, 2009, ANAESTHESIA, V64, P674, DOI 10.1111/j.1365-2044.2009.05898.x; Sanuki T, 2011, EUR J ANAESTH, V28, P597, DOI 10.1097/EJA.0b013e32834698f4; Apfelbaum Jeffrey L, 2013, Anesthesiology, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Asai T, 2002, ANAESTHESIA, V57, P918, DOI 10.1046/j.1365-2044.2002.02783.x; de Montblanc J, 2014, ANAESTHESIA, V69, P1151, DOI 10.1111/anae.12772; Japanese Society of Anesthesiologists, 2014, J ANESTH, V28, P482; Komasawa N, 2014, J ANESTH, V28, P676, DOI 10.1007/s00540-014-1802-1; Komasawa N, 2014, J CLIN ANESTH, V26, P663, DOI 10.1016/j.jclinane.2014.08.009; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Russo SG, 2012, BRIT J ANAESTH, V109, P996, DOI 10.1093/bja/aes314; Theiler L, 2012, BRIT J ANAESTH, V109, P990, DOI 10.1093/bja/aes309	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					654	659		10.1007/s00540-015-2016-x		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600002		
J	Ota, K; Sadamori, T; Kusunoki, S; Otani, T; Tamura, T; Une, K; Kida, Y; Itai, J; Iwasaki, Y; Hirohashi, N; Nakao, M; Tanigawa, K				Ota, Kohei; Sadamori, Takuma; Kusunoki, Shinji; Otani, Tadatsugu; Tamura, Tomoko; Une, Kazunobu; Kida, Yoshiko; Itai, Junji; Iwasaki, Yasumasa; Hirohashi, Nobuyuki; Nakao, Masakazu; Tanigawa, Koichi			Influence of clinical experience of the Macintosh laryngoscope on performance with the Pentax-AWS Airway Scope(A (R)), a rigid video-laryngoscope, by paramedics in Japan	JOURNAL OF ANESTHESIA			English	Article						Rigid video-laryngoscope; Endotracheal intubation; Paramedic	INTUBATION SUCCESS RATES; TRACHEAL INTUBATION; SCOPE; MANNEQUIN; AIRTRAQ(R); PERSONNEL	We sought to establish the clinical utility of the Pentax-AWS Airway Scope(A (R)) (AWS) when used by paramedics to intubate the trachea, and to evaluate whether their performance was influenced by previous clinical experience with the Macintosh laryngoscope (ML). Twenty paramedics attempted tracheal intubation using the AWS in five patients each in the operating room. We recorded the success rate, the number of intubation attempts, and the time for intubation and adverse events, and compared these based on the paramedics' previous clinical experience with the ML. Ten paramedics had no prior clinical experience of the ML (group A) and 10 had used it on more than 30 occasions (group B). The intubation success rate was 99 % (99/100). Notably, 96 % (47/49) of intubations were achieved on the first attempt by the inexperienced paramedics in group A, compared with 64 % (32/50) by the experienced paramedics in group B (p = 0.0001). The time to intubation (mean +/- A SD) was significantly shorter in group A than in group B (37 +/- A 24 vs. 48 +/- A 21 s, p = 0.002). There were marked variations in the times taken to intubate, but no apparent improvement as the intubators gained experience between their first and fifth cases. No complications were encountered in either group. We found that paramedics could achieve a high tracheal intubation success rate using the AWS independent of previous airway management experience. Better intubation performance with the AWS was observed in paramedics without clinical experience with the ML.	[Ota, Kohei; Sadamori, Takuma; Otani, Tadatsugu; Tamura, Tomoko; Une, Kazunobu; Kida, Yoshiko; Itai, Junji; Iwasaki, Yasumasa; Hirohashi, Nobuyuki; Tanigawa, Koichi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Emergency & Crit Care Med, Minami Ku, Hiroshima 7348551, Japan; [Kusunoki, Shinji] Hiroshima Prefectural Hosp, Ctr Emergency Med, Hiroshima, Japan; [Nakao, Masakazu] Hiroshima Gen Hosp, Dept Anesthesiol, Hiroshima, Japan	Ota, K (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Emergency & Crit Care Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kota@hiroshima-u.ac.jp			Science and Technology Promotion Grant of the Fire and Disaster Management Agency, Japan	The authors give special thanks to Drs. Masashi Kawamoto and Hideki Fukuda at Hiroshima University Hospital, Keiichi Tada at Hiroshima City Hospital, Miwako Nakao at Hiroshima Prefectural Hospital, and Masaki Senami at Onomichi General Hospital for their assistance with data collection. This study was supported by a Science and Technology Promotion Grant 2010 of the Fire and Disaster Management Agency, Japan. A portion of our findings was presented in the report of the Emergency Medical Activities Development promoting panel (Kyukyugyoumu Koudoka Suishin Kentoukai) meeting in 2011 [21].	Enomoto Y, 2008, BRIT J ANAESTH, V100, P544, DOI 10.1093/bja/aen002; Sadamori T, 2008, RESUSCITATION, V77, P155, DOI 10.1016/j.resuscitation.2007.11.014; Sakles JC, 2008, INTERN EMERG MED, V3, P139, DOI 10.1007/s11739-008-0101-y; Sadamori Takuma, 2008, Hiroshima Journal of Medical Sciences, V57, P99; Liu LJ, 2010, ANESTH ANALG, V110, P1049, DOI 10.1213/ANE.0b013e3181d2aad7; Hirabayashi Y, 2009, J CLIN ANESTH, V21, P268, DOI 10.1016/j.jclinane.2008.08.024; Hirabayashi Y, 2008, J ANESTH, V22, P81, DOI 10.1007/s00540-007-0580-4; Suzuki A, 2008, ANAESTHESIA, V63, P641, DOI 10.1111/j.1365-2044.2008.05452.x; Koyama JI, 2006, J NEUROSURG ANESTH, V18, P247, DOI 10.1097/00008506-200610000-00005; STEWART RD, 1984, ANN EMERG MED, V13, P1032, DOI 10.1016/S0196-0644(84)80064-5; Maharaj CH, 2006, ANAESTHESIA, V61, P671, DOI 10.1111/j.1365-2044.2006.04653.x; Miki T, 2007, ACTA ANAESTH SCAND, V51, P1378, DOI 10.1111/j.1399-6576.2007.01450.x; Garza AG, 2003, J EMERG MED, V25, P251, DOI 10.1016/S0736-4679(03)00198-7; Maharaj CH, 2006, ANAESTHESIA, V61, P469, DOI 10.1111/j.1365-2044.2006.04547.x; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Nasim Sajid, 2009, BMC Emerg Med, V9, P9, DOI 10.1186/1471-227X-9-9; Okazaki Yumiko, 2011, Masui, V60, P757; The Fire and Disaster Management Agency and the Ministry of Health, 2011, STRENGTH MED CONTR S; The Ministry of Health, PRECL CLIN TRAIN PAR	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					672	677		10.1007/s00540-014-1960-1		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600005		
J	Ono, Y; Kikuchi, H; Hashimoto, K; Sasaki, T; Ishii, J; Tase, C; Shinohara, K				Ono, Yuko; Kikuchi, Hiroaki; Hashimoto, Katsuhiko; Sasaki, Tetsu; Ishii, Jyunya; Tase, Choichiro; Shinohara, Kazuaki			Emergency endotracheal intubation-related adverse events in bronchial asthma exacerbation: can anesthesiologists attenuate the risk?	JOURNAL OF ANESTHESIA			English	Article						Airway management; Status asthmaticus; Mechanical ventilation; Fatal asthma	INTENSIVE-CARE-UNIT; CEREBRAL-BLOOD-FLOW; TRACHEAL INTUBATION; AIRWAY MANAGEMENT; RESPIRATORY RESISTANCE; MECHANICAL VENTILATION; PROPOFOL; MEDICINE; KETAMINE; COMPLICATIONS	Airway management in severe bronchial asthma exacerbation (BAE) carries very high risk and should be performed by experienced providers. However, no objective data are available on the association between the laryngoscopist's specialty and endotracheal intubation (ETI)-related adverse events in patients with severe bronchial asthma. In this paper, we compare emergency ETI-related adverse events in patients with severe BAE between anesthesiologists and other specialists. This historical cohort study was conducted at a Japanese teaching hospital. We analyzed all BAE patients who underwent ETI in our emergency department from January 2002 to January 2014. Primary exposure was the specialty of the first laryngoscopist (anesthesiologist vs. other specialist). The primary outcome measure was the occurrence of an ETI-related adverse event, including severe bronchospasm after laryngoscopy, hypoxemia, regurgitation, unrecognized esophageal intubation, and ventricular tachycardia. Of 39 patients, 21 (53.8 %) were intubated by an anesthesiologist and 18 (46.2 %) by other specialists. Crude analysis revealed that ETI performed by an anesthesiologist was significantly associated with attenuated risk of ETI-related adverse events [odds ratio (OR) 0.090, 95 % confidence interval (CI) 0.020-0.41, p = 0.001]. The benefit of attenuated risk remained significant after adjusting for potential confounders, including Glasgow Coma Score, age, and use of a neuromuscular blocking agent (OR 0.058, 95 % CI 0.010-0.35, p = 0.0020). Anesthesiologist as first exposure was independently associated with attenuated risk of ETI-related adverse events in patients with severe BAE. The skill and knowledge of anesthesiologists should be applied to high-risk airway management whenever possible.	[Ono, Yuko; Kikuchi, Hiroaki; Hashimoto, Katsuhiko; Sasaki, Tetsu; Ishii, Jyunya; Shinohara, Kazuaki] Ohta Gen Hosp Fdn, Ohta Nishinouchi Hosp, Dept Anesthesiol, Koriyama, Fukushima 9638558, Japan; [Ono, Yuko; Tase, Choichiro] Fukushima Med Univ Hosp, Emergency & Crit Care Med Ctr, Fukushima, Japan	Ono, Y (reprint author), Ohta Gen Hosp Fdn, Ohta Nishinouchi Hosp, Dept Anesthesiol, 2-5-20 Nishinouchi, Koriyama, Fukushima 9638558, Japan.	windmill@fmu.ac.jp					CONTI G, 1993, INTENS CARE MED, V19, P305, DOI 10.1007/BF01690555; Brown RH, 1999, ANESTHESIOLOGY, V90, P822, DOI 10.1097/00000542-199903000-00025; Hasegawa K, 2012, RESUSCITATION, V83, P428, DOI 10.1016/j.resuscitation.2011.11.027; Langeron O, 2000, ANESTHESIOLOGY, V92, P1229, DOI 10.1097/00000542-200005000-00009; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Combes X, 2007, BRIT J ANAESTH, V99, P276, DOI 10.1093/bja/aem147; [Anonymous], 2001, CHEST; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Tayal VS, 1999, ACAD EMERG MED, V6, P31, DOI 10.1111/j.1553-2712.1999.tb00091.x; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; ZIMMERMAN JL, 1993, CRIT CARE MED, V21, P1727, DOI 10.1097/00003246-199311000-00023; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024; Eames WO, 1996, ANESTHESIOLOGY, V84, P1307, DOI 10.1097/00000542-199606000-00005; Oshima T, 2002, ACTA ANAESTH SCAND, V46, P831, DOI 10.1034/j.1399-6576.2002.460713.x; Phipps P, 2003, THORAX, V58, P81, DOI 10.1136/thorax.58.1.81; Petrillo TM, 2001, J ASTHMA, V38, P657; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; O'Malley RN, 2001, ANN EMERG MED, V38, P441, DOI 10.1067/mem.2001.118018; Pendergraft TB, 2004, ANN ALLERG ASTHMA IM, V93, P29; Papiris S, 2002, CRIT CARE, V6, P30; LHOMMEDIEU CS, 1987, ANN EMERG MED, V16, P568, DOI 10.1016/S0196-0644(87)80688-1; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Yanagawa Y, 2005, AM J EMERG MED, V23, P182, DOI 10.1016/j.ajem.2004.10.009; Wu RSC, 1996, BRIT J ANAESTH, V77, P735; HEMMINGSEN C, 1994, AM J EMERG MED, V12, P417, DOI 10.1016/0735-6757(94)90051-5; Hasegawa Kohei, 2013, Int J Emerg Med, V6, P12, DOI 10.1186/1865-1380-6-12; Moorman JE, 2012, VITAL HLTH STAT, V3, P1; Vandesteene A, 1988, Anaesthesia, V43 Suppl, P42, DOI 10.1111/j.1365-2044.1988.tb09067.x	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					678	685		10.1007/s00540-015-2003-2		8	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600006		
J	Sugimoto, E; Kuroda, T; Fujita, Y; Namba, Y; Mitani, S				Sugimoto, Etsuko; Kuroda, Takayuki; Fujita, Yoshihisa; Namba, Yoshifumi; Mitani, Shigeru			D-dimer testing cannot rule out thromboembolism after major lower extremity arthroplasties and thromboprophylaxis treatment	JOURNAL OF ANESTHESIA			English	Article						D-dimer; Pulmonary embolism; Total hip arthroplasty; Total knee arthroplasty; Multidetector computed tomography	COMPUTED-TOMOGRAPHY	Our previous study showed, for the first time, that a guideline-recommended thromboprophylactic strategy reduced the prevalence of venous thromboembolism (VTE) including venous thromboembolism and pulmonary embolism after arthroplasties of the major lower extremities, such as total hip arthroplasty (THA) or total or partial knee arthroplasty (TPKA), to 4.4 %. In this retrospective study, we examined the diagnostic value of D-dimer for VTE and try to confirm the low prevalence of VTE after THA or TPKA. This was a retrospective study including 380 procedures of 361 patients who underwent elective 129 TPKA or 251 THA, as well as multidetector computed tomography (MDCT) on postoperative day 7 with D-timer testing to screen for VTE. In 303 of 380 procedures, D-timer testing was performed on the same day as MDCT. The antithrombotic prophylaxes included medical and mechanical therapy and early ambulation. The prevalence of VTE was 4.5 % (17 cases) (95 % confidence interval 2.4-6.6 %). The D-dimer level was significantly greater in patients with VTE than in those without (13.4 +/- A 11.1 vs 10.1 +/- A 6.5 mu g/mL). At the lowest cut-off value of 4.0 mu g/mL, D-dimer testing ruled out VTE in only 26 of 303 cases with 1 (6 %) false negative result. The low incidence of postoperative VTE with the strict anticoagulation strategy was confirmed in this validation study. D-dimer testing is not useful for excluding VTE postoperatively in patients who undergo THA or TPKA.	[Sugimoto, Etsuko; Fujita, Yoshihisa] Kawasaki Med Univ, Dept Anestheisol, Kurashiki, Okayama 7010192, Japan; [Sugimoto, Etsuko; Fujita, Yoshihisa] Kawasaki Med Univ, Dept ICM, Kurashiki, Okayama 7010192, Japan; [Kuroda, Takayuki; Namba, Yoshifumi; Mitani, Shigeru] Kawasaki Med Univ, Dept Orthoped, Kurashiki, Okayama 7010192, Japan	Fujita, Y (reprint author), Kawasaki Med Univ, Dept Anestheisol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fujitay@med.kawasaki-m.ac.jp					Watanabe H, 2011, J ARTHROPLASTY, V26, P1488, DOI 10.1016/j.arth.2011.01.001; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Bytniewski P, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0089-0; Fujita Y, 2014, EUR J ANAESTH, V31, P93; Fujita Y, 2014, J ANESTH IN PRESS; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Shiota Naofumi, 2002, J Orthop Sci, V7, P444, DOI 10.1007/s007760200077	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					686	689		10.1007/s00540-015-2020-1		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600007		
J	Miyaji, T; Fukakura, Y; Usuda, Y; Maruyama, K; Hirabayashi, G; Yamada, R; Akihisa, Y; Nishioka, H; Andoh, T				Miyaji, Tetsuya; Fukakura, Yoshimasa; Usuda, Yutaka; Maruyama, Koichi; Hirabayashi, Go; Yamada, Rieko; Akihisa, Yuki; Nishioka, Hiroko; Andoh, Tomio			Effects of gas composition on the delivered tidal volume of the Avance Carestation	JOURNAL OF ANESTHESIA			English	Article						Anesthesia machine; Flowmeter; Gas density; Ventilation		Measurements with various flowmeters are affected by changes in gas mixture density. The Avance Carestation incorporates ventilator feedback controlled by a built-in flowmeter with a variable orifice sensor. We hypothesised that changes in the composition of delivered gas may cause changes in the delivered tidal volume by affecting the flow measurement unless appropriate corrections are made. We used 100 % O-2, 40 % O-2 in N-2 and 40 % O-2 in N2O as carrier gases with/without sevoflurane and desflurane. We measured delivered tidal volume using the FlowAnalyzer (TM) PF 300 calibrated with the corresponding gas mixtures during volume control ventilation with 500-ml tidal volume using the Avance Carestation connected to a test lung. Change of carrier gas and addition of sevoflurane and desflurane significantly altered delivered tidal volume. Desflurane 6 % reduced delivered tidal volume by 7.6, 3.6 and 16 % of the pre-set volume at 100 % O-2, 40 % O-2 in N-2 and 40 % O-2 in N2O, respectively. Importantly, the Carestation panel indicator did not register these changes in measured expired tidal volume. Ratios of delivered tidal volume to 500 ml correlated inversely with the square root of the delivered gas density. These results support our hypothesis and suggest that changing gas composition may alter delivered tidal volume of anesthesia machines with built-in ventilators that are feedback-controlled by uncorrected flowmeters due to changes in gas mixture density.	[Miyaji, Tetsuya; Fukakura, Yoshimasa] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Div Med Engn, Kawasaki, Kanagawa 2138507, Japan; [Usuda, Yutaka] Saitama Int Med Ctr, Saitama Med Sch, Dept Anesthesiol, Saitama, Japan; [Maruyama, Koichi; Hirabayashi, Go; Yamada, Rieko; Akihisa, Yuki; Nishioka, Hiroko; Andoh, Tomio] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Anesthesiol,Takatsu Ku, Kawasaki, Kanagawa 2138507, Japan	Andoh, T (reprint author), Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Anesthesiol,Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan.	psdelico06@yahoo.co.jp					ELLIOTT SE, 1977, J APPL PHYSIOL, V42, P456; OSBORN JJ, 1978, CRIT CARE MED, V6, P349, DOI 10.1097/00003246-197809000-00013; Habre W, 2001, BRIT J ANAESTH, V87, P602, DOI 10.1093/bja/87.4.602; Goto T, 1999, ANESTHESIOLOGY, V90, P555, DOI 10.1097/00000542-199902000-00032; Hess DR, 2006, RESPIR CARE, V51, P608; [Anonymous], 2011, RIKA NENPYO CHRONOLO, P388; [Anonymous], 2006, MERCK INDEX ENCY CHE, P6655; Cotes JE, 2006, LUNG FUNCTION PHYSL, P61; Schena E, 2015, MED ENG PHYS, V37, P257, DOI 10.1016/j.medengphy.2015.01.010	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					690	695		10.1007/s00540-015-2018-8		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600008		
J	Soga, T; Kume, K; Kakuta, N; Hamaguchi, E; Tsutsumi, R; Kawanishi, R; Fukuta, K; Tanaka, K; Tsutsumi, YM				Soga, Tomohiro; Kume, Katsuyoshi; Kakuta, Nami; Hamaguchi, Eisuke; Tsutsumi, Rie; Kawanishi, Ryosuke; Fukuta, Kohei; Tanaka, Katsuya; Tsutsumi, Yasuo M.			Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study	JOURNAL OF ANESTHESIA			English	Article						Fosaprepitant; Gynecologic abdominal surgery; Ondansetron; Patient-controlled epidural analgesia; Postoperative nausea and vomiting	RECEPTOR ANTAGONIST; APREPITANT; EFFICACY; EMESIS; SAFETY; TRIAL	Postoperative nausea and vomiting (PONV) is the most common postoperative complication. The postoperative use of opioids is known to increase the incidence. We compared fosaprepitant, a neurokinin-1 (NK1) receptor antagonist, and ondansetron for their preventive effects on PONV in patients who underwent gynecologic abdominal surgery with patient-controlled epidural analgesia. This prospective, double-blind, randomized study comprised 44 patients who underwent gynecologic abdominal surgery. They were randomly allocated to receive 150 mg intravenous fosaprepitant (n = 24; NKI group) or 4 mg ondansetron (n = 20; ONS group) before anesthesia, which was maintained with volatile anesthetics, remifentanil, fentanyl, and rocuronium. All patients received postoperative fentanyl by patient-controlled epidural anesthesia. The incidence of nausea and vomiting, complete response rate (i.e., no vomiting and no rescue antiemetic use), rescue antiemetic use, nausea score (0-3), and visual analog scale score (VAS 0-10) for pain were recorded at 2, 24, 48, and 72 h after surgery. No (0 %) patient in the NKI group experienced vomiting after surgery; however, 4-6 (20-30 %) of 20 patients in the ONS group experienced vomiting. This difference was significant at 0-24, 0-48, and 0-72 h. During the study period, no significant differences existed between the NK1 and ONS groups in the incidence of PONV, complete response rate, rescue antiemetic use, nausea score, and VAS score for pain. Compared to ondansetron, fosaprepitant more effectively decreased the incidence of vomiting in patients who underwent gynecologic abdominal surgery with patient-controlled epidural analgesia.	[Soga, Tomohiro; Kume, Katsuyoshi; Kakuta, Nami; Hamaguchi, Eisuke; Kawanishi, Ryosuke; Fukuta, Kohei; Tanaka, Katsuya; Tsutsumi, Yasuo M.] Univ Tokushima, Grad Sch, Dept Anesthesiol, Tokushima 7708503, Japan; [Tsutsumi, Rie] Univ Tokushima, Grad Sch, Dept Nutr, Tokushima 7708503, Japan	Tsutsumi, YM (reprint author), Univ Tokushima, Grad Sch, Dept Anesthesiol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tsutsumi@tokushima-u.ac.jp			JSPS KAKENHI from Japan Society for the Promotion of Science, Tokyo [25861378]	Supported by JSPS KAKENHI Number 25861378 from Japan Society for the Promotion of Science, Tokyo.	Jung WS, 2013, J ANESTH, V27, P396, DOI 10.1007/s00540-012-1529-9; Marbury TC, 2011, J CLIN PHARMACOL, V51, P1712, DOI 10.1177/0091270010387792; Scuderi PE, 2011, ANESTH ANALG, V112, P750, DOI 10.1213/ANE.0b013e31820d979c; Sinclair DR, 1999, ANESTHESIOLOGY, V91, P109, DOI 10.1097/00000542-199907000-00018; Tramer MR, 1997, ANESTHESIOLOGY, V87, P1277, DOI 10.1097/00000542-199712000-00004; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; TATTERSALL FD, 1994, NEUROPHARMACOLOGY, V33, P259, DOI 10.1016/0028-3908(94)90018-3; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Lasseter KC, 2007, J CLIN PHARMACOL, V47, P834, DOI 10.1177/0091270007301800; Koivuranta M, 1997, ANAESTHESIA, V52, P443, DOI 10.1111/j.1365-2044.1997.117-az0113.x; RUST M, 1994, ANAESTHESIA, V49, P16, DOI 10.1111/j.1365-2044.1994.tb03578.x; Saito H, 2013, ANN ONCOL, V24, P1067, DOI 10.1093/annonc/mds541; Gonsalves S, 1996, EUR J PHARMACOL, V305, P181, DOI 10.1016/0014-2999(96)00216-6; Behera BK, 2008, J POSTGRAD MED, V54, P86; Gan TJ, 2007, ANESTH ANALG, V104, P1082, DOI 10.1213/01.ane.0000263277.35140.a3; Gan TJ, 1996, ANESTHESIOLOGY, V85, P1036, DOI 10.1097/00000542-199611000-00011; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Tsutsumi YM, 2014, BIOMED RES INT, DOI 10.1155/2014/307025; Diemunsch P, 2007, BRIT J ANAESTH, V99, P202, DOI 10.1093/bja/aem133; Diemunsch Pierre, 2007, Curr Med Res Opin, V23, P2559, DOI 10.1185/030079907X233115; Kakuta Nami, 2011, J Med Invest, V58, P246; Kawano H, 2014, MINERVA ANE IN PRESS	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					696	701		10.1007/s00540-015-2006-z		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600009		
J	Zhang, EQ; Maruyama, J; Yokochi, A; Mitani, Y; Sawada, H; Nishikawa, M; Ma, N; Maruyama, K				Zhang, Erquan; Maruyama, Junko; Yokochi, Ayumu; Mitani, Yoshihide; Sawada, Hirofumi; Nishikawa, Masakatsu; Ma, Ning; Maruyama, Kazuo			Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats	JOURNAL OF ANESTHESIA			English	Article						Pulmonary hypertension; Hypoxia; Nitric oxide; Sarpogrelate hydrochloride; Serotonin 2A receptor	ARTERIAL-HYPERTENSION; PLASMA SEROTONIN; CORONARY-ARTERY; MICE; DISEASE; CIRCULATION; INHALATION; RECOVERY; EFFICACY; IMPROVES	The purpose of the present study was to determine if sarpogrelate hydrochloride (SPG), a serotonin 5HT2A receptor antagonist, prevented the development of chronic hypoxia-induced pulmonary hypertension (PH) and hypertensive pulmonary vascular remodeling. Forty-one male Sprague-Dawley rats were exposed to hypobaric hypoxia (380 mmHg, 10 % oxygen) or room air and administered 50 mg/kg SPG or vehicle by gavage once daily from day -2 to day 14. The mean pulmonary artery pressure (PAP) and right ventricular hypertrophy (RVH) were measured. Hypertensive pulmonary vascular remodelings were assessed morphometrically by light microscopy. Serotonin-induced contraction was determined in isolated pulmonary artery rings from 24 rats. In another set of rats, Western blotting, real-time polymerase chain reaction and immunofluorescent staining (n = 9) for lung tissue were performed. Chronic hypoxia induced a rise in mean PAP and RVH, increased the percentage of muscularized arteries in peripheral pulmonary arteries and medial wall thickness in small muscular arteries, and potentiated serotonin-induced contraction, each of which was significantly (p < 0.05) ameliorated by SPG. Chronic hypoxia significantly increased the expression of endothelial nitric oxide synthase (eNOS) and phosphorylated eNOS (peNOS) protein levels, cyclic guanosine monophosphate, and matrix metalloproteinase-13 (MMP-13) mRNA levels in whole lung tissues. SPG increased peNOS expression in the immunofluorescent staining of peripheral pulmonary arteries from chronic hypoxic rats and decreased the MMP-13 mRNA in lung tissue in chronic hypoxic rats. The administration of SPG ameliorated the development of chronic hypoxic PH and hypertensive pulmonary vascular changes.	[Zhang, Erquan; Maruyama, Junko; Yokochi, Ayumu; Sawada, Hirofumi; Maruyama, Kazuo] Mie Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Tsu, Mie 5148507, Japan; [Mitani, Yoshihide; Sawada, Hirofumi] Mie Univ, Sch Med, Dept Pediat, Tsu, Mie 5148507, Japan; [Nishikawa, Masakatsu] Mie Univ, Sch Med, Dept Inst Human Res Promot & Drug Dev, Tsu, Mie 5148507, Japan; [Maruyama, Junko] Suzuka Univ Med Sci, Fac Med Engn, Suzuka, Mie 5100293, Japan; [Ma, Ning] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie 5100293, Japan	Maruyama, K (reprint author), Mie Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	k-maru@clin.medic.mie-u.ac.jp			Japanese Association for the Promotion of Science	This study was supported in part by Grants-In-Aid for Scientific Research from the Japanese Association for the Promotion of Science. The authors thank Ms. A Okada and N Hiramtsu for the technical and secretarial assistance.	RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818; Rashid M, 2002, JPN J PHARMACOL, V89, P405, DOI 10.1254/jjp.89.405; Maruyama J, 1997, AM J PHYSIOL-HEART C, V272, pH517; Mitani Y, 1997, CIRCULATION, V96, P689; Keegan A, 2001, CIRC RES, V89, P1231, DOI 10.1161/hh2401.100426; MacLean MR, 1999, TRENDS PHARMACOL SCI, V20, P490, DOI 10.1016/S0165-6147(99)01389-9; MARUYAMA K, 1995, ANESTH ANALG, V80, P786, DOI 10.1097/00000539-199504000-00024; Zhang EQ, 2010, CIRC J, V74, P1696, DOI 10.1253/circj.CJ-10-0097; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Iwabayashi M, 2012, ATHEROSCLEROSIS, V220, P337, DOI 10.1016/j.atherosclerosis.2011.10.042; MEYRICK B, 1978, LAB INVEST, V38, P188; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Vajner L, 2006, INT J EXP PATHOL, V87, P383, DOI 10.1111/j.1365-2613.2006.00493.x; Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484; HERVE P, 1995, AM J MED, V99, P249, DOI 10.1016/S0002-9343(99)80156-9; Satomura K, 2002, CLIN CARDIOL, V25, P28, DOI 10.1002/clc.4950250108; Israilova M, 2002, PHARMACOLOGY, V65, P69, DOI 10.1159/000056189; Hironaka E, 2003, CARDIOVASC RES, V60, P692, DOI 10.1016/j.cardiores.2003.09.023; Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC; Miyata M, 2001, CHEST, V119, P554, DOI 10.1378/chest.119.2.554; Miyazaki M, 2007, J CARDIOVASC PHARM, V49, P221, DOI 10.1097/FJC.0b013e3180325af3; Miyata M, 2000, LUNG, V178, P63, DOI 10.1007/s004080000009; Kato S, 2000, J INT MED RES, V28, P258; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157572.70560.7b; MARUYAMA J, 1994, AM J PHYSIOL, V266, pH2476; Mitani Y, 2008, J THORAC CARDIOV SUR, V136, P142, DOI 10.1016/j.jtcvs.2007.10.061; MARUYAMA K, 1991, AM J PHYSIOL, V261, pH1716; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Campbell AIM, 1999, AM J RESP CELL MOL, V21, P567; RABINOVITCH M, 1983, CIRC RES, V52, P432; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Callebert J, 2006, J PHARMACOL EXP THER, V317, P724, DOI 10.1124/jpet.105.098269; Golembeski SA, 2005, CHEST, V128, p572S, DOI 10.1378/chest.128.6_suppl.572S-a; Igarashi M, 2000, J Dermatol, V27, P643; ILKIW R, 1989, CIRC RES, V64, P814; KOUYOUMDJIAN C, 1994, J CLIN INVEST, V94, P578, DOI 10.1172/JCI117372	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					715	723		10.1007/s00540-015-2015-y		9	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600012		
J	Utada, K; Ishida, K; Tohyama, S; Urushima, Y; Mizukami, Y; Yamashita, A; Uchida, M; Matsumoto, M				Utada, Kohji; Ishida, Kazuyoshi; Tohyama, Suguru; Urushima, Yutaka; Mizukami, Yoichi; Yamashita, Atsuo; Uchida, Masato; Matsumoto, Mishiya			The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits	JOURNAL OF ANESTHESIA			English	Article						Spinal cord ischemia; Insulin-like growth factor 1; Erythropoietin; Rabbit	BLOOD-BRAIN-BARRIER; TYROSINE KINASE; FACTOR-I; RECEPTOR; NEURONS; VIVO	Insulin-like growth factor 1 (IGF-1) and erythropoietin (EPO) have been reported to independently protect against ischemic spinal cord injury in rabbits. In the present study, we investigated whether the combination of IGF-1 and EPO protects against ischemic spinal cord injury in rabbits. Animals were assigned to 1 of 4 groups (n = 6 in each): a control group (saline), an IGF-1 group (IGF-1 0.3 mg/kg), an EPO group (EPO 800 U/kg), or an IGF-1 + EPO group (IGF-1 0.3 mg/kg + EPO 800 U/kg). Spinal cord ischemia was produced by occluding the abdominal aorta for 15 min. Saline, IGF-1, and EPO were administered intravenously just after the start of reperfusion. Hindlimb motor function was assessed daily for 7 days, after which histopathological evaluation was performed. To analyze phosphorylation of signal transduction molecules, animals were assigned to 1 of the 4 groups (n = 8 in each). Spinal cord ischemia and the treatment were the same as those described above. The spinal cords were removed at 15 or 30 min after reperfusion and used to analyze phosphorylation of signal transduction molecules. Four animals served as the preischemic control, and the spinal cord was removed just before the start of ischemia. In the IGF-1 + EPO group, both neurological and histopathological outcomes were significantly improved as compared to the control group, which was consistent with the increase of Janus kinase-2 (JAK2) phosphorylation. The combination of IGF-1 and EPO protects against ischemic spinal cord injury in rabbits. JAK2 might contribute to the protective effect.	[Utada, Kohji; Ishida, Kazuyoshi; Tohyama, Suguru; Urushima, Yutaka; Mizukami, Yoichi; Yamashita, Atsuo; Uchida, Masato; Matsumoto, Mishiya] Yamaguchi Univ, Dept Anesthesiol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Matsumoto, M (reprint author), Yamaguchi Univ, Dept Anesthesiol, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	utada@yamaguchi-u.ac.jp; ishid002@yamaguchi-u.ac.jp; sugurutohyama@yahoo.co.jp; t003uf@yamaguchi-u.ac.jp; mizukami@yamaguchi-u.ac.jp; ymst2699@yamaguchi-u.ac.jp; uch0809@yamaguchi-u.ac.jp; mishiya@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [21591974]	This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 21591974) from the Japan Society for the Promotion of Science.	Shirasawa Y, 2009, J ANESTH, V23, P242, DOI 10.1007/s00540-009-0741-8; Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; Digicaylioglu M, 2004, P NATL ACAD SCI USA, V101, P9855, DOI 10.1073/pnas.0403172101; Nagamizo D, 2007, ANESTH ANALG, V105, P1397, DOI 10.1213/01.ane.0000281146.33391.69; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Matsumoto M, 1997, ANESTHESIOLOGY, V86, P1120, DOI 10.1097/00000542-199705000-00016; Nakao Y, 2001, J THORAC CARDIOV SUR, V122, P136, DOI 10.1067/mtc.2001.114101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Smith PD, 2011, J THORAC CARDIOV SUR, V141, P256, DOI 10.1016/j.jtcvs.2010.09.017; MIURA O, 1994, BLOOD, V84, P1501; Ehrenreich H, 2002, MOL MED, V8, P495; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					741	748		10.1007/s00540-015-2031-y		8	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600016		
J	Tobe, M; Saito, S				Tobe, Masaru; Saito, Shigeru			History of T-cain: a local anesthetic developed and manufactured in Japan	JOURNAL OF ANESTHESIA			English	Article						Local anesthetic; T-cain; Dibucaine; Spinal anesthesia; Topical anesthesia		In many anesthesia textbooks written in English, lidocaine, tetracaine, bupivacaine, ropivacaine, and chloroprocaine are listed as useful local anesthetics for spinal anesthesia. In contrast, T-cain is not included in these lists, even though it has been reported to be suitable for spinal anesthesia in Japan. T-cain was developed as a local anesthetic in the early 1940s by Teikoku Kagaku Sangyo Inc. in Itami, Japan, by replacing a methyl group on tetracaine (Pantocaine(A (R))) with an ethyl group. T-cain was clinically approved for topical use in Japan in November 1949, and a mixture of dibucaine and T-cain (Neo-Percamin S-A (R)) was approved for spinal use in May 1950. Simply because of a lack of foreign marketing strategy, T-cain has never attracted global attention as a local anesthetic. However, in Japan, T-cain has been used topically or intrathecally (as Neo-Percamin S-A (R)) for more than 60 years. Other than the side effects generally known for all local anesthetics, serious side effects have not been reported for T-cain. In fact, several articles have reported that T-cain decreases the neurotoxicity of dibucaine. In this historical review, the characteristics of T-cain and its rise to become a major spinal anesthetic in Japan are discussed.	[Tobe, Masaru] Gunma Univ Hosp, Intens Care Unit, Maebashi, Gunma 3718511, Japan; [Saito, Shigeru] Gunma Univ, Grad Sch Med, Dept Anesthesiol, Maebashi, Gumma 371, Japan	Tobe, M (reprint author), Gunma Univ Hosp, Intens Care Unit, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	to-be@f3.dion.ne.jp			Nagase Medicals Inc.	We express our sincere appreciation to Nagase Medicals Inc. for their support of the preparation of this manuscript.	SAKLAD M, 1947, ANESTHESIOLOGY, V8, P270, DOI 10.1097/00000542-194705000-00006; Whiteside JB, 2001, BRIT J ANAESTH, V87, P27, DOI 10.1093/bja/87.1.27; Fujita T, 1987, NIPPON MASUIKAGAKUSH; Fukui M., 1970, LEGAL MED, V24, P136; Goto S, 1943, CHIRYOU SHOHOU, V24, P697; Hirabayashi Y, 1993, Masui, V42, P1274; Honda K, 1952, MASUI, V1, P104; Ishiyama F, CLIN STUDY JAPAN MAD, P1; Japanese Society of Hospital Pharmacists, 2013, BYOIN YAKK JIR; Kan B, 1944, JICCHIIKARINSHO, V21, P115; Kaneko R., 1957, JPN REV CLIN OPTHALM, V51, P743; Kato T., 1954, RINSHO FUJINKA SANKA, V8, P43; Kitahara T, 1955, SHUJYUTSU, V9, P42; Koshinaga J, 1959, NIPPON DAIGAKU IGAKU, V18, P1250; Matsuki A., 1999, SPINAL ANESTHESIA RE; McLure H A, 2005, Minerva Anestesiol, V71, P59; Mori S., 1956, MASUI, V5, P273; Nishioka K., 1973, JPN REV CLIN OPTHALM, V67, P249; Otsuka M, 1975, PHARMACOMETRICS, V9, P413; Ruetsch Yvan A., 2001, Current Topics in Medicinal Chemistry, V1, P175, DOI 10.2174/1568026013395335; Saeki S, 1997, SHINYAKU TO RINSHOU, V46, P1721; Saito M., 1942, J JPN SURG SOC, V43, P773; Sakai T, 1962, MASUI, V11, P477; Strichartz GR, 2005, MILLERS ANESTHESIA, P573; Yuasa Y., 1955, J YONAGO MED ASSOC, V6, P135	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					763	768		10.1007/s00540-015-2066-0		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600019		
J	Yatabe, T; Yamashita, K; Yokoyama, M				Yatabe, Tomoaki; Yamashita, Koichi; Yokoyama, Masataka			Drug fever caused by propofol in the intensive care unit	JOURNAL OF ANESTHESIA			English	Article						Drug fever; Remittent fever; Propofol; Dexmedetomidine; Type I glycogen storage disease	GLYCOGEN-STORAGE-DISEASE; ANESTHESIA; HYPERTHERMIA; CHILD	Few studies have reported that fever is caused by intravenous sedative drugs even though these agents are widely used. We present a case of propofol-induced drug fever. A 57-year-old woman underwent hepatic segmentectomy. Although she was diagnosed with type I glycogen storage disease when in her twenties, her liver function was normal. As the operative hemorrhage was high, the patient was transferred to the intensive care unit (ICU). Her temperature at ICU admission was 35.8 A degrees C, and sedation with propofol and dexmedetomidine was initiated. Two hours after admission to the ICU, the patient had a fever of 38-39.5 A degrees C. Remittent fever persisted until day 5 after surgery. Because of her persistent fever, pneumonia was suspected and antibiotics were initiated on day 4 after surgery. As the fever persisted after the initiation of antibiotics, drug fever was suspected. On day 5 after surgery, propofol infusion was discontinued and the patient was extubated. Her temperature of 37.7 A degrees C at the discontinuation of propofol infusion, and rapidly decreased to 36.1 A degrees C in the following 3 h. Propofol-induced drug fever must be considered in cases of fever of unknown origin when patients receive propofol and appear inappropriately well for the degree of fever that they have.	[Yatabe, Tomoaki; Yamashita, Koichi; Yokoyama, Masataka] Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Nankoku, Kochi 7838505, Japan	Yatabe, T (reprint author), Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	yatabe@kochi-u.ac.jp					Wang LYJ, 2007, PEDIATR ANESTH, V17, P738, DOI 10.1111/j.1460-9592.2007.02215.x; EDELSTEIN G, 1980, ANESTHESIOLOGY, V52, P90, DOI 10.1097/00000542-198001000-00025; Circiumaru B, 1999, INTENS CARE MED, V25, P668, DOI 10.1007/s001340050928; Bustamante SE, 2006, PEDIATR ANESTH, V16, P680, DOI 10.1111/j.1460-9592.2005.01833.x; Okabe T, 2009, ANESTH ANALG, V108, P1589, DOI 10.1213/ane.0b013e31819f1985; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Vodovar D, 2012, DRUG SAFETY, V35, P759, DOI 10.2165/11630640-000000000-00000; Bollig G, 2005, ACTA ANAESTH SCAND, V49, P1077, DOI 10.1111/j.1399-6576.2005.00755.x; Lee Hyun Kyu, 2011, Korean J Anesthesiol, V61, P112, DOI 10.4097/kjae.2011.61.2.112; Patel RA, 2010, PHARMACOTHERAPY, V30, P57, DOI 10.1592/phco.30.1.57; Rehman T, 2014, CHEST, V145, P158, DOI 10.1378/chest.12-2843	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					786	789		10.1007/s00540-015-2007-y		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600021		
J	Fujita, Y; Moriyama, S; Aoki, S; Yoshizawa, S; Tomita, M; Kojima, T; Mori, Y; Takeuchi, N; So, MH; Yano, M; Sobue, K				Fujita, Yoshihito; Moriyama, Satoru; Aoki, Satoshi; Yoshizawa, Saya; Tomita, Maiko; Kojima, Taiki; Mori, Yukiko; Takeuchi, Naoko; So, Min-Hye; Yano, Motoki; Sobue, Kazuya			Estimation of the success rate of anesthetic management for thymectomy in patients with myasthenia gravis treated without muscle relaxants: a retrospective observational cohort study	JOURNAL OF ANESTHESIA			English	Article						Myasthenia gravis; MG; Thymectomy; Muscle relaxant	SUGAMMADEX; PROPOFOL	Although maintaining anesthesia for myasthenia gravis (MG) with minimal muscle relaxants (MR) is common, the success rate of anesthetic management for MG without MR is not clear. We therefore retrospectively examined the success rate of anesthetic management for MG without MR among 66 consecutive cases of thymectomy for MG performed at our hospital between January 2004 and April 2010, before approval of using sugammadex. A total of 60 patients (90.9 %) were treated without MR (N group). Among the 60 cases, 17 (28.3 %) patients were not extubated in the operating room due to postoperative respiratory depression or other reasons. Therefore, the success rate of anesthetic management for thymectomy in patients with MG without treating MR was 71.7 % (43/60) [95 % confident interval (CI): 65.9-77.5 %]. The reasons for using MR included coughing at intubation in one case, bucking during surgery in two cases, and MR was considered to be safer by the attending anesthesiologist in three cases. The number of cases of impossible extubation requiring ventilation on that day was three in the N group and none in the R group. Finally, the success rate of anesthetic management for MG without MR was estimated to be 71.1 % (95 % CI: 65.9-77.5 %).	[Fujita, Yoshihito] Aichi Med Univ, Dept Anesthesiol, Sch Med, Nagakute, Aichi 4801195, Japan; [Moriyama, Satoru; Yano, Motoki] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Aoki, Satoshi; Yoshizawa, Saya; Tomita, Maiko; Kojima, Taiki; Mori, Yukiko; Takeuchi, Naoko; So, Min-Hye; Sobue, Kazuya] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Nagoya, Aichi, Japan	Fujita, Y (reprint author), Aichi Med Univ, Dept Anesthesiol, Sch Med, 1-1 Karimata, Nagakute, Aichi 4801195, Japan.	fujita.yoshihito.823@mail.aichi-med-u.ac.jp					Della Rocca G, 2003, CAN J ANAESTH, V50, P547; Combes X, 2007, BRIT J ANAESTH, V99, P276, DOI 10.1093/bja/aem147; Bouvet L, 2008, CAN J ANAESTH, V55, P674, DOI 10.1007/BF03017743; EISENKRAFT JB, 1990, CAN J ANAESTH, V37, P301; Bouaggad A, 2005, EUR J ANAESTH, V22, P393, DOI 10.1017/S0265021505220677; Unterbuchner C, 2010, ANAESTHESIA, V65, P302, DOI 10.1111/j.1365-2044.2009.06236.x; Sanfilippo M, 1997, ACTA ANAESTH SCAND, V41, P1365; Chevalley C, 2001, CAN J ANAESTH, V48, P446; Le Corre F, 2011, CAN J ANESTH, V58, P944, DOI 10.1007/s12630-011-9554-y	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					794	797		10.1007/s00540-015-1999-7		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600023		
J	Iwata, K; Iida, H; Iida, M; Fukuoka, N; Kito, K; Tanabe, K				Iwata, Kenji; Iida, Hiroki; Iida, Mami; Fukuoka, Naokazu; Kito, Kazuhiro; Tanabe, Kumiko			Effects of topical and intravenous JM-1232(-) infusion on cerebrovascular reactivity in rats	JOURNAL OF ANESTHESIA			English	Article						JM-1232(-); Cerebrovascular reactivity; Cranial window	CEREBRAL VASOMOTOR RESPONSIVENESS; CARBON-DIOXIDE; PROPOFOL; MIDAZOLAM; ISOFLURANE; VESSELS; HUMANS	A novel short-acting benzodiazepine receptor agonist, JM-1232(-), has been shown to have a sedative/hypnotic effect and wide safety margin. However, its effect on cerebral vessels is not well known. Therefore, we investigated the cerebrovascular reactivity to topical and intravenous JM-1232(-) and during hypotension or hypercapnia with intravenous administration of JM-1232(-). We used a closed cranial window preparation to measure the changes of cerebral pial arteriolar diameters in isoflurane-anesthetized Sprague-Dawley rats. We first measured the direct effect of topical JM-1232(-). We then determined the effect of intravenous JM-1232(-) and then we measured the response to hypercapnia before and after JM-1232(-) infusion. Finally, we measured the reaction to stepwise induction of hypotension before and after JM-1232(-) infusion. Topical infusion of JM-1232(-) dilated pial arterioles. Intravenous infusion of JM-1232(-) changed pial arterioles by 4.5 +/- A 2.7 %, 5.0 +/- A 3.9 %, and -2.8 +/- A 2.6 % (at 0.1, 0.3, and 1.0 mg/kg/min, respectively). Hypercapnia dilated pial arterioles before and after JM-1232(-) infusion. The diameters of pial arterioles did not change during hypotension before or after intravenous JM-1232(-) infusion. These results indicate that topical JM-1232(-) has a dilative effect on pial arterioles and that intravenous administration of JM-1232(-) may not affect cerebrovascular reactivity to hypotension or hypercapnia.	[Iwata, Kenji; Iida, Hiroki; Fukuoka, Naokazu; Kito, Kazuhiro; Tanabe, Kumiko] Gifu Univ, Dept Anesthesiol & Pain Med, Grad Sch Med, Gifu, Gifu 5011194, Japan; [Iida, Mami] Gifu Prefectural Gen Med Ctr, Div Internal Med & Cardiol, Gifu, Japan	Iida, H (reprint author), Gifu Univ, Dept Anesthesiol & Pain Med, Grad Sch Med, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	iida@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21591970, 24592294]	This research was supported by Grant-in-Aid for Scientific Research No. 21591970 and 24592294 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors would like to thank Enago (www.enago.jp) for the English language review.	Kanamitsu N, 2007, CHEM PHARM BULL, V55, P1682, DOI 10.1248/cpb.55.1682; KUMANO H, 1993, ACTA ANAESTH SCAND, V37, P567; Shibuya K, 2009, J NEUROSURG ANESTH, V21, P40, DOI 10.1097/ANA.0b013e31818b22d5; Iida H, 1998, ANESTHESIOLOGY, V89, P954, DOI 10.1097/00000542-199810000-00020; Iida M, 2012, J ANESTH, V26, P928, DOI 10.1007/s00540-012-1433-3; MATTA BF, 1995, ANESTHESIOLOGY, V83, P980, DOI 10.1097/00000542-199511000-00011; Sneyd JR, 2012, ANESTHESIOLOGY, V116, P385, DOI 10.1097/ALN.0b013e318242b2af; PARK WK, 1992, ANESTHESIOLOGY, V77, P956, DOI 10.1097/00000542-199211000-00019; Moriyama T, 2011, J CARDIOTHOR VASC AN, V25, P72, DOI 10.1053/j.jvca.2010.03.013; STREBEL S, 1994, ANESTH ANALG, V78, P884; FORSTER A, 1983, J CEREBR BLOOD F MET, V3, P246; Iida H, 2010, J THROMB THROMBOLYS, V29, P483, DOI 10.1007/s11239-009-0382-7	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					798	802		10.1007/s00540-015-2017-9		5	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600024		
J	Ueshima, H; Kitamura, A				Ueshima, Hironobu; Kitamura, Akira			The use of a needle guide kit improves the stability of ultrasound-guided techniques	JOURNAL OF ANESTHESIA			English	Article						Needle guide kit; Ultrasound-guided techniques; Stability	BLOCK	A needle guide kit will be able to improve visibility on ultrasonic images. We examined the degree of stability using a SIVA guide. The SIVA guide is a needle guide kit in which the angle is not restricted, allowing the puncture to be made at any angle. We punctured the Blue Phantom (TM) with a high-frequency linear probe with a SIVA guide and measured the intensities of the needle at depths of 0.5, 1.0, 1.5, and 2.0 cm on the ultrasound image with Image J software. We set all punctures angles at 45 degrees from the Blue Phantom (TM). Six anesthesiologists with > 7 years experience performed two punctures-one case was punctured with a SIVA guide and the other was punctured without a SIVA guide. Some significant differences were noted in the results between the two punctures at depths of 1.0, 1.5, and 2.0 cm. We were able to prove that the use of a needle guide kit could improve visibility on ultrasonic images.	[Ueshima, Hironobu; Kitamura, Akira] Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Saitama, Japan	Ueshima, H (reprint author), Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Yamane 1397-1, Saitama, Japan.	ueshimhi@yahoo.co.jp					Barrington MJ, 2013, REGION ANESTH PAIN M, V38, P289, DOI 10.1097/AAP.0b013e318292669b; Jacob AK, 2011, ANESTHESIOLOGY, V115, P1172, DOI 10.1097/ALN.0b013e3182326c20; MacLennan N, 2014, EUR J ANAESTH, V31, P244, DOI 10.1097/EJA.0000000000000021; Yoshida H, 2010, J ANESTH, V24, P653, DOI 10.1007/s00540-010-0957-7; Schafhalter-Zoppoth I, 2004, REGION ANESTH PAIN M, V29, P480, DOI 10.1016/j.rapm.2004.07.001; Tadokoro T, 2015, J ANESTH, V29, P131, DOI 10.1007/s00540-014-1869-8	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					803	804		10.1007/s00540-015-2021-0		2	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600025		
J	Nishiwada, T; Kawaraguchi, Y; Uemura, K; Sugimoto, H; Kawaguchi, M				Nishiwada, Tadashi; Kawaraguchi, Yoshitaka; Uemura, Keiko; Sugimoto, Hiroshi; Kawaguchi, Masahiko			Effect of sevoflurane on human hepatocellular carcinoma HepG2 cells under conditions of high glucose and insulin	JOURNAL OF ANESTHESIA			English	Article						Sevoflurane; Hepatocellular carcinoma; Diabetes; Proliferation	VOLATILE ANESTHETICS; IN-VITRO; PROPOFOL ANESTHESIA; DIABETES-MELLITUS; APOPTOSIS; MODULATION; MECHANISMS; ISOFLURANE; RISK; RATS	Diabetes mellitus is associated with morbidity and progression of some cancers, such as hepatocellular carcinoma. It has been reported that sevoflurane, a volatile anesthetic agent commonly used in cancer surgery, can lead to lower overall survival rates than those observed when propofol is used to treat cancer patients, and sevoflurane increases cancer cell proliferation in in vitro studies. It has been also reported that glucose levels in rats anesthetized with sevoflurane were higher than those in rats anesthetized with propofol. We investigated the effect of sevoflurane, under conditions of high glucose and insulin, on cell proliferation in the human hepatocellular carcinoma cell line, HepG2. First, we exposed HepG2 cells to sevoflurane at 1 or 2 % concentration for 6 h in various glucose concentrations and then evaluated cell proliferation using the MTT assay. Subsequently, to mimic diabetic conditions observed during surgery, HepG2 cells were exposed to sevoflurane at 1 or 2 % concentration in high glucose concentrations at various concentrations of insulin for 6 h. One-percent sevoflurane exposure enhanced cell proliferation under conditions of high glucose, treated with 0.05 mg/l insulin. Our study implies that sevoflurane may affect cell proliferation in human hepatocellular carcinoma cells in a physiological situation mimicking that of diabetes.	[Nishiwada, Tadashi; Kawaraguchi, Yoshitaka; Uemura, Keiko; Sugimoto, Hiroshi; Kawaguchi, Masahiko] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 634, Japan	Nishiwada, T (reprint author), Nara Med Univ, Dept Anesthesiol, 840 Shijo Cho, Kashihara, Nara 634, Japan.	t-nishiwada@naramed-u.ac.jp					Kitamura T, 2012, ANESTH ANALG, V114, P110, DOI 10.1213/ANE.0b013e3182373552; WOODS GM, 1986, BRIT J ANAESTH, V58, P535, DOI 10.1093/bja/58.5.535; Benzonana LL, 2013, ANESTHESIOLOGY, V119, P593, DOI 10.1097/ALN.0b013e31829e47fd; Enlund M, 2014, UPSALA J MED SCI, V119, P251, DOI 10.3109/03009734.2014.922649; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Kawaraguchi Y, 2011, ANESTHESIOLOGY, V115, P499, DOI 10.1097/ALN.0b013e3182276d42; Kotani N, 1998, ANESTHESIOLOGY, V89, P1125, DOI 10.1097/00000542-199811000-00012; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; Feng YH, 2011, MED ONCOL, V28, P1080, DOI 10.1007/s12032-010-9650-9; PETERSON PK, 1993, BIOCHEM PHARMACOL, V46, P343, DOI 10.1016/0006-2952(93)90508-T; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Eisenstein TK, 1998, J NEUROIMMUNOL, V83, P36, DOI 10.1016/S0165-5728(97)00219-1; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Sato K, 2013, ANESTH ANALG, V117, P627, DOI 10.1213/ANE.0b013e31829e4028; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Kudoh A, 2002, ANESTH ANALG, V95, P123, DOI 10.1097/00000539-200207000-00022; Ecimovic P, 2013, ANTICANCER RES, V33, P4255; Ben Q, 2011, EUR J CANCER, V47, P1928, DOI [10.1016/j.ejca.2011.03.003, DOI 10.1016/J.EJCA.2011.03.003]; Tanaka K, 2014, JPN J CLIN ONCOL, V44, P986, DOI 10.1093/jjco/hyu108	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					805	808		10.1007/s00540-015-2025-9		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600026		
J	Hamaguchi, S; Tezuka, N; Nagao, M				Hamaguchi, Shinsuke; Tezuka, Nobuko; Nagao, Masaru			Rocuronium and sugammadex under TOF monitoring on mECT	JOURNAL OF ANESTHESIA			English	Letter							SUXAMETHONIUM		[Hamaguchi, Shinsuke; Tezuka, Nobuko; Nagao, Masaru] Dokkyo Univ, Sch Med, Dept Anesthesia & Pain Med, Mibu, Tochigi 3210293, Japan	Hamaguchi, S (reprint author), Dokkyo Univ, Sch Med, Dept Anesthesia & Pain Med, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	s-hama@dokkyomed.ac.jp		Hamaguchi, Shinsuke/0000-0001-5872-4421			Hoshi H, 2011, J ANESTH, V25, P286, DOI 10.1007/s00540-011-1095-6; Isono S, 2008, J ANESTH, V22, P337, DOI 10.1007/s00540-008-0630-6; VALDRIGHI JB, 1994, BRIT J ANAESTH, V72, P237, DOI 10.1093/bja/72.2.237	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					815	815		10.1007/s00540-015-2009-9		1	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600030		
J	Hiraki, T; Ito, A; Ushijima, K				Hiraki, Teruyuki; Ito, Asuka; Ushijima, Kazuo			Corneal depression immediately after cardiac surgery	JOURNAL OF ANESTHESIA			English	Letter									[Hiraki, Teruyuki; Ito, Asuka; Ushijima, Kazuo] Kurume Univ, Sch Med, Dept Anesthesiol, Kurume, Fukuoka 8300011, Japan	Hiraki, T (reprint author), Kurume Univ, Sch Med, Dept Anesthesiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hiraki_teruyuki@kurume-u.ac.jp					BAVBEK T, 1991, THORAC CARDIOV SURG, V39, P29, DOI 10.1055/s-2007-1013925; Donlon Jr JV, 2005, MILLERS ANESTHESIA, P2527	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					816	816		10.1007/s00540-015-2022-z		1	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600031		
J	Seki, T; Kimura, K; Reid, ME; Miyazaki, A; Banno, H; Jin, W; Wachino, J; Yamada, K; Arakawa, Y				Seki, Tomomi; Kimura, Kouji; Reid, Megan E.; Miyazaki, Akira; Banno, Hirotsugu; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Arakawa, Yoshichika			High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							RESISTANCE; PBP2X; PRGBS	Objectives: In Japan, the isolation rate of group B Streptococcus (GBS) with reduced penicillin susceptibility (PRGBS) was 2.3% between 2005 and 2006. However, no data on this have been available since then; moreover, the isolation rate of MDR-PRGBS has never been reported. The aim of this study was to obtain recent data on the PRGBS isolation rate and to investigate, for the first time, the isolation rate of MDR-PRGBS. Methods: We collected 306 clinical GBS isolates from various regions in Japan between January 2012 and July 2013. The MICs of penicillin G, oxacillin, ceftizoxime and ceftibuten for all GBS isolates and the MICs of erythromycin and levofloxacin for PRGBS isolates were determined by the agar dilution method. The mutations in the genes involved in antibiotic resistance and antibiotic resistance geneswere analysed by PCR and DNA sequencing. Results: We detected 45 clinical PRGBS isolates, with a PRGBS isolation rate among GBS of 14.7% (45/306). Among the PRGBS isolates, 32 (32/45, 71.1%) and 43 (43/45, 95.6%) were resistant/non-susceptible to erythromycin and levofloxacin, respectively. Furthermore, 31 PRGBS isolates, which constituted 68.9% of the PRGBS (31/45) and 10.1% of the GBS (31/306), respectively, were resistant/non-susceptible to both macrolides and fluoroquinolones, indicating multidrug resistance. Conclusions: These results suggest that the number of clinical PRGBS isolates with a tendency to multidrug resistance increased rapidly between 2005-06 and 2012-13 in Japan.	[Seki, Tomomi; Kimura, Kouji; Reid, Megan E.; Miyazaki, Akira; Banno, Hirotsugu; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, Nagoya, Aichi 4668550, Japan	Kimura, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	koujikim@med.nagoya-u.ac.jp	Kimura, Kouji/C-1847-2015; Arakawa, Yoshichika/P-5997-2015		Ministry of Health, Labour and Welfare of Japan [H24-Shinkou-Ippan-010]	This work was supported by grant H24-Shinkou-Ippan-010 from the Ministry of Health, Labour and Welfare of Japan. The grant covered the cost of editing by Editage (see the Transparency declarations below).	Kimura K, 2013, JPN J INFECT DIS, V66, P158; Kimura K, 2009, J CLIN MICROBIOL, V47, P4154, DOI 10.1128/JCM.02063-08; Banno H, 2014, J CLIN MICROBIOL, V52, P2169, DOI 10.1128/JCM.00226-14; Kimura K, 2013, J ANTIMICROB CHEMOTH, V68, P539, DOI 10.1093/jac/dks423; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Nagano N, 2008, ANTIMICROB AGENTS CH, V52, P4258, DOI 10.1128/AAC.00596-08; Kimura K, 2013, J ANTIMICROB CHEMOTH, V68, P1533, DOI 10.1093/jac/dkt060; Kimura K, 2013, J ANTIMICROB CHEMOTH, V68, P1442, DOI 10.1093/jac/dkt008; Kamiya C, 2015, DIAGN MICR INFEC DIS, V82, P269, DOI 10.1016/j.diagmicrobio.2015.04.010; Longtin J, 2011, ANTIMICROB AGENTS CH, V55, P2983, DOI 10.1128/AAC.01243-10; Murayama SY, 2009, ANTIMICROB AGENTS CH, V53, P2650, DOI 10.1128/AAC.01716-08; Nagano N, 2012, J ANTIMICROB CHEMOTH, V67, P849, DOI 10.1093/jac/dkr546; Baker CJ, 2000, STREPTOCOCCAL INFECT, P222; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Gaudreau C, 2009, J ANTIMICROB CHEMOTH, V65, P594; Japan Nosocomial Infections Surveillance (JANIS), OP REP APR 2014 JUN; Kimura K, 2006, 46 INT C ANT AG CHEM, P128; Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	OCT	2015	70	10					2725	2728		10.1093/jac/dkv203		4	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU0ZZ	WOS:000363249800006		
J	Morinaka, A; Tsutsumi, Y; Yamada, M; Suzuki, K; Watanabe, T; Abe, T; Furuuchi, T; Inamura, S; Sakamaki, Y; Mitsuhashi, N; Ida, T; Livermore, DM				Morinaka, Akihiro; Tsutsumi, Yuko; Yamada, Mototsugu; Suzuki, Kenji; Watanabe, Takashi; Abe, Takao; Furuuchi, Takeshi; Inamura, Seiichi; Sakamaki, Yoshiaki; Mitsuhashi, Nakako; Ida, Takashi; Livermore, David M.			OP0595, a new diazabicyclooctane: mode of action as a serine beta-lactamase inhibitor, antibiotic and beta-lactam 'enhancer'	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; AMDINOCILLIN MECILLINAM; PSEUDOMONAS-AERUGINOSA; AVIBACTAM; ENTEROBACTERIACEAE; COMBINATION; RESISTANCE; PENICILLIN; CARBAPENEMASES	Objectives: The production of a growing diversity of beta-lactamases by Gram-negative bacteria challenges antimicrobial chemotherapy. OP0595, discovered separately by each of Meiji Seika Pharma and Fedora Pharmaceuticals, is a new diazabicyclooctane serine beta-lactamase inhibitor that also acts as an antibiotic and as a beta-lactamase-independent beta-lactam 'enhancer'. Methods: Inhibitory activity against serine beta-lactamases and affinity for PBPs were determined using nitrocefin and Bocillin FL, respectively. MICs alone and in combination with beta-lactam agents were measured according to CLSI recommendations. Morphological changes in Escherichia coli were examined by phase-contrast microscopy. Results: IC(50)s of OP0595 for class A and C beta-lactamases were <1000 nM, with covalent binding demonstrated to the active-site serine of CTX-M-44 and AmpC enzymes. OP0595 also had direct antibiotic activity against many Enterobacteriaceae, associated with inhibition of PBP2 and conversion of the bacteria into spherical forms. Synergy between OP0595 and beta-lactam agents was seen against strains producing class A and C beta-lactamases vulnerable to inhibition. Lastly, OP0595 lowered the MICs of PBP3-targeted partner beta-lactam agents for a non-beta-lactamase-producing E. coli mutant that was resistant to OP0595 itself, indicating beta-lactamase-independent 'enhancer'-based synergy. Conclusions: OP0595 acts in three ways: (i) as an inhibitor of class A and C beta-lactamases, covalently binding at their active sites; (ii) as an antibacterial, by inhibiting PBP2 of several Enterobacteriaceae; and (iii) as an 'enhancer' of beta-lactam agents that bind to other PBPs besides PBP2 for several Enterobacteriaceae. OP0595 has considerable potential to overcome resistance when it is combined with various beta-lactam agents.	[Morinaka, Akihiro; Tsutsumi, Yuko; Yamada, Mototsugu; Suzuki, Kenji; Watanabe, Takashi; Abe, Takao; Furuuchi, Takeshi; Inamura, Seiichi; Sakamaki, Yoshiaki; Mitsuhashi, Nakako; Ida, Takashi] Meiji Seika Pharma Co Ltd, Yokohama, Kanagawa, Japan; [Livermore, David M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Morinaka, A (reprint author), Meiji Seika Pharma Co Ltd, Yokohama, Kanagawa, Japan.	akihiro.morinaka@meiji.com					Abe T, Meiji Seika Pharma, Patent No. [WO2013180197, 2013180197]; Livermore DM, 2013, J ANTIMICROB CHEMOTH, V68, P2286, DOI 10.1093/jac/dkt178; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Ehmann DE, 2013, J BIOL CHEM, V288, P27960, DOI 10.1074/jbc.M113.485979; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Dalhoff A, 2003, CHEMOTHERAPY, V49, P172, DOI 10.1159/000071141; Hirsch EB, 2012, ANTIMICROB AGENTS CH, V56, P3753, DOI 10.1128/AAC.05927-11; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; CURTIS NAC, 1985, J ANTIMICROB CHEMOTH, V16, P287, DOI 10.1093/jac/16.3.287; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; VERBIST L, 1985, J ANTIMICROB CHEMOTH, V16, P719; JOSELEAUPETIT D, 1994, MOL MICROBIOL, V13, P911, DOI 10.1111/j.1365-2958.1994.tb00482.x; GUTMANN L, 1986, ANTIMICROB AGENTS CH, V30, P906; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Young KD, 2008, J BACTERIOL, V190, P1497, DOI 10.1128/JB.01975-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Zhanel GG, 2013, DRUGS, V73, P159, DOI 10.1007/s40265-013-0013-7; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; IIDA K, 1978, ANTIMICROB AGENTS CH, V14, P257; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Livermore DM, 2013, J ANTIMICROB CHEMOTH, V68, P153, DOI 10.1093/jac/dks350; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Clinical and Laboratory Standards Institute, 2015, M7A10 CLSI; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI; ISENBERG HD, 1982, CRC CR REV MICROBIOL, V10, P1, DOI 10.3109/10408418209113505; Kano A, 2015, 25 EUR C CLIN MICR I; Lahiri SD, 2014, ANTIMICROB AGENTS CH, V58, P5704, DOI 10.1128/AAC.03057-14; McRee DE, 1993, PRACTICAL PROTEIN CR; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Thulin E, 2015, ANTIMICROB AGENTS CH, V59, P1723, DOI 10.1128/AAC.04819-14; Watkins R. R., 2013, FRONT MICROBIOL, V4, P1	31	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	OCT	2015	70	10					2779	2786		10.1093/jac/dkv166		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU0ZZ	WOS:000363249800015		
J	Sriwilaijaroen, N; Suzuki, K; Takashita, E; Hiramatsu, H; Kanie, O; Suzuki, Y				Sriwilaijaroen, Nongluk; Suzuki, Katsuhiko; Takashita, Emi; Hiramatsu, Hiroaki; Kanie, Osamu; Suzuki, Yasuo			6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							HUMAN AIRWAY; SIALIC-ACID; MDCK CELLS; A VIRUSES; HEMAGGLUTININ; INHIBITORS; INFECTION; OLIGOSACCHARIDES; DERIVATIVES; ANTAGONISM	Objectives: The purpose of this study was to develop a new compound to overcome influenza epidemics and pandemics as well as drug resistance. Methods: We synthesized a new compound carrying: (i) Neu5Ac alpha 2-6Gal beta 1-4GlcNAc (6SLN) for targeting immutable haemagglutinins (HAs) unless switched from human-type receptor preference; (ii) an acyl chain (lipo) for locking the compound with the viral HA via hydrophobic interactions; and (iii) a flexible poly-alpha-L-glutamic acid (PGA) for enhancing the compound solubility and for coating the viral surface, precluding accessibility of the PGA-coated virus to the negatively charged sialic acid on the host cell surface. Results: 6SLN-lipo PGA appears to subvert binding of pandemic H1 and seasonal H3 HAs to receptors, as assessed by using guinea pig erythrocytes, which is critical for virus entry into host cells for multiplication. It shows high potency with IC50 values in the range of 300-500 nM against multiplication of both influenza pandemic H1N1/2009 and seasonal H3N2/2004 viruses in cell culture. It acts in synergism with either of the two FDA-approved neuraminidase inhibitor (NAI) clinical drugs, zanamivir (Relenza(R)) and oseltamivir carboxylate (active form of Tamiflu(R)), and it has the potential to aid NAI drugs to achieve complete clearance of the virus from the culture. Conclusions: 6SLN-lipo PGA is a new potential candidate drug for influenza control and is an attractive candidate for use in combination with an NAI drug for minimized toxicity, delayed development of resistance, prevention and treatment with the potential for eradication of human influenza.	[Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Dept Preclin Sci, Pathum Thani 12120, Thailand; [Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Chubu, Aichi 4878501, Japan; [Suzuki, Katsuhiko] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Takashita, Emi] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo 2080011, Japan; [Kanie, Osamu] Tokai Univ, Inst Glycosci, Isehara, Kanagawa 2591292, Japan	Sriwilaijaroen, N (reprint author), Thammasat Univ, Fac Med, Dept Preclin Sci, Rangsit Campus, Pathum Thani 12120, Thailand.	snongluk@hotmail.com			A-STEP (Adaptative and Seamless Technology transfer Program through Target driven RD, JST) project; MEXT COE project for private universities from the Ministry of Education, Culture, Sports, Science and Technology and Chubu University [S0801055]	Research in Y. S.'s lab is supported by the A-STEP (Adaptative and Seamless Technology transfer Program through Target driven R&D, JST) project and by the MEXT COE project for private universities from the Ministry of Education, Culture, Sports, Science and Technology and Chubu University (No. S0801055).	Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; BURNET FM, 1948, AUST J EXP BIOL MED, V26, P381, DOI 10.1038/icb.1948.39; Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI [/10.1016/j.antiviral.2012.02.013, 10.1016/j.antiviral.2012.02.013]; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; HUANG RTC, 1980, VIROLOGY, V107, P313, DOI 10.1016/0042-6822(80)90299-8; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Sriwilaijaroen Nongluk, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P607; Gubareva LV, 1996, J VIROL, V70, P1818; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; SHIBUYA N, 1987, ARCH BIOCHEM BIOPHYS, V254, P1, DOI 10.1016/0003-9861(87)90074-9; Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5; Kobasa D, 1999, J VIROL, V73, P6743; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Sriwilaijaroen N, 2011, FOOD CHEM, V127, P1, DOI 10.1016/j.foodchem.2010.12.031; [Anonymous], 2007, NAT REV MICROBIOL, V5, P2; MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007; Wheeler AH, 1942, SCIENCE, V96, P92, DOI 10.1126/science.96.2482.92; Magesh Sadagopan, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P198; Kamitakahara H, 1998, ANGEW CHEM INT EDIT, V37, P1524; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI [10.1093/infdis/jiq012, 10.1093/infdis/jig012]; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; LIS H, 1986, ANNU REV BIOCHEM, V55, P35, DOI 10.1146/annurev.biochem.55.1.35; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; LoGuidice JM, 1997, BIOCHEM J, V326, P431; Baum L G, 1990, Acta Histochem Suppl, V40, P35; CDC, 2013 2014 INFL SEAS; CDC, ANT DRUG RES INFL VI; CDC, INFL ANT DRUG RES; FDA, FDA APPR RAP TREAT F; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Meijer A, 2014, ANTIVIR RES, V110, P31, DOI 10.1016/j.antiviral.2014.07.001; Nielsen E, 2008, TOXICOLOGICAL RISK A, P371; PLACKETT RL, 1952, J ROY STAT SOC B, V14, P141; Sriwilaijaroen N, 2014, METHODS MOL BIOL, V1200, P107, DOI 10.1007/978-1-4939-1292-6_10; Sriwilaijaroen N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-124; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Vavricka CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2487; von Itzstein M., 2012, INFLUENZA VIRUS SIAL; WHO, LAB METH TEST ANT SU; WHO, INFL SEAS	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	OCT	2015	70	10					2797	2809		10.1093/jac/dkv193		13	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU0ZZ	WOS:000363249800017		
J	Hasegawa, T; Otani, T; Takeda, K; Matsumoto, H; Harato, K; Toyama, Y; Nagura, T				Hasegawa, Takayuki; Otani, Toshiro; Takeda, Kentaro; Matsumoto, Hideo; Harato, Kengo; Toyama, Yoshiaki; Nagura, Takeo			Anterior Cruciate Ligament Reconstruction Does Not Fully Restore Normal 3D Knee Kinematics at 12 Months During Walking and Walk-Pivoting: A Longitudinal Gait Analysis Study	JOURNAL OF APPLIED BIOMECHANICS			English	Article						ACL; motion analysis; biomechanics	EXCESSIVE TIBIAL ROTATION; ACL RECONSTRUCTION; DEFICIENT KNEE; JOINT; CARTILAGE; SURGERY; MOTION; OSTEOARTHRITIS; INSTABILITY; STRENGTH	The purpose of the current study was to longitudinally evaluate how preoperative knee kinematics change after ACL reconstruction. Three-dimensional gait analysis using the point cluster method was undertaken on the same subjects preoperatively and at 3, 6, and 12 months after ACL reconstructive surgery. Thirteen subjects (7 males, 6 females) were examined while performing 2 different activities at self-selected speeds: walking and walk-pivoting (walking, pivoting toward the landed limb side and walking away). The contralateral knees of subjects at 12 months postoperatively were selected as control knees. Flexion range in the stance phase increased with time after surgery, but remained lower than in the contralateral knee, even at 12 months postoperatively (P < .05) during walking and walk-pivoting. The rotation pattern during walking and walk-pivoting showed an offset toward external rotation by 6 months postoperatively compared with control knees, while at 12 months postoperatively the offset had nearly disappeared and the movement pattern resembled that in control knees. These findings suggest that a return to sport participation by 6 months after ACL reconstruction requires careful consideration. Depending on the type of sport, activity restriction even after 12 months may need to be considered to allow complete kinematic restoration.	[Hasegawa, Takayuki; Takeda, Kentaro; Harato, Kengo; Toyama, Yoshiaki; Nagura, Takeo] Keio Univ, Dept Orthopaed Surg, Tokyo, Japan; [Otani, Toshiro] Keio Univ, Fac Nursing & Med Care, Tokyo, Japan; [Matsumoto, Hideo] Keio Univ, Inst Integrated Sports Med, Tokyo, Japan; [Nagura, Takeo] Keio Univ, Dept Clin Biomech, Tokyo, Japan	Hasegawa, T (reprint author), Keio Univ, Dept Orthopaed Surg, Tokyo, Japan.	t.hasegawa@jasinine.ocn.ne.jp					Gokeler A, 2003, KNEE SURG SPORT TR A, V11, P372, DOI 10.1007/s00167-003-0432-1; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Andriacchi TP, 2006, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01.blo.0000197079.26600.09; Keays SL, 2001, KNEE, V8, P229, DOI 10.1016/S0968-0160(01)00099-0; Chaudhari AMW, 2008, MED SCI SPORT EXER, V40, P215, DOI 10.1249/mss.0b013e31815cbb0e; Hurd WI, 2007, J ORTHOP RES, V25, P1369, DOI 10.1002/jor.20440; Beynnon BD, 2002, J ORTHOPAED RES, V20, P332, DOI 10.1016/S0736-0266(01)00115-2; Asano H, 2004, ARTHROSCOPY, V20, P474, DOI 10.1016/j.arthro.2004.03.006; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Brandsson S, 2002, AM J SPORT MED, V30, P361; Gao B, 2010, CLIN BIOMECH, V25, P222, DOI 10.1016/j.clinbiomech.2009.11.006; Patel RR, 2003, AM J SPORT MED, V31, P68; Ristanis S, 2006, CLIN J SPORT MED, V16, P111, DOI 10.1097/00042752-200603000-00005; Knoll Z, 2004, J ELECTROMYOGR KINES, V14, P287, DOI 10.1016/j.jelekin.2003.12.005; Takeda K, 2014, J BIOMECH, V47, P2526, DOI 10.1016/j.jbiomech.2014.03.027; Okazaki K, 2007, AM J SPORT MED, V35, P1091, DOI 10.1177/0363546507299530; Kozanek M, 2008, AM J SPORT MED, V36, P2151, DOI 10.1177/0363546508319051; Ristanis S, 2005, ARTHROSCOPY, V21, P1323, DOI 10.1016/j.arthro.2005.08.032; Majewski M, 2006, KNEE, V13, P184, DOI 10.1016/j.knee.2006.01.005; Webster KE, 2012, GAIT POSTURE, V36, P167, DOI 10.1016/j.gaitpost.2012.02.004; Scanlan SF, 2010, J BIOMECH, V43, P1817, DOI 10.1016/j.jbiomech.2010.02.010; Papannagari R, 2006, AM J SPORT MED, V34, P2006, DOI 10.1177/0363546506290403; Almekinders LC, 2004, J BONE JOINT SURG AM, V86A, P983; BERCHUCK M, 1990, J BONE JOINT SURG AM, V72A, P871; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Georgoalis AD, 2007, CLIN ORTHOP RELAT R, P89, DOI 10.1097/BLO.0b013e31802b4a0a; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Maclntosh DL, 1980, CLIN ORTHOPAEDICS, P45; Reinschmidt C, 1997, GAIT POSTURE, V6, P98, DOI 10.1016/S0966-6362(97)01110-7	29	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	OCT	2015	31	5					330	339		10.1123/jab.2014-0175		10	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	CU5VN	WOS:000363600200006		
J	Wada, I; Shimada, Y; Ikeda, M; Sadr, A; Nakashima, S; Tagami, J; Sumi, Y				Wada, Ikumi; Shimada, Yasushi; Ikeda, Masaomi; Sadr, Alireza; Nakashima, Syozi; Tagami, Junji; Sumi, Yasunori			Clinical assessment of non carious cervical lesion using swept-source optical coherence tomography	JOURNAL OF BIOPHOTONICS			English	Article						NCCL; SS-OCT; TMR; demineralization; attenuation coefficient; in vivo	IN-VITRO; REFRACTIVE-INDEX; ABRASION; ENAMEL; DENTIN; EROSION; REMINERALIZATION; VALIDATION; ABFRACTION; MICROSCOPY	Non-carious cervical lesions (NCCLs) involve various forms of tooth loss with different etiologies. This study aimed to utilize swept-source optical coherence tomography (SS-OCT) at 1300 nm wavelength range in vitro and in vivo to evaluate and clarify the mechanism of NCCLs. In the in vitro phase, a dentin attenuation coefficient (mu(t)) derived from the SS-OCT signal at NCCL was compared with mineral loss obtained from transverse microradiography (TMR) to determine a mu(t) threshold to discriminate demineralization of cervical dentin in vivo. In the clinical study, 242 buccal surfaces were investigated in 35 subjects. Presence and dimensions of NCCLs, cervical cracking and the degree of demineralization at the exposed cervical dentin were determined using SS-OCT. Dentin demineralization was observed in 69% of NCCLs. SS-OCT results confirm that dentin mineral loss and occlusal attrition were associated with larger NCCLs, and can be considered as an etiological factor in formation and progress of these lesions.	[Wada, Ikumi; Shimada, Yasushi; Nakashima, Syozi; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Tokyo, Japan; [Ikeda, Masaomi; Tagami, Junji] Tokyo Med & Dent Univ, Fac Dent, Dept Oral Hlth Care Sci, Clin Oral Sci, Tokyo, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Int Exchange Ctr, Tokyo, Japan; [Sumi, Yasunori] Natl Hosp Geriatr Med, Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Aichi, Japan	Shimada, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Tokyo, Japan.	shimada.ope@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS) [24592861]; Research Grant for Longevity Sciences from Ministry of Health, Labor and Welfare [21A-8]	This work was supported by a Grant-in-Aid for Scientific Research (No. 24592861) from the Japan Society for the Promotion of Science (JSPS); and a Research Grant for Longevity Sciences (21A-8) from the Ministry of Health, Labor and Welfare.	Nakagawa H, 2013, J DENT, V41, P80, DOI 10.1016/j.jdent.2012.10.007; Zucchelli G, 2011, J PERIODONTOL, V82, P1713, DOI 10.1902/jop.2011.110080; Aw TC, 2002, J AM DENT ASSOC, V133, P725; Shimada Y, 2010, J DENT, V38, P655, DOI 10.1016/j.jdent.2010.05.004; Hariri I, 2012, J DENT, V40, P387, DOI 10.1016/j.jdent.2012.01.017; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Le MH, 2010, LASER SURG MED, V42, P62, DOI 10.1002/lsm.20862; Jaeggi T, 1999, CARIES RES, V33, P455, DOI 10.1159/000016551; Brandini DA, 2011, OPER DENT, V36, P581, DOI 10.2341/10-152-S; Piotrowski BT, 2001, J AM DENT ASSOC, V132, P1694; Nazari A, 2013, J BIOPHOTONICS, V6, P171, DOI 10.1002/jbio.201200012; Knuttel A, 2004, J BIOMED OPT, V9, P265, DOI [10.1117/1.1647544, 10.1117/1.16475441]; Bakhsh TA, 2011, DENT MATER, V27, P915, DOI 10.1016/j.dental.2011.05.003; Meng Z, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130322; Mandurah MM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046006; Azzopardi A, 2004, BRIT DENT J, V196, P351, DOI 10.1038/sj.bdj.4811083; Bartlett DW, 2006, J DENT RES, V85, P306; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Popescu DP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2992129; BRADY JM, 1977, J AM DENT ASSOC, V94, P726; ARENDS J, 1989, CARIES RES, V23, P36; Heilman JR, 1997, CARIES RES, V31, P423; Imai K, 2012, J ENDODONT, V38, P1269, DOI 10.1016/j.joen.2012.05.008; Senna P, 2012, J ORAL REHABIL, V39, P450, DOI 10.1111/j.1365-2842.2012.02290.x; Natsume Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600448; Grippo JO, 2012, J ESTHET RESTOR DENT, V24, P10, DOI 10.1111/j.1708-8240.2011.00487.x; Jones RS, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161192; Fried D, 2013, P SOC PHOTO-OPT INST, P8566; Fried W. A., 2014, P SOC PHOTOOPTICAL I, V8929; Mandurah M. M., 2014, LASERS MED SCI; Meyers Ian A, 2008, Ann R Australas Coll Dent Surg, V19, P27	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	OCT	2015	8	10					846	854		10.1002/jbio.201400113		9	Biochemical Research Methods; Biophysics; Optics	Biochemistry & Molecular Biology; Biophysics; Optics	CU4ES	WOS:000363480400008		
J	Koide, H; Holmbeck, K; Lui, JC; Guo, XXC; Driggers, P; Chu, T; Tatsuno, I; Quaglieri, C; Kino, T; Baron, J; Young, MF; Robey, PG; Segars, JH				Koide, Hisashi; Holmbeck, Kenn; Lui, Julian C.; Guo, Xiaoxiao C.; Driggers, Paul; Chu, Tiffany; Tatsuno, Ichiro; Quaglieri, Caroline; Kino, Tomoshige; Baron, Jeffrey; Young, Marian F.; Robey, Pamela G.; Segars, James H.			Mice Deficient in AKAP13 (BRX) Are Osteoporotic and Have Impaired Osteogenesis	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEOPOROSIS; BRX; RHO-GEF; OSTEOGENESIS; RUNX2	NUCLEOTIDE-EXCHANGE FACTORS; MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; RHO-GTPASES; PROTEIN; ACTIVATION; KINASE; LBC; CBFA1	Mechanical stimulation is crucial to bone growth and triggers osteogenic differentiation through a process involving Rho and protein kinase A. We previously cloned a gene (AKAP13, aka BRX) encoding a protein kinase A-anchoring protein in the N-terminus, a guanine nucleotide-exchange factor for RhoA in the mid-section, coupled to a carboxyl region that binds to estrogen and glucocorticoid nuclear receptors. Because of the critical role of Rho, estrogen, and glucocorticoids in bone remodeling, we examined the multifunctional role of Akap13. Akap13 was expressed in bone, and mice haploinsufficient for Akap13 (Akap13(+/-)) displayed reduced bone mineral density, reduced bone volume/total volume, and trabecular number, and increased trabecular spacing; resembling the changes observed in osteoporotic bone. Consistent with the osteoporotic phenotype, Colony forming unit-fibroblast numbers were diminished in Akap13(+/-) mice, as were osteoblast numbers and extracellular matrix production when compared to control littermates. Transcripts of Runx2, an essential transcription factor for the osteogenic lineage, and alkaline phosphatase (Alp), an indicator of osteogenic commitment, were both reduced in femora of Akap13(+/-) mice. Knockdown of Akap13 reduced levels of Runx2 and Alp transcripts in immortalized bone marrow stem cells. These findings suggest that Akap13 haploinsufficient mice have a deficiency in early osteogenesis with a corresponding reduction in osteoblast number, but no impairment of mature osteoblast activity. (C) 2015 American Society for Bone and Mineral Research.	[Koide, Hisashi; Guo, Xiaoxiao C.; Driggers, Paul; Chu, Tiffany; Quaglieri, Caroline; Kino, Tomoshige; Segars, James H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Reprod Endocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Holmbeck, Kenn; Young, Marian F.; Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Lui, Julian C.; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Tatsuno, Ichiro] Toho Univ, Sakura Med Ctr, Ctr Diabet Metab & Endocrinol, Chiba 2748510, Japan	Segars, JH (reprint author), Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.	jsegars2@jhmi.edu	Lui, Chun Kin Julian/E-2253-2012				Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; Ishizaki T, 1996, EMBO J, V15, P1885; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Satomura K, 2000, J CELL BIOCHEM, V78, P391; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; TOKSOZ D, 1994, ONCOGENE, V9, P621; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Ren JQ, 2011, CYTOTHERAPY, V13, P661, DOI 10.3109/14653249.2010.548379; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Gopalakrishnan R, 2005, CELLS TISSUES ORGANS, V181, P166, DOI 10.1159/000091378; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bear MD, 2010, J BIOL CHEM, V285, P32919, DOI 10.1074/jbc.M109.062513; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Dutt P, 2002, FEBS LETT, V531, P565, DOI 10.1016/S0014-5793(02)03625-6; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; Kim JM, 2013, J CELL PHYSIOL, V228, P617, DOI 10.1002/jcp.24171; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Krum SA, 2011, J CELL BIOCHEM, V112, P401, DOI 10.1002/jcb.22970; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Kino T, 2010, EXPERT REV ENDOCRINO, V5, P603, DOI 10.1586/eem.10.3; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Roshandel D, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-19	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	OCT	2015	30	10					1887	1895		10.1002/jbmr.2534		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CU1MR	WOS:000363286500017		
J	Miyazaki, S; Taniguchi, H; Nakamura, H; Hachiya, H; Ichihara, N; Araki, M; Kuroi, A; Takagi, T; Iwasawa, J; Hirao, K; Iesaka, Y				Miyazaki, Shinsuke; Taniguchi, Hiroshi; Nakamura, Hiroaki; Hachiya, Hitoshi; Ichihara, Noboru; Araki, Makoto; Kuroi, Akio; Takagi, Takamitsu; Iwasawa, Jin; Hirao, Kenzo; Iesaka, Yoshito			Adenosine Triphosphate Test After Cryothermal Pulmonary Vein Isolation: Creating Contiguous Lesions Is Essential for Eliminating Dormant Conduction	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						adenosine; atrial fibrillation; cryoablation; dormant conduction; pulmonary vein isolation	RADIOFREQUENCY CATHETER ABLATION; ATRIAL-FIBRILLATION; 2ND-GENERATION CRYOBALLOON; CAVOTRICUSPID ISTHMUS; EFFICACY; SAFETY; CRYOABLATION; FLUTTER; BALLOON	Dormant Conduction After Cryothermal PVI BackgroundAdenosine triphosphate (ATP) testing reveals dormant pulmonary vein (PV) conduction after electrical PV isolation (PVI). This study aimed to evaluate the incidence of latent PV conduction after cryothermal PVI. MethodsFifty-four consecutive paroxysmal atrial fibrillation patients undergoing cryothermal PVI were prospectively enrolled. PVI was performed with one 28-mm second-generation balloon using a 3-minute freeze technique, and touch-up lesions were created by focal cryothermal applications. ATP testing was performed following PVI with a 20-mm circular mapping catheter placed in each PV. ResultsOf 217 PVs, 205 (94.5%) were isolated using a cryoballoon, and 12 required additional focal ablation. ATP testing was performed in 46 patients for 173 and 8 PVs, which were isolated by cryoballoons and focal ablation, respectively. No dormant PV conduction was provoked in any PVs, which were isolated by cryoballoons, whereas 4 (50.0%) out of 8 PVs requiring focal ablation had transient ATP-provoked reconnections (0 vs. 50.0%, P < 0.0001) with a median duration of 11.3 (10.7-17.1) seconds. The latent PV conduction site was identical to the residual conduction gap site after cryoballoon ablation in all. All latent conduction was successfully eliminated by 2 (2.0-9.5) additional focal applications. At a mean follow-up of 7.7 1.6 months, 81.5% of the patients were arrhythmia free after a single procedure. ConclusionsNo dormant PV conduction was provoked in PVs, which were isolated by 28-mm second-generation cryoballoons, but was provoked in 50% of PVs, which were isolated by focal cryoablation. These findings suggest that creating contiguous lesions is essential for eliminating dormant conduction in cryothermal ablation.	[Miyazaki, Shinsuke; Taniguchi, Hiroshi; Nakamura, Hiroaki; Hachiya, Hitoshi; Ichihara, Noboru; Araki, Makoto; Kuroi, Akio; Takagi, Takamitsu; Iwasawa, Jin; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Tsuchiura, Ibaraki 3000053, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Macle L, 2012, CAN J CARDIOL, V28, P184, DOI 10.1016/j.cjca.2011.10.008; Miller MA, 2012, EUROPACE, V14, P653, DOI 10.1093/europace/eus048; Lehrmann H, 2012, HEART RHYTHM, V9, P1942, DOI 10.1016/j.hrthm.2012.08.020; Manusama R, 2004, CIRCULATION, V109, P1636, DOI 10.1161/01.CIR.0000124478.98343.00; Khairy P, 2008, J CARDIOVASC ELECTR, V19, P1203, DOI 10.1111/j.1540-8167.2008.01224.x; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Haissaguerre M, 2000, CIRCULATION, V102, P2463; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Andrade JG, 2013, J CARDIOVASC ELECTR, V24, P692, DOI 10.1111/jce.12114; Gula LJ, 2011, J CARDIOVASC ELECTR, V22, P982, DOI 10.1111/j.1540-8167.2011.02037.x; Franceschi F, 2011, HEART RHYTHM, V8, P1068, DOI 10.1016/j.hrthm.2011.01.047; Sarabanda AV, 2005, J AM COLL CARDIOL, V46, P1902, DOI 10.1016/j.jacc.2005.07.046; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Datino T, 2010, CIRCULATION, V121, P963, DOI 10.1161/CIRCULATIONAHA.109.893107; Kojodjojo P, 2010, HEART, V96, P1379, DOI 10.1136/hrt.2009.192419; Arentz T, 2004, J CARDIOVASC ELECTR, V15, P1041, DOI 10.1046/j.1540-8167.2004.04031.x; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Tritto M, 2004, EUR HEART J, V25, P2155, DOI 10.1016/j.ehj.2004.08.023; Chierchia GB, 2009, EUROPACE, V11, P1606, DOI 10.1093/europace/eup339; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050; Feld GK, 2008, HEART RHYTHM, V5, P1009, DOI 10.1016/j.hrthm.2008.03.019; Ciconte G, 2014, HEART RHYTHM, V12, P673; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Macle L, 2014, HEART RHYTHM, V01-02; Martins RP, 2014, HEART RHYTHM, V11, P386, DOI 10.1016/j.hrthm.2014.01.002; Miyazaki S, 2014, J CARDIOVASC ELECTR, V26, P260; VansBelle YL, 2012, NETH HEART J, V20, P447	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	OCT	2015	26	10					1069	1074		10.1111/jce.12726		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU0MR	WOS:000363211600011		
J	Konno, T; Hayashi, K; Fujino, N; Oka, R; Nomura, A; Nagata, Y; Hodatsu, A; Sakata, K; Furusho, H; Takamura, M; Nakamura, H; Kawashiri, MA; Yamagishi, M				Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Oka, Rie; Nomura, Akihiro; Nagata, Yoji; Hodatsu, Akihiko; Sakata, Kenji; Furusho, Hiroshi; Takamura, Masayuki; Nakamura, Hiroyuki; Kawashiri, Masa-Aki; Yamagishi, Masakazu			Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						cardiac magnetic resonance; fragmented QRS; fibrosis; hypertrophic cardiomyopathy; pathological Q waves	CARDIOVASCULAR MAGNETIC-RESONANCE; QUANTIFICATION; DISEASE; EVENTS; BRANCH; DEATH; WAVES; SCAR; CMR	fQRS Predicts Myocardial Fibrosis in HCM IntroductionMyocardial fibrosis in patients with hypertrophic cardiomyopathy (HCM) usually shows a patchy distribution, which may not be detected by pathological Q waves on 12-lead ECGs. Fragmented QRS complexes (fQRS) reflect intraventricular conduction delay and can be a marker of myocardial fibrosis. We assessed whether fQRS show better correlation with myocardial fibrosis than pathological Qwaves in HCM. Methods and ResultsThis cross-sectional study included 108 patients with HCM who underwent 12-lead ECG and cardiac magnetic resonance imaging with late gadolinium enhancement (LGE-CMR). The number of leads with pathological Q waves was not correlated with the extent of LGE measured at any different standard deviations (SDs) (2, 4, 6, 8, and 10 SD), whereas the number of leads with fQRS showed the best correlation with LGE at 6 SD (r = 0.32, P = 0.0008). Further, the number of leads with fQRS was an independent predictor for the extent of LGE at 6 SD. fQRS showed higher accuracy for detecting myocardial fibrosis defined by LGE at 6 SD than pathological Q waves; the overall sensitivity, specificity, and accuracy of fQRS were 40%, 80%, and 64%, respectively, whereas those of pathological Q waves were 7%, 97%, and 60%, respectively. fQRS in lateral leads showed the highest accuracy (75%), followed by inferior leads (59%) and anterior leads (57%), for detecting LGE at 6 SD in the corresponding left ventricular segment. ConclusionsThese findings suggest that fQRS may have a substantially higher sensitivity and diagnostic accuracy compared with pathological Q waves for detecting myocardial fibrosis in HCM.	[Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Nomura, Akihiro; Nagata, Yoji; Hodatsu, Akihiko; Sakata, Kenji; Furusho, Hiroshi; Takamura, Masayuki; Kawashiri, Masa-Aki; Yamagishi, Masakazu] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan; [Konno, Tetsuo; Nakamura, Hiroyuki; Yamagishi, Masakazu] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa 9208640, Japan; [Oka, Rie] Hokuriku Cent Hosp, Dept Internal Med, Oyabe, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Publ Hlth, Kanazawa, Ishikawa 9208640, Japan	Konno, T (reprint author), Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	konnokontetsu@staff.kanazawa-u.ac.jp			Ministry of Education, Science and Culture of Japan [24790748, 26461105]	Tetsuo Konno was funded by a grant from the Ministry of Education, Science and Culture of Japan (Research Project Number: 24790748). Masakazu Yamagishi was funded by a grant from the Ministry of Education, Science and Culture of Japan (Research Project Number: 26461105).	Konno T, 2004, EUR HEART J, V25, P246, DOI 10.1016/j.ehj.2003.10.031; Debonnaire P, 2015, J CARDIOVASC ELECTR, V26, P547, DOI 10.1111/jce.12629; [Anonymous], 2011, J AM COLL CARDIOL, V58, pe212; Todiere G, 2012, J AM COLL CARDIOL, V60, P922, DOI 10.1016/j.jacc.2012.03.076; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Kang KW, 2014, HEART RHYTHM, V11, P1433, DOI 10.1016/j.hrthm.2014.05.002; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Harimoto K, 2014, J ELECTROCARDIOL, V47, P636, DOI 10.1016/j.jelectrocard.2014.06.010; Chen XY, 2014, EUR J RADIOL, V83, P297, DOI 10.1016/j.ejrad.2013.10.025; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONHA.105.595892; Moon J, 2013, CIRC J, V77, P1742, DOI 10.1253/circj.CJ-12-1378; Hayashi T, 2013, CIRC J, V77, P2889, DOI 10.1253/circj.CJ-13-0335; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284; FLOWERS NC, 1969, CIRCULATION, V39, P531; Kosuge M, 2012, CIRC J, V76, P462, DOI 10.1253/circj.CJ-11-1036; Femenia F, 2013, J INTERV CARD ELECTR, V38, P159, DOI 10.1007/s10840-013-9829-z; Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018; Nagata Y, 2015, CAN J CARDIOL, V31, P702, DOI 10.1016/j.cjca.2014.12.036; Chen XY, 2014, INT J CARDIOVAS IMAG, V30, P55, DOI 10.1007/s10554-014-0416-x; Das MK, 2009, HEART RHYTHM S, V6, pS8; Kawasaki T, 2015, CIRC J, V79, P847, DOI 10.1253/circj.CJ-14-1109; Konno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101465; Nomura A, 2015, CIRC J, V79, P136, DOI 10.1253/circj.CJ-14-0822; Spiewak M, 2010, EUR J RADIOL, V74, pE150, DOI 10.1016/j.ejrad.2009.05.035; Suwa K, 2014, OPEN HEART, V1	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	OCT	2015	26	10					1081	1087		10.1111/jce.12742		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU0MR	WOS:000363211600013		
J	Toyama, M; Kishimoto, H; Mishiro, K; Nakano, R; Ihara, F				Toyama, Masatoshi; Kishimoto, Hidenari; Mishiro, Koji; Nakano, Ryo; Ihara, Fumio			Sticky Traps Baited with Synthetic Aggregation Pheromone Predict Fruit Orchard Infestations of Plautia stali (Hemiptera: Pentatomidae)	JOURNAL OF ECONOMIC ENTOMOLOGY			English	Article						Plautia stali; prediction method; sticky trap; aggregation pheromone; Chamaecyparis obtusa	WINGED GREEN BUG; SCOTT HETEROPTERA	The brown-winged green bug, Plautia stali Scott, mainly reproduces on Japanese cedar or cypress cones in Japanese plantation forests during summer and autumn. It often depletes its food sources in forest habitats and moves to cultivated crops in large numbers. To establish an easy method for assessing the risk of fruit orchard infestation by P. stali, we conducted a 3-yr field survey that monitored the attraction of bugs to the synthetic P. stali aggregation pheromone using a sticky trap. We used a morphological indicator, variable body size depending on food intake, to estimate the nutritional status in nymphs, which showed that nymphs attracted to the synthetic pheromone were starving. Comparisons between increasing changes in the number of stylet sheaths left on the cones by P. stali and the number of trapped nymphs show that monitoring nymphs with the pheromone-baited sticky trap is useful for inferring conditions regarding food resources in forest habitats. The trend toward trapping second instars can provide a timely overview of resource competition for cones. Trapping middle-to-late (third-fifth) instars is a warning that the cones are finally depleted and that there is a high probability that adults will leave the forests and invade the orchards. In addition, trends in trapping adults suggest that there is a potential risk of orchard infestation by the pest and predict the intensity and period of the invasion. The pheromone-baited sticky trap is an easy but useful survey tool for predicting P. stali orchard infestations.	[Toyama, Masatoshi; Mishiro, Koji; Nakano, Ryo; Ihara, Fumio] NARO, Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan; [Kishimoto, Hidenari] NARO, Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan	Toyama, M (reprint author), NARO, Inst Fruit Tree Sci, Grape & Persimmon Res Stn, 301-2 Akitsu, Higashihiroshima, Hiroshima 7392494, Japan.	tym@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries, Japan	We thank Mitsue Fukuda and Nana Yanagita for their excellent technical assistance in measuring morphological characters and Enago (www.enago.jp) for the English language review. This work was financially supported by the Ministry of Agriculture, Forestry, and Fisheries, Japan, through a project entitled "Revision of forecasting systems for crop pests and diseases."	Sugie H, 1996, APPL ENTOMOL ZOOL, V31, P427; Adachi I, 2007, APPL ENTOMOL ZOOL, V42, P425, DOI 10.1303/aez.2007.425; MORIYA S, 1984, APPL ENTOMOL ZOOL, V19, P317; Morishita M, 2007, JPN J APPL ENTOMOL Z, V51, P21, DOI 10.1303/jjaez.2007.21; BOWLING CC, 1979, J ECON ENTOMOL, V72, P259; Ide Y., 1997, PLANT PROTECT, V51, P155; Inoue K., 1986, PLANT PROT, V40, P289; Katase M., 2005, B CHIBA AGR RES CTR, V4, P135; Moriya S, 1995, B OKINAWA AGR EXP ST, V5, P1; Noda M., 1985, B FUKUOKA AGR RES B, V4, P17; Ohira Y., 2002, P ASS PLANT PROT KYU, V48, P76; Sato R., 1997, PLANT PROT, V51, P158; Shiga M., 1980, PRANT PROTECT, V34, P303; Shiga M., 1984, B FRUIT TREE RES STN, V11, P107; Shiga M, 1989, B FRUIT TREE RES S A, V16, P133; Takagi K., 1997, PLANT PROT, V51, P150; Toyama M., 2015, B NARO I FRUIT TREE, V19, P23; Tsutsumi T, 2001, PLANT PROT, V55, P560; Umeya K., 1976, PLANT PROTECT, V30, P133; Umeya K., 1974, PLANT PROT, V28, P279; Yanase N., 1997, PLANT PROT, V51, P160	21	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-0493	1938-291X		J ECON ENTOMOL	J. Econ. Entomol.	OCT	2015	108	5					2366	2372		10.1093/jee/tov198		7	Entomology	Entomology	CT5DQ	WOS:000362828300024		
J	Kera, S; Ueno, N				Kera, Satoshi; Ueno, Nobuo			Photoelectron spectroscopy on the charge reorganization energy and small polaron binding energy of molecular film	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Hopping mobility; Electron-phonon coupling; Hole-vibration coupling; Vibronic satellite; HOMO fine feature; Polaron; Reorganization energy; Relaxation energy; Ultraviolet photoelectron spectroscopy; Organic semiconductor; Pentacene, Perfluoropentacene	PHTHALOCYANINE ULTRATHIN-FILM; HIGHEST OCCUPIED BAND; ORGANIC THIN-FILMS; POSTCOLLISION INTERACTION; ELECTRONIC-STRUCTURE; OTI-PHTHALOCYANINE; FINE-STRUCTURES; MONOLAYER; TRANSPORT; IONIZATION	Understanding of electron-phonon coupling as well as intermolecular interaction is required to discuss the mobility of charge carrier in functional molecular solids. This article summarizes recent progress in direct measurements of valence hole-vibration coupling in ultrathin films of organic semiconductors by using ultraviolet photoelectron spectroscopy (UPS). The experimental study of hole-vibration coupling of the highest occupied molecular orbital (HOMO) state in ordered monolayer film by UPS is essential to comprehend hole-hopping transport and small-polaron related transport in organic semiconductors. Only careful measurements can attain the high-resolution spectra and provide key parameters in holetransport dynamics, namely the charge reorganization energy and small polaron binding energy. Analyses methods of the UPS HOMO fine feature and resulting charge reorganization energy and small polaron binding energy are described for pentacene and perfluoropentacene films. Difference between thin-film and gas-phase results is discussed by using newly measured high-quality gas-phase spectra of pentacene. Methodology for achieving high-resolution UPS measurements for molecular films is also described. (C) 2015 The Authors. Published by Elsevier B.V.	[Kera, Satoshi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Kera, Satoshi; Ueno, Nobuo] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanomat Sci, Inage Ku, Chiba 2638522, Japan	Kera, S (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	kera@ims.ac.jp	Ueno, Nobuo/F-4358-2014	Ueno, Nobuo/0000-0003-2051-1492	JSPS [24245034, 20245039, 20685014, 20656002, 17685019]; MEXT	The authors are very grateful to Prof. V. Coropceanu, Prof. S. Duhm, Dr. H. Yamane, Dr. H. Fukagawa, and Dr. S. Nagamatsu for stimulating discussions on the computation as well as many students in the Graduate School of Chiba University for doing experiments. The study is partly supported by JSPS KAKENHI (24245034, 20245039, 20685014, 20656002, 17685019), 21st Century CUE program (MEXT) and Global CUE program (MEXT).	CAPEK V, 1995, CHEM PHYS, V200, P309, DOI 10.1016/0301-0104(95)00290-1; Sakamoto Y, 2004, J AM CHEM SOC, V126, P8138, DOI 10.1021/ja0476258; Heimel G, 2013, NAT CHEM, V5, P187, DOI [10.1038/nchem.1572, 10.1038/NCHEM.1572]; Fukagawa H, 2005, J ELECTRON SPECTROSC, V144, P475, DOI 10.1016/j.elspec.2005.01.083; Yamane H, 2005, SYNTHETIC MET, V152, P297, DOI 10.1016/j.synthmet.2005.07.334; Koch N, 2007, ADV MATER, V19, P112, DOI 10.1002/adma.200601825; Yamamoto I, 2008, SURF SCI, V602, P2232, DOI 10.1016/j.susc.2008.04.037; Wang JZ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/9/095704; Yamane H, 2004, J ELECTRON SPECTROSC, V137, P223, DOI 10.1016/j.elspec.02.054; SCHMIDT V, 1981, PHYS REV A, V24, P1803, DOI 10.1103/PhysRevA.24.1803; Matzdorf R, 1998, SURF SCI REP, V30, P153, DOI 10.1016/S0167-5729(97)00013-7; Chong DP, 2002, J CHEM PHYS, V116, P1760, DOI 10.1063/1.1430255; Yamane H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086602; Stadtmuller B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106103; Scholl A, 2010, SCIENCE, V329, P303, DOI 10.1126/science.1189106; Duhm S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.045418; Bredas JL, 2004, CHEM REV, V104, P4971, DOI 10.1021/cr040084k; Coropceanu V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.275503; SALANECK WR, 1978, PHYS REV LETT, V40, P60, DOI 10.1103/PhysRevLett.40.60; Yamane H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153412; Tanaka A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033101; Troisi A, 2011, CHEM SOC REV, V40, P2347, DOI 10.1039/c0cs00198h; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; Inokuchi H, 2006, ORG ELECTRON, V7, P62, DOI 10.1016/j.orgel.2005.12.007; MILLER T, 1984, PHYS REV B, V29, P1121, DOI 10.1103/PhysRevB.29.1121; SALANECK WR, 1980, PHYS REV LETT, V45, P280, DOI 10.1103/PhysRevLett.45.280; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Ortmann F, 2015, ADV FUNCT MATER, V25, P1933, DOI 10.1002/adfm.201402334; Shionoiri M, 2007, JPN J APPL PHYS 1, V46, P1625, DOI 10.1143/JJAP.46.1625; Sugiyama T, 2007, CHEM PHYS LETT, V449, P319, DOI 10.1016/j.cplett.2007.10.088; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Willenbockel M, 2015, PHYS CHEM CHEM PHYS, V17, P1530, DOI 10.1039/c4cp04595e; Kera S, 2009, PROG SURF SCI, V84, P135, DOI 10.1016/j.progsurf.2009.03.002; Ohtomo M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232205; Kera S, 2013, J PHYS CHEM C, V117, P22428, DOI 10.1021/jp4032089; Delgado MCR, 2009, J AM CHEM SOC, V131, P1502, DOI 10.1021/ja807528w; Hovel H, 1998, PHYS REV LETT, V81, P4608, DOI 10.1103/PhysRevLett.81.4608; Kera S, 2004, SURF SCI, V566, P571, DOI 10.1016/j.susc.2004.05.110; Kera S, 2002, CHEM PHYS LETT, V364, P93, DOI 10.1016/S0009-2614(02)01302-7; Kataoka T, 2008, CHEM PHYS LETT, V451, P43, DOI 10.1016/j.cplett.2007.11.072; Duhm S, 2012, ADV MATER, V24, P901, DOI 10.1002/adma.201103262; Sugiyama T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388922; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Fukagawa H, 2007, ADV MATER, V19, P665, DOI 10.1002/adma.200601678; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; SEKI K, 1974, B CHEM SOC JPN, V47, P1608, DOI 10.1246/bcsj.47.1608; Capek V., 1994, ORGANIC MOL CRYSTALS; Dauth M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103005; Feyer V., J ELECT SPE IN PRESS; Fujii K., 2007, J ELECTRON SPECTROSC, V174, P65; Fujii K., 2009, SURF SCI, V601, P3765; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.041302; Fukagawa H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085304; Ishii H., 2015, SPRINGER SERIES MAT, V209; Kera S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121305; Kosugi N., J ELECT SPE IN PRESS; Nakayama Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.01AD03; Offenbacher H., J ELECT SPE IN PRESS; Paramonov PB, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.041403; Stadtmuller B., J ELECT SPE IN PRESS; Takeya J, 2005, JPN J APPL PHYS 2, V44, pL1393, DOI 10.1143/JJAP.44.L1393; Ueno N., 1976, THESIS TOHOKU U; Ueno N, 2008, APPL PHYS A-MATER, V92, P495, DOI 10.1007/s00339-008-4553-8; Ueno N., 2015, PROG SURF SCI, V209, pChapl	67	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		2	11		10.1016/j.elspec.2015.07.007		10	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400002		
J	Bussolotti, F				Bussolotti, Fabio			High-sensitivity ultraviolet photoemission spectroscopy technique for direct detection of gap states in organic thin films	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Photoemission spectroscopy; Gap states; Organic molecules; Organic/inorganic interface; Organic/organic interface	COPPER PHTHALOCYANINE; INTERFACE; ELECTRONS; ENERGY; CUPC	We developed ultrahigh sensitivity, low-background ultraviolet photoemission spectroscopy (UPS) technique which does not introduce detectable radiation damages into organic materials. The UPS allows to detect density of states of the order of similar to 10(16) states eV(-1) cm(-3) even for radiation-sensitive organic films, this results being comparable to electrical measurements of charge trapping centers. In this review we introduce the method of ultrahigh sensitivity photoemission measurement and we present some results on the energy distribution of gap states in pentacene (Pn) films deposited on SiO2 and Au(1 1 1) substrate. For Pn/SiO2 thin film the results show that exposure to inert gas (N-2 and Ar) atmosphere produces a sharp rise in gap states from 10(16) to 10(18) states eV(-1) cm(-3) and pushes the Fermi level closer to the valence band (0.15-0.17 eV), as does exposure to O-2 (0.20 eV), while no such gas-induced effects are observed for Pn/Au(1 1 1) system. The results demonstrate that these gap states originate from small imperfections in the Pn packing structure, which are induced by gas penetration into the film through the Pn crystal grain boundaries. Similar results were obtained for CuPc/F16CuPc thin films, a prototypical example of donor/acceptor interface for photovoltaic application. (C) 2015 Elsevier B.V. All rights reserved.	[Bussolotti, Fabio] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanomat Sci, Chiba 2638522, Japan	Bussolotti, F (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	fabio@ims.ac.jp			MEXT	The ultrahigh sensitivity UPS project is supported by 21st Century COE program (MEXT) and 388 Global COE program (MEXT).	Heimel G, 2013, NAT CHEM, V5, P187, DOI [10.1038/nchem.1572, 10.1038/NCHEM.1572]; VOS M, 1989, PHYS REV B, V39, P3274, DOI 10.1103/PhysRevB.39.3274; Hosokai T, 2012, CHEM PHYS LETT, V544, P34, DOI 10.1016/j.cplett.2012.07.006; Kajiro H, 2010, INT J MOL SCI, V11, P3803, DOI 10.3390/ijms11103803; Hoshino A, 2003, ACTA CRYSTALLOGR B, V59, P393, DOI 10.1107/S010876810300942X; Koch N, 2007, ADV MATER, V19, P112, DOI 10.1002/adma.200601825; Kera S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085304; Schwieger T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155207; Mao HY, 2011, ORG ELECTRON, V12, P534, DOI 10.1016/j.orgel.2011.01.003; Amy F, 2005, ORG ELECTRON, V6, P85, DOI 10.1016/j.orgel.2005.03.003; Ye RB, 2008, APPL SURF SCI, V254, P7885, DOI 10.1016/j.apsusc.2008.03.048; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Duhm S, 2008, NAT MATER, V7, P326, DOI 10.1038/nmat2119; Bussolotti F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155120; Hwang J, 2007, J PHYS CHEM C, V111, P1378, DOI 10.1021/jp067004w; Chen W, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857460; Kalb WL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155315; Bussolotti F, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115319; Bussolotti F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.267602; De Angelis F., 2006, APPL PHYS LETT, V88; Fahlman M., 2007, J PHYS CONDENS MATT, V19; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; Fukagawa H., 2007, ADV MATER, V19, P668; Hinderhofer A, 2011, THESIS U TUBINGEN GE; Hosokai T., 2010, APPL PHYS LETT, V97; Kafer D., 2007, PHYS REV B, V75, P1; Kafer D, 2009, APPL PHYS A-MATER, V95, P273, DOI 10.1007/s00339-008-5011-3; Kang J.H., 2005, APPL PHYS LETT, V86; Lang DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086802; Ono M., 2006, MOL CRYST LIQ CRYST, V455, P241; Salzmann I, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767972; Sueyoshi T., 2009, APPL PHYS LETT, V95; Sueyoshi T., 2010, APPL PHYS LETT, V96	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		29	38		10.1016/j.elspec.2015.04.002		10	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400005		
J	Yamane, H; Kosugi, N				Yamane, Hiroyuki; Kosugi, Nobuhiro			Systematic study on intermolecular valence-band dispersion in molecular crystalline films	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Organic semiconductor; Phthalocyanine; Intermolecular interaction; Valence band dispersion; Angle-resolved photoemission spectroscopy; Synchrotron radiation	ULTRAVIOLET PHOTOELECTRON-SPECTROSCOPY; ENERGY-LEVEL ALIGNMENT; ORGANIC MONOLAYER FILM; ORIENTED THIN-FILMS; ELECTRONIC-STRUCTURE; CHARGE-TRANSPORT; PHTHALOCYANINE; PHOTOEMISSION; STATES; SEMICONDUCTORS	Functionalities of organic semiconductors are governed not only by individual properties of constituent molecules but also by solid-state electronic states near the Fermi level such as frontier molecular orbitals, depending on weak intermolecular interactions in various conformations. The individual molecular property has been widely investigated in detail; on the other hand, the weak intermolecular interaction is difficult to investigate precisely due to the presence of the structural and thermal energy broadenings in organic solids. Here we show quite small but essential intermolecular valence band dispersions and their temperature dependence of sub-0.1-eV scale in crystalline films of metal phthalocyanines (H2Pc, ZnPc, CoPc, MnPc, and F16ZnPc) by using angle-resolved photoemission spectroscopy (ARPES) with synchrotron radiation. The observed bands show intermolecular and site dependent dispersion widths, phases, and periodicities, for different chemical substitution of terminal groups and central metals in the phthalocyanine molecule. The precise and systematic band-dispersion measurement would be a credible approach toward the comprehensive understanding of intermolecular interactions and resultant charge transport properties as well as their tuning by substituents in organic molecular systems. (C) 2015 Elsevier B.V. All rights reserved.	[Yamane, Hiroyuki; Kosugi, Nobuhiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Yamane, Hiroyuki; Kosugi, Nobuhiro] SOKENDAI, Okazaki, Aichi 4448585, Japan	Yamane, H (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	yamane@ims.ac.jp			Japan Society for the Promotion of Science [23245007, 24685032]	The authors would like to thank the staff of the UVSOR Synchrotron for their kind supports, in particular, Toshio Horigome in the development of the ARPES system at BL6U. We also thank Dr. Toshihiko Kaji and Prof. Masahiro Hiramoto (Department of Materials Molecular Science, IMS) for their fruitful assistance of the purification of CoPc. HY would like to offer sincere thanks to Prof. Nobuo Ueno for initiating the ARPES work on organic systems during the Ph.D. study and for continuous encouragements until now. This work was partly supported by Grant-in-Aid for Scientific Research (A) (no. 23245007) and Grant-in-Aid for Young Scientists (A) (no. 24685032) from Japan Society for the Promotion of Science.	Yoshimura D, 1999, PHYS REV B, V60, P9046, DOI 10.1103/PhysRevB.60.9046; DAY P, 1963, NATURE, V197, P589, DOI 10.1038/197589b0; Kera S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212406; Kanai K, 2009, THIN SOLID FILMS, V517, P3276, DOI 10.1016/j.tsf.2008.12.012; Bussolotti F, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643717; Kera S, 2006, CHEM PHYS, V325, P113, DOI 10.1016/j.chemphys.2005.10.023; Taguchi Y, 1997, J PHYS-CONDENS MAT, V9, P6761, DOI 10.1088/0953-8984/9/31/025; Witte G, 2004, J MATER RES, V19, P1889, DOI 10.1557/JMR.2004.0251; Kahn A, 2003, J POLYM SCI POL PHYS, V41, P2529, DOI 10.1002/polb.10642; Ziroff J, 2009, SURF SCI, V603, P354, DOI 10.1016/j.susc.2008.11.019; Xin Q, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226401; Yamane H, 2008, PHYS STATUS SOLIDI B, V245, P793, DOI 10.1002/pssb.200743448; Schwalb CH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.146801; Koller G, 2007, SCIENCE, V317, P351, DOI 10.1126/science.1143239; Annese E, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205417; Yamane H, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4902912; HASEGAWA S, 1994, J CHEM PHYS, V100, P6969, DOI 10.1063/1.467013; Yamane H, 2009, J ELECTRON SPECTROSC, V174, P28, DOI 10.1016/j.elspec.2009.03.002; Yamane H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086602; Annese E, 2011, J PHYS CHEM C, V115, P17409, DOI 10.1021/jp203200s; Ueno N, 1997, J CHEM PHYS, V107, P2079, DOI 10.1063/1.474558; AKAMATU H, 1950, J CHEM PHYS, V18, P810, DOI 10.1063/1.1747780; Suemori K, 2004, JPN J APPL PHYS 2, V43, pL1014, DOI 10.1143/JJAP.43.L1014; SAITO T, 1994, J PHYS CHEM-US, V98, P2726, DOI 10.1021/j100062a003; Tamai A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075134; Yamane H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153412; Petraki F, 2011, J PHYS CHEM C, V115, P21334, DOI 10.1021/jp207568q; Yamane H, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.033102; FROHLICH H, 1959, P PHYS SOC LOND, V74, P643, DOI 10.1088/0370-1328/74/5/420; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Yamane H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165436; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; SEKI K, 1984, CHEM PHYS, V91, P459, DOI 10.1016/0301-0104(84)80078-6; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Kera S, 2009, PROG SURF SCI, V84, P135, DOI 10.1016/j.progsurf.2009.03.002; Ohtomo M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232205; Giovannetti G, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035133; Beernink G, 2004, APPL PHYS LETT, V85, P398, DOI 10.1063/1.1775040; Bussolotti F, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.153402; Kera S, 2002, CHEM PHYS LETT, V364, P93, DOI 10.1016/S0009-2614(02)01302-7; Huang YL, 2010, LANGMUIR, V26, P3329, DOI 10.1021/la9030798; Betti MG, 2010, J PHYS CHEM C, V114, P21638, DOI 10.1021/jp108734u; Berkebile S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115312; Friedlein R, 2010, J AM CHEM SOC, V132, P12808, DOI 10.1021/ja104839d; Ding HJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3446849; Braun S, 2009, ADV MATER, V21, P1450, DOI 10.1002/adma.200802893; Li Y, 2012, J PHYS CHEM LETT, V3, P3325, DOI 10.1021/jz301575u; Temirov R, 2006, NATURE, V444, P350, DOI 10.1038/nature05270; Scheybal A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115406; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Okajima T, 2002, SURF REV LETT, V9, P441, DOI 10.1142/S0218625X0200252X; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; Annese E, 2007, SURF SCI, V601, P4242, DOI [10.1016/j.susc.2007.04.131, 10.1016/j.suse.2007.04.131]; Yamane H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2192978; Peisert H, 2010, CHEM PHYS LETT, V493, P126, DOI 10.1016/j.cplett.2010.05.020; Salzmann I, 2012, ACS NANO, V6, P10874, DOI 10.1021/nn3042607; Vollmer A, 2012, J ELECTRON SPECTROSC, V185, P55, DOI 10.1016/j.elspec.2012.01.003; Wang Y, 2011, CHEM COMMUN, V47, P12349, DOI 10.1039/c1cc14942c; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; Stadtmuller B, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085416; Stohr J., 1992, NEXAFS SPECTROSCOPY; Ueno N., 1985, Journal of Molecular Electronics, V1; UENO N, 1991, PHYS REV B, V44, P6472, DOI 10.1103/PhysRevB.44.6472; Ules T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155430; Wiessner M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2522; Wiessner M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075437; Yanagisawa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245141	71	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		61	67		10.1016/j.elspec.2015.04.014		7	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400008		
J	Aoki, M; Masuda, S				Aoki, M.; Masuda, S.			Local electronic structure at organic-metal interface studied by UPS, MAES, and first-principles calculation	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Organic-metal interface; Valence electronic state; Ultraviolet photoemission spectroscopy; Metastable atom electron spectroscopy; First-principles calculation	ENERGY-LEVEL ALIGNMENT; SOLID-SURFACES; WORK FUNCTION; GAP STATES; THIN-FILMS; SPECTROSCOPY; PT(111); TRANSPORT; ALKANETHIOLS; ADSORPTION	Understanding and controlling local electronic structures at organic-metal interfaces are crucial for fabricating novel organic-based electronics, as in the case of heterojunctions in semiconductor devices. Here, we report recent studies of valence electronic states at organic-metal interfaces (especially those near the Fermi level of a metal substrate) by the combined analysis of ultraviolet photoemission spectroscopy (UPS), metastable atom electron spectroscopy (MAES), and first-principles calculations. New electronic states in the HOMO (highest occupied molecular orbital)-LUMO (lowest unoccupied molecular orbital) gap formed at an organic-metal interface are classified as a chemisorption-induced gap state (CIGS) and a complex-based gap state (CBGS). The CIGS is further characterized by an asymptotic feature of the metal wave function in the chemisorbed species. The CIGSs in alkanethiolates on Pt(1 1 1) and C-60 on Pt(1 1 1) can be regarded as damping and propagating types, respectively. The CBGSs in K-doped dibenzopentacene (DBP) are composed of DBP-derived MOs and K sp states and distributed over the complex film. No metallic structures were found in the K1DBP and K3DBP phases, suggesting that they are Mott-Hubbard insulators due to strong electron correlation. The local electronic structures of a pentacene film bridged by Au electrodes under bias voltages were examined by an FET-like specimen. The pentacene-derived bands were steeply shifted at the positively biased electrode, reflecting the p-type character of the film. (C) 2015 Elsevier B.V. All rights reserved.	[Aoki, M.; Masuda, S.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Aoki, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cmaoki@mail.ecu.u-tokyo.ac.jp			JSPS [26390044]	This study was financially supported by JSPS KAKENHI Grant Number 26390044.	Lee YM, 2011, CURR APPL PHYS, V11, P1168, DOI 10.1016/j.cap.2011.02.013; Ruff A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216403; Masuda S, 2010, PHYS CHEM CHEM PHYS, V12, P10914, DOI 10.1039/c001016b; Koch N, 2007, CHEMPHYSCHEM, V8, P1438, DOI 10.1002/cphc.200700177; Flores F, 2009, PHYS CHEM CHEM PHYS, V11, P8658, DOI 10.1039/b902492c; HARADA Y, 1984, PHYS REV LETT, V52, P2269, DOI 10.1103/PhysRevLett.52.2269; Aoki M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1899148; Engelkes VB, 2004, J AM CHEM SOC, V126, P14287, DOI 10.1021/ja046274u; WEAVER JH, 1991, PHYS REV LETT, V66, P1741, DOI 10.1103/PhysRevLett.66.1741; Kim DH, 2008, ADV FUNCT MATER, V18, P1363, DOI 10.1002/adfm.200701019; Aoki M, 2012, PHYS CHEM CHEM PHYS, V14, P4101, DOI 10.1039/c2cp23206e; MORIKAWA Y, 1995, PHYS REV B, V51, P14802, DOI 10.1103/PhysRevB.51.14802; Masuda S, 2010, APPL SURF SCI, V256, P4054, DOI 10.1016/j.apsusc.2010.01.063; Yoshinobu J, 1997, PHYS REV LETT, V79, P3942, DOI 10.1103/PhysRevLett.79.3942; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Braun S, 2007, ORG ELECTRON, V8, P14, DOI 10.1016/j.orgel.2006.10.006; Aoki M, 2001, J ELECTRON SPECTROSC, V114, P507, DOI 10.1016/S0368-2048(00)00331-5; HARADA Y, 1983, J CHEM PHYS, V79, P3251, DOI 10.1063/1.446218; Gao WY, 2003, J APPL PHYS, V94, P359, DOI 10.1063/1.1577400; Harada Y, 1997, CHEM REV, V97, P1897, DOI 10.1021/cr940315v; Bussolotti F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155120; Lin TH, 2005, J PHYS CHEM B, V109, P14079, DOI 10.1021/jp058084r; Kim SS, 1998, J CHEM PHYS, V109, P9574, DOI 10.1063/1.477619; Sogo M, 2010, J PHYS CHEM C, V114, P3504, DOI 10.1021/jp9044836; Sogo M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3482849; Aoki M, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204663; Aoki M, 2007, J ELECTRON SPECTROSC, V156, P383, DOI 10.1016/j.elspec.2006.12.044; MERKEL M, 1993, PHYS REV B, V47, P11470, DOI 10.1103/PhysRevB.47.11470; Masuda S, 2007, J PHYS CHEM C, V111, P11747, DOI 10.1021/jp074101w; Aoki M., IN PRESS; Kiguchi M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204466; Masuda S., 2014, TUN JAP S R D EN MAT, P28; Morgner H, 2000, ADV ATOM MOL OPT PHY, V42, P387, DOI 10.1016/S1049-250X(08)60191-3; Roth F, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30247-3; Salaneck W.R., 2001, CONJUGATED POLYM MOL; Sato H., 2014, AVS 61 INT S EXH BAL; Sato H., 2012, PHYS CHEM CHEM PHYS, V14, P15229; Suzuki R., 2002, Physical Review B (Condensed Matter and Materials Physics), V65, DOI 10.1103/PhysRevB.65.035416; Toyoshima S., 2008, JPN J APPL PHYS, V47, P1397; Xue MQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00389	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		68	74		10.1016/j.elspec.2015.04.005		7	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400009		
J	Yoshida, H				Yoshida, Hiroyuki			Principle and application of low energy inverse photoemission spectroscopy: A new method for measuring unoccupied states of organic semiconductors	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Low-energy inverse photoemission spectroscopy; Unoccupied state; Electron affinity; Organic semiconductor	INCIDENCE GRATING SPECTROMETER; VUV ISOCHROMAT SPECTROSCOPY; ULTRAVIOLET PHOTON DETECTOR; ELECTRONIC-STRUCTURE; THIN-FILM; MOLECULAR SEMICONDUCTOR; IMPROVED RESOLUTION; PHOTOVOLTAIC CELLS; VACUUM-ULTRAVIOLET; LEVEL ALIGNMENT	Information about the unoccupied states is crucial to both fundamental and applied physics of organic semiconductors. However, there were no available experimental methods that meet the requirement of such research. In this review, we describe a new experimental method to examine the unoccupied states, called low-energy inverse photoemission spectroscopy (LEIPS). An electron having the kinetic energy lower than the damage threshold of organic molecules is introduced to a sample film, and an emitted photon in the near-ultraviolet range is detected with high resolution and sensitivity. Unlike the previous inverse photoemission spectroscopy, the sample damage is negligible and the overall resolution is a factor of two improved to 0.25 eV. Using LEIPS, electron affinity of organic semiconductor can be determined with the same precision as photoemission spectroscopy for ionization energy. The instruments including an electron source and photon detectors as well as application to organic semiconductors are presented. (C) 2015 Published by Elsevier B.V.	Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan	Yoshida, H (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	hyoshida@chiba-u.jp			JST PRESTO; JST A-STEP; JST ALCA; JSPS KAKENHI [26288007]	The author thanks Mr. Yamada, Dr. Richard Murdey, and Professor Naoki Sato of Kyoto University for helpful discussion. This work is supported by JST PRESTO, JST A-STEP, JST ALCA and JSPS KAKENHI (Grant number 26288007).	Kim SH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773941; Djurovich PI, 2009, ORG ELECTRON, V10, P515, DOI 10.1016/j.orgel.2008.12.011; Krause S, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/085001; Nishi T, 2008, CHEM PHYS LETT, V455, P213, DOI 10.1016/j.cplett.2008.01.049; GAO Y, 1988, J PHYS E SCI INSTRUM, V21, P489, DOI 10.1088/0022-3735/21/5/014; FRANK KH, 1986, CHEM PHYS LETT, V132, P83, DOI 10.1016/0009-2614(86)80700-X; JOHNSON PD, 1986, REV SCI INSTRUM, V57, P1324, DOI 10.1063/1.1138596; Kahn A, 2003, J POLYM SCI POL PHYS, V41, P2529, DOI 10.1002/polb.10642; Zhou NJ, 2015, P NATL ACAD SCI USA, V112, P7897, DOI 10.1073/pnas.1508578112; DOSE V, 1977, APPL PHYS, V14, P117, DOI 10.1007/BF00882639; OLLONQVIST TE, 1995, VACUUM, V46, P1177, DOI 10.1016/0042-207X(95)00135-2; STOFFEL NG, 1985, NUCL INSTRUM METH A, V234, P230, DOI 10.1016/0168-9002(85)90910-6; Maniraj M, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3630948; Yoshida H, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4822119; Sato N, 1998, J ELECTRON SPECTROSC, V88, P861, DOI 10.1016/S0368-2048(97)00171-0; Han WN, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821445; BABBE N, 1985, J PHYS E SCI INSTRUM, V18, P158, DOI 10.1088/0022-3735/18/2/014; CHAUVET G, 1981, J ELECTRON SPECTROSC, V24, P255, DOI 10.1016/0368-2048(81)80012-6; FRANK KH, 1988, J CHEM PHYS, V89, P7569, DOI 10.1063/1.455720; Lipton-Duffin JA, 2002, REV SCI INSTRUM, V73, P3149, DOI 10.1063/1.1499536; LANG JK, 1979, REV SCI INSTRUM, V50, P221, DOI 10.1063/1.1135791; ERDMAN PW, 1982, REV SCI INSTRUM, V53, P225, DOI 10.1063/1.1136932; Gao WY, 2001, APPL PHYS LETT, V79, P4040, DOI 10.1063/1.1424067; Geng YF, 2011, CHEM MATER, V23, P4257, DOI 10.1021/cm2018423; Han WN, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4850531; Yoshida H, 2001, J ELECTRON SPECTROSC, V121, P83, DOI 10.1016/S0368-2048(01)00328-0; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; PENDRY JB, 1980, PHYS REV LETT, V45, P1356, DOI 10.1103/PhysRevLett.45.1356; Gorgoi M, 2004, APPL SURF SCI, V234, P138, DOI 10.1016/j.apsusc.2004.05.065; Lipton-Duffin JA, 2004, REV SCI INSTRUM, V75, P445, DOI 10.1063/1.1637435; Stiepel R, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1928192; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Hirose Y, 1997, APPL SURF SCI, V113, P291, DOI 10.1016/S0169-4332(96)00886-0; Schedin F, 1997, REV SCI INSTRUM, V68, P41, DOI 10.1063/1.1147844; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Li Z, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862327; Yoshida H, 2012, CHEM PHYS LETT, V539, P180, DOI 10.1016/j.cplett.2012.04.058; DUDDE R, 1992, CHEM PHYS LETT, V196, P91, DOI 10.1016/0009-2614(92)85934-3; JOST MB, 1991, CHEM PHYS LETT, V184, P423, DOI 10.1016/0009-2614(91)80012-M; Duhm S, 2008, NAT MATER, V7, P326, DOI 10.1038/nmat2119; FAUSTER T, 1985, REV SCI INSTRUM, V56, P1212, DOI 10.1063/1.1137977; DOSE V, 1986, APPL PHYS A-MATER, V40, P203, DOI 10.1007/BF00616595; Adachi C, 2001, ORG ELECTRON, V2, P37, DOI 10.1016/S1566-1199(01)00010-6; Wu CI, 1997, CHEM PHYS LETT, V272, P43, DOI 10.1016/S0009-2614(97)00481-8; FUNNEMANN D, 1986, J PHYS E SCI INSTRUM, V19, P554, DOI 10.1088/0022-3735/19/7/011; Tsutsumi K, 2002, CHEM PHYS LETT, V361, P367, DOI 10.1016/S0009-2614(02)00990-9; Zhong YF, 2015, J PHYS CHEM C, V119, P23, DOI 10.1021/jp506296j; YANNOULIS P, 1991, SURF SCI, V241, P325, DOI 10.1016/0039-6028(91)90092-7; Brabec CJ, 2001, ADV FUNCT MATER, V11, P374, DOI 10.1002/1616-3028(200110)11:5<374::AID-ADFM374>3.3.CO;2-N; Wei QS, 2009, J AM CHEM SOC, V131, P17597, DOI 10.1021/ja9057053; Zahn DRT, 2006, CHEM PHYS, V325, P99, DOI 10.1016/j.chemphys.2006.02.003; Yoshida H, 2014, J PHYS CHEM C, V118, P24377, DOI 10.1021/jp509141y; DENNINGER G, 1979, APPL PHYS, V18, P375, DOI 10.1007/BF00899691; OTTO A, 1985, SURF SCI, V163, P140, DOI 10.1016/0039-6028(85)90854-4; ANDREWS PT, 1988, VACUUM, V38, P257, DOI 10.1016/0042-207X(88)90056-5; Braun S, 2009, ADV MATER, V21, P1450, DOI 10.1002/adma.200802893; Hwang J, 2009, MAT SCI ENG R, V64, P1, DOI 10.1016/j.mser.2008.12.001; Seki K, 2006, MOL CRYST LIQ CRYST, V455, P145, DOI 10.1080/15421400600803713; SANCROTTI M, 1991, REV SCI INSTRUM, V62, P639, DOI 10.1063/1.1142062; Kipp L, 1997, REV SCI INSTRUM, V68, P2144, DOI 10.1063/1.1148077; JOST MB, 1991, PHYS REV B, V44, P1966, DOI 10.1103/PhysRevB.44.1966; Yoshida H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4860055; Murdey R, 2006, MOL CRYST LIQ CRYST, V455, P211, DOI 10.1080/15421400600698469; Ie Y, 2014, CHEM COMMUN, V50, P4123, DOI 10.1039/c4cc00940a; Namatame H, 1996, J ELECTRON SPECTROSC, V80, P393, DOI 10.1016/0368-2048(96)03000-9; Yoshida H, 2014, ANAL BIOANAL CHEM, V406, P2231, DOI 10.1007/s00216-014-7659-1; Budke M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2771096; FAUSTER T, 1983, REV SCI INSTRUM, V54, P68, DOI 10.1063/1.1137218; Hawkes P.W., 1997, SPRINGER SERIES OPTI; SATO N, 1981, J CHEM SOC FARAD T 2, V77, P1621, DOI 10.1039/f29817701621; Yamada K., 2015, METHOD EVALUAT UNPUB; Yamada K., 2015, THESIS KYOTO U KYOTO; Yoshida H., PHYS REV B IN PRESS; Yoshida H, 2015, ORG ELECTRON, V20, P24, DOI 10.1016/j.orgel.2015.01.037	74	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		116	124		10.1016/j.elspec.2015.07.003		9	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400014		
J	Yamada, T; Yamamoto, R; Munakata, T				Yamada, T.; Yamamoto, R.; Munakata, T.			Microspot two-photon photoemission spectroscopy for CuPc film on HOPG	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Article						Microspectroscopy; Two-photon photoemission; CuPc; Unoccupied states; Image potential states; Charge transfer exciton	SCANNING-TUNNELING-MICROSCOPY; LEAD PHTHALOCYANINE FILM; IMAGE POTENTIAL STATES; COPPER-PHTHALOCYANINE; GRAPHITE; NAPHTHALENE; CU(111)	Microspot two-photon photoemission (micro-2PPE) spectroscopy has been applied to measure the lateral distribution of unoccupied levels on copper phthalocyanine (CuPc) film on HOPG. In addition to the LUMO-derived level and the image potential state (IPS) on the film, we identified the modified IPS which is stabilized by the hole localized in a molecule. We show that modified IPS is observed only on bilayer area, reflecting the localization of the hole in a molecule. The modified IPS is absent on monolayer area, because the hole strongly interacts with substrate. (C) 2015 Elsevier B.V. All rights reserved.	[Yamada, T.; Yamamoto, R.; Munakata, T.] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan	Munakata, T (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	munakata@chem.sci.osaka-u.ac.jp			MEXT [24685004, 24656036, 25600004]	This work was supported by a Grant-in-Aid for Young Scientists (A) from MEXT Grant no. 24685004, Grant-in-Aids for Challenging Exploratory Research from MEXT Grant nos. 24656036 and 25600004.	Dougherty DB, 2006, CHEM PHYS LETT, V431, P303, DOI 10.1016/j.cplett.2006.09.104; Munakata T, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165404; Yamamoto I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115404; Yang QX, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115214; Yamada T, 2014, J PHYS CHEM C, V118, P1035, DOI 10.1021/jp4097875; DAVIDSON AT, 1982, J CHEM PHYS, V77, P168, DOI 10.1063/1.443636; Park J, 2012, J PHYS CHEM C, V116, P5821, DOI 10.1021/jp211938h; Yamada T, 2010, J PHYS CHEM C, V114, P13334, DOI 10.1021/jp1045194; Yamamoto R, 2011, SURF SCI, V605, P982, DOI 10.1016/j.susc.2011.02.018; Muntwiler M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196403; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Kera S, 2009, PROG SURF SCI, V84, P135, DOI 10.1016/j.progsurf.2009.03.002; Yamamoto R, 2012, PHYS CHEM CHEM PHYS, V14, P9601, DOI 10.1039/c2cp40922d; Kera S, 2002, CHEM PHYS LETT, V364, P93, DOI 10.1016/S0009-2614(02)01302-7; Shibuta M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115426; Sugiyama T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388922; Munakata T, 2002, SURF SCI, V507, P434, DOI 10.1016/S0039-6028(02)01282-7; Shibuta M, 2011, J PHYS CHEM C, V115, P19269, DOI 10.1021/jp205922q; LUDWIG C, 1994, J VAC SCI TECHNOL B, V12, P1963, DOI 10.1116/1.587680; Bovensiepen U., 2010, DYNAMICS SOLID STATE, V1; Chen J., 2008, INTRO SCANNING TUNNE; Fukagawa H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085304; Hufner S., 2003, PHOTOELECTRON SPECTR	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		145	148		10.1016/j.elspec.2015.04.020		4	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400018		
J	Yanagisawa, S; Okuma, K; Inaoka, T; Hamada, I				Yanagisawa, Susumu; Okuma, Koji; Inaoka, Takeshi; Hamada, Ikutaro			Recent progress in predicting structural and electronic properties of organic solids with the van der Waals density functional	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						van der Waals interaction; Organic solids; First-principles method; Density functional; Cohesive property; Band structure	GENERALIZED GRADIENT APPROXIMATION; THIN-FILM TRANSISTORS; AUGMENTED-WAVE METHOD; CRYSTAL-STRUCTURE; EXCHANGE-ENERGY; DISPERSION INTERACTIONS; POWDER DIFFRACTION; CHARGE-TRANSPORT; SOLAR-CELLS; BASIS-SET	We review recent studies on electronic properties of the organic solids with the first-principles electronic structure methods, with the emphasis on the roles of the intermolecular van der Waals (vdW) interaction in electronic properties of the organic semiconductors. After a brief summary of the recent vdW inclusive first-principle theoretical methods, we discuss their performance in predicting cohesive properties of oligoacene crystals as examples of organic crystals. We show that a variant of the van der Waals density functional describes structure and energetics of organic crystals accurately. In addition, we review our recent study on the zinc phthalocyanine crystal and discuss the importance of the intermolecular distance and orientational angle in the band dispersion. Finally, we draw some general conclusions and the future perspectives. (C) 2015 Elsevier B.V. All rights reserved.	[Yanagisawa, Susumu; Okuma, Koji; Inaoka, Takeshi] Univ Ryukyus, Fac Sci, Dept Phys & Earth Sci, Nishihara, Okinawa 9030213, Japan; [Hamada, Ikutaro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Yanagisawa, S (reprint author), Univ Ryukyus, Fac Sci, Dept Phys & Earth Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	shou@sci.u-ryukyu.ac.jp; Hamada.Ikutaro@nims.go.jp	Hamada, Ikutaro/E-8040-2010	Hamada, Ikutaro/0000-0001-5112-2452	Japan Society for the Promotion of Science [22540332, 26810009, 26105011]; Cooperative Research Program of Network Joint Research Center for Materials and Devices in ISIR, Osaka University	This work was partly supported by the Grants-in-Aid for Scientific Research (C) (No. 22540332), for Young Scientists (B) (No. 26810009), and for Scientific Research on Innovative Areas "3D Active-Site Science" (No. 26105011) from Japan Society for the Promotion of Science, and by Cooperative Research Program of Network Joint Research Center for Materials and Devices in ISIR, Osaka University. The numerical calculations were carried out at the Institute for Solid State Physics at the University of Tokyo.	ALT HC, 1982, ACTA CRYSTALLOGR B, V38, P2595, DOI 10.1107/S056774088200942X; Andersson Y, 1996, PHYS REV LETT, V76, P102, DOI 10.1103/PhysRevLett.76.102; Otero-de-la-Roza A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4738961; Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30; Vydrov OA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063004; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; Grimme S, 2010, ANGEW CHEM INT EDIT, V49, P1402, DOI 10.1002/anie.200905484; Toyoda K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3373389; Bussolotti F, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643717; Tanaka Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.073408; Lin YY, 1997, IEEE ELECTR DEVICE L, V18, P606, DOI 10.1109/55.644085; Kannemann FO, 2009, J CHEM THEORY COMPUT, V5, P719, DOI 10.1021/ct800522r; Dobson JF, 1996, PHYS REV LETT, V76, P1780, DOI 10.1103/PhysRevLett.76.1780; Holmes D, 1999, CHEM-EUR J, V5, P3399, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3399::AID-CHEM3399>3.0.CO;2-V; Hoshino A, 2003, ACTA CRYSTALLOGR B, V59, P393, DOI 10.1107/S010876810300942X; Haruyama J, 2014, J PHYS CHEM LETT, V5, P2903, DOI 10.1021/jz501510v; Sato T, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3503040; Xin Q, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226401; Bucko T, 2013, J CHEM THEORY COMPUT, V9, P4293, DOI 10.1021/ct400694h; Koller G, 2007, SCIENCE, V317, P351, DOI 10.1126/science.1143239; Puschnig P, 1999, PHYS REV B, V60, P7891, DOI 10.1103/PhysRevB.60.7891; Vydrov OA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3398840; SCHEIDT WR, 1977, J AM CHEM SOC, V99, P1101, DOI 10.1021/ja00446a021; Ruiz VG, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.146103; Wen SH, 2009, J PHYS CHEM B, V113, P8813, DOI 10.1021/jp900512s; Hummer K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205205; Schatschneider B, 2013, J PHYS CHEM A, V117, P8323, DOI 10.1021/jp406573n; Reilly AM, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812819; DAVID WIF, 1992, PHYSICA B, V180, P597, DOI 10.1016/0921-4526(92)90406-I; Silvestrelli PL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816964; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; WOHRLE D, 1991, ADV MATER, V3, P129, DOI 10.1002/adma.19910030303; SCHEIN LB, 1977, PHYS REV B, V15, P1024, DOI 10.1103/PhysRevB.15.1024; ROBERTSON J, 1961, ACTA CRYSTALLOGR, V14, P697, DOI 10.1107/S0365110X61002151; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Yamane H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086602; Siegrist T, 2001, ANGEW CHEM INT EDIT, V40, P1732, DOI 10.1002/1521-3773(20010504)40:9<1732::AID-ANIE17320>3.0.CO;2-7; Brede J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047204; Bultinck P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715563; LACKS DJ, 1993, PHYS REV A, V47, P4681, DOI 10.1103/PhysRevA.47.4681; Schiefer S, 2007, J AM CHEM SOC, V129, P10316, DOI 10.1021/ja0730516; Tamura H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035208; Tiago ML, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115212; Tkatchenko A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.236402; Johnson ER, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2190220; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; MASON R, 1964, ACTA CRYSTALLOGR, V17, P547, DOI 10.1107/S0365110X64001281; Troisi A, 2011, CHEM SOC REV, V40, P2347, DOI 10.1039/c0cs00198h; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Marom N, 2010, J CHEM THEORY COMPUT, V6, P81, DOI 10.1021/ct900410j; Mattheus CC, 2003, SYNTHETIC MET, V138, P475, DOI 10.1016/S0379-6779(02)00467-8; Tonigold K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3439691; Cooper VR, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161104; Mercurio G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.036102; Bucko T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.064110; Zhang YK, 1997, J CHEM PHYS, V107, P7921, DOI 10.1063/1.475105; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Takeya J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711393; Grimme S, 2008, ANGEW CHEM INT EDIT, V47, P3430, DOI 10.1002/anie.200705157; BECKE AD, 1986, J CHEM PHYS, V85, P7184, DOI 10.1063/1.451353; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Bjorkman T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4893329; Wu J, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4727850; CAMPBELL RB, 1962, ACTA CRYSTALLOGR, V15, P289, DOI 10.1107/S0365110X62000699; Murray ED, 2009, J CHEM THEORY COMPUT, V5, P2754, DOI 10.1021/ct900365q; Toyoda K, 2011, J PHYS CHEM C, V115, P5767, DOI 10.1021/jp1107262; Siegrist T, 2007, ADV MATER, V19, P2079, DOI 10.1002/adma.200602072; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Nan GJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115203; Berkebile S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115312; Kruse H, 2012, J ORG CHEM, V77, P10824, DOI 10.1021/jo302156p; Hamada I, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.121103; Ding HJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3446849; Ortmann F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205101; Atodiresei N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136809; Becke AD, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1884601; McNellis ER, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205414; Sabatini R, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.041108; Toyoda K, 2011, ORG ELECTRON, V12, P295, DOI 10.1016/j.orgel.2010.11.010; Wu Q, 2002, J CHEM PHYS, V116, P515, DOI 10.1063/1.1424928; HEDIN L, 1965, PHYS REV, V139, pA796, DOI 10.1103/PhysRev.139.A796; Langreth DC, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/8/084203; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Silvestrelli PL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.053002; Wellendorff J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235149; Okamoto H, 2008, J AM CHEM SOC, V130, P10470, DOI 10.1021/ja803291a; Sato T, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3269802; Marom N, 2013, ANGEW CHEM INT EDIT, V52, P6629, DOI 10.1002/anie.201301938; Klimes J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/022201; Yanagisawa S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115438; Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Ortmann F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.186101; Ambrosch-Draxl C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/125010; Becke AD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768530; Becke AD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2795701; Becke AD, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2139668; Berland K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035412; Berland K, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871731; Bjork J, 2014, CHEMPHYSCHEM, V15, P2851, DOI 10.1002/cphc.201402063; Bjorkman T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165109; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bredas JL, 2002, P NATL ACAD SCI USA, V99, P5804, DOI 10.1073/pnas.092143399; Bucko T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890003; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Gulans A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.201105; Hamada I, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153412; Ishii H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245206; Johnson ER, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949201; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Kawasaki N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076124; Klimes J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195131; Liu W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245405; Loncaric I, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075414; Mattheus CC, 2001, ACTA CRYSTALLOGR C, V57, P939, DOI 10.1107/S010827010100703X; Morisaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6400; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Puschnig P, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235321; Reilly AM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.055701; Roman-Perez G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096102; Rydberg H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126402; Schatschneider B, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.060104; Schunemann C, 2011, THIN SOLID FILMS, V519, P3939, DOI 10.1016/j.tsf.2011.01.356; Stradi D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.186102; Yanagisawa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245141; Yanagisawa S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FY02; Yoshida H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2349307	131	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		159	167		10.1016/j.elspec.2015.04.007		9	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400020		
J	Fujikawa, T; Niki, K; Sakuma, H				Fujikawa, Takashi; Niki, Kaori; Sakuma, Hiroto			Theory of photoelectron spectroscopy for organic molecules and their crystals	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Photoemission; Keldysh Green's function; Organic solids; Electron-phonon interaction	X-RAY PHOTOEMISSION; CORE-LEVEL PHOTOEMISSION; DEBYE-WALLER; XAFS SPECTRA; THIN-FILMS; SOLIDS; STATE; XPS	In this short review we discuss recent progress in photoemission theory for organic molecules and their crystals. We discuss some important features in Keldysh Green's function theory for the photoemission. We briefly discuss many-body aspects in photoemission from core and extended levels. In particular phonon effects are investigated in more detail since organic solids are typically soft where electron-phonon interaction is important. Debye-Waller factor suppresses the interference effects of photoelectron waves which makes ARPES analyses useless, particularly in high energy region. (C) 2015 Elsevier B.V. All rights reserved.	[Fujikawa, Takashi; Niki, Kaori; Sakuma, Hiroto] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Japan	Fujikawa, T (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Yayoi Cho 1-33, Chiba, Japan.	tfujikawa@faculty.chiba-u.jp			Career-Support Program for Woman Scientist at Chiba University; Ministry of Education, Science and Culture of Japan [25246041]	This paper is dedicated to Professor Nobuo Ueno for his mandatory retirement at Chiba University, and for his great contribution to progress in organic solid science. One of the authors (KN) is grateful to the financial support by the Career-Support Program for Woman Scientist at Chiba University. TF is grateful to the financial support from a Grant-in-Aid for Scientific Research from Ministry of Education, Science and Culture of Japan, Project No. 25246041.	ALMBLADH CO, 1983, HDB SYNCHROTRON RAD, V1, P607; CAROLI C, 1973, PHYS REV B, V8, P4552, DOI 10.1103/PhysRevB.8.4552; Moritz B, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165112; Fujikawa T, 2005, J ELECTRON SPECTROSC, V149, P61, DOI 10.1016/j.elspec.2005.07.003; FUJIKAWA T, 1981, J PHYS SOC JPN, V50, P1321, DOI 10.1143/JPSJ.50.1321; Kazama M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063417; Fujikawa T, 2002, J ELECTRON SPECTROSC, V123, P19, DOI 10.1016/S0368-2048(01)00370-X; BARDYSZEWSKI W, 1985, PHYS SCRIPTA, V32, P439, DOI 10.1088/0031-8949/32/4/033; Niki K, 2014, SURF INTERFACE ANAL, V46, P924, DOI 10.1002/sia.5504; Kuleff AI, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124002; Hedin L, 1998, PHYS REV B, V58, P15565, DOI 10.1103/PhysRevB.58.15565; Suga S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035146; Fujikawa T, 2003, CHEM PHYS LETT, V368, P147, DOI 10.1016/S0009-2614(02)01814-6; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Yamane H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153412; Arai H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075102; Kazama M, 2010, CHEM PHYS, V373, P261, DOI 10.1016/j.chemphys.2010.04.038; Cuk T, 2005, PHYS STATUS SOLIDI B, V242, P11, DOI 10.1002/pssb.200404959; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Hatch RC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.047601; Fujikawa T, 2009, J ELECTRON SPECTROSC, V174, P85, DOI 10.1016/j.elspec.2009.07.007; Shang MH, 2013, ANAL CHEM, V85, P3739, DOI 10.1021/ac4000865; Fujikawa T, 2008, J ELECTRON SPECTROSC, V162, P146, DOI 10.1016/j.elspec.2008.01.001; FUJIKAWA T, 1985, J PHYS SOC JPN, V54, P2747, DOI 10.1143/JPSJ.54.2747; FUJIKAWA T, 1982, J PHYS SOC JPN, V51, P251, DOI 10.1143/JPSJ.51.251; MERMIN ND, 1966, J MATH PHYS, V7, P1038, DOI 10.1063/1.1704995; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; Fujikawa T, 2000, PHYS REV B, V62, P5387, DOI 10.1103/PhysRevB.62.5387; GELIUS U, 1972, FARADAY DISCUSS, V54, P257, DOI 10.1039/dc9725400257; Sebilleau D, 2006, LECT NOTES PHYS, V697, P15; BAYM G, 1961, ANN PHYS-NEW YORK, V14, P1, DOI 10.1016/0003-4916(61)90050-1; Braun J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205409; Dauth M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103005; DuBois D. F., 1967, LECTURES THEORETICAL, P469; Fadley C.S., 1992, SYNCHROTRON RAD RES, V1, P421; Freericks J.K., 2009, PHYS REV LETT, V102, P13640; Fujikawa T., 2008, E J SURF SCI NANOTEC, V6, P263, DOI 10.1380/ejssnt.2008.263; Fujikawa T, 1996, J ELECTRON SPECTROSC, V79, P25, DOI 10.1016/0368-2048(96)02793-4; Fujikawa T, 2009, J ELECTRON SPECTROSC, V173, P51, DOI 10.1016/j.elspec.2009.04.011; Fujikawa T, 2004, J ELECTRON SPECTROSC, V136, P85, DOI 10.1016/j.elspec.2004.02.135; Fujikawa T., 2006, Journal of Electron Spectroscopy and Related Phenomena, V151, DOI 10.1016/j.elspec.2005.11.011; Hedin L., 1969, SOLID STATE PHYS, V23, P1; Hedin L, 2003, SOLID STATE PHOTOEMI, P116, DOI 10.1002/9783527602506.ch3; IGARASHI J, 1994, PHYS REV B, V50, P17820, DOI 10.1103/PhysRevB.50.17820; Kazama M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045110; Kazama M, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012048; Langreth D. C., 1976, LINEAR NONLINEAR ELE, P3; Perveaux A, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124010; Puschnig P., 2013, SMALL ORGANIC MOL SU, P3; Schattke W., 2003, SOLID STATE PHOTOEMI, P50, DOI 10.1002/9783527602506.ch2; Shang MH, 2011, J ELECTRON SPECTROSC, V184, P261, DOI 10.1016/j.elspec.2010.10.006; Shang M., 2012, E J SURF SCI NANOTEC, V10, P128; Shinotsuka H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.085404; Shinotsuka H., 2008, J SURF ANAL, V14, P332; Suzuki R., 2005, E J SURF SCI NANOTEC, V3, P373, DOI 10.1380/ejssnt.2005.373	58	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		168	176		10.1016/j.elspec.2015.07.001		9	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400021		
J	Sato, F; Omura, T; Ishimaru, M; Endo, Y; Murase, H; Yamashita, E				Sato, Fumio; Omura, Takaya; Ishimaru, Mutsuki; Endo, Yoshiro; Murase, Harutaka; Yamashita, Eiji			Effects of Daily Astaxanthin and L-Carnitine Supplementation for Exercise-Induced Muscle Damage in Training Thoroughbred Horses	JOURNAL OF EQUINE VETERINARY SCIENCE			English	Article						Equine; Astaxanthin; L-carnitine; Supplement	L-TARTRATE SUPPLEMENTATION; OXIDATIVE STRESS MARKERS; EXERTIONAL RHABDOMYOLYSIS; EQUINE RHABDOMYOLYSIS; SKELETAL-MUSCLE; CREATINE-KINASE; UNITED-KINGDOM; VITAMIN-E; TYING-UP; RESPONSES	The effects of dietary supplementation with astaxanthin and L-carnitine on serum markers and clinical incidence rate of exercise-induced muscle damage were studied in training horses. Sixty-three healthy Thoroughbred horses were randomly assigned to two groups and received the same base diet and exercise training throughout this study. The supplement (supp.) group (n = 31) received daily supplementation with astaxanthin (75 mg) and L-carnitine (3,000 mg) for 8 weeks, and the control (cont.) group (n = 32) received no supplementation. Blood samples were collected after high-intensity exercise training at 5 weeks before supplementation, 3 days (3d), and 8 weeks (8w) after the start of the supplementation. The blood samples were analyzed for creatine kinase (CK) activity and lactate dehydrogenase isoenzyme-5 (LDH-5), and a retrospective study was carried out by analyzing medical records for symptoms of exercise-induced muscle damage in both groups. Five horses (two of supp. group and three of cont. group) were excluded from this study for other disease. In the cont. group, CK activity at 8w was significantly increased compared with 3d, whereas the supp. group showed no significant change. After 8w, the CK activity of the supp. group was significantly lower than that of the cont. group. Additionally, the LDH-5 concentration of the supp. group also tended to be lower as compared with that of the cont. group. The incidence rate of exercise-induced muscle damage was significantly lower in the supp. group compared with the cont. group. These results suggest that continuous dietary administration of astaxanthin and L-carnitine attenuates exercise-induced muscle damage in horses. (C) 2015 Elsevier Inc. All rights reserved.	[Sato, Fumio; Omura, Takaya; Ishimaru, Mutsuki; Endo, Yoshiro; Murase, Harutaka] Japan Racing Assoc, Hidaka Training & Res Ctr, Equine Breeding Sci Div, Urakawa, Hokkaido 0570171, Japan; [Yamashita, Eiji] AstaReal Co Ltd, Dept Res & Dev, Med Nutr Div, Osaka, Japan	Sato, F (reprint author), Japan Racing Assoc, Hidaka Training & Res Ctr, Equine Breeding Sci Div, 535-13 Nishicha, Urakawa, Hokkaido 0570171, Japan.	Fumio_Sato@jra.go.jp					DUARTE JA, 1994, EUR J APPL PHYSIOL O, V68, P48, DOI 10.1007/BF00599241; Ikeuchi M, 2006, BIOL PHARM BULL, V29, P2106, DOI 10.1248/bpb.29.2106; McKenzie EC, 2009, VET CLIN N AM-EQUINE, V25, P121, DOI 10.1016/j.cveq.2008.12.001; Valberg SJ, 1999, EQUINE VET J, V31, P43; Fukuzawa K, 1998, BIOFACTORS, V7, P31, DOI 10.1002/biof.5520070106; Stewart JS, 2008, FOOD CHEM TOXICOL, V46, P3030, DOI 10.1016/j.fct.2008.05.038; McKenzie EC, 2003, J VET INTERN MED, V17, P693, DOI 10.1892/0891-6640(2003)017<0693:EODSFA>2.3.CO;2; El-Deeb WM, 2010, VET RES COMMUN, V34, P677, DOI 10.1007/s11259-010-9439-5; Brass EP, 1998, J AM COLL NUTR, V17, P207; Maoka T, 2011, MAR DRUGS, V9, P278, DOI 10.3390/md9020278; McGowan CM, 2002, VET REC, V151, P623; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Aoi W, 2004, FREE RADICAL BIO MED, V37, P480, DOI 10.1016/j.freeradbiomed.2004.05.008; Djordjevic B, 2012, J SPORT MED PHYS FIT, V52, P382; Oyanagi E, 2011, BIOCHEM BIOPH RES CO, V412, P61, DOI 10.1016/j.bbrc.2011.07.039; Bacurau RFP, 2003, NUTRITION, V19, P337, DOI 10.1016/S0899-9007(02)01015-8; Aoi W, 2003, ANTIOXID REDOX SIGN, V5, P139, DOI 10.1089/152308603321223630; Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Goto S, 2001, BBA-BIOMEMBRANES, V1512, P251, DOI 10.1016/S0005-2736(01)00326-1; Miyawaki H, 2008, J CLIN BIOCHEM NUTR, V43, P69, DOI 10.3164/jcbn.2008048; MacLeay JM, 1999, AM J VET RES, V60, P1562; Spiering BA, 2008, J STRENGTH COND RES, V22, P1130, DOI 10.1519/JSC.0b013e31817d48d9; Williams CA, 2004, J ANIM SCI, V82, P588; Earnest CP, 2011, INT J SPORTS MED, V32, P882, DOI 10.1055/s-0031-1280779; Siciliano PD, 1997, J ANIM SCI, V75, P1553; Tozaki T, 2010, ANIM GENET, V41, P80, DOI 10.1111/j.1365-2052.2010.02112.x; Martin HD, 1999, PURE APPL CHEM, V71, P2253, DOI 10.1351/pac199971122253; Zeyner A, 1999, ARCH ANIM NUTR, V52, P115; White A, 2001, COMP BIOCHEM PHYS A, V128, P99, DOI 10.1016/S1095-6433(00)00286-5; Wall BT, 2011, J PHYSIOL-LONDON, V589, P963, DOI 10.1113/jphysiol.2010.201343; Tominaga K, 2012, ACTA BIOCHIM POL, V59, P43; THORNTON JR, 1979, EQUINE VET J, V11, P235; Avellini L, 1999, COMP BIOCHEM PHYS B, V123, P147, DOI 10.1016/S0305-0491(99)00045-0; Volek JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE474; Brass EP, 2000, AM J CLIN NUTR, V72, P618; HARRIS PA, 1991, BRIT VET J, V147, P373; McKenzie EC, 2003, CURRENT THERAPY EQUI, P727, DOI 10.1016/B978-0-7216-9540-2.50197-3; Miki W., 1991, PURE APPL CHEM, V63, P144; Nishida Y., 2007, CAROTENOID SCI, V11, P16; Notin C, 2010, EQUINE VET J S, V38, P375; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rivero JL, 2002, EQUINE VET J S, V34, P269; Sato F, 2012, CAROTENOID SCI, V17, P16; Sawaki H, 2002, RINSHO IYAKU, V10, P1085; The National Academies Press, 2007, NUTR REQUIREMENTS HO	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0737-0806	1542-7412		J EQUINE VET SCI	J. Equine Vet. Sci.	OCT	2015	35	10					836	842		10.1016/j.jevs.2015.08.003		7	Veterinary Sciences	Veterinary Sciences	CU2MP	WOS:000363357900008		
J	Ogawa, T; Kawashima, N; Obata, H; Kanosue, K; Nakazawa, K				Ogawa, Tetsuya; Kawashima, Noritaka; Obata, Hiroki; Kanosue, Kazuyuki; Nakazawa, Kimitaka			Mode-dependent control of human walking and running as revealed by split-belt locomotor adaptation	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Walk; Run; Adaptation; Split belt; Transfer	GAIT TRANSITIONS; REDUCED GRAVITY; RUN TRANSITION; SPEED; NETWORKS	Here, we investigate the association of neural control between walking and running, and in particular, how these two gait modes at different velocities are controlled by the central nervous system. The subjects were fully adapted by acquiring modified motor patterns to either walk or run on a split-belt treadmill driven in split mode (asymmetry in the velocities of two belts at 1.0 and 2.0 m s(-1)). Subsequently, we tested how the adaptation affected walking and running at three different velocities in the tied mode (equal belt velocities). At 0.75 m s(-1), we found a preference to walk, at 1.50 m s(-1), there was a preference to both walk and run, and at a velocity of 2.25 m s(-1) there was a preference to run. Both walking and running on the split belt resulted in the emergence of a significant aftereffect (asymmetrical movement) at all of the velocities tested when walking after adapting to walk and running after adapting to run. However, for contrasting modes (i.e. running after adapting to walk and walking after adapting to run), such aftereffects were far less evident at all velocities; thus showing only limited transfer across gait modes. The results demonstrate a clear mode dependency in the neural control of human walking and running. In addition, only for walking, was there a degree of velocity dependency.	[Ogawa, Tetsuya; Kanosue, Kazuyuki] Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama 3591192, Japan; [Ogawa, Tetsuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Ogawa, Tetsuya; Obata, Hiroki; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan	Ogawa, T (reprint author), Waseda Univ, Fac Sports Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	ogawa@idaten.c.u-tokyo.ac.jp			 [14J08094]	This work was supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows [14J08094 to T.O.].	HRELJAC A, 1993, GAIT POSTURE, V1, P217, DOI 10.1016/0966-6362(93)90049-7; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; GRILLNER S, 1979, BRAIN RES, V165, P177, DOI 10.1016/0006-8993(79)90059-3; Budick SA, 2000, J EXP BIOL, V203, P2565; Ivanenko YP, 2011, J APPL PHYSIOL, V110, P781, DOI 10.1152/japplphysiol.00799.2010; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037//0096-1523.21.1.183; Hagio Shota, 2015, Front Hum Neurosci, V9, P48, DOI 10.3389/fnhum.2015.00048; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Kram R, 1997, J EXP BIOL, V200, P821; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349	17	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	OCT	2015	218	20					3192	3198		10.1242/jeb.120865		7	Biology	Life Sciences & Biomedicine - Other Topics	CU3UO	WOS:000363451300008		
J	Bessho, Y; Nakamura, T; Nagura, T; Nishiwaki, M; Sato, K; Toyama, Y				Bessho, Y.; Nakamura, T.; Nagura, T.; Nishiwaki, M.; Sato, K.; Toyama, Y.			Effect of volar angulation of extra-articular distal radius fractures on distal radioulnar joint stability: a biomechanical study	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Article						Distal radioulnar joint; distal radius fracture; volar angulation; stability; triangular fibrocartilage complex	TRIANGULAR FIBROCARTILAGE COMPLEX; CORRECTIVE OSTEOTOMY; FOREARM ROTATION; INSTABILITY; DEFORMITY; WRIST; ANATOMY; ADULTS	The relationship between increased volar tilt of the distal radius and distal radioulnar joint stability was examined. Distal radioulnar joint stiffness was recorded at 10 degrees intervals from 10 degrees dorsal angulation to 20 degrees of volar angulation from the anatomical position of the radius. Tests were performed with the intact radioulnar ligament and repeated after partial and then complete sectioning of the radioulnar ligament at the ulnar fovea. With the intact radioulnar ligament, distal radioulnar joint stiffness increased significantly at 10 degrees and 20 degrees of volar angulation. Partial sectioning of the radioulnar ligament resulted in an approximate 10% decrease of distal radioulnar joint stiffness compared with the intact state, but distal radioulnar joint stiffness still increased significantly with greater volar tilt. Complete sectioning of the radioulnar ligament significantly decreased distal radioulnar joint stiffness, and increasing the volar tilt did not result in increased distal radioulnar joint stiffness. These results suggest that volar angulation deformities of the distal radius should be corrected to 10 degrees of volar tilt when the triangular fibrocartilage complex is intact.	[Bessho, Y.; Nagura, T.; Nishiwaki, M.; Sato, K.; Toyama, Y.] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Nakamura, T.] Int Univ Hlth & Welf, Clin Res Ctr, Tokyo 1070052, Japan	Nakamura, T (reprint author), Int Univ Hlth & Welf, Sanno Hosp, Dept Orthopaed Surg, Clin Res Ctr, 8-10-16 Akasaka, Tokyo 1070052, Japan.	toshiyasu@ae.em-net.ne.jp					Adams BD, 2010, GREENS OPERATIVE HAN, P523; Szabo RM, 2006, J BONE JOINT SURG AM, V88A, P884; Nishiwaki M, 2008, J HAND SURG-AM, V33A, P198, DOI 10.1016/j.jhsa.2007.11.024; Gordon KD, 2003, J HAND SURG-AM, V28A, P943, DOI 10.1016/S0363-5023(03)00487-8; Kramer S, 2013, J HAND SURG-EUR VOL, V38, P710, DOI 10.1177/1753193412469582; Kihara H, 1996, J HAND SURG-AM, V21A, P40, DOI 10.1016/S0363-5023(96)80152-3; AFEKENSTAM F, 1985, SCAND J PLAST RECONS, V19, P175; Stoffelen D, 1998, J HAND SURG-BRIT EUR, V23B, P507, DOI 10.1016/S0266-7681(98)80134-4; Scheer JH, 2011, J HAND SURG-EUR VOL, V36E, P503, DOI 10.1177/1753193411403690; Fraser GS, 2009, J HAND SURG-AM, V34A, P838, DOI 10.1016/j.jhsa.2009.02.011; Haugstvedt JR, 2006, J HAND SURG-AM, V31A, P445, DOI 10.1016/j.jhsa.2005.11.008; Sato K, 2009, J HAND SURG-AM, V34A, P27, DOI 10.1016/j.jhsa.2008.09.018; PALMER AK, 1981, J HAND SURG-AM, V6, P153; Nakamura T, 2001, J HAND SURG-BRIT EUR, V26, P446, DOI 10.1054/jhsb.2001.0562; MCQUEEN M, 1988, J BONE JOINT SURG BR, V70, P649; Miyake J, 2012, J HAND SURG-EUR VOL, V37E, P506, DOI 10.1177/1753193412443644; Nakamura T, 1996, J HAND SURG-BRIT EUR, V21B, P581, DOI 10.1016/S0266-7681(96)80135-5; Lindau T, 2000, CLIN ORTHOP RELAT R, P229; COONEY WP, 1980, J BONE JOINT SURG AM, V62, P613; Nishiwaki M, 2005, J HAND SURG-AM, V30A, P719, DOI 10.1016/j.jhsa.2005.04.015; Nishiwaki M, 2014, J HAND SURG-AM, V39, P656, DOI 10.1016/j.jhsa.2014.01.013; Nakamura T, 2011, HAND CLIN, V27, P281, DOI 10.1016/j.hcl.2011.05.002; Hirahara H, 2003, J HAND SURG-AM, V28A, P614, DOI 10.1016/S0363-5023(03)00249-1; ADAMS BD, 1993, J HAND SURG-AM, V18A, P492, DOI 10.1016/0363-5023(93)90098-N; Gliatis JD, 2000, J HAND SURG-BRIT EUR, V25B, P535, DOI 10.1054/jhsb.2000.0373; Saito T, 2013, J HAND SURG-EUR VOL, V38, P739, DOI 10.1177/1753193412473036; Ellis J, 1965, J Bone Joint Surg Br, V47, P724; FERNANDEZ DL, 1982, J BONE JOINT SURG AM, V64, P1164; Gofton WT, 2004, J HAND SURG-AM, V29A, P423, DOI 10.1016/j.jhsa.2004.01.020; Wolfe SW, 2010, GREENS OPERATIVE HAN, P561; Zimmerman RM, 2014, J HAND SURG-EUR VOL, V39, P727, DOI 10.1177/1753193414527052	31	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	OCT	2015	40	8					775	782		10.1177/1753193415584716		8	Orthopedics; Surgery	Orthopedics; Surgery	CU3ZD	WOS:000363464400002		
J	Kurahashi, T; Shinohara, T; Hirata, H				Kurahashi, T.; Shinohara, T.; Hirata, H.			Modified dorsal percutaneous screw fixation through a transtrapezial approach for scaphoid fractures	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Kurahashi, T.; Hirata, H.] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan; [Shinohara, T.] Chunichi Hosp, Nagoya Hand Surg Ctr, Nagoya, Aichi, Japan	Kurahashi, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan.	t-kurahashi@med.nagoya-u.ac.jp					Suzuki M, 2010, J BONE JOINT SURG BR, V92B, P963, DOI 10.1302/0301-620X.92B7.23410; Jeon IH, 2009, J HAND SURG-AM, V34A, P228, DOI 10.1016/j.jhsa.2008.10.016; Meermans G, 2008, J HAND SURG-EUR VOL, V33E, P791, DOI 10.1177/1753193408092785; HERBERT TJ, 1984, J BONE JOINT SURG BR, V66, P114	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	OCT	2015	40	8					868	869		10.1177/1753193414566553		3	Orthopedics; Surgery	Orthopedics; Surgery	CU3ZD	WOS:000363464400019		
J	Schandl, H; Muller, DB; Moriguchi, Y				Schandl, Heinz; Muller, Daniel B.; Moriguchi, Yuichi			Socioeconomic Metabolism Takes the Stage in the International Environmental Policy Debate: A Special Issue to Review Research Progress and Policy Impacts	JOURNAL OF INDUSTRIAL ECOLOGY			English	Editorial Material							MATERIAL FLOW-ANALYSIS; STOCK DYNAMICS; CYCLE; CONSUMPTION; RESOURCES; PATTERNS; BIOMASS		[Schandl, Heinz] CSIRO, Canberra, ACT 2601, Australia; [Schandl, Heinz] Australian Natl Univ, Sch Sociol, Canberra, ACT, Australia; [Schandl, Heinz] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Schandl, Heinz; Moriguchi, Yuichi] United Nations Environm Programme, Int Resource Panel, Nairobi, Kenya; [Muller, Daniel B.] Norwegian Univ Sci & Technol, Ind Ecol Programme, Dept Energy & Proc Engn, N-7034 Trondheim, Norway; [Moriguchi, Yuichi] Univ Tokyo, Urban Engn, Tokyo, Japan; [Moriguchi, Yuichi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan	Schandl, H (reprint author), CSIRO, Black Mt Labs, Clunies Ross St,Acton GPO Box 1700, Canberra, ACT 2601, Australia.	Heinz.Schandl@csiro.au					Allesch A., 2015, J IND ECOL, DOI [10.1111/jiec12354, DOI 10.1111/JIEC12354]; Hashimoto S, 2012, J IND ECOL, V16, P459, DOI 10.1111/j.1530-9290.2012.00522.x; Krausmann F, 2008, ECOL ECON, V65, P471, DOI 10.1016/j.ecolecon.2007.07.012; Liu G, 2013, NAT CLIM CHANGE, V3, P338, DOI 10.1038/NCLIMATE1698; Shove E, 2010, ENVIRON PLANN A, V42, P1273, DOI 10.1068/a42282; Kennedy C, 2012, J IND ECOL, V16, P780, DOI 10.1111/j.1530-9290.2012.00548.x; Bringezu S, 2012, LAND USE POLICY, V29, P224, DOI 10.1016/j.landusepol.2011.06.010; Steger S, 2011, J CLEAN PROD, V19, P816, DOI 10.1016/j.jclepro.2010.08.016; Graedel TE, 2004, ENVIRON SCI TECHNOL, V38, P1242, DOI 10.1021/es030433c; Weisz H, 2008, J IND ECOL, V12, P629, DOI 10.1111/j.1530-9290.2008.00097.x; Moriguchi Y, 2007, J MATER CYCLES WASTE, V9, P112, DOI 10.1007/s10163-007-0182-0; Giljum S, 2008, ENVIRON SCI POLICY, V11, P204, DOI 10.1016/j.envsci.2007.07.005; Takiguchi H, 2008, J IND ECOL, V12, P792, DOI 10.1111/j.1530-9290.2008.00093.x; Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034; Weisz H, 2010, CURR OPIN SUST, V2, P185, DOI 10.1016/j.cosust.2010.05.010; Kharrazi A, 2015, J IND ECOL, V19, P805, DOI 10.1111/jiec.12328; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Schandl H, 2010, GLOBAL ENVIRON CHANG, V20, P636, DOI 10.1016/j.gloenvcha.2010.06.003; Lifset R, 2009, J IND ECOL, V13, P837, DOI 10.1111/j.1530-9290.2009.00189.x; Pauliuk S, 2015, J IND ECOL, V19, P728, DOI 10.1111/jiec.12306; Muller DB, 2013, ENVIRON SCI TECHNOL, V47, P11739, DOI 10.1021/es402618m; Fischer-Kowalski M, 1999, ADVAN HUMAN ECOL, V8, P215; Binder CR, 2009, J IND ECOL, V13, P643, DOI 10.1111/j.1530-9290.2009.00182.x; Commission European, 2011, RES EFF EUR FLAGSH I; Di Donato M., 2015, J IND ECOL, DOI [10.1111/jiec12356, DOI 10.1111/JIEC12356]; Fischer-Kowalski M., 1999, J IND ECOL, V2, P107; Fischer-Kowalski M., 1997, INT HDB ENV SOCIOLOG; Giljum S, 2015, J IND ECOL, V19, P792, DOI 10.1111/jiec.12214; Haas W, 2015, J IND ECOL, V19, P765, DOI 10.1111/jiec.12244; Infante-Amate J, 2015, J IND ECOL, V19, P866, DOI 10.1111/jiec.12261; Kastner T, 2015, J IND ECOL, V19, P825, DOI 10.1111/jiec.12238; Lederer J, 2015, J IND ECOL, V19, P695, DOI 10.1111/jiec.12320; Licht C, 2015, J IND ECOL, V19, P890, DOI 10.1111/jiec.12287; Madrid-Lopez C, 2015, J IND ECOL, V19, P853, DOI 10.1111/jiec.12340; Patricio J, 2015, J IND ECOL, V19, P837, DOI 10.1111/jiec.12336; Schaffartzik A, 2015, J IND ECOL, V19, P703, DOI 10.1111/jiec.12258; Schandl H., 2015, J CLEAN PROD, DOI [10.1016/j.jclepro.2015.06.100, DOI 10.1016/J.JCLEPRO.2015.06.100]; Shahrokni H, 2015, J IND ECOL, V19, P917, DOI 10.1111/jiec.12308; Tanikawa H, 2015, J IND ECOL, V19, P778, DOI 10.1111/jiec.12284; UNEP (United Nations Environment Programme), 2015, CHAIRS SUMM 1 MIN EN; UNEP (United Nations Environment Programme), 2015, IND RES EFF GREEN AS; United Nations, 2014, OP WORK GROUP PROP S; Wallsten B, 2015, J IND ECOL, V19, P742, DOI 10.1111/jiec.12361; Wang T, 2015, J IND ECOL, V19, P877, DOI 10.1111/jiec.12319; Wassenaar T, 2015, J IND ECOL, V19, P715, DOI 10.1111/jiec.12349; Wenzlik M, 2015, J IND ECOL, V19, P814, DOI 10.1111/jiec.12341	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		689	694		10.1111/jiec.12357		6	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800001		
J	Tanikawa, H; Fishman, T; Okuoka, K; Sugimoto, K				Tanikawa, Hiroki; Fishman, Tomer; Okuoka, Keijiro; Sugimoto, Kenji			The Weight of Society Over Time and Space: A Comprehensive Account of the Construction Material Stock of Japan, 1945-2010	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						bottom-up accounts; construction materials; database compilation; geographic information systems (GIS); material stocks; socieconomic metabolism	MATERIAL FLOW-ANALYSIS; IN-USE STOCKS; NIGHTTIME LIGHTS; METAL STOCKS; STEEL STOCK; BUILDINGS; IRON; EVOLUTION; DYNAMICS; COPPER	In order to fully comprehend the socioeconomic metabolic (SEM) dynamics and material balance of nations, long-term accounting of economy-wide material stock is necessary in parallel to material flow accounts. Nevertheless, material stock accounts have been scarce, isolated, and mostly focused either on single materials, short time spans, or small regions. This study has two objectives: (1) review the state of the art of material stock research in the SEM discourse and (2) present a project to map, in a high level of detail, the in-use construction material stocks of Japan and its 47 prefectures from the 1940s until the present era. This project documents the two major depositories of material stock: buildings and infrastructure. We describe the challenges and benefits of utilizing a bottom-up approach, in order to promote its usage in material stock studies. The resulting database presents the accumulation of stock over time, as well as visually displaying the spatial distribution of the stock using geographical information systems (GIS), which, we argue, is an essential aspect of material stock analysis in the context of socioeconomic metabolism research.	[Tanikawa, Hiroki] Nagoya Univ, Grad Sch Environm Studies, Environm Syst Res, Nagoya, Aichi 4648601, Japan; [Fishman, Tomer; Okuoka, Keijiro; Sugimoto, Kenji] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Fishman, T (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, D2-1 510 Furo Cho, Nagoya, Aichi 4648601, Japan.	tomer.fishman@nagoya-u.jp	Fishman, Tomer/C-9772-2015	Fishman, Tomer/0000-0003-4405-2382	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [1-1402]	This research was financially supported by the Environment Research and Technology Development Fund (1-1402) of the Ministry of the Environment, Japan. The authors thank Keisuke Tanaka, Takayuki Hirakawa, and Yohei Hayakawa for their contributions to the compilation of the database.	ADRIAANSE A., 1997, RESOURCE FLOWS MAT B; Hsu FC, 2013, INT J REMOTE SENS, V34, P490, DOI 10.1080/01431161.2012.712232; Kovanda J, 2007, J IND ECOL, V11, P140, DOI 10.1162/jiec.2007.1155; Huang T, 2013, RESOUR CONSERV RECY, V72, P91, DOI 10.1016/j.resconrec.2012.12.013; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Gerst MD, 2009, ENVIRON SCI TECHNOL, V43, P6320, DOI 10.1021/es900845v; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Muller E, 2014, ENVIRON SCI TECHNOL, V48, P2102, DOI 10.1021/es403506a; Muller DB, 2006, P NATL ACAD SCI USA, V103, P16111, DOI 10.1073/pnas.0603375103; [Anonymous], 1974, HDB SEAP AIRP DES WO; Hashimoto S, 2009, WASTE MANAGE, V29, P2859, DOI 10.1016/j.wasman.2009.06.011; Fishman T, 2015, ECOL ECON, V113, P76, DOI 10.1016/j.ecolecon.2015.03.001; Daigo I, 2007, ISIJ INT, V47, P1065, DOI 10.2355/isijinternational.47.1065; Han J, 2013, SUSTAIN SCI, V8, P553, DOI 10.1007/s11625-012-0196-y; Liang HW, 2014, REMOTE SENS-BASEL, V6, P4780, DOI 10.3390/rs6064780; Krausmann F, 2014, J IND ECOL, V18, P294, DOI 10.1111/jiec.12100; Krausmann F, 2011, J IND ECOL, V15, P877, DOI 10.1111/j.1530-9290.2011.00376.x; Laner D, 2014, J IND ECOL, V18, P859, DOI 10.1111/jiec.12143; Hashimoto S, 2007, WASTE MANAGE, V27, P1725, DOI 10.1016/j.wasman.2006.10.009; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Rechberger H, 2014, J IND ECOL, V18, P159, DOI 10.1111/jiec.12087; Takahashi KI, 2009, MATER TRANS, V50, P1871, DOI 10.2320/matertrans.M2009030; Lauk C, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034023; Bergsdal H, 2007, BUILD RES INF, V35, P557, DOI 10.1080/09613210701287588; Rauch JN, 2009, P NATL ACAD SCI USA, V106, P18920, DOI 10.1073/pnas.0900658106; Pauliuk S, 2014, GLOBAL ENVIRON CHANG, V24, P132, DOI 10.1016/j.gloenvcha.2013.11.006; Fishman T, 2014, J IND ECOL, V18, P407, DOI 10.1111/jiec.12114; Tanikawa H, 2014, J IND ECOL, V18, P421, DOI 10.1111/jiec.12126; Schandl H, 2012, J IND ECOL, V16, P352, DOI 10.1111/j.1530-9290.2011.00420.x; Hu MM, 2010, RESOUR CONSERV RECY, V54, P591, DOI 10.1016/j.resconrec.2009.10.016; Tanikawa H, 2009, BUILD RES INF, V37, P483, DOI 10.1080/09613210903169394; West J, 2013, ECOL ECON, V94, P19, DOI 10.1016/j.ecolecon.2013.06.015; Muller DB, 2011, ENVIRON SCI TECHNOL, V45, P182, DOI 10.1021/es102273t; Gordon RB, 2006, P NATL ACAD SCI USA, V103, P1209, DOI 10.1073/pnas.0509498103; Gierlinger S, 2012, J IND ECOL, V16, P365, DOI 10.1111/j.1530-9290.2011.00404.x; Pauliuk S, 2013, RESOUR CONSERV RECY, V71, P22, DOI 10.1016/j.resconrec.2012.11.008; Liu G, 2013, ENVIRON SCI TECHNOL, V47, P4882, DOI 10.1021/es305108p; Pauliuk S, 2014, URBAN WATER J, V11, P274, DOI 10.1080/1573062X.2013.795234; Eurostat, 2013, EC WID MAT FLOW ACC; Eurostat, 2001, EC WID MAT FLOW ACC; Hayakawa Y, 2013, THESIS NAGOYA U NAGO; Hirakawa T., 2012, THESIS NAGOYA U NAGO; Inazu R., 2009, PAPERS ENV INFORM SC, V23, P89; Infrastructure Construction Editorial Board, 1968, CAS STUD INFR CONSTR, V7; Japan Dam Foundation, 2012, YB DAMS; Japan Industrial Standards Committee, 2012, JIS STAND DAT; Japan Sewage Works Association, 1977, SEW STAT; Komatsu Y, 2008, J ARCHITECTURE PLANN, V73, P2197; Komatsu Y., 1992, J ARCHIT PLANN ENV E, V439, P101; Lichtensteiger T., 2008, ENV ENG MANAGEMENT, V18, P41; Matthews E., 2000, WEIGHT NATIONS MAT O; Ministry of Land Infrastructure Transport and Tourism, 1965, YB RAILW STAT; Ministry of Land Infrastructure Transport and Tourism, 1965, YB ROAD STAT; Ministry of Land Infrastructure Transport and Tourism, 2012, NAT LAND NUM INF DOW; Ministry of Land Infrastructure Transport and Tourism, 2010, BUILD STOCK STAT; Ministry of Land Infrastructure Transport and Tourism, 1970, YB BUILD STAT; Ministry of Land Infrastructure Transport and Tourism, 2011, 2011 WHIT PAP LAND I; Ministry of Land Infrastructure Transport and Tourism, 2011, SURV DEM CONSTR MAT; Ministry of Land Infrastructure Transport and Tourism Chubu Branch, 2012, GUID ROAD CONSTR DES; Ministry of the Environment, 2009, MAT FLOW JAP 2006; Nagaoka K., 2009, SELECTED PAPERS ENV, V37, P213; Tanaka K., 2014, THESIS NAGOYA U NAGO; Zenrin Co. Ltd, 2011, ZMAP TOWNII 2003 200	63	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		778	791		10.1111/jiec.12284		14	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800009		
J	Kharrazi, A; Kraines, S; Rovenskaya, E; Avtar, R; Iwata, S; Yarime, M				Kharrazi, Ali; Kraines, Steven; Rovenskaya, Elena; Avtar, Ram; Iwata, Shuichi; Yarime, Masaru			Examining the Ecology of Commodity Trade Networks Using an Ecological Information-Based Approach: Toward Strategic Assessment of Resilience	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						ecological information-based approach; ecology of commodity trade networks; industrial ecology; resilience; strategic risk management; sustainability	INDUSTRIAL ECOLOGY; TROPICAL FOREST; SUSTAINABILITY; INDICATORS; ECOSYSTEM; FLOWS	Commodity trade networks exhibit certain patterns in the configuration of material flows that are similar to natural ecological networks. This article develops and explores an ecological information-based approach to examine the ecology of commodity trade networks. We demonstrate that commodity trade networks show a pattern of commonality when viewed through the introduced ecological information-based metrics. Specifically, we show how the network metrics of effective connectivity and effective number of roles can convey boundaries where commodity trade networks are robust. Further, the temporal trends of these metrics suggest the existence of multiple basins of attractions and provide clues on the dynamics of resilience of these networks over time.	[Kharrazi, Ali] Univ Tokyo, Grad Sch Publ Policy, Tokyo 1130033, Japan; [Kharrazi, Ali; Rovenskaya, Elena] Int Inst Appl Syst Anal, Adv Syst Anal Program, Laxenburg, Austria; [Kraines, Steven] Tokyo City Univ, Tokyo, Japan; [Rovenskaya, Elena] Lomonosov Moscow State Univ MSU, Fac Computat Math & Cybernet, Moscow, Russia; [Avtar, Ram] UN Univ, Inst Adv Study Sustainabil, Tokyo, Japan; [Iwata, Shuichi] Grad Sch Project Design, Tokyo, Japan; [Iwata, Shuichi] Univ Tokyo, Tokyo 1130033, Japan; [Yarime, Masaru] Univ Tokyo, Grad Sch Publ Policy, Sci Technol & Innovat Governance, Tokyo 1130033, Japan; [Yarime, Masaru] UCL, Dept Sci Technol Engn & Publ Policy STEaPP, London WC1E 6BT, England	Kharrazi, A (reprint author), Univ Tokyo, Grad Sch Publ Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ali@pp.u-tokyo.ac.jp			Japan's Ministry of Environment	The authors thank Japan's Ministry of Environment for financial support to conduct this research.	Allenby B., 1995, IND ECOLOGY; Ulanowicz RE, 2009, ECOL MODEL, V220, P1886, DOI 10.1016/j.ecolmodel.2009.04.015; Lifset R, 2005, J IND ECOL, V9, P1, DOI 10.1162/1088198054821717; Linkov I, 2014, NAT CLIM CHANGE, V4, P407; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Vandermeer J, 2004, ECOLOGY, V85, P575, DOI 10.1890/02-3140; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Chen ZZ, 2011, OCEAN COAST MANAGE, V54, P601, DOI 10.1016/j.ocecoaman.2011.06.003; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; KAUFFMAN SA, 1991, SCI AM, V265, P78; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Kharrazi A, 2013, ECOL ECON, V90, P177, DOI 10.1016/j.ecolecon.2013.03.018; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Kraines S, 2005, J IND ECOL, V9, P31, DOI 10.1162/1088198054821690; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Bodini A, 2012, ECOL INDIC, V15, P140, DOI 10.1016/j.ecolind.2011.09.032; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Davis C, 2010, J IND ECOL, V14, P707, DOI 10.1111/j.1530-9290.2010.00281.x; RUTLEDGE RW, 1976, J THEOR BIOL, V57, P355, DOI 10.1016/0022-5193(76)90007-2; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Kharrazi A, 2014, ECOL INDIC, V37, P81, DOI 10.1016/j.ecolind.2013.10.003; Fath BD, 2015, OCEAN COAST MANAGE, V108, P13, DOI 10.1016/j.ocecoaman.2014.06.020; Fiscus Daniel A, 2001, B ECOL SOC AM, V82.4, P248; Haydon D., 1994, AM NAT, V144, P1; Hey A.J.G., 2009, 4 PARADIGM DATA INTE; Holling C, 2002, PANARCHY UNDERSTANDI; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100923; Tilley David Rogers, 2003, Journal of Industrial Ecology, V7, P13, DOI 10.1162/108819803322564325; Ulanowicz Robert E., 1997, ECOLOGY ASCENDENT PE; Walker B, 2004, ECOL SOC, V19, P2; Zorach A. C., 2003, Complexity, V8, DOI 10.1002/cplx.10075	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		805	813		10.1111/jiec.12328		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800011		
J	Wang, T; Muller, DB; Hashimoto, S				Wang, Tao; Muller, Daniel B.; Hashimoto, Seiji			The Ferrous Find: Counting Iron and Steel Stocks in China's Economy	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						industrial ecology; iron and steel stocks; material stock accounting; recycling potential; sampling; steel intensity	MATERIAL FLOW-ANALYSIS; IN-USE STOCKS; CARBON EMISSIONS; LIFE-SPAN; CYCLE; COMMODITIES; EVOLUTION; DYNAMICS; INTERNET; ELEMENTS	A detailed understanding of material stocks in use is essential for anticipating future scrap availability, identifying critical drivers for material use, and developing strategies for resource efficiency. Here, we present a bottom-up assessment of iron and steel stocks in use in urban and rural China for the years 2000 and 2010, including >250 subcategories of products and components, and grouping them into five main end-use categories (i.e., buildings, infrastructure, domestic appliances, machinery, and transport equipment). The uncertainty range of the steel content per type of stock, a determinant of the accuracy and usefulness of the stock accounting, is probed by multiple means, including sample analysis. Important findings are that (1) iron and steel stocks in China have climbed to 2.4 tonnes/capita (t/cap) in 2010, up from 0.9 t/cap in 2000. The use of reinforced concrete in construction of the urban built environment was the major driver for stock growth; (2) a rural-urban difference was uncovered, with rural iron and steel stocks of approximately 1.1 t/cap and the urban iron and steel stocks of approximately 3.7 t/cap in 2010. Both are, nevertheless, far below the level of 10 to 16 t/cap observed in highly industrialized and urbanized countries. For this reason, further stock increase is foreseeable as urbanization and industrialization proceeds and quality of life improves; (3) nearly half of the steel stocks were embedded in concrete structures, and 23% were located in the countryside. Only a fraction of these stocks are currently recovered at end of life.	[Wang, Tao] Ritsumeikan Univ, Global Innovat Res Org, Kyoto, Japan; [Wang, Tao] Norwegian Univ Sci & Technol NTNU, Trondheim, Norway; [Muller, Daniel B.] NTNU, Ind Ecol Programme, Trondheim, Norway; [Muller, Daniel B.] NTNU, Dept Energy & Proc Engn, Trondheim, Norway; [Hashimoto, Seiji] Ritsumeikan Univ, Coll Sci & Engn, Dept Environm Syst Engn, Kusatsu, Shiga 5258577, Japan	Wang, T (reprint author), Ritsumeikan Univ, Global Innovat Res Org, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	a.t.wang@gmail.com			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-6-4]	This research was supported by the Environment Research and Technology Development Fund (S-6-4) of the Ministry of the Environment, Japan. Part of the research was instructed by Dr. T.E. Graedel at Yale University. The authors sincerely thank many experts from the industries and academia for their data provision and advice.	Hvistendahl M, 2012, SCIENCE, V336, P1223, DOI 10.1126/science.336.6086.1223; Yuan HP, 2013, PROJ MANAG J, V44, P101, DOI 10.1002/pmj.21349; Hu D, 2010, RESOUR CONSERV RECY, V54, P1177, DOI 10.1016/j.resconrec.2010.03.011; Gerst MD, 2008, ENVIRON SCI TECHNOL, V42, P7038, DOI 10.1021/es800420p; Gubbi J, 2013, FUTURE GENER COMP SY, V29, P1645, DOI 10.1016/j.future.2013.01.010; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Murakami S, 2010, J IND ECOL, V14, P598, DOI 10.1111/j.1530-9290.2010.00250.x; Pauliuk S, 2013, ENVIRON SCI TECHNOL, V47, P3448, DOI 10.1021/es303149z; Muller E, 2014, ENVIRON SCI TECHNOL, V48, P2102, DOI 10.1021/es403506a; Muller DB, 2006, P NATL ACAD SCI USA, V103, P16111, DOI 10.1073/pnas.0603375103; Hashimoto S, 2009, WASTE MANAGE, V29, P2859, DOI 10.1016/j.wasman.2009.06.011; Oguchi M, 2010, J IND ECOL, V14, P613, DOI 10.1111/j.1530-9290.2010.00251.x; Yang W, 2008, BUILD RES INF, V36, P1, DOI 10.1080/09613210701702883; Wang T, 2007, ENVIRON SCI TECHNOL, V41, P5120, DOI 10.1021/es062761t; [Anonymous], 2013, COMMUNICATION; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P148, DOI 10.1021/es201904c; Hashimoto S, 2007, WASTE MANAGE, V27, P1725, DOI 10.1016/j.wasman.2006.10.009; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Milford RL, 2013, ENVIRON SCI TECHNOL, V47, P3455, DOI 10.1021/es3031424; Allwood JM, 2010, ENVIRON SCI TECHNOL, V44, P1888, DOI 10.1021/es902909k; Muller DB, 2011, ENVIRON SCI TECHNOL, V45, P182, DOI 10.1021/es102273t; Chen WQ, 2012, ENVIRON SCI TECHNOL, V46, P8574, DOI 10.1021/es3010333; Muller DB, 2013, ENVIRON SCI TECHNOL, V47, P11739, DOI 10.1021/es402618m; Pauliuk S, 2013, RESOUR CONSERV RECY, V71, P22, DOI 10.1016/j.resconrec.2012.11.008; [Anonymous], 2002, CHIN STAT YB 2002; Li JR, 2013, RESOUR CONSERV RECY, V74, P20, DOI 10.1016/j.resconrec.2013.02.015; CATRC (China Automotive Technology and Research Center), 2012, CHIN AUT IND YB 2011; CEC (China Electricity Council), 2012, CHIN EL YB 2011; CEC (China Electricity Council), 2002, CHIN EL POW YB 2001; Chen X., 2005, RAIL TRACK ENG; CISA (China Iron and Steel Association), 2006, CHIN STEEL YB 2005; CISA (China Iron and Steel Association), 2007, CHIN STEEL YB 2006; CNPC (China National Petroleum Corporation), 2011, CNPC ANN REP 2010; CNPC (China National Petroleum Corporation), 2011, CNPC YB 2010; CSCS (China Steel Construction Society), 2006, CHIN STEEL CONSTR YB; DRCSCC (Development Research Center of the State Council of China), 2005, FOR REP STEEL CONS C; Gartner, 2013, GARTN HYP CYCL SPEC; Gu Z., 2012, COMMUNICATION; Han Y., 2012, COMMUNICATION; Hashimoto S., 2008, P 8 INT C ECOBALANCE; He W., 2012, COMMUNICATION; IMF, 2013, WOR ECON OUTLOOK, P1; Kumrajva, 2007, DIAM TRA; Li MS, 2012, INT ADV EDU-GLOB, P103; Li Z., 1985, RURAL BUILDING ARCHI; Maddison A., 2006, WORLD EC; Manyika J, 2011, BIG DATA NEXT FRONTI; MOAC (Ministry of Agriculture of China), 2001, CHIN AGR STAT REP 20; MOAC (Ministry of Agriculture of China), 2011, CHIN AGR STAT REP 20; MOHURD (Ministry of Housing and Urban-Rural Development of China), 2007, STAT B URB RUR CONST; MORC (Ministry of Railways of China), 2011, CHIN RAILW YB 2010; MORC (Ministry of Railways of China), 2001, CHIN RAILW YB 2000; MOTC (Ministry of Transportation of China), 2011, STAT B HIGHW WAT TRA; NBSC, 2012, CHIN STAT YB 2012; NBSC (National Bureau of Statistics of China), 2012, TAB 2010 POP CENS PE; NBSC (National Bureau of Statistics of China), 2002, TAB 2000 POP CENS PE; NBSC (National Bureau of Statistics of China), 2014, CHIN STAT YB 2013; NBSC (National Bureau of Statistics of China), 1997, DAT COLL IND CENS PE; NBSC (National Bureau of Statistics of China), 2001, CHIN STAT YB 2001; NBSC (National Bureau of Statistics of China), 2011, CHIN STAT YB 2011; Niu L., 2006, WISCO TECHNOLOGY, V44, P48; Qin L., 2012, COMMUNICATION; Rechberger H., 2004, PRACTICAL HDB MAT FL; SAC (Standardization Administration of China), 1999, 971121999 SAC GBT; SAC (Standardization Administration of China), 2000, 1772000 SAC YBT; Schmandt-Besserat Denise, 1996, WRITING CAME; Song Y., 2012, COMMUNICATION; SRI (Steel Recycling Institute), 2012, 2010 STEEL REC RAT; [谭泽先 Tan Zexian], 2007, [建筑结构, Building Structure], V37, P17; UNEP (United Nations Environment Programme) International Panel for Sustainable Resource Management, 2010, MET STOCK SOC SCI SY; Wang D., 1996, MANUAL COSTING BUILD; WardsAuto, 2011, WARDS MOT VEH FACTS; Yang W., 2010, MODELING EVOLUTION C; Zhong Q., 2012, COMMUNICATION; Zhou J., 2012, COMMUNICATION	75	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		877	889		10.1111/jiec.12319		13	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800017		
J	Kawamura, Y; Nakayama, A; Kato, T; Miura, H; Ishihara, N; Ihira, M; Takahashi, Y; Matsuda, K; Yoshikawa, T				Kawamura, Yoshiki; Nakayama, Ai; Kato, Taichi; Miura, Hiroki; Ishihara, Naoko; Ihira, Masaru; Takahashi, Yukitoshi; Matsuda, Kazumi; Yoshikawa, Tetsushi			Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy	JOURNAL OF INFECTIOUS DISEASES			English	Article						human herpesvirus 6; lobe; mesial temporal sclerosis	MONOCYTE CHEMOATTRACTANT PROTEIN-1; REAL-TIME PCR; EXANTHEM-SUBITUM; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; VIRAL LOAD; RAT-BRAIN; ENCEPHALITIS; EXPRESSION; HUMAN-HERPESVIRUS-6	Background. Human herpesvirus 6B (HHV-6B) is the causative agent for exanthem subitum. HHV-6B was associated with mesial temporal sclerosis (MTS), leading to mesial temporal lobe epilepsy (MTLE). In this study, we sought to elucidate the pathogenic role of HHV-6B in patients with MTLE. Methods. Seventy-five intractable MTLE patients, including 52 MTS patients and 23 non-MTS patients, were enrolled in this study. Resected hippocampus, amygdala, and mixed samples of amygdala and uncus samples were examined by real-time polymerase chain reaction (PCR) and reverse-transcriptase PCR to detect viral DNA and messenger RNA (mRNA), respectively. Host gene expressions, including neural markers, were measured using the TaqMan Gene Expression Assay. Results. Detection of HHV-6 DNA was higher in MTS patients than non-MTS patients (median/interquartile range: 19.1/0-89.2 vs 0.0/0.0-0.0 copies/mu g DNA; P = .004). HHV-6B viral DNA was determined in 12/27 HHV-6 DNA-positive samples, and no HHV-6B mRNA were detected in all samples. In MTS patients, expression of monocyte chemotactic protein-1 (P = .029) and glial fibrillary acidic protein (P = .043) were significantly higher in the amygdala samples with HHV-6 DNA than those without viral DNA. Conclusions. This study suggests that HHV-6B may play an important role in the pathogenesis of MTS via modification of host gene expression.	[Kawamura, Yoshiki; Nakayama, Ai; Kato, Taichi; Miura, Hiroki; Ishihara, Naoko; Yoshikawa, Tetsushi] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Ihira, Masaru] Fujita Hlth Univ, Fac Clin Engn, Sch Hlth Sci, Toyoake, Aichi 4701192, Japan; [Takahashi, Yukitoshi; Matsuda, Kazumi] Shizuoka Inst Epilepsy & Neurol Disorder, Natl Epilepsy Ctr, Shizuoka, Japan	Yoshikawa, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Pediat, 1-98 Deagakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	tetsushi@fujita-hu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461610, 25860888]; Japan Society for the Promotion of Science [H25-Jisedai-003, H25-Shinko-003]	This work was supported in part by a Grant-in-Aid for Scientific Research(C) (No. 25461610) and Young Scientist(B) (No. 25860888) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Japan Society for the Promotion of Science (H25-Jisedai-003 and H25-Shinko-003).	Tanaka N, 2000, BONE MARROW TRANSPL, V26, P1193, DOI 10.1038/sj.bmt.1702710; Karatas H, 2008, J NEUROL SCI, V264, P151, DOI 10.1016/j.jns.2007.08.010; Auer T, 2008, EPILEPSIA, V49, P1562, DOI 10.1111/j.1528-1167.2008.01679.x; Caserta MT, 1998, J PEDIATR-US, V133, P386, DOI 10.1016/S0022-3476(98)70275-6; Little AR, 2002, NEUROSCIENCE, V115, P307, DOI 10.1016/S0306-4522(02)00359-7; Donati D, 2003, NEUROLOGY, V61, P1405; Suga S, 2000, ARCH DIS CHILD, V82, P62, DOI 10.1136/adc.82.1.62; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1; STEWARD O, 1990, J NEUROSCI, V10, P2373; Kawamura Y, 2011, J CLIN VIROL, V51, P12, DOI 10.1016/j.jcv.2011.02.002; Blumcke I, 2002, BRAIN PATHOL, V12, P199; Torigoe S, 1996, J PEDIATR-US, V129, P301, DOI 10.1016/S0022-3476(96)70259-7; Ihira M, 2012, J MED VIROL, V84, P1388, DOI 10.1002/jmv.23350; Galasso JM, 2000, EXP NEUROL, V165, P295, DOI 10.1006/exnr.2000.7466; HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703; Li YQ, 2009, NEUROCHEM RES, V34, P1594, DOI 10.1007/s11064-009-9948-1; Yoshikawa T, 2002, J MED VIROL, V66, P497, DOI 10.1002/jmv.2172; YOSHIKAWA T, 1992, PEDIATRICS, V89, P888; Pevenstein SR, 1999, J VIROL, V73, P10514; Yoshikawa T, 2009, PEDIATR NEUROL, V41, P353, DOI 10.1016/j.pediatrneurol.2009.05.012; SAITO Y, 1995, J NEUROVIROL, V1, P30, DOI 10.3109/13550289509111008; Glabinski AR, 1996, J IMMUNOL, V156, P4363; ABLASHI DV, 1988, INT J CANCER, V42, P787, DOI 10.1002/ijc.2910420526; YAMANISHI K, 1988, LANCET, V1, P1065; Ward KN, 2005, CURR OPIN INFECT DIS, V18, P247, DOI 10.1097/01.qco.0000168386.16519.93; Fellin T, 2005, TRENDS MOL MED, V11, P530, DOI 10.1016/j.molmed.2005.10.007; TanakaTaya K, 1996, J MED VIROL, V48, P88, DOI 10.1002/(SICI)1096-9071(199601)48:1<88::AID-JMV14>3.0.CO;2-2; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; He J, 1996, J VIROL, V70, P1296; Seeley WW, 2007, NEUROLOGY, V69, P156, DOI 10.1212/01.wnl.0000265591.10200.d7; Kimura H, 1999, J CLIN MICROBIOL, V37, P132; Engel J, 2001, NEUROSCIENTIST, V7, P340; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Chan PKS, 2001, J MED VIROL, V64, P42, DOI 10.1002/jmv.1015; Ogata M, 2010, BONE MARROW TRANSPL, V45, P129, DOI 10.1038/bmt.2009.116; Lallemand F, 2000, J CLIN MICROBIOL, V38, P1404; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; ASANO Y, 1992, ARCH DIS CHILD, V67, P1484; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Caruso A, 2003, J MED VIROL, V70, P451, DOI 10.1002/jmv.10416; Cuomo L, 2001, J MED VIROL, V63, P45, DOI 10.1002/1096-9071(200101)63:1<45::AID-JMV1006>3.0.CO;2-K; SUGA S, 1993, ANN NEUROL, V33, P597, DOI 10.1002/ana.410330607; ABLASHI DV, 1991, VIROLOGY, V184, P545, DOI 10.1016/0042-6822(91)90424-A; Bhanushali MJ, 2013, NEUROLOGY, V80, P1494, DOI 10.1212/WNL.0b013e31828cf8a2; Fotheringham J, 2007, PLOS MED, V4, P848, DOI 10.1371/journal.pmed.0040180	45	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212	7					1014	1021		10.1093/infdis/jiv160		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0FK	WOS:000363191300002		
J	Iwanaga, N; Nakamura, S; Oshima, K; Kajihara, T; Takazono, T; Miyazaki, T; Izumikawa, K; Yanagihara, K; Sugawara, A; Sunazuka, T; Omura, S; Kohno, S				Iwanaga, Naoki; Nakamura, Shigeki; Oshima, Kazuhiro; Kajihara, Toshiki; Takazono, Takahiro; Miyazaki, Taiga; Izumikawa, Koichi; Yanagihara, Katsunori; Sugawara, Akihiro; Sunazuka, Toshiaki; Omura, Satoshi; Kohno, Shigeru			Macrolides Promote CCL2-Mediated Macrophage Recruitment and Clearance of Nasopharyngeal Pneumococcal Colonization in Mice	JOURNAL OF INFECTIOUS DISEASES			English	Article						Streptococcus pneumoniae; macrolides; colonization; CCL2; macrophage	STREPTOCOCCUS-PNEUMONIAE COLONIZATION; AZITHROMYCIN; ROXITHROMYCIN; ERYTHROMYCIN; ANTIBIOTICS; EXPRESSION; INFECTION; RECEPTOR; DISEASE; CELLS	Background. Streptococcus pneumoniae (pneumococcus) colonizes mucosal surfaces of the upper respiratory tract (URT), resulting in invasive disease. Macrolides are known for their immunomodulatory effects. We investigated the potency of macrolides to reduce pneumococcal colonization by activating host innate immunity. Methods. The kinetics of colonization, cellular response, and inflammatory cytokine levels in the URT were assessed after nasal inoculation of pneumococci. EM900 (a novel 12-membered nonantibiotic macrolide with an immunomodulatory effect) was orally administered throughout the experiment. Survival was evaluated for 10 days. Macrolide-mediated CCL2 production from peritoneal macrophages was determined by enzyme-linked immuosorbent assay. The cell-signaling pathway was analyzed by means of Western blotting and gene silencing assays. Results. Streptococcus pneumoniae was significantly reduced from EM900-treated mice 14 days after pneumococcal inoculation. Macrophage recruitment and Ccl2 messenger RNA expression were promoted. CCL2 production from peritoneal macrophages was significantly induced by macrolides and was dependent on NF-kappa B phosphorylation through the myeloid differentiation primary-response gene 88- or TIR domain-containing adapter-inducing interferon-beta-mediated pathway. Mortality of mice with invasive pneumococcal disease was improved by pretreatment with EM900. Conclusions. Macrolides may inhibit invasive pneumococcal infections by accelerating the clearance of pneumococcal nasopharyngeal colonization via promotion of macrophage-mediated innate immunity.	[Iwanaga, Naoki; Nakamura, Shigeki; Oshima, Kazuhiro; Kajihara, Toshiki; Takazono, Takahiro; Miyazaki, Taiga; Izumikawa, Koichi; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 8528501, Japan; [Nakamura, Shigeki; Izumikawa, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Unit Mol Microbiol & Immunol, Nagasaki 8528501, Japan; [Yanagihara, Katsunori] Kitasato Univ, Dept Lab Med, Nagasaki Univ Hosp, Tokyo, Japan; [Sugawara, Akihiro; Sunazuka, Toshiaki; Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan	Nakamura, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	moju516@nagasaki-u.ac.jp					MARRIE TJ, 1989, REV INFECT DIS, V11, P586; ANDERSON R, 1989, J INFECT DIS, V159, P966; Sunazuka T, 2003, J ANTIBIOT, V56, P721; Vrancic M, 2012, BRIT J PHARMACOL, V165, P1348, DOI 10.1111/j.1476-5381.2011.01576.x; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Yanagihara K, 1997, AM J RESP CRIT CARE, V155, P337; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Kim JO, 1998, J INFECT DIS, V177, P368; KONNO S, 1992, LIFE SCI, V51, pPL107; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Otsu K, 2011, PHARMACOLOGY, V88, P327, DOI 10.1159/000334339; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Sugawara A, 2011, BIOORG MED CHEM LETT, V21, P3373, DOI 10.1016/j.bmcl.2011.04.004; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Tanaka A, 2011, LETT APPL MICROBIOL, V53, P35, DOI 10.1111/j.1472-765X.2011.03079.x; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Beisswenger C, 2009, INFECT IMMUN, V77, P2212, DOI 10.1128/IAI.01224-08; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Gavilanes X, 2009, J CYST FIBROS, V8, P203, DOI 10.1016/j.jcf.2009.03.003; Bergner PM, 2006, J IMMUNOL, V176, P2366; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; GRAY BM, 1986, PEDIATR INFECT DIS J, V5, P201, DOI 10.1097/00006454-198603000-00009; Shinkai M, 2006, AM J PHYSIOL-LUNG C, V290, pL75, DOI 10.1152/ajplung.00093.2005	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212	7					1150	1159		10.1093/infdis/jiv157		10	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0FK	WOS:000363191300016		
J	Hill-Batorski, L; Halfmann, P; Marzi, A; Lopes, TJS; Neumann, G; Feldmann, H; Kawaoka, Y				Hill-Batorski, Lindsay; Halfmann, Peter; Marzi, Andrea; Lopes, Tiago J. S.; Neumann, Gabriele; Feldmann, Heinz; Kawaoka, Yoshihiro			Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola virus; interleukin 1 receptor antagonist; Il1rn; IL-1Ra	COLONY-STIMULATING FACTOR; HEMORRHAGIC-FEVER; NEUTROPHIL RECRUITMENT; INFLAMMATORY RESPONSE; MOUSE MODEL; GENE; MICE; PATHOGENESIS; EXPRESSION; IL-1-BETA	The current outbreak of Ebola virus (EBOV) infection in West Africa is unprecedented, with nearly 26 000 confirmed cases and >10 000 deaths. Comprehensive data on the pathogenesis of EBOV infection are lacking; however, recent studies suggested that fatal EBOV infections are characterized by dysregulation of the innate immune response and a subsequent cytokine storm. Specifically, several studies suggested that hypersecretion of interleukin 1 receptor antagonist (IL-1Ra) correlates with lethal EBOV infections. To examine the significance of IL-1Ra in EBOV infections, we infected mice that lack the gene encoding IL-1Ra, Il1rn (IL-1RNKO), and mice with wild-type Il1rn (IL-1RN-WT) with a mouse-adapted EBOV (MA-EBOV). Infected IL-1RN-KO mice lost more weight and had a lower survival rate than IL-1RN-WT mice infected with MA-EBOV. In addition, IL-1RN-KO mice infected with wild-type EBOV, which does not cause lethal infection in adult immunocompetent mice, such as C57BL/6 mice, experienced greater weight loss than IL-1RN-WT mice infected with wild-type EBOV. Further studies revealed that the levels of 6 cytokines in spleens-IL-1 alpha, IL-1 beta, interleukin 12p40, interleukin 17, granulocyte colony-stimulating factor, and regulated on activation, normal T-cell expressed and secreted-were significantly different between IL-1RN-KO mice and IL-1RN-WT mice infected with MA-EBOV. Collectively, our data suggest that IL-1Ra may have a protective effect upon EBOV infection, likely by damping an overactive proinflammatory immune response.	[Hill-Batorski, Lindsay; Halfmann, Peter; Lopes, Tiago J. S.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Marzi, Andrea; Feldmann, Heinz] NIAID, Div Intramural Res, Virol Lab, NIH, Hamilton, MT USA; [Lopes, Tiago J. S.; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Div Virol, Tokyo 1138654, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	Kawaoka, Y (reprint author), 575 Sci Dr, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu			National Institutes of Health (NIH) [5 U19 AI106772-02]; National Institute of Allergy and Infectious Diseases, NIH	This work was supported by the National Institutes of Health (NIH; project5 U19 AI106772-02) and by the intramural research program of the National Institute of Allergy and Infectious Diseases, NIH.	Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; GINSBURG I, 1995, FREE RADICAL RES, V22, P489, DOI 10.3109/10715769509150323; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; GRANOWITZ EV, 1991, LANCET, V338, P1423, DOI 10.1016/0140-6736(91)92725-H; Raymond J, 2011, J INFECT DIS, V204, pS986, DOI 10.1093/infdis/jir335; Ebihara H, 2011, J INFECT DIS, V204, pS991, DOI 10.1093/infdis/jir336; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Arnalich F, 2002, CLIN EXP IMMUNOL, V127, P331, DOI 10.1046/j.1365-2249.2002.01743.x; Cilloniz C, 2011, J VIROL, V85, P9060, DOI 10.1128/JVI.00659-11; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Sullivan N, 2003, J VIROL, V77, P9733, DOI 10.1128/JVI.77.18.9733-9737.2003; Kreuzer KA, 1997, CLIN EXP IMMUNOL, V109, P54, DOI 10.1046/j.1365-2249.1997.4181315.x; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Leroy EM, 2001, CLIN EXP IMMUNOL, V124, P453, DOI 10.1046/j.1365-2249.2001.01517.x; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; FISHERHOCH SP, 1983, LANCET, V2, P1055; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Endo S, 1996, J MED, V27, P57; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; VANDERGROEN G, 1979, J MED VIROL, V4, P239, DOI 10.1002/jmv.1890040309; Miller LS, 2007, J IMMUNOL, V179, P6933; Fragoso JM, 2010, IMMUNOL LETT, V133, P106, DOI 10.1016/j.imlet.2010.08.003; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Lind H, 2005, LUNG CANCER-J IASLC, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Thea DM, 1996, ANN INTERN MED, V124, P757; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Bray M, 1998, J INFECT DIS, V178, P651; Centers for Disease Control and Prevention, 2015, OUTBR CHRON EB HEM F; de-Oliveira-Pinto LM, 2012, MEM I OSWALDO CRUZ, V107, P48, DOI 10.1590/S0074-02762012000100007; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Fisher-Hoch S., 1985, J INFECT DIS, V5, P887; Lehr HA, 1994, OPIN HEMATOL, V1, P92; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Meyer NJ, 2014, AM J RESP CRIT CARE, V190, P656, DOI 10.1164/rccm.201403-0586OC	48	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S329	S335		10.1093/infdis/jiv335		7	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100033		
J	Ogawa, H; Miyamoto, H; Nakayama, E; Yoshida, R; Nakamura, I; Sawa, H; Ishii, A; Thomas, Y; Nakagawa, E; Matsuno, K; Kajihara, M; Maruyama, J; Nao, N; Muramatsu, M; Kuroda, M; Simulundu, E; Changula, K; Hang'ombe, B; Namangala, B; Nambota, A; Katampi, J; Igarashi, M; Ito, K; Feldmann, H; Sugimoto, C; Moonga, L; Mweene, A; Takada, A				Ogawa, Hirohito; Miyamoto, Hiroko; Nakayama, Eri; Yoshida, Reiko; Nakamura, Ichiro; Sawa, Hirofumi; Ishii, Akihiro; Thomas, Yuka; Nakagawa, Emiko; Matsuno, Keita; Kajihara, Masahiro; Maruyama, Junki; Nao, Naganori; Muramatsu, Mieko; Kuroda, Makoto; Simulundu, Edgar; Changula, Katendi; Hang'ombe, Bernard; Namangala, Boniface; Nambota, Andrew; Katampi, Jackson; Igarashi, Manabu; Ito, Kimihito; Feldmann, Heinz; Sugimoto, Chihiro; Moonga, Ladslav; Mweene, Aaron; Takada, Ayato			Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola virus; Marburg virus; filovirus; specific antibody; fruit bat; Zambia	EBOLA-VIRUS; ANTIBODY PREVALENCE; GLYCOPROTEIN	Fruit bats are suspected to be a natural reservoir of filoviruses, including Ebola and Marburg viruses. Using an enzyme-linked immunosorbent assay based on the viral glycoprotein antigens, we detected filovirus-specific immunoglobulin G antibodies in 71 of 748 serum samples collected from migratory fruit bats (Eidolon helvum) in Zambia during 2006-2013. Although antibodies to African filoviruses (eg, Zaire ebolavirus) were most prevalent, some serum samples showed distinct specificity for Reston ebolavirus, which that has thus far been found only in Asia. Interestingly, the transition of filovirus species causing outbreaks in Central and West Africa during 2005-2014 seemed to be synchronized with the change of the serologically dominant virus species in these bats. These data suggest the introduction of multiple species of filoviruses in the migratory bat population and point to the need for continued surveillance of filovirus infection of wild animals in sub-Saharan Africa, including hitherto nonendemic countries.	[Ogawa, Hirohito; Ishii, Akihiro; Thomas, Yuka; Nakagawa, Emiko; Moonga, Ladslav] Hokudai Ctr Zoonosis Control, Lusaka, Zambia; [Ogawa, Hirohito; Nakamura, Ichiro; Sawa, Hirofumi; Ishii, Akihiro; Thomas, Yuka; Nakagawa, Emiko; Simulundu, Edgar; Nambota, Andrew; Sugimoto, Chihiro; Mweene, Aaron; Takada, Ayato] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Changula, Katendi; Hang'ombe, Bernard; Namangala, Boniface; Moonga, Ladslav] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Katampi, Jackson] Zambia Wildlife Author, Chilanga, Zambia; [Miyamoto, Hiroko; Nakayama, Eri; Yoshida, Reiko; Matsuno, Keita; Kajihara, Masahiro; Maruyama, Junki; Nao, Naganori; Muramatsu, Mieko; Kuroda, Makoto; Igarashi, Manabu; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido 0010020, Japan; [Nakamura, Ichiro; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido 0010020, Japan; [Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido 0010020, Japan; [Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Sapporo, Hokkaido 0010020, Japan; [Sawa, Hirofumi; Matsuno, Keita; Igarashi, Manabu; Ito, Kimihito; Sugimoto, Chihiro; Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Hang'ombe, Bernard; Mweene, Aaron] Southern African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA	Takada, A (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido 0010020, Japan.	atakada@czc.hokudai.ac.jp	Maruyama, Junki/H-7993-2013; Ogawa, Hirohito/F-6918-2012		Japan Initiative for Global Research Network on Infectious Diseases; Japan Science and Technology Agency; Japan International Cooperation Agency; Global Center Of Excellence Program "Establishment of International Collaboration Centers for Zoonosis Control" from Ministry of Education, Culture, Sports, Science and Technology, Japan [F-001]; Science and Technology Research Partnership for Sustainable Development	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases, the Japan Science and Technology Agency, and the Japan International Cooperation Agency within the framework of the Science and Technology Research Partnership for Sustainable Development. Funding was also provided by the Global Center Of Excellence Program "Establishment of International Collaboration Centers for Zoonosis Control" (grant F-001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Manicassamy B, 2007, VIROLOGY, V358, P79, DOI 10.1016/j.virol.2006.06.041; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Allela L, 2005, EMERG INFECT DIS, V11, P385; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Olival KJ, 2013, EMERG INFECT DIS, V19, P270, DOI 10.3201/eid1902.120524; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; de Jong Carol, 2011, FAO Animal Production and Health Manual, V12, P1; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Ogawa H, 2011, J VIROL METHODS, V171, P310, DOI 10.1016/j.jviromet.2010.11.010; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321; Centers for Disease Control and Prevention, OUTBR; DeFrees SL, 1988, MAMMAL SPECIES, V312, P1, DOI DOI 10.2307/3504095; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nidom CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040740; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; World Health Organization, GLOB AL RESP	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S101	S108		10.1093/infdis/jiv063		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100005		
J	Tsuda, Y; Hoenen, T; Banadyga, L; Weisend, C; Ricklefs, SM; Porcella, SF; Ebihara, H				Tsuda, Yoshimi; Hoenen, Thomas; Banadyga, Logan; Weisend, Carla; Ricklefs, Stacy M.; Porcella, Stephen F.; Ebihara, Hideki			An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola virus; reverse genetics system; mutation; RNA editing site	REPLICATION; RNA; TRANSCRIPTION; GLYCOPROTEIN; POLYMERASE; PARTICLES; RECOVERY; CULTURE	Reverse genetics systems represent a key technique for studying replication and pathogenesis of viruses, including Ebola virus (EBOV). During the rescue of recombinant EBOV from Vero cells, a high frequency of mutations was observed throughout the genomes of rescued viruses, including at the RNA editing site of the glycoprotein gene. The influence that such genomic instability could have on downstream uses of rescued virus may be detrimental, and we therefore sought to improve the rescue system. Here we report an improved EBOV rescue system with higher efficiency and genome stability, using a modified full-length EBOV clone in Huh7 cells. Moreover, by evaluating a variety of cells lines, we revealed that EBOV genome instability is cell-type dependent, a fact that has significant implications for the preparation of standard virus stocks. Thus, our improved rescue system will have an impact on both basic and translational research in the filovirus field.	[Tsuda, Yoshimi; Banadyga, Logan; Weisend, Carla; Ebihara, Hideki] NIAID, Mol Virol & Host Pathogen Interact Unit, NIH, Hamilton, MT 59840 USA; [Hoenen, Thomas] NIAID, Dis Modeling & Transmiss Sect, Virol Lab, NIH, Hamilton, MT 59840 USA; [Ricklefs, Stacy M.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Div Intramural Res,NIH, Hamilton, MT 59840 USA; [Tsuda, Yoshimi] Hokkaido Univ, Grad Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan	Ebihara, H (reprint author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	ebiharah@niaid.nih.gov			Intramural Research Program, NIH	This work was supported by the Intramural Research Program, NIH.	Yanai H, 2006, MICROBES INFECT, V8, P1522, DOI 10.1016/j.micinf.2006.01.010; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Muhlberger E, 1999, J VIROL, V73, P2333; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Hoenen T, 2011, ANTIVIR RES, V91, P195, DOI 10.1016/j.antiviral.2011.06.003; Ebihara H, 2000, J VIROL, V74, P9245, DOI 10.1128/JVI.74.19.9245-9255.2000; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Hoenen T, 2012, J VIROL, V86, P11779, DOI 10.1128/JVI.01525-12; Ebihara H, 2005, THROMB HAEMOSTASIS, V94, P240, DOI 10.1160/TH05-05-0335; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI79.4.2413-2419.2005; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Conzelmann KK, 2004, CURR TOP MICROBIOL, V283, P1; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Feldmann H, 2013, FIELDS VIROLOGY, P923; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Mehedi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003677	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S129	S137		10.1093/infdis/jiu681		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100008		
J	Wrensch, F; Karsten, CB; Gnirss, K; Hoffmann, M; Lu, K; Takada, A; Winkler, M; Simmons, G; Pohlmann, S				Wrensch, Florian; Karsten, Christina B.; Gnirss, Kerstin; Hoffmann, Markus; Lu, Kai; Takada, Ayato; Winkler, Michael; Simmons, Graham; Poehlmann, Stefan			Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola; glycoprotein; entry; IFITM; interferon	INFLUENZA-A VIRUS; EBOLA-VIRUS; MARBURG VIRUS; ENVELOPE GLYCOPROTEIN; HEMORRHAGIC-FEVER; RESTON-EBOLAVIRUS; DENGUE VIRUS; DC-SIGN; INFECTION; CORONAVIRUS	Ebolaviruses are highly pathogenic in humans and nonhuman primates and pose a severe threat to public health. The interferon-induced transmembrane (IFITM) proteins can restrict entry of ebolaviruses, influenza A viruses, and other enveloped viruses. However, the breadth and mechanism of the antiviral activity of IFITM proteins are incompletely understood. Here, we employed ebolavirus glycoprotein-pseudotyped vectors and ebolavirus-like particles to address this question. We show that IFITM proteins inhibit the cellular entry of diverse ebolaviruses and demonstrate that type I interferon induces IFITM protein expression in macrophages, major viral targets. Moreover, we show that IFITM proteins block entry of influenza A viruses and ebolaviruses by different mechanisms and provide evidence that antibodies and IFITM proteins can synergistically inhibit cellular entry of ebolaviruses. These results provide insights into the role of IFITM proteins in infection by ebolaviruses and suggest a mechanism by which antibodies, though poorly neutralizing in vitro, might contribute to viral control in vivo.	[Wrensch, Florian; Karsten, Christina B.; Gnirss, Kerstin; Hoffmann, Markus; Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, D-37077 Gottingen, Germany; [Karsten, Christina B.] Hannover Med Sch, Inst Cellular Chem, Hannover, Germany; [Lu, Kai; Simmons, Graham] Blood Syst Res Inst, San Francisco, CA USA; [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan	Pohlmann, S (reprint author), German Primate Ctr, Infect Biol Unit, Kellnerweg 4, D-37077 Gottingen, Germany.	spoehlmann@dpz.eu			German Research Foundation [PO 716/8-1]; German Ministry for Research and Education (subproject within EBOCON); National Institute of Allergy and Infectious Diseases [R21AI107165]; Leibniz Graduate School Emerging Infectious Diseases; Leibniz Foundation	This work was supported by the German Research Foundation (grant PO 716/8-1 to S. P.), the German Ministry for Research and Education (subproject within EBOCON [S. P.]), Leibniz Graduate School Emerging Infectious Diseases (S. P.), the Leibniz Foundation, and the National Institute of Allergy and Infectious Diseases (grant R21AI107165 to G. S.).	Agua-Agum J, 2015, NEW ENGL J MED, V372, P584, DOI DOI 10.1056/NEJMC1414992; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452; Saphire EO, 2013, IMMUNOTHERAPY-UK, V5, P1221, DOI [10.2217/imt.13.124, 10.2217/IMT.13.124]; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.21.12090-12095.2004; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Kuhl A, 2012, ZOONOSES PUBLIC HLTH, V59, P116, DOI 10.1111/j.1863-2378.2012.01454.x; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Miranda MEG, 2011, J INFECT DIS, V204, pS757, DOI 10.1093/infdis/jir296; Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Martinez O, 2012, ANTIVIR RES, V93, P416, DOI 10.1016/j.antiviral.2012.01.011; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12; Hutchinson KL, 2007, J INFECT DIS, V196, pS357, DOI 10.1086/520611; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Ng M, 2014, VIROLOGY, V468, P637, DOI 10.1016/j.virol.2014.08.019; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Misasi J, 2014, CELL, V159, P477, DOI 10.1016/j.cell.2014.10.006; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Williams DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110096; World Health Organization (WHO), EB RESP ROADM SIT RE; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265	44	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S210	S218		10.1093/infdis/jiv255		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100019		
J	Carrasco, N; Green, T; Itoh, N				Carrasco, Noelia; Green, Timothy; Itoh, Naoki			Marteilia spp. parasites in bivalves: A revision of recent studies	JOURNAL OF INVERTEBRATE PATHOLOGY			English	Article						Marteilia sp.; M. refringens; M. sydneyi; M. cochillia; M. granula; M. chungmuensis	OYSTER CRASSOSTREA-GIGAS; SYDNEY ROCK OYSTERS; COCKLE CERASTODERMA-EDULE; IN-SITU HYBRIDIZATION; MUSSELS MYTILUS-GALLOPROVINCIALIS; GALICIA NW SPAIN; SPANISH MEDITERRANEAN COAST; SACCOSTREA-GLOMERATA GOULD; COPEPOD PARACARTIA-GRANI; INITIAL INFECTIVE STAGES	Marteilia spp. parasites are Paramyxean organisms that affect several commercial species of molluscs, and thus have a socio-economical impact. These parasites also have an ecological impact on the biodiversity and population dynamics of natural mollusc beds. It has been over forty years since the first description of Marteilia refringens, the first Marteilia species described. Despite four decades of research, the biology, cellular development, as well as the life cycle of Marteilia parasites are not fully understood. In recent years, new studies have reported advances in knowledge of the life cycle, the description of new species, the development of new molecular detection/discrimination tools, new data on biotype geographical distribution, as well as new information on host response and defence mechanisms. Such information is summarized, reported and discussed in the present review in order to facilitate a new overview of the subject. However, numerous knowledge gaps are still unresolved and need to be prioritized in the research and funding institution agendas. (C) 2015 Elsevier Inc. All rights reserved.	[Carrasco, Noelia] IRTA St Carles Rapita, Tarragona 43540, Spain; [Green, Timothy] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Itoh, Naoki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Fish Dis, Tokyo 1138657, Japan	Carrasco, N (reprint author), IRTA, Ctra Poblenou Km 5,AP 200, Tarragona 43540, Spain.	noelia.carrasco@irta.es			Macquarie University Postdoctoral Research Scheme [9201300681]	NC, would like to thank the INIA postdoctoral contract (Spanish Government) that has partially covered her professional life between 2009 and early 2015. Thanks also to the INIA Complementary Action project 2014/2015, which supported the 1st Paramyxean Working Group meeting in February 2015. The authors acknowledge funding provided to TG by Macquarie University Postdoctoral Research Scheme (Grant: 9201300681).	Adlard R. D., 1995, Bulletin of the European Association of Fish Pathologists, V15, P119; Adlard R.D., 2005, AQUATIC ANIMAL HLTH, P1; Anderson R.S., 1994, AUST J MAR FRESHW RE, V45, P1285; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Kleeman SN, 2002, PARASITOLOGY, V125, P131, DOI 10.1017/S0031182002001919; Kleeman SN, 2000, DIS AQUAT ORGAN, V40, P137, DOI 10.3354/dao040137; Carrasco N, 2011, AQUACULTURE, V321, P197, DOI 10.1016/j.aquaculture.2011.09.018; Renault T, 1995, DIS AQUAT ORGAN, V23, P161, DOI 10.3354/dao023161; Novoa B, 2005, J FISH DIS, V28, P331, DOI 10.1111/j.1365-2761.2005.00634.x; Green TJ, 2010, MAR ECOL PROG SER, V402, P161, DOI 10.3354/meps08430; Boyer S, 2013, INT J PARASITOL, V43, P1089, DOI 10.1016/j.ijpara.2013.07.008; Carrasco N, 2008, J FISH DIS, V31, P153, DOI 10.1111/j.1365-2761.2007.00865.x; Balseiro P, 2007, B EUR ASSOC FISH PAT, V27, P148; Itoh N, 2003, DIS AQUAT ORGAN, V54, P163, DOI 10.3354/dao054163; Choi HJ, 2012, J INVERTEBR PATHOL, V111, P27, DOI 10.1016/j.jip.2012.05.004; Berthe FCJ, 1998, DIS AQUAT ORGAN, V34, P135, DOI 10.3354/dao034135; Kleeman SN, 2004, MOL CELL PROBE, V18, P133, DOI 10.1016/j.mcp.2003.11.002; Longshaw M, 2001, DIS AQUAT ORGAN, V44, P137, DOI 10.3354/dao044137; Carrasco N, 2012, AQUACULTURE, V324, P20, DOI 10.1016/j.aquaculture.2011.10.017; FRANC A, 1980, CAH BIOL MAR, V21, P99; Peters R, 2003, AQUACULTURE, V223, P29, DOI 10.1016/S0044-8486(03)00169-8; Lopez-Flores I, 2008, MOL CELL PROBE, V22, P151, DOI 10.1016/j.mcp.2008.01.002; Audemard C, 2002, PARASITOLOGY, V124, P315, DOI 10.1017/S0031182001001111; AUFFRET M, 1987, AQUACULTURE, V67, P255, DOI 10.1016/0044-8486(87)90048-2; Audemard C, 2001, J EXP MAR BIOL ECOL, V257, P87, DOI 10.1016/S0022-0981(00)00330-0; Carrasco N, 2008, J FISH DIS, V31, P497, DOI 10.1111/j.1365-2761.2008.00910.x; Itoh N, 2002, FISH PATHOL, V37, P23; Itoh N, 2004, INT J PARASITOL, V34, P1129, DOI 10.1016/j.ijpara.2004.06.001; Arzul I, 2014, PARASITOLOGY, V141, P227, DOI 10.1017/S0031182013001418; Dove MC, 2013, AQUAC RES, V44, P1791, DOI 10.1111/are.12012; Villalba A, 2014, DIS AQUAT ORGAN, V109, P55, DOI 10.3354/dao02723; NORTON JH, 1993, J INVERTEBR PATHOL, V61, P328, DOI 10.1006/jipa.1993.1063; Itoh N, 2004, J FISH DIS, V27, P311, DOI 10.1111/j.1365-2761.2004.00540.x; Kleeman SN, 2002, INT J PARASITOL, V32, P767, DOI 10.1016/S0020-7519(02)00025-5; Feist SW, 2009, FOLIA PARASIT, V56, P73; Simonian M, 2009, J FISH DIS, V32, P367, DOI 10.1111/j.1365-2761.2009.01022.x; Itoh N, 2003, FISH PATHOL, V38, P163; ROBLEDO JAF, 1994, DIS AQUAT ORGAN, V18, P211, DOI 10.3354/dao018211; Lopez C, 2006, J INVERTEBR PATHOL, V92, P109, DOI 10.1016/j.jip.2006.03.002; Wang ZW, 2012, J AQUAT ANIM HEALTH, V24, P161, DOI 10.1080/08997659.2012.675926; Lopez-Flores I, 2004, PARASITOLOGY, V129, P411, DOI 10.1017/S0031182004005827; Lee MK, 2001, AQUACULTURE, V201, P199, DOI 10.1016/S0044-8486(01)00648-2; Itoh N, 2005, J INVERTEBR PATHOL, V88, P201, DOI 10.1016/j.jip.2004.12.001; MOYER MA, 1993, J SHELLFISH RES, V12, P305; Lopez-Flores I, 2008, DIS AQUAT ORGAN, V82, P79, DOI 10.3354/dao01966; ROUBAL FR, 1989, AUST J MAR FRESH RES, V40, P155; Le Roux F, 1999, MAR BIOTECHNOL, V1, P588, DOI 10.1007/PL00011814; Carrasco N, 2013, AQUACULTURE, V412, P223, DOI 10.1016/j.aquaculture.2013.07.027; COMPS M, 1975, CR ACAD SCI D NAT, V281, P179; Butt D, 2007, MAR FRESHWATER RES, V58, P213, DOI 10.1071/MF06080; Wesche SJ, 1999, DIS AQUAT ORGAN, V36, P221, DOI 10.3354/dao036221; Diggles BK, 2013, NEW ZEAL J MAR FRESH, V47, P561, DOI 10.1080/00288330.2013.781511; Carrasco N, 2007, PARASITOLOGY, V134, P1541, DOI 10.1017/S0031182007003009; Green TJ, 2011, J SHELLFISH RES, V30, P47, DOI 10.2983/035.030.0108; VANBANNING P, 1979, MAR FISH REV, V41, P8; Tun KL, 2008, DIS AQUAT ORGAN, V80, P157, DOI 10.3354/dao01924; Kuchel RP, 2010, J INVERTEBR PATHOL, V104, P97, DOI 10.1016/j.jip.2010.02.001; Camacho AP, 1997, J SHELLFISH RES, V16, P77; Adlard RD, 2015, INT J PARASITOL, V45, P419, DOI 10.1016/j.ijpara.2015.02.002; Imanaka S, 2001, FISH PATHOL, V36, P83; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Ngo TTT, 2003, DIS AQUAT ORGAN, V56, P259, DOI 10.3354/dao056259; ANDERSON TJ, 1992, J PROTOZOOL, V39, P502, DOI 10.1111/j.1550-7408.1992.tb04839.x; Elgharsalli R, 2013, J INVERTEBR PATHOL, V112, P175, DOI 10.1016/j.jip.2012.11.004; BALOUET G, 1979, MAR FISH REV, V41, P64; Green TJ, 2009, FISH SHELLFISH IMMUN, V26, P799, DOI 10.1016/j.fsi.2009.03.003; Hine PM, 2000, DIS AQUAT ORGAN, V40, P67, DOI 10.3354/dao040067; Tun KL, 2008, INT J PARASITOL, V38, P211, DOI 10.1016/j.ijpara.2007.07.002; BOUGRIER S, 1986, AQUACULTURE, V58, P151, DOI 10.1016/0044-8486(86)90165-1; Butt D, 2006, AQUACULTURE, V251, P159, DOI 10.1016/j.aquaculture.2005.05.045; CAHOUR A, 1979, MAR FISH REV, V41, P19; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Le Roux F, 2001, J EUKARYOT MICROBIOL, V48, P449, DOI 10.1111/j.1550-7408.2001.tb00178.x; Robert R, 1991, AQUAT LIVING RESOUR, V4, P265, DOI 10.1051/alr:1991028; Jenkins C, 2013, DIS AQUAT ORGAN, V105, P109, DOI 10.3354/dao02623; ALDERMAN DJ, 1979, MAR FISH REV, V41, P67; PERKINS FO, 1976, J PARASITOL, V62, P528, DOI 10.2307/3279407; O'Connor WA, 2009, J SHELLFISH RES, V28, P803, DOI 10.2983/035.028.0409; Anderson TJ, 1995, J FISH DIS, V18, P507, DOI 10.1111/j.1365-2761.1995.tb00354.x; Berthe FCJ, 2004, AQUAT LIVING RESOUR, V17, P433, DOI 10.1051/alr:2004051; Gombac M, 2014, J FISH DIS, V37, P805, DOI 10.1111/jfd.12174; Balouet G, 1977, HAPL HAPL LIK DIS SH, V41, P64; Carrasco N., 2013, 16 INT C EUR ASS FIS, P226; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Ceschia G., 1992, B SOC ITAL PATOL ITT, P24; Ceschia G., 2001, B SOC ITAL PATOL ITT, V13, P20; Chatton E., 1911, CR HEBD ACAD SCI, V152, P631; Comps M., 1985, Revue des Travaux de l'Institut des Peches Maritimes, V47, P99; Comps M., 1982, PARASITIC DIS DUE MA, P3; Comps M., 1980, SCI PECHE, P19; Comps M., 1970, Revue Trav. Inst. Pech. marit., V34, P317; COMPS M, 1986, Protistologica, V22, P279; Fuentes J., 2002, AQUACULTURE, V213, P1; Garcia C., 2009, 101 ANN M NAT SHELLF; Grizel H., 1974, SCI PECHE, V240-241, P1; Grizel H., 1983, Revue des Travaux de l'Institut des Peches Maritimes, V46, P209; Grizel H., 1985, THESIS U SCI TECHNIQ; Hegaret H., 2005, J SHELLFISH RES, V24, P1263; Herrbach B., 1971, REV TRAV I PECHES, V35, P79; Hine, 1997, DIS AQUAT ORGAN, V29, P197; HUTCHINGS P, 1979, J NAT HIST, V13, P745, DOI 10.1080/00222937900770561; Itoh N, 2014, FISH PATHOL, V49, P181; Jones B.J., 2006, J SHELLFISH RES, V25, P233; Kapllan S., 2006, ITTIOPATOLOGIA, V3, P47; Lester R.J.G., 1986, P33; Limpanont Yanin, 2013, J Invertebr Pathol, V114, P277, DOI 10.1016/j.jip.2013.08.008; Montes J., 1998, Bulletin of the European Association of Fish Pathologists, V18, P124; Nell J.A., 2001, MAR FISH REV, V63, P14; Park M.S., 1986, J FISH PATHOL, V2, P53; Pascual M., 1991, TESTING ARGENTINA OY; Pasqual S., 2010, BIOL INVASIONS, V12, P2091; Poder M., 1983, C BAS BIOL AQ DEC 12, P125; ROBLEDO JAF, 1995, J PARASITOL, V81, P354, DOI 10.2307/3283816; Roy M.A., 1978, J ANIM ECOL, V47, P219; Ruano F, 1994, SEMINARIO RECURSOS H, V1, P195; Siihnel S., 2014, DIS AQUAT ORGAN, V109, P241; Taveekijakarn P., 2008, DIS ASIAN AQUACULTUR, VVI, P335; Taveekijakarn P., 2002, AAHRI NEWS, V11, P1; Tige G., 1976, CIEM CM K, V21, P1; Tiscar P.G., 1993, B SOC ITAL PATOL ITT, V5, P40; Villalba A., 1992, CUAD AREA CIENC MAR, P201; VILLALBA A, 1993, DIS AQUAT ORGAN, V17, P205, DOI 10.3354/dao017205; Villalba A., 1993, ACT 4 C NAC AC, P551; Virilis C., 2006, AQUACULTURE, V259, P1; Wesche S.J., 1995, Bulletin of the European Association of Fish Pathologists, V15, P23; Zrnicic S., 2001, DIS AQUAT ORGAN, V44, P143	126	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2011	1096-0805		J INVERTEBR PATHOL	J. Invertebr. Pathol.	OCT	2015	131						43	57		10.1016/j.jip.2015.07.016		15	Zoology	Zoology	CT8PA	WOS:000363077300005		
J	Schaller, M; Ito, T; Allen, RM; Kroetz, D; Kittan, N; Ptaschinski, C; Cavassani, K; Carson, WF; Godessart, N; Grembecka, J; Cierpicki, T; Dou, YL; Kunkel, SL				Schaller, Matthew; Ito, Toshihiro; Allen, Ronald M.; Kroetz, Danielle; Kittan, Nicolai; Ptaschinski, Catherine; Cavassani, Karen; Carson, William F.; Godessart, Nuria; Grembecka, Jolanta; Cierpicki, Tomasz; Dou, Yali; Kunkel, Steven L.			Epigenetic regulation of IL-12-dependent T cell proliferation	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						trithorax; Th1 differentiation; histone methylation; STAT4	MIXED-LINEAGE LEUKEMIA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TARGET GENES; IFN-GAMMA; TH2 CELLS; CYCLIN D3; IN-VIVO; MLL; RESPONSES	It is well established that the cytokine IL-12 and the transcription factor STAT4, an essential part of the IL-12 signaling pathway, are critical components of the Th1 differentiation process in T cells. In response to pathogenic stimuli, this process causes T cells to proliferate rapidly and secrete high amounts of the cytokine IFN-gamma, leading to the Th1 proinflammatory phenotype. However, there are still unknown components of this differentiation pathway. We here demonstrated that the expression of the histone methyltransferase Mll1 is driven by IL-12 signaling through STAT4 in humans and mice and is critical for the proper differentiation of a naive T cell to a Th1 cell. Once MLL1 is upregulated by IL-12, it regulates the proliferation of Th1 cells. As evidence of this, we show that Th1 cells from Mll1(+/-) mice are unable to proliferate rapidly in a Th1 environment in vitro and in vivo. Additionally, upon restimulation with cognate antigen Mll1(+/-), T cells do not convert to a Th1 phenotype, as characterized by IFN-gamma output. Furthermore, we observed a reduction in IFN-gamma production and proliferation in human peripheral blood stimulated with tetanus toxoid by use of a specific inhibitor of the MLL1/menin complex. Together, our results demonstrate that the MLL1 gene plays a previously unrecognized but essential role in Th1 cell biology and furthermore, describes a novel pathway through which Mll1 expression is regulated.	[Schaller, Matthew; Allen, Ronald M.; Kroetz, Danielle; Kittan, Nicolai; Ptaschinski, Catherine; Cavassani, Karen; Carson, William F.; Grembecka, Jolanta; Cierpicki, Tomasz; Dou, Yali; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [Ito, Toshihiro] Nara Med Univ, Dept Immunol, Nara, Japan; [Godessart, Nuria] Almirall SA, Dermatol Res, Sant Feliu de Llobregat, Spain	Schaller, M (reprint author), Univ Michigan, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	mschalle@umich.edu			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [HL112897, HL31237, HL89216]	Funding for this research was provided by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grants HL112897, HL31237, and HL89216. The authors thank the Pathology Flow Cytometry Core for its help and support, Lisa Johnson for preparation of histological samples, and Dr. Judith Connett for her critical reading of the manuscript.	Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Hess JL, 1997, BLOOD, V90, P1799; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; Kaech SM, 2001, NAT IMMUNOL, V2, P415; Li QS, 2006, J IMMUNOL, V177, P7618; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Finkelman FD, 2000, J IMMUNOL, V164, P2303; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Nishikomori R, 2002, J IMMUNOL, V169, P4388; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lund RJ, 2004, J IMMUNOL, V172, P6775; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Yagi H, 1998, BLOOD, V92, P108; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Weng AP, 2003, CANCER CELL, V4, P417, DOI 10.1016/S1535-6108(03)00305-2; Pakpour N, 2008, J IMMUNOL, V180, P8299; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Miyatake S, 1997, EUR J IMMUNOL, V27, P1816, DOI 10.1002/eji.1830270733; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Yoo JK, 2002, J IMMUNOL, V169, P3637; Martino A, 2001, J IMMUNOL, V166, P1723; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Kock J, 2014, J BIOL CHEM, V289, P26752, DOI 10.1074/jbc.M114.587865; Savarin C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-104; Warner J. D., 2011, J IMMUNOL, V186, P4234	56	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	OCT	2015	98	4					601	613		10.1189/jlb.1A0814-375RR		13	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CT5FA	WOS:000362832700018		
J	Bsat, M; Chapuy, L; Baba, N; Rubio, M; Panzini, B; Wassef, R; Richard, C; Soucy, G; Mehta, H; Sarfati, M				Bsat, Marwa; Chapuy, Laurence; Baba, Nobuyasu; Rubio, Manuel; Panzini, Benoit; Wassef, Ramses; Richard, Carole; Soucy, Genevieve; Mehta, Heena; Sarfati, Marika			Differential accumulation and function of proinflammatory 6-sulfo LacNAc dendritic cells in lymph node and colon of Crohn's versus ulcerative colitis patients	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						inflammatory bowel diseases; human; CD172; CD47; cytokines	INFLAMMATORY-BOWEL-DISEASE; CD47; HOMEOSTASIS; EXPRESSION; SUBSET; TISSUE; TNF	Human Slan DCs have been studied in patients with psoriasis, rheumatoid arthritis, cancer, and autoimmune diseases. In this study, we investigated the frequency, phenotype, and function of Slan DCs in blood, colon, as well as mLNs of patients with IBD. We first show that the frequency of circulating CD14(dull)Slan DCs was reduced in CD patients refractory to immunosuppressive drugs or TNF-alpha blockers relative to untreated CD, UC, and healthy subjects. In blood of CD patients, Slan DCs expressed CD172a, as detected by CD47 fusion protein binding, when compared with its lack of expression in control subjects. Next, we demonstrate that CD172a(+)Slan DCs that produced IL-1 beta and TNF-alpha accumulated in mLNs and colons of CD patients. The CD172a(+)Slan DCs upregulated their expression of CD14 in CD tissues and the proinflammatory cytokines were produced in CD14(bright)CD172a(+)Slan DCs. By contrast, no difference was noted in the frequency of Slan DCs between inflamed, noninflamed colonic mucosa of UC patients and control, non-IBD donors. Finally, the percentage of cytokine-producing Slan DCs also augmented in response to TLR2 and NOD2 in in vitro stimulation in PBMCs of CD, but not UC, patients. In conclusion, we propose that proinflammatory CD14(bright)CD172a(+)Slan DCs are a distinguishing feature between CD and UC, as these cells accumulate uniquely in mLNs and colonic mucosa of CD patients. Thus, Slan DCs may contribute to CD immunopathogenesis.	[Bsat, Marwa; Chapuy, Laurence; Rubio, Manuel; Mehta, Heena; Sarfati, Marika] CRCHUM, Immunoregulat Lab, Montreal, PQ H2X 0A9, Canada; [Baba, Nobuyasu] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Kochi 780, Japan; [Panzini, Benoit] Ctr Hosp Univ Montreal, Dept Gastroenterol, Montreal, PQ, Canada; [Wassef, Ramses; Richard, Carole] Ctr Hosp Univ Montreal, Dept Digest Tract Surg, Montreal, PQ, Canada; [Soucy, Genevieve] Ctr Hosp Univ Montreal, Dept Pathol, Montreal, PQ, Canada	Sarfati, M (reprint author), CRCHUM, Immunoregulat Lab, Tour Viger R-12-424-204,900 St Denis St East, Montreal, PQ H2X 0A9, Canada.	m.sarfati@umontreal.ca			Canadian Institutes for Health and Research (CIHR); Faculte des Etudes Superieures de l'Universite de Montreal	This work has been supported by grants from Canadian Institutes for Health and Research (CIHR) and Faculte des Etudes Superieures de l'Universite de Montreal. The authors thank Carole Bergeron, R.N., for her help in obtaining the surgical samples and the Histology Department in the Centre de Recherche du Centre Hospitalier de l'Universite de Montreal for its technical assistance with the IHC studies.	Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; de Baey A, 2003, J IMMUNOL, V170, P5089; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Gunther C, 2013, EXP DERMATOL, V22, P535, DOI 10.1111/exd.12190; Costantini C, 2011, BLOOD, V117, P1677, DOI 10.1182/blood-2010-06-287243; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Gunther C, 2012, CLIN EXP DERMATOL, V37, P169, DOI 10.1111/j.1365-2230.2011.04213.x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Brunner PM, 2013, J ALLERGY CLIN IMMUN, V132, P1184, DOI 10.1016/j.jaci.2013.05.036; Ogino T, 2013, GASTROENTEROLOGY, V145, P1380, DOI 10.1053/j.gastro.2013.08.049; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Dobel T, 2013, BLOOD, V121, P3609, DOI 10.1182/blood-2012-08-447045; Hansel A, 2013, J AUTOIMMUN, V40, P1, DOI 10.1016/j.jaut.2012.07.005; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Clatworthy MR, 2014, NAT MED, V20, P1458, DOI 10.1038/nm.3709; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Thomas Katja, 2014, Neurol Neuroimmunol Neuroinflamm, V1, pe33, DOI 10.1212/NXI.0000000000000033; Vermi W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4029	24	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	OCT	2015	98	4					671	681		10.1189/jlb.5A1014-509RR		11	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CT5FA	WOS:000362832700025		
J	Nakamura, T; Tamada, D; Yanagi, Y; Itoh, Y; Nemoto, T; Utumi, H; Kose, K				Nakamura, Takashi; Tamada, Daiki; Yanagi, Yousuke; Itoh, Yoshitaka; Nemoto, Takahiro; Utumi, Hiroaki; Kose, Katsumi			Development of a superconducting bulk magnet for NMR and MRI	JOURNAL OF MAGNETIC RESONANCE			English	Article						NMR; MRI; Superconducting bulk magnet; High temperature superconducting material; Shim coil	COIL DESIGN; MAGNETIZATION; SYSTEMS	A superconducting bulk magnet composed of six vertically stacked annular single-domain c-axis-oriented Eu-Ba-Cu-O crystals was energized to 4.74 T using a conventional superconducting magnet for high-resolution NMR spectroscopy. Shim coils, gradient coils, and radio frequency coils for high resolution NMR and MRI were installed in the 23 mm-diameter room-temperature bore of the bulk magnet. A 6.9 ppm peak-to-peak homogeneous region suitable for MRI was achieved in the central cylindrical region (6.2 mm diameter, 9.1 mm length) of the bulk magnet by using a single layer shim coil. A 21 Hz spectral resolution that can be used for high resolution NMR spectroscopy was obtained in the central cylindrical region (1.3 mm diameter, 4 mm length) of the bulk magnet by using a multichannel shim coil. A clear 3D MR image dataset of a chemically fixed mouse fetus with (50 mu m)(3) voxel resolution was obtained in 5.5 h. We therefore concluded that the cryogen-free superconducting bulk magnet developed in this study is useful for high-resolution desktop NMR, MRI and mobile NMR device. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Takashi] RIKEN, Wako, Saitama 3510198, Japan; [Tamada, Daiki; Kose, Katsumi] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Yanagi, Yousuke; Itoh, Yoshitaka] IMRA Mat R&D Co Ltd, Kariya, Aichi 4480021, Japan; [Nemoto, Takahiro; Utumi, Hiroaki] JEOL Resonance, Akishima, Tokyo 1968558, Japan	Kose, K (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	kose@bk.tsukuba.ac.jp			Development of Systems and Technologies for Advanced Measurement and Analysis project by Japan Science and Technology Agency	This study was supported by a Development of Systems and Technologies for Advanced Measurement and Analysis project by Japan Science and Technology Agency.	Hashi K, 2015, J MAGN RESON, V256, P30, DOI 10.1016/j.jmr.2015.04.009; Zalesskiy SS, 2014, CHEM REV, V114, P5641, DOI 10.1021/cr400063g; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Parkinson BJ, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2235893; Terao Y, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2239342; Razeti M, 2008, IEEE T APPL SUPERCON, V18, P882, DOI 10.1109/TASC.2008.920661; Tamada D, 2013, PHYSICA C, V492, P174, DOI 10.1016/j.physc.2013.06.016; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Tamada D, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.056701; TURNER R, 1993, MAGN RESON IMAGING, V11, P903, DOI 10.1016/0730-725X(93)90209-V; Tamada D, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/9/095010; Nariki S, 2008, PHYSICA C, V468, P1451, DOI 10.1016/j.physc.2008.05.256; Nakamura T, 2007, CONCEPT MAGN RESON B, V31B, P65, DOI 10.1002/cmr.b.20083; Nariki S, 2002, SUPERCOND SCI TECH, V15, P648, DOI 10.1088/0953-2048/15/5/302; Maeda H, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287707; Ogawa K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3598440; Bliimich B., 2009, CHEM PHYS LETT, V477, P231; Haishi T., 2005, P INT SOC MAGN RESON, V13, P869; Kose K., 2006, NMR IMAGING CHEM ENG, P77; Mitchell J, 2014, PROG NUCL MAG RES SP, V76, P1, DOI 10.1016/j.pnmrs.2013.09.001; Nakamura T., 2011, TEION KOGAKU, V48, P139; ROMEO F, 1984, MAGNET RESON MED, V1, P44, DOI 10.1002/mrm.1910010107; Sakai Naomichi, 2011, Teion Kogaku (Journal of the Cryogenic Society of Japan), V46, DOI 10.2221/jcsj.46.131; Shigeki R., 2010, P INT SOC MAGN RESON, V19, P1542; Slade R A, 2014, IEEE T APPL SUPERCON, V24, P1	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						68	75		10.1016/j.jmr.2015.07.012		8	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800008		
J	Matsuki, Y; Nakamura, S; Fukui, S; Suematsu, H; Fujiwara, T				Matsuki, Yoh; Nakamura, Shinji; Fukui, Shigeo; Suematsu, Hiroto; Fujiwara, Toshimichi			Closed-cycle cold helium magic-angle spinning for sensitivity-enhanced multi-dimensional solid-state NMR	JOURNAL OF MAGNETIC RESONANCE			English	Article						Cryogenic magic-angle spinning; Closed-loop helium circulation; Solid-state NMR; Sensitivity enhancement	DYNAMIC NUCLEAR-POLARIZATION; SPECTROSCOPY; TEMPERATURES; RESOLUTION	Magic-angle spinning (MAS) NMR is a powerful tool for studying molecular structure and dynamics, but suffers from its low sensitivity. Here, we developed a novel helium-cooling MAS NMR probe system adopting a closed-loop gas recirculation mechanism. In addition to the sensitivity gain due to low temperature, the present system has enabled highly stable MAS (v(R) = 4-12 kHz) at cryogenic temperatures (T= 35-120 K) for over a week without consuming helium at a cost for electricity of 16 kW/h. High-resolution 1D and 2D data were recorded for a crystalline tri-peptide sample at T=40 K and B-0 = 16.4 T, where an order of magnitude of sensitivity gain was demonstrated versus room temperature measurement. The low-cost and long-term stable MAS strongly promotes broader application of the brute-force sensitivity-enhanced multi-dimensional MAS NMR, as well as dynamic nuclear polarization (DNP)-enhanced NMR in a temperature range lower than 100 K. (C) 2015 The Authors. Published by Elsevier Inc.	[Matsuki, Yoh; Fujiwara, Toshimichi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Nakamura, Shinji; Suematsu, Hiroto] JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan; [Fukui, Shigeo] Cryovac Corp, Nishi Yodogawa, Osaka 5550013, Japan	Fujiwara, T (reprint author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tfjwr@protein.osaka-u.ac.jp			SENTAN, JST; NMR Platform, MEXT	This research was partly supported by SENTAN, JST and the NMR Platform, MEXT.	Beduz C, 2012, P NATL ACAD SCI USA, V109, P12894, DOI 10.1073/pnas.1210790109; Wickramasinghe NP, 2009, NAT METHODS, V6, P215, DOI [10.1038/nmeth.1300, 10.1038/NMETH.1300]; Li SH, 2013, ANNU REP NMR SPECTRO, V78, P1, DOI 10.1016/B978-0-12-404716-7.00001-8; Mizuno T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3263908; Bajaj VS, 2009, J AM CHEM SOC, V131, P118, DOI 10.1021/ja8045926; Matsuki Y, 2010, ANGEW CHEM INT EDIT, V49, P9215, DOI 10.1002/anie.201003329; TYCKO R, 1995, SCIENCE, V268, P1460, DOI 10.1126/science.7539550; Matsuki Y, 2012, J MAGN RESON, V225, P1, DOI 10.1016/j.jmr.2012.09.008; Thurber KR, 2008, J MAGN RESON, V195, P179, DOI 10.1016/j.jmr.2008.09.015; MACHO V, 1983, J MAGN RESON, V52, P450, DOI 10.1016/0022-2364(83)90170-1; Yan S, 2013, ACCOUNTS CHEM RES, V46, P2047, DOI 10.1021/ar300309s; Beckett P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4751476; Bajaj VS, 2009, P NATL ACAD SCI USA, V106, P9244, DOI 10.1073/pnas.0900908106; BECERRA LR, 1993, PHYS REV LETT, V71, P3561, DOI 10.1103/PhysRevLett.71.3561; DOTY FD, 1981, REV SCI INSTRUM, V52, P1868, DOI 10.1063/1.1136530; STYLES P, 1984, J MAGN RESON, V60, P397, DOI 10.1016/0022-2364(84)90050-7; Lipton AS, 2001, J MAGN RESON, V151, P48, DOI 10.1006/jmre.2001.2353; Concistre M, 2013, ACCOUNTS CHEM RES, V46, P1914, DOI 10.1021/ar300323c; Barnes AB, 2010, PHYS CHEM CHEM PHYS, V12, P5861, DOI 10.1039/c003763j; Hansen MR, 2013, ACCOUNTS CHEM RES, V46, P1996, DOI 10.1021/ar300338b; Koers EJ, 2014, J BIOMOL NMR, V60, P157, DOI 10.1007/s10858-014-9865-8; Mito T., 2004, J CRYOGENICS SUPERCO, V39, P182; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1923, DOI 10.1021/ar300358z	23	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						76	81		10.1016/j.jmr.2015.08.003		6	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800009		
J	Suzuki, T				Suzuki, Takayuki			Perturbative harmonic modulation of longitudinal electron-spin magnetization for short T-1 determination	JOURNAL OF MAGNETIC RESONANCE			English	Article						Electron spin resonance (ESR); Spin-lattice relaxation; Longitudinal detection (LOD); LOD-T-1; Perturbative harmonic modulation	PULSED EPR SPECTROMETER; RELAXATION; SPECTROSCOPY; RESONANCE; NMR	Longitudinally detected T-1 measurement scheme (LOD-T-1) is studied in detail. In contrast to the original work on LOD-T-1, using high power microwave pulses, this work deals with general and practically frequent cases in which perfect inversion of the electron-spin magnetization is not feasible due to the effect of relaxation during microwave pulses. Theoretical studies, numerical simulations, and experiments reveal a pair of separate contributions of the dynamics of the longitudinal magnetization to the LOD signal, namely, the periodic modulation and the relaxation contributions. The latter alone which is of interest can be extracted to give relaxation curves. In addition, it is shown that T-1 information can be obtained even when the available microwave power is so low that the electron magnetization can only be perturbatively modulated, at the cost of reduced sensitivity. To overcome this, a modified pulse sequence is proposed. In this new method, the pulse excitations are repeated during half a period of the resonance of the longitudinal detection circuit. The method is called the perturbative harmonic modulation method for longitudinally detected T-1 measurement (HM-LOD-T-1). HM-LOD-T-1 experiments are demonstrated in 2,2-diphenyl-1-picrylhydrazyl (DPPH). (C) 2015 Elsevier Inc. All rights reserved.	JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan	Suzuki, T (reprint author), JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan.	taksuzuk@jeol.co.jp					Granwehr J, 2001, APPL MAGN RESON, V20, P137, DOI 10.1007/BF03162315; BRANDLE R, 1970, Z NATURFORSCH PT A, VA 25, P1; BLOEMBERGEN N, 1954, PHYS REV, V93, P72, DOI 10.1103/PhysRev.93.72; Cernescu A, 2008, J MAGN RESON, V192, P78, DOI 10.1016/j.jmr.2008.02.018; Panagiotelis I, 2001, J MAGN RESON, V149, P74, DOI 10.1006/jmre.2000.2282; PERCIVAL PW, 1975, REV SCI INSTRUM, V46, P1522, DOI 10.1063/1.1134096; SCHWEIGER A, 1988, J MAGN RESON, V77, P512, DOI 10.1016/0022-2364(88)90009-1; HUISJEN M, 1974, REV SCI INSTRUM, V45, P669, DOI 10.1063/1.1686710; Takeda K, 2011, ANNU REP NMR SPECTRO, V74, P355, DOI 10.1016/B978-0-08-097072-1.00007-8; Takeda K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712940; Takeda K, 2008, J MAGN RESON, V192, P218, DOI 10.1016/j.jmr.2008.02.019; Colligiani A, 1992, APPL MAGN RESON, V3, P107; Brunner W., 1971, Experimentelle Technik der Physik, V19; Eaton G. R., 1998, FDN MODERN EPR; Schweiger A., 2001, PRINCIPLES PULSE ELE	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						95	101		10.1016/j.jmr.2015.08.006		7	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800012		
J	Sakurai, T; Fujimoto, K; Matsui, R; Kawasaki, K; Okubo, S; Ohta, H; Matsubayashi, K; Uwatoko, Y; Tanaka, H				Sakurai, T.; Fujimoto, K.; Matsui, R.; Kawasaki, K.; Okubo, S.; Ohta, H.; Matsubayashi, K.; Uwatoko, Y.; Tanaka, H.			Development of multi-frequency ESR system for high-pressure measurements up to 2.5 GPa	JOURNAL OF MAGNETIC RESONANCE			English	Article						High-pressure ESR; Hybrid-type pressure cell; ZrO2-based ceramic; NiSnCl6 center dot 6H(2)O; CsCuCl3	DIAMOND-ANVIL CELL; HIGH-FIELD; SUPERCONDUCTIVITY; NISNCL6.6H2O	A new piston-cylinder pressure cell for electron spin resonance (ESR) has been developed. The pressure cell consists of a double-layer hybrid-type cylinder with internal components made of the ZrO2-based ceramics. It can generate a pressure of 2 GPa repeatedly and reaches a maximum pressure of around 2.5 GPa. A high-pressure ESR system using a cryogen-free superconducting magnet up 10T has also been developed for this hybrid-type pressure cell. The frequency region is from 50 GHz to 400 GHz. This is the first time a pressure above 2 GPa has been achieved in multi-frequency ESR system using a piston-cylinder pressure cell. We demonstrate its potential by showing the results of the high-pressure ESR of the S = 1 system with the single ion anisotropy NiSnCl6 center dot 6H(2)O and the S = 1/2 quantum spin system CsCuCl3. We performed ESR measurements of these systems above 2 GPa successfully. (C) 2015 Elsevier Inc. All rights reserved.	[Sakurai, T.] Kobe Univ, Ctr Supports Res & Educ Act, Nada Ku, Kobe, Hyogo 6578501, Japan; [Fujimoto, K.; Matsui, R.; Kawasaki, K.; Ohta, H.] Kobe Univ, Grad Sch Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Okubo, S.; Ohta, H.] Kobe Univ, Mol Photosci Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Matsubayashi, K.; Uwatoko, Y.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Tanaka, H.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528550, Japan	Sakurai, T (reprint author), Kobe Univ, Ctr Supports Res & Educ Act, Nada Ku, Kobe, Hyogo 6578501, Japan.	tsakurai@kobe-u.ac.jp			Japan Society for the Promotion of Science [25400341]	This research was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 25400341) from the Japan Society for the Promotion of Science.	Mirebeau I, 2002, NATURE, V420, P54, DOI 10.1038/nature01157; BARNETT JD, 1978, REV SCI INSTRUM, V49, P348, DOI 10.1063/1.1135405; SMITH TF, 1967, PHYS REV, V159, P353, DOI 10.1103/PhysRev.159.353; Sakurai T, 2012, J MAGN RESON, V223, P41, DOI 10.1016/j.jmr.2012.07.020; BIRECKOVEN B, 1988, J PHYS E SCI INSTRUM, V21, P841, DOI 10.1088/0022-3735/21/9/004; Sakurai T, 2006, J PHYS CONF SER, V51, P565, DOI 10.1088/1742-6596/51/1/128; MYERS BE, 1972, PHYS REV B, V6, P3488, DOI 10.1103/PhysRevB.6.3488; Sakurai T, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012184; TANAKA H, 1992, J PHYS SOC JPN, V61, P1344, DOI 10.1143/JPSJ.61.1344; Uwatoko Y, 2003, PHYSICA B, V329, P1658, DOI 10.1016/S0921-4526(02)02449-3; AJIRO Y, 1975, PHYS REV B, V12, P39, DOI 10.1103/PhysRevB.12.39; Ono T, 2001, PHYS REV B, V63; Merchant P, 2014, NAT PHYS, V10, P373, DOI [10.1038/nphys2902, 10.1038/NPHYS2902]; SAKAI N, 1985, REV SCI INSTRUM, V56, P726, DOI 10.1063/1.1138215; Matsumoto M, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.073709; Nafradi B, 2008, J MAGN RESON, V195, P206, DOI 10.1016/j.jmr.2008.09.014; CHRISTY AG, 1994, J PHYS-CONDENS MAT, V6, P3125, DOI 10.1088/0953-8984/6/17/005; Fujiwara N., 2007, REV SCI INSTRUM, V78; Goto K., 2007, J PHYS SOC JPN, V76; Hong T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184424; Hong T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.224409; Kawasaki K., APPL MAGN RESON; Kozlenko DP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187207; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Sakurai T., 2003, J PHYS SOC JPN, V72, P156; Sakurai T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2746818; Sakurai T, 2009, J PHYS CONF SER, V150, DOI 10.1088/1742-6596/150/4/042171; Tajiri T., 2006, J PHYS SOC JPN, V75; Thede M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.087204; Waki T, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.073710	30	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						108	113		10.1016/j.jmr.2015.08.005		6	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800014		
J	Blondelle, J; Ohno, Y; Gache, V; Guyot, S; Storck, S; Blanchard-Gutton, N; Barthelemy, I; Walmsley, G; Rahier, A; Gadin, S; Maurer, M; Guillaud, L; Prola, A; Ferry, A; Aubin-Houzelstein, G; Demarquoy, J; Relaix, F; Piercy, RJ; Blot, S; Kihara, A; Tiret, L; Pilot-Storck, F				Blondelle, Jordan; Ohno, Yusuke; Gache, Vincent; Guyot, Stephane; Storck, Sebastien; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Walmsley, Gemma; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Ferry, Arnaud; Aubin-Houzelstein, Genevieve; Demarquoy, Jean; Relaix, Frederic; Piercy, Richard J.; Blot, Stephane; Kihara, Akio; Tiret, Laurent; Pilot-Storck, Fanny			HACD1, a regulator of membrane composition and fluidity, promotes myoblast fusion and skeletal muscle growth	JOURNAL OF MOLECULAR CELL BIOLOGY			English	Article						centronuclear myopathy; LPC; MUFA; PTPLA; VLCFA	CONGENITAL MYOPATHIES; CENTRONUCLEAR MYOPATHY; SPHINGOLIPID SYNTHESIS; MYOTUBULAR MYOPATHY; FATTY-ACIDS; CELLS; DIFFERENTIATION; REGENERATION; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION	The reduced diameter of skeletal myofibres is a hallmark of several congenital myopathies, yet the underlying cellular and molecular mechanisms remain elusive. In this study, we investigate the role of HACD1/PTPLA, which is involved in the elongation of the very long chain fatty acids, in muscle fibre formation. In humans and dogs, HACD1 deficiency leads to a congenital myopathy with fibre size disproportion associated with a generalized muscle weakness. Through analysis of HACD1-deficient Labradors, Hacd1-knockout mice, and Hacd1-deficient myoblasts, we provide evidence that HACD1 promotes myoblast fusion during muscle development and regeneration. We further demonstrate that in normal differentiating myoblasts, expression of the catalytically active HACD1 isoform, which is encoded by a muscle-enriched splice variant, yields decreased lysophosphatidylcholine content, a potent inhibitor of myoblast fusion, and increased concentrations of >= C18 and monounsaturated fatty acids of phospholipids. These lipid modifications correlate with a reduction in plasma membrane rigidity. In conclusion, we propose that fusion impairment constitutes a novel, non-exclusive pathological mechanism operating in congenital myopathies and reveal that HACD1 is a key regulator of a lipid-dependent muscle fibre growth mechanism.	[Blondelle, Jordan; Gache, Vincent; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Aubin-Houzelstein, Genevieve; Relaix, Frederic; Blot, Stephane; Tiret, Laurent; Pilot-Storck, Fanny] INSERM, IMRB U955 E10, F-94000 Creteil, France; [Blondelle, Jordan; Gache, Vincent; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Aubin-Houzelstein, Genevieve; Relaix, Frederic; Blot, Stephane; Tiret, Laurent; Pilot-Storck, Fanny] Univ Paris Est, Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France; [Blondelle, Jordan; Gache, Vincent; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Aubin-Houzelstein, Genevieve; Relaix, Frederic; Blot, Stephane; Tiret, Laurent; Pilot-Storck, Fanny] Univ Paris Est Creteil, Fac Med, F-94000 Creteil, France; [Ohno, Yusuke; Kihara, Akio] Hokkaido Univ, Biochem Lab, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Guyot, Stephane] Univ Bourgogne, UMR PAM EPMB A 02 102, AgroSup Dijon, F-21000 Dijon, France; [Storck, Sebastien] Univ Paris 05, Sorbonne Paris Cite, Inst Necker Enfants Malad, INSERM,U1151,CNRS UMR 8253,Fac Med, F-75015 Paris, France; [Walmsley, Gemma; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London NW1 0TU, England; [Ferry, Arnaud] Univ Paris 06, Univ Paris Descartes, Therapie Malad Muscle Strie INSERM, Inst Myol,U974,CNRS UMR7215,UPMC UM76, F-75000 Paris, France; [Demarquoy, Jean] Univ Bourgogne, Fac Sci Gabriel, BioperoxIL, F-21000 Dijon, France	Pilot-Storck, F (reprint author), INSERM, IMRB U955 E10, F-94000 Creteil, France.	ltiret@vet-alfort.fr; fstorck@vet-alfort.fr	GACHE, Vincent/M-9556-2015; KIHARA, AKIO/A-3802-2012	GACHE, Vincent/0000-0002-2928-791X; KIHARA, AKIO/0000-0001-5889-0788	Agence Nationale de la Recherche [ANR-12-JSV1-0005]; Association Francaise contre les Myopathies [14577, 15882, 16143]; CNM Project; Alliance program [22866ZM]; Myotubular Trust; Japan Society for the Promotion of Science [23370057]; French Ministry of Research and Technologies; Universite Paris 6 (Paris); ANR; AFM; BBSRC CASE	This work was supported by the Agence Nationale de la Recherche (ANR-12-JSV1-0005), the Association Francaise contre les Myopathies (14577, 15882, and 16143), the CNM Project (www.labradorcnm.com), the Alliance program (22866ZM), the Myotubular Trust and Grants-in-Aid for Scientific Research (B) to A.K. from Japan Society for the Promotion of Science (23370057). J.B. was supported by the French Ministry of Research and Technologies and the Universite Paris 6 (Paris), V.G., A.P., and A.R. were supported by the ANR, N.B-G. and I. B. were supported by the AFM, and G.W. was supported by the BBSRC CASE and the Myotubular Trust.	Lenhart KC, 2014, DEV BIOL, V393, P298, DOI 10.1016/j.ydbio.2014.06.025; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Lee JH, 2009, LIFE SCI, V84, P415, DOI 10.1016/j.lfs.2009.01.004; Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; YEAGLE PL, 1994, BIOCHEMISTRY-US, V33, P1820, DOI 10.1021/bi00173a027; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Ciechonska M, 2014, J VIROL, V88, P6528, DOI 10.1128/JVI.00314-14; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Tiret L, 2003, HUM GENET, V113, P297, DOI 10.1007/s00439-003-0984-7; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Nakanishi M, 2001, CELL BIOL INT, V25, P971, DOI 10.1006/cbir.2001.0750; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; PRIVES J, 1977, NATURE, V268, P761, DOI 10.1038/268761a0; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Briolay A, 2013, BBA-BIOMEMBRANES, V1828, P602, DOI 10.1016/j.bbamem.2012.10.006; Molino D, 2014, BBA-MOL CELL BIOL L, V1841, P1422, DOI 10.1016/j.bbalip.2014.06.014; REPORTER M, 1973, SCIENCE, V181, P863, DOI 10.1126/science.181.4102.863; Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Pierson CR, 2007, NEUROMUSCULAR DISORD, V17, P562, DOI 10.1016/j.nmd.2007.03.010; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Maurer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046408; Ravenscroft G, 2015, BRAIN, V138, P246, DOI 10.1093/brain/awu368; Teng SZ, 2015, MOL BIOL CELL, V26, P506, DOI 10.1091/mbc.E14-03-0802	45	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1674-2788	1759-4685		J MOL CELL BIOL	J. Mol. Cell Biol.	OCT	2015	7	5					429	440		10.1093/jmcb/mjv049		12	Cell Biology	Cell Biology	CU0JJ	WOS:000363201800005		
J	Tamura, K				Tamura, Koji			Beyond the Frozen Accident: Glycine Assignment in the Genetic Code	JOURNAL OF MOLECULAR EVOLUTION			English	Article						Origin; Genetic code; Glycine; tRNA; CCA	TRANSFER-RNA SYNTHETASES; CHIRAL-SELECTIVE AMINOACYLATION; THERMUS-THERMOPHILUS; PROTEIN-SYNTHESIS; ACCEPTOR STEM; AMINO-ACIDS; ORIGIN; STABILITY; EVOLUTION; RECOGNITION	tRNA with a terminal UCCA-3' forms a structure in which the 3'-sequence folds back. The adenine of glycyl-AMP can base-pair with the uridine of the UCCA-3' region, which places the glycine residue in close proximity to the 3'-terminal adenosine of tRNA, possibly enabling the transfer of glycine from glycyl-AMP to tRNA. Thus, the UCCA-3'-containing tRNA (as seen in eubacterial tRNA(Gly)s) would possess an intrinsic property of glycylation by glycyl-AMP. This model provides a new perspective on the origins of the glycine assignment in the genetic code, beyond the "frozen accident" hypothesis.	[Tamura, Koji] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Tamura, Koji] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Tamura, K (reprint author), Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	koji@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25291082]	The author thanks Drs. Chien-Chia Wang, Tetsuo Kushiro, Shin-ichi Yokobori, and Nobukazu Nameki for helpful discussions. This work was supported by the Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Grant No. 25291082).	JURKA J, 1987, J MOL EVOL, V25, P15, DOI 10.1007/BF02100036; Yarus M, 1998, J MOL EVOL, V47, P109, DOI 10.1007/PL00006357; Ohnuma M, 2011, J MOL BIOL, V408, P971, DOI 10.1016/j.jmb.2011.03.025; Osawa K, 2005, ORIGINS LIFE EVOL B, V35, P213, DOI 10.1007/s11084-005-2405-5; Tamura K, 2004, SCIENCE, V305, P1253, DOI 10.1126/science.1099141; PUGLISI EV, 1994, P NATL ACAD SCI USA, V91, P11467, DOI 10.1073/pnas.91.24.11467; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Tamura K, 2006, P NATL ACAD SCI USA, V103, P13750, DOI 10.1073/pnas.0606070103; CARPENTER FH, 1960, J AM CHEM SOC, V82, P1111, DOI 10.1021/ja01490a024; Bernhardt HS, 2014, J MOL EVOL, V78, P307, DOI 10.1007/s00239-014-9627-y; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Calderone CT, 2004, CURR OPIN CHEM BIOL, V8, P645, DOI 10.1016/j.cbpa.2004.09.003; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; SHIMIZU M, 1982, J MOL EVOL, V18, P297, DOI 10.1007/BF01733895; KAGAWA Y, 1984, J BIOL CHEM, V259, P2956; Komatsu R, 2014, J MOL EVOL, V78, P310, DOI 10.1007/s00239-014-9629-9; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Nameki N, 1997, J MOL BIOL, V268, P640, DOI 10.1006/jmbi.1997.0993; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; LIMMER S, 1993, P NATL ACAD SCI USA, V90, P6199, DOI 10.1073/pnas.90.13.6199; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.biochem.56.1.125; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Schimmel P, 1996, P NATL ACAD SCI USA, V93, P4521, DOI 10.1073/pnas.93.10.4521; LACEY JC, 1983, ORIGINS LIFE EVOL B, V13, P3, DOI 10.1007/BF00928761; Kool ET, 2001, ANNU REV BIOPH BIOM, V30, P1, DOI 10.1146/annurev.biophys.30.1.1; Bernhardt HS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-16; Bernhardt HS, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-53; Chien CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094659; Fontecilla-Camps Juan C., 2014, Life-Basel, V4, P1013, DOI 10.3390/life4041013; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KVENVOLD.K, 1970, NATURE, V228, P923, DOI 10.1038/228923a0; Orgel LE, 1976, ORG EXPRESSION EUKAR, P499; PAECHTHO.M, 1973, J MOL EVOL, V2, P91, DOI 10.1007/BF01653989	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2844	1432-1432		J MOL EVOL	J. Mol. Evol.	OCT	2015	81	3-4					69	71		10.1007/s00239-015-9694-8		3	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CT8IR	WOS:000363059500001		
J	Murakami, H				Murakami, Hiroshi			Terahertz dynamics of water before and after water shedding from reverse micelles	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Water; Reverse micelle; Confinement effect; Terahertz spectroscopy; Temperature dependence; Water shedding	TIME-DOMAIN SPECTROSCOPY; STRUCTURAL PARAMETERS; DIELECTRIC-PROPERTIES; LIQUID; PROTEIN; SIZE; PROBES; MODEL	Picosecond relaxation dynamics of water before and after water shedding from reverse micelles are studied using temperature-dependent terahertz time-domain spectroscopy measurements to clarify the confinement effect of the reverse micelle on the dynamics of water. Before water shedding, the relaxation process due to the collective motion of bulk-like water in the core of the reverse micelle exhibits a considerable slowing down in comparison with that in liquid water as the temperature decreases. This is attributed to the confinement effect of reverse micelles. Moreover, the time constant abruptly drops at the water shedding, and its temperature behavior is similar to that of liquid water afterwards. These results demonstrate that the water extracted from the reverse micelle attains the property of liquid water by reduction in the confinement imposed on the motion of the water. (C) 2015 Elsevier B.V. All rights reserved.	Japan Atom Energy Agcy, Kansai Photon Sci Inst, Kizu, Kyoto 6190215, Japan	Murakami, H (reprint author), Japan Atom Energy Agcy, Kansai Photon Sci Inst, 8-1 Umemidai, Kizu, Kyoto 6190215, Japan.	murakami.hiroshi@jaea.go.jp			 [23654139];  [22310038]	The author thanks Dr. M. Kado, Dr. N. Shikazono, and Dr. A. Tanaka for fruitful discussions, and Dr. K. Akamatsu for his assistance with the DLS experiment. This study was partly supported by Grants-in-Aid for Scientific Research (23654139 and 22310038).	DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; Piletic IR, 2006, J PHYS CHEM A, V110, P4985, DOI 10.1021/jp061065c; Boyd JE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.147401; Stanley HE, 2011, J NON-CRYST SOLIDS, V357, P629, DOI 10.1016/j.jnoncrysol.2010.07.029; ZAMPIERI GG, 1986, J PHYS CHEM-US, V90, P1849, DOI 10.1021/j100400a023; Amararene A, 2000, PHYS REV E, V61, P682, DOI 10.1103/PhysRevE.61.682; Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514; Mishima O, 1998, NATURE, V396, P329; Ronne C, 2002, J MOL LIQ, V101, P199, DOI 10.1016/S0167-7322(02)00093-4; Riter RE, 1998, J PHYS CHEM B, V102, P2705, DOI 10.1021/jp973330n; Cringus D, 2007, J PHYS CHEM B, V111, P14193, DOI 10.1021/jp0723158; Dokter AM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178301; Dutt GB, 2008, J PHYS CHEM B, V112, P7220, DOI 10.1021/jp711633u; Spehr T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031404; Murakami H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052304; Hedstrom J, 2007, EUR PHYS J-SPEC TOP, V141, P53, DOI 10.1141/epjst/e2007-00010-6; Moilanen DE, 2009, J PHYS CHEM B, V113, P8560, DOI 10.1021/jp902004r; Liu L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117802; ANGELL CA, 1983, ANNU REV PHYS CHEM, V34, P593, DOI 10.1146/annurev.pc.34.100183.003113; SCHOEMAN BJ, 1994, ZEOLITES, V14, P110, DOI 10.1016/0144-2449(94)90004-3; Yoshida K, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/6/064101; Gallo P, 2010, J PHYS CHEM LETT, V1, P729, DOI 10.1021/jz9003125; Arikawa T, 2008, CHEM PHYS LETT, V457, P12, DOI 10.1016/j.cplett.2008.03.062; MASHIMO S, 1989, J PHYS CHEM-US, V93, P4963, DOI 10.1021/j100349a057; GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006; Keiding SR, 1997, J PHYS CHEM A, V101, P5250, DOI 10.1021/jp970605q; ONORI G, 1993, J PHYS CHEM-US, V97, P5430, DOI 10.1021/j100122a040; Munson CA, 2004, LANGMUIR, V20, P1551, DOI 10.1021/la0302753; KOTLARCHYK M, 1985, J PHYS CHEM-US, V89, P4382, DOI 10.1021/j100266a046; Mittleman DM, 1997, CHEM PHYS LETT, V275, P332, DOI 10.1016/S0009-2614(97)00760-4; BARTHEL J, 1990, CHEM PHYS LETT, V165, P369, DOI 10.1016/0009-2614(90)87204-5; CHRIST S, 1994, J PHYS CHEM-US, V98, P12708, DOI 10.1021/j100099a039; Simorellis AK, 2006, J AM CHEM SOC, V128, P5082, DOI 10.1021/ja0568401; Murakami H, 2011, J PHYS CHEM B, V115, P5877, DOI 10.1021/jp111852s; KAATZE U, 1981, Z PHYS CHEM NEUE FOL, V126, P151; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Berne B.J., 2000, DYNAMIC LIGHT SCATTE; Franks F., 1982, WATER COMPREHENSIVE, V7, P1; Gordon R.G., 1968, ADV MAGN RESON, V3, P1, DOI DOI 10.1103/PHYSREVB.75.155119; Kato A., 2012, SCI REP, V2; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; Lee Y.-S., 2009, PRINCIPLES TERAHERTZ; Luisi P.L., 1984, REVERSE MICELLES; Murakami H., 2012, CHEM PHYS LETT, P519; Murakami H, 2013, ADV PROTEIN CHEM STR, V93, P183, DOI 10.1016/B978-0-12-416596-0.00006-3; Pileni M P, 1989, STRUCTURE REACTIVITY; van de Hulst H. C., 1981, LIGHT SCATTERING SMA	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		A		SI		37	43		10.1016/j.molliq.2015.03.015		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2IH	WOS:000363346700006		
J	Kofu, M; Inamura, Y; Moriya, Y; Podlesnyak, A; Ehlers, G; Yamamuro, O				Kofu, Maiko; Inamura, Yasuhiro; Moriya, Yosuke; Podlesnyak, Andrey; Ehlers, Georg; Yamamuro, Osamu			Inelastic neutron scattering study on boson peaks of imidazolium-based ionic liquids	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Ionic liquid; Inelastic neutron scattering; Boson peak; Glass	LOW-ENERGY EXCITATIONS; THERMODYNAMIC PROPERTIES; VITREOUS SILICA; PHYSICOCHEMICAL PROPERTIES; AMORPHOUS SILICATES; MOLECULAR GLASSES; FLOPPY MODES; CRYSTALLINE; DYNAMICS; PHONONS	Low energy excitations of 1-alkyl-3-methylimidazolium ionic liquids (ILs) have been investigated by means of neutron spectroscopy. In the spectra of inelastic scattering, a broad excitation peak referred to as a "boson peak" appeared at 1-3 meV in all of the ILs measured. The intensity of the boson peak was enhanced at the Q positions corresponding to the diffraction peaks, reflecting the in-phase vibrational nature of the boson peak. Furthermore the boson peak energy (E-BP) was insensitive to the length of the alkyl-chain but changed depending on the radius of the anion. From the correlation among E-BP, the anion radius, and the glass transition temperature T-g, we conclude that both E-BP and T-g in ILs are predominantly governed by the inter-ionic Coulomb interaction which is less influenced by the alkyl-chain length. We also found that the E-BP is proportional to the inverse square root of the molecular weight as observed in molecular glasses. (C) 2015 Elsevier B.V. All rights reserved.	[Kofu, Maiko; Inamura, Yasuhiro; Moriya, Yosuke; Yamamuro, Osamu] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Podlesnyak, Andrey; Ehlers, Georg] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA	Yamamuro, O (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	yamamuro@issp.u-tokyo.ac.jp		Podlesnyak, Andrey/0000-0001-9366-6319	Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy; US-Japan Cooperative Program on Neutron Scattering	We thank Prof. M. Nakakoshi, Dr. T. Ueki, and Prof. M. Watanabe in Yokohama National University for the synthesis of the samples. We are deeply grateful to the Oak Ridge National Laboratory for giving us the opportunity to carry out our experiments when the Japan Proton Accelerator Research Complex (J-PARC) was closed due to the earthquake in 2011. Research at ORNL's Spallation Neutron Source was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. This work is financially supported by the US-Japan Cooperative Program on Neutron Scattering.	BUCHENAU U, 1984, PHYS REV LETT, V53, P2316, DOI 10.1103/PhysRevLett.53.2316; Ribeiro MCC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3462962; Yamamuro O, 2002, PHYSICA B, V311, P84, DOI 10.1016/S0921-4526(01)01060-2; POCSIK I, 1990, SOLID STATE COMMUN, V74, P1253, DOI 10.1016/0038-1098(90)90986-L; Arai M, 1999, PHYSICA B, V263, P268, DOI 10.1016/S0921-4526(98)01354-4; Paulechka YU, 2007, J CHEM THERMODYN, V39, P158, DOI 10.1016/j.jct.2006.05.008; Chun S, 2001, ANAL CHEM, V73, P3737, DOI 10.1021/ac010061v; Chumakov AI, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225501; MALINOVSKY VK, 1991, PHYS LETT A, V153, P63, DOI 10.1016/0375-9601(91)90363-D; Ehlers G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626935; Ruocco G, 2001, J PHYS-CONDENS MAT, V13, P9141, DOI 10.1088/0953-8984/13/41/307; Yamamuro O, 2006, AIP CONF PROC, V832, P73; FRICK B, 1995, PHYSICA B, V213, P506, DOI 10.1016/0921-4526(95)00194-E; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Penna TC, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793760; Nakamura M, 2001, J NON-CRYST SOLIDS, V293, P377, DOI 10.1016/S0022-3093(01)00688-3; Dove MT, 1997, PHYS REV LETT, V78, P1070, DOI 10.1103/PhysRevLett.78.1070; KAJITANI T, 1995, PHYSICA B, V213, P872, DOI 10.1016/0921-4526(95)00308-V; Yamamuro O, 1997, J CHEM PHYS, V106, P2997, DOI 10.1063/1.473045; Harris MJ, 2000, MINERAL MAG, V64, P435, DOI 10.1180/002646100549490; Tokuda H, 2006, J PHYS CHEM B, V110, P19593, DOI 10.1021/jp064159v; BUCHENAU U, 1986, PHYS REV B, V34, P5665, DOI 10.1103/PhysRevB.34.5665; Nemoto F, 2015, J PHYS CHEM B, V119, P5028, DOI 10.1021/acs.jpcb.5b01080; Hong L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134201; WUTTKE J, 1993, Z PHYS B CON MAT, V91, P357, DOI 10.1007/BF01344065; Ruocco G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.079601; Paulechka YU, 2007, J CHEM THERMODYN, V39, P866, DOI 10.1016/j.jct.2006.11.006; Kofu M, 2013, J PHYS CHEM B, V117, P2773, DOI 10.1021/jp312608r; Ruffle B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.045502; Zhang SJ, 2006, J PHYS CHEM REF DATA, V35, P1475, DOI 10.1063/1.2204959; Blokhin AV, 2008, J PHYS CHEM B, V112, P4357, DOI 10.1021/jp710872s; Derlet PM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20902-0; Harris MJ, 1999, PHYSICA B, V263, P357, DOI 10.1016/S0921-4526(98)01379-9; Kabo GJ, 2004, J CHEM ENG DATA, V49, P453, DOI 10.1021/je034102r; Matsuda Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.033801; Monaco A., 2009, P NATL ACAD SCI USA, V106, P3659; Ribeiro MCC, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3604533; Ue M, 2002, J ELECTROCHEM SOC, V149, pA1385, DOI 10.1149/1.1507593; Yamamuro O, 2006, CHEM PHYS LETT, V423, P371, DOI 10.1016/j.cplett.2006.03.074; Yamamuro O., UNPUB; Yamamuro O, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3622598; Yamamuro O, 1997, PROG THEOR PHYS SUPP, P93	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		B		SI		164	168		10.1016/j.molliq.2015.07.021		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2II	WOS:000363346800002		
J	Abe, H; Takekiyo, T; Aono, M; Kishimura, H; Yoshimura, Y; Hamaya, N				Abe, Hiroshi; Takekiyo, Takahiro; Aono, Masami; Kishimura, Hiroaki; Yoshimura, Yukihiro; Hamaya, Nozomu			Polymorphs in room-temperature ionic liquids: Hierarchical structure, confined water and pressure-induced frustration	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Room temperature ionic liquids; Nearly-free hydrogen bonding; Hierarchical structure; Confined water; H/D effect; Nanoheterogeneity engineering; 'Conformation glass'; High pressure crystal polymorph	N,N-DIETHYL-N-METHYL-N-(2-METHOXYETHYL) AMMONIUM TETRAFLUOROBORATE; DENSITY AMORPHOUS ICE; ANGLE NEUTRON-SCATTERING; IN-SITU CRYSTALLIZATION; RAMAN SPECTRAL CHANGES; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; 1-ETHYL-3-METHYLIMIDAZOLIUM TETRAFLUOROBORATE; PHASE-TRANSITION; HYDROGEN-BONDS; X-RAY	Room-temperature ionic liquids (RTILs) can extract hidden information about water. Various types of hydrogen bonds of water are detected clearly in the liquid, glass, and crystal states. In addition to hydrogen bonding in water, balancing among charge (scalar), dipole (vector), and coordination number (topology) contribute to heterogeneous structure on the multiple scales in RTILs-water systems. The water-mediated hierarchical structure in the liquid is connected to macroscopic properties such as AC impedance, pH oscillations, density, and differential scanning calorimetry trace as a function of water concentration. Nanoscale water confinement was observed inside the RTILs, and the size and distribution of confined water were tuned by water concentration and temperature. The loosely packed confinement plays an important role in the engineering of next generation novel nanoheterogeneous materials. High-pressure crystal polymorphs were identified in pure RTILs by X-ray diffraction and Raman spectroscopy. By further compression, amorphous appeared partially in the deformed crystalline. (C) 2015 Elsevier B.V. All rights reserved.	[Abe, Hiroshi; Aono, Masami; Kishimura, Hiroaki] Natl Def Acad, Dept Mat Sci & Engn, Yokosuka, Kanagawa 2398686, Japan; [Takekiyo, Takahiro; Yoshimura, Yukihiro] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa 2398686, Japan; [Hamaya, Nozomu] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Abe, H (reprint author), Natl Def Acad, Dept Mat Sci & Engn, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.				J-PARC [2012B0001]; Photon Factory [2010G546, 2013G017]	We appreciate Dr. Y. Imai, Mr. N. Hatano, Mr. T. Goto, Ms. M. Shigemi of the National Defense Academy for experimental supports. We also thank Prof. A. Shimizu of Soka University and Prof. T. Hanasaki of Ritsumeikan University for helpful discussions. We acknowledge the supports of J-PARC (Proposal No. 2012B0001) and Photon Factory (Proposal Nos. 2010G546, 2013G017).	Abe H., 2013, OPEN J PHYS CHEM, V3, P14; Abe H., 2012, J CHEM CHEM ENG, V6, P383; Abe H., 2014, IOP C SER MAT SCI EN, V54; Abe H., 2012, J THERMODYN; Abe H., 2007, J PHYS SOC JPN, V76; Abe H, 2014, J SOLUTION CHEM, V43, P1791, DOI 10.1007/s10953-014-0241-9; Abe H., 2015, J PHYS SOC IN PRESS; Abe H., 2015, HIGH PRESSURE UNPUB; Tsuzuki S, 2008, J PHYS CHEM B, V112, P9914, DOI 10.1021/jp803866u; Li HN, 2014, J PHYS CHEM B, V118, P8684, DOI 10.1021/jp500866z; Endo T, 2013, CRYST GROWTH DES, V13, P5383, DOI 10.1021/cg401293g; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; Otto KE, 2014, PHYS CHEM CHEM PHYS, V16, P9849, DOI 10.1039/c3cp54272f; Loerting T, 2001, PHYS CHEM CHEM PHYS, V3, P5355, DOI 10.1039/b108676f; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Saouane S, 2013, CHEM SCI, V4, P1270, DOI 10.1039/c2sc21959j; Yoshimura Y, 2013, J PHYS CHEM B, V117, P3264, DOI 10.1021/jp400341r; Favre-Nicolin V, 2002, J APPL CRYSTALLOGR, V35, P734, DOI 10.1107/S0021889802015236; Pallares G, 2014, P NATL ACAD SCI USA, V111, P7936, DOI 10.1073/pnas.1323366111; Abe H, 2010, J PHYS CHEM B, V114, P2834, DOI 10.1021/jp910947z; Yoshimura Y, 2009, J PHYS CHEM B, V113, P8091, DOI 10.1021/jp902125f; Sato T, 2004, ELECTROCHIM ACTA, V49, P3603, DOI 10.1016/j.electacta.2004.03.030; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; Bai JI, 2012, P NATL ACAD SCI USA, V109, P21240, DOI 10.1073/pnas.1213342110; Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511; Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514; Mishima O, 1998, NATURE, V396, P329; Aono M, 2014, CHEM PHYS LETT, V598, P65, DOI 10.1016/j.cplett.2014.02.058; Takekiyo T, 2012, J PHYS CHEM B, V116, P11092, DOI 10.1021/jp3057064; Abe H, 2011, CHEM PHYS LETT, V512, P204, DOI 10.1016/j.cplett.2011.07.022; Mishima O, 1996, NATURE, V384, P546, DOI 10.1038/384546a0; Smallenburg F, 2014, NAT PHYS, V10, P653, DOI [10.1038/nphys3030, 10.1038/NPHYS3030]; Takekiyo T, 2012, HIGH PRESSURE RES, V32, P150, DOI 10.1080/08957959.2011.637036; Bahadur I, 2012, J CHEM THERMODYN, V49, P24, DOI 10.1016/j.jct.2012.01.002; Yoshimura Y, 2013, J PHYS CHEM B, V117, P12296, DOI 10.1021/jp4055507; Lopes JNAC, 2006, J PHYS CHEM B, V110, P3330, DOI 10.1021/jp056006y; Bulavin LA, 2002, APPL PHYS A-MATER, V74, pS546, DOI [10.1007/s003390201545, 10.1007/s03390201545]; Endo T, 2013, J PHYS CHEM B, V117, P326, DOI 10.1021/jp310947c; Takekiyo T, 2013, J PHYS CHEM B, V117, P10142, DOI 10.1021/jp405834n; Abe H, 1997, J PHYS SOC JPN, V66, P1860, DOI 10.1143/JPSJ.66.1860; Abe H, 2014, J PHYS CHEM LETT, V5, P1175, DOI 10.1021/jz500299z; Takekiyo T, 2011, HIGH PRESSURE RES, V31, P35, DOI 10.1080/08957959.2010.521501; Su L, 2012, J PHYS CHEM B, V116, P2216, DOI 10.1021/jp2108939; Strechan AA, 2008, THERMOCHIM ACTA, V474, P25, DOI 10.1016/j.tca.2008.05.002; Imai Y, 2009, HIGH PRESSURE RES, V29, P536, DOI 10.1080/08957950903392084; Jiang W, 2007, J PHYS CHEM B, V111, P4812, DOI 10.1021/jp0671421; Takekiyo T, 2011, CHEM PHYS LETT, V511, P241, DOI 10.1016/j.cplett.2011.06.022; Takekiyo T, 2014, CHEM PHYS LETT, V602, P22, DOI 10.1016/j.cplett.2014.03.089; FULLER J, 1994, J CHEM SOC CHEM COMM, P299, DOI 10.1039/c39940000299; Heimer NE, 2006, J MOL LIQ, V124, P84, DOI 10.1016/j.molliq.2005.08.004; Angell CA, 2014, NAT MATER, V13, P673, DOI 10.1038/nmat4022; Loerting T, 2006, PHYS CHEM CHEM PHYS, V8, P2810, DOI 10.1039/b603159e; Choudhury AR, 2005, J AM CHEM SOC, V127, P16792, DOI 10.1021/ja055956u; ABE H, 1995, MATER T JIM, V36, P1200; Endo T, 2012, J PHYS CHEM B, V116, P3780, DOI 10.1021/jp300636s; Imai Y, 2008, CHEM PHYS, V352, P224, DOI 10.1016/j.chemphys.2008.06.003; Russina O, 2011, PHYS CHEM CHEM PHYS, V13, P12067, DOI 10.1039/c0cp02684k; Matsumoto K, 2006, SOLID STATE SCI, V8, P1250, DOI 10.1016/j.solidstatesciences.2005.12.018; Imai Y, 2010, CHEM PHYS LETT, V486, P37, DOI 10.1016/j.cplett.2009.12.084; Aono M, 2012, THERMOCHIM ACTA, V532, P179, DOI 10.1016/j.tca.2011.06.011; Aono M, 2012, CHEM LETT, V41, P1532, DOI 10.1246/cl.2012.1532; Abe H, 2009, J MOL LIQ, V150, P16, DOI 10.1016/j.molliq.2009.09.004; Kuhne TD, 2014, J AM CHEM SOC, V136, P3395, DOI 10.1021/ja411161a; Russo J, 2014, NAT MATER, V13, P733, DOI [10.1038/nmat3977, 10.1038/NMAT3977]; Wang YT, 2006, J PHYS CHEM B, V110, P18601, DOI 10.1021/jp063199w; Yoshimura Y, 2015, J MOL LIQ, V206, P89, DOI 10.1016/j.molliq.2015.02.010; Triolo A, 2007, J PHYS CHEM B, V111, P4641, DOI 10.1021/jp067705t; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Yoshimura Y, 2013, J RAMAN SPECTROSC, V44, P475, DOI 10.1002/jrs.4197; Abe H, 2014, J PHYS CHEM B, V118, P1138, DOI 10.1021/jp409924h; Shigemi M, 2013, HIGH PRESSURE RES, V33, P229, DOI 10.1080/08957959.2013.774390; Aono M, 2011, METALL MATER TRANS A, V42A, P37, DOI 10.1007/s11661-010-0311-6; Chen JY, 2011, P NATL ACAD SCI USA, V108, P7685, DOI 10.1073/pnas.1100752108; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Wen XD, 2011, J AM CHEM SOC, V133, P9023, DOI 10.1021/ja201786y; Bernardes CES, 2011, J PHYS CHEM B, V115, P2067, DOI 10.1021/jp1113202; Imai Y, 2011, HIGH PRESSURE RES, V31, P53, DOI 10.1080/08957959.2010.521731; Shinohara T, 2009, NUCL INSTRUM METH A, V600, P111, DOI 10.1016/j.nima.2008.11.074; Dibrov SM, 2006, ACTA CRYSTALLOGR C, V62, pO19, DOI 10.1107/S0108270105037200; Engelsman JD, 2011, PHARM RES, V28, P920; Giovambattista N., 2012, SCI REP, V2, P1; Holbrey JD, 1999, CLEAN PRODUCTS PROCE, V1, P223, DOI DOI 10.1007/S100980050036; Imai Y., 2010, J PHYS C SER, V215; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; Russina O., 2009, J PHYS CONDENS MATT, V21; Schroder C., 2007, J CHEM PHYS, V127; Shigemi M, 2014, J SOLUTION CHEM, V43, P1614, DOI 10.1007/s10953-014-0233-9; SHIMOMURA O, 1992, REV SCI INSTRUM, V63, P967, DOI 10.1063/1.1143793; Stanley H. E., 1971, INTRO PHASE TRANSITI; Takekiyo T., 2012, ADV PHYS CHEM; Takekiyo T, 2014, J SOLUTION CHEM, V43, P1701, DOI 10.1007/s10953-014-0226-8; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; Yamaguchi E., 2014, CRYOBIOL CRYOTECHNOL, V60, P127; Yoshimura Y, 2014, J SOLUTION CHEM, V43, P1509, DOI 10.1007/s10953-014-0181-4	94	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		B		SI		200	214		10.1016/j.molliq.2015.05.057		15	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2II	WOS:000363346800006		
J	Marekha, BA; Bria, M; Moreau, M; De Waele, I; Miannay, FA; Smortsova, Y; Takamuku, T; Kalugin, ON; Kiselev, M; Idrissi, A				Marekha, Bogdan A.; Bria, Marc; Moreau, Myriam; De Waele, Isabelle; Miannay, Francois-Alexandre; Smortsova, Yevheniia; Takamuku, Toshiyuki; Kalugin, Oleg N.; Kiselev, Mikael; Idrissi, Abdenacer			Intermolecular interactions in mixtures of 1-n-butyl-3-methylimidazolium acetate and water: Insights from IR, Raman, NMR spectroscopy and quantum chemistry calculations	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Ionic liquids; Acetate hydration; Intermolecular interactions	TEMPERATURE IONIC LIQUID; MOLECULAR-DYNAMICS SIMULATIONS; HYDROGEN-BONDED COMPLEXES; CENTER-DOT-O; NONCOVALENT INTERACTIONS; INFRARED-SPECTRA; CHEMICAL-SHIFTS; DFT CALCULATIONS; 1-ETHYL-3-METHYLIMIDAZOLIUM ACETATE; VIBRATIONAL SPECTROSCOPY	The intermolecular interactions in 1-n-butyl-3-methylimidazolium acetate (BmimAc)/water mixture were studied by examining the mole fraction dependence of the vibrational modes measured with infrared and Raman spectroscopy, as well as of the H-1, C-13, N-15 and O-17 NMR chemical shifts. Quantum chemistry calculations were carried out to assign as clearly as possible the vibrational modes of the cation and anion as well as to get information on the expected effect of the mixture composition on the vibrational modes and charge distribution in BmimAc. The behavior of the obtained spectroscopic data is consistent with the physical picture that when water is added to BmimAc, the interactions between cation-anion are weakened in favor of those between water and anion. The clear spectral signature is associated with the strong blue/red shift of the stretching and bending modes of the C-(2)-H, respectively. Consistently with this spectral behavior, the corresponding H-1 and C-13 chemical shifts decrease when adding water to BmimAc. The strengthening of the water-anion interactions is also traced back to both the blue shift of the nu(COO-) at around 1380 cm(-1) and nu(C-C) of acetate at around 920 cm(-1) as well as the blue shift of the delta(COO-) at around 637 cm(-1) and omega(COO-) at 615 cm(-1). The H-1, C-13 and O-17 chemical shifts of COO- are consistent with the corresponding spectral behavior. (C) 2015 Elsevier B.V. All rights reserved.	[Marekha, Bogdan A.; Moreau, Myriam; De Waele, Isabelle; Miannay, Francois-Alexandre; Smortsova, Yevheniia; Idrissi, Abdenacer] Univ Lille Sci & Technol, Lab Spectrochim Infrarouge & Raman, UMR CNRS 8516, F-59655 Villeneuve, France; [Bria, Marc] Univ Lille Sci & Technol, CCM RMN, F-59655 Villeneuve, France; [Smortsova, Yevheniia; Kalugin, Oleg N.] Kharkov Natl Univ, Dept Inorgan Chem, UA-61022 Kharkov, Ukraine; [Takamuku, Toshiyuki] Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Honjo, Saga 8408502, Japan; [Kiselev, Mikael] RAS, Inst Solut Chem, Ivanovo 153045, Russia	Idrissi, A (reprint author), Univ Lille Sci & Technol, Lab Spectrochim Infrarouge & Raman, UMR CNRS 8516, Bat C5, F-59655 Villeneuve, France.	nacer.idrissi@univ-lille1.fr			Marie Curie program IRSES (International Research Staff Exchange Scheme) [247500]	This project was supported by the Marie Curie program IRSES (International Research Staff Exchange Scheme, GANo247500). The Centre de Ressources Informatiques (CRI) de l'Universite de Lille is thankfully acknowledged for the CPU time allocation.	Radhi A, 2015, J PHYS CHEM B, V119, P1633, DOI 10.1021/jp5112108; Bowers J, 2004, LANGMUIR, V20, P2191, DOI 10.1021/la035940m; Zhang LQ, 2008, J PHYS CHEM B, V112, P6411, DOI 10.1021/jp8001349; Chen Y, 2014, J MOL STRUCT, V1058, P244, DOI 10.1016/j.molstruc.2013.11.010; van der Rest G, 1999, J MOL SPECTROSC, V196, P146, DOI 10.1006/jmsp.1999.7856; Kiefer J, 2010, J PHYS CHEM A, V114, P6713, DOI 10.1021/jp1031527; Noack K, 2010, PHYS CHEM CHEM PHYS, V12, P14153, DOI 10.1039/c0cp00486c; Ding ZD, 2012, J MOL STRUCT, V1015, P147, DOI 10.1016/j.molstruc.2012.02.020; Jeon Y, 2008, J PHYS CHEM B, V112, P923, DOI 10.1021/jp0746650; Walker AJ, 2004, CHEM COMMUN, P2570, DOI 10.1039/b410467f; Rudolph WW, 2014, DALTON T, V43, P3174, DOI 10.1039/c3dt52580e; Moreno M, 2008, J PHYS CHEM B, V112, P7826, DOI 10.1021/jp800383g; Izgorodina EI, 2014, PHYS CHEM CHEM PHYS, V16, P7209, DOI 10.1039/c3cp53035c; Cammarata L, 2001, PHYS CHEM CHEM PHYS, V3, P5192, DOI 10.1039/b106900d; Kempter V, 2010, J MOL STRUCT, V972, P22, DOI 10.1016/j.molstruc.2010.02.003; Chen Y, 2014, J PHYS CHEM B, V118, P6896, DOI 10.1021/jp502995k; Noack K, 2012, J MOL STRUCT, V1018, P45, DOI 10.1016/j.molstruc.2012.02.031; Wu TY, 2010, J TAIWAN INST CHEM E, V41, P315, DOI 10.1016/j.jtice.2009.10.003; Chen S, 2013, J PHYS CHEM B, V117, P3186, DOI 10.1021/jp310267x; GARFINKEL D, 1958, J AM CHEM SOC, V80, P3807, DOI 10.1021/ja01548a001; Chen Y, 2014, CHEM ENG TECHNOL, V37, P527, DOI 10.1002/ceat.201300583; Rodrigues F, 2010, VIB SPECTROSC, V54, P123, DOI 10.1016/j.vibspec.2010.06.009; Jeon Y, 2008, J PHYS CHEM B, V112, P4735, DOI 10.1021/jp7120752; Feng S, 2010, FLUID PHASE EQUILIBR, V294, P148, DOI 10.1016/j.fluid.2010.02.034; Addicoat MA, 2013, J COMPUT CHEM, V34, P2591, DOI 10.1002/jcc.23420; LEGRAND N, 1995, FEBS LETT, V364, P152, DOI 10.1016/0014-5793(95)00377-L; Tran CD, 2003, APPL SPECTROSC, V57, P152, DOI 10.1366/000370203321535051; Zakrzewska ME, 2010, ENERG FUEL, V24, P737, DOI 10.1021/ef901215m; Goerigk L, 2011, PHYS CHEM CHEM PHYS, V13, P6670, DOI 10.1039/c0cp02984j; KAKIHANA M, 1983, J PHYS CHEM-US, V87, P2526, DOI 10.1021/j100237a016; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P8731, DOI 10.1002/anie.200803446; Endo T, 2010, J PHYS CHEM B, V114, P9201, DOI 10.1021/jp104123v; Yokozeki A, 2007, PHYS CHEM CHEM PHYS, V9, P5018, DOI 10.1039/b706497g; Goerigk L, 2011, CHEMPHYSCHEM, V12, P3421, DOI 10.1002/cphc.201100826; Masaki T, 2010, J PHYS CHEM B, V114, P6323, DOI 10.1021/jp1017967; Akai N, 2010, J PHYS CHEM A, V114, P12662, DOI 10.1021/jp108209q; Takamuku T, 2009, J PHYS CHEM B, V113, P10817, DOI 10.1021/jp9042667; Mendez-Morales T, 2011, J PHYS CHEM B, V115, P6995, DOI 10.1021/jp202692g; Li A, 2014, J CHEM THEORY COMPUT, V10, P1563, DOI 10.1021/ct401111c; Hanke CG, 2003, J PHYS CHEM B, V107, P10873, DOI 10.1021/jp034221d; Zvereva EE, 2009, RUSS CHEM B+, V58, P1812; Chen Y, 2014, J MOL LIQ, V190, P151, DOI 10.1016/j.molliq.2013.11.010; Hall CA, 2012, J PHYS CHEM B, V116, P12810, DOI 10.1021/jp306829c; KAKIHANA M, 1982, J PHYS CHEM-US, V86, P4385, DOI 10.1021/j100219a022; Zhang QG, 2010, J PHYS CHEM B, V114, P4747, DOI 10.1021/jp1009498; Singh T, 2011, VIB SPECTROSC, V55, P119, DOI 10.1016/j.vibspec.2010.09.009; Jiang W, 2007, J PHYS CHEM B, V111, P4812, DOI 10.1021/jp0671421; Hatano N, 2012, J PHYS CHEM A, V116, P1208, DOI 10.1021/jp2097873; Annapureddy HVR, 2008, J PHYS CHEM B, V112, P1770, DOI 10.1021/jp077623k; Chapman K, 2001, J PHYS CHEM A, V105, P5442, DOI 10.1021/jp004409m; Zhu Q, 2007, J ELECTROANAL CHEM, V601, P229, DOI 10.1016/j.jelechem.2006.11.016; WILMSHURST KJ, 1955, J CHEM PHYS, V23, P2463, DOI 10.1063/1.1741932; Katayanagi H, 2004, J PHYS CHEM B, V108, P19451, DOI 10.1021/jp0477607; Mizuno K, 1998, J CHEM PHYS, V109, P9502, DOI 10.1063/1.477612; Li WJ, 2007, J PHYS CHEM B, V111, P6452, DOI 10.1021/jp071051m; Izgorodina EI, 2011, J PHYS CHEM B, V115, P14659, DOI 10.1021/jp208150b; Danten Y, 2010, J MOL LIQ, V153, P57, DOI 10.1016/j.molliq.2009.07.001; Cha S, 2014, PHYS CHEM CHEM PHYS, V16, P9591, DOI 10.1039/c4cp00589a; Cabaco MI, 2012, J PHYS CHEM A, V116, P1605, DOI 10.1021/jp211211n; Izgorodina EI, 2012, CHEM COMMUN, V48, P1493, DOI 10.1039/c1cc15056a; Zhang QG, 2011, J PHYS CHEM B, V115, P11127, DOI 10.1021/jp204305g; Mele A, 2003, ANGEW CHEM INT EDIT, V42, P4364, DOI 10.1002/anie.200351783; Gao Y, 2010, J PHYS CHEM B, V114, P2828, DOI 10.1021/jp910528m; Fong-Padron C, 2014, CHEM PHYS LETT, V593, P181, DOI 10.1016/j.cplett.2014.01.013; Zahn S, 2008, ANGEW CHEM INT EDIT, V47, P3639, DOI 10.1002/anie.200705526; Wu B, 2009, CHEM-EUR J, V15, P6889, DOI 10.1002/chem.200802742; Angenendt K, 2010, J PHYS CHEM C, V114, P20577, DOI 10.1021/jp104961r; Dominguez-Vidal A, 2007, J PHYS CHEM B, V111, P4446, DOI 10.1021/jp068777n; Hohenstein EG, 2008, J CHEM THEORY COMPUT, V4, P1996, DOI 10.1021/ct800308k; Fazio B, 2008, J RAMAN SPECTROSC, V39, P233, DOI 10.1002/jrs.1825; Katsyuba SA, 2004, HELV CHIM ACTA, V87, P2556, DOI 10.1002/hlca.200490228; Dhumal NR, 2009, J PHYS CHEM A, V113, P10397, DOI 10.1021/jp907394v; Devlin JP, 2001, J PHYS CHEM A, V105, P974, DOI 10.1021/jp003455j; Zarrougui R, 2010, J SOLUTION CHEM, V39, P1531, DOI 10.1007/s10953-010-9600-3; Stangret J, 2002, J PHYS CHEM A, V106, P5393, DOI 10.1021/jp014063v; Mizuno K, 2000, J MOL LIQ, V85, P139, DOI 10.1016/S0167-7322(99)00170-1; Oomens J, 2008, J PHYS CHEM A, V112, P3281, DOI 10.1021/jp801806e; Zhang R, 2005, J PHYS CHEM B, V109, P7482, DOI 10.1021/jp044566b; GEROTHANASSIS IP, 1994, J ORG CHEM, V59, P2341, DOI 10.1021/jo00088a013; Bowron DT, 2010, J PHYS CHEM B, V114, P7760, DOI 10.1021/jp102180q; Xiao D, 2010, CHEM PHYS LETT, V497, P37, DOI 10.1016/j.cplett.2010.07.085; Castner J.E.W., 2010, J CHEM PHYS, V132; Chen Y, 2014, J PHYS CHEM B, V118, P11523, DOI 10.1021/jp5091075; Danten Y, 2009, J PHYS CHEM A, V113, P2873, DOI 10.1021/jp8108368; Falk M., 1984, ACTA, V40, P43; Grondin J., 2010, J RAMAN SPECTROSC, V42, P733; Jorgensen W.L, 1992, BOSS VERSION 3 3; Nagaraju M., 2010, J MOL MODEL, V17, P1801; Paulechka YU, 2003, J CHEM ENG DATA, V48, P457, DOI 10.1021/je025591i; Vreven J.A.J., 2013, GAUSSIAN 09 REVISION; YingJie X., 2010, SCI CHINA CHEM, V53, P1561; Yuan XX, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-6; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zheng J., 2014, DATABASE FREQUENCY S	95	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		B		SI		227	237		10.1016/j.molliq.2015.05.015		11	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2II	WOS:000363346800009		
J	Wu, YQ; Kazumura, K; Maruyama, W; Osawa, T; Naoi, M				Wu, Yuqiu; Kazumura, Kimiko; Maruyama, Wakako; Osawa, Toshihiko; Naoi, Makoto			Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection	JOURNAL OF NEURAL TRANSMISSION			English	Article						Calcium; Apoptosis; Mitochondria; Rasagiline; Selegiline; Neuroprotection; Membrane permeability transition pore; PK11195; Outer membrane translocator protein 18 kDa	ADENINE-NUCLEOTIDE TRANSLOCASE; MONOAMINE-OXIDASE INHIBITORS; CELL-DEATH; NEURODEGENERATIVE DISORDERS; MEMBRANE PERMEABILIZATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CYTOCHROME-C; CA2+; INDUCTION	Rasagiline and selegiline, inhibitors of type B monoamine oxidase (MAO-B), protect neurons from cell death in cellular and animal models. Suppression of mitochondrial membrane permeabilization and subsequent activation of apoptosis cascade, and induction of antiapoptotic, pro-survival genes are proposed to contribute the anti-apoptotic function. Rasagiline suppresses neurotoxin- and oxidative stress-induced membrane permeabilization in isolated mitochondria, but the mechanism has been not fully clarified. In this paper, regulation of the mitochondrial permeability transition pore by rasagiline and selegiline was examined in apoptosis induced by PK11195, a ligand of the outer membrane translocator protein 18 kDa (TSPO) in SH-SY5Y cells. The pore opening was quantitatively measured using a simultaneous monitoring system for calcium (Ca2+) and superoxide (O-2(-)) (Ishibashi et al. in Biochem Biophys Res Commun 344:571-580, 2006). The association of the pore opening with Ca2+ efflux and ROS increase was proved by the inhibition of Bcl-2 overexpression and cyclosporine A treatment. Potency to release Ca2+ was correlated with the cytotoxicity of TSPO antagonists, PK11195, FGIN-1-27 and protoporphyrin IX, whereas a TSPO agonist, 4-chloro-diazepamine, did not significantly increase Ca2+ or cause cell death. Rasagiline and selegiline inhibited mitochondrial Ca2+ efflux through the mitochondrial permeability transition pore dose dependently. Ca2+ efflux was confirmed as the initial signal in mitochondrial apoptotic cascade, and the suppression of Ca2+ efflux may account for the neuroprotective function of rasagiline and selegiline. The quantitative measurement of Ca2+ efflux can be applied to determine anti-apoptotic activity of neuroprotective compounds. The role of mitochondrial Ca2+ release in neuronal death and also in neuroprotection by MAO-B inhibitors is discussed.	[Wu, Yuqiu; Osawa, Toshihiko; Naoi, Makoto] Aichi Gakuin Univ, Dept Hlth & Nutr, Fac Psychol & Phys Sci, Nisshin, Aichi 4700195, Japan; [Kazumura, Kimiko] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Maruyama, Wakako] Natl Res Ctr Geriatr & Gerontol, Dept Cognit Brain Sci, Obu, Aichi, Japan	Naoi, M (reprint author), Aichi Gakuin Univ, Dept Hlth & Nutr, Fac Psychol & Phys Sci, 12 Araike,Iwasaki Cho, Nisshin, Aichi 4700195, Japan.	mnaoi@dpc.agu.ac.jp			Ministry of Health, Labour and Welfare, Japan [21A-13]	This work was supported by the Research Grant for Longevity Science (21A-13) from the Ministry of Health, Labour and Welfare, Japan (W. M., M. N., Y. W.).	Inaba-Hasegawa K, 2012, J NEURAL TRANSM, V119, P405, DOI 10.1007/s00702-011-0730-6; De Marchi U, 2003, BIOCHEM PHARMACOL, V66, P1749, DOI 10.1016/S0006-2952(03)00474-X; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Ishibashi K, 2006, BIOCHEM BIOPH RES CO, V344, P571, DOI 10.1016/j.bbrc.2006.02.173; Giacomello M, 2013, PRION, V7, P76, DOI 10.4161/pri.23581; Vaarmann A, 2010, J BIOL CHEM, V285, P25018, DOI 10.1074/jbc.M110.111450; Striessnig J, 2006, BIOCHEM SOC T, V34, P903; Maruyama W, 2001, J NEUROCHEM, V78, P727, DOI 10.1046/j.1471-4159.2001.00448.x; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Akao Y, 2002, J NEUROCHEM, V82, P913, DOI 10.1046/j.1471-4159.2002.01047.x; Maruyama W, 2013, J NEURAL TRANSM, V120, P83, DOI 10.1007/s00702-012-0876-x; Kazumura K, 2013, J PHARMACEUT BIOMED, V84, P90, DOI 10.1016/j.jpba.2013.05.048; Naoi M, 2013, EXPERT REV NEUROTHER, V13, P671, DOI [10.1586/ern.13.60, 10.1586/ERN.13.60]; Naoi M, 2006, J NEURAL TRANSM-SUPP, P67; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Tatton WG, 2002, J PHARMACOL EXP THER, V301, P753, DOI 10.1124/jpet.301.2.753; Eriksson O, 1997, FEBS LETT, V409, P361, DOI 10.1016/S0014-5793(97)00549-8; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; COSTANTINI P, 1995, FEBS LETT, V362, P239, DOI 10.1016/0014-5793(95)00256-9; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Czerniczyniec A, 2007, NEUROSCIENCE, V144, P685, DOI 10.1016/j.neuroscience.2006.09.050; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Naoi M, 2009, EXPERT REV NEUROTHER, V9, P1233, DOI [10.1586/ern.09.68, 10.1586/ERN.09.68]; Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Riederer P, 2004, CURR MED CHEM, V11, P2033; Naoi M, 2010, CURR PHARM DESIGN, V16, P2799; Weinreb O, 2006, J NEURAL TRANSM-SUPP, P457; Naoi M, 2013, J NEURAL TRANSM, V120, P1539, DOI 10.1007/s00702-013-1033-x; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Wadia JS, 1998, J NEUROSCI, V18, P932; Ebadi M, 2006, CURR DRUG TARGETS, V7, P1513; Czerniczyniec A, 2006, NEUROCHEM INT, V48, P235, DOI 10.1016/j.neuint.2005.09.006; Vay L, 2009, CELL CALCIUM, V45, P243, DOI 10.1016/j.ceca.2008.10.007; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Kaludercic N, 2011, BBA-MOL CELL RES, V1813, P1323, DOI 10.1016/j.bbamcr.2010.09.010; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Magyar K, 2011, INT REV NEUROBIOL, V100, P65, DOI 10.1016/B978-0-12-386467-3.00004-2; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Brenner C, 2012, CIRC RES, V111, P1222; Burke Robert E, 2007, Handb Clin Neurol, V83, P591, DOI 10.1016/S0072-9752(07)83029-6; Park D, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-11; Sorato E, 2014, FREE RADICAL BIO MED, V75, P40, DOI 10.1016/j.freeradbiomed.2014.07.006; Vila M, 2003, NAT REV NEUROSCI, V4, P1; Wu Y, 2015, ANTIAPOPTOT IN PRESS	55	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	OCT	2015	122	10					1399	1407		10.1007/s00702-015-1398-0		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CU1IH	WOS:000363273700006		
J	Wada, A; Kawakami, M; Liu, MG; Otaka, E; Nishimura, A; Liu, FM; Otsuka, T				Wada, Ayako; Kawakami, Michiyuki; Liu, Meigen; Otaka, Eri; Nishimura, Atsuko; Liu, Fumio; Otsuka, Tomoyoshi			Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS)	JOURNAL OF NEUROLOGY			English	Article						Muscular dystrophy; Amyotrophic lateral sclerosis; Swallowing disorders; Instrument; Psychometric properties	DUCHENNE MUSCULAR-DYSTROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; STROKE	Dysphagia is one of the most critical problems in patients with progressive neuromuscular diseases. However, clinically useful and practical scales to evaluate dysphagia are limited. Therefore, the aim of this study was to develop such a scale. An 8-stage Neuromuscular Disease Swallowing Status Scale (NdSSS) was developed and tested for its inter- and intrarater reliabilities, concurrent validity, and responsiveness. The NdSSS was used to evaluate 134 patients with Duchenne muscular dystrophy (DMD) and 84 patients with amyotrophic lateral sclerosis (ALS). Inter- and intrarater reliabilities were examined with weighted kappa statistics. Concurrent validity was assessed by correlating the NdSSS with the existing scales [Functional Oral Intake Scale (FOIS), Functional Intake LEVEL Scales (FILS), and ALS Functional Rating Scale-Revised Swallow (ALSFRS-R Sw)], using Spearman's correlation coefficients. Responsiveness was determined with the standardized response mean (SRM). For inter- and intrarater reliabilities, the weighted kappas were 0.95 and 1.00, respectively, for DMD; and 0.98 and 0.98, respectively, for ALS. The NdSSS showed strong correlations with the FOIS (rs = 0.87 for DMD, rs = 0.93 for ALS, p < 0.001), FILS (rs = 0.89 for DMD, rs = 0.92 for ALS, p < 0.001), and ALSFRS-R SW (rs = 0.93, p < 0.001). SRMs were 0.65 for DMD and 1.21 for ALS. The SRM was higher in DMD patients for the NdSSS than for the other scales, while it was similar in ALS patients and the other scales. Our originally developed NdSSS demonstrated sufficient reliability, validity, and responsiveness in patients with DMD and ALS. It is also useful in evaluating dysphagia in patients with progressive neuromuscular diseases.	[Wada, Ayako; Otsuka, Tomoyoshi] Natl Higashisaitama Hosp, Dept Rehabil Med, Saitama, Japan; [Kawakami, Michiyuki; Liu, Meigen; Otaka, Eri; Nishimura, Atsuko; Liu, Fumio] Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo 1608582, Japan	Kawakami, M (reprint author), Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	michiyukikawakami@hotmail.com					Martigne L, 2010, CLIN NUTR, V29, P60, DOI 10.1016/j.clnu.2009.06.009; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Shinonaga C, 2008, DEV MED CHILD NEUROL, V50, P478, DOI 10.1111/j.1469-8749.2008.00478.x; Briani C, 1998, J NEUROL, V245, P211, DOI 10.1007/s004150050207; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Han TR, 2008, DYSPHAGIA, V23, P59, DOI 10.1007/s00455-007-9097-0; Higo R, 2004, AURIS NASUS LARYNX, V31, P247, DOI 10.1016/j.anl.2004.05.009; Greenwood DI, 2013, NUTR CLIN PRACT, V28, P392, DOI 10.1177/0884533613476554; Kim J, 2014, DYSPHAGIA, V29, P438, DOI 10.1007/s00455-014-9524-y; Aloysius A, 2008, EUR J PAEDIATR NEURO, V12, P239, DOI 10.1016/j.ejpn.2007.08.009; JAFFE KM, 1990, ARCH PHYS MED REHAB, V71, P742; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Garratt A M, 1994, Qual Health Care, V3, P186, DOI 10.1136/qshc.3.4.186; SWINYARD C A, 1957, Arch Phys Med Rehabil, V38, P574	16	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2015	262	10					2225	2231		10.1007/s00415-015-7836-y		7	Clinical Neurology	Neurosciences & Neurology	CT7ZZ	WOS:000363035800003		
J	Sofue, K; Arai, Y; Takeuchi, Y; Tsurusaki, M; Sakamoto, N; Sugimura, K				Sofue, Keitaro; Arai, Yasuaki; Takeuchi, Yoshito; Tsurusaki, Masakatsu; Sakamoto, Noriaki; Sugimura, Kazuro			Ultrasonography-guided central venous port placement with subclavian vein access in pediatric oncology patients	JOURNAL OF PEDIATRIC SURGERY			English	Article						Central venous port; Ultrasonography; Subclavian vein; Oncologic; Children	RANDOMIZED-TRIAL; RADIOLOGICAL PLACEMENT; RETROSPECTIVE ANALYSIS; CHEST PORTS; ULTRASOUND; COMPLICATIONS; POPULATION; CHILDREN; CATHETERIZATION; INFANTS	Background/Purpose: To evaluate the technical success and complications of image-guided central venous port (CVP) placement with subclavian vein (SCV) access in pediatric oncology population. Materials and methods: Ninety-two children (52 boys, 40 girls; mean age, 8.5 years) underwent CVP implantation under local anesthesia with conscious sedation. SCV access was firstly attempted under ultrasonographic guidance and CVP implantation was performed under fluoroscopic guidance. Technical success, peri-procedural (<24 h) complication, and post-procedural (>24 h) complication were assessed. Results: In total, 102 CVPs were implanted in 92 children with a mean catheter time of 364 days (total, 38,224 days; range, 14-1911 days). In three small children, conversion of SCV access to internal jugular vein access yielded a primary technical success rate of 97.1% and overall technical success rate of 100%. Three minor peri-procedural complications were observed (2.9%) and seven post-procedural infectious complications occurred (infection rate, 6.7%; 0.18/1000 catheter days). No pneumothorax, catheter malposition, venous thrombosis, or mortality occurred. Conclusion: Image-guided CVP placement with SCV access in a pediatric population was performed with high technical success and low complication rate without general anesthesia. This procedure can be taken into account as a choice of procedure when internal jugular venous access is not possible. (C) 2015 Elsevier Inc. All rights reserved.	[Sofue, Keitaro; Arai, Yasuaki; Takeuchi, Yoshito; Tsurusaki, Masakatsu; Sakamoto, Noriaki] Natl Canc Ctr, Div Diagnost Radiol, Tokyo 1040045, Japan; [Sofue, Keitaro; Tsurusaki, Masakatsu; Sakamoto, Noriaki; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo, Japan	Sofue, K (reprint author), Natl Canc Ctr, Div Diagnost Radiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	keitarosofue@yahoo.co.jp					Plumhans C, 2011, EUR J RADIOL, V79, P338, DOI 10.1016/j.ejrad.2009.12.010; Pirotte T, 2007, BRIT J ANAESTH, V98, P509, DOI 10.1093/bja/aem041; Nosher JL, 2001, CARDIOVASC INTER RAD, V24, P395, DOI 10.1007/s00270-001-0071-1; Cil BE, 2004, EUR RADIOL, V14, P2015, DOI 10.1007/s00330-004-2380-7; Byon HJ, 2013, BRIT J ANAESTH, V111, P788, DOI 10.1093/bja/aet202; Samaras P, 2008, ONCOLOGY-BASEL, V74, P237, DOI 10.1159/000151393; Marcy PY, 2008, EUR RADIOL, V18, P2333, DOI 10.1007/s00330-008-0981-2; Pitetti RD, 2003, ARCH PEDIAT ADOL MED, V157, P1090, DOI 10.1001/archpedi.157.11.1090; Chang DH, 2012, ROFO-FORTSCHR RONTG, V184, P726, DOI 10.1055/s-0032-1312745; Gray BW, 2012, J PEDIATR SURG, V47, P1159, DOI 10.1016/j.jpedsurg.2012.03.043; Bruzoni M, 2013, J AM COLL SURGEONS, V216, P939, DOI 10.1016/j.jamcollsurg.2013.01.054; Hengartner H, 2004, EUR J CANCER, V40, P2452, DOI 10.1016/j.ejca.2004.07.017; Biffi R, 2009, ANN ONCOL, V20, P935, DOI 10.1093/annonc/mdn701; Sakamoto N, 2010, CARDIOVASC INTER RAD, V33, P989, DOI 10.1007/s00270-010-9841-y; MORRIS SL, 1992, RADIOLOGY, V184, P149; CIMOCHOWSKI GE, 1990, NEPHRON, V54, P154, DOI 10.1159/000185837; Randolph AG, 1996, CRIT CARE MED, V24, P2053, DOI 10.1097/00003246-199612000-00020; NOSHER JL, 1994, RADIOLOGY, V192, P265; Lin CK, 2010, KAOHSIUNG J MED SCI, V26, P192, DOI 10.1016/S1607-551X(10)70028-0; Sofue K, 2013, EUR J RADIOL, V82, pE691, DOI 10.1016/j.ejrad.2013.07.003; Peynircioglu B, 2007, J VASC INTERV RADIOL, V18, P1389, DOI 10.1016/j.jvir.2007.07.010; Lorenz JM, 2001, AM J ROENTGENOL, V176, P991; Aribas BK, 2012, EXP THER MED, V4, P675, DOI 10.3892/etm.2012.649; Teichgraber UKM, 2011, EUR RADIOL, V21, P1224, DOI 10.1007/s00330-010-2045-7; Biffi R, 2014, ANN SURG ONCOL, V21, P3725, DOI 10.1245/s10434-014-3784-5; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602	26	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2015	50	10					1707	1710		10.1016/j.jpedsurg.2015.05.013		4	Pediatrics; Surgery	Pediatrics; Surgery	CU1HI	WOS:000363271000018		
J	Fukumoto, K; Miyano, G; Yamoto, M; Nouso, H; Miyake, H; Kaneshiro, M; Nakajima, H; Koyama, M; Mochizuki, K; Shinkai, M; Urushihara, N				Fukumoto, Koji; Miyano, Go; Yamoto, Masaya; Nouso, Hiroshi; Miyake, Hiromu; Kaneshiro, Masakatsu; Nakajima, Hideaki; Koyama, Mariko; Mochizuki, Kyoko; Shinkai, Masato; Urushihara, Naoto			Endoscopic repair of laryngotracheoesophageal clefts	JOURNAL OF PEDIATRIC SURGERY			English	Article						Laryngotracheoesophageal cleft (LTEC); Endoscopic surgery; Complications	POSTERIOR LARYNGEAL; MANAGEMENT; IV	Background/Purpose: In Japan, surgical repair of a laryngotracheoesophageal cleft (LTEC) typically consists of the anterior approach, with the lateral approach as an alternative. Endoscopic surgery to repair the tracheoesophageal septum has been reported, and this study reviewed our experience treating several cases of LTEC endoscopically. Methods: Endoscopic repair of LTEC was performed in 7 patients (3 boys, 4 girls; age range 4 months to 2 years 10 months; mean age 11 months; mean weight at surgery 7.23 kg; weight range 3.85-12.24 kg) between 2009 and 2014. LTEC was type I in 5 patients and types II and IV in 1 patient each. The patient with type IV was first operated on by the lateral approach, and the remaining cleft, which level was type III, was repaired endoscopically. Postoperative outcomes were retrospectively studied. Results: Endoscopic surgery was successful in all patients. All 6 patients with types I and II LTEC were extubated easily, while in the patient with type IV LTEC, it was difficult to remove the tracheostomy cannula because of tracheomalacia. Postoperatively, tracheostomy cannulation became more stable, and the patient is gradually being weaned off the ventilator. All patients could be fed orally without difficulty postoperatively. Conclusions: Endoscopic surgery provides a view from the cephalic aspect permitting the surgeon to form a normal larynx with only minimal risk of complications. (C) 2015 Elsevier Inc. All rights reserved.	[Fukumoto, Koji; Miyano, Go; Yamoto, Masaya; Nouso, Hiroshi; Miyake, Hiromu; Kaneshiro, Masakatsu; Nakajima, Hideaki; Koyama, Mariko; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Surg, Shizuoka 4208660, Japan; [Mochizuki, Kyoko; Shinkai, Masato] Kanagawa Childrens Med Ctr, Dept Surg, Yokohama, Kanagawa, Japan	Fukumoto, K (reprint author), Shizuoka Childrens Hosp, Dept Surg, Aoi Ku, 860 Urushiyama, Shizuoka 4208660, Japan.	koji-fukumoto@i.shizuoka-pho.jp					YAMASHITA M, 1979, CAN ANAESTH SOC J, V26, P502, DOI 10.1007/BF03006166; DUBOIS JJ, 1990, J PEDIATR SURG, V25, P855, DOI 10.1016/0022-3468(90)90191-B; Sandu K, 2006, LARYNGOSCOPE, V116, P630, DOI 10.1097/01.mlg.0000200794.78614.87; Mochizuki K, 2014, PEDIATR SURG INT, V30, P941, DOI 10.1007/s00383-014-3568-9; EVANS KL, 1995, ARCH OTOLARYNGOL, V121, P1380; GEIDUSCHEK JM, 1993, ANN OTO RHINOL LARYN, V102, P827; Garabedian EN, 2010, ARCH OTOLARYNGOL, V136, P70, DOI 10.1001/archoto.2009.197; DONAHOE PK, 1984, J PEDIATR SURG, V19, P143, DOI 10.1016/S0022-3468(84)80434-0; Olney DR, 1999, LARYNGOSCOPE, V109, P1770, DOI 10.1097/00005537-199911000-00009; RYAN DP, 1991, J PEDIATR SURG, V26, P962, DOI 10.1016/0022-3468(91)90844-J; BENJAMIN B, 1989, ANN OTO RHINOL LARYN, V98, P417; Pattersson G, 1969, Z KINDERCHIR, V7, P43	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2015	50	10					1801	1804		10.1016/j.jpedsurg.2015.07.018		4	Pediatrics; Surgery	Pediatrics; Surgery	CU1HI	WOS:000363271000035		
J	Kawai, H; Hanyuda, T; Yamagishi, T; Kai, A; Lane, CE; McDevit, D; Kupper, FC; Saunders, GW				Kawai, Hiroshi; Hanyuda, Takeaki; Yamagishi, Takahiro; Kai, Atsushi; Lane, Chris E.; McDevit, Dan; Kuepper, Frithjof C.; Saunders, Gary W.			REPRODUCTIVE MORPHOLOGY AND DNA SEQUENCES OF THE BROWN ALGA PLATYSIPHON VERTICILLATUS SUPPORT THE NEW COMBINATION PLATYSIPHON GLACIALIS	JOURNAL OF PHYCOLOGY			English	Article						Arctic Ocean; life history; molecular phylogeny; Phaeophyceae; Platysiphon glacialis comb. nov.	LIFE-HISTORY; SEA-ICE; PHAEOPHYCEAE; NOV; PHYLOGENY; IDENTITY; UTILITY	Platysiphon verticillatus, a brown alga endemic to the Arctic, was described based on vegetative specimens collected at Inglefield Bay, West Greenland. The species is distinctive in having a lanceolate blade-like thallus terminated by a terete portion, both covered with hair-like assimilatory filaments. Punctaria glacialis was described from Eastern Greenland, and the species differs from other Punctaria species in lacking hairs and plurilocular zoidangia. Unilocular zoidangia were reported, but instead of zoids being released they formed cell walls in situ developing the appearance of plurilocular zoidangia. However, the fate of the zoids, as well as the walled cells was not traced, and the life history of the alga has remained unclear. By comparing DNA sequences (cox1, cox3, and rDNA ITS2) of specimens morphologically referable to Platysiphon verticillatus and Punctaria glacialis collected at Baffin Island, as well as re-examining morphology and studying crude cultures, we concluded that they are the same taxonomic entity. Furthermore, their cox3 sequence and vegetative morphology agreed with those of the type specimen of Punctaria glacialis. Consequently, we propose Platysiphon glacialis comb. nov. The life cycle could not be completed in culture, but we hypothesize that in situ germination of the unizoids produces reduced gametophytes housed in peripheral tissue of erect sporophytic thalli.	[Kawai, Hiroshi; Hanyuda, Takeaki; Yamagishi, Takahiro; Kai, Atsushi] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan; [Lane, Chris E.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [McDevit, Dan] Edison State Coll, Dept Biol, Ft Myers, FL USA; [Kuepper, Frithjof C.] Univ Aberdeen, Oceanlab, Newburgh AB41 6AA, England; [Saunders, Gary W.] Univ New Brunswick, Fredericton, NB, Canada	Kawai, H (reprint author), Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan.	kawai@kobe-u.ac.jp			National Science Foundation in the USA; TOTAL Foundation; NERC (Natural Environment Research Council) UK; NSF [DEB-0212138]; JSPS [22370034, 25291087]; Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute; NSERC; Canada Research Chair Program	The 2003 collecting trip to northern Canada was funded by the National Science Foundation in the USA, on a grant to Dr. Robert ("Arctic Bob") Wilce - we are profoundly indebted to both NSF and Bob for this unique opportunity that has enriched our lives and widened our research directions. The 2009 expedition was supported by grants of the TOTAL Foundation and the NERC (Natural Environment Research Council) UK National Facility for Scientific Diving (NFSD) led by F.C.K. We are very grateful to Martin D.J. Sayer, Elaine Azzopardi and Hugh Brown (UK NFSD diving team). Dr. Eric. C. Henry provided helpful comments, and the University of Copenhagen Herbarium kindly loaned type specimens of Puntaria gracialis. For the Kawai lab a portion of the study was supported by NSF grant DEB-0212138 (PI: R.A. Andersen) and a JSPS Grants-in-Aid for Scientific Research (nos'. 22370034 and 25291087) to H. K. For the Saunders lab support was provided by the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC, and other sponsors listed at www.BOL-NET.ca. Additional support was provided by the Canada Research Chair Program; infrastructure support was from the Canada Foundation for Innovation and the New Brunswick Innovation Foundation.	Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Kawai H, 2004, J PHYCOL, V40, P1156, DOI 10.1111/j.1529-8817.2004.03153.x; Rousseau F, 2001, CR ACAD SCI III-VIE, V324, P305, DOI 10.1016/S0764-4469(01)01306-3; Kawai H, 2012, PHYCOL RES, V60, P241, DOI 10.1111/j.1440-1835.2012.00651.x; HENRY EC, 1983, PHYCOLOGIA, V22, P387, DOI 10.2216/i0031-8884-22-4-387.1; McDevit DC, 2009, PHYCOL RES, V57, P131, DOI 10.1111/j.1440-1835.2009.00530.x; Kogishi K, 2010, J PHYCOL, V46, P553, DOI 10.1111/j.1529-8817.2010.00818.x; Boo SM, 2011, BOT MAR, V54, P159, DOI 10.1515/BOT.2011.017; WALKER DC, 1978, NEW PHYTOL, V80, P193, DOI 10.1111/j.1469-8137.1978.tb02281.x; Saunders GW, 2012, BOTANY, V90, P191, DOI [10.1139/B11-079, 10.1139/b11-079]; Mathieson AC, 2010, RHODORA, V112, P396, DOI 10.3119/09-12.1; KAWAI H, 1990, BOT MAG TOKYO, V103, P325, DOI 10.1007/BF02488643; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Kawai H., 1992, KOREAN J PHYCOLOGY, V7, P33; Kawai H, 2015, J PHYCOL, V51, P918, DOI 10.1111/jpy.12332; Lane E. E., 2006, J PHYCOL, V42, P493; Lee R.K., 1980, NAT MUS NAT SCI CANA, V9, P1; Lis J T, 1980, Methods Enzymol, V65, P347; LUND SOREN, 1959, MEDDEL GR0NLAND, V156, P1; Ni-Ni-Win, 2011, J PHYCOL, V47, P1193; Ni-Ni-Win, 2008, PHYCOL RES, V56, P288; Pedersen P. M., 1976, MEDD GRONL, V199, P80; Rosenvinge L. K., 1910, MARINE ALGAE N E GRE, V43; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; TANAKA A., 2010, EUROPEAN J PHYCOLOGY, V45, P109; Tatewaki M., 1966, PHYCOLOGIA, V6, P62, DOI 10.2216/i0031-8884-6-1-62.1; WILCE R. T., 1962, BOT TIDSSKR, V58, P35	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	OCT	2015	51	5					910	917		10.1111/jpy.12331		8	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CU1ET	WOS:000363263500008		
J	Kawai, H; Hanyuda, T; Draisma, SGA; Wilce, RT; Andersen, RA				Kawai, Hiroshi; Hanyuda, Takeaki; Draisma, Stefano G. A.; Wilce, Robert T.; Andersen, Robert A.			MOLECULAR PHYLOGENY OF TWO UNUSUAL BROWN ALGAE, PHAEOSTROPHION IRREGULARE AND PLATYSIPHON GLACIALIS, PROPOSAL OF THE STSCHAPOVIALES ORD. NOV AND PLATYSIPHONACEAE FAM. NOV., AND A RE-EXAMINATION OF DIVERGENCE TIMES FOR BROWN ALGAL ORDERS	JOURNAL OF PHYCOLOGY			English	Article						divergence time; molecular phylogeny; Phaeophyceae; Platysiphon; Platysiphonaceae fam. nov.; Stschapoviales ord. nov.	CRETACEOUS-PALEOGENE BOUNDARY; LIFE-HISTORY; MAXIMUM-LIKELIHOOD; AUREOPHYCUS-ALEUTICUS; MASS EXTINCTION; SEQUENCE DATA; PHAEOPHYCEAE; TILOPTERIDALES; LAMINARIALES; MORPHOLOGY	The molecular phylogeny of brown algae was examined using concatenated DNA sequences of seven chloroplast and mitochondrial genes (atpB, psaA, psaB, psbA, psbC, rbcL, and cox1). The study was carried out mostly from unialgal cultures; we included Phaeostrophion irregulare and Platysiphon glacialis because their ordinal taxonomic positions were unclear. Overall, the molecular phylogeny agreed with previously published studies, however, Platysiphon clustered with Halosiphon and Stschapovia and was paraphyletic with the Tilopteridales. Platysiphon resembled Stschapovia in showing remarkable morphological changes between young and mature thalli. Platysiphon, Halosiphon and Stschapovia also shared parenchymatous, terete, erect thalli with assimilatory filaments in whorls or on the distal end. Based on these results, we proposed a new order Stschapoviales and a new family Platysiphonaceae. We proposed to include Phaeostrophion in the Sphacelariales, and we emended the order to include this foliose member. Finally, using basal taxa not included in earlier studies, the origin and divergence times for brown algae were re-investigated. Results showed that the Phaeophyceae branched from Schizocladiophyceae similar to 260 Ma during the Permian Period. The early diverging brown algae had isomorphic life histories, whereas the derived taxa with heteromorphic life histories evolved 155-110 Ma when they branched from the basal taxa. Based on these results, we propose that the development of heteromorphic life histories and their success in the temperate and cold-water regions was induced by the development of the remarkable seasonality caused by the breakup of Pangaea. Most brown algal orders had diverged by roughly 60 Ma, around the last mass extinction event during the Cretaceous Period, and therefore a drastic climate change might have triggered the divergence of brown algae.	[Kawai, Hiroshi; Hanyuda, Takeaki] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan; [Draisma, Stefano G. A.] Prince Songkla Univ, Hat Yai 90112, Songkhla, Thailand; [Wilce, Robert T.] Univ Massachusetts, Amherst, MA 01003 USA; [Andersen, Robert A.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	Kawai, H (reprint author), Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan.	kawai@kobe-u.ac.jp			NSF [DEB-0212138]; JSPS [22370034]	We are grateful to Dr. Eric C. Henry for helpful advice in writing the manuscript. A part of this work was supported by the NSF grant DEB-0212138 (PI: R.A. Andersen), and JSPS Grants-in-Aid for Scientific Research (no. 22370034) to H.K.	Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Kawai H, 2004, J PHYCOL, V40, P1156, DOI 10.1111/j.1529-8817.2004.03153.x; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Kawai H, 2003, PROTIST, V154, P211, DOI 10.1078/143446103322166518; Kawai H, 2012, PHYCOL RES, V60, P241, DOI 10.1111/j.1440-1835.2012.00651.x; Daugbjerg N, 1997, J PHYCOL, V33, P1031, DOI 10.1111/j.0022-3646.1997.01031.x; Kawai H, 2007, J PHYCOL, V43, P186, DOI 10.1111/j.1529-8817.2006.00308.x; KAWAI H, 1989, PHYCOLOGIA, V28, P243, DOI 10.2216/i0031-8884-28-2-243.1; Kawai H, 2008, J PHYCOL, V44, P1013, DOI 10.1111/j.1529-8817.2008.00548.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; HENRY EC, 1983, PHYCOLOGIA, V22, P387, DOI 10.2216/i0031-8884-22-4-387.1; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; HENRY EC, 1984, PHYCOLOGIA, V23, P419, DOI 10.2216/i0031-8884-23-4-419.1; RAJANIKANTH A, 1989, CURR SCI INDIA, V58, P78; Jo BY, 2013, PHYCOLOGIA, V52, P266, DOI 10.2216/12-107.1; Kawai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02491; Mathieson AC, 2010, RHODORA, V112, P396, DOI 10.3119/09-12.1; MAIER I, 1984, BRIT PHYCOL J, V19, P95; HOOPER RG, 1988, PHYCOLOGIA, V27, P395, DOI 10.2216/i0031-8884-27-3-395.1; Draisma SGA, 2010, EUR J PHYCOL, V45, P308, DOI 10.1080/09670262.2010.490959; KAWAI H, 1990, BOT MAG TOKYO, V103, P325, DOI 10.1007/BF02488643; Lim PE, 2007, PHYCOLOGIA, V46, P456, DOI 10.2216/06-90.1; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Kawai H, 2005, PHYCOLOGIA, V44, P169, DOI 10.2216/0031-8884(2005)44[169:MAMPOP]2.0.CO;2; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Alegret L, 2012, P NATL ACAD SCI USA, V109, P728, DOI 10.1073/pnas.1110601109; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Hanyuda T, 2004, J PHYCOL, V40, P581, DOI 10.1046/j.1529-8817.2004.03159.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Draisma SGA, 2001, J PHYCOL, V37, P586, DOI 10.1046/j.1529-8817.2001.037004586.x; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Bailey JC, 1998, PROTIST, V149, P245; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; JAASUND ERIK, 1957, BOT NOTISER, V110, P205; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawai H., 2014, PERSPECT PHYCOL, V1, P27; Kawai H, 2015, J PHYCOL, V51, P910, DOI 10.1111/jpy.12331; KUHLENKAMP R, 1985, BRIT PHYCOL J, V20, P301; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; LIM BL, 1986, JPN J GENET, V61, P169, DOI 10.1266/jjg.61.169; Lis J T, 1980, Methods Enzymol, V65, P347; Medlin Linda K., 1997, Plant Systematics and Evolution Supplement, V11, P187; PARKER BRUCE C., 1965, NOVA KEDWIGIA Z KRYPTOGAMENK, V10, P273; Pedersen P.M., 1976, MEDDR GRONLAND, V199, P1; Phillips N, 2008, J PHYCOL, V44, P394, DOI 10.1111/j.1529-8817.2008.00473.x; Rambaut A, 2007, TRACER V 1 5; Silver P. A., 2007, CAN J BOT, V85, P83; Sinninghe Damste Jaap S., 2004, Science (Washington D C), V304, P584; Tatewaki M., 1966, PHYCOLOGIA, V6, P62, DOI 10.2216/i0031-8884-6-1-62.1; Wilce R. T., 2007, JOINT M PHYC SOC AM, P67; WILCE R. T., 1962, BOT TIDSSKR, V58, P35; Zinova A. D., 1954, CONTR BOT I KOMARO 2, V9, P223	59	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	OCT	2015	51	5					918	928		10.1111/jpy.12332		11	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CU1ET	WOS:000363263500009		
J	Kawasaki, Y; Nakada, T; Tomita, M				Kawasaki, Yuriko; Nakada, Takashi; Tomita, Masaru			TAXONOMIC REVISION OF OIL-PRODUCING GREEN ALGAE, CHLOROCOCCUM OLEOFACIENS (VOLVOCALES, CHLOROPHYCEAE), AND ITS RELATIVES	JOURNAL OF PHYCOLOGY			English	Article						18S rRNA; Chlorococcum oleofaciens; green algae; ITS rDNA; molecular phylogeny; morphology; taxonomy	GENE SEQUENCE DATA; MOLECULAR PHYLOGENY; ELECTRON-MICROSCOPY; SP-NOV; CHLOROMONAS; MORPHOLOGY; SYSTEMATICS; EMENDATION; POSITION; LIGHT	Historically, species in Volvocales were classified based primarily on morphology. Although the taxonomy of Chlamydomonas has been re-examined using a polyphasic approach including molecular phylogeny, that of Chlorococcum (Cc.), the largest coccoid genus in Volvocales, has yet to be reexamined. Six species thought to be synonymous with the oil-producing alga Cc. oleofaciens were previously not confirmed by molecular phylogeny. In this study, seven authentic strains of Cc. oleofaciens and its putative synonyms, along with 11 relatives, were examined based on the phylogeny of the 18S ribosomal RNA (rRNA) gene, comparisons of secondary structures of internal transcribed spacer 1 (ITS1) and ITS2 rDNA, and morphological observations by light microscopy. Seven 18S rRNA types were recognized among these strains and three were distantly related to Cc. oleofaciens. Comparisons of ITS rDNA structures suggested possible separation of the remaining four types into different species. Shapes of vegetative cells, thickness of the cell walls in old cultures, the size of cells in old cultures, and stigma morphology of zoospores also supported the 18S rRNA grouping. Based on these results, the 18 strains examined were reclassified into seven species. Among the putative synonyms, synonymy of Cc. oleofaciens, Cc. croceum, and Cc. granulosum was confirmed, and Cc. microstigmatum, Cc. rugosum, Cc. aquaticum, and Cc. nivale were distinguished from Cc. oleofaciens. Furthermore, another related strain is described as a new species, Macrochloris rubrioleum sp. nov.	[Nakada, Takashi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2520882, Japan	Nakada, T (reprint author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan.	naktak@ttck.keio.ac.jp			Yamagata Prefectural Government	The authors thank Drs. Takuro Ito and Kenji Nakahigashi (Keio University) for their technical support and fruitful discussions, and Mr. Hiroaki Abe (Keio University) for his isolation of strains TKAC1016, TKAC1035, and TKAC1036. This work was supported by grants from Yamagata Prefectural Government and Tsuruoka City.	Agardh C. A., 1830, ICONES ALGARUM EUR 3, pxxi; Andersen R. A., 2005, ALGAL CULTURING TECH, P429, DOI 10.1016/B978-012088426-1/50027-5; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; FRIEDL T, 1994, J PHYCOL, V30, P500, DOI 10.1111/j.0022-3646.1994.00500.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Krienitz L, 2003, BIOLOGIA, V58, P437; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; ETTL H, 1987, NOVA HEDWIGIA, V44, P509; KOMAREK J, 1989, ARCH PROTISTENKD, V137, P255; Matsuzaki R, 2012, PHYCOLOGIA, V51, P74, DOI 10.2216/11-18.1; Hayama M, 2010, PHYCOLOGIA, V49, P221, DOI 10.2216/09-56.1; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Fulneckova J, 2012, GENOME BIOL EVOL, V4, P248, DOI 10.1093/gbe/evs007; Demchenko E, 2012, EUR J PHYCOL, V47, P264, DOI 10.1080/09670262.2012.678388; Wolf M, 2003, BIOLOGIA, V58, P433; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; TRAINOR FR, 1953, AM J BOT, V40, P758, DOI 10.2307/2438272; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Buchheim MA, 1997, J PHYCOL, V33, P286, DOI 10.1111/j.0022-3646.1997.00286.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Nakada T, 2010, PHYCOL RES, V58, P62, DOI 10.1111/j.1440-1835.2009.00559.x; SLUIMAN HJ, 1990, PHYCOLOGIA, V29, P133, DOI 10.2216/i0031-8884-29-2-133.1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; ARCHIBALD P, 1979, BRIT PHYCOL J, V14, P305; Remias D, 2010, PROTOPLASMA, V243, P73, DOI 10.1007/s00709-010-0123-y; Archibald P. A., 1970, PHYCOL STUD, V11, P1; Chodat R., 1894, B H BOSSIER, V2, P585; Corda K. J., 1833, DEUTSCHLANDS FLORA A, P2; Eftl H., 1988, SUSSWASSERFLORA MITT, V10, P436; Ettl H., 1995, SYLLABUS BODEN LUFT; Ettl H, 2014, SYLLABUS BODEN LUFT; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Graham L. E., 2009, ALGAE; Holzinger Andreas, 2014, Algological Studies, V144, P95, DOI 10.1127/1864-1318/2014/0179; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Nakada T, 2008, J PHYCOL, V44, P751, DOI 10.1111/j.1529-8817.2008.00525.x; Nakayama Takeshi, 1996, Phycological Research, V44, P47, DOI 10.1111/j.1440-1835.1996.tb00037.x; Nylander J.A.A., 2004, MRMODELTEST V2; PASCHER ADOLF, 1928, ARCH PROTISTENK, V61, P239; PROSCHOLD T., 2007, UNRAVELLING ALGAE PR, P123; Satoh Akira, 2010, Journal of the Japan Institute of Energy, V89, DOI 10.3775/jie.89.909; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Swofford D. L., 2002, PAUP PHYLOGENETIC AN	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	OCT	2015	51	5					1000	1016		10.1111/jpy.12343		17	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CU1ET	WOS:000363263500015		
J	Makino, R; Sugahara, M; Kita, K				Makino, Ryosuke; Sugahara, Misaki; Kita, Kazurni			Nutritional Evaluation of Glycated Valine and Tryptophan as a Precursor for Protein Synthesis in Chicken Embryo Myoblasts	JOURNAL OF POULTRY SCIENCE			English	Article						glycation; myoblast; protein degradation; protein synthesis; tryptophan; valine	GROWTH-FACTOR-I; BROILER-CHICKENS; AMINO-ACIDS; IGF-II; METABOLISM; PLASMA; LEUCINE; GLUCOSE; HUMANS	Valine and Tryptophan play a role of being a precursor for protein synthesis. Glycation is a non-enzymatic reaction causing dehydrating condensation between the carbonyl group of glucose and the alpha-amino group of amino acids. Glycation of tryptophan forms two types of glycated compounds, Amadori product and (1R,3S)-1-(D-gluco-1, 2,3,4,5-pentahydroxypentyl)-1,2,3,4-tetrahydro-8-carboline-3-carboxylic acid (PHP-TH beta C). In ease of valine, only Amadori product is formed by glycation. These compounds are lack of the alpha-amino group, which might not make glycated amino acids be a precursor for protein synthesis. It is known that glycation proceeds more readily in chickens than in mammals because hyperglycemia and high body temperature are features in avian species. In this study, therefore, we attempted to evaluate nutritional value of glycated valine and tryptophan as a precursor for protein synthesis. Myoblasts from chicken embryos were incubated in valine or tryptophan-free medium supplemented with or without insulin-like growth factor-I (IGF-I). In this cell culture system, the effect of glucose-valine Amadori product supplemented in the valine deficient medium was compared to that of supplemented valine. The effect of PHP-TH beta C supplementation, was also examined. Protein synthesis and degradation of myoblasts were measured using a radioactive tracer, [H-3]-phenylalanine. Protein synthesis of chicken embryo myoblasts was not affected by the addition of glucose-valine Amadori product into valine-deficient medium. When IGF-I was added in the medium, and the addition of PHP-TH beta C into tryptophan-deficient medium increased protein synthesis of chicken embryo myoblasts, but the extent of elevation of protein synthesis was lower than that in case of tryptophan supplementation into.tryptophan-deficient medium. In the absence of IGF-I, PHP-TH beta C did not increase protein synthesis. These results suggest that valine-glucose Amadori product and PHP-TH beta C does not have nutritional value for being a precursor of protein synthesis.	[Makino, Ryosuke; Kita, Kazurni] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Sugahara, Misaki; Kita, Kazurni] Iwate Univ, Fac Agr, Anim Nutr Lab, Morioka, Iwate 0208550, Japan	Kita, K (reprint author), Iwate Univ, Fac Agr, Anim Nutr Lab, Morioka, Iwate 0208550, Japan.	kitak@iwate-u.ac.jp			JSPS from the Ministry of Education, Science and Culture of Japan;  [23658215];  [13J03782]	This study was supported by a Grant-in Aid (No. 23658215, 13J03782) for Challenging Exploratory Research and JSPS Fellows from the Ministry of Education, Science and Culture of Japan.	Rosebrough RW, 1996, J NUTR, V126, P2888; ROPER H, 1983, CARBOHYD RES, V116, P183, DOI 10.1016/0008-6215(83)88108-7; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003; Kita K, 1996, J ENDOCRINOL, V149, P181, DOI 10.1677/joe.0.1490181; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Tomas FM, 1998, GEN COMP ENDOCR, V110, P262, DOI 10.1006/gcen.1998.7072; DUCLOS MJ, 1993, J ENDOCRINOL, V137, P465, DOI 10.1677/joe.0.1370465; ALVESTRAND A, 1990, EUR J CLIN INVEST, V20, P293, DOI 10.1111/j.1365-2362.1990.tb01858.x; BALLARD FJ, 1990, GEN COMP ENDOCR, V79, P459, DOI 10.1016/0016-6480(90)90076-X; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Silber BY, 2010, NEUROSCI BIOBEHAV R, V34, P387, DOI 10.1016/j.neubiorev.2009.08.005; NAIR KS, 1992, AM J PHYSIOL, V263, pE928; Kita K, 2014, J POULT SCI, V51, P191, DOI 10.2141/jpsa.0130162; Kita K, 1998, BRIT POULTRY SCI, V39, P679, DOI 10.1080/00071669888566; Blomstrand E, 2006, J NUTR, V136, P544; Kita Kazumi, 1999, Japanese Poultry Science, V36, P25; Makino R, 2015, J POULT SCI, V52, P23, DOI [10.2141/jpsa.0130185, 10.2141/jps]; Nishimagi R, 2012, J POULT SCI, V49, P300, DOI 10.2141/jpsa.011114; Oki Mai, 2007, Journal of Poultry Science, V44, P161, DOI 10.2141/jpsa.44.161; SAS Institute, 2012, SAS STAT US GUID 13	21	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					253	259		10.2141/jpsa.0150016		7	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400002		
J	Furukawa, K; Kikusato, M; Kamizono, T; Yoshida, H; Toyomizu, M				Furukawa, Kyohei; Kikusato, Motoi; Kamizono, Tomomi; Yoshida, Hayami; Toyomizu, Masaaki			Possible Involvement of Mitochondrial Reactive Oxygen Species Production in Protein Degradation Induced by Heat Stress in Avian Muscle Cells	JOURNAL OF POULTRY SCIENCE			English	Article						atrogin-1; 4-Hydroxy Tempo; mitochondria superoxide; MuRF1; skeletal muscle cells; ubiquitin-proteasome system	HYDROGEN-PEROXIDE PRODUCTION; SKELETAL-MUSCLE; SUPEROXIDE-PRODUCTION; BROILER-CHICKENS; C2C12 MYOTUBES; DROSOPHILA MITOCHONDRIA; GROWTH-PERFORMANCE; GENE-EXPRESSION; ACTIVATION; ALPHA	Heat stress (HS) stimulates mitochondrial reactive oxygen species (ROS) production and protein degradation in skeletal muscle. The present study investigated the stimulatory effects of HS-induced mitochondrial ROS production on the ubiquitin-proteasome protein degradation system in primary cultured avian muscle cells. Cells were isolated from the breast muscle of neonatal chicks, and then grown for 48 h. Thereafter, the cells were subjected to 37 degrees C or 41 degrees C (HS). Exposure to 6 h of HS treatment significantly decreased the cellular protein content compared to that of normal cells, an effect was completely suppressed by the addition of a proteasome-specific inhibitor. Whereas the mRNA levels of the 20S proteasome C2 subunit, which is one of the subunits of the 26S proteasome, did not change at any time during HS treatment (1, 3, 6 h), the mRNA levels of atrogin-1 and muscle ring-fmger protein 1, both of which are muscle-specific ubiquitin ligases, increased after 1 h of HS but then decreased to near-normal values with time. Intracellular ROS production (the sum of H2O2, hydroxyl radicals, peroxyl radicals, peroxynitrite) did not change in the 1 h HS-exposed cells, but was significantly increased after 3 h and 6 h of HS. Mitochondrial superoxide production was significantly increased after 1 h of HS, which might increase the mRNA expression of ubiquitin ligase in muscle cells. In cells pretreated with 4-hydroxy TEMPO, which is able to decrease mitochondrial superoxide production, the increases in mitochondrial superoxide production and ubiquitin ligase mRNA levels observed after 1 h of HS were suppressed. The protein content of these cells was not decreased, which was observed after the longest period of HS (6 h). These findings suggest that mitochondrial superoxide production may play an important role in activating the ubiquitin-proteasome system, probably via the induction of ubiquitin ligases, in HS-exposed muscle cells.	[Furukawa, Kyohei; Kikusato, Motoi; Kamizono, Tomomi; Yoshida, Hayami; Toyomizu, Masaaki] Tohoku Univ, Anim Nutr, Life Sci, Grad Sch Agr Sci,Aoba Ku, Sendai, Miyagi 9818555, Japan	Kikusato, M (reprint author), Tohoku Univ, Anim Nutr, Life Sci, Grad Sch Agr Sci,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	kmotoi@bios.tohoku.ac.jp			Ministry of Education, Science and Culture of Japan [24380147, 25850182]; Japan Poultry Science Association	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (24380147: M.T; 25850182: M.K). Acknowledgment is also made to the Japan Poultry Science Association for providing a travel grant to K. F. to allow presentation of some of the findings at the 10th Asian Pacific Poultry Conference, Jeju, Korea	Yunianto VD, 1997, BRIT J NUTR, V77, P897, DOI 10.1079/BJN19970088; Nakashima K, 2009, BIOSCI BIOTECH BIOCH, V73, P1869, DOI 10.1271/bbb.90134; Luo GJ, 2000, AM J PHYSIOL-REG I, V278, pR749; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Rahman M, 2014, ANTIOXID REDOX SIGN, V20, P443, DOI 10.1089/ars.2013.5410; Mujahid A, 2005, POULTRY SCI, V84, P307; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Abe T, 2006, FEBS LETT, V580, P4815, DOI 10.1016/j.febstet.2006.07.070; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; Drahota Z, 2002, J BIOENERG BIOMEMBR, V34, P105, DOI 10.1023/A:1015123908918; Laight DW, 1997, ENVIRON TOXICOL PHAR, V3, P65, DOI 10.1016/S1382-6689(96)00143-3; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sato K, 2012, GEN COMP ENDOCR, V175, P457, DOI 10.1016/j.ygcen.2011.11.043; Ohtsuka A, 2011, J POULT SCI, V48, P92, DOI 10.2141/jpsa.010093; Morita S, 1996, BIOCHEM BIOPH RES CO, V228, P813, DOI 10.1006/bbrc.1996.1737; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058; Krishna MC, 1996, J BIOL CHEM, V271, P26026; Corda S, 2001, AM J RESP CELL MOL, V24, P762; Tretter L, 2007, J NEUROCHEM, V100, P650, DOI 10.1111/j.1471-4159.2006.04223.x; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Willemsen H, 2011, POULTRY SCI, V90, P2311, DOI 10.3382/ps.2011-01353; Joubert R, 2011, AM J PHYSIOL-REG I, V301, pR201, DOI 10.1152/ajpregu.00087.2010; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Li YP, 1999, ANTIOXID REDOX SIGN, V1, P97, DOI 10.1089/ars.1999.1.1-97; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Inarrea P, 2005, BIOCHEM J, V387, P203, DOI 10.1042/BJ20041683; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Nakashima K, 2006, BIOSCI BIOTECH BIOCH, V70, P2775, DOI 10.1271/bbb.60274; Welc SS, 2012, AM J PHYSIOL-CELL PH, V303, pC455, DOI 10.1152/ajpcell.00028.2012; BARACOS VE, 1984, AM J PHYSIOL, V246, pC125; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bonetto A, 2009, FREE RADICAL BIO MED, V47, P906, DOI 10.1016/j.freeradbiomed.2009.07.002; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Kikusato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064412; Kikusato M., 2013, EAAP PUBL, V134, P267; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Nakashima Kazuki, 2004, Animal Science Journal, V75, P353, DOI 10.1111/j.1740-0929.2004.00197.x; Nakashima K., 2004, ANIM SCI J, V50, P45; On AWF, 2012, J PHARM HLTH SERV RE, V3, P3; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044; Yoshida H, 2013, EAAP PUBLICATION, V134, P309	48	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					260	267		10.2141/jpsa.0150028		8	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400003		
J	Honda, K; Saneyasu, T; Okuda, M; Uemura, T; Kamisoyama, H				Honda, Kazuhisa; Saneyasu, Takaoki; Okuda, Mika; Uemura, Taku; Kamisoyama, Hiroshi			Glucagon and Neuromedin U Suppress Food Intake in Broiler Chicks	JOURNAL OF POULTRY SCIENCE			English	Article						appetite; chickens; glucose; hyperglycemia; wing-flapping	FEEDING-BEHAVIOR; LAYER CHICKS; INJECTION; RESPONSES; POULTRY; NEURONS; PROTEIN; ENERGY; RAT	Several peptides show different effects on food intake between broiler and layer chicks. For example, the central administration of R-melanocyte-stimulating hormone decreased food intake in layer chicks but not in broiler chicks. The central administration of agouti-related protein increased food intake in layer chicks but not in broiler chicks. We previously reported that glucagon and neuromedin U (NMU) suppress food intake in layer chicks when administered centrally. However, the effects of these peptides on food intake in broiler chicks have not been examined. In the present study, we thus examined whether these peptides also show anorexigenic effects in broiler chicks. The intracerebroventricular administration of glucagon significantly suppressed food intake and increased plasma glucose concentration in broiler chicks. The hyperglycemic effect of glucagon had been shown in layer chicks in our previous studies. Intracerebroventricular administration of NMU significantly suppressed food intake and induced wing-flapping behavior in broiler chicks as well as in layer chicks. All our findings demonstrate that glucagon and NMU function as anorxigenic peptides in both broiler and layer chicks.	[Honda, Kazuhisa; Saneyasu, Takaoki; Uemura, Taku; Kamisoyama, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Okuda, Mika] Kobe Univ, Fac Agr, Kobe, Hyogo 6578501, Japan	Honda, K (reprint author), Kobe Univ, Dept Bioresource Sci, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	honda@tiger.kobe-u.ac.jp					Ivanov TR, 2004, J NEUROENDOCRINOL, V16, P612, DOI 10.1111/j.1365-2826.2004.01210.x; Tachibana T, 2004, NEUROSCI LETT, V360, P165, DOI 10.1016/j.neulet.2004.02.055; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Honda K, 2015, ANIM SCI J, V86, P312, DOI 10.1111/asj.12282; Honda K, 2012, PEPTIDES, V37, P13, DOI 10.1016/j.peptides.2012.06.015; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Honda K, 2015, J POULT SCI, V52, P183, DOI 10.2141/jpsa.0150011; Honda K, 2014, PEPTIDES, V52, P98, DOI 10.1016/j.peptides.2013.12.008; Bungo T, 2011, J POULT SCI, V48, P1, DOI 10.2141/jpsa.010117; Niimi M, 2001, ENDOCRINE, V16, P201, DOI 10.1385/ENDO:16:3:201; Julian RJ, 2005, VET J, V169, P350, DOI 10.1016/j.tvjl.2004.04.015; Wang YQ, 2010, PUBLIC HEALTH NUTR, V13, P400, DOI 10.1017/S1368980009991157; Hanada R, 2001, BIOCHEM BIOPH RES CO, V289, P225, DOI 10.1006/bbrc.2001.5945; Tachibana T, 2001, NEUROSCI LETT, V305, P131, DOI 10.1016/S0304-3940(01)01827-4; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Honda K, 2012, COMP BIOCHEM PHYS A, V163, P260, DOI 10.1016/j.cbpa.2012.08.005; Honda K, 2007, NEUROSCI LETT, V416, P198, DOI 10.1016/j.neulet.2007.02.011; Masunari K, 2013, REGUL PEPTIDES, V187, P1, DOI 10.1016/j.regpep.2013.10.004; Shiraishi J, 2011, PHYSIOL BEHAV, V103, P233, DOI 10.1016/j.physbeh.2011.02.008; Richards MP, 2007, POULTRY SCI, V86, P1478; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Honda K, 2014, NEUROSCI LETT, V564, P57, DOI 10.1016/j.neulet.2014.02.008; Saneyasu T, 2011, COMP BIOCHEM PHYS A, V159, P422, DOI 10.1016/j.cbpa.2011.04.008; Ozaki Y, 2002, ENDOCRINOLOGY, V143, P4320, DOI 10.1210/en.2002-2200201; Vrang N, 2010, PROG NEUROBIOL, V92, P442, DOI 10.1016/j.pneurobio.2010.07.003; Kamisoyama H, 2007, NEUROSCI LETT, V420, P1, DOI 10.1016/j.neulet.2007.03.062; INOKUCHI A, 1984, PHYSIOL BEHAV, V33, P397, DOI 10.1016/0031-9384(84)90160-4; Kurose Y, 2009, ANIM SCI J, V80, P686, DOI 10.1111/j.1740-0929.2009.00685.x; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Furuse M., 2002, Animal Science Journal, V73, P83, DOI 10.1046/j.1344-3941.2002.00014.x; KUENZEL WJ, 1994, J NUTR, V124, pS1355	31	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					268	273		10.2141/jpsa.0150020		6	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400004		
J	Ohtsu, H; Yamazaki, M; Abe, H; Murakami, H; Toyomizu, M				Ohtsu, Haruhiko; Yamazaki, Makoto; Abe, Hiroyuki; Murakami, Hitoshi; Toyomizu, Masaaki			Heat Stress Modulates Cytokine Gene Expression in the Spleen of Broiler Chickens	JOURNAL OF POULTRY SCIENCE			English	Article						broiler chicken; heat stress; spleen involution; splenic cytokine	IMMUNE-RESPONSES; PERFORMANCE; PROFILES; SUPPLEMENTATION; PARAMETERS	Heat stress has negative effects on biological defense mechanisms such as the immune response in chickens, and organs of the immune system, such as the spleen, are atrophied by heat stress in broiler chickens. In order to assess heat stress-induced functional changes of immune mechanisms in the spleen of broiler chickens, expression of genes encoding splenic cytokines (Th1 type, Th2 type, and pro-inflammatory cytokines) was analyzed. Heat exposure at 34 degrees C for 15 days significantly induced the spleen involution, increased interleukin (IL)-4 and IL-12 expression and decreased interferon (IFN)-gamma. However, expression of IL-6, 10, 13, and 18 was not affected. Heat stress reduced feed intake, which may affect the spleen weight and cytokine expression. Therefore, a pair-fed group at 24 degrees C (24PF) was included in which chickens received the same amount of feed as those in the group at 34 degrees C. Spleen weight was not affected by the reduction in feed intake. IL-4 expression in the 24PF group was higher than that in the control group. Further, IFN-gamma expression increased and IL-12 expression was not affected by the reduction of feed intake, suggesting that the feed intake reduction induced by heat stress does not modulate splenic cytokine expression in broiler chickens. These data suggest that heat stress induces spleen involution and affects the expression of splenic cytokines such as IL-12 and IFN-gamma in broiler chickens, but not through the feed intake reduction.	[Ohtsu, Haruhiko; Yamazaki, Makoto; Abe, Hiroyuki; Murakami, Hitoshi] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050902, Japan; [Toyomizu, Masaaki] Tohoku Univ, Dept Anim Sci, Fac Agr, Sendai, Miyagi 9818555, Japan	Ohtsu, H (reprint author), Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan.	hotsu@affrc.go.jp			Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science.	Li YP, 2005, VET MICROBIOL, V110, P155, DOI 10.1016/j.vetmic.2005.06.014; Mashaly MM, 2004, POULTRY SCI, V83, P889; Niu ZY, 2009, POULTRY SCI, V88, P2101, DOI 10.3382/ps.2009-00220; Mujahid A, 2006, POULTRY SCI, V85, P1259; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Degen WGJ, 2005, VET MICROBIOL, V105, P163, DOI 10.1016/j.vetmic.2004.12.001; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Han AY, 2010, POULTRY SCI, V89, P2063, DOI 10.3382/ps.2010-00715; Bartlett JR, 2003, POULTRY SCI, V82, P1580; Coble DJ, 2011, POULTRY SCI, V90, P1659, DOI 10.3382/ps.2010-01279; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Khajavi M, 2003, BRIT POULTRY SCI, V44, P490, DOI [10.1080/000071660310001598328, 10.1080/00071660301979]; Cheng TK, 1997, J APPL POULTRY RES, V6, P18; Abdul-Careem MF, 2007, POULTRY SCI, V86, P1351; Takahashi K, 2011, ANIM SCI J, V82, P753, DOI 10.1111/j.1740-0929.2011.00898.x; Kaiser P, 2004, DEV COMP IMMUNOL, V28, P375, DOI 10.1016/j.dci.2003.09.004; JEURISSEN SHM, 1991, RES IMMUNOL, V142, P352, DOI 10.1016/0923-2494(91)90090-6; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812	19	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					282	287		10.2141/jpsa.0150062		6	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400006		
J	Nishii, M; Yasutomi, M; Sone, Y				Nishii, Mari; Yasutomi, Masaharu; Sone, Yoshiaki			Inhibitory Effect of Whole Grain Paddy Rice Feeding on the Colonization of Campylobacter jejuni in the Cecum of Broiler Chicks	JOURNAL OF POULTRY SCIENCE			English	Article						Campylobacter; broiler chick; gizzard; paddy rice	DIGESTIVE-TRACT; NUTRIENT UTILIZATION; PARTICLE-SIZE; GASTROINTESTINAL-TRACT; MICROBIAL COMPOSITION; GROWTH-PERFORMANCE; CORN; FIBER; DIETS; WHEAT	To examine the inhibitory effect of whole grain paddy rice diet (WPR) feeding on the colonization of Campylobacter jejuni in the cecum of broiler chicks, we performed the following examination. Sixty female broiler chicks (14 days of age) were allocated into two groups, thirty birds were fed a ground corn diet (GC) as a control group, and 30 chicks were fed WPR as an examination group. After feeding with the different diets for 16 days, six chicks were selected from each group (12 chicks in total), and each chick was inoculated with 2 X 10(3) colony-forming units of C. jejuni GTC03263. Forty-eight hours after the bacterial inoculation (the birds continued to be fed with the corresponding diets after the bacterial inoculation), the chicks (six from each group) were killed and dissected to detect bacterial colonization in the cecum. The other six chicks were dissected to weigh the chick gizzard and to measure the pH of its contents. No bacterial colonization was observed in the cecum of chicks in the WPR group, whereas bacteria were found in the cecum of five of six chicks in the GC group. The average ratios of gizzard weight to body weight of the WPR-fed chicks was significantly higher than that of the GC-fed chicks, whereas the average pH value of the gizzard contents was not different between the two groups. These results suggest that WPR feeding in broiler chicks has a positive effect on development of the gizzard muscle and grinding activity of the gizzard. Increased grinding activity may eliminate the regional differences in pH within the gizzard, resulting in less bacterial survival in the gizzard and then less bacterial colonization in the cecum of WPR-fed chicks than in GC-fed chicks.	[Nishii, Mari; Yasutomi, Masaharu] Kyoto Prefecture Agr Expt Stn, Ayabe 6230211, Japan; [Sone, Yoshiaki] Mimasaka Univ, Tuyama 7088511, Japan	Nishii, M (reprint author), Kyoto Prefecture Agr Expt Stn, Ayabe 6230211, Japan.	m-nishii34@pref.kyoto.lg.jp					Sacranie A, 2012, POULTRY SCI, V91, P693, DOI 10.3382/ps.2011-01790; Singh Y, 2014, POULTRY SCI, V93, P607, DOI 10.3382/ps.2013-03542; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365; Jimenez-Moreno E, 2009, ANIM FEED SCI TECH, V154, P93, DOI 10.1016/j.anifeedsci.2009.06.020; Jackson DN, 2009, ANTON LEEUW INT J G, V96, P377, DOI 10.1007/s10482-009-9378-8; STERN NJ, 1988, J APPL BACTERIOL, V64, P247, DOI 10.1111/j.1365-2672.1988.tb03382.x; Walk CL, 2012, POULTRY SCI, V91, P1371, DOI 10.3382/ps.2011-01928; Mateos GG, 2012, J APPL POULTRY RES, V21, P156, DOI 10.3382/japr.2011-00477; Hilmi HTA, 2007, APPL ENVIRON MICROB, V73, P7867, DOI 10.1128/AEM.01128-07; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Jacobs CM, 2010, POULTRY SCI, V89, P539, DOI 10.3382/ps.2009-00434; Svihus B, 2011, WORLD POULTRY SCI J, V67, P207, DOI 10.1017/S0043933911000249; Evans SJ, 2000, PREV VET MED, V46, P209, DOI 10.1016/S0167-5877(00)00143-4; Bjerrum L, 2005, AVIAN DIS, V49, P9, DOI 10.1637/7223-061504R; Achen M, 1998, AVIAN DIS, V42, P732, DOI 10.2307/1592708; Moen B, 2012, J APPL MICROBIOL, V113, P1176, DOI 10.1111/j.1365-2672.2012.05404.x; Engberg RM, 2002, BRIT POULTRY SCI, V43, P569, DOI 10.1080/0007166022000004480; Jimenez-Moreno E, 2013, ANIM FEED SCI TECH, V182, P44, DOI 10.1016/j.anifeedsci.2013.03.012; Sola-Oriol D, 2009, J ANIM SCI, V87, P571, DOI 10.2527/jas.2008-0951; Engberg RM, 2004, POULTRY SCI, V83, P925; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Hetland H, 2002, BRIT POULTRY SCI, V43, P416, DOI 10.1080/00071660120103693; Santos FBO, 2008, POULTRY SCI, V87, P405, DOI 10.3382/ps.2006-00417; Gabriel I, 2003, BRIT POULTRY SCI, V44, P283, DOI [10.1080/0007166031000096470, 10.1080/00071660301955]; Jimenez-Moreno E, 2009, POULTRY SCI, V88, P1925, DOI 10.3382/ps.2009-00193; Kita K, 2013, J POULT SCI, V50, P114, DOI 10.2141/jpsa.011113; Sittiya J, 2014, J POULT SCI, V51, P52, DOI 10.2141/jpsa.0130042; Duke G.E., 1986, P269; Gonzalez-Alvarado JM, 2008, POULTRY SCI, V87, P1779, DOI 10.3382/ps.2008-00070; International Standards Organization, 2006, 102721 ISO; Mituoka T, 1994, STUDIES BIFIDBACTERI; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Skånseng B., 2013, Agriculture, V3, P741, DOI 10.3390/agriculture3040741	34	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					312	317		10.2141/jpsa.0140193		6	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400010		
J	Nakashima, K; Ishida, A				Nakashima, Kazuki; Ishida, Aiko			Effects of Fasting and Refeeding on Expression of Atrogin-1/MAFbx in Cardiac Muscle of Broiler Chickens	JOURNAL OF POULTRY SCIENCE			English	Article						atrogin-1/MAFbx; broiler; cardiac muscle; fasting; heart; refeeding	FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; UBIQUITIN LIGASES; PROTEIN BREAKDOWN; GENE-EXPRESSION; ATROPHY; PATHWAY; GROWTH; HEART; MURF1	The expression of atrogin-1/MAFbx, a muscle-specific E3 ubiquitin ligase, is high under catabolic conditions that result in muscle atrophy. We previously showed that expression of atrogin-1/MAFbx was expressed in skeletal, smooth and cardiac muscles of chickens and its expression in skeletal and smooth muscles was regulated by nutritional conditions. In this study, the effects of fasting and refeeding on the expression of atrogin-1/MAFbx and other proteolytic-related genes, including 20S proteasome C2 subunit, m-calpain large,subunit, and cathepsin B, in cardiac muscle of broiler chickens were investigated. Chickens were fasted for 24 h, and refed for 2 h. Atrogin-1/MAFbx mRNA expression was increased by fasting, but subsequent refeeding reduced the increase. The mRNA expression of the 20S proteasome C2 subunit and m-calpain large subunit mRNA was not affected by fasting or refeeding. Cathepsin B mRNA expression was increased by fasting, but unlike atrogin-1/MAFbx mRNA expression, the increase was not reduced by refeeding. These results demonstrate the muscle-specific ubiquitin ligase atrogin-1/MAFbx gene expression in cardiac muscle as well as skeletal and smooth muscles of chicken is regulated by food deprivation and nutritional supply.	[Nakashima, Kazuki; Ishida, Aiko] NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Div, Tsukuba, Ibaraki 3050901, Japan	Nakashima, K (reprint author), NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Div, Tsukuba, Ibaraki 3050901, Japan.	kaznaka@affrc.go.jp			 [24580414]	This work was supported in part by a Grant-in-Aid for Scientific Research [(C) #24580414].	Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Yoshizawa F, 1997, BIOCHEM BIOPH RES CO, V240, P825, DOI 10.1006/bbrc.1997.7652; Dehoux M, 2004, ENDOCRINOLOGY, V145, P4806, DOI 10.1210/en.2004-0406; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; HALLANGERAS M, 1991, METABOLISM, V40, P302, DOI 10.1016/0026-0495(91)90114-C; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Razeghi P, 2006, BIOCHEM BIOPH RES CO, V342, P361, DOI 10.1016/j.bbre.2006.01.163; Ohtsuka A, 2011, J POULT SCI, V48, P92, DOI 10.2141/jpsa.010093; Paula-Gomes S, 2013, HORM METAB RES, V45, P849, DOI 10.1055/s-0033-1347209; Carvalho RF, 2010, J MOL HISTOL, V41, P81, DOI 10.1007/s10735-010-9262-x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Nakashima K, 2005, J NUTR SCI VITAMINOL, V51, P248; Li QH, 2011, SCI CHINA LIFE SCI, V54, P904, DOI 10.1007/s11427-011-4226-2; Nakashima K, 2013, BIOSCI BIOTECH BIOCH, V77, P1092, DOI 10.1271/bbb.120885; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Nakashima K, 2006, BIOSCI BIOTECH BIOCH, V70, P2775, DOI 10.1271/bbb.60274; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; GOLL DE, 1992, BIOCHIMIE, V74, P225, DOI 10.1016/0300-9084(92)90121-T; GOLL DE, 1991, J BIOL CHEM, V266, P8501; Lecker SH, 1999, J NUTR, V129, p227S; Mitch WE, 1996, NEW ENGL J MED, V335, P1897; SEENE T, 1994, J STEROID BIOCHEM, V50, P1, DOI 10.1016/0960-0760(94)90165-1; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4	27	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					318	322		10.2141/jpsa.0150036		5	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400011		
J	Ohara, A; Oyakawa, C; Yoshihara, Y; Ninomiya, S; Sato, S				Ohara, Ai; Oyakawa, Chisako; Yoshihara, Yu; Ninomiya, Shigeru; Sato, Shusuke			Effect of Environmental Enrichment on the Behavior and Welfare of Japanese Broilers at a Commercial Farm	JOURNAL OF POULTRY SCIENCE			English	Article						behavior; footpad dermatitis; hay bale; heterophil/lymphocyte ratio; perch	FOOT-PAD DERMATITIS; SLOW-GROWING BROILERS; PERCHING BEHAVIOR; BREAST BLISTERS; LEG HEALTH; CHICKENS; DENSITY; AVAILABILITY; PERFORMANCE; PREVALENCE	The effect of hay bales and perches as environmental enrichment material was investigated on the behavior, heterophil/lymphocyte (H/L) ratio, footpad dermatitis (FPD), and productivity of Japanese broilers in a commercial farm. About 21,500 birds were allocated to 4 houses: male versus female X control versus treatment house. We observed maintenance behavior, the utilization of hay bales and perches, and the H/L ratio of birds at 3, 5, and 8 weeks of age. FPD was scored and productivity was calculated at about 60 days after hatching. Compared to birds in the control houses, birds in the treatment houses invested more time in stand-resting and moving behaviors (P<0.01, for each behavior) and less time feeding, drinking, and sit-resting (P<0.01, for each behavior). Females used the hay bales and perches more than the males (P<0.1 and P<0.01, respectively). The activity and utilization of hay bales and perches decreased with age (P<0.01, for each behavior, respectively). The H/L ratio of birds in the treatment houses was lower than that in the control houses (P<0.01). The prevalence of FPD was milder in the treatment houses compared to the control houses for females (P<0.01), but not for males. In conclusion, hay bales and perches represent effective enrichment materials, allowing broilers to express normal behavior, alleviating stress in the younger and lighter birds of both sexes, and reducing FPD in female birds using the hay bales and perches more than males.	[Ohara, Ai; Oyakawa, Chisako; Ninomiya, Shigeru; Sato, Shusuke] Tohoku Univ, Grad Sch Agr Sci, Donated Fund Lab Anim Welf Ishii, Ohsaki, Miyagi 9896711, Japan; [Yoshihara, Yu; Sato, Shusuke] Tohoku Univ, Grad Sch Agr Sci, Lab Land Ecol, Ohsaki, Miyagi 9896711, Japan	Sato, S (reprint author), Tohoku Univ, Grad Sch Agr Sci, 232-3 Yomogita, Ohsaki, Miyagi 9896711, Japan.	shusato@bios.tohoku.ac.jp			Ishii Co., Ltd.	This study was supported by a grant from Ishii Co., Ltd. We thank Ishii Co., Ltd. and Nichirei Fresh Farm Inc. for participating in the current study. We are grateful for the constructive advice from the members of Land Ecology, Graduate School of Agricultural Science, Tohoku University, Japan.	Amory JK, 2002, J ANDROL, V23, P84; Gouveia KG, 2009, ANIM WELFARE, V18, P43; Taira K, 2014, J VET MED SCI, V76, P583, DOI 10.1292/jvms.13-0321; Nielsen BL, 2004, BRIT POULTRY SCI, V45, P306, DOI 10.1080/00071660410001730798; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Kestin SC, 2001, VET REC, V148, P195; Hashimoto S, 2011, J VET MED SCI, V73, P293, DOI 10.1292/jvms.10-0329; Nielsen BL, 2003, BRIT POULTRY SCI, V44, P161, DOI 10.1080/0007166031000088389; WEEKS CA, 1994, ANIM WELFARE, V3, P179; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; Lee YP, 2007, BRIT POULTRY SCI, V48, P113, DOI 10.1080/00071660701261302; HUGHES BO, 1973, BRIT POULTRY SCI, V14, P341, DOI 10.1080/00071667308416038; Heckert RA, 2002, POULTRY SCI, V81, P451; Bokkers EAM, 2003, APPL ANIM BEHAV SCI, V81, P59, DOI 10.1016/S0168-1591(02)00251-4; MENCH JA, 1988, APPL ANIM BEHAV SCI, V21, P233, DOI 10.1016/0168-1591(88)90112-8; Bailie CL, 2013, ANIMAL, V7, P618, DOI 10.1017/S1751731112002108; Kells A, 2001, ANIM WELFARE, V10, P347; Allain V, 2009, BRIT POULTRY SCI, V50, P407, DOI 10.1080/00071660903110901; Kjaer JB, 2006, POULTRY SCI, V85, P1342; Martrenchar A, 2001, BRIT POULTRY SCI, V42, P161, DOI 10.1080/00071660120048393; Martrenchar A, 2000, BRIT POULTRY SCI, V41, P125, DOI 10.1080/713654921; Ventura BA, 2010, POULTRY SCI, V89, P1574, DOI 10.3382/ps.2009-00576; HUGHES BO, 1977, BRIT POULTRY SCI, V18, P715, DOI 10.1080/00071667708416426; de Jong IC, 2012, POULTRY SCI, V91, P1569, DOI 10.3382/ps.2012-02156; Olsson IAS, 2002, ANIM WELFARE, V11, P11; Rozenboim I, 1999, POULTRY SCI, V78, P135; Pettit-Riley R, 2001, APPL ANIM BEHAV SCI, V71, P127, DOI 10.1016/S0168-1591(00)00174-X; Pagazaurtundua A, 2006, BRIT POULTRY SCI, V47, P529, DOI 10.1080/00071660600963024; Bizeray D, 2002, POULTRY SCI, V81, P767; DAWKINS MS, 1989, APPL ANIM BEHAV SCI, V24, P77, DOI 10.1016/0168-1591(89)90126-3; FAWC (Farm Animal Welfare Council) FAWC updates the five freedoms, 1992, VET REC, V131, P357; Jockenhövel F, 2004, Aging Male, V7, P319; Mench J., 2004, Measuring and auditing broiler welfare, P3, DOI 10.1079/9780851998053.0003; RSPCA, WELF STAND CHICK; Sato S, 2011, ETHOGRAMS FARM ANIMA, P18	35	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					323	330		10.2141/jpsa.0150034		8	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400012		
J	Chowdhury, VS; Shigemura, A; Erwan, E; Ito, K; Bahry, MA; Tran, PV; Furuse, M				Chowdhury, Vishwajit S.; Shigemura, Asako; Erwan, Edi; Ito, Kentaro; Bahry, Mohammad A.; Tran, Phuong V.; Furuse, Mitsuhiro			Oral Administration of L-Citrulline, but not L-Arginine or L-Ornithine, Acts as a Hypothermic Agent in Chicks	JOURNAL OF POULTRY SCIENCE			English	Article						body temperature; chick; L-arginine; L-citrulline; L-ornithine	HIGH AMBIENT-TEMPERATURE; HEAT-EXPOSED CHICKS; FREE AMINO-ACID; BROILER-CHICKENS; NEONATAL CHICKS; NITRIC-OXIDE; D-ASPARTATE; FOOD-INTAKE; STRESS; INJECTION	Some amino acids are important regulators of key metabolic pathways and necessary for several physiological functions. However, little is know about thermoregulatory functions of amino acids. In this study, therefore chicks were either centrally or orally administered with L-citrulline (L-Cit), L-arginine (L-Arg) or L-ornithine (L-Orn) to monitor changes in rectal temperature. In Experiment 1, the amino acids (L-Cit, L-Arg and L-Orn) were administered into the left ventricle of the chicks by intracerebroventricular (i.c.v.) injection at a dose of 1 mu mol/10 mu l to monitor the effects of these amino acids on rectal temperature during 120 min of the experimental period. In Experiment 2, chicks received the same amino acids by oral administration at a dose of 15 mmol/10 ml/kg body weight. In Experiment 3, chicks received three doses of L-Cit (3.75, 7.5 or 15 mmol/10 ml/kg body weight) by oral administration. I.c.v. injection with any of the amino acids studied did not alter body temperature, but oral administration of L-Cit significantly reduced body temperature. Importantly, the highest does effectively reduced body temperature. These results suggest that peripheral L-Cit has a hypothermic function in chicks, which may be a new candidate to minimize high body temperature in poultry during summer heat stress.	[Chowdhury, Vishwajit S.] Kyushu Univ, Fac Arts & Sci, Div Expt Nat Sci, Fukuoka 8190395, Japan; [Shigemura, Asako; Erwan, Edi; Ito, Kentaro; Bahry, Mohammad A.; Tran, Phuong V.; Furuse, Mitsuhiro] Kyushu Univ, Lab Regulat Metab & Behav, Fac Agr, Fukuoka 8128581, Japan	Chowdhury, VS (reprint author), Kyushu Univ, Fac Arts & Sci, Div Expt Nat Sci, Fukuoka 8190395, Japan.	vc-sur@artsci.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23248046, 15K07694]; Kiekai Research Grant	This work was supported by a Grant-in-Aid for Scientific Research (No. 23248046 to MF and No. 15K07694 to VSC) from the Japan Society for the Promotion of Science and Kiekai Research Grant Support to VSC.	Alberts B., 2014, ESSENTIAL CELL BIOL; Chowdhury VS, 2014, COMP BIOCHEM PHYS A, V169, P70, DOI 10.1016/j.cbpa.2013.12.020; Ito K, 2014, BRIT POULTRY SCI, V55, P644, DOI 10.1080/00071668.2014.957653; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; Furuse M, 1999, BRIT POULTRY SCI, V40, P698, DOI 10.1080/00071669987115; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Soleimani AF, 2010, J ANIM PHYSIOL AN N, V94, P641, DOI 10.1111/j.1439-0396.2009.00951.x; Chowdhury VS, 2012, COMP BIOCHEM PHYS A, V162, P227, DOI 10.1016/j.cbpa.2012.03.009; MARDER J, 1989, COMP BIOCHEM PHYS A, V94, P395, DOI 10.1016/0300-9629(89)90112-6; Koutoku T, 2005, NEUROCHEM INT, V47, P183, DOI 10.1016/j.neuint.2005.03.006; Chowdhury VS, 2012, J POULT SCI, V49, P212, DOI 10.2141/jpsa.011071; Brake J, 1998, BRIT POULTRY SCI, V39, P639, DOI 10.1080/00071669888511; Erwan E, 2014, EUR J PHARMACOL, V736, P138, DOI 10.1016/j.ejphar.2014.04.042; Suenaga R, 2008, AMINO ACIDS, V35, P107, DOI 10.1007/s00726-007-0617-x; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; TAMIR H, 1963, ARCH BIOCHEM BIOPHYS, V102, P249, DOI 10.1016/0003-9861(63)90178-4; Yahav S, 1996, POULTRY SCI, V75, P402; Erwan E, 2012, AMINO ACIDS, V43, P1969, DOI 10.1007/s00726-012-1272-4; Rimando AM, 2005, J CHROMATOGR A, V1078, P196, DOI 10.1016/j.chroma.2005.05.009; Monti JM, 2004, LIFE SCI, V75, P2027, DOI 10.1016/j.lfs.2004.02.036; Mendes AA, 1997, POULTRY SCI, V76, P472; Dai SF, 2012, BRIT POULTRY SCI, V53, P471, DOI 10.1080/00071668.2012.719148; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Willemsen H, 2011, POULTRY SCI, V90, P2311, DOI 10.3382/ps.2011-01353; TEDESCO TA, 1984, PEDIATRICS, V73, P879; Erwan E, 2014, LIFE SCI, V109, P65, DOI 10.1016/j.lfs.2014.05.015; Rose SP, 1997, BRIT POULTRY SCI, V38, pS36; Figueroa A, 2010, AM J HYPERTENS, V8, P1; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Windmueller HG, 1981, AM J PHYSIOL, V241, P473	30	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					331	335		10.2141/jpsa.0150014		5	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400013		
J	Takahashi, K; Sakurai, N; Emura, N; Hashizume, T; Sawai, K				Takahashi, Kazuki; Sakurai, Nobuyuki; Emura, Natsuko; Hashizume, Tsutomu; Sawai, Ken			Effects of downregulating GLIS1 transcript on preimplantation development and gene expression of bovine embryos	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Bovine embryo; Early development; Gene expression; GLIS1; RNA interference	ZINC-FINGER PROTEIN; NUCLEAR TRANSFER; HEAT-SHOCK-PROTEIN-70 FAMILY; SOMATIC-CELLS; MOUSE EMBRYOS; STAGE; METHYLATION; ACTIVATION; MECHANISMS; OOCYTES	Kruppel-like protein Gli-similar 1 (GLIS1) is known as a direct reprogramming factor for the generation of induced pluripotent stem cells. The objective of this study was to investigate the role of GLIS1 in the preimplantation development of bovine embryos. GLIS1 transcripts in in vitro-matured oocytes and 1-cell to 4-cell stage embryos were detected, but they were either absent or at trace levels at the 8-cell to blastocyst stages. We attempted GLIS1 downregulation of bovine early embryos by RNA interference and evaluated developmental competency and gene transcripts, which are involved in zygotic gene activation (ZGA) in GLIS1-downregulated embryos. Injection of specific siRNA resulted in a distinct decrease in GLIS1 transcript in bovine embryos at the 4-cell stage. Although the bovine embryos injected with GLIS1-siRNA could develop to the 16-cell stage, these embryos had difficulty in developing beyond the 32-cell stage. Gene transcripts of PDHAI and HSPA8, which are transcribed after ZGA, showed lower level in GLIS1 downregulated embryos. It is possible that GLIS1-downregulated embryos fail to initiate ZGA. Our results indicated that GLIS1 is an important factor for the preimplantation development of bovine embryos.	[Takahashi, Kazuki; Emura, Natsuko; Hashizume, Tsutomu; Sawai, Ken] Iwate Univ, Fac Agr, Takizawa, Iwate 0208550, Japan; [Sakurai, Nobuyuki; Hashizume, Tsutomu; Sawai, Ken] Iwate Univ, United Grad Sch Agr Sci, Takizawa, Iwate 0208550, Japan	Sawai, K (reprint author), Iwate Univ, Fac Agr, Takizawa, Iwate 0208550, Japan.	kensawai@iwate-u.ac.jp			JSPS [26292162]	This study was supported by JSPS KAKENHI Grant number 26292162.	Zheng P, 2004, BIOL REPROD, V70, P1411, DOI 10.1095/biolreprod.103.023788; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; KIDDER GM, 1985, DEV BIOL, V112, P265, DOI 10.1016/0012-1606(85)90397-5; Hyttel P, 2000, ANIM REPROD SCI, V60, P49, DOI 10.1016/S0378-4320(00)00087-7; Nakashima M, 2002, MECH DEVELOP, V119, P21, DOI 10.1016/S0925-4773(02)00291-5; Schultz RM, 1999, J EXP ZOOL, V285, P276, DOI 10.1002/(SICI)1097-010X(19991015)285:3<276::AID-JEZ11>3.0.CO;2-K; FREI RE, 1989, J REPROD FERTIL, V86, P637; WILLADSEN SM, 1991, THERIOGENOLOGY, V35, P161, DOI 10.1016/0093-691X(91)90155-7; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Sawai K, 2011, J REPROD DEVELOP, V57, P236, DOI 10.1262/jrd.10-035A; WILSON JM, 1995, ANIM REPROD SCI, V38, P73, DOI 10.1016/0378-4320(94)01353-N; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Minami N, 2007, J REPROD DEVELOP, V53, P707, DOI 10.1262/jrd.19029; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; BEHBOODI E, 1995, THERIOGENOLOGY, V44, P227, DOI 10.1016/0093-691X(95)00172-5; Khalesi E, 2013, BIOCHEM BIOPH RES CO, V441, P499, DOI 10.1016/j.bbrc.2013.10.083; Abe H, 1999, MOL REPROD DEV, V53, P325, DOI 10.1002/(SICI)1098-2795(199907)53:3<325::AID-MRD8>3.0.CO;2-T; CAMOUS S, 1986, BIOL CELL, V58, P195; Svarcova O, 2007, MOL REPROD DEV, V74, P1428, DOI 10.1002/mrd.20727; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Sawai K, 2005, CLONING STEM CELLS, V7, P189, DOI 10.1089/clo.2005.7.189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; DAHL HHM, 1995, AM J HUM GENET, V56, P553; Laurincik J, 2002, MOL REPROD DEV, V61, P477, DOI 10.1002/mrd.10109; Nakanishi G, 2006, J INVEST DERMATOL, V126, P49, DOI 10.1038/sj.jid.5700018; Wrenzycki C, 2005, REPROD FERT DEVELOP, V17, P23, DOI 10.1071/RD04109; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; MONK M, 1987, DEVELOPMENT, V99, P371; Machado GM, 2013, REPROD FERT DEVELOP, V25, P600, DOI 10.1071/RD11282; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; den Dass JHG, 1997, THERIOGENOLOGY, V47, P43; Song BS, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-44	41	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					369	374				6	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400002		
J	Otaka, K; Hiradate, Y; Kobayashi, N; Shirakata, Y; Tanemura, K				Otaka, Kosuke; Hiradate, Yuuki; Kobayashi, Norio; Shirakata, Yoshiki; Tanemura, Kentaro			Distribution of the sex chromosome during mouse spermatogenesis in testis tissue sections	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Fluorescence in situ hybridization; Sex chromosome; Spermatogenesis	IN-SITU HYBRIDIZATION; HUMAN SPERM NUCLEI; CATTLE BOS-TAURUS; Y-CHROMOSOMES; GERM-CELLS; FISH; INACTIVATION; CHROMATIN; MICE; SPERMATOZOA	During mammalian spermatogenesis, spermatogenic cells undergo mitotic division and are subsequently divided into haploid spermatids by meiotic division, but the dynamics of sex chromosomes during spermatogenesis are unclear in vivo. To gain insight into the distribution of sex chromosomes in the testis, we examined the localization of sex chromosomes before and after meiosis in mouse testis sections. Here, we developed a method of fluorescence in situ hybridization (FISH) using specific probes for the X and Y chromosomes to obtain their positional information in histological testis sections. FISH analysis revealed the sex chromosomal position during spermatogenesis in each stage of seminiferous epithelia and in each spermatogenic cell. In the spermatogonia and leptotene spermatocytes, sex chromosomes were distantly positioned in the cell. In the zygotene and pachytene spermatocytes at prophase I, X and Y chromosomes had a random distribution. After meiosis, the X and Y spermatids were random in every seminiferous epithelium. We also detected aneuploidy of sex chromosomes in spermatogenic cells using our developed FISH analysis. Our results provide further insight into the distribution of sex chromosomes during spermatogenesis, which could help to elucidate a specific difference between X and Y speimatids and sex chromosome-specific behavior.	[Otaka, Kosuke; Hiradate, Yuuki; Kobayashi, Norio; Shirakata, Yoshiki; Tanemura, Kentaro] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod & Dev, Sendai, Miyagi 9818555, Japan	Tanemura, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod & Dev, Sendai, Miyagi 9818555, Japan.	kentaro@m.tohoku.ac.jp					Nicodemo D, 2009, CYTOGENET GENOME RES, V126, P217, DOI 10.1159/000245923; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Oi M, 2013, J REPROD DEVELOP, V59, P92; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Bugno M, 2010, REPROD DOMEST ANIM, V45, P1015, DOI 10.1111/j.1439-0531.2009.01478.x; Lowe X, 1996, CHROMOSOMA, V105, P204; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Toth A, 2010, CURR BIOL, V20, pR1022, DOI 10.1016/j.cub.2010.11.002; HECHT NB, 1990, J REPROD FERTIL, V88, P679; Egozcue J, 1997, HUM REPROD UPDATE, V3, P441, DOI 10.1093/humupd/3.5.441; Habermann FA, 2005, J ANIM BREED GENET, V122, P22, DOI 10.1111/j.1439-0388.2005.00488.x; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; Attia SM, 2012, MUTAGENESIS, V27, P31, DOI 10.1093/mutage/ger051; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Whyte JJ, 2007, THERIOGENOLOGY, V67, P1022, DOI 10.1016/j.theriogenology.2006.11.014; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Lee JT, 2005, CURR BIOL, V15, pR249, DOI 10.1016/j.cub.2005.03.024; Kauppi L, 2012, ANN NY ACAD SCI, V1267, P18, DOI 10.1111/j.1749-6632.2012.06593.x; Ko E, 2001, CYTOGENET CELL GENET, V95, P143, DOI 10.1159/000059336; Baarends WM, 2003, CYTOGENET GENOME RES, V103, P225, DOI 10.1159/000076808; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Attia SM, 2008, MUTAT RES-GEN TOX EN, V651, P105, DOI 10.1016/j.mrgentox.2007.10.011; LEBLOND CP, 1952, AM J ANAT, V90, P167, DOI 10.1002/aja.1000900202; Kawarasaki T, 1996, MOL REPROD DEV, V43, P548; Komaki H, 2014, THERIOGENOLOGY, V82, P652, DOI 10.1016/j.theriogenology.2014.05.018; Baumgartner A, 2001, MUTAT RES-GEN TOX EN, V490, P11, DOI 10.1016/S1383-5718(00)00141-8; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Garcia-Quevedo L, 2014, ANDROLOGY-US, V2, P892, DOI 10.1111/j.2047-2927.2014.00272.x; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Kim J, 2015, NATURE, V517, P466, DOI 10.1038/nature14097; Kobayashi J, 1999, THERIOGENOLOGY, V52, P1043, DOI 10.1016/S0093-691X(99)00193-4; Rens W, 2001, REPRODUCTION, V121, P541, DOI 10.1530/rep.0.1210541; Russell L. D., 1990, HISTOLOGICAL HISTOPA	39	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					375	381				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400003		
J	Yazama, F; Sato, H; Sonoda, T				Yazama, Futoshi; Sato, Haruki; Sonoda, Tomoko			Malfunction of spermatogenesis in experimental ischemic mice	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Blood-testis barrier (BTB); Heat shock protein (HSP) 70; Ischemia; Mouse; Testis	BLOOD-TESTIS BARRIER; GERM-CELL APOPTOSIS; HEAT-SHOCK PROTEINS; MALE-INFERTILITY; SERTOLI-CELLS; EXPRESSION; HSP72; GENE; ELECTROPHORESIS; LOCALIZATION	An experimental ischemia (EI)-induced mouse model was used to analyze pathological and biochemical alterations in testes. Initial morphological changes were observed in Sertoli cells of El testes at the light microscopic level. Examination of the ultrastructure using transmission electron microscopy confirmed that Sertoli cells were partially detached from the basement membrane of the seminiferous epithelium and that the cell membranes of adjacent Sertoli cells were not joined. The functional integrity of the blood-testis barrier (BTB) was assessed using the lanthanum tracer technique. Lanthanum had penetrated into the spaces between adjacent Satoli cells in the adluminal compartment up to the lumen of the seminiferous epithelium in EI testes. Proteome analysis showed that the expression of heat shock protein (HSP) 70 was significantly upregulated in EI testes. Western blot analysis confirmed that the expression of HSP70 increased in a time-dependent manner after the EI procedure. HSP70 immunostaining was observed in spermatocytes and in round and elongated spermatids in El testes. Our results suggest that a change in the junctions between adjacent Sertoli cells on the basal compartment is involved in the BTB disruption in EI testes. Therefore, male infertility caused by the BTB disruption could be associated with heat stress induced by ischemia.	[Yazama, Futoshi; Sato, Haruki] Prefectural Univ Hiroshima, Dept Life Sci, Lab Cell Biol & Morphol, Hiroshima 7270023, Japan; [Sonoda, Tomoko] Yokohama City Univ, Sch Med, Dept Mol Biodef Res, Lab Mol Physiol, Yokohama, Kanagawa 2360004, Japan	Yazama, F (reprint author), Prefectural Univ Hiroshima, Dept Life Sci, Lab Cell Biol & Morphol, Hiroshima 7270023, Japan.	fyzma@pu-hiroshima.ac.jp					Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Sasaki T, 2008, J CELL BIOL, V182, P449, DOI 10.1083/jcb.200802113; Deng Y, 2008, UROLOGY, V71, P878, DOI 10.1016/j.urology.2007.12.055; ALLEN RL, 1988, MOL CELL BIOL, V8, P828; Yazama F, 2008, J REPROD DEVELOP, V54, P299, DOI 10.1262/jrd.19169; HIRANO H, 1982, PHYTOCHEMISTRY, V21, P1513, DOI 10.1016/S0031-9422(82)85008-5; HAGENAS L, 1977, ANDROLOGIA, V9, P250; McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321; Itoh N, 2001, J ANDROL, V22, P40; ALLEN RL, 1988, MOL CELL BIOL, V8, P3260; Mori C, 1997, DEV DYNAM, V208, P125; Iammarrone E, 2003, BEST PRACT RES CL OB, V17, P211, DOI 10.1053/ybeog.2003.359; Fink C, 2006, NEOPLASIA, V8, P1019, DOI 10.1593/neo.06559; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; ZAKERI ZF, 1990, J CELL BIOL, V111, P1785, DOI 10.1083/jcb.111.5.1785; Zhou XC, 2001, ENDOCRINE, V16, P89, DOI 10.1385/ENDO:16:2:089; Vydra N, 2006, CELL DEATH DIFFER, V13, P212, DOI 10.1038/sj.cdd.4401758; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Yazama F, 2006, ANAT SCI INT, V81, P115, DOI 10.1111/j.1447-073X.2006.00139.x; Zaprjanova S, 2013, EUR J OBSTET GYN R B, V168, P54, DOI 10.1016/j.ejogrb.2012.12.021; FUJISAWA M, 1988, J REPROD FERTIL, V84, P123; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; ROSARIO MO, 1992, DEV BIOL, V150, P1, DOI 10.1016/0012-1606(92)90002-X; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Kaushal N, 2009, EUR J NUTR, V48, P221, DOI 10.1007/s00394-009-0005-2; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Smith JF, 2010, FERTIL STERIL, V93, P2169, DOI 10.1016/j.fertnstert.2010.02.054; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077; Gunn SA, 1975, HDB PHYSL, P117; Hirano H., 1989, METHODS PROTEIN SEQU, P42; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ruchalski K, 2003, AM J PHYSIOL-CELL PH, V285, pC1483, DOI 10.1152/ajpcell.00049.2003; Setchell BP, 1975, HDB PHYSL, P143	35	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					399	406				8	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400006		
J	Kitayama, C; Sasaki, M; Ishikawa, H; Mogoe, T; Ohsumi, S; Fukui, Y; Budipitojo, T; Kondoh, D; Kitamura, N				Kitayama, Chiyo; Sasaki, Motoki; Ishikawa, Hajime; Mogoe, Toshihiro; Ohsumi, Seiji; Fukui, Yutaka; Budipitojo, Teguh; Kondoh, Daisuke; Kitamura, Nobuo			Structure and functions of the placenta in common minke (Balaenoptera acutorostrata), Bryde's (B. brydei) and sei (B. borealis) whales	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Arcola; Aromatase; Placenta; Uteroferrin; Whale	STEROIDOGENIC ENZYMES; CORPUS-LUTEUM; AROMATASE CYTOCHROME-P450; ESTROGEN SYNTHESIS; PORCINE PLACENTA; BALEEN WHALE; UTEROFERRIN; PREGNANCY; IMMUNOLOCALIZATION; EXPRESSION	The structure and functions of placentas were examined in 3 species of rorqual whales, common minke (Balaenoptera acutorostrata), Bryde's (B. brydei) and sei (B. borealis) whales, with the aim of confirming the structural characteristics of the chorion, including the presence of the areolar part, and clarifying steroidogenic activities and fetomatemal interactions in the placentas of these whales. Placentas were collected from the second phase of the Japanese Whale Research Program under Special Permit in the North Pacific (JARPN II). Histological and ultrastructural examinations revealed that these whale placentas were epitheliochorial placentas with the interdigitation of chorionic villi lined by monolayer uninucleate cells (trophoblast cells) and endometrial crypts as well as folded placentation by fold-like chorionic villi. Moreover, well-developed pouch-like areolae were observed in the placentas, and active absorption was suggested in the chorionic epithelial cells of the areolar part (areolar trophoblast cells). Berlin blue staining showed the presence of ferric ions (Fe3+) in the uterine glandular epithelial cells and within the stroma of chorionic villi in the areolar part. An immunohistochemical examination revealed tartrate-resistant acid phosphatase (TRAP; known as uteroferrin in uteri) in the cytoplasm of glandular cells and areolar trophoblast cells. This result suggested that, in cetaceans, uteroferrin is used to supply iron to the fetus. Furthermore, immunoreactivity for P450scc and P450arom was detected in trophoblast cells, but not in areolar trophoblast cells, suggesting that trophoblast cells synthesize estrogen in whale placentas. Therefore, we herein immunohistochemically revealed the localization of aromatase and uteroferrin in cetacean placentas during pregnancy for the first time.	[Kitayama, Chiyo; Sasaki, Motoki; Kondoh, Daisuke; Kitamura, Nobuo] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Lab Vet Anat, Sapporo, Hokkaido 0808555, Japan; [Sasaki, Motoki; Kitamura, Nobuo] Gifu Univ, United Grad Sch Vet Med, Gifu 5011193, Japan; [Ishikawa, Hajime; Mogoe, Toshihiro; Ohsumi, Seiji] Inst Cetacean Res, Tokyo 1040055, Japan; [Fukui, Yutaka] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Sapporo, Hokkaido 0808555, Japan; [Budipitojo, Teguh] Gadjah Mada Univ, Fac Vet Med, Yogyakarta 55281, Indonesia	Sasaki, M (reprint author), Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Lab Vet Anat, Sapporo, Hokkaido 0808555, Japan.	sasakim@obihiro.ac.jp					AMOROSO E. C, 1958, PROC ZOOL SOC LONDON, V130, P437; RYAN KJ, 1971, AM J OBSTET GYNECOL, V109, P299; DANTZER V, 1984, ACTA ANAT, V118, P96; SCHULER G, 1994, EXP CLIN ENDOCRINOL, V102, P169; Wislocki GB, 1941, AM J ANAT, V68, P97, DOI 10.1002/aja.1000680105; Pereira FTV, 2010, REPROD DOMEST ANIM, V45, P907, DOI 10.1111/j.1439-0531.2009.01462.x; BURTON GJ, 1982, PLACENTA, V3, P407, DOI 10.1016/S0143-4004(82)80033-7; BENIRSCHKE K, 1987, MAR MAMMAL SCI, V3, P82, DOI 10.1111/j.1748-7692.1987.tb00153.x; Conley AJ, 2007, PLACENTA, V28, P668, DOI 10.1016/j.placenta.2006.11.004; FRIESS AE, 1981, ANAT EMBRYOL, V163, P43, DOI 10.1007/BF00315769; Wislocki GB, 1933, BIOL BULL-US, V65, P80, DOI 10.2307/1537189; Schuler G, 2006, REPRODUCTION, V131, P669, DOI 10.1530/rep.1.01033; Weng Q, 2005, J REPROD DEVELOP, V51, P247, DOI 10.1262/jrd.16081; Flood PF, 2005, ANIM REPROD SCI, V85, P147, DOI 10.1016/j.anireprosci.2004.03.001; Li Y, 2005, PLACENTA, V26, P387, DOI 10.1016/j.placenta.2004.07.008; PATIL DR, 1974, J ANAT, V118, P33; Olivera L, 2003, ANAT EMBRYOL, V207, P45, DOI 10.1007/s00429-003-0328-3; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875; Enders AC, 2004, PLACENTA, V25, pS3, DOI 10.1016/j.placenta.2004.01.011; Braun BC, 2012, J STEROID BIOCHEM, V132, P295, DOI 10.1016/j.jsbmb.2012.07.005; Wada S, 2003, NATURE, V426, P278, DOI 10.1038/nature02103; Tsubota T, 2001, REPRODUCTION, V121, P587, DOI 10.1530/rep.0.1210587; Hoffmann B, 2002, DOMEST ANIM ENDOCRIN, V23, P309, DOI 10.1016/S0739-7240(02)00166-2; LING P, 1993, J BIOL CHEM, V268, P6896; Silvers LE, 1997, MAR MAMMAL SCI, V13, P711, DOI 10.1111/j.1748-7692.1997.tb00095.x; Wilsher S, 2013, REPRODUCTION, V145, P541, DOI 10.1530/REP-13-0060; de Oliveira CM, 2012, AN ACAD BRAS CIENC, V84, P1115, DOI 10.1590/S0001-37652012005000055; Sasaki M, 2013, J REPROD DEVELOP, V59, P159, DOI 10.1262/jrd.2012-132; Abd-Elnaeim MMM, 2003, ANAT HISTOL EMBRYOL, V32, P326, DOI 10.1111/j.1439-0264.2003.00465.x; Nishiyama T, 1999, ANAT HISTOL EMBRYOL, V28, P125, DOI 10.1046/j.1439-0264.1999.00170.x; Ellenberger C, 2008, THERIOGENOLOGY, V70, P746, DOI 10.1016/j.theriogenology.2008.04.050; Sasaki T, 2006, MOL PHYLOGENET EVOL, V41, P40, DOI 10.1016/j.ympev.2006.03.032; RENEGAR RH, 1982, BIOL REPROD, V27, P1247, DOI 10.1095/biolreprod27.5.1247; Sasaki M, 2014, J REPROD DEVELOP, V60, P62, DOI 10.1262/jrd.2013-063; DANTZER V, 1993, ANAT EMBRYOL, V188, P257; Burton GJ, 2008, COMP PLACENTATION ST, P301; Calle PP, 1994, VERT BER ERKRG ZOOTI, V36, P309; da Silva VMF, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-26; Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013; Gao H. J., 2010, Journal of Animal Science and Biotechnology, V1, P137; HOFFMANN B, 1979, ANIM REPROD SCI, V2, P253, DOI 10.1016/0378-4320(79)90051-4; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; Kato H, 1990, BIOL MARINE MAMMALS, P128; Mead JG, 2005, MAMMAL SPECIES WORLD, P723; Miller Debra L., 2007, P331; Padua MB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097964; Pereira F., 2006, Reproduction Fertility and Development, V18, P141, DOI 10.1071/RDv18n2Ab66; Stump C. W., 1960, Australian Journal of Marine and Freshwater Research, V11, P365; Turner W, 1872, T ROY SOC EDINBURGH, V226, P466; YOSHINAGAHIRABAYASHI T, 1990, HISTOCHEMISTRY, V93, P223; ZHEMKOVA Z. P., 1967, FOLIA MORPHOL [PRAGUE], V15, P104	51	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					415	421				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400008		
J	Mori, M; Hayashi, T; Isozaki, Y; Takenouchi, N; Sakatani, M				Mori, Miyuki; Hayashi, Takeshi; Isozaki, Yoshihiro; Takenouchi, Naoki; Sakatani, Miki			Heat shock decreases the embryonic quality of frozen-thawed bovine blastocysts produced in vitro	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Blastocysts; Cryopreservation; Heat shock; IVF	LACTATING DAIRY-COWS; INCREASE PREGNANCY RATES; PREIMPLANTATION EMBRYOS; HEAT-SHOCK-PROTEIN-70 SYNTHESIS; ARTIFICIAL-INSEMINATION; GENE-EXPRESSION; CONCEPTION RATE; STRESS; CATTLE; CULTURE	In this study, the effect of heat shock on frozen-thawed blastocysts was evaluated using in vitro-produced (IVP) bovine embryos. In experiment 1, the effects of 6 h of heat shock at 41.0 C on fresh blastocysts were evaluated. HSPA14 expression as a reflection of stress was increased by heat shock (P < 0.05), but the expressions of the quality markers IFNT and POU5F1 were not affected. In experiment 2, frozen-thawed blastocysts were incubated at 38.5 C for 6 h (cryo-con) or exposed to heat shock at 41.0 C for 6 h (cryo-HS). Then, blastocysts were cultured at 38.5 C until 48 h after thawing (both conditions). Cryo-HS blastocysts exhibited a decreased recovery rate: HSPA14 expression was dramatically increased compared with that in fresh or cryo-con blastocysts at 6 h, and IFNT expression was decreased compared with that in cryo-con blastocysts at 6 h (both P < 0.05). Cryo-con blastocysts at 6 h also exhibited higher HSPA1A expression than fresh blastocysts (P < 0.05). At 48 h after thawing, the number of hatched blastocysts and blastocyst diameter were lower in cryo-HS blastocysts (P < 0.05). Cryo-con blastocysts showed lower POU5F1 levels at 48 h than fresh, cryo-con or cryo-HS blastocysts at 6 h (P < 0.05), but their POU5F1 levels were not different from those of cryo-HS blastocysts at 48 h. These results indicated that application of heat shock to frozen-thawed blastocysts was highly damaging. The increase in damage by the interaction of freezing-thawing and heat shock might be one reason for the low conception rate in frozen-thawed embryo transfer in summer.	[Mori, Miyuki; Hayashi, Takeshi; Isozaki, Yoshihiro] Fukuoka Agr & Forestry Res Ctr, Fukuoka 8188549, Japan; [Takenouchi, Naoki; Sakatani, Miki] Natl Agr & Food Res Org NARO, Kyushu Okinawa Agr Res Ctr, Livestock & Grassland Res Div, Kumamoto 8611192, Japan	Sakatani, M (reprint author), Natl Agr & Food Res Org NARO, Kyushu Okinawa Agr Res Ctr, Livestock & Grassland Res Div, Kumamoto 8611192, Japan.	msaka@affrc.go.jp			Ito Foundation Research Grant [2014-25]	This project was supported by an Ito Foundation Research Grant (Grant #: 2014-25).	Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2<186::AID-MRD8>3.0.CO;2-N; Block J, 2003, J ANIM SCI, V81, P1590; Chebel RC, 2008, THERIOGENOLOGY, V69, P98, DOI 10.1016/j.theriogenology.2007.09.008; Mori M, 2014, THERIOGENOLOGY, V81, P683, DOI 10.1016/j.theriogenology.2013.11.015; Dikmen S, 2012, J DAIRY SCI, V95, P3401, DOI 10.3168/jds.2011-4306; Edwards JL, 1997, MOL REPROD DEV, V46, P138, DOI 10.1002/(SICI)1098-2795(199702)46:2<138::AID-MRD4>3.0.CO;2-R; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; PUTNEY DJ, 1988, BIOL REPROD, V39, P717, DOI 10.1095/biolreprod39.3.717; Nabenishi H, 2011, J REPROD DEVELOP, V57, P450, DOI 10.1262/jrd.10-135T; Correa GA, 2008, ANIM REPROD SCI, V104, P132, DOI 10.1016/j.anireprosci.2007.02.002; Agca Y, 1998, THERIOGENOLOGY, V50, P147, DOI 10.1016/S0093-691X(98)00121-6; EALY AD, 1993, J DAIRY SCI, V76, P2899; Tani M, 2010, J VET MED SCI, V72, P627; da Silva FM, 2005, REPROD DOMEST ANIM, V40, P205, DOI 10.1111/j.1439-0531.2005.00575.x; Hansen PJ, 1999, J ANIM SCI, V77, P36; Rutledge JJ, 2001, THERIOGENOLOGY, V55, P105, DOI 10.1016/S0093-691X(00)00449-0; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; PUTNEY DJ, 1989, ANIM REPROD SCI, V19, P37, DOI 10.1016/0378-4320(89)90045-6; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Chandolia RK, 1999, BIOL REPROD, V61, P1644, DOI 10.1095/biolreprod61.6.1644; Park SY, 2006, ZYGOTE, V14, P125, DOI 10.1017/S0967199406003649; Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021; Mori M, 2012, J REPROD DEVELOP, V58, P717, DOI 10.1262/jrd.2012-085; Drost M, 1999, THERIOGENOLOGY, V52, P1161, DOI 10.1016/S0093-691X(99)00208-3; Ambrose JD, 1999, J DAIRY SCI, V82, P2369; Moghaddam A, 2009, VET RES COMMUN, V33, P567, DOI 10.1007/s11259-009-9205-8; Ozawa M, 2012, THERIOGENOLOGY, V78, P1243, DOI 10.1016/j.theriogenology.2012.05.020; Dobson H, 2001, THERIOGENOLOGY, V55, P65, DOI 10.1016/S0093-691X(00)00446-5; Hansen PJ, 2001, THERIOGENOLOGY, V55, P91, DOI 10.1016/S0093-691X(00)00448-9; Sakatani M, 2008, J REPROD DEVELOP, V54, P496, DOI 10.1262/jrd.20017; Edwards JL, 1997, MOL REPROD DEV, V48, P25, DOI 10.1002/(SICI)1098-2795(199709)48:1<25::AID-MRD4>3.0.CO;2-R; Imai K, 2002, J VET MED SCI, V64, P887, DOI 10.1292/jvms.64.887; Villa-Mancera A, 2011, TROP ANIM HEALTH PRO, V43, P597, DOI 10.1007/s11250-010-9737-5; Sakatani M, 2004, MOL REPROD DEV, V67, P77, DOI 10.1002/mrd.20014; Collier RJ, 2006, J DAIRY SCI, V89, P1244; Hickman CF, 2013, AM J REPROD IMMUNOL, V70, P177, DOI 10.1111/aji.12131; Al-Katanani YM, 2002, THERIOGENOLOGY, V58, P171, DOI 10.1016/S0093-691X(02)00916-0; Stewart BM, 2011, J DAIRY SCI, V94, P3437, DOI 10.3168/jds.2010-4008; Mori M, 2002, REPROD DOMEST ANIM, V37, P181, DOI 10.1046/j.1439-0531.2002.00354.x; Rivera RM, 2001, REPRODUCTION, V121, P107, DOI 10.1530/rep.0.1210107; Garcia-Ispierto I, 2007, THERIOGENOLOGY, V67, P1379, DOI 10.1016/j.theriogenology.2007.02.009; Bazer FW, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-23; Hansen PJ, 2002, J ANIM SCI S2, V80, pE33; Leidenfrost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022121	45	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					423	429				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400009		
J	Punyawai, K; Anakkul, N; Srirattana, K; Aikawa, Y; Sangsritavong, S; Nagai, T; Imai, K; Parnpai, R				Punyawai, Kanchana; Anakkul, Nitira; Srirattana, Kanokwan; Aikawa, Yoshio; Sangsritavong, Siwat; Nagai, Takashi; Imai, Kei; Parnpai, Rangsun			Comparison of Cryotop and micro volume air cooling methods for cryopreservation of bovine matured oocytes and blastocysts	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Blastocysts; Cryodevice; Cryotop; Micro volume air cooling; Oocytes	PREGNANCIES FOLLOWING TRANSFER; BUBALUS-BUBALIS EMBRYOS; IN-VITRO FERTILIZATION; CELL NUCLEAR TRANSFER; HIGH SURVIVAL RATE; LIQUID-NITROGEN; PORCINE EMBRYOS; VITRIFICATION METHODS; MEIOTIC SPINDLES; VAPOR-PHASE	This study was designed to compare the efficiency of the Cryotop method and that of two methods that employ a micro volume air cooling (MVAC) device by analyzing the survival and development of bovine oocytes and blastocysts vitrified using each method. In experiment I, in vitro-matured (IVM) oocytes were vitrified using an MVAC device without direct contact with liquid nitrogen (LN2; MVAC group) or directly plunged into LN2 (MVAC in LN2 group). A third group of IVM oocytes was vitrified using a Cryotop device (Cryotop group). After warming, vitrified oocytes were fertilized in vitro. There were no significant differences in cleavage and blastocyst formation rates among the three vitrified groups, with the rates ranging from 53.1% to 56.6% and 20.0% to 25.5%, respectively; however, the rates were significantly lower (P < 0.05) than those of the fresh control group (89.3% and 43.3%, respectively) and the solution control group (87.3% and 42.0%, respectively). In experiment II, in vitro-produced (IVP) expanded blastocysts were vitrified using the MVAC, MVAC in LN2 and Cryotop methods, warmed and cultured for survival analysis and then compared with the solution control group. The rate of development of vitrified-warmed expanded blastocysts to the hatched blastocyst stage after 24 h of culture was lower in the MVAC in LN2 group than in the solution control group; however, after 48-72 h of culture, the rates did not significantly differ between the groups. These results indicate that the MVAC method without direct LN2 contact is as effective as the standard Cryotop method for vitrification of bovine IVM oocytes and IVP expanded blastocysts.	[Punyawai, Kanchana; Srirattana, Kanokwan; Parnpai, Rangsun] Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima 30000, Thailand; [Punyawai, Kanchana; Srirattana, Kanokwan; Parnpai, Rangsun] Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima 30000, Thailand; [Punyawai, Kanchana; Anakkul, Nitira; Aikawa, Yoshio; Imai, Kei] Natl Livestock Breeding Ctr, Fukushima 9618571, Japan; [Anakkul, Nitira] Chulalongkorn Univ, Fac Vet Sci, Dept Obstet Gynecol & Reprod, Bangkok 10330, Thailand; [Sangsritavong, Siwat] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei 10648, Taiwan; [Nagai, Takashi] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151742, South Korea; [Nagai, Takashi] Natl Agr & Food Res Org NARO, NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Ibaraki 3050901, Japan; [Imai, Kei] Rakuno Gakuen Univ, Dept Sustainable Agr, Sapporo, Hokkaido 0698501, Japan	Imai, K (reprint author), Natl Livestock Breeding Ctr, Fukushima 9618571, Japan.	imai@rakuno.ac.jp; rangsun@g.sut.ac.th			NRCT-JSPS; Suranaree University of Technology (SUT); Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand; Thailand Graduate Institute of Science and Technology's scholarship program [TGIS-CPMO-22-19-54-008D]	The authors would like to thank all members of the Embryo Transfer Team of the National Livestock Breeding Center, Fukushima, Japan, for technical support and Dr C Laowtammathron for his helpful suggestions regarding the manuscript. This work was supported by the NRCT-JSPS 2010 Joint Research Program, Suranaree University of Technology (SUT) and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand. K Punyawai was supported by a scholarship from Thailand Graduate Institute of Science and Technology's scholarship program (TGIS-CPMO-22-19-54-008D), awarded through the National Science and Technology Development Agency, Thailand. K Srirattana was supported by SUT postgraduate research fellowships.	AbdelHafez F, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-29; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Isachenko V, 2001, CRYO-LETT, V22, P157; Bielanski A, 2005, CRYOBIOLOGY, V50, P206, DOI 10.1016/j.cryobiol.2004.12.004; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Morato R, 2014, CRYOBIOLOGY, V68, P288, DOI [10.1016/j.cryobiol.2014.02.010, 10.1016/j.cryobio1.2014.02.010]; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1<53::AID-MRD6>3.0.CO;2-V; Min SH, 2013, CRYOBIOLOGY, V66, P195, DOI 10.1016/j.cryobiol.2013.01.004; Chen SU, 2003, MOL CELL ENDOCRINOL, V202, P101, DOI 10.1016/S0303-7207(03)00070-4; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Grout BWW, 2009, THERIOGENOLOGY, V71, P1079, DOI 10.1016/j.theriogenology.2008.12.011; Vajta G, 1997, ACTA VET SCAND, V38, P349; Liebermann J, 2002, REPRODUCTION, V124, P483; Morris GJ, 2005, CRYOBIOLOGY, V50, P231, DOI 10.1016/j.crybiol.2005.01.005; Pessoa GA, 2014, REV BRAS ZOOTECN, V43, P244, DOI 10.1590/S1516-35982014000500004; MASSIP A, 1986, CRYO-LETT, V7, P270; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3<342::AID-MRD13>3.0.CO;2-X; Dhali A, 2000, THERIOGENOLOGY, V53, P1295, DOI 10.1016/S0093-691X(00)00273-9; Chian RC, 2004, J REPROD DEVELOP, V50, P685, DOI 10.1262/jrd.50.685; HOCHI S, 1994, THERIOGENOLOGY, V42, P483, DOI 10.1016/0093-691X(94)90686-D; Chen SU, 2000, HUM REPROD, V15, P2598, DOI 10.1093/humrep/15.12.2598; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Esaki R, 2004, BIOL REPROD, V71, P432, DOI 10.1095/biolreprod.103.026542; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Misumi K, 2013, J REPROD DEVELOP, V59, P520; Katayama KP, 2003, FERTIL STERIL, V80, P223, DOI 10.1016/S0015-0282(03)00551-X; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Bielanski A, 2012, THERIOGENOLOGY, V77, P467, DOI 10.1016/j.theriogenology.2011.07.043; Ushijima H, 2004, J REPROD DEVELOP, V50, P481, DOI 10.1262/jrd.50.481; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Hufana-Duran D, 2004, THERIOGENOLOGY, V61, P1429, DOI 10.1016/j.theriogenology.2003.08.011; Rho GJ, 2002, MOL REPROD DEV, V63, P464, DOI 10.1002/mrd.10196; Lane M, 1999, FERTIL STERIL, V72, P1073, DOI 10.1016/S0015-0282(99)00418-5; Hamawaki A, 1999, THERIOGENOLOGY, V51, P165, DOI 10.1016/S0093-691X(99)91724-7; ARAV A, 1993, J REPROD FERTIL, V99, P353; Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8; De Rosa A, 2007, ITAL J ANIM SCI, V6, P747; Gasparrini B, 2007, ANIM REPROD SCI, V98, P335, DOI 10.1016/j.anireprosci.2006.04.046; Laowtammathron C, 2005, THERIOGENOLOGY, V64, P1185, DOI 10.1016/j.theriogenology.2005.02.001; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; Imai K, 2006, J REPROD DEVELOP, V52, P19; Kuwayama M, 2000, J ASSIST REPROD GEN, V17, P477, DOI DOI 10.1023/A:1017399518757; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Rall WF, 1985, NATURE, V313, P573; Thouas G. A., 2001, REPROD BIOMED ONLINE, V3, P25, DOI [10.1016/S1472-6483(10)61960-8, DOI 10.1016/S1472-6483(10)61960-8]; Vanderzwalmen P, 2000, FERTIL STERIL, V74, pS215, DOI DOI 10.1016/S0015-0282(00)01358-3	48	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					431	437				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400010		
J	Sano, M; Hashiba, K; Nio-Kobayashi, J; Okuda, K				Sano, Masahiro; Hashiba, Kazuhisa; Nio-Kobayashi, Junko; Okuda, Kiyoshi			The luteotrophic function of galectin-1 by binding to the glycans on vascular endothelial growth factor receptor-2 in bovine luteal cells	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Corpus luteum; Galectin-1; Lectin; Ovary; vascular endothelial growth factor receptor (VEGFR)	CORPUS-LUTEUM; PROGESTERONE PRODUCTION; LUTEINIZING-HORMONE; GLYCOSYLATION SITES; CANCER PROGRESSION; MAMMARY-CARCINOMA; IMMUNE-RESPONSE; ESTROUS-CYCLE; N-GLYCANS; IN-VITRO	The corpus luteum (CL) is a temporary endocrine gland producing a large amount of progesterone, which is essential for the establishment and maintenance of pregnancy. Galectin-1 is a beta-galactose-binding protein that can modify functions of membrane glycoproteins and is expressed in the CL of mice and women. However, the physiological role of galectin-1 in the CL is unclear. In the present study, we investigated the expression and localization of galectin-1 in the bovine CL and the effect of galectin-1 on cultured luteal steroidogenic cells (LSCs) with special reference to its binding to the glycans on vascular endothelial growth factor receptor-2 (VEGFR-2). Galectin-1 protein was highly expressed at the mid and late luteal stages in the membrane fraction of bovine CL tissue and was localized to the surface of LSCs in a carbohydrate-dependent manner. Galectin-1 increased the viability in cultured LSCs. However, the viability of LSCs was decreased by addition of beta-lactose, a competitive carbohydrate inhibitor of galectin-1 binding activity. VEGFR-2 protein, like galectin-1, is also highly expressed in the mid CL, and it was modified by multi-antennary glycans, which can be recognized by galectin-1. An overlay assay using biotinylated galectin-1 revealed that galectin-1 directly binds to asparagine-linked glycans (N-glycans) on VEGFR-2. Enhancement of LSC viability by galectin-1 was suppressed by a selective inhibitor of VEGFR-2. The overall findings suggest that galectin-1 plays a role as a survival factor in the bovine CL, possibly by binding to N-glycans on VEGFR-2.	[Sano, Masahiro; Hashiba, Kazuhisa; Okuda, Kiyoshi] Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan; [Nio-Kobayashi, Junko] Hokkaido Univ, Grad Sch Med, Dept Anat, Lab Histol & Cytol, Sapporo, Hokkaido 0600808, Japan	Okuda, K (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan.	kokuda@cc.okayama-u.ac.jp			Research Program on Innovative Technology for Animal Breeding, Reproduction and Vaccine Development of the Ministry of Agriculture, Forestry and Fisheries of Japan [REP-1002]	This study was supported by a grant from the Research Program on Innovative Technology for Animal Breeding, Reproduction and Vaccine Development (REP-1002) of the Ministry of Agriculture, Forestry and Fisheries of Japan.	KITANAKA J, 1994, NEUROCHEM RES, V19, P1545, DOI 10.1007/BF00969004; Fischer I, 2009, PLACENTA, V30, P1078, DOI 10.1016/j.placenta.2009.10.003; Okuda K, 2004, BIOL REPROD, V71, P2065, DOI 10.1095/biolreprod.104.028076; Kobayashi S, 2001, J ENDOCRINOL, V170, P369, DOI 10.1677/joe.0.1700369; Skarzynski DJ, 2008, REPROD DOMEST ANIM, V43, P57, DOI 10.1111/j.1439-0531.2008.01143.x; ZHANG R, 1995, J BIOL CHEM, V270, P21722; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Berisha B, 2000, BIOL REPROD, V63, P1106, DOI 10.1095/biolreprod63.4.1106; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; Wulff C, 2000, J CLIN ENDOCR METAB, V85, P4302, DOI 10.1210/jc.85.11.4302; Kawaguchi S, 2013, J REPROD DEVELOP, V59, P225, DOI 10.1262/jrd.2012-187; Imai N, 2006, BRIT J HAEMATOL, V135, P673, DOI 10.1111/j.1365-2141.2006.06372.x; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Chouhan VS, 2014, ANIM REPROD SCI, V148, P251, DOI 10.1016/j.anireprosci.2014.06.009; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Meidan R, 1999, J Reprod Fertil Suppl, V54, P217; Chouhan VS, 2013, REPROD DOMEST ANIM, V48, P810, DOI 10.1111/rda.12168; Kim HJ, 2013, HUM PATHOL, V44, P62, DOI 10.1016/j.humpath.2012.04.010; Anginot A, 2013, J IMMUNOL, V190, P5526, DOI 10.4049/jimmunol.1201885; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Kawaguchi S, 2013, MOL REPROD DEV, V80, P204, DOI 10.1002/mrd.22150; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Kumagai A, 2014, MOL REPROD DEV, V81, P646, DOI 10.1002/mrd.22332; McCracken JA, 1999, PHYSIOL REV, V79, P263; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Stanley P, 2014, CELL, V156, P625, DOI 10.1016/j.cell.2014.01.059; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; HIRAIZUMI S, 1992, JPN J CANCER RES, V83, P1063; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Miyamoto Y, 2000, BIOL REPROD, V62, P1109, DOI 10.1095/biolreprod62.5.1109; [Anonymous], 2006, GLYCOBIOLOGY, DOI DOI 10.1093/GLYC0B/CWL025; Nio-Kobayashi J, 2010, J HISTOCHEM CYTOCHEM, V58, P741, DOI 10.1369/jhc.2010.956227; Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; ALLEN HJ, 1993, TUMOR BIOL, V14, P360; BUDNIK LT, 1991, J BIOL CHEM, V266, P13908; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p; Niswender GD, 2000, PHYSIOL REV, V80, P1; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Nio J, 2007, J HISTOCHEM CYTOCHEM, V55, P423, DOI 10.1369/jhc.6A7053.2007; Taniguchi N, 2001, PROTEOMICS, V1, P239; Abroun S, 2008, BRIT J HAEMATOL, V142, P754, DOI 10.1111/j.1365-2141.2008.07252.x; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Wada Y, 2013, ENDOCRINOLOGY, V154, P900, DOI 10.1210/en.2012-1967; KNICKERBOCKER JJ, 1988, DOMEST ANIM ENDOCRIN, V5, P91, DOI 10.1016/0739-7240(88)90011-2; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Shimizu T, 2006, REPRODUCTION, V131, P555, DOI 10.1530/rep.1.00937; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; OKUDA K, 1992, BIOL REPROD, V46, P1001, DOI 10.1095/biolreprod46.6.1001; Stillman BN, 2006, J IMMUNOL, V176, P778; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; D'Haene N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067029; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Galvao A, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097147; Hakomori S, 1996, CANCER RES, V56, P5309; Hashiba K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119057; Nio-Kobayashi J, 2014, J CLIN ENDOCR METAB, V99, P4616, DOI 10.1210/jc.2014-2716; Okuda Kiyoshi, 1998, Journal of Reproduction and Development, V44, P79, DOI 10.1262/jrd.44.79; Vaitaitis GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038708; Yoshioka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084186	69	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					439	448				10	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400011		
J	Miyagawa, S; Matsunari, H; Watanabe, M; Nakano, K; Umeyama, K; Sakai, R; Takayanagi, S; Takeishi, T; Fukuda, T; Yashima, S; Maeda, A; Eguchii, H; Okuyama, H; Nagaya, M; Nagashima, H				Miyagawa, Shuji; Matsunari, Hitomi; Watanabe, Masahito; Nakano, Kazuaki; Umeyama, Kazuhiro; Sakai, Rieko; Takayanagi, Shuko; Takeishi, Toki; Fukuda, Tooru; Yashima, Sayaka; Maeda, Akira; Eguchii, Hiroshi; Okuyama, Hiroomi; Nagaya, Masaki; Nagashima, Hiroshi			Generation of alpha 1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH); Double knockout pig; H-D antigen; Transcription activator-like effector nucleases (TALENs); Zinc-finger nucleases (ZFNs)	ZINC-FINGER NUCLEASES; GLYCOLYLNEURAMINIC ACID; CLONED PIGS; HUMAN XENOTRANSPLANTATION; HOMOLOGOUS RECOMBINATION; EMBRYO MICROINJECTION; BIALLELIC KNOCKOUT; DEFICIENT PIGS; CELLS; GENOME	Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are new tools for producing gene knockout (KO) animals. The current study reports produced genetically modified pigs, in which two endogenous genes were knocked out. Porcine fibroblast cell lines were derived from homozygous alpha 1,3-galactosyltransferase (GalT) KO pigs. These cells were subjected to an additional KO for the cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH) gene. A pair of ZFN-encoding mRNAs targeting exon 8 of the CMAH gene was used to generate the heterozygous CMAH KO cells, from which cloned pigs were produced by somatic cell nuclear transfer (SCNT). One of the cloned pigs obtained was re-cloned after additional KO of the remaining CMAH allele using the same ZFN-encoding mRNAs to generate GalT/CMAH-double homozygous KO pigs. On the other hand, the use of TALEN-encoding mRNAs targeting exon 7 of the CMAH gene resulted in efficient generation of homozygous CMAHKO cells. These cells were used for SCNT to produce cloned pigs homozygous for a double Gall! CMAH KO. These results demonstrate that the combination of TALEN-encoding mRNA, in vitro selection of the nuclear donor cells and SCNT provides a robust method for generating KO pigs.	[Miyagawa, Shuji; Maeda, Akira; Eguchii, Hiroshi; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, Suita, Osaka 5650871, Japan; [Miyagawa, Shuji; Matsunari, Hitomi; Watanabe, Masahito; Umeyama, Kazuhiro; Nagaya, Masaki; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res, Kawasaki, Kanagawa 2148571, Japan; [Matsunari, Hitomi; Watanabe, Masahito; Nakano, Kazuaki; Umeyama, Kazuhiro; Sakai, Rieko; Takayanagi, Shuko; Takeishi, Toki; Fukuda, Tooru; Yashima, Sayaka; Nagashima, Hiroshi] Meiji Univ, Sch Agr, Dept Life Sci, Lab Dev Engn, Kawasaki, Kanagawa 2148571, Japan	Miyagawa, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, Suita, Osaka 5650871, Japan.	miyagawa@orgtrp.med.osaka-u.ac.jp; hnagas@meiji.ac.jp			Health and Labor Sciences Research Grants, Japan; Meiji University International Institute for Bio-Resource Research (MUIIBR); JSPS [26870630]; JST/ERATO Nakauchi Stem Cell and Organ Regeneration Project	We thank Dr Milton S Feather for his editing of the manuscript and H Kadoi for his help with maintenance of the pigs. This work was supported by Health and Labor Sciences Research Grants, Japan, the Meiji University International Institute for Bio-Resource Research (MUIIBR), JSPS Grant-in-Aid for Young Scientists (B) Grant Number 26870630 and the JST/ERATO Nakauchi Stem Cell and Organ Regeneration Project.	Watanabe M, 2015, J REPROD DEVELOP, V61, P169, DOI 10.1262/jrd.2014-153; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/nmeth.1456, 10.1038/NMETH.1456]; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Miwa Y, 2004, XENOTRANSPLANTATION, V11, P247, DOI 10.1111/j.1399-3089.2004.00126.x; Fujimura T, 2008, MOL REPROD DEV, V75, P1372, DOI 10.1002/mrd.20890; Song KH, 2010, BIOCHEM J, V427, P179, DOI 10.1042/BJ20090835; Galili U, 2013, XENOTRANSPLANTATION, V20, P267, DOI 10.1111/xen.12051; Kurome M, 2008, J REPROD DEVELOP, V54, P254, DOI 10.1262/jrd.20038; Basnet NB, 2010, XENOTRANSPLANTATION, V17, P440, DOI 10.1111/j.1399-3089.2010.00610.x; Li P, 2013, J SURG RES, V181, pE39, DOI 10.1016/j.jss.2012.06.035; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Yamamoto A, 2013, SURG TODAY, V43, P782, DOI 10.1007/s00595-012-0274-x; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Ikeda K, 2012, TRANSPL P, V44, P1136, DOI 10.1016/j.transproceed.2012.01.092; Miyagawa S, 2012, CURR OPIN ORGAN TRAN, V17, P174, DOI 10.1097/MOT.0b013e3283508189; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Lutz AJ, 2013, XENOTRANSPLANTATION, V20, P27, DOI 10.1111/xen.12019; Zhu A, 2002, XENOTRANSPLANTATION, V9, P376, DOI 10.1034/j.1399-3089.2002.02138.x; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Nottle MB, 2007, XENOTRANSPLANTATION, V14, P339, DOI 10.1111/j.1399-3089.2007.0041.x; Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Magnusson S, 2003, XENOTRANSPLANTATION, V10, P432, DOI 10.1034/j.1399-3089.2003.02052.x; Matsunari H, 2009, J REPROD DEVELOP, V55, P225, DOI 10.1262/jrd.20164; Cooper DKC, 2014, XENOTRANSPLANTATION, V21, P397, DOI 10.1111/xen.12127; Fujimura T, 2008, J REPROD DEVELOP, V54, P58, DOI 10.1262/jrd.19110; Kurome M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-43; Kurome M, 2015, METHODS MOL BIOL, V1222, P37, DOI 10.1007/978-1-4939-1594-1_4; Li P, 2015, XENOTRANSPLANTATION, V22, P20, DOI 10.1111/xen.12131; Lunney JK, 2007, INT J BIOL SCI, V3, P179; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Matsunari H, 2012, XENOTRANSPLANTATION, P37; Nakano K, 2013, 12 C INT XEN ASS OS; Prather RS, 2013, ANNU REV ANIM BIOSCI, P203; Watanabe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076478; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250	54	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					449	457				9	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400012		
J	Tanaka, T; Kanatsu-Shinohara, M; Hirose, M; Ogura, A; Shinohara, T				Tanaka, Takashi; Kanatsu-Shinohara, Mito; Hirose, Michiko; Ogura, Atsuo; Shinohara, Takashi			Pluripotent cell derivation from male germline cells by suppression of Dmrt1 and Trp53	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Dmrt1; Pluripotency; Primordial germ cells; Spermatogonia; Trp53	SPERMATOGONIAL STEM-CELLS; LONG-TERM PROLIFERATION; SELF-RENEWAL; MOUSE TESTIS; TESTICULAR TERATOMAS; MICE; CULTURE; TUMORS; SPERMATOGENESIS; DIFFERENTIATION	Diploid germ cells are thought to have pluripotency potential. We recently described a method to derive pluripotent stem cells (PSCs) from cultured spermatogonial stem cells (SSCs) by depleting Trp53 and Dmrt1, both of which are known suppressors of teratomas. In this study, we used this technique to analyze the effect of this protocol in deriving PSCs from the male germline at different developmental stages. We collected primordial germ cells (PGCs), gonocytes and spermatogonia, and the cells were transduced with lentiviruses expressing short hairpin RNA against Dmrt1 and/or Trp53. We found that PGCs are highly susceptible to reprogramming induction and that only Trp53 depletion was sufficient to induce pluripotency. In contrast, gonocytes and spermatogonia were resistant to reprogramming by double knockdown of Dmrt1 and Trp53. PSCs derived from PGCs contributed to chimeras produced by blastocyst injection, but some of the embryos showed placentaonly phenotypes suggestive of epigenetic abnormalities of PGC-derived PSCs. These results show that PGCs and gonocytes/spermatogonia have distinct reprogramming potential and also suggest that fresh and cultured SSCs do not necessarily have the same properties.	[Tanaka, Takashi; Kanatsu-Shinohara, Mito; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Kanatsu-Shinohara, Mito] Japan Sci & Technol Agcy, PRESTO, Kyoto 6068501, Japan; [Hirose, Michiko; Ogura, Atsuo] Inst Phys & Chem Res RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	Shinohara, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	tshinoha@virus.kyoto-u.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988	Uehara Foundation for Medical and Pharmaceutical Research; Japan Science and Technology Agency (PRESTO); Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This research was supported by the Uehara Foundation for Medical and Pharmaceutical Research, Japan Science and Technology Agency (PRESTO), Takeda Science Foundation and Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We thank Ms Y Ogata for technical assistance.	Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Takashima S, 2013, GENE DEV, V27, P1949, DOI 10.1101/gad.220194.113; Huang Y, 2011, CELL BIOL INT, V35, P905, DOI 10.1042/CBI20110161; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; De Rooij DG, 2000, J ANDROL, V21, P776; Kawase Y, 2001, CONTEMP TOP LAB ANIM, V40, P31; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Nagamatsu G, 2013, STEM CELLS, V31, P479, DOI 10.1002/stem.1303; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Sabour D, 2012, CURR OPIN CELL BIOL, V24, P716, DOI 10.1016/j.ceb.2012.08.006; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; STEWART CL, 1994, DEV BIOL, V161, P626; HARVEY M, 1993, FASEB J, V7, P938; Spiller CM, 2013, INT J DEV BIOL, V57, P211, DOI 10.1387/ijdb.130028pk; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Lee JY, 2009, BIOL REPROD, V80, P518, DOI 10.1095/biolreprod.108.072330; Zhu R, 2007, ANN NY ACAD SCI, V1120, P181, DOI 10.1196/annals.1411.006; Hirasawa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076422; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Heaney JD, 2012, DEVELOPMENT, V139, P1577, DOI 10.1242/dev.076851; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biloreprod.103.017012; Page D, 1998, APMIS, V106, P196; Looijenga LHJ, 1998, APMIS, V106, P187; Matsui Y, 2014, DEVELOPMENT, V141, P4457, DOI 10.1242/dev.113779; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Morimoto H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095307; Illmensee K, 1979, Sci Am, V240, P120; Takashima S, 2015, STEM CELL REP, V4, P489, DOI 10.1016/j.stemcr.2015.01.010	48	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					473	484				12	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400015		
J	Irshad, AR; Sasaki, T; Kubo, T; Odashima, N; Katano, K; Osawa, T; Takahashi, T; Izaike, Y				Irshad, Abdul Razaq; Sasaki, Taihei; Kubo, Tomoaki; Odashima, Naoyuki; Katano, Keiji; Osawa, Takeshi; Takahashi, Toru; Izaike, Yoshiaki			Development of a programmable piggyback syringe pump and four-times-a-day injection regimen for superovulation in non-lactating Holstein cows	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Cows; Follicles; Piggyback syringe pump; Porcine follicle-stimulating hormone (pFSH); Superovulation	FOLLICULAR-GROWTH; CATTLE; LH	The objectives of the present study were to develop a programmable piggyback syringe pump for bovine superovulation and to evaluate the effects of a four-times-a-day injection regimen using the pump. Non-lactating Holstein cows were treated with a total of 30 armour units of porcine FSH by injection four times a day with the pump (study, n = 9) or injection twice a day manually (control, n = 9) for four consecutive days from D10 of the estrous cycle. The pump-driven program successfully induced superovulation in all cows tested. The numbers of small (3- < 5 mm in diameter) and large (>= 10 mm in diameter) follicles were greater in the study group on D11-13 and D14, respectively. There were fewer unovulated follicles detected on D21 (7 days after estrus) in the study group than in the control group (1.2 +/- 0.4 and 3.2 +/- 0.6, respectively).	[Irshad, Abdul Razaq; Kubo, Tomoaki; Takahashi, Toru; Izaike, Yoshiaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Irshad, Abdul Razaq; Sasaki, Taihei; Kubo, Tomoaki; Takahashi, Toru; Izaike, Yoshiaki] Iwate Univ, Fac Agr, Cooperat Dept Vet Med, Morioka, Iwate 0208550, Japan; [Odashima, Naoyuki; Katano, Keiji] Icomes Lab, Morioka, Iwate 0200857, Japan; [Osawa, Takeshi] Miyazaki Univ, Fac Agr, Dept Vet Med, Miyazaki 8892192, Japan	Izaike, Y (reprint author), Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan.	izaike@iwate-u.ac.jp			Iwate Industry Promotion Center	The authors thank all of the members of the Laboratory of Theriogenology, Iwate University, for their assistance during experimental procedures and handling of cows. A part of this research was supported by the Iwate Industry Promotion Center.	Monteiro FM, 2009, ANIM REPROD SCI, V110, P128, DOI 10.1016/j.anireprosci.2008.01.003; JENSEN AM, 1982, THERIOGENOLOGY, V18, P33, DOI 10.1016/0093-691X(82)90046-2; LASTER DB, 1972, J REPROD FERTIL, V30, P407; ADAMS GP, 1994, THERIOGENOLOGY, V42, P1103, DOI 10.1016/0093-691X(94)90858-3; HERRLER A, 1991, THERIOGENOLOGY, V35, P633, DOI 10.1016/0093-691X(91)90459-Q; Sato T, 2005, J REPROD DEVELOP, V51, P573, DOI 10.1262/jrd.16070; Treloar AF, 1997, LAB ANIM SCI, V47, P313; Kelly P, 1997, ANIM REPROD SCI, V46, P1, DOI 10.1016/S0378-4320(96)01589-8; MONNIAUX D, 1983, THERIOGENOLOGY, V19, P55, DOI 10.1016/0093-691X(83)90124-3; MOOR RM, 1984, THERIOGENOLOGY, V21, P103, DOI 10.1016/0093-691X(84)90310-8; Sugano M, 1997, J VET MED SCI, V59, P223, DOI 10.1292/jvms.59.223; DEMOUSTIER MM, 1988, THERIOGENOLOGY, V30, P379, DOI 10.1016/0093-691X(88)90185-9; NAKAMURA Y, 1993, FERTIL STERIL, V60, P254; Mapletoft RJ, 2002, REPROD NUTR DEV, V42, P601, DOI 10.1051/rnd:2002046; Takahashi Toru, 2001, Journal of Reproduction and Development, V47, P119, DOI 10.1262/jrd.47.119	15	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					485	488				4	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400016		
J	Sugimoto, H; Kakehi, M; Satomi, Y; Kamiguchi, H; Jinno, F				Sugimoto, Hiroshi; Kakehi, Masaaki; Satomi, Yoshinori; Kamiguchi, Hidenori; Jinno, Fumihiro			Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode	JOURNAL OF SEPARATION SCIENCE			English	Article						Atmospheric pressure chemical ionization; Chromatographic separation; 24S-Hydroxycholesterol; Saponification; Surrogate matrices	CHOLESTEROL OXIDATION-PRODUCTS; BIOLOGICAL SAMPLES; BRAIN; 24(S)-HYDROXYCHOLESTEROL; QUANTIFICATION; 24-HYDROXYLASE; QUANTITATION; HOMEOSTASIS; VALIDATION; TURNOVER	We developed a highly sensitive and specific high-performance liquid chromatography with tandem mass spectrometry method with an atmospheric pressure chemical ionization interface to determine 24S-hydroxycholesterol, a major metabolite of cholesterol formed by cytochrome P450 family 46A1, in human plasma without any derivatization step. Phosphate buffered saline including 1% Tween 80 was used as the surrogate matrix for preparation of calibration curves and quality control samples. The saponification process to convert esterified 24S-hydroxycholesterol to free sterols was optimized, followed by liquid-liquid extraction using hexane. Chromatographic separation of 24S-hydroxycholesterol from other isobaric endogenous oxysterols was successfully achieved with gradient mobile phase comprised of 0.1% propionic acid and acetonitrile using L-column2 ODS (2 mu m, 2.1 mm id x 150 mm). This assay was capable of determining 24S-hydroxycholesterol in human plasma (200 mu L) ranging from 1 to 100 ng/mL with acceptable intra-and inter-day precision and accuracy. The potential risk of in vitro formation of 24S-hydroxycholesterol by oxidation from endogenous cholesterol in human plasma was found to be negligible. The stability of 24S-hydroxycholesterol in relevant solvents and human plasma was confirmed. This method was successfully applied to quantify the plasma concentrations of 24S-hydroxycholesterol in male and female volunteers.	[Sugimoto, Hiroshi; Kakehi, Masaaki; Jinno, Fumihiro] Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Satomi, Yoshinori; Kamiguchi, Hidenori] Takeda Pharmaceut Co Ltd, Integrated Technol Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Sugimoto, H (reprint author), Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	hiroshi.sugimoto1@takeda.com					Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Mendiara I, 2012, J SEP SCI, V35, P3308, DOI 10.1002/jssc.201200519; Honda A, 2009, J LIPID RES, V50, P350, DOI 10.1194/jlr.D800040-JLR200; DeBarber AE, 2008, ANAL BIOCHEM, V381, P151, DOI 10.1016/j.ab.2008.05.037; Sidhu R, 2015, J LIPID RES, V56, P1222, DOI 10.1194/jlr.D058487; Diczfalusy U, 2004, J AOAC INT, V87, P467; van de Merbel NC, 2008, TRAC-TREND ANAL CHEM, V27, P924, DOI 10.1016/j.trac.2008.09.002; Leoni V, 2013, BIOCHIMIE, V95, P595, DOI 10.1016/j.biochi.2012.09.025; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Jones BR, 2012, BIOANALYSIS, V4, P2343, DOI [10.4155/bio.12.200, 10.4155/BIO.12.200]; Sugimoto H, 2015, ANAL BIOANAL CHEM, V407, P7889, DOI 10.1007/s00216-015-8999-1; Bretillon L, 2000, J LIPID RES, V41, P840; Razzazi-Fazeli E, 2000, J CHROMATOGR A, V896, P321, DOI 10.1016/S0021-9673(00)00719-6; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Houghton R, 2009, BIOANALYSIS, V1, P1365, DOI [10.4155/bio.09.139, 10.4155/BIO.09.139]; CSALLANY AS, 1989, LIPIDS, V24, P645, DOI 10.1007/BF02535082; Xu YD, 2013, J PHARMACEUT BIOMED, V85, P145, DOI 10.1016/j.jpba.2013.07.016; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Sugimoto H, 2015, ANAL BIOCHEM, V487, P38, DOI 10.1016/j.ab.2015.07.004; Burkard I, 2004, J LIPID RES, V45, P776, DOI 10.1194/jlr.D300036-JLR200; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Papassotiropoulos A, 2000, NEUROREPORT, V11, P1959, DOI 10.1097/00001756-200006260-00030; Wang YL, 2015, J SEP SCI, V38, P796, DOI 10.1002/jssc.201400850	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	OCT	2015	38	20					3516	3524		10.1002/jssc.201500719		9	Chemistry, Analytical	Chemistry	CU3HF	WOS:000363414300005		
J	Boucard, H; Watanabe, M; Takami, S; Weiss-Hortala, E; Barna, R; Adschiri, T				Boucard, Helene; Watanabe, Masaru; Takami, Seiichi; Weiss-Hortala, Elsa; Barna, Radu; Adschiri, Tadafumi			Beneficial use of CeO2 nanocatalyst for black liquor conversion under sub and supercritical conditions	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Hydrothermal conversion; Black liquor; CeO2 nanocatalyst; Hydrogen	WATER GASIFICATION; PYROLYSIS; LIGNIN	Black liquor is an alkaline liquid residue from paper industry, containing similar to 80 wt% of water and similar to 20 wt% of organics and minerals. Hydrothermal conversion of black liquor in a batch reactor is particularly interesting towards hydrogen production, as the carbon dioxide is highly solubilized in the basic aqueous media. Thus hydrogen with higher purity than other processes is obtained. Cerium oxide nanocatalyst (cubic CeO2) is used to improve the amount of hydrogen produced and to decrease the coke formation, based on the water splitting into active species. Experiments have been carried out at sub and supercritical conditions 350 degrees C or 450 degrees C, 25 MPa) in a batch reactor for 15 min or 60 min. CeO2 nanocatalyst improved the conversion of black liquor at sub and supercritical conditions as expected. The amount of carbonaceous solid recovered was decreased due to the catalytic effect. Recovered hydrogen was not significantly affected by the catalyst as it was involved in secondary reactions such as hydrogenation. Oxidations reactions, as well as O-2 production, were also improved using catalyst and supercritical media. Supercritical water media combined with catalyst clearly affects the fragmentation of dissolved lignin compared to subcritical conditions. Then it was assumed that water splitting occurs and produces active hydrogen and oxygen species. Thus these actives species produced using catalyst are able to improve hydrogenation and oxidation reactions, as well as recombination into H-2 and O-2. (C) 2015 Elsevier B.V. All rights reserved.	[Boucard, Helene; Weiss-Hortala, Elsa; Barna, Radu] Univ Toulouse, Mines Albi, CNRS, UMR 5302,Ctr RAPSODEE, F-81013 Albi 09, France; [Watanabe, Masaru] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Takami, Seiichi; Adschiri, Tadafumi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Adschiri, Tadafumi] Tohoku Univ, World Premier Int Res Ctr, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Adschiri, Tadafumi] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan	Boucard, H (reprint author), Univ Toulouse, Mines Albi, CNRS, UMR 5302,Ctr RAPSODEE, Campus Jarlard, F-81013 Albi 09, France.	boucard.h@gmail.com; ajiri@tagen.tohoku.ac.jp					Ronnlund I, 2011, ENERGY, V36, P2151, DOI 10.1016/j.energy.2010.03.027; Demirbas A, 2002, ENERG CONVERS MANAGE, V43, P877, DOI 10.1016/S0196-8904(01)00087-5; Titirici MM, 2006, CHEM MATER, V18, P3808, DOI 10.1021/cm052768u; Dejhosseini M, 2013, ENERG FUEL, V27, P4624, DOI 10.1021/ef400855k; Guo DL, 2012, APPL ENERG, V95, P22, DOI 10.1016/j.apenergy.2012.01.042; Kang SM, 2012, BIORESOURCE TECHNOL, V110, P715, DOI 10.1016/j.biortech.2012.01.093; Byrappa K, 2008, ADV DRUG DELIVER REV, V60, P299, DOI 10.1016/j.addr.2007.09.001; Cao CQ, 2011, INT J HYDROGEN ENERG, V36, P13528, DOI 10.1016/j.ijhydene.2011.07.101; Kruse A, 2007, J SUPERCRIT FLUID, V39, P362, DOI 10.1016/j.supflu.2006.03.016; Saisu M, 2003, ENERG FUEL, V17, P922, DOI 10.1021/ef0202844; Boucard H., 2014, P 14 EUR M SUP FLUID; Leask R.A., 1987, MECH PULPING, V2; Wahyudiono, 2008, CHEM ENG PROCESS, V47, P1609; Titirici M., 2012, THESIS U POTSDAM POT; Wu M., 2012, THESIS U TOULOUSE TO	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	OCT	2015	105				SI		66	76		10.1016/j.supflu.2015.02.008		11	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CU2JV	WOS:000363350700010		
J	Uchida, H; Nishijima, M; Sano, K; Demoto, K; Sakabe, J; Shimoyama, Y				Uchida, Hirohisa; Nishijima, Masamichi; Sano, Kyohei; Demoto, Kohei; Sakabe, Junichi; Shimoyama, Yusuke			Production of theophylline nanoparticles using rapid expansion of supercritical solutions with a solid cosolvent (RESS-SC) technique	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						RESS-SC; Nanoparticle; Supercritical carbon dioxide; Theophylline; Solid cosolvents; Particle collection conditions effects	WATER-SOLUBLE COMPOUNDS; FLUID TECHNOLOGIES; PARTICLE DESIGN; MICRONIZATION PROCESSES; DISSOLUTION RATES; PHARMACEUTICS; FUNDAMENTALS; EQUILIBRIUM; SOLUBILITY; POWDERS	We report on the production of theophylline nanoparticles by rapid expansion of supercritical solutions with a solid cosolvent (RESS-SC) using CO2 with L-menthol or vanillin. The effects of particle collection conditions such as collection temperatures and spray distances on the theophylline nanoparticles produced were investigated in order to elucidate crystal growth mechanism of the present RESS-SC process. A liquid phase appeared at a pre-expansion section in the case of using L-menthol, and this suggests that it is unsuitable for a solid cosolvent in the present conditions. In the case of using vanillin, nano-sized particles of around 85 nm, which are about one-third as large as those produced by the conventional RESS technique, were obtained. Particle collection conditions have negligible effects on the particle sizes. This result suggests that crystal growth of theophylline particles crystallized in a collection vessel are blocked by crystallized vanillin particles those surrounds theophylline particles. (C) 2015 Elsevier B.V. All rights reserved.	[Uchida, Hirohisa; Nishijima, Masamichi; Sano, Kyohei; Demoto, Kohei] Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, Nagano, Nagano 3808553, Japan; [Sakabe, Junichi; Shimoyama, Yusuke] Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, Tokyo 1528550, Japan	Uchida, H (reprint author), Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, 4-17-1 Wakasato, Nagano, Nagano 3808553, Japan.	uchida@shinshu-u.ac.jp					Yesil-Celiktas O, 2010, IND ENG CHEM RES, V49, P7017, DOI 10.1021/ie100115x; Cocero MJ, 2009, J SUPERCRIT FLUID, V47, P546, DOI 10.1016/j.supflu.2008.08.015; Sovova H, 2007, J SUPERCRIT FLUID, V41, P1, DOI 10.1016/j.supflu.2006.08.007; Chaumeil JC, 1998, METHOD FIND EXP CLIN, V20, P211; Szterner P, 2010, J THERM ANAL CALORIM, V99, P325, DOI 10.1007/s10973-009-0186-1; Pourasghar M, 2012, POWDER TECHNOL, V225, P21, DOI 10.1016/j.powtec.2012.03.027; Seton L, 2010, CRYST GROWTH DES, V10, P3879, DOI 10.1021/cg100165t; MATSON DW, 1986, MATER LETT, V4, P429, DOI 10.1016/0167-577X(86)90113-8; Chehroudi B, 2006, COMBUST SCI TECHNOL, V178, P555, DOI 10.1080/00102200500294247; Zhang XX, 2014, RSC ADV, V4, P61137, DOI 10.1039/c4ra10662h; Blagden N, 2007, ADV DRUG DELIVER REV, V59, P617, DOI 10.1016/j.addr.2007.05.011; Thakur R, 2006, J SUPERCRIT FLUID, V37, P307, DOI 10.1016/j.supflu.2005.12.008; Priamo WL, 2013, ACTA SCI-TECHNOL, V35, P695, DOI 10.4025/actascitechnol.v35i4.18819; Jung J, 2001, J SUPERCRIT FLUID, V20, P179, DOI 10.1016/S0896-8446(01)00064-X; Yasuji T, 2008, ADV DRUG DELIVER REV, V60, P388, DOI 10.1016/j.addr.2007.03.025; Chan HK, 2011, ADV DRUG DELIVER REV, V63, P406, DOI 10.1016/j.addr.2011.03.011; Fages J, 2004, POWDER TECHNOL, V141, P219, DOI 10.1016/j.powtec.2004.02.007; Subramaniam B, 1997, J PHARM SCI-US, V86, P885, DOI 10.1021/js9700661; Girotra P, 2013, PHARM DEV TECHNOL, V18, P22, DOI 10.3109/10837450.2012.726998; Thakur R, 2005, IND ENG CHEM RES, V44, P7380, DOI 10.1021/ie050417j; Lin PC, 2011, RES CHEM INTERMEDIAT, V37, P153, DOI 10.1007/s11164-011-0262-6; Hu JH, 2004, DRUG DEV IND PHARM, V30, P233, DOI 10.1081/DDC-120030422; Fukne-Kokot K, 2000, FLUID PHASE EQUILIBR, V173, P297, DOI 10.1016/S0378-3812(00)00437-4; Samei M, 2012, J SUPERCRIT FLUID, V70, P1, DOI 10.1016/j.supflu.2012.05.011; Martin A, 2008, ADV DRUG DELIVER REV, V60, P339, DOI 10.1016/j.addr.2007.06.019; Thakur R, 2006, INT J PHARM, V308, P190, DOI 10.1016/j.ijpharm.2005.11.005; Khamar D, 2012, CRYST GROWTH DES, V12, P109, DOI 10.1021/cg2008478; Knez Z, 2003, CURR OPIN SOLID ST M, V7, P353, DOI 10.1016/j.cossms.2003.11.002; Sheth P, 2012, CURR DRUG DELIV, V9, P269; PETERSEN RC, 1986, J AM CHEM SOC, V108, P2100, DOI 10.1021/ja00268a066; Foster N, 2003, IND ENG CHEM RES, V42, P6476, DOI 10.1021/ie030219x; Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Pasquali I, 2008, INT J PHARMACEUT, V364, P176, DOI 10.1016/j.ijpharm.2008.05.014; Sinha B, 2013, INT J PHARMACEUT, V453, P126, DOI 10.1016/j.ijpharm.2013.01.019; Ashby M.F., 2009, NANOTECHNOLOGIES DES; Galushko A.A., 2006, CHEM IND CHEM ENG Q, V12, P152; Kohler M., 2007, INTRO NANOSTRUCTURIN; Lipinski C. A., 2001, CURR DRUG DISCOV, V4, P17; Lipinski CA, 2002, AM PHARM REV, V5, P82; Matson D, 1986, ADV CERAM MATER, V1, P242; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Merisko-Liversidge E, 2003, EUR J PHARM SCI, V18, P113, DOI 10.1016/S0928-0987(02)00251-8; Nues A.V.M., 2011, MATERIALS, V4, P2017; Parikh D.M., 2010, HDB PHARM GRANULATIO; Pasquali I, 2006, EUR J PHARM SCI, V27, P299, DOI 10.1016/j.ejps.2005.11.007; Radtke M, 2001, NEW DRUGS, V3, P62; Reverchon E, 2006, J SUPERCRIT FLUID, V37, P1, DOI 10.1016/j.supflu.2005.08.003; Sakabe J., 2012, P 10 INT S SUP FLUID, P1505; Sakabe J., 2011, THESIS SHINSHU U JAP; Ttirk M., 2014, PARTICLE FORMATION S; Uchida H., 2011, J SOC POWDER TECHNOL, V48, P641; Williams RO, 2012, AAPS ADV PHARM SCI, V3, P1, DOI 10.1007/978-1-14614-1144-4; York P, 1999, PHARM SCI TECHNOL TO, V2, P430, DOI 10.1016/S1461-5347(99)00209-6	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	OCT	2015	105				SI		128	135		10.1016/j.supflu.2015.05.005		8	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CU2JV	WOS:000363350700017		
J	Momose, T; Kondo, A; Kamiya, T; Yamada, H; Ohara, J; Kitamura, Y; Uchida, H; Shimogaki, Y; Sugiyama, M				Momose, Takeshi; Kondo, Aiko; Kamiya, Tatsuya; Yamada, Hideo; Ohara, Junji; Kitamura, Yasuhiro; Uchida, Hirohisa; Shimogaki, Yukihiro; Sugiyama, Masakazu			Solubility of bis-(2,2,6,6-tetramethyl-3,5-heptanedionato)copper(II) in mixed supercritical CO2 and H-2 systems for application in supercritical fluid deposition of Cu	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Solubility; Supercritical carbon dioxide; Hydrogen; Metal organics; Copper	CARBON-DIOXIDE; THIN-FILMS; REACTIVE DEPOSITION; P-TOLUENESULFONAMIDE; MULTIWAFER REACTOR; REACTION-MECHANISM; PHASE-BEHAVIOR; NICKEL FILMS; METAL-OXIDE; COPPER	We measured the solubility of bis-(2,2,6,6-tetramethyl-3,5-heptanedionato)copper(II) (Cu(tmhd)2) in pure supercritical CO2 (scCO(2)) and binary mixtures of H-2 and scCO(2) at 40-100 degrees C and 11-20 MPa using spectrometric method. The solubility in scCO(2) was dependent on the density of CO2. The addition of H-2 to the scCO(2) had negative impact on the solubility, and the solubility was proportional to density of CO2 with a constant mole fraction of H-2. The equations proposed by Mendez-Santiago and Teja as well as Sauceau et al. were able to correlate the solubility in the pure CO2 and binary systems. This approach provides a framework to determine the precursor concentration for supercritical fluid deposition (SCFD) of Cu. The precursor feed system for optimal Cu-SCFD was discussed. In addition, the same effect was found with the addition of O-2 and N-2 into scCO(2), suggesting that further investigation into the solubility of SCFD precursors in these binary systems is warranted. (C) 2015 Elsevier B.V. All rights reserved.	[Momose, Takeshi; Shimogaki, Yukihiro] Univ Tokyo, Dept Mat Engn, Tokyo, Japan; [Kondo, Aiko] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kamiya, Tatsuya; Yamada, Hideo; Ohara, Junji; Kitamura, Yasuhiro] DENS Corp, Tokyo, Japan; [Uchida, Hirohisa] Shinshu Univ, Fac Engn, Matsumoto, Nagano, Japan; [Sugiyama, Masakazu] Univ Tokyo, Inst Engn Innovat, Tokyo, Japan	Momose, T (reprint author), Univ Tokyo, Dept Mat Engn, Tokyo, Japan.	momo@dpe.mm.t.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038			Alsten J.G.V., 1993, J CHEM ENG DATA, V38, P605; RICE JK, 1995, ANAL CHEM, V67, P4354, DOI 10.1021/ac00119a024; Uchida H, 2012, J SUPERCRIT FLUID, V66, P59, DOI 10.1016/j.supflu.2011.12.023; Morere J, 2013, J CHEM THERMODYN, V58, P55, DOI 10.1016/j.jct.2012.09.029; Li JL, 2010, J SUPERCRIT FLUID, V52, P11, DOI 10.1016/j.supflu.2009.11.011; Teoh WH, 2013, J ORGANOMET CHEM, V724, P102, DOI 10.1016/j.jorganchem.2012.10.005; Cortesi A, 1996, J SUPERCRIT FLUID, V9, P141, DOI 10.1016/S0896-8446(96)90024-8; Gil L, 2010, J PHYS CHEM B, V114, P5447, DOI 10.1021/jp100184r; Blackburn JM, 2001, SCIENCE, V294, P141, DOI 10.1126/science.1064148; Su ZM, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2189245; Matsubara M, 2009, J ELECTROCHEM SOC, V156, pH443, DOI 10.1149/1.3110918; Cabanas A, 2004, CHEM MATER, V16, P2028, DOI 10.1021/cm034739u; Tsai CC, 2008, J CHEM ENG DATA, V53, P2163, DOI 10.1021/je8003673; Garriga R, 2001, J SUPERCRIT FLUID, V20, P55, DOI 10.1016/S0896-8446(01)00055-9; Ruckenstein E, 2001, FLUID PHASE EQUILIBR, V180, P345, DOI 10.1016/S0378-3812(01)00372-7; Momose T, 2005, JPN J APPL PHYS 2, V44, pL1199, DOI 10.1143/JJAP.44.L1199; Skerget M, 2011, J CHEM ENG DATA, V56, P694, DOI 10.1021/je1011373; Aschenbrenner O, 2007, J SUPERCRIT FLUID, V41, P179, DOI 10.1016/j.supflu.2006.10.011; DOBBS JM, 1986, J CHEM ENG DATA, V31, P303, DOI 10.1021/je00045a014; Lee HBR, 2012, J ELECTROCHEM SOC, V159, pD46, DOI 10.1149/2.031202jes; Karanikas CF, 2010, MICROELECTRON ENG, V87, P566, DOI 10.1016/j.mee.2009.08.011; Uejima T, 2013, J ELECTROCHEM SOC, V160, pD3290, DOI 10.1149/2.044312jes; Eckert CA, 1996, NATURE, V383, P313, DOI 10.1038/383313a0; Bush D, 1997, ACS SYM SER, V670, P37; Span R, 1996, J PHYS CHEM REF DATA, V25, P1509; Kordikowski A, 1995, J SUPERCRIT FLUID, V8, P205, DOI 10.1016/0896-8446(95)90033-0; DOBBS JM, 1987, IND ENG CHEM RES, V26, P56, DOI 10.1021/ie00061a011; Yang JX, 2009, ADV MATER, V21, P4115, DOI 10.1002/adma.200803751; Haruki M, 2009, FLUID PHASE EQUILIBR, V280, P49, DOI 10.1016/j.fluid.2009.03.010; O'Neil A, 2006, CHEM MATER, V18, P5652, DOI 10.1021/cm060142d; Kondoh E, 2005, JPN J APPL PHYS 1, V44, P5799, DOI 10.1143/JJAP.44.5799; WALSH JM, 1987, FLUID PHASE EQUILIBR, V33, P295, DOI 10.1016/0378-3812(87)85042-2; Andersen WC, 2001, J CHEM ENG DATA, V46, P1045, DOI 10.1021/je000257c; Tsai CC, 2007, FLUID PHASE EQUILIBR, V260, P287, DOI 10.1016/j.fluid.2007.07.070; Hunde ET, 2004, CHEM MATER, V16, P498, DOI 10.1021/cm034433n; LEMERT RM, 1991, IND ENG CHEM RES, V30, P1222, DOI 10.1021/ie00054a024; Momose T, 2008, JPN J APPL PHYS, V47, P885, DOI 10.1143/JJAP.47.885; Zhao B, 2008, MICROELECTRON ENG, V85, P675, DOI 10.1016/j.mee.2007.12.034; Lee JH, 2009, ELECTROCHEM SOLID ST, V12, pD45, DOI 10.1149/1.3092891; Kondoh E, 2002, MICROELECTRON ENG, V64, P495, DOI 10.1016/S0167-9317(02)00826-2; Li JL, 2009, J CHEM ENG DATA, V54, P1142, DOI 10.1021/je8008842; Zong YF, 2005, CHEM MATER, V17, P560, DOI 10.1021/cm048665d; Gougousi T, 2008, THIN SOLID FILMS, V516, P6197, DOI 10.1016/j.tsf.2007.11.104; Barua D, 2006, APPL PHYS LETT, V88, DOI [10.1063/1.2181651, 10.1063/1.218165]; Mendez-Santiago J, 1999, FLUID PHASE EQUILIBR, V158, P501, DOI 10.1016/S0378-3812(99)00154-5; Zhao B, 2006, JPN J APPL PHYS 2, V45, pL1296, DOI 10.1143/JJAP.45.L1296; Haruki M, 2011, J CHEM ENG DATA, V56, P2230, DOI 10.1021/je101255v; O'Neil A, 2007, CHEM MATER, V19, P5460, DOI 10.1021/cm070288s; Smart NG, 1997, TALANTA, V44, P137, DOI 10.1016/S0039-9140(96)02008-5; Song QR, 2010, J CHEM ENG DATA, V55, P3946, DOI 10.1021/je901025f; Sauceau M, 2003, FLUID PHASE EQUILIBR, V208, P99, DOI 10.1016/S0378-3812(03)00005-0; Momose T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.097002; SAITO N, 1990, B CHEM SOC JPN, V63, P1532, DOI 10.1246/bcsj.63.1532; LAGALANTE AF, 1995, INORG CHEM, V34, P5781, DOI 10.1021/ic00127a015; Zhao Y, 2014, THIN SOLID FILMS, V553, P184, DOI 10.1016/j.tsf.2013.11.062; Jung K, 2013, ECS SOLID STATE LETT, V2, pP79, DOI 10.1149/2.009309ssl; Ohashi A, 2006, ANAL SCI, V22, P1399, DOI 10.2116/analsci.22.1399; Aida T, 2010, J SUPERCRIT FLUID, V55, P71, DOI 10.1016/j.supflu.2010.05.025; Hamdi R.M., 1991, J SUPERCRIT FLUID, V4, P55; Jin JS, 2012, J CHEM ENG DATA, V57, P2217, DOI 10.1021/je300023v; Jung K., 2013, SOLID STATE LETT, V2, pP70; Kubota M., 2012, P IEEE 25 INT C MICR, P204; Kumik R. T., 1982, FLUID PHASE EQUILIBR, V8, P93; Momose T., 2011, P IEEE 24 INT C MICR, P49; Momose T., 2008, P ADV MET C, P289; Momose T, 2014, J CHEM ENG JPN, V47, P743, DOI 10.1252/jcej.13we274; Momose T, 2014, J CHEM ENG JPN, V47, P737, DOI 10.1252/jcej.13we225; Tenorio MJ, 2012, J SUPERCRIT FLUID, V70, P106, DOI 10.1016/j.supflu.2012.06.014; Vafajoo L., 2011, DETERMINING CORRELAT, P790; Zhao Y, 2013, ECS J SOLID STATE SC, V2, pN191, DOI 10.1149/2.003311jss	70	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	OCT	2015	105				SI		193	200		10.1016/j.supflu.2015.04.002		8	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CU2JV	WOS:000363350700025		
J	Iwamoto, J; Takada, T				Iwamoto, Jun; Takada, Tetsuya			Effect of minodronate on the speed of sound of the calcaneus in postmenopausal women with an increased risk of fractures: A clinical practice-based observational study	JOURNAL OF THE CHINESE MEDICAL ASSOCIATION			English	Article						bone turnover; minodronate; postmenopausal women; quantitative ultrasound; speed of sound	ONCE-WEEKLY ALENDRONATE; PRIMARY OSTEOPOROSIS; DIAGNOSTIC-CRITERIA; AMERICAN-SOCIETY; MINERAL-RESEARCH; TASK-FORCE; BONE; ULTRASOUND; THERAPY; TRIAL	Background: We previously reported that alendronate and risedronate reduce the urinary levels of cross-linked N-terminal telopeptides of type I collagen (NTX) by 44.9% and 34.7%, respectively, at 3 months after the start of treatment, and increase the speed of sound (SOS) of the calcaneus by 0.6% and 0.65%, respectively, at 12 months after the start of treatment in postmenopausal women with osteoporosis. The aim of the present clinical practice-based observational study was to examine the effect of treatment with minodronate for 12 months on the SOS of the calcaneus and on bone turnover markers in postmenopausal women with an increased risk of fractures. Methods: Forty-two postmenopausal women with osteoporosis or osteopenia with a clinical risk factor for fractures who had been treated with minodronate for > 12 months were enrolled in the study. The SOS and bone turnover markers were monitored during treatment with minodronate for 12 months. Results: Compared to their baseline values, the urinary levels of NTX at 3 months and the serum levels of alkaline phosphatase at 12 months were significantly decreased at 47.5% and 25.8%, respectively. At 12 months, the SOS increased modestly, but significantly, by 0.47%, compared to the baseline value. Conclusion: The present study confirmed that minodronate suppressed bone turnover and modestly increased the SOS of the calcaneus in postmenopausal women with an increased risk of fractures. Copyright (C) 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.	[Iwamoto, Jun] Keio Univ, Sch Med, Inst Integrated Sports Med, Tokyo 1608582, Japan; [Takada, Tetsuya] Hiyoshi Med Clin, Dept Internal Med, Kanagawa, Japan	Iwamoto, J (reprint author), Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jiwamoto@keio.jp					Adami S, 2009, OSTEOPOROSIS INT, V20, P239, DOI 10.1007/s00198-008-0650-y; Ito M, 2003, OSTEOPOROSIS INT, V14, P959, DOI 10.1007/s00198-003-1497-x; Emkey R, 2005, CURR MED RES OPIN, V21, P1895, DOI 10.1185/030079905X74862; Wuster C, 1998, EXP CLIN ENDOCR DIAB, V106, P277; Hagino H, 2009, BONE, V44, P1078, DOI 10.1016/j.bone.2009.02.016; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Orimo H, 1998, J BONE MINER METAB, V16, P139, DOI 10.1007/s007740050038; Pazianas M, 2010, J BONE MINER RES, V25, P2, DOI 10.1359/jbmr.091201; Okazaki R, 2012, OSTEOPOROSIS INT, V23, P1737, DOI 10.1007/s00198-011-1782-z; Iwamoto J, 2012, THER CLIN RISK MANAG, V8, P287, DOI 10.2147/TCRM.S32794; Matsumoto T, 2009, OSTEOPOROSIS INT, V20, P1429, DOI 10.1007/s00198-008-0816-7; Sebba AI, 2004, CURR MED RES OPIN, V20, P2031, DOI 10.1185/030079904X16768; Fujiwara S, 2005, OSTEOPOROSIS INT, V16, P2107, DOI 10.1007/s00198-005-2008-z; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Nishizawa Y, 2005, J BONE MINER METAB, V23, P97, DOI 10.1007/s00774-004-0547-6; Yamaguchi T, 2011, J BONE MINER METAB, V29, P626, DOI 10.1007/s00774-011-0265-9; Iwamoto Jun, 2013, World J Orthop, V4, P316, DOI 10.5312/wjo.v4.i4.316; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kishimoto H, 2003, OSTEOPOROSIS JPN, V11, P307; Orimo H., 2006, GUIDELINES PREVENTIO	20	1	1	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1726-4901	1728-7731		J CHIN MED ASSOC	J. Chin. Med. Assoc.	OCT	2015	78	10					591	596		10.1016/j.jcma.2015.06.010		6	Medicine, General & Internal	General & Internal Medicine	CU3QE	WOS:000363439100005		
J	Ichikawa, Y; Ogawa, K				Ichikawa, Yuji; Ogawa, Kazuhiro			Effect of Substrate Surface Oxide Film Thickness on Deposition Behavior and Deposition Efficiency in the Cold Spray Process	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						cold spray; MCrAlY; modeling of coating formation; secondary electron microscopy (SEM); splat morphology; deposition efficiency; substrate preparation	PARTICLE-VELOCITY; SIMULATION; COATINGS; IMPACT	The mechanism of cold spray deposition is not yet completely understood. The impinging velocity and deformation behavior of the particles are believed to be critical deposition conditions. However, such substrate conditions as oxide-film thickness and mechanical properties may also affect cold spray deposition. In this study we investigated the effect of substrate conditions, especially oxide film thickness, on the deposition process. The efficiency of deposition and the relationship between the impinging position of the particles and the number of particles deposited were investigated for two substrates coated with oxide films of different thickness; the particles were deposited sparsely on the substrates. Results showed that efficiency of deposition was lower for the oxide film with the greater thickness. Deposition tendency was also associated with impinging velocity, i.e., the critical velocity on which oxide film thickness depends; this is the reason for the different efficiency of deposition. An oxide film may inhibit deposition on a new surface. These results indicate that oxide film thickness has a substantial effect on the efficiency of deposition on the substrate. They also imply that creation of a newly-formed surface is important to the deposition process.	[Ichikawa, Yuji; Ogawa, Kazuhiro] Tohoku Univ, Fracture & Reliabil Res Inst, Sendai, Miyagi 980, Japan	Ichikawa, Y (reprint author), Tohoku Univ, Fracture & Reliabil Res Inst, Sendai, Miyagi 980, Japan.	ichikawa@rift.mech.tohoku.ac.jp		Ichikawa, Yuji/0000-0002-9474-3467			Kim K, 2010, SCRIPTA MATER, V63, P215, DOI 10.1016/j.scriptamat.2010.03.061; Gilmore DL, 1999, J THERM SPRAY TECHN, V8, P576, DOI 10.1361/105996399770350278; Guetta S, 2009, J THERM SPRAY TECHN, V18, P331, DOI 10.1007/s11666-009-9327-0; Li WY, 2007, APPL SURF SCI, V253, P5084, DOI 10.1016/j.apsusc.2006.11.020; Kosarev VF, 2003, J THERM SPRAY TECHN, V12, P265, DOI 10.1361/105996303770348384; Papyrin A, 2001, ADV MATER PROCESS, V159, P49; Yokoyama K, 2006, MATER TRANS, V47, P1697, DOI 10.2320/matertrans.47.1697; Stoltenhoff T, 2002, J THERM SPRAY TECHN, V11, P542, DOI 10.1361/105996302770348682; Grujicic M, 2004, MATER DESIGN, V25, P681, DOI 10.1016/j.matdes.2004.03.008; Grujicic M, 2003, APPL SURF SCI, V219, P211, DOI 10.1016/S0169-4332(03)00643-3; Alkhimov A. P., 1990, Soviet Physics - Doklady, V35; Achar DRG, 2004, SURF COAT TECH, V187, P272, DOI 10.1016/j.surfocat.2004.02.018; Schmidt T, 2006, ACTA MATER, V54, P729, DOI 10.1016/j.actamat.2005.10.005; Ogawa K, 2008, J THERM SPRAY TECHN, V17, P728, DOI 10.1007/s11666-008-9254-5; Dykhuizen RC, 1999, J THERM SPRAY TECHN, V8, P559, DOI 10.1361/105996399770350250; Dorfman M. R., 2004, ADV TECHNOLOGY APPL, P90; Ichikawa Y., 2007, THERMAL SPRAY 2007 G, P54; Ichikawa Y., 2008, THERMAL SPRAY 2008 C, P281; Karthikeyan J., 2003, THERMAL SPRAY 2003 A, P117; Katanoda H., 2003, J THERM SPRAY TECHN, V16, P627	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	OCT	2015	24	7					1269	1276		10.1007/s11666-015-0299-y		8	Materials Science, Coatings & Films	Materials Science	CT8AZ	WOS:000363038600015		
J	Mori, R; Kamei, N; Okawa, S; Nakabayashi, A; Yokota, K; Higashi, Y; Ochi, M				Mori, Ryo; Kamei, Naosuke; Okawa, Shingo; Nakabayashi, Akihiro; Yokota, Kazunori; Higashi, Yukihito; Ochi, Mitsuo			Promotion of skeletal muscle repair in a rat skeletal muscle injury model by local injection of human adipose tissue-derived regenerative cells	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						human adipose tissue; adipose tissue derived cell; skeletal muscle; muscle repair; myogenesis; angiogenesis	MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; BONE-MARROW; CD34-POSITIVE CELLS; SATELLITE CELLS; IN-VITRO; DIFFERENTIATION; EXPRESSION; ADULT	Human adipose tissue-derived regenerative cells (ADRCs) can be isolated easily and aseptically from unwanted subcutaneous fat without culturing. ADRCs have been used in clinical cosmetic therapy. In addition, they are expected to be an attractive and feasible source of cell-based therapies in regenerative medicine. Therefore, this paper investigates whether transplantation of human adult ADRCs into skeletal muscle injury models promotes the repair of muscle tissues. This was done by locally injecting human ADRCs into an injured site after laceration of the nude-rat tibialis anterior muscle. Phosphate-buffered saline (PBS) and bone marrow mononuclear cells (MNCs) were injected as negative and positive controls, respectively. After injury, recovery of muscle strength was accelerated by transplantation of ADRCs compared to administration of PBS and MNCs. Moreover, transplantation of ADRCs also enhanced angiogenesis and myogenesis, but the number of vascular and muscular cells labeled with the human cell-specific maker was limited at the injury site. Results showed that transplantation of ADRCs into a skeletal muscle injury model promoted repair of muscle tissues in a paracrine manner rather than differentiation of itself into blood vessels and myofibres. Thus, it is believed that ADRCs are a useful and feasible cell source not only for cosmetic therapy but also for regenerative therapy. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Mori, Ryo; Kamei, Naosuke; Okawa, Shingo; Nakabayashi, Akihiro; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Hiroshima 7348551, Japan; [Kamei, Naosuke; Higashi, Yukihito] Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan; [Yokota, Kazunori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Plast & Reconstruct Surg, Hiroshima 7348551, Japan	Mori, R (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	d103584@hiroshima-u.ac.jp		Mori, Ryo/0000-0002-6451-8250	Ministry of Education, Culture, Sports, Science and Technology, Japan [23592188]	This work was supported by a Grant-in-Aid for Scientific Research of Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 23592188 to K Y).	Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U; Romanov YA, 2005, B EXP BIOL MED+, V140, P138, DOI 10.1007/s10517-005-0430-z; Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165; Tobita M, 2011, DISCOV MED, V57, P160; Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Jackson WM, 2009, J TISSUE ENG REGEN M, V3, P129, DOI 10.1002/term.149; Terayama H, 2011, J TISSUE ENG REGEN M, V5, P32, DOI 10.1002/term.285; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Aldahmash A, 2012, ANN SAUDI MED, V32, P68, DOI 10.5144/0256-4947.2012.68; BACIGALUPO A, 1992, BONE MARROW TRANSPL, V9, P467; Shi M, 2009, STEM CELLS, V27, P949, DOI 10.1002/stem.4; Tei K, 2008, STEM CELLS, V26, P819, DOI 10.1634/stemcells.2007-0671; Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI 10.1089/ten.TEA.2009.0826; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Kamakura T, 2011, AESTHET PLAST SURG, V35, P1022, DOI 10.1007/s00266-011-9727-7; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190; Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x; Negroni E, 2011, EXPERT OPIN BIOL TH, V11, P157, DOI 10.1517/14712598.2011.542748; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/ten.2004.10.1093; Li H, 2011, INT J SPORTS MED, V32, P735, DOI 10.1055/s-0031-1279771; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Lin K, 2008, CYTOTHERAPY, V10, P417, DOI 10.1080/14653240801982979; Asahara T, 1997, SCIENCE, V14, P275; Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0; Hildner F, 2011, J TISSUE ENG REGEN M, V5, P36; Wagatsuma A, 2007, MOL CELL BIOCHEM, V298, P151, DOI 10.1007/s11010-006-9361-x; Xia JH, 2006, CHINESE MED J-PEKING, V119, P117	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	OCT	2015	9	10					1150	1160		10.1002/term.1659		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CU1FO	WOS:000363265700004		
J	Asai, Y				Asai, Yukiko			Parental leave reforms and the employment of new mothers: Quasi-experimental evidence from Japan	LABOUR ECONOMICS			English	Article						Parental leave; Cash benefit; Job continuity; Labour supply	INCOME-TAX CREDIT; MATERNAL EMPLOYMENT; YOUNG-CHILDREN; BENEFIT REFORM; IN-DIFFERENCES; FAMILY LEAVE; LABOR; WORK; PARTICIPATION; CONSEQUENCES	This study examines the changes in job continuity of new mothers following an increase in cash benefits provided during parental leave. The cash benefit was first introduced in 1995 and the replacement rate was 25%. The replacement rate was raised from 25% to 40% in 2001. During this period, the maximum duration of paid leave and that of job-protection remained unchanged, and therefore, I can isolate the effects of changes in the amount of cash benefit from those due to changes in duration of leave. By comparing the job continuity of women who gave birth to their child before the reform and those who did so after the reform, I find little evidence that the labour supply pattern of new mothers changed in response to the increased cash benefit. (C) 2015 Elsevier B.V. All rights reserved.	Univ Tokyo, Inst Sociol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Asai, Y (reprint author), Univ Tokyo, Inst Sociol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	y_asai@iss.u-tokyo.ac.jp					Ai C., 2003, ECON LETT, V80, P123; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Sanchez-Mangas R, 2008, LABOUR ECON, V15, P1127, DOI 10.1016/j.labeco.2007.10.002; Naz G, 2004, J POPUL ECON, V17, P369, DOI 10.1007/s00148-003-0157-y; Conley TG, 2011, REV ECON STAT, V93, P113, DOI 10.1162/REST_a_00049; Lundin D, 2008, LABOUR ECON, V15, P647, DOI 10.1016/j.labeco.2008.04.005; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Azmat G, 2010, LABOUR ECON, V17, P487, DOI 10.1016/j.labeco.2009.09.006; Hanratty M, 2009, J POPUL ECON, V22, P693, DOI 10.1007/s00148-008-0211-x; Waldfogel J, 1999, J POPUL ECON, V12, P523, DOI 10.1007/s001480050112; Berlinski S, 2007, LABOUR ECON, V14, P665, DOI 10.1016/j.labeco.2007.01.003; Lefebvre P, 2008, J LABOR ECON, V26, P519, DOI 10.1086/587760; Jukic AM, 2013, HUM REPROD, V28, P2848, DOI 10.1093/humrep/det297; Baker M, 2008, J LABOR ECON, V26, P655, DOI 10.1086/591955; Baum CL, 2003, LABOUR ECON, V10, P573, DOI 10.1016/S0927-5371(03)00037-X; Francesconi M, 2007, J HUM RESOUR, V42, P1; Gelbach JB, 2002, AM ECON REV, V92, P307, DOI 10.1257/000282802760015748; Asai Y., 2014, PARENTAL LEAVE REFOR; Blundell R., 1999, HDB LABOR EC A, V3, P1559, DOI 10.1016/S1573-4463(99)03008-4; Boeri T., 2013, EC IMPERFECT LABOR M; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Eissa N, 1996, Q J ECON, V111, P605, DOI 10.2307/2946689; GEBCO, 2007, WHIT PAP GEND EQ 200; GRUBER J, 1994, AM ECON REV, V84, P622; Kato T., 2013, NBER JAP PROJ M TOK; Klerman A., 1997, GENDER FAMILY ISSUES, P65; Lalive R., 2013, REV ECON STUD, V93, P113; Lalive R, 2009, Q J ECON, V124, P1363, DOI 10.1162/qjec.2009.124.3.1363; Meghir C., 2010, DIMENSIONS TAX DESIG, P202; Meyer BD, 2001, Q J ECON, V116, P1063, DOI 10.1162/00335530152466313; MHLW, 2007, BAS SURV GEND EQ EMP; MHLW, 2002, BAS SURV GEND EQ EMP; MOULTON BR, 1990, REV ECON STAT, V72, P334, DOI 10.2307/2109724; Ruhm CJ, 1998, Q J ECON, V113, P285, DOI 10.1162/003355398555586; Schone P, 2004, J POPUL ECON, V17, P703, DOI 10.1007/s001-003-0176-58; Schonberg U., 2007, IZA DISCUSSION PAPER; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yamaguchi S., 2014, DYNAMIC EFFECTS PARE	38	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-5371	1879-1034		LABOUR ECON	Labour Econ.	OCT	2015	36				SI		72	83		10.1016/j.labeco.2015.02.007		12	Economics	Business & Economics	CT8QB	WOS:000363080000006		
J	Fujiki, M; Miyamoto, S; Hayashi, R; Sakuraba, M				Fujiki, Masahide; Miyamoto, Shimpei; Hayashi, Ryuichi; Sakuraba, Minoru			Evaluation of Routine Contrast Swallow Following Total Pharyngolaryngectomy and Free Jejunal Transfer	LARYNGOSCOPE			English	Article						Total pharyngolaryngectomy; free jejunal transfer; contrast swallow; anastomotic leakage; sensitivity	COMPUTED-TOMOGRAPHY; ANASTOMOTIC LEAKS; RECONSTRUCTION; ESOPHAGECTOMY; FLUOROSCOPY; DEFECTS; FLAP	Objective: Anastomotic leakage is a serious complication following total pharyngolaryngectomy (TPL) and free jejunal transfer (FJT). Although routine radiological assessment using contrast swallow is widely performed postoperatively for the detection of anastomotic leakage before oral intake, the accuracy remains unclear. We evaluated the clinical usefulness of routine contrast swallow for screening of anastomotic leakage. Study Design: Retrospective chart review. Methods: We retrospectively reviewed 232 patients who had undergone TPL and FIT from 2009 to 2013. Initial contrast swallow was performed near the seventh postoperative day in patients without a history of radiation for head and neck region preoperatively and near the 14th postoperative day in patients with a history. The accuracy of routine contrast swallow was calculated. Results: Clinical anastomotic leakage occurred in 12 patients (5.2%); of these, anastomotic leakage was detected by initial contrast swallow in six patients. The sensitivity and specificity of contrast swallow were 50.0% and 99.1%, respectively. Conclusion: Contrast swallow has low sensitivity and a high false-negative rate for the diagnosis of clinical leakage after TPL and FJT, and routine contrast swallow was insufficient for the screening of anastomotic leakage. Therefore, contrast swallow should be performed in a targeted fashion for patients with clinical signs of anastomotic leakage.	[Fujiki, Masahide; Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kashiwa, Chiba 2778577, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Kashiwa, Chiba 2778577, Japan; [Miyamoto, Shimpei] Natl Canc Ctr, Div Plast & Reconstruct Surg, Tokyo, Japan	Fujiki, M (reprint author), Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	masahide-fujiki@gumin.ac.jp					Tirnaksiz MB, 2005, EUR SURG RES, V37, P123, DOI 10.1159/000084544; Perez-Smith D, 2013, J PLAST RECONSTR AES, V66, P9, DOI 10.1016/j.bjps.2012.08.033; Sarukawa S, 2006, LARYNGOSCOPE, V116, P976, DOI 10.1097/01.mlg.0000216915.62574.ba; DeArmond DT, 2013, J SURG RES, V182, P192, DOI 10.1016/j.jss.2012.10.025; Hogan BA, 2008, SURG ENDOSC, V22, P767, DOI 10.1007/s00464-007-9629-6; Strauss C, 2010, ANN SURG, V251, P647, DOI 10.1097/SLA.0b013e3181c1aeb8; Kimata Y, 2000, LARYNGOSCOPE, V110, P1230, DOI 10.1097/00005537-200007000-00031; COLEMAN JJ, 1989, PLAST RECONSTR SURG, V84, P589, DOI 10.1097/00006534-198984040-00005; Cools-Lartigue J, 2014, ANN SURG ONCOL, V21, P2573, DOI 10.1245/s10434-014-3654-1; Miyamoto S, 2013, MICROSURG, V33, P119, DOI 10.1002/micr.22017; REECE GP, 1995, PLAST RECONSTR SURG, V96, P1307, DOI 10.1097/00006534-199511000-00012; Tanomkiat W, 2000, ACTA RADIOL, V41, P482, DOI 10.1080/028418500127345730; Upponi S, 2008, BRIT J RADIOL, V81, P545, DOI 10.1259/bjr/30515892; Frezza EE, 2009, ARCH SURG-CHICAGO, V144, P766, DOI 10.1001/archsurg.2009.138; Boone J, 2008, ANZ J SURG, V79, P784; Cordeiro PG, 1999, PLAST RECONSTR SURG, V103, P1165	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	OCT	2015	125	10					2280	2283		10.1002/lary.25302		4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CU2XF	WOS:000363386300020		
J	Kanazawa, T; Komazawa, D; Indo, K; Akagi, Y; Lee, Y; Nakamura, K; Matsushima, K; Kunieda, C; Misawa, K; Nishino, H; Watanabe, Y				Kanazawa, Takeharu; Komazawa, Daigo; Indo, Kanako; Akagi, Yusuke; Lee, Yogaku; Nakamura, Kazuhiro; Matsushima, Koji; Kunieda, Chikako; Misawa, Kiyoshi; Nishino, Hiroshi; Watanabe, Yusuke			Single Injection of Basic Fibroblast Growth Factor to Treat Severe Vocal Fold Lesions and Vocal Fold Paralysis	LARYNGOSCOPE			English	Article						Basic fibroblast growth factor; local anesthesia; regenerative medicine; single injection; vocal fold lesion	MESENCHYMAL STEM-CELLS; HYALURONIC-ACID; REGENERATION; SULCUS; BIOMECHANICS; COLLAGEN; CANINE; MODEL; SCAR	Objectives/Hypothesis: Severe vocal fold lesions such as vocal fold sulcus, scars, and atrophy induce a communication disorder due to severe hoarseness, but a treatment has not been established. Basic fibroblast growth factor (bFGF) therapies by either four-time repeated local injections or regenerative surgery for vocal fold scar and sulcus have previously been reported, and favorable outcomes have been observed. In this study, we modified bFGF therapy using a single of bFGF injection, which may potentially be used in office procedures. Study Design: Retrospective chart review. Methods: Five cases of vocal fold sulcus, six cases of scars, seven cases of paralysis, and 17 cases of atrophy were treated by a local injection of bFGF. The injection regimen involved injecting 50 mu g of bFGF dissolved in 0.5 mL saline only once into the superficial lamina propria using a 23-gauge injection needle. Two months to 3 months after the injection, phonological outcomes were evaluated. Results: The maximum phonation time (MPT), mean airflow rate, pitch range, speech fundamental frequency, jitter, and voice handicap index improved significantly after the bFGF injection. Furthermore, improvement in the MPT was significantly greater in patients with (in increasing order) vocal fold atrophy, scar, and paralysis. The improvement in the MPT among all patients was significantly correlated with age; the MPT improved more greatly in younger patients. Conclusions: Regenerative treatments by bFGF injection even a single injection effectively improve vocal function in vocal fold lesions.	[Kanazawa, Takeharu; Komazawa, Daigo; Indo, Kanako; Akagi, Yusuke; Lee, Yogaku; Nakamura, Kazuhiro; Kunieda, Chikako; Watanabe, Yusuke] Int Univ Hlth & Welf, Tokyo Voice Ctr, Tokyo, Japan; [Kanazawa, Takeharu; Nishino, Hiroshi] Jichi Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shimotsuke, Tochigi 3290498, Japan; [Indo, Kanako] Kagawa Univ, Sch Med, Dept Otolaryngol, Miki, Kagawa, Japan; [Akagi, Yusuke] Okayama Med Ctr, Dept Otolaryngol Head & Neck Surg, Okayama, Japan; [Nakamura, Kazuhiro] Tokyo Med Univ, Dept Otolaryngol Head & Neck Surg, Hachioji Med Ctr, Hachioji, Tokyo, Japan; [Matsushima, Koji] Toho Univ, Omori Med Ctr, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Kunieda, Chikako] Hashima City Hosp, Dept Otorhinolaryngol, Hashima, Japan; [Misawa, Kiyoshi] Hamamatsu Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Hamamatsu, Shizuoka 4312102, Japan	Kanazawa, T (reprint author), Jichi Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kanatake@omiya.jichi.ac.jp			Tokyo Voice Center in the International University of Health and Welfare, Tokyo, Japan	This work was performed at and funded internally by the Tokyo Voice Center in the International University of Health and Welfare, Tokyo, Japan.	Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db; Nakagawa H, 2012, J VOICE, V26, pE107, DOI 10.1016/j.jvoice.2011.07.005; Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906; Hsiung MW, 2006, ACTA OTO-LARYNGOL, V126, P191, DOI 10.1080/00016480500339854; Kim HS, 1998, CYTOGENET CELL GENET, V83, P73, DOI 10.1159/000015129; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001; Koga C, 1999, BIOCHEM BIOPH RES CO, V261, P756, DOI 10.1006/bbrc.1999.1039; Hirano S, 2012, LARYNGOSCOPE, V122, P327, DOI 10.1002/lary.22393; Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915; Remacle M, 2000, ANN OTO RHINOL LARYN, V109, P141; Hirano S, 2005, ANN OTO RHINOL LARYN, V114, P304; Hirano S, 2013, LARYNGOSCOPE, V123, P2749, DOI 10.1002/lary.24092; BOUCHAYER M, 1992, FOLIA PHONIATR, V44, P155; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P617; Roberts T, 2011, CLIN ANAT, V24, P544, DOI 10.1002/ca.21114; Svensson B, 2010, LARYNGOSCOPE, V120, P1370, DOI 10.1002/lary.20926; PONTES P, 1993, J VOICE, V7, P365, DOI 10.1016/S0892-1997(05)80260-7; Sato K, 1997, ANN OTO RHINOL LARYN, V106, P44; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618; Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123; Hom David B, 2002, Facial Plast Surg, V18, P41, DOI 10.1055/s-2002-19826; Matsumoto Shigeru, 2013, Plast Reconstr Surg Glob Open, V1, pe44, DOI 10.1097/GOX.0b013e3182a88787; Rammage L, 2001, MANAGEMENT VOICE ITS, P269; Taguchi A, 2012, J VOICE, V26, P668, DOI DOI 10.1016/J.JV0ICE.2011.11.005; Tsunoda Koichi, 2005, Laryngoscope, V115, P1, DOI 10.1097/01.mlg.0000183966.72921.31	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	OCT	2015	125	10					E338	E344		10.1002/lary.25315		7	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CU2XF	WOS:000363386300003		
J	Hata, Y; Matsumoto, T; Tanaka, T; Kondo, A				Hata, Yuto; Matsumoto, Takuya; Tanaka, Tsutomu; Kondo, Akihiko			C-Terminal-oriented Immobilization of Enzymes Using Sortase A-mediated Technique	MACROMOLECULAR BIOSCIENCE			English	Article						enzymes; immobilization of enzymes; sortase A	STAPHYLOCOCCUS-AUREUS SORTASE; DIRECT ELECTRON-TRANSFER; SILICA NANOPARTICLES; ESCHERICHIA-COLI; BETA-GLUCOSIDASE; PROTEIN LIGATION; SURFACE-PROTEINS; ALPHA-AMYLASES; CELL-WALL; DEGRADATION	In the present study, sortase A-mediated immobilization of enzymes was used for the preparation of immobilized enzymes. Thermobifida fusca YX -glucosidase (BGL) or Streptococcus bovis 148 -amylase (AmyA) were produced with C-terminal sortase A recognition sequences. The resulting fusion proteins were successfully immobilized on nanoparticle surfaces using sortase A. Some properties (activity, stability, and reusability) of the immobilized fusion proteins were evaluated. Both immobilized BGL and immobilized AmyA prepared by the sortase A-mediated technique retained their catalytic activity, exhibiting activities 3.0- or 1.5-fold (respectively) of those seen with the same enzymes immobilized by chemical crosslinking. Immobilized enzymes prepared by the sortase A-mediated technique did not undergo dramatic changes in stability compared with the respective free enzymes. Thus, the sortase A-mediated technique provides a promising method for immobilization of active, stable enzymes.	[Hata, Yuto; Tanaka, Tsutomu; Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Matsumoto, Takuya] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan	Tanaka, T (reprint author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	tanaka@kitty.kobe-u.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovation Bioproduction Kobe), MEXT, Japan	This work was supported by Special Coordination Funds for Promoting Science and Technology, provided by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovation Bioproduction Kobe), MEXT, Japan.	Agyei D, 2014, J BIOTECHNOL, V188, P53, DOI 10.1016/j.jbiotec.2014.08.007; Yehezkeli O, 2011, ACS NANO, V5, P2385, DOI 10.1021/nn200313t; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Zhen GL, 2004, LANGMUIR, V20, P10464, DOI 10.1021/la0482812; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Guzik U, 2014, MOLECULES, V19, P8995, DOI 10.3390/molecules19078995; Sijbrandij T, 2013, BIOCONJUGATE CHEM, V24, P828, DOI 10.1021/bc4000146; Warden-Rothman R, 2013, ANAL CHEM, V85, P11090, DOI 10.1021/ac402871k; Cho EJ, 2012, CHEM COMMUN, V48, P886, DOI 10.1039/c2cc16661e; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Liese A, 2013, CHEM SOC REV, V42, P6236, DOI 10.1039/c3cs35511j; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; He SM, 1997, J BIOL CHEM, V272, P24864, DOI 10.1074/jbc.272.40.24864; Blasco MA, 2014, BIOORGAN MED CHEM, V22, P5539, DOI 10.1016/j.bmc.2014.06.024; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Schmohl L, 2014, CURR OPIN CHEM BIOL, V22, P122, DOI 10.1016/j.cbpa.2014.09.020; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Solano DM, 2012, BIORESOURCE TECHNOL, V115, P196, DOI 10.1016/j.biortech.2011.11.131; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Yamamoto K, 2013, NEW BIOTECHNOL, V30, P531, DOI 10.1016/j.nbt.2013.04.005; Kuwahara Y, 2012, CHEM COMMUN, V48, P2882, DOI 10.1039/c2cc17896f; Kamiya N, 2005, BIOMACROMOLECULES, V6, P35, DOI 10.1021/bm0494895; Holland JT, 2011, J AM CHEM SOC, V133, P19262, DOI 10.1021/ja2071237; UPDIKE SJ, 1967, NATURE, V214, P986, DOI 10.1038/214986a0; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Ito T, 2010, BIOCHEMISTRY-US, V49, P2604, DOI 10.1021/bi100094g; Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651; Diao JP, 2005, ANAL BIOCHEM, V343, P322, DOI 10.1016/j.ab.2005.05.010; Nakazawa H, 2013, ACS CATAL, V3, P1342, DOI 10.1021/cs400012v; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; Davis F, 2007, BIOSENS BIOELECTRON, V22, P1224, DOI 10.1016/j.bios.2006.04.029; He YC, 2014, BIORESOURCE TECHNOL, V161, P461, DOI 10.1016/j.biortech.2014.03.133; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; Clouthier CM, 2012, CHEM SOC REV, V41, P1585, DOI 10.1039/c2cs15286j; Bhat MK, 1997, BIOTECHNOL ADV, V15, P583, DOI 10.1016/S0734-9750(97)00006-2; Blanchette C., 2012, PLOS ONE, V7, P8; Nielsen JE, 2000, BBA-PROTEIN STRUCT M, V1543, P253, DOI 10.1016/S0167-4838(00)00240-5; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Fernandez-Lorente G, 2006, BIOMACROMOLECULES, V7, P2610, DOI 10.1021/bm060408+; Gutierrez-Sanchez C, 2011, LANGMUIR, V27, P6449, DOI 10.1021/la200141t; Ikeda N, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-67; Li S., 2012, COMPUT STRUCT BIOTEC, V2; Matsumoto Takuya, 2012, Biotechnol J, V7, P1137, DOI 10.1002/biot.201200022; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shi L, 2014, J HAZARD MATER, V279, P203, DOI 10.1016/j.jhazmat.2014.06.070	47	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	OCT	2015	15	10					1375	1380		10.1002/mabi.201500113		6	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CU3GV	WOS:000363413300006		
J	Shikinaka, K; Misu, M; Furukawa, H; Kakugo, A; Gong, JP				Shikinaka, Kazuhiro; Misu, Manami; Furukawa, Hidemitsu; Kakugo, Akira; Gong, Jian Ping			Anisotropic Gelation Induced by Very Little Amount of Filamentous Actin	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						actin; hydrogel; liquid crystal; template polymerization	F-ACTIN; BUNDLE FORMATION; POLYELECTROLYTES; GROWTH; MYOSIN	In this paper, the hydrogel is created with oriented structure by addition of very little amount of dopant, filamentous actin (F-actin), which is 1/50 000 of lower critical concentration for nematic phase in F-actin aqueous solution. The orientation mechanism of polymer network differs depending on the concentration of F-actin. Furthermore, it is first exhibited that the role of polyelectrolyte for the emergence of anisotropy of gel is differed depending on its concentration by using digestion method to F-actins, experimentally.	[Shikinaka, Kazuhiro] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan; [Misu, Manami; Gong, Jian Ping] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Furukawa, Hidemitsu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9918510, Japan; [Kakugo, Akira] Hokkaido Univ, Fac Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Shikinaka, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	k-shiki@cc.tuat.ac.jp	Gong, Jian Ping/B-7019-2009	Gong, Jian Ping/0000-0003-2228-2750	Ministry of Education, Science, Sports, and Culture, Japan [18002002]	This research was financially supported by the Ministry of Education, Science, Sports, and Culture, Japan (Grant-in-Aid for Specially Promoted Scientific Research, Grant No. 18002002).	Evdokimov YM, 1996, MOL BIOL+, V30, P219; Wu ZL, 2009, ADV MATER, V21, P4696, DOI 10.1002/adma.200900933; Shikinaka K, 2009, J APPL POLYM SCI, V114, P2087, DOI 10.1002/app.30821; Kakugo A, 2003, BIOCONJUGATE CHEM, V14, P1185, DOI 10.1021/bc0340722; Kwon HJ, 2006, BIOCHEMISTRY-US, V45, P10313, DOI 10.1021/bi060721w; Petrache HI, 1998, PHYS REV E, V57, P7014, DOI 10.1103/PhysRevE.57.7014; Tang JX, 1996, J BIOL CHEM, V271, P8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Kwon HJ, 2005, BIOMACROMOLECULES, V6, P3005, DOI 10.1021/bm050320g; Lai GH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.187802; Das P, 1999, J CHEM PHYS, V111, P8240, DOI 10.1063/1.480157; Shigekura Y, 2007, MACROMOLECULES, V40, P2477, DOI 10.1021/ma061511u; Tang JX, 1996, BER BUNSEN PHYS CHEM, V100, P796; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0; Shigekura Y, 2005, ADV MATER, V17, P2695, DOI 10.1002/adma.200500707; Wu ZL, 2010, J AM CHEM SOC, V132, P10064, DOI 10.1021/ja101969k; DUVERT M, 1984, TISSUE CELL, V16, P469, DOI 10.1016/0040-8166(84)90064-8; HUXLEY HE, 1990, J BIOL CHEM, V265, P8347; Shikinaka K, 2008, BIOMACROMOLECULES, V9, P537, DOI 10.1021/bm701068n; SPENCER M, 1962, NATURE, V194, P1014, DOI 10.1038/1941014a0; Born M., 1959, PRINCIPLES OPTICS; Bray D., 2001, CELL MOVEMENTS MOL M; COPPIN CM, 1992, BIOPHYS J, V63, P794	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	OCT	2015	216	20					2007	2011		10.1002/macp.201500265		5	Polymer Science	Polymer Science	CU0PN	WOS:000363219600003		
J	Ovsyanikova, E; Fedutin, I; Belonovich, O; Burdin, A; Burkanov, V; Dolgova, E; Filatova, O; Fomin, S; Hoyt, E; Mamaev, E; Richard, G; Savenko, O; Sekiguchi, K; Shpak, O; Sidorenko, M; Titova, O				Ovsyanikova, Ekaterina; Fedutin, Ivan; Belonovich, Olga; Burdin, Alexander; Burkanov, Vladimir; Dolgova, Evgenia; Filatova, Olga; Fomin, Sergey; Hoyt, Erich; Mamaev, Evgeny; Richard, Gaetan; Savenko, Oksana; Sekiguchi, Keiko; Shpak, Olga; Sidorenko, Maksim; Titova, Olga			Opportunistic sightings of the endangered North Pacific right whales (Eubalaena japonica) in Russian waters in 2003-2014	MARINE MAMMAL SCIENCE			English	Article							ATLANTIC RIGHT WHALES; SOVIET CATCHES; GLACIALIS; RATES		[Ovsyanikova, Ekaterina] Univ Canterbury, Gateway Antarctica, Christchurch 8041, New Zealand; [Ovsyanikova, Ekaterina; Dolgova, Evgenia; Shpak, Olga] Marine Mammal Council, Moscow 117218, Russia; [Fedutin, Ivan; Filatova, Olga] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Fedutin, Ivan] Pacific Inst Geog DVO RAS, Kamchatka Branch, Petropavlovsk Kamchatski 683000, Russia; [Belonovich, Olga] Kamchatka Res Inst Fisheries & Oceanog, Petropavlovsk Kamchatski, Russia; [Burdin, Alexander; Burkanov, Vladimir; Fomin, Sergey] Pacific Geog Inst, Kamchatka Branch, Petropavlovsk Kamchatski 683000, Russia; [Burkanov, Vladimir] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, NMFS, Seattle, WA 98115 USA; [Hoyt, Erich] WDC, Far East Russia Orca Project, Russian Cetacean Habitat Project, Chippenham SN15 1LJ, Wilts, England; [Mamaev, Evgeny] SV Marakov Commander Isl Nat & Biosphere Reserve, Nikolskoye, Commander Islan, Russia; [Richard, Gaetan] Univ Bretagne Occidentale, UFR Sci & Tech, Brest, France; [Savenko, Oksana] Natl Acad Sci Ukraine, II Schmalhausen Inst Zool, UA-01601 Kiev, Ukraine; [Sekiguchi, Keiko] Int Christian Univ, Grad Sch Arts & Sci, Mitaka, Tokyo 1818585, Japan; [Shpak, Olga] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow 117218, Russia; [Sidorenko, Maksim] VI Ilichev Pacific Oceanol Inst, Vladivostok, Russia; [Titova, Olga] Pacific Inst Geog RAS, Kamchatka Branch, Petropavlovsk Kamchatski, Russia	Ovsyanikova, E (reprint author), Univ Canterbury, Gateway Antarctica, 20 Kirkwood Ave, Christchurch 8041, New Zealand.	katya.ovsyanikova@gmail.com					Allen B. M., 2012, ALASKA MARINE MAMMAL, P203; Sekiguchi K, 2014, MAR MAMMAL SCI, V30, P1199, DOI 10.1111/mms.12105; Josephson E, 2008, FISH FISH, V9, P155, DOI 10.1111/j.1467-2979.2008.00275.x; Ivashchenko Y. V., 2013, Journal of Cetacean Research and Management, V13, P59; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Knowlton AR, 2012, MAR ECOL PROG SER, V466, P293, DOI 10.3354/meps09923; Ivashchenko Yulia V., 2012, Endangered Species Research, V18, P201, DOI 10.3354/esr00443; Gregr EJ, 2009, PROG OCEANOGR, V80, P188, DOI 10.1016/j.pocean.2008.12.004; Belonovich O. A., 2012, 7 C MAR MAMM HOL SUZ; Brownell Robert L. Jr, 2001, Journal of Cetacean Research and Management Special Issue, V2, P269; Burdin A. M., 2004, SC56BRG41; Burdin A. M., 2004, 3 INT C MAR MAMM HOL; Clapham P. J., 2009, IWC SCI COMM M UNPUB; Clapham Phillip J., 2004, Journal of Cetacean Research and Management, V6, P1; Fisheries and Oceans Canada, 2014, SPECIES RISK ACT REC; Fomin S. V., 2012, REPORTS SCI PROGRAMM; Gendron Diane, 1999, Aquatic Mammals, V25, P31; Gregr Edward James, 2011, Endangered Species Research, V15, P223, DOI 10.3354/esr00381; Hoyt E., 2011, MARINE PROTECTED ARE; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; Matsuoka K., 2012, IWC SCI COMM J UNPUB; Matsuoka K., 2014, IWC SCI COMM JUN 201; Miyashita T., 1998, IWC SPEC M SCI COMM; NMFS (National Marine Fisheries Service), 2013, FIN REC PLAN N PAC R; Omura H., 1958, Scientific Reports of the Whales Research Institute Tokyo, VNo. 13, P1; Omura H., 1986, REP INT WHAL COMMN, V10, P35; Scarff J. E., 1991, REPORT INT WHALING C, V41, P467; Shpak O. V., 2012, 7 C MAR MAMM HOL SUZ; Shulezhko T., 2012, 26 EUR CET SOC C GAL; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	OCT	2015	31	4					1559	1567		10.1111/mms.12243		9	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CU1MB	WOS:000363284900015		
J	Hines, E; Chansang, H; Cherdsukjai, P; Thongsukdee, S; Boonyanate, P; Monanunsap, S; Manopawitr, P; Ponnampalam, L; Ilangakoon, A; Akamatsu, T; Ichikawa, K; Kwan, D; Dearden, P				Hines, Ellen; Chansang, Hansa; Cherdsukjai, Phaothep; Thongsukdee, Surasak; Boonyanate, Potchana; Monanunsap, Somchai; Manopawitr, Petch; Ponnampalam, Louisa; Ilangakoon, Anouk; Akamatsu, Tomanari; Ichikawa, Kotaro; Kwan, Donna; Dearden, Phil			DR. KANJANA ADULYANUKOSOL (14 April 1962-10 January 2015)	MARINE MAMMAL SCIENCE			English	Biographical-Item							DUGONG DUGONG-DUGON; CONSERVATION NEEDS; ANDAMAN COAST; THAILAND		[Hines, Ellen] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Dept Geog & Environm, Tiburon, CA 94920 USA; [Chansang, Hansa] Phuket Marine Biol Ctr, Dept Marine & Coastal Resources, Phuket 83000, Thailand; [Cherdsukjai, Phaothep; Thongsukdee, Surasak] Upper Gulf Thailand, Marine & Coastal Resource Res & Dev Ctr, Dept Marine & Coastal Resources, Samut Sakhon, Thailand; [Boonyanate, Potchana] Eastern Gulf Marine & Coastal Resources Res Ctr, Dept Marine & Coastal Resources, Klaeng, Rayong, Thailand; [Monanunsap, Somchai] Southern Marine & Coastal Resources Res Ctr, Dept Marine & Coastal Resources, Songkhla, Thailand; [Manopawitr, Petch] IUCN Asia Reg Off, Bangkok, Thailand; [Ponnampalam, Louisa] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Ponnampalam, Louisa] MareCet Res Org, Shah Alam, Malaysia; [Akamatsu, Tomanari] Fisheries Res Agcy, Kanagana, Japan; [Ichikawa, Kotaro] Kyoto Univ, Kyoto, Japan; [Kwan, Donna] UNEP CMS Dugong MoU Secretariat, Abu Dhabi, U Arab Emirates; [Dearden, Phil] Univ Victoria, Dept Geog, Victoria, BC V8W 2Y2, Canada	Hines, E (reprint author), San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Dept Geog & Environm, Tiburon, CA 94920 USA.	ehines@sfsu.edu					Adulyanukosol K., 2014, BRYDES WHALES UPPER; Adulyanukosol K., 2003, J ENV RES MAHIDOL U, V1, P112; Adulyanukosol Kanjana, 1997, Thai Fisheries Gazette, V50, P359; Adulyanukosol K., 2011, GUIDELINES WHALE WAT; Adulyanukosol K., 1998, P 4 INT SCI S ROL OC, P369; Adulyanukosol K., 2004, NUI LEARN SURVIVE WI; Adulyanukosol K, 2010, THESIS U RYUKYUS OKI; Adulyanukosol K., 2011, BRYDES WHALES THAILA; Adulyanukosol K., 2002, P 6 BRT ANN C 9 12 O, P302; Adulyanukosol K., 1995, P SEM FISH 1995 ROYA, P385; Adulyanukosol K., 2000, P 1 SEASTAR2000 WORK, P33; Adulyanukosol K, 2011, LITTLE EDEN HAPPY SE; Adulyanukosol K., 1999, REPORT AERIAL SURVEY; Adulyanukosol K., 1997, P SEM FISH ROYAL THA; Adulyanukosol K, 2002, THAI FISH GAZ, V55, P47; Adulyanukosol K., 2012, DOLPHIN WHALE WATCHI; Adulyanukosol K., 2002, DUGONG THAILAND STAT; Adulyanukosol K., 2000, Biologia Marina Mediterranea, V7, P191; Adulyanukosol K., 1994, P SEM FISH ROYAL THA, P386; Adulyanukosol K., 2007, CUTE DUGONG; Adulyanukosol K., 1999, P 1 KOR THAIL JOINT; Adulyanukosol K., 1998, DUGONG THAILAND; Amamoto N., 2009, P 4 INT S SEASTAR200, P41; Ichikawa K, 2006, J ACOUST SOC AM, V119, P3726, DOI 10.1121/1.2201468; Hines E, 2005, ENVIRON MANAGE, V36, P654, DOI 10.1007/s00267-003-0287-8; Ichikawa K, 2011, J ACOUST SOC AM, V129, P3623, DOI 10.1121/1.3586791; Hines EM, 2005, MAR MAMMAL SCI, V21, P536, DOI 10.1111/j.1748-7692.2005.tb01247.x; Adulyanukosol K, 2007, MAR BIOL, V151, P1887, DOI 10.1007/s00227-007-0619-y; Hines E, 2008, ORYX, V42, P113, DOI 10.1017/S0030605308000094; Chantrapornsyl S., 1994, P SEM FISH ROYAL THA, P380; Hines E., 2003, POPULATION HABITAT A; Hines E., 2004, CONSERVATION DUGONGS; Hines E., 2001, POPULATION HABITAT A; Ichikawa K., 2012, P AC 2012 FREM, P130; Ichikawa K., 2003, P 4 SEASTAR 2000 WOR, P72; Ichikawa K., 2009, J ACOUST SOC AM, V126, P954; Okumura N., 2006, P OCEANS 2006 AS PAC, DOI [10.1109/OCEANSAP.2006.4393936, DOI 10.1109/OCEANSAP.2006.4393936]; Ponnampalam LS, 2015, ORYX, V49, P743, DOI 10.1017/S0030605313001580; Ponnampalam L., 2013, AQUAT MAMM, V39, P401; Poovachiranon S., 1999, P 1 KOREATHAILAND JO, P84; Sakamoto S., 2005, P 3 INT S SEASTAR200, P69; Shiraki R., 2009, P 4 INT S SEASTAR200, P59; Tsutsumi C., 2006, J ACOUST SOC AM, V120, P1256; Wiayasak W., 1993, 31 TECHN C KAS U SCI, P263	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	OCT	2015	31	4					1587	1593		10.1111/mms.12265		7	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CU1MB	WOS:000363284900018		
J	Bannister, J; Findlay, K; Brownell, RL; Butterworth, D; Cawthorn, M; Donovan, G; Gambell, R; Kato, H; Mate, B; Moore, M; Ohsumi, S; Perrin, W; Reeb, D; Reeves, R; Rowntree, V; Shaughnessy, P				Bannister, John; Findlay, Ken; Brownell, Robert L.; Butterworth, Doug; Cawthorn, Martin; Donovan, Greg; Gambell, Ray; Kato, Hidehiro; Mate, Bruce; Moore, Michael; Ohsumi, Seiji; Perrin, William; Reeb, Desray; Reeves, Randall; Rowntree, Vicky; Shaughnessy, Peter			PETER B. BEST (1939-2015) Memories	MARINE MAMMAL SCIENCE			English	Biographical-Item									[Bannister, John] Western Australian Museum, Welshpool Dc, WA 6986, Australia; [Findlay, Ken] Univ Pretoria, Whale Unit, Mammal Res Inst, ZA-0001 Pretoria, South Africa; [Brownell, Robert L.] NOAA, Granite Canyon Res Stn, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Monterey, CA 93940 USA; [Butterworth, Doug] Univ Cape Town, Dept Math & Appl Math, ZA-7701 Rondebosch, South Africa; [Donovan, Greg] Int Whaling Commiss, Cambridge CB24 9NP, England; [Kato, Hidehiro] Tokyo Univ Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Mate, Bruce] Oregon State Univ, Marine Mammal Inst, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Moore, Michael] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Ohsumi, Seiji] Inst Cetacean Res, Chuou Ku, Tokyo 1040055, Japan; [Reeb, Desray] Bur Ocean Energy Management, Off Renewable Energy Programs, Sterling, VA 20166 USA; [Reeves, Randall] Okapi Wildlife Associates, Hudson, PQ JOP 1HO, Canada; [Rowntree, Vicky] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Shaughnessy, Peter] South Australian Museum, Adelaide, SA 5000, Australia	Bannister, J (reprint author), Western Australian Museum, Locked Bag 49, Welshpool Dc, WA 6986, Australia.	bannisj@bigpond.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	OCT	2015	31	4					1594	1597		10.1111/mms.12277		4	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CU1MB	WOS:000363284900019		
J	Chapellier, B; Tange, S; Tasaki, H; Yoshida, K; Zhou, Y; Sakon, N; Katayama, K; Nakanishi, A				Chapellier, Benoit; Tange, Shoichiro; Tasaki, Hidetaka; Yoshida, Kazuhiro; Zhou, Yan; Sakon, Naomi; Katayama, Kazuhiko; Nakanishi, Akira			Examination of a plasmid-based reverse genetics system for human astrovirus	MICROBIOLOGY AND IMMUNOLOGY			English	Article						animal RNA virus; human astrovirus; reverse genetics system	TERMINAL NSP1A PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; RNA; CELL; DNA; EXPRESSION; SEQUENCE; GENOME; VIRUS; TRANSCRIPTION	A plasmid-based reverse genetics system for human astrovirus type 1 (HAstV1) is examined. Upon transfection into 293T cells, the plasmid vector, which harbors a HAstV1 expression cassette, expressed astroviral RNA that appeared to be capable of viral RNA replication, as indicated by the production of subgenomic RNA and capsid protein expression irrespective of the heterologous 5 ends of the transcribed RNA. Particles infectious to Caco-2 cells were made in this system; however, their infectivity was much lower than would be expected from the amount of particles apparently produced. Using Huh-7 cells as the transfection host with the aim of improving viral capsid processing for virion maturation partially restored the efficiency of infectious particle formation. Our results support the possibility that the DNA transfection process induces a cellular response that targets late, but not early, stages of HAstV1 infection.	[Chapellier, Benoit; Tange, Shoichiro; Tasaki, Hidetaka; Yoshida, Kazuhiro; Zhou, Yan; Nakanishi, Akira] Natl Ctr Geriatr & Gerontol, Dept Aging Intervent, Lab Gene Therapy, Obu, Aichi 4748522, Japan; [Sakon, Naomi] Osaka Prefectural Inst Publ Hlth, Osaka, Osaka 5370025, Japan; [Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Lab Gastroenteritis Viruses, Tokyo 2080011, Japan	Nakanishi, A (reprint author), Natl Ctr Geriatr & Gerontol, Dept Aging Intervent, Sect Gene Therapy, 7-430 Morioka, Obu, Aichi 4748522, Japan.	nakanish@ncgg.go.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [NIBIO-05-27]; Health Labour Sciences Research Grant for Research on Emerging and Re-emerging Infectious Diseases	We thank Drs. Mituaki Oseto (Ehime Hygiene Environmental Institute) and Albert Bosch (University of Barcelona) for providing the HAstV1 virus and pAVIC V DNA, respectively. The initial stages of the study were supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO-05-27 to A.N.), and the later stages, by a Health Labour Sciences Research Grant for Research on Emerging and Re-emerging Infectious Diseases (to A.N.).	Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; MARCZINKE B, 1994, J VIROL, V68, P5588; Trask SD, 2010, P NATL ACAD SCI USA, V107, P18652, DOI 10.1073/pnas.1011948107; NIWA H, 1991, GENE, V108, P193; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Banos-Lara MD, 2010, VIROLOGY, V401, P322, DOI 10.1016/j.virol.2010.02.028; TSURIMOTO T, 1987, P NATL ACAD SCI USA, V84, P444, DOI 10.1073/pnas.84.2.444; ROLLAND V, 1995, J BIOL CHEM, V270, P1102; JIANG BM, 1993, P NATL ACAD SCI USA, V90, P10539, DOI 10.1073/pnas.90.22.10539; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Geigenmuller U, 2002, J GEN VIROL, V83, P1691; PHILIPPE J, 1991, P NATL ACAD SCI USA, V88, P7224, DOI 10.1073/pnas.88.16.7224; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Nakanishi A, 2008, VIROLOGY, V379, P110, DOI 10.1016/j.virol.2008.06.032; Claeyssens S, 2003, AM J PHYSIOL-GASTR L, V285, pG840, DOI 10.1152/ajpgi.00060.2003; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; Guix S, 2005, VIROLOGY, V333, P124, DOI 10.1016/j.virol.2004.12.023; Guix S, 2004, J VIROL, V78, P13627, DOI 10.1128/JVI.78.24.13627-13636.2004; Geigenmuller U, 2002, J VIROL, V76, P2003, DOI 10.1128/JVI.76.4.2003-2008.2002; Bass DM, 2000, J VIROL, V74, P1810, DOI 10.1128/JVI.74.4.1810-1814.2000; Walter JE, 2003, CURR OPIN INFECT DIS, V16, P247, DOI 10.1097/01.qco.0000073775.11390.60; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Guix S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123087; Iwasaki A., 2013, FIELDS VIROLOGY; Katayama K, 2014, P NATL ACAD SCI USA, V111, pE4043, DOI 10.1073/pnas.1415096111; Mendez E., 2013, FIELDS VIROLOGY; Sumpter Rhea Jr, 2005, Journal of Virology, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tange S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-153; Velazquez-Moctezuma R, 2012, J VIROL METHODS, V179, P295, DOI 10.1016/j.jviromet.2011.11.005	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					586	596		10.1111/1348-0421.12317		11	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100002		
J	Tsurudome, Y; Kimachi, K; Okada, Y; Matsuura, K; Ooyama, Y; Ibaragi, K; Kino, Y; Ueda, K				Tsurudome, Yukari; Kimachi, Kazuhiko; Okada, Yusuke; Matsuura, Kenta; Ooyama, Yusuke; Ibaragi, Kayo; Kino, Yoichiro; Ueda, Kohji			Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan	MICROBIOLOGY AND IMMUNOLOGY			English	Article						immunogenicity; inactivated quadrivalent vaccine; influenza; safety	AGED GREATER-THAN-OR-EQUAL-TO-18 YEARS; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS; CHILDREN; CANDIDATE; REACTOGENICITY; LINEAGES	Two antigenically distinct B strain lineages of influenza virus have co-circulated since the mid-1980s; however, inactivated trivalent influenza vaccines contain only one B lineage. The mismatch between the circulating and vaccine lineages has been a worldwide issue. In this study, an inactivated quadrivalent influenza vaccine (QIV) candidate containing two B lineages was manufactured and its immunogenicity and safety evaluated in an open-label, uncontrolled trial. In this phase II trial, 50 subjects aged 20-64 years received two doses of QIV s.c. 1 to 4 weeks apart. Sera were collected pre- and post-vaccination and safety assessed from the first vaccination to 21 +/- 7 days after the second vaccination. After the first vaccination, hemagglutination inhibition titers against each strain increased markedly; the seroconversion rate, geometric mean titer ratio and seroprotection rate being 94.0%, 24.93, and 100.0%, respectively, for the A/H1N1pdm09 strain; 94.0%, 12.47, and 98.0%, respectively, for the A/H3N2 strain; 54.0%, 4.99, and 66.0%, respectively, for B/Yamagata strain, and 72.0%, 6.23 and 80.0%, respectively, for the B/Victoria strain, thus fulfilling the criteria of the European Medical Agency's Committee for Medicinal Products for Human Use. Also, the QIV induced sufficient single radial hemolysis and neutralizing antibodies against all four vaccine strains. No noteworthy adverse events were noted. The results of this trial demonstrate that QIV is well tolerated and immunogenic for each strain, suggesting that QIV potentially improves protection against influenza B by resolving the issue of B lineage mismatch.	[Tsurudome, Yukari; Kimachi, Kazuhiko; Okada, Yusuke; Ibaragi, Kayo; Kino, Yoichiro] Chemo Sero Therapeut Res Inst Kaketsuken, Kikuchi Res Ctr, Kikuchi 8691298, Japan; [Matsuura, Kenta; Ooyama, Yusuke] Chemo Sero Therapeut Res Inst KAKETSUKEN, Kumamoto 8608568, Japan; [Ueda, Kohji] Seinan Jo Gakuin Univ, Kitakyushu, Fukuoka 8030835, Japan	Tsurudome, Y (reprint author), Chemo Sero Therapeut Res Inst Kaketsuken, 1314-1 Kyokushi Kawabe, Kikuchi 8691298, Japan.	tsurudome-yu@kaketsuken.or.jp			Kaketsuken	Yukari Tsurudome, Kazuhiko Kimachi, Yusuke Okada, Kenta Matsuura, Yusuke Ooyama, Kayo Ibaragi and Yoichiro Kino are employees of Kaketsuken. Kohji Ueda belongs to Seinan Jo Gakuin University and advised us about the conduct of this clinical trial. The authors have no potential conflicts of interest. Kaketsuken designed and implemented this trial and evaluated the trial results. Data analysis for this trial was performed by EPS Corporation. Kaketsuken was the sole funding source for this trial.	Greenberg DP, 2013, VACCINE, V31, P770, DOI 10.1016/j.vaccine.2012.11.074; Ikeno D, 2010, MICROBIOL IMMUNOL, V54, P81, DOI 10.1111/j.1348-0421.2009.00191.x; [Anonymous], 2013, ANAL INFLUENZA STRAI, V34, P328; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Block SL, 2012, PEDIATR INFECT DIS J, V31, P745, DOI 10.1097/INF.0b013e31825687b0; Walter EB, 2006, PEDIATRICS, V118, pE570, DOI 10.1542/peds.2006-0198; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; [Anonymous], 2014, ANAL INFLUENZA STRAI, V35, P254; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Clements KM, 2014, HUM VACC IMMUNOTHER, V10, P1171, DOI 10.4161/hv.28221; Pepin S, 2013, VACCINE, V31, P5572, DOI 10.1016/j.vaccine.2013.08.069; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Block SL, 2011, VACCINE, V29, P9391, DOI 10.1016/j.vaccine.2011.09.109; Tinoco JC, 2014, VACCINE, V32, P1480, DOI 10.1016/j.vaccine.2014.01.022; Traynor K, 2012, AM J HEALTH-SYST PH, V69, P538, DOI 10.2146/news120021; Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Langley JM, 2013, J INFECT DIS, V208, P544, DOI 10.1093/infdis/jit263; [Anonymous], 2012, ANAL INFLUENZA STRAI, V33, P288; Suryadevara M, 2014, HUM VACC IMMUNOTHER, V10, P596, DOI 10.4161/hv.27115; European Medicines Agency, 1997, CPMPBWP21496 EUR MED; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Lo YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058222; Meier G., 2015, J MED ECON, V1, P1; National Institute of Infectious Diseases (NIID), 2010, ANN REP 2010 NAT EP; Newall AT, 2014, VACCINE, V32, P1323, DOI 10.1016/j.vaccine.2014.01.017; Odagiri T., 2012, PEDIATR JPN, V53, P1355; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; WHO, REC COMP INFL VIR VA; WHO, 2002, WHO MAN AN INFL DIAG; You JHS, 2015, HUM VACC IMMUNOTHER, V11, P564, DOI 10.1080/21645515.2015.1011016	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					597	604		10.1111/1348-0421.12316		8	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100003		
J	Do, LP; Doan, YH; Nakagomi, T; Gauchan, P; Kaneko, M; Agbemabiese, C; Dang, AD; Nakagomi, O				Do, Loan Phuong; Doan, Yen Hai; Nakagomi, Toyoko; Gauchan, Punita; Kaneko, Miho; Agbemabiese, Chantal; Anh Duc Dang; Nakagomi, Osamu			Whole genome analysis of Vietnamese G2P[4] rotavirus strains possessing the NSP2 gene sharing an ancestral sequence with Chinese sheep and goat rotavirus strains	MICROBIOLOGY AND IMMUNOLOGY			English	Article						NSP2; NSP4; rotavirus; Vietnam	MOLECULAR EPIDEMIOLOGY; VACCINATION PROGRAMS; GENOTYPE; CHILDREN; CIRCULATION; POPULATION; FOOTPRINTS; DIVERSITY; DS-1-LIKE; AFRICA	Because imminent introduction into Vietnam of a vaccine against Rotavirus A is anticipated, baseline information on the whole genome of representative strains is needed to understand changes in circulating strains that may occur after vaccine introduction. In this study, the whole genomes of two G2P[4] strains detected in Nha Trang, Vietnam in 2008 were sequenced, this being the last period during which virtually no rotavirus vaccine was used in this country. The two strains were found to be > 99.9% identical in sequence and had a typical DS-1 like G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2 genotype constellation. Analysis of the Vietnamese strains with > 184 G2P[4] strains retrieved from GenBank/EMBL/DDBJ DNA databases placed the Vietnamese strains in one of the lineages commonly found among contemporary strains, with the exception of the NSP2 and NSP4 genes. The NSP2 genes were found to belong to a previously undescribed lineage that diverged from Chinese sheep and goat rotavirus strains, including a Chinese rotavirus vaccine strain LLR with 95% nucleotide identity; the time of their most recent common ancestor was 1975. The NSP4 genes were found to belong, together with Thai and USA strains, to an emergent lineage (VIII), adding further diversity to ever diversifying NSP4 lineages. Thus, there is a need to enhance surveillance of locallycirculating strains from both children and animals at the whole genome level to address the effect of rotavirus vaccines on changing strain distribution.	[Do, Loan Phuong; Doan, Yen Hai; Nakagomi, Toyoko; Gauchan, Punita; Kaneko, Miho; Agbemabiese, Chantal; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, Nagasaki 8528523, Japan; [Do, Loan Phuong; Anh Duc Dang] Natl Inst Hyg & Epidemiol, Hanoi 112800, Vietnam	Nakagomi, O (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	onakagom@nagasaki-u.ac.jp			Ministry of Health, Labour, and Welfare, Japan; Japan Agency for Medical Research and Development	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Health, Labour, and Welfare, Japan, and a grant from the Japan Agency for Medical Research and Development.	Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004; Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z; Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Chen YJ, 2009, VIRUS GENES, V38, P302, DOI 10.1007/s11262-009-0332-7; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Luchs A, 2015, J MED VIROL, V87, P1881, DOI 10.1002/jmv.24241; Doan YH, 2012, INFECT GENET EVOL, V12, P1202, DOI 10.1016/j.meegid.2012.04.023; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Dennis AF, 2014, J VIROL, V88, P3789, DOI 10.1128/JVI.03516-13; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276; Page NA, 2004, J CLIN MICROBIOL, V42, P595, DOI 10.1128/JCM.42.2.595-600.2004; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Matsushima Y, 2012, J VIROL, V86, P10236, DOI 10.1128/JVI.01588-12; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Wu FT, 2014, INFECT GENET EVOL, V28, P530, DOI 10.1016/j.meegid.2014.09.033; Nakagomi T, 2009, VACCINE, V27, pF93, DOI 10.1016/j.vaccine.2009.08.067; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Cunliffe N. A., 2012, Medical microbiology: a guide to microbial infections: pathogenesis, immunity, laboratory investigation and control, P559; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Estes M.K., 2013, FIELDS VIROLOGY, P1347; Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070; Le T. L., 2013, J PREV MED, V13, P73; Nei M, 2000, MOL EVOLUTION PHYLOG; Nyaga MM, 2014, VIRUS GENES, V49, P196, DOI 10.1007/s11262-014-1091-7; Page NA, 2004, J MED VIROL, V72, P320, DOI 10.1002/jmv.10571; Papp Hajnalka, 2014, VirusDisease, V25, P215, DOI 10.1007/s13337-014-0203-2; Rambaut A, 2014, TRACER V1 6; Van Trang Nguyen, 2014, J Clin Microbiol, V52, P1366, DOI 10.1128/JCM.02927-13; World Health Organisation, 2009, WKLY EPIDEMIOL REC, V86, P533; World Health Organisation, 2012, GLOB ROT INF SURV B	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					605	613		10.1111/1348-0421.12323		9	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100004		
J	Hasibuan, FM; Shiratori, B; Senoputra, MA; Chagan-Yasutan, H; Koesoemadinata, RC; Apriani, L; Takahashi, Y; Niki, T; Alisjahbana, B; Hattori, T				Hasibuan, Fakhrial Mirwan; Shiratori, Beata; Senoputra, Muhammad Andrian; Chagan-Yasutan, Haorile; Koesoemadinata, Raspati Cundarani; Apriani, Lika; Takahashi, Yayoi; Niki, Toshiro; Alisjahbana, Bachti; Hattori, Toshio			Evaluation of matricellular proteins in systemic and local immune response to Mycobacterium tuberculosis infection	MICROBIOLOGY AND IMMUNOLOGY			English	Article						galectin-9; osteopontin; tenascin-C; tuberculosis	TENASCIN-C; LATENT TUBERCULOSIS; IFN-GAMMA; OSTEOPONTIN; GALECTIN-9; DISEASE; EXPRESSION; CELLS; MICE; INFLAMMATION	Matricellular proteins such as osteopontin (OPN), galectin-9 (Gal-9), and tenascin-C (TN-C) are expressed not only under normal physiological conditions, but also during infection, inflammation and tumorigenesis. Plasma concentrations of matricellular proteins were studied to determine their diagnostic value as potential markers of tuberculosis (TB) activity. It was found that concentrations of OPN and TN-C were higher in patients with active TB than in healthy controls and individuals with latent infection. Moreover, LTBI patients had higher concentrations of OPN than did healthy controls. Gal-9 concentrations did not differ significantly between groups. Concentrations of matricellular proteins were higher in pleural fluid than in the plasma of patients with TB. Expression of matricellular proteins was also investigated in TB granulomas and other granulomatous diseases. Positive OPN and Gal-9 staining was observed in TB and sarcoidosis granulomas, but not in Crohn disease granulomas. The fibrotic ring around granulomas stained positive for TN-C in TB and sarcoidosis, but not in Crohn disease. Of the three matricellular proteins studied, OPN and TN-C may serve as reliable plasma markers for monitoring TB activity, whereas Gal-9 seems to be expressed more at the site of infection than in the systemic circulation.	[Hasibuan, Fakhrial Mirwan; Shiratori, Beata; Senoputra, Muhammad Andrian; Chagan-Yasutan, Haorile; Hattori, Toshio] Tohoku Univ, Grad Sch Med, Div Emerging Infect Dis, Sendai, Miyagi 9808574, Japan; [Hasibuan, Fakhrial Mirwan; Senoputra, Muhammad Andrian; Hattori, Toshio] Tohoku Univ, Int Res Inst Disaster Sci, Publ Hlth Sci Program, Sendai, Miyagi 9808574, Japan; [Shiratori, Beata; Chagan-Yasutan, Haorile] Tohoku Univ, Int Res Inst Disaster Sci, Div Disaster Related Infect Dis, Sendai, Miyagi 9808574, Japan; [Koesoemadinata, Raspati Cundarani; Apriani, Lika; Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, TB HIV Res Ctr, Bandung 40161, West Java, Indonesia; [Takahashi, Yayoi] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Niki, Toshiro] GalPharma Co, Div Res, Takamatsu, Kagawa 7600301, Japan	Hattori, T (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, Div Disaster Related Infect Dis, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	toshatto@med.tohoku.ac.jp			Scientific Research Expenses for Health and Welfare program from the Ministry of Health, Labour and Welfare, Japan; Science and Technology Research Partnership for Sustainable Development from the Japan Science and Technology Agency, Japan; Research Centre for Zoonosis Control at Hokkaido University; International Research Institute of Disaster Science of Tohoku University (IRIDeS)	This work was supported by the Scientific Research Expenses for Health and Welfare program from the Ministry of Health, Labour and Welfare, Japan, the Science and Technology Research Partnership for Sustainable Development from the Japan Science and Technology Agency, Japan, collaborative funding from the Research Centre for Zoonosis Control at Hokkaido University and a special research grant from the International Research Institute of Disaster Science of Tohoku University (IRIDeS). We are grateful to Professor Kiyoshi Ito from Tohoku University, Disaster Obstetrics and Gynecology, for providing histopathological specimens.	Kuriyama N, 2011, HEPATOLOGY, V54, P2125, DOI 10.1002/hep.24639; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Ellis SL, 2013, EXP HEMATOL, V41, P1050, DOI 10.1016/j.exphem.2013.09.009; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; Wada J, 1997, J BIOL CHEM, V272, P6078; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Uede T, 1997, MICROBIOL IMMUNOL, V41, P641; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; Kaarteenaho-Wiik R, 2007, HUM PATHOL, V38, P147, DOI 10.1016/j.humpath.2006.07.001; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115; Gieseke F, 2013, EUR J IMMUNOL, V43, P2741, DOI 10.1002/eji.201343335; Khajoee V, 2006, CLIN EXP IMMUNOL, V143, P260, DOI 10.1111/j.1365-2249.2005.02985.x; Chagan-Yasutan H, 2011, LEUKEMIA RES, V35, P1484, DOI 10.1016/j.leukres.2011.05.011; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279; Nau GJ, 2000, AM J PATHOL, V157, P37, DOI 10.1016/S0002-9440(10)64514-2; Nau GJ, 1999, INFECT IMMUN, V67, P4223; O'Regan AW, 2001, AM J RESP CRIT CARE, V164, P2243, DOI 10.1164/rccm2104139; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Ridruechai C, 2011, SE ASIAN J TROP MED, V42, P876; Ungerer C, 2014, STEM CELLS DEV, V23, P755, DOI 10.1089/scd.2013.0335; Kaarteenaho-Wiik R, 2000, J HISTOCHEM CYTOCHEM, V48, P1257, DOI 10.1177/002215540004800909; Sada-Ovalle I, 2012, J IMMUNOL, V189, P5896, DOI 10.4049/jimmunol.1200990; Shiratori B, 2012, ANTIMICROB AGENTS CH, V56, P2868, DOI 10.1128/AAC.06062-11; Bornstein P, 2000, MATRIX BIOL, V19, P555, DOI 10.1016/S0945-053X(00)00103-7; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; Rabinovich GA, 2002, J LEUKOCYTE BIOL, V71, P741; Al Shammari B, 2015, J INFECT DIS, V212, P463, DOI 10.1093/infdis/jiv076; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Ladel CH, 1997, INFECT IMMUN, V65, P4843; Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Cowan J., 2011, CLIN EXP IMMUNOL, V167, P317; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69; Senoputra MA, 2015, DIAGN MICR INFEC DIS, V83, P278, DOI 10.1016/j.diagmicrobio.2015.07.021; Shiratori B, 2014, MEDIAT INFLAMM, V2014; World Health Organization, GLOB TUB REP 2013	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					623	632		10.1111/1348-0421.12320		10	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100006		
J	Sato, H; Oshiumi, H; Takaki, H; Hikono, H; Seya, T				Sato, Haruko; Oshiumi, Hiroyuki; Takaki, Hiromi; Hikono, Hirokazu; Seya, Tsukasa			Evolution of the DEAD box helicase family in chicken: chickens have no DHX9 ortholog	MICROBIOLOGY AND IMMUNOLOGY			English	Article						chicken innate immunity; DEAD box helicase; phylogeny; type I interferon	PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; RIG-I; INNATE IMMUNITY; RNA HELICASE; TRANSCRIPTIONAL REGULATION; VIRUS-INFECTION; GENE FAMILY; INFLUENZA; IDENTIFICATION	Viral RNA represents a pattern molecule that can be recognized by RNA sensors in innate immunity. Humans and mice possess cytoplasmic DNA/RNA sensors for detecting viral replication. There are a number of DEAD (Asp-Glu-Ala-Asp; DExD/H) box-type helicases in mammals, among which retinoic acid-inducible gene 1 (RIG-I) and melanoma differentiation-associated protein 5 (MDA50) are indispensable for RNA sensing; however, they are functionally supported by a number of sensors that directly bind viral RNA or replicative RNA intermediates to convey signals to RIG-I and MDA5. Some DEAD box helicase members recognize DNA irrespective of the origin. These sensors transmit IFN-inducing signals through adaptors, including mitochondrial antiviral signaling. Viral double-stranded RNAs are reportedly sensed by the helicases DDX1, DDX21, DHX36, DHX9, DDX3, DDX41, LGP2 and DDX60, in addition to RIG-I and MDA5, and induce type I IFNs, thereby blocking viral replication. Humans and mice have all nucleic acid sensors listed here. In the RNA sensing system in chicken, it was found in the present study that most DEAD box helicases are conserved; however, DHX9 is genetically deficient in addition to reported RIG-I. Based on the current genome databases, similar DHX9 deficiency was observed in ducks and several other bird species. Because chicken, but not duck, was found to be deficient in RIG-I, the RNA-sensing system of chicken lacks RIG-I and DHX9 and is thus more fragile than that of duck or mammal. DHX9 may generally compensate for the function of RIG-I and deficiency of DHX9 possibly participates in exacerbations of viral infection such as influenza in chickens.	[Sato, Haruko; Oshiumi, Hiroyuki; Takaki, Hiromi; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Hikono, Hirokazu] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3058642, Japan	Seya, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	seya-tu@pop.med.hokudai.ac.jp	OSHIUMI, HIROYUKI/G-1645-2012		Ministry of Agriculture, Forestry, and Fisheries of Japan	We are grateful to our laboratory colleagues for their invaluable discussions and to Drs. H. Kida (CZC, Hokkaido University, Sapporo), T. Saito (National Institute of Animal Health, Tsukuba) and H. Hasegawa (National Institute of Infectious Diseases, Tokyo) for valuable discussions. This work was supported in part by a Grant-in-Aid for Scientific Research from the Zoonoses Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Oshiumi H, 2015, CELL REP, V11, P1193, DOI 10.1016/j.celrep.2015.04.047; Oshiumi H, 2005, J IMMUNOL, V175, P1724; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Hikono H, 2013, VET IMMUNOL IMMUNOP, V151, P83, DOI 10.1016/j.vetimm.2012.10.005; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Fujii R, 2001, J BIOL CHEM, V276, P5445, DOI 10.1074/jbc.M006892200; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Kotani M, 2010, HYBRIDOMA, V29, P259, DOI 10.1089/hyb.2009.0107; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Fuchsova B, 2002, J CELL BIOL, V158, P463, DOI 10.1083/jcb.200202035; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Keestra AM, 2013, DEV COMP IMMUNOL, V41, P316, DOI 10.1016/j.dci.2013.04.009; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Cornelissen JBWJ, 2013, AVIAN PATHOL, V42, P347, DOI 10.1080/03079457.2013.807325; Liu Y, 2014, CELL MOL IMMUNOL, V11, P49, DOI 10.1038/cmi.2013.40; Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; Ariumi Yasuo, 2014, Frontiers in Genetics, V5, P423, DOI 10.3389/fgene.2014.00423; Fuku A, 2001, J BIOL CHEM, V276, P47143, DOI 10.1074/jbc.M103902200; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SEYA T, 1985, J IMMUNOL, V135, P2661; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					633	640		10.1111/1348-0421.12322		8	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100007		
J	Kanaly, RA; Micheletto, R; Matsuda, T; Utsuno, Y; Ozeki, Y; Hamamura, N				Kanaly, Robert A.; Micheletto, Ruggero; Matsuda, Tomonari; Utsuno, Youko; Ozeki, Yasuhiro; Hamamura, Natsuko			Application of DNA adductomics to soil bacterium Sphingobium sp strain KK22	MICROBIOLOGYOPEN			English	Article						Acrolein; bacterium; DNA adductomics; DNA adducts; LC-MS/MS; Sphingobium	TANDEM MASS-SPECTROMETRY; LIPID-PEROXIDATION; ESCHERICHIA-COLI; 1,N(2)-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-PROPANODEOXYGUANOSINE ADDUCTS; DEOXYGUANOSINE ADDUCTS; PURINE NUCLEOSIDES; MUTATION ASSAY; CROSS-LINKS; HUMAN LUNG	Toward the development of ecotoxicology methods to investigate microbial markers of impacts of hydrocarbon processing activities, DNA adductomic analyses were conducted on a sphingomonad soil bacterium. From growing cells that were exposed or unexposed to acrolein, a commonly used biocide in hydraulic fracturing processes, DNA was extracted, digested to 2'-deoxynucleosides and analyzed by liquid chromatography-positive ionization electrospray-tandem mass spectrometry in selected reaction monitoring mode transmitting the [M + H](+) > [M + H - 116](+) transition over 100 transitions. Overall data shown as DNA adductome maps revealed numerous putative DNA adducts under both conditions with some occurring specifically for each condition. Adductomic analyses of triplicate samples indicated that elevated levels of some targeted putative adducts occurred in exposed cells. Two exposure-specific adducts were identified in exposed cells as 3-(2'-deoxyribosyl)-5,6,7,8-tetrahydro-6-hydroxy- (and 8-hydroxy-)pyrimido[1,2-a]-purine-(3H)-one (6- and 8-hydroxy-PdG) following synthesis of authentic standards of these compounds and subsequent analyses. A time course experiment showed that 6- and 8-hydroxy-PdG were detected in bacterial DNA within 30 min of acrolein exposure but were not detected in unexposed cells. This work demonstrated the first application of DNA adductomics to examine DNA damage in a bacterium and sets a foundation for future work.	[Kanaly, Robert A.; Utsuno, Youko; Ozeki, Yasuhiro] Yokohama City Univ, Dept Life & Environm Syst Sci, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Micheletto, Ruggero] Yokohama City Univ, Dept Nanosyst Sci, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Hamamura, Natsuko] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan; [Hamamura, Natsuko] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Kanaly, RA (reprint author), Yokohama City Univ, Dept Life & Environm Syst Sci, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	kanaly@yokohama-cu.ac.jp			Yokohama City University Strategic Research Grant [K20002]; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [26505010]; JSPS NEXT Program Grant [GS023]	This work was supported in part by Yokohama City University Strategic Research Grant, K20002 and the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 26505010 to R. K., and the JSPS NEXT Program Grant GS023 to N. H.	Szyf M, 2011, TOXICOL SCI, V120, P235, DOI 10.1093/toxsci/kfr024; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Nath RG, 1996, CANCER RES, V56, P452; Zhang SY, 2007, CHEM RES TOXICOL, V20, P565, DOI 10.1021/tx700023z; Hua YS, 2001, J AM SOC MASS SPECTR, V12, P80, DOI 10.1016/S1044-0305(00)00191-4; Kanaly R, 1997, APPL ENVIRON MICROB, V63, P4511; Kanaly RA, 2013, CHEMOSPHERE, V92, P1442, DOI 10.1016/j.chemosphere.2013.03.054; Tompkins EM, 2008, RAPID COMMUN MASS SP, V22, P19, DOI 10.1002/rcm.3328; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Maeda AH, 2014, MICROB BIOTECHNOL, V7, P114, DOI 10.1111/1751-7915.12102; MARINELLI ER, 1990, CHEM RES TOXICOL, V3, P49, DOI 10.1021/tx00013a009; Kawai K, 2010, CHEM RES TOXICOL, V23, P630, DOI 10.1021/tx9003819; Swenberg JA, 2008, CHEM RES TOXICOL, V21, P253, DOI 10.1021/tx700408t; FUJII T, 1990, CHEM PHARM BULL, V38, P3326; Gaskell M, 2004, MUTAT RES-FUND MOL M, V554, P387, DOI 10.1016/j.mrfmmm.2004.06.032; Singh R, 2010, RAPID COMMUN MASS SP, V24, P2329, DOI 10.1002/rcm.4645; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Wu KY, 1999, CARCINOGENESIS, V20, P1787, DOI 10.1093/carcin/20.9.1787; FOILES PG, 1989, CARCINOGENESIS, V10, P87, DOI 10.1093/carcin/10.1.87; Loureiro APM, 2004, CHEM RES TOXICOL, V17, P641, DOI 10.1021/tx034225; Nath RG, 1998, CANCER RES, V58, P581; Kanaly RA, 2007, MUTAT RES-FUND MOL M, V625, P83, DOI 10.1016/j.mrfmmm.2007.05.006; Kanaly RA, 2000, APPL ENVIRON MICROB, V66, P4205, DOI 10.1128/AEM.66.10.4205-4211.2000; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; Chen HJC, 1996, CHEM RES TOXICOL, V9, P306, DOI 10.1021/tx9501389; Pradenas GA, 2012, MICROBIOL-SGM, V158, P1279, DOI 10.1099/mic.0.056903-0; Nakamura J, 2014, DNA REPAIR, V19, P3, DOI 10.1016/j.dnarep.2014.03.031; Yang IY, 2002, BIOCHEMISTRY-US, V41, P13826, DOI 10.1021/bi0264723; Kamat SS, 2011, J AM CHEM SOC, V133, P2080, DOI 10.1021/ja110157u; Kanaly RA, 2006, ANTIOXID REDOX SIGN, V8, P993, DOI 10.1089/ars.2006.8.993; Beland FA, 2005, CHEM RES TOXICOL, V18, P1306, DOI 10.1021/tx050068y; Li HY, 2009, J MASS SPECTROM, V44, P641, DOI 10.1002/jms.1539; CHUNG FL, 1984, CANCER RES, V44, P990; Kadlubar FF, 1998, MUTAT RES-FUND MOL M, V405, P125, DOI 10.1016/S0027-5107(98)00129-8; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Beach DG, 2011, ANAL CHEM, V83, P9107, DOI 10.1021/ac202044h; Pradenas GA, 2013, BIOMED RES INT, DOI 10.1155/2013/563756; KAMBARA H, 1982, ANAL CHEM, V54, P143, DOI 10.1021/ac00238a044; Cheng G, 2003, CHEM RES TOXICOL, V16, P145, DOI 10.1021/tx025614r; Balbo S, 2014, CHEM RES TOXICOL, V27, P356, DOI 10.1021/tx4004352; Spilsberg B, 2010, J AGR FOOD CHEM, V58, P6370, DOI 10.1021/jf903065a; Nordone AJ, 1996, CHEMOSPHERE, V32, P807, DOI 10.1016/0045-6535(95)00371-1; Cunliffe M, 2006, APPL MICROBIOL BIOT, V72, P1083, DOI 10.1007/s00253-006-0374-x; Matsuda T, 2013, CARCINOGENESIS, V34, P121, DOI 10.1093/carcin/bgs327; Balbo S, 2014, ANAL CHEM, V86, P1744, DOI 10.1021/ac403565m; FARMER PB, 1973, BIOCHEM J, V135, P203; Nakao LS, 1998, CHEM RES TOXICOL, V11, P888, DOI 10.1021/tx9800351; Chou PH, 2010, CHEM RES TOXICOL, V23, P1442, DOI 10.1021/tx100047d; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; Kunihiro M, 2013, APPL ENVIRON MICROB, V79, P4410, DOI 10.1128/AEM.01129-13; Tretyakova N, 2013, CHEM REV, V113, P2395, DOI 10.1021/cr300391r; Dudley E, 2004, RAPID COMMUN MASS SP, V18, P2730, DOI 10.1002/rcm.1685; Singh R, 2006, CARCINOGENESIS, V27, P178, DOI 10.1093/carcin/bgi260; DONNELLY KC, 1995, ENVIRON TOXICOL CHEM, V14, P1281, DOI 10.1897/1552-8618(1995)14[1281:MPOESB]2.0.CO;2; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Vandegehuchte MB, 2014, MUTAT RES-GEN TOX EN, V764, P36, DOI 10.1016/j.mrgentox.2013.08.008; Chen HJC, 2010, ANAL CHEM, V82, P4486, DOI 10.1021/ac100391f; Kanuri M, 2002, CHEM RES TOXICOL, V15, P1572, DOI 10.1021/tx025591g; Ishii Y, 2014, ANAL BIOANAL CHEM, V406, P2467, DOI 10.1007/s00216-014-7621-2; Nechev LV, 2000, CHEM RES TOXICOL, V13, P421, DOI 10.1021/tx990167+; HEMMINKI K, 1980, ARCH TOXICOL, V46, P277, DOI 10.1007/BF00310445; Selzer RR, 1996, CHEM RES TOXICOL, V9, P875, DOI 10.1021/tx960039a; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Kim YH, 2003, ARCH BIOCHEM BIOPHYS, V416, P209, DOI 10.1016/S0003-9861(03)00297-2; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Bessette E. E., 2008, ANAL CHEM, V81, P809; Cabiscol E., 2010, J INT MICROBIOL, V3, P3; CHENNA A, 1993, CHEM RES TOXICOL, V6, P261, DOI 10.1021/tx00033a003; da Costa GG, 2003, CHEM RES TOXICOL, V16, P1328, DOI 10.1021/tx034108e; Kertesz M. A., 2010, HDB HYDROCARBON LIPI, P1694; Maeda AH, 2015, INT J SYST EVOL MICR, V65, P2919, DOI 10.1099/ijs.0.000356; Maeda A. H., 2013, GENOME ANNOUNC, V1; Pawowicz A. J., 2006, BIOORG CHEM, V34, P39; Pawowicz A. J, 2008, CHEM BIODIVERS, V5, P177; Penkala J., 2004, CORROSION; US EPA (United States Environmental Protection Agency), 2000, EPA453R000005 OFF PL; vansDorst J, 2014, APPL ENVIRON MICROB, V80, P4021	80	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-8827			MICROBIOLOGYOPEN	MicrobiologyOpen	OCT	2015	4	5					841	856		10.1002/mbo3.283		16	Microbiology	Microbiology	CU3LS	WOS:000363427500012		
J	Fujiki, M; Miyamoto, S; Sakuraba, M				Fujiki, Masahide; Miyamoto, Shimpei; Sakuraba, Minoru			Flow-through anastomosis for both the artery and vein in leg free flap transfer	MICROSURGERY			English	Article							END-TO-SIDE; FREE-TISSUE TRANSFERS; LOWER-EXTREMITY; RECONSTRUCTION; SELECTION; VELOCITY; DEFECTS; PATENCY	ObjectiveFree flap transfer is an essential part of limb-sparing surgery for leg sarcoma; however, this procedure is associated with a high failure rate. The aim of this study was to identify factors that contribute to microvascular compromise and flap failure for leg free flap transfer, while focusing on anastomotic techniques (end-to-end, end-to-side, and flow-through anastomoses). Patients and methodsData from 56 consecutive patients who underwent leg free flap transfer after oncologic resection were retrospectively reviewed. Of these patients, flow-through anastomosis was performed with the artery in 29 and the vein in 24, whereas conventional techniques were performed in others. The variables contributing to microvascular compromise and flap failure were statistically analyzed. ResultsVenous thrombosis (four patients, 7.1%) was more frequent than arterial thrombosis (one patient, 1.8%) and (4 patients, 7.1%) resulted in flap loss. All anastomotic failures occurred in end-to-end anastomoses. All flow-through anastomoses achieved patency both for the artery and vein. No anastomotic failure or flap loss occurred in 22 flaps which were transferred with flow-through anastomosis for both the artery and vein. Flow-through venous anastomosis tended to have a lower rate of microvascular compromise and flap loss than conventional techniques (P=0.13 and 0.25, respectively). ConclusionThe key to successful leg free flap transfer is to prevent venous failure; thus, flow-through venous anastomosis may be a breakthrough solution. Preferential use of flow-through anastomosis for both the artery and vein can provide predictable results in leg free flap transfer. (c) 2015 Wiley Periodicals, Inc. Microsurgery 35:536-540, 2015.	[Fujiki, Masahide; Miyamoto, Shimpei] Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, Tokyo 1040045, Japan; [Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kashiwa, Chiba, Japan	Fujiki, M (reprint author), Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mfujiki@ncc.go.jp					Dotson RJN, 1998, MICROSURG, V18, P125, DOI 10.1002/(SICI)1098-2752(1998)18:2<125::AID-MICR11>3.0.CO;2-#; ALBERTENGO JB, 1981, PLAST RECONSTR SURG, V67, P194, DOI 10.1097/00006534-198167020-00009; Koshima I, 1999, PLAST RECONSTR SURG, V103, P1483, DOI 10.1097/00006534-199904050-00021; Muramatsu K, 2001, MICROSURG, V21, P362, DOI 10.1002/micr.21807; Hanasono MM, 2009, J RECONSTR MICROSURG, V25, P417, DOI 10.1055/s-0029-1223850; Barner-Rasmussen I, 2009, BRIT J SURG, V96, P482, DOI 10.1002/bjs.6581; Koshima I, 2005, PLAST RECONSTR SURG, V115, P155, DOI 10.1097/01.PRS.0000146870.33661.E7; GODINA M, 1979, PLAST RECONSTR SURG, V64, P673, DOI 10.1097/00006534-197964050-00013; Miyamoto S, 2008, PLAST RECONSTR SURG, V122, P449, DOI 10.1097/PRS.0b013e31817d62c5; Fischer JP, 2013, J RECONSTR MICROSURG, V29, P407, DOI 10.1055/s-0033-1343952; Kim JT, 2008, J PLAST RECONSTR AES, V61, P1157, DOI 10.1016/j.bjps.2008.03.048; Jang YJ, 2014, J PLAST RECONSTR AES, V67, P1136, DOI 10.1016/j.bjps.2014.04.021; Ridgway EB, 2010, J RECONSTR MICROSURG, V26, P559, DOI 10.1055/s-0030-1263292; Bodor R, 1997, J RECONSTR MICROSURG, V13, P463, DOI 10.1055/s-2007-1006426; Wettstein R, 2008, J PLAST RECONSTR AES, V61, P772, DOI 10.1016/j.bjps.2007.11.037; Lorenzo AR, 2011, J PLAST RECONSTR AES, V64, P649, DOI 10.1016/j.bjps.2010.07.028; Sakurai H, 2009, MICROSURG, V29, P101, DOI 10.1002/micr.20570; FRODEL J L, 1986, Microsurgery, V7, P117, DOI 10.1002/micr.1920070304; Miyamoto S, 2014, PLAST RECONSTR SURG, V7, pe127	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	OCT	2015	35	7					536	540		10.1002/micr.22476		5	Surgery	Surgery	CU3IN	WOS:000363418000006		
J	Yamamoto, T; Mito, D; Hayashi, A; Narushima, M				Yamamoto, Takumi; Mito, Daisuke; Hayashi, Akitatsu; Narushima, Mitsunaga			Multiple-in-one concept for lymphatic supermicrosurgery	MICROSURGERY			English	Letter							ANASTOMOSIS		[Yamamoto, Takumi; Mito, Daisuke; Hayashi, Akitatsu; Narushima, Mitsunaga] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2015, MICROSURG, V35, P129, DOI 10.1002/micr.22272	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	OCT	2015	35	7					588	589		10.1002/micr.22345		2	Surgery	Surgery	CU3IN	WOS:000363418000015		
J	Miyamoto, Y; Torii, T; Takada, S; Ohno, N; Saitoh, Y; Nakamura, K; Ito, A; Ogata, T; Terada, N; Tanoue, A; Yamauchi, J				Miyamoto, Yuki; Torii, Tomohiro; Takada, Shuji; Ohno, Nobuhiko; Saitoh, Yurika; Nakamura, Kazuaki; Ito, Akihito; Ogata, Toru; Terada, Nobuo; Tanoue, Akito; Yamauchi, Junji			Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination	MOLECULAR BIOLOGY OF THE CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; TYROSINE KINASE; PROTEIN-S; GAS6; PHOSPHORYLATION; MIGRATION; FAMILY; SRC; DEMYELINATION; NEUREGULIN-1	During early development of the peripheral nervous system, Schwann cell precursors proliferate, migrate, and differentiate into premyelinating Schwann cells. After birth, Schwann cells envelop neuronal axons with myelin sheaths. Although some molecular mechanisms underlying myelination by Schwann cells have been identified, the whole picture remains unclear. Here we show that signaling through Tyro3 receptor tyrosine kinase and its binding partner, Fyn nonreceptor cytoplasmic tyrosine kinase, is involved in myelination by Schwann cells. Impaired formation of myelin segments is observed in Schwann cell neuronal cultures established from Tyro3-knockout mouse dorsal root ganglia (DRG). Indeed, Tyro3-knockout mice exhibit reduced myelin thickness. By affinity chromatography, Fyn was identified as the binding partner of the Tyro3 intracellular domain, and activity of Fyn is downregulated in Tyro3-knockout mice, suggesting that Tyro3, acting through Fyn, regulates myelination. Ablating Fyn in mice results in reduced myelin thickness. Decreased myelin formation is observed in cultures established from Fyn-knockout mouse DRG. Furthermore, decreased kinase activity levels and altered expression of myelination-associated transcription factors are observed in these knockout mice. These results suggest the involvement of Tyro3 receptor and its binding partner Fyn in Schwann cell myelination. This constitutes a newly recognized receptor-linked signaling mechanism that can control Schwann cell myelination.	[Miyamoto, Yuki; Torii, Tomohiro; Nakamura, Kazuaki; Tanoue, Akito; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan; [Takada, Shuji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Setagaya Ku, Tokyo 1578535, Japan; [Ohno, Nobuhiko; Saitoh, Yurika] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi 4093898, Japan; [Ito, Akihito] Nissei Bilis, Res Ctr, Koga, Shiga 5280052, Japan; [Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan; [Terada, Nobuo] Shinshu Univ, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Yamauchi, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan	Yamauchi, J (reprint author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan.	yamauchi-j@ncchd.go.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare; Takeda Foundation	We thank K. Ikenaka, Y. Matsubara, H. Saito, and A. Umezawa for helpful discussions and acknowledge H. Sakonjo and T. Amano for measuring the nerve conduction velocity. We also thank C. Rowthorn and W. Fumanski for reading the manuscript. This work was supported by Grants-in-Aid for Young Scientist Research B, Scientific Research C, Scientific Research B, and Scientific Research on Innovative Areas (Glial assembly: a new regulatory machinery of brain function and disorders) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor, and Welfare and partially by the Takeda Foundation.	Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Li RH, 1996, J NEUROSCI, V16, P2012; Miyamoto Y, 2012, CELL SIGNAL, V24, P2061, DOI 10.1016/j.cellsig.2012.06.013; Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Hossain S, 2010, EXP NEUROL, V226, P47, DOI 10.1016/j.expneurol.2010.08.002; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Sperber BR, 2001, J NEUROSCI, V21, P2039; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Terada N, 2013, HISTOCHEM CELL BIOL, V140, P213, DOI 10.1007/s00418-012-1073-6; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Ratner N, 2006, METHOD ENZYMOL, V407, P22, DOI 10.1016/S0076-6879(05)07003-5; Yamauchi J, 2010, J NEUROSCI RES, V88, P3189, DOI 10.1002/jnr.22460; Torii T, 2013, J MOL NEUROSCI, V51, P522, DOI 10.1007/s12031-013-0018-4; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; Novak N, 2011, J CELL BIOL, V192, P243, DOI 10.1083/jcb.201010013; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Fritsch R, 2013, CELL, V154, P940, DOI 10.1016/j.cell.2013.07.045; Klein C, 2002, J NEUROSCI, V22, P698; TOSHIMA J, 1995, BIOCHEM BIOPH RES CO, V209, P656, DOI 10.1006/bbrc.1995.1549; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Binder MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017727; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Krishnan A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003945; Macklin WB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3140pe32; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Miyamoto Y, 2014, SCHWANN CELL DEV PAT, P5; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ness JK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2928; Tsiperson V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015748; Yamauchi J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002802	47	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	OCT 1	2015	26	19					3489	3503		10.1091/mbc.E14-05-1020		15	Cell Biology	Cell Biology	CT8AA	WOS:000363035900011		
J	Sato, T; Shimosato, T; Ueda, A; Ishigatsubo, Y; Klinman, DM				Sato, Takashi; Shimosato, Takeshi; Ueda, Atsuhisa; Ishigatsubo, Yoshiaki; Klinman, Dennis M.			Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors	MOLECULAR CANCER THERAPEUTICS			English	Article							RECEPTOR 9 AGONIST; TLR9 AGONIST; T-CELLS; DENDRITIC CELLS; DRUG-DELIVERY; CONTAINING OLIGODEOXYNUCLEOTIDES; POLYKETAL MICROPARTICLES; INHALED DOXORUBICIN; COMPUTED-TOMOGRAPHY; ESTABLISHED TUMORS	CpG oligonucleotides (ODN) stimulate the innate immune system by triggering cells that express TLR9. The resulting response promotes tumor regression, an effect optimized by delivery of CpG ODN to the tumor site. This work examines the effect of instilling CpG ODN adsorbed onto polyketal microparticles (CpG-MP) into the lungs of mice with non-small cell lung cancer. Intrapulmonary delivery of CpG-MP improved ODN uptake and retention at the tumor site, thereby inducing a stronger Th1 response than systemically administered or unadsorbed CpG ODN. CpG-MP reversed the immunosuppression that characterized the tumor microenvironment by (i) decreasing the number of immunosuppressive Tregs and M2 macrophages while (ii) increasing the number of tumoricidal CD8(+) T cells and M1 macrophages. These effects promoted tumor regression and culminated in 82% permanent survival of mice with otherwise fatal Lewis lung cancer. (C) 2015 AACR.	[Sato, Takashi; Klinman, Dennis M.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Sato, Takashi; Ueda, Atsuhisa; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Shimosato, Takeshi] Shinshu Univ, Grad Sch Agr, Nagano, Japan	Klinman, DM (reprint author), NCI, Bldg 567,Room 205, Frederick, MD 21702 USA.	klinmand@mail.nih.gov			NCI; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790778, 23790917, 15K09224]	D.M. Klinman's lab is internally funded by the NCI. T. Sato received grants (no. 21790778, 23790917, and 15K09224) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Arndt CAS, 2010, CLIN CANCER RES, V16, P4024, DOI 10.1158/1078-0432.CCR-10-0662; Tahara K, 2008, INT J PHARM, V354, P210, DOI 10.1016/j.ijpharm.2007.11.002; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Kawarada Y, 2001, J IMMUNOL, V167, P5247; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s; Guiducci C, 2005, CANCER RES, V65, P3437; Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034; Manegold C, 2012, ANN ONCOL, V23, P72, DOI 10.1093/annonc/mdr030; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Sorrentino R, 2011, AM J RESP CRIT CARE, V183, P1369, DOI 10.1164/rccm.201010-1738OC; Heffernan MJ, 2005, BIOCONJUGATE CHEM, V16, P1340, DOI 10.1021/bc050176w; Savai R, 2005, AM J PATHOL, V167, P937, DOI 10.1016/S0002-9440(10)61184-4; Belani CP, 2013, CANCER BIOL THER, V14, P557, DOI 10.4161/cbt.24598; Otterson GA, 2007, CLIN CANCER RES, V13, P1246, DOI 10.1158/1078-0432.CCR-06-1096; Ohtaki Y, 2010, J THORAC ONCOL, V5, P1507, DOI 10.1097/JTO.0b013e3181eba692; Petersen RP, 2006, CANCER, V107, P2866, DOI 10.1002/cncr.22282; TATSUMURA T, 1993, BRIT J CANCER, V68, P1146, DOI 10.1038/bjc.1993.495; Shimizu K, 2010, J THORAC ONCOL, V5, P585, DOI 10.1097/JTO.0b013e3181d60fd7; Wang HY, 1997, ANN THORAC SURG, V64, P216, DOI 10.1016/S0003-4975(97)00343-3; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Lonsdorf AS, 2003, J IMMUNOL, V171, P3941; Otterson GA, 2010, CLIN CANCER RES, V16, P2466, DOI 10.1158/1078-0432.CCR-09-3015; Bradbury PA, 2008, J THORAC ONCOL, V3, pS164, DOI 10.1097/JTO.0b013e318174e9a7; Hirsh V, 2011, J CLIN ONCOL, V29, P2667, DOI 10.1200/JCO.2010.32.8971; Chang GJ, 2012, J CLIN ONCOL, V30, P3165, DOI 10.1200/JCO.2012.43.5743; Heckelsmiller K, 2002, J IMMUNOL, V169, P3892; Yamada K, 2010, CANCER SCI, V101, P188, DOI 10.1111/j.1349-7006.2009.01361.x; Manegold C, 2008, J CLIN ONCOL, V26, P3979, DOI 10.1200/JCO.2007.12.5807; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Baines J, 2003, CLIN CANCER RES, V9, P2693; Fiore VF, 2010, BIOMATERIALS, V31, P810, DOI 10.1016/j.biomaterials.2009.09.100; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Sorrentino R, 2010, J IMMUNOL, V185, P4641, DOI 10.4049/jimmunol.1000881; Zeni E, 2007, EUR RESPIR J, V30, P627, DOI 10.1183/09031936.00129306; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Klinman DM, 1994, CURRENT PROTOCOLS IM; Langer R, 1998, NATURE, V392, P5; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Nierkens S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008368; Verhoef C, 2011, EJC SUPPL, V3, pS61; Weeratna RD, 2004, J CLIN ONCOL, V22, p702S	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2198	2205		10.1158/1535-7163.MCT-15-0401		8	Oncology	Oncology	CU3EA	WOS:000363405600004		
J	Tsukamoto, S; Huang, YH; Kumazoe, M; Lesnick, C; Yamada, S; Ueda, N; Suzuki, T; Yamashita, S; Kim, YH; Fujimura, Y; Miura, D; Kay, NE; Shanafelt, TD; Tachibana, H				Tsukamoto, Shuntaro; Huang, Yuhui; Kumazoe, Motofumi; Lesnick, Connie; Yamada, Shuhei; Ueda, Naoki; Suzuki, Takashi; Yamashita, Shuya; Kim, Yoon Hee; Fujimura, Yoshinori; Miura, Daisuke; Kay, Neil E.; Shanafelt, Tait D.; Tachibana, Hirofumi			Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs	MOLECULAR CANCER THERAPEUTICS			English	Article							GROWTH-FACTOR-I; TEA POLYPHENOL EGCG; GREEN TEA; LAMININ RECEPTOR; CELL-DEATH; THERAPEUTIC IMPLICATIONS; QUANTITATIVE-ANALYSIS; PROSTATE-CANCER; UP-REGULATION; TUMOR-CELLS	Activation of acid sphingomyelinase (ASM) leads to ceramide accumulation and induces apoptotic cell death in cancer cells. In the present study, we demonstrate that the activation of ASM by targeting cancer-overexpressed 67-kDa laminin receptors (67LR) induces lipid raft disruption and inhibits receptor tyrosine kinase (RTK) activation in multiple myeloma cells. Sphingosine kinase 1 (SphK1), a negative regulator of ceramide accumulation with antiapoptotic effects, was markedly elevated in multiple myeloma cells. The silencing of SphK1 potentiated the apoptotic effects of the green tea polyphenol epigallocatechin-3-O-gallate (EGCG), an activator of ASM through 67LR. Furthermore, the SphK1 inhibitor safingol synergistically sensitized EGCG-induced proapoptotic cell death and tumor suppression in multiple myeloma cells by promoting the prevention of RTK phosphorylation and activation of death-associated protein kinase 1 (DAPK1). We propose that targeting 67LR/ASM and SphK1 may represent a novel therapeutic strategy against multiple myeloma. (C) 2015 AACR.	[Tsukamoto, Shuntaro; Huang, Yuhui; Kumazoe, Motofumi; Yamada, Shuhei; Ueda, Naoki; Suzuki, Takashi; Yamashita, Shuya; Kim, Yoon Hee; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem, Fukuoka 812, Japan; [Lesnick, Connie; Kay, Neil E.; Shanafelt, Tait D.] Mayo Clin, Dept Med, Rochester, MN USA; [Fujimura, Yoshinori; Miura, Daisuke; Tachibana, Hirofumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Tachibana, Hirofumi] Kyushu Univ, Food Funct Design Res Ctr, Fukuoka 812, Japan	Tachibana, H (reprint author), 6-10-1 Hakozaki,Higashi Ku, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science [22228002, 15H02448, 11J01340, 13J03437]; International Myeloma Foundation (IMF) Japan's grants; MEXT	This work was kindly supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science to H. Tachibana (grants 22228002 and 15H02448); International Myeloma Foundation (IMF) Japan's grants to H. Tachibana; Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science DC2 (11J01340) to S. Tsukamoto and DC1 (13J03437) to Y. Huang; and MEXT Funding-Project for Developing Innovation Systems-Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in Japan to Y. Fujimura and D. Miura.	Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Giuliani N, 2004, LEUKEMIA, V18, P628, DOI 10.1038/sj.leu.2403269; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Gombos I, 2008, CYTOM PART A, V73A, P220, DOI 10.1002/cyto.a.20516; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; KEDDERIS LB, 1995, FUND APPL TOXICOL, V25, P201, DOI 10.1006/faat.1995.1056; Frassanito MA, 2001, BLOOD, V97, P483, DOI 10.1182/blood.V97.2.483; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Schwartz GK, 1997, CLIN CANCER RES, V3, P537; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Britschgi A, 2010, BRIT J HAEMATOL, V149, P55, DOI 10.1111/j.1365-2141.2009.08040.x; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Shimizu M, 2005, BIOCHEM BIOPH RES CO, V334, P947, DOI 10.1016/j.bbrc.2005.06.182; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Hong S, 2004, CELL DEATH DIFFER, V11, P714, DOI 10.1038/sj.cdd.4401405; Ogata A, 1997, J IMMUNOL, V159, P2212; Liu LL, 2009, INT J CANCER, V124, P1707, DOI 10.1002/ijc.24135; Viacava P, 1997, J PATHOL, V182, P36, DOI 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W; Ito J, 2000, J LIPID RES, V41, P894; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Dimanche-Boitrel MT, 2005, DRUG RESIST UPDATE, V8, P5, DOI 10.1016/j.drup.2005.02.003; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1016/S0093-7754(01)90036-3; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cuvillier Olivier, 2010, Curr Mol Pharmacol, V3, P53; GeorgiiHemming P, 1996, BLOOD, V88, P2250; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011051; Mahtouk K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-198; Megha, 2004, J Biol Chem, V279, P9997; Megha, 2007, BBA-BIOMEMBRANES, V1768, P2205, DOI 10.1016/j.bbamem.2007.05.007; Scheiman J, 2009, MOL THER, V18, P63; Tagoug I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022641	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2303	2312		10.1158/1535-7163.MCT-15-0185		10	Oncology	Oncology	CU3EA	WOS:000363405600014		
J	Kiyonari, S; Iimori, M; Matsuoka, K; Watanabe, S; Morikawa-Ichinose, T; Miura, D; Niimi, S; Saeki, H; Tokunaga, E; Oki, E; Morita, M; Kadomatsu, K; Maehara, Y; Kitao, H				Kiyonari, Shinichi; Iimori, Makoto; Matsuoka, Kazuaki; Watanabe, Sugiko; Morikawa-Ichinose, Tomomi; Miura, Daisuke; Niimi, Shinichiro; Saeki, Hiroshi; Tokunaga, Eriko; Oki, Eiji; Morita, Masaru; Kadomatsu, Kenji; Maehara, Yoshihiko; Kitao, Hiroyuki			The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis	MOLECULAR CANCER THERAPEUTICS			English	Article							COLON-CANCER CELLS; INDUCED DNA-DAMAGE; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; CYCLE PROGRESSION; P53; EXPRESSION; 5-FLUOROURACIL; SURVIVAL; THERAPY	Platinum-based chemotherapeutic drugs are widely used as components of combination chemotherapy in the treatment of cancer. One such drug, oxaliplatin, exerts a synergistic effect against advanced colorectal cancer in combination with 5-fluorouracil (5-FU) and leucovorin. In the p53-proficient colorectal cancer cell line HCT116, oxaliplatin represses the expression of deoxyuridine triphosphatase (dUTPase), a ubiquitous pyrophosphatase that catalyzes the hydrolysis of dUTP to dUMP and inhibits dUTP-mediated cytotoxicity. However, the underlying mechanism of this activity has not been completely elucidated, and it remains unclear whether factors other than downregulation of dUTPase contribute to the synergistic effect of 5-FU and oxaliplatin. In this study, we found that oxaliplatin and dachplatin, platinum-based drugs containing the 1,2-diaminocyclohexane (DACH) carrier ligand, repressed the expression of nuclear isoform of dUTPase (DUT-N), whereas cisplatin and carboplatin did not. Oxaliplatin induced early p53 accumulation, upregulation of primary miR-34a transcript expression, and subsequent downregulation of E2F3 and E2F1. Nutlin-3a, which activates p53 nongenotoxically, had similar effects. Introduction of miR-34a mimic also repressed E2F1 and DUT-N expression, indicating that this miRNA plays a causative role. In addition to DUT-N, oxaliplatin repressed, in a p53-dependent manner, the expression of genes encoding enzymes involved in thymidylate biosynthesis. Consequently, oxaliplatin significantly decreased the level of dTTP in the dNTP pool in a p53-dependent manner. These data indicate that the DACH carrier ligand in oxaliplatin triggers signaling via the p53-miR-34a-E2F axis, leading to transcriptional regulation that ultimately results in accumulation of dUTP and reduced dTTP biosynthesis, potentially enhancing 5-FU cytotoxicity. (C) 2015 AACR.	[Kiyonari, Shinichi; Matsuoka, Kazuaki; Watanabe, Sugiko; Niimi, Shinichiro; Maehara, Yoshihiko; Kitao, Hiroyuki] Kyushu Univ, Innovat Ctr Med Redox Nav, Innovat Anticanc Strategy Therapeut & Diag Grp, Fukuoka, Kyushu 8128582, Japan; [Kiyonari, Shinichi; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan; [Iimori, Makoto; Kitao, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka, Kyushu 8128582, Japan; [Matsuoka, Kazuaki; Niimi, Shinichiro] Taiho Pharmaceut Co Ltd, Tokushima, Japan; [Morikawa-Ichinose, Tomomi; Miura, Daisuke] Kyushu Univ, Innovat Ctr Med Redox Nav, Metab Profiling Res Grp, Fukuoka, Kyushu 8128582, Japan; [Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Kyushu 8128582, Japan; [Tokunaga, Eriko] Kyushu Univ, Grad Sch Med Sci, Dept Comprehens Clin Oncol, Fukuoka, Kyushu 8128582, Japan	Kitao, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Kyushu 8128582, Japan.	hkitao@surg2.med.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014; Kadomatsu, Kenji/G-8083-2012		Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan (JSPS KAKENHI) [24701028]	This work was supported by the Science and Technology Incubation Program in Advanced Regions from the funding program "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" from the Japan Science and Technology Agency, commissioned by the Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. Kiyonari, JSPS KAKENHI grant number 24701028).	Kim ST, 2010, CANCER CHEMOTH PHARM, V66, P659, DOI 10.1007/s00280-009-1206-3; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Setoyama D, 2013, GENES CELLS, V18, P1107, DOI 10.1111/gtc.12098; Zaanan A, 2010, ANN ONCOL, V21, P772, DOI 10.1093/annonc/mdp383; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Ladner RD, 2000, CANCER RES, V60, P3493; Alcindor T, 2011, CURR ONCOL, V18, P18; Koehler SE, 2004, MOL PHARMACOL, V66, P620; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc.1074; Zauli G, 2011, CLIN CANCER RES, V17, P2712, DOI 10.1158/1078-0432.CCR-10-3244; Liu HF, 2010, CHEM-BIOL INTERACT, V188, P535, DOI 10.1016/j.cbi.2010.08.001; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539; Paris R, 2008, CELL CYCLE, V7, P2427; Wilson PM, 2012, MOL CANCER THER, V11, P616, DOI 10.1158/1535-7163.MCT-11-0781; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; de Bruijn MT, 2010, BRIT J CANCER, V102, P1254, DOI 10.1038/sj.bjc.6605633; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Yeh KH, 2004, ANTI-CANCER DRUG, V15, P371, DOI 10.1097/01.cad.0000125225.57491.8b; Matsuoka K, 2015, MOL CANCER THER, V14, P1004, DOI 10.1158/1535-7163.MCT-14-0236; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Voland C, 2006, MOL CANCER THER, V5, P2149, DOI 10.1158/1535-7163.MCT-05-0212; McEntee G, 2011, P NATL ACAD SCI USA, V108, P15157, DOI 10.1073/pnas.1103605108; Dong S, 2000, J CELL BIOCHEM, V77, P50, DOI 10.1002/(SICI)1097-4644(20000401)77:1<50::AID-JCB6>3.0.CO;2-C; Wilson PM, 2009, NUCLEIC ACIDS RES, V37, P78, DOI 10.1093/nar/gkn910; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Kato H, 2012, J BIOSCI BIOENG, V113, P665, DOI 10.1016/j.jbiosc.2011.12.013; He GG, 2011, GYNECOL ONCOL, V122, P402, DOI 10.1016/j.ygyno.2011.04.034; Takatori H, 2010, LIVER INT, V30, P438, DOI 10.1111/j.1478-3231.2009.02177.x; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591	44	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2332	2342		10.1158/1535-7163.MCT-14-0748		11	Oncology	Oncology	CU3EA	WOS:000363405600017		
J	Ono, YJ; Tanabe, A; Tanaka, T; Tanaka, Y; Hayashi, M; Terai, Y; Ohmichi, M				Ono, Yoshihiro Joshua; Tanabe, Akiko; Tanaka, Tomohito; Tanaka, Yoshimichi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide			Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines	MOLECULAR CANCER THERAPEUTICS			English	Article							INDEPENDENT PROGNOSTIC MARKER; MULTIDRUG-RESISTANCE; PATIENT SURVIVAL; OVARIAN-CANCER; BREAST-CANCER; P-SELECTIN; IN-VITRO; EXPRESSION; CARCINOMA; PACLITAXEL	Endometrial cancer is the most prevalent gynecologic cancer in the Western world, and the number of advanced chemotherapy-resistant cancers is increasing with the absolute increase in patients. The development of resistance to chemotherapeutic drugs by cancer cells represents a major challenge in the clinical cure of advanced and metastatic cancers. CD24 has been reported to be a marker for a poor prognosis in several tumors, and we herein examined the functions of CD24 in human endometrioid adenocarcinoma cell lines and evaluated how it contributes to cancer drug resistance. We demonstrated that CD24 was responsible for the recruitment of phosphorylated Met to the lipid raft domain of the cell membrane, resulting in amplification of the Met signaling cascade, ultimately leading endometrial cancer cells to express higher levels of ATP-binding cassette (ABC) transporters. Our findings suggest that CD24-mediated amplification of the Met cascade may contribute to the drug resistance of endometrial cancer. (C) 2015 AACR.	[Ono, Yoshihiro Joshua; Tanabe, Akiko; Tanaka, Tomohito; Tanaka, Yoshimichi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan	Ono, YJ (reprint author), Osaka Med Coll, Dept Obstet & Gynecol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	bigfootman@mac.com			JSPS KAKENHI [22591869]	This work was supported by JSPS KAKENHI grant number 22591869 (to Y. Terai).	Ahmedin J, 2006, CA CANC J CLIN, V56, P106; Ohmichi M, 2005, TRENDS PHARMACOL SCI, V26, P113, DOI 10.1016/j.tips.2005.01.002; Kim KH, 2009, HISTOL HISTOPATHOL, V24, P309; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Zarn JA, 1996, BIOCHEM BIOPH RES CO, V225, P384, DOI 10.1006/bbrc.1996.1184; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Allen JD, 2000, CANCER RES, V60, P5761; Roberg K, 2007, HEAD NECK-J SCI SPEC, V29, P325, DOI 10.1002/hed.20520; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Sammar M, 1997, BBA-PROTEIN STRUCT M, V1337, P287, DOI 10.1016/S0167-4838(96)00177-X; Karahan N, 2006, EUR J GYNAECOL ONCOL, V27, P500; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Baumann P, 2012, CELL MOL LIFE SCI, V69, P435, DOI 10.1007/s00018-011-0756-9; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Friederichs J, 2000, CANCER RES, V60, P6714; Hiramatsu HP, 2000, ANTI-CANCER DRUG, V11, P573, DOI 10.1097/00001813-200008000-00009; Aigner S, 1997, BLOOD, V89, P3385; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Frederic A, 2005, LANCET, V366, P491; Milas L, 2005, SEMIN ONCOL, V32, P78, DOI 10.1053/j.seminoncol.2005.04.028	36	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2353	2363		10.1158/1535-7163.MCT-15-0187		11	Oncology	Oncology	CU3EA	WOS:000363405600019		
J	Stintzing, S; Zhang, W; Heinemann, V; Neureiter, D; Kemmerling, R; Kirchner, T; Jung, A; Folwaczny, M; Yang, DY; Ning, Y; Sebio, A; Stremitzer, S; Sunakawa, Y; Matsusaka, S; Yamauchi, S; Loupakis, F; Cremolini, C; Falcone, A; Lenz, HJ				Stintzing, Sebastian; Zhang, Wu; Heinemann, Volker; Neureiter, Daniel; Kemmerling, Ralf; Kirchner, Thomas; Jung, Andreas; Folwaczny, Matthias; Yang, Dongyun; Ning, Yan; Sebio, Ana; Stremitzer, Stefan; Sunakawa, Yu; Matsusaka, Satoshi; Yamauchi, Shinichi; Loupakis, Fotios; Cremolini, Chiara; Falcone, Alfredo; Lenz, Heinz-Josef			Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer	MOLECULAR CANCER THERAPEUTICS			English	Article							GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; TYROSINE KINASES; DOWN-REGULATION; ERBB FAMILY; DEGRADATION; UBIQUITINATION; MUTATIONS; THERAPY; UBIQUITYLATION	Transmembrane receptors, such as the EGFR, are regulated by their turnover, which is dependent on the ubiquitin-proteasome system. We tested in two independent study cohorts whether SNPs in genes involved in EGFR turnover predict clinical outcome in cetuximab-treated metastatic colorectal cancer (mCRC) patients. The following SNPs involved in EGFR degradation were analyzed in a screening cohort of 108 patients treated with cetuximab in the chemorefractory setting: c-CBL (rs7105971; rs4938637; rs4938638; rs251837), EPS15 (rs17567; rs7308; rs1065754), NAE1 (rs363169; rs363170; rs363172), SH3KBP1 (rs7051590; rs5955820; rs1017874; rs11795873), SGIP1 (rs604737; rs6570808; rs7526812), UBE2M (rs895364; rs895374), and UBE2L3 (rs5754216). SNPs showing an association with response or survival were analyzed in BRAF and RAS wild-type samples from the FIRE-3 study. One hundred and fifty-three FOLFIRI plus cetuximab-treated patients served as validation set, and 168 patients of the FOLFIRI plus bevacizumab arm served as controls. EGFR FISH was done in 138 samples to test whether significant SNPs were associated with EGFR expression. UBE2M rs895374 was significantly associated with progression-free survival (log-rank P = 0.005; HR, 0.60) within cetuximab-treated patients. No association with bevacizumab-treated patients (n = 168) could be established (P = 0.56; HR, 0.90). rs895374 genotype did not affect EGFR FISH measurements. EGFR recycling is an interesting mechanism of secondary resistance to cetuximab in mCRC. This is the first report suggesting that germline polymorphisms in the degradation process predict efficacy of cetuximab in patients with mCRC. Genes involved in EGFR turnover may be new targets in the treatment of mCRC. (C) 2015 AACR.	[Stintzing, Sebastian; Zhang, Wu; Ning, Yan; Sebio, Ana; Stremitzer, Stefan; Sunakawa, Yu; Matsusaka, Satoshi; Yamauchi, Shinichi; Lenz, Heinz-Josef] USC Norris Comprehens Canc Ctr, Keck Sch Med, Sharon Carpenter Laboatory, Los Angeles, CA USA; [Stintzing, Sebastian; Heinemann, Volker] Univ Munich, Dept Med Oncol, D-81377 Munich, Germany; [Stintzing, Sebastian; Heinemann, Volker] Univ Munich, Ctr Comprehens Canc, D-81377 Munich, Germany; [Heinemann, Volker; Kirchner, Thomas] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Neureiter, Daniel; Kemmerling, Ralf] Paracelsus Med Univ, Salzburger Landeskliniken SALK, Inst Pathol, Salzburg, Austria; [Kemmerling, Ralf] Med Versorgungszentrum Histol Zytol & Mol Diagnos, Trier, Germany; [Kirchner, Thomas; Jung, Andreas] Univ Munich, Inst Pathol, D-81377 Munich, Germany; [Folwaczny, Matthias] Univ Munich, Dept Prevent Dent & Periodontol, D-81377 Munich, Germany; [Yang, Dongyun; Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Sebio, Ana] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Yamauchi, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan; [Loupakis, Fotios; Cremolini, Chiara; Falcone, Alfredo] Univ Pisana, Aziendo Osped, UO Oncol Med 2, Pisa, Italy	Stintzing, S (reprint author), Univ Munich, Marchioninistr 15, D-81377 Munich, Germany.	sebastian.stintzing@med.uni-muenchen.de			NCI [P30CA014089]; Wunderglo foundation; German Cancer Aid (Mildred-Scheel-Foundation)	H.-J. Lenz was funded by the NCI (award number P30CA014089) and the Wunderglo foundation. S. Stintzing has been granted a postdoctoral fellowship by the German Cancer Aid (Mildred-Scheel-Foundation).	Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Stintzing S, 2014, CLIN CANCER RES, V20, P3064, DOI 10.1158/1078-0432.CCR-13-3175; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; McWhinney SR, 2009, PHARMACOGENOMICS, V10, P489, DOI 10.2217/14622416.10.3.489; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Cercek A, 2011, CURR TREAT OPTION ON, V12, P126, DOI 10.1007/s11864-011-0147-3; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Loupakis F, 2014, PHARMACOGENOMICS J, V14, P322, DOI 10.1038/tpj.2014.1; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Consortium EP, 2004, SCIENCE, V306, P636, DOI DOI 10.1126/SCIENCE.1105136; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Iida Mari, 2013, Neoplasia, V15, P1196; Jiang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056205; Oliner KS, 2013, J CLIN ONCOL S; Schmidt MH, 2006, SCI STKE SIGNAL TRAN, V2006, pe50; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stintzing S, 2013, ANN ONCOL, V24, pLBA17; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214	45	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2374	2381		10.1158/1535-7163.MCT-15-0121		8	Oncology	Oncology	CU3EA	WOS:000363405600021		
J	Ochi, A; Mori, K; Nakatani, S; Emoto, M; Morioka, T; Motoyama, K; Fukumoto, S; Imanishi, Y; Shoji, T; Ishimura, E; Inaba, M				Ochi, Akinobu; Mori, Katsuhito; Nakatani, Shinya; Emoto, Masanori; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Shoji, Tetsuo; Ishimura, Eiji; Inaba, Masaaki			Indoxyl sulfate suppresses hepatic fetuin-A expression via the aryl hydrocarbon receptor in HepG2 cells	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						AHSG; fetuin-A; hepatocyte; indoxyl sulfate	CONTAINING CALCIPROTEIN PARTICLES; CHRONIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; P-CRESYL SULFATE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; GLYCOPROTEIN/FETUIN-A; DIALYSIS PATIENTS; UREMIC TOXICITY; MINERAL COMPLEX	Background. Fetuin-A is a liver-derived circulating protein that has potent calcification-inhibitory activity. Uraemic patients exhibit decreased serum fetuin-A levels, increased vascular calcification and elevated cardiovascular mortality. Because the mechanisms for fetuin-A deficiency are unknown, we hypothesized that some uraemic toxins suppressed hepatic fetuin-A production, which resulted in accelerated vascular calcification and poor outcome. Among these potential candidates, indoxyl sulfate (IS) has highly toxic properties. Methods. We examined the direct effects of IS on hepatic fetuin-A expression using the human hepatoma HepG2 cell line. Results. IS, but not p-cresyl sulfate, suppressed the mRNA and protein expression of fetuin-A in a dose-and time-dependent manner. As reported previously, IS stimulated p38 MAPK phosphorylation and reactive oxygen species (ROS) production, although the knockdown of p38 and inhibition of ROS generation had no effect on IS-induced fetuin-A suppression. Then, because IS is a potent endogenous ligand of the aryl hydrocarbon receptor (AhR), we assessed whether IS suppresses fetuin-A production via AhR. The knockdown of AhR prevented IS-induced fetuin-A suppression. However, some attention should be paid to no effect of IS on fetuin-A expression in mouse and human primary cultured hepatocytes. Conclusions. These findings suggest that IS could suppress hepatic fetuin-A expression by activating AhR, suggesting a relationship between uraemia and fetuin-A deficiency.	[Ochi, Akinobu; Mori, Katsuhito; Nakatani, Shinya; Emoto, Masanori; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Ishimura, Eiji; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; [Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 558, Japan	Mori, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan.	ktmori@med.osaka-cu.ac.jp					Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Takata H, 2009, J ATHEROSCLER THROMB, V16, P448; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Masai N, 2010, CIRC J, V74, P2216, DOI 10.1253/circj.CJ-10-0117; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Gangneux C, 2003, NUCLEIC ACIDS RES, V31, P5957, DOI 10.1093/nar/gkg788; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Woltje M, 2006, J MOL ENDOCRINOL, V36, P261, DOI 10.1677/jme.1.02001; Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI200317202; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Schinke T, 1996, J BIOL CHEM, V271, P20789; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Ichii O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108448; Mori Katsuhito, 2011, Recent Pat Endocr Metab Immune Drug Discov, V5, P124; Ng HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091517; Ochi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088704	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	OCT	2015	30	10					1683	1692		10.1093/ndt/gfv250		11	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	CT9YG	WOS:000363171900012		
J	Momosaki, R; Abo, M; Watanabe, S; Kakuda, W; Yamada, N; Kinoshita, S				Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji			Repetitive Peripheral Magnetic Stimulation With Intensive Swallowing Rehabilitation for Poststroke Dysphagia: An Open-Label Case Series	NEUROMODULATION			English	Article						Dysphagia; magnetic stimulation; stroke	ELECTRICAL-STIMULATION; STROKE PATIENTS; OROPHARYNGEAL DYSPHAGIA; MOTOR FUNCTION; BRAIN; SCALE; RELIABILITY; ASPIRATION; MANAGEMENT; VALIDITY	ObjectiveThe purpose of this pilot study was to determine the safety and feasibility of a six-day protocol of in-hospital repetitive peripheral magnetic stimulation combined with intensive swallowing rehabilitation (rPMS-ISR) for poststroke dysphagia. MethodsThe subjects were eight patients with dysphagia caused by bilateral cerebral infarction (age: 62-70; time from onset of stroke: 27-39 months). rPMS was applied to the suprahyoid muscles, at strength set at 90% of the minimal intensity that elicited pain with a parabolic coil. One train of stimuli comprised 20Hz for 3 sec followed by 27-sec rest. A single session included delivery of repetitive 20 trains of stimuli over 10min, followed by 20 min of swallowing rehabilitation. Each patient received this combination treatment twice daily, morning and afternoon, over six consecutive days. Swallowing function was evaluated before and after intervention. ResultsrPMS-ISR induced significant improvement in swallowing ability, laryngeal elevation delay time, penetration aspiration scale, and swallowing quality of life (p < 0.01), but had no significant effect on the functional oral intake scale. ConclusionThe six-day in-hospital RPMS-ISR protocol seems safe and feasible for poststroke patients with dysphagia. The combination protocol improved swallowing function. Further larger studies are needed to confirm its efficacy.	[Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji] Jikei Univ Sch Med, Dept Rehabil Med, Minato Ku, Tokyo, Japan; [Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji] Jikei Univ, Dept Rehabil Med, Sch Med, Minato Ku, Tokyo 1058461, Japan	Momosaki, R (reprint author), Jikei Univ, Dept Rehabil Med, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	momosakiryo@gmail.com			Magnetic Health Science Foundation; Japan Society for the Promotion of Science	This work was supported by The Magnetic Health Science Foundation. The Japan Society for the Promotion of Science provided funding for the study.	Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Park JW, 2012, DYSPHAGIA, V27, P521, DOI 10.1007/s00455-012-9403-3; Bulow M, 2008, DYSPHAGIA, V23, P302, DOI 10.1007/s00455-007-9145-9; Struppler A, 2007, NEUROIMAGE, V36, pT174, DOI 10.1016/j.neuroimage.2007.03.033; Krewer C, 2014, ARCH PHYS MED REHAB, V95, P1039, DOI 10.1016/j.apmr.2014.02.003; McHorney CA, 2002, DYSPHAGIA, V17, P97, DOI 10.1007/s00455-001-0109-1; Heldmann B, 2000, NEUROREPORT, V11, P3193, DOI 10.1097/00001756-200009280-00029; Beom Jaewon, 2011, Ann Rehabil Med, V35, P322, DOI 10.5535/arm.2011.35.3.322; Lim KB, 2009, J REHABIL MED, V41, P174, DOI 10.2340/16501977-0317; Permsirivanich Wutichai, 2009, Journal of the Medical Association of Thailand, V92, P259; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Kawai S, 2003, DYSPHAGIA, V18, P1, DOI 10.1007/s00547-002-0074-z; Lin VW, 2001, ARCH PHYS MED REHAB, V82, P167, DOI 10.1053/apmr.2001.18215; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Verin E, 2009, DYSPHAGIA, V24, P204, DOI 10.1007/s00455-008-9195-7; Khedr EM, 2010, J NEUROL NEUROSUR PS, V81, P495, DOI 10.1136/jnnp.2009.188482; Verin E, 2012, ARCH PHYS MED REHAB, V93, P1987, DOI 10.1016/j.apmr.2011.10.020; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919; Kim SJ, 2009, NEUROMODULATION, V12, P134, DOI 10.1111/j.1525-1403.2009.00200.x; Kiger M, 2006, DYSPHAGIA, V21, P243, DOI 10.1007/s00455-006-9056-1; Logemann JA, 1997, OTOLARYNG HEAD NECK, V116, P335, DOI 10.1016/S0194-5998(97)70269-9; Antunes EB, 2012, GERODONTOLOGY, V29, P247, DOI 10.1111/j.1741-2358.2012.00638.x; Lin VWH, 2002, ARCH PHYS MED REHAB, V83, P806, DOI 10.1053/apmr.2002.32644; Chiu CM, 2009, J REHABIL MED, V41, P1085, DOI 10.2340/16501977-0456; Szecsi J, 2009, ARCH PHYS MED REHAB, V90, P564, DOI 10.1016/j.apmr.2008.09.572; Michou E, 2014, BRAIN STIMUL, V7, P66, DOI 10.1016/j.brs.2013.09.005; Miller M, 2008, ARCH PHYS MED REHAB, V89, P2031, DOI 10.1016/j.apmr.2008.03.025; Hamdy S, 2003, NEUROGASTROENT MOTIL, V15, P69, DOI 10.1046/j.1365-2982.2003.00390.x; Hubsher CP, 2012, CAN J UROL, V19, P6480; Beaulieu LD, 2013, NEUROPHYSIOL CLIN, V43, P251, DOI 10.1016/j.neucli.2013.05.003; Krause P, 2008, NEUROL RES, V30, P690, DOI 10.1179/174313208X297959; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Gallas S, 2010, DYSPHAGIA, V25, P291, DOI 10.1007/s00455-009-9259-3; Gonzalez-Fernandez M, 2011, AM J SPEECH-LANG PAT, V20, P331, DOI 10.1044/1058-0360(2011/10-0082); Keith R A, 1987, Adv Clin Rehabil, V1, P6; Momosaki R, 2013, NEUROMODULATION, V17, P637; Park JW, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12063; Flamand VH, 2014, ARCH PHYS MED REHAB, V95, P1984, DOI 10.1016/j.apmr.2014.05.014; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	OCT	2015	18	7					630	635		10.1111/ner.12308		6	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	CU1FH	WOS:000363264900013		
J	Jang, S; Takata, T; Yamaguchi, A; Uchibori, A; Kurihara, A; Ohshima, H				Jang, Sunghyon; Takata, Takashi; Yamaguchi, Akira; Uchibori, Akihiro; Kurihara, Akikazu; Ohshima, Hiroyuki			NUMERICAL APPROACH FOR QUANTIFICATION OF SELFWASTAGE PHENOMENA IN SODIUM-COOLED FAST REACTOR	NUCLEAR ENGINEERING AND TECHNOLOGY			English	Article						Computational Fluid Dynamics; Self-Wastage Phenomena; Sodium Faster Breeder Reactor; Sodium-Water Reaction	WATER REACTION	Sodium-cooled fast breeder reactors use liquid sodium as a moderator and coolant to transfer heat from the reactor core. The main hazard associated with sodium is its rapid reaction with water. Sodium-water reaction (SWR) takes place when water or vapor leak into the sodium side through a crack on a heat-transfer tube in a steam generator. If the SWR continues for some time, the SWR will damage the surface of the defective area, causing it to enlarge. This self-enlargement of the crack is called "self-wastage phenomena." A stepwise numerical evaluation model of the self-wastage phenomena was devised using a computational code of multicomponent multiphase flow involving a sodium-water chemical reaction: sodiumwater reaction analysis physics of interdisciplinary multiphase flow (SERAPHIM). The temperature of gas mixture and the concentration of NaOH at the surface of the tube wall are obtained by a numerical calculation using SERAPHIM. Averaged thermophysical properties are used to assess the local wastage depth at the tube surface. By reflecting the wastage depth to the computational grid, the self-wastage phenomena are evaluated. A two-dimensional benchmark analysis of an SWAT (Sodium-Water reAction Test rig) experiment is carried out to evaluate the feasibility of the numerical model. Numerical results show that the geometry and scale of enlarged cracks show good agreement with the experimental result. Enlarged cracks appear to taper inward to a significantly smaller opening on the inside of the tube wall. The enlarged outer diameter of the crack is 4.72 mm, which shows good agreement with the experimental data (4.96 mm). Copyright (C) 2015, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society.	[Jang, Sunghyon; Takata, Takashi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yamaguchi, Akira] Univ Tokyo, Grad Sch Engn, Tokai, Ibaraki 3191188, Japan; [Uchibori, Akihiro; Kurihara, Akikazu; Ohshima, Hiroyuki] Japan Atom Energy Agcy, Higashiibaraki, Ibaraki 3111393, Japan	Jang, S (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	jang_s@qe.see.eng.osaka-u.ac.jp					Jeong JY, 2009, KOREAN J CHEM ENG, V26, P1004, DOI 10.2478/s11814-009-0167-x; Takata T, 2003, J NUCL SCI TECHNOL, V40, P708, DOI 10.3327/jnst.40.708; Perry J, 2003, J PRESS VESS-T ASME, V125, P248, DOI 10.1115/1.1593078; Currie R., 1990, P IAEA IWGFR SPEC M; Dumm K., 1974, IAEA STUD GROUP M ST; Green D. A., 1976, INT C LIQ MET TECHN; Hori M., 1980, ATOM ENERGY REV, V183, P707; Kozlov F. A., 1976, INT C LIQ MET TECHN; Kurihara A., 2001, P AESJ 2011 FALL M S, P781; Kuroha M., 1982, PNCTN94182101; Mott R. L., 2002, APPL STRENGTH MAT; Neely H. H., 1990, P IAEA IWGFR SPEC M; Okano Y., 2001, 2001 ANN M AT EN SOC; Sandusky D. W., 1976, INT C LIQ MET TECHN	14	0	0	KOREAN NUCLEAR SOC	DAEJEON	NUTOPIA BLDG, 342-1 JANGDAE-DONG, DAEJEON, 305-308, SOUTH KOREA	1738-5733			NUCL ENG TECHNOL	Nucl. Eng. Technol.	OCT	2015	47	6					700	711		10.1016/j.net.2015.06.008		12	Nuclear Science & Technology	Nuclear Science & Technology	CU1JR	WOS:000363277800005		
J	Arita, R; Morishige, N; Shirakawa, R; Sato, Y; Amano, S				Arita, Reiko; Morishige, Naoyuki; Shirakawa, Rika; Sato, Yoichi; Amano, Shiro			Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction	OCULAR SURFACE			English	Article						dry eye; eyelid warming; meibomian gland; meibomian gland dysfunction; meibography; tear film	LIPID LAYER THICKNESS; DRY EYE; INTERNATIONAL WORKSHOP; THERMODYNAMIC TREATMENT; SURFACE-TEMPERATURE; OCULAR SURFACE; PREVALENCE; SYSTEM; SUBCOMMITTEE; COMPRESSION	Purpose: To evaluate the effects of commercially available eyelid warming devices on ocular temperatures, tear film function, and meibomian glands in normal subjects and patients with meibomian gland dysfunction (MGD). Methods: Ten healthy volunteers were enrolled to evaluate the effects of a single warming and of repeated warming for 2 weeks. Ten MGD patients were enrolled for evaluation of repeated warming over 1 month. Two non-wet (Azuki no Chikara, Eye Hot R) and three wet (hot towel, Hot Eye Mask, Memoto Este) devices were compared in a masked manner. Visual analog scale (VAS) score for ocular symptoms, tear film breakup time (TFBUT), meibum grade, temperatures (eyelid skin, tarsal conjunctiva, central cornea), Schirmer test value, and meibomian gland area were measured before and after warming application. Results: The single application of the five warming devices improved the VAS score, TFBUT, and ocular temperatures. In the repeated warming application, Azuki no Chikara as a representative non-wet warming device induced a stable and significant improvement in TFBUT and increased the tarsal conjunctival temperature and meibomian gland area in both normal subjects and MGD patients. It also improved meibum grade in MGD patients. Conclusion: Our results suggest that repeated eyelid warming with a non-wet device improves tear film function in normal individuals and may have beneficial effects on both tear film and meibomian gland function in MGD patients.	[Arita, Reiko] Itoh Clin, Dept Ophthalmol, Saitama 3370042, Japan; [Arita, Reiko; Shirakawa, Rika] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Arita, Reiko] Keio Univ, Dept Ophthalmol, Tokyo, Japan; [Arita, Reiko; Morishige, Naoyuki; Shirakawa, Rika] Lid & Meibomian Gland Working Grp, Saitama, Japan; [Morishige, Naoyuki] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Yamaguchi, Japan; [Sato, Yoichi] Yamaguchi Univ, Yamaguchi, Japan; [Amano, Shiro] Inoue Eye Hosp, Tokyo, Japan; [Amano, Shiro] Miyata Eye Hosp, Miyazaki, Japan	Arita, R (reprint author), Itoh Clin, Dept Ophthalmol, 626-11 Minami Nakano, Saitama 3370042, Japan.	ritoh@za2.so-net.ne.jp					Mitra M, 2005, EYE, V19, P657, DOI 10.1038/sj.eye.6701611; BRON AJ, 1968, ARCH OPHTHALMOL-CHIC, V79, P119; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Borchman D, 2011, INVEST OPHTH VIS SCI, V52, P3805, DOI 10.1167/iovs.10-6514; Blackie CA, 2008, OPTOMETRY VISION SCI, V85, P675, DOI 10.1097/OPX.0b013e318181adef; Mori A, 2003, JPN J OPHTHALMOL, V47, P578, DOI 10.1016/S0021-5155(03)00142-4; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Borchman D, 2007, CHEM PHYS LIPIDS, V147, P87, DOI 10.1016/j.chemphyslip.2007.04.001; MORGAN PB, 1995, EYE, V9, P615; Lane SS, 2012, CORNEA, V31, P396, DOI 10.1097/ICO.0b013e318239aaea; Arita R, 2014, BRIT J OPHTHALMOL, V98, P746, DOI 10.1136/bjophthalmol-2012-303014; Greiner JV, 2012, CURR EYE RES, V37, P272, DOI 10.3109/02713683.2011.631721; Efron N, 2013, INVEST OPHTH VIS SCI, V54, P98, DOI 10.1167/iovs.13-13187; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Goto E, 2002, ADV EXP MED BIOL, V506, P1149; Korb DR, 2013, EYE CONTACT LENS, V39, pE1, DOI 10.1097/ICL.0b013e31824ccbda; Arita R, 2013, JAMA OPHTHALMOL, V131, P818, DOI 10.1001/jamaophthalmol.2013.1895; Friedland BR, 2011, CURR EYE RES, V36, P79, DOI 10.3109/02713683.2010.509529; Solomon JD, 2007, OPTOMETRY VISION SCI, V84, P580, DOI 10.1097/OPX.0b013e3180dc99d5; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; BRON AJ, 1969, BRIT J OPHTHALMOL, V53, P760, DOI 10.1136/bjo.53.11.760; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; Nagymihalyi A, 2004, EXP EYE RES, V78, P367, DOI 10.1016/S0014-4835(03)00197-0; McCulley JP, 1998, ADV EXP MED BIOL, V438, P319; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Blackie CA, 2013, CORNEA, V32, pE146, DOI 10.1097/ICO.0b013e318292a7b7; Matsumoto Y, 2006, CORNEA, V25, P644; Geerling G, 2011, INVEST OPHTH VIS SCI, V52, P2050, DOI 10.1167/iovs.10-6997g; Mori A, 1999, CORNEA, V18, P188, DOI 10.1097/00003226-199903000-00008; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI [10.1016/j.ophtha.2007.06.031, 10.1016/j.ophtha.2007.06.03]; BRON AJ, 1968, BRIT J OPHTHALMOL, V52, P659, DOI 10.1136/bjo.52.9.659; Bron A J, 2004, Ocul Surf, V2, P149; Finis D, 2014, OCUL SURF, V12, P146, DOI 10.1016/j.jtos.2013.12.001; Goto E, 2002, BRIT J OPHTHALMOL, V86, P1403, DOI 10.1136/bjo.86.12.1403; Ishida R, 2008, OPTOMETRY VISION SCI, V85, P684, DOI 10.1097/OPX.0b013e318181ae83; Miyashita K, 1991, JPN J CLIN OPHTHAL, V45, P1017; Olson Mary Catherine, 2003, Eye Contact Lens, V29, P96, DOI 10.1097/01.ICL.0000060998.20142.8D; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE1035, DOI 10.1097/OPX.0b013e31825c3479; Record NB, 2015, JAMA-J AM MED ASSOC, V313, P147, DOI 10.1001/jama.2014.16969; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266; Terada Osamu, 2004, Nippon Ganka Gakkai Zasshi, V108, P690	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1542-0124	1937-5913		OCUL SURF	Ocul. Surf.	OCT	2015	13	4					321	330				10	Ophthalmology	Ophthalmology	CU1KW	WOS:000363281300007		
J	Brown, DM; Schmidt-Erfurth, U; Do, DV; Holz, FG; Boyer, DS; Midena, E; Heier, JS; Terasaki, H; Kaiser, PK; Marcus, DM; Nguyen, QD; Jaffe, GJ; Slakter, JS; Simader, C; Soo, Y; Schmelter, T; Yancopoulos, GD; Stahl, N; Vitti, R; Berliner, AJ; Zeitz, O; Metzig, C; Korobelnik, JF				Brown, David M.; Schmidt-Erfurth, Ursula; Do, Diana V.; Holz, Frank G.; Boyer, David S.; Midena, Edoardo; Heier, Jeffrey S.; Terasaki, Hiroko; Kaiser, Peter K.; Marcus, Dennis M.; Nguyen, Quan D.; Jaffe, Glenn J.; Slakter, Jason S.; Simader, Christian; Soo, Yuhwen; Schmelter, Thomas; Yancopoulos, George D.; Stahl, Neil; Vitti, Robert; Berliner, Alyson J.; Zeitz, Oliver; Metzig, Carola; Korobelnik, Jean-Francois			Intravitreal Aflibercept for Diabetic Macular Edema 100-Week Results From the VISTA and VIVID Studies	OPHTHALMOLOGY			English	Article							RANIBIZUMAB PLUS PROMPT; VEGF TRAP-EYE; DEFERRED LASER; RANDOMIZED-TRIAL; GROWTH-FACTOR; DA VINCI; BEVACIZUMAB; RETINOPATHY; PREVALENCE; MANAGEMENT	Purpose: To compare efficacy and safety of 2 dosing regimens of intravitreal aflibercept injection (IAI) with macular laser photocoagulation for diabetic macular edema (DME). Design: Two similarly designed, randomized, phase 3 trials, VISTA(DME) and VIVIDDME. Participants: Patients (eyes; n = 872) with type 1 or 2 diabetes mellitus who had DME with central involvement. Methods: Eyes received IAI 2 mg every 4 weeks (2q4), IAI 2 mg every 8 weeks after 5 monthly doses (2q8), or laser control. Main Outcome Measures: The primary end point was mean change from baseline in best-corrected visual acuity (BCVA) at week 52. This report presents the 100-week results including mean change from baseline in BCVA, proportion of eyes that gained >= 15 letters, and proportion of eyes with a >= 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) score. Results: Mean BCVA gain from baseline to week 100 with IAI 2q4, IAI 2q8, and laser control was 11.5, 11.1, and 0.9 letters (P < 0.0001) in VISTA and 11.4, 9.4, and 0.7 letters (P < 0.0001) in VIVID, respectively. The proportion of eyes that gained >= 15 letters from baseline at week 100 was 38.3%, 33.1%, and 13.0% (P < 0.0001) in VISTA and 38.2%, 31.1%, and 12.1% (P <= 0.0001) in VIVID. The proportion of eyes that lost >= 15 letters at week 100 was 3.2%, 0.7%, and 9.7% (P <= 0.0220) in VISTA and 2.2%, 1.5%, and 12.9%(P <= 0.0008) in VIVID. Significantly more eyes in the IAI 2q4 and 2q8 groups versus those in the laser control group had a >= 2 step improvement in the DRSS score in both VISTA (37.0% and 37.1% vs. 15.6%; P < 0.0001) and VIVID (29.3% and 32.6% vs. 8.2%; P <= 0.0004). In an integrated safety analysis, the most frequent serious ocular adverse event was cataract (2.4%, 1.0%, and 0.3% for 2q4, 2q8, and control). Conclusions: In both VISTA and VIVID, the 52-week visual and anatomic superiority of IAI over laser control was sustained through week 100, with similar efficacy in the 2q4 and 2q8 groups. Safety in these studies was consistent with the known safety profile of IAI. (C) 2015 by the American Academy of Ophthalmology.	[Brown, David M.] Retina Consultants Houston, Houston, TX USA; [Schmidt-Erfurth, Ursula; Simader, Christian] Med Univ Vienna, Vienna, Austria; [Do, Diana V.; Nguyen, Quan D.] Univ Nebraska Med Ctr, Truhlsen Eye Inst, Omaha, NE USA; [Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Midena, Edoardo] Univ Padua, Dept Ophthalmol, Padua, Italy; [Heier, Jeffrey S.] Ophthalm Consultants Boston, Boston, MA USA; [Heier, Jeffrey S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Terasaki, Hiroko] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Kaiser, Peter K.] Cole Eye Inst, Cleveland, OH USA; [Marcus, Dennis M.] Southeast Retina Ctr, Augusta, GA USA; [Jaffe, Glenn J.] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Slakter, Jason S.] Vitreous Retina Macula Consultants New York, New York, NY USA; [Soo, Yuhwen; Yancopoulos, George D.; Stahl, Neil; Vitti, Robert; Berliner, Alyson J.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Schmelter, Thomas; Zeitz, Oliver; Metzig, Carola] Bayer HealthCare, Berlin, Germany; [Zeitz, Oliver] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Korobelnik, Jean-Francois] CHU Bordeaux, Hop Pellegrin, Serv Ophtalmol, Bordeaux, France; [Korobelnik, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Korobelnik, Jean-Francois] INSERM, Ctr INSERM Epidemiol Biostat U897, ISPED, Bordeaux, France	Korobelnik, JF (reprint author), CHU Bordeaux, Serv Ophtalmol, Hop Pellegrin, Pl Amelie Raba Leon, F-33000 Bordeaux, France.	jean-francois.korobelnik@chu-bordeaux.fr			Regeneron Pharmaceuticals, Inc, Tarrytown, New York; Bayer HealthCare, Berlin, Germany	The VISTA and VIVID studies were funded by Regeneron Pharmaceuticals, Inc, Tarrytown, New York, and Bayer HealthCare, Berlin, Germany. The sponsors participated in the design and conduct of the study, analysis of the data, and preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P823; Do DV, 2011, OPHTHALMOLOGY, V118, P1819, DOI 10.1016/j.ophtha.2011.02.018; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Kocur I, 2002, BRIT J OPHTHALMOL, V86, P716, DOI 10.1136/bjo.86.7.716; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Nepomuceno AB, 2013, AM J OPHTHALMOL, V156, P502, DOI 10.1016/j.ajo.2013.04.026; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; [Anonymous], 1996, ICH HARM TRIP GUID G; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P1045, DOI 10.1016/j.ophtha.2013.11.041; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; Ciulla TA, 2014, EXPERT OPIN PHARMACO, V15, P953, DOI 10.1517/14656566.2014.896899; Antcliff R J, 1999, Semin Ophthalmol, V14, P223, DOI 10.3109/08820539909069541; Boyer David S, 2013, Ther Adv Endocrinol Metab, V4, P151, DOI 10.1177/2042018813512360; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Photocoagulation for diabetic macular edema, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796; Shikari H, 2014, SEMIN OPHTHALMOL, V29, P276, DOI 10.3109/08820538.2014.962167	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	OCT	2015	122	10					2044	2052		10.1016/j.ophtha.2015.06.017		9	Ophthalmology	Ophthalmology	CU4IP	WOS:000363491500021		
J	Watanabe, S; Oie, Y; Fujimoto, H; Soma, T; Koh, S; Tsujikawa, M; Maeda, N; Nishida, K				Watanabe, Shinya; Oie, Yoshinori; Fujimoto, Hisataka; Soma, Takeshi; Koh, Shizuka; Tsujikawa, Motokazu; Maeda, Naoyuki; Nishida, Kohji			Relationship between Corneal Guttae and Quality of Vision in Patients with Mild Fuchs' Endothelial Corneal Dystrophy	OPHTHALMOLOGY			English	Article							COMPENSATION COMPARISON METHOD; RETINAL STRAYLIGHT; INTRAOCULAR STRAYLIGHT; CATARACT-SURGERY; FOLLOW-UP; KERATOPLASTY	Purpose: To investigate the effect of the severity of corneal guttae on quality of vision (QOV) in patients with mild Fuchs' endothelial corneal dystrophy (FECD). Design: Cross-sectional study. Participants: Twenty-three eyes of 14 patients with mild FECD without corneal edema on slit-lamp examination (5 pseudophakic eyes and 18 phakic eyes with mild lens opacity; grade 1.0-2.0 nuclear opalescence, grade 1.0-2.0 nuclear color, grade 1.0 cortical cataract, and grade 1.0 posterior subcapsular cataract on the Lens Opacities Classification System, version III). Methods: The area ratio of the corneal guttae (ARCG) in the endothelial cells was measured by multifocal specular microscopy. The QOV parameters, that is, corrected distance visual acuity (CDVA), letter contrast sensitivity (LCS), and intraocular straylight, also were measured. The correlations were assessed between the ARCG and QOV parameters and between the straylight and CDVA and LCS. Main Outcome Measures: The ARCG, logarithm of the minimum angle of resolution CDVA, LCS, and straylight. Results: Univariate analysis showed that the ARCG was correlated significantly with the CDVA, LCS, and straylight (R-2 = 0.41, P = 0.001; R-2 = 0.55, P = 0.001; and R-2 = 0.39, P = 0.002, respectively). Univariate analysis also showed that straylight was correlated significantly with the CDVA and LCS (R-2 = 0.47, P = 0.001 and R-2 = 0.41, P = 0.001, respectively). Conclusions: Corneal guttae without edema caused the QOV to deteriorate in eyes with FECD. Patients with higher straylight had worse CDVA or LCS. Intraocular forward light scatter caused by corneal guttae may result in visual disturbances. Quantification of corneal guttae can be useful to evaluate the effect of guttae on the QOV and determine the surgical indications of endothelial keratoplasty for eyes with mild FECD. (C) 2015 by the American Academy of Ophthalmology.	[Watanabe, Shinya; Oie, Yoshinori; Fujimoto, Hisataka; Soma, Takeshi; Koh, Shizuka; Tsujikawa, Motokazu; Maeda, Naoyuki; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan	Oie, Y (reprint author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Room E7,Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	yoie@ophthal.med.osaka-u.ac.jp			Japanese Ministry of the Education, Culture, Sports, Science and Technology (Tokyo, Japan); Health, Labour and Welfare Ministry (Tokyo, Japan); Japanese Society for the Promotion of Science (Tokyo, Japan); New Energy and Industrial Technology Development Organization (Kawasaki, Japan)	Supported in part by the Japanese Ministry of the Education, Culture, Sports, Science and Technology (N.M., K.N., Tokyo, Japan); the Health, Labour and Welfare Ministry (K.N., Tokyo, Japan); Japanese Society for the Promotion of Science (K.N., Tokyo, Japan); and the New Energy and Industrial Technology Development Organization (K.N., Kawasaki, Japan). NIDEK (Hiroishi, Japan) and Chuo Sangio Co (Nishinomiya, Japan), respectively, provided the noncontact multifocal specular microscope (CEM 530) and the C-Quant Straylight Meter (Oculus, Wetzlar, Germany) without cost.	van der Meulen IJE, 2012, CORNEA, V31, P380, DOI 10.1097/ICO.0b013e31823f8ab7; Guber I, 2011, GRAEF ARCH CLIN EXP, V249, P1367, DOI 10.1007/s00417-011-1704-y; Wright AF, 2010, NEW ENGL J MED, V363, P1072, DOI 10.1056/NEJMe1007495; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; de Vries NE, 2008, J CATARACT REFR SURG, V34, P957, DOI 10.1016/j.jcrs.2008.02.016; Repp DJ, 2013, OPHTHALMOLOGY, V120, P687, DOI 10.1016/j.ophtha.2012.09.022; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; van den Berg TJTP, 2013, Z MED PHYS, V23, P6, DOI 10.1016/j.zemedi.2012.10.009; Eghrari AO, 2010, CURR OPIN OPHTHALMOL, V21, P15, DOI 10.1097/ICU.0b013e328333e9d6; Van den Berg TJTP, 2007, AM J OPHTHALMOL, V144, P358, DOI 10.1016/j.ajo.2007.05.037; WARING GO, 1982, OPHTHALMOLOGY, V89, P531; WILSON SE, 1988, CORNEA, V7, P2; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Guerra FP, 2011, OPHTHALMOLOGY, V118, P2368, DOI 10.1016/j.ophtha.2011.06.002; ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; BURNS RR, 1981, INVEST OPHTH VIS SCI, V20, P77; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327; Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012; Melles GRJ, 2006, CORNEA, V25, P987; Franssen L, 2007, INVEST OPHTH VIS SCI, V48, P2375, DOI 10.1167/iovs.06-0759; Feng MT, 2013, CORNEA, V32, P1080, DOI 10.1097/ICO.0b013e318292a7e5; Price MO, 2013, CURR OPIN OPHTHALMOL, V24, P329, DOI 10.1097/ICU.0b013e32836229ab; Elhalis H, 2010, OCUL SURF, V8, P173; van der Meulen IJE, 2011, ARCH OPHTHALMOL-CHIC, V129, P1537, DOI 10.1001/archophthalmol.2011.247; Trousdale ER, 2014, OPHTHALMOLOGY, V121, P2147, DOI 10.1016/j.ophtha.2014.04.046; Franssen L, 2006, INVEST OPHTH VIS SCI, V47, P768, DOI 10.1167/iovs.05-0690; Lapid-Gortzak R, 2010, J CATARACT REFR SURG, V36, P465, DOI 10.1016/j.jcrs.2009.10.029; Chaurasia S, 2014, OPHTHALMOLOGY, V121, P454, DOI 10.1016/j.ophtha.2013.09.032; van Gaalen KW, 2010, J CATARACT REFR SURG, V36, P923, DOI 10.1016/j.jcrs.2009.12.048; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831; Chogyoji S, 2006, FOLIA OPHTHALMOL JPN, V57, P655; Fuchs E., 1910, GRAEFES ARCH CLIN EX, P478; Fujimoto H, 2014, INVEST OPHTH VIS SCI, V24, P5090; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036; LORENZET.DW, 1967, AM J OPHTHALMOL, V64, P1155; VANDENBERG TJTP, 1995, OPTOMETRY VISION SCI, V72, P52, DOI 10.1097/00006324-199502000-00003	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	OCT	2015	122	10					2103	2109		10.1016/j.ophtha.2015.06.019		7	Ophthalmology	Ophthalmology	CU4IP	WOS:000363491500027		
J	Saito, M; Tokutsu, I				Saito, Mika; Tokutsu, Ichiro			Revisiting the 'great trade collapse' with the endogenous input-choice model	OXFORD ECONOMIC PAPERS-NEW SERIES			English	Article							WORLD-TRADE; VERTICAL SPECIALIZATION; GROWTH	We revisit the role of vertical specialization and supply constraints during the 'great trade collapse' with new data and a new model that allows us to resolve some of the conceptual and data limitations faced by previous studies. We find that (i) demand factors explain a smaller (than previously understood) fraction of the collapse in trade during 2008-9; and (ii) models tend to over-estimate (or under-estimate) the decline in the demand for domestic (or imported) inputs. These model errors are equivalent to an increase of about 4% in the export price premium, on average.	[Saito, Mika] Int Monetary Fund, Washington, DC 20431 USA; [Tokutsu, Ichiro] Kobe Univ, Grad Sch Business Adm, Kobe, Hyogo 6578501, Japan	Saito, M (reprint author), Int Monetary Fund, Washington, DC 20431 USA.	tokutsu@port.kobe-u.ac.jp			Japan Society for the Promotion of Science [23530254]	Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (23530254 to I.T.)	HOUTHAKKER HS, 1969, REV ECON STAT, V51, P111, DOI 10.2307/1926720; Levchenko AA, 2010, IMF ECON REV, V58, P214, DOI 10.1057/imfer.2010.11; Yi KM, 2003, J POLIT ECON, V111, P52, DOI 10.1086/344805; Bems R, 2010, IMF ECON REV, V58, P295, DOI 10.1057/imfer.2010.15; Johnson RC, 2012, J INT ECON, V86, P224, DOI 10.1016/j.jinteco.2011.10.003; Daudin G, 2011, CAN J ECON, V44, P1403, DOI 10.1111/j.1540-5982.2011.01679.x; Bems R, 2011, AM ECON REV, V101, P308, DOI 10.1257/aer.101.3.308; Ahn J, 2011, AM ECON REV, V101, P298, DOI 10.1257/aer.101.3.298; Baldwin R., 2009, GREAT TRADE COLLAPSE; Eaton J., 2013, EC WORKING PAPER SER, V2013-21; Freund C., 2009, WORLD BANK POLICY RE, V5015; Hummels D, 2001, J INT ECON, V54, P75, DOI 10.1016/S0022-1996(00)00093-3; Hummels David, 1998, FEDERAL RESERVE BANK, V4, P79; Irwin D. A., 2002, WORLD TRADE REV, V1, P89; Koopman R., 2010, 16426 NBER; SAITO M, 1971, REV ECON STAT, V53, P11, DOI 10.2307/1925375; Timmer M., 2012, 10 WORLD INP OUTP DA; Yi K. M., 2009, COLLAPSE GLOBAL TRAD	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0030-7653	1464-3812		OXFORD ECON PAP	Oxf. Econ. Pap.-New Ser.	OCT	2015	67	4					1123	1145		10.1093/oep/gpv044		23	Economics	Business & Economics	CU0EC	WOS:000363187800014		
J	Cameron, D; Polgar, E; Gutierrez-Mecinas, M; Gomez-Lima, M; Watanabe, M; Todd, AJ				Cameron, Darren; Polgar, Erika; Gutierrez-Mecinas, Maria; Gomez-Lima, Maria; Watanabe, Masahiko; Todd, Andrew J.			The organisation of spinoparabrachial neurons in the mouse	PAIN			English	Article						Spinal cord; Lamina I; Neurokinin 1 receptor; Giant cell; Lateral parabrachial area; Substance P	RAT SPINAL-CORD; SUBSTANCE-P RECEPTOR; NEUROKININ 1 RECEPTOR; I PROJECTION NEURONS; SUPERFICIAL DORSAL-HORN; LAMINA-I; PARABRACHIAL NUCLEUS; MESSENGER-RNAS; BRAIN-STEM; MORPHOLOGICAL CHARACTERIZATION	The anterolateral tract (ALT), which originates from neurons in lamina I and the deep dorsal horn, represents a major ascending output through which nociceptive information is transmitted to brain areas involved in pain perception. Although there is detailed quantitative information concerning the ALT in the rat, much less is known about this system in the mouse, which is increasingly being used for studies of spinal pain mechanisms because of the availability of genetically modified lines. The aim of this study was therefore to determine the extent to which information about the ALT in the rat can be extrapolated to the mouse. Our results suggest that as in the rat, most lamina I ALT projection neurons in the lumbar enlargement can be retrogradely labelled from the lateral parabrachial area, that the majority of these cells (similar to 90%) express the neurokinin 1 receptor (NK1r), and that these are larger than other NK1r-expressing neurons in this lamina. This means that many lamina I spinoparabrachial cells can be identified in NK1r-immunostained sections from animals that have not received retrograde tracer injections. However, we also observed certain species differences, in particular we found that many spinoparabrachial cells in laminae III and IV lack the NK1r, meaning that they cannot be identified based solely on the expression of this receptor. We also provide evidence that the majority of spinoparabrachial cells are glutamatergic and that some express substance P. These findings will be important for studies designed to unravel the complex neuronal circuitry that underlies spinal pain processing.	[Cameron, Darren; Polgar, Erika; Gutierrez-Mecinas, Maria; Gomez-Lima, Maria; Todd, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Todd, AJ (reprint author), Univ Glasgow, Spinal Cord Grp, West Med Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	andrew.todd@glasgow.ac.uk	Todd, Andrew/A-6855-2011		MAC [MR/L003430/1]; Wellcome Trust [102645]	The work was supported by grants from the MAC (MR/L003430/1) and the Wellcome Trust (102645).	HYLDEN JLK, 1989, NEUROSCIENCE, V28, P27, DOI 10.1016/0306-4522(89)90229-7; VIGNA SR, 1994, J NEUROSCI, V14, P834; CLIFFER KD, 1988, BRAIN RES, V460, P356, DOI 10.1016/0006-8993(88)90381-2; STANDAERT DG, 1986, J NEUROSCI, V6, P1220; Polgar E, 2010, BRAIN RES, V1308, P58, DOI 10.1016/j.brainres.2009.10.041; CORTES R, 1990, SYNAPSE, V6, P369, DOI 10.1002/syn.890060410; GRIFFOND B, 1993, NEUROSCI LETT, V156, P91, DOI 10.1016/0304-3940(93)90447-S; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; MCMAHON SB, 1985, BRAIN RES, V333, P19, DOI 10.1016/0006-8993(85)90119-2; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Naim MM, 1998, EUR J NEUROSCI, V10, P3012; Szucs P, 2010, J COMP NEUROL, V518, P2645, DOI 10.1002/cne.22391; Miura E, 2006, J NEUROCHEM, V97, P1431, DOI 10.1111/j.1471-4159.2006.03835.x; Al Ghamdi KS, 2009, NEUROSCIENCE, V164, P1794, DOI 10.1016/j.neuroscience.2009.09.071; Bester H, 2000, J NEUROPHYSIOL, V83, P2239; DING YQ, 1995, BRAIN RES, V674, P336, DOI 10.1016/0006-8993(95)00022-I; Polgar E, 2006, NEUROSCIENCE, V139, P687, DOI 10.1016/j.neuroscience.2005.12.021; Todd AJ, 2002, J NEUROSCI, V22, P4103; SLUGG RM, 1994, J COMP NEUROL, V339, P49, DOI 10.1002/cne.903390106; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Polgar E, 2008, J NEUROSCI, V28, P13150, DOI 10.1523/JNEUROSCI.4053-08.2008; Davidson S, 2010, J COMP NEUROL, V518, P3193, DOI 10.1002/cne.22392; Al-Khater KM, 2008, J COMP NEUROL, V511, P1, DOI 10.1002/cne.21811; McLeod AL, 2000, J COMP NEUROL, V420, P349; BLEAZARD L, 1994, J NEUROSCI, V14, P7655; Naim M, 1997, J NEUROSCI, V17, P5536; Andrew D, 2009, J PHYSIOL-LONDON, V587, P2005, DOI 10.1113/jphysiol.2009.170290; Al-Khater KM, 2009, J COMP NEUROL, V515, P629, DOI 10.1002/cne.22081; Polgar E, 1999, J NEUROSCI, V19, P2637; Polgar E, 2011, J COMP NEUROL, V519, P1007, DOI 10.1002/cne.22570; Baseer N, 2012, J NEUROSCI, V32, P11854, DOI 10.1523/JNEUROSCI.2707-12.2012; WARDEN MK, 1988, J COMP NEUROL, V272, P90, DOI 10.1002/cne.902720107; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Almarestani L, 2007, J COMP NEUROL, V504, P287, DOI 10.1002/cne.21410; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Gamboa-Esteves FO, 2004, J CHEM NEUROANAT, V27, P251, DOI 10.1016/j.jchemneu.2004.04.001; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; Todd AJ, 1998, NEUROSCIENCE, V85, P459, DOI 10.1016/S0306-4522(97)00669-6; BLOMQVIST A, 1995, NEUROREPORT, V6, P605, DOI 10.1097/00001756-199503000-00005; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; RETHELYI M, 1991, NEUROSCIENCE, V42, P531, DOI 10.1016/0306-4522(91)90395-5; Kardon AP, 2014, NEURON, V82, P573, DOI 10.1016/j.neuron.2014.02.046; Fell K, 1995, J COMP NEUROL, V353, P506; Franklin K, 2007, MOUSE BRAIN STEREOTA; Gutierrez-Mecinas M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-79; LIU HT, 1994, P NATL ACAD SCI USA, V91, P1009, DOI 10.1073/pnas.91.3.1009; Polgar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078309; Polgar E, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-4	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	OCT	2015	156	10					2061	2071		10.1097/j.pain.0000000000000270		11	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CU2OG	WOS:000363362200025		
J	Soga, A; Lin, HY; Su, BH				Soga, Akiko; Lin, Hsiang-Yu; Su, Bai-Horng			Thumbprint Sign in the Colon: A Diagnostic Finding of Necrotizing Enterocolitis in Premature Infants	PEDIATRICS AND NEONATOLOGY			English	Editorial Material							TWIN TRANSFUSION SYNDROME		[Soga, Akiko] Nihon Univ Hosp, Dept Pediat Surg, Tokyo, Japan; [Lin, Hsiang-Yu; Su, Bai-Horng] China Med Univ, Dept Neonatol, Childrens Hosp, Taichung 404, Taiwan; [Su, Bai-Horng] China Med Univ, Coll Med, Taichung 404, Taiwan	Su, BH (reprint author), China Med Univ, Dept Neonatol, Childrens Hosp, 2 Yuh Der Rd, Taichung 404, Taiwan.	subh1168@gmail.com					LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mosquera C, 2012, SEMIN PERINATOL, V36, P182, DOI 10.1053/j.semperi.2012.02.006; Simpson LL, 2013, AM J OBSTET GYNECOL, V208, P3, DOI 10.1016/j.ajog.2012.10.880	3	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1875-9572			PEDIATR NEONATOL	Pediatr. Neonatol.	OCT	2015	56	5					360	361		10.1016/j.pedneo.2015.04.003		2	Pediatrics	Pediatrics	CU3QD	WOS:000363439000015		
J	Kimura, H; Kolokolova, L; Li, AG; Augereau, JC; Kaneda, H; Jager, C				Kimura, Hiroshi; Kolokolova, Ludmilla; Li, Aigen; Augereau, Jean-Charles; Kaneda, Hidehiro; Jaeger, Cornelia			Cosmic Dust VII	PLANETARY AND SPACE SCIENCE			English	Editorial Material							ACTIVE GALACTIC NUCLEI; STARDUST SPACECRAFT; COMET 81P/WILD-2; WATER ICE; PARTICLES; SPECTRA; GRAINS; EVOLUTION; ORIGIN; DISKS		[Kimura, Hiroshi] Kobe Univ, Grad Sch Sci, CPS, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kolokolova, Ludmilla] Univ Maryland, Dept Astron, Planetary Data Syst Grp, College Pk, MD 20742 USA; [Li, Aigen] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Augereau, Jean-Charles] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Augereau, Jean-Charles] CNRS, IPAG, F-38000 Grenoble, France; [Kaneda, Hidehiro] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Jaeger, Cornelia] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Jaeger, Cornelia] Univ Jena, Lab Astrophys & Clusterphys Grp, D-07743 Jena, Germany; [Jaeger, Cornelia] Univ Jena, Inst Solid State Phys, D-07743 Jena, Germany	Kimura, H (reprint author), Kobe Univ, Grad Sch Sci, CPS, Chuo Ku, Minatojima Minamimachi 7-1-48, Kobe, Hyogo 6500047, Japan.						A'Hearn M.F., 2014, COSM DUST 7; Terada H, 2007, ASTROPHYS J, V667, P303, DOI 10.1086/520951; Fabian D, 2001, ASTRON ASTROPHYS, V378, P228, DOI 10.1051/0004-6361:20011196; Nikutta R, 2009, ASTROPHYS J, V707, P1550, DOI 10.1088/0004-637X/707/2/1550; Kimura H, 2014, ICARUS, V232, P133, DOI 10.1016/j.icarus.2014.01.009; Protopapa S, 2014, ICARUS, V238, P191, DOI 10.1016/j.icarus.2014.04.008; Koike C, 2006, ASTRON ASTROPHYS, V449, P583, DOI 10.1051/0004-6361:20053256; Kimura H, 2014, PLANET SPACE SCI, V100, P1, DOI 10.1016/j.pss.2014.02.009; Cami J, 1998, ASTROPHYS SPACE SCI, V255, P339; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; Westphal AJ, 2014, SCIENCE, V345, P786, DOI 10.1126/science.1252496; Pontoppidan KM, 2008, ASTROPHYS J, V678, P1005, DOI 10.1086/533431; Keller LP, 2011, GEOCHIM COSMOCHIM AC, V75, P5336, DOI 10.1016/j.gca.2011.06.040; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Busemann H, 2009, EARTH PLANET SC LETT, V288, P44, DOI 10.1016/j.epsl.2009.09.007; Flynn GJ, 2013, EARTH PLANETS SPACE, V65, P1159, DOI 10.5047/eps.2013.05.007; Kaneda H, 2014, PLANET SPACE SCI, V100, P6, DOI 10.1016/j.pss.2014.01.017; ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Do Duy T., 2015, PLANET SPACE SCI; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Gibb E, 2014, COSM DUST 7; Gonzalez JF, 2015, PLANET SPACE SCI, V116, P48, DOI 10.1016/j.pss.2015.05.018; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hammonds M, 2015, PLANET SPACE SCI, V116, P73, DOI 10.1016/j.pss.2015.05.010; Hattori Y, 2015, PLANET SPACE SCI, V116, P57, DOI 10.1016/j.pss.2015.04.006; Jones AP, 2014, PLANET SPACE SCI, V100, P26, DOI 10.1016/j.pss.2013.11.011; Juvela M, 2015, PLANET SPACE SCI, V116, P64, DOI 10.1016/j.pss.2015.03.005; Kokusho T, 2015, PLANET SPACE SCI, V116, P92, DOI 10.1016/j.pss.2015.04.009; Kolokolova L, 2015, PLANET SPACE SCI, V116, P30, DOI 10.1016/j.pss.2015.03.006; Krelowski J., 2015, PLANET SP SCI; Mason RE, 2015, PLANET SPACE SCI, V116, P97, DOI 10.1016/j.pss.2015.02.013; Moores JE, 2015, PLANET SPACE SCI, V116, P6, DOI 10.1016/j.pss.2015.01.001; Mori S., 2014, COSM DUST 7; Nozawa T, 2014, COSM DUST 7; Oberg KI, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/109; Olofsson J., 2014, COSM DUST 7; Onaka T, 2015, PLANET SPACE SCI, V116, P84, DOI 10.1016/j.pss.2015.03.025; Onaka T., 2014, COSM DUST 7; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Senshu H, 2015, PLANET SPACE SCI, V116, P18, DOI 10.1016/j.pss.2015.03.009; Shalima P, 2015, PLANET SPACE SCI, V116, P39, DOI 10.1016/j.pss.2015.03.017; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Yamagishi M., 2014, COSM DUST 7	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		1	5		10.1016/j.pss.2015.03.002		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900001		
J	Senshu, H; Kimura, H; Yamamoto, T; Wada, K; Kobayashi, M; Namiki, N; Matsui, T				Senshu, H.; Kimura, H.; Yamamoto, T.; Wada, K.; Kobayashi, M.; Namiki, N.; Matsui, T.			Photoelectric dust levitation around airless bodies revised using realistic photoelectron velocity distributions	PLANETARY AND SPACE SCIENCE			English	Article						Dust; Levitation; Photoelectron emission; Dusty plasma	SOLAR-WIND; LUNAR DUST; SURFACE; GRAINS; SHEATH; PHOTOEMISSION; SATELLITE; SPECTROSCOPY; TERMINATOR; TRANSPORT	The velocity distribution function of photoelectrons from a surface exposed to solar UV radiation is fundamental to the electrostatic status of the surface. There is one and only one laboratory measurement of photoelectron emission from astronomically relevant material, but the energy distribution function was measured only in the emission angle from the normal to the surface of 0 to about pi/4. Therefore, the measured distribution is not directly usable to estimate the vertical structure of a photoelectric sheath above the surface. In this study, we develop a new analytical method to calculate an angle-resolved velocity distribution function of photoelectrons from the laboratory measurement data. We find that the photoelectric current and yield for lunar surface fines measured in a laboratory have been underestimated by a factor of two. We apply our new energy distribution function of photoelectrons to model the formation of photoelectric sheath above the surface of asteroid 433 Eros. Our model shows that a 0.1 mu m-radius dust grain can librate above the surface of asteroid 433 Eros regardless of its launching velocity. In addition, a 0.5 mu m grain can hover over the surface if the grain was launched at a velocity slower than 0.4 m/s, which is a more stringent condition for levitation than previous studies. However, a lack of high-energy data on the photoelectron energy distribution above 6 eV prevents us from firmly placing a constraint on the levitation condition. (C) 2015 Elsevier Ltd. All rights reserved.	[Senshu, H.; Wada, K.; Kobayashi, M.; Matsui, T.] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Kimura, H.] Kobe Univ, Grad Sch Sci, CPS, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yamamoto, T.] Kobe Univ, Integrated Res Ctr, CPS, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Namiki, N.] Natl Astron Observ Japan, RISE Project Off, Mitaka, Tokyo 1818588, Japan; [Namiki, N.] Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Miura, Kanagawa, Japan	Senshu, H (reprint author), Chiba Inst Technol, Planetary Explorat Res Ctr, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hsenshu@gmail.com			MEXT [23103004]; JSPS [21340040, 26400230]	We thank anonymous reviewer 1 for helpful comments on the manuscript. H.K. is grateful to JSPS's Grants-in-Aid for Scientific Research (#21340040, #26400230). T.Y. acknowledges the support by Grant-in-Aid Scientific Research on Innovative Area (23103004) from MEXT.	Grun E, 2011, PLANET SPACE SCI, V59, P1672, DOI 10.1016/j.pss.2011.04.005; WYATT SP, 1969, PLANET SPACE SCI, V17, P155, DOI 10.1016/0032-0633(69)90034-8; Poppe A, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015286; Meyer-Vernet N, 1998, J GEOPHYS RES-SPACE, V103, P29705, DOI 10.1029/98JA02853; BERG OE, 1978, EARTH PLANET SC LETT, V39, P377, DOI 10.1016/0012-821X(78)90025-0; Poppe AR, 2012, ICARUS, V221, P135, DOI 10.1016/j.icarus.2012.07.018; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; REASONER DL, 1972, J GEOPHYS RES, V77, P6671, DOI 10.1029/JA077i034p06671; GRARD RJL, 1973, J GEOPHYS RES, V78, P2885, DOI 10.1029/JA078i016p02885; ROHATGI VK, 1957, J APPL PHYS, V28, P951, DOI 10.1063/1.1722919; Kohnlein W, 1996, SOL PHYS, V169, P209, DOI 10.1007/BF00153841; Hirata N, 2012, ICARUS, V220, P106, DOI 10.1016/j.icarus.2012.03.028; Le Chat G, 2011, SOL PHYS, V271, P141, DOI 10.1007/s11207-011-9797-3; Colwell JE, 2005, ICARUS, V175, P159, DOI 10.1016/j.icarus.2004.11.001; Hechenblaikner G, 2012, J APPL PHYS, V111, DOI 10.1063/1.4730638; Kimura H, 1998, ASTROPHYS J, V499, P454, DOI 10.1086/305613; MENDIS DA, 1981, ASTROPHYS J, V249, P787, DOI 10.1086/159337; SHULL JM, 1978, ASTROPHYS J, V226, P858, DOI 10.1086/156666; Richardson JE, 2004, SCIENCE, V306, P1526, DOI 10.1126/science.1104731; Stubbs TJ, 2006, ADV SPACE RES, V37, P59, DOI 10.1016/j.asr.2005.04.048; Kimura H, 2014, PLANET SPACE SCI, V100, P64, DOI 10.1016/j.pss.2014.03.017; Nitter T, 1998, J GEOPHYS RES-SPACE, V103, P6605, DOI 10.1029/97JA03523; Pei ZT, 2002, JPN J APPL PHYS 2, V41, pL52, DOI 10.1143/JJAP.41.L52; GRARD RJL, 1971, J GEOPHYS RES, V76, P2498, DOI 10.1029/JA076i010p02498; DRAINE BT, 1979, ASTROPHYS J, V231, P77, DOI 10.1086/157165; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651; REASONER DL, 1973, J GEOPHYS RES, V78, P5844; GUERNSEY RL, 1970, J GEOPHYS RES, V75, P3193, DOI 10.1029/JA075i016p03193; HAVNES O, 1987, J GEOPHYS RES, V92, P2281, DOI 10.1029/JA092iA03p02281; Bergstrom D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2738417; FADLEY CS, 1974, J ELECTRON SPECTROSC, V4, P93, DOI 10.1016/0368-2048(74)90001-2; Fadley C.S., 1976, PROGR SOLID STATE CH, V11, P265, DOI 10.1016/0079-6786(76)90013-3; FEUERBAC.B, 1972, J APPL PHYS, V43, P1563, DOI 10.1063/1.1661362; Feuerbacher B., 1972, GEOCHIM COSM SUPPL, V3, P2655; Katz I., 1977, CR135256 NASA, P334; MUKAI T, 1981, ASTRON ASTROPHYS, V99, P1; Willis R.F., PHOTON PARTICLE INTE, P389	37	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		18	29		10.1016/j.pss.2015.03.009		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900003		
J	Shalima, P; Wada, K; Kimura, H				Shalima, P.; Wada, K.; Kimura, H.			Ejecta curtain radiative transfer modeling for probing its geometry and dust optical properties	PLANETARY AND SPACE SCIENCE			English	Article						Dust; ScatteringImpact ejecta; Impact ejecta	MICROSCOPII DEBRIS DISK; DEEP IMPACT; METEORITE PARTICLES; SCATTERING; DENSITY; LIGHT; SAND	An ejecta curtain is produced as a result of impact cratering of celestial bodies that excavates and ejects their surface and underground material. Since ejecta particles are thought to reflect the interior materials and structures of celestial bodies, ejecta and ejecta curtains provide us with valuable information about the interior of the bodies. Following the Deep Impact mission, more and more in situ data on ejecta curtains are expected to become available in future space missions. To draw valuable information from such in situ measurements, a radiative-transfer model of the ejecta curtain plays an important role. This urges us to carefully assess the model parameters with experimental results as well as understand the contribution of each model parameter to the predicted intensities of the radiative calculations. In this work, we study the dependences of the projected intensity images of the ejecta on the scattering phase function and the geometry of an ejecta curtain produced by impact on an airless-body's surface, as a first step toward a correct interpretation of ejecta observations. Using the Monte-Carlo multiple scattering method, we have calculated the scattered intensities for three different orientations of the ejecta curtain. We have also computed the intensities for ejecta material using different phase functions. We find that the scattered intensities are highest for the isotropic phase function irrespective of the orientation of the ejecta cone for the scattering angles and geometry considered here. Observations from the other side could lead to higher intensities for forward scattering grains that are typical for asteroids. Therefore in situ observations of ejecta-curtains at different angles will enable us to use our model predictions to extract the phase functions as well as column densities of its component dust grains. (C) 2015 Elsevier Ltd. All rights reserved.	[Shalima, P.] Indian Inst Astrophys, Bangalore 560034, Karnataka, India; [Wada, K.] Chiba Inst Technol, Planetary Explorat Res Ctr, Chiba, Japan; [Kimura, H.] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan	Shalima, P (reprint author), Indian Inst Astrophys, Bangalore 560034, Karnataka, India.	shalima.p@gmail.com			DST-SERB FAST Track Program [SR/FTP/PS-68/2008]; JSPS (Japan Society for the Promotion of Science) [21340040, 26400230]	SP would like to thank the DST-SERB FAST Track Program (SR/FTP/PS-68/2008) for financial support. We are grateful to JSPS (Japan Society for the Promotion of Science) under Grants-in-Aid for Scientific Research (B) #21340040 and (C) #26400230.	Anderson JLB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002075; OBERBECK VR, 1975, REV GEOPHYS, V13, P337, DOI 10.1029/RG013i002p00337; Kuppers M, 2005, NATURE, V437, P987, DOI 10.1038/nature04236; Wada K, 2006, ICARUS, V180, P528, DOI 10.1016/j.icarus.2005.10.002; Richardson JE, 2007, ICARUS, V190, P357, DOI 10.1016/j.icarus.2007.08.001; Augereau JC, 2006, ASTRON ASTROPHYS, V455, P987, DOI 10.1051/0004-6361:20054250; Kolokolova L, 2007, ASTRON ASTROPHYS, V463, P1189, DOI 10.1051/0004-6361:20065069; Kimura H, 2006, ASTRON ASTROPHYS, V449, P1243, DOI 10.1051/0004-6361:20051783; MILLIS RL, 1982, ASTRON J, V87, P1310, DOI 10.1086/113218; Cintala MJ, 1999, METEORIT PLANET SCI, V34, P605; Graham JR, 2007, ASTROPHYS J, V654, P595, DOI 10.1086/509318; Piironen J, 1998, PLANET SPACE SCI, V46, P937, DOI 10.1016/S0032-0633(98)00035-X; Tiscareno MS, 2013, SCIENCE, V340, P460, DOI 10.1126/science.1233524; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Shalima P, 2004, MON NOT R ASTRON SOC, V352, P1319, DOI 10.1111/j.1365-2966.2004.08022.x; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Housen KR, 2011, ICARUS, V211, P856, DOI 10.1016/j.icarus.2010.09.017; Nagdimunov L, 2014, PLANET SPACE SCI, V100, P73, DOI 10.1016/j.pss.2014.05.018; Bohren C.F., 1995, HDB OPTICS, V1; Divine N., 1981, ESA SP, V174, P47; HONG SS, 1985, ASTRON ASTROPHYS, V146, P67; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Kadono T, 2015, ICARUS, V250, P215, DOI 10.1016/j.icarus.2014.11.030; Marcus Joseph N, 2007, International Comet Quarterly, V29; Meech KJ, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L1; Metropolis N., 1949, J AM STAT ASSOC, V44, P247; Munoz O, 2000, ASTRON ASTROPHYS, V360, P777; Veillet C., 2007, LUN PLAN SCI C LUN P, V38, P1520	29	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		39	47		10.1016/j.pss.2015.03.017		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900005		
J	Hattori, Y; Kaneda, H; Ishihara, D; Yamagishi, M; Kondo, T; Sano, H				Hattori, Y.; Kaneda, H.; Ishihara, D.; Yamagishi, M.; Kondo, T.; Sano, H.			An AKARI infrared study of dust emission in Galactic bubbles indicative of large-scale cloud-cloud collisions	PLANETARY AND SPACE SCIENCE			English	Article						Infrared; Interstellar dust; Galactic bubbles; Massive stars	MOLECULAR CLOUDS; CLUSTER FORMATION; STARS; SHOCKS	We report our systematic study on dust emission in massive star-forming regions indicative of large-scale cloud-cloud collisions, using the AKARI infrared (IR) all-sky survey data at wavelengths of 9, 18, 65, 90, 140, and 160 pm. We focus on the Galactic bubbles catalogued by Spitzer, which are categorized into two types of morphology, closed and broken bubbles. A broken bubble has a possibility of being created by a cloud-cloud collision, judging from its morphological similarity to the structure theoretically predicted as a product of the collision. Therefore we search for systematic differences in IR properties between the two types. We performed aperture photometry for 111 Spitzer bubbles and created the spectral energy distribution (SED) of each bubble. We decomposed the SED into polycyclic aromatic hydrocarbon (PAH), warm and cold dust components by model fitting, and calculated their luminosities, L-PAH, L-warm and L-cold respectively, by integrating each SED component as a function of the wavelength. We then investigated the total IR luminosity (L-TIR = L-PAH + L-warm + L-cold), the ratio of L-PAH to L-TIR and the ratio of L-warm to L-TIR as a function of the bubble radius. As a result, we find systematic differences between the closed and broken bubbles for the former two relations. We discuss the implications of the differences for the scenario of the large-scale cloud-cloud collisions. (C) 2015 Elsevier Ltd. All rights reserved.	[Hattori, Y.; Kaneda, H.; Ishihara, D.; Yamagishi, M.; Kondo, T.; Sano, H.] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Hattori, Y (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	hattori@u.phys.nagoya-u.ac.jp			JSPS KAKENHI [25247020]	This research is based on observations with AKARI, a JAXA project with the participation of ESA. The authors thank all the members of the AKARI project, particularly the all-sky survey data reduction team. This research was supported by JSPS KAKENHI Grant Number 25247020.	HABE A, 1992, PUBL ASTRON SOC JPN, V44, P203; Watson C, 2010, ASTROPHYS J, V716, P1478, DOI 10.1088/0004-637X/716/2/1478; ELMEGREEN BG, 1977, ASTROPHYS J, V214, P725, DOI 10.1086/155302; Zhang CF, 2013, CHIN CONT DECIS CONF, P550; Vacca WD, 1996, ASTROPHYS J, V460, P914, DOI 10.1086/177020; Ishihara D, 2007, PUBL ASTRON SOC JPN, V59, pS443; Furukawa N, 2009, ASTROPHYS J LETT, V696, pL115, DOI 10.1088/0004-637X/696/2/L115; Churchwell E, 2006, ASTROPHYS J, V649, P759, DOI 10.1086/507015; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Beaumont C.N., 2009, ASTROPHYS J, V709, P791; Deharveng L., 2010, ASTRON ASTROPHYS, V523, P6; Fukui Y, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/36; Inoue T, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L31; Micelotta ER, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911682; Pavel MD, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/150; Torii K, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/46	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		57	63		10.1016/j.pss.2015.04.006		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900007		
J	Hammonds, M; Mori, T; Usui, F; Onaka, T				Hammonds, M.; Mori, T.; Usui, F.; Onaka, T.			Variations in the 3.3 mu m feature and carbonaceous dust in AKARI data	PLANETARY AND SPACE SCIENCE			English	Article						Interstellar medium; H II regions; Astrochemistry; Infrared spectroscopy; Interstellar dust	POLYCYCLIC AROMATIC-HYDROCARBONS; UNIDENTIFIED EMISSION BANDS; INFRARED-EMISSION; INTERSTELLAR-MEDIUM; FUNCTIONAL-GROUPS; RED RECTANGLE; SPECTROSCOPY; SPECTRUM; EVOLUTION; NGC-7027	A wealth of near infrared spectroscopic data for a large number of galactic objects was recorded with AKARI during its active lifetime. The hydrocarbon emission features around 3.3-3.5 m are modelled here as a series of 6 Voigt profiles arising due to hydrogen atoms found in different molecular structures within the emitting spectroscopic carriers. This model is compared and contrasted with a model consisting of 3 Gaussian profiles and found to produce a superior fit to AKARI data. Analysis of the 6 Voigt model shows that the 3.3 m aromatic hydrocarbon band is well described by two components at 3.28 m and 3.30 m. We confirm that the 3.28 pm band is due to emission from aromatic molecules, and find a good correlation between the 3.28 mu m and 3.41 m bands, assigned to bay-hydrogen sites and linking methylene groups respectively. Results are discussed in terms of molecular processing and dust formation. (C) 2015 Elsevier Ltd. All rights reserved.	[Hammonds, M.; Mori, T.; Usui, F.; Onaka, T.] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Hammonds, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hammonds@astron.s.u-tokyo.ac.jp			 [P13771]	The authors thank Ronin Wu for excellent suggestions and advice, Aigen Li and Christine Joblin for interesting and insightful discussions, and the two anonymous referees for helpful suggestions. This work is supported by a Grand-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (ID: P13771). This research is based on observations with AKARI, a JAXA project with the participation of ESA. Quoted quantum chemical calculations were performed using the University of Nottingham High Performance Computing Facility.	ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; Angus J., 1987, HYDROGENATED AMORPHO; GEBALLE TR, 1985, ASTROPHYS J, V292, P500, DOI 10.1086/163182; West B, 2012, J PHYS CHEM A, V116, P10999, DOI 10.1021/jp3091705; Imanishi M, 2010, ASTROPHYS J, V721, P1233, DOI 10.1088/0004-637X/721/2/1233; Khramtsova MS, 2014, MON NOT R ASTRON SOC, V444, P757, DOI 10.1093/mnras/stu1482; SANDFORD SA, 1991, ASTROPHYS J, V376, P599, DOI 10.1086/170307; Hrivnak BJ, 2007, ASTROPHYS J, V662, P1059, DOI 10.1086/518109; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; HUMMER DG, 1987, MON NOT R ASTRON SOC, V224, P801; NAGATA T, 1988, ASTROPHYS J, V326, P157, DOI 10.1086/166076; Duley WW, 2001, ASTROPHYS J, V554, pL209, DOI 10.1086/321704; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Boersma C, 2009, ASTROPHYS J, V690, P1208, DOI 10.1088/0004-637X/690/2/1208; Kwok S, 2011, NATURE, V479, P80, DOI 10.1038/nature10542; Kaneda H, 2009, ADV SPACE RES, V44, P1038, DOI 10.1016/j.asr.2009.07.002; GILLETT FC, 1973, ASTROPHYS J, V183, P87, DOI 10.1086/152211; Rapacioli M, 2005, ASTRON ASTROPHYS, V429, P193, DOI 10.1051/0004-6361:20041247; BARKER JR, 1987, ASTROPHYS J, V315, pL61, DOI 10.1086/184861; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; Candian A, 2012, MON NOT R ASTRON SOC, V426, P389, DOI 10.1111/j.1365-2966.2012.21760.x; Chiar JE, 2000, ASTROPHYS J, V537, P749, DOI 10.1086/309047; TOKUNAGA AT, 1991, ASTROPHYS J, V380, P452, DOI 10.1086/170603; Pauzat F, 1999, MON NOT R ASTRON SOC, V304, P241, DOI 10.1046/j.1365-8711.1999.02240.x; Sloan GC, 1997, ASTROPHYS J, V474, P735, DOI 10.1086/303484; DULEY WW, 1981, MON NOT R ASTRON SOC, V196, P269; Hammonds M, 2009, PHYS CHEM CHEM PHYS, V11, P4458, DOI 10.1039/b903237a; Wagner DR, 2000, ASTROPHYS J, V545, P854, DOI 10.1086/317868; ALLAMANDOLA LJ, 1989, ASTROPHYS J, V345, pL59, DOI 10.1086/185552; Joblin C, 1996, ASTROPHYS J, V458, P610, DOI 10.1086/176843; PAINTER PC, 1981, APPL SPECTROSC, V35, P475, DOI 10.1366/0003702814732256; Bauschlicher CW, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/102; Candian A, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/1/L10; Chiar JE, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/78; Dartois E., 2007, MOL SPACE LAB; Gadallah KAK, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219248; Garcia-Hernandez DA, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/2/L30; GIARD M, 1988, ASTRON ASTROPHYS, V201, pL1; Imanishi M., 2011, PASJ, V63, P447; Joblin C., 2011, EAS PUBLICATIONS SER, V46; Jones AP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321686; Kwok S, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/5; Li AG, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L35; Micelotta ER, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/35; Mori TI, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/53; Onaka T., 2012, SPIE SPIE C SERIES, V8442; Onaka T., 2012, PUBL KOREAN ASTRON S, V27, P187; Onaka T., 2007, PASJ, V59, P401; Pilleri P, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425590; SAKATA A, 1984, ASTROPHYS J, V287, pL51, DOI 10.1086/184396; Sandford SA, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/1/8; Shao Y., 2006, PHYS CHEM CHEM PHYS; Song IO, 2003, MON NOT R ASTRON SOC, V346, pL1, DOI 10.1046/j.1365-2966.2003.07148.x; Steglich M, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/26; Wexler A.S., 1967, APPL SPECTROSC REV, V1, P29, DOI DOI 10.1080/05704926708547581; Yang XP, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-3	57	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		73	83		10.1016/j.pss.2015.05.010		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900009		
J	Onaka, T; Mori, TI; Okada, Y				Onaka, Takashi; Mori, Tamami I.; Okada, Yoko			Dust processing in the Carina nebula region	PLANETARY AND SPACE SCIENCE			English	Article						Infrared; ISM; Lines and bands; Dust; Abundances; Carina nebula	POLYCYCLIC AROMATIC-HYDROCARBON; SPECTRAL ENERGY-DISTRIBUTION; DIFFUSE GALACTIC EMISSION; STAR-FORMING GALAXIES; INTERSTELLAR-MEDIUM; INFRARED-EMISSION; PHOTODISSOCIATION REGIONS; WAVELENGTH SPECTROMETER; ELLIPTIC GALAXIES; GLOBAL PROPERTIES	Dust processing in the Carina nebula is investigated based on mid-to far-infrared spectroscopy with Infrared Space Observatory (ISO). Mapping observations over a central 40' x 20' area of the nebula with PHT-S, SWS, and LWS onboard ISO not only reveal spectroscopically that the mid-infrared unidentified infrared (UIR) bands at 6.2, 7.7, 8.6, and 11.3 mu m are absent in the ionized region, but also indicate that the 11.3 mu m may behave differently from the other three UIR bands near the edge of the ionized region, suggesting a variation either in the size distribution or in the ionization fraction of the band carriers. The correlation of [NII]122 mu m and [SiII]35 mu m line emissions observed with SWS and LWS is reinvestigated based on the recent atomic data as well as the latest cosmic abundance, suggesting that a large fraction (>70%), if not all, of silicon returns to the gas phase in the Carina nebula, suggesting that silicates cannot survive under harsh conditions, such as massive star-forming regions. The present observations clearly show dust processing taking place in active regions in the Galaxy. (C) 2015 Elsevier Ltd. All rights reserved.	[Onaka, Takashi; Mori, Tamami I.] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan; [Okada, Yoko] Univ Cologne, Phys Inst 1, D-50937 Cologne, Germany	Onaka, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan.	onaka@astron.s.u-tokyo.ac.jp			JSPS KAKENHI [23244021]; JSPS Research Fellowship	This work is supported in part by JSPS KAKENHI (23244021). T.I.M. is supported by a JSPS Research Fellowship for Young Scientist.	Berne O, 2007, ASTRON ASTROPHYS, V469, P575, DOI 10.1051/0004-6361:20066282; Allain T, 1996, ASTRON ASTROPHYS, V305, P602; Hudson CE, 2004, MON NOT R ASTRON SOC, V348, P1275, DOI 10.1111/j.1365-2966.2004.07461.x; Mizutani M, 2002, ASTRON ASTROPHYS, V382, P610, DOI 10.1051/0004-6361:20011611; Sakon I, 2004, ASTROPHYS J, V609, P203, DOI 10.1086/420919; Galliano F, 2008, ASTROPHYS J, V679, P310, DOI 10.1086/587051; Povich MS, 2007, ASTROPHYS J, V660, P346, DOI 10.1086/513073; LEISAWITZ D, 1988, ASTROPHYS J, V332, P954, DOI 10.1086/166704; Bautista MA, 2009, ASTRON ASTROPHYS, V508, P1527, DOI 10.1051/0004-6361/200913179; Dale DA, 2001, ASTROPHYS J, V549, P215, DOI 10.1086/319077; Onaka T, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913770; Aggarwal KM, 2014, MON NOT R ASTRON SOC, V442, P388, DOI 10.1093/mnras/stu883; Okada Y, 2006, ASTROPHYS J, V640, P383, DOI 10.1086/499801; Kaneda H, 2008, ASTROPHYS J, V684, P270, DOI 10.1086/590243; Draine BT, 2001, ASTROPHYS J, V551, P807, DOI 10.1086/320227; Smith JDT, 2007, ASTROPHYS J, V656, P770, DOI 10.1086/510549; BERNARD JP, 1994, ASTRON ASTROPHYS, V289, P524; BENTLEY AF, 1984, ASTROPHYS J, V278, P665, DOI 10.1086/161834; Lemke D, 1996, ASTRON ASTROPHYS, V315, pL64; Miller A, 2007, ASTROPHYS J, V659, P441, DOI 10.1086/512178; Bradford CM, 2002, APPL OPTICS, V41, P2561, DOI 10.1364/AO.41.002561; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Rosenthal D, 2000, ASTRON ASTROPHYS, V356, P705; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Irwin JA, 2006, ASTRON ASTROPHYS, V445, P123, DOI 10.1051/0004-6361:20053233; Sakon I, 2007, PUBL ASTRON SOC JPN, V59, pS483; Kwok S, 2011, NATURE, V479, P80, DOI 10.1038/nature10542; Clegg PE, 1996, ASTRON ASTROPHYS, V315, pL38; Onaka T, 1996, PUBL ASTRON SOC JPN, V48, pL59; Rapacioli M, 2005, ASTRON ASTROPHYS, V429, P193, DOI 10.1051/0004-6361:20041247; Mattila K, 1996, ASTRON ASTROPHYS, V315, pL353; Onaka T, 2007, PUBL ASTRON SOC JPN, V59, pS401; Smith N, 2007, MON NOT R ASTRON SOC, V379, P1279, DOI 10.1111/j.1365-2966.2007.12021.x; Jones AP, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117623; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Onaka T, 2007, ASTROPHYS J, V654, P844, DOI 10.1086/509113; Okada Y, 2003, ASTRON ASTROPHYS, V412, P199, DOI 10.1051/0004-6361:20031415; Kaufman MJ, 2006, ASTROPHYS J, V644, P283, DOI 10.1086/503596; Fuente A, 2000, ASTRON ASTROPHYS, V354, P1053; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Cartledge SIB, 2006, ASTROPHYS J, V641, P327, DOI 10.1086/500297; Okada Y, 2008, ASTROPHYS J, V682, P416, DOI 10.1086/589229; Matsumoto H, 2008, ASTROPHYS J, V677, P1120, DOI 10.1086/533526; Onaka T, 2000, ADV SPACE RES, V25, P2167, DOI 10.1016/S0273-1177(99)01149-7; COHEN M, 1986, ASTROPHYS J, V302, P737, DOI 10.1086/164035; Oberst TE, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/100; deGraauw T, 1996, ASTRON ASTROPHYS, V315, pL49; SCHUTTE WA, 1993, ASTROPHYS J, V415, P397, DOI 10.1086/173173; Bregman JD, 2008, ASTR SOC P, V381, P34; Berne O, 2009, ASTROPHYS J LETT, V706, pL160, DOI 10.1088/0004-637X/706/1/L160; Bocchio M, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219705; Bocchio M, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424368; Boulanger F, 1998, ASTR SOC P, V132, P15; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; GIARD M, 1988, ASTRON ASTROPHYS, V201, pL1; Helou G., 2000, APJ, V532, P21; Jenkins EB, 2009, ASTROPHYS J, V700, P1299, DOI 10.1088/0004-637X/700/2/1299; Jones AP, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201014440; Jones A. P., 2004, ASP C SER, V309, P347; Jones AP, 2000, J GEOPHYS RES-SPACE, V105, P10257, DOI 10.1029/1999JA900264; Jones AP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321686; Jones AP, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117624; Jones AP, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118483; Kaneda H., 2005, APJ, V632, P83; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; Meixner M., 2006, AJ, V132, P2288; Micelotta ER, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911682; Micelotta ER, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911683; Mizutani M., 2004, Astronomy & Astrophysics, V423, DOI 10.1051/0004-6361:20041063; Mori TI, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/68; Mori TI, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/53; Nieva MF, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118158; Onaka T., 2013, P IAU S, V292, P259; Preibisch T, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201218851; Sandstrom KM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/20; Sellgren K., ASTROPHYS J, V349, P120; Tanaka M, 1996, PUBL ASTRON SOC JPN, V48, pL53; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056	79	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		84	91		10.1016/j.pss.2015.03.025		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900010		
J	Kokusho, T; Nagayama, T; Kaneda, H; Ishihara, D; Lee, HG; Onaka, T				Kokusho, Takuma; Nagayama, Takahiro; Kaneda, Hidehiro; Ishihara, Daisuke; Lee, Ho-Gyu; Onaka, Takashi			A study of iron and dust in the supernova remnant IC 443	PLANETARY AND SPACE SCIENCE			English	Article						Supernova remnant; Interstellar dust; Iron; IRSF; AKARI; Suzaku	X-RAY-STRUCTURE; GRAIN DESTRUCTION; IC-443; SPECTROSCOPY; SHOCK; CASSIOPEIA; SPECTRUM; NEBULA; GAS	We performed near-infrared line mapping of the supernova remnant IC 443 with the IRSF 1.4-m telescope, using the narrow-band filters tuned for [Fe II] 1.257 mu m, [Fe II] 1.644 mu m, and Pa beta. We detected the [Fe II] and Pa beta emissions from a very wide area of the observed region (30' x 35'). These line intensity maps reveal a global correlation between [Fe II] and Pa beta. Kokusho et al. (2013) found that the [Fe II] emission is notably strong while dust emission is faint in inner regions of IC 443. These results indicate that the abundant Fe+ is likely to be of interstellar origins through shock destruction of dust, rather than of ejecta origins. From the X-ray intensity map of the 6.7 key Fe-K line obtained with Suzaku, we find that highly ionized He-like Fe ions exist in the inner regions of IC 443, toward which Fe+ is detected. The presence of the He-like Fe ions and the faint dust emission indicates that Fe is likely to be interacting with X-ray plasma for a time long enough to be highly ionized. We discuss the implications of the detection of the lowly ionized Fe ions in such regions for the processing and composition of dust in the interstellar environment around IC 443. (C) 2015 Elsevier Ltd. All rights reserved.	[Kokusho, Takuma; Kaneda, Hidehiro; Ishihara, Daisuke] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Nagayama, Takahiro] Kagoshima Univ, Dept Astrophys, Kagoshima 8900065, Japan; [Lee, Ho-Gyu] Korea Astron & Space Sci Inst, Daejeon 305348, South Korea; [Onaka, Takashi] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan	Kokusho, T (reprint author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.	kokusho@u.phys.nagoya-u.ac.jp			Sumitomo foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [10147207, 10147214]; Joint Development Research of National Astronomical Observatory of Japan; Optical Near-Infrared Astronomy Inter-University Cooperation Program; MEXT of Japan; space agencies of Japan (JAXA); USA (NASA);  [26003136]	The IRSF project was financially supported by the Sumitomo foundation and Grants-in-Aid for Scientific Research on Priority Areas (A) (Nos. 10147207 and 10147214) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The operation of IRSF is supported by Joint Development Research of National Astronomical Observatory of Japan, and Optical Near-Infrared Astronomy Inter-University Cooperation Program, funded by the MEXT of Japan. This research is based on observations with AKARI, a JAXA project with the participation of ESA, and with Spitzer, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. This research has made use of data obtained from the Suzaku satellite, a collaborative mission between the space agencies of Japan (JAXA) and the USA (NASA). T.K. is financially supported by Grantsin-Aid for JSPS Fellows No. 26003136.	PETRE R, 1988, ASTROPHYS J, V335, P215, DOI 10.1086/166922; Rho J, 2008, ASTROPHYS J, V673, P271, DOI 10.1086/523835; RICHTER MJ, 1995, ASTROPHYS J, V454, P277, DOI 10.1086/176481; Draine BT, 1995, ASTROPHYS SPACE SCI, V233, P111, DOI 10.1007/BF00627339; Troja E, 2008, ASTRON ASTROPHYS, V485, P777, DOI 10.1051/0004-6361:20079123; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; Hughes JP, 2000, ASTROPHYS J, V528, pL109, DOI 10.1086/312438; Olbert CM, 2001, ASTROPHYS J, V554, pL205, DOI 10.1086/321708; GRAHAM JR, 1987, ASTROPHYS J, V313, P847, DOI 10.1086/165023; Nagayama T, 2003, P SOC PHOTO-OPT INS, V4841, P459, DOI 10.1117/12.460770; Bykov AM, 2008, ASTROPHYS J, V676, P1050, DOI 10.1086/529117; Welsh BY, 2003, ASTRON ASTROPHYS, V408, P545, DOI 10.1051/0004-6361:20030908; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Rho J, 2001, ASTROPHYS J, V547, P885, DOI 10.1086/318398; Kushino A, 2002, PUBL ASTRON SOC JPN, V54, P327; LOWE RP, 1979, ASTROPHYS J, V228, P191, DOI 10.1086/156835; Yamaguchi H, 2009, ASTROPHYS J LETT, V705, pL6, DOI 10.1088/0004-637X/705/1/L6; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Gaensler BM, 2006, ASTROPHYS J, V648, P1037, DOI 10.1086/506246; TIELENS AGGM, 1994, ASTROPHYS J, V431, P321, DOI 10.1086/174488; Castelletti G, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201016081; Henning T, 2010, ANNU REV ASTRON ASTR, V48, P21, DOI 10.1146/annurev-astro-081309-130815; Kokusho T, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L8; Koyama K., 2007, PASJ, V59, P23; Lee JJ, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/34; McDonald I, 2010, ASTROPHYS J LETT, V717, pL92, DOI 10.1088/2041-8205/717/2/L92; Nagashima C., 1999, STAR FORMATION 1999, P397; Noriega-Crespo A., 2009, EVOLVING ISM MILKY W; Shinn JH, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/124	30	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		92	96		10.1016/j.pss.2015.04.009		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900011		
J	Takatori, K; Matsumoto, D				Takatori, Katsuhiko; Matsumoto, Daisuke			Relationships Between Simple Toe Elevation Angle in the Standing Position and Dynamic Balance and Fall Risk Among Community-Dwelling Older Adults	PM&R			English	Article								Objective: To investigate the relationships between toe elevation ability in the standing position and dynamic balance and fall risk among community-dwelling older adults. Design: Cross-sectional survey. Setting: General community. Participants: Community-dwelling older adults (N = 287). Main Outcome Measure: Toe elevation angles in the standing position. Results: Intra-rater and inter-rater reliability of measurements of the toe elevation angle was high (internal coefficient of correlation [ICC] (1,2) = 0.94 for the former and ICC (2,1) = 0.90 for the latter). Significant correlations were found between the toe elevation angle and age (r = -0.20, P < .01), 5-m walking time (r = -0.31, P < .01), Functional Reach Test (r = 0.36, P < .01), Timed Up and Go Test (r = -0.36, P < .01), and Chair Stand Test (r = 0.26, P < .01). Subjects who experienced a fall in the previous 6 months had a significantly lower toe elevation angle compared with subjects who did not experience a fall (t = 2.19, P < .05). Multiple regression analysis revealed that results of the Functional Reach Test (beta = 2.19, P < .001) and Timed Up and Go Test (beta = -0.74, P < .001) were significantly associated with the toe elevation angle. Conclusions: Toe elevation angle was an index of dynamic balance ability and appears to be a simple screening test for fall risk in community-dwelling older adults.	[Takatori, Katsuhiko; Matsumoto, Daisuke] Kio Univ, Fac Hlth Sci, Dept Phys Therapy, Koryo, Nara, Japan	Takatori, K (reprint author), Kio Univ, Fac Hlth Sci, Dept Phys Therapy, 4-2-2 Umami Naka, Koryo, Nara, Japan.	k.takatori@kio.ac.jp					Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113; Shumway-Cook A, 2000, PHYS THER, V80, P896; Juras G, 2008, J HUM KINET, V19, P39; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Toba K, 2012, GERIATR GERONTOL INT, V12, P563, DOI 10.1111/j.1447-0594.2011.00787.x; Jonsson E, 2003, J REHABIL MED, V35, P26, DOI 10.1080/16501970306099; Arai Takeshi, 2010, Nihon Ronen Igakkai Zasshi, V47, P585, DOI 10.3143/geriatrics.47.585; Duncan PW, 1990, J GERONTOL, V45, P192; Khasnis A, 2003, J Postgrad Med, V49, P169; Ministry of Health Labour and Welfare, 2014, ANN HLTH LAB WELF RE; World Health Organization, WORLD HLTH STAT 2014	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2015	7	10					1059	1063		10.1016/j.pmrj.2015.04.006		5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CU5WP	WOS:000363603000006		
J	Hassan, MM; Koyama, K				Hassan, Mohammad Mahbubul; Koyama, Kiyohito			Thermal, physico-mechanical, and morphological properties of HDPE graft-copolymerized with polystyrene	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article						graft copolymerization; PS-grafted HDPE; thermal properties; mechanical properties; contact angle	HIGH-DENSITY POLYETHYLENE; CROSS-LINKING; GLYCIDYL METHACRYLATE; MECHANICAL-PROPERTIES; MALEIC-ANHYDRIDE; ACRYLIC-ACID; SURFACE-PROPERTIES; ELECTRON-BEAM; MOLTEN STATE; RADIATION	In this study, polystyrene was graft-copolymerized onto high-density polyethylene (HDPE) by in situ polymerization of styrene monomer to change the physico-mechanical and thermal properties of HDPE. The grafting was carried out in a Brabender-type static mixer by injecting styrene monomer directly into the molten HDPE in the presence of a free-radical initiator (lauroyl peroxide or LP). The effect of wt% of styrene and initiator concentrations on thermal, physico-mechanical, and morphological properties of HDPE was investigated. The neat and modified HDPE was characterized by differential scanning calorimetry, thermogravimetric analysis, scanning electron microscopy, Fourier transform infrared spectroscopy, scanning electron microscopy, and also by tensile strength and contact angle measurements. It was found that the increase in wt% of styrene and LP dosage reduced elongation at break, hygroscopic expansion and also the melting, and the crystallization temperatures of HDPE but increased its tensile strength. The tensile strength was increased from 14.6MPa for the neat HDPE to 20.6MPA for the 10 wt% of styrene grafted onto HDPE using 0.8% LP. Scanning electron microscopy results show that there was no phase separation, and the grafted polystyrene became integral part of HDPE. The results demonstrate that styrene could be used in melt compounding to improve various properties of HDPE. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Hassan, Mohammad Mahbubul; Koyama, Kiyohito] Yamagata Univ, Venture Business Lab, Yonezawa, Yamagata, Japan; [Koyama, Kiyohito] Yamagata Univ, Dept Polymer Sci & Engn, Yonezawa, Yamagata, Japan; [Hassan, Mohammad Mahbubul] AgResearch Ltd, Food & Biobased Prod Grp, Christchurch 7608, New Zealand	Hassan, MM (reprint author), AgResearch Ltd, Food & Biobased Prod Grp, Cnr Springs Rd & Gerald St, Christchurch 7608, New Zealand.	mahbubul.hassan@agresearch.co.nz					Ao YH, 2007, POLYM BULL, V59, P279, DOI 10.1007/s00289-007-0764-y; Kang TK, 2000, POLYM TEST, V19, P773, DOI 10.1016/S0142-9418(99)00048-3; Wang HL, 2004, J POLYM SCI POL CHEM, V42, P253, DOI 10.1002/pola.11022; Yamada K, 2012, J APPL POLYM SCI, V125, P2614, DOI 10.1002/app.36399; Park JS, 2015, MATERIALS, V8, P1626, DOI 10.3390/ma8041626; Zu JH, 2005, RADIAT PHYS CHEM, V72, P759, DOI 10.1016/j.radphyschem.2004.05.021; Huang CY, 2002, SURF COAT TECH, V153, P194, DOI 10.1016/S0257-8972(01)01675-9; Krause B, 2006, J APPL POLYM SCI, V99, P260, DOI 10.1002/app.22471; HO RM, 1993, POLYMER, V34, P3264, DOI 10.1016/0032-3861(93)90400-5; LUCAS EF, 1992, J APPL POLYM SCI, V46, P733, DOI 10.1002/app.1992.070460420; Qiu WL, 2005, EUR POLYM J, V41, P1979, DOI 10.1016/j.eurpolumj.2005.03.016; Nagesh N, 1999, J PHYS D APPL PHYS, V32, P1189, DOI 10.1088/0022-3727/32/11/301; Heinen W, 1996, MACROMOLECULES, V29, P1151, DOI 10.1021/ma951015y; Maillard D, 2011, NANO LETT, V11, P4569, DOI 10.1021/nl202651u; Dikobe DG, 2009, EXPRESS POLYM LETT, V3, P190, DOI 10.3144/expresspolymlett.2009.24; Jose S, 2004, EUR POLYM J, V40, P2105, DOI 10.1016/j.eurpolymj.2004.02.026; Torres N, 2001, J APPL POLYM SCI, V81, P581, DOI 10.1002/app.1473; CHEN CJ, 1991, COLLOID POLYM SCI, V269, P353, DOI 10.1007/BF00654582; Torres N, 2001, J APPL POLYM SCI, V81, P2377, DOI 10.1002/app.1678; Cheng S, 2009, RADIAT PHYS CHEM, V78, P563, DOI 10.1016/j.radphyschem.2009.03.043; Ahirwal D, 2014, J RHEOL, V58, P635, DOI 10.1122/1.4867555; QU BJ, 1995, POLYM ENG SCI, V35, P1161, DOI 10.1002/pen.760351406; Anbarasan R, 2004, J APPL POLYM SCI, V93, P75, DOI 10.1002/app.20390; Pages P, 1996, J APPL POLYM SCI, V60, P153, DOI 10.1002/(SICI)1097-4628(19960411)60:2<153::AID-APP2>3.0.CO;2-R; Senna MMH, 2013, J IND ENG CHEM, V19, P48, DOI 10.1016/j.jiec.2012.06.022; Stadler FJ, 2009, RHEOL ACTA, V48, P479, DOI 10.1007/s00397-008-0334-8; Sugimoto M, 2001, MACROMOLECULES, V34, P6056, DOI 10.1021/ma0015525; Zu JH, 2006, J APPL POLYM SCI, V99, P3396, DOI 10.1002/app.23033; Khonakdar HA, 2003, POLYMER, V44, P4301, DOI 10.1016/S0032-3861(03)00363-X; Li ZR, 2005, J APPL POLYM SCI, V96, P772, DOI 10.1002/app.21508; BARENTSE.WM, 1973, POLYMER, V14, P579, DOI 10.1016/0032-3861(73)90143-2; BERNETT MK, 1977, POLYM ENG SCI, V17, P450, DOI 10.1002/pen.760170706; Dimitrova T. L., 2005, BULGAR J PHYS, V32, P214; Fasce L. A., 2010, EXPRESS POLYM LETT, V2, P779; Huff T., 1964, J APPL POLYM SCI, V8, P825, DOI 10.1002/app.1964.070080222; LIANG CY, 1956, J CHEM PHYS, V25, P543, DOI 10.1063/1.1742962; Pasto D. J., 1967, ORGANIC STRUCTURE DE, P133; Siripattanasak T., 2013, ADV CHEM ENG SCI, V3, P202	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	OCT	2015	26	10					1285	1293		10.1002/pat.3566		9	Polymer Science	Polymer Science	CU3VX	WOS:000363455200010		
J	Doi, R; Kuwahara, T				Doi, Rieko; Kuwahara, Takuo			Combustion of Aluminum Particles near the Burning Surface in AP/AN Composite Propellants	PROPELLANTS EXPLOSIVES PYROTECHNICS			English	Article						Agglomerate; Aluminum particle; Luminous flame; Burning rate; Activation energy	POCKET MODEL; AGGLOMERATION	Aluminum (Al) particles are commonly used in ammonium perchlorate (AP) composite propellants of solid rockets for increasing performance. When propellants including Al particles burn, Al particles easily agglomerate on the burning surface of the propellant. The diameters of agglomerated Al particles are greater than those of mixed particles. The combustion efficiency of the propellant decreases with increasing burning time of the agglomerated Al particles. Therefore, it is important to observe how the agglomerated Al particles burn on the burning surface of AP composite propellant. A lot of researchers have studied Al agglomerate characteristics. Previous studies clarified the relation between the agglomerated Al particle diameter and luminous flame diameter around Al particles near the burning surface. The shapes of luminous flames around agglomerated Al particles are spherical or elliptical. This study evaluates the shapes of the luminous flame around agglomerated Al particles at a constant diameter or a different diameter. When the proportion of the luminous flame diameter (D-f) to the diameter of agglomerated Al particles (D-0) is 1.54-1.71 at a constant D-0, the luminous flames are almost perfectly spherical. Otherwise, the luminous flames are elliptical at a constant D-0. Furthermore, when D-f/D-0 is close to the mean value, the luminous flame is more spherical than elliptical at different D-0. The evaporation rate and the burning rate of Al vapor are inversely proportional to D-0. The oxidation gas temperatures were changed and the activation energy of Al vapor was obtained as 39.2 kJ mol(-1).	[Doi, Rieko; Kuwahara, Takuo] Nihon Univ, Coll Sci & Technol, Dept Aerosp Engn, Funabashi, Chiba 2748501, Japan	Doi, R (reprint author), Nihon Univ, Coll Sci & Technol, Dept Aerosp Engn, 7-24-1 Narashinodai, Funabashi, Chiba 2748501, Japan.	csri11083@g.nihon-u.ac.jp			Foundation for the Promotion of the Industrial Explosives Technology	This work was sponsored by the Foundation for the Promotion of the Industrial Explosives Technology.	De Luca LT, 2010, J PROPUL POWER, V26, P724, DOI 10.2514/1.45262; Gallier S, 2009, PROPELL EXPLOS PYROT, V34, P97, DOI 10.1002/prep.200700260; Rashkovskii SA, 2002, COMBUST EXPLO SHOCK+, V38, P435, DOI 10.1023/A:1016211215981; Cai WD, 2008, COMBUST SCI TECHNOL, V180, P2143, DOI 10.1080/00102200802414915; COHEN NS, 1983, AIAA J, V21, P720, DOI 10.2514/3.8139; Babuk VA, 1999, J PROPUL POWER, V15, P783, DOI 10.2514/2.5497; Beckstead M. W., 2004, RTO VKI SPECIAL COUR; Bucher P, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P1899; Cerri S., 2009, CENT EUR J ENERG MAT, V6, P149; DeLuca L. D., 2010, 46 AIAA ASME ASE ASE; Gordon S., 1994, NASA REFERENCE PUBLI; Habu H., 2008, J JAPAN I LIGHT META, V58, P162, DOI 10.2464/jilm.58.162; Kubota N., 2007, PROPELL EXPLOS PYROT, P186; Kuwahara T., 2013, JPN EXPLOS SOC, V2013; Lengelle G., 2002, RTO VKI SPECIAL COUR; Maggi F., 2012, ACTA ASTRONAUTICA; Melcher J. C., 2001, 37 AIAA ASME ASE ASE; Oide S., 2012, 48 AIAA ASME SAE ASE, P2012; Oide S., 2013, THESIS NIHON U JAPAN; Propellant Committee, 2005, PROP HDB, P142; Sasaki T., 2013, 9 HIGH EN MAT HEMS S, P115; Takahashi K., 2013, PROPELL EXPLOS PYROT, V38, P1; Takahashi K., 2013, THESIS NIHON U JAPAN; Walfhard H.G., 1964, AM I AERONAUTICS AST, V15, P44	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0721-3115	1521-4087		PROPELL EXPLOS PYROT	Propellants Explos. Pyrotech.	OCT	2015	40	5					765	771		10.1002/prep.201400270		7	Chemistry, Applied; Engineering, Chemical	Chemistry; Engineering	CU2FH	WOS:000363338500021		
J	Kainuma, S; Tokuda, H; Kuroyanagi, G; Yamamoto, N; Ohguchi, R; Fujita, K; Matsushima-Nishiwaki, R; Kozawa, O; Otsuka, T				Kainuma, Shingo; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Ohguchi, Reou; Fujita, Kazuhiko; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Otsuka, Takanobu			PGD(2) stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						AMP-activated protein kinase; PGD(2); Osteoprotegerin; Osteoblast	D-2-STIMULATED HEAT-SHOCK-PROTEIN-27 INDUCTION; PROSTANOID RECEPTORS; OVARIECTOMIZED RATS; PROSTAGLANDIN D-2; CYCLIC-AMP; CELLS; DIFFERENTIATION; CALCIFICATION; RESVERATROL; INVOLVEMENT	AMP-activated protein kinase (AMPK), a key enzyme sensing cellular energy metabolism, is currently known to regulate multiple metabolic pathways. Osteoprotegerin plays a pivotal role in the regulation of bone metabolism by inhibiting osteoclast activation. We have previously reported that prostaglandin D-2 (PGD(2)) stimulates the synthesis of osteoprotegerin through the activation of p38 mitogen-activated protein (MAP) kinase, p44/p42 MAP kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblast-like MC3T3-E1 cells. On the basis of these findings, we herein investigated the implication of AMPK in PGD(2)-stimulated osteoprotegerin synthesis in these cells. PGD2 induced the phosphorylation of AMPK alpha (Thr-172) and AMPK beta (Ser-108), and the phosphorylation of acetyl-coenzyme A carboxylase, a direct AMPK substrate. Compound C, an AMPK inhibitor, which suppressed the phosphorylation of acetyl-coenzyme A carboxylase, significantly attenuated both the release and the mRNA levels of osteoprotegerin stimulated by PGD2. The PGD(2)-induced phosphorylation of p44/p42 MAP kinase and SAPK/JNK but not p38 MAP kinase were markedly inhibited by compound C. These results strongly suggest that AMPK regulates the PGD2-stimulated osteoprotegerin synthesis at a point upstream of p44/p42 MAP kinase and SAPK/JNK in osteoblasts. (C) 2015 Elsevier Ltd. All rights reserved.	[Kainuma, Shingo; Kuroyanagi, Gen; Yamamoto, Naohiro; Ohguchi, Reou; Fujita, Kazuhiko; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678601, Japan; [Kainuma, Shingo; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Ohguchi, Reou; Fujita, Kazuhiko; Matsushima-Nishiwaki, Rie; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan	Tokuda, H (reprint author), Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan.	tokuda@ncgg.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19591042]; Ministry of Health, Labour and Welfare [H25-Aging-General-004]; National Center for Geriatrics and Gerontology (NCGC), Japan [25-4, 26-12]	We are very grateful to Yumiko Kurokawa for her skillful technical assistance. This investigation was supported in part by a Grant-in-Aid for Scientific Research (19591042) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant in Aid for Scientific Research (H25-Aging-General-004) from the Ministry of Health, Labour and Welfare, and the Research Funding for Longevity Sciences (25-4, 26-12) from National Center for Geriatrics and Gerontology (NCGC), Japan.	Hawley SA, 1996, J BIOL CHEM, V271, P27879; Kyriakis JM, 2001, PHYSIOL REV, V81, P807; Kozawa O, 2001, CELL SIGNAL, V13, P535, DOI 10.1016/S0898-6568(01)00180-2; Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Takeda S, 2001, J BONE MINER METAB, V19, P195, DOI 10.1007/s007740170042; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Widmann C, 1999, PHYSIOL REV, V79, P143; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034; Kato K, 2010, BIOCHEM BIOPH RES CO, V400, P123, DOI 10.1016/j.bbrc.2010.08.024; Kuroyanagi G, 2014, PROSTAG LEUKOTR ESS, V91, P73, DOI 10.1016/j.plefa.2014.04.003; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Yoshida M, 2004, PROSTAG LEUKOTR ESS, V71, P351, DOI 10.1016/j.plefa.2004.06.003; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; TAKAGI T, 1993, CALCIFIED TISSUE INT, V52, P442, DOI 10.1007/BF00571334; Yue L, 2012, BONE, V51, P338, DOI 10.1016/j.bone.2012.06.003; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Hikiji H, 2008, PROG LIPID RES, V47, P107, DOI 10.1016/j.plipres.2007.12.003; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Kato K, 2012, LIFE SCI, V90, P71, DOI 10.1016/j.lfs.2011.10.023; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; TASAKI Y, 1991, PROSTAGLANDINS, V41, P303, DOI 10.1016/0090-6980(91)90001-V; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Kato K, 1996, J NEUROCHEM, V66, P946; Kong YY, 1999, NATURE, V397, P315; KOZAWA O, 1992, EXP CELL RES, V198, P130, DOI 10.1016/0014-4827(92)90158-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Yamamoto N, 2014, INT J MOL MED, V34, P1439, DOI 10.3892/ijmm.2014.1934	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	OCT	2015	101						23	29		10.1016/j.plefa.2015.08.003		7	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CU2LR	WOS:000363355500004		
J	Shimizu, N; Ooka, M; Takagi, T; Takeda, S; Hirota, K				Shimizu, Naoto; Ooka, Masato; Takagi, Tokiyo; Takeda, Shunichi; Hirota, Kouji			Distinct DNA Damage Spectra Induced by Ionizing Radiation in Normoxic and Hypoxic Cells	RADIATION RESEARCH			English	Article							DOUBLE-STRAND BREAKS; FACILITATE HOMOLOGOUS RECOMBINATION; CROSS-LINKING AGENTS; TRANSLESION SYNTHESIS; VERTEBRATE CELLS; CELLULAR-DNA; REPAIR; MECHANISMS; INDUCTION; OXIDATION	Ionizing radiation induces more cell death under normoxic conditions than under hypoxic conditions. This phenomenon, which is known as the oxygen enhancement effect, occurs primarily because ionizing radiation causes more DNA lesions in the presence of oxygen than in its absence. However, the roles these lesions play in terms of cell survival and chromosome damage have not been fully characterized. We exposed a panel of chicken DT40 mutant cells to ionizing radiation to categorize the type of lesion induced and the DNA-repair pathway involved under both normoxic and hypoxic conditions. Among the mutant panel, RAD54(-/-)/KU70(-/-) cells exhibited the greatest radiosensitivity, which was found to be significantly higher under normoxic conditions. This indicates that double-strand breaks (DSBs) were the major cause of cell death and that ionizing radiation induces more DSBs under normoxic condition. Interestingly, the sensitivity of the REV3(-/-) cells increased under hypoxic conditions. Indeed, the REV3(-/-) mutant exhibited a greater number of chromosomal aberrations under hypoxic conditions than under normoxic conditions. These results suggest that the Rev3-mediated translesion-synthesis pathway is more critical for cellular tolerance to ionizing radiation in hypoxic cells than in normoxic cells, and that more chemically modified DNA might be induced under hypoxic conditions. In this study, we identify a previously unappreciated radiation-induced pattern of DNA damage under hypoxic conditions. (C) 2015 by Radiation Research Society	[Shimizu, Naoto; Ooka, Masato; Takagi, Tokiyo; Hirota, Kouji] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan	Hirota, K (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	khirota@tmu.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [RF-1005, C-0801]	We would like to acknowledge the Radioisotope Research Center, Tokyo Metropolitan University for its help with the use of isotopes. This work was supported by grants from the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [grant nos. RF-1005 (KH) and C-0801 (ST)]. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; [Anonymous], 1985, INT SYSTEM HUMAN CYT; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Cadet J, 2014, INT J RADIAT BIOL, V90, P423, DOI 10.3109/09553002.2013.877176; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; GRAY LH, 1953, BRIT J RADIOL, V26, P638; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Nakano T, 2015, MUTAT RES-FUND MOL M, V771, P45, DOI 10.1016/j.mrfmmm.2014.12.003; Dedon PC, 2008, CHEM RES TOXICOL, V21, P206, DOI 10.1021/tx700283c; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Kobayashi S, 2015, ONCOGENE, V34, P4403, DOI 10.1038/onc.2014.371; Cadet J, 2014, ARCH BIOCHEM BIOPHYS, V557, P47, DOI 10.1016/j.abb.2014.05.001; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Yamamoto KN, 2011, ENVIRON MOL MUTAGEN, V52, P547, DOI 10.1002/em.20656; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Kikuchi K, 2009, J BIOL CHEM, V284, P26360, DOI 10.1074/jbc.M109.029348; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; BRYANT PE, 1993, MUTAT RES, V299, P289, DOI 10.1016/0165-1218(93)90105-M; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; BENDER MA, 1974, MUTAT RES, V23, P197, DOI 10.1016/0165-1218(74)90277-8; Richardson C, 2000, NATURE, V405, P697; Fujita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060043; Georgakilas Alexandros, 2011, World J Biol Chem, V2, P173, DOI 10.4331/wjbc.v2.i7.173; Hirota K, 2010, PLOS GENET, V6	33	0	0	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	OCT	2015	184	4					442	448		10.1667/RR14117.1		7	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CU0QB	WOS:000363221200010		
J	Nakai, N; Otsuka, S; Myung, JW; Takumi, T				Nakai, Nobuhiro; Otsuka, Susumu; Myung, Jihwan; Takumi, Toru			Autism spectrum disorder model mice: Focus on copy number variation and epigenetics	SCIENCE CHINA-LIFE SCIENCES			English	Review						copy number variations; DNA methylation; histone modification; ASD model mouse	FRAGILE-X-SYNDROME; DE-NOVO MUTATIONS; MOUSE MODEL; RETT-SYNDROME; SYNAPTIC FUNCTION; MAMMALIAN DNA; KNOCKOUT MICE; VALPROIC ACID; BRAIN; CHILDREN	Autism spectrum disorder (ASD) is gathering concerns in socially developed countries. ASD is a neuropsychiatric disorder of genetic origin with high prevalence of 1%-2%. The patients with ASD characteristically show impaired social skills. Today, many genetic studies identify numerous susceptible genes and genetic loci associated with ASD. Although some genetic factors can lead to abnormal brain function linked to ASD phenotypes, the pathogenic mechanism of ASD is still unclear. Here, we discuss a new mouse model for ASD as an advanced tool to understand the mechanism of ASD.	[Nakai, Nobuhiro; Otsuka, Susumu; Myung, Jihwan; Takumi, Toru] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima 7348553, Japan; [Nakai, Nobuhiro] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Nakai, Nobuhiro; Myung, Jihwan; Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Takumi, Toru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Takumi, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima 7348553, Japan.	toru.takumi@riken.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology KAKENHI; Core Research for Evolutional Science and Technology, Strategic International Cooperative Program of Japan Science and Technology Agency; Takeda Science Foundation; Naito Foundation; Terumo Life Science Foundation	The authors acknowledge all members of Takumi laboratory. This work was supported in part by a grant from Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology KAKENHI, Core Research for Evolutional Science and Technology, Strategic International Cooperative Program of Japan Science and Technology Agency, and by research grants from Takeda Science Foundation, the Naito Foundation and Terumo Life Science Foundation.	Allis C.D., 2007, EPIGENETICS; [Anonymous], 1999, NAT GENET, DOI DOI 10.1038/13810; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Gropman AL, 2010, J DEV BEHAV PEDIATR, V31, P582, DOI 10.1097/DBP.0b013e3181ee384e; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Machado-Vieira R, 2011, CNS NEUROSCI THER, V17, P699, DOI 10.1111/j.1755-5949.2010.00203.x; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; van der Weyden L, 2006, ANNU REV GENOM HUM G, V7, P247, DOI 10.1146/annurev.genom.7.080505.115741; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sultan FA, 2011, EPIGENOMICS-UK, V3, P157, DOI [10.2217/epi.11.6, 10.2217/EPI.11.6]; Kemper TL, 2002, MOL PSYCHIATR, V7, pS12, DOI 10.1038/sj.mp.4001165; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1046/j.1601-183X.2003.00037.x; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; James SJ, 2010, AM J MED GENET B, V153B, P1209, DOI 10.1002/ajmg.b.31094; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; BAKKER CE, 1994, CELL, V78, P23; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Kappeler L, 2010, BIOESSAYS, V32, P818, DOI 10.1002/bies.201000015; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Sharma RP, 2006, SCHIZOPHR RES, V88, P227, DOI 10.1016/j.schres.2006.07.015; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.00123.x; Nguyen A, 2010, FASEB J, V24, P3036, DOI [10.1096/fj.10-154484, 10.1096/fj.09-154484]; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Autism Developmental Disabilities Monitoring Network Surveillance Year Principal I Centers for Disease C Prevention, 2012, MMWR-MORBID MORTAL W, V61, P1; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; WARD AJ, 1990, CHILD PSYCHIAT HUM D, V20, P279, DOI 10.1007/BF00706020	91	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	OCT	2015	58	10					976	984		10.1007/s11427-015-4891-7		9	Biology	Life Sciences & Biomedicine - Other Topics	CU1HB	WOS:000363270200006		
J	Tanaka, M; Nakamura, M				Tanaka, Motonobu; Nakamura, Masahiro			Spatially distinct responses within willow to bark stripping by deer: effects on insect herbivory	SCIENCE OF NATURE			English	Article						Canopy; Bark-stripping intensity; Defensive compounds; Induced response; Opposite plant-mediated interactions; Resprouting; Whole-plant scale	BOTTOM-UP CASCADES; TRI-TROPHIC SYSTEM; QUERCUS-ROBUR L; APICAL DOMINANCE; RESOURCE HETEROGENEITY; NITROGEN-CONTENT; HOST-PLANT; TREES; CHEMISTRY; EVOLUTION	Within individual plants, cervid herbivory may cause positive or negative plant-mediated effects on insect herbivores, depending on where it occurs. Using a combination of field observations and artificial bark-stripping experiments in Hokkaido, Japan, we examined the plant-mediated effects of bark stripping by sika deer (Cervus nippon yesoensis) on insect herbivory in two spatially distinct parts of willow (Salix udensis) trees: resprouting leaves below bark-stripping wounds and canopy leaves above. Natural and artificial bark stripping stimulated resprouting from trunks below wounds. Resprouting leaves on bark-stripped trees had lower total phenolics, condensed tannin, and C/N ratios than did canopy leaves on control trees. Herbivory rates were higher in resprouting leaves on bark-stripped trees than in canopy leaves on controls. Conversely, above-wound canopy leaves on bark-stripped trees had higher total phenolics than did those on controls, while herbivory rates were lower in the canopy leaves of bark-stripped trees than in those on controls. These results demonstrate that plant-mediated effects of bark stripping diverge between plant tissues below and above wounds in individual willow trees. We submit that focusing on multiple plant parts can elucidate plant-mediated effects at the whole-plant scale.	[Tanaka, Motonobu] Hokkaido Univ, Grad Sch Environm Sci, Nayoro, Hokkaido 0960071, Japan; [Nakamura, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nakagawa Expt Forest, Otoineppu, Nakagawa 0982501, Japan	Nakamura, M (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nakagawa Expt Forest, Otoineppu, Nakagawa 0982501, Japan.	masahiro@fsc.hokudai.ac.jp			Japan Society for the Promotion of Science [26450188]; Environment Research and Technology Development Fund [S-9-3]	This study was funded by grants from the Japan Society for the Promotion of Science (No 26450188 to MN) and the Environment Research and Technology Development Fund (S-9-3).	Johnson SN, 2013, J ANIM ECOL, V82, P1021, DOI 10.1111/1365-2656.12070; Cline M, 1997, PLANT CELL PHYSIOL, V38, P659; Nakamura M, 2008, CAN J FOREST RES, V38, P1603, DOI 10.1139/X08-006; Roininen H, 1997, OIKOS, V80, P481, DOI 10.2307/3546621; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; NOEL ARA, 1970, BOT REV, V36, P162, DOI 10.1007/BF02858959; Nakamura M, 2003, FUNCT ECOL, V17, P851, DOI 10.1111/j.1365-2435.2003.00786.x; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Lind EM, 2012, ENVIRON ENTOMOL, V41, P1409, DOI 10.1603/EN12094; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331; Jordan MO, 1996, J EXP BOT, V47, P79, DOI 10.1093/jxb/47.1.79; den Herder M, 2009, ANN ZOOL FENN, V46, P63; Kersch-Becker MF, 2012, ECOLOGY, V93, P9, DOI 10.1890/11-0756.1; BRYANT JP, 1987, OECOLOGIA, V72, P510, DOI 10.1007/BF00378975; Orians CM, 2001, OIKOS, V94, P493, DOI 10.1034/j.1600-0706.2001.940311.x; Utsumi S, 2009, J ANIM ECOL, V78, P953, DOI 10.1111/j.1365-2656.2009.01570.x; AARSSEN LW, 1995, OIKOS, V74, P149, DOI 10.2307/3545684; Hiura T, 2013, BASIC APPL ECOL, V14, P480, DOI 10.1016/j.baae.2013.06.004; ELMQVIST T, 1987, ECOLOGY, V68, P1623, DOI 10.2307/1939854; WATERMAN PG, 1984, J CHEM ECOL, V10, P387, DOI 10.1007/BF00988087; WIGNALL TA, 1987, FORESTRY, V60, P45, DOI 10.1093/forestry/60.1.45; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; BROWN CL, 1967, AM J BOT, V54, P153, DOI 10.2307/2440793; ORIANS CM, 1995, J CHEM ECOL, V21, P1245, DOI 10.1007/BF02027559; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.2307/176874; Li CY, 2003, ANN BOT-LONDON, V92, P137, DOI 10.1093/aob.mcg108; LARSSON S, 1986, OIKOS, V47, P205, DOI 10.2307/3566047; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; DANELL K, 1985, OIKOS, V44, P75, DOI 10.2307/3544046; Bailey JK, 2006, ECOL ENTOMOL, V31, P294, DOI 10.1111/j.1365-2311.2006.00774.x; GANGE AC, 1989, OECOLOGIA, V81, P38, DOI 10.1007/BF00377007; WIGNALL TA, 1988, J EXP BOT, V39, P1667, DOI 10.1093/jxb/39.12.1667; Nakamura M, 2005, J ANIM ECOL, V74, P683, DOI 10.1111/j.1365-2656.2005.00960.x; Bezemer TM, 2003, OIKOS, V101, P555, DOI 10.1034/j.1600-0706.2003.12424.x; Meier AR, 2012, TREE PHYSIOL, V32, P565, DOI 10.1093/treephys/tps040; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Kaji K, 2006, CONSERVATION MANAGEM; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Nakamura M, 2006, OIKOS, V113, P259, DOI 10.1111/j.2006.0030-1299.14251.x	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0028-1042	1432-1904		SCI NAT-HEIDELBERG	Sci. Nat.	OCT	2015	102	9-10							46	10.1007/s00114-015-1296-1		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CT8EC	WOS:000363046800001		
J	Yamaguchi, N; Sekiguchi, T				Yamaguchi, Naofumi; Sekiguchi, Tomohiro			Effects of tsunami magnitude and terrestrial topography on sedimentary processes and distribution of tsunami deposits in flume experiments	SEDIMENTARY GEOLOGY			English	Article						Tsunami deposit; Flume experiment; Sediment transport; Coastal lowland	TOHOKU-OKI TSUNAMI; INDIAN-OCEAN-TSUNAMI; BRITISH-COLUMBIA; VANCOUVER-ISLAND; SUBDUCTION ZONE; SENDAI PLAIN; LAKE; JAPAN; FLOW; INUNDATION	To identify and interpret tsunami deposits correctly, a better understanding of the effects of both tsunami magnitude and topographic setting are required. In the present study, laboratory experiments were performed to model these effects on sedimentary processes and the distribution of tsunami deposits on coastal lowlands. The experiments directed tsunamis of eight different magnitudes on to three different models of terrestrial topography: one with flat topography, one with a shallow water-filled pool, and one with a deep water-filled pool. The results suggested a relationship between the distribution of tsunami deposits and the hydraulic condition of the tsunami flow onto the terrestrial topography. In particular, the tsunami deposits in the pools were spatially more variable than those on land because of the variation in flow intensity associated with transformation of the flow from supercritical to subcritical with a hydraulic jump. We observed a gap between the landward extent of deposits and the tsunami inundation distance, particularly in the experiments with a pool. The total amount of sediment in tsunami deposits on the terrestrial area was found to depend on the magnitude of the tsunami, but the thickness of the deposits at any one given spot did not always depend on the tsunami magnitude, even in the same topographic. These results show that terrestrial topography has significant effects on the spatial distribution of tsunami deposits that must be taken into consideration when interpreting the history and magnitude of paleotsunami events from tsunami deposits. (C) 2015 Elsevier B.V. All rights reserved.	[Yamaguchi, Naofumi] Ibaraki Univ, Ctr Water Environm Studies, Itako, Ibaraki 3112402, Japan; [Sekiguchi, Tomohiro] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki 3058577, Japan	Yamaguchi, N (reprint author), Ibaraki Univ, Ctr Water Environm Studies, Ohu 1375, Itako, Ibaraki 3112402, Japan.	naofumi.yamaguchi.sci@vc.ibaraki.ac.jp			Sasagawa Scientific Grant from the Japan Science Society	The authors thank Kazuhisa Goto (International Research Institute of Disaster Science, Tohoku University) and Kentaro Imai (Japan Agency for Marine-Earth Science and Technology) for valuable comments about the experimental design. The authors also thank anonymous reviewers and journal editor Jasper Knight for their helpful comments, which improved this paper. This work was partly supported by Sasagawa Scientific Grant from the Japan Science Society.	Sawai Y, 2002, J ASIAN EARTH SCI, V20, P903, DOI 10.1016/S1367-9120(01)00077-3; Matsutomi H, 2006, COAST ENG J, V48, P167, DOI 10.1142/S0578563406001350; Sugawara D, 2008, TSUNAMIITES: FEATURES AND IMPLICATIONS, P9, DOI 10.1016/B978-0-444-51552-0.00003-5; Gelfenbaum G, 2003, PURE APPL GEOPHYS, V160, P1969, DOI 10.1007/s00024-003-2416-y; Donato SV, 2009, MAR GEOL, V257, P54, DOI 10.1016/j.margeo.2008.10.012; Bondevik S, 1997, SEDIMENTOLOGY, V44, P1115, DOI 10.1046/j.1365-3091.1997.d01-63.x; Kobayashi N, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002084; Namegaya Y, 2014, GEOPHYS RES LETT, V41, P2297, DOI 10.1002/2013GL058678; Clague JJ, 1999, J COASTAL RES, V15, P45; Goto K, 2012, EARTH PLANETS SPACE, V64, P1247, DOI 10.5047/eps.2012.02.007; Nanayama F, 2003, NATURE, V424, P660, DOI 10.1038/nature01864; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Apotsos A, 2011, EARTH-SCI REV, V107, P1, DOI 10.1016/j.earscirev.2010.11.001; Hutchinson I, 1997, J COASTAL RES, V13, P545; Fujino S, 2008, TSUNAMIITES: FEATURES AND IMPLICATIONS, P123, DOI 10.1016/B978-0-444-51552-0.00008-4; Hutchinson I, 2000, HOLOCENE, V10, P429, DOI 10.1191/095968300666654539; Jaffe BE, 2007, SEDIMENT GEOL, V200, P347, DOI 10.1016/j.sedgeo.2007.01.013; MacInnes BT, 2009, GEOLOGY, V37, P995, DOI 10.1130/G30172A.1; Takashimizu Y, 2012, SEDIMENT GEOL, V282, P124, DOI 10.1016/j.sedgeo.2012.07.004; Lopez GI, 2012, NAT HAZARDS, V60, P43, DOI 10.1007/s11069-011-9952-z; Morton RA, 2011, SEDIMENT GEOL, V242, P34, DOI 10.1016/j.sedgeo.2011.09.004; Matsumoto D, 2010, SEDIMENT GEOL, V230, P95, DOI 10.1016/j.sedgeo.2010.06.021; Young YL, 2010, MAR GEOL, V269, P107, DOI 10.1016/j.margeo.2009.12.009; Tsujimoto G, 2008, INT OFFSHORE POLAR E, P523; Chen J, 2012, J COASTAL RES, V28, P1303, DOI 10.2112/JCOASTRES-D-11-00180.1; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Smith DE, 2007, SEDIMENT GEOL, V200, P362, DOI 10.1016/j.sedgeo.2007.01.014; Cheng W, 2013, EARTH PLANET SC LETT, V362, P305, DOI 10.1016/j.epsl.2012.12.004; Abe T, 2012, SEDIMENT GEOL, V282, P142, DOI 10.1016/j.sedgeo.2012.05.004; Kelsey HM, 2005, GEOL SOC AM BULL, V117, P1009, DOI 10.1130/B25452.1; Furusato E, 2014, MAR GEOL, V353, P128, DOI 10.1016/j.margeo.2014.04.006; Naruse H, 2012, SEDIMENT GEOL, V282, P199, DOI 10.1016/j.sedgeo.2012.08.012; Sawai Y, 2008, HOLOCENE, V18, P517, DOI 10.1177/0959683608089206; Chague-Goff C, 2012, SEDIMENT GEOL, V282, P65, DOI 10.1016/j.sedgeo.2012.05.021; Goto K, 2014, MAR GEOL, V358, P2, DOI 10.1016/j.margeo.2014.08.008; Goto K, 2014, MAR GEOL, V358, P38; Hasegawa F., 2001, P COASTAL ENG JSCE, V48, P311; Jaffe BE, 2006, EARTHQ SPECTRA, V22, pS105, DOI 10.1193/1.2207724; MINOURA K, 1991, J GEOL, V99, P265; Shishikura M., 2012, INLAND LIMIT TSUNAMI, V12, P45; Sugawara D., 2004, GEOL SOC JPN MEM, V58, P153; Sugawara D, 2014, MAR GEOL, V358, P18, DOI 10.1016/j.margeo.2014.05.005	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0037-0738	1879-0968		SEDIMENT GEOL	Sediment. Geol.	OCT	2015	328						115	121		10.1016/j.sedgeo.2015.08.008		7	Geology	Geology	CT8QT	WOS:000363081800008		
J	Ge, N; Nakajima, S; Pantel, M				Ge, Ning; Nakajima, Shin; Pantel, Marc			Online diagnosis of accidental faults for real-time embedded systems using a hidden Markov model	SIMULATION-TRANSACTIONS OF THE SOCIETY FOR MODELING AND SIMULATION INTERNATIONAL			English	Article						Real-time embedded system; simulation; online diagnosis; accidental fault; hidden Markov model	ALGORITHM	This article proposes an approach for the online analysis of accidental faults for real-time embedded systems using hidden Markov models (HMMs). By introducing reasonable and appropriate abstraction of complex systems, HMMs are used to describe the healthy or faulty states of system's hardware components. They are parametrized to statistically simulate the real system's behavior. As it is not easy to obtain rich accidental fault data from a system, the Baum-Welch algorithm cannot be employed here to train the parameters in HMMs. Inspired by the principles of fault tree analysis and the maximum entropy in Bayesian probability theory, we propose to compute the failure propagation distribution to estimate the parameters in HMMs and to adapt the parameters using a backward algorithm. The parameterized HMMs are then used to online diagnose accidental faults using a vote algorithm integrated with a low-pass filter. We design a specific test bed to analyze the sensitivity, specificity, precision, accuracy and F1-score measures by generating a large amount of test cases. The test results show that the proposed approach is robust, efficient and accurate.	[Ge, Ning; Pantel, Marc] Univ Toulouse, IRIT, Toulouse, France; [Nakajima, Shin] Natl Inst Informat, Tokyo, Japan	Ge, N (reprint author), Univ Toulouse, IRIT, Toulouse, France.	ning.ge@enseeiht.fr			Japan NII Scholarship; French ministry of Industry; French ministry of Research	This work is supported by the Japan NII Scholarship and the French ministries of Industry and Research and the Midi-Pyrenees regional authorities through the ITEA2 OPEES project.	SMYTH P, 1994, PATTERN RECOGN, V27, P149, DOI 10.1016/0031-3203(94)90024-8; Tobon-Mejia DA, 2012, IEEE T RELIAB, V61, P491, DOI 10.1109/TR.2012.2194177; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Clarke EM, 2011, LECT NOTES COMPUT SC, V6996, P1, DOI 10.1007/978-3-642-24372-1_1; Madan BB, 2004, PERFORM EVALUATION, V56, P167, DOI 10.1016/j.peva.2003.07.008; Boutros T, 2011, MECH SYST SIGNAL PR, V25, P2102, DOI 10.1016/j.ymssp.2011.01.013; Isermann R, 1997, CONTROL ENG PRACT, V5, P709, DOI 10.1016/S0967-0661(97)00053-1; Ying J, 2000, IEEE T SYST MAN CY C, V30, P463, DOI 10.1109/5326.897073; Avizienis A, 2004, IEEE T DEPEND SECURE, V1, P11, DOI 10.1109/TDSC.2004.2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Avizienis A, 2001, TECHNICAL REPORT SER; Baum L. E., 1972, INEQUALITIES, V3, P1; Elliott R. J., 1995, HIDDEN MARKOV MODELS; Ge N, P S THEOR MOD SIM DE, P16; Ge N, 4 IEEE INT C SOFTW E, P184; Gertler J., 1998, FAULT DETECTION DIAG; Hertz J., 1991, INTRO THEORY NEURAL, V1; Isermann R, 2005, ANNU REV CONTROL, V29, P71, DOI 10.1016/j.arcontrol.2004.12.002; Lee EA, 11 IEEE INT S OBJ OR, P363; Rabiner L. R., 1986, IEEE ASSP Magazine, V3, DOI 10.1109/MASSP.1986.1165342; ROSENBLATT M, 1956, P NATL ACAD SCI USA, V42, P43, DOI 10.1073/pnas.42.1.43; Silverman BW, 1986, DENSITY ESTIMATION S, V26; Venkatsubramanian V, 2003, COMPUT CHEM ENG, V27, P293, DOI 10.1016/S0098-1354(02)00160-6	24	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0037-5497	1741-3133		SIMUL-T SOC MOD SIM	Simul.-Trans. Soc. Model. Simul. Int.	OCT	2015	91	10					851	868		10.1177/0037549715590598		18	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering	Computer Science	CU1XA	WOS:000363314400001		
J	Okamura, M; Bhandary, NP; Mori, S; Marasini, N; Hazarika, H				Okamura, Mitsu; Bhandary, Netra P.; Mori, Shinichiro; Marasini, Narayan; Hazarika, Hemanta			Report on a reconnaissance survey of damage in Kathmandu caused by the 2015 Gorkha Nepal earthquake	SOILS AND FOUNDATIONS			English	Article						Gorkha Nepal earthquake; Earthquake damage survey; Natural frequency; Liquefaction; Road embankment	GREAT EARTHQUAKES; 1905 KANGRA; HIMALAYA; REGION	Nepal was hit by the M7.8 Gorkha earthquake on April 25, 2015, which was the largest earthquake in Nepal's history since 1934. The recent report presented by the Government of Nepal indicates that the recorded death toll has reached about 8800. Following the earthquake, the Japanese Geotechnical Society (JGS), Asian Technical Committee of ISSMGE on Geotechnical Natural Hazards (ATC3), Japan Society of Civil Engineers (JSCE) and Japan Association for Earthquake Engineering (JAEE) decided to jointly dispatch a survey team to Nepal to conduct a reconnaissance survey of the major damage caused by the earthquake. This report summarizes the results of the survey of the geotechnical and structural damage in the Kathmandu valley, which were observed by the survey sub-team between May 1 and 8, 2015. Geotechnical and geological characteristics of a deep soil profile up to 600 m and a shallow profile up to 30 m are also described with the help of the database system established by Bhandary et al. (2012). In order to study the correlation between building damage ratios and the predominant period of ground vibration, a partial exhaustive type survey was conducted along NS line where microtremor measurements had been previously conducted in 2008. The predominant period of ground vibration was short at the ridge of the valley and long at its center, ranging from 1.2 to 4.5 s. A total of 532 buildings were assessed and more than 90% were classified as "No damage" or "Negligible to slight Damage" (Grade 0 and Grade 1), whereas only 5% of buildings were assessed as "Substantial to heavy damage" to "Destruction" (Grade 3 to Grade 5). Five locations were identified where the soil had liquefied. Liquefaction-induced damage to structures at these locations was not found, except at Nepal Engineering College where minor settlement of the college building was observed. During the 1934 earthquake, foundation liquefaction was observed in Tundhikhel area, but in the 2015 earthquake no evidence of liquefaction was detected in this area. The Kathmandu-Bhaktapur Road of Araniko Highway was heavily damaged in the Lokanthali area. The subsidence of soft soils and their lateral spreading in this area may have exacerbated the damage to this road. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Okamura, Mitsu; Bhandary, Netra P.; Mori, Shinichiro; Marasini, Narayan] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 790, Japan; [Hazarika, Hemanta] Kyushu Univ, Fac Engn, Fukuoka 812, Japan	Okamura, M (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 790, Japan.	okamura@cee.ehime-u.ac.jp; netra@ehime-u.ac.jp; mori@ehime-u.ac.jp; narayanmarasini@gmail.com; hazarika@civil.kyushu-u.ac.jp					Hough SE, 2008, J EARTH SYST SCI, V117, P773; CHANDER R, 1988, TECTONOPHYSICS, V149, P289, DOI 10.1016/0040-1951(88)90179-5; PANDEY MR, 1995, GEOPHYS RES LETT, V22, P751, DOI 10.1029/94GL02971; Ambraseys NN, 2004, GEOPHYS J INT, V159, P165, DOI 10.1111/j.1365-246X.2004.02323.x; MOLNAR P, 1989, P INDIAN AS-EARTH, V98, P61; Bettinelli P, 2006, J GEODESY, V80, P567, DOI 10.1007/s00190-006-0030-3; CHANDER R, 1989, TECTONOPHYSICS, V170, P115, DOI 10.1016/0040-1951(89)90106-6; Banerjee P., 2002, GEOPHYS RES LETT, V29, P3; Bhandary N.P., 2012, P AWAM INT C CIV ENG, P860; Bilham R., 2008, AM I PHYS C P, P224; Bilham R, 1995, J NEPAL GEOL SOC, V11, P73; Dunn JA, 1939, MEM GEOL SURV INDIA, V73, P391; GoN, 1994, NEP NAT BUILD COD NB; GoN, 2015, NEP DIS RISK RED POR; Grunthal G., 1998, EUR MACR SCAL 1998 E; JICA, 2002, STUD EARTHQ DIS MIT, VII; JICA, 2002, STUD EARTHQ DIS MIT, VIII; JICA (Japan International cooperation Agency), 2002, STUD EARTHQ DIS MIT, VIV; JICA Japan International Cooperation Agency, 2002, STUD EARTHQ DIS MIT, V1; JICA (Japan International cooperation Agency), 2007, PLANN IMPR KATHM BHA; KHATTRI KN, 1987, TECTONOPHYSICS, V138, P79, DOI 10.1016/0040-1951(87)90067-9; KHATTRI KN, 1992, CURR SCI INDIA, V62, P109; Kukidome T., 2009, P 44 ANN C JAP GEOT, P1543; MoHA DPNet Nepal UNDP Oxfam, 2009, NEP DIS REP HAZ VULN, P116; Molnar P., 1990, HIMAL GEOL, V1, P131; NSET GHI, 1999, NAT SOC EARTHQ TECHN; Pandey M.R., 1988, J NEPAL GEOL SOC, V5, P22; Rana BJB, 1935, NEPAL KO MAHA BHUKAM; Sakai H., 2001, J NEPAL GEOLOGICAL S, V25, P19; Seeber L., 1981, Zagros - Hindu Kush - Himalaya - Geodynamic evolution; Seeber L., 1981, M EWING SERIES, V4, P259, DOI DOI 10.1029/ME004P0259; UNDP/HMG/UNCHS (Habitt), 1994, SEISM HAZ MAPP RISK; USGS, 2011, MAGN 6 9 IND NEP BOR	33	1	1	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1015	1029		10.1016/j.sandf.2015.09.005		15	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500009		
J	Chiaro, G; Kiyota, T; Pokhrel, RM; Goda, K; Katagiri, T; Sharma, K				Chiaro, Gabriele; Kiyota, Takashi; Pokhrel, Rama Mohan; Goda, Katsuichiro; Katagiri, Toshihiko; Sharma, Keshab			Reconnaissance report on geotechnical and structural damage caused by the 2015 Gorkha Earthquake, Nepal	SOILS AND FOUNDATIONS			English	Article						2015 Gorkha Nepal earthquake; Earthquake damage survey; Liquefaction; Embankment; Historical monuments; Masonry structures; Landslide		On 25 April 2015, a moment magnitude (M-w) 7.8 earthquake struck the Gorkha District of Nepal. Two major aftershocks (M-w 6.6 and M-w 6.7) followed the mainshock contributing to devastation in many villages in mountainous areas north of Kathmandu. This report summarizes geotechnical and structural damage features caused by the earthquake, which were observed during a field investigation conducted by a survey team dispatched by the Japan Geotechnical Society (JGS), the Asian Technical Committee of ISSMGE on Geotechnical Natural Hazards (ATC3) and the Japan Society of Civil Engineers (JSCE). The post-earthquake damage survey was conducted in Kathmandu, Trishuli, Melamchi, Baluwa (epicentral area) and Pokhara from 1 to 6 May 2015. A significant damage to the historical architectures in the Durbar Square of Downtown Kathmandu was observed, while the damage to masonry structures in the surrounding area was limited. In mountainous areas including epicentral area, non-engineered masonry structures were severely damaged, and traces of medium to large scale landslides and rock falls were frequently observed. Dam embankment in Trishuli suffered from cracking at the reservoir side along its entire length. Such damages to the structures and slopes are posing risks of secondary disasters to the local residents. Based on the field survey, recommendations related to immediate policy following the earthquake and addressed to policy makers are made in the conclusion. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Chiaro, Gabriele] Univ Canterbury, Dept Civil & Nat Resources Engn, Christchurch 8140, New Zealand; [Kiyota, Takashi; Pokhrel, Rama Mohan; Katagiri, Toshihiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538585, Japan; [Goda, Katsuichiro] Univ Bristol, Dept Civil Engn, Bristol BS8 1TR, Avon, England; [Sharma, Keshab] Univ Alberta, Dept Civil & Environm Engn, NREF, Edmonton, AB T6G 2W2, Canada; [Chiaro, Gabriele] Univ Tokyo, Inst Ind Sci, Tokyo 1538585, Japan	Kiyota, T (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538585, Japan.	gabriele.chiaro@canterbury.ac.nz; kiyota@iis.u-tokyo.ac.jp; pokhrel@iis.u-tokyo.ac.jp; Katsu.Goda@bristol.ac.uk; toshi@iis.u-tokyo.ac.jp; keshab@ualberta.ca		Chiaro, Gabriele/0000-0001-7328-2932	JSPS [15H02631]; Engineering and Physical Sciences Research Council [EP/M001067/1]	The authors thank Mr. Pradeep Pokhrel for his great assistance during the field survey. Financial support by the JSPS KAKENHI Grant number 15H02631 is greatly acknowledged. Katsuichiro Goda was funded by the Engineering and Physical Sciences Research Council (EP/M001067/1).	Sakai H, 2002, J ASIAN EARTH SCI, V20, P267, DOI 10.1016/S1367-9120(01)00046-3; Ambraseys NN, 2004, GEOPHYS J INT, V159, P165, DOI 10.1111/j.1365-246X.2004.02323.x; Avouac JP, 2003, ADV GEOPHYS, V46, P1, DOI 10.1016/S0065-2687(03)46001-9; Ader T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009071; Sapkota SN, 2013, NAT GEOSCI, V6, P71, DOI [10.1038/ngeo1669, 10.1038/NGEO1669]; Chaulagain H, 2015, STRUCT ENG MECH, V53, P791; Goda K., 2015, FRONT BUILT ENV, V1, P1; JICA Japan International Cooperation Agency, 2002, STUD EARTHQ DIS MIT, V1; NAKATA T., 2002, ACTIVE FAULT RES, V22, P7; Okamura M, 2015, SOILS FOUND, V55, P1015, DOI 10.1016/j.sandf.2015.09.005; Pokhrel R.M., 2015, P INT C GEOT ENG AUG, P109	11	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1030	1043		10.1016/j.sandf.2015.09.006		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500010		
J	Nguyen, HS; Tashiro, M; Inagaki, M; Yamada, S; Noda, T				Nguyen, Hong-Son; Tashiro, Mutsumi; Inagaki, Motohiro; Yamada, Shotaro; Noda, Toshihiro			Simulation and evaluation of improvement effects by vertical drains/vacuum consolidation on peat ground under embankment loading based on a macro-element method with water absorption and discharge functions	SOILS AND FOUNDATIONS			English	Article						Peat; Embankment loading; Vertical drain; Vacuum consolidation; Soil water coupled analysis; Macro-element method	VACUUM CONSOLIDATION; RESIDUAL SETTLEMENT; DEFORMATION; SOIL; FAILURE; DRAIN	The authors previously extended the macro-element method proposed by Sekiguchi to include water absorption and discharge functions and incorporated this into a soil water coupled finite deformation analysis code capable of accounting for inertial forces. The primary objective of this study is to validate the ability of the proposed method to simulate actual ground behavior by comparing the simulation results with the actual measurements of the embankment loading of a soft peat ground improved with vertical drains and vacuum consolidation. It was found that the proposed method is capable of comprehensively and closely simulating not only the magnitude of settlement, but also various ground behaviors, including the deformation of the surrounding ground and pore water pressure distributions. Furthermore, additional simulations were performed to elucidate the effect of a continuous middle sand layer found to exist and to span the entire improved area at an actual embankment site. The next objective of this study is to investigate the impact of ground improvement, using vertical drains and vacuum consolidation with embankment loading on a soft ground, placing a particular focus on the effect of drain spacing. In this case, an ultra-soft ground with alternating peat and clay layers was modeled to represent a typical ground to which vacuum consolidation would be applied. Based on a series of simulations, it was found that, although the use of vacuum consolidation in combination with vertical drains is effective in cases where it is necessary to limit the deformation of the surrounding ground, the same reduction in residual settlement can be achieved using vertical drains alone, provided that the drains are deployed at a sufficient frequency. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Nguyen, Hong-Son; Noda, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tashiro, Mutsumi; Yamada, Shotaro] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Inagaki, Motohiro] Cent Nippon Expressway Co Ltd, Tsuruga Construct Off, Nagoya, Aichi, Japan	Nguyen, HS (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hongsondc3005@gmail.com					Asaoka A, 2002, SOILS FOUND, V42, P47; Indraratna B, 2005, CAN GEOTECH J, V42, P994, DOI 10.1139/T05-029; Chai JC, 2008, GEOTEXT GEOMEMBRANES, V26, P220, DOI 10.1016/j.geotexmem.2007.10.004; Takaine T, 2010, SOILS FOUND, V50, P245, DOI 10.3208/sandf.50.245; Tashiro M, 2011, SOILS FOUND, V51, P133, DOI 10.3208/sandf.51.133; Chai JC, 2006, CAN GEOTECH J, V43, P985, DOI 10.1139/T06-056; Chai JC, 2005, J GEOTECH GEOENVIRON, V131, P1552, DOI 10.1061/(ASCE)1090-0241(2005)131:12(1552); Saowapakpiboon J, 2011, GEOTEXT GEOMEMBRANES, V29, P74, DOI 10.1016/j.geotexmem.2010.06.008; Noda T, 2008, SOILS FOUND, V48, P771, DOI 10.3208/sandf.48.771; Noda T, 2005, SOILS FOUND, V45, P39; Indraratna B, 2004, CAN GEOTECH J, V41, P1098, DOI 10.1139/T04-054; Tashiro M, 2015, SOILS FOUND, V55, P343, DOI 10.1016/j.sandf.2015.02.010; Rujikiatkamjorn C, 2007, CAN GEOTECH J, V44, P326, DOI 10.1139/T06-124; BARRON RA, 1948, T AM SOC CIV ENG, V113, P718; Ariyarathna P.R.C., 2010, ANN T IESL, P27; Asaoka A., 1995, SOILS FOUND, V35, P43; Asaoka A., 2007, P INT WORKSH CONST M, P11; Association of vacuum consolidation technology, 2013, TECHN MAT KOUSH N H; Bergman David, 1998, PUBLIC SEX GAY SPACE, P95; Cognon J.M., 1994, ASCE SPECIAL PUBLICA, V40, P1237; Karunawardena A., 2013, P 18 INT C SOIL MECH, P2949; Kosaka T., 2011, P INT C GEOT SUST DE, P65; Mersi G., 2012, J GEOTECH GEOENVIRON, V138, P680; Nakano M., 2010, GEOTECHNICAL SPECIAL, V201, P139; Noda T., 2008, THEOR APPL MECH JPN, V57, P41; Noda T., 2015, SOILS FOUND, V55, P1130; Osorio J.P., 2010, P JOINT S BRIDG INFR, P255; Sekiguchi H., 1986, P 31 S JSSMFE, P111; Taylor D. W., 1948, FUNDAMENTALS SOIL ME; Yamada S., 2013, P 18 INT C SOIL MECH, P841; Yamada S, 2015, SOILS FOUND, V55, P1113, DOI 10.1016/j.sandf.2015.09.012	31	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1044	1057		10.1016/j.sandf.2015.09.007		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500011		
J	Sakai, T; Nakano, M				Sakai, Takayuki; Nakano, Masaki			Interpretation of the mechanical behavior of embankments having various compaction properties based on the soil skeleton structure	SOILS AND FOUNDATIONS			English	Article						Compaction; Embankment; FEM analysis; Soil water coupled analysis; Soil skeleton structure; Triaxial test	CAM-CLAY MODEL; CRITICAL-STATE; SUBLOADING SURFACE; EQUATION; SHEAR	After the Hanshin Awaji Earthquake disaster, the seismic resistance of embankments was evaluated, and design principles were changed from specification-based to performance-based. However, compaction properties and the mechanical behavior of compacted soil were not sufficiently considered in the Manual of Highway Earthworks on Embankments. The first objective of the present study is to reproduce the mechanical behavior of three embankment materials having different compaction properties. A series of triaxial compression tests and oedometer tests is carried out. The mechanical behavior is reproduced by the SYS Cam-clay model and the influence of compaction on the mechanical behavior is interpreted based on the soil skeleton structure. The second objective is to evaluate the seismic stability of the embankment, which depends on the compaction properties of the embankment material, using GEOASIA, a soil water coupled finite deformation analysis code. The primary conclusions are as follows. (1) Through the triaxial tests, the maximum deviator stress increases as the degree of compaction, Dc, increases. However, the trends in the increase differ depending on the material. (2) Based on one-dimensional consolidation tests, the compression curve is approximately a straight line with a large vertical effective stress. In the present study, a greater maximum dry density corresponds to less compressibility and a lower compression curve. (3) The mechanical behavior of each material is reproduced by the SYS Camclay model using one set of material constants for each material and representing the differences in Dc by different initial conditions for the structure and overconsolidation. An increase in Dc causes the decay of the structure, as well as the accumulation of overconsolidation. In the case of material A, the decay of the structure and the loss of overconsolidation occur quickly, whereas in the case of material C, the decay of the structure is slight and the loss of overconsolidation is moderate. (4) The seismic response analysis reveals different deformations of the embankment for different materials, even for the same Dc. The seismic stability of the embankments was increased by increasing Dc. Materials, such as material A, that have fast decay of the structure and fast loss of overconsolidation produce embankments with high seismic stability. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Sakai, Takayuki] Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nakano, Masaki] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Sakai, T (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	t-sakai@civil.nagoya-u.ac.jp; nakano@civil.nagoya-u.ac.jp					Toll DG, 2003, GEOTECHNIQUE, V53, P93, DOI 10.1680/geot.53.1.93.37255; Maatouk A, 1995, GEOTECHNIQUE, V45, P465; Asaoka A, 2002, SOILS FOUND, V42, P47; Wheeler SJ, 2000, GEOTECHNIQUE, V50, P369; Alonso EE, 2013, GEOTECHNIQUE, V63, P463, DOI [10.1680/geot.11.P134, 10.1680/geot.11.P.134]; Hashiguchi K, 1998, INT J NUMER ANAL MET, V22, P197, DOI 10.1002/(SICI)1096-9853(199803)22:3<197::AID-NAG914>3.3.CO;2-K; Wheeler SJ, 1995, GEOTECHNIQUE, V45, P35; JOYNER WB, 1975, B SEISMOL SOC AM, V65, P1315; Noda T, 2008, SOILS FOUND, V48, P771, DOI 10.3208/sandf.48.771; HASHIGUCHI K, 1989, INT J SOLIDS STRUCT, V25, P917, DOI 10.1016/0020-7683(89)90038-3; Nakano M, 2005, SOILS FOUND, V45, P141; ESCARIO V, 1986, GEOTECHNIQUE, V36, P453; Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; Asaoka A., 2000, SOILS FOUND, V40, P99; Asaoka A, 1998, P 4 EUR C NUM METH G, V98, P232; Asaoka A., 1997, SOILS FOUND, V37, P13; Asaoka A., 2007, P INT WORKSH CONST M, P11; Cokca E., 2004, GEOTECHNICAL GEOLOGI, V22, P285, DOI DOI 10.1023/B:GEGE.0000018349.40866.3E; Hashiguchi K., 1978, P US JAP SEM CONT ME, P321; Heitor A., 2013, P 18 INT C SOIL MECH, P1007; Japan Road Association, 2010, MAN HIGHW EARTHW EMB; Japan Road Association, 2012, ACC WAV US DYN AN AS; Kong L.W., 2000, P AS C UNS SOILS SIN, P515; Kuno G., 1974, TSUCHI TO KISO, V22, P5; Mikuni E., 1963, SOILS FOUND, V3, P3; Naghdi P.M., 1965, ARCH RATION MECH AN, V18, P251, DOI DOI 10.1007/BF00251666; Nakamura H., 2012, P 47 JAP NAT C GEOT, P1005; Proctor R.R., 1933, ENG NEWS-REC, V111, P348; Sekiguchi H., 1977, P 9 ICSMFE SPEC SESS, P229; Shima H., 1980, TSUCHI TO KISO, V28, P4; Zhou A., 2014, COMPUT GEOTECH, V63, P46	31	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1069	1085		10.1016/j.sandf.2015.09.009		17	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500013		
J	Uchimura, T; Towhata, I; Wang, L; Nishie, S; Yamaguchi, H; Seko, I; Qiao, J				Uchimura, Taro; Towhata, Ikuo; Wang, Lin; Nishie, Shunsaku; Yamaguchi, Hiroshi; Seko, Ichiro; Qiao, Jianping			Precaution and early warning of surface failure of slopes using tilt sensors	SOILS AND FOUNDATIONS			English	Article						Slope failure; Monitoring; Early warning; Tilt angle; Sensor network	LANDSLIDE; RAINFALL	A simple monitoring method for the early warning of rainfall-induced landslides is proposed. Tilting angles in the surface layer of the slope are mainly monitored in this method. In the first stage of this study with a scaled model slope, distinct behaviors were observed in the tilt angles monitored on the surface of the slope prior to failure. Hence, a set of equipment has been developed for practical use, which is equipped with a Micro Electro Mechanical Systems (MEMS) tilt sensor and a volumetric water content sensor. An optional arrangement of tilt sensors has also been developed in order to investigate the deformation of the deeper layers. These sets of equipment have been deployed at several slope sites in Japan and China, and their performances have been recorded. Slope failure tests were also conducted on a natural slope by applying artificial heavy rainfall. The developed system detected distinct behaviors in the tilting angles at these sites in the pre-failure stages. Considering the behaviors of tilting monitored on the surfaces of these slopes, it is proposed that a precaution be issued at a tilting rate of 0.01 degrees per hour and a warning be issued at a tilting rate of 0.1 degrees per hour, to be on the conservative side. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Uchimura, Taro; Towhata, Ikuo] Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Wang, Lin; Nishie, Shunsaku; Yamaguchi, Hiroshi; Seko, Ichiro] Chuo Kaihatsu Corp, Tokyo, Japan; [Qiao, Jianping] Inst Mt Hazards & Environm, Chengdu, Peoples R China	Uchimura, T (reprint author), Univ Tokyo, Dept Civil Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.				Japan Society for the Promotion of Science (JSPS); Ministry of Land, Infrastructure, Transport and Tourism of Japan; International Cooperate Project of the Chinese Ministry of Science and Technology [07 (2007DFA21150), 09(2009M-1320190)]	This research was supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS), Core-to-Core Program "B. Asia-Africa Science Platforms" (JSPS), Construction Technology Research and Development Subsidy Program of the Ministry of Land, Infrastructure, Transport and Tourism of Japan, and the International Cooperate Project of the Chinese Ministry of Science and Technology (07 (2007DFA21150) and 09(2009M-1320190)). The slope model tests were conducted with the cooperation of Dr. K. Furumoto, Dr. H. Mori, and Ms. Y. Saito of the Public Works Research Institute, Tsukuba, Japan.	KEEFER DK, 1987, SCIENCE, V238, P921, DOI 10.1126/science.238.4829.921; Ochiai H, 2004, LANDSLIDES, V1, P211, DOI 10.1007/s10346-004-0030-4; [Anonymous], 2003, 14332003 JGS; Yin YP, 2010, LANDSLIDES, V7, P359, DOI 10.1007/s10346-010-0225-9; Orense R, 2004, SOILS FOUND, V44, P15; [Anonymous], 1995, P 8 ISRM C TOK SEPT; Uchimura T, 2010, LANDSLIDES, V7, P351, DOI 10.1007/s10346-009-0178-z; Casagli N, 2010, LANDSLIDES, V7, P291, DOI 10.1007/s10346-010-0215-y; Osanai N, 2010, LANDSLIDES, V7, P325, DOI 10.1007/s10346-010-0229-5; Azzam R., 2011, P 5 INT C EARTHQ GEO; Baum L.B., 2010, LANDSLIDES, V7, P259, DOI [10.1007/s10346-009-0177-0., DOI 10.1007/S10346-009-0177-0]; Fukuzono T., 1985, P 4 INT C FIELD WORK, P145, DOI DOI 10.1016/0148-9062(87)91524-5; Ishihara Y., 1979, B DISASTER PREVENTIO, V29, P27; Maruyama K., 1994, J JAPAN LANDSLIDE SO, V31; Nishiyama S., 2012, P INT WORKSH ICT GEO, P251; Okada K., 2001, SOIL WATER INDEX SOK; Orense R.P., 2003, P INT C FAST SLOP MO; Osanai N., 2009, 530 NAT I LAND INFR; Saito M, 1965, P 6 ICSMFE, V2, P537; Saito M., 1987, J JAPAN LANDSLIDE SO, V24, P30; Sawada M., 2012, P INT WORKSH ICT GEO, P89; Uchimura T, 2009, P 17 ISSMGE AL, V3, P1897; Uchimura T., 2011, INTERPRETATION MONIT, P807; Uchimura T., 2011, P 14 AS REG C SOIL M; Wang L., 2012, P INT WORKSH ICT GEO, P267	25	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1086	1099		10.1016/j.sandf.2015.09.010		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500014		
J	Yamada, S; Noda, T; Tashiro, M; Nguyen, HS				Yamada, Shotaro; Noda, Toshihiro; Tashiro, Mutsumi; Nguyen, Hong-Son			Macro-element method with water absorption and discharge functions for vertical drains	SOILS AND FOUNDATIONS			English	Article						Macro-element method; Vertical drain method; Vacuum consolidation method; Well resistance; Soil water coupled analysis; Finite element method; Finite deformation theory; Elasto-plasticity; Multilayered ground	SUBLOADING SURFACE; SOILS; EMBANKMENTS	When simulating the vertical drain method using a soil water coupled finite element analysis, a macro-element method can be used as a means of approximately applying the water absorption function of drains to individual elements. In this paper, the discharge function of vertical drains was added to the method by treating the water pressure in the drain as an unknown and adding a continuity equation for the drains to the governing equations. By extending the method in this way, the analytical results came to exhibit the well-resistance phenomenon automatically, depending on the analytical conditions. Numerical analyses were conducted after incorporating the proposed macro-element method into a quasistatic soil water coupled elasto-plastic finite element method based on the finite deformation theory. The main conclusions are as follows: (1) the proposed method enables highly accurate approximations for problems involving material and/or geometrical nonlinearity and multilayered grounds; (2) the proposed macro-element method is capable of reproducing various phenomena that occur when the vacuum consolidation method is applied to a clayey ground containing a middle sand layer; (3) by following the formulation used in this paper, it is unnecessary to match the mesh division width to the drain arrangement and spacing. In addition, it is possible to obtain solutions that are minimally affected by the mesh size. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Yamada, Shotaro; Tashiro, Mutsumi; Nguyen, Hong-Son] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan; [Noda, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan	Yamada, S (reprint author), Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan.	s-yamada@civil.nagoya-u.ac.jp					Aasoka A., 1995, SOILS FOUND, V35, P43; Akai K., 1978, P JSCE, V269, P95; Chai JC, 2001, J GEOTECH GEOENVIRON, V127, P965, DOI 10.1061/(ASCE)1090-0241(2001)127:11(965); Asaoka A, 2002, SOILS FOUND, V42, P47; Hashiguchi K, 1998, INT J NUMER ANAL MET, V22, P197, DOI 10.1002/(SICI)1096-9853(199803)22:3<197::AID-NAG914>3.3.CO;2-K; Noda T, 2005, SOILS FOUND, V45, P51; HASHIGUCHI K, 1989, INT J SOLIDS STRUCT, V25, P917, DOI 10.1016/0020-7683(89)90038-3; Borges JL, 2004, COMPUT GEOTECH, V31, P665, DOI 10.1016/j.compgeo.2004.11.001; Indraratna B, 2004, CAN GEOTECH J, V41, P1098, DOI 10.1139/T04-054; HIRD CC, 1992, GEOTECHNIQUE, V42, P499; Arai A., 2008, P 43 ANN C JSCE 2, P889; Asaoka A., 2000, SOILS FOUND, V40, P99; Asaoka A., 1994, SOILS FOUND, V34, P91; Asaoka A, 1997, SOILS FOUND, V37, P29; Asaoka A., 1997, SOILS FOUND, V37, P13; Asaoka A., 1998, P 4 EUR C NUM METH G, P233; Barron, 1948, T ASCE, V113, P718; Chai J.C., 2013, GROUND IMPROV, V166, P65; Christian J.T., 1970, J SOIL MECH FOUND DI, V96, P1435; Hansbo S, 1979, GROUND ENG, V2, P16; Hashiguchi K., 1978, P US JAP SEM CONT ME, P321; Hirata M., 2010, J APPL MECH, V13, P431; Roscoe KH, 1968, ENG PLASTICITY, P535; Sekiguchi H., 1988, BEHAV SEAWALL BRIDGE, P123; Sekiguchi H., 1986, P 31 S JSSMFE, P111; Sekiguchi H., 1977, P 9 ICSMFE SPEC SESS, P229; Shinsha H., 1982, JAPANESE SOC SOIL ME, V30, P7; Takeyama T., 2008, P 43 ANN C JSCE 1, P887; Yoshikuni H, 1979, THESIS; Yoshikuni H, 1974, SOILS FOUND, V14, P35, DOI DOI 10.3208/SANDF1972.14.2_35	30	2	2	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1113	1128		10.1016/j.sandf.2015.09.012		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500016		
J	Noda, T; Yamada, S; Nonaka, T; Tashiro, M				Noda, Toshihiro; Yamada, Shotaro; Nonaka, Toshihiro; Tashiro, Mutsumi			Study on the pore water pressure dissipation method as a liquefaction countermeasure using soil water coupled finite deformation analysis equipped with a macro-element method	SOILS AND FOUNDATIONS			English	Article						Pore water pressure dissipation method; Liquefaction countermeasure; Soil water coupled analysis; Macro-element method	BEHAVIOR	A numerical simulation of the pore water pressure dissipation method was performed using the GEOASIA soil water coupled finite deformation analysis code, which is capable of accounting for inertial forces, together with the elasto-plastic constitutive SYS Cam-clay model based on the soil skeleton structure concept, with the goal of quantitatively assessing the effects of this method as a countermeasure to liquefaction. At the same time, an effort was made to improve/enhance the calculation efficiency of the GEOASIA analysis code by incorporating a macro-element method, which up to this point has only been applied to consolidation problems. The main findings of this study are as follows: (1) the macro-element method is capable of yielding highly accurate approximations even for dynamic problems, (2) the method is capable of reproducing the suppression effect of the increase in pore water pressure associated with the pore water pressure dissipation method, even when a relatively coarse mesh is used, (3) the method is capable of reproducing the suppression effect of the decrease in effective stress due to the pore water pressure dissipation method, along with the resulting reduction in shear stiffness, lateral ground movement, and settlement and (4) it is possible to efficiently design the pore water pressure dissipation method with this method by first performing calculations using a 1-D mesh to determine the effective drain spacing prior to performing calculations using 2-D or 3-D meshes. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Noda, Toshihiro; Nonaka, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan; [Yamada, Shotaro; Tashiro, Mutsumi] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan	Noda, T (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan.	noda@nagoya-u.jp			JSPS [21226012, 25249064]	This paper reports on research carried out by the Technical Committee for the Mechanisms of Earthquake-Induced Ground Deformations (Chairman Akira Asaoka), a committee for seismic response research operating under the Japanese Geotechnical Society. In addition, this work was supported by JSPS KAKENHI Grant numbers 21226012 and 25249064.	Asaoka A, 2002, SOILS FOUND, V42, P47; Takaine T, 2010, SOILS FOUND, V50, P245, DOI 10.3208/sandf.50.245; Noda T, 2005, SOILS FOUND, V45, P51; Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; Lysmer J., 1969, ASCE J ENG MECH DIV, V95, P859; Noda T., 2008, SOILS FOUND, V45, P771; Sekiguchi H., 1988, ANN DISAS PREV RES I, V32, P123; Sekiguchi H., P 31 S JGS 1986, P111; Tanaka Y., 1984, P JSCE, V352, p[89, 98]; Unno T., 2012, P JSCE B, V68, pI_480; Yamada S, 2015, SOILS FOUND, V55, P1113, DOI 10.1016/j.sandf.2015.09.012	11	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1129	1138		10.1016/j.sandf.2015.09.013		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500017		
J	Ahmed, A; Soliman, AM; El Naggar, MH; Kamei, T				Ahmed, Aly; Soliman, Ahmed M.; El Naggar, M. Hesham; Kamei, Takeshi			An assessment of geo-environmental properties for utilization of recycled gypsum in earthwork projects	SOILS AND FOUNDATIONS			English	Article						Geo-environment; Gypsum wastes; Earthworks; Stabilization; Soft clay soil	SOFT CLAY; BASSANITE; DURABILITY; ETTRINGITE; STRENGTH; SYSTEM	This paper presents an assessment of geo-environmental properties for the incorporation of recycled gypsum, produced from gypsum waste, as an additive material in earthwork projects. In this study, the solubility of Fluorine, Boron and hexavalent Chromium and the emission of hydrogen sulfide gas refer to geo-environmental properties. To achieve this objective, the tested soil was mixed with recycled gypsum in conjunction with lime and cement in different proportions to overcome the solubility of gypsum and to reduce the solubility of harmful substances. The results of the study show that the utilization of recycled gypsum alone, as an additive material for earthwork projects, has a negative effect on the emission of hydrogen sulfide, while the addition of a solidification agent, such as cement or lime, to the recycled gypsum reduced the emission of hydrogen sulfide gas. The suggested contents and ratios for the gypsum cement and gypsum lime admixtures used in this study are safe against the emission of hydrogen sulfide because their measurements were found to be below the standard limits. Increasing the proportion of cement or lime in a gypsum soil mixture has a significant effect on the reduction in Fluorine solubility. The content of the admixture has a significant effect on the reduction in Fluorine solubility in the case of gypsum cement, while there is not much difference in the measured values of Fluorine in the gypsum lime admixture. The intensity of ettringite increases with the increase in admixture content and the decrease in the admixture ratio, while the intensity of calcite increases with increases in both the content and the ratio of the admixture. The formation of ettringite has a significant effect on the capture of Fluorine, namely, the solubility of Fluorine decreases with the increase in ettringite intensity. The measured values for the solubility of harmful substances, including Fluorine, Boron and hexavalent Chromium and the emission of hydrogen sulfide gas, were found to lie within the standards for the investigated limits of the gypsum soil mixture treated with cement or lime in the present study. This proves that the utilization of recycled gypsum in conjunction with cement or lime, as a stabilizer material and within the investigated limits, is safe and meets the environmental standards. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Ahmed, Aly; Soliman, Ahmed M.; El Naggar, M. Hesham] Univ Western Ontario, Dept Civil & Environm Engn, London, ON, Canada; [Kamei, Takeshi] Miyazaki Univ, Dept Civil & Environm Engn, Miyazaki, Japan; [Ahmed, Aly] Beni Suef Univ, Dept Civil Engn, Bani Suwayf, Egypt; [Soliman, Ahmed M.] Ain Shams Univ, Dept Civil Engn, Cairo, Egypt	Ahmed, A (reprint author), Univ Western Ontario, Dept Civil & Environm Engn, London, ON, Canada.	aly_76@hotmail.com					Ahmed A., 2014, J SOILS FDN, V54, P405; Ahmed A., 2011, GEOTECHNICAL SPECIAL, V217, P9; Ahmed A., 2010, P 6 INT C ENV GEOT 2, V2, P1469; DAMIDOT D, 1992, CEMENT CONCRETE RES, V22, P1179, DOI 10.1016/0008-8846(92)90047-Y; Ahmed A, 2011, COLD REG SCI TECHNOL, V66, P84, DOI 10.1016/j.coldregions.2010.12.004; Kamei T, 2013, SOILS FOUND, V53, P155, DOI 10.1016/j.sandf.2012.12.011; Ahmed A, 2011, SOILS FOUND, V51, P975, DOI 10.3208/sandf.51.975; Chrysochoou M, 2006, J HAZARD MATER, V136, P20, DOI 10.1016/j.jhazmat.2005.11.008; Kamei T, 2012, COLD REG SCI TECHNOL, V82, P124, DOI 10.1016/j.coldregions.2012.05.016; SOLEMTISHMACK JK, 1995, CEMENT CONCRETE RES, V25, P658, DOI 10.1016/0008-8846(95)00054-G; [Anonymous], 2013, ENV QUAL STAND SOIL; Kamei T, 2013, CONSTR BUILD MATER, V38, P224, DOI 10.1016/j.conbuildmat.2012.08.028; DAMIDOT D, 1993, CEMENT CONCRETE RES, V23, P1195, DOI 10.1016/0008-8846(93)90180-H; Kamei T., 2011, P 14 PAN C SOIL MECH; Kamei T., 2007, GEOTECHNICAL SOC ELE, V2, P245; Kamei T., 2008, JAPANESE GEOTECHNICA, V4, P91; Keller I.R.A., 2002, THESIS SWISS FEDERAL; Wang L., 2002, THESIS LOUISIANA STA; Waste & Resources Action Programme (WRAP), PLAST CAS STUD INT P; Waste & Resources Action Program (WRAP), 2007, PLAST TECHN REP US R	20	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1139	1147		10.1016/j.sandf.2015.09.014		9	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500018		
J	Watabe, Y; Sassa, S; Kaneko, T; Nakata, Y				Watabe, Yoichi; Sassa, Shinji; Kaneko, Takashi; Nakata, Yukio			Mechanical characteristics of reconstituted coral gravel soils with different fractions of finger-coral fragments and silt matrix	SOILS AND FOUNDATIONS			English	Article						Coral gravel soil; Coral fragments; Silt matrix; Particle crush; Mechanical properties; Triaxial test	GRANULAR-MATERIALS; SHEAR-STRENGTH; MIXTURES; CLAY; TESTS	Coral gravel soils, which are composite soils consisting of finger-coral fragments and silt matrix, are often found in coastal regions of subtropical islands. In this study, for reconstituted soils with various volumetric percentages of coral fragments up to 44% (coral particle fraction of 59%) as the densest package, a series of triaxial CU-bar and CD tests was conducted to study the determination method for the soil design parameters in consideration of the interaction between the soil skeleton, consisting of coral fragments, and the silt matrix. For samples with volumetric percentages of coral fragments less than 20% (coral particle fraction of 31%), the shear strength obtained from the CD tests was slightly larger than that obtained from the CU-bar tests; however, the difference between the two tests was very small. For samples with volumetric percentages of fragments more than 20% (coral particle fraction of 31%), the shear strength obtained from the CU-bar tests was significantly overestimated because of the unrealistically large negative excess pore pressure in the field corresponding to significant dilation. The shear strength obtained from the CD tests also showed a similar tendency corresponding to volume expansion; however, these values are much smaller than those obtained from the CU-bar tests. For the samples with a dense package of coral fragments, shear resistance angle 0 was much larger than that for normal soils; however, it tended to decrease in association with the particle crush of coral fragments. The tendency of the particle crush was visually evidenced through CT-images taken before and after the triaxial tests. The soil parameters were significantly influenced by the volumetric percentages of the coral fragments in association with particle interaction and particle crush, when the percentage was more than 20% (coral particle fraction of 31%) for the coral gravel soils examined in this study. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Watabe, Yoichi; Kaneko, Takashi] Port & Airport Res Inst, Soil Mech & Geoenvironm Grp, Yokosuka, Kanagawa 2390826, Japan; [Sassa, Shinji] Port & Airport Res Inst, Soil Dynam Grp, Yokosuka, Kanagawa 2390826, Japan; [Nakata, Yukio] Yamaguchi Univ, Dept Environm Geotech Engn, Ube, Yamaguchi 7558611, Japan	Watabe, Y (reprint author), Port & Airport Res Inst, Soil Mech & Geoenvironm Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	watabe@ipc.pari.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23360208]	The authors thank Mr. Kazufumi Yonamine and Mr. Norikazu Maekochi of the Okinawa General Bureau, Cabinet Office, Government of Japan for providing the coral gravel soils and active discussions on this study from engineering viewpoints. We also thank Mr Shinichi Yamada of Kisojiban Consultants Co., Ltd., Japan for his kind help in the preparation of the reconstituted samples, Mr Akihiko Yanagisawa and Mr. Ikuro Nozaki of Toa Corporation for assistance with the laboratory tests, and Dr. Takaaki Mizutani of the Port and Airport Research Institute for the CT scanning. This research work was supported by Grant-in-Aid for Scientific Research (No. 23360208) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Crawford BR, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004634; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kumar GV, 1999, GEOTECHNIQUE, V49, P727; Lobo-Guerrero S, 2005, GEOTECHNIQUE, V55, P617, DOI 10.1680/geot.2005.55.8.617; Vallejo LE, 2001, CAN GEOTECH J, V38, P1097, DOI 10.1139/cgj-38-5-1097; Vallejo LE, 2000, ENG GEOL, V58, P125, DOI 10.1016/S0013-7952(00)00051-X; Lobo-Guerrero S, 2006, SOILS FOUND, V46, P147, DOI 10.3208/sandf.46.147; Watabe Y, 2011, GEOTECHNIQUE, V61, P211, DOI 10.1680/geot.8.R087; CHALKER B, 1985, CORAL REEFS, V4, P95, DOI 10.1007/BF00300867; FRAGASZY RJ, 1992, J GEOTECH ENG-ASCE, V118, P920, DOI 10.1061/(ASCE)0733-9410(1992)118:6(920); Fragaszy R.J., 1990, ASTM GEOTECH TEST J, V13, P106; Jones N, 2011, NATURE; Lade PV, 1996, J GEOTECH ENG-ASCE, V122, P309, DOI 10.1061/(ASCE)0733-9410(1996)122:4(309); Oyadomari Zen, 2004, J GEOTECH ENG JPN SO, P1; Simoni A., 2006, GEOTECHNICAL GEOLOGI, V24, P523, DOI DOI 10.1007/S10706-004-5832-6; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	16	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1233	1242		10.1016/j.sandf.2015.09.022		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500026		
J	Eab, KH; Likitlersuang, S; Takahashi, A				Eab, Kreng Hav; Likitlersuang, Suched; Takahashi, Akihiro			Laboratory and modelling investigation of root-reinforced system for slope stabilisation	SOILS AND FOUNDATIONS			English	Article						Centrifuge modelling; Laboratory tests; Slopes; Vegetation	SOIL; VEGETATION; STRENGTH	Most natural slope failures are induced by seepage and/or rainfall. Soil bioengineering is an environmentally friendly method which employs vegetation to reinforce the soil in sloping terrain. The vegetation can contribute to slope stability in two ways, mechanical and hydrological. This paper demonstrates the effect of a vegetation root matrix on a soil slope and focuses on mechanical reinforcement using an example of vetiver grass. Vetiver grass (Vetiveria nemoralis A. Camus) specimens, grown for under a year, were used in this study. The investigation programme includes root observations, direct shear tests and centrifuge model tests. The growing rate of the vetiver roots and the root area ratios were observed during the tests. The cohesion and angle of internal friction of root-reinforced soils were determined from a standard direct shear apparatus and a large direct shear apparatus. A series of centrifuge tests was carried out to demonstrate the effect of vegetation on seepage- and rainfall-induced slope failures. The results indicate that the vetiver roots showed rapid growth within a year and that the shear strength of the root-reinforced soil was significantly increased by the bundle of roots. The results also reveal that the bundle of root fibres in the centrifuge model tests helped to reduce the deformation of the soil slope due to instability by increasing the shear strength of the slope. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Eab, Kreng Hav] Chulalongkorn Univ, Fac Engn, Dept Civil Engn, Bangkok 10330, Thailand; [Takahashi, Akihiro] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan; [Likitlersuang, Suched] Chulalongkorn Univ, Fac Engn, Dept Civil Engn, Geotech Res Unit, Bangkok 10330, Thailand	Likitlersuang, S (reprint author), Chulalongkorn Univ, Fac Engn, Dept Civil Engn, Geotech Res Unit, Bangkok 10330, Thailand.	krenghav_eab@yahoo.com; fceslk@eng.chula.ac.th; takihiro@cv.titech.ac.jp	Takahashi, Akihiro/B-9306-2015	Takahashi, Akihiro/0000-0003-1206-5066	Thailand Research Fund under the TRF Research Scholar Award [RSA-5880023]; AUN/SEED-Net (JICA)	This research was supported by the Thailand Research Fund under the TRF Research Scholar Award Grant no. RSA-5880023. The first author would like to acknowledge the AUN/SEED-Net (JICA) for his Ph.D. scholarship during his study. The work was also conducted under the research and development project on landslide prevention and protection according to the Royal Initiatives of the Chaipattana Foundation.	Alsheimer L., 2007, BLACK WHITE PHOTOSHO, P91, DOI 10.1016/B978-0-240-52084-1.50011-8; Sonnenberg R, 2010, CAN GEOTECH J, V47, P1415, DOI 10.1139/T10-037; WU TH, 1979, CAN GEOTECH J, V16, P19; Ali FH, 2008, SOILS FOUND, V48, P587, DOI 10.3208/sandf.48.587; [Anonymous], 1998, D3080 ASTM; Ng CWW, 1998, COMPUT GEOTECH, V22, P1, DOI 10.1016/S0266-352X(97)00036-0; Cerato A. B., 2006, GEOTECH TEST J, V29, P1, DOI DOI 10.1520/GTJ100312; Chinapan W., 1997, STUDY ECOTYPE COMP V; Coppin N.J., 1990, USE VEGETATION CIVIL; Eab KH, 2014, GEOTECH LETT, V4, P211, DOI 10.1680/geolett.14.00029; Gray D., 1996, BIOTECHNICAL SOIL BI; Gray D.H., 1982, BIOTECHNICAL SLOPE P; Greenfield J.C., 1996, P 1 INT C VET CHIANG, P1; Greenway D.R., 1978, SLOPE STABILITY; Hengchaovanich D., 1998, P 1 INT C VET MIR GR, P153; Kaewsaeng W., 2000, THESIS KING MONGKUTS; LDD, 1998, VET GRASS OV; Lyr H., 1967, Int. Rev. For Res., N. Y., V2, P181; Takahashi A., 2014, P 8 INT C PHYS MOD G, P1233; Taylor R. N., 1995, GEOTECHNICAL CENTRIF; Wu T.H., 1995, SLOPE STABILIZATION	21	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1270	1281		10.1016/j.sandf.2015.09.025		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500029		
J	Goto, H; Tanaka, N; Sawada, S; Inatani, H				Goto, Hiroyuki; Tanaka, Nobuaki; Sawada, Sumio; Inatani, Hideki			S-wave impedance measurements of the uppermost material in surface ground layers: Vertical load excitation on a circular disk	SOILS AND FOUNDATIONS			English	Article						S-wave impedance; Elastic wave exploration; Numerical experiment (IGC: C02, E08, G08)	NORMALIZED ENERGY DENSITY; SEISMIC SITE CONDITIONS; TOHOKU EARTHQUAKE; PACIFIC COAST; EMBEDDED FOUNDATIONS; ARRAY OBSERVATIONS; JAPAN; AMPLIFICATION; LIQUEFACTION; MOTION	S-wave impedance is one of the most effective parameters used to study the ground motion amplification of soil deposits. We propose a new approach to measure the S-wave impedance of the uppermost material in surface ground layers. First, a circular disk is set on the ground surface, and it is vertically loaded by sinusoidal wave excitation. When the time series of the loading velocity is synchronized with the reaction force, the ratio of the reaction force to the loading velocity is proportional to the S-wave impedance. We then estimate the proportionality coefficient from numerical experiments and check its accuracy. The measurement error is estimated to be within 1% for the homogeneous half-space case. We also discuss the applicability of this new approach and its limitations on the basis of numerical experiments for inhomogeneous media: a two-layered medium and a one-dimensional (1-D) random medium. The proposed approach is effective for both cases if we select the appropriate circular disk size. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Goto, Hiroyuki; Sawada, Sumio] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Tanaka, Nobuaki] Chem Grouting Co Ltd, Minato Ward, Tokyo 1050001, Japan; [Inatani, Hideki] Katsujima Co Ltd, Katsushika Ward, Tokyo 1250063, Japan	Goto, H (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	goto@catfish.dpri.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25709039]	We thank the editor and anonymous reviewers for their fruitful comments. The research was supported by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (JSPS) (No. 25709039).	Aki K, 1957, B EARTHQ RES I TOKYO, V25, P415; Jia R, 2013, SOILS FOUND, V53, P671, DOI 10.1016/j.sandf.2013.08.005; Park CB, 1999, GEOPHYSICS, V64, P800, DOI 10.1190/1.1444590; Allen TI, 2009, B SEISMOL SOC AM, V99, P935, DOI 10.1785/0120080255; Lee VW, 2010, SOIL DYN EARTHQ ENG, V30, P1250, DOI 10.1016/j.soildyn.2010.05.007; Yasuda S, 2012, SOILS FOUND, V52, P793, DOI 10.1016/j.sandf.2012.11.004; Unjoh S, 2012, SOILS FOUND, V52, P830, DOI 10.1016/j.sandf.2012.11.006; Gerolymos N, 2006, SOIL DYN EARTHQ ENG, V26, P347, DOI 10.1016/j.soildyn.2005.12.003; Wald DJ, 2007, B SEISMOL SOC AM, V97, P1379, DOI 10.1785/0120060267; JOYNER WB, 1981, B SEISMOL SOC AM, V71, P1333; Liu HP, 2000, B SEISMOL SOC AM, V90, P666, DOI 10.1785/0119980186; Thompson EM, 2014, B SEISMOL SOC AM, V104, P2313, DOI 10.1785/0120130312; Whitcombe DN, 2002, GEOPHYSICS, V67, P60, DOI 10.1190/1.1451331; AKI K, 1965, GEOPHYSICS, V30, P665, DOI 10.1190/1.1439640; Kausel E, 2010, SOIL DYN EARTHQ ENG, V30, P822, DOI 10.1016/j.soildyn.2009.11.001; ALLEN SJ, 1980, GEOPHYSICS, V45, P1619, DOI 10.1190/1.1441053; Goto H, 2012, SEISMOL RES LETT, V83, P765, DOI 10.1785/0220120044; Castellaro S, 2008, SEISMOL RES LETT, V79, P540, DOI 10.1785/gssrl.79.4.540; Lu SM, 2004, GEOPHYSICS, V69, P164, DOI 10.1190/1.1649385; Mori T, 2012, SOILS FOUND, V52, P910, DOI 10.1016/j.sandf.2012.11.011; Goto H, 2013, GEOPHYS J INT, V194, P488, DOI 10.1093/gji/ggt104; GAZETAS G, 1987, J GEOTECH ENG-ASCE, V113, P458; WOLF JP, 1986, EARTHQUAKE ENG STRUC, V14, P683, DOI 10.1002/eqe.4290140502; Goto H, 2009, SOILS FOUND, V49, P651, DOI 10.3208/sandf.49.651; Nakagawa K, 1997, GEOTECHNIQUE, V47, P133; Yang J, 2000, B SEISMOL SOC AM, V90, P275, DOI 10.1785/0119990068; Yokokura T, 1995, J PHYS EARTH, V43, P321; Boore DM, 2007, SOIL DYN EARTHQ ENG, V27, P971, DOI 10.1016/j.soildyn.2007.03.005; Goto H, 2011, WAVE MOTION, V48, P603, DOI 10.1016/j.wavemoti.2011.04.011; Goto H, 2012, SOILS FOUND, V52, P769, DOI 10.1016/j.sandf.2012.11.002; Boore D.M., 2006, P 3 INT S EFF SURF G; Borcherdt R.D., 1994, EARTHQ SPECTRA, V10, P617, DOI DOI 10.1193/1.1585791; Boussinesq J., 1885, APPL POTENTIELS ETUD; Bouzorgnia Y., 2004, EARTHQUAKE ENG ENG S; Connolly P, 1999, LEADING EDGE, V18, P438, DOI DOI 10.1190/1.1438307; GAZETAS G, 1984, J ENG MECH-ASCE, V110, P937; GAZETAS G, 1991, J GEOTECH ENG-ASCE, V117, P1363, DOI 10.1061/(ASCE)0733-9410(1991)117:9(1363); Hata Y, 2014, SOILS FOUND, V54, P573, DOI 10.1016/j.sandf.2014.06.003; Kokusho T., 1980, SOILS FOUND, V20, P45; LADE PV, 1987, INT J NUMER ANAL MET, V11, P521, DOI 10.1002/nag.1610110507; Lamb H., 1902, P LOND MATH SOC, V34, P276; Okada H, 2003, MICROTREMOR SURVEY M; Robertson I.A., 1966, MATH P CAMBRIDGE PHI, V62, P547, DOI 10.1017/S0305004100040184; Sato H, 2012, SEISMIC WAVE PROPAGA; Seed H. B., 1971, J SOIL MECHANICS FOU, V107, P1249; Sugano T, 2014, SOILS FOUND, V54, P883, DOI 10.1016/j.sandf.2014.06.018; Towhata I, 2014, SOILS FOUND, V54, P859, DOI 10.1016/j.sandf.2014.06.016; Wakamatsu K., 2006, B EARTHQ RES I TOKYO, V81, P317; Wald D.J., 2010, PAGER RAPID ASSESSME; Wolf JP, 1997, EARTHQUAKE ENG STRUC, V26, P931, DOI 10.1002/(SICI)1096-9845(199709)26:9<931::AID-EQE686>3.0.CO;2-M	50	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1282	1292		10.1016/j.sandf.2015.09.026		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500030		
J	Horikoshi, K; Takahashi, A				Horikoshi, Kazuki; Takahashi, Akihiro			Suffusion-induced change in spatial distribution of fine fractions in embankment subjected to seepage flow	SOILS AND FOUNDATIONS			English	Article						Suffusion; Internal erosion; Seepage; Physical model tests	INTERNAL STABILITY; COHESIONLESS SOIL; BACKWARD EROSION; DAMS; CRITERIA; INITIATION; FILTERS	Suffusion describes the phenomenon whereby finer particles are eroded through the voids of coarse particles by the seepage flow. This may cause the deterioration of the hydraulic structure and, in the worst case, result in the failure of the hydraulic structure. The suffusion process is presented in this paper in an embankment under transient and steady seepage conditions. A series of physical model tests on seepage-induced suffusion on a small-scale model embankment is performed under constant boundary head conditions. A binary mixture, consisting of two Silica sands (Silica sands Nos. 3 and 8), which is categorized as "internally unstable material" by several previous criteria for the seepage-induced internal stability, is used for the model embankment. The cumulative eroded soil mass and the discharged rate of water are recorded during the seepage tests. The spatial extent of the variation in erosion-induced fines contents is discussed through sieve analyzes on subdivided areas of the model embankment after seepage testing. The test results reveal that a decrease in fines propagates along the phreatic surface from downstream in the embankment. Below the phreatic surface, the eroded fines not only move laterally by the seepage flow, but also vertically due to the gravitational force, and are deposited in the foundation. This deposition of the fines results in the expansion of the fine-rich region in the foundation and causes a decrease in the permeability of the whole embankment. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Horikoshi, Kazuki; Takahashi, Akihiro] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan	Takahashi, A (reprint author), 2-12-1-M1-3 Oh Okayama, Tokyo 1528552, Japan.	takihiro@cv.titech.ac.jp	Takahashi, Akihiro/B-9306-2015	Takahashi, Akihiro/0000-0003-1206-5066	JSPS KAKENHI [25420498]	This work was supported by JSPS KAKENHI, Grant number 25420498.	Tomlinson SS, 2000, CAN GEOTECH J, V37, P1, DOI 10.1139/cgj-37-1-1; Chang DS, 2013, SOILS FOUND, V53, P569, DOI 10.1016/j.sandf.2013.06.008; Fell R, 2013, CIV ENG GEOMECH SER, P1; Lindow N, 2009, EARTH SURF PROC LAND, V34, P1693, DOI 10.1002/esp.1874; Richards KS, 2014, ENVIRON ENG GEOSCI, V20, P85; Bendahmane F, 2008, J GEOTECH GEOENVIRON, V134, P57, DOI 10.1061/(ASCE)1090-0241(2008)134:1(57); Li MX, 2008, CAN GEOTECH J, V45, P1303, DOI 10.1139/T08-046; Wan CF, 2008, J GEOTECH GEOENVIRON, V134, P401, DOI 10.1061/(ASCE)1090-0241(2008)134:3(401); Richards KS, 2007, B ENG GEOL ENVIRON, V66, P381, DOI 10.1007/s10064-007-0095-0; KENNEY TC, 1985, CAN GEOTECH J, V22, P215; Ke L, 2012, SOILS FOUND, V52, P698, DOI 10.1016/j/sandf.2012.07.010; Richards KS, 2012, GEOTECHNIQUE, V62, P933, DOI 10.1680/geot.11.P.058; Moffat R, 2011, CAN GEOTECH J, V48, P399, DOI 10.1139/T10-071; Foster M, 2001, J GEOTECH GEOENVIRON, V127, P398, DOI 10.1061/(ASCE)1090-0241(2001)127:5(398); Foster M, 2000, CAN GEOTECH J, V37, P1000, DOI 10.1139/cgj-37-5-1000; Moffat R, 2011, CAN GEOTECH J, V48, P413, DOI 10.1139/T10-070; Fell R, 2003, J GEOTECH GEOENVIRON, V129, P307, DOI 10.1061/(ASCE)1090-0241(2003)129:4(307); SKEMPTON AW, 1994, GEOTECHNIQUE, V44, P449; Beguin R., 2012, P 6 INT C SCOUR ER P, P1551; Cividini A., 2009, International Journal of Geomechanics, V9, P187, DOI 10.1061/(ASCE)1532-3641(2009)9:4(187); Cividini A., 2004, International Journal of Geomechanics, V4, P191, DOI 10.1061/(ASCE)1532-3641(2004)4:3(191); Foster M., 1999, UNICIV REPORTS; Fry J.J., 2012, P 6 INT C SCOUR ER P, P273; Fry J.J., 2012, EROSION GEOMATERIALS, P1; Honjo Y., 1996, P GEOF 96, P227; Ke L, 2014, SOILS FOUND, V54, P713, DOI 10.1016/j.sandf.2014.06.024; Khomenko V.P., 2006, P 10 IAEG INT C NOTT, P1; Kuwano R., 2012, P 6 INT C SCOUR ER P, P265; Ladd RS, 1978, GEOTECH TEST J, V1, P16, DOI DOI 10.1520/GTJ10364J; Lafleur J., 1999, GEOTEXT GEOMEMBRANES, V17, P299, DOI DOI 10.1016/S0266-1144(99)00007-2; Luo Y., 2012, NAT HAZARDS, V65, P1361; Marot D., 2012, P 6 INT C SCOUR ER P, P887; Moraci N, 2014, CAN GEOTECH J, V51, P1063, DOI 10.1139/cgj-2014-0006; Perzlmaier S, 2007, INTERNAL EROSION DAM, P179; Saito Y., 2012, P 47 JAP NAT C GEOT, P903; Sterpi D., 2003, INT J GEOMECH, V3, P111, DOI 10.1061/(ASCE)1532-3641(2003)3:1(111); Terzaghi K, 1939, J I CIVIL ENG, V12, P106, DOI 10.1680/ijoti.1939.14534; Uzuoka R., 2012, P 6 INT C SCOUR ER P, P655; Zhang X., 2014, ENV EARTH SCI; Zhang X. S., 2013, Geotechnical and Geological Engineering, V31, DOI 10.1007/s10706-012-9600-8	40	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1293	1304		10.1016/j.sandf.2015.09.027		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500031		
J	Tsuchida, T; Athapaththu, AMRG; Hanaoka, T; Kawaguchi, M				Tsuchida, Takashi; Athapaththu, A. M. R. G.; Hanaoka, Takashi; Kawaguchi, Masaki			Investigation of landslide calamity due to torrential rainfall in Shobara City, Japan	SOILS AND FOUNDATIONS			English	Article						Slope failure; Rainfall; Site investigation; Model test; Slope stability		On 16th July 2010, a series of slope failures occurred in the city of Shobara, Japan due to a torrential rainfall. The slope failures were found to have occurred at about 200 locations in a narrow area of 16 km(2). Most of the failures in this catastrophic disaster were due to the collapse of the middle portion of a mountainous slope. The primary purpose of this study was to present the landslide event that took place in Shobara City and to explore the mechanism of the multiple planar slope failures in the region. A series of field tests was carried out using a recently developed lightweight dynamic cone penetrometer in the middle portion of the selected planar slopes. The results revealed that the slopes were composed of two soil layers, weathered Rhyolite and Kuroboku. The failures took place at the boundary of these two soil layers. Laboratory tests were conducted to find the relevant parameters for the stability analysis, and laboratory scale model tests were performed to understand the mechanism of the slope failures in this region. The results of the model tests revealed that the Kuroboku layer led to a rise in the water table in the middle portion of the slope, while preventing the downward flow of groundwater. As a result, the failures are found to have initiated and occurred in the middle portion of the mountainous slope. The factor of safety, evaluated based on a slope stability analysis, was found to be close to 1, when the groundwater level rose to the ground surface and the apparent cohesion of the weathered Rhyolite soil over the Kuroboku layer decreased to 1.3 kPa. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Tsuchida, Takashi; Athapaththu, A. M. R. G.] Hiroshima Univ, Inst Engn, Dept Civil & Environm Engn, Higashihiroshima 7398527, Japan; [Hanaoka, Takashi] Hiroshima Prefectural Hiroshima Tech High Sch, Hiroshima, Japan; [Kawaguchi, Masaki] Tottori City Govt, Tottori, Japan	Tsuchida, T (reprint author), Hiroshima Univ, Inst Engn, Dept Civil & Environm Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	tkstsuchida@mse.biglobe.ne.jp					Aboshhi H., 1972, P 7 ANN M JSSMFE, P507; Yamada M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052174; Tsuchida T, 2011, SOILS FOUND, V51, P497; Uchida T, 2001, HYDROL PROCESS, V15, P2151, DOI 10.1002/hyp.281; Athapaththu A.M.R.G., 2007, J JAPANESE SOC CIV C, V63, P403; Athapaththu A.M.R.G., 2007, J JAPANESE SOC CIV C, V63, P848; Athapaththu A.M.R.G., 2006, INT OFFSHORE POLAR E, V2, P324; Fukuoka H., 2009, NAT DISASTER SCI, V28, P185; Janbu N., 1954, P EUR C STAB EARTH S, P43; Japanese Geotechnical Society, 2000, JAP STAND GEOT GEOEN, P563; Jones J.A.A., 1994, CUATERNARIO GEOMORFO, V8, P77; Kitahara H., 1994, Journal of the Japanese Forestry Society, V76, P10; Langton D.D., 1999, PANDA LIGHTWEIGHT PE; Matsui A., 2010, GROUND CONSTR, V28, P55; Miyabuchi Y., 2012, J GEOGR, V121, P1073; PIERSON TC, 1983, Q J ENG GEOL, V16, P1, DOI 10.1144/GSL.QJEG.1983.016.01.01; Thi H., 2003, P INT S GROUNDW PROB, P181; Tsuchida T, 2014, SOILS FOUND, V54, P806, DOI 10.1016/j.sandf.2014.06.012; Tsuchida T., 2010, J JPN NAT DISASTERS, V29, P245	19	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1305	1317		10.1016/j.sandf.2015.09.028		13	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500032		
J	Nigorikawa, N; Asaka, Y				Nigorikawa, Naohiro; Asaka, Yoshiharu			Leveling of long-term settlement of Holocene clay ground induced by the 2011 off the Pacific coast of Tohoku earthquake	SOILS AND FOUNDATIONS			English	Article						Earthquake; Holocene clay; Leveling survey; Long-term settlement; Reclaimed land; (IGC: E08)		The aim of the study reported in this paper is to reveal the long-term settlement of a Holocene clay ground after the 2011 off the Pacific coast of Tohoku earthquake. The authors took level readings six times across Urayasu City, Chiba Prefecture, during the period from April 2011 to April 2013. The results are a chronological record of changes in settlement of first-order benchmarks and survey points showing that long-term ground settlement was taking place due to the earthquake. In Phase I reclaimed land (which was constructed between 1968 and 1975), the settlement rate is shown to be approximately 6 mm/year, more than twice the rate of the settlement before the earthquake. In Phase II reclaimed land (which was constructed between 1978 and 1980), the settlement behavior is found to differ according to whether the reclaimed land had been improved or not. Furthermore, the natural alluvial lowland has not settled since the earthquake. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Nigorikawa, Naohiro; Asaka, Yoshiharu] Shimizu Corp, Inst Technol, Tokyo 1358530, Japan	Nigorikawa, N (reprint author), Shimizu Corp, Inst Technol, Tokyo 1358530, Japan.	n.nigorikawa@shimz.co.jp					Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; Chiba Prefecture, 2015, RESULT ANN LEVELING; Chiba Prefecture, 2015, INFORM BANK GEOLOGIC; Chiba Prefecture Urayasu City, 2015, LAND RECLAMATIONS; Chiba Prefecture Urayasu City, 1986, REPORT BASIC FINDING; Fiegel G.L., 1998, P INT C CENTR, V98, P231; Fukutake K., 2013, J JSCE, V1, P307; Geospatial Information Authority of Japan GSI, 2015, SURV SPEC; Geospatial Information Authority of Japan GSI, 2015, LAND COND MAPS; Geospatial Information Authority of Japan GSI, 2015, GEOD SURV; Hotta H., 1998, ANN M ARCH I JAP, P557; Ishihara K., 1992, SOILS FOUND, V32, P173; Japan Railway Construction Public Corporation, 1991, CONSTR REC JR KEIYO; Japanese Geotechnical Society JGS, 2014, HAND 3 WORKSH CONST; Japanese Geotechnical Society JGS, 2009, JAP STAND EXPL LAB T, P51; Jinbo H., 1994, CIVIL ENG, P56; Koishi Y., 2012, P 47 JGS C SOIL MECH, P265; Matsuda H., 2000, J JSCE DIVISION C, V659, P63; Murakami T., 2013, P 48 JGS C SOIL MECH, P437; Towhata I., 2008, GEOTECHNICAL EARTHQU, P359; Yasuhara K., 1998, TSUCHI TO KISO, V46, P57; Zeevaert L., 1972, FDN ENG DIFFICULT SU, P521	22	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1318	1325		10.1016/j.sandf.2015.09.029		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500033		
J	Birkel, A; DeCino, NA; Cozzan, C; Mikhailovsky, AA; Hong, BC; Seshadri, R				Birkel, Alexander; DeCino, Nicholas A.; Cozzan, Clayton; Mikhailovsky, Alexander A.; Hong, Byung-Chul; Seshadri, Ram			A single-phase full-color phosphor based on Ba3MgSi2O8 co-activated with Eu2+, Tb3+, and Mn2+	SOLID STATE SCIENCES			English	Article						Phosphors; Solid-state lighting; Microwave preparation; Merwinite; Full-color	LIGHT-EMITTING-DIODES; RAPID MICROWAVE PREPARATION; INORGANIC-COMPOUNDS; SOLID-SOLUTIONS; BA PHOSPHORS; CA; LUMINESCENCE; FLUORESCENCE; SR; PHOTOLUMINESCENCE	We present a rapid and energy-efficient microwave-assisted approach to prepare a single-phase fullcolor phosphor based on Ba3MgSi2O8. The samples were prepared using a citric acid based sal gel preparation pathway with a microwave-assisted heating step, which reduces the time required for the final heat treatment to less than 30 min. Thermogravimetric analysis was utilized to optimize the solution-based preparation prior to microwave heating. The structural properties of the obtained luminescent materials have been thoroughly investigated by means of X-ray powder diffraction and Rietveld analyses. To study the optical behavior, the excitation and emission spectra were recorded. Full-color emission is achieved using Eu2+ (blue), Tb3+ (green), and Mn2+ (red) as the activator ions. The thermally robust emission was investigated using temperature-dependent luminescence spectroscopy. The energy-transfer processes within the samples were studied using time-dependent spectroscopy, and the quantum yield of this true color phosphor as a function of the composition was determined. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Birkel, Alexander; DeCino, Nicholas A.; Cozzan, Clayton; Seshadri, Ram] Univ Calif Santa Barbara, Mitsubishi Chem Ctr Adv Mat, Santa Barbara, CA 93106 USA; [Birkel, Alexander; DeCino, Nicholas A.; Cozzan, Clayton; Seshadri, Ram] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Mikhailovsky, Alexander A.; Seshadri, Ram] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Hong, Byung-Chul] Mitsubishi Chem Grp, Sci & Technol Res Ctr, Yokohama, Kanagawa 2278502, Japan; [Seshadri, Ram] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Seshadri, R (reprint author), Univ Calif Santa Barbara, Mitsubishi Chem Ctr Adv Mat, Santa Barbara, CA 93106 USA.	seshadri@mrl.ucsb.edu	Seshadri, Ram/C-4205-2013		National Science Foundation [DGE 1144085]; MRSEC Program of the NSF [DMR 1121053]; NSF	We would like to thank Dr. Christina Birkel for the help with the TGA analysis, Dr. Kristin Denault and Dr. Nathan George for useful discussions, and Dr. Jakoah Brgoch for careful reading of the manuscript. CC gratefully acknowledges this material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1144085. The research carried out here made extensive use of shared experimental facilities of the Materials Research Laboratory: The MRL Central Facilities are supported by the MRSEC Program of the NSF under Award No. DMR 1121053; a member of the NSF-funded Materials Research Facilities Network (www.mrfn.org).	Aitasalo T., 2007, Z KRIST S, V26, P461; Dorenbos P, 2000, J LUMIN, V91, P91, DOI 10.1016/S0022-2313(00)00197-6; Kim JS, 2005, SOLID STATE COMMUN, V133, P445, DOI 10.1016/j.ssc.2004.12.002; Kim JS, 2005, SOLID STATE COMMUN, V135, P21, DOI 10.1016/j.ssc.2005.03.068; BLASSE G, 1968, PHILIPS RES REP, V23, P189; BARRY TL, 1968, J ELECTROCHEM SOC, V115, P733, DOI 10.1149/1.2411413; Im WB, 2009, J MATER CHEM, V19, P8761, DOI 10.1039/b912793c; Ma L, 2008, ELECTROCHEM SOLID ST, V11, pE1, DOI 10.1149/1.2817472; Paulose PI, 2003, J PHYS CHEM SOLIDS, V64, P841, DOI 10.1016/S0022-3697(02)00416-X; Chen HY, 2012, CERAM INT, V38, P125, DOI 10.1016/j.ceramint.2011.06.044; Ye S, 2010, MAT SCI ENG R, V71, P1, DOI 10.1016/j.mser.2010.07.001; Birkel A, 2013, SOLID STATE SCI, V19, P51, DOI 10.1016/j.solidstatesciences.2013.02.003; Chambers MD, 2009, ANNU REV MATER RES, V39, P325, DOI 10.1146/annurev-matsci-112408-125237; Biswas K, 2011, MATER RES BULL, V46, P2288, DOI 10.1016/j.materresbull.2011.08.058; Dorenbos P, 2003, J LUMIN, V104, P239, DOI 10.1016/S0022-2313(03)00078-4; Birkel A, 2012, CHEM MATER, V24, P1198, DOI 10.1021/cm3000238; Im WB, 2009, INORG CHEM, V48, P557, DOI 10.1021/ic8012798; Poort SHM, 1997, J PHYS CHEM SOLIDS, V58, P1451, DOI 10.1016/S0022-3697(97)00010-3; ROY R, 1985, J AM CERAM SOC, V68, P392, DOI 10.1111/j.1151-2916.1985.tb10150.x; LEBAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Birkel CS, 2013, PHYS CHEM CHEM PHYS, V15, P6990, DOI 10.1039/c3cp50918d; Bachmann V, 2009, CHEM MATER, V21, P2077, DOI 10.1021/cm8030768; Birkel A, 2012, SOLID STATE SCI, V14, P739, DOI 10.1016/j.solidstatesciences.2012.03.014; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Daldosso M, 2008, OPT MATER, V30, P1162, DOI 10.1016/j.optmat.2007.05.042; Kim JS, 2007, J LUMIN, V122, P583, DOI 10.1016/j.jlumin.2006.01.231; Im WB, 2009, OPT EXPRESS, V17, P22673, DOI 10.1364/OE.17.022673; Im WB, 2009, J MATER CHEM, V19, P1325, DOI 10.1039/b818313a; Yonesaki Y, 2009, J SOLID STATE CHEM, V182, P547, DOI 10.1016/j.jssc.2008.11.032; KLASENS HA, 1957, J ELECTROCHEM SOC, V104, P93, DOI 10.1149/1.2428519; Rack PD, 1998, MAT SCI ENG R, V21, P171, DOI 10.1016/S0927-796X(97)00010-7; Ishigaki T, 2010, MATER SCI ENG B-ADV, V173, P109, DOI 10.1016/j.mseb.2009.11.004; Kim JS, 2004, APPL PHYS LETT, V84, P2931, DOI 10.1063/1.1695441; Birkel CS, 2012, CHEM MATER, V24, P2558, DOI 10.1021/cm3011343; Park CH, 2009, J SOLID STATE CHEM, V182, P496, DOI 10.1016/j.jssc.2008.11.024; Smet PF, 2011, J ELECTROCHEM SOC, V158, pR37, DOI 10.1149/1.3568524; GREENHAM NC, 1995, CHEM PHYS LETT, V241, P89, DOI 10.1016/0009-2614(95)00584-Q; BAGHURST DR, 1988, NATURE, V332, P311, DOI 10.1038/332311a0; Becker W., 2005, SPRINGER SERIES CHEM, V81; Blasse W., 1994, LUMINESCENT MAT; Coelho A.A., 2007, TOPAS ACAD V4 1; Dorenbos P, 2003, J PHYS-CONDENS MAT, V15, P4797, DOI 10.1088/0953-8984/15/27/311; Dorenbos P, 2005, J PHYS-CONDENS MAT, V17, P8103, DOI 10.1088/0953-8984/17/50/027; George N.C., 2013, ANN REV MATER RES, V43; Im WB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976138; Lue W., 2011, INORG CHEM, V50, P7846; Pimputkar S., 2009, NAT PHOTONICS, V3, P2; Wang DJ, 2009, ELECTROCHEM SOLID ST, V12, pH179, DOI 10.1149/1.3086729	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	OCT	2015	48						82	89		10.1016/j.solidstatesciences.2015.07.005		8	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CU2IS	WOS:000363347800014		
J	Tachikawa, H; Kawabata, H				Tachikawa, Hiroto; Kawabata, Hiroshi			Electronic states of alkali metal-NTCDA complexes: A DFT study	SOLID STATE SCIENCES			English	Article						Organic-inorganic hybrid complex; Li(NTCDA); Na(NTCDA); Paramagnetic species	ORGANIC SEMICONDUCTOR; FILMS; SYSTEM; ATOM; AL	Structures and electronic states of organic inorganic compound of 1,4,5,8-naphthalene-tetracarboxylic-dianhydride (NTCDA) with alkali metals, M-n(NTCDA) (M=Li and Na, n = 0-2), have been investigated by means of hybrid density functional theory (DFT) calculations. From the DFT calculations, it was found that the electronic state of the complex at the ground state is characterized by a charge-transfer state expressed by (M)(+)(NTCDA)(-). The alkali metals were bound equivalently to the carbonyl oxygen and ether oxygen atoms of NTCDA. The C=O double bond character of NTCDA was changed to a C-O single bond like character by the strong interaction of M to the C=O and O sites. This change was the origin of the red-shift of the IR spectrum. The UV-vis absorption spectra of M-n(NTCDA) were theoretically predicted on the basis of theoretical results. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Tachikawa, Hiroto] Hokkaido Univ, Grad Sch Engn, Div Appl Chem, Sapporo, Hokkaido 0608628, Japan; [Kawabata, Hiroshi] Kyoto Univ, Venture Business Lab, Sakyo Ku, Kyoto 6068501, Japan	Tachikawa, H (reprint author), Hokkaido Univ, Grad Sch Engn, Div Appl Chem, Sapporo, Hokkaido 0608628, Japan.	hiroto@eng.hokudai.ac.jp			JSPS KAKENHI Grant [15K05371]; MEXT KAKENHI Grant [25108004]	The author acknowledges partial support from JSPS KAKENHI Grant Number 15K05371 and MEXT KAKENHI Grant Number 25108004.	Kera S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115204; Forrest SR, 1997, CHEM REV, V97, P1793, DOI 10.1021/cr941014o; Tachikawa H, 2007, J ORGANOMET CHEM, V692, P5541, DOI 10.1016/j.jorganchem.2007.08.041; Azuma Y, 2000, J APPL PHYS, V87, P766, DOI 10.1063/1.371938; Hirose Y, 1996, PHYS REV B, V54, P13748, DOI 10.1103/PhysRevB.54.13748; Katz HE, 2000, NATURE, V404, P478, DOI 10.1038/35006603; Nakayama K, 2003, J APPL PHYS, V94, P3216, DOI 10.1063/1.1599052; HIROSE Y, 1994, APPL PHYS LETT, V64, P3482, DOI 10.1063/1.111247; HASHIMOTO K, 1991, B CHEM SOC JPN, V64, P3245, DOI 10.1246/bcsj.64.3245; Palma A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155314; Tachikawa H, 2005, J PHYS CHEM B, V109, P3139, DOI 10.1021/jp046168e; Heimer K, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2722748; BURROUGHES JH, 1988, NATURE, V335, P137, DOI 10.1038/335137a0; Tsunoyama H, 2001, J AM CHEM SOC, V123, P683, DOI 10.1021/ja002155c; Tsunoyama H, 2000, CHEM PHYS LETT, V316, P442, DOI 10.1016/S0009-2614(99)01308-1; Tachikawa H, 2003, J MATER CHEM, V13, P1293, DOI 10.1039/b301913f; Azuma Y, 2002, J APPL PHYS, V91, P5024, DOI 10.1063/1.1457543; Frisch M.J., 2009, AB INITIO MO PROGRAM; Greenham N.C., 1995, SOLID STATE PHYS, V49, P1; Tachikawa H., 2008, THIN SOLID FILMS, V16, P3287; Wu J., 2011, J AM SOC MASS SPECTR, V12, P1229; Wuesten J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125205; Wusten J, 2007, J APPL PHYS, V102, DOI 10.1063/1.2756513	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	OCT	2015	48						141	146		10.1016/j.solidstatesciences.2015.08.002		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CU2IS	WOS:000363347800022		
J	Inomata, M; Kishida, K; Maruyama, Y; Watanabe, T				Inomata, Masayuki; Kishida, Kazuhisa; Maruyama, Yuki; Watanabe, Tomoaki			Synthesis of a new scheelite-type Eu3+-doped Gd2W2O9 red light emitting phosphor by the polymerized complex method	SOLID STATE SCIENCES			English	Article						Gd2W2O9; Red light emitting phosphor; Scheelite; Raman	OXIDE-ION CONDUCTION; LUMINESCENT PROPERTIES; DIFFRACTION REFINEMENT; NEUTRON-DIFFRACTION; RAMAN-SPECTROSCOPY; CRYSTAL STRUCTURE; TUNGSTATE; EU3+; CAWO4; PBWO4	New scheelite-type Gd2W2O9 and (Gd0.8Eu0.2)(2)W2O9 were synthesized by the polymerized complex method at 700 degrees C for 2 h and were characterized by powder X-ray diffraction (XRD) as well as X-ray photoelectron (XPS), Raman, and luminescence spectroscopies. XRD patterns suggested that the samples crystallized in a scheelite-type structure. XPS results confirmed the existence of Gd3+ and W6+ ions in Gd2W2O9. The scheelite-type samples were expected to exhibit WO4 groups by Raman spectroscopy. Scheelite-type (Gd0.8Eu0.2)(2)W2O9 showed red light emission corresponding to the D-5(0)-F-7(2) transition of Eu3+ under blue light excitation. Its fluorescence lifetime was approximately 1.6 times longer than that of the monoclinic polymorph. These optical properties suggest that scheelite-type Gd2W2O9 may be a suitable host material for phosphors. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Inomata, Masayuki; Kishida, Kazuhisa; Maruyama, Yuki; Watanabe, Tomoaki] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Watanabe, T (reprint author), Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, 1-1-1 Higashi Mita, Kawasaki, Kanagawa 2148571, Japan.	tomowata@meiji.ac.jp					Rosa ILV, 2006, MATER RES BULL, V41, P1791, DOI 10.1016/j.materresbull.2006.03.026; Qi ZM, 2001, PHYSICA B, V307, P45, DOI 10.1016/S0921-4526(01)00973-5; Errandonea D, 2009, MATER RES BULL, V44, P807, DOI 10.1016/j.materresbull.2008.09.024; Tsaryuk VI, 2001, SPECTROCHIM ACTA A, V57, P355, DOI 10.1016/S1386-1425(00)00378-4; Balaji D, 2014, J LUMIN, V146, P458, DOI 10.1016/j.jlumin.2013.10.008; Su YG, 2009, J MATER CHEM, V19, P2316, DOI 10.1039/b819287a; Wang Y, 2013, OPT MATER, V35, P998, DOI 10.1016/j.optmat.2012.12.003; Al-Kandari H, 2006, J ELECTRON SPECTROSC, V151, P128, DOI 10.1016/j.elspec.2005.11.007; Kim SW, 2011, CHEM LETT, V40, P498, DOI 10.1246/cl.2011.498; Tomaszewicz E, 2009, J RARE EARTH, V27, P569, DOI 10.1016/S1002-0721(08)60290-2; Basiev TT, 2000, OPT MATER, V15, P205, DOI 10.1016/S0925-3467(00)00037-9; ESAKA T, 1992, SOLID STATE IONICS, V57, P319, DOI 10.1016/0167-2738(92)90165-L; Kishida K, 2014, J PHYS CHEM SOLIDS, V75, P486, DOI 10.1016/j.jpcs.2013.12.003; Shen HB, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.112704; Kakihana M, 2009, J CERAM SOC JPN, V117, P857, DOI 10.2109/jcersj2.117.857; GURMEN E, 1971, J CHEM PHYS, V55, P1093; NASSAU K, 1971, J SOLID STATE CHEM, V3, P411, DOI 10.1016/0022-4596(71)90078-8; Chen Y, 2012, J ALLOY COMPD, V511, P123, DOI 10.1016/j.jallcom.2011.09.004; Yang XM, 2015, SUPERLATTICE MICROST, V80, P188, DOI 10.1016/j.spmi.2015.01.008; ZALKIN A, 1964, J CHEM PHYS, V40, P501, DOI 10.1063/1.1725143; TEMPLETON DH, 1963, ACTA CRYSTALLOGR, V16, P762, DOI 10.1107/S0365110X63001985; Voron'ko YK, 2000, INORG MATER+, V36, P947, DOI 10.1007/BF02758711; Su YG, 2008, CHEM MATER, V20, P6060, DOI 10.1021/cm8014435; Kang FW, 2013, J LUMIN, V135, P113, DOI 10.1016/j.jlumin.2012.10.041; Basiev TT, 1999, OPT MATER, V11, P307, DOI 10.1016/S0925-3467(98)00030-5; Kaczmarek SM, 2010, MATER CHEM PHYS, V124, P646, DOI 10.1016/j.matchemphys.2010.07.028; Kang FW, 2013, MATER SCI ENG B-ADV, V178, P477, DOI 10.1016/j.mseb.2013.01.021; Takai S, 1999, MATER RES BULL, V34, P193, DOI 10.1016/S0025-5408(99)00010-0; Du CF, 2013, J COLLOID INTERF SCI, V394, P94, DOI 10.1016/j.jcis.2012.11.012; Liu Y, 2014, INORG CHEM, V53, P11457, DOI 10.1021/ic501284y; ANTOINE P, 1987, REV INT HAUTES TEMP, V24, P43; Meng QY, 2011, J NANOSCI NANOTECHNO, V11, P182, DOI 10.1166/jnn.2011.3078; Esaka T, 1996, SOLID STATE IONICS, V92, P129, DOI 10.1016/S0167-2738(96)00462-6; RAISER D, 1991, J ELECTRON SPECTROSC, V57, P91, DOI 10.1016/0368-2048(91)85016-M; Lou ZD, 2002, MATER RES BULL, V37, P1573, DOI 10.1016/S0025-5408(02)00851-6; KAY MI, 1964, J CHEM PHYS, V40, P504, DOI 10.1063/1.1725144; Burcham LJ, 1998, SPECTROCHIM ACTA A, V54, P1355; Fomichev V.V., 1978, RUSS J INORG CHEM, V23, P47; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; TREADAWA.MJ, 1974, J CHEM PHYS, V61, P4003, DOI 10.1063/1.1681693	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	OCT	2015	48						251	255		10.1016/j.solidstatesciences.2015.08.003		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CU2IS	WOS:000363347800038		
J	Ishii, K; Suzuki, N; Mabuchi, Y; Ito, N; Kikura, N; Fukada, S; Okano, H; Takeda, S; Akazawa, C				Ishii, Kana; Suzuki, Nobuharu; Mabuchi, Yo; Ito, Naoki; Kikura, Naomi; Fukada, So-ichiro; Okano, Hideyuki; Takeda, Shin'ichi; Akazawa, Chihiro			Muscle Satellite Cell Protein Teneurin-4 Regulates Differentiation During Muscle Regeneration	STEM CELLS			English	Article						Satellite cell; Muscle stem cell; Regeneration; Muscle; Quiescence; Teneurin-4/Odz4	SKELETAL-MUSCLE; PROGENITOR CELLS; SELF-RENEWAL; PAX7; DISTINCT; SPECIFICATION; MAINTENANCE; POPULATION; QUIESCENCE; PROMOTES	Satellite cells are maintained in an undifferentiated quiescent state, but during muscle regeneration they acquire an activated stage, and initiate to proliferate and differentiate as myoblasts. The transmembrane protein teneurin-4 (Ten-4) is specifically expressed in the quiescent satellite cells; however, its cellular and molecular functions remain unknown. We therefore aimed to elucidate the function of Ten-4 in muscle satellite cells. In the tibialis anterior (TA) muscle of Ten-4-deficient mice, the number and the size of myofibers, as well as the population of satellite cells, were reduced with/without induction of muscle regeneration. Furthermore, we found an accelerated activation of satellite cells in the regenerated Ten-4-deficient TA muscle. The cell culture analysis using primary satellite cells showed that Ten-4 suppressed the progression of myogenic differentiation. Together, our findings revealed that Ten-4 functions as a crucial player in maintaining the quiescence of muscle satellite cells.	[Ishii, Kana; Suzuki, Nobuharu; Mabuchi, Yo; Kikura, Naomi; Akazawa, Chihiro] Tokyo Med & Dent Univ, Dept Biochem & Biophys, Grad Sch Hlth Care Sci, Tokyo 1138510, Japan; [Ito, Naoki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 187, Japan; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Akazawa, C (reprint author), Tokyo Med & Dent Univ, Dept Biochem & Biophys, Grad Sch Hlth Care Sci, Bunkyo Ku, 1-5-45 Yushima,Bldg 3, Tokyo 1138510, Japan.	c.akazawa.bb@tmd.ac.jp	Okano, Hideyuki/J-5973-2013; Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan [25505001]; MEXT in Japan [25860701]; Ministry of Health, Labor and Welfare of Japan [2260201]	We thank Dr. Yoshihiko Yamada (NIDCR, NIH, Bethesda, MD) and Dr. Shinsuke Shibata (Keio University, Tokyo, Japan) for providing the furue mouse line and maintaining the line, respectively. We also thank Dr. Hidetoshi Sakurai (CiRA, Kyoto University, Kyoto, Japan) and Dr. Susana de Vega (Juntendo University, Tokyo, Japan) for his advice regarding the experiment and for critical reading the manuscript, respectively. This work was supported by the Grant-in-Aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan (25505001) (C.A., N.S., and Y.M.), the Grant-in-Aid for Young Scientists of the MEXT in Japan (25860701) (N.S.), and the Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan (2260201) (C.A.).	Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Shin J, 2013, INT J BIOCHEM CELL B, V45, P2266, DOI 10.1016/j.biocel.2013.05.001; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Chacon MR, 2011, CELL ADHES MIGR, V5, P52, DOI 10.4161/cam.5.1.13681; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Suzuki N, 2014, FASEB J, V28, P1386, DOI 10.1096/fj.13-241034; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Yamaguchi M, 2012, J MOL HISTOL, V43, P581, DOI 10.1007/s10735-012-9421-3; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Fujimaki S, 2013, STEM CELLS INT, V2013; Kenzelmann-Broz Daniela, 2010, Int J Dev Biol, V54, P1509, DOI 10.1387/ijdb.103139dk; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	OCT	2015	33	10					3017	3027		10.1002/stem.2058		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CU1FD	WOS:000363264500013		
J	Kato, T				Kato, Tsukasa			Frequently Used Coping Scales: A Meta-Analysis	STRESS AND HEALTH			English	Article						COPE; coping behaviour; questionnaire; meta-analysis; ways of coping questionnaire	PRELIMINARY VALIDATION; PAIN PATIENTS; QUESTIONNAIRE; STRATEGIES; INVENTORY; STRESS; COPE; ADJUSTMENT	This article reports the frequency of the use of coping scales in academic journals published from 1998 to 2010. Two thousand empirical journal articles were selected from the EBSCO database. The COPE, Ways of Coping Questionnaire, Coping Strategies Questionnaire, Coping Inventory for Stressful Situations, Religious-COPE and Coping Response Inventory were frequently mentioned. In particular, the COPE (20.2%) and Ways of Coping Questionnaire (13.6%) were used the most frequently. In this literature reviewed, coping scales were most often used to assess coping with health issues (e.g. illness, pain and medical diagnoses) over other types of stressors, and patients were the most frequent participants. Further, alpha coefficients were estimated for the COPE subscales, and correlations between the COPE subscales and coping outcomes were calculated, including depressive symptoms, anxiety, negative affect, psychological distress, physical symptoms and well-being. Copyright (c) 2013 John Wiley & Sons, Ltd.	Toyo Univ, Dept Social Psychol, Bunkyo Ku, Tokyo 1128606, Japan	Kato, T (reprint author), Toyo Univ, Dept Social Psychol, Bunkyo Ku, 5-28-20 Hakusan, Tokyo 1128606, Japan.	mtsukasa@hotmail.com	Kato, Tsukasa/C-2066-2014	Kato, Tsukasa/0000-0002-0827-0051	Amour Science Project in Japan	This research was supported in part by the Amour Science Project in Japan.	Thompson B, 2000, EDUC PSYCHOL MEAS, V60, P174, DOI 10.1177/0013164400602002; STONE AA, 1984, J PERS SOC PSYCHOL, V46, P892, DOI 10.1037//0022-3514.46.4.892; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; LATACK JC, 1986, J APPL PSYCHOL, V71, P377, DOI 10.1037/0021-9010.71.3.377; JALOWIEC A, 1981, NURS RES, V30, P10, DOI 10.1097/00006199-198101000-00003; BENPORATH YS, 1991, J PERS ASSESS, V57, P162; AMIRKHAN JH, 1990, J PERS SOC PSYCHOL, V59, P1066, DOI 10.1037//0022-3514.59.5.1066; MCCUBBIN HI, 1983, J MARRIAGE FAM, V45, P359, DOI 10.2307/351514; Endler NS, 1998, PSYCHOL ASSESSMENT, V10, P195, DOI 10.1037/1040-3590.10.3.195; Lyne K, 2000, PERS INDIV DIFFER, V29, P321, DOI 10.1016/S0191-8869(99)00196-8; JENSEN MP, 1995, PAIN, V60, P203, DOI 10.1016/0304-3959(94)00118-X; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Eisengart SP, 2006, PSYCHOL ASSESSMENT, V18, P278, DOI 10.1037/1040-3590.18.3.278; Litman JA, 2006, PERS INDIV DIFFER, V41, P273, DOI 10.1016/j.paid.2005.11.032; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Ghaderi A, 2000, J NERV MENT DIS, V188, P273, DOI 10.1097/00005053-200005000-00004; Reid GJ, 1998, PAIN, V76, P83, DOI 10.1016/S0304-3959(98)00029-3; Harding R, 2011, PSYCHOL HEALTH MED, V16, P564, DOI 10.1080/13548506.2011.580352; Connor-Smith JK, 2000, J CONSULT CLIN PSYCH, V68, P976, DOI 10.1037/0022-006X.68.6.976; Rexrode KR, 2008, EDUC PSYCHOL MEAS, V68, P262, DOI 10.1177/0013164407310128; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; PARGAMENT KI, 1990, AM J COMMUN PSYCHOL, V18, P793, DOI 10.1007/BF00938065; WATSON M, 1988, PSYCHOL MED, V18, P203; TOBIN DL, 1989, COGNITIVE THER RES, V13, P343, DOI 10.1007/BF01173478; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Carver C. S., 1981, ATTENTION SELF REGUL; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037//0022-3514.56.2.267; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037//0022-3514.58.5.844; Endler N.S., 1990, COPING INVENTORY STR; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; Folkman S., 1988, MANUAL WAYS COPING Q; Folkman S., 1984, STRESS APPRAISAL COP; Frydenberg E., 1993, ADOLESCENT COPING SC; Kraaimaat F. W., 1997, GEDRAGSTHERAPIE, V22, P267; Lazarus R. S., 1999, STRESS EMOTION NEW S; Moos L. H., 1988, COPING RESPONSE INVE; Moos L. H., 1993, COPING RESPONSE INVE; Parker J. D. A., 2000, COPING HLTH INJURIES; PARKER JDA, 1992, EUR J PERSONALITY, V6, P321, DOI 10.1002/per.2410060502; Patterson J. M., 1987, FAMILY ASSESSMENT IN, P225; Schreurs P. J. G., 1984, GEDRAG TIJDSCHRIFT P, V12, P107; Seiffge-Krenke I., 1989, Z DIFFERENTIELLE DIA, V10, P201; Seiffge-Krenke I., 1995, STRESS COPING RELATI	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1532-3005	1532-2998		STRESS HEALTH	Stress Health	OCT	2015	31	4					315	323		10.1002/smi.2557		9	Psychology, Applied; Psychiatry; Psychology	Psychology; Psychiatry	CT8UC	WOS:000363091000008		
J	Miyasaka, K; Mutsuura, M; Miyazaki, K; Okuno, M; Mizu, M; Kawai, T				Miyasaka, Kiyoaki; Mutsuura, Mizuki; Miyazaki, Kohei; Okuno, Masahiro; Mizu, Masami; Kawai, Toshikazu			Difference in taste of Japanese sugars - A taste sensing system and a sensory evaluation method	SUGAR INDUSTRY-ZUCKERINDUSTRIE			English	Editorial Material						sugar; taste; sensory evaluation method; taste model membrane		Japanese traditional cuisine "Washoku" was registered as one of the intangible cultural heritages in December 2013. "Washoku" contains and requires large amount of sugar, therefore, sugar is an important seasoning in taste. Japanese have been using many kinds of sugar such as Granulated sugar, White soft sugar, Brown soft sugar, White crystal sugar and Light brown crystal sugar according to application, for both home cooking and processed foods. Mitsui Sugar is focusing on the difference in taste of sugars to develop new attractive sugar products. With a sensory evaluation method, trained panelists could recognize the difference between these sugars though it is quite difficult to explain. Therefore one attempted to detect the taste difference in these sugars by using a taste sensing system. The system comes with a human taste model membrane and can analyze the density and balance of several tastes such as sweetness, bitterness, umami** and saltiness. The accuracy of the sensing system was evaluated by comparing the results against the sensory evaluation method by trained panelists. The sensing system was able to detect the difference in taste of Japanese sugars, and the results from the sensing system seemed to match with the ones from the sensory evaluation method. The results were plotted on a taste map. This map will be helpful not only in showing the difference between the sugars, but also in explaining the characteristics of the new products.	[Miyasaka, Kiyoaki; Mutsuura, Mizuki; Miyazaki, Kohei; Okuno, Masahiro; Mizu, Masami; Kawai, Toshikazu] Mitsui Sugar Co Ltd, Chou Ku, Tokyo 1038423, Japan	Miyasaka, K (reprint author), Mitsui Sugar Co Ltd, Chou Ku, 36-2 Nihonbashi Hakozakicho, Tokyo 1038423, Japan.	Kiyoaki.Miyasaka@mitsui-sugar.co.jp					Office of Nutrition Cancer Measures and Health Promotion Division Health Service Bureau Ministry of Health Labour and Welfare Japan, 2012, NAT HLTH NUTR SURV J; Yoshikazu Kobayashi, 2010, SENSORS, V10, P3411	2	0	0	VERLAG DR ALBERT BARTENS	BERLIN 38	LUCKHOFFSTRASSE 16, D-14129 BERLIN 38, GERMANY	0344-8657			SUGAR IND	Sugar Ind.	OCT	2015	140	10					624	627				4	Food Science & Technology	Food Science & Technology	CU4JF	WOS:000363493800010		
J	Ogawa, T; Koeda, M; Nitta, K				Ogawa, Tetsuya; Koeda, Misato; Nitta, Kosaku			Left Ventricular Diastolic Dysfunction in End-Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment	THERAPEUTIC APHERESIS AND DIALYSIS			English	Review						Dialysis; Diastolic dysfunction; Doppler echocardiography; End-stage kidney disease; Mortality	LEFT ATRIAL VOLUME; CHRONIC-HEMODIALYSIS PATIENTS; PRESERVED EJECTION FRACTION; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; GROWTH-FACTOR 23; VITAMIN-D; RENAL-DISEASE; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS	Diastolic dysfunction is frequently observed in end-stage kidney disease (ESKD), and ESKD patients have many risk factors for heart failure (HF), including hypertension, diabetes, and coronary artery disease. Diastolic HF, also called HF with preserved ejection fraction, refers to a clinical syndrome in which patients have symptoms and signs of HF, normal or near normal left ventricular (LV) systolic function, and evidence of diastolic dysfunction manifested by abnormal LV filling and elevated filling pressure. Recent reports suggest that HF with preserved ejection fraction is more common in hemodialysis patients than HF with low ejection fraction. Diastolic HF in ESKD patients is a strong predictor of death. In this article, we review the information available in the literature on the pathogenesis, diagnosis, and potential treatment strategies of diastolic dysfunction or diastolic HF based on evidence obtained in the general population that is potentially applicable to ESKD patients.	Tokyo Womens Med Univ, Dept Med, Med Ctr East, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Kidney Ctr, Tokyo 1628666, Japan	Nitta, K (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo 1628666, Japan.	knitta@kc.twmu.ac.jp					Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Sharma R, 2006, J AM SOC ECHOCARDIOG, V19, P266, DOI 10.1016/j.echo.2005.10.006; Jono S, 2000, CIRC RES, V87, pE10; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Saudan P, 2003, NEPHROL DIAL TRANSPL, V18, P2359, DOI 10.1093/ndt/gfg388; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.000017264.66561.3D; Lemmila S, 1998, AM J NEPHROL, V18, P404, DOI 10.1159/000013384; Angomachalelis N, 1996, HEART VESSELS, V11, P303, DOI 10.1007/BF01747189; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; Laviades C, 2000, HYPERTENSION, V36, P517; Cuppari L, 2009, J RENAL NUTR, V19, P38, DOI 10.1053/j.jrn.2008.10.005; Valdivielso JM, 2008, KIDNEY INT, V74, pS44, DOI 10.1038/ki.2008.545; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Barberato SH, 2004, AM J CARDIOL, V94, P1208, DOI 10.1016/j.amjcard.2004.07.100; Drechsler C, 2010, EUR HEART J, V31, P2253, DOI 10.1093/eurheartj/ehq246; MARANTZ PR, 1994, SOUTHERN MED J, V87, P728, DOI 10.1097/00007611-199407000-00011; Yip G, 2002, HEART, V87, P121, DOI 10.1136/heart.87.2.121; Tripepi G, 2006, J HYPERTENS, V24, P1173, DOI 10.1097/01.hjh.0000226208.11184.bb; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Ogata H, 2003, J AM SOC NEPHROL, V14, P959, DOI 10.1097/01.ASN.0000056188.23717.E5; Bucharles S, 2011, NEPHRON CLIN PRACT, V118, pC384, DOI 10.1159/000323664; Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409; Dhingra R, 2010, EUR J HEART FAIL, V12, P812, DOI 10.1093/eurjhf/hfq106; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Fagugli RM, 2006, J NEPHROL, V19, P77; Shizuku J, 2012, INTERNAL MED, V51, P1479, DOI 10.2169/internalmedicine.51.7284; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Parfrey PS, 2009, CLIN J AM SOC NEPHRO, V4, P755, DOI 10.2215/CJN.02730608; Yamamoto K, 2009, CIRC J, V73, P404; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Cottone S, 2007, CLIN NEPHROL, V67, P209; Quiroga B, 2013, BLOOD PURIFICAT, V36, P98, DOI 10.1159/000354080; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Mattioli AV, 2004, INT J CARDIOL, V97, P383, DOI 10.1016/j.ijcard.2003.10.018; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Zoccali C, 2011, AM J NEPHROL, V33, P370, DOI 10.1159/000326239; Ortega O, 2004, NEPHRON CLIN PRACT, V97, pC125, DOI 10.1159/000079170; Ohtake T, 2012, THER APHER DIAL, V16, P181, DOI 10.1111/j.1744-9987.2011.01042.x; Koleganova N, 2009, LAB INVEST, V89, P520, DOI 10.1038/labinvest.2009.7; Tyralla K, 2003, KIDNEY INT, V63, pS80; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; Ferreira-Martins J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/807084; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Sato A, 1999, AM J HYPERTENS, V12, P867, DOI 10.1016/S0895-7061(99)00066-7; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; BONOW RO, 1992, ANN INTERN MED, V117, P502; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Habibi J, 2011, AM J PHYSIOL-HEART C, V300, pH1484, DOI 10.1152/ajpheart.01000.2010; Matias PJ, 2010, CLIN J AM SOC NEPHRO, V5, P905, DOI 10.2215/CJN.06510909; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; Lutsey PL, 2014, AM J CLIN NUTR, V100, P756, DOI 10.3945/ajcn.114.085167; Barberato SH, 2010, ARQ BRAS CARDIOL, V94, P457, DOI 10.1590/S0066-782X2010005000016; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Mitsunami K, 1998, CARDIOVASC DRUG THER, V12, P469, DOI 10.1023/A:1007754100351; Skaluba SJ, 2004, CIRCULATION, V109, P972, DOI 10.1161/01.CIR.0000117405.74491.D2; Barberato SH, 2007, J AM SOC ECHOCARDIOG, V20, P359, DOI 10.1016/j.echo.2006.09.002; Garcia EH, 2006, INT J CARDIOL, V108, P181, DOI 10.1016/j.ijcard.2005.04.026; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Chetow GM, 2010, NEW ENGL J MED, V363, P2287; Komamura K., 2013, CARDIOL RES PRACT, V2013; Rostand SG, 1999, KIDNEY INT, V56, P383, DOI 10.1046/j.1523-1755.1999.00575.x; Vlahakos DV, 1997, J AM SOC NEPHROL, V8, P1764	76	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					427	435		10.1111/1744-9987.12301		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700002		
J	Takura, T; Nakanishi, T; Kawanishi, H; Nitta, K; Akizawa, T; Hiramatsu, M; Kawasaki, T; Kukita, K; Soejima, H; Hirakata, H; Yoshida, T; Miyamoto, T; Takahashi, S				Takura, Tomoyuki; Nakanishi, Takeshi; Kawanishi, Hideki; Nitta, Kosaku; Akizawa, Tadao; Hiramatsu, Makoto; Kawasaki, Tadayuki; Kukita, Kazutaka; Soejima, Hidehisa; Hirakata, Hideki; Yoshida, Toyohiko; Miyamoto, Takashi; Takahashi, Susumu			Cost-Effectiveness of Maintenance Hemodialysis in Japan	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Cost effectiveness analysis; Diabetic nephropathy; Hemodialysis; Incremental cost utility ratio; Quality adjusted life year	MORTALITY; THERAPY	The cost-effectiveness according to primary disease or dialysis duration has never been analyzed with respect to maintenance hemodialysis (MHD). Study candidates were>20 years of age and had received hemodialysis for at least 6 months. Hemodialysis patients were prospectively observed for 36 months, and patient utility was assessed based on the Euro-QOL 5-dimensions (EQ-5D), from which the quality adjusted life years (QALYs) were estimated. Medical costs were calculated based on medical service fees. The cost-effectiveness defined as the incremental cost utility ratio (ICUR) was analyzed from a social perspective. A total of 29 patients (mean age; 59.9 +/- 13.1 years) undergoing 437 dialysis sessions were analyzed. Utility based upon the EQ-5D score was 0.75 +/- 0.21, and the estimated total medical cost for one year of MHD treatment was 4.52 +/- 0.88 US$10000. ICUR was 6.88 +/- 4.47 US$10000/QALY on average, and when comparing ICUR based on the causes of kidney failure, the value for diabetic nephropathy was found to be higher than that for glomerulonephritis (8.17 +/- 6.28 vs. 6.82 +/- 4.07). ICUR after 36 months observation increased mainly in the patients below 65 years of age (All; P<0.05, <65; P<0.01, 65; not significant). MHD is a treatment that could improve the socioeconomic state of elderly patients with end-stage kidney disease (ESKD), but the ICUR for diabetic nephropathy was higher than that for glomerulonephritis.	[Takura, Tomoyuki] Osaka Univ, Grad Sch Med, Dept Hlth Econ & Ind Policy, Suita, Osaka 5650871, Japan; [Nakanishi, Takeshi] Hyogo Coll Med, Div Kidney & Dialysis, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Miyamoto, Takashi] Miyamoto Clin, Kobe, Hyogo, Japan; [Kawanishi, Hideki] Tsuchiya Gen Hosp, Hiroshima, Japan; [Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Div Nephrol, Sch Med, Tokyo, Japan; [Takahashi, Susumu] Int Kidney Evaluat Assoc Japan IKEAJ, Tokyo, Japan; [Hiramatsu, Makoto] Okayama Saiseikai Gen Hosp, Dept Nephrol, Okayama, Japan; [Kawasaki, Tadayuki] Maeda Inst Renal Res, Dept Clin Engn, Chiba, Japan; [Yoshida, Toyohiko] Mihama Hosp, Dept Urol, Chiba, Japan; [Kukita, Kazutaka] Sapporo Hokuyu Hosp, Dept Surg, Sapporo, Hokkaido, Japan; [Soejima, Hidehisa] Saiseikai Kumamoto Hosp, Dept Nephrol, Kumamoto, Japan; [Soejima, Hidehisa] Saiseikai Kumamoto Hosp, Urol Ctr, Kumamoto, Japan; [Hirakata, Hideki] Fukuoka Red Cross Hosp, Dept Nephrol, Fukuoka, Japan	Takura, T (reprint author), Osaka Univ, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takura@heip.med.osaka-u.ac.jp			Osaka University Graduate School of Medicine	This study was self-funded by the Osaka University Graduate School of Medicine.	Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kontodimopoulos N, 2008, HEALTH POLICY, V86, P85, DOI 10.1016/j.healthpol.2007.10.002; Wake N, 2000, DIABETES RES CLIN PR, V48, P201, DOI 10.1016/S0168-8227(00)00122-4; Schweitzer EJ, 2007, AM J TRANSPLANT, V7, P1515, DOI 10.1111/j.1600-6143.2007.01769.x; Takura T, 2013, BLOOD PURIFICAT, V35, P85, DOI 10.1159/000346358; Kiberd BA, 1995, BRIT MED J, V311, P1595; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; MAYNARD A, 1991, ECON J, V101, P1277, DOI 10.2307/2234443; Liem YS, 2003, RADIOLOGY, V226, P53, DOI 10.1148/radiol.2261011893; Black C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14210; Herman WH, 2005, ANN INTERN MED, V142, P323; Fukuda T, 2013, J NATL I PUBLIC HLTH, V62, P590; Takura T, 2009, TRANSPLANTATION, V44, P60	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					441	449		10.1111/1744-9987.12314		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700004		
J	Washida, N; Inoue, S; Kasai, T; Shinozuka, K; Hosoya, K; Morimoto, K; Wakino, S; Hayashi, K; Itoh, H				Washida, Naoki; Inoue, Shuji; Kasai, Takahiro; Shinozuka, Keisuke; Hosoya, Koji; Morimoto, Kohkichi; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi			Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Blood pressure; Darbepoetin alfa; Epoetin beta pegol; Iron utilization	ERYTHROPOIETIN RECEPTOR ACTIVATOR; CHRONIC KIDNEY-DISEASE; STABLE HEMOGLOBIN LEVELS; HEMODIALYSIS-PATIENTS; RENAL ANEMIA; PHASE-II; CERA; CONVERSION; EFFICACY; HEPCIDIN	New erythropoiesis-stimulating agents with a longer half-life have been developed for the treatment of anemia in patients with end-stage renal disease. This study evaluated the efficacy of darbepoetin alfa (DA) and long-acting epoetin beta pegol (continuous erythropoietin receptor activator, CERA) in patients on peritoneal dialysis (PD). Twenty-nine patients who had undergone PD for at least 6 months and were iron replacement-naive and negative for inflammatory parameters were enrolled. Hemoglobin (Hgb) levels and blood pressure were evaluated before and after switching from DA to CERA. Percent transferrin saturation (TSAT), serum ferritin levels and blood pressure were also assessed. Twenty-eight patients were subject to the analysis, excluding one patient with a decrease in Hgb by 10%. Switching from DA to CERA did not alter Hgb levels. The doses of DA and CERA after 12 month treatment of each agent were 118.48 +/- 79.63 and 89.88 +/- 47.50g/4 weeks, respectively (conversion ratio, 1:0.76). The CERA dose administered during the final 6 months was abated, compared with that given during the initial 6 months (P=0.035). The frequency of CERA injection over a 12-month period was less than that of DA (10.0 +/- 3.0 vs. 16.4 +/- 5.0, P<0.01). The conversion from DA to CERA did not alter TSAT, but decreased serum ferritin levels (from 202.69 +/- 132.57 to 150.15 +/- 110.07ng/mL, P=0.012) and systolic blood pressure (from 133.8 +/- 17.3 to 129.5 +/- 11.3mm Hg, P=0.024). In PD patients, lower doses and less frequent injection of CERA are sufficient to maintain Hgb at levels similar to those achieved by DA therapy, with improved iron utilization and reduced blood pressure.	[Washida, Naoki; Kasai, Takahiro; Shinozuka, Keisuke; Morimoto, Kohkichi; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Tokyo 1608582, Japan; [Hosoya, Koji] Saiseikai Cent Hosp, Dept Nephrol, Tokyo, Japan; [Inoue, Shuji] Saitama Med Ctr, Dept Nephrol, Saitama, Japan	Washida, N (reprint author), Keio Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	naoki_washida@yahoo.co.jp			Chugai Pharmaceutical Co., Ltd.; Kyowa-Hakko Kirin Pharmaceutical Co., Ltd.	Naoki Washida, Shuji Inoue, Takahiro Kasai, Keisuke Shinozuka, Koji Hosoya, Kohkichi Morimoto and Shu Wakino declare that they have no conflict of interest. The authors report no conflict of interest in the preparation of this paper. Hiroshi Itoh has received research funding from Chugai Pharmaceutical Co., Ltd. Koichi Hayashi has received consultancy fees from Kyowa-Hakko Kirin Pharmaceutical Co., Ltd.	Sasaki Y, 2014, INT J HEMATOL, V99, P561, DOI 10.1007/s12185-014-1554-6; Hussein AAM, 2012, CAN J PHYSIOL PHARM, V90, P1535, DOI 10.1139/y2012-120; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; Vankar SG, 2014, INDIAN J MED RES, V139, P112; Kubota M, 2011, CLIN EXP NEPHROL, V15, P884, DOI 10.1007/s10157-011-0527-9; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Bradbury BD, 2009, NEPHROL DIAL TRANSPL, V24, P919, DOI 10.1093/ndt/gfn543; Trincavelli ML, 2013, INT J MOL SCI, V14, P2258, DOI 10.3390/ijms14022258; Jonckheere S, 2010, ACTA HAEMATOL-BASEL, V124, P27, DOI 10.1159/000313785; Weinreich T, 2012, HEMODIAL INT, V16, P11, DOI 10.1111/j.1542-4758.2011.00608.x; Levin NW, 2007, LANCET, V370, P1415, DOI 10.1016/S0140-6736(07)61599-2; Besarab A, 2007, CLIN THER, V29, P626, DOI 10.1016/j.clinthera.2007.04.014; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Provenzano R, 2007, CLIN NEPHROL, V67, P306; Gonzalez MT, 2013, RENAL FAILURE, V35, P314, DOI 10.3109/0886022X.2012.755903; Chen CY, 2011, PERITON DIALYSIS INT, V31, P592, DOI 10.3747/PDI.2011.00013; Locatelli F, 2013, J NEPHROL, V26, P1114, DOI 10.5301/jn.5000251; Minutolo R, 2010, BLOOD PURIFICAT, V30, P186, DOI 10.1159/000321486; Galle JC, 2012, NEPHROL DIAL TRANSPL, V27, P2303, DOI 10.1093/ndt/gfr677; Sasaki Y, 2012, INT J HEMATOL, V96, P692, DOI 10.1007/s12185-012-1217-4; Carrera F, 2010, NEPHROL DIAL TRANSPL, V25, P4009, DOI 10.1093/ndt/gfq305; Selby NM, 2012, PERITON DIALYSIS INT, V32, P177, DOI 10.3747/pdi.2010.00299; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Jordan Jessica, 2012, Can J Hosp Pharm, V65, P443; Feriani M, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-13; Kakimoto-Shino M, 2014, THER APHER DIAL, V18, P421, DOI 10.1111/1744-9987.12161; Lo WK, 2008, PERITON DIALYSIS INT, V28, pS76; Morikami Y, 2014, THER APHER DIAL, V18, P414, DOI 10.1111/1744-9987.12164; Suzuki Hiromichi, 2011, Adv Perit Dial, V27, P60	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					450	456		10.1111/1744-9987.12306		7	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700005		
J	Tsubakihara, Y; Akizawa, T; Iwasaki, M; Shimazaki, R				Tsubakihara, Yoshiharu; Akizawa, Tadao; Iwasaki, Manabu; Shimazaki, Ryutaro			High Hemoglobin Levels Maintained by an Erythropoiesis-Stimulating Agent Improve Renal Survival in Patients with Severe Renal Impairment	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Anemia; Chronic kidney disease; Erythropoiesis stimulating agents; Renal function	CHRONIC KIDNEY-DISEASE; ANEMIA; FAILURE; TRIAL; ALPHA	Our goal was to investigate the effect modification of maintaining a high Hb target range through erythropoiesis-stimulating agent therapy on the renal outcome with respect to chronic kidney disease (CKD) stage and concurrent diabetes condition in patients with CKD. We used data from a previously reported randomized controlled trial involving 321 CKD patients not on dialysis, with Hb levels of <10g/dL, and serum creatinine (Cr) of 2.0 to 6.0mg/dL, and in which maintaining Hb levels at 11.0-13.0g/dL with darbepoetin- (High Hb group) resulted in a greater renal protective effect than maintaining Hb levels at 9.0-11.0g/dL with epoetin- (Low Hb group). We conducted a post-hoc analysis of the effects of baseline CKD stage and concurrent diabetic condition on the renal composite endpoint, consisting of death, initiation of renal replacement therapy, and doubling of the serum Cr level. Both groups with stage 4 CKD had a 3-year cumulative renal survival rate of 53.8%, whereas in patients with stage 5 CKD, the rate in the High Hb group (31.0%) was significantly (P=0.012) higher than that in the Low Hb group (19.1%). The observations made in patients with stage 5 CKD were maintained on further analysis of non-diabetic patients, but were not seen in those with diabetes or stage 4 CKD. These results suggest that in patients with stage 5 CKD, especially those without diabetes, achieving a higher target Hb level with erythropoiesis-stimulating agents is associated with a greater renoprotective effect.	[Tsubakihara, Yoshiharu] Osaka Univ, Dept Comprehens Kidney Dis Res, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Nephrol, Tokyo 142, Japan; [Iwasaki, Manabu] Seikei Univ, Fac Sci & Technol, Tokyo, Japan; [Shimazaki, Ryutaro] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan	Tsubakihara, Y (reprint author), Osaka Univ, Dept Comprehens Kidney Dis Res, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	cyq06075@nifty.ne.jp			Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan [121, CRG030600049]	This RCT was sponsored by Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan (Registration of Clinical Trials: The Cochrane Renal Group registry: autoid 121, crg_id CRG030600049).	Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Slinin Y, 2010, CLIN J AM SOC NEPHRO, V5, P1574, DOI 10.2215/CJN.01320210; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Tsubakihara Y, 2012, THER APHER DIAL, V16, P529, DOI 10.1111/j.1744-9987.2012.01082.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Kuriyama S, 1997, NEPHRON, V77, P176; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Akizawa T, 2011, CLIN EXP NEPHROL, V15, P248, DOI 10.1007/s10157-010-0396-7; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Akizawa T, 2011, THER APHER DIAL, V15, P431, DOI 10.1111/j.1744-9987.2011.00931.x	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					457	465		10.1111/1744-9987.12308		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700006		
J	Kamei, K; Sako, M; Ishikawa, T; Sato, M; Ogura, M; Uno, T; Kiyotani, C; Mori, T; Tanaka, H; Ito, S; Nakamura, H				Kamei, Koichi; Sako, Mayumi; Ishikawa, Tomoaki; Sato, Mai; Ogura, Masao; Uno, Teruaki; Kiyotani, Chikako; Mori, Tetsuya; Tanaka, Hideaki; Ito, Shuichi; Nakamura, Hidefumi			Pharmacokinetics of Carboplatin in a One-Year-Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Carboplatin; Hemodialysis; Hepatoblastoma; Infant; Pharmacokinetic analysis	DEPENDENT RENAL-INSUFFICIENCY; CANCER; CHILDREN; PATIENT; FORMULA; ETOPOSIDE	There have been few reports of carboplatin-based chemotherapy for anuric infants. As we had a chance to treat a one-year-old anuric hepatoblastoma patient with carboplatin, we performed a pharmacokinetic analysis and examined the optimal treatment strategy. A one-year-old anuric boy under peritoneal dialysis was diagnosed with hepatoblastoma. Surgical resection was performed, and administration of carboplatin was scheduled postoperatively aiming at 5mg<bold>min</bold>/mL of the area under the curve from the time of dosing to the time of the last observation (AUC(0-t)). We set the initial dose at 50mg, higher than that calculated by the Calvert formula (34mg); the time from the end of carboplatin infusion to the initiation of hemodialysis at 2h; and the hemodialysis duration at 24h. The actual AUC(0-t) was 3.05mg<bold>min</bold>/mL because the elimination half-lives before and during hemodialysis were shorter than expected. The AUC(0-t) after the second dose (100mg) and the third dose (80mg) were 7.00 and 4.68mg<bold>min</bold>/mL, respectively. The Calvert formula is not suitable for hemodialysis patients because removal of platinum by hemodialysis is not taken into account. It appears that extrarenal clearance in anuric infants is different from that in adults. We obtained an optimal AUC(0-t) using a dose of 80mg (200mg/m(2)), setting the time from the end of carboplatin infusion to the initiation of hemodialysis at 2h, and performing 8-h hemodialysis. Further accumulation of the pharmacokinetic data of carboplatin is necessary for anuric children.	[Kamei, Koichi; Ishikawa, Tomoaki; Sato, Mai; Ogura, Masao; Ito, Shuichi] Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Tokyo 1578535, Japan; [Sako, Mayumi; Nakamura, Hidefumi] Natl Ctr Child Hlth & Dev, Div Clin Trials, Dept Dev Strategy, Ctr Social & Clin Res,Natl Res Inst Child Hlth &, Tokyo 1578535, Japan; [Uno, Teruaki; Kiyotani, Chikako; Mori, Tetsuya] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo 1578535, Japan; [Tanaka, Hideaki] Natl Ctr Child Hlth & Dev, Dept Surg, Tokyo 1578535, Japan	Kamei, K (reprint author), Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kamei-k@ncchd.go.jp					Oguri T, 2010, CANCER CHEMOTH PHARM, V66, P813, DOI 10.1007/s00280-010-1366-1; Hiraike M, 2012, CANCER CHEMOTH PHARM, V69, P845, DOI 10.1007/s00280-011-1802-x; ELYAZIGI A, 1995, J CLIN PHARMACOL, V35, P1003; Du Bois D, 1916, ARCH INTERN MED, V17, P863; PENG B, 1995, EUR J CANCER, V31A, P1804, DOI 10.1016/0959-8049(95)00382-S; MOTZER RJ, 1990, CANCER CHEMOTH PHARM, V27, P234, DOI 10.1007/BF00685719; CHATELUT E, 1994, NEPHRON, V66, P157; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; DOZ F, 1990, MED PEDIATR ONCOL, V18, P459, DOI 10.1002/mpo.2950180605; Mann JR, 2000, J CLIN ONCOL, V18, P3809; NEWELL DR, 1993, J CLIN ONCOL, V11, P2314; English MW, 1996, BRIT J CANCER, V73, P776, DOI 10.1038/bjc.1996.135; Go RS, 1999, J CLIN ONCOL, V17, P409	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					491	496		10.1111/1744-9987.12302		6	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700011		
J	Gu, XZ; Itoh, K				Gu, Xiuzhu; Itoh, Kenji			Construct of Dialysis Employee Satisfaction: Acquiring Satisfaction Factors and Their Contributions	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Dialysis; Job satisfaction; Questionnaires; Satisfaction factors; Validity	JOB-SATISFACTION	We developed a construct of dialysis employees' satisfaction as an assessment framework and identified the crucial factors that contribute to overall job satisfaction. We also seek to capture some important characteristics of dialysis professionals' job satisfaction/dissatisfaction in Japan. A questionnaire was developed, including 35 facet-specific job-related satisfaction and 10 general satisfaction items in closed-ended questions. A questionnaire-based survey was conducted between August and October 2013. A total of 799 valid responses (87% of response rate) were collected from 46 physicians, 470 nurses and 251 technologists in the dialysis department of 43 facilities in Japan. Five satisfaction factors were derived by applying principal component analysis with 61% of cumulative variance accounted for. Physicians, nurses and technologists in the dialysis department shared a similar trend of job satisfaction that they were more satisfied with leadership, and communication and teamwork among the five factors, whereas their satisfaction level was relatively low with salary and welfare conditions. Physicians expressed the strongest satisfaction with any factor while nurses were the least satisfied. Nurses' and technologists' overall job satisfaction was mostly determined by satisfaction with self-actualization, and work demands and workload. A five-factor construct of dialysis employee satisfaction was identified. Overall job satisfaction of dialysis nurses and technologists were not overly high in Japan, and this seems to be caused by their relatively low satisfaction with self-actualization and with work demands and workload. Therefore, it is suggested that their work conditions and environment must be improved to support their self-actualization and to reduce their workload.	[Gu, Xiuzhu; Itoh, Kenji] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Ind Engn & Management, Tokyo 152, Japan	Gu, XZ (reprint author), W9-55,2-12-1 Oh Okayama,Meguro Ku, Tokyo 1528552, Japan.	xiuzhu.g.aa@m.titech.ac.jp			Japan Society for the Promotion of Science [23241048]	This work was in part supported by a Grant-in-Aid for Scientific Research (A) (No. 23241048), Japan Society for the Promotion of Science. We would like to acknowledge Takashi Akiba, Professor, MD, Tokyo Women's Medical University and Satoshi Suzuki, Professor, Kanagawa Institute of Technology, for their insightful discussions and comments. We are grateful to dialysis professionals for their participation in our survey and to hospital staff for their assistance in data collection.	Acorn S, 1999, Can Nurse, V95, P33; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; Leigh JP, 2002, ARCH INTERN MED, V162, P1577, DOI 10.1001/archinte.162.14.1577; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Tsang SS, 2012, J NURS RES, V20, P9, DOI 10.1097/JNR.0b013e318247bf11; Brayfield AH, 1951, J APPL PSYCHOL, V35, P307, DOI 10.1037/h0055617; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Shimazu A, 2004, PSYCHOL REP, V94, P449; Labiris G, 2008, J MED SYST, V32, P333, DOI 10.1007/s10916-008-9138-8; JUDGE TA, 1993, J APPL PSYCHOL, V78, P939, DOI 10.1037//0021-9010.78.6.939; Brokalaki H, 2001, EDTNA ERCA J, V27, P181; Hayes B, 2010, REN CARE, V36, P174; Hofstede G., 1984, CULTURES CONSEQUENCE; Judge T. A., 2007, SCI SUBJECTIVE WELL, P393; Krogstad U, 2006, HUM RESOUR HEALTH, V17, P3; Nakahara N, 2004, EDTNA ERCA J, V30, P217; Nunnaly J.C., 1978, PSYCHOMETRIC THEORY; OECD, 2013, HLTH GLANC 2013 OECD; Perumal Seena, 2003, Nephrol Nurs J, V30, P523; Portoghese Igor, 2014, Saf Health Work, V5, P152, DOI 10.1016/j.shaw.2014.05.004; Ross Jamie, 2009, J Ren Care, V35, P127, DOI 10.1111/j.1755-6686.2009.00102.x; Smith P. C., 1969, MEASUREMENT SATISFAC; Spector PE, 1997, JOB SATISFACTION APP; The Japanese Society for Dialysis Therapy, 2013, CURR STAT CHRON DIAL; van Saane N, 2003, OCCUP MED-OXFORD, V53, P191, DOI 10.1093/occmed/kqg038; Weiss DJ, 1967, MANUAL MINNESOTA STA	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					503	512		10.1111/1744-9987.12297		10	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700013		
J	Wada, K; Araki, M; Wada, Y				Wada, Kentaro; Araki, Motoo; Wada, Yuko			Rare but Life-Threatening Complication: Delayed Common Iliac Vein Perforation by Hemodialysis Catheter	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Wada, Kentaro] Nippon Kokan Fukuyama Hosp, Div Nephrol & Dialysis, Dept Internal Med, Hiroshima, Japan; [Araki, Motoo] Cent Hosp, Dept Internal Med, Hiroshima, Japan; [Wada, Yuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan	Wada, K (reprint author), Nippon Kokan Fukuyama Hosp, Div Nephrol & Dialysis, Dept Internal Med, Hiroshima, Japan.	kyw620@hotmail.co.jp					Oliver MJ, 2001, SEMIN DIALYSIS, V14, P432, DOI 10.1046/j.1525-139x.2001.00107.x; Sirvent AE, 2012, HEMODIAL INT, V16, P315, DOI 10.1111/j.1542-4758.2011.00632.x; Kukita K, 2011, J JPN SOC DIAL THER, V44, P855	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					523	524		10.1111/1744-9987.12311		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700017		
J	Kitajima, S; Kaneko, S; Wada, T				Kitajima, Shinji; Kaneko, Shuichi; Wada, Takashi			Septic Pulmonary Embolism Caused by Internal Shunt Infection	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Kitajima, Shinji; Wada, Takashi] Kanazawa Univ, Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Kaneko, Shuichi] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Sch Hlth Sci, Dept Lab Sci, Kanazawa, Ishikawa, Japan	Kitajima, S (reprint author), Kanazawa Univ, Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan.	kitajimajima@ybb.ne.jp					Cook RJ, 2005, CHEST, V128, P162, DOI 10.1378/chest.128.1.162; Schubert Claudia, 2007, Hemodial Int, V11, P379, DOI 10.1111/j.1542-4758.2007.00204.x	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					524	525		10.1111/1744-9987.12309		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700018		
J	Miyazawa, H; Ookawara, S; Tabei, K				Miyazawa, Haruhisa; Ookawara, Susumu; Tabei, Kaoru			Aggravation of Cerebral Oxygenation due to Intradialytic Hypotension Induced by Blood Volume Reduction During Hemodialysis: A Case Report	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Miyazawa, Haruhisa; Ookawara, Susumu; Tabei, Kaoru] Jichi Medial Univ, Saitama Med Ctr, Div Nephrol, Dept Integrated Med 1, Saitama, Japan	Miyazawa, H (reprint author), Jichi Medial Univ, Saitama Med Ctr, Div Nephrol, Dept Integrated Med 1, Saitama, Japan.	su-ooka@hb.tp1.jp					Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Hoshino T, 2014, NEPHRON CLIN PRACT, V126, P57, DOI 10.1159/000358432; Ishida I, 1999, AM J KIDNEY DIS, V34, P1096, DOI 10.1016/S0272-6386(99)70016-8; Aslid R, 1989, STROKE, V20, P45	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					525	527		10.1111/1744-9987.12303		3	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700019		
J	Kumaragurubaran, S; Nagata, T; Tsunekawa, Y; Takahashi, K; Ri, SG; Suzuki, S; Chikyow, T				Kumaragurubaran, Somu; Nagata, Takahiro; Tsunekawa, Yoshifumi; Takahashi, Kenichiro; Ri, Sung-Gi; Suzuki, Setsu; Chikyow, Toyohiro			Epitaxial growth of high dielectric constant lead-free relaxor ferroelectric for high-temperature operational film capacitor	THIN SOLID FILMS			English	Article						Relaxor ferroelectric; High dielectric constant; High-temperature operational capacitor; Pulsed laser deposition	CERAMICS	An epitaxial thin-film capacitor based on relaxor ferroelectric oxide, BaTiO3-Bi(Mg2/3Nb1/3)O-3 ( BT-BMN), has been realized on Nb:SrTiO3 substrates. A high dielectric constant exceeding 400 was attained on high-temperature annealed films at frequencies below 100 kHz. BT-BMN thin-film exhibited a broad dielectric constant variation against temperature and also the frequency dependent dielectric-constant-maximum temperature. Excellent dielectric constant stability below 10% was achieved in 75-400 degrees C temperature range with a low dielectric loss. This exemplifies BT-BMN as a dielectric for monolithically integrated capacitors that can function up to 400 degrees C, breaking the present 175 degrees C limit of bulky capacitors, in high-power high-temperature electronic devices. (C) 2015 Elsevier B.V. All rights reserved.	[Kumaragurubaran, Somu; Nagata, Takahiro; Tsunekawa, Yoshifumi; Takahashi, Kenichiro; Ri, Sung-Gi; Suzuki, Setsu; Chikyow, Toyohiro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Tsunekawa, Yoshifumi; Takahashi, Kenichiro; Ri, Sung-Gi; Suzuki, Setsu] Natl Inst Mat Sci, Comet Inc, Tsukuba, Ibaraki 3050044, Japan	Nagata, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	NAGATA.Takahiro@nims.go.jp			Japan Science and Technology Agency (JST) - Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP) [AS2315002B]; World Premier International Research Center Initiative Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Funding from Japan Science and Technology Agency (JST) - Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP, No. AS2315002B) and World Premier International Research Center Initiative Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, is gratefully acknowledged.	COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Matsunami H, 2006, MICROELECTRON ENG, V83, P2, DOI 10.1016/j.mee.2005.10.012; Griggio F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157604; Szwagierczak D, 2004, J EUR CERAM SOC, V24, P1979, DOI 10.1016/S0955-2219(03)00358-3; Zhao XH, 2008, J AM CERAM SOC, V91, P3031, DOI 10.1111/j.1551-2916.2008.02552.x; Tinberg DS, 2007, J APPL PHYS, V101, DOI 10.1063/1.2430627; Correia TM, 2013, J AM CERAM SOC, V96, P2699, DOI 10.1111/jace.12508; Ohnishi T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146069; Tanaka H, 2012, J APPL PHYS, V111, DOI 10.1063/1.4704384; Kachi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.100210; Shvartsman VV, 2012, J AM CERAM SOC, V95, P1, DOI 10.1111/j.1551-2916.2011.04952.x; Umezawa H, 2012, DIAM RELAT MATER, V24, P201, DOI 10.1016/j.diamond.2012.01.011; Ohnishi T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2921972; Ikeda K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.011202; Kwon DK, 2004, J AM CERAM SOC, V87, P1088; Prosandeev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.247602; Ogihara H, 2009, J AM CERAM SOC, V92, P1719, DOI 10.1111/j.1551-2916.2009.03104.x; MORKOC H, 1994, J APPL PHYS, V76, P1363; Yuan Y, 2010, J ELECTROCERAM, V25, P212, DOI 10.1007/s10832-010-9617-4; Huang CC, 2008, J APPL PHYS, V104, DOI 10.1063/1.2960469; Zhao T, 2000, J APPL PHYS, V87, P7442, DOI 10.1063/1.373007; Buttay C, 2011, MATER SCI ENG B-ADV, V176, P283, DOI 10.1016/j.mseb.2010.10.003; Neudeck PG, 2008, IEEE ELECTR DEVICE L, V29, P456, DOI 10.1109/LED.2008.919787; Kumaragurubaran S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DH02; Malhan R. K., 2012, Patent No. [US 8,194,392, B2, 8194392]; Tyunina M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224102; Wicklein S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754112; Yasui S, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MB04; Zang J., 2014, J EUR CERAM SOC, V34, P37	29	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				29	33		10.1016/j.tsf.2015.09.012		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100005		
J	Tsukamoto, T; Hirose, N; Kasamatsu, A; Mimura, T; Matsui, T; Suda, Y				Tsukamoto, Takahiro; Hirose, Nobumitsu; Kasamatsu, Akifumi; Mimura, Takashi; Matsui, Toshiaki; Suda, Yoshiyuki			Control of surface flatness of Ge layers directly grown on Si (001) substrates by DC sputter epitaxy method	THIN SOLID FILMS			English	Article						Germanium; Sputtering; Crystal growth; Epitaxy	THREADING DISLOCATION DENSITY; DOT ARRAY; HYDROGEN; TEMPERATURE; ROUGHNESS; SI(001); DEPOSITION; QUALITY; FILMS	The formation of Ge layers on Si (001) substrates with 3.5 Omega cm resistivity by the sputter epitaxy method with DC magnetron sputtering has been investigated. The surface morphology of Ge layers grown on Si substrates depends on the sputtering power and the deposited film thickness of Ge. At the initial stage of film deposition, the higher sputtering power yields smaller and more closely packed Ge islands due probably to an increase in the collision rate of the Ge atoms migrating on the Si substrate, which preserves more compressive strains in the films. With the preserved strains, the surface roughening derived from the strain relaxation is reduced. Furthermore, the surface flatness can be improved with the initially smaller islands and additional deposition; this is probably due to the effect of Ge adatom anchoring at concave areas where many bonding sites are available for stable Ge residence. The root-mean-square surface roughness of a 200-nm-thick Ge layer formed at a sputtering power of 100 W is about 0.23 nm. (C) 2015 Elsevier B.V. All rights reserved.	[Tsukamoto, Takahiro; Suda, Yoshiyuki] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan; [Hirose, Nobumitsu; Kasamatsu, Akifumi; Mimura, Takashi; Matsui, Toshiaki] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Tsukamoto, T (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	t-tsuka@cc.tuat.ac.jp	TSUKAMOTO, Takahiro/F-9253-2013		JSPS KAKENHI [25630123, 25820121]	This work was supported by JSPS KAKENHI Grant Numbers 25630123 and 25820121. This work was partly carried out in Advanced ICT Devices Lab in NICT.	Choi D, 2008, J CRYST GROWTH, V310, P4273, DOI 10.1016/j.jcrysgro.2008.07.029; Sun XC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3170870; Kanakaraju S, 2000, PHYS REV B, V61, P8334, DOI 10.1103/PhysRevB.61.8334; Tsukamoto T, 2015, J MATER SCI, V50, P4366, DOI 10.1007/s10853-015-8990-4; GUPTA P, 1988, PHYS REV B, V37, P8234, DOI 10.1103/PhysRevB.37.8234; Yamamoto Y, 2011, SOLID STATE ELECTRON, V60, P2, DOI 10.1016/j.sse.2011.01.032; SAKAI A, 1994, APPL PHYS LETT, V64, P52, DOI 10.1063/1.110919; Suda Y, 2004, THIN SOLID FILMS, V464, P190, DOI 10.1016/j.stf.2004.06.028; Kobayashi S, 2010, THIN SOLID FILMS, V518, pS136, DOI 10.1016/j.tsf.2009.10.072; Sakai A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1943493; Liu JF, 2010, OPT LETT, V35, P679, DOI 10.1364/OL.35.000679; Liao XZ, 1999, PHYS REV B, V60, P15605, DOI 10.1103/PhysRevB.60.15605; Nayfeh A, 2004, APPL PHYS LETT, V85, P2815, DOI 10.1063/1.1802381; Hanafusa H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.024102; Hanafusa H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.055502; Kitayama D, 2006, THIN SOLID FILMS, V508, P203, DOI 10.1016/j.tsf.2005.08.388; Hanafusa H, 2008, JPN J APPL PHYS, V47, P3020, DOI 10.1143/JJAP.47.3020; Tsukamoto T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907863; Shin KW, 2010, THIN SOLID FILMS, V518, P6496, DOI 10.1016/j.tsf.2010.03.148; Kitayama D, 2004, JPN J APPL PHYS 1, V43, P3822, DOI 10.1143/JJAP.43.3822; Olubuyide OO, 2006, THIN SOLID FILMS, V508, P14, DOI 10.1016/j.tsf.2005.06.120; Yoshikawa M, 2012, ECS TRANSACTIONS, V50, P145, DOI 10.1149/05009.0145ecst; Kurdi M.E., 2009, APPL PHYS LETT, V94; Tsukamoto T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826501	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				34	38		10.1016/j.tsf.2015.08.044		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100006		
J	Kamiyama, E; Sueoka, K; Terasawa, K; Yamaha, T; Nakatsuka, O; Zaima, S; Izunome, K; Kashima, K; Uchida, H				Kamiyama, Eiji; Sueoka, Koji; Terasawa, Kengo; Yamaha, Takashi; Nakatsuka, Osamu; Zaima, Shigeaki; Izunome, Koji; Kashima, Kazuhiko; Uchida, Hiroshi			Atom probe tomography study on Ge1-x - ySnxCy hetero-epitaxial film on Ge substrates	THIN SOLID FILMS			English	Article						Atom probe tomography; Ge1- (x -) ySnxCy film; Magnetron sputtering; Zigzag chain; Binding energy	C-INCORPORATION; SOLAR-CELLS	We analyzed the incorporation of C atoms into a ternary alloy Ge1 - x - ySnxCy epitaxial film on Ge substrates on a sub-nanometer scale by using atom probe tomography. Periodic atom distributions from individual (111) atomic planes were observed both in the Ge1 - x - ySnxCy film and at the Ge substrates. Sn/C atoms had non-uniform distributions in the film. They also demonstrated a clear positive correlation in their distributions. Substitutional C atoms were only incorporated into the film when an Sn atom beam was applied onto the substrates under film growth conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Kamiyama, Eiji; Izunome, Koji; Kashima, Kazuhiko] GlobalWafers Japan Corp Ltd, Technol, Niigata 9570197, Japan; [Kamiyama, Eiji; Sueoka, Koji] Okayama Prefectural Univ, Dept Commun Engn, Soja, Okayama 7191197, Japan; [Terasawa, Kengo; Yamaha, Takashi; Nakatsuka, Osamu; Zaima, Shigeaki] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zaima, Shigeaki] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Uchida, Hiroshi] Toshiba Nanoanal Corp, Phys Anal Technol Ctr, Isogo Ku, Yokohama, Kanagawa 2358522, Japan	Kamiyama, E (reprint author), GlobalWafers Japan Corp Ltd, Technol, 6-861-5 Higashiko, Niigata 9570197, Japan.	ejkamiyama@aol.com			Advanced Low Carbon Technology Research and the Development (ALCA) program; Japan Science and Technology (JST) agency in Japan	This work was partially supported by the Advanced Low Carbon Technology Research and the Development (ALCA) program provided by the Japan Science and Technology (JST) agency in Japan.	Seidman DN, 2009, MRS BULL, V34, P717, DOI 10.1557/mrs2009.194; Ronsheim P, 2008, APPL SURF SCI, V255, P1547, DOI 10.1016/j.apsusc.2008.05.247; Shimizu Y, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236673; Okinaka M, 2003, J CRYST GROWTH, V249, P78, DOI 10.1016/S0022-0248(02)02107-3; Chroneos A, 2007, PHYS STATUS SOLIDI B, V244, P3206, DOI 10.1002/pssb.200642622; Kumar A, 2013, ULTRAMICROSCOPY, V132, P171, DOI 10.1016/j.ultramic.2013.02.009; Koelling S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3243461; Matsutani R, 2014, PHYS STATUS SOLIDI C, V11, P1718, DOI 10.1002/pssc.201400029; Cadel E, 2009, J APPL PHYS, V106, DOI 10.1063/1.3186617; Suwa R, 2014, PHYS STATUS SOLIDI B, V251, P2221, DOI 10.1002/pssb.201400030; Fang Q., 2010, P AUSTR SOL EN SOC 4; Gall D, 2000, PHYS REV B, V62, pR7723, DOI 10.1103/PhysRevB.62.R7723; Gault B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194089; Gault B, 2010, J APPL PHYS, V108, DOI 10.1063/1.3462399; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Terasawa K., 2014, 7 INT SIGE TECHN DEV, P179	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				54	58		10.1016/j.tsf.2015.09.002		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100008		
J	Sari, H; Sakakura, H; Kawade, D; Itagaki, M; Sugiyama, M				Sari, Huseyin; Sakakura, Hidenori; Kawade, Daisuke; Itagaki, Masayuki; Sugiyama, Mutsumi			Quantification of sputtering damage during NiO film deposition on a Si/SiO2 substrate using electrochemical impedance spectroscopy	THIN SOLID FILMS			English	Article						Nickel oxide; Impedance spectroscopy; Constant phase element; Sputtering damage; Solar cells	OPTICAL-PROPERTIES; SOLAR-CELL; ADMITTANCE; ABSORPTION; DISPERSION; INTERFACE	Sputtering damage during NiO deposition on SiO2 coated Si+ substrate is investigated using an electrochemical impedance spectroscopy. The degree of sputtering damage for samples located at different positions relative to the sputtering source is evaluated by proposing an equivalent circuit that includes a constant phase element (CPE) to represent the area around the SiO2/NiO interface. By fitting the impedance data, CPE-T and CPE-p index parameters (which are related to the interface uniformity and quality) are obtained. Using these parameters, the capacitance and time constants of the SiO2 layer and the SiO2/NiO interface are estimated. By comparing the CPE-p index values, it is concluded that the sample that is closer to the sputtering target is exposed to more damage than samples located at greater distances during the deposition process. This result is significant because it may help to reduce growth-related defects and improve the quality of NiO films grown using the sputtering technique. (C) 2015 Elsevier B.V. All rights reserved.	[Sari, Huseyin] Ankara Univ, Fac Engn, Dept Engn Phys, TR-06100 Ankara, Turkey; [Sakakura, Hidenori; Kawade, Daisuke; Sugiyama, Mutsumi] Tokyo Univ Sci, Dept Elect Engn, Fac Sci & Technol, Noda, Chiba 2788510, Japan; [Itagaki, Masayuki] Tokyo Univ Sci, Dept Pure & Appl Chem, Fac Sci & Technol, Noda, Chiba 2788510, Japan	Sari, H (reprint author), Ankara Univ, Fac Engn, Dept Engn Phys, TR-06100 Ankara, Turkey.	hsari@eng.ankara.edu.tr			Turkish Council of Higher Education (YOK); Sasakawa Scientific Research Grant from The Japan Science Society; Kurata Memorial Hitachi Science and Technology Foundation; Network Joint Research Center for Materials and Devices; Research Center for Green and Safety Sciences; Photovoltaic Science and Technology Research Division, Research Institute for Science and Technology under Tokyo University of Science	Author H. Sari would like to thank to the Turkish Council of Higher Education (YOK) for the financial support during his research visit in Japan. The authors thank Prof. S. F. Chichibu, Tohoku University and Prof. Y. Watanabe, Tokyo University of Science Suwa for their stimulationg discussions. In addition, the authors thank H. Nakai, A. Ogasawara, R. Maeda, R. Sakai, and K. Moriyama for their assistance in conducting the experiments. This work was supported in part by the Sasakawa Scientific Research Grant from The Japan Science Society, the Kurata Memorial Hitachi Science and Technology Foundation, the Network Joint Research Center for Materials and Devices, the Research Center for Green and Safety Sciences, and the Photovoltaic Science and Technology Research Division, Research Institute for Science and Technology under Tokyo University of Science.	Adler D, 1970, PHYS REV B-SOLID ST, V2, P3112, DOI 10.1103/PhysRevB.2.3112; SPEAR WE, 1973, PHYS REV B, V7, P831, DOI 10.1103/PhysRevB.7.831; Ai L, 2008, APPL SURF SCI, V254, P2401, DOI 10.1016/j.apsusc.2007.09.051; SCOFIELD JH, 1995, SOL ENERG MAT SOL C, V37, P217, DOI 10.1016/0927-0248(95)00016-X; Warasawa M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.021102; MANGHI F, 1994, PHYS REV LETT, V73, P3129, DOI 10.1103/PhysRevLett.73.3129; SATO H, 1993, THIN SOLID FILMS, V236, P27, DOI 10.1016/0040-6090(93)90636-4; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Jiang J, 2013, PHYS CHEM CHEM PHYS, V15, P6875, DOI 10.1039/c3cp50197c; Itagaki M, 2011, ELECTROCHIM ACTA, V56, P7975, DOI 10.1016/j.electacta.2011.01.087; Xi YY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898505; Lu YM, 2002, THIN SOLID FILMS, V420, P54, DOI 10.1016/S0040-6090(02)00654-5; Ohta H, 2003, THIN SOLID FILMS, V445, P317, DOI 10.1016/S0040-6090(03)01178-7; Sugiyama M, 2013, THIN SOLID FILMS, V535, P287, DOI 10.1016/j.tsf.2012.11.070; Bayhan H, 2006, SOL ENERGY, V80, P1160, DOI 10.1016/j.solener.2005.09.004; Rhee JH, 2009, CHEM PHYS LETT, V477, P345, DOI 10.1016/j.cplett.2009.07.014; Loef R, 2008, SOL ENERG MAT SOL C, V92, P1579, DOI 10.1016/j.solmat.2008.07.005; Cole KS, 1942, J CHEM PHYS, V10, P98, DOI 10.1063/1.1723677; Kobayashi T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.126602; Loef R, 2007, J APPL PHYS, V102, DOI 10.1063/1.2759470; Nomura K., 2004, NATURE, V432, P48892; Reislohner U, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730379; Tsai WC, 2009, PROC SPIE, V7356, DOI 10.1117/12.820546	23	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				150	154		10.1016/j.tsf.2015.09.017		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100022		
J	Ma, JS; Fukuda, D				Ma, Jiangshan; Fukuda, Daisuke			A hyperpath-based network generalized extreme-value model for route choice under uncertainties	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Hyperpath; Network GEV model; Route choice; Uncertainties	EQUILIBRIUM TRAFFIC ASSIGNMENT; VEHICLE NAVIGATION; TRANSIT NETWORKS; LOGIT MODEL; ALGORITHM; ENUMERATION; PATHS; TRANSPORTATION; ALTERNATIVES; HYPERSTAR	Previous route choice studies treated uncertainties as randomness; however, it is argued that other uncertainties exist beyond random effects. As a general modeling framework for route choice under uncertainties, this paper presents a model of route choice that incorporates hyperpath and network generalized extreme-value-based link choice models. Accounting for the travel time uncertainty, numerical studies of specified models within the proposed framework are conducted. The modeling framework may be helpful in various research contexts dealing with both randomness and other non-probabilistic uncertainties that cannot be exactly perceived. (C) 2015 Elsevier Ltd. All rights reserved.	[Ma, Jiangshan] Shanghai Maritime Univ, Shanghai 201306, Peoples R China; [Ma, Jiangshan; Fukuda, Daisuke] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Ma, JS (reprint author), Shanghai Maritime Univ, 1550 Harbour Rd, Shanghai 201306, Peoples R China.	tonny.achilles@gmail.com					Akamatsu T, 1996, TRANSPORT RES B-METH, V30, P369, DOI 10.1016/0191-2615(96)00003-3; Bell MGH, 2012, TRANSPORT RES A-POL, V46, P790, DOI 10.1016/j.tra.2012.02.002; Chorus CG, 2012, TRANSPORTMETRICA, V8, P291, DOI 10.1080/18128602.2010.498391; Miller-Hooks E, 2001, NETWORKS, V37, P35, DOI 10.1002/1097-0037(200101)37:1<35::AID-NET4>3.0.CO;2-G; Papola A, 2013, COMPUT-AIDED CIV INF, V28, P560, DOI 10.1111/mice.12007; Fonzone A, 2012, TRANSPORT RES REC, P119, DOI 10.3141/2322-13; Fosgerau M, 2013, TRANSPORT RES B-METH, V56, P70, DOI 10.1016/j.trb.2013.07.012; Nguyen S, 1998, TRANSPORT SCI, V32, P54, DOI 10.1287/trsc.32.1.54; Dial RB, 2006, TRANSPORT RES B-METH, V40, P917, DOI 10.1016/j.trb.2006.02.008; de Palma A, 2005, TRANSPORT RES A-POL, V39, P295, DOI 10.1016/j.tra.2004.10.001; Daly A, 2006, TRANSPORT RES B-METH, V40, P285, DOI 10.1016/j.trb.2005.03.003; Bell MGH, 1995, TRANSPORT RES B-METH, V29, P287, DOI 10.1016/0191-2615(95)00005-X; Cascetta E, 2001, TRANSPORT RES C-EMER, V9, P249, DOI 10.1016/S0968-090X(00)00036-X; Yai T, 1997, TRANSPORT RES B-METH, V31, P195, DOI 10.1016/S0191-2615(96)00025-2; Razo M, 2013, TRANSPORT RES C-EMER, V27, P117, DOI 10.1016/j.trc.2011.08.009; Ma JS, 2013, TRANSPORTMETRICA A, V9, P925, DOI 10.1080/18128602.2012.719165; Schmocker JD, 2013, TRANSPORT RES C-EMER, V36, P406, DOI 10.1016/j.trc.2013.06.014; Gao S, 2006, TRANSPORT RES B-METH, V40, P93, DOI 10.1016/j.trb.2005.02.001; Bar-Gera H, 2002, TRANSPORT SCI, V36, P398, DOI 10.1287/trsc.36.4.398.549; Bell MGH, 2009, TRANSPORT RES B-METH, V43, P97, DOI 10.1016/j.trb.2008.05.010; Eppstein D, 1998, SIAM J COMPUT, V28, P652, DOI 10.1137/S0097539795290477; Bovy P, 2009, TRANSPORT REV, V29, P43, DOI 10.1080/01441640802078673; Vovsha P, 1998, TRANSPORT RES REC, P133; Levinson D, 2013, TRANSPORT RES C-EMER, V35, P232, DOI 10.1016/j.trc.2013.03.001; Ben Akiva M., 1985, DISCRETE CHOICE ANAL; Ben-Akiva M., 1984, P 9 INT S TRANSP TRA, P299; Ben-Akiva M., 1999, HDB TRANSPORTATION S, P5; Bierlaire M., 2002, P 2 SWISS TRANSP RES; Chriqui C., 1975, Transportation Science, V9, DOI 10.1287/trsc.9.2.115; Daganzo C. F., 1977, Transportation Science, V11, DOI 10.1287/trsc.11.3.253; DIAL RB, 1971, TRANSPORT RES, V5, P83, DOI 10.1016/0041-1647(71)90012-8; Florian M., 2012, EURO J TRANSPORT LOG, V1, P28; Flotterod G, 2013, TRANSPORT RES B-METH, V48, P53, DOI 10.1016/j.trb.2012.11.002; Freginger E., 2009, TRANSPORT RES B-METH, V43, P984; Freginger E., 2007, TRANSPORT RES B-METH, V41, P363; Hare Y., 2012, JSCE P INFRASTRUCT P, V46; Marcotte P, 1998, EQUILIBRIUM AND ADVANCED TRANSPORTATION MODELLING, P175; McFadden D., 1978, SPATIAL INTERACTION, P75; NGUYEN S, 1988, EUR J OPER RES, V37, P176, DOI 10.1016/0377-2217(88)90327-X; Nguyen Sang, 1989, LECT NOTES MATH, V1403, P258; Prato C.G., 2009, J CHOICE MODEL, V2, P65, DOI DOI 10.1016/S1755-5345(13)70005-8; Puterman ML, 2005, MARKOV DECISION PROC; SPIESS H, 1989, TRANSPORT RES B-METH, V23, P83, DOI 10.1016/0191-2615(89)90034-9; Yang JF, 2014, TRANSPORT RES C-EMER, V47, P168, DOI 10.1016/j.trc.2014.06.009	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		19	31		10.1016/j.trc.2015.05.015		13	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800003		
J	Fonzone, A; Schmocker, JD; Liu, RH				Fonzone, Achille; Schmoecker, Jan-Dirk; Liu, Ronghui			A model of bus bunching under reliability-based passenger arrival patterns	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Bus bunching; Passenger arrival process; Service reliability	REAL-TIME INFORMATION; SCHEDULE RELIABILITY; CONTROL STRATEGIES; TRANSIT NETWORKS; HOLDING PROBLEM; SIMULATION; ROUTE; CHOICE; STOPS	If bus service departure times are not completely unknown to the passengers, non-uniform passenger arrival patterns can be expected. We propose that passengers decide their arrival time at stops based on a continuous logit model that considers the risk of missing services. Expected passenger waiting times are derived in a bus system that allows also for overtaking between bus services. We then propose an algorithm to derive the dwell time of subsequent buses serving a stop in order to illustrate when bus bunching might occur. We show that non-uniform arrival patterns can significantly influence the bus bunching process. With case studies we find that, even without exogenous delay, bunching can arise when the boarding rate is insufficient given the level of overall demand. Further, in case of exogenous delay, non-uniform arrivals can either worsen or improve the bunching conditions, depending on the level of delay. We conclude that therefore such effects should be considered when service control measures are discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Fonzone, Achille] Edinburgh Napier Univ, Transport Res Inst, Edinburgh, Midlothian, Scotland; [Schmoecker, Jan-Dirk] Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan; [Liu, Ronghui] Univ Leeds, Inst Transport Studies, Leeds LS2 9JT, W Yorkshire, England	Fonzone, A (reprint author), Edinburgh Napier Univ, Transport Res Inst, Edinburgh, Midlothian, Scotland.	a.fonzone@napier.ac.uk					Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P267, DOI 10.1016/j.trb.2010.06.005; Nesheli MM, 2014, TRANSPORT RES C-EMER, V48, P491, DOI 10.1016/j.trc.2014.09.013; Eberlein XJ, 2001, TRANSPORT SCI, V35, P1, DOI 10.1287/trsc.35.1.1.10143; Hadas Y, 2010, TRANSPORT RES C-EMER, V18, P879, DOI 10.1016/j.trc.2010.04.002; Munoz JC, 2013, TRANSPORT RES C-EMER, V28, P101, DOI 10.1016/j.trc.2012.12.010; Hickman MD, 2001, TRANSPORT SCI, V35, P215, DOI 10.1287/trsc.35.3.215.10150; Nagatani T, 2001, PHYSICA A, V296, P320, DOI 10.1016/S0378-4371(01)00151-0; Hollander Y, 2008, TRANSPORT RES C-EMER, V16, P212, DOI 10.1016/j.trc.2007.07.005; Pelletier MP, 2011, TRANSPORT RES C-EMER, V19, P557, DOI 10.1016/j.trc.2010.12.003; Schmocker JD, 2013, TRANSPORT RES C-EMER, V36, P406, DOI 10.1016/j.trc.2013.06.014; Xuan YG, 2011, TRANSPORT RES B-METH, V45, P1831, DOI 10.1016/j.trb.2011.07.009; Gentile G, 2005, TRANSPORT SCI, V39, P289, DOI 10.1287/trsc.1040.0109; Watkins KE, 2011, TRANSPORT RES A-POL, V45, P839, DOI 10.1016/j.tra.2011.06.010; Liu ZY, 2013, TRANSPORT RES C-EMER, V35, P46, DOI 10.1016/j.trc.2013.06.004; Daganzo CF, 2009, TRANSPORT RES B-METH, V43, P913, DOI 10.1016/j.trb.2009.04.002; Sorratini JA, 2008, TRANSPORT PLAN TECHN, V31, P303, DOI 10.1080/03081060802086512; QUARMBY DA, 1967, J TRANSP ECON POLICY, V1, P273; Meng Q, 2013, TRANSPORT RES C-EMER, V36, P61, DOI 10.1016/j.trc.2013.08.007; Bartholdi JJ, 2012, TRANSPORT RES B-METH, V46, P481, DOI 10.1016/j.trb.2011.11.001; BOWMAN LA, 1981, TRANSPORT RES A-POL, V15, P465, DOI 10.1016/0191-2607(81)90114-X; Boyd C.W., 1987, TRANSPORT RES A-POL, V17, P347; Cats O, 2011, TRANSPORT RES REC, P51, DOI 10.3141/2216-06; Crout D.T., 2007, TRANSP RES BOARD 86; Hollander Y., 2007, P EUR TRANSP C LEID; Khoo H.L., 2013, P E ASIA SOC TRANSPO, V9; Lamp J.D., 2010, TRANSPORT RES B-METH, V44, P646; Larson R., 1981, URBAN OPERATIONS RES; Liu R., 2007, P INT S TRANSP NETW; Luethi M., 2007, TRANSP RES BOARD 86; Newell G. F., 1974, Transportation Science, V8, DOI 10.1287/trsc.8.3.248; Newell G.F., 1964, P 2 AUSTR ROAD RES B, V2, P388; Noekel K., 2009, TRANSP RES REC; Osuna E. E., 1972, Transportation Science, V6, DOI 10.1287/trsc.6.1.52; Pilachowski J.M., 2009, THESIS U CALIFORNIA; Schmocker J-D., 2015, 6 INT S TRANSP NETW; SPIESS H, 1989, TRANSPORT RES B-METH, V23, P83, DOI 10.1016/0191-2615(89)90034-9	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		164	182		10.1016/j.trc.2015.05.020		19	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800011		
J	Shiomi, Y; Taniguchi, T; Uno, N; Shimamoto, H; Nakamura, T				Shiomi, Yasuhiro; Taniguchi, Tomoki; Uno, Nobuhiro; Shimamoto, Hiroshi; Nakamura, Toshiyuki			Multilane first-order traffic flow model with endogenous representation of lane-flow equilibrium	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Multilane traffic flow; Lane flow distribution; LWR model; IT principle; Parameter calibration	BEHAVIORAL-THEORY; 2-LANE	In this study, we develop a multilane first-order traffic flow model for freeway networks. In the model, lane changing is considered as a stochastic behavior that can decrease an individual driver's disutility or cost, and is represented as dynamics toward the equilibrium of lane-flow distribution along with longitudinal traffic dynamics. The proposed method can be differentiated from those in previous studies because in this study, the motivation of lane changing is explicitly considered and it is treated as a utility defined by the current macroscopic traffic state. In addition, the entire process of lane changing is computed macroscopically by an extension of the kinematic wave theory employing IT principle; moreover, in the model framework, the lane-flow equilibrium curve is endogenously generated because of self-motivated lane changes. Furthermore, the parsimonious representation enables parameter calibration using the data collected from conventional loop detectors. The calibration of the data collected at four different sites, including a sag bottleneck, on the Chugoku expressway in Japan reveals that the proposed method can represent the lane-flow distribution of any observation site with high accuracy, and that the estimated parameters can reasonably explain the multilane traffic dynamics and the bottleneck phenomena uphill of sag sections. (C) 2015 Elsevier Ltd. All rights reserved.	[Shiomi, Yasuhiro] Ritsumeikan Univ, Kusatsu 5258577, Japan; [Taniguchi, Tomoki; Nakamura, Toshiyuki] Kyoto Univ, Grad Sch Engn, Katsura 6158530, Japan; [Uno, Nobuhiro] Kyoto Univ, Grad Sch Management, Kyoto 6068501, Japan; [Shimamoto, Hiroshi] Miyazaki Univ, Miyazaki 8892192, Japan	Shiomi, Y (reprint author), Ritsumeikan Univ, 1-1-1 Nojihigashi, Kusatsu 5258577, Japan.	shiomi@fc.ritsumei.ac.jp					Jin WL, 2010, TRANSPORT RES B-METH, V44, P1001, DOI 10.1016/j.trb.2009.12.014; Duret A, 2012, TRANSPORT RES C-EMER, V24, P157, DOI 10.1016/j.trc.2012.02.009; van Lint JWC, 2008, TRANSPORT RES REC, P177, DOI 10.3141/2088-19; Tang TQ, 2009, J ADV TRANSPORT, V43, P245; Shvetsov V, 1999, PHYS REV E, V59, P6328, DOI 10.1103/PhysRevE.59.6328; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; MUNJAL PK, 1971, TRANSPORT RES, V5, P241, DOI 10.1016/0041-1647(71)90036-0; Knoop VL, 2012, TRANSPORT RES REC, P31, DOI 10.3141/2278-04; Daganzo CF, 2002, TRANSPORT RES B-METH, V36, P159, DOI 10.1016/S0191-2615(00)00043-6; Patire AD, 2011, TRANSPORT RES B-METH, V45, P656, DOI 10.1016/j.trb.2011.01.003; Jin WL, 2013, TRANSPORT RES B-METH, V57, P361, DOI 10.1016/j.trb.2013.06.002; Laval JA, 2006, TRANSPORT RES B-METH, V40, P251, DOI 10.1016/j.trb.2005.04.003; Wang YB, 2005, TRANSPORT RES B-METH, V39, P141, DOI 10.1016/j.trb.2004.03.003; Daganzo CF, 2002, TRANSPORT RES B-METH, V36, P131, DOI 10.1016/S0191-2615(00)00042-4; Farhi N., 2013, TRB 92 ANN M; GIPPS PG, 1986, TRANSPORT RES B-METH, V20, P403, DOI 10.1016/0191-2615(86)90012-3; Hong S., 2010, SEISAN KENKYU, V62, P158; Hoogendoom S.P., 2001, NETW SPAT ECON, V1, P137, DOI 10.1023/A:1011533228599; Kits H., 1999, TRANSPORT RES A-POL, V33, P305; Knoop V.L., 2010, P 13 INT IEEE C INT, P485; Okaue M., 2011, J JPN SOC CIV ENG, V67; Salvucci Dario D., 2002, TRANSPORT RES F-TRAF, P123, DOI DOI 10.1016/S1369-8478(02)00011-6; Sheffi Y., 1984, URBAN TRANSPORTATION; Shiomi Y., 2013, TRB 92 ANN M; Toledo T, 2009, TRANSPORT RES C-EMER, V17, P365, DOI 10.1016/j.trc.2009.01.005; Webster N.A., 2007, SEISAN KENKYU, V59, P42; Wu N., 2006, TRANSPORT RES REC, V1965, P48, DOI 10.3141/1965-06; Xing J., 2014, INT J INTELL TRANSP, V12, P26	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		198	215		10.1016/j.trc.2015.07.002		18	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800013		
J	Kusakabe, T; Nakano, Y				Kusakabe, Takahiko; Nakano, Yuta			Information provision strategies eliminating deluded equilibrium caused by travellers' misperception	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Deluded equilibrium; Bounded rational choice; Advanced travel information systems; Dynamic assignment	TIME INFORMATION; STOCHASTIC EQUILIBRIUM; TRAFFIC ASSIGNMENT; BEHAVIOR; SYSTEMS; MODEL; STABILITY; NETWORKS; UNCERTAINTY; PERCEPTION	Providing travel time information may be effective at reducing travel costs. However, this information does not always match the actual travel time that travellers will experience. Furthermore, the information is often asymmetrically provided within the network, owing to the limitations of observation devices, prediction model calibration, and uncertainty about road conditions. The purpose of this study is to investigate the effects of predictive travel time information that is asymmetrically provided to travellers. This study formulated a dynamic traffic assignment model in origin-destination (OD) pair with two parallel routes, while considering travellers' learning processes and within-day and day-to-day dynamics. In this study: it is assumed that different information will be provided to each traveller, according to within-day traffic dynamics. Furthermore, the information is provided for only one of two possible routes, because of observation limitations. The effects of information accuracy are also discussed in this study. The results of numerical analysis indicated that information provisions possibly reduced the negative effects of deluded equilibrium state, even when the information was only provided for one of the routes. Different effects of the travel time information and its variation were illustrated according to the allocation of the bottleneck capacities of two routes. (C) 2015 Elsevier Ltd. All rights reserved.	[Kusakabe, Takahiko; Nakano, Yuta] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Kusakabe, T (reprint author), Tokyo Inst Technol, Meguro Ku, 2-12-1-M1-20 O Okayama, Tokyo 1528552, Japan.	t.kusakabe@plan.cv.titech.ac.jp	Kusakabe, Takahiko/C-1893-2015	Kusakabe, Takahiko/0000-0003-3019-5243			Avineri E, 2006, TRANSPORTATION, V33, P393, DOI 10.1007/s11116-005-5710-y; Hato E, 1999, TRANSPORT RES C-EMER, V7, P109, DOI 10.1016/S0968-090X(99)00015-7; Watling D, 1999, TRANSPORT RES B-METH, V33, P281, DOI 10.1016/S0191-2615(98)00033-2; Mahmassani HS, 1999, TRANSPORT RES C-EMER, V7, P91, DOI 10.1016/S0968-090X(99)00014-5; Ettema D, 2006, TRANSPORT RES C-EMER, V14, P335, DOI 10.1016/j.trc.2006.09.001; Jha M, 1998, TRANSPORT RES C-EMER, V6, P189, DOI 10.1016/S0968-090X(98)00015-1; Wu JJ, 2013, TRANSPORT RES C-EMER, V31, P73, DOI 10.1016/j.trc.2013.01.010; FRIESZ TL, 1994, OPER RES, V42, P1120, DOI 10.1287/opre.42.6.1120; Guo XL, 2011, TRANSPORT RES B-METH, V45, P1606, DOI 10.1016/j.trb.2011.05.026; Bie J, 2010, TRANSPORT RES B-METH, V44, P90, DOI 10.1016/j.trb.2009.06.007; Peeta S, 2006, TRANSPORT RES C-EMER, V14, P114, DOI 10.1016/j.trc.2006.05.008; MAHMASSANI HS, 1987, TRANSPORT SCI, V21, P89, DOI 10.1287/trsc.21.2.89; Chen R., 2009, EXPANDING SPHERE TRA, P791; Chen R, 2004, TRANSPORT RES REC, P209; Chorus C.G., 2006, 85 ANN M TRANSP RES; Dia H, 2002, TRANSPORT RES C-EMER, V10, P331, DOI 10.1016/S0968-090X(02)00025-6; EMMERINK RHM, 1995, TRANSPORTATION, V22, P21, DOI 10.1007/BF01151617; HOROWITZ JL, 1984, TRANSPORT RES B-METH, V18, P13, DOI 10.1016/0191-2615(84)90003-1; Khattak A., 1996, TRANSPORT RES REC, V1537, P46, DOI DOI 10.3141/1537-07; lida Y., 1994, P VEH NAV INF SYST C, P377, DOI 10.1109/VNIS.1994.396810; Nakayama S., 1999, TRANSPORT RES REC, V1676, P30, DOI DOI 10.3141/1676-04; SMITH MJ, 1984, TRANSPORT SCI, V18, P245, DOI 10.1287/trsc.18.3.245	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		278	291		10.1016/j.trc.2015.05.018		14	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800018		
J	Seo, T; Kusakabe, T				Seo, Toru; Kusakabe, Takahiko			Probe vehicle-based traffic state estimation method with spacing information and conservation law	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Probe vehicle; Traffic flow; Traffic state estimation; Conservation law; Spacing measurement; Advanced driver assistance system	FREEWAY; WAVES; FLOW	This paper proposes a method of estimating a traffic state based on probe vehicle data that contain spacing and position of probe vehicles. The probe vehicles were assumed to observe spacing by utilizing an advanced driver assistance system, that has been implemented in practice and is expected to spread in the near future. The proposed method relies on the conservation law of the traffic flow but is independent of a fundamental diagram. The conservation law is utilized for reasonable aggregation of the spacing data to acquire the traffic state, i.e., a flow, density and speed. Its independence from a fundamental diagram means that the proposed method does not require predetermined nor exogenous assumptions with regard to the traffic flow model parameters. The proposed method was validated through a simulation experiment under ideal conditions and a field experiment conducted under actual traffic conditions; and empirical characteristics of the proposed method were investigated. (C) 2015 Elsevier Ltd. All rights reserved.	[Seo, Toru; Kusakabe, Takahiko] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan	Seo, T (reprint author), Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, 2-12-1-M1-20 O Okayama, Tokyo 1528552, Japan.	t.seo@plan.cv.titech.ac.jp	Kusakabe, Takahiko/C-1893-2015	Kusakabe, Takahiko/0000-0003-3019-5243			Daganzo CF, 2008, TRANSPORT RES B-METH, V42, P771, DOI 10.1016/j.trb.2008.06.008; Laval JA, 2013, TRANSPORT RES B-METH, V52, P17, DOI 10.1016/j.trb.2013.02.008; Nanthawichit C, 2003, TRANSPORT RES REC, P49; Laval JA, 2011, TRANSPORT RES B-METH, V45, P385, DOI 10.1016/j.trb.2010.07.006; Mehran B, 2012, TRANSPORT RES C-EMER, V20, P144, DOI 10.1016/j.trc.2011.05.006; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; [Anonymous], 1955, PROC R SOC LON SER A, DOI [DOI 10.1098/RSPA.1955.0089, 10.1098/rspa.1955.0089]; Herrera JC, 2010, TRANSPORT RES B-METH, V44, P460, DOI 10.1016/j.trb.2009.10.005; Daganzo C. F., 1997, FUNDAMENTALS TRANSPO; Edie L.C., 1963, P 2 INT S THEOR TRAF, P139; GIPPS PG, 1981, TRANSPORT RES B-METH, V15, P105, DOI 10.1016/0191-2615(81)90037-0; Leclercq L., 2007, TRANSPORTATION TRAFF, P735; Makigami Y, 1971, TRANSPORT SCI, V5, P302, DOI 10.1287/trsc.5.3.302; RICHARDS PI, 1956, OPER RES, V4, P42, DOI 10.1287/opre.4.1.42; van Wageningen-Kessels F, 2013, TRANSPORT RES C-EMER, V34, P148, DOI 10.1016/j.trc.2011.08.004	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		391	403		10.1016/j.trc.2015.05.019		13	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800025		
J	Fukuhara, T; Ono, C; Puig-Basagoiti, F; Matsuura, Y				Fukuhara, Takasuke; Ono, Chikako; Puig-Basagoiti, Francesc; Matsuura, Yoshiharu			Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus	TRENDS IN MICROBIOLOGY			English	Review							LOW-DENSITY LIPOPROTEINS; TRIGLYCERIDE-RICH LIPOPROTEINS; VIRION-ASSOCIATED CHOLESTEROL; HYPERVARIABLE REGION 1; B TYPE-I; SCAVENGER RECEPTOR; CELL-CULTURE; HCV INFECTION; EXCHANGEABLE APOLIPOPROTEINS; ENVELOPE GLYCOPROTEINS	More than 160 million people worldwide are infected with hepatitis C virus (HCV), and cirrhosis and hepatocellular carcinoma induced by HCV infection are life-threatening diseases. HCV takes advantage of many aspects of lipid metabolism for an efficient propagation in hepatocytes. Due to the morphological and physiological similarities of HCV particles to lipoproteins, lipid-associated HCV particles are named lipoviroparticles. Recent analyses have revealed that exchangeable apolipoproteins directly interact with the viral membrane to generate infectious HCV particles. In this review, we summarize the roles of lipid metabolism in the life cycle of HCV.	[Fukuhara, Takasuke; Ono, Chikako; Puig-Basagoiti, Francesc; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan	Matsuura, Y (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan.	matsuura@blken.osaka-u.ac.jp			Japan Agency for Medical Research and Development (AMED); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation	We thank M. Tomiyama for her secretarial work and M. Ishibashi and Y. Sugiyama for their technical assistance. This work was supported in part by grants-in-aid from the Japan Agency for Medical Research and Development (AMED), the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and Takeda Science Foundation.	Albecka A, 2011, HEPATOLOGY, V55, P998; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Forde KA, 2009, WORLD J GASTROENTERO, V15, P5020, DOI 10.3748/wjg.15.5020; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Felmlee DJ, 2013, VIRUSES-BASEL, V5, P1292, DOI 10.3390/v5051292; Zhu QQ, 2013, ANTIVIR RES, V98, P373, DOI 10.1016/j.antiviral.2013.04.009; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Fletcher NF, 2012, GASTROENTEROLOGY, V142, P634, DOI 10.1053/j.gastro.2011.11.028; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Bankwitz D, 2014, J VIROL, V88, P12644, DOI 10.1128/JVI.01145-14; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; Swift LL, 1996, J BIOL CHEM, V271, P31491; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mancone C, 2011, GUT, V60, P378, DOI 10.1136/gut.2010.211292; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Pecheur EI, 2010, J BIOL CHEM, V285, P25802, DOI 10.1074/jbc.M110.131664; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Bassendine MF, 2011, J HEPATOL, V55, P1428, DOI 10.1016/j.jhep.2011.06.004; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Barretto N, 2014, J VIROL, V88, P5050, DOI 10.1128/JVI.03241-13; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; GUMBER SC, 1995, ANN INTERN MED, V123, P615; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Shimizu Y, 2011, CURR OPIN VIROL, V1, P19, DOI 10.1016/j.coviro.2011.05.017; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Prentoe J, 2014, J VIROL, V88, P1725, DOI 10.1128/JVI.02017-13; Pan MH, 2002, J BIOL CHEM, V277, P4413, DOI 10.1074/jbc.M107460200; Bader T, 2013, J VIRAL HEPATITIS, V20, P622, DOI 10.1111/jvh.12085; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674; Maillard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026637; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; SCHAEFER EJ, 1978, BIOCHEM BIOPH RES CO, V80, P405, DOI 10.1016/0006-291X(78)90691-5; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Bocchetta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092140; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Ding Q, 2014, CELL HOST MICROBE, V16, P562, DOI 10.1016/j.chom.2014.10.009; Frentzen A, 2014, HEPATOLOGY, V59, P78, DOI 10.1002/hep.26626; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lefevre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095550; Lin CC, 2014, J HEPATOL, V61, P984, DOI 10.1016/j.jhep.2014.06.026; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Miyanari Y, 2007, NAT CELL BIOL, V9, P961; Pileri P, 1998, SCIENCE; Ploss A, 2009, NATURE, V457; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; SEGREST JP, 1992, J LIPID RES, V33, P141; Steinmann E, 2013, CURR TOP MICROBIOL, V369, P17, DOI 10.1007/978-3-642-27340-7_2; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Tanl H, 2007, J VIROL, V81, P8601; Thi V.L.D., 2012, J BIOL CHEM, V287, P31242, DOI DOI 10.1074/JBC.M112.365924; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Zaldi N, 2013, PROG LIPID RES, V52, P585	98	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-842X	1878-4380		TRENDS MICROBIOL	Trends Microbiol.	OCT	2015	23	10					618	629		10.1016/j.tim.2015.07.007		12	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CT8PD	WOS:000363077600009		
J	Dryzek, J; Nojiri, S; Fujinami, M; Dryzek, E; Siemek, K; Pachla, W				Dryzek, Jerzy; Nojiri, Shigehiro; Fujinami, Masanori; Dryzek, Ewa; Siemek, Krzysztof; Pachla, Waclaw			The Positron Probe Microanalyser Studies of Defect Distribution Induced by Machining of Copper, Iron and Titanium	TRIBOLOGY LETTERS			English	Article						Positron probe microanalyser; Subsurface defects; Machining; Titanium; Copper; Iron	SURFACE INTEGRITY; ANNIHILATION; WAFERS; ZONES	We demonstrate the application of the new experimental technique: positron probe microanalyser for studies of the defect profiles induced by milling. Metal foils of Cu, Fe and Ti were subjected to machining in a milling machine with different cutting speed. This technique revealed well-defined profiles of defects below the machined surface which was extended up to hundreds of micrometres. The extent of the profile depended on the metal and the cutting speed. The positron probe microanalyser allowed us to trace the evolution of the profile after annealing in different temperatures. Surprisingly, the high thermal stability of a few tens of micrometres thick layer adjacent to the machined surface was detected.	[Dryzek, Jerzy; Dryzek, Ewa; Siemek, Krzysztof] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland; [Nojiri, Shigehiro; Fujinami, Masanori] Chiba Univ, Dept Appl Chem, Inage Ku, Chiba 2638522, Japan; [Pachla, Waclaw] Polish Acad Sci, Inst High Pressure Phys, PL-01142 Warsaw, Poland	Dryzek, J (reprint author), Polish Acad Sci, Inst Nucl Phys, Ul Radzikowskiego 152, PL-31342 Krakow, Poland.	jerzy.dryzek@ifj.edu.pl					Che-Haron CH, 2005, J MATER PROCESS TECH, V166, P188, DOI 10.1016/j.jmatprotec.2004.08.012; Iino Y, 1996, WEAR, V199, P211, DOI 10.1016/0043-1648(96)06921-9; Dryzek J, 2014, TRIBOL LETT, V56, P101, DOI 10.1007/s11249-014-0389-x; Dryzek J, 2014, APPL PHYS A-MATER, V114, P465, DOI 10.1007/s00339-013-7667-6; Fujinami M, 2008, ANAL SCI, V24, P73, DOI 10.2116/analsci.24.73; Borner F, 1998, J APPL PHYS, V84, P2255, DOI 10.1063/1.368291; Dryzek J, 1997, TRIBOL LETT, V3, P269, DOI 10.1023/A:1019141424218; Horodek P, 2012, TRIBOL LETT, V45, P341, DOI 10.1007/s11249-011-9890-7; McNeil SP, 2003, J ELECTRON MATER, V32, P583, DOI 10.1007/s11664-003-0145-8; Ulutan D, 2011, INT J MACH TOOL MANU, V51, P250, DOI 10.1016/j.ijmachtools.2010.11.003; Dryzek J, 1999, TRIBOL LETT, V7, P57, DOI 10.1023/A:1019196615016; Jawahir IS, 2011, CIRP ANN-MANUF TECHN, V60, P603, DOI 10.1016/j.cirp.2011.05.002; M'Saoubi R, 2005, MAT SCI ENG A-STRUCT, V405, P339, DOI 10.1016/j.msea.2005.06.002; Dryzek J, 2010, TRIBOL INT, V43, P447, DOI 10.1016/j.triboint.2009.07.009; Coleman P. G., 2000, POSITRON BEAMS THEIR; Elmadagli M, 2003, MAT SCI ENG A-STRUCT, V355, P249, DOI 10.1016/S0921-5093(03)00072-8; Krause-Rehberg R., 1999, POSITRON ANNIHILATIO; Kuiczyk M., 2006, P 9 INT ESA FORM C M; Ni H, 2004, MAT SCI ENG A-STRUCT, V385, P267, DOI 10.1016/j.msea.2004.06.048; Oshima N., 2008, J APPL PHYS, V103; Petropoulos GP, 2010, SURFACE INTEGRITY IN MACHINING, P37, DOI 10.1007/978-1-84882-874-2_2; Robles Campillo J.M., 2007, J PHYS CONDENS MATT, V19; Sun J, 2009, J MATER PROCESS TECH, V209, P4036, DOI 10.1016/j.jmatprotec.2008.09.022	23	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	OCT	2015	60	1							16	10.1007/s11249-015-0587-1		7	Engineering, Chemical; Engineering, Mechanical	Engineering	CT8FV	WOS:000363051300011		
J	Itoh, S; Norizuki, Y; Fukuzawa, K; Zhang, HD				Itoh, Shintaro; Norizuki, Yusuke; Fukuzawa, Kenji; Zhang, Hedong			Effect of Chemically Adsorbed Molecules on the Viscous Friction of Nanometer-Thick Liquid Lubricant Films Coated on a Diamond-Like Carbon Surface	TRIBOLOGY LETTERS			English	Article						Nanotribology; Magnetic data storage; Lubricant thin film; Shear thinning; Confinement	ZDOL PERFLUOROPOLYETHER LUBRICANT; FIBER WOBBLING METHOD; HEAD-DISK INTERFACE; ULTRAVIOLET-IRRADIATION; CONFINED FLUIDS; PERFORMANCE; TRIBOLOGY; MEDIA	Nanometer-thick liquid lubricant films are used for lubrication of miniaturized mechanical systems such as hard disk drives and microelectromechanical systems. In particular at the head-disk interface of hard disk drives, the lubricant thin film is coated on a diamond-like carbon surface, and the films are usually composed of both chemically and physically adsorbed lubricant molecules. The combination of these two types of molecules leads to high lubrication performance. However, the detailed mechanism is not fully understood. The aim of this study was to clarify the effect of chemically adsorbed lubricant molecules on the viscous friction of lubricant films. Two different samples were tested: One was the lubricant film composed of both chemically and physically adsorbed molecules, and the other was the lubricant film with only physically adsorbed molecules. We used a fiber wobbling method (FWM), which we developed in our previous study, to measure the viscous friction. The FWM uses a spherical-ended glass fiber as a shearing probe and enables friction forces in the order of 0.1 nN to be measured at precisely controlled nanometer-scale gap widths. For the fair comparison of friction forces between the samples with different compositions, the contact area between the probe tip and the lubricant film must be the same. To determine the contact area in the friction measurement, we improved the FWM system to enable simultaneous measurement of friction force and contact area. Experimental results showed the 1-nm-thick layer of chemically adsorbed molecules in the lubricant film effectively reduced the viscous friction.	[Itoh, Shintaro; Norizuki, Yusuke; Fukuzawa, Kenji] Nagoya Univ, Dept Micro Nano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zhang, Hedong] Nagoya Univ, Dept Complex Syst Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Itoh, S (reprint author), Nagoya Univ, Dept Micro Nano Syst Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	s_itoh@nuem.nagoya-u.ac.jp			Storage Research Consortium; Asahi Glass Foundation	The present research was partially supported by the Storage Research Consortium and the Asahi Glass Foundation.	Itoh S, 2013, TRIBOL LETT, V49, P1, DOI 10.1007/s11249-012-0067-9; Gui J, 2003, IEEE T MAGN, V39, P716, DOI 10.1109/TMAG.2003.808999; Zhang H, 2007, TRIBOL LETT, V28, P163, DOI 10.1007/s11249-007-9261-6; Rymuza Z, 1999, MICROSYST TECHNOL, V5, P173, DOI 10.1007/s005420050160; Pit R, 2000, PHYS REV LETT, V85, P980, DOI 10.1103/PhysRevLett.85.980; Itoh S, 2008, TRIBOL LETT, V30, P177, DOI 10.1007/s11249-008-9325-2; Ruths M, 1999, TRIBOL LETT, V7, P161, DOI 10.1023/A:1019137824102; Luengo G, 1996, WEAR, V200, P328, DOI 10.1016/S0043-1648(96)07248-1; Zhang H, 2005, TRIBOL LETT, V20, P191, DOI 10.1007/s11249-005-8326-7; Chen CY, 2001, TRIBOL LETT, V10, P195, DOI 10.1023/A:1016697417275; Yamada S, 2002, TRIBOL LETT, V13, P167, DOI 10.1023/A:1020151824274; VURENS GH, 1993, IEEE T MAGN, V29, P282, DOI 10.1109/20.195583; Itoh S, 2005, MICROSYST TECHNOL, V11, P894, DOI 10.1007/s00542-005-0568-7; Waltman RJ, 1998, TRIBOL LETT, V4, P267, DOI 10.1023/A:1019127910531; Chiba H, 2003, TRIBOL INT, V36, P367, DOI 10.1016/S0301-679X(02)00211-6; Eapen KC, 2002, TRIBOL LETT, V12, P35, DOI 10.1023/A:1013971321480; Zhao ZM, 1996, WEAR, V202, P50, DOI 10.1016/S0043-1648(96)07307-3; Tyndall GW, 1998, LANGMUIR, V14, P7527, DOI 10.1021/la9802825; Fukuzawa K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061602; Itoh S, 2009, IEEE T MAGN, V45, P5055, DOI 10.1109/TMAG.2009.2029605; Gennes P.-G.D., 2003, CAPILLARITY WETTING; Hedong Zhang, 2008, IEEE Transactions on Magnetics, V44, DOI 10.1109/TMAG.2008.2001594; Itoh S, 2014, TRIBOL LETT, V53, P555, DOI 10.1007/s11249-014-0294-3; Junho C., 2003, IEEE T MAGN, V39, P2492, DOI 10.1109/TMAG.2003.816450; Lu R., 2013, TRIBOL LETT, V54, P237; Marchon B., 2013, ADV TRIBOL, V2013, P1	26	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	OCT	2015	60	1							7	10.1007/s11249-015-0583-5		9	Engineering, Chemical; Engineering, Mechanical	Engineering	CT8FV	WOS:000363051300007		
J	Nanao, H; Hoshi, Y; Shizuku, T; Takiwatari, K; Mori, S				Nanao, Hidetaka; Hoshi, Yasushi; Shizuku, Takahisa; Takiwatari, Koji; Mori, Shigeyuki			Direct Observation of Lubricant Components Between Wire and Diamond Die for Wire Drawing with a Micro-FTIR	TRIBOLOGY LETTERS			English	Article						Wire drawing; Direct observation; Micro-FTIR; Oil film; Brass wire; Tribochemical reaction; Oleic acid; Soap	MOLECULAR INTERACTION; POLYPROPYLENE GLYCOL; OLEIC-ACID; TEMPERATURE; PRESSURE; CONTACT; STRESS; FILM; OILS	Lubricant oil film between a brass wire and a diamond die was observed directly with a micro-FTIR after drawing the wire. A new method using a diamond die with a side view for the direct observation has been developed using a micro-FTIR. PAO, oleic acid and PAO with 20 mass% of oleic acid were used as a lubricant. The profile of the oil film thickness in the reduction region of the die was obtained from the absorbance of IR spectra. The result shows a good linear relation depending on the semi-reduction angle of the die. A dent of film thickness with PAO was observed at 50-100 mu m of the position from the end of reduction region, and it disappeared when wire drawing was carried out with oleic acid solution. The formation mechanism of the dent was discussed from the viewpoint of lubrication property of the lubricants. It was found from IR measurements that oleic acid reacts with zinc oxide on brass wire and soap as the reaction product was accumulated at the end of reduction region.	[Nanao, Hidetaka; Hoshi, Yasushi; Mori, Shigeyuki] Iwate Univ, Morioka, Iwate 020, Japan; [Shizuku, Takahisa] Bridgestone Holdings, Tokyo, Japan; [Takiwatari, Koji] Ichinoseki Coll, Natl Inst Technol, Ichinoseki, Japan	Mori, S (reprint author), Iwate Univ, Morioka, Iwate 020, Japan.	mori@iwate-u.ac.jp			project on Green Tribology Network Innovation in GRENE Project from MEXT	A part of this work was supported by the project on Green Tribology Network Innovation in GRENE Project from MEXT. The authors would like to appreciate for the support.	El-Domiaty A, 1998, J MATER PROCESS TECH, V83, P72, DOI 10.1016/S0924-0136(98)00045-4; Tomar P, 2013, PROCEDIA ENGINEER, V64, P1320, DOI 10.1016/j.proeng.2013.09.213; Obi AI, 1996, WEAR, V194, P30, DOI 10.1016/0043-1648(95)06664-0; Takiwatari K, 2014, LUBR SCI, V26, P13, DOI 10.1002/ls.1223; Takiwatari K, 2010, LUBR SCI, V22, P89, DOI 10.1002/ls.107; Hsu SM, 2002, TRIBOL LETT, V13, P131, DOI 10.1023/A:1020112901674; Shimotomai N, 2011, J JPN SOC TRIBOLOGIS, V56, P47; Feser T, 2013, WEAR, V303, P465, DOI 10.1016/j.wear.2013.03.047; Mori S, 1996, TRIBOL INT, V29, P35, DOI 10.1016/0301-679X(95)00032-Y; Takiwatari K, 2010, LUBR SCI, V22, P367, DOI 10.1002/ls.132; Felder E, 2012, WEAR, V286, P27, DOI 10.1016/j.wear.2011.05.029; Bech J, 1999, WEAR, V232, P134, DOI 10.1016/S0043-1648(99)00136-2; Azushima A, 2005, TRIBOL INT, V38, P105, DOI 10.1016/j.triboint.2004.04.006; Hollinger S, 2003, WEAR, V255, P1291, DOI 10.1016/S0043-1648(03)00168-6	14	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	OCT	2015	60	1							12	10.1007/s11249-015-0592-4		6	Engineering, Chemical; Engineering, Mechanical	Engineering	CT8FV	WOS:000363051300016		
J	Sasaki, M; Hsu, M; Yeh, MM; Nakanuma, Y				Sasaki, Motoko; Hsu, Maylee; Yeh, Matthew M.; Nakanuma, Yasuni			In recurrent primary biliary cirrhosis after liver transplantation, biliary epithelial cells show increased expression of mitochondrial proteins	VIRCHOWS ARCHIV			English	Article						Primary biliary cirrhosis; Post-liver transplant rejection; Pyruvate dehydrogenase complex-E2 component; Biliary epithelial cell; Autophagy and cellular senescence	SMALL BILE-DUCTS; CELLULAR SENESCENCE; AUTOPHAGY; P21(WAF1/CIP1); REJECTION; TREE	In biliary epithelial lesions in primary biliary cirrhosis (PBC), mitochondrial proteins associated with deregulated autophagy are abnormally expressed. We examined whether this could be used as a diagnostic marker for end-stage PBC and recurrent PBC after liver transplantation. We examined the expression of the mitochondrial protein pyruvate dehydrogenase complex-E2 component and cytochrome c oxidase, subunit I (CCO), the autophagy-related marker microtubule-associated protein-light chain 3 (LC3), and p62/sequestosome-1 and the senescence markers p16(Ink4a) and p21(WAF1/Cip1) in small bile ducts and bile ductules in explanted livers from patients with PBC (n = 20) in comparison with liver tissue from control patients (n = 21) and post-transplant samples including recurrent PBC and cellular rejection (n = 28). Intense granular expression of mitochondrial proteins was significantly more frequent in small bile ducts in explanted livers with PBC than in control livers (p < 0.05). Post-transplant samples comprised of three groups: group A (positive for mitochondrial proteins, n = 7), group B (positive for either autophagy-related or senescence markers but negative for mitochondrial proteins, n = 7), and group C (all negative, n = 14). All but one case of group A were clinically and histologically diagnosed as recurrent PBC. In contrast, all cases of group B were diagnosed as cellular rejection. This study suggests that the expression of mitochondrial proteins in small bile ducts may be a useful diagnostic marker for end-stage PBC and recurrent PBC after liver transplantation.	[Sasaki, Motoko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Hsu, Maylee; Yeh, Matthew M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan	Sasaki, M (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.	m8sasaki@med.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports and Science and Technology of Japan [24590409, 15K08341]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports and Science and Technology of Japan (24590409 and 15K08341).	VandeWater J, 1996, HEPATOLOGY, V24, P1079; Sasaki M, 2013, LIVER INT, V33, P312, DOI 10.1111/liv.12049; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Brain JG, 2013, AM J TRANSPLANT, V13, P1688, DOI 10.1111/ajt.12271; Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348; Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; NEUBERGER J, 1995, HEPATOLOGY, V22, P798, DOI 10.1016/0270-9139(95)90299-6; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326; Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8; Hubscher S, 2012, PATHOLOGY LIVER, P853; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Portmann B, 2007, PATHOLOGY LIVER, P517	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	OCT	2015	467	4					417	425		10.1007/s00428-015-1819-3		9	Pathology	Pathology	CT8HM	WOS:000363055900006		
J	Wang, J; Kondo, T; Yamane, T; Nakazawa, T; Oish, N; Mochizuki, K; Katoh, R				Wang, Jieying; Kondo, Tetsuo; Yamane, Tetsu; Nakazawa, Tadao; Oish, Naoki; Mochizuki, Kunio; Katoh, Ryohei			Expression of nuclear membrane proteins in normal, hyperplastic, and neoplastic thyroid epithelial cells	VIRCHOWS ARCHIV			English	Article						Nuclear membrane proteins; Thyroid; Carcinoma; Immunohistochemistry; Polymerase chain reaction (PCR)	LEM-DOMAIN; ENVELOPE; LAMINS; EMERIN; CARCINOMAS; TRANSCRIPTION; ORGANIZATION; ROLES; COMPLEXES; LESIONS	Emerin, lamin A/C, lamin B, and lamin-associated polypeptide 2 (LAP2) are nuclear membrane proteins that play an important role in maintaining nuclear structure and coordinating cell activity. We studied the expression and significance of nuclear membrane proteins in neoplastic thyroid cells by immunohistochemistry, RT-PCR, and real-time PCR. In papillary carcinomas (PCs), the nuclear proteins most frequently expressed at high levels were emerin (82 % positive), lamin A/C (64 %), and LAP2 (82 %). Follicular carcinomas (FCs) most frequently expressed lamin B, while none of the undifferentiated carcinomas (UCs) showed strong expression of emerin or lamin A/C. In all medullary carcinomas (MCs), intermediate to high levels of expression of lamin A/C and LAP2 were found. By RT-PCR analysis, messenger RNA (mRNA) expression of all nuclear membrane proteins except emerin was higher in PC than in normal tissue. Real-time PCR analysis showed that mRNA expression of nuclear membrane protein varied between cell lines. Our findings suggest that expression of nuclear membrane proteins may be related to follicular function in normal and hyperplastic follicles, and we hypothesize that they are also involved in the proliferation and differentiation of neoplastic thyroid cells. We suggest that they reflect the biological nature and/or function of normal, hyperplastic, and neoplastic thyroid cells and may have some value in diagnosing thyroid tumors.	[Wang, Jieying; Kondo, Tetsuo; Yamane, Tetsu; Nakazawa, Tadao; Oish, Naoki; Mochizuki, Kunio; Katoh, Ryohei] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pathol, Chuo Ku, Yamanashi 4093898, Japan	Katoh, R (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pathol, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	rkatoh@yamanashi.ac.jp					Rezk S, 2004, ENDOCR PATHOL, V15, P329, DOI 10.1385/EP:15:4:329; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Mendez-Lopez I, 2012, CHROMOSOMA, V121, P153, DOI 10.1007/s00412-012-0360-2; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Asioli S, 2010, VIRCHOWS ARCH, V457, P43, DOI 10.1007/s00428-010-0910-z; Asioli S, 2009, HISTOPATHOLOGY, V54, P571, DOI 10.1111/j.1365-2559.2009.03259.x; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Sun S, 2010, J PROTEOME RES, V9, P70, DOI 10.1021/pr9002118; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Worman HJ, 2000, J MEMBRANE BIOL, V177, P1, DOI 10.1007/s002320001096; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Fischer AH, 2001, HISTOL HISTOPATHOL, V16, P1; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; AARONSON RP, 1975, P NATL ACAD SCI USA, V72, P1007, DOI 10.1073/pnas.72.3.1007; Hutchison CJ, 2001, J CELL SCI, V114, P9; Kondo T, 2007, HUM PATHOL, V38, P1810, DOI 10.1016/j.humpath.2007.04.014; Coradeghini R, 2006, ONCOL REP, V15, P609; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bis602636m; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; Katoh R, 2000, HUM PATHOL, V31, P386, DOI 10.1016/S0046-8177(00)80255-5; DeLellis RA, 2004, PATHOLOGY GENETICS T; Fisher AH, 2003, AM J SURG PATHOL, V163, P1091; Franke WW, 1981, J CELL BIOL, V91, P39; Kim HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039482; Rubin, 2007, ENDOCRINE SYSTEM, P933; Wang JY, 2014, ACTA HISTOCHEM CYTOC, V47, P289, DOI 10.1267/ahc.14041; Willis N. D., 2008, PLOS ONE, V3	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	OCT	2015	467	4					427	436		10.1007/s00428-015-1816-6		10	Pathology	Pathology	CT8HM	WOS:000363055900007		
J	Taneda, S; Honda, K; Ohno, M; Uchida, K; Nitta, K; Oda, H				Taneda, Sekiko; Honda, Kazuho; Ohno, Mayuko; Uchida, Keiko; Nitta, Kosaku; Oda, Hideaki			Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis	VIRCHOWS ARCHIV			English	Article						Electron microscopy; Focal segmental glomerulosclerosis; Foot process effacement; Podocyte detachment; Subendothelial widening	FOOT PROCESS EFFACEMENT; GLOMERULAR SCLEROSIS; THROMBOTIC MICROANGIOPATHY; TRANSPLANT GLOMERULOPATHY; NEPHROTIC SYNDROME; REMNANT-KIDNEY; PROTEINURIA; HYPERTENSION; PROGRESSION; INHIBITION	Podocyte injury contributes to the development of focal segmental glomerulosclerosis (FSGS). Endocapillary hypercellularity, which is one of the pathological characteristics of FSGS, suggests that glomerular endothelial injury may also be involved in the pathogenesis of FSGS. In electron micrographs of patients with FSGS (n = 43), we conducted morphometric measurements of foot process width (FPW) and podocyte detachment (PD) as markers of podocyte injury and subendothelial widening (SW) of the glomerular basement membrane as a marker of endothelial injury and compared them to those in patients with minimal change nephrotic syndrome (MCNS; n = 11) and control kidney donors (n = 5). Associations between ultrastructural and clinical parameters were analyzed according to the FSGS variants defined by the Columbia classification. FPW was significantly higher in the FSGS group than that in the MCNS and control groups, particularly in the collapsing, tip, and cellular variants of FSGS. Percentage of glomerular basement membrane (GBM) length showing PD and SW was significantly increased in the FSGS group, especially in the collapsing, cellular, and not otherwise specified variants. In FSGS, FPW was inversely correlated with disease duration, but not with proteinuria. Finally, the percentage of GBM length with SW significantly correlated with clinical parameters indicative of poor prognosis, such as lower remission rate and lower estimated glomerular filtration rate at the final observation. Quantitative measurement of podocyte and endothelial injury by electron microscopy might be useful for evaluating histological activity and predicting prognosis in FSGS.	[Taneda, Sekiko; Honda, Kazuho; Ohno, Mayuko; Oda, Hideaki] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Uchida, Keiko; Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Internal Med, Tokyo, Japan; [Honda, Kazuho] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan	Taneda, S (reprint author), Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan.	sekikosekiko@gmail.com					Opocensky M, 2006, HYPERTENSION, V48, P965, DOI 10.1161/01.HYP.0000245117.57524.d6; Taneda S, 2012, INT UROL NEPHROL, V44, P183, DOI 10.1007/s11255-011-9932-y; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; GRISHMAN E, 1975, KIDNEY INT, V7, P111, DOI 10.1038/ki.1975.16; Henderson JM, 2009, J AM SOC NEPHROL, V20, P961, DOI 10.1681/ASN.2008060613; SCHWARTZ MM, 1985, KIDNEY INT, V28, P968, DOI 10.1038/ki.1985.225; Sinha A, 2013, CLIN EXP NEPHROL, V17, P66, DOI 10.1007/s10157-012-0656-9; Bolbrinker J, 2006, J PHARMACOL EXP THER, V316, P8, DOI 10.1124/jpet.105.093112; Asanuma K, 2011, AM J NEPHROL, V33, P537, DOI 10.1159/000327995; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; MARYNIAK RK, 1985, KIDNEY INT, V27, P799, DOI 10.1038/ki.1985.83; Zhang QY, 2012, NEPHROLOGY, V17, P338, DOI 10.1111/j.1440-1797.2012.01575.x; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Griffin SV, 2003, NEPHROL DIAL TRANSPL, V18, P8, DOI 10.1093/ndt/gfg1069; Tada M, 2001, PEDIATR NEPHROL, V16, P482; YOSHIKAWA N, 1986, J PEDIATR-US, V109, P65, DOI 10.1016/S0022-3476(86)80574-1; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; KATAFUCHI R, 1984, CLIN NEPHROL, V22, P1; HSU HC, 1980, HISTOPATHOLOGY, V4, P351, DOI 10.1111/j.1365-2559.1980.tb02931.x; Kitamura H, 1998, EXP NEPHROL, V6, P328; Liakopoulos V, 2011, CLIN NEPHROL, V75, P362, DOI 10.5414/CN106544; Duner F, 2008, NEPHROL DIAL TRANSPL, V23, P2504, DOI 10.1093/ndt/gfn100; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; NEWMAN WJ, 1976, MEDICINE, V55, P67, DOI 10.1097/00005792-197601000-00004; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Daehn I, J CLIN INVEST, V124, P1608; Lee YC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-5; Leontsini M, 2003, HIPPOKRATIA, V7, P147; Miki Yusuke, 2002, Nihon Jinzo Gakkai Shi, V44, P547; Ogino S, 1999, Nihon Jinzo Gakkai Shi, V41, P413; Schwartz, 2007, HEPT PATH KIDN	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	OCT	2015	467	4					449	458		10.1007/s00428-015-1821-9		10	Pathology	Pathology	CT8HM	WOS:000363055900010		
J	Hayashi, N; Naumkin, PI				Hayashi, Nakao; Naumkin, Pavel I.			Factorization technique for the fourth-order nonlinear Schrodinger equation	ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK			English	Article						Fourth-order nonlinear Schrodinger equation; Factorization formula; Large time asymptotics of solutions; Logarithmic phase correction; Critical order of nonlinearity	GLOBAL WELL-POSEDNESS; SCATTERING-THEORY; VORTEX FILAMENT; ASYMPTOTICS; DIMENSIONS; DISPERSION; EXISTENCE	We consider the Cauchy problem for the cubic fourth-order nonlinear Schrodinger equation where We introduce the factorization formula for the free evolution group to prove the global existence of solutions. Also we show that the large time asymptotics of solutions has a logarithmic correction in the phase comparing with the corresponding linear case.	[Hayashi, Nakao] Osaka Univ, Grad Sch Sci, Dept Math, Osaka, Toyonaka 5600043, Japan; [Naumkin, Pavel I.] Ctr Ciencias Matemat, Morelia 58089, Michoacan, Mexico	Hayashi, N (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Osaka, Toyonaka 5600043, Japan.	nhayashi@math.sci.osaka-u.ac.jp; pavelni@matmor.unam.mx			JSPS KAKENHI Grant [25220702]; CONACYT; PAPIIT Project [IN100113]	We would like to thank an unknown referee for useful suggestions and comments. The work of N.H. is supported by JSPS KAKENHI Grant Number 25220702. The work of P.I.N. is partially supported by CONACYT and PAPIIT Project IN100113.	Ben-Artzi M, 2000, CR ACAD SCI I-MATH, V330, P87, DOI 10.1016/S0764-4442(00)00120-8; Guo CH, 2006, APPL MATH LETT, V19, P706, DOI 10.1016/j.aml.2005.10.002; Fukumoto Y, 2001, FLUID MEC A, V59, P211; Huo ZH, 2005, J DIFFER EQUATIONS, V214, P1, DOI 10.1016/j.jde.2004.09.005; Karpman VI, 1996, PHYS REV E, V53, pR1336; Hao CC, 2006, J MATH ANAL APPL, V320, P246, DOI 10.1016/j.jmaa.2005.06.091; Karpman VI, 2000, PHYSICA D, V144, P194, DOI 10.1016/S0167-2789(00)00078-6; Pausader B, 2007, DYNAM PART DIFFER EQ, V4, P197; Hayashi N, 2008, Z ANGEW MATH PHYS, V59, P1002, DOI 10.1007/s00033-007-7008-8; Pausader B, 2013, NONLINEARITY, V26, P2175, DOI 10.1088/0951-7715/26/8/2175; KENIG CE, 1991, INDIANA U MATH J, V40, P33, DOI 10.1512/iumj.1991.40.40003; Wang YZ, 2012, NONLINEAR ANAL-THEOR, V75, P2534, DOI 10.1016/j.na.2011.10.047; Wang YZ, 2012, B AUST MATH SOC, V85, P371, DOI 10.1017/S0004972711003327; DYSTHE KB, 1979, P ROY SOC LOND A MAT, V369, P105, DOI 10.1098/rspa.1979.0154; Fedoryuk M.V., 1987, ASYMPTOTICS INTEGRAL; Hayashi N, 2015, J DIFFER EQUATIONS, V258, P880, DOI 10.1016/j.jde.2014.10.007; HAYASHI N, 1988, ANN I H POINCARE-PHY, V48, P17; HAYASHI N, 1993, COMMUN PART DIFF EQ, V18, P1109, DOI 10.1080/03605309308820965; KENIG CE, 1993, COMMUN PUR APPL MATH, V46, P527, DOI 10.1002/cpa.3160460405; Pausader B, 2010, J HYPERBOL DIFFER EQ, V7, P651, DOI 10.1142/S0219891610002256; Segata J., 2006, MATH METHOD APPL SCI, V26, P1785; Segata J., 2003, DIFFERENTIAL INTEGRA, V16, P841; Stein E.M., 2011, PRINCETON LECT ANAL, V4	23	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0044-2275	1420-9039		Z ANGEW MATH PHYS	Z. Angew. Math. Phys.	OCT	2015	66	5					2343	2377		10.1007/s00033-015-0524-z		35	Mathematics, Applied	Mathematics	CT8JO	WOS:000363062100013		
J	Saito, R; Miselki, Y; Nini, W; Sayama, K				Saito, Rie; Miselki, Yugo; Nini, Wang; Sayama, Kazuhiro			Discovery of Overcoating Metal Oxides on Photoelectrode for Water Splitting by Automated Screening	ACS COMBINATORIAL SCIENCE			English	Article						photoelectrode library; composite multilayer; water splitting metal oxides; automated screening; photocurrent	BIVO4 THIN-FILM; VISIBLE-LIGHT; CARBONATE ELECTROLYTE; EFFICIENT; PHOTOANODES; COMPOSITE; PHOTOOXIDATION; DECOMPOSITION; OXIDATION; CATALYST	We applied an automated semiconductor synthesis and screen system to discover overcoating film materials and optimize coating conditions on the BiVO4/WO3 composite photoelectrode to enhance stability and photocurrent. Thirteen metallic elements for overcoating oxides were examined with various coating amounts. The stability of the BiVO4/WO3 photoelectrode in a highly concentrated carbonate electrolyte aqueous solution was significantly improved by overcoating with Ta2O5 film, which was amorphous and porous when calcined at 550 degrees C. The photocurrent for the water oxidation reaction was only minimally inhibited by the presence of the Ta2O5 film on the BiVO4/WO3 photoelectrode.	[Saito, Rie; Miselki, Yugo; Nini, Wang; Sayama, Kazuhiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Sayama, K (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	k.sayama@aist.go.jp			Next Generation World-Leading Researchers (NEXT Program) from Cabinet Office; Government of Japan; Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies	The present work was partially supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Cabinet Office and by the Government of Japan and the Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies.	Hu S, 2014, SCIENCE, V344, P1005, DOI 10.1126/science.1251428; Arai T, 2007, J COMB CHEM, V9, P574, DOI 10.1021/cc0700142; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Fujimoto I, 2014, INT J HYDROGEN ENERG, V39, P2454, DOI 10.1016/j.ijhydene.2013.08.114; Cowan AJ, 2013, CHEM SOC REV, V42, P2281, DOI 10.1039/c2cs35305a; Zhong DK, 2011, J AM CHEM SOC, V133, P18370, DOI 10.1021/ja207348x; Luo WJ, 2011, ENERG ENVIRON SCI, V4, P4046, DOI 10.1039/c1ee01812d; Kusama H, 2010, J COMB CHEM, V12, P356, DOI 10.1021/cc9001845; Lyons MEG, 2011, PHYS CHEM CHEM PHYS, V13, P5314, DOI 10.1039/c0cp02875d; Sayama K, 2003, CHEM COMMUN, P2908, DOI 10.1039/b310428a; Hong SJ, 2011, ENERG ENVIRON SCI, V4, P1781, DOI 10.1039/c0ee00743a; Saito R, 2013, J PHOTOCH PHOTOBIO A, V258, P51, DOI 10.1016/j.jphotochem.2013.02.019; Li ZS, 2013, ENERG ENVIRON SCI, V6, P347, DOI 10.1039/c2ee22618a; Osterloh FE, 2013, CHEM SOC REV, V42, P2294, DOI 10.1039/c2cs35266d; Liu X, 2012, PHYS CHEM CHEM PHYS, V14, P7894, DOI 10.1039/c2cp40976c; Sayama K, 2010, CHEM LETT, V39, P17, DOI 10.1246/cl.2010.17; Saito R, 2012, CHEM COMMUN, V48, P3833, DOI 10.1039/c2cc30713h; Park Y, 2013, CHEM SOC REV, V42, P2321, DOI 10.1039/c2cs35260e; Sivula K, 2011, CHEMSUSCHEM, V4, P432, DOI 10.1002/cssc.201000416; Seabold JA, 2012, J AM CHEM SOC, V134, P2186, DOI 10.1021/ja209001d; Sayama K, 2006, J PHYS CHEM B, V110, P11352, DOI 10.1021/jp057539+; Xu Y, 2000, AM MINERAL, V85, P543; Matsui Y, 2005, J ELECTROCHEM SOC, V152, pF54, DOI 10.1149/1.1885365	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2156-8952	2156-8944		ACS COMB SCI	ACS Comb. Sci.	OCT	2015	17	10					592	599		10.1021/acscombsci.5b00022		8	Chemistry, Applied; Chemistry, Medicinal; Chemistry, Multidisciplinary	Chemistry; Pharmacology & Pharmacy	CT5PT	WOS:000362863200004		
J	Choi, H; Kim, HJ; Matsuura, A; Mikami, B; Yoon, HJ; Lee, HH				Choi, Hwajung; Kim, Hee Jung; Matsuura, Atsushi; Mikami, Bunzo; Yoon, Hye-Jin; Lee, Hyung Ho			Structural and functional studies of a metallo-beta-lactamase unveil a new type of structurally encoded nickel-containing heterodinuclear site	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						metalloenzyme; nickel; phosphodiesterase; antibiotics; X-ray absorption spectroscopy	BINDING-SITES; INHIBITORS; PURIFICATION; RESISTANCE; RESOLUTION; CATALYSIS; SOFTWARE; PROTEINS; ZINC; ION	The selection of correct metal ions with high fidelity against competing cellular cations is crucial for the function of many metalloenzymes; however, the understanding of the principles that govern metal selectivity is still incomplete. In this study, the crystal structure of the Tm1162 protein from Thermotoga maritima, a metallo-beta-lactamase, is reported. Several crystal structures of wildtype Tm1162 and its mutants were solved. Homologues of Tm1162 are widely distributed in bacteria and archaea, including several human pathogens. The monomer possesses an alpha beta/beta alpha fold, with the core beta-strands having the beta-sheet sandwich structure common to the metallo-beta-lactamase superfamily. Tm1162 exists as a trimer in the crystal and this trimeric unit is likely to be present in solution. In the trimer, three active sites reside at the interface between subunits, suggesting that the oligomeric assembly is crucial for catalysis. A new type of structurally encoded heterodinuclear site has been identified by confirming the identity of nickel-containing heteronuclear sites in Tm1162 via X-ray absorption spectroscopy and anomalous difference Fourier maps. The second coordination sphere, including His8 and Glu73, maintains the side-chain orientations of histidines and stabilizes the metal-binding site. Nickel coordination was crucial for the oligomerization of Tm1162. The nickel-dependent and manganese-dependent beta-lactamase and phosphodiesterase activities of Tm1162 have also been characterized.	[Choi, Hwajung; Yoon, Hye-Jin; Lee, Hyung Ho] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea; [Kim, Hee Jung; Matsuura, Atsushi] Kookmin Univ, Dept Bio & Nano Chem, Seoul 136702, South Korea; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Qual Design & Exploitat, Kyoto 6110011, Japan	Lee, HH (reprint author), Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea.	hyungholee@snu.ac.kr			National Research Foundation (NRF) of Korea - Korean government [2013R1A1A1008195, 2015R1A5A1008958]; Korea CCS RD Center (KCRC) [2013M1A8A1038187]; NRF [2014R1A1A3A04050250]	The authors thank the staff of beamlines 5C and 7A at Pohang Light Source and BL44XU at SPring-8, Japan for their assistance during the X-ray experiments. This study was supported by a grant from the National Research Foundation (NRF) of Korea funded by the Korean government (2013R1A1A1008195 and 2015R1A5A1008958) and a grant from the Korea CCS R&D Center (KCRC; 2013M1A8A1038187) to HHL. This study was also supported by an NRF grant (2014R1A1A3A04050250) to HJY.	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Garces F, 2010, J MOL BIOL, V398, P715, DOI 10.1016/j.jmb.2010.03.041; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Dudev T, 2014, CHEM REV, V114, P538, DOI 10.1021/cr4004665; Perez-Llarena FJ, 2009, CURR MED CHEM, V16, P3740; Hu Z, 2009, BIOCHEMISTRY-US, V48, P2981, DOI 10.1021/bi802295z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; de la Torre JG, 2000, BIOPHYS J, V78, P719; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Wang ZG, 1998, J BIOL CHEM, V273, P22402, DOI 10.1074/jbc.273.35.22402; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Saito R, 2004, ACTA CRYSTALLOGR D, V60, P792, DOI 10.1107/S0907444904003166; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Feng H, 2014, J AM CHEM SOC, V136, P14694, DOI 10.1021/ja508388e; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; CHEONG CG, 1995, PROTEINS, V21, P105, DOI 10.1002/prot.340210204; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eidam O, 2012, P NATL ACAD SCI USA, V109, P17448, DOI 10.1073/pnas.1208337109; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Quiroga MI, 2000, CHEMOTHERAPY, V46, P177, DOI 10.1159/000007275; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Punta M, 2011, NUCLEIC ACIDS RES, V40, pD290, DOI DOI 10.1093/NAR/GKR1065; Raj SB, 2014, BIOCHEMISTRY-US, V53, P5791, DOI 10.1021/bi5006442; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068	39	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	OCT	2015	71		10				2054	2065		10.1107/S1399004715014807		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CT5LH	WOS:000362851300007		
J	Hasumi, M				Hasumi, Masato			Social interactions during the aquatic breeding phase of the family Hynobiidae (Amphibia: Caudata)	ACTA ETHOLOGICA			English	Review						Increased head width; Mating ball; Midwifing; Parental care; Scramble competition; Territoriality	MALE REPRODUCTIVE-BEHAVIOR; RED-COLLARED WIDOWBIRDS; PARENTAL CARE; SEXUAL-DIMORPHISM; SEASONAL-CHANGES; MALE SALAMANDERS; WATER-DRIVE; BODY-SIZE; SCRAMBLE COMPETITION; TRITURUS-VIRIDESCENS	Social animals with a monophasic life cycle exhibit a more complex social system for reproduction than that of other social animals in which the life cycle is biphasic. The family Hynobiidae (Amphibia: Caudata) is phylogenetically basal to most other salamander families, practices external fertilization, and has a biphasic life cycle alternating between aquatic breeding and terrestrial nonbreeding phases. There are many controversial and specific social interactions during the aquatic breeding phase in several of the inspected species of this family when comparing their sexual or social behaviors with those of other animal species. Some papers describing these social interactions have misled us by erroneously referring to phenomena of territoriality, chase, amplexus/midwifing, mating ball formation, scramble competition, and parental care. Especially, I am skeptical of the male's premating displays (e.g., chase, clasp, snout contact, chin rubbing, tail undulation, smelling, digging) regarded as "courtship" in some papers, except for Ranodon sibiricus that may produce a single large spermatophore, because most of these displays result in the female's escape from the male. Also, I am skeptical of the behavior of a male, staying near deposited egg sacs, regarded as "parental care" because such a male can be predicted to change easily with other males and not to guard eggs or embryos against predators. Thus, I provide a focal review and correct observations on hynobiid sexual and social behavior by incorporating some unignorable descriptions that do not fit with previous descriptions on aquatic social interactions of this family.	Niigata Univ, Inst Biol, Fac Sci, Niigata 9502181, Japan	Hasumi, M (reprint author), Niigata Univ, Inst Biol, Fac Sci, Niigata 9502181, Japan.	mhasumi@bio.sc.niigata-u.ac.jp	Hasumi, Masato/K-2082-2012	Hasumi, Masato/0000-0001-6608-0267			Andersson M.B., 1994, SEXUAL SELECTION; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; MAHER CR, 1995, ANIM BEHAV, V49, P1581, DOI 10.1016/0003-3472(95)90080-2; Park Daesik, 2006, Integrative Biosciences, V10, P137; Lee TJ, 2011, AM NAT, V178, pE1, DOI 10.1086/660197; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; SCHWAGMEYER PL, 1986, BEHAV ECOL SOCIOBIOL, V19, P359, DOI 10.1007/BF00295709; HASUMI M, 1993, GEN COMP ENDOCR, V90, P51, DOI 10.1006/gcen.1993.1059; Hasumi M, 2012, ORG DIVERS EVOL, V12, P167, DOI 10.1007/s13127-012-0091-5; Hasumi M, 2007, HERPETOLOGICA, V63, P163, DOI 10.1655/0018-0831(2007)63[163:PAEBMP]2.0.CO;2; HASUMI M, 1994, J HERPETOL, V28, P264, DOI 10.2307/1564635; Hasumi M, 2009, COPEIA, P46, DOI 10.1643/CP-07-237; Rojas B, 2014, BEHAV ECOL SOCIOBIOL, V68, P551, DOI 10.1007/s00265-013-1670-y; COOPER WE, 1989, AM NAT, V133, P729; Hasumi M, 1997, J HERPETOL, V31, P45, DOI 10.2307/1565327; Toll SJ, 2000, COPEIA, P276, DOI 10.1643/0045-8511(2000)2000[0276:SOATSF]2.0.CO;2; VERRELL PA, 1989, HERPETOLOGICA, V45, P265; Chadwick CS, 1941, J EXP ZOOL, V86, P175, DOI 10.1002/jez.1400860203; Kerfoot JR, 2006, ENVIRON BIOL FISH, V76, P1, DOI 10.1007/s10641-006-9000-0; Eom J, 2009, COMP BIOCHEM PHYS A, V154, P61, DOI 10.1016/j.cbpa.2009.05.006; Hou WS, 2010, ECOL ENG, V36, P791, DOI 10.1016/j.ecoleng.2010.02.004; SEVER DM, 1991, J MORPHOL, V207, P283, DOI 10.1002/jmor.1052070306; Cahan SH, 2002, OIKOS, V96, P206, DOI 10.1034/j.1600-0706.2002.960202.x; Hasumi M, 2010, EVOL BIOL, V37, P38, DOI 10.1007/s11692-010-9080-9; HASUMI M, 1992, HERPETOLOGICA, V48, P279; GROSS MR, 1981, EVOLUTION, V35, P775, DOI 10.2307/2408247; Pryke SR, 2002, BEHAV ECOL, V13, P622, DOI 10.1093/beheco/13.5.622; Loher T, 2012, FISH B-NOAA, V110, P46; Alcorn MA, 2013, J HERPETOL, V47, P321, DOI 10.1670/11-317; HOWARD RD, 1981, ECOLOGY, V62, P303, DOI 10.2307/1936704; Hasumi M, 1996, HERPETOLOGICA, V52, P598; Kim JK, 2013, ZOOL SCI, V30, P929, DOI 10.2108/zsj.30.929; Moya-Larano J, 2007, BIOLOGY LETT, V3, P475, DOI 10.1098/rsbl.2007.0300; Fiumera AC, 2004, CONSERV BIOL, V18, P94, DOI 10.1111/j.1523-1739.2004.00521.x; Houck Lynne D., 1995, Amphibian Biology, V2, P677; Hasumi M, 1996, HERPETOLOGICA, V52, P605; Komdeur J, 2006, ETHOLOGY, V112, P729, DOI 10.1111/j.1439-0310.2006.01243.x; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Hasumi M, 2011, LIMNOLOGY, V12, P37, DOI 10.1007/s10201-010-0319-z; Kusano Tamotsu, 2011, Current Herpetology, V30, P129; HASUMI M, 1990, J HERPETOL, V24, P113, DOI 10.2307/1564217; Sever DM, 2002, J EXP ZOOL, V292, P165, DOI 10.1002/jez.1152; Chadwick CS, 1940, P SOC EXP BIOL MED, V45, P335; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Hasumi Masato, 2007, Current Herpetology, V26, P107, DOI 10.3105/1881-1019(2007)26[107:PWTIMS]2.0.CO;2; Pryke SR, 2001, ANIM BEHAV, V62, P695, DOI 10.1006/anbe.2001.1804; Park D, 2008, J HERPETOL, V42, P615, DOI 10.1670/07-285R1.1; Woodley S, 2015, HORM BEHAV, V68, P3, DOI 10.1016/j.yhbeh.2014.06.008; NUSSBAUM RA, 1987, RES POPUL ECOL, V29, P27, DOI 10.1007/BF02515423; Hasumi M, 2014, POLAR BIOL, V37, P459, DOI 10.1007/s00300-013-1443-0; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Lindstrom L, 1999, EVOL ECOL, V13, P605, DOI 10.1023/A:1011004129607; Edenbrow M, 2011, ANIM BEHAV, V81, P551, DOI 10.1016/j.anbehav.2010.11.026; Kajiura SM, 2001, ENVIRON BIOL FISH, V61, P125, DOI 10.1023/A:1011028312787; Park D, 2000, J HERPETOL, V34, P594, DOI 10.2307/1565276; Zamudio KR, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P300, DOI 10.1017/CBO9780511542602.012; OBIKA M, 1964, SCIENCE, V143, P485, DOI 10.1126/science.143.3605.485; Crump Martha L., 1995, Amphibian Biology, V2, P518; Forester DC, 1998, BEHAVIOUR, V135, P99; STRONG DR, 1973, ECOLOGY, V54, P1383; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; HOLMES WG, 1983, AM SCI, V71, P46; Anthony CD, 1997, BEHAVIOUR, V134, P71, DOI 10.1163/156853997X00287; Hasumi M, 2001, HERPETOLOGICA, V57, P396; Arnold S.J., 1977, P141; Bulakhova NA, 2014, POLAR BIOL, V37, P123, DOI 10.1007/s00300-013-1418-1; Burrowes PA, 2000, HERPETOLOGICA, V56, P375; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Crews D, 1982, SCI AM, V247, P158, DOI DOI 10.1038/SCIENTIFICAMERICAN1182-158; Crump Martha L., 1996, Advances in the Study of Behavior, V25, P109; Elgar M.A., 1988, P59; Etchison Luke, 2012, International Journal of Biology, V4, P163; Hasumi Masato, 2001, Herpetological Review, V32, P223; HASUMI M, 1990, COPEIA, P367, DOI 10.2307/1446342; Houck Lynne D., 2010, P409; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Kami Haji Gholi, 2004, Asiatic Herpetological Research, V10, P182; Kuzmin SL, 2001, ADV AMPHIBIAN RES FO, V6; Lanza B, 1998, ENCY REPTILES AMPHIB, P60; Linder G, 2003, AMPHIBIAN DECLINE IN; Lofts B., 1987, P283; Luddecke Horst, 2000, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P303; Mann T, 1984, SPERMATOPHORES; Moore F.L., 1987, P505; Nakamura D, 1941, BOTANY ZOOLOGY TOKYO, V9, P515; NUSSBAUM R. A., 1985, MISC PUBL MUSEUM ZOO, V169, P1; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; Paraskiv KP, 1953, IZV AN KAZSSR B, V8, P47; Park Daesik, 2005, Current Herpetology, V24, P7, DOI 10.3105/1345-5834(2005)24[7:TFOOBO]2.0.CO;2; Park Shi-Ryong, 1996, Korean Journal of Zoology, V39, P437; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI 10.1016/B978-012100543-6/50026-X; Petranka J.W., 1998, SALAMANDERS US CANAD; Pough FH, 2001, HERPETOLOGY; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Reinhard S, 2013, ZOOL ANZ, V253, P1, DOI 10.1016/j.jcz.2013.06.002; Sasaki M, 1924, J COLL AGR HOKKAIDO, V15, P1; Sato Takanori, 1992, Japanese Journal of Herpetology, V14, P184; Sato T, 1991, B OBIHIRO CENTENNIAL, V9, P15; Serbinova I.A., 1995, Asiatic Herpetological Research, V6, P114; Sparreboom M, 2014, SALAMANDERS OLD WORL; Tago K, 1931, NEWTS SALAMANDERS; Tanaka K., 1989, P437; TANAKA K, 1986, Japanese Journal of Herpetology, V11, P173; Thorn R, 1968, SALAMANDRES EUROPE A; Thorn R., 1994, Russian Journal of Herpetology, V1, P86; Thorn R., 1962, Copeia, V1962, P638, DOI 10.2307/1441191; Usuda Hiroshi, 1993, Japanese Journal of Herpetology, V15, P64; Wells K. D., 2007, ECOLOGY BEHAV AMPHIB; Whittier J.M., 1987, P385; Wilson E.O., 1975, SOCIOBIOLOGY NEW SYN	110	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0873-9749	1437-9546		ACTA ETHOL	Acta Ethol.	OCT	2015	18	3					243	253		10.1007/s10211-015-0214-z		11	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CT5WA	WOS:000362880600001		
J	Kimura, K; Hirano, T; Chiba, S				Kimura, Kazuki; Hirano, Takahiro; Chiba, Satoshi			Assortative mating with respect to size in the simultaneously hermaphroditic land snail Bradybaena pellucida	ACTA ETHOLOGICA			English	Article						Land snails; Mate choice; Simultaneous hermaphrodites; Size-assortative mating; Bradybaena pellucida	EARTHWORM LUMBRICUS-TERRESTRIS; MATE-CHOICE; BODY-SIZE; SEXUAL SELECTION; SUCCESS; GENDER	There is ample evidence that body size is tightly linked with quality and fecundity of individuals in simultaneously hermaphroditic species. Especially in simultaneous hermaphrodites with reciprocal intromission, it has been thought that assortative mating with respect to body size occurs. Contrary to this expectation, studies on size-assortative mating in such simultaneous hermaphrodites have shown inconsistent mating patterns. It is important to gain an understanding of mating patterns with regard to body size in various hermaphroditic species as a first step for considering the causes for such species differences. In the present study, we examined the relationship between body size and fecundity in the simultaneously hermaphroditic land snail Bradybaena pellucida. We also tested size-assortative mating patterns in this species under a laboratory condition. The results of the experiments showed that life-span fecundity was positively correlated with body size and that the snails tended to choose mating partners of similar body size. As we had predicted, size also affected the mating pattern and assortative mating in simultaneous hermaphrodites with reciprocal intromission. This size-assortative mating pattern seems to result from sexual selection processes, not from mechanical constraints and habitat heterogeneity between large and small individuals.	[Kimura, Kazuki; Hirano, Takahiro; Chiba, Satoshi] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Aoba Ku, Sendai, Miyagi 9800862, Japan	Kimura, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Aoba Ku, Kawauchi 41, Sendai, Miyagi 9800862, Japan.	k.kimura.000@gmail.com			Environment Research and Technology Development Fund of Ministry of the Environment [4-1402]	We express our sincere gratitude to Y. Kameda and N. Nyumura for valuable comments on this study. This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment (4-1402).	Ferrer M, 2003, ANIM BEHAV, V66, P137, DOI 10.1006/anbe.2003.2158; Koene JM, 2007, ANIM BIOL, V57, P247, DOI 10.1163/157075607780377983; Michiels NK, 2001, BEHAV ECOL, V12, P612, DOI 10.1093/beheco/12.5.612; Scharer L, 2001, J EVOLUTION BIOL, V14, P55, DOI 10.1046/j.1420-9101.2001.00263.x; ENNOS RA, 1987, HEREDITY, V58, P119, DOI 10.1038/hdy.1987.16; Kimura K, 2013, ANIM BEHAV, V85, P631, DOI 10.1016/j.anbehav.2012.12.026; Arnqvist G, 1996, EVOL ECOL, V10, P265, DOI 10.1007/BF01237684; Chaine A, 2005, BEHAV ECOL SOCIOBIOL, V59, P58, DOI 10.1007/s00265-005-0009-8; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Yu TL, 2013, ETHOLOGY, V119, P738, DOI 10.1111/eth.12114; Vreys C, 1997, P ROY SOC B-BIOL SCI, V264, P1559; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Bollache L, 2004, J ZOOL, V264, P135, DOI 10.1017/S0952836904005643; Peters A, 1996, FRESHWATER BIOL, V36, P623, DOI 10.1046/j.1365-2427.1996.00128.x; Hoefler CD, 2007, ANIM BEHAV, V73, P943, DOI 10.1016/j.anbehav.2006.10.017; Koene JM, 2005, BEHAV ECOL SOCIOBIOL, V59, P243, DOI 10.1007/s00265-005-0030-y; Arak A., 1983, P181; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; BAUR B, 1992, ANIM BEHAV, V43, P511, DOI 10.1016/S0003-3472(05)80109-5; BROWN WD, 1993, BEHAV ECOL SOCIOBIOL, V33, P151, DOI 10.1007/BF00216595; CRESPI BJ, 1989, ANIM BEHAV, V38, P980, DOI 10.1016/S0003-3472(89)80138-1; Han CS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-359; Leonard JL, 2013, CURR ZOOL, V59, P589; R Development Core Team, 2012, R LANG ENV STAT COMP; Ridley M, 1983, EXPLANATION ORGANIC; Tomiyama K, 1996, J MOLLUS STUD, V62, P101, DOI 10.1093/mollus/62.1.101	26	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0873-9749	1437-9546		ACTA ETHOL	Acta Ethol.	OCT	2015	18	3					265	268		10.1007/s10211-014-0211-7		4	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CT5WA	WOS:000362880600003		
J	Kueakhai, P; Changklungmoa, N; Chaichanasak, P; Jaikua, W; Itagaki, T; Sobhon, P				Kueakhai, Pornanan; Changklungmoa, Narin; Chaichanasak, Pannigan; Jaikua, Wipaphorn; Itagaki, Tadashi; Sobhon, Prasert			Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice	ACTA TROPICA			English	Article						Fasciola gigantica; Cathepsin L1; Vaccine; Mice; Protection	SAPOSIN-LIKE PROTEIN-2; LEUCINE AMINOPEPTIDASE; MOLECULAR-CLONING; IMMUNE-RESPONSES; HEPATICA; PROTECTION; INFECTION; CATTLE; SHEEP; L1	In Fasciola gigantica cathepsin L1 (CatL1) is a family of predominant proteases that is expressed in caecal epithelial cells and secreted into the excretory-secretory products (ES). CatL1 isotypes are expressed in both early and late stages of the life cycle and the parasites use them for migration and digestion. Therefore, CatL1 is a plausible target for vaccination against this parasite. Recombinant pro-F.gigantica CatL1 (rproFgCatL1) and recombinant mature F.gigantica CatL1 (rmatFgCatL1) were expressed in Escherichia coli BL21. The vaccination was performed in Imprinting Control Region (ICR) mice (n=10) by subcutaneous injection with 50 mu g of rproFgCatL1 and rmatFgCatL1 combined with Freund's adjuvant. Two weeks after the second boost, mice were infected with 15 metacercariae by the oral route. The level of protection of rproFgCatL1 and rmatFgCatL1 vaccines was estimated to be 39.1,41.7% and 44.9,47.2% when compared with non vaccinated-infected and adjuvant-infected controls, respectively. Antibodies in the immune sera of vaccinated mice were shown by immuno-blotting to react with the native FgCatL1 in the extract of newly excysted juveniles (NEJ), 4-week-old juveniles and the ES products of 4 week-old juveniles. By determining the levels of IgG1 and IgG2a in the immune sera, which are indicative of Th2 and Th1 immune response, respectively, it was found that both Th1 and Th2 responses were significantly increased in rproFgCatL1- and rmatFgCatL1-immunized groups compared with the control groups, with higher levels of Th2 (IgG1) than Th1 (IgG2a). The levels of serum aspartate aminotransferase (AST) and alanine transaminase (ALT) in rmatFgCatL1-immunized group showed a significant decrease when compared to rproFgCatL1-immunized group, indicating that rmatFgCatL1-vaccinated mice had reduced liver parenchyma damage. The pathological lesions of liver in vaccinated groups were significantly decreased when compared with control groups. This study indicates that rFgCatL1 has a potential as a vaccine candidate against F. gigantica in mice, and this potential will be tested in ruminants. (C) 2015 Elsevier B.V. All rights reserved.	[Kueakhai, Pornanan; Changklungmoa, Narin] Burapha Univ, Fac Allied Hlth Sci, Mueang Dist 20131, Chonburi, Thailand; [Chaichanasak, Pannigan] Mahanakorn Univ Technol, Fac Vet Med, Bangkok 10530, Thailand; [Jaikua, Wipaphorn] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand; [Itagaki, Tadashi] Iwate Univ, Fac Agr, Lab Vet Parasitol, Morioka, Iwate 0208550, Japan; [Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand	Kueakhai, P (reprint author), Burapha Univ, Fac Allied Hlth Sci, Long Hard Bangsaen Rd, Mueang Dist 20131, Chonburi, Thailand.	pornanan@buu.ac.th			Faculty of Allied Health Sciences, Burapha University, Thailand [AHS03/2557]; Burapha University through National Research Council of Thailand [134/2558]	This research was supported by grants from Faculty of Allied Health Sciences, Burapha University, Thailand, to Pornanan Kueakhai (Grant no. AHS03/2557) and the Research Grant of Burapha University through National Research Council of Thailand to Pornanan Kueakhai (Grant no. 134/2558).	Maggioli G, 2011, EXP PARASITOL, V129, P323, DOI 10.1016/j.exppara.2011.09.013; Kueakhai P, 2011, PARASITOL RES, V108, P1493, DOI 10.1007/s00436-010-2201-7; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Clery D, 1996, VET PARASITOL, V62, P71, DOI 10.1016/0304-4017(95)00858-6; Kueakhai P, 2013, ACTA TROP, V125, P157, DOI 10.1016/j.actatropica.2012.11.001; Raadsma HW, 2007, VET PARASITOL, V143, P275, DOI 10.1016/j.vetpar.2006.09.008; Moreau E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/428593; SANDEMAN RM, 1981, RES VET SCI, V30, P294; Changklungmoa N, 2013, PARASITOL RES, V112, P3653, DOI 10.1007/s00436-013-3553-6; Berasain P, 1997, J PARASITOL, V83, P1, DOI 10.2307/3284308; Sethadavit M, 2009, ACTA TROP, V112, P164, DOI 10.1016/j.actatropica.2009.07.016; Espino AM, 2004, J PARASITOL, V90, P876, DOI 10.1645/GE-215R; Lane G, 1998, VET REC, V143, P232; Dalton JP, 2001, VET PARASITOL, V98, P149, DOI 10.1016/S0304-4017(01)00430-7; Norbury LJ, 2011, BIOCHIMIE, V93, P604, DOI 10.1016/j.biochi.2010.12.004; Golden O, 2010, VACCINE, V28, P5551, DOI 10.1016/j.vaccine.2010.06.039; Sansri V, 2015, VACCINE, V33, P1596, DOI 10.1016/j.vaccine.2015.02.010; Espino AM, 2010, ETHNIC DIS, V20, P17; Mulcahy G, 1999, RES VET SCI, V67, P27, DOI 10.1053/rvsc.1998.0270; Kueakhai P, 2013, VACCINE, V31, P5518, DOI 10.1016/j.vaccine.2013.09.027; Moll L, 2000, VET PARASITOL, V91, P153, DOI 10.1016/S0304-4017(00)00267-3; Mulcahy G, 1998, VACCINE, V16, P932, DOI 10.1016/S0264-410X(97)00289-2; Grams R, 2001, PARASITOL INT, V50, P105, DOI 10.1016/S1383-5769(01)00068-X; Maggioli G, 2011, VACCINE, V29, P9057, DOI 10.1016/j.vaccine.2011.09.020; Sansri V, 2013, ACTA TROP, V128, P76, DOI 10.1016/j.actatropica.2013.06.013; Meemon K, 2010, EXP PARASITOL, V125, P371, DOI 10.1016/j.exppara.2010.03.003; Raina OK, 2011, ACTA TROP, V118, P217, DOI 10.1016/j.actatropica.2011.02.008; Jayaraj R, 2009, VET PARASITOL, V160, P230, DOI 10.1016/j.vetpar.2008.10.099; Piacenza L, 1999, INFECT IMMUN, V67, P1954; Chantree P, 2013, EXP PARASITOL, V135, P102, DOI 10.1016/j.exppara.2013.06.010; Dalton JP, 1996, INFECT IMMUN, V64, P5066; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; DALTON JP, 1989, MOL BIOCHEM PARASIT, V35, P161, DOI 10.1016/0166-6851(89)90118-7; FORD EJH, 1974, J COMP PATHOL, V84, P231, DOI 10.1016/0021-9975(74)90064-4; Golden O., 2010, VACCINE, V28, P2557; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Overend D.J., 1995, AUST VET J, V72, P75; Preyavichyapugdee N, 2008, EXP PARASITOL, V119, P229, DOI 10.1016/j.exppara.2008.01.014	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	OCT	2015	150						71	78		10.1016/j.actatropica.2015.06.020		8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CT5OK	WOS:000362859500011		
J	Barroso, PA; Nevot, MC; Hoyos, CL; Locatelli, FM; Lauthier, JJ; Ruybal, P; Cardozo, RM; Russo, PD; Vassiliades, CN; Mora, MC; Estevez, JO; Hashiguchi, Y; Korenaga, M; Basombrio, MA; Marco, JD				Barroso, Paola A.; Cecilia Nevot, M.; Hoyos, Carlos L.; Locatelli, Fabricio M.; Lauthier, Juan J.; Ruybal, Paula; Cardozo, Ruben M.; Russo, Pablo D.; Vassiliades, Carola N.; Mora, Maria C.; Octavio Estevez, J.; Hashiguchi, Yoshihisa; Korenaga, Masataka; Basombrio, Miguel A.; Marco, Jorge D.			Genetic and clinical characterization of canine leishmaniasis caused by Leishmania (Leishmania) infanturn in northeastern Argentina	ACTA TROPICA			English	Article						Leishmania infantum; Argentina; Canine; Typing; Cytochrome b; Dog	CYTOCHROME-B GENE; AMERICAN TEGUMENTARY LEISHMANIASIS; MULTILOCUS ENZYME ELECTROPHORESIS; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; RESERVOIRS; INFECTION; DOGS; IDENTIFICATION; BRAZILIENSIS	Leishmaniases comprise zoonotic diseases caused by protozoan flagellates of the Leishmania genus. They are endemic to South America, and the visceral form has been recently reported in Argentina. Dogs can play different roles in the Leishmania transmission cycles, depending mainly on the species of parasite involved. Here we focused on the clinical characterization of canine leishmaniasis (CanL) in Northeast Argentina and on the molecular typing of its etiological agent. The nested polymerase chain reaction and sequence analysis of the Leishmania cytochrome b (cyt b) gene was performed on DNA templates purified from lymph nodes, bone marrow or spleen aspirates obtained from 48 dogs previously diagnosed by the observation of Leishmania amastigotes on smears from these aspirates. Their clinical and epidemiological data were also recorded. Systemic abnormalities were observed in 46 subjects (95.8%), most frequently lymphadenopathy, and emaciation (89.6 and 75%). Furthermore, 87% also presented tegumentary abnormalities, such as alopecia (54.2%) or secondary skin lesions (47.9%), among others. Twenty three dogs were positive for cyt b amplification. The sequence analysis showed the presence of two genotypes, LiA1 and LiA2, assigned to Leishmania (Leishmania) infantum, with 99.9 and 100% homology with the reference strain MHOM/TN/80/IPT1 respectively. LiA1 was identified in 18 cases (78.3%) and LiA2 in five (21.7%). Two cyt b variants of L. (L.) infantum were incriminated as the causative agents of CanL cases from three cities: Posadas, Garupa, and Ituzaingo. All three cities are located in the northeastern area of the country, where these parasites seem to be spreading in urban areas. (C) 2015 Elsevier B.V. All rights reserved.	[Barroso, Paola A.; Lauthier, Juan J.; Mora, Maria C.; Basombrio, Miguel A.; Marco, Jorge D.] UNSa, CONICET, Fac Ciencias Salud, Inst Patol Expt, RA-5150 Bolivia, Argentina; [Barroso, Paola A.; Hoyos, Carlos L.] UNSa, Sede Reg Oran, Inst Invest Enfermedades Trop, Salta, Argentina; [Cecilia Nevot, M.; Russo, Pablo D.; Vassiliades, Carola N.; Octavio Estevez, J.] Vet Oeste, Buenos Aires, DF, Argentina; [Locatelli, Fabricio M.; Hashiguchi, Yoshihisa; Korenaga, Masataka] Kochi Univ, Kochi Med Sch, Dept Parasitol, Nanko Ku, Kochi 7838505, Japan; [Ruybal, Paula] Univ Buenos Aires, CONICET, Fac Med, Inst Invest Microbiol & Parasitol Med, RA-2155 Buenos Aires, DF, Argentina; [Cardozo, Ruben M.] Minist Salud Publ, Coordinac Gest Epidemiol, Ctr Civ Grand Bourg, RA-4400 Salta, Argentina; [Hashiguchi, Yoshihisa] Univ Cent Ecuador & Proyecto Prometeo, SNESCYT, Ctr Biomed, Quito, Ecuador; [Marco, Jorge D.] UNSa, Fac Ciencias Exactas, Catedra Microbiol, RA-5150 Bolivia, Argentina	Marco, JD (reprint author), UNSa, CONICET, Fac Ciencias Salud, Inst Patol Expt, A4408FVY Salta, RA-5150 Bolivia, Argentina.	paobarar@yahoo.com.ar; cecilianevot@yahoo.com.ar; carloslhoyos@gmail.com; fm.locatelli@gmail.com; juanjoselauthier@gmail.com; pruybal@gmail.com; cardozo_rm@yahoo.com.ar; veterinariorusso@hotmail.com; laboratoriomisiones@hotmail.com; mariaceliamora@yahoo.com.ar; octavioes2003@yahoo.com.ar; hasiguti@kochi-u.ac.jp; korenaga@kochi-u.ac.jp; basombri@unsa.edu.ar; diegomarcoar@gmail.com			National Agency for Science and Technology, Argentina [PICT-2009-0135]; Research Council of the National University of Salta [2041]; Japanese Society for the Promotion of Science [KAKENHI 18-06242]	We are grateful to Taketoshi Taniguchi, Keiko Morisawa, Jose Gil, Kyoko Imamura, and Daniel Ribble for their contributions and valuable comments. Financial support was obtained from the National Agency for Science and Technology, Argentina (PICT-2009-0135); The Research Council of the National University of Salta (Grant No. 2041); the Japanese Society for the Promotion of Science (KAKENHI 18-06242).	Dantas-Torres F, 2011, EMERG INFECT DIS, V17, P326, DOI 10.3201/eid1702.091823; Acardi SA, 2010, MEM I OSWALDO CRUZ, V105, P796, DOI 10.1590/S0074-02762010000600011; Kato H, 2010, J CLIN MICROBIOL, V48, P3661, DOI 10.1128/JCM.00498-10; Marco JD, 2001, MEM I OSWALDO CRUZ, V96, P649, DOI 10.1590/S0074-02762001000500009; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Luyo-Acero GE, 2004, PARASITOLOGY, V128, P483, DOI 10.1017/S0031182004004792; Barroso PA, 2015, AM J TROP MED HYG, V93, P334, DOI 10.4269/ajtmh.14-0267; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; Padilla AM, 2002, VET PARASITOL, V110, P1, DOI 10.1016/S0304-4017(02)00330-8; Kato H, 2008, AM J TROP MED HYG, V79, P438; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Foulet F, 2007, J CLIN MICROBIOL, V45, P2110, DOI 10.1128/JCM.02555-06; Barrio A, 2012, EMERG INFECT DIS, V18, P354, DOI [10.3291/eid1802.110924, 10.3201/eid1802.110924]; Marco JD, 2006, AM J TROP MED HYG, V75, P261; Marco JD, 2005, AM J TROP MED HYG, V72, P606; Marco JD, 2006, AM J TROP MED HYG, V75, P256; Sobrino R, 2008, VET PARASITOL, V155, P198, DOI 10.1016/j.vetpar.2008.05.003; Cruz I, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-342; Echenique H, 2010, DIRECCION EPIDEMIOLO; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lima IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087742; Locatelli FM, 2014, ACTA TROP, V131, P16, DOI 10.1016/j.actatropica.2013.11.015; Marco J.D., 2007, RES REPORT SERIES, V8, P96; Marco JD, 2015, INFECT GENET EVOL, V30, P308, DOI 10.1016/j.meegid.2014.12.031; Organization WH, 2010, WORLD MAL REP 2010, P1; Souza TD, 2014, VET PARASITOL, V200, P233, DOI 10.1016/j.vetpar.2013.12.025; WHO, 2004, REP JOINT WHO FAO WO, P1	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	OCT	2015	150						218	223		10.1016/j.actatropica.2015.08.007		6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CT5OK	WOS:000362859500033		
J	Iwamoto, A; Izumidate, R; De Craene, LPR				Iwamoto, Akitoshi; Izumidate, Ryoko; De Craene, Louis P. Ronse			Floral anatomy and vegetative development in Ceratophyllum demersum: A morphological picture of an "unsolved" plant	AMERICAN JOURNAL OF BOTANY			English	Article						anisoclady; basal angiosperm; Ceratophyllaceae; Ceratophyllum demersum; floral anatomy; mechanical force; phyllotaxis; vegetative development	BASAL ANGIOSPERMS; GENES; ORIGIN; EXPRESSION; EVOLUTION; FLOWERS	PREMISE OF THE STUDY: The phylogenetic position of Ceratophyllum is still controversial in recent molecular analyses of angiosperms, with various suggestions of a sister group relation to all other angiosperms, eudicots, monocots, eudicots + monocots, and magnoliids. Therefore, the morphological characters of Ceratophyllum are important for resolving the phylogeny of angiosperms. In this study, we observed the detailed developmental anatomy of all lateral organs and their configurations to elucidate the floral development and phyllotactic pattern of Ceratophyllum demersum. METHODS: We observed fixed shoots of C. demersum with scanning electron microscopy and serial sections of the samples with light microscopy. KEY RESULTS: Bract primordia arise first, followed by the stamen primordia in staminate flowers. Both bracts and stamens initiate unidirectionally, first on the abaxial side of the floral apex and later on the adaxial side, most likely due to the contact pressure imposed by the leaf primordium at the superior node. In pistillate flowers, bract primordia on the abaxial side were also initiated first. The configuration of buds at one node showed six patterns and each pattern included at least one vegetative bud, and flower buds were always accompanied by vegetative buds at the same node. CONCLUSIONS: The initiation pattern of organs in the outer whorls of C. demersum flowers is distorted by mechanical pressure, resulting in the phyllotactic variation of staminate flowers. Vegetative buds are the main axillary buds with floral buds as accessory buds, which suggests that the shoot of C. demersum has been modified from a decussate phyllotaxis.	[Iwamoto, Akitoshi; Izumidate, Ryoko] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan; [De Craene, Louis P. Ronse] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland	Iwamoto, A (reprint author), Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan.	akitoshi@u-gakugei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25119707]	We thank Mr. Koji Okuda and Mr. Michio Usuba for the support to collect materials. Our thanks also go to Dr. Kester Bull and members of FLO-RE-S network for helpful advice on the manuscript, and Dr. Don Les and an anonymous reviewer for helpful suggestions to improve the manuscript. This study was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 25119707 to AI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aboy H. E., 1936, THESIS CORNEL U ITHA; Robinson S, 2013, J EXP BOT, V64, P4729, DOI 10.1093/jxb/ert199; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Maia VH, 2014, INT J PLANT SCI, V175, P613, DOI 10.1086/676675; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Katayama N, 2010, PLANT CELL, V22, P2131, DOI 10.1105/tpc.109.073189; Endress PK, 2011, AM J BOT, V98, P370, DOI 10.3732/ajb.1000299; LES DH, 1988, TAXON, V37, P326, DOI 10.2307/1222142; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Rutishauser R, 1999, INT J PLANT SCI, V160, pS81, DOI 10.1086/314221; Weber A, 2013, ANN BOT-LONDON, V112, P1577, DOI 10.1093/aob/mct156; Goremykin VV, 2009, J MOL EVOL, V68, P197, DOI 10.1007/s00239-009-9206-9; Naghiloo S, 2012, PLANTA, V235, P793, DOI 10.1007/s00425-011-1538-1; SEHGAL A, 1981, BOT J LINN SOC, V82, P343, DOI 10.1111/j.1095-8339.1981.tb00966.x; JERNSTEDT JA, 1992, ANN BOT-LONDON, V69, P351; Buzgo M, 2000, INT J PLANT SCI, V161, P23, DOI 10.1086/314241; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Iwamoto A, 2003, AM J BOT, V90, P1124, DOI 10.3732/ajb.90.8.1124; Bremer B, 2009, BOT J LINN SOC, V161, P105; Bell A. D., 2008, PLANT FORM; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Endress P. K., 1994, PLANT SYST EVOL S, V8, P175; Endress PK, 2001, INT J PLANT SCI, V162, P1111, DOI 10.1086/321919; Goebel K, 1905, ORGANOGRAPHY PLANT 2; Iwamoto A, 2012, NEW PLANT SYSTEMATIC, P52; JONES EDWARD N., 1931, UNIV IOWA STUDIES NAT HIST, V13, P11; Judd W.S., 1999, PLANT SYSTEMATICS PH; Les D. H., 1986, THESIS OHIO STATE U; Les D. H., 1993, FAMILIES GENERA VASC, V3, P248; Loiseau J. E., 1963, B SOC BOT FRANCE, V110, P76; MAJUMDAR GIRUA P., 1958, PROC INDIAN ACAD SCI SECT B, V48, P211; Raynal Roques A., 1981, THESIS U MONTPELLIER; RUTISHAUSER R, 1987, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V109, P227; SCHAEPPI HANS JAKOB, 1935, PLANTA, V24, P755, DOI 10.1007/BF01910980; Schneider E. L., 1996, CONTRIBUTIONS BOT, V17, P437; SHAMROV I I, 1983, Botanicheskii Zhurnal (St. Petersburg), V68, P1357; SHAMROV I I, 1981, Botanicheskii Zhurnal (St. Petersburg), V66, P1464; Shamrov I. I., 1997, Botanicheskii Zhurnal (St. Petersburg), V82, P1; SOLTIS P. S., 2003, INT J PLANT SCI, V164, pS329; Tucker Shirley C., 1996, P141, DOI 10.1007/978-0-585-23095-5_7	41	0	0	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	0002-9122	1537-2197		AM J BOT	Am. J. Bot.	OCT	2015	102	10					1578	1589		10.3732/ajb.1500124		12	Plant Sciences	Plant Sciences	CT5NA	WOS:000362855900003		
J	Thomason, J; Reyes, M; Allen, SR; Jones, RO; Beeram, MR; Kuehl, TJ; Suzuki, F; Uddin, MN				Thomason, Jessica; Reyes, Michelle; Allen, Steven R.; Jones, Richard O.; Beeram, Madhava R.; Kuehl, Thomas J.; Suzuki, Fumiaki; Uddin, Mohammad Nasir			Elevation of (Pro)Renin and (Pro)Renin Receptor in Preeclampsia	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; hypertension; placenta; preeclampsia; (pro)renin; (pro)renin receptor; renin-angiotensin system	RENIN-ANGIOTENSIN SYSTEM; PREGNANCY-INDUCED HYPERTENSION; NONPROTEOLYTIC ACTIVATION; PRORENIN RECEPTOR; GENE-EXPRESSION; BLOOD-PRESSURE; HUMAN PLACENTA; DECOY PEPTIDE; HUMAN TISSUES; ACTIVE RENIN	OBJECTIVE Preeclampsia (preE), a syndrome of hypertension, proteinuria, and edema, has many elusive triggers. The renin-angiotensin system has been implicated in preE pathogenesis. In this study, we test the hypothesis that (pro)renin levels are increased in preE patients and that levels of (pro)renin and (pro)renin receptor ((P)RR) are elevated in a rat model of preE. METHODS We recruited 30 preE and 43 normal pregnant consenting patients. We used normally pregnant rats (NP, n = 10) and pregnant rats receiving weekly injections of desoxycorticosterone acetate and whose drinking water was replaced with 0.9% saline (preE, n = 10). Plasma and placental levels of (pro)renin were assayed by ELISA. Placental and kidney (P)RR was measured both by immunoblotting and immunohistochemistry. RESULTS The mean plasma (pro)renin of 27.1 +/- 5.2 in preE patients differs from that in patients without preE: 14.8 +/- 5.2 ng Ang I/ml/hour (P < 0.0001). In rats, both plasma (NP: 22.7 +/- 4.3 and preE: 49.2 +/- 10.0 ng Ang I/ml/hour) and placental (NP: 152 +/- 24 and preE: 302 +/- 39 ng/g tissue) levels of (pro)renin were higher (P < 0.001) in preE compared to NP rats. (P)RR expression was greater (P < 0.05) in placental tissue of preE rats, while kidney (P)RR expression was similar. CONCLUSION Elevated levels of circulating (pro)renin have been observed in preE patients and in a rat model of preE. We also found the increased expression of placental (P)RR in preE rats.	[Thomason, Jessica; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Texas A&M Univ, Coll Med, Hlth Sci Ctr, Temple, TX 76508 USA; [Reyes, Michelle; Allen, Steven R.; Jones, Richard O.; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Dept Obstet, Temple, TX USA; [Reyes, Michelle; Allen, Steven R.; Jones, Richard O.; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Dept Gynecol, Temple, TX USA; [Beeram, Madhava R.; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Scott & White Healthcare, Texas A&M Hlth Sci Ctr, Dept Pediat, Coll Med, Temple, TX USA; [Suzuki, Fumiaki] Gifu Univ, Dept Appl Biol Sci, Gifu, Japan; [Uddin, Mohammad Nasir] Texas A&M Univ, Coll Med, Dept Internal Med, Hlth Sci Ctr, Temple, TX 76508 USA	Uddin, MN (reprint author), Texas A&M Univ, Coll Med, Hlth Sci Ctr, Temple, TX 76508 USA.	mnuddin@sw.org			Scott, Sherwood and Brindley Foundation [R4047UDDI]; Noble Centennial Endowment for Research in Obstetrics and Gynecology [R4500KUEH]; Scott & White Healthcare; Scott & White Research & Education Division, Temple, TX [R9240UDDI]	Funding for this work was provided by Scott, Sherwood and Brindley Foundation (R4047UDDI to M.N.U.) and the Noble Centennial Endowment for Research in Obstetrics and Gynecology (R4500KUEH to T.J.K.), Scott & White Healthcare, and from the Scott & White Research & Education Division (R9240UDDI), Temple, TX.	Anton L, 2009, ENDOCRINOLOGY, V150, P4316, DOI 10.1210/en.2009-0076; Singh HJ, 2004, PLACENTA, V25, P631, DOI 10.1016/j.placenta.2004.01.013; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCl200421398; ITSKOVITZ J, 1992, J CLIN ENDOCR METAB, V75, P906, DOI 10.1210/jc.75.3.906; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Xia Y, 2002, BIOL REPROD, V66, P135, DOI 10.1095/biolreprod66.1.135; Pridjian G, 2002, OBSTET GYNECOL SURV, V57, P598, DOI 10.1097/01.OGX.0000028585.23086.5E; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; BROWN MA, 1992, AM J HYPERTENS, V5, P366; Suzuki F, 2003, J BIOL CHEM, V278, P22217, DOI 10.1074/jbc.M302579200; Uddin MN, 2008, FRONT BIOSCI-LANDMRK, V13, P745, DOI 10.2741/2716; Anton L, 2008, HYPERTENSION, V51, P1066, DOI 10.1161/HYPERTENSIONAHA.107.103861; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Lenz T, 1996, ACTA OBSTET GYN SCAN, V75, P291, DOI 10.3109/00016349609047104; Uddin MN, 2010, AM J NEPHROL, V31, P171, DOI 10.1159/000267099; BRAR HS, 1987, AM J OBSTET GYNECOL, V157, P363; Merrill DC, 2002, ENDOCRINE, V18, P239, DOI 10.1385/ENDO:18:3:239; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284; Kalenga MK, 1996, CLIN ENDOCRINOL, V44, P429, DOI 10.1046/j.1365-2265.1996.703525.x; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; Kataoka K, 1996, IMMUNOPHARMACOLOGY, V32, P146, DOI 10.1016/0162-3109(95)00077-1; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418; Nielsen AH, 2000, PLACENTA, V21, P468, DOI 10.1053/plac.2000.0535; Uddin MN, 2009, AM J NEPHROL, V30, P26, DOI 10.1159/000193220; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Marques FZ, 2011, PLACENTA, V32, P214, DOI 10.1016/j.placenta.2010.12.006; Ringholm L, 2011, DIABETOLOGIA, V54, P1615, DOI 10.1007/s00125-011-2087-7; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Cooper AC, 1999, PLACENTA, V20, P467, DOI 10.1053/plac.1999.0404; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Shah DM, 2005, AM J PHYSIOL-RENAL, V288, pF614, DOI 10.1152/ajprenal.00410.2003; Hirose T, 2009, AM J HYPERTENS, V22, P294, DOI 10.1038/ajh.2008.357; Ito M, 2002, J CLIN ENDOCR METAB, V87, P1871, DOI 10.1210/jc.87.4.1871; DERKX FHM, 1987, J CLIN ENDOCR METAB, V65, P349; MORRIS BJ, 1992, J HYPERTENS, V10, P209, DOI 10.1097/00004872-199203000-00002; Nabi AH, 2007, FRONT BIOSCI, V12, P4810; Ott C, 2010, PHARMACOGENET GENOM, V21, P347; Tanosi-Irimie M, 2005, CLIN EXP HYPERTENS, V8, P605; Uddin MN, 2005, INT J MOL MED, V16, P1077; Uddin MN, 1998, BIOSCI BIOTECH BIOCH, V62, P338; World Health Organization, 2000, MAT MORT 2000 EST DE	43	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	OCT	2015	28	10					1277	1284		10.1093/ajh/hpv019		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CT5HP	WOS:000362839900012		
J	Hayase, T; Sugino, S; Moriya, H; Yamakage, M				Hayase, T.; Sugino, S.; Moriya, H.; Yamakage, M.			TACR1 gene polymorphism and sex differences in postoperative nausea and vomiting	ANAESTHESIA			English	Article							GENOME-WIDE ASSOCIATION; CHEMOTHERAPY-INDUCED NAUSEA; RISK-FACTORS; ANTAGONIST APREPITANT; TRANSCRIPTION FACTORS; RANDOMIZED-TRIAL; SUBSTANCE-P; III TRIALS; RECEPTOR; SCALE	We hypothesised that the genetic effect of single nucleotide polymorphisms in the TACR1 gene, which encodes NK1 receptors, could influence the sex difference in postoperative nausea and vomiting. Thirty-two selected single nucleotide polymorphisms were genotyped by the Sanger sequencing method in 200 patients who underwent lower abdominal surgery. The incidence and severity of postoperative nausea and vomiting were evaluated after surgery. The rs3755468-SNP showed significant association with the incidence and severity of postoperative nausea and vomiting (p = 0.016). The TT haplotype defined by two single nucleotide polymorphisms, including the rs3755468-SNP, was associated with reduced incidence and severity of postoperative nausea and vomiting in female patients (p = 0.03). The rs3755468-SNP is located within the predicted oestrogen response element and a DNase I hypersensitive site. The single nucleotide polymorphisms in the TACR1 gene are associated with sex differences in postoperative nausea and vomiting and may help to elucidate the mechanisms underlying these differences.	[Hayase, T.; Sugino, S.; Yamakage, M.] Sapporo Med Univ, Sch Med, Dept Anesthesiol, Sapporo, Hokkaido, Japan; [Moriya, H.] Hokkaido Pharmaceut Univ, Sch Pharm, Dept Pharm, Otaru, Hokkaido, Japan	Hayase, T (reprint author), Sapporo Med Univ, Sch Med, Dept Anesthesiol, Sapporo, Hokkaido, Japan.	eric.core2006@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [24791606, 23592301]	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 24791606, 2012-2014, to T.H.) and a Grant-in-Aid for Scientific Research (C) (no. 23592301, 2011-2013, to S.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. No competing interests declared.	Gan TJ, 2011, ANESTH ANALG, V112, P804, DOI 10.1213/ANE.0b013e31820886c3; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Levran O, 2011, J HUM GENET, V56, P147, DOI 10.1038/jhg.2010.150; Borgeat A, 2003, ANESTHESIOLOGY, V98, P530, DOI 10.1097/00000542-200302000-00036; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Martin AR, 2003, EUR J CANCER, V39, P1395, DOI 10.1016/S0959-8049(03)00299-5; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Janicki PK, 2011, ANESTHESIOLOGY, V115, P54, DOI 10.1097/ALN.0b013e31821810c7; Wengritzky R, 2010, BRIT J ANAESTH, V104, P158, DOI 10.1093/bja/aep370; Nakagawa M, 2008, J ANESTH, V22, P397, DOI 10.1007/s00540-008-0661-z; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Candiotti KA, 2005, ANESTHESIOLOGY, V102, P543, DOI 10.1097/00000542-200503000-00011; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Hesketh PJ, 2006, SUPPORT CARE CANCER, V14, P354, DOI 10.1007/s00520-005-0914-4; Gan TJ, 2007, CNS DRUGS, V21, P813, DOI 10.2165/00023210-200721100-00003; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Buchanan FF, 2011, BRIT J ANAESTH, V106, P832, DOI 10.1093/bja/aer094; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Chandrakantan A, 2011, BRIT J ANAESTH, V107, P27, DOI 10.1093/bja/aer358; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Boogaerts JG, 2000, ACTA ANAESTH SCAND, V44, P470, DOI 10.1034/j.1399-6576.2000.440420.x; Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Nielsen M, 2008, BRIT J ANAESTH, V101, P441, DOI 10.1093/bja/aen246; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Nesher N, 2008, PHARMACOL RES, V58, P38, DOI 10.1016/j.phrs.2008.06.003; Seneviratne C, 2009, NEUROPSYCHOPHARMACOL, V34, P2442, DOI 10.1038/npp.2009.65; MacKenzie A, 2013, TRENDS MOL MED, V19, P99, DOI 10.1016/j.molmed.2012.11.003; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Hesketh PJ, 2010, SUPPORT CARE CANCER, V18, P1171, DOI 10.1007/s00520-009-0737-9; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Janicki PK, 2014, EXP BRAIN RES, V232, P2613, DOI 10.1007/s00221-014-3968-z; Villablanca AC, 1997, MOL CELL ENDOCRINOL, V135, P109, DOI 10.1016/S0303-7207(97)00193-7; Wagner MJ, 2013, PHARMACOGENOMICS, V14, P413, DOI [10.2217/pgs.13.36, 10.2217/PGS.13.36]; Leslie K, 2008, BRIT J ANAESTH, V101, P498, DOI 10.1093/bja/aen230; Qian QH, 2010, CHINESE MED J-PEKING, V123, P478, DOI 10.3760/cma.j.issn.0366-6999.2010.04.017; Renner SP, 2009, GYNECOL ENDOCRINOL, V25, P726, DOI 10.3109/09513590903159631; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; Cheng R, 2005, ANN HUM GENET, V69, P102, DOI 10.1046/j.1529-8817.2004.00140.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Rueffert H, 2009, ANESTH ANALG, V109, P1442, DOI 10.1213/ane.0b013e3181b2359b; Bradesi S, 2003, PAIN, V102, P227, DOI 10.1016/S0304-3959(02)00056-8; Choi EM, 2010, ANAESTHESIA, V65, P996, DOI 10.1111/j.1365-2044.2010.06476.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Le Brun I, 2008, Neuroscience, V152, P56, DOI 10.1016/j.neuroscience.2007.12.024; Lin LH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-473; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NAKANISHI S, 1991, ANNU REV NEUROSCI, V14, P123, DOI 10.1146/annurev.neuro.14.1.123; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	OCT	2015	70	10					1148	1159		10.1111/anae.13082		12	Anesthesiology	Anesthesiology	CT2WY	WOS:000362667400007		
J	Toyama, S				Toyama, S.			Hypotension during spinal anaesthesia for caesarean section	ANAESTHESIA			English	Letter									Tokyo Med & Dent Univ, Hosp Med, Tokyo, Japan	Toyama, S (reprint author), Tokyo Med & Dent Univ, Hosp Med, Tokyo, Japan.	s-toyama@suite.plala.or.jp					Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; Scharwood-Smith G, 2009, BRIT J ANAESTH, V102, P291; Sumikura H, 2008, ANESTHESIOLOGY, V109, pA587; Toyama S, 2013, BRIT J ANAESTH, V36, P219; Yokose M, 2015, ANAESTHESIA, V70, P555, DOI 10.1111/anae.12992	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	OCT	2015	70	10					1208	1209		10.1111/anae.13202		3	Anesthesiology	Anesthesiology	CT2WY	WOS:000362667400016		
J	Yokose, M; Mihara, T; Goto, T				Yokose, M.; Mihara, T.; Goto, T.			Hypotension during spinal anaesthesia for caesarean section - a reply	ANAESTHESIA			English	Letter							INDEX		[Yokose, M.; Mihara, T.; Goto, T.] Kanagawa Childrens Med Ctr, Yokohama, Kanagawa, Japan	Yokose, M (reprint author), Kanagawa Childrens Med Ctr, Yokohama, Kanagawa, Japan.	yokose_p12@yahoo.co.jp					Toyama S, 2013, BRIT J ANAESTH, V111, P235, DOI 10.1093/bja/aet058; Sun S, 2014, INT J OBSTET ANESTH, V23, P324, DOI 10.1016/j.ijoa.2014.05.011; Yokose M, 2015, ANAESTHESIA, V70, P555, DOI 10.1111/anae.12992	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	OCT	2015	70	10					1210	1210		10.1111/anae.13229		1	Anesthesiology	Anesthesiology	CT2WY	WOS:000362667400018		
J	Sugimoto, H; Kakehi, M; Jinno, F				Sugimoto, Hiroshi; Kakehi, Masaaki; Jinno, Fumihiro			Method development for the determination of d and l-isomers of leucine in human plasma by high-performance liquid chromatography tandem mass spectrometry and its application to animal plasma samples	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						D- and L-Leucine; LC/MS/MS; Enantiomer separation; Surrogate matrix; Species difference	D-AMINO ACIDS; CHIRAL STATIONARY PHASES; GAS-CHROMATOGRAPHY; MUSCLE; URINE; SEPARATIONS; DIAGNOSIS; CINCHONA; MAMMALS; RODENTS	We developed a highly sensitive and specific high-performance liquid chromatography tandem mass spectrometry method with an electrospray ionization for the determination of d- and l-isomers of leucine in human plasma. Phosphate-buffered saline was used as the surrogate matrix for preparation of calibration curves and quality control samples. The extraction of d- and l-leucine in plasma samples (100 mu L) was performed using cationic exchange solid-phase extraction. The enantiomer separation of d- and l-leucine was successfully achieved without derivatization using a CHIRALPAK ZWIX(-) with an isocratic mobile phase comprised of methanol/acetonitrile/1 mol/L ammonium formate/formic acid (500:500:25:2, v/v/v/v) at a flow rate of 0.5 mL/min. In addition, the discrimination of dl-leucine from structural isomers dl-isoleucine and dl-allo-isoleucine was performed using the unique precursor and product ion pair transition of dl-leucine (m/z 132.1 > 43.0) and dl-leucine-d (7) (m/z 139.2 > 93.0) in positive electrospray ionization mode. The standard curves were linear throughout the calibration range from 0.001 to 1 mu g/mL for d-leucine and from 1 to 1000 mu g/mL for l-leucine, respectively, with acceptable intra- and inter-day precision and accuracy. The stability of d- and l-leucine in human plasma and solvents was confirmed. The endogenous level of d- and l-leucine in human plasma was 0.00197 similar to 0.00591 and 9.63 similar to 24.7 mu g/mL, respectively. This method was also successfully applied to investigate the species difference in the ratios of d-leucine to total leucine from individual plasma concentrations in humans and various animals. The plasma d-leucine concentrations or their ratio to total leucine in rodents was much higher than that in humans.	[Sugimoto, Hiroshi; Kakehi, Masaaki; Jinno, Fumihiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa 2518555, Japan	Sugimoto, H (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	hiroshi.sugimoto1@takeda.com					Alterman NA, 2012, AMINO ACID HDB; Kirschner DL, 2009, J SEP SCI, V32, P2305, DOI 10.1002/jssc.200900101; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; Jones BR, 2012, BIOANALYSIS, V4, P2343, DOI [10.4155/bio.12.200, 10.4155/BIO.12.200]; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Hoffmann CV, 2009, J CHROMATOGR A, V1216, P1157, DOI 10.1016/j.chroma.2008.12.044; Deng CH, 2003, J CHROMATOGR B, V792, P261, DOI 10.1016/S1570-0232(03)00270-8; Bruckner H, 2001, BIOMED CHROMATOGR, V15, P166, DOI 10.1002/bmc.57; Zhang T, 2014, J SEP SCI, V37, P1237, DOI 10.1002/jssc.201400149; Houghton R, 2009, BIOANALYSIS, V1, P1365, DOI [10.4155/bio.09.139, 10.4155/BIO.09.139]; Yamanaka M, 2012, AMINO ACIDS, V43, P1811, DOI 10.1007/s00726-012-1384-x; Salem AA, 2012, J CHROMATOGR B, V908, P27, DOI 10.1016/j.jchromb.2012.09.026; Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054; Miller JH, 2011, ANAL BIOANAL CHEM, V400, P237, DOI 10.1007/s00216-011-4740-x; Zhang T, 2014, J CHROMATOGR A, V1363, P191, DOI 10.1016/j.chroma.2014.06.012; NAGATA Y, 1992, J CHROMATOGR-BIOMED, V575, P147, DOI 10.1016/0378-4347(92)80516-S; McAllan L, 2013, J PHYSIOL BIOCHEM, V69, P155, DOI 10.1007/s13105-012-0170-2; Hoffmann CV, 2008, ANAL CHEM, V80, P8780, DOI 10.1021/ac801384f; Visser WF, 2011, J CHROMATOGR A, V1218, P7130, DOI 10.1016/j.chroma.2011.07.087; Hamase K, 2002, J CHROMATOGR B, V781, P73, DOI 10.1016/S1570-0232(02)00690-6; Tojo M, 2012, J CHROMATOGR SCI, V50, P393, DOI 10.1093/chromsci/bmr004; Hamase K, 2001, ANAL BIOCHEM, V298, P253, DOI 10.1006/abio.2001.5382; Simek P, 2012, METHODS MOL BIOL, V828, P137, DOI 10.1007/978-1-61779-445-2_13; Hamase K, 2007, J CHROMATOGR A, V1143, P105, DOI 10.1016/j.chroma.2006.12.078; ARMSTRONG DW, 1993, AMINO ACIDS, V5, P299, DOI 10.1007/BF00805992; Ham DJ, 2014, CLIN NUTR, V33, P937, DOI 10.1016/j.clnu.2014.09.016; Hamase K, 1997, BBA-GEN SUBJECTS, V1334, P214, DOI 10.1016/S0304-4165(96)00095-5; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Waldhier Magdalena C, 2011, J Chromatogr A, V1218, P4537, DOI 10.1016/j.chroma.2011.05.039	29	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	OCT	2015	407	26					7889	7898		10.1007/s00216-015-8999-1		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CT0UM	WOS:000362512800005		
J	Ogawa, T; Oikawa, S; Hirose, T				Ogawa, Takahiro; Oikawa, Shimpei; Hirose, Tadaki			Leaf dynamics in growth and reproduction of Xanthium canadense as influenced by stand density	ANNALS OF BOTANY			English	Article						Leaf dynamics; leaf longevity; leaf productivity; mean residence time; nitrogen resorption; nitrogen use efficiency; stand density; Xanthium canadense; cocklebur; Asteraceae	NITROGEN-USE-EFFICIENCY; NUTRIENT USE EFFICIENCY; MEAN RESIDENCE TIME; CARBON GAIN; LIFE-SPAN; CANOPY PHOTOSYNTHESIS; ANNUAL HERB; RESORPTION EFFICIENCY; HERBACEOUS PLANTS; INDIVIDUAL PLANTS	Background and Aims Leaf longevity is controlled by the light gradient in the canopy and also by the nitrogen (N) sink strength in the plant. Stand density may influence leaf dynamics through its effects on light gradient and on plant growth and reproduction. This study tests the hypothesis that the control by the light gradient is manifested more in the vegetative period, whereas the opposite is true when the plant becomes reproductive and develops a strong N sink. Methods Stands of Xanthium canadense were established at two densities. Emergence, growth and death of every leaf on the main stem and branches, and plant growth and N uptake were determined from germination to full senescence. Mean residence time and dry mass productivity were calculated per leaf number, leaf area, leaf mass and leaf N (collectively termed 'leaf variables') in order to analyse leaf dynamics and its effect on plant growth. Key Results Branching and reproductive activities were higher at low than at high density. Overall there was no significant difference in mean residence time of leaf variables between the two stands. However, early leaf cohorts on the main stem had a longer retention time at low density, whereas later cohorts had a longer retention time at high density. Branch leaves emerged earlier and tended to live longer at low than at high density. Leaf efficiencies, defined as carbon export per unit investment of leaf variables, were higher at low density in all leaf variables except for leaf number. Conclusions In the vegetative phase of plant growth, the light gradient strongly controls leaf longevity, whereas later the effects of branching and reproductive activities become stronger and over-rule the effect of light environment. As leaf N supports photosynthesis and also works as an N source for plant development, N use is pivotal in linking leaf dynamics with plant growth and reproduction.	[Ogawa, Takahiro; Oikawa, Shimpei; Hirose, Tadaki] Tokyo Univ Agr, Dept Int Agr Dev, Tokyo 1568502, Japan	Hirose, T (reprint author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan.	tadakihirose@gmail.com			Japan Society for the Promotion of Science [KAKENHI-20370015, 21114009, 23770027, 25440230]	We thank Kouki Hikosaka, Toshihiko Kinugasa and Marinus Werger for comments and discussion. The comments of anonymous referees were helpful in improving the manuscript. We are also grateful for the support of the staff members and students of the Laboratory for Agricultural Environmental Studies, Tokyo University of Agriculture. This work was financially supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (KAKENHI-20370015, 21114009, 23770027, 25440230).	Aerts R, 2000, ADV ECOL RES, V30, P1; Aerts R., 1996, J ECOL, V84, P596; Hikosaka K, 2005, ANN BOT-LONDON, V95, P521, DOI 10.1093/aob/mci050; BAZZAZ FA, 1977, NEW PHYTOL, V78, P193, DOI 10.1111/j.1469-8137.1977.tb01558.x; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Schieving F, 1999, NEW PHYTOL, V143, P201, DOI 10.1046/j.1469-8137.1999.00431.x; SHITAKA Y, 1993, OECOLOGIA, V95, P334, DOI 10.1007/BF00320985; AERTS R, 1990, OECOLOGIA, V84, P391; Anten NPR, 2005, ANN BOT-LONDON, V95, P495, DOI 10.1093/aob/mci048; DERMAN BD, 1978, AM J BOT, V65, P205, DOI 10.2307/2442454; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; ESASHI Y, 1968, PLANT PHYSIOL, V43, P871, DOI 10.1104/pp.43.6.871; Nishimura E, 2010, ECOL RES, V25, P383, DOI 10.1007/s11284-009-0666-6; HIKOSAKA K, 1994, OECOLOGIA, V97, P451, DOI 10.1007/BF00325881; GEBER MA, 1990, EVOLUTION, V44, P799, DOI 10.2307/2409547; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; Franklin O, 2002, FUNCT ECOL, V16, P727, DOI 10.1046/j.1365-2435.2002.00674.x; SCHMID B, 1994, ECOL MONOGR, V64, P177, DOI 10.2307/2937040; WEINER J, 1990, J ECOL, V78, P459, DOI 10.2307/2261124; Hirose T, 2012, OECOLOGIA, V169, P927, DOI 10.1007/s00442-012-2266-3; WERGER MJA, 1991, VEGETATIO, V97, P11; ACKERLY DD, 1992, OECOLOGIA, V89, P596; Osada N, 2013, PLANT ECOL, V214, P1493, DOI 10.1007/s11258-013-0270-2; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Hirose T, 2012, OECOLOGIA, V169, P591, DOI 10.1007/s00442-011-2223-6; NAGASHIMA H, 1995, ANN BOT-LONDON, V75, P173, DOI 10.1006/anbo.1995.1009; Yasumura Y, 2007, FUNCT PLANT BIOL, V34, P409, DOI 10.1071/FP06307; HOCKING PJ, 1983, ANN BOT-LONDON, V51, P787; HIROSE T, 1988, OECOLOGIA, V77, P145, DOI 10.1007/BF00379180; Oikawa S, 2006, NEW PHYTOL, V172, P104, DOI 10.1111/j.1469-8137.2006.01813.x; Vincent G, 2006, ANN BOT-LONDON, V97, P245, DOI 10.1093/aob/mcj023; Watari R, 2014, ANN BOT-LONDON, V114, P179, DOI 10.1093/aob/mcu088; Silla F, 2004, FUNCT ECOL, V18, P511, DOI 10.1111/j.0269-8463.2004.00872.x; Hikosaka K, 2012, FUNCT ECOL, V26, P1024, DOI 10.1111/j.1365-2435.2012.02042.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Hirose T, 2011, OECOLOGIA, V166, P863, DOI 10.1007/s00442-011-1942-z; Watari R, 2012, PHYSIOL PLANTARUM, V144, P335, DOI 10.1111/j.1399-3054.2011.01563.x; KIKUZAWA K, 1983, CAN J BOT, V61, P2133; INGESTAD T, 1979, PHYSIOL PLANTARUM, V45, P149, DOI 10.1111/j.1399-3054.1979.tb01679.x; Berendse F, 1987, FUNCT ECOL, V1, P293; SINCLAIR TR, 1975, SCIENCE, V189, P565, DOI 10.1126/science.189.4202.565; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Ono K, 1996, PLANT CELL PHYSIOL, V37, P1083; Hikosaka K, 2003, AM NAT, V162, P149, DOI 10.1086/376576; Norby RJ, 2000, PLANT SOIL, V224, P15, DOI 10.1023/A:1004629231766; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; PUGNAIRE FI, 1992, OECOLOGIA, V90, P120, DOI 10.1007/BF00317817; Shitaka Y, 1998, OECOLOGIA, V114, P361, DOI 10.1007/PL00008818; Casper BB, 1998, NEW PHYTOL, V140, P231, DOI 10.1046/j.1469-8137.1998.00271.x; Eckstein RL, 2001, NEW PHYTOL, V150, P641, DOI 10.1046/j.1469-8137.2001.00130.x; CRAFTSBRANDNER SJ, 1987, PLANT PHYSIOL, V85, P662, DOI 10.1104/pp.85.3.662; ANTEN NPR, 1995, OECOLOGIA, V101, P504, DOI 10.1007/BF00329431; Makino A, 2003, PLANT CELL PHYSIOL, V44, P952, DOI 10.1093/pcp/pcg113; Marty C, 2010, NEW PHYTOL, V187, P407, DOI 10.1111/j.1469-8137.2010.03290.x; CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; CHAPIN FS, 1991, ECOLOGY, V72, P709, DOI 10.2307/2937210; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Hikosaka K, 2010, AM J BOT, V97, P1944, DOI 10.3732/ajb.1000045; Fischer Andreas M., 2007, V26, P87; Marty C, 2009, NEW PHYTOL, V183, P1114, DOI 10.1111/j.1469-8137.2009.02893.x; Kinugasa T, 2005, ANN BOT-LONDON, V96, P81, DOI 10.1093/aob/mci152; Escudero A, 2003, J ECOL, V91, P880, DOI 10.1046/j.1365-2745.2003.00818.x; Oikawa S, 2005, OECOLOGIA, V143, P517, DOI 10.1007/s00442-005-0007-6; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; KARLSSON PF, 1994, OIKOS, V70, P191, DOI 10.2307/3545630; Oikawa S, 2008, NEW PHYTOL, V178, P617, DOI 10.1111/j.1469-8137.2008.02415.x; Bazzaz FA, 1995, OECOLOGIA, V101, P300; Evans GC, 1972, QUANTITATIVE ANAL PL; Evans JR, 1989, PHOTOSYNTHESIS, P183; Falster D. S., 2011, NEW PHYTOL, V193, P409; FARQUHAR GD, 1989, PHILOS T ROY SOC B, V323, P357, DOI 10.1098/rstb.1989.0016; Field C, 1986, EC PLANT FORM FUNCTI, P25; Garnier E, 1998, INHERENT VARIATION IN PLANT GROWTH, P515; Givnish Thomas J., 1995, P3, DOI 10.1016/B978-012276460-8/50003-5; Givnish TJ, 1982, AM NAT, V120, P743; Harper JL, 1989, PLANT CANOPIES THEIR, P103; HIROSE T, 1975, Journal of the Faculty of Science University of Tokyo Section III Botany, V11, P355; HIROSE T, 1978, Japanese Journal of Ecology, V28, P25; Hirose T, 2005, REPROD ALLOCATION PL, P159, DOI 10.1016/B978-012088386-8/50006-5; HIROSE T, 1971, Japanese Journal of Ecology, V21, P18; HIROSE T, 1984, ANN BOT-LONDON, V54, P695; Jones HG, 2014, PLANTS AND MICROCLIMATE: A QUANTITATIVE APPROACH TO ENVIRONMENTAL PLANT PHYSIOLOGY, 3RD EDITION, P1; Keenan TF, 2014, NEW PHYTOL, V205, P656; Lambers H., 1998, PLANT PHYSL ECOLOGY; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; Monsi M., 1960, Bot. Mag., V73, P81; SAEKI T., 1958, BOT MAG [TOKYO], V71, P235; Pons TL, 1989, CAUSES CONSEQUENCES, P175; Poorter Hendrik, 1994, P111; Possato L, 2001, J EXPT BOT, V52, P1655; R Development Core Team, 2010, R LANG ENV STAT COMP; SAKAI S, 1991, J THEOR BIOL, V148, P535, DOI 10.1016/S0022-5193(05)80235-8; Schieving F., 1992, PLANT SOIL, V14, P9; Stoddart JL, 1982, NUCL ACIDS PROTEINS, P592; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931	100	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	OCT	2015	116	5					807	819		10.1093/aob/mcv114		13	Plant Sciences	Plant Sciences	CT5IO	WOS:000362842400014		
J	Orman, O; Szewczyk, J				Orman, Olga; Szewczyk, Janusz			European beech, silver fir, and Norway spruce differ in establishment, height growth, and mortality rates on coarse woody debris and forest floor-a study from a mixed beech forest in the Western Carpathians	ANNALS OF FOREST SCIENCE			English	Article						Regeneration; Colonization pattern; Decaying wood; Microsite	SUB-ALPINE FOREST; TSUGA-HETEROPHYLLA FORESTS; BAVARIAN LIMESTONE ALPS; TEMPERATE RAIN-FOREST; FALLEN LOGS; SEEDLING RECRUITMENT; TREE REGENERATION; NORTHERN JAPAN; DWARF BAMBOO; MICROSITES	Key message In mixed forests, coarse woody debris promotes the successful establishment and growth of conifers and beech. In contrast to beech and fir, older spruce seedlings were only present on coarse woody debris and not on the forest floor. Context Coarse woody debris (CWD) is considered a suitable seedbed for small-seeded and light-demanding species. Its role in enhancing tree regeneration is well reported in boreal or subalpine spruce forests. Less is known about its role in the establishment, growth, and survival of other species, particularly in mixed forests. Aims We analyzed the role of CWD in seedling establishment, growth, and survival for European beech, silver fir, and Norway spruce. Methods We tracked the growth and survival of all germinants and seedlings over 5 years. Results Conifers were relatively more successful than beech at colonizing on CWD. The density of seedlings was variable in all CWD decay classes but was the highest on well-decomposed CWD. CWD supported the growth of all species. Beech cohorts and older seedlings had similar mortality rates on both microsites. Spruce germinants did not survive on the forest floor for more than a year, and older seedlings were only observed on CWD. Fir cohorts had similar mortality rates on both microsites, but older seedlings survived better on the forest floor. Conclusion Although the three species differed in their preferred microsite for establishment, CWD can be considered a suitable regeneration microsite for all three species by enhancing their growth and, in the case of spruce, both short- and long-term survival.	[Orman, Olga; Szewczyk, Janusz] Univ Agr, Forest Ecol & Silviculture Inst, Dept Forest Biodivers, PL-31425 Krakow, Poland	Orman, O (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778563, Japan.	olaorm@gmail.com; rljszewc@cyf-kr.edu.pl			Polish Ministry of Science and Higher Education [N N304 325436, N N309 716440]	This study was supported by the research grants: N N304 325436 (2009-12) and N N309 716440 (2011-14) of the Polish Ministry of Science and Higher Education.	Zielonka T, 2004, PLANT ECOL, V172, P63, DOI 10.1023/B:VEGE.0000026037.03716.fc; Odor P, 2006, BIOL CONSERV, V131, P58, DOI 10.1016/j.biocon.2006.02.004; Iijima H, 2007, J FOREST RES-JPN, V12, P262, DOI 10.1007/s10310-007-0012-1; Pouska V, 2010, EUR J FOREST RES, V129, P219, DOI 10.1007/s10342-009-0324-0; Mori A, 2004, FOREST ECOL MANAG, V196, P287, DOI 10.1016/j.foreco.2004.03.027; Mori A, 2005, FOREST ECOL MANAG, V210, P461, DOI 10.1016/j.foreco.2005.02.027; Iijima H, 2010, J FOREST RES-JPN, V15, P46, DOI 10.1007/s10310-009-0133-9; Narukawa Y, 2002, FOREST ECOL MANAG, V163, P61, DOI 10.1016/S0378-1127(01)00527-8; Parent S, 2006, CAN J FOREST RES, V36, P1976, DOI 10.1139/X06-091; Baier R, 2007, EUR J FOREST RES, V126, P11, DOI 10.1007/s10342-005-0091-5; Svoboda M, 2010, FOREST ECOL MANAG, V260, P707, DOI 10.1016/j.foreco.2010.05.027; Hunziker U, 2005, FOREST ECOL MANAG, V210, P67, DOI 10.1016/j.foreco.2005.02.019; Ulanova NG, 2000, FOREST ECOL MANAG, V135, P155, DOI 10.1016/S0378-1127(00)00307-8; Holeksa J, 2003, PLANT ECOL, V168, P57, DOI 10.1023/A:1024457303815; McKenny HJA, 1999, AUST J BOT, V47, P745, DOI 10.1071/BT98001; Christie DA, 2003, J ECOL, V91, P776, DOI 10.1046/j.1365-2745.2003.00813.x; Szwagrzyk J, 2001, FOREST ECOL MANAG, V141, P237, DOI 10.1016/S0378-1127(00)00332-7; Carlton GC, 1998, ECOL MONOGR, V68, P99, DOI 10.1890/0012-9615(1998)068[0099:ROTSBS]2.0.CO;2; Bellingham PJ, 2006, CAN J FOREST RES, V36, P910, DOI 10.1139/X05-308; SOLLINS P, 1982, CAN J FOREST RES, V12, P18, DOI 10.1139/x82-003; Iijima H, 2006, CAN J FOREST RES, V36, P664, DOI 10.1139/X05-285; Lusk CH, 2003, NEW PHYTOL, V158, P535, DOI 10.1046/j.1469-8137.2003.00760.x; KNAPP AK, 1982, CAN J BOT, V60, P2753; Takahashi M, 2000, CAN J FOREST RES, V30, P1148, DOI 10.1139/cjfr-30-7-1148; HARMON ME, 1989, AM MIDL NAT, V121, P112, DOI 10.2307/2425662; Bace R, 2011, SILVA FENN, V45, P1065, DOI 10.14214/sf.87; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Baier R, 2006, ANN FOREST SCI, V63, P339, DOI 10.1051/forest:2006014; Simon A, 2011, FOREST ECOL MANAG, V262, P1289, DOI 10.1016/j.foreco.2011.06.028; CHRISTY EJ, 1984, J ECOL, V72, P75, DOI 10.2307/2260007; Laiho R, 2004, CAN J FOREST RES, V34, P763, DOI 10.1139/X03-241; Szewczyk J, 1996, VEGETATIO, V122, P37, DOI 10.1007/BF00052814; Brunner A, 2003, CAN J FOREST RES, V33, P1670, DOI 10.1139/X03-085; Ota T, 2012, CAN J FOREST RES, V42, P1976, DOI 10.1139/x2012-141; Zielonka T, 2006, J VEG SCI, V17, P739, DOI 10.1658/1100-9233(2006)17[739:WDDWTI]2.0.CO;2; Noguchi M, 2004, FOREST ECOL MANAG, V190, P335, DOI 10.1016/j.foreco.2003.10.024; Narukawa Y, 2003, ECOL RES, V18, P267, DOI 10.1046/j.1440-1703.2003.00553.x; Stancioiu PT, 2006, EUR J FOREST RES, V125, P151, DOI 10.1007/s10342-005-0069-3; Bace R, 2012, FOREST ECOL MANAG, V266, P254, DOI 10.1016/j.foreco.2011.11.025; HARMON ME, 1989, CAN J BOT, V67, P1833; Harmon ME, 2004, ADV ECOL RES, V34, P59, DOI DOI 10.1016/S0065-2504(03)34002-4; Jezek K., 2004, Journal of Forest Science (Prague), V50, P405; Maser C, 1988, PNWGTR229 USDA FOR S; Pawlaczek M, 2010, THESIS U AGR CRACOW; Rozanski W, 2006, GORCZANSKI PARK NARO; Saniga M., 2011, Beskydy, V4, P39; GRODZINS.W, 1970, OIKOS, V21, P52, DOI 10.2307/3543838; Stokland JN, 2012, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9781139025843; Vrska T, 2009, FOREST ECOL MANAG, V258, P347, DOI 10.1016/j.foreco.2009.03.007; Zielonka T, 2001, ECOL B, V49, P159	50	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1286-4560	1297-966X		ANN FOREST SCI	Ann. For. Sci.	OCT	2015	72	7					955	965		10.1007/s13595-015-0492-7		11	Forestry	Forestry	CT5WE	WOS:000362881000010		
J	Yoshioka, H; Azuma, K; Yamamoto, N; Takahashi, T; Nishio, M; Katakami, N; Ahn, MJ; Hirashima, T; Maemondo, M; Kim, SW; Kurosaki, M; Akinaga, S; Park, K; Tsai, CM; Tamura, T; Mitsudomi, T; Nakagawa, K				Yoshioka, H.; Azuma, K.; Yamamoto, N.; Takahashi, T.; Nishio, M.; Katakami, N.; Ahn, M. J.; Hirashima, T.; Maemondo, M.; Kim, S. W.; Kurosaki, M.; Akinaga, S.; Park, K.; Tsai, C. M.; Tamura, T.; Mitsudomi, T.; Nakagawa, K.			A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)	ANNALS OF ONCOLOGY			English	Article						tivantinib; erlotinib; phase III study; nonsmall-cell lung cancer; c-Met inhibitor	JAPANESE PATIENTS; MONOTHERAPY; MUTATIONS; GEFITINIB; SURVIVAL; SAFETY; TUMORS; NSCLC; PLUS	Background: A previous randomized phase II study demonstrated that the addition of a c-Met inhibitor tivantinib to an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib might prolong progression-free survival (PFS) in patients with previously treated, nonsquamous nonsmall-cell lung cancer (NSCLC). On a subset analysis, the survival benefit was greater in patients with wild-type EGFR (WT-EGFR) than in those with activating EGFR mutations. Herein, this phase III study compared overall survival (OS) between Asian nonsquamous NSCLC patients with WT-EGFR who received erlotinib plus tivantinib (tivantinib group) or erlotinib plus placebo (placebo group). Methods: A total of 460 NSCLC patients were planned to be randomized to the tivantinib or placebo group. Primary end point was OS. Secondary end points were PFS, tumor response, and safety. Tissue was collected for biomarker analysis, including c-Met and HGF expression. Results: Enrollment was stopped when 307 patients were randomized, following the Safety Review Committee's recommendation based on an imbalance in the interstitial lung disease (ILD) incidence between the groups. ILD developed in 14 patients (3 deaths) and 6 patients (0 deaths) in the tivantinib and the placebo groups, respectively. In the enrolled patients, median OS was 12.7 and 11.1 months in the tivantinib and the placebo groups, respectively [hazard ratio (HR) = 0.891, P = 0.427]. Median PFS was 2.9 and 2.0 months in the tivantinib and the placebo groups, respectively (HR = 0.719, P = 0.019). The commonly observed grade >= 3 adverse events in the tivantinib group were neutropenia (24.3%), leukopenia (18.4%), febrile neutropenia (13.8%), and anemia (13.2%). Conclusions: This study was prematurely terminated due to the increased ILD incidence in the tivantinib group. Although this study lacked statistical power because of the premature termination and did not demonstrate an improvement in OS, our results suggest that tivantinib plus erlotinib might improve PFS than erlotinib alone in nonsquamous NSCLC patients with WT-EGFR.	[Yoshioka, H.] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama 7108602, Japan; [Azuma, K.] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Yamamoto, N.] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan; [Takahashi, T.] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan; [Nishio, M.] Canc Inst Hosp JFCR, Dept Thorac Med Oncol, Tokyo, Japan; [Katakami, N.] Inst Biomed Res, Div Integrated Oncol, Kobe, Hyogo, Japan; [Katakami, N.] Innovat Hosp, Kobe, Hyogo, Japan; [Ahn, M. J.; Park, K.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Hirashima, T.] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Habikino, Osaka, Japan; [Maemondo, M.] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan; [Kim, S. W.] Univ Ulsan, Coll Med, ASAN Med Ctr, Dept Oncol, Seoul, South Korea; [Kurosaki, M.; Akinaga, S.] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan; [Tsai, C. M.] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Tamura, T.] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Mitsudomi, T.] Kinki Univ, Fac Med, Dept Thorac Surg, Osakasayama, Japan; [Nakagawa, K.] Kinki Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan	Yoshioka, H (reprint author), Kurashiki Cent Hosp, Dept Resp Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	hirotin@kchnet.or.jp			Kyowa Hakko Kirin, Co., Ltd (Tokyo, Japan)	This work was supported by Kyowa Hakko Kirin, Co., Ltd (Tokyo, Japan), and there is no grant number.	Yamamoto N, 2013, BRIT J CANCER, V109, P2803, DOI 10.1038/bjc.2013.588; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Tanaka A, 2012, LUNG CANCER, V75, P89, DOI 10.1016/j.lungcan.2011.06.004; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740; Yoshioka H, 2010, J THORAC ONCOL, V5, P99, DOI 10.1097/JTO.0b013e3181c20063; Kubota K, 2008, J THORAC ONCOL, V3, P1439, DOI 10.1097/JTO.0b013e31818d6702; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Yamamoto N, 2013, ANN ONCOL, V24, P1653, DOI 10.1093/annonc/mdt014; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Aramaki T, 2014, INT LIV CANC ASS ANN; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Jassem J, 2013, LANCET ONCOL, V14, P916, DOI 10.1016/S1470-2045(13)70352-8; Kubota T, 2001, XENOBIO METAB DISPOS, V16, P69; Scagliotti G, 2013, EUR CANC C AMST NETH	21	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	OCT	2015	26	10					2066	2072		10.1093/annonc/mdv288		7	Oncology	Oncology	CT5JF	WOS:000362844300009		
J	Ryu, MH; Baba, E; Lee, KH; Park, YI; Boku, N; Hyodo, I; Nam, BH; Esaki, T; Yoo, C; Ryoo, BY; Song, EK; Cho, SH; Kang, WK; Yang, SH; Zang, DY; Shin, DB; Park, SR; Shinozaki, K; Takano, T; Kang, YK				Ryu, M. -H.; Baba, E.; Lee, K. H.; Park, Y. I.; Boku, N.; Hyodo, I.; Nam, B. -H.; Esaki, T.; Yoo, C.; Ryoo, B. -Y.; Song, E. -K.; Cho, S. -H.; Kang, W. K.; Yang, S. H.; Zang, D. Y.; Shin, D. B.; Park, S. R.; Shinozaki, K.; Takano, T.; Kang, Y. -K.		SOS Study Investigators	Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)	ANNALS OF ONCOLOGY			English	Article						gastric cancer; S-1; cisplatin; chemotherapy	2ND-LINE CHEMOTHERAPY; SUPPORTIVE CARE; ADENOCARCINOMA; NONINFERIORITY; FLUOROURACIL; CAPECITABINE; METAANALYSIS; DOCETAXEL; SURVIVAL; THERAPY	Background: Five-weekly S-1 plus cisplatin (SP5) is one of the standard first-line regimens for advanced gastric cancer (GC), proven in a Japanese phase III study. To enhance the dose intensity of cisplatin, 3-weekly S-1 plus cisplatin (SP3) was developed. Patients and methods: This multicenter, randomized, open-label, phase III study evaluated whether SP3 (S-1 80 mg/m(2)/day on days 1-14 and cisplatin 60 mg/m(2) on day 1) was noninferior/superior to SP5 (S-1 80-120 mg/day on days 1-21 and cisplatin 60 mg/m(2) on day 1 or 8) in terms of progression-free survival (PFS). Chemotherapy-naive patients with metastatic, recurrent gastric or gastroesophageal junction adenocarcinoma were randomized 1 : 1 to receive either SP3 or SP5. The trial is registered at ClinicalTrials.gov (NCT00915382). Results: Between February 2009 and January 2012, 625 patients were randomized at 42 sites in Korea and Japan. With a median follow-up duration of 32.4 months (range, 13.3-48.6 months) in surviving patients, SP3 was not only noninferior but also superior to SP5 in terms of PFS [median 5.5 versus 4.9 months; hazard ratio (HR) = 0.82; 95% confidence interval (CI) 0.68-0.99; P = 0.0418 for superiority). There was no difference in overall survival (OS) between the groups (median 14.1 versus 13.9 months; HR = 0.99; 95% CI 0.81-1.21; P = 0.9068). In patients with measurable disease, the response rates were 60% in the SP3 arm and 50% in the SP5 arm (P = 0.065). Both regimens were generally well tolerated, but grade 3 or higher anemia (19% versus 9%) and neutropenia (39% versus 9%) were more frequent in SP3. Conclusions: SP3 is superior to SP5 in terms of PFS. However, since the improvement in PFS was only slight and there was no difference in OS, both SP3 and SP5 can be recommended as first-line treatments for patients with advanced GC.	[Ryu, M. -H.; Yoo, C.; Ryoo, B. -Y.; Park, S. R.; Kang, Y. -K.] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul 138736, South Korea; [Baba, E.] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan; [Lee, K. H.] Yeungnam Univ Hosp, Dept Hematooncol, Daegu, South Korea; [Park, Y. I.] Natl Canc Ctr, Res Inst & Hosp, Ctr Gastr Canc, Goyang, Gyeonggi, South Korea; [Boku, N.] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; [Hyodo, I.] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan; [Nam, B. -H.] Natl Canc Ctr, Biometr Res Branch, Goyang, Gyeonggi, South Korea; [Esaki, T.] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; [Song, E. -K.] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Jeonju 561756, South Korea; [Cho, S. -H.] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Gwangju, South Korea; [Kang, W. K.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Yang, S. H.] Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea; [Zang, D. Y.] Hallym Univ, Coll Med, Med Ctr, Div Hematol Oncol,Dept Internal MEd, Anyang, South Korea; [Shin, D. B.] Gachon Univ, Gil Hosp, Dept Internal Med, Div Hematol Oncol, Inchon, South Korea; [Shinozaki, K.] Hiroshima Prefectural Hosp, Div Clin Oncol, Hiroshima, Japan; [Takano, T.] Toranomon Gen Hosp, Dept Med Oncol, Minato Ku, Tokyo, Japan	Kang, YK (reprint author), Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 138736, South Korea.	ykkang@amc.seoul.kr			Jeil and TAIHO Pharmaceutical Co., Ltd	This study was supported in part by Jeil and TAIHO Pharmaceutical Co., Ltd (no grant number).	Freidlin B, 2007, J CLIN ONCOL, V25, P5019, DOI 10.1200/JCO.2007.11.8711; Bang YJ, 2010, LANCET, V376, P1302; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kim HS, 2013, ANN ONCOL, V24, P2850, DOI 10.1093/annonc/mdt351; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Lee JL, 2008, CANCER CHEMOTH PHARM, V61, P837, DOI 10.1007/s00280-007-0541-5; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Lee JL, 2008, BRIT J CANCER, V99, P584, DOI 10.1038/sj.bjc.6604536; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	OCT	2015	26	10					2097	2101		10.1093/annonc/mdv316		6	Oncology	Oncology	CT5JF	WOS:000362844300014		
J	Ueda, T; Morioka, H; Nishida, Y; Kakunaga, S; Tsuchiya, H; Matsumoto, Y; Asami, Y; Inoue, T; Yoneda, T				Ueda, T.; Morioka, H.; Nishida, Y.; Kakunaga, S.; Tsuchiya, H.; Matsumoto, Y.; Asami, Y.; Inoue, T.; Yoneda, T.			Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial	ANNALS OF ONCOLOGY			English	Article						giant cell tumor of bone; denosumab; RANKL; primary bone tumor; objective tumor response	BISPHOSPHONATES	Background: Giant cell tumor of bone (GCTB) is a rare primary bone tumor, characterized by osteoclast-like giant cells that express receptor activator of nuclear factor-kappa B (RANK), and stromal cells that express RANK ligand (RANKL), a key mediator of osteoclast activation. A RANKL-specific inhibitor, denosumab, was predicted to reduce osteolysis and control disease progression in patients with GCTB. Patients and methods: Seventeen patients with GCTB were enrolled. Patients were treated with denosumab at 120 mg every 4 weeks, with a loading dose of 120 mg on days 8 and 15. To evaluate efficacy, objective tumor response was evaluated prospectively by an independent imaging facility on the basis of prespecified criteria. Results: The proportion of patients with an objective tumor response was 88% based on best response using any tumor response criteria. The proportion of patients with an objective tumor response using individual response criteria was 35% based on the modified Response Evaluation Criteria in Solid Tumors (RECIST) criteria, 82% based on the modified European Organization for Research and Treatment of Cancer (EORTC) criteria, and 71% based on inverse Choi criteria. The median time of study treatment was 13.1 months. Conclusion: The findings demonstrate that denosumab has robust clinical efficacy in the treatment of GCTB.	[Ueda, T.; Kakunaga, S.] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka 5400006, Japan; [Morioka, H.] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Nishida, Y.] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan; [Tsuchiya, H.] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Matsumoto, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan; [Asami, Y.; Inoue, T.] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Yoneda, T.] Indiana Univ Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA	Ueda, T (reprint author), Osaka Natl Hosp, Dept Orthopaed Surg, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	uedat@onh.go.jp			Daiichi Sankyo	This work was supported by Daiichi Sankyo. No grant number is applicable.	Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Miller PD, 2011, BONE, V49, P77, DOI 10.1016/j.bone.2010.12.024; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Chawla S, 2013, LANCET ONCOL, V14, P901, DOI 10.1016/S1470-2045(13)70277-8; Caudell JJ, 2003, INT J RADIAT ONCOL, V57, P158, DOI 10.1016/S0360-3016(03)00416-4; Lin PP, 2002, CANCER, V95, P1317, DOI 10.1002/cncr.10803; Brien EW, 1997, SKELETAL RADIOL, V26, P246; Szendroi M, 2004, J BONE JOINT SURG BR, V86B, P5, DOI 10.1302/0301-620X.86B1.14053; Tse LF, 2008, BONE, V42, P68, DOI 10.1016/j.bone.2007.08.038; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Arbeitsgemeinschaft Knochentumoren, 2008, J Bone Joint Surg Am, V90, P1060, DOI 10.2106/JBJS.D.02771; Cleeland CS, 1991, EFFECT CANC QUALITY, P293; Malawer M, 2008, CANC PRINCIPLES PRAC, P1794	13	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	OCT	2015	26	10					2149	2154		10.1093/annonc/mdv307		7	Oncology	Oncology	CT5JF	WOS:000362844300022		
J	Nakajima, L; Yusof, NNM; Kobayashi, T				Nakajima, Lisa; Yusof, Nor Nadia Mohamad; Kobayashi, Takaomi			Calixarene-Composited Host-Guest Membranes Applied for Heavy Metal Ion Adsorbents	ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING			English	Article						Calixarene; Host-guest chemistry; Membrane; Hybridization; Heavy metal ion; Natural source chemical; Resorcinol; Vanillin	SELECTIVE ADSORPTION; ALPHA-TOCOPHEROL; AQUEOUS-SOLUTION; PHASE INVERSION; LIQUID-MEMBRANE; WASTE-WATER; DERIVATIVES; TRANSPORT; REMOVAL	Calixarene host-guest membranes were prepared with hybridization of calixarene and poly(ethersulfone) (PES) by phase inversion process. Herein, the calixarene, 2,18,14,20-tetra(3-hydroxy-4-methoxybenzyl)calix[4]resorcinarene-4,6,10,12,16,18,22,24-octol, was successfully synthesized from resorcinol and vanillin. The phase inversion process was carried out in phase change of the solution of N-methyl-2-pyrrolidone containing both PES and the vanillin calixarene to solid membrane in water coagulation. The composited membranes having different loading amounts of the vanillin calixarene were prepared with 10, 25, 50 and 60 wt% loading. The observation of SEM pictures indicated porous morphology in the PES scaffold. The porous morphology in the cross section of the membrane caused high water content in the range of 371-375 %, meaning easy accessibility of aqueous solution in the membrane. The adsorption behavior of aqueous heavy metal ions: Pb(II), Ni(II), Cu(II) and Cd(II), was examined for the composited membranes containing 10, 25, 50 and 60 wt% of the calixarene host. It was evidenced that each composited membrane adsorbed effectively Pb2+ ion, as the solution was permeated at 4.0 x 10(4) Pa applied pressure. When the calixarene was loaded at 50 and 60 wt% in the membranes, the Pb2+ capacity was 13 and 15 mu mol/g-membrane, respectively, for the batch experiment. In addition, when the quarterly mixture of the aqueous heavy metal ions was permeated through the membrane, the composited membrane having 50 and 60 wt% of the calixarene loading maintained high retention of the Pb2+ ion.	[Nakajima, Lisa; Yusof, Nor Nadia Mohamad; Kobayashi, Takaomi] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Kobayashi, T (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	takaomi@nagaokaut.ac.jp					Ngah WSW, 2008, BIOCHEM ENG J, V39, P521, DOI 10.1016/j.bej.2007.11.006; Minhas FT, 2010, DESALINATION, V262, P215, DOI 10.1016/j.desal.2010.06.014; Johnson PD, 2002, WASTE MANAGE, V22, P471, DOI 10.1016/S0956-053X(01)00036-8; Caira MR, 2006, CRYSTENGCOMM, V8, P275, DOI 10.1039/b601560c; ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739; IZATT SR, 1985, J AM CHEM SOC, V107, P63, DOI 10.1021/ja00287a012; Faizal CKM, 2009, J MEMBRANE SCI, V334, P110, DOI 10.1016/j.memsci.2009.02.019; Yusof NNM, 2013, IND ENG CHEM RES, V52, P16951, DOI 10.1021/ie4029158; Yusof NNM, 2014, INT J ENVIRON SCI TE, V11, P1063, DOI 10.1007/s13762-013-0298-9; IZATT RM, 1983, J AM CHEM SOC, V105, P1782, DOI 10.1021/ja00345a016; Faizal CKM, 2008, J MEMBRANE SCI, V322, P503, DOI 10.1016/j.memsci.2008.05.046; Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.hazmat.2005.05.003; Acemioglu B, 2003, J APPL POLYM SCI, V89, P1537, DOI 10.1002/app.12251; Yusof NNM, 2013, CHEM LETT, V42, P1119, DOI 10.1246/cl.130427; Friberg L., 1979, HDB TOXICOLOGY METAL, P1; Gutsche C.D., 1989, CALIXARENES, P149; Jumina J, 2007, J CHIN CHEM SOC-TAIP, V54, P1167; Mulder M., 1991, BASIC PRINCIPLES MEM; Rengaraj S, 2001, J HAZARD MATER, V87, P273, DOI 10.1016/S0304-3894(01)00291-6; Shammas N.K., 2004, PHYSICOCHEMICAL TREA, P103; Son LT, 2011, J MEMBRANE SCI, V375, P295, DOI 10.1016/j.memsci.2011.03.054; Takeda K, 2006, J MEMBRANE SCI, V275, P61, DOI 10.1016/j.memsci.2005.09.004	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1319-8025	2191-4281		ARAB J SCI ENG	Arab. J. Sci. Eng.	OCT	2015	40	10					2881	2888		10.1007/s13369-015-1796-5		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CT6WP	WOS:000362954000006		
J	Koizumi, M; Oyama, K; Yamakami, Y; Kida, T; Satoh, R; Kato, S; Hidema, S; Oe, T; Goto, T; Clevers, H; Nawa, A; Nishimori, K				Koizumi, Masae; Oyama, Kazunori; Yamakami, Yukiko; Kida, Tomoyo; Satoh, Ryo; Kato, Shigeki; Hidema, Shizu; Oe, Tomoyuki; Goto, Takaaki; Clevers, Hans; Nawa, Akihiro; Nishimori, Katsuhiko			Lgr4 Controls Specialization of Female Gonads in Mice	BIOLOGY OF REPRODUCTION			English	Article						female reproductive tract; sex differentiation; steroid hormones/steroid hormone receptor; testosterone	TRANSCRIPTION FACTOR FOXL2; PROTEIN-COUPLED RECEPTORS; SEX DETERMINATION; SIGNALING PATHWAY; WNT/BETA-CATENIN; HORMONE RECEPTOR; DIFFERENTIATION; OVARY; R-SPONDIN1; LIGANDS	Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is a type of membrane receptor with a seven-transmembrane structure. LGR4 is homologous to gonadotropin receptors, such as follicle-stimulating hormone receptor (Fshr) and luteinizing hormone/choriogonadotropin receptor (Lhcgr). Recently, it has been reported that Lgr4 is a membrane receptor for R-spondin ligands, which mediate Wnt/beta-catenin signaling. Defects of R-spondin homolog (Rspo1) and wingless-type MMTV integration site family, member 4 (Wnt4) cause masculinization of female gonads. We observed that Lgr4(-/-) female mice show abnormal development of the Wolffian ducts and somatic cells similar to that in the male gonads. Lgr4(-/-) female mice exhibited masculinization similar to that observed in Rspo1-deficient mice. In Lgr4(-/-) ovarian somatic cells, the expression levels of lymphoid enhancer-binding factor 1 (Lefl) and Axin2 (Axin2), which are target genes of Wnt/beta-catenin signaling, were lower than they were in wild-type mice. This study suggests that Lgr4 is critical for ovarian somatic cell specialization via the cooperative signaling of Rspo1 and Wnt/beta-catenin.	[Koizumi, Masae; Oyama, Kazunori; Yamakami, Yukiko; Kida, Tomoyo; Kato, Shigeki; Hidema, Shizu; Nishimori, Katsuhiko] Tohoku Univ, Mol Biol Lab, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Satoh, Ryo; Oe, Tomoyuki; Goto, Takaaki] Tohoku Univ, Dept Bioanalyt Chem, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9818555, Japan; [Koizumi, Masae; Nawa, Akihiro] Ehime Univ, Dept Obstet & Gynecol, Sch Med, Toon, Japan; [Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst, Royal Netherlands Acad Arts & Sci, Utrecht, Netherlands	Nishimori, K (reprint author), Tohoku Univ, Mol Biol Lab, Grad Sch Agr Sci, Aoba Ku, Tsutsumidori Amamiyamachi 1-1, Sendai, Miyagi 9818555, Japan.	knishimori@m.tohoku.ac.jp			Japan Society for the Promotion of Science; Japanese Society for the Promotion of Science for Young Scientists	Supported by a Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research on Innovative Areas, and research fellowships of the Japanese Society for the Promotion of Science for Young Scientists to K.O.	de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Ji TH, 1997, RECENT PROG HORM RES, V52, P431; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Sone M, 2013, FASEB J, V27, P4917, DOI 10.1096/fj.13-232215; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Vodstrcil LA, 2007, REPROD FERT DEVELOP, V19, P530, DOI 10.1071/RD07007; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; McNamara KM, 2010, J STEROID BIOCHEM, V121, P611, DOI 10.1016/j.jsbmb.2010.02.001; Ng A, 2014, NAT CELL BIOL, V16, P745, DOI 10.1038/ncb3000; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Ji TH, 1997, RECENT PROG HORM RES, V52; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; Kohn L D, 1995, Vitam Horm, V50, P287, DOI 10.1016/S0083-6729(08)60658-5; Maatouk DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047238; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Rastetter RH, 2014, DEV BIOL, V394, P242, DOI 10.1016/j.ydbio.2014.08.013; TANAKA Y, 1962, J Jpn Obstet Gynecol Soc, V14, P273	37	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	OCT 1	2015	93	4							90	10.1095/biolreprod.114.123638		11	Reproductive Biology	Reproductive Biology	CT5YF	WOS:000362886300012		
J	Masuda, H; Maruyama, T; Gargett, CE; Miyazaki, K; Matsuzaki, Y; Okano, H; Tanaka, M				Masuda, Hirotaka; Maruyama, Tetsuo; Gargett, Caroline E.; Miyazaki, Kaoru; Matsuzaki, Yumi; Okano, Hideyuki; Tanaka, Mamoru			Endometrial Side Population Cells: Potential Adult Stem/Progenitor Cells in Endometrium	BIOLOGY OF REPRODUCTION			English	Review						endometriosis; endometrium; endothelial cells; side population; stem/progenitor cells	HEMATOPOIETIC STEM-CELLS; ESTROGEN-RECEPTOR-ALPHA; TUMOR-INITIATING CELLS; PROGENITOR CELLS; MOUSE MODEL; IN-VITRO; ACCUMULATING EVIDENCE; UNRESOLVED QUESTIONS; MURINE ENDOMETRIUM; UTERINE PHYSIOLOGY	Uterine endometrium is one of the most important organs for species preservation. However, the physiology of human endometrium remains poorly understood, because the human endometrium undergoes rapid and large changes during each menstrual cycle and it is very difficult to investigate human endometrium as one organ. This remarkable regenerative capacity of human endometrium strongly suggests the existence of adult stem cells, and physiology of endometrium cannot be explained without adult stem cells. Therefore, investigating endometrial stem/progenitor cells should lead to a breakthrough in understanding the normal endometrial physiology and the pathophysiology of endometrial neoplastic disorders, such as endometriosis and endometrial cancer. Several cell populations have been discovered as putative endometrial stem/progenitor cells. Emerging evidence reveals that the endometrial side population (SP) is one of the potential endometrial stem/progenitor populations. Of all the endometrial stem/progenitor cell candidates, the endometrial SP (ESP) is best investigated in vitro and in vivo, and has the largest number of references. In this review, we provide an overview of the accumulating evidence for the ESP cells, both directly from human endometria and from cultured endometrial cells. Furthermore, SP cells are compared to other potential stem/progenitor cells, and we discuss their stem cell properties. We also discuss the difficulties and unsolved issues in endometrial stem cell biology.	[Masuda, Hirotaka; Maruyama, Tetsuo; Miyazaki, Kaoru; Tanaka, Mamoru] Keio Univ, Dept Obstet & Gynecol, Sch Med, Tokyo 1608582, Japan; [Gargett, Caroline E.] Monash Univ, Ritchie Ctr, Hudson Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Life Sci, Lab Tumor Biol, Izumo, Shimane, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan	Masuda, H (reprint author), Keio Univ, Dept Obstet & Gynecol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hirotaka@a3.keio.jp	Okano, Hideyuki/J-5973-2013		Japan Society for the Promotion of Science; Cell Science Research Foundation; Takeda Science foundation; National Health and Medical Research Council of Australia in the form of Senior Research Fellowship [1042298]; Victorian Government's Operational Infrastructure Support Program	Supported by grants-in-aid from the Japan Society for the Promotion of Science to H.M. and T.M., the Cell Science Research Foundation to H.M., the Takeda Science foundation to H.M., the National Health and Medical Research Council of Australia in the form of Senior Research Fellowship 1042298 to C.E.G., and from the Victorian Government's Operational Infrastructure Support Program to C.E.G.	MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Rutella S, 2009, CLIN CANCER RES, V15, P4299, DOI 10.1158/1078-0432.CCR-08-1883; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/192276999; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; WOLF NS, 1993, EXP HEMATOL, V21, P614; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Hyodo S, 2011, TOHOKU J EXP MED, V224, P47, DOI 10.1620/tjem.224.47; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Kyo S, 2011, CANCER LETT, V308, P123, DOI 10.1016/j.canlet.2011.05.015; Kato K, 2010, AM J PATHOL, V176, P381, DOI 10.2353/ajpath.2010.090056; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; PARK CH, 1971, J NATL CANCER I, V46, P411; Behbod F, 2006, STEM CELLS, V24, P1065, DOI 10.1634/stemcells.2005-0375; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Mas A, 2012, FERTIL STERIL, V98, P741, DOI 10.1016/j.fertnstert.2012.04.044; Kubota M, 2010, INVEST OPHTH VIS SCI, V51, P5617, DOI 10.1167/iovs.10-5463; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Pierre-Louis O, 2009, STEM CELLS, V27, P2552, DOI 10.1002/stem.186; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Hu FF, 2010, REPROD SCI, V17, P629, DOI 10.1177/1933719110369180; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; LORD BI, 1986, LYMPHOKINE RES, V5, P59; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; RASWEILER JJ, 1991, AM J ANAT, V191, P1, DOI 10.1002/aja.1001910102; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Nakamura M, 2010, HUM PATHOL, V41, P1516, DOI 10.1016/j.humpath.2010.05.006; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P18350, DOI 10.1073/pnas.0608861103; Inowa T, 2008, INT J UROL, V15, P272, DOI 10.1111/j.1442-2042.2007.01984.x; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Maruyama T, 2014, J OBSTET GYNAECOL RE, V40, P2015, DOI 10.1111/jog.12501; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Kato K, 2011, MOL CANCER THER, V10, P1430, DOI 10.1158/1535-7163.MCT-10-1062; Munksgaard PS, 2011, GYNECOL ONCOL, V123, P157, DOI 10.1016/j.ygyno.2011.06.017; MULLERSIEBURG CE, 1988, J EXP MED, V167, P1825, DOI 10.1084/jem.167.6.1825; Kato K, 2012, ANTICANCER RES, V32, P2283; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hubbard SA, 2010, REPRODUCTION, V140, P23, DOI 10.1530/REP-09-0411; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Critchley HOD, 2001, J CLIN ENDOCR METAB, V86, P1370, DOI 10.1210/jc.86.3.1370; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; Terrace JD, 2009, EXP CELL RES, V315, P2141, DOI 10.1016/j.yexcr.2009.02.004; KAUPPILA AJI, 1986, CANCER RES, V46, P5380; Machado DE, 2010, FERTIL STERIL, V93, P2674, DOI 10.1016/j.fertnstert.2009.11.037; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Vigano P, 2006, HUM REPROD UPDATE, V12, P77, DOI 10.1093/humupd/dmi037; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Becker CM, 2008, AM J PATHOL, V172, P534, DOI 10.2353/ajpath.2008.061244; Kusunoki S, 2013, GYNECOL ONCOL, V129, P598, DOI 10.1016/j.ygyno.2013.03.005; Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014; OGAWA M, 1993, BLOOD, V81, P2844; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Friel AM, 2008, CELL CYCLE, V7, P242; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Gargett CE, 2002, MOL HUM REPROD, V8, P770, DOI 10.1093/molehr/8.8.770; Mylonas I, 2010, ONCOL REP, V24, P385, DOI 10.3892/or_00000871; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; RASWEILER JJ, 1992, J REPROD FERTIL, V95, P231; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Richard V, 2013, BIOMED RES INT, DOI 10.1155/2013/517237; Sampson JA, 1927, AM J PATHOL, V3, P93; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Oberley CC, 2008, EXP CELL RES, V314, P720, DOI 10.1016/j.yexcr.2007.11.002; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005.0116; FINN CA, 1987, PERSPECT BIOL MED, V30, P566; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Cervello I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030260; Chen D, 2015, MOL MED REP, V11, P4309, DOI 10.3892/mmr.2015.3279; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Friel AM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-147; Huang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044285; Kaitu'u-Lino TJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099309; Maruyama T, 2013, PLACENTA, V34, pS68, DOI 10.1016/j.placenta.2012.12.010; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Miyazaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050749; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Wang MJ, 2015, MOL MED REP, V11, P4297, DOI 10.3892/mmr.2015.3291; Xu J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-103	101	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	OCT 1	2015	93	4							84	10.1095/biolreprod.115.131490		8	Reproductive Biology	Reproductive Biology	CT5YF	WOS:000362886300006		
J	Satouh, Y; Nozawa, K; Ikawa, M				Satouh, Yuhkoh; Nozawa, Kaori; Ikawa, Masahito			Sperm Postacrosomal WW Domain-Binding Protein Is Not Required for Mouse Egg Activation	BIOLOGY OF REPRODUCTION			English	Article						acrosome; Ca2+; fertilization; meiotic arrest; spermatogenesis	PLC-ZETA; EMBRYO DEVELOPMENT; CA2+ OSCILLATIONS; OOCYTE ACTIVATION; MALE-INFERTILITY; PAWP; FERTILIZATION; GENERATION; RELEASE; MICE	To begin embryonic development, the zygote must resume the cell cycle correctly after stimulation by sperm-borne oocyte-activating factors (SOAFs). The postacrosomal WW domain-binding protein (PAWP) is one of the strongest SOAF candidates and is widely conserved among eutherian mammals. It has been reported that the microinjection of recombinant PAWP protein can trigger not only Ca2+ oscillations in mammalian eggs but also intracellular Ca2+ release in amphibian eggs. It was also suggested that PAWP is involved in the formation of high-quality spermatozoa. On the other hand, negligible SOAF activity for PAWP cRNA has also been reported. In this study, we generated PAWP null mice and examined the fertilizing ability of male mice. Electron microscopy showed no aberrant morphology in spermatogenesis. Intracytoplasmic injection of a single spermatozoon from the null mouse line showed that depletion of PAWP elicited no quantitative differences in Ca2+ oscillations or in subsequent development of the embryos. We conclude that PAWP does not play an essential role in mouse fertilization.	[Satouh, Yuhkoh; Nozawa, Kaori; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Nozawa, Kaori; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ikawa, Masahito] Osaka Univ, Sch Pharmaceut Sci, Osaka, Japan	Ikawa, M (reprint author), Osaka Univ, Microbial Dis Res Inst, Osaka, Japan.	ikawa@biken.osaka-u.ac.jp	Satouh, Yuhkoh/A-9917-2009	Satouh, Yuhkoh/0000-0001-9207-9374	Japan Society for the Promotion of Science KAKENHI [25113714, 24770210]	This work was supported by Japan Society for the Promotion of Science KAKENHI grants 25113714 and 24770210.	Aarabi M, 2014, FASEB J, V28, P4434, DOI 10.1096/fj.14-256495; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Ducibella T, 2008, DEV BIOL, V315, P257, DOI 10.1016/j.ydbio.2007.12.012; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Nomikos M, 2015, MOL HUM REPROD, V21, P702, DOI 10.1093/molehr/gav034; Aarabi M, 2014, FERTIL STERIL, V102, P440, DOI 10.1016/j.fertnstert.2014.05.003; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; SWANN K, 1990, DEVELOPMENT, V110, P1295; Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Kashir J, 2012, HUM REPROD, V27, P222, DOI 10.1093/humrep/der384; Wu ATH, 2007, J BIOL CHEM, V282, P12164, DOI 10.1074/jbc.M609132200; Dale B, 2010, REPROD BIOMED ONLINE, V21, P1, DOI 10.1016/j.rbmo.2010.02.015; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Nomikos M, 2014, MOL HUM REPROD, V20, P938, DOI 10.1093/molehr/gau056; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Aarabi M, 2010, MOL REPROD DEV, V77, P249, DOI 10.1002/mrd.21140; Miao YL, 2012, MOL REPROD DEV, V79, P742, DOI 10.1002/mrd.22078; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Kennedy CE, 2014, MOL REPROD DEV, V81, P436, DOI 10.1002/mrd.22309; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Wakai T, 2011, COLD SPRING HARB PER, V3, P1	33	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	OCT 1	2015	93	4							94	10.1095/biolreprod.115.131441		7	Reproductive Biology	Reproductive Biology	CT5YF	WOS:000362886300016		
J	Fang, J; Kawano, S; Tajima, K; Kondo, T				Fang, Ju; Kawano, Shin; Tajima, Kenji; Kondo, Tetsuo			In Vivo Curdlan/Cellulose Bionanocomposite Synthesis by Genetically Modified Gluconacetobacter xylinus	BIOMACROMOLECULES			English	Article							CELLULOSE NANOPAPER STRUCTURES; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; MICROBIAL CELLULOSE; CURDLAN BIOSYNTHESIS; BIOFILM FORMATION; HIGH TOUGHNESS; ANILINE BLUE; EXOPOLYSACCHARIDES; POLYSACCHARIDES	Bacterial cellulose pellicle produced by Gluconacetobacter xylinus (G. xylinus) is one of the best biobased materials having a unique supernetwork structure with remarkable physiochemical properties for a wide range of medical and tissue-engineering applications. It is still necessary to modify them to obtain materials suitable for biomedical use with satisfactory mechanical strength, biodegradability, and bioactivity. The aim of this research was to develop a gene-transformation route for the production of bacterial cellulose/Curdlan (beta-1,3-glucan) nanocomposites by separate but simultaneous in vivo synthesis of cellulose and Curdlan. Modification of the cellulose-nanofiber-producing system of G. xylinus enabled Curdlan to be synthesized simultaneously with cellulose nanofibers in vivo, resulting in biopreparation of nanocomposites. The obtained Curdlan/cellulose composites were characterized, and their properties were compared with those of normal bacterial cellulose pellicles, indicating that Curdlan mixed with the cellulose nanofibers at the nanoscale without disruption of the nanofiber network structure in the pellicle.	[Fang, Ju; Kondo, Tetsuo] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Kawano, Shin] Res Org Informat & Syst, Database Ctr Life Sci, Kashiwa, Chiba 2770871, Japan; [Tajima, Kenji] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Kondo, T (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tekondo@agr.kyushu-u.ac.jp					Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; Taajamaa L, 2012, J MATER CHEM, V22, P12072, DOI 10.1039/c2jm30572k; Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378; Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097; Duboc P, 2001, INT DAIRY J, V11, P759, DOI 10.1016/S0958-6946(01)00119-4; ZAAR K, 1979, J CELL BIOL, V80, P773, DOI 10.1083/jcb.80.3.773; SAXENA IM, 1994, J BACTERIOL, V176, P5735; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Lee KY, 2009, COMPOS SCI TECHNOL, V69, P2724, DOI 10.1016/j.compscitech.2009.08.016; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; HARADA T, 1968, ARCH BIOCHEM BIOPHYS, V124, P292, DOI 10.1016/0003-9861(68)90330-5; Karnezis T, 2003, GLYCOBIOLOGY, V13, P693, DOI 10.1093/glycob/cwg093; HALL PE, 1992, PLASMID, V28, P194, DOI 10.1016/0147-619X(92)90051-B; McIntosh M, 2005, APPL MICROBIOL BIOT, V68, P163, DOI 10.1007/s00253-005-1959-5; Wu CH, 2012, CARBOHYD POLYM, V89, P497, DOI 10.1016/j.carbpol.2012.03.034; Sutherland IW, 2001, MICROBIOL-UK, V147, P3; Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51; Larsson PA, 2014, BIOMACROMOLECULES, V15, P2218, DOI 10.1021/bm500360c; SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123; EVANS NA, 1984, CARBOHYD POLYM, V4, P215, DOI 10.1016/0144-8617(84)90012-2; Svagan AJ, 2007, BIOMACROMOLECULES, V8, P2556, DOI 10.1021/bm0703160; NAKANISHI I, 1976, J GEN APPL MICROBIOL, V22, P1, DOI 10.2323/jgam.22.1; Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97; Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040; Zhan XB, 2012, APPL MICROBIOL BIOT, V93, P525, DOI 10.1007/s00253-011-3740-2; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Brown EE, 2007, BIOMACROMOLECULES, V8, P3074, DOI 10.1021/bm700448x; YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032; Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n; Sunagawa N, 2012, CELLULOSE, V19, P1989, DOI 10.1007/s10570-012-9777-2; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; Kim DY, 2002, CELLULOSE, V9, P361, DOI 10.1023/A:1021140726936; Blaker JJ, 2009, GREEN CHEM, V11, P1321, DOI 10.1039/b913740h; Sehaqui H, 2012, BIOMACROMOLECULES, V13, P3661, DOI 10.1021/bm301105s; Stasinopoulos SJ, 1999, GLYCOBIOLOGY, V9, P31, DOI 10.1093/glycob/9.1.31; Sehaqui H, 2011, BIOMACROMOLECULES, V12, P3638, DOI 10.1021/bm2008907; Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; Brown RM, 2000, PLANT PHYSIOL BIOCH, V38, P57, DOI 10.1016/S0981-9428(00)00168-6; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980; Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61; Lin K.-W., 2004, J FOOD SCI, V69; White D. G., 1989, CELLULOSE WOOD CHEM, P573	46	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	OCT	2015	16	10					3154	3160		10.1021/acs.biomac.5b01075		7	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CT5PW	WOS:000362863500008		
J	Tanaka, Y; Kato, M; Hasegawa, D; Urayama, KY; Nakadate, H; Kondoh, K; Nakamura, K; Koh, K; Komiyama, T; Manabe, A				Tanaka, Yoichi; Kato, Motohiro; Hasegawa, Daisuke; Urayama, Kevin Y.; Nakadate, Hisaya; Kondoh, Kensuke; Nakamura, Kozue; Koh, Katsuyoshi; Komiyama, Takako; Manabe, Atsushi			Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						NUDT15; 6-MP; toxicities; childhood acute lymphoblastic leukaemia; Japanese	MAINTENANCE CHEMOTHERAPY; CHILDHOOD; 6-MERCAPTOPURINE; THERAPY; RISK; INTOLERANCE; DOSAGE; GENE	Genotyping of TPMT prior to 6-mercaptopurine (6-MP) administration in acute lymphoblastic leukaemia (ALL) patients has been integrated into clinical practice in some populations of European ancestry. However, the comparable rates of 6-MP myelotoxicity, but rarity of TPMT variants, in Asians suggest that major determinants have yet to be discovered in this population. We genotyped 92 Japanese paediatric ALL patients for NUDT15 rs116855232, a 6-MP toxicity-related locus discovered in Asians. Logistic regression and survival analysis were used to evaluate its association with leucopenia, hepatotoxicity, 6-MP dose reduction, therapy interruption and event-free survival. The allele frequency of rs116855232 was 0.16, and leucopenia was more common in carriers of the T allele (odds ratio, 7.20; 95% confidence interval, 2.49-20.80; P = 2.7 x 10(-4)). As leucopenia results in 6-MP dose reduction, we observed average doses during maintenance therapy of 40.7, 29.3 and 8.8 mg/m(2) for patients with CC, CT and TT genotypes, respectively (P < 0.001). Hepatotoxicity was observed only in CC genotype patients. Event-free survival did not significantly differ by NUDT15 genotype. rs116855232 is an important determinant of 6-MP myelotoxicity in Japanese children with ALL and may represent the most robust toxicity-related locus in Asians to date. Considerations for clinical application may be warranted.	[Tanaka, Yoichi; Komiyama, Takako] Kitasato Univ, Sch Pharm, Ctr Clin Pharm & Sci, Dept Clin Pharm, Tokyo 1088641, Japan; [Kato, Motohiro] Univ Tokyo, Dept Paediat, Tokyo, Japan; [Hasegawa, Daisuke; Manabe, Atsushi] St Lukes Int Hosp, Dept Paediat, Tokyo, Japan; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Dept Human Genet & Dis Divers, Tokyo, Japan; [Urayama, Kevin Y.] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Nakadate, Hisaya] Natl Ctr Child Hlth & Dev, Dept Gen Paediat & Interdisciplinary Med, Tokyo, Japan; [Kondoh, Kensuke] St Marianna Univ, Sch Med, Dept Paediat, Kawasaki, Kanagawa, Japan; [Nakamura, Kozue] Teikyo Univ, Dept Paediat, Tokyo 173, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Haematol Oncol, Saitama, Japan	Tanaka, Y (reprint author), Kitasato Univ, Sch Pharm, Ctr Clin Pharm & Sci, Dept Clin Pharm,Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tanakay@pharm.kitasato-u.ac.jp					Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Nygaard U, 2004, CLIN PHARMACOL THER, V75, P274, DOI 10.1016/j.clpt.2003.12.-001; Tanaka Y, 2012, LEUKEMIA RES, V36, P560, DOI 10.1016/j.leukres.2011.11.015; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Toyoda Y, 2000, J CLIN ONCOL, V18, P1508; Relling MV, 1999, J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Stanulla M, 2009, BLOOD, V114, P1314, DOI 10.1182/blood-2008-12-193250; SCHMIEGELOW K, 1991, PEDIATR HEMAT ONCOL, V8, P301, DOI 10.3109/08880019109028803; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Kubota T, 2001, BRIT J CLIN PHARMACO, V51, P475, DOI 10.1046/j.1365-2125.2001.01371.x; SCHMIEGELOW K, 1990, AM J PEDIAT HEMATOL, V12, P462; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 2013, HEMATOL-AM SOC HEMAT, P126; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; Schmiegelow K, 2003, J CLIN ONCOL, V21, P1332, DOI 10.1200/JCO.2003.04.039; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; LENNARD L, 1989, J CLIN ONCOL, V7, P1816; Tanaka Y., 2014, PHARMACOGENOMICS J, DOI [10.1038/tpj.2014.74, DOI 10.1038/TPJ.2014.74.IN]	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171	1					109	115		10.1111/bjh.13518		7	Hematology	Hematology	CT4LJ	WOS:000362777600013		
J	Sakakibara, Y; Nakazuru, S; Yamada, T; Iwasaki, T; Iwasaki, R; Ishihara, A; Nishio, K; Ishida, H; Kodama, Y; Mita, E				Sakakibara, Yuko; Nakazuru, Shoichi; Yamada, Takuya; Iwasaki, Tetsuya; Iwasaki, Ryuichiro; Ishihara, Akio; Nishio, Kumiko; Ishida, Hisashi; Kodama, Yoshinori; Mita, Eiji			Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma with colon involvement	CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Sakakibara, Yuko; Nakazuru, Shoichi; Yamada, Takuya; Iwasaki, Tetsuya; Iwasaki, Ryuichiro; Ishihara, Akio; Nishio, Kumiko; Ishida, Hisashi; Mita, Eiji] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Osaka 5400006, Japan; [Kodama, Yoshinori] Osaka Natl Hosp, Natl Hosp Org, Dept Pathol, Osaka, Osaka 5400006, Japan	Sakakibara, Y (reprint author), Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Chuo Ku, 2-1-14 Houenzaka, Osaka, Osaka 5400006, Japan.	yuko.s@onh.go.jp					Matsumoto H, 2005, GASTROINTEST ENDOSC, V61, P607, DOI 10.1016/S0016-5107(04)02785-3; Savage KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/blood-2008-01-134270; Ferreri AJM, 2013, CRIT REV ONCOL HEMAT, V85, P206, DOI 10.1016/j.critrevonc.2012.06.004; Shukla T, 2014, CAN J GASTROENTEROL, V28, P11	4	0	0	PULSUS GROUP INC	OAKVILLE	2902 S SHERIDAN WAY, OAKVILLE, ONTARIO L6J 7L6, CANADA	0835-7900			CAN J GASTROENTEROL	Can. J. Gastroenterol. Hepatol.	OCT	2015	29	7					345	346				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT6BT	WOS:000362896500002		
J	Kuramitsu, S; Ohno, M; Ohka, F; Shiina, S; Yamamichi, A; Kato, A; Tanahashi, K; Motomura, K; Kondo, G; Kurimoto, M; Senga, T; Wakabayashi, T; Natsume, A				Kuramitsu, S.; Ohno, M.; Ohka, F.; Shiina, S.; Yamamichi, A.; Kato, A.; Tanahashi, K.; Motomura, K.; Kondo, G.; Kurimoto, M.; Senga, T.; Wakabayashi, T.; Natsume, A.			Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses	CANCER GENE THERAPY			English	Article							IMMUNOLOGICAL SYNAPSE; ADJUVANT TEMOZOLOMIDE; POTENT INHIBITORS; STEM-CELLS; TNF-ALPHA; EGFRVIII; GLIOBLASTOMA; ACTIVATION; GLIOMA; IMMUNOTHERAPY	The epidermal growth factor receptor variant III (EGFRvIII) is exclusively expressed on the cell surface in similar to 50% of glioblastoma multiforme (GBM). This variant strongly and persistently activates the phosphatidylinositol 3-kinase-Akt signaling pathway in a ligand-independent manner resulting in enhanced tumorigenicity, cellular motility and resistance to chemoradiotherapy. Our group generated a recombinant single-chain variable fragment (scFv) antibody specific to the EGFRvIII, referred to as 3C10-scFv. In the current study, we constructed a lentiviral vector transducing the chimeric antigen receptor (CAR) that consisted of 3C10-scFv, CD3., CD28 and 4-1BB (3C10-CAR). The 3C10-CAR-transduced peripheral blood mononuclear cells (PBMCs) and CD3(+) T cells specifically lysed the glioma cells that express EGFRvIII. Moreover, we demonstrated that CAR CD3(+) T cells migrated to the intracranial xenograft of GBM in the mice treated with 3C10-CAR PBMCs. An important and novel finding of our study was that a thalidomide derivative lenalidomide induced 3C10-CAR PBMC proliferation and enhanced the persistent antitumor effect of the cells in vivo. Lenalidomide also exhibited enhanced immunological synapses between the effector cells and the target cells as determined by CD11a and F-actin polymerization. Collectively, lentiviral-mediated transduction of CAR effectors targeting the EGFRvIII showed specific efficacy, and lenalidomide even intensified CAR cell therapy by enhanced formation of immunological synapses.	[Kuramitsu, S.; Ohno, M.; Ohka, F.; Shiina, S.; Yamamichi, A.; Kato, A.; Tanahashi, K.; Motomura, K.; Kondo, G.; Kurimoto, M.; Wakabayashi, T.; Natsume, A.] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Kuramitsu, S.] Koujunkai Daido Hosp, Div Neurosurg, Nagoya, Aichi, Japan; [Ohno, M.] Natl Hosp Org, Nagoya Med Ctr, Div Neurosurg, Nagoya, Aichi, Japan; [Senga, T.] Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan	Natsume, A (reprint author), Nagoya Univ, Sch Med, Dept Neurosurg, Show Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	anatsume@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23107010, 25861270]	This work was supported by a Grant-in Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (AN no. 23107010) and a Grant-in-Aid for Young Scientists B (MO no. 25861270). We would like to thank Mr Masamitsu Harada (Cellgene) for his constructive suggestions and Mr Yutaka Hattori (Keyence) for his technical assistance in immunofluorescence imaging.	Johnson LA, 2010, CURR NEUROL NEUROSCI, V10, P259, DOI 10.1007/s11910-010-0111-9; Alexander BM, 2013, J NEURO-ONCOL, V111, P33, DOI 10.1007/s11060-012-0987-0; Sakamaki I, 2014, LEUKEMIA, V28, P329, DOI 10.1038/leu.2013.177; Ramsay AG, 2009, BLOOD, V114, P4713, DOI 10.1182/blood-2009-04-217687; Chung DS, 2014, J IMMUNOL RES, DOI 10.1155/2014/326545; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Lammering G, 2003, ONCOGENE, V22, P5545, DOI 10.1038/sj.onc.1206788; Giglio P, 2012, CANCER-AM CANCER SOC, V118, P3599, DOI 10.1002/cncr.26663; Lammering G, 2004, CLIN CANCER RES, V10, P6732, DOI 10.1158/1078-0432.CCR-04-0393; Ohno M, 2010, CANCER SCI, V101, P2518, DOI 10.1111/j.1349-7006.2010.01734.x; Lu L, 2009, MICROVASC RES, V77, P78, DOI 10.1016/j.mvr.2008.08.003; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Desai Madhav, 2014, Ther Adv Hematol, V5, P91, DOI 10.1177/2040620714532124; Nakayashiki N, 2000, JPN J CANCER RES, V91, P1035; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Montgomery RB, 2000, J BIOL CHEM, V275, P17358, DOI 10.1074/jbc.M000966200; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Idler I, 2010, BRIT J HAEMATOL, V148, P948, DOI 10.1111/j.1365-2141.2009.08014.x; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Muller GW, 1999, BIOORG MED CHEM LETT, V9, P1625, DOI 10.1016/S0960-894X(99)00250-4; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Okamoto S, 1996, BRIT J CANCER, V73, P1366, DOI 10.1038/bjc.1996.260; Curran KJ, 2012, J GENE MED, V14, P405, DOI 10.1002/jgm.2604; Corral LG, 1999, J IMMUNOL, V163, P380; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Luptakova K, 2013, CANCER IMMUNOL IMMUN, V62, P39, DOI 10.1007/s00262-012-1308-3; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Zoller S, 2007, REV ESP ENFERM DIG, V99, P547, DOI 10.4321/s1130-01082007000900011; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; LeBlanc R, 2004, BLOOD, V103, P1787, DOI 10.1182/blood-2003-02-0361; Cartellieri M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956304; Ohno Masasuke, 2013, J Immunother Cancer, V1, P21, DOI 10.1186/2051-1426-1-21	45	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0929-1903	1476-5500		CANCER GENE THER	Cancer Gene Ther.	OCT	2015	22	10					487	495		10.1038/cgt.2015.47		9	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Research & Experimental Medicine	CT6GS	WOS:000362912100004		
J	Oh, DY; Lee, SH; Han, SW; Kim, MJ; Kim, TM; Kim, TY; Heo, DS; Yuasa, M; Yanagihara, Y; Bang, YJ				Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Yuasa, Miyuki; Yanagihara, Yasuo; Bang, Yung-Jue			Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors	CANCER RESEARCH AND TREATMENT			English	Article						OPB-31121; STAT3; STAT3 nhibitor; Solid tumor; Phase I	TYROSINE KINASE JAK2; HUMAN GASTRIC-CANCER; SIGNAL TRANSDUCER; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; GROWTH-FACTOR; ACTIVATOR; MUTATION; TRANSCRIPTION-3; PATHWAY	Purpose OPB-31121 is an oral STAT3 inhibitor with a good preclinica I antitumor activity. This phase I dose-escalation study of OPB-31121 was conducted to determine maximum-tolerated dose (MTD), safety, pharmacokinetics, and preliminary antitumor efficacy in patients with advanced solid tumors. Materials and Methods Patients received OPB-31121 once daily for 28 days of each cycle followed by 2 weeks rest. A standard 3+3 design was used for dose-escalation. Safety and response were evaluated by the National Cancer Institute-Common Terminology Criteria for Adverse Events (NCICTCAE) ver. 3.0 and Response Evaluation Criteria in Solid Tumor (RECIST) ver. 1.0, respectively. Results Twenty-five patients were treated with OPB-31121 at five dose levels: 100 mg (n=4), 200 mg (n=3), 400 mg (n=3), 600 mg (n=7), and 800 mg (n=8). Seven patients discontinued treatment during cycle 1 for various reasons other than study drug-related adverse events. Among 18 patients who were evaluable for dose-limiting toxicity (DLT), three DLTs were observed: one DLT (grade 3 vomiting) at 600 mg and two DLTs (grade 3 vomiting, grade 3 diarrhea) at 800 mg. The MTD was determined as 800 mg/day. Common adverse events were gastrointestinal adverse event including nausea (84%), vomiting (80%), and diarrhea (72%). Pharmacokinetics did not demonstrate dose-proportionality of OPB-31121. Eight patients had stable disease and 10 patients had disease progression. Two patients (1 colon cancer, 1 rectal cancer) showed tumor shrinkage. One gastric cancer patient continued treatment up to cycle 13 before disease progression. Conclusion This study demonstrates feasibility of STAT3 inhibition in patients with advanced solid tumor. OPB-31121, at the MTD of 800 mg/day, was safe and relatively well tolerated, and has a preliminary antitumor activity.	[Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 03080, South Korea; [Kim, Mi-Jung] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Yuasa, Miyuki] Otsuka Pharmaceut Co Ltd, Dept Clin Res & Dev, Tokyo, Japan; [Yanagihara, Yasuo] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Tokyo, Japan	Bang, YJ (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.	bangyj@snu.ac.kr			Otsuka Pharmaceutical	Yung-Jue Bang received research funding from Otsuka Pharmaceutical and Miyuki Yuasa and Yasuo Yanagihar are Employee from Otsuka Pharmaceutical. None of the other investigators have any conflicts of interest to disclose.	Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; MIZUTANI Y, 1995, CANCER RES, V55, P590; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Mankan AK, 2011, EXPERT OPIN INV DRUG, V20, P1263, DOI 10.1517/13543784.2011.601739; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Alas S, 2003, CLIN CANCER RES, V9, P316; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Kim MJ, 2013, CANCER LETT, V335, P145, DOI 10.1016/j.canlet.2013.02.010; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Motte N, 2007, INT J CANCER, V121, P2113, DOI 10.1002/ijc.22939; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; Bendell JC, 2014, CANCER CHEMOTH PHARM, V74, P125, DOI 10.1007/s00280-014-2480-2; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Jove R, 2000, ONCOGENE, V19, P2466, DOI 10.1038/sj.onc.1203549; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Verstovsek S., 2009, HEMATOL-AM SOC HEMAT, V2009, P636	25	0	0	KOREAN CANCER ASSOCIATION	SEOUL	RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA	1598-2998	2005-9256		CANCER RES TREAT	Cancer Res. Treat.	OCT	2015	47	4					607	615		10.4143/crt.2014.249		9	Oncology	Oncology	CT6BN	WOS:000362895800009		
J	Oh, DY; Doi, T; Shirao, K; Lee, KW; Park, SR; Chen, Y; Yang, LQ; Valota, O; Bang, YJ				Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue			Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer	CANCER RESEARCH AND TREATMENT			English	Article						Axitinib; Stomach neoplasms; Cisplatin; Capecitabine; Pharmacokinetics; Clinical trial; Phase I	ENDOTHELIAL GROWTH-FACTOR; 1ST-LINE THERAPY; DOUBLE-BLIND; OPEN-LABEL; MULTICENTER; CARCINOMA; PLACEBO; TRIAL; PHARMACOLOGY; BEVACIZUMAB	Purpose This phase I trial evaluated the question of whether the standard starting dose of axitinib could be administered in combination with therapeutic doses of cisplatin/capecita bine in patients with previously untreated advanced gastric cancer, and assessed overall safety, pharmacokinetics, and preliminary antitumor activity of this combination. Materials and Methods Patients in dose level (DL) 1 received axitinib 5 mg twice a day (days 1 to 21) with cisplatin 80 mg/m2 (day 1) and capecita bine 1,000 mg/m2 twice a day (days 1 to 14) in 21-day cycles. Maximum tolerated dose (MTD) was the highest dose at which 30% of the first 12 patients experienced a dose-limiting toxicity (DLT) during cycle 1. Ten additional patients were enrolled and treated at the MTD in order to obtain additional safety and pharmacokinetic data Results Three DLTs occurred during cycle 1 in three (25%) of the first 12 patients: ruptured abdominal aortic aneurysm, acute renal failure, and > 5 consecutive days of missed axitinib due to thrombocytopenia. DL1 was established as the MTD, since higher DL cohorts were not planned. Common grade 3/4 non hematologic adverse events in 22 patients treated at DL1 included hypertension (36.4%) and decreased appetite and stomatitis (18.2% each). Cisplatin/capecitabine slightly increased axitinib exposure; axitinib decreased capecitabine and 5-fluorouracil exposure. Eight patients (36.4%) each had partial response or stable disease. Median response duration was 9.1 months; median progression-free survival was 3.8 months. Conclusion In patients with advanced gastric cancer, standard doses of axitinib plus therapeutic doses of cisplatin and capecitabine could be administered in combination. Adverse events were manageable.	[Oh, Do-Youn; Bang, Yung-Jue] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Oh, Do-Youn; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Doi, Toshihiko] Natl Canc Ctr Hosp East, Div Gastroenterol, Chiba, Japan; [Shirao, Kuniaki] Oita Univ, Fac Med, Dept Med Oncol, Yufu, Japan; [Lee, Keun-Wook] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Songnam, South Korea; [Park, Sook Ryun] Natl Canc Ctr, Res Inst & Hosp, Dept Internal Med, Goyang, South Korea; [Chen, Ying; Yang, Liqiang] Pfizer Oncol, San Diego, CA USA; [Valota, Olga] Pfizer Oncol, Milan, Italy	Bang, YJ (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.	bangyj@snu.ac.kr			Pfizer Inc.	Ying Chen, Ligiang Yang, and Olga Valota are Pfizer employees and hold Pfizer Inc. stock. Yung-Je Bang has performed consulting services for and received honoraria and research funding from Pfizer Inc. Do-Youn Oh, Toshihiko Doi, Kuniaki Shirao, Sook Ryun Park, and Keun-Wook Lee have no conflicts of interest to disclose. This study was sponsored by Pfizer Inc. Medical writing support was provided by Lilliam Poltorack, PharmD, and Joanna Bloom, PhD, of Engage Scientific Solutions, and was funded by Pfizer Inc.	Schiller JH, 2009, J CLIN ONCOL, V27, P3836, DOI 10.1200/JCO.2008.20.8355; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Bang YJ, 2010, LANCET, V376, P1302; Spano JP, 2008, LANCET, V371, P2101, DOI 10.1016/S0140-6736(08)60661-3; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Rugo HS, 2011, J CLIN ONCOL, V29, P2459, DOI 10.1200/JCO.2010.31.2975; Fruehauf J, 2011, CLIN CANCER RES, V17, P7462, DOI 10.1158/1078-0432.CCR-11-0534; Shi H, 2003, WORLD J GASTROENTERO, V9, P1421; Kim C, 2012, INVEST NEW DRUG, V30, P306, DOI 10.1007/s10637-010-9531-2; Chen Y, 2013, CLIN PHARMACOKINET, V52, P713, DOI 10.1007/s40262-013-0068-3; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; Bang YJ, 2011, INVEST NEW DRUG, V29, P1449, DOI 10.1007/s10637-010-9438-y; Moehler M, 2011, EUR J CANCER, V47, P1511, DOI 10.1016/j.ejca.2011.04.006; Postel-Vinay S, 2011, J CLIN ONCOL, V29, P1728, DOI 10.1200/JCO.2010.31.9236; VERMORKEN JB, 1984, CANCER TREAT REP, V68, P505; Hu-Lowe DD, 2008, CLIN CANCER RES, V14, P7272, DOI 10.1158/1078-0432.CCR-08-0652; Go RS, 1999, J CLIN ONCOL, V17, P409; Infante JR, 2013, CANCER-AM CANCER SOC, V119, P2555, DOI 10.1002/cncr.28112; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; National comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Park SR, 2010, 35 ANN C EUR SOC MED	24	0	0	KOREAN CANCER ASSOCIATION	SEOUL	RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA	1598-2998	2005-9256		CANCER RES TREAT	Cancer Res. Treat.	OCT	2015	47	4					687	696		10.4143/crt.2014.225		10	Oncology	Oncology	CT6BN	WOS:000362895800018		
J	Hashimoto, M; Misaka, T; Ishiguro, M; Masuda, K				Hashimoto, Makoto; Misaka, Takumi; Ishiguro, Masaji; Masuda, Katsuyoshi			Synthesis and property of photoaffinity labeling reagents for functional analysis of taste receptor	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Hashimoto, Makoto] Hokkaido Univ, Grad Sch Agr, Div Appl Sci, Sapporo, Hokkaido 0608589, Japan; [Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata 9568603, Japan; [Masuda, Katsuyoshi] Suntory Inst Bioorgan Res, Osaka 6188503, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				3	587	588				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500008		
J	Miyazawa, T				Miyazawa, Toshio			Effect of the herb component, spilanthol, on salty taste enhancement	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Miyazawa, Toshio] Ogawa & Co Ltd, Funct Prod R&D Lab, Chiba 2790032, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				2	587	587				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500007		
J	Ueda, H				Ueda, Hiroshi			Involvement of neuroendocrine functions on olfactory imprinting and homing in Pacific salmon	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Ueda, Hiroshi] Hokkaido Univ, Grad Sch Environm Sci, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido 0600809, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				1	587	587				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500006		
J	Ando, H; Tadokoro, O; Iwasaki, T; Asanuma, N				Ando, Hiroshi; Tadokoro, Osamu; Iwasaki, Takami; Asanuma, Naokazu			Immunoreactivities of calretinin and calbindin in fungiform papilla of frog	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Ando, Hiroshi; Iwasaki, Takami; Asanuma, Naokazu] Matsumoto Dent Univ, Dept Oral Physiol, Shiojiri 3990781, Japan; [Tadokoro, Osamu] Matsumoto Dent Univ, Dept Oral Anat, Shiojiri 3990781, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				4	588	588				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500009		
J	Furuyama, A; Kojima, T; Munakata, Y				Furuyama, Akira; Kojima, Tadayuki; Munakata, Yoshiei			The effect of yeast ingestion on the salt ingestion behavior of Drosophila	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Furuyama, Akira; Munakata, Yoshiei] Ohu Univ, Sch Dent, Div Oral Func Mol Biol, Fukushima 9638611, Japan; [Kojima, Tadayuki] Ohu Univ, Grad Sch Dent, Dept Oral Maxillofacial Surg, Fukushima 9638611, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				6	588	589				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500011		
J	Shibata, M; Suzuki, H				Shibata, Minori; Suzuki, Hideaki			Longitudinal observation of taste sensation and trace elements during pregnancy	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Shibata, Minori; Suzuki, Hideaki] Univ Occupat & Environm Hlth, Dept Otorhinolaryngol Head & Neck Surg, Kitakyushu, Fukuoka 8078555, Japan; [Shibata, Minori] Univ Occupat & Environm Hlth, Hlth Ctr, Kitakyushu, Fukuoka 8078555, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				5	588	588				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500010		
J	Eguchi, K; Kashima, H; Ueoka, H; Endo, MY; Fukuba, Y				Eguchi, Kohei; Kashima, Hideaki; Ueoka, Hatsumi; Endo, Masako Y.; Fukuba, Yoshiyuki			The acute responses of celiac artery blood flow and gastric motility to oral sensation of sweetness	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Eguchi, Kohei] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Hiroshima 7348558, Japan; [Kashima, Hideaki; Endo, Masako Y.; Fukuba, Yoshiyuki] Prefectural Univ Hiroshima, Dept Hlth Sci, Hiroshima 7348558, Japan; [Ueoka, Hatsumi] Yasuda Womens Univ, Dept Nutr Sci, Hiroshima 7310153, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				8	589	589				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500013		
J	Inui, T; Shimura, T				Inui, Tadashi; Shimura, Tsuyoshi			Approach-avoidance conflict during the retrieval of conditioned taste aversion	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Inui, Tadashi; Shimura, Tsuyoshi] Osaka Univ, Grad Sch Human Sci, Div Behav Physiol, Dept Behav Sci, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				9	589	590				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500014		
J	Mizutani, S; Kobashi, M; Shimatani, Y; Fujita, M; Mitoh, Y; Mizutani, M; Matsuo, R				Mizutani, Satoshi; Kobashi, Motoi; Shimatani, Yuichi; Fujita, Masako; Mitoh, Yoshihiro; Mizutani, Masatoshi; Matsuo, Ryuji			Identification of the effective site of GLP-1 to suppress reflex swallowing	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Mizutani, Satoshi; Kobashi, Motoi; Fujita, Masako; Mitoh, Yoshihiro; Matsuo, Ryuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Physiol, Okayama 7008525, Japan; [Shimatani, Yuichi] Tokyo City Univ, Dept Biomed Engn, Tokyo 1588557, Japan; [Mizutani, Masatoshi] Kibi Int Univ, Sch Hlth Sci & Social Welf, Dept Phys Therapy, Okayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				7	589	589				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500012		
J	Cao, L; Kawai, M; Uneyama, H				Cao, Lili; Kawai, Misako; Uneyama, Hisayuki			Development of an easy taste test using whole mouth tasting procedure	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Cao, Lili; Kawai, Misako; Uneyama, Hisayuki] Ajinomoto Co Inc, Inst Innovat, Yokohama, Kanagawa 2108681, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				10	590	590				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500015		
J	Kato, K; Otake, K				Kato, Kenji; Otake, Keiko			Sensory-specific satiety depending on the appearance of food	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kato, Kenji] Tohoku Gakuin Univ, Dept Human Sci, Sendai, Miyagi 9803193, Japan; [Otake, Keiko] Kwansei Gakuin Univ, Dept Integrated Psychol Sci, Nishinomiya, Hyogo 6628501, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				12	590	591				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500017		
J	Mitsuda, T; Komatsu, S				Mitsuda, Takashi; Komatsu, Sota			The effects of familiarity on hedonic evaluations of drinks	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Mitsuda, Takashi; Komatsu, Sota] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu 5258577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				11	590	590				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500016		
J	Kawai, M; Yajima, Y; Kobayashi, M; Cao, L; Kikutani, T				Kawai, Misako; Yajima, Yuri; Kobayashi, Minatsu; Cao, Lili; Kikutani, Takeshi			Discrepancy between subjective and objective taste sensitivity in the elderly	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kawai, Misako; Cao, Lili] Ajinomoto Co Inc, Inst Innovat, Yokohama, Kanagawa 2108681, Japan; [Yajima, Yuri; Kikutani, Takeshi] Nippon Dent Univ Tokyo, Grad Sch Life Dent, Div Oral Rehabil, Tokyo 1028158, Japan; [Kobayashi, Minatsu] Otsuma Womens Univ, Fac Home Econ, Dept Food Sci, Tokyo 1028357, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				14	591	591				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500019		
J	Onuma, T; Sakai, N				Onuma, Takuya; Sakai, Nobuyuki			Taste-odor learning and hedonic transfer in rats	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Onuma, Takuya; Sakai, Nobuyuki] Tohoku Univ, Grad Sch Arts & Letters, Sendai, Miyagi 9808576, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				15	591	592				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500020		
J	Tamura, K; Yamazaki, M; Shimizu, T; Miyamoto, M; Otsuka, Y; Sugasawa, T; Ohta, M				Tamura, Kyoko; Yamazaki, Madoka; Shimizu, Tomomi; Miyamoto, Masahide; Otsuka, Yuko; Sugasawa, Takehito; Ohta, Makoto			The sense of taste is influenced by visual information	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Tamura, Kyoko; Yamazaki, Madoka; Miyamoto, Masahide; Otsuka, Yuko; Ohta, Makoto] Daito Bunka Univ, Dept Hlth Sci, Tokyo 1758571, Japan; [Shimizu, Tomomi] Toin Univ Yokohama, Dept Biomed Engn, Yokohama, Kanagawa 2258503, Japan; [Sugasawa, Takehito] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				13	591	591				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500018		
J	Nishioka, H; Yamaguchi, E; Yasoshima, Y; Shimura, T				Nishioka, Haruna; Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi			Taste-guided behaviors in mice carrying mutated dopamine transporter gene	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Nishioka, Haruna; Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi] Osaka Univ, Div Behav Physiol, Grad Sch Human Sci, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				17	592	592				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500022		
J	Shoji, Y; Miyazawa, T; Togawa, M; Sakuma, K; Muranishi, S; Hamaguchi, T; Wise, P; Bryant, B				Shoji, Yasutaka; Miyazawa, Toshio; Togawa, Makoto; Sakuma, Katsuya; Muranishi, Shuichi; Hamaguchi, Takashi; Wise, Paul; Bryant, Bruce			Evaluation of enhancing effect of spilanthol on carbonation bite using half-tongue test	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Shoji, Yasutaka; Miyazawa, Toshio; Togawa, Makoto; Sakuma, Katsuya; Muranishi, Shuichi; Hamaguchi, Takashi] Ogawa & Co Ltd, Chiba 2790032, Japan; [Wise, Paul; Bryant, Bruce] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				16	592	592				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500021		
J	Yamaguchi, E; Yasoshima, Y; Shimura, T				Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi			Peptide YY fails to induce conditioned taste aversion in mice	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi] Osaka Univ, Div Behav Physiol, Grad Sch Human Sci, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				18	592	593				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500023		
J	Inui-Yamamoto, C; Inui, T; Yamamoto, T; Ueda, K; Nakatsuka, M; Kumabe, S; Iwai, Y; Yoshioka, Y				Inui-Yamamoto, Chizuko; Inui, Tadashi; Yamamoto, Takashi; Ueda, Katsura; Nakatsuka, Michiko; Kumabe, Shunji; Iwai, Yasutomo; Yoshioka, Yoshichika			Brain activation of age-related changes in taste hedonics of bitter taste in rats	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Inui-Yamamoto, Chizuko; Ueda, Katsura; Nakatsuka, Michiko; Kumabe, Shunji; Iwai, Yasutomo] Osaka Dent Univ, Dept Oral Anat, Osaka 5731144, Japan; [Inui, Tadashi] Osaka Univ, Grad Sch Human Sci, Suita, Osaka 5650871, Japan; [Yamamoto, Takashi] Kio Univ, Fac Hlth Sci, Nara 6350832, Japan; [Inui-Yamamoto, Chizuko; Yoshioka, Yoshichika] Osaka Univ, WPI IFReC, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				21	593	594				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500026		
J	Murata, Y; Kimura, M; Kato, T; Touhata, K				Murata, Yuko; Kimura, Meiko; Kato, Tomomi; Touhata, Ken			Effect of trimethylamine (TMA) on the taste preference in mice	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Murata, Yuko; Kimura, Meiko; Kato, Tomomi; Touhata, Ken] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				19	593	593				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500024		
J	Ueji, K; Minematsu, Y; Yamamoto, T				Ueji, Kayoko; Minematsu, Yuji; Yamamoto, Takashi			Conditioned flavor preference with saccharin solutions in weanling rats	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Ueji, Kayoko; Minematsu, Yuji; Yamamoto, Takashi] Kio Univ, Dept Hlth & Nutr, Fac Hlth Sci, Nara 6350832, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				20	593	593				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500025		
J	Kobayashi, M; Horiguchi, M; Cao, L; Kawai, M				Kobayashi, Minatsu; Horiguchi, Mieko; Cao, Lili; Kawai, Misako			High concentration solution intake experience prior to a taste sensitivity test affects tasting performance	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kobayashi, Minatsu] Otsuma Womens Univ, Fac Home Econ, Dept Food Sci, Chiyoda Ku, Tokyo 1028357, Japan; [Horiguchi, Mieko] Otsuma Womens Univ, Dept Domest Sci, Jr Coll Div, Chiyoda Ku, Tokyo 1028357, Japan; [Cao, Lili; Kawai, Misako] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				24	594	595				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500029		
J	Makita, Y; Ishida, T; Kobayashi, N; Fujio, M; Fujimoto, K; Moritomo, R; Fujiwara, S				Makita, Yoshimasa; Ishida, Tomoko; Kobayashi, Noriko; Fujio, Mai; Fujimoto, Kyoko; Moritomo, Rina; Fujiwara, Shin-ichi			Study of bitterness masking effect using Kinako	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Makita, Yoshimasa; Fujiwara, Shin-ichi] Osaka Dent Univ, Dept Chem, Osaka 5731121, Japan; [Ishida, Tomoko; Kobayashi, Noriko; Fujio, Mai; Fujimoto, Kyoko; Moritomo, Rina] Osaka Dent Univ, Osaka 5731121, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				22	594	594				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500027		
J	Minematsu, Y; Ueji, K; Yamamoto, T				Minematsu, Yuji; Ueji, Kayoko; Yamamoto, Takashi			Detection of brain activities reflecting hedonic aspects of taste: a fNIRS study	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Minematsu, Yuji; Ueji, Kayoko; Yamamoto, Takashi] Kio Univ, Dept Hlth & Nutr, Fac Hlth Sci, Nara 6350832, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				23	594	594				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500028		
J	Shimazaki, N; Yamamori, T; Tazaki, T; Kawamura, K; Toyoda, K; Takebe, J; Kondo, H				Shimazaki, Nobuko; Yamamori, Tetsuo; Tazaki, Tomoko; Kawamura, Kenichi; Toyoda, Katsuhiko; Takebe, Jun; Kondo, Hisatomo			Screening of taste dysfunction using zinc-binding protein in saliva	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Shimazaki, Nobuko; Takebe, Jun; Kondo, Hisatomo] Iwate Med Univ, Sch Dent, Dept Prosthodont & Oral Implantol, Morioka, Iwate 0208505, Japan; [Yamamori, Tetsuo] Ohu Univ, Sch Dent, Dept Prosthet Dent, Fukushima 9638611, Japan; [Tazaki, Tomoko; Kawamura, Kenichi; Toyoda, Katsuhiko] NIPPUN ENGN CO LTD, Tokyo 1510051, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				26	595	596				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500031		
J	Takao, T; Kogomori, C; Oyama, Y; Yonezawa, K; Maekawa, I; Aoki, M; Koike, F; Takao, K; Shiga, S				Takao, Tetsuya; Kogomori, Chieko; Oyama, Yuka; Yonezawa, Kaori; Maekawa, Iwao; Aoki, Mieko; Koike, Fumihiko; Takao, Kyoichi; Shiga, Seigo			The expression of hTAS2Rs in suckling infants	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Takao, Tetsuya; Kogomori, Chieko; Shiga, Seigo] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo 1548533, Japan; [Takao, Tetsuya; Oyama, Yuka; Yonezawa, Kaori; Shiga, Seigo] Showa Womens Univ, Fac Human Life & Environm Sci, Tokyo 1548533, Japan; [Maekawa, Iwao] Maekawasanfujinka Clin, Shizuoka 4110934, Japan; [Aoki, Mieko] Sanyo Gakuen Coll, Dept Food & Nutr, Okayama 7038501, Japan; [Koike, Fumihiko; Takao, Kyoichi] Nippon Univ, Sch Med, Tokyo 1738610, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				25	595	595				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500030		
J	Kosaka, K; Kosaka, T				Kosaka, Katsuko; Kosaka, Toshio			A review of three newly identified nonprincipal neurons in the rodent olfactory bulb	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kosaka, Katsuko] Int Univ Hlth & Welf, Fac Hlth & Welf Sci Fukuoka, Dept Med Sci Technol, Fukuoka 8318501, Japan; [Kosaka, Toshio] Kyushu Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Fukuoka 8128582, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				29	596	597				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500034		
J	Nakai, M; Sugiura, M; Yajima, T; Hiranuma, K				Nakai, Mari; Sugiura, Motohiko; Yajima, Toshiyuki; Hiranuma, Kota			Prediction of international standards cupping evaluation of Guatemalan Arabica coffee by Electronic Tongue and Electronic Nose	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Nakai, Mari; Sugiura, Motohiko] Tokyo Allied Coffee Roasters Co LTD, Tokyo 1460081, Japan; [Yajima, Toshiyuki] Alpha MOS Japan KK, Tokyo 1080074, Japan; [Hiranuma, Kota] TASTE TECHNOL INC, Tokyo 2030023, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				27	596	596				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500032		
J	Okazaki, H; Yasuura, M; Tahara, Y; Ikezaki, H; Toko, K				Okazaki, Hirotaka; Yasuura, Masato; Tahara, Yusuke; Ikezaki, Hidekazu; Toko, Kiyoshi			A study on development of a sweetness sensor for high potency sweeteners with negative charge and measurement of the commercial drinks	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Okazaki, Hirotaka; Yasuura, Masato] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan; [Yasuura, Masato] Kyushu Univ, Fukuoka 8190395, Japan; [Tahara, Yusuke; Toko, Kiyoshi] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 8190395, Japan; [Ikezaki, Hidekazu] Intelligent Sensor Technol Inc, Atsugi, Kagawa 2430032, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				28	596	596				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500033		
J	Miyazono, S; Osada, K; Kashiwayanagi, M				Miyazono, Sadaharu; Osada, Kazumi; Kashiwayanagi, Makoto			Pyrazine analogs in wolf urine induced fear-associated aversive behaviors in deer	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Miyazono, Sadaharu; Kashiwayanagi, Makoto] Asahikawa Med Univ, Dept Sensory Physiol, Sapporo, Hokkaido 0788510, Japan; [Osada, Kazumi] Hlth Sci Univ Hokkaido, Div Physiol, Dept Oral Biol, Sch Dent, Sapporo, Hokkaido 0610293, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				31	597	597				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500036		
J	Nakazawa, H; Suzuki, AC; Nagai, T				Nakazawa, Hideo; Suzuki, Atsushi C.; Nagai, Takatoshi			Subdivisions of the olfactory epithelium in Japanese toads with distinct cell types and odor responsiveness	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Nakazawa, Hideo; Suzuki, Atsushi C.; Nagai, Takatoshi] Keio Univ, Sch Med, Dept Biol, Yokohama, Kanagawa 2238521, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				30	597	597				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500035		
J	Taniguchi, M; Namba, T; Kaba, H				Taniguchi, Mutsuo; Namba, Toshiharu; Kaba, Hideto			Suppressive action of vasopressin on the reciprocal synaptic transmission between mitral and granule cells in the mouse accessory olfactory bulb	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Taniguchi, Mutsuo; Namba, Toshiharu; Kaba, Hideto] Kochi Med Sch, Dept Physiol, Kochi 7838505, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				32	597	598				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500037		
J	Hara, C; Tomi, K; Hayashi, T				Hara, Chiaki; Tomi, Kenichi; Hayashi, Takahiro			Effects of the major component limonene and the other minor components of citrus essential oils on the psychology and physiology of human	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Hara, Chiaki; Tomi, Kenichi; Hayashi, Takahiro] Kinki Univ, Fac Agr, Nara 6318505, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				33	598	598				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500038		
J	Taniguchi, G; Hamakawa, M; Uozumi, T; Kiriyama, K; Kamizaki, T; Hirotsu, T				Taniguchi, Gun; Hamakawa, Masayuki; Uozumi, Takayuki; Kiriyama, Keisuke; Kamizaki, Tomoko; Hirotsu, Takaaki			Different olfactory receptors function depending on odor concentrations in C. elegans	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Taniguchi, Gun; Hamakawa, Masayuki; Uozumi, Takayuki; Kiriyama, Keisuke; Hirotsu, Takaaki] Kyushu Univ, Fac Sci, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Kamizaki, Tomoko; Hirotsu, Takaaki] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				35	598	599				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500040		
J	Uozumi, T; Deno, YK; Hirotsu, T				Uozumi, Takayuki; Deno, Yu-Ki; Hirotsu, Takaaki			Voltage-dependent anion channel (VDAC-1) plays a key role in olfactory sensory signaling in C. elegans	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Uozumi, Takayuki; Deno, Yu-Ki; Hirotsu, Takaaki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8120053, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				34	598	598				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500039		
J	Fujiwara, S; Matsumoto, T; Ohmori, Y; Nakamura, A; Nammoku, T; Mori, K				Fujiwara, Satoshi; Matsumoto, Tomona; Ohmori, Yuichiro; Nakamura, Akio; Nammoku, Takashi; Mori, Kensaku			Sensation of carbonated water and its enhancement by a flavor compound accompany enhanced salivary hemodynamic responses	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Fujiwara, Satoshi; Matsumoto, Tomona; Ohmori, Yuichiro; Nakamura, Akio; Nammoku, Takashi] T Hasegawa Co Ltd, R&D Ctr, Kawasaki, Kanagawa 2110022, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				38	599	600				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500043		
J	Iizumi, K; Matsumoto, T; Nakamura, A; Nammoku, T; Mori, K				Iizumi, Kana; Matsumoto, Tomona; Nakamura, Akio; Nammoku, Takashi; Mori, Kensaku			High palatability of pungent spices accompanies larger salivary hemodynamic responses	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Iizumi, Kana; Matsumoto, Tomona; Nakamura, Akio; Nammoku, Takashi] T Hasegawa Co Ltd, R&D Ctr, Kawasaki, Kanagawa 2110022, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				37	599	599				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500042		
J	Iwamatsu, T; Mitsuno, H; Sakurai, T; Kanzaki, R				Iwamatsu, Takuma; Mitsuno, Hidefumi; Sakurai, Takeshi; Kanzaki, Ryohei			Behavioral responses of body lice, Pediculus humanus corporis, to human body-odor components.	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Iwamatsu, Takuma; Kanzaki, Ryohei] Univ Tokyo, Grad Sch Engn, Meguro Ku, Tokyo 1538904, Japan; [Mitsuno, Hidefumi; Sakurai, Takeshi; Kanzaki, Ryohei] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				36	599	599				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500041		
J	Abe, Y; Takamizawa, T; Miyagi, K; Liu, CJ; Hayashi, K				Abe, Yosuke; Takamizawa, Tadashi; Miyagi, Kazuki; Liu, Chuanjun; Hayashi, Kenshi			Development of odor sensing system using the odor clustering based on molecular size	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Abe, Yosuke; Takamizawa, Tadashi; Miyagi, Kazuki] USE Co Ltd, Shibuya Ku, Tokyo 1500013, Japan; [Liu, Chuanjun; Hayashi, Kenshi] Kyushu Univ, Grad Sch Informat Sci, Dept Elect, Fukuoka 8190395, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				41	600	601				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500046		
J	Takoi, K; Itoga, Y; Takayanagi, J; Matsumoto, I; Nakamura, T				Takoi, Kiyoshi; Itoga, Yutaka; Takayanagi, Junji; Matsumoto, Ichiro; Nakamura, Takeshi			Evaluation of synergy among characteristic flavor compounds derived from Flavor Hops	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Takoi, Kiyoshi; Matsumoto, Ichiro; Nakamura, Takeshi] Sapporo Breweries Ltd, Prod & Technol Innovat Dept, Shizuoka 4250013, Japan; [Itoga, Yutaka] Sapporo Breweries Ltd, Bioresources Res & Dev Dept, Sapporo, Hokkaido 0710551, Japan; [Takayanagi, Junji] Pokka Sapporo Food & Beverage Ltd, Cent Lab, Nagoya, Aichi 4818515, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				39	600	600				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500044		
J	Yoshioka, M; Ono, Y; Nakazawa, Y; Komasa, Y				Yoshioka, Masataka; Ono, Yoshiaki; Nakazawa, Yuri; Komasa, Yutaka			Evaluation of the smell of dental materials	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Yoshioka, Masataka; Ono, Yoshiaki; Nakazawa, Yuri; Komasa, Yutaka] Osaka Dent Univ, Dept Geriatr Dent, Osaka 5400008, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				40	600	600				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500045		
J	Noyori, R				Noyori, Ryoji			Vibrant Science Needed for Future Society	CHEMISTRY-AN ASIAN JOURNAL			English	Editorial Material									[Noyori, Ryoji] Nagoya Univ, Nagoya, Aichi 4648602, Japan; [Noyori, Ryoji] RIKEN, Wako, Saitama 3510198, Japan	Noyori, R (reprint author), Nagoya Univ, Nagoya, Aichi 4648602, Japan.	noyori@riken.jp						0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2006	2007		10.1002/asia.201500618		2	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200002		
J	Shigemitsu, H; Hamachi, I				Shigemitsu, Hajime; Hamachi, Itaru			Supramolecular Assemblies Responsive to Biomolecules toward Biological Applications	CHEMISTRY-AN ASIAN JOURNAL			English	Article						biological applications; biomolecules; hydrogels; stimuli responsiveness; supramolecular assembly	AGGREGATION-INDUCED EMISSION; SMALL MOLECULES; IN-VIVO; RATIONAL DESIGN; ENZYMATIC FORMATION; PROTEIN-DETECTION; GENE DELIVERY; CELL-CULTURE; HYDROGELS; NANOPROBES	Stimuli-responsive supramolecular assemblies consisting of small molecules are attractive functional materials for biological applications such as drug delivery, medical diagnosis, enzyme immobilization, and tissue engineering. By use of their dynamic and reversible properties, many supramolecular assemblies responsive to a variety of biomolecules have been designed and synthesized. This review focuses on promising strategies for the construction of such dynamic supramolecular assemblies and their functions. While studies of biomolecule-responsive supramolecular assemblies have mainly been performed in vitro, it has recently been demonstrated that some of them can work in live cells. Supramolecular assemblies now open up new avenues in chemical biology and biofunctional materials.	[Shigemitsu, Hajime; Hamachi, Itaru] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura, Kyoto 6158510, Japan; [Hamachi, Itaru] JST, CREST, Chiyoda Ku, Tokyo, Japan	Hamachi, I (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura, Kyoto 6158510, Japan.	ihamachi@sbchem.kyoto-u.ac.jp					Qi ZH, 2014, ACCOUNTS CHEM RES, V47, P2222, DOI 10.1021/ar500193z; Liu J, 2011, J AM CHEM SOC, V133, P17370, DOI 10.1021/ja2057924; Liang GL, 2010, NAT CHEM, V2, P54, DOI [10.1038/nchem.480, 10.1038/NCHEM.480]; Lee MH, 2013, CHEM REV, V113, P5071, DOI 10.1021/cr300358b; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030; Takaoka Y, 2013, CHEM LETT, V42, P1426, DOI 10.1246/cl.130697; Gao Y, 2013, ACS NANO, V7, P9055, DOI 10.1021/nn403664n; Zhang XL, 2012, ANGEW CHEM INT EDIT, V51, P4388, DOI 10.1002/anie.201108612; Guo DS, 2012, J AM CHEM SOC, V134, P10244, DOI 10.1021/ja303280r; Guo DS, 2013, CHEM COMMUN, V49, P6779, DOI 10.1039/c3cc41918e; Ikeda M, 2012, CHEM COMMUN, V48, P2716, DOI 10.1039/c2cc17503g; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Ye DJ, 2014, NAT CHEM, V6, P519, DOI [10.1038/nchem.1920, 10.1038/NCHEM.1920]; Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z; Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/nchem.1937, 10.1038/NCHEM.1937]; Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340; Anees P, 2014, J AM CHEM SOC, V136, P13233, DOI 10.1021/ja503850b; Yang ZM, 2007, J AM CHEM SOC, V129, P266, DOI 10.1021/ja0675604; Jiang LX, 2012, CHEM COMMUN, V48, P7347, DOI 10.1039/c2cc32533k; Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239; Kuang Y, 2014, ANGEW CHEM INT EDIT, V53, P8104, DOI 10.1002/anie.201402216; Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k; Mizusawa K, 2012, J AM CHEM SOC, V134, P13386, DOI 10.1021/ja304239g; Li JY, 2013, J AM CHEM SOC, V135, P9907, DOI 10.1021/ja404215g; Wang YX, 2013, RSC ADV, V3, P8058, DOI 10.1039/c3ra40453f; Wang M, 2009, ANAL CHEM, V81, P4444, DOI 10.1021/ac9002722; Yang ZM, 2007, SMALL, V3, P558, DOI 10.1002/smll.200700015; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Yang CH, 2012, J PHYS CHEM B, V116, P633, DOI 10.1021/jp209441r; Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b; Wada A, 2009, J AM CHEM SOC, V131, P5321, DOI 10.1021/ja900500j; Guo J, 2014, J AM CHEM SOC, V136, P2220, DOI 10.1021/ja4108676; Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l; Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914; Boekhoven J, 2012, J AM CHEM SOC, V134, P12908, DOI 10.1021/ja3051876; Takaoka Y, 2011, J AM CHEM SOC, V133, P11725, DOI 10.1021/ja203996c; Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j; Huang P, 2014, J AM CHEM SOC, V136, P11748, DOI 10.1021/ja505212y; Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Busseron E, 2013, NANOSCALE, V5, P7098, DOI 10.1039/c3nr02176a; Kasai H, 2012, ANGEW CHEM INT EDIT, V51, P10315, DOI 10.1002/anie.201204596; Ren CH, 2011, CHEM COMMUN, V47, P1619, DOI 10.1039/c0cc04135a; Cash KJ, 2010, TRENDS MOL MED, V16, P584, DOI 10.1016/j.molmed.2010.08.002; Takaoka Y, 2009, NAT CHEM, V1, P557, DOI [10.1038/nchem.365, 10.1038/NCHEM.365]; Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z; Blum AP, 2015, J AM CHEM SOC, V137, P2140, DOI 10.1021/ja510147n; Mizusawa K, 2010, J AM CHEM SOC, V132, P7291, DOI 10.1021/ja101879g; Miao XM, 2013, ANGEW CHEM INT EDIT, V52, P7781, DOI 10.1002/anie.201303199; Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y; Takaoka Y, 2011, CHEM SCI, V2, P511, DOI 10.1039/c0sc00513d; Ikeda M, 2011, ADV MATER, V23, P2819, DOI 10.1002/adma.201004658; Matsuo K, 2013, CHEM-EUR J, V19, P12875, DOI 10.1002/chem.201300817; Shi HB, 2012, J AM CHEM SOC, V134, P17972, DOI 10.1021/ja3064588; Yang ZM, 2006, ADV MATER, V18, P3043, DOI 10.1002/adma.200600400; Micklitsch CM, 2011, ANGEW CHEM INT EDIT, V50, P1577, DOI 10.1002/anie.201006652; Bhuniya S, 2006, CHEM COMMUN, P1842, DOI 10.1039/b516632b; Cohen-Stuart M. A., 2010, NAT MATER, V9, P101; Fleming S, 2014, CHEM SOC REV, V43, P8150, DOI 10.1039/c4cs00247d; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Kasai H, 2012, ANGEW CHEM, V124, P10461; Kuang Y., 2014, ANGEW CHEM, V126, P8242; Kumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6793; Miao X. M., 2013, ANGEW CHEM, V125, P7935; Qiu ZJ, 2009, CHEM COMMUN, P3342, DOI 10.1039/b822840j; Ren CH, 2014, CHEM SOC REV, V43, P7257, DOI 10.1039/c4cs00161c; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106968; Yoshii T, 2014, J AM CHEM SOC, V136, P16635, DOI 10.1021/ja508955y; You Jin-Oh, 2010, J Biol Eng, V4, P15, DOI 10.1186/1754-1611-4-15; Zhang X, 2012, ANGEW CHEM, V124, P4464	71	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2026	2038		10.1002/asia.201500563		13	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200003		
J	Wang, C; Yamamoto, H				Wang, Chuan; Yamamoto, Hisashi			Asymmetric Epoxidation Using Hydrogen Peroxide as Oxidant	CHEMISTRY-AN ASIAN JOURNAL			English	Article						asymmetric synthesis; catalysis; epoxidation; hydrogen peroxide; olefins	ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; HIGHLY ENANTIOSELECTIVE EPOXIDATION; TERMINAL NONCONJUGATED OLEFINS; ELECTRON-DEFICIENT OLEFINS; STEREOSELECTIVE EPOXIDATION; UNFUNCTIONALIZED OLEFINS; MANGANESE COMPLEXES; SYNTHETIC ENZYMES; SALALEN CATALYSTS; TRIPHASE SYSTEM	Asymmetric epoxidation is one of the most important transformations in organic synthesis. Although tremendous progress was achieved in this field in the 1980s and 1990s, it is still desirable from both economical and ecological views to develop environmentally friendly catalytic epoxidation with a broad substrate scope. Hydrogen peroxide is a safe and cheap oxidant, which is easy to handle and generates water as the sole byproduct. Therefore, asymmetric epoxidation of olefins using hydrogen peroxide as oxidant has been a very active research field and has been investigated by many research groups in recent years. In this review, the exciting very recent developments of this rapidly growing area are surveyed and organized according to the catalyst systems.	[Wang, Chuan; Yamamoto, Hisashi] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yamamoto, Hisashi] Chubu Univ, Mol Catalyst Res Ctr, Kasugai, Aichi 4878501, Japan	Yamamoto, H (reprint author), Univ Chicago, Dept Chem, 5735 South Ellis Ave, Chicago, IL 60637 USA.	yamamoto@uchicago.edu			Japan Science Promotion Foundation (JSP-ACT-C); National Institutes of Health (NIH) [2R01M068433]; Alexander von Humboldt Foundation	Japan Science Promotion Foundation (JSP-ACT-C) and the National Institutes of Health (NIH, 2R01M068433) are greatly appreciated for providing financial support. C.W. thanks the Alexander von Humboldt Foundation for his postdoctoral fellowship.	Abascal NC, 2014, CHEM SCI, V5, P4504, DOI 10.1039/c4sc01440e; Adam W, 2005, SYNLETT, P1047, DOI 10.1055/s-2005-865214; Amiri N, 2014, TETRAHEDRON, V70, P8836, DOI 10.1016/j.tet.2014.10.001; COLONNA S, 1983, TETRAHEDRON, V39, P1635, DOI 10.1016/S0040-4020(01)88574-4; Weyer A, 2012, CHEMCATCHEM, V4, P337, DOI 10.1002/cctc.201100243; Lichtor PA, 2014, J AM CHEM SOC, V136, P5301, DOI 10.1021/ja410567a; Maity NC, 2014, CATAL SCI TECHNOL, V4, P208, DOI 10.1039/c3cy00528c; Burke CP, 2007, J ORG CHEM, V72, P6320, DOI 10.1021/jo0708644; Russo A, 2012, CHEMCATCHEM, V4, P901, DOI 10.1002/cctc.201200139; Lifchits O, 2013, J AM CHEM SOC, V135, P6677, DOI 10.1021/ja402058v; Matsumoto K, 2011, TETRAHEDRON, V67, P6474, DOI 10.1016/j.tet.2011.06.022; Wang X, 2008, J AM CHEM SOC, V130, P6070, DOI 10.1021/ja801181u; IRIE R, 1991, TETRAHEDRON-ASYMMETR, V2, P481, DOI 10.1016/S0957-4166(00)86102-9; Wang QF, 2015, CHEM-EUR J, V21, P247, DOI 10.1002/chem.201404639; Wu SX, 2013, ADV SYNTH CATAL, V355, P1917, DOI 10.1002/adsc.201300249; Sawada Y, 2006, ANGEW CHEM INT EDIT, V45, P3478, DOI 10.1002/anie.200600636; Lee A, 2012, ADV SYNTH CATAL, V354, P1701, DOI 10.1002/adsc.201200072; Reisinger CM, 2008, ANGEW CHEM INT EDIT, V47, P8112, DOI 10.1002/anie.200803238; Murphy A, 2003, J AM CHEM SOC, V125, P5250, DOI 10.1021/ja0299962r; Jat JL, 2015, ORG LETT, V17, P1058, DOI 10.1021/acs.orglett.5b00281; Xia QH, 2005, CHEM REV, V105, P1603, DOI 10.1021/cr0406458; McGarrigle EM, 2005, CHEM REV, V105, P1563, DOI 10.1021/cr0306945; Chu YY, 2014, ADV SYNTH CATAL, V356, P2214, DOI 10.1002/adsc.201400341; Wang C, 2014, J AM CHEM SOC, V136, P1222, DOI 10.1021/ja411379e; BANFI S, 1984, TETRAHEDRON, V40, P5207, DOI 10.1016/S0040-4020(01)91272-4; Matsumoto K, 2005, ANGEW CHEM INT EDIT, V44, P4935, DOI 10.1002/anie.200501318; Berkessel A, 2001, ORG LETT, V3, P3839, DOI 10.1021/oi0166451; Berkessel A, 2007, ADV SYNTH CATAL, V349, P2385, DOI 10.1002/adse.200700221; Dai W, 2013, ORG LETT, V15, P4138, DOI 10.1021/ol401812h; Cusso O, 2013, J AM CHEM SOC, V135, P14871, DOI 10.1021/ja4078446; GROVES JT, 1983, J AM CHEM SOC, V105, P5791, DOI 10.1021/ja00356a016; [Anonymous], 1996, ORG REACTIONS; Talsi EP, 2014, CHEM-EUR J, V20, P14329, DOI 10.1002/chem.201404157; Marigo M, 2005, J AM CHEM SOC, V127, P6964, DOI 10.1021/ja051808s; Matsumoto K, 2008, PURE APPL CHEM, V80, P1071, DOI 10.1351/pac200880051071; Romney DK, 2012, ORG LETT, V14, P1138, DOI 10.1021/ol3000712; Garcia-Bosch I, 2012, ADV SYNTH CATAL, V354, P65, DOI 10.1002/adsc.201100409; Davis RL, 2014, CHEM-EUR J, V20, P64, DOI 10.1002/chem.201303942; Grigoropoulou G, 2003, GREEN CHEM, V5, P1, DOI 10.1039/b208925b; Wong OA, 2008, CHEM REV, V108, P3958, DOI 10.1021/cr068367v; Ottenbacher RV, 2014, ACS CATAL, V4, P1599, DOI 10.1021/cs500333c; Tu Y, 1996, J AM CHEM SOC, V118, P9806, DOI 10.1021/ja962345g; Shu LH, 2001, TETRAHEDRON, V57, P5213, DOI 10.1016/S0040-4020(01)00362-3; Cusso O, 2013, ORG LETT, V15, P6158, DOI 10.1021/ol403018x; Li Z, 2013, ACCOUNTS CHEM RES, V46, P506, DOI 10.1021/ar300216r; Dai W, 2014, J ORG CHEM, V79, P6688, DOI 10.1021/jo501178k; Wang X, 2013, CHEMCATCHEM, V5, P2489, DOI 10.1002/cctc.201300102; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; Chu YY, 2012, CHEM SCI, V3, P1996, DOI 10.1039/c2sc20218b; De Faveri G, 2011, CHEM SOC REV, V40, P1722, DOI 10.1039/c0cs00077a; Ottenbacher RV, 2011, ADV SYNTH CATAL, V353, P885, DOI 10.1002/adsc.201100030; Buckley BR, 2013, SYNLETT, V24, P2266, DOI 10.1055/s-0033-1339681; Le Maux P, 2012, TETRAHEDRON, V68, P5824, DOI 10.1016/j.tet.2012.05.014; Lyakin OY, 2012, ACS CATAL, V2, P1196, DOI 10.1021/a300205n; Demizu Y, 2011, TETRAHEDRON, V67, P6155, DOI 10.1016/j.tet.2011.06.075; Matsumoto K, 2009, ANGEW CHEM INT EDIT, V48, P7432, DOI 10.1002/anie.200903567; Arends IWCE, 2002, TOP CATAL, V19, P133, DOI 10.1023/A:1013897703249; Shu LH, 1999, TETRAHEDRON LETT, V40, P8721, DOI 10.1016/S0040-4039(99)01814-6; JULIA S, 1980, ANGEW CHEM INT EDIT, V19, P929, DOI 10.1002/anie.198009291; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052; Weitz E, 1921, BER DTSCH CHEM GES, V54, P2327, DOI 10.1002/cber.19210540922; Berkessel A., 2013, ANGEW CHEM, V125, P8625; Berkessel A, 2013, ANGEW CHEM INT EDIT, V52, P8467, DOI 10.1002/anie.201210198; Cusso O, 2015, ANGEW CHEM INT EDIT, V54, P2729, DOI 10.1002/anie.201410557; Cusso O., 2015, ANGEW CHEM, V127, P2767; JULIA S, 1982, J CHEM SOC PERK T 1, P1317, DOI 10.1039/p19820001317; Julia S., 1980, ANGEW CHEM, V92, P968, DOI 10.1002/ange.19800921137; Katsuki T., 1999, COMPREHENSIVE ASYMME, V2, P621; Lichtor PA, 2012, NAT CHEM, V4, P990, DOI [10.1038/nchem.1469, 10.1038/NCHEM.1469]; Matsu-moto K., 2005, ANGEW CHEM, V117, P5015, DOI 10.1002/ange.200501318; Matsumoto K., 2009, ANGEW CHEM, V121, P7568; Matsumoto K, 2006, SYNLETT, P3545, DOI 10.1055/s-2006-956496; Reisinger C. M., 2008, ANGEW CHEM, V120, P8232, DOI 10.1002/ange.200803238; Sawada Y., 2006, ANGEW CHEM, V118, P3558, DOI 10.1002/ange.200600636; Shen DY, 2014, EUR J INORG CHEM, P5777, DOI 10.1002/ejic.201402663; Shimada Y, 2007, SYNLETT, P2445, DOI 10.1055/s-2007-985605; Xiong DL, 2011, EUR J ORG CHEM, P4289, DOI 10.1002/ejoc.201100512	78	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2056	2068		10.1002/asia.201500293		13	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200005		
J	Moteki, SA; Maruyama, H; Nakayama, K; Li, HB; Petrova, G; Maeda, S; Morokuma, K; Maruoka, K				Moteki, Shin A.; Maruyama, Hiroki; Nakayama, Keiji; Li, Hai-Bei; Petrova, Galina; Maeda, Satoshi; Morokuma, Keiji; Maruoka, Keiji			Positive Effect of Water in Asymmetric Direct Aldol Reactions with Primary Amine Organocatalyst: Experimental and Computational Studies	CHEMISTRY-AN ASIAN JOURNAL			English	Article						aldol; amine; computation; organocatalysis; water	ENAMINE CATALYSIS; AQUEOUS-MEDIA; ALDEHYDES; ACID; DESIGN; STEREOSELECTIVITIES; PREDICTIONS; MOLECULES; MECHANISM; ENERGIES	The origin of higher reactivity in water-accelerated asymmetric aldol reactions with our designed primary amine organocatalyst was elucidated by both computational and experimental methods. As suggested by the calculated transition-state structures for water-promoted imine-enamine isomerization, anti-selective aldol reaction and hemiaminal formation, the rate of this aldol reaction was found experimentally to be even more accelerated by the addition of cis-2-butene-1,4-diol as additive.	[Moteki, Shin A.; Maruyama, Hiroki; Nakayama, Keiji; Maruoka, Keiji] Kyoto Univ, Grad Sch Sci, Lab Synthet Organ Chem, Dept Chem, Sakyo, Kyoto 6068502, Japan; [Moteki, Shin A.; Maruyama, Hiroki; Nakayama, Keiji; Maruoka, Keiji] Kyoto Univ, Grad Sch Sci, Special Lab Organocatalyt Chem, Dept Chem, Sakyo, Kyoto 6068502, Japan; [Li, Hai-Bei; Petrova, Galina; Morokuma, Keiji] Kyoto Univ, Fukui Inst Fundamental Chem, Sakyo, Kyoto 6068103, Japan; [Li, Hai-Bei] Shandong Univ, Sch Ocean, Weihai 264209, Peoples R China; [Maeda, Satoshi] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Morokuma, K (reprint author), Kyoto Univ, Fukui Inst Fundamental Chem, Sakyo, Kyoto 6068103, Japan.	morokuma@fukui.kyoto-u.ac.jp; maruoka@kuchem.kyoto-u.ac.jp	Maeda, Satoshi/H-3613-2014		MEXT, Japan	This work was partially supported by a Grant-in-Aid for Scientific Research from the MEXT, Japan. The computer resources at the Academic Center for Computing and Media Studies (ACCMS) at Kyoto University and Research Center of Computer Science (RCCS) at the Institute for Molecular Science are acknowledged.	Groger H, 1998, CHEM-EUR J, V4, P1137; Markert M, 2009, J AM CHEM SOC, V131, P16642, DOI 10.1021/ja907054y; Kano T, 2006, CHEM-ASIAN J, V1, P210, DOI 10.1002/asia.200600077; Butler RN, 2010, CHEM REV, V110, P6302, DOI 10.1021/cr100162c; Allemann C, 2004, ACCOUNTS CHEM RES, V37, P558, DOI 10.1021/ar0300524; Mase N, 2006, J AM CHEM SOC, V128, P734, DOI 10.1021/ja0573312; Matsunaga S, 2011, CHEM REC, V11, P260, DOI 10.1002/tcr.201100020; Hayashi Y, 2006, ANGEW CHEM INT EDIT, V45, P958, DOI 10.1002/anie.200502488; Lindstrom UM, 2002, CHEM REV, V102, P2751, DOI 10.1021/cr010122p; Tanaka F, 2005, BIOCHEMISTRY-US, V44, P7583, DOI 10.1021/bi050216j; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Palomo C, 2004, CHEM SOC REV, V33, P65, DOI 10.1039/b202901d; Zhang X, 2012, ASIAN J CHEM, V24, P751; Bisai V, 2012, TETRAHEDRON, V68, P4541, DOI 10.1016/j.tet.2012.03.099; Cordova A, 2006, CHEM-EUR J, V12, P5383, DOI 10.1002/chem.200501639; Kano T, 2006, TETRAHEDRON LETT, V47, P7423, DOI 10.1016/j.tetlet.2006.08.051; Zhu XY, 2009, J AM CHEM SOC, V131, P18206, DOI 10.1021/ja907271a; Kano T, 2007, ANGEW CHEM INT EDIT, V46, P1738, DOI 10.1002/anie.200604640; Zotova N, 2007, J AM CHEM SOC, V129, P15100, DOI 10.1021/ja0738881; Dickerson TJ, 2004, J ORG CHEM, V69, P6603, DOI 10.1021/jo048894j; Kano T, 2012, CHEM COMMUN, V48, P7037, DOI 10.1039/c2cc32772d; Gruttadauria M, 2009, ADV SYNTH CATAL, V351, P33, DOI 10.1002/adsc.200800731; Bahmanyar S, 2003, J AM CHEM SOC, V125, P2475, DOI 10.1021/ja028812d; Heravi MM, 2012, TETRAHEDRON-ASYMMETR, V23, P1431, DOI 10.1016/j.tetasy.2012.10.002; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Mlynarski J, 2008, CHEM SOC REV, V37, P1502, DOI 10.1039/b710577k; Jiang ZQ, 2010, ORG BIOMOL CHEM, V8, P1368, DOI 10.1039/b921460g; Xu LW, 2008, ORG BIOMOL CHEM, V6, P2047, DOI 10.1039/b803116a; Ma X, 2009, TETRAHEDRON-ASYMMETR, V20, P1419, DOI 10.1016/j.tetasy.2009.05.032; Amedjkouh M, 2005, TETRAHEDRON-ASYMMETR, V16, P1411, DOI 10.1016/j.tetasy.2005.02.031; Clapes P, 2011, ADV SYNTH CATAL, V353, P2263, DOI 10.1002/adsc.201100236; Wu XY, 2007, ADV SYNTH CATAL, V349, P812, DOI 10.1002/adsc.200600564; Miura T, 2009, TETRAHEDRON LETT, V50, P2632, DOI 10.1016/j.tetlet.2009.03.053; Mangion IK, 2004, ANGEW CHEM INT EDIT, V43, P6722, DOI 10.1002/anie.200461851; Geary LM, 2009, TETRAHEDRON-ASYMMETR, V20, P131, DOI 10.1016/j.tetasy.2008.12.030; Nakayama K, 2008, J AM CHEM SOC, V130, P17666, DOI 10.1021/ja807807p; Maeda S, 2013, PHYS CHEM CHEM PHYS, V15, P3683, DOI 10.1039/c3cp44063j; Clemente FR, 2005, J AM CHEM SOC, V127, P11294, DOI 10.1021/ja0507620; Peng FZ, 2008, ADV SYNTH CATAL, V350, P2199, DOI 10.1002/adsc.200800335; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; List B, 2004, P NATL ACAD SCI USA, V101, P5839, DOI 10.1073/pnas.0307979101; Kano T, 2005, ANGEW CHEM INT EDIT, V44, P3055, DOI 10.1002/anie.200500408; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Trost BM, 2010, CHEM SOC REV, V39, P1600, DOI 10.1039/b923537j; Zhao QQ, 2012, J ORG CHEM, V77, P4784, DOI 10.1021/jo300569c; Fu AP, 2006, J ORG CHEM, V71, P320, DOI 10.1021/jo052088a; Mlynarski J, 2014, CHEM SOC REV, V43, P577, DOI 10.1039/c3cs60202h; Liu J, 2008, J AM CHEM SOC, V130, P5654, DOI [10.1021/ja800839w, 10.1021/ja800839W]; Clemente Fernando R, 2004, Angew Chem Int Ed Engl, V43, P5765; Clemente FR, 2004, ANGEW CHEM, V116, P5890, DOI 10.1002/ange.200460916; Cordova A, 2005, CHEM COMMUN, P3586, DOI 10.1039/b507968n; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Frisch MJ, 2009, GAUSSIAN 09 REVISION; Hayashi Y, 2008, SYNLETT, P1565, DOI 10.1055/s-2008-1077789; Hayashi Y., 2006, ANGEW CHEM, V118, P972, DOI 10.1002/ange.200502488; Heathcock C. H., 1991, COMPREHENSIVE ORGANI, V2, P99; Jiang ZQ, 2006, CHEM COMMUN, P2801, DOI 10.1039/b606154k; Jung YS, 2007, J AM CHEM SOC, V129, P5492, DOI 10.1021/ja068120f; Kano T., 2007, ANGEW CHEM, V119, P1768, DOI 10.1002/ange.200604640; Kano T., 2005, ANGEW CHEM, V117, P3115, DOI 10.1002/ange.200500408; Lu LQ, 2012, SYNLETT, P490, DOI 10.1055/s-0031-1290131; Machajewski T. D., 2000, ANGEW CHEM, V112, P1406, DOI DOI 10.1002/(SICI)1521-3757(20000417)112:8<1406::AID-ANGE1406>3.0.CO;2-R; Mahrwald R., 2004, MODERN ALDOL REACTIO, V1; Mahrwald R., 2013, MODERN METHODS STERE; Mahrwald R., 2004, MODERN ALDOL REACTIO, V2; Mangion I. K., 2004, ANGEW CHEM, V116, P6890, DOI 10.1002/ange.200461851; MUKAIYAMA T, 1982, ORG REACTIONS, V28, P203; Raj M, 2009, CHEM COMMUN, P6687, DOI 10.1039/b910861k; Xu LW, 2009, CHEM COMMUN, P1807, DOI 10.1039/b821070e; Zhang L, 2012, SYNLETT, P1575, DOI 10.1055/s-0031-129068	70	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2112	2116		10.1002/asia.201500078		5	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200009		
J	Yamashita, Y; Sato, I; Suzuki, H; Kobayashi, S				Yamashita, Yasuhiro; Sato, Io; Suzuki, Hirotsugu; Kobayashi, Shu			Catalytic Asymmetric 1,4-Addition Reactions of Simple Alkylnitriles	CHEMISTRY-AN ASIAN JOURNAL			English	Article						1,4-addition; asymmetric synthesis; catalyst; nitrile; strong base	ALDOL-TYPE REACTION; ENANTIOSELECTIVE SYNTHESIS; COOPERATIVE CATALYSIS; ORGANIC-SYNTHESIS; NICKEL-CATALYST; ACETONITRILE; ALDEHYDES; NITRILES; PROAZAPHOSPHATRANES; ACTIVATION	The development of catalytic asymmetric carbon-carbon bond-forming reactions of alkylnitriles that do not have an activating group at the alpha-position, under proton-transfer conditions, is a challenging research topic. Here, we report catalytic asymmetric direct-type 1,4-addition reactions of alkylnitriles with alpha,beta-unsaturated amides by using a catalytic amount of potassium hexamethyldisilazide (KHMDS) with a chiral macro crown ether. The desired reactions proceeded in high yields with good diastereo- and enantioselectivities. To our knowledge, this is the first example of catalytic asymmetric direct-type 1,4-addition reaction of alkylnitriles without any activating group at the alpha-position.	[Yamashita, Yasuhiro; Sato, Io; Suzuki, Hirotsugu; Kobayashi, Shu] Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo, Japan	Kobayashi, S (reprint author), Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Kobayashi, Shu/E-9214-2012		Japan Society for the Promotion of Science (JSPS); Global COE Program; University of Tokyo; MEXT, Japan; Japan Science and Technology Agency (JST); MERIT program, The University of Tokyo	This work was partially supported by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), Global COE Program, The University of Tokyo, MEXT, Japan, and the Japan Science and Technology Agency (JST). I.S. and H.S. thank the MERIT program, The University of Tokyo for financial support.	Anastas P. T., 2009, HDB GREEN CHEM; Chakraborty S, 2013, ANGEW CHEM INT EDIT, V52, P7523, DOI 10.1002/anie.201302613; Yamashita Y, 2012, ORG BIOMOL CHEM, V10, P5750, DOI 10.1039/c2ob25522g; Sureshkumar D, 2014, CHEM-EUR J, V20, P15723, DOI 10.1002/chem.201404808; Kumagai N, 2007, TETRAHEDRON, V63, P8598, DOI 10.1016/j.tet.2007.04.051; Kisanga P, 1999, J ORG CHEM, V64, P3090, DOI 10.1021/jo981858y; D'Sa BA, 1998, J ORG CHEM, V63, P3961, DOI 10.1021/jo972343u; Chen JP, 2010, J AM CHEM SOC, V132, P15493, DOI 10.1021/ja106703y; Kisanga PB, 2000, J ORG CHEM, V65, P5431, DOI 10.1021/jo000427o; Poisson T, 2009, J ORG CHEM, V74, P3516, DOI 10.1021/jo802763b; Rodriguez AL, 2000, ORG LETT, V2, P3285, DOI 10.1021/ol0001741; Goto A, 2011, CHEM-ASIAN J, V6, P1740, DOI 10.1002/asia.201000921; HEATHCOCK CH, 1985, J ORG CHEM, V50, P3022, DOI 10.1021/jo00216a051; Verkade JG, 2004, ALDRICHIM ACTA, V37, P3; HEATHCOCK CH, 1985, J AM CHEM SOC, V107, P2797, DOI 10.1021/ja00295a037; Kisanga PB, 2001, TETRAHEDRON, V57, P467, DOI 10.1016/S0040-4020(00)01016-4; Suto Y, 2003, ORG LETT, V5, P3147, DOI 10.1021/ol035206u; Kumagai N, 2004, J AM CHEM SOC, V126, P13632, DOI 10.1021/ja0450509; Kawato Y, 2013, CHEM COMMUN, V49, P11227, DOI 10.1039/c3cc47117a; Verkade JG, 2003, TETRAHEDRON, V59, P7819, DOI 10.1016/S0040-4020(03)01204-3; Amat M, 2001, ORG LETT, V3, P611, DOI 10.1021/ol007010p; Suzuki H, 2015, J AM CHEM SOC, V137, P4336, DOI 10.1021/jacs.5b01943; Kobayashi S, 2009, CHEM-EUR J, V15, P10694, DOI 10.1002/chem.200901515; Suto Y, 2005, ORG LETT, V7, P3757, DOI 10.1021/ol051423e; Fleming FF, 2002, TETRAHEDRON, V58, P1, DOI 10.1016/S0040-4020(01)01134-6; Arseniyadis S., 1984, ORG REACTIONS, V31, P1, DOI DOI 10.1002/0471264180.OR031.01; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Chakraborty S., 2013, ANGEW CHEM, V125, P7671; Deng T, 2014, EUR J ORG CHEM, P7259, DOI 10.1002/ejoc.201402852; ENDERS D, 1994, SYNLETT, P1054; Fan L, 2005, CHEM COMMUN, P4450, DOI 10.1039/b505778g; Goto A, 2008, CHEM COMMUN, P2212, DOI 10.1039/b800634b; Knochel P., 2014, COMPREHENSIVE ORGANI; Kumagai N., 2011, ANGEW CHEM, V123, P4856; Kumagai N, 2011, ANGEW CHEM INT EDIT, V50, P4760, DOI 10.1002/anie.201100918; Kumagai N, 2005, CHEM COMMUN, P3600, DOI 10.1039/b504519c; Larock R. C., 1999, COMPREHENSIVE ORGANI; Trost B. M., 1991, COMPREHENSIVE ORGANI	38	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2143	2146		10.1002/asia.201500405		4	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200016		
J	Egami, H; Usui, Y; Kawamura, S; Nagashima, S; Sodeoka, M				Egami, Hiromichi; Usui, Yoshihiko; Kawamura, Shintaro; Nagashima, Sayoko; Sodeoka, Mikiko			Product Control in Alkene Trifluoromethylation: Hydrotrifluoromethylation, Vinylic Trifluoromethylation, and Iodotrifluoromethylation using Togni Reagent	CHEMISTRY-AN ASIAN JOURNAL			English	Article						additive effect; alkenes; difunctionalization; Togni reagent; trifluoromethylation	COPPER-CATALYZED TRIFLUOROMETHYLATION; C-H TRIFLUOROMETHYLATION; P450-CATALYZED HYDROXYLATION REACTIONS; HYPERSENSITIVE MECHANISTIC PROBE; FLUORINATED AMINO-ACIDS; BOND FORMATION; ELECTROPHILIC TRIFLUOROMETHYLATION; RADICAL TRIFLUOROMETHYLATION; PERFLUOROALKYL IODIDES; SODIUM TRIFLUOROMETHANESULFINATE	Hydrotrifluoromethylation, vinylic trifluoromethylation, and iodotrifluoromethylation of simple alkenes have been achieved by using Togni reagent in the absence of any transition metal catalyst. These reactions were readily controllable by selection of appropriate salts and solvents. The addition of K2O3 afforded the hydrotrifluoromethylation product, with DMF acting not only as a solvent, but also as the hydrogen source. In contrast, the use of tetra-n-butylammonium iodide (TBAI) in 1,4-dioxane resulted in vinylic trifluoromethylation, while the use of KI afforded the iodotri-fluoromethylation product. The vinylic trifluoromethylation product was obtained by treatment of the iodotrifluoromethylation product with ammonium 2-iodobenzoate, indicating that it was formed through an elimination reaction of the in-situ-generated iodotrifluoromethylation product, and the solubility of the resulting 2-iodobenzoate salt plays a key role in the product switching. A radical-clock experiment showed that these reactions proceed via radical intermediates.	[Egami, Hiromichi; Usui, Yoshihiko; Kawamura, Shintaro; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Egami, Hiromichi; Kawamura, Shintaro; Sodeoka, Mikiko] Japan Sci & Technol Agcy, ERATO, Sodeoka Live Cell Chem Project, Wako, Saitama 3510198, Japan; [Usui, Yoshihiko; Nagashima, Sayoko; Sodeoka, Mikiko] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Kawamura, Shintaro; Sodeoka, Mikiko] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Egami, Hiromichi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Sodeoka, M (reprint author), RIKEN, Synthet Organ Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008; Egami, Hiromichi/F-7744-2012; 	Sodeoka, Mikiko/0000-0002-1344-364X; Egami, Hiromichi/0000-0002-7784-4987	RIKEN	This work was supported in part by Project Funding from RIKEN. We are grateful to Prof. Teiji Chihara and Prof. Hideki Kurokawa of Saitama University for helpful discussions.	Janson PG, 2012, ORG LETT, V14, P2882, DOI 10.1021/ol3011419; Liu TF, 2011, ORG LETT, V13, P2342, DOI 10.1021/ol2005903; Jiang XY, 2013, ANGEW CHEM INT EDIT, V52, P14177, DOI 10.1002/anie.201307595; Cao XH, 2014, CHEM COMMUN, V50, P3359, DOI 10.1039/c3cc49689a; Dubbaka SR, 2005, CHEM-EUR J, V11, P2633, DOI 10.1002/chem.200400838; Lin QY, 2014, J ORG CHEM, V79, P10434, DOI 10.1021/jo502040t; Lu DF, 2013, CHEM SCI, V4, P2478, DOI 10.1039/c3sc50582k; Zhu R, 2012, J AM CHEM SOC, V134, P12462, DOI 10.1021/ja305840g; UNEYAMA K, 1990, J ORG CHEM, V55, P3909, DOI 10.1021/jo00299a039; FUJITA M, 1986, TETRAHEDRON LETT, V27, P3655, DOI 10.1016/S0040-4039(00)84873-X; Hirotaki K, 2015, J FLUORINE CHEM, V171, P169, DOI 10.1016/j.jfluchem.2014.07.018; Eisenberger P, 2006, CHEM-EUR J, V12, P2579, DOI 10.1002/chem.200501052; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P7841, DOI 10.1002/anie.201303350; Xu T, 2014, ANGEW CHEM INT EDIT, V53, P4910, DOI 10.1002/anie.201402511; Gao P, 2013, CHEM-EUR J, V19, P14420, DOI 10.1002/chem.201303025; Mizuta S, 2012, CHEM-EUR J, V18, P8583, DOI 10.1002/chem.201201707; Matousek V, 2013, J ORG CHEM, V78, P6763, DOI 10.1021/jo400774u; Parsons AT, 2012, ANGEW CHEM INT EDIT, V51, P2947, DOI 10.1002/anie.201108267; Xu J, 2011, J AM CHEM SOC, V133, P15300, DOI 10.1021/ja206330m; Ignatowska J, 2007, J FLUORINE CHEM, V128, P997, DOI 10.1016/j.jfluchem.2007.04.028; Wu XY, 2013, ANGEW CHEM INT EDIT, V52, P2198, DOI 10.1002/anie.201208971; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Kong WQ, 2013, ANGEW CHEM INT EDIT, V52, P13086, DOI 10.1002/anie.201307377; Mu X, 2012, J AM CHEM SOC, V134, P878, DOI 10.1021/ja210614y; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Egami H, 2013, CHEM COMMUN, V49, P7346, DOI 10.1039/c3cc43936d; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; Zhang B, 2013, ANGEW CHEM INT EDIT, V52, P10792, DOI 10.1002/anie.201306082; Iqbal N, 2012, J ORG CHEM, V77, P11383, DOI 10.1021/jo3022346; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Roy S, 2011, TETRAHEDRON, V67, P2161, DOI 10.1016/j.tet.2011.01.002; Chu LL, 2012, ORG LETT, V14, P2106, DOI 10.1021/ol300639a; Oh SH, 2014, ORG LETT, V16, P1310, DOI 10.1021/ol403716t; FUCHIKAMI T, 1984, TETRAHEDRON LETT, V25, P303, DOI 10.1016/S0040-4039(00)99868-X; Pitre SP, 2014, ACS CATAL, V4, P2530, DOI 10.1021/cs5005823; Kawamura S, 2015, J AM CHEM SOC, V137, P4865, DOI 10.1021/jacs.5b02046; Prakash GKS, 2012, ORG LETT, V14, P1146, DOI 10.1021/ol300076y; Liu XW, 2013, ANGEW CHEM INT EDIT, V52, P6962, DOI 10.1002/anie.201302673; Yajima T, 2007, ORG LETT, V9, P2513, DOI 10.1021/ol0707620; Ilchenko NO, 2013, J ORG CHEM, V78, P11087, DOI 10.1021/jo401831t; Li Y, 2012, ANGEW CHEM INT EDIT, V51, P8221, DOI 10.1002/anie.201202623; Feng C, 2012, CHEM SCI, V3, P3458, DOI 10.1039/c2sc21164e; Kobayashi T, 2002, J ORG CHEM, V67, P3156, DOI 10.1021/jo0111311; Wang F, 2014, J AM CHEM SOC, V136, P10202, DOI 10.1021/ja504458j; UNEYAMA K, 1991, TETRAHEDRON, V47, P555, DOI 10.1016/S0040-4020(01)87045-9; Chen ZM, 2013, ANGEW CHEM INT EDIT, V52, P9781, DOI 10.1002/anie.201304557; Erdbrink H, 2012, ORG BIOMOL CHEM, V10, P8583, DOI 10.1039/c2ob26810h; Wang X, 2013, ORG LETT, V15, P3730, DOI 10.1021/ol4016095; Shimizu R, 2010, TETRAHEDRON LETT, V51, P5947, DOI 10.1016/j.tetlet.2010.09.027; Besset T, 2014, J ORG CHEM, V79, P413, DOI 10.1021/jo402385g; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Hang ZJ, 2014, ORG LETT, V16, P3648, DOI 10.1021/ol501380e; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; ANDRIEUX CP, 1989, TETRAHEDRON LETT, V30, P4961, DOI 10.1016/S0040-4039(01)80554-2; Billard T, 2000, TETRAHEDRON LETT, V41, P3069, DOI 10.1016/S0040-4039(00)00337-3; Wallentin CJ, 2012, J AM CHEM SOC, V134, P8875, DOI 10.1021/ja300798k; Omote M, 2012, ORG LETT, V14, P2286, DOI 10.1021/ol300670n; Shimizu M, 2001, J AM CHEM SOC, V123, P6947, DOI 10.1021/ja016077k; Wang XP, 2013, BEILSTEIN J ORG CHEM, V9, P2635, DOI 10.3762/bjoc.9.299; UNEYAMA K, 1992, B CHEM SOC JPN, V65, P1976, DOI 10.1246/bcsj.65.1976; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; Kim E, 2013, CHEM-EUR J, V19, P6209, DOI 10.1002/chem.201300564; Parsons AT, 2011, ANGEW CHEM INT EDIT, V50, P9120, DOI 10.1002/anie.201104053; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; Wilger DJ, 2013, CHEM SCI, V4, P3160, DOI 10.1039/c3sc51209f; He ZB, 2012, ANGEW CHEM INT EDIT, V51, P3944, DOI 10.1002/anie.201200140; Fiederling N, 2013, ORG PROCESS RES DEV, V17, P318, DOI 10.1021/op400035b; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P4000, DOI 10.1002/anie.201210250; Egami H, 2013, J FLUORINE CHEM, V152, P51, DOI 10.1016/j.jfluchem.2013.03.009; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Ilchenko NO, 2013, CHEM COMMUN, V49, P6614, DOI 10.1039/c3cc43357a; Phipps RJ, 2012, J AM CHEM SOC, V134, P10773, DOI 10.1021/ja3039807; Wu XF, 2012, CHEM-ASIAN J, V7, P1744, DOI 10.1002/asia.201200211; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Merino E, 2014, CHEM SOC REV, V43, P6598, DOI 10.1039/c4cs00025k; Feng C, 2013, ANGEW CHEM INT EDIT, V52, P12414, DOI 10.1002/anie.201307245; UMEMOTO T, 1987, B CHEM SOC JPN, V60, P3307, DOI 10.1246/bcsj.60.3307; Toy PH, 1998, J AM CHEM SOC, V120, P7719, DOI 10.1021/ja981157i; Mizuta S, 2013, J AM CHEM SOC, V135, P2505, DOI 10.1021/ja401022x; Isanbor C, 2006, J FLUORINE CHEM, V127, P303, DOI 10.1016/j.jfluchem.2006.01.011; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Sato K, 2004, ORG LETT, V6, P4359, DOI 10.1021/ol048134v; Kong W, 2013, J AM CHEM SOC, V135, P14480, DOI 10.1021/ja403954g; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; NEWCOMB M, 1994, J AM CHEM SOC, V116, P9753, DOI 10.1021/ja00100a052; Egami H, 2014, CHEM-EUR J, V20, P12061, DOI 10.1002/chem.201403447; Fang ZX, 2014, ORG LETT, V16, P1522, DOI 10.1021/ol5004498; Miyazaki A, 2012, HETEROCYCLES, V86, P979, DOI 10.3987/COM-12-S(N)101; Tsuchii K, 2004, J ORG CHEM, V69, P6658, DOI 10.1021/jo0495889; TAKEYAMA Y, 1989, TETRAHEDRON LETT, V30, P3159, DOI 10.1016/S0040-4039(00)99190-1; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; Begue J.-P., 2008, BIOORGANIC MED CHEM; BROOKES CJ, 1978, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19780000202; Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h; Chen Z.-M., 2013, ANGEW CHEM, V125, P9963; Egami H., 2013, ANGEW CHEM, V125, P7995; Egami H, 2014, J FLUORINE CHEM, V167, P172, DOI 10.1016/j.jfluchem.2014.05.009; Egami H, 2014, ANGEW CHEM INT EDIT, V53, P8294, DOI 10.1002/anie.201309260; Egami H., 2013, ANGEW CHEM, V125, P4092; Feng C., 2013, ANGEW CHEM, V725, P12640; FUCHIKAMI T, 1981, SYNTHESIS-STUTTGART, P365; Gouverneur V., 2012, PHARM MED CHEM BIOPH; Hanamoto T, 2003, EUR J ORG CHEM, P4279, DOI 10.1002/ejoc.200300395; He Z.-B., 2012, ANGEW CHEM, V124, P4010; Jiang X.-Y., 2013, ANGEW CHEM, V125, P14427; KAMIGATA N, 1991, J CHEM SOC PERK T 1, P627, DOI 10.1039/p19910000627; Kieltsch I., 2007, ANGEW CHEM, V119, P768, DOI 10.1002/ange.200603497; Kirsch P., 2004, MODERN FLUOROORGANIC; KITAZUME T, 1982, CHEM LETT, P1453, DOI 10.1246/cl.1982.1453; Kong W., 2013, ANGEW CHEM, V125, P13324; Li L, 2014, ORG LETT, V16, P6032, DOI 10.1021/ol503067g; Li Y., 2012, ANGEW CHEM, V124, P8345; Liang T., 2013, ANGEW CHEM, V125, P8372, DOI DOI 10.1002/ANGE.201206566; Liu TF, 2012, EUR J ORG CHEM, P6679, DOI 10.1002/ejoc.201200648; Liu X., 2013, ANGEW CHEM, V125, P7100; Mace Y, 2012, EUR J ORG CHEM, P2479, DOI 10.1002/ejoc.201101535; MARUOKA K, 1985, CHEM LETT, P1689, DOI 10.1246/cl.1985.1689; MULLER N, 1986, J ORG CHEM, V51, P263, DOI 10.1021/jo00352a032; Ojima I., 2009, FLUORINE MED CHEM CH; Parsons A. T., 2012, ANGEW CHEM, V124, P3001; Parsons A. T., 2011, ANGEW CHEM, V123, P9286; Schlosser M., 2006, ANGEW CHEM, V118, P5558, DOI 10.1002/ange.200600449; Schlosser M, 2006, ANGEW CHEM INT EDIT, V45, P5432, DOI 10.1002/anie.200600449; Shimizu M., 2005, ANGEW CHEM, V117, P218, DOI 10.1002/ange.200460441; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Shimizu R., 2012, ANGEW CHEM, V124, P4655; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Studer A., 2012, ANGEW CHEM, V124, P9082; Tommasino T.-B., 2002, SYNLETT, P1697; Tonoi T, 2008, EUR J ORG CHEM, P1331, DOI 10.1002/ejoc.200701052; Wang F, 2014, ANGEW CHEM INT EDIT, V53, P1881, DOI 10.1002/anie.201309991; Wu X., 2013, ANGEW CHEM, V125, P2254; Yajima T, 2010, EUR J ORG CHEM, P2461, DOI 10.1002/ejoc.201000017; Yang XY, 2015, CHEM REV, V115, P826, DOI 10.1021/cr500277b; Yasu Y., 2012, ANGEW CHEM, V124, P9705, DOI DOI 10.1135/CCCC2011078; Ye YD, 2012, SYNLETT, P2005, DOI 10.1055/s-0032-1316988; Zhang B., 2013, ANGEW CHEM, V125, P10992; Zhu R., 2013, ANGEW CHEM, V125, P12887; Zhu R, 2013, ANGEW CHEM INT EDIT, V52, P12655, DOI 10.1002/anie.201307790	141	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2190	2199		10.1002/asia.201500359		10	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200023		
J	Ishida, S; Osuka, A				Ishida, Shin-ichiro; Osuka, Atsuhiro			meso-Aryl [28]Hexaphyrin Silicon Complexes Bearing Various Si-Substituents and 1,16-Dihydrohexaphyrin bis-Chlorosilicon Complex	CHEMISTRY-AN ASIAN JOURNAL			English	Article						Mobius aromaticity; porphyrins; silane reduction; silicon complexes; substituent effects	EXPANDED PORPHYRINS; ORGANOSILICON PORPHYRINS; MOBIUS AROMATICITY; METAL-COMPLEXES; REACTIVITY; HEXAPHYRIN(1.1.1.1.1.1); REARRANGEMENT; SUBPORPHYRIN; CHEMISTRY; INSERTION	Herein, the synthesis of Mobius aromatic [28]hexaphyrin silicon complexes bearing various Si-substituents from reactions of [28]hexaphyrin 1 with suitable silicon sources in the presence of a base is reported. Si-substituents newly introduced are vinyl (4), phenyl (6), hydroxy (7), and hydride groups (8). X-ray crystallographic analysis of complexes 6 and 7 has shown trigonal bipyramidal penta-coordinated silicon atoms, which are favorable for the hexaphyrin ligands to take on smoothly twisted Mobius conformations. N-fused Si-vinyl complex 5 was also isolated and structurally well characterized. Through these studies, the Si-substituent effect has been shown to be relatively small. Reaction of 1 with HSiCl3 in CH2Cl2 gave 1,16-dihydrohexaphyrin bis-chlorosilicon complex 9, probably through intramolecular hydride transfer from the silane to the pyrrolic alpha-carbon.	[Ishida, Shin-ichiro; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	Osuka, A (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan.	osuka@kuchem.kyoto-u.ac.jp			JSPS KAKENHI [25220802, 25620031]; JSPS	This work was supported by JSPS KAKENHI Grant Numbers 25220802 and 25620031. S.I. acknowledges a JSPS Fellowship for Young Scientists.	Higashino T, 2010, ANGEW CHEM INT EDIT, V49, P4950, DOI 10.1002/anie.201001765; Moriya K, 2010, ANGEW CHEM INT EDIT, V49, P4297, DOI 10.1002/anie.201001052; Osuka A, 2011, CHEM COMMUN, V47, P4330, DOI 10.1039/c1cc10534e; Higashino T, 2012, ANGEW CHEM INT EDIT, V51, P13105, DOI 10.1002/anie.201208147; Mori S, 2007, INORG CHEM, V46, P4374, DOI 10.1021/ic7004216; Inoue M, 2010, ANGEW CHEM INT EDIT, V49, P9488, DOI 10.1002/anie.201005334; Tokuji S, 2011, CHEM-EUR J, V17, P7154, DOI 10.1002/chem.201100872; Sessler JL, 2007, ACCOUNTS CHEM RES, V40, P371, DOI 10.1021/ar600006n; Naoda K, 2013, CHEM-ASIAN J, V8, P1395, DOI 10.1002/asia.201300320; Suzuki M, 2014, ORG LETT, V16, P327, DOI 10.1021/ol403242z; Chandrashekar TK, 2003, ACCOUNTS CHEM RES, V36, P676, DOI 10.1021/ar020284n; Higashino T, 2012, CHEM SCI, V3, P103, DOI 10.1039/c1sc00653c; Herrero-Garcia N, 2011, CHEM-EUR J, V17, P7327, DOI 10.1002/chem.201003511; Sakamoto R, 2010, CHEM LETT, V39, P439, DOI 10.1246/cl.2010.439; Mori S, 2007, J AM CHEM SOC, V129, P11344, DOI 10.1021/ja0744908; Kane KM, 1998, INORG CHEM, V37, P669, DOI 10.1021/ic9710925; Tanaka Y, 2008, ANGEW CHEM INT EDIT, V47, P681, DOI 10.1002/anie.200704407; Saito S, 2011, ANGEW CHEM INT EDIT, V50, P4342, DOI 10.1002/anie.201003909; Mori S, 2008, INORG CHEM, V47, P3937, DOI 10.1021/ic8004147; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Zheng JY, 1998, INORG CHEM, V37, P2591, DOI 10.1021/ic971266i; Yoon MC, 2013, CHEM SCI, V4, P1756, DOI 10.1039/c3sc22151b; Yoneda T, 2014, ANGEW CHEM INT EDIT, V53, P13169, DOI 10.1002/anie.201408506; KANE KM, 1995, INORG CHEM, V34, P4085, DOI 10.1021/ic00120a012; Mori S, 2005, J AM CHEM SOC, V127, P8030, DOI 10.1021/ja051662x; Yoon ZS, 2009, NAT CHEM, V1, P113, DOI [10.1038/nchem.172, 10.1038/NCHEM.172]; Sessler JL, 2003, ANGEW CHEM INT EDIT, V42, P5134, DOI 10.1002/anie.200200561; Kane KM, 1997, INORG CHEM, V36, P1354, DOI 10.1021/ic960639x; Miura T, 2010, CHEM-EUR J, V16, P55, DOI 10.1002/chem.200902708; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; Saito S, 2007, ANGEW CHEM INT EDIT, V46, P5591, DOI 10.1002/anie.200701682; KADISH KM, 1988, INORG CHEM, V27, P1191, DOI 10.1021/ic00280a020; Ishida S, 2014, CHEM-EUR J, V20, P8274, DOI 10.1002/chem.201402929; Ishida S, 2009, CHEM LETT, V38, P362, DOI 10.1246/cl.2009.362; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; Herrero-Garcia N, 2012, EUR J ORG CHEM, P2643, DOI 10.1002/ejoc.201200159; Higashino T., 2012, HETEROCYCLES, V87, P31; Higashino T., 2010, ANGEW CHEM, V122, P5070; Higashino T., 2012, ANGEW CHEM, V124, P13282; Inoue M., 2010, ANGEW CHEM, V122, P9678, DOI 10.1002/ange.201005334; Moriya K., 2010, ANGEW CHEM, V122, P4393; Rath H, 2009, CHEM COMMUN, P3762, DOI 10.1039/b905859a; Saito S., 2007, ANGEW CHEM, V119, P5687, DOI 10.1002/ange.200701682; Saito S., 2011, ANGEW CHEM, V50, P4342, DOI DOI 10.1002/ANIE.201003909; Sessler J. L., 2003, ANGEW CHEM, V115, P5292, DOI 10.1002/ange.200200561; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu S, 2006, EUR J INORG CHEM, P1319, DOI 10.1002/ejic.200501097; Soya T, 2015, CHEM-ASIAN J, V10, P231, DOI 10.1002/asia.201402933; Stepien M., 2011, ANGEW CHEM, V123, P4376, DOI DOI 10.1002/ANIE.201003353; Tanaka Y., 2008, ANGEW CHEM, V120, P693, DOI 10.1002/ange.200704407; Yoneda T., 2014, ANGEW CHEM, V126, P13385, DOI DOI 10.1002/ANGE.201408506; Zheng JY, 1998, CHEM LETT, P453, DOI 10.1246/cl.1998.453	53	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2200	2206		10.1002/asia.201500381		7	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200024		
J	Sasaki, T; Tada, M; Wang, LS; Malwadkar, S; Iwasawa, Y				Sasaki, Takehiko; Tada, Mizuki; Wang, Linsheng; Malwadkar, Sachin; Iwasawa, Yasuhiro			Structure of the Active Platinum Cluster and Reaction Pathway of the Selective Synthesis of Phenol from Benzene and Oxygen Regulated with Ammonia on a Platinum Cluster/beta-Zeolite Catalyst Studied by DFT Calculations	CHEMISTRY-AN ASIAN JOURNAL			English	Article						density functional theory; indispensable ammonia effect; oxidation; phenol synthesis; zeolites	MODIFIED TITANIUM SILICALITE; DIRECT HYDROXYLATION; MOLECULAR-OXYGEN; HYDROGEN-PEROXIDE; MEMBRANE REACTOR; NITROUS-OXIDE; GAS-PHASE; PALLADIUM MEMBRANE; AROMATIC-COMPOUNDS; TRANSITION-STATES	DFT calculations were used to investigate the structure of the active Pt cluster and the catalytic reaction pathway for the selective synthesis of phenol from benzene and molecular oxygen regulated with ammonia on a Pt cluster/beta-zeolite catalyst that was reported to be active for the selective hydroxylation of benzene only in the coexistence of ammonia. It was found that Pt-5-Pt-6 clusters were active for the direct synthesis of phenol, and they provided the reaction sites for bond rearrangements among ammonia, oxygen, and benzene; furthermore, the coexistence of ammonia was crucial for the selective oxidation of benzene to phenol, as it suppressed benzene combustion to CO2 and promoted the selective synthesis of phenol. It was further found that water coexisting in the system also played a significant role in desorbing phenol on the Pt cluster surface, which resulted in promotion of the overall selective synthesis of phenol. The energy diagram for the reaction sequences and the structures of the transition states were obtained, which indicated the origin of the Pt/b catalysis.	[Sasaki, Takehiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Tada, Mizuki] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Wang, Linsheng; Malwadkar, Sachin; Iwasawa, Yasuhiro] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Iwasawa, Yasuhiro] Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan	Sasaki, T (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan.	takehiko@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26120509]; Institute for Quantum Chemical Exploration (IQCE)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research on Innovative Areas "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" (No. 26120509) and a Grant-in-Aid for Scientific Research (S). M.T. acknowledges the Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers. T.S. thanks the Institute for Quantum Chemical Exploration (IQCE) for financial support.	Kubacka A, 2007, J CATAL, V250, P184, DOI 10.1016/j.jcat.2007.05.017; Song SQ, 2010, APPL CATAL A-GEN, V375, P265, DOI 10.1016/j.apcata.2010.01.008; KUNAI A, 1989, B CHEM SOC JPN, V62, P2613, DOI 10.1246/bcsj.62.2613; Choi JS, 2005, APPL CATAL A-GEN, V290, P1, DOI 10.1016/j.apcata.2005.04.060; Bhaumik A, 1998, J CATAL, V178, P101, DOI 10.1006/jcat.1998.2131; Bianchi D, 2007, ADV SYNTH CATAL, V349, P979, DOI 10.1002/adsc.200600371; Gao XH, 2006, APPL CLAY SCI, V33, P1, DOI 10.1016/j.clay.2005.12.002; Cornils B, 2003, J CATAL, V216, P23, DOI 10.1016/S0021-9517(02)00128-8; Hensen EJM, 2005, J CATAL, V233, P136, DOI 10.1016/j.jcat.2005.04.008; Centi G, 2004, CATAL TODAY, V91-2, P17, DOI 10.1016/j.cattod.2004.03.004; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Neidig ML, 2011, CATAL COMMUN, V12, P480, DOI 10.1016/j.catcom.2010.10.024; Tada M, 2007, J PHYS CHEM C, V111, P10095, DOI 10.1021/jp072928k; Kollmer F, 2004, J CATAL, V227, P398, DOI 10.1016/j.jcat.2004.07.008; Sato K, 2006, CATAL TODAY, V118, P57, DOI 10.1016/j.cattod.2005.11.090; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Molinari R, 2006, CATAL TODAY, V118, P52, DOI 10.1016/j.cattod.2005.11.089; Lemke K, 2003, APPL CATAL A-GEN, V243, P41, DOI 10.1016/S0926-860X(02)00535-5; Bahidsky M, 2005, CATAL TODAY, V99, P187, DOI 10.1016/j.cattod.2004.09.039; Dittmeyer R, 2011, APPL CATAL A-GEN, V391, P311, DOI 10.1016/j.apcata.2010.07.024; Liptakova B, 2000, CATAL TODAY, V61, P143, DOI 10.1016/S0920-5861(00)00359-X; Watari N, 1998, PHYS REV B, V58, P1665, DOI 10.1103/PhysRevB.58.1665; Mita S, 2005, TETRAHEDRON LETT, V46, P7729, DOI 10.1016/j.tetlet.2005.09.016; Tani M, 2005, ANGEW CHEM INT EDIT, V44, P2586, DOI 10.1002/anie.200462769; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Sasaki T, 2009, TOP CATAL, V52, P880, DOI 10.1007/s11244-009-9225-1; Hamada R, 2003, PHYS CHEM CHEM PHYS, V5, P956, DOI 10.1039/b209706k; Liang P, 2010, CATAL COMMUN, V11, P560, DOI 10.1016/j.catcom.2009.12.019; Sato K, 2005, CATAL TODAY, V104, P260, DOI 10.1016/j.cattod.2005.03.067; Orita H, 2004, APPL CATAL A-GEN, V258, P17, DOI 10.1016/j.apcata.2003.08.001; Santra S, 2010, PHYS CHEM CHEM PHYS, V12, P6345, DOI 10.1039/b921531j; Sumimoto S, 2006, IND ENG CHEM RES, V45, P7444, DOI 10.1021/ie060743e; Ivanov AA, 2003, APPL CATAL A-GEN, V249, P327, DOI 10.1016/S0926-860X(03)00224-2; Hoelderich WF, 2000, CATAL TODAY, V62, P115, DOI 10.1016/S0920-5861(00)00413-2; Motz JL, 1998, J MOL CATAL A-CHEM, V136, P175, DOI 10.1016/S1381-1169(98)00048-X; Bahidsky M, 2004, CATAL TODAY, V91-2, P13, DOI 10.1016/j.cattod.2004.03.003; Ene AB, 2011, J PHYS CHEM C, V115, P3688, DOI 10.1021/jp1104664; Bal R, 2006, ANGEW CHEM INT EDIT, V45, P448, DOI 10.1002/anie.200502940; Shiota Y, 2005, ORGANOMETALLICS, V24, P3532, DOI 10.1021/om050136b; Yoshizawa K, 2000, J PHYS CHEM B, V104, P734, DOI 10.1021/jp991844b; Wang LS, 2013, CHEMCATCHEM, V5, P2203, DOI 10.1002/cctc.201300166; PANOV GI, 1992, APPL CATAL A-GEN, V82, P31, DOI 10.1016/0926-860X(92)80003-U; Li Y, 2008, J CATAL, V255, P190, DOI 10.1016/j.jcat.2008.02.001; Lucke B, 2004, ADV SYNTH CATAL, V346, P1407, DOI 10.1002/adsc.200404027; Ichihashi Y, 2010, CATAL LETT, V134, P324, DOI 10.1007/s10562-009-0240-4; Castagnola NB, 2005, APPL CATAL A-GEN, V290, P110, DOI 10.1016/j.apcata.2005.05.022; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Centi G, 2006, APPL CATAL A-GEN, V307, P30, DOI 10.1016/j.apcata.2006.03.018; Niwa S, 2002, SCIENCE, V295, P105, DOI 10.1126/science.1066527; Balducci L, 2003, ANGEW CHEM INT EDIT, V42, P4937, DOI 10.1002/anie.200352184; Passoni LC, 1997, J MOL CATAL A-CHEM, V120, P117, DOI 10.1016/S1381-1169(96)00440-2; Jensen C, 2013, J PHYS CHEM C, V117, P22732, DOI 10.1021/jp406303x; Kuznetsova NI, 2005, CATAL TODAY, V99, P193, DOI 10.1016/j.cattod.2004.09.040; Chammingkwan P, 2009, APPL CATAL A-GEN, V352, P1, DOI 10.1016/j.apcata.2008.09.009; MIYAKE T, 1995, APPL CATAL A-GEN, V131, P33, DOI 10.1016/0926-860X(95)00134-4; Watari N, 1997, J CHEM PHYS, V106, P7531, DOI 10.1063/1.473751; Tada M, 2010, PHYS CHEM CHEM PHYS, V12, P5701, DOI 10.1039/c000843p; Bahidsky M, 2004, PETROL COAL, V46, P49; Bal R., 2006, ANGEW CHEM, V118, P462, DOI 10.1002/ange.200502940; Balducci L., 2003, ANGEW CHEM, V115, P5087, DOI 10.1002/ange.200352184; Ehrich H, 2002, APPL CATAL A-GEN, V230, P271, DOI 10.1016/S0926-860X(02)00040-6; HAGGIN J, 1993, CHEM ENG NEWS, V71, P23, DOI 10.1021/cen-v071n022.p023; JINTOKU T, 1987, CHEM LETT, P1865, DOI 10.1246/cl.1987.1865; Kusakari T, 2004, CHEM COMMUN, P992, DOI 10.1039/b401373e; Laufer W, 2002, CHEM COMMUN, P1684, DOI 10.1039/b204033f; Liptakov B, 2004, APPL CATAL A-GEN, V263, P33, DOI 10.1016/j.apcata.2003.12.002; Mizuno T, 2005, J CHEM ENG JPN, V38, P849, DOI 10.1252/jcej.38.849; Panov G. I., 2000, CATTECH, V4, P18, DOI 10.1023/A:1011991110517; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; TANEV PT, 1994, NATURE, V368, P321, DOI 10.1038/368321a0; Tani M., 2005, ANGEW CHEM, V117, P2642, DOI 10.1002/ange.200462769; THANGARAJ A, 1990, APPL CATAL, V57, pL1, DOI 10.1016/S0166-9834(00)80718-6	72	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2283	2291		10.1002/asia.201500323		9	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200034		
J	Yokoyama, H; Ueda, Y; Fujita, D; Sato, S; Fujita, M				Yokoyama, Hiroyuki; Ueda, Yoshihiro; Fujita, Daishi; Sato, Sota; Fujita, Makoto			Finely Resolved Threshold for the Sharp M12L24/M24L48 Structural Switch in Multi-Component MnL2n Polyhedral Assemblies: X-ray, MS, NMR, and Ultracentrifugation Analyses	CHEMISTRY-AN ASIAN JOURNAL			English	Article						cage compounds; nanostructures; polyhedera; self-assembly; supramolecular chemistry	IONIZATION MASS-SPECTROMETRY; METAL-ORGANIC POLYHEDRA; COORDINATION CHEMISTRY; M24L48 POLYHEDRA; DESIGN; PRINCIPLES; COMPLEXES; LIGANDS; CAPSULE; FINITE	In the self-assembly of MnL2n polyhedra, the bend angle (theta) of the divalent ligand components determines the final structure. The threshold for the sharp structural switch between M12L24 and M24L48 was finely resolved to within just 4 degrees by demonstrating the exclusive formation of M12L24 cuboctahedra or M24L48 rhombicuboctahedra from two similar ligands with theta values of 130 degrees and 134 degrees. This sharp structural switch was fully confirmed by X-ray crystallography, mass spectrometry, NMR spectroscopy, and ultracentrifugation analyses.	[Yokoyama, Hiroyuki; Ueda, Yoshihiro; Fujita, Daishi; Sato, Sota; Fujita, Makoto] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Yokoyama, Hiroyuki; Ueda, Yoshihiro; Fujita, Daishi; Sato, Sota; Fujita, Makoto] Japan Sci & Technol Agcy JST, ACCEL, Bunkyo Ku, Tokyo 1138656, Japan	Fujita, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, 7-3-1 Hongo, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp			KAKENHI (MEXT) [24685010, 25102007]	We thank Prof. Fumio Arisaka and Prof. Shuichi Hiraoka for experimental support and helpful discussion on AUC. This research was in part supported by KAKENHI (MEXT) (24685010 and 25102007). The synchrotron X-ray crystallography was performed at the NE3A beamline at the KEK Photon Factory (2011G522, 2013G640) and at the BL38B1 beamline at SPring-8 (2012B0039, 2013A0039).	Sakamoto S, 2000, TETRAHEDRON, V56, P955, DOI 10.1016/S0040-4020(99)01092-3; Yamaguchi K, 2003, J MASS SPECTROM, V38, P473, DOI 10.1002/jms.488; Bilbeisi RA, 2013, ANGEW CHEM INT EDIT, V52, P9027, DOI 10.1002/anie.201302976; Fujita M, 2005, ACCOUNTS CHEM RES, V38, P369, DOI 10.1021/ar040153h; Muller A, 1999, CHEM COMMUN, P1347, DOI 10.1039/a901436e; Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v; Bunzen J, 2012, ANGEW CHEM INT EDIT, V51, P3161, DOI 10.1002/anie.201108731; Hiraoka S, 2006, ANGEW CHEM INT EDIT, V45, P6488, DOI 10.1002/anie.200601431; Abrahams BF, 1999, J AM CHEM SOC, V121, P3535, DOI 10.1021/ja990016t; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422; Saalfrank RW, 2008, ANGEW CHEM INT EDIT, V47, P8794, DOI 10.1002/anie.200702075; Harris K, 2013, CHEM COMMUN, V49, P6703, DOI 10.1039/c3cc43191f; Smulders MMJ, 2013, CHEM SOC REV, V42, P1728, DOI 10.1039/c2cs35254k; Young NJ, 2013, CHEM COMMUN, V49, P1354, DOI 10.1039/c2cc37776d; Eddaoudi M, 2001, J AM CHEM SOC, V123, P4368, DOI 10.1021/ja0104352; SAALFRANK RW, 1988, ANGEW CHEM INT EDIT, V27, P851, DOI 10.1002/anie.198808511; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; Saalfrank RW, 2008, ANGEW CHEM INT EDIT, V47, P8941, DOI 10.1002/anie.200804225; Schuck P, 2000, BIOPHYS J, V78, P1606; Meng WJ, 2011, ANGEW CHEM INT EDIT, V50, P3479, DOI 10.1002/anie.201100193; Al-Rasbi NK, 2008, J AM CHEM SOC, V130, P11641, DOI 10.1021/ja803847w; Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; Olenyuk B, 1999, NATURE, V398, P796; Li JR, 2010, NAT CHEM, V2, P893, DOI [10.1038/nchem.803, 10.1038/NCHEM.803]; Caulder DL, 1998, ANGEW CHEM INT EDIT, V37, P1840, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1840::AID-ANIE1840>3.0.CO;2-D; Peixoto TP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041908; Wang XS, 2012, CHEM SCI, V3, P2823, DOI 10.1039/c2sc20330h; Bilbeisi R. A., 2013, ANGEW CHEM, V125, P9197, DOI DOI 10.1002/ANGE.201302976; Bunzen J., 2012, ANGEW CHEM, V124, P3215; Caulder D. L., 1998, ANGEW CHEM, V110, P1940, DOI 10.1002/(SICI)1521-3757(19980703)110:13/14<1940::AID-ANGE1940>3.0.CO;2-J; Fujita D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2093; Fultz B, 2014, PHASE TRANSITIONS IN MATERIALS, P1; Gale P. A., 2012, SUPRAMOLECULAR CHEM; Granzhan A., 2010, ANGEW CHEM, V122, P5647; Granzhan A, 2010, ANGEW CHEM INT EDIT, V49, P5515, DOI 10.1002/anie.201002748; Hiraoka S., 2006, ANGEW CHEM, V118, P6638, DOI 10.1002/ange.200601431; Jensen H. J., 1998, CAMBRIDGE LECT NOTES; Meng W. J., 2011, ANGEW CHEM, V123, P3541, DOI 10.1002/ange.201100193; Mitra-Delmotte G, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00366; Moulton B, 2001, CHEM COMMUN, P863, DOI 10.1039/b102714j; Onuki A., 2002, PHASE TRANSITION DYN; Pasquale S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1793; Saalfrank R. W., 2008, ANGEW CHEM, V120, P8924, DOI 10.1002/ange.200702075; Saalfrank R. W., 2008, ANGEW CHEM, V120, P9073, DOI 10.1002/ange.200804225; Saalfrank R. W., 1988, ANGEW CHEM, V100, P878, DOI 10.1002/ange.19881000623; Sole R. V., 2011, PHASE TRANSITIONS PR; Tominaga M., 2004, ANGEW CHEM, V116, P5739, DOI 10.1002/ange.200461422	48	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2292	2295		10.1002/asia.201500519		4	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200035		
J	Yang, J; Zhou, R; Wei, LL; Yang, HX; Li, JQ; Zhao, ZX; Zheng, GQ				Yang Jie; Zhou Rui; Wei Lin-Lin; Yang Huai-Xin; Li Jian-Qi; Zhao Zhong-Xian; Zheng Guo-Qing			New Superconductivity Dome in LaFeAsO1-xFx Accompanied by Structural Transition	CHINESE PHYSICS LETTERS			English	Article							PHASE-DIAGRAM; IRON; ORDER	High-temperature superconductivity is often found in the vicinity of antiferromagnetism. This is also true in LaFeAsO1-xFx (x <= 0.2) and many other iron-based superconductors, which leads to proposals that superconductivity is mediated by fluctuations associated with the nearby magnetism. Here we report the discovery of a new superconductivity dome without low-energy magnetic fluctuations in LaFeAsO1-xFx with 0.25 <= x <= 0.75, where the maximal critical temperature T-c at x(opt) = 0.5-0.55 is even higher than that at x <= 0.2. By nuclear magnetic resonance and transmission electron microscopy, we show that a C4 rotation symmetry-breaking structural transition takes place for x > 0.5 above T-c. Our results point to a new paradigm of high temperature superconductivity.	[Yang Jie; Zhou Rui; Wei Lin-Lin; Yang Huai-Xin; Li Jian-Qi; Zhao Zhong-Xian; Zheng Guo-Qing] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Yang Jie; Zhou Rui; Wei Lin-Lin; Yang Huai-Xin; Li Jian-Qi; Zhao Zhong-Xian; Zheng Guo-Qing] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Zheng Guo-Qing] Okayama Univ, Dept Phys, Okayama 7008530, Japan	Zheng, GQ (reprint author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.	gqzheng@iphy.ac.cn	Zheng, Guo-qing/B-1524-2011; yang, jie/F-4389-2012	yang, jie/0000-0002-5549-6926	Chinese Academy of Sciences [XDB07020200]; National Basic Research Program of China [2012CB821402, 2011CBA00109, 2011CBA00101]; National Natural Science Foundation of China [11204362]	Supported by the Strategic Priority Research Program of the Chinese Academy of Sciences under Grant No XDB07020200, the National Basic Research Program of China under Grant Nos 2012CB821402, 2011CBA00109 and 2011CBA00101, and the National Natural Science Foundation of China under Grant No 11204362.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Hiraishi M, 2014, NAT PHYS, V10, P300, DOI [10.1038/nphys2906, 10.1038/NPHYS2906]; NARATH A, 1967, PHYS REV, V162, P320, DOI 10.1103/PhysRev.162.320; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; MORIYA T, 1991, J MAGN MAGN MATER, V100, P261, DOI 10.1016/0304-8853(91)90824-T; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Nakai Y, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045004; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Mathur ND, 1998, NATURE, V394, P39; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Luetkens H, 2009, NAT MATER, V8, P305, DOI [10.1038/nmat2397, 10.1038/NMAT2397]; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Sefat AS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117004; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Fernandes RM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.137001; Graser S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214503; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Lu W, 2008, SOLID STATE COMMUN, V148, P168, DOI 10.1016/j.ssc.2008.07.032; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Fernandes RM, 2014, NAT PHYS, V10, P97; Fu M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.247001; Iimura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1913; Li Z, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.140506; Ma C, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/47002; Matano K, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/57001; Ning FL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.037001; Oka T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.047001; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Ren ZA, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/17002; Yamase H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.180502; Zhou R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3265	36	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0256-307X	1741-3540		CHINESE PHYS LETT	Chin. Phys. Lett.	OCT	2015	32	10							107401	10.1088/0256-307X/32/10/107401		6	Physics, Multidisciplinary	Physics	CT6SZ	WOS:000362944000030		
J	Ohishi, S; Sugimoto, S; Hanawa, K				Ohishi, Shun; Sugimoto, Shusaku; Hanawa, Kimio			Zonal movement of the Mascarene High in austral summer	CLIMATE DYNAMICS			English	Article						Mascarene High; Indian Ocean Subtropical Dipole; Southern Annular Mode; El Nino-Southern Oscillation; Storm track activity	SOUTHERN INDIAN-OCEAN; SST DIPOLE EVENTS; VARIABILITY; TEMPERATURE; CIRCULATION; HEMISPHERE; ATLANTIC; MODES	Temporal variations in the Mascarene High (MH), defined by the sea level pressure (SLP) maximum within the region of [40A degrees-120A degrees E, 50A degrees-10A degrees S] in austral summer (November-January), were investigated using atmospheric reanalysis datasets. The MH longitudinal position has a dominant timescale at about 6 years, which appears to be independent of the MH intensity variation. The MH longitudinal movement is caused by a combination of SLP variations in the eastern South Indian Ocean (ESIO) and in the western South Indian Ocean (WSIO), as follows. (1) Pressure variations in the ESIO region are confined to the lower atmosphere up to the mid-troposphere, and are associated with the El Nio-Southern Oscillation events. (2) Pressure variations in the WSIO region, characterized by a quasi-barotropic structure throughout the troposphere, are related to the meridional movement of storm track. Sea surface temperature anomalies associated with the longitudinal movement of the MH show a southwest-northeast dipole structure, but this is shifted 10A degrees westward in longitude compared with that associated with the MH intensity.	[Ohishi, Shun] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugimoto, Shusaku; Hanawa, Kimio] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan	Ohishi, S (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohishi@eps.s.u-tokyo.ac.jp			Sasakawa Scientific Research Grant from Japan Science Society	The authors express their sincere gratitude to the members of the Physical Oceanography Group at Tohoku University. Numerous comments from and discussions with Dr. Tozuka and Dr. Morioka were very useful and appreciated. We are also grateful to two anonymous reviewers for their constructive comments, which helped improved our manuscript. The first author was financially supported by the Sasakawa Scientific Research Grant from the Japan Science Society.	Reason CJC, 2001, GEOPHYS RES LETT, V28, P2225, DOI 10.1029/2000GL012735; Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; Behera SK, 2001, GEOPHYS RES LETT, V28, P327, DOI 10.1029/2000GL011451; Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Nan S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018381; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Morioka Y, 2013, CLIM DYNAM, V41, P1955, DOI 10.1007/s00382-012-1584-9; Ashok K, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038847; Chiodi AM, 2007, J CLIMATE, V20, P4835, DOI 10.1175/JCLI4271.1; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Tozuka T, 2014, CLIM DYNAM, V43, P2197, DOI 10.1007/s00382-013-2044-x; Hermes JC, 2005, J CLIMATE, V18, P2864, DOI 10.1175/JCLI3422.1; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Fauchereau N, 2003, INT J CLIMATOL, V23, P663, DOI 10.1002/joc.905; Miyasaka T, 2010, J CLIMATE, V23, P2115, DOI 10.1175/2009JCLI3008.1; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Suzuki R, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001974; Morioka Y, 2012, J CLIMATE, V25, P4029, DOI 10.1175/JCLI-D-11-00396.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Manatsa D, 2014, CLIM DYNAM, V42, P1259, DOI 10.1007/s00382-013-1848-z; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Morioka Y, 2010, CLIM DYNAM, V35, P1075, DOI 10.1007/s00382-010-0843-x	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	OCT	2015	45	7-8					1739	1745		10.1007/s00382-014-2427-7		7	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2WV	WOS:000362667100003		
J	Abe, M; Shiogama, H; Yokohata, T; Emori, S; Nozawa, T				Abe, Manabu; Shiogama, Hideo; Yokohata, Tokuta; Emori, Seita; Nozawa, Toru			Asymmetric impact of the physiological effect of carbon dioxide on hydrological responses to instantaneous negative and positive CO2 forcing	CLIMATE DYNAMICS			English	Article						Carbon dioxide physiological effect; Hydrological response; Carbon dioxide forcing; Land surface model; General circulation model	STOMATAL CONDUCTANCE; CLIMATE-CHANGE; MODEL; PHOTOSYNTHESIS; ADJUSTMENT; RUNOFF; LEAVES	We conducted sensitivity experiments using a coupled atmosphere-ocean general circulation model to examine the asymmetry between the hydrological responses to instantaneous positive and negative CO2 forcing and the impact of the CO2 physiological effects (CDPEs) on these responses. This study focuses on the fast response occurring on time scales shorter than 1 year after imposing CO2 forcing. Experiments investigating the CO2 physiological effect show that the fast response of precipitation to positive CO2 forcing is a decrease in the global and annual mean, whereas that of negative forcing is an increase the global and annual mean precipitation. The fast global precipitation response to negative forcing is stronger than the response to positive forcing. In contrast, the experiments without the CDPE reveal similar magnitudes of the fast global precipitation responses to negative and positive CO2 forcing. Significant differences in the magnitudes of the fast precipitation response due to the CDPE are found in tropical regions such as the Amazon Basin, the Maritime Continents, and tropical Africa, where C3-type plants are common. The stomatal conductance of plant leaves is decreased by both positive and negative CO2 forcing, which suppress the transpiration from the leaves. Consequently, the CDPE enhances the asymmetry of the fast precipitation responses to positive and negative CO2 forcing. The asymmetric impact of CDPE requires a careful evaluation of future hydrological changes which is constrained by paleoclimate evidence.	[Abe, Manabu] Japan Agcy Marine Earth Sci & Technol, Dept Integrated Climate Change Predict Res, Yokohama, Kanagawa 2360001, Japan; [Shiogama, Hideo; Yokohata, Tokuta; Emori, Seita] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Nozawa, Toru] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Abe, M (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Integrated Climate Change Predict Res, Yokohama, Kanagawa 2360001, Japan.	abe.mnb@gmail.com	Shiogama, Hideo/B-9598-2012		Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [S-10]	This work was supported by the Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Environment Research and Technology Development Fund (S-10) of the Ministry of the Environment of Japan. The Earth Simulator at JAMSTEC and an NEC SX at NIES were employed to perform the AOGCM simulations. We thank two anonymous reviewers for helping to significant improve this paper.	Chadwick R, 2013, GEOPHYS RES LETT, V40, P4911, DOI 10.1002/grl.50932; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Boucher O, 2009, CLIM DYNAM, V32, P237, DOI 10.1007/s00382-008-0459-6; Andrews T, 2011, CLIM DYNAM, V36, P783, DOI 10.1007/s00382-010-0742-1; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Andrews T, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011749; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Andrews T, 2009, J CLIMATE, V22, P2557, DOI 10.1175/2008JCLI2759.1; Sellers PJ, 1996, SCIENCE, V271, P1402, DOI 10.1126/science.271.5254.1402; Joshi M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036234; Dong BW, 2009, J CLIMATE, V22, P3079, DOI 10.1175/2009JCLI2652.1; Gregory J, 2008, J CLIMATE, V21, P58, DOI 10.1175/2007JCLI1834.1; Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; Good P, 2012, CLIM DYNAM, V39, P2789, DOI 10.1007/s00382-012-1571-1; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519; Yoshimori M, 2009, J CLIMATE, V22, P3374, DOI 10.1175/2009JCLI2801.1; Chadwick R, 2013, CLIM DYNAM, V40, P295, DOI 10.1007/s00382-012-1287-2; COLLATZ GJ, 1990, PLANT CELL ENVIRON, V13, P219, DOI 10.1111/j.1365-3040.1990.tb01306.x; Bala G, 2008, P NATL ACAD SCI USA, V105, P7664, DOI 10.1073/pnas.0711648105; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Cao L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034015; Doutriaux-Boucher M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036273; Emori S, 2004, 1 K 1 MOD DEV; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI DOI 10.1029/2003GL018747; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	OCT	2015	45	7-8					2181	2192		10.1007/s00382-014-2465-1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2WV	WOS:000362667100030		
J	Duan, WL; He, B; Takara, K; Luo, PP; Hu, MC; Alias, NE; Nover, D				Duan, Weili; He, Bin; Takara, Kaoru; Luo, Pingping; Hu, Maochuan; Alias, Nor Eliza; Nover, Daniel			Changes of precipitation amounts and extremes over Japan between 1901 and 2012 and their connection to climate indices	CLIMATE DYNAMICS			English	Article						Precipitation variation; Extreme indices; Climate indices; Continuous wavelet transform; Japan	PACIFIC DECADAL OSCILLATION; SUMMER MONSOON; DAILY TEMPERATURE; RAINFALL; TRENDS; EVENTS; SERIES; FREQUENCY; WEATHER; REGION	Annual and seasonal precipitation amounts and annual precipitation extreme indices for Japan were characterized for the period 1901-2012 using the Mann-Kendall Tau test, regional analysis, and probability distribution functions, and possible correlations with climate indices including the Atlantic Multidecadal Oscillation, the Pacific Decadal Oscillation, the Southern Oscillation Index (SOI), and the sea surface temperature were explored using wavelet analysis. The results indicate that precipitation amounts exhibited a substantial dec rease at both the annual and seasonal scales, and the fluctuation became more frequent and stronger in the recent decades. Precipitation tended to be concentrated in summer and autumn throughout Japan and the southwest had higher precipitation than the southeast in the spring, summer, and autumn, with precipitation concentrated in the southeast in the winter. On a regional scale, the number of heavy precipitation days, consecutive wet days and total wet-day precipitation indicated a decreasing trend, while an increasing trend for maximum 1- and 5-day precipitation amount, precipitation in very wet days and the number of consecutive dry days. These changes have been an important issue for supplying the demand of water resources in Japan. Continuous wavelet analysis shows that there were significant periodic variations at 2-3 and 5-13 years frequency in extreme precipitation. In addition, climate indices have significant correlations with extreme precipitation, for example, there is statistically significant association between the increasing extreme precipitation and SOI.	[Duan, Weili] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Duan, Weili; He, Bin; Luo, Pingping] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Duan, Weili; He, Bin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing 210008, Jiangsu, Peoples R China; [Duan, Weili; Luo, Pingping; Hu, Maochuan] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Kyoto, Japan; [Duan, Weili; Takara, Kaoru; Alias, Nor Eliza] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Nover, Daniel] US Agcy Int Dev, Accra, Ghana	Duan, WL (reprint author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China.	duan.scut.cn@gmail.com; hebin@niglas.ac.cn			National Natural Science Foundation of China [41471460, 41130750]; "One Hundred Talents Program" of the Chinese Academy of Sciences; Kyoto University Global COE program; China Scholarship Council (CSC)	This study was sponsored by the National Natural Science Foundation of China (Nos. 41471460, 41130750), the "One Hundred Talents Program" of the Chinese Academy of Sciences, and the Kyoto University Global COE program "Sustainability/Survivability Science for a Resilient Society Adaptable to Extreme Weather Conditions" and "Global Center for Education and Research on Human Security Engineering for Asian Megacities". We also wish to acknowledge Dr. Enric Aguilar and Dr. Masahito Ishihara for their comments. The first author would like to thank China Scholarship Council (CSC) for his PhD scholarships.	Aguilar E, 2003, WMO TD, V1186, P53; Aguilar E, 2009, J GEOPHYS RES, V114, P10; Alexander L., 2006, J GEOPHYS RES-ATMOS, V1984-2012, P111, DOI DOI 10.1029/2005JD006290; Li ZX, 2012, GLOBAL PLANET CHANGE, V80-81, P255, DOI 10.1016/j.gloplacha.2011.06.008; Manton MJ, 2001, INT J CLIMATOL, V21, P269, DOI 10.1002/joc.610; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Jin YH, 2005, J HYDROL, V301, P54, DOI 10.1016/j.jhydrol.2004.06.026; Giorgi F, 2000, GEOPHYS RES LETT, V27, P1295, DOI 10.1029/1999GL011016; Vincent LA, 2005, J CLIMATE, V18, P5011, DOI 10.1175/JCLI3589.1; Zalina MD, 2002, WATER SCI TECHNOL, V45, P63; Krishnan R, 2003, CLIM DYNAM, V21, P233, DOI 10.1007/s00382-003-0330-8; Sillmann J, 2013, J GEOPHYS RES-ATMOS, V118, P1716, DOI 10.1002/jgrd.50203; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Zhai PM, 2005, J CLIMATE, V18, P1096, DOI 10.1175/JCLI-3318.1; Nakamura H, 2002, J CLIMATE, V15, P1855, DOI 10.1175/1520-0442(2002)015<1855:IADMRO>2.0.CO;2; Kimoto M, 2005, SOLA, V1, P85, DOI 10.2151/sola.2005.023; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Villarini G, 2011, J HYDROL, V400, P103, DOI 10.1016/j.jhydrol.2011.01.027; Fujibe F, 2013, ATMOS SCI LETT, V14, P127, DOI 10.1002/asl2.428; Jung HS, 2002, INT J CLIMATOL, V22, P1327, DOI 10.1002/joc.797; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561; Duan WL, 2014, NAT HAZARDS, V73, P1255, DOI 10.1007/s11069-014-1134-3; Kuo YM, 2011, J HYDROL, V409, P749, DOI 10.1016/j.jhydrol.2011.09.015; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Haylock M, 2000, INT J CLIMATOL, V20, P1533, DOI 10.1002/1097-0088(20001115)20:13<1533::AID-JOC586>3.0.CO;2-J; Wang XLL, 2008, J APPL METEOROL CLIM, V47, P2423, DOI 10.1175/2008JAMC1741.1; Qian W, 2002, THEOR APPL CLIMATOL, V73, P151, DOI 10.1007/s00704-002-0679-3; Saito H, 2010, GEOMORPHOLOGY, V118, P167, DOI 10.1016/j.geomorph.2009.12.016; del Rio S, 2011, INT J CLIMATOL, V31, P656, DOI 10.1002/joc.2111; Wang B, 2013, P NATL ACAD SCI USA, V110, P5347, DOI 10.1073/pnas.1219405110; Lee SM, 2012, J APPL METEOROL CLIM, V51, P1087, DOI 10.1175/JAMC-D-11-0157.1; Rajczak J, 2013, J GEOPHYS RES-ATMOS, V118, P3610, DOI 10.1002/jgrd.50297; Miyajima J, 2011, SOLA, V7, P157, DOI 10.2151/sola.2011-040; Kawamoto N, 2011, INT GEOSCI REMOTE SE, P2590, DOI 10.1109/IGARSS.2011.6049771; Choi G, 2009, INT J CLIMATOL, V29, P1906, DOI 10.1002/joc.1979; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Fujibe F, 2006, J METEOROL SOC JPN, V84, P1033, DOI 10.2151/jmsj.84.1033; Fujibe F, 2005, SOLA, V1, P41, DOI 10.2151/sola.2005.012; Duan WL, 2013, CHEMOSPHERE, V93, P946, DOI [10.1016/j.chemosphere.2013.05.060, 10.1016/j.chemoshere.2013.05.060]; Chang CP, 2000, J CLIMATE, V13, P4310, DOI 10.1175/1520-0442(2000)013<4310:IAIVOT>2.0.CO;2; Iwasaki H, 2009, SOLA, V5, P157, DOI 10.2151/sola.2009-040; Sen Roy S, 2004, INT J CLIMATOL, V24, P457, DOI 10.1002/joc.995; Wang XL, 2003, J CLIMATE, V16, P3383, DOI 10.1175/1520-0442(2003)016<3383:CODOUC>2.0.CO;2; Krishnamurthy CKB, 2009, J CLIMATE, V22, P4737, DOI 10.1175/2009JCLI2896.1; Suzuki Kenji, 2006, Journal of Agricultural Meteorology, V62, P127, DOI 10.2480/agrmet.62.127; Yamaguchi K, 2006, J METEOROL SOC JPN, V84, P221, DOI 10.2151/jmsj.84.221; Villafuerte MQ, 2014, ATMOS RES, V137, P1, DOI 10.1016/j.atmosres.2013.09.021; Sugiyama M, 2010, P NATL ACAD SCI USA, V107, P571, DOI 10.1073/pnas.0903186107; Bertacchi UC, 2001, HYDROL EARTH SYST SC, V5, P259, DOI 10.5194/hess-5-259-2001; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031601; Guttman NB, 1998, HOMOGENEITY DATA ADJ; Hipel KW, 2005, TIME SERIES MODELLIN; Latif M, 2003, GEOPHYS RES LETT, V30, P10; Press W. H., 2007, NUMERICAL RECIPES; Rowell DP, 2012, CLIM DYNAM, V39, P1929, DOI 10.1007/s00382-011-1210-2; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Stocker T. F., 2013, CLIMATE CHANGE 2013; Takeshita S., 2010, Bulletin of the Faculty of Agriculture, Miyazaki University, V56, P73; Wang YQ, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL023344, 10.1029/2005GL022574]; Zhang X, 2004, RCLIMDEX 1 0 USER MA; Zhang XB, 2011, WIRES CLIM CHANGE, V2, P851, DOI 10.1002/wcc.147	62	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	OCT	2015	45	7-8					2273	2292		10.1007/s00382-015-2778-8		20	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2WV	WOS:000362667100035		
J	Takei, K; Mitoma, C; Hashimoto-Hachiya, A; Takahara, M; Tsuji, G; Nakahara, T; Furue, M				Takei, K.; Mitoma, C.; Hashimoto-Hachiya, A.; Takahara, M.; Tsuji, G.; Nakahara, T.; Furue, M.			Galactomyces fermentation filtrate prevents T helper 2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Article							ATOPIC-DERMATITIS; DIOXIN RECEPTOR; SKIN BARRIER; KERATINOCYTE DIFFERENTIATION; EXPRESSION; MECHANISMS; AHR	Background. The aryl hydrocarbon receptor (AhR) recognizes diverse small molecules such as dioxins, tryptophan photoproducts and phytochemicals. It also plays crucial roles in epidermal homeostasis by upregulating epidermal barrier proteins. In preliminary screening, we found that Galactomyces fermentation filtrate (GFF), a cosmetic compound, was capable of activating AhR. Aim. To examine whether GFF upregulates the expression of the filaggrin and loricrin genes, FLG and LOR, in an AhR-dependent manner. Methods. The activation (cytoplasmic to nuclear translocation) of AhR was confirmed by immunofluorescence study and by upregulation of an AhR-specific marker, cytochrome P450-1A1 (CYP1A1). Gene expression levels were compared by quantitative reverse transcription PCR with or without GFF, interleukin (IL)-4 or IL-13 in normal human keratinocytes. AhR or control knockdown was carried out by transfection with AhR or control small interfering RNA. The protein expression of FLG and LOR was examined by immunohistochemistry using a three-dimensional epidermal equivalent treated with or without GFF or T helper (Th) 2 cytokines. Results. GFF induced the nuclear translocation of AhR with significant and dose-dependent upregulation of CYP1A1, FLG and LOR gene expression. The enhancing effects of GFF were abolished in AhR-knockdown keratinocytes. Th2 cytokines decreased expression of genes for FLG and LOR, and this expression was completely restored in the presence of GFF. The downregulated expression of the FLG gene with its restoration by GFF was also evident in the epidermal equivalent. GFF also upregulated the gene expression of genes encoding occludin, claudin-1 and 4, and kallikrein 5 and 7. Conclusions. Use of GFF is feasible to prevent the Th2-mediated reduction of FLG in an AhR-dependent fashion.	[Takei, K.; Mitoma, C.; Hashimoto-Hachiya, A.; Takahara, M.; Tsuji, G.; Nakahara, T.; Furue, M.] Kyushu Univ, Dept Dermatol, Fukuoka 8128582, Japan; [Mitoma, C.; Furue, M.] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Fukuoka 8128582, Japan; [Nakahara, T.; Furue, M.] Kyushu Univ, Div Skin Surface Sensing, Fukuoka 8128582, Japan	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp			P&G Innovation Godo Kaisha; Ministry of Health, Labour and Welfare; Environment Technology Development Fund of the Ministry of the Environment, Japan	This work was partly supported by research grants from P&G Innovation Godo Kaisha, the Ministry of Health, Labour and Welfare, and the Environment Technology Development Fund of the Ministry of the Environment, Japan.	McLean WHI, 2013, J CLIN INVEST, V123, P551, DOI 10.1172/JCI67438; Ray SS, 2003, TOXICOL APPL PHARM, V192, P131, DOI 10.1016/S0041-008X(03)00277-1; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kim B, 2014, PHYTOTHER RES, V28, P1359, DOI 10.1002/ptr.5138; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; Kohda F, 2013, J DERMATOL SCI, V72, P75, DOI 10.1016/j.jdermsci.2013.05.008; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Loertscher JA, 2001, TOXICOL APPL PHARM, V175, P121, DOI 10.1006/taap.2001.9202; Loertscher JA, 2002, TOXICOL SCI, V68, P465, DOI 10.1093/toxsci/68.2.465; Rico-Leo EM, 2013, J BIOL CHEM, V288, P7841, DOI 10.1074/jbc.M112.425009; Elias PM, 2014, J ALLERGY CLIN IMMUN, V134, P781, DOI 10.1016/j.jaci.2014.05.048; Furue M, 2014, ARCH DERMATOL RES, V306, P769, DOI 10.1007/s00403-014-1481-7; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Mohammadi-Bardbori A, 2012, CHEM RES TOXICOL, V17, P1878; Wong WR, 2011, J COSMET DERMATOL SC, V1, P15	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	OCT	2015	40	7					786	793		10.1111/ced.12635		8	Dermatology	Dermatology	CT5JS	WOS:000362846300015		
J	Imaizumi, T; Aizawa, T; Segawa, C; Shimada, M; Tsuruga, K; Kawaguchi, S; Matsumiya, T; Yoshida, H; Joh, K; Tanaka, H				Imaizumi, Tadaatsu; Aizawa, Tomomi; Segawa, Chihiro; Shimada, Michiko; Tsuruga, Kazushi; Kawaguchi, Shogo; Matsumiya, Tomoh; Yoshida, Hidemi; Joh, Kensuke; Tanaka, Hiroshi			Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						CXCL1; Human mesangial cells; IFN-beta; Inflammatory renal diseases; Lupus nephritis; Psuedoviral immunity; TLR3	POLYINOSINIC-POLYCYTIDYLIC ACID; INDUCIBLE GENE-I; LUPUS NEPHRITIS; INNATE IMMUNITY; GLOMERULAR EXPRESSION; ENDOTHELIAL-CELLS; PATHOGENESIS; INVOLVEMENT; PROTEIN-1; INFECTION	Mesangial proinflammatory chemokine/cytokine expressions via innate immunity play a pivotal role in the pathogenesis of glomerulonephritis. CXCL1/GRO alpha is a strong neutrophil chemoattractant cytokine and reportedly plays an important role in regional inflammatory reactions. However, detailed signaling of mesangial CXCL1 expression induced by viral or "pseudoviral" immunity remains to be determined. We treated normal human mesangial cells (MCs) in culture with polyinosinic-polycytidylic acid (poly IC), an authentic double-stranded RNA, and analyzed the expression of CXCL1 by reverse transcription-polymerase chain reaction (RT-PCR), real-time quantitative RT-PCR and enzyme-linked immunosorbent assay. To elucidate the poly IC-induced signaling pathway for CXCL1 expression, we subjected the cells to RNA interference against Toll-like receptor (TLR) 3, retinoic acid-inducible gene-I (RIG-I), melanoma differentiation-associated gene 5 (MDA5), interferon (IFN)-beta, nuclear factor (NF)-kappa B p65 and IFN regulatory factor (IRF) 3. We also conducted an immunofluorescence study to examine mesangial CXCL1 expression in biopsy specimens from patients with lupus nephritis (LN) and IgA nephropathy (IgAN). We found that activation of TLR3 signaling could induce the expression of CXCL1 in MCs. NF-kappa B, IRF3 and IFN-beta, but neither RIG-I nor MDA5, were found to be involved in mesangial CXCL1 expression in this setting. Induction of CXCL1 by poly IC was inhibited by pretreatment of cells with dexamethasone. Intense glomerular CXCL1 expression was observed in biopsy specimens from patients with LN, whereas only a trace staining occurred in specimens from patients with IgAN. TLR3 signaling also contributes to the CXCL1 expression in MCs. These observations further support the implication of viral and "pseudoviral" immunity in the pathogenesis of inflammatory renal diseases, especially in LN.	[Imaizumi, Tadaatsu; Segawa, Chihiro; Matsumiya, Tomoh; Yoshida, Hidemi] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan; [Aizawa, Tomomi; Tsuruga, Kazushi; Tanaka, Hiroshi] Hirosaki Univ Hosp, Dept Pediat, Hirosaki, Aomori 0368563, Japan; [Shimada, Michiko] Hirosaki Univ, Grad Sch Med, Dept Cardiol Resp Med & Nephrol, Hirosaki, Aomori 0368562, Japan; [Kawaguchi, Shogo] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Hirosaki, Aomori 0368562, Japan; [Joh, Kensuke] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Tanaka, Hiroshi] Hirosaki Univ, Dept Sch Hlth Sci, Fac Educ, Hirosaki, Aomori 0368560, Japan	Tanaka, H (reprint author), Hirosaki Univ, Dept Sch Hlth Sci, Fac Educ, 1 Bunkyo Cho, Hirosaki, Aomori 0368560, Japan.	hirotana@cc.hirosaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant for Hirosaki University Institutional Research	This work was supported by grants-in-aid for Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T. I., M. S. and H. T.), and by Grant for Hirosaki University Institutional Research (T. I. and T. M.). The authors thank A. Yamamoto, K. Nakata, A. Ono and K. Munakata for assistance.	Flur K, 2009, AM J PATHOL, V175, P2014, DOI 10.2353/ajpath.2009.080585; Aizawa-Yashiro T, 2013, PEDIATR RES, V73, P180, DOI 10.1038/pr.2012.165; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Imaizumi T, 2012, TOHOKU J EXP MED, V228, P17, DOI 10.1620/tjem.228.17; Coppo R, 2010, J NEPHROL, V23, P626; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Imaizumi T, 2010, NEPHROL DIAL TRANSPL, V25, P3534, DOI 10.1093/ndt/gfq270; Wood LD, 1995, J BIOL CHEM, V270, P30619; Imaizumi T, 2011, NEPHRON EXP NEPHROL, V119, pE40, DOI 10.1159/000328923; Watanabe S, 2013, NEPHROLOGY, V18, P833, DOI 10.1111/nep.12155; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Carrigan SO, 2010, J IMMUNOL, V185, P3602, DOI 10.4049/jimmunol.0903429; Robson MG, 2009, NEPHRON EXP NEPHROL, V113, pE1, DOI 10.1159/000228077; Tanaka H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/984708; Yamashita M, 2013, J INNATE IMMUN, V5, P231, DOI 10.1159/000345255; Zernecke A, 2001, J IMMUNOL, V166, P5755; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Anders HJ, 2009, TRENDS MOL MED, V15, P553, DOI 10.1016/j.molmed.2009.10.004; Migliorini A, 2013, J NEPHROL, V26, P437, DOI 10.5301/jn.5000247; Aizawa T, 2014, NEPHROLOGY, V19, P47, DOI 10.1111/nep.12171; Kanapathippillai P, 2013, CYTOKINE, V62, P244, DOI 10.1016/j.cyto.2013.03.016; Zhu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054028	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					761	770		10.1007/s10157-014-1060-4		10	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700001		
J	Yasuoka, Y; Sato, Y; Healy, JM; Nonoguchi, H; Kawahara, K				Yasuoka, Yukiko; Sato, Yuichi; Healy, Jillian M.; Nonoguchi, Hiroshi; Kawahara, Katsumasa			pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidney	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Calcium-sensing receptor; Neomycin; Urinary calcium concentration; Acid/base diet; Kidney collecting duct intercalated cell	EXTRACELLULAR CA2+-SENSING RECEPTOR; VASOPRESSIN V1A RECEPTOR; RAT-KIDNEY; URINARY ACIDIFICATION; PTH/PTHRP RECEPTOR; CL-/HCO3-EXCHANGER; METABOLIC-ACIDOSIS; LOCALIZATION; PENDRIN; CLONING	The localization and role of the calcium-sensing receptor (CaSR) along the nephron including the collecting ducts is still open to debate. Using the quantitative, highly sensitive in situ hybridization technique and a double-staining immunohistochemistry technique, we investigated the axial distribution and expression of CaSR along the nephron in mice (C57B/6J) treated for 6 days with acid or alkali diets. Under control condition, CaSR was specifically localized in the cortical and medullary thick ascending limb of Henle's loop (CTAL and MTAL), macula densa (MD), distal convoluted tubule (DCT), and CCD (TALs, MD > DCT, CCD). Along the CCD, CaSR was co-localized with an anion exchanger type 4 (AE4), a marker of the basolateral membrane of type-B intercalated cell (IC-B) in mice. On the contrary, CaSR was not detected either in principal cells (PC) or in type-A intercalated cell (IC-A). CaSR expression levels in IC-B significantly (P < 0.005) decreased when mice were fed NH4Cl (acid) diets and increased when animals were given NaHCO3 (alkali) diets. As expected, cell heights of IC-A and IC-B significantly (P < 0.005) increased in the above experimental conditions. Surprisingly, single infusion (ip) of neomycin, an agonist of CaSR, significantly (P < 0.005) increased urinary Ca excretion without further increasing the hourly urine volume and significantly (P < 0.05) decreased urine pH. CaSR, cloned from rat kidney, was localized in the basolateral membrane of IC-B and was more expressed during alkali-loading. Its alkali-sensitive expression may promote urinary alkali secretion for body acid-base balance.	[Yasuoka, Yukiko; Kawahara, Katsumasa] Kitasato Univ, Sch Med, Dept Physiol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Yasuoka, Yukiko; Kawahara, Katsumasa] Kitasato Univ, Grad Sch Med Sci, Dept Cellular & Mol Physiol, Sagamihara, Kanagawa 2520374, Japan; [Sato, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa 2520374, Japan; [Healy, Jillian M.] Univ Tokyo, Coll Art & Sci, ALESS Program, Komaba Org Educ Excellence,Meguro Ku, Tokyo 1538902, Japan; [Nonoguchi, Hiroshi] Kitasato Univ, Div Internal Med, Med Ctr, Kitamoto 3648501, Japan	Kawahara, K (reprint author), Kitasato Univ, Sch Med, Dept Physiol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kawahara@kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24790222, 23591224, 26461259]	This study was supported by grants from the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Y.Y. (No. 24790222) and to K.K. (No. 23591224, 26461259). Special thanks are given to Y. Nakabayashi (Kitasato Univ Sch of Med) for her technical assistance. Parts of this study were presented at the meetings of American Society of Nephrology (Philadelphia, 2011) and International Union of Physiological Sciences (Birmingham (UK), 2013).	Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Brown EM, 2001, PHYSIOL REV, V81, P239; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; KERSTENS HMJ, 1995, J HISTOCHEM CYTOCHEM, V43, P347; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Yasuoka Y, 2013, CLIN EXP NEPHROL, V17, P783, DOI 10.1007/s10157-013-0783-y; Quinn SJ, 2004, J BIOL CHEM, V279, P37241, DOI 10.1074/jbc.M404520200; Yasuoka Y, 2013, CLIN EXP NEPHROL, V17, P183, DOI 10.1007/s10157-012-0686-3; MADSEN KM, 1984, LAB INVEST, V51, P268; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; KRIZ W, 1988, KIDNEY INT, V33, P1; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Loretz CA, 2008, COMP BIOCHEM PHYS A, V149, P225, DOI 10.1016/j.cbpa.2008.01.037; Brown D, 2012, J AM SOC NEPHROL, V23, P774, DOI 10.1681/ASN.2012010029; Loupy A, 2012, J CLIN INVEST, V122, P3355, DOI 10.1172/JCI57407; Toka HR, 2012, J AM SOC NEPHROL, V23, P1879, DOI 10.1681/ASN.2012030323; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Sands JM, 1997, J CLIN INVEST, V99, P1399, DOI 10.1172/JCI119299; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Hebert SC, 1997, J EXP BIOL, V200, P295; Houillier P, 2013, CURR OPIN NEPHROL HY, V22, P566, DOI 10.1097/MNH.0b013e328363ff5f; BROWN EM, 1994, NEPHROL DIAL TRANSPL, V9, P1703; Bergsland KJ, 2009, AM J PHYSIOL-RENAL, V297, pF1017, DOI 10.1152/ajprenal.00223.2009; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Tsuganezawa H, 2001, J BIOL CHEM, V276, P8180, DOI 10.1074/jbc.M004513200; Kobayashi M, 2011, CLIN EXP NEPHROL, V15, P355, DOI 10.1007/s10157-011-0414-4; Suzuki T, 2003, ARCH HISTOL CYTOL, V66, P347, DOI 10.1679/aohc.66.347; Ikebe M, 2001, J AM SOC NEPHROL, V12, P423; Casare F, 2014, CAN J PHYSIOL PHARM, V92, P181, DOI 10.1139/cjpp-2013-0256; Alfadda TI, 2014, AM J PHYSIOL-CELL PH, V307, pC221, DOI 10.1152/ajpcell.00139.2014; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Sumida K, 2013, AM J NEPHROL, V37, P405, DOI 10.1159/000350211; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611; Chattopadhyay N, 1996, AM J PHYSIOL-RENAL, V271, pF736; Ko SBH, 2002, AM J PHYSIOL-CELL PH, V283, pC1206, DOI 10.1152/ajpcell.00512.2001; Purkerson JM, 2014, AM J PHYSIOL-RENAL, V307, pF601, DOI 10.1152/ajprenal.00404.2013; Riccardi D, 1996, AM J PHYSIOL-RENAL, V271, pF951; Xu J, 2003, AM J PHYSIOL-GASTR L, V285, pG1225, DOI 10.1152/ajpgi.00236.2003; Yang TX, 1997, AM J PHYSIOL-RENAL, V272, pF751	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					771	782		10.1007/s10157-014-1063-1		12	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700002		
J	Sato, Y; Fujimoto, S; Konta, T; Iseki, K; Moriyama, T; Yamagata, K; Tsuruya, K; Kimura, K; Narita, I; Kondo, M; Asahi, K; Kurahashi, I; Ohashi, Y; Watanabe, T				Sato, Yuji; Fujimoto, Shouichi; Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi			Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Specific Health Checkup; Estimated GFR; Body mass index; Cardiovascular disease; Cerebrovascular disease	CHRONIC KIDNEY-DISEASE; METABOLIC SYNDROME; RISK-FACTOR; PROTEINURIA; ATHEROSCLEROSIS; GLUCOSE; SYSTEM	The Japanese Specific Health Checkup mainly focuses on metabolic syndrome for preventing cardiovascular events. Subjects are stratified by measuring waist circumference, body mass index, blood pressure, triglycerides, and fasting plasma glucose. However, estimated glomerular filtration rate (eGFR) is not considered essential. A longitudinal cohort study assessed the association of eGFR with new-onset brain or heart attacks in a large Japanese nationwide Specific Health Checkup database. A total of 109,349 Japanese subjects (mean age 63.2 years, 39.5 % men) were examined for the events 2 years later. The odds ratios were calculated for new events in the total and subgroup populations divided by BMI < or a parts per thousand yen25 kg/m(2), obese and non-obese, respectively. Obese subjects were more often male and had proteinuria (dipstick test a parts per thousand yen1+), lower eGFR, and higher systolic and diastolic BP, fasting plasma glucose, hemoglobin A1c, and triglycerides (TG). Rates of new-onset brain or heart attacks were 3.1 and 4.0 % in the groups of non-obese and obese subjects, respectively. In the total population, eGFR as well as higher BMI (a parts per thousand yen25 kg/m(2)), higher BP (high-normal hypertension or greater), higher TG (a parts per thousand yen150 mg/dl), and proteinuria were significant risk factors for developing brain or heart attacks. The eGFR was significant in non-obese subjects, but not in the obese. As the ultimate aim of 'Specific Health Checkup' is to prevent cardiovascular events, our study suggests that eGFR should be evaluated in non-obese subjects.	[Sato, Yuji] Univ Miyazaki Hosp, Dialysis Div, Kiyotake, Miyazaki 8891692, Japan; [Fujimoto, Shouichi] Miyazaki Univ, Fac Med, Dept Hemovasc Med & Artificial Organs, Miyazaki, Japan; [Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Watanabe, Tsuyoshi] Steering Comm Design Comprehens Hlth Care Syst CK, Individual Risk Assessment Specif Hlth Checkups, Fukushima, Japan; [Kurahashi, Issei] iAnalysis LLC, Tokyo, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan	Sato, Y (reprint author), Univ Miyazaki Hosp, Dialysis Div, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	ysato@med.miyazaki-u.ac.jp			Ministry of Health, Labour and Welfare of Japan [20230601]	This work was supported by Health and Labour Sciences Research Grants for "Research on the Positioning of Chronic Kidney Disease in Specific Health Check and Guidance in Japan" (20230601) from the Ministry of Health, Labour and Welfare of Japan.	American Diabetes Association, 2011, DIABETES CARE S1, V34, pS62, DOI DOI 10.2337/DC11-S062; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Nagai K, 2014, NEPHROLOGY, V19, P574, DOI 10.1111/nep.12286; Palatini P, 2006, KIDNEY INT, V70, P578, DOI 10.1038/sj.ki.5001603; Sato Y, 2012, NEPHROL DIAL TRANSPL, V27, P3862, DOI 10.1093/ndt/gfs324; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Yano Y, 2012, DIABETES CARE, V35, P1310, DOI 10.2337/dc11-2245; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Konta T, 2007, CLIN EXP NEPHROL	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					790	796		10.1007/s10157-014-1062-2		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700004		
J	Hayashi, N; Akiyama, S; Okuyama, H; Matsui, Y; Adachi, H; Yamaya, H; Maruyama, S; Imai, E; Matsuo, S; Yokoyama, H				Hayashi, Norifumi; Akiyama, Shin'ichi; Okuyama, Hiroshi; Matsui, Yuki; Adachi, Hiroki; Yamaya, Hideki; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi; Yokoyama, Hitoshi			Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Electron microscopic findings; IgG subclass staining; Membranous nephropathy; Phospholipase A2 receptor; Western blotting	RENAL BIOPSIES; AUTOANTIBODIES; ANTIBODIES; SUBCLASS; GLOMERULONEPHRITIS; MALIGNANCY; DEPOSITS; OUTCOMES; IGG4	Recent studies have suggested that assessments of serum antibodies against M-type phospholipase A2 receptor (PLA2R) and the glomerular expression of PLA2R antigen in biopsy specimens are useful for the diagnosis of primary membranous nephropathy (MN). In this study, we assessed both of them and investigated the clinicopathological characteristics of PLA2R-related Japanese MN. We retrospectively enrolled 22 primary and 3 secondary Japanese patients whose serum samples and renal specimens were collected before treatment. According to the findings of serum antibodies and antigen in glomeruli, the primary MN patients were classified into PLA2R-related or -unrelated MN. We compared their clinicopathological findings, including IgG subclass staining, and electron microscopic findings, and evaluated the predictors of proteinuria remission. In primary MN, 16 patients (73 %) were classified into the PLA2R-related group, and 6 patients into the PLA2R-unrelated group. There was no significant difference in baseline laboratory data and electron microscopic findings, except for eGFR and serum IgG levels. IgG4-dominant deposition was more common in the related group (63 vs. 0 %). The 10 PLA2R-related patients with dominant IgG4 deposition had a lower rate and prolonged time in remission compared with the 6 PLA2R-related patients with non-dominant IgG4 (log-rank, p = 0.032). Furthermore, dominant IgG4 deposition was an unfavorable predictor of remission by multivariable Cox proportional hazard analysis. Assessments of both serum PLA2R antibodies and PLA2R antigen in glomeruli were more sensitive for the diagnosis of PLA2R-related MN, and among affected Japanese patients, those with dominant IgG4 deposition had worse clinical outcomes.	[Hayashi, Norifumi; Okuyama, Hiroshi; Matsui, Yuki; Adachi, Hiroki; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Div Nephrol, Uchinada, Ishikawa 9200293, Japan; [Akiyama, Shin'ichi; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Nephrol,Showa Ku, Nagoya, Aichi 4668550, Japan	Yokoyama, H (reprint author), Kanazawa Med Univ, Div Nephrol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	h-yoko@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [25461237, 24406029, 2530502]; Ministry of Health, Labour, and Welfare of Japan	We are grateful to the staff members of the Division of Nephrology for their cooperation and support. This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; (C) No. 25461237 (HY), (B) No. 24406029 (HY), and (B) No. 2530502 (HY, SM), and a Grant-in-Aid for Progressive Renal Disease Research and Intractable Renal Disease Research, Research on Rare and Intractable Diseases, and Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare of Japan.	Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Rahimi S, 2004, AM J TRANSPLANT, V4, P326, DOI 10.1111/j.1600-6143.2004.00334.x; Yokoyama H, 1999, NEPHROL DIAL TRANSPL, V14, P2379, DOI 10.1093/ndt/14.10.2379; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Yoshimoto K, 2004, KIDNEY INT, V65, P148, DOI 10.1111/j.1523-1755.2004.00403.x; EHRENREICH T, 1976, NEW ENGL J MED, V295, P741, DOI 10.1056/NEJM197609302951401; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Qu Z, 2012, NEPHROL DIAL TRANSPL, V27, P1931, DOI 10.1093/ndt/gfr534; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Debiec H, 2012, J AM SOC NEPHROL, V23, P1949, DOI 10.1681/ASN.2012060577; Larsen CP, 2013, MODERN PATHOL, V26, P709, DOI 10.1038/modpathol.2012.207; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Salant DJ, 2013, J AM SOC NEPHROL, V24, P525, DOI 10.1681/ASN.2013020166; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					797	803		10.1007/s10157-014-1064-0		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700005		
J	Fujimoto, K; Imura, J; Atsumi, H; Matsui, Y; Adachi, H; Okuyama, H; Yamaya, H; Yokoyama, H				Fujimoto, Keiji; Imura, Junko; Atsumi, Hirokatsu; Matsui, Yuki; Adachi, Hiroki; Okuyama, Hiroshi; Yamaya, Hideki; Yokoyama, Hitoshi			Clinical significance of serum and urinary soluble urokinase receptor (suPAR) in primary nephrotic syndrome and MPO-ANCA-associated glomerulonephritis in Japanese	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						suPAR; Nephrotic syndrome; MPO-ANCA-associated glomerulonephritis	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PLASMINOGEN-ACTIVATOR RECEPTOR; PRIMARY FSGS; CHILDREN	The soluble urokinase receptor (suPAR) has been implicated as a cause of primary focal segmental glomerulosclerosis (FSGS). However, the clinical significance of suPAR in glomerular diseases currently remains unclear. In this retrospective single-center cohort study, we investigated serum (s-) and urinary (u-) suPAR in patients with primary nephrotic syndrome (NS) (serum/urine: 37/32 cases) and MPO-ANCA-associated glomerulonephritis (ANCA-GN) (serum/urine: 13/11 cases). In pretreatment s- and u-suPAR, no significant differences were observed between the primary NS and ANCA-GN groups or among the pathological types of primary NS. An inverse correlation was noted between pretreatment s-suPAR and eGFR in the primary NS and ANCA-GN groups. A positive correlation was noted between pretreatment u-suPAR and proteinuria in the primary NS group. Furthermore, time-course changes in s- and u-suPAR over 2 months after therapy were associated with the therapeutic responsiveness of primary NS, particularly the differentiation of MCNS from FSGS (s-suPAR: AUC-ROC = 0.905, p = 0.007; u-suPAR: AUC-ROC = 0.816, p = 0.048). In the ANCA-GN group, a positive correlation was found between pretreatment s-suPAR and clinical severity or crescent formation, whereas u-suPAR was not correlated with these parameters. S- and u-suPAR after therapy may serve as clinical markers to judge the treatment response of untreated NS and differentiate MCNS from FSGS, but not in pretreatment patients. S-, but not u-suPAR may predict the severity of and crescent formation in ANCA-GN.	[Fujimoto, Keiji; Imura, Junko; Atsumi, Hirokatsu; Matsui, Yuki; Adachi, Hiroki; Okuyama, Hiroshi; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Div Nephrol, Uchinada, Ishikawa 9200293, Japan	Yokoyama, H (reprint author), Kanazawa Med Univ, Sch Med, Div Nephrol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	h-yoko@kanazawa-med.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science [25461237, 24406029, 25305028]	The authors gratefully acknowledge the help and assistance of their colleagues at the Division of Nephrology. This study was supported, in part, by a Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labour, and Welfare of Japan and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (HY, (C) No. 25461237; (B) No. 24406029, No. 25305028).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Maas RJH, 2012, KIDNEY INT, V81, P1043, DOI 10.1038/ki.2012.32; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Maas RJH, 2013, PEDIATR NEPHROL, V28, P1041, DOI 10.1007/s00467-013-2452-5; Bock ME, 2013, CLIN J AM SOC NEPHRO, V8, P1304, DOI 10.2215/CJN.07680712; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Yilmaz G, 2011, CLIN BIOCHEM, V44, P1227, DOI 10.1016/j.clinbiochem.2011.07.006; BARALDI A, 1995, NEPHROL DIAL TRANSPL, V10, P1155; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; The Japanese Society of Nephrology, 2011, NIHON JINZO GAKKAI S, V53, P78; The Japanese Society of Nephrology, 2011, NIHON JINZO GAKKAI S, V53, P509; Zang B, 2012, J MOL MED BERL, V90, P1407	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					804	814		10.1007/s10157-014-1067-x		11	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700006		
J	Tanaka, K; Moriyama, T; Iwasaki, C; Takei, T; Nitta, K				Tanaka, Kayu; Moriyama, Takahito; Iwasaki, Chihiro; Takei, Takashi; Nitta, Kosaku			Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						IgA nephropathy; Hematuria; Urinary red blood cells; Mild proteinuria; Renal function	ISOLATED MICROSCOPIC HEMATURIA; IMMUNOGLOBULIN-A NEPHROPATHY; NATURAL-HISTORY; PROGNOSTIC-FACTORS; OXFORD CLASSIFICATION; RENAL SURVIVAL; RISK-FACTORS; PATHOLOGY	The effects of hematuria on the outcome of IgA nephropathy (IgAN) remain unknown and treatment of IgAN with severe hematuria is controversial. Eighty-eight IgAN patients with proteinuria < 0.5 g/day and who had not received corticosteroids, immunosuppressive agents, or undergone a tonsillectomy were divided into two groups: (1) patients with low (< 20/high-power field [HPF]) urinary red blood cell (U-RBC) counts (L-RBC group, n = 48); and (2) patients with high (a parts per thousand yen20/HPF) U-RBC counts (H-RBC group, n = 40). Clinical and histological findings, renal survival rate and risk factors for progression were analyzed. The male ratio and blood pressure were significantly higher in the L-RBC group. Median proteinuria, mean estimated glomerular filtration rate and histological findings according to Oxford classifications were similar. During the 5 years after renal biopsy, the median amount of proteinuria remained at < 0.5 g/day or g/g creatinine in both groups, and the median U-RBC decreased to < 10/HPF in both groups without any intensive therapy. The 15-year renal survival rate, estimated using the Kaplan-Meier method, was 100 % in the H-RBC group, but decreased to 83.4 % in the L-RBC group, although it was not significant. The treatment of inhibitors of renin-angiotensin system (RAS inhibitors) decreased the risk for progression by Cox regression analysis (hazard ratio: 0.14, p = 0.027). Severe hematuria at the time of biopsy naturally improved without any intensive therapy, and there were no negative effects of hematuria on the outcome of IgAN with mild proteinuria. Its prognosis was relatively good, and the treatment of RAS inhibitors might prevent from progression.	[Tanaka, Kayu; Moriyama, Takahito; Iwasaki, Chihiro; Takei, Takashi; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjyuku Ku, Tokyo 1628666, Japan	Moriyama, T (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjyuku Ku, Kawada Cho 8-1, Tokyo 1628666, Japan.	takamori@kc.twmu.ac.jp					Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Shen P, 2008, NETH J MED, V66, P242; ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12; Kim Byung Soo, 2009, Korean Journal of Internal Medicine, V24, P356, DOI 10.3904/kjim.2009.24.4.356; Manno C, 2007, AM J KIDNEY DIS, V49, P763, DOI 10.1053/j.ajkd.2007.03.013; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Rauta V, 2002, CLIN NEPHROL, V58, P85; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Harmankaya Ozlem, 2002, International Urology and Nephrology, V33, P167, DOI 10.1023/A:1014424723466; Jalalah SM, 2002, NEPHROL DIAL TRANSPL, V17, P2586; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					815	821		10.1007/s10157-014-1068-9		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700007		
J	Ogawa, S; Takiguchi, J; Nako, K; Okamura, M; Sakamoto, T; Kabayama, S; Mori, T; Kinouchi, Y; Ito, S				Ogawa, Susumu; Takiguchi, Junko; Nako, Kazuhiro; Okamura, Masashi; Sakamoto, Takuya; Kabayama, Shigeru; Mori, Takefumi; Kinouchi, Yoshitaka; Ito, Sadayoshi			Elucidation of the etiology and characteristics of pink urine in young healthy subjects	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Pink urine syndrome; Urinary pH; Oxidative stress; Angiotensinogen; Methylglyoxal	GLYCATION END-PRODUCTS; PROXIMAL-TUBULE; OXIDATIVE STRESS; METABOLIC-ACIDOSIS; NA+/H+ EXCHANGER; KIDNEY-DISEASE; BLOOD-PRESSURE; METHYLGLYOXAL; CELLS; DIETARY	Pink urine syndrome (PUS) is attributed to the precipitation of uric acid caused by low urinary pH (U-pH). However, the reasons for the lower U-pH are unclear. To investigate the occurrence of PUS and verified the cause of U-pH reduction. Participants comprised 4,940 students who had undergone a physical examination. Data on the presence [PUS (+)] or absence [PUS (-)] of PUS, as well as age, gender, body mass index (BMI), blood pressure (BP), heart rate (HR), and U-pH were collected. Of these participants, 300 randomly selected individuals were evaluated for their waist circumference, as well as their levels of urinary C-peptide, angiotensinogen, methylglyoxal, thiobarbituric acid-reactive substances (TBARS), and Na+ excretion. Independent risk factors of lower U-pH were decided by a multiple-regression analysis. PUS was observed in 216 students (4.4 %). A greater number of men comprised the PUS (+) group compared with the PUS (-) group, and subjects in this group had high BMI, BP, and HR values, as well as low U-pH. A logistic regression analysis revealed that the BMI and U-pH were independent risk factors for PUS (+). The decrease of U-pH was closely related to the progress of chronic kidney disease (CKD). BMI value was related to PUS (+) in the CKD (-) subjects. On the other hand, low U-pH was related to PUS (+) in the CKD (+) subjects. All factors other than HR showed a significant negative correlation with U-pH. However, multiple-regression analysis revealed that TBARS and angiotensinogen were independent risk factors. Obesity and lower U-pH were each independently related to PUS, whereas increased intrarenal oxidative stress and exacerbation of the renin-angiotensin system activation were associated with the lowering of U-pH. U-pH low value is related to potential CKD.	[Ogawa, Susumu; Nako, Kazuhiro; Okamura, Masashi; Sakamoto, Takuya; Mori, Takefumi; Ito, Sadayoshi] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Ogawa, Susumu; Takiguchi, Junko; Kinouchi, Yoshitaka] Tohoku Univ, Sect Clin Med, Div Res Student Support, Inst Excellence Higher Educ, Sendai, Miyagi 980, Japan; [Kabayama, Shigeru] Trim Med Inst Co Ltd, Osaka, Japan	Ogawa, S (reprint author), Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ogawa-s@hosp.tohoku.ac.jp			21st Century Center of Excellence Program Special Research Grant from the Ministry of Education, Sports and Culture; Tohoku University's Center for the Advancement of Higher Education President's Research Fund	The authors acknowledge the editorial assistance and clinical support of Miss Manami Shimizu for her help with preparing the references and for her expert assistance in the preparation of the tables and figures. The authors wish to thank Miss Manami Shimizu, Miss Asako Chiba and Mrs. Yasuko Sato for their assistance with gathering the urine samples for the study. We also wish to thank nurses Eiko Mitsui, Yoko Hasegawa, Michiko Ota, Megumi Ito and Hiromi Sato for their efforts in gathering student data. This work was supported by a 21st Century Center of Excellence Program Special Research Grant from the Ministry of Education, Sports and Culture, and Tohoku University's Center for the Advancement of Higher Education President's Research Fund.	Saito A, 2005, ANN NY ACAD SCI, V1043, P637, DOI 10.1196/annals.1333.072; Mandel EI, 2013, CLIN J AM SOC NEPHRO, V8, P901, DOI 10.2215/CJN.07190712; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Miyazawa N, 2010, FREE RADICAL RES, V44, P101, DOI 10.3109/10715760903321788; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Li XC, 2009, AM J PHYSIOL-RENAL, V297, pF1342, DOI 10.1152/ajprenal.90734.2008; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; Otsuki M, 2011, ENDOCR J, V58, P363, DOI 10.1507/endocrj.K10E-319; Guo Q, 2009, J HYPERTENS, V27, P1664, DOI 10.1097/HJH.0b013e32832c419a; Krupp D, 2014, KIDNEY INT, V85, P204, DOI 10.1038/ki.2013.331; Saran R, 1998, NEPHROL DIAL TRANSPL, V13, P1579, DOI 10.1093/ndt/13.6.1579; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Archibeque SL, 2007, J ANIM SCI, V85, P1496, DOI 10.2527/jas.2006-208; Gaens KHJ, 2013, CURR OPIN LIPIDOL, V24, P4, DOI 10.1097/MOL.0b013e32835aea13; Scialla JJ, 2013, ADV CHRONIC KIDNEY D, V20, P141, DOI 10.1053/j.ackd.2012.11.001; Ozdemir AM, 2008, AM J NEPHROL, V28, P14, DOI 10.1159/000108757; DEITEL M, 1984, CAN MED ASSOC J, V130, P1007; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj/jhh/1001307; Yamagishi S, 2003, KIDNEY INT, V63, P464, DOI 10.1046/j.1523-1755.2003.00752.x; Azuma K, 2007, J CLIN BIOCHEM NUTR, V40, P131, DOI 10.3164/jcbn.40.131; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Goraya N, 2013, CLIN J AM SOC NEPHRO, V8, P371, DOI 10.2215/CJN.02430312; Ogawa S, 2010, HYPERTENSION, V56, P471, DOI 10.1161/HYPERTENSIONAHA.110.156786; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Dhar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074212; Odunewu A, 2013, AM J PHYSIOL-RENAL, V305, pF370, DOI 10.1152/ajprenal.00598.2012; Ogawa Susumu, 2009, Biomark Insights, V4, P97; Zuckerman Jack M, 2009, Rev Urol, V11, P134	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					822	829		10.1007/s10157-014-1066-y		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700008		
J	Yamada, K; Doi, S; Nakashima, A; Kawaoka, K; Ueno, T; Doi, T; Yokoyama, Y; Arihiro, K; Kohno, N; Masaki, T				Yamada, Kyoko; Doi, Shigehiro; Nakashima, Ayumu; Kawaoka, Koichiro; Ueno, Toshinori; Doi, Toshiki; Yokoyama, Yukio; Arihiro, Koji; Kohno, Nobuoki; Masaki, Takao			Expression of age-related factors during the development of renal damage in patients with IgA nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Aging; Oxidative DNA damage; Cell cycle arrest; Klotho; IgA nephropathy	UNILATERAL URETERAL OBSTRUCTION; CHRONIC KIDNEY-DISEASE; OXFORD CLASSIFICATION; CELL CARCINOMA; RISK-FACTORS; FIBROSIS; INJURY; PROGRESSION; SENESCENCE; BIOPSY	Chronic kidney disease patients share clinical and pathological features with the general aging population. Increased oxidative DNA damage, accumulation of cell cycle-arrested cells and decreased Klotho expression are assumed to be age-related factors that are reportedly linked to kidney disease. This study sought to determine the association between these age-related factors and renal damage in patients with IgA nephropathy (IgAN). We performed a cross-sectional analysis of 71 patients who were diagnosed with IgAN by renal biopsy. Expression of 8-hydroxydeoxyguanosine (8-OHdG, a marker of oxidative DNA damage), p16 (a marker of cell cycle-arrest) and Klotho (an anti-aging protein) were evaluated by immunohistochemical staining of renal biopsy samples. We correlated the changes in expression of these markers with Lee's pathologic grades and the Oxford classification. We also investigated the independent association between these markers and interstitial fibrosis using multiple linear regression analysis. 8-OHdG and p16 increased but Klotho decreased with progression of pathologic grade. Expression of 8-OHdG and p16 increased with the deterioration of mesangial hypercellularity and segmental glomerulosclerosis. In addition, p16 increased but Klotho decreased with progression of tubular atrophy/interstitial fibrosis. In univariate regression analysis, age, body mass index, systolic blood pressure, urinary protein excretion and expression of 8-OHdG, p16 and Klotho showed significant correlations with interstitial fibrosis. Multivariable regression analyses revealed that aging, increased renal expression of p16 and decreased expression of Klotho were independently correlated with interstitial fibrosis. The age-related factors might play important roles in the development of IgAN.	[Yamada, Kyoko; Doi, Shigehiro; Nakashima, Ayumu; Kawaoka, Koichiro; Ueno, Toshinori; Doi, Toshiki; Yokoyama, Yukio; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, Hiroshima 7348551, Japan; [Nakashima, Ayumu] Hiroshima Univ Hosp, Dept Regenerat & Med, Hiroshima 7348551, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima 7348551, Japan; [Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan	Doi, S (reprint author), Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	sdoi@hiroshima-u.ac.jp			Tsuchiya Memorial Medical Foundation; Ryokufukai Medical Foundation	This work was supported by Tsuchiya Memorial Medical Foundation (to S.D.), and Ryokufukai Medical Foundation (to K.K.)	Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Hsu RK, 2011, CURR OPIN NEPHROL HY, V20, P211, DOI 10.1097/MNH.0b013e3283454f8d; Klatte T, 2011, CURR OPIN UROL, V21, P376, DOI 10.1097/MOU.0b013e32834962bf; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Miyake H, 2004, UROLOGY, V64, P1057, DOI 10.1016/j.urology.2004.06.019; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Zhu Y, 2013, CANCER SCI, V104, P663, DOI 10.1111/cas.12134; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; LEE SMK, 1982, HUM PATHOL, V13, P314, DOI 10.1016/S0046-8177(82)80221-9; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Terada Y, 1997, J AM SOC NEPHROL, V8, P51; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1053/ajkd.2001.22834; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					830	837		10.1007/s10157-014-1070-2		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700009		
J	Misaki, T; Naka, S; Kuroda, K; Nomura, R; Shiooka, T; Naito, Y; Suzuki, Y; Yasuda, H; Isozaki, T; Nakano, K				Misaki, Taro; Naka, Shuhei; Kuroda, Keiko; Nomura, Ryota; Shiooka, Tempei; Naito, Yoshitaka; Suzuki, Yumiko; Yasuda, Hideo; Isozaki, Taisuke; Nakano, Kazuhiko			Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						IgA nephropathy; cnm; Collagen-binding protein; Streptococcus mutans	OXFORD CLASSIFICATION; INDUCED NEPHRITIS; GLOMERULONEPHRITIS; RABBITS; ADHESIN; SAMPLES; GENES	IgA nephropathy (IgAN) is the most common primary chronic glomerulonephritis; however, its precise initiating pathogenesis remains unclear. Streptococcus mutans is a major pathogen of human dental caries. S. mutans strains with the cnm gene encoding Cnm, a collagen-binding protein, have been reported to contribute to the development of systemic diseases. However, the contribution of S. mutans with Cnm in the development of IgAN has not been reported. The aim of this study was to investigate the prevalence of cnm-positive S. mutans in IgAN patients and clarify the effects of cnm-positive S. mutans on the histological pathology of IgAN. We identified the cnm gene in S. mutans isolated in saliva specimens, which were collected from IgAN patients (n = 53) and control subjects (n = 50). We evaluated the collagen-binding properties of S. mutans in IgAN patients and controls. The clinical parameters and histological scores were also assessed in IgAN patients. The rates of S. mutans isolation in IgAN and control groups were 84.0 and 84.9 %, respectively, not significantly dfferent. cnm-positive strains were significantly more prevalent in the IgAN group than in controls (32.1 vs. 14.0 %, p < 0.05). With regard to collagen-binding assays, the binding rates of cnm-positive strains were significantly higher in the IgAN group than in controls (96.6 vs. 30.0, p < 0.05). In addition, the segmental glomerulosclerosis scores were significantly higher in cnm-positive patients with IgAN than in cnm-negative patients with IgAN (0.94 vs. 0.57, p < 0.05). cnm-positive S. mutans strains are potentially associated with the pathogenesis of IgAN.	[Misaki, Taro; Shiooka, Tempei; Naito, Yoshitaka; Suzuki, Yumiko; Isozaki, Taisuke] Seirei Hamamatsu Gen Hosp, Div Nephrol, Naka Ku, Hamamatsu, Shizuoka 4308558, Japan; [Naka, Shuhei; Kuroda, Keiko; Nomura, Ryota; Nakano, Kazuhiko] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Osaka, Japan; [Yasuda, Hideo] Hamamatsu Univ, Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4312102, Japan	Misaki, T (reprint author), Seirei Hamamatsu Gen Hosp, Div Nephrol, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	misakitar@sis.seirei.or.jp			Osaka University Graduate School of Dentistry	The authors thank Prof. Howard K. Kuramitsu, State University of New York at Buffalo, for editing the manuscript. This study was supported by Osaka University Graduate School of Dentistry.	Abrahamson, 2013, J HISTOCHEM CYTOCHEM, V61, P706; Park KS, 2014, HUM PATHOL, V45, P236, DOI 10.1016/j.humpath.2013.08.019; Nomura R, 2009, J MED MICROBIOL, V58, P469, DOI 10.1099/jmm.0.007559-0; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Kokubo T, 1998, J AM SOC NEPHROL, V9, P2048; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Lee H, 2012, KOREAN J INTERN MED, V27, P293, DOI 10.3904/kjim.2012.27.3.293; ALBINI B, 1985, AM J PATHOL, V118, P408; Nakano K, 2004, J CLIN MICROBIOL, V42, P198, DOI 10.1128/JCM.421.1.198-202.2004; Kusano K, 2007, HUM PATHOL, V38, P1788, DOI 10.1016/j.humpath.2007.04.012; Lapirattanakul J, 2014, FUTURE MICROBIOL, V9, P807, DOI [10.2217/fmb.14.37, 10.2217/FMB.14.37]; Sato Y, 2004, J DENT RES, V83, P534; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Iwama H, 1998, AM J KIDNEY DIS, V32, P785, DOI 10.1016/S0272-6386(98)70134-9; MIYATA M, 1995, INT ARCH ALLERGY IMM, V108, P360; Nakano K, 2007, J CLIN MICROBIOL, V45, P2616, DOI 10.1128/JCM.02343-06; Nomura R, 2013, ARCH ORAL BIOL, V58, P1627, DOI 10.1016/j.archoralbio.2013.06.008; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Narita I, 2008, CLIN EXP NEPHROL, V12, P332, DOI 10.1007/s10157-008-0054-5; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; DAMICO G, 1987, Q J MED, V64, P709; Kojima Ayuchi, 2012, Sci Rep, V2, P332, DOI 10.1038/srep00332; Nagasawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081636; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.028647-0	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					844	850		10.1007/s10157-014-1072-0		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700011		
J	Ohashi, N; Ishigaki, S; Kitajima, K; Tsuji, N; Isobe, S; Iwakura, T; Ono, M; Fujikura, T; Tsuji, T; Sakao, Y; Kato, A; Yasuda, H				Ohashi, Naro; Ishigaki, Sayaka; Kitajima, Kazuto; Tsuji, Naoko; Isobe, Shinsuke; Iwakura, Takamasa; Ono, Masafumi; Fujikura, Tomoyuki; Tsuji, Takayuki; Sakao, Yukitoshi; Kato, Akihiko; Yasuda, Hideo			The level of urinary alpha 1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Antineutrophil cytoplasmic antibody associated vasculitis; Necrotizing crescentic glomerulonephritis; Peritubular capillaritis; Arteriolitis; Urinary alpha 1 microglobulin	GLOMERULONEPHRITIS; CLASSIFICATION; NEPHRITIS; DIAGNOSIS; PATHOLOGY; INJURY	Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis affects small vessels in the kidney (i.e., arterioles, glomerular or peritubular capillaries, or venules). Although crescentic glomerulonephritis is a common histological finding, the incidence of peritubular capillaritis (PTC) or arteriolitis is unclear. Moreover, the laboratory data that reflect the degree of renal histological damage and distinguish between PTC and arteriolitis have not yet been clarified. We investigated laboratory data and histological findings from 11 patients diagnosed with ANCA-associated vasculitis (2 men and 9 women, mean age 70.3 +/- A 3.3 years) whose renal biopsies were performed between 2009 and 2014. All patients were positive for myeloperoxidase (MPO)-ANCA. PTC or arteriolitis was detected in six patients (54.5 %), respectively. The only significant positive relationship between laboratory data and histological findings observed was that between levels of urinary alpha 1 microglobulin (u-alpha 1MG) excretion and the percentage of tubular atrophy and interstitial fibrosis (r = 0.67, p = 0.035). No significant differences in laboratory data were found between patients with or without arteriolitis. However, the levels of u-alpha 1MG excretion were significantly higher in patients with PTC than in those without PTC (75.2 +/- A 19.5 vs. 15.0 +/- A 3.6 mg/dl, p = 0.035). PTC or arteriolitis occurs at a high rate independently of crescentic glomerulonephritis in ANCA-associated vasculitis patients. The levels of u-alpha 1MG excretion reflect the degrees of tubular atrophy and interstitial fibrosis. Moreover, high levels of u-alpha 1MG excretion suggest that PTC is more likely than arteriolitis in ANCA-associated vasculitis patients.	[Ohashi, Naro; Ishigaki, Sayaka; Kitajima, Kazuto; Tsuji, Naoko; Isobe, Shinsuke; Iwakura, Takamasa; Ono, Masafumi; Fujikura, Tomoyuki; Tsuji, Takayuki; Yasuda, Hideo] Hamamatsu Univ, Sch Med, Internal Med 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Sakao, Yukitoshi; Kato, Akihiko] Hamamatsu Univ, Sch Med, Blood Purificat Unit, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Ohashi, N (reprint author), Hamamatsu Univ, Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ohashi-n@hama-med.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Banerjee A, 2001, J CLIN PATHOL, V54, P787; Ohashi R, 2000, J AM SOC NEPHROL, V11, P47; Hauer HA, 2002, KIDNEY INT, V61, P80, DOI 10.1046/j.1523-1755.2002.00089.x; Kallenberg CGM, 2014, J AUTOIMMUN, V48-49, P90, DOI 10.1016/j.jaut.2014.01.023; ARIMURA Y, 1993, CLIN NEPHROL, V40, P256; Roth R, 2013, AM J NEPHROL, V37, P249, DOI 10.1159/000347219; FINE LG, 1993, EUR J CLIN INVEST, V23, P259, DOI 10.1111/j.1365-2362.1993.tb00771.x; Penders J, 2004, CLIN CHIM ACTA, V346, P107, DOI 10.1016/j.cccn.2004.03.037; Joh K, 2008, CLIN EXP NEPHROL, V12, P277, DOI 10.1007/s10157-008-0052-7; Wen YK, 2006, RENAL FAILURE, V28, P189, DOI 10.1080/08860220500531559; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Nakabayashi K, 2009, CLIN EXP NEPHROL, V13, P605, DOI 10.1007/s10157-009-0200-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Yamagata K, 2012, CLIN EXP NEPHROL, V16, P580, DOI 10.1007/s10157-012-0598-2; Everaert K, 1998, CLIN CHEM LAB MED, V36, P309, DOI 10.1515/CCLM.1998.052; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 2007, HEPTINSTALLS PATHOLO, P643; Vestweber D, 1999, GUIDEBOOK EXTRACELLU, P301	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					851	858		10.1007/s10157-014-1073-z		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700012		
J	Muto, S; Kawano, H; Higashihara, E; Narita, I; Ubara, Y; Matsuzaki, T; Ouyang, J; Torres, VE; Horie, S				Muto, Satoru; Kawano, Haruna; Higashihara, Eiji; Narita, Ichiei; Ubara, Yoshifumi; Matsuzaki, Takayuki; Ouyang, John; Torres, Vicente E.; Horie, Shigeo			The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Tolvaptan; Japanese population; Autosomal dominant polycystic kidney disease; TEMPO 3:4 trial; Total kidney volume; Kidney function decline	GENE; PROGRESSION; PREVALENCE; PROTEIN; ENCODES	Japan is the first country in the world to approve tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD), which was based on the results of Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes (TEMPO) 3:4 trial. To evaluate the safety and efficacy of tolvaptan, we performed a subgroup analysis in the participating Japanese ADPKD patient population. The primary outcome was the annual rate of percentage change in the total kidney volume (TKV). The secondary endpoint was the rate of kidney function change. The tolvaptan and placebo groups included 118 and 59 patients, respectively. The annual rate of percentage changes in TKV were 1.3 % [95 % confidence interval (CI) 0.4-2.1] in the tolvaptan group, and 5.0 % (95 % CI 3.9-6.2) in the placebo group (P < 0.001). The annual estimated glomerular filtration rate change was -3.83 mL/min/1.73 m(2) in the tolvaptan group and -5.05 mL in the placebo group for a treatment effect of +1.22 mL/min/1.73 m(2) (95 % CI 0.41-2.02: P = 0.003). Hepatic function abnormal as a serious adverse event was observed in 3 patients (2.5 %) in the tolvaptan group. Administration of tolvaptan in the Japanese sub-population reduced the annual rate of TKV growth and slowed the rate of kidney function decline over 36 months compared to patients on placebo, thus providing a novel and effective therapy for the treatment of ADPKD. (TEMPO 3:4 ClinicalTrials.gov number, NCT00428948).	[Muto, Satoru] Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan; [Kawano, Haruna; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Tokyo 1138431, Japan; [Higashihara, Eiji] Kyorin Univ, Sch Med, Dept ADPKD Res, Tokyo, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan; [Matsuzaki, Takayuki] Otsuka Pharmaceut Co Ltd, Tokyo, Japan; [Ouyang, John] Otsuka Pharmaceut Dev & Commercializat Inc, Rockville, MD USA; [Torres, Vicente E.] Mayo Clin, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN USA	Horie, S (reprint author), Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Hongo 3-1-3, Tokyo 1138431, Japan.	shorie@juntendo.ac.jp			Otsuka Pharmaceutical	SH has received honoraria for presentations and research funding from and has consulted and been an advisory board member for Otsuka Pharmaceutical. EH has received research funding from Otsuka Pharmaceutical and is a member of the Steering Committee for several Otsuka studies involving the TEMPO 3:4 trial. TM and JO are employees of Otsuka. VET is an investigator and Chair of the Steering Committee for several Otsuka studies involving the TEMPO 3:4 trial. All the other authors declared no competing interests.	Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Parikh CR, 2012, KIDNEY INT, V81, P784, DOI 10.1038/ki.2011.465; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Torres VE, 2011, AM J KIDNEY DIS, V57, P692, DOI 10.1053/j.ajkd.2010.11.029; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Mochizuki T, 2013, CLIN EXP NEPHROL, V17, P317, DOI 10.1007/s10157-012-0741-0; Masoumi Amirali, 2008, Ther Clin Risk Manag, V4, P393; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS33, DOI 10.1007/s10557-011-6304-x; Sakaida I, 2014, HEPATOL RES, V44, P73, DOI 10.1111/hepr.12098; The International Society of Nephrology, 2013, KIDNEY INT S, V3, P5	18	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					867	877		10.1007/s10157-015-1086-2		11	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700014		
J	Yamamoto, T; Nakayama, M; Miyazaki, M; Matsushima, M; Sato, T; Taguma, Y; Sato, H; Ito, S				Yamamoto, Tae; Nakayama, Masaaki; Miyazaki, Mariko; Matsushima, Masato; Sato, Toshinobu; Taguma, Yoshio; Sato, Hiroshi; Ito, Sadayoshi			Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Blood pressure; Cardiovascular disease; Hypertension; Kidney failure; Outcome; Proteinuria	CARDIOVASCULAR EVENTS; RENAL-DISEASE; RISK; STROKE; TRIAL; PROGRESSION; METAANALYSIS; PROTEINURIA; NEPHROPATHY; INHIBITION	Previous studies established a J-shaped association between blood pressure (BP) and cardiovascular disease (CVD) in chronic kidney disease (CKD), and the different clinical profiles of CVD by ethnicity. However, the adequately lower BP target remains unclear in Asian patients with CKD. This prospective observational study included 2,655 Japanese outpatients with CKD under nephrologist care who met the inclusion criteria, namely estimated glomerular filtration rate < 60 mL/min and/or presenting proteinuria. The patients were divided by 10-mmHg BP increments by clinical data. The end points were death, cardiovascular events (CVEs), and end-stage kidney disease (ESKD) that requires renal replacement therapy. During a 3.02-year median follow-up, 64 patients died, 120 developed CVEs, and 225 progressed to ESKD. In the adjusted Cox models, the risks of CVEs and all-cause mortality were higher in the patients with systolic BPs (SBPs) < 110 mmHg than in those with SBPs of 130-139 mmHg. Moreover, the risk was higher in those with diastolic BPs (DBPs) < 70 mmHg than in those with DBPs of 80-89 mmHg. Although SBPs a parts per thousand yen 140 mmHg were associated with higher incidence rates of ESKD, no significant increased risk was associated with BPs < 130/80 mmHg. SBPs < 110 mmHg and DBPs < 70 mmHg were independent risk factors of CVEs and all-cause mortality. No lower BPs were observed as significant risk factors of progression to ESKD. This study suggests that the lower BP target in Asian patients with CKD should be a parts per thousand yen110/70 mmHg.	[Yamamoto, Tae; Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Nakayama, Masaaki; Miyazaki, Mariko; Matsushima, Masato; Taguma, Yoshio; Sato, Hiroshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Ctr Adv Integrated Renal Sci, Sendai, Miyagi 9808574, Japan; [Nakayama, Masaaki] Fukushima Med Univ, Div Nephrol Endocrinol Vasc Med & Diabetol, Fukushima, Japan; [Matsushima, Masato] Jikei Univ, Sch Med, Dept Clin Res, Tokyo, Japan; [Sato, Toshinobu; Taguma, Yoshio] Japan Community Hlth Care Org, Kidney Ctr, Sendai Hosp, Sendai, Miyagi, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Sendai, Miyagi 9808574, Japan	Yamamoto, T (reprint author), Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	tae.yamamoto@med.tohoku.ac.jp			Astellas Pharm Inc.; Miyagi Kidney Foundation	This study was supported by grants from Astellas Pharm Inc. and the Miyagi Kidney Foundation. The authors express special thanks to Ms. Makiko Nakayama and to Ms. Ayuko Momoi for administrative and secretarial assistance. Study contributors: Yuji Yamaguchi (Japanese Red Cross Sendai Hospital), Katsuya Obara (Tohoku Kosai Hospital), Isao Kurihara (Tohoku Kosai Miyagino Hospital), Yasumichi Kinoshita and Kazuto Sato (Japanese Red Cross Ishinomaki Hospital), Kazuro Kaise (Sendai Medical Center), Akira Sugiura and Masahiro Miyata (Osaki Citizen Hospital), Kazuhisa Takeuchi (Koujinkai Central Clinic), Kenji Nakayama and Naoki Akiu (Sendai City Hospital) and Tetsuya Otaka (Katta General Hospital).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Hyun KK, 2013, INT J STROKE, V8, P606, DOI 10.1111/ijs.12166; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Nakayama M, 2011, HYPERTENS RES, V34, P1106, DOI 10.1038/hr.2011.96; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Reynolds JC, 2010, PREHOSP EMERG CARE, V14, P78, DOI 10.3109/10903120903349796; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Mann JFE, 2013, J HYPERTENS, V31, P414, DOI 10.1097/HJH.0b013e32835bf7b0; Ogihara T, 2009, HYPERTENS RES, V32, P248, DOI 10.1038/hr.2008.34; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Ninomiya T, 2008, KIDNEY INT, V73, P963, DOI 10.1038/ki.2008.5; [Anonymous], 1990, STROKE, V21, P637; PETERSON JC, 1995, ANN INTERN MED, V123, P754; Banach M, 2012, CURR HYPERTENS REP, V14, P556, DOI 10.1007/s11906-012-0314-3; Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P830, DOI 10.2215/CJN.06201208; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Weiner DE, 2007, J AM SOC NEPHROL, V18, P960, DOI 10.1681/ASN.2006080858; Jafar TH, 2003, ANN INTERN MED, V139, P244; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S8, V2	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					878	886		10.1007/s10157-015-1084-4		9	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700015		
J	Nakade, Y; Toyama, T; Furuichi, K; Kitajima, S; Miyajima, Y; Fukamachi, M; Sagara, A; Shinozaki, Y; Hara, A; Shimizu, M; Iwata, Y; Oe, H; Nagahara, M; Horita, H; Sakai, Y; Kaneko, S; Wada, T				Nakade, Yusuke; Toyama, Tadashi; Furuichi, Kengo; Kitajima, Shinji; Miyajima, Yoshiyasu; Fukamachi, Mihiro; Sagara, Akihiro; Shinozaki, Yasuyuki; Hara, Akinori; Shimizu, Miho; Iwata, Yasunori; Oe, Hiroyasu; Nagahara, Mikio; Horita, Hiroshi; Sakai, Yoshio; Kaneko, Shuichi; Wada, Takashi			Impact of kidney function and urinary protein excretion on intima-media thickness in Japanese patients with type 2 diabetes	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Carotid ultrasonography; Chronic kidney disease; Intima-media thickness; Type 2 diabetes	GLOMERULAR-FILTRATION-RATE; CAROTID-ARTERY INTIMA; INSULIN-RESISTANCE ATHEROSCLEROSIS; PRIOR MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; RISK-FACTORS; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR RISK; INCIDENT STROKE; ALL-CAUSE	Carotid echo indexes [intima-media thickness (IMT)] are commonly used surrogate markers for cardiovascular disease; however, the impacts of chronic kidney disease (CKD) on changes in IMT are unclear. We examined associations between CKD and IMT in participants with and without type 2 diabetes through longitudinal analysis. In total, 424 subjects were enrolled in this study. IMT was measured as per carotid echo indexes. Relationships between IMT and risk factors were analyzed using multiple linear regression analysis, in which we defined IMT as the dependent variable and atherosclerosis-related factors (age, sex, systolic pressure, total cholesterol, body mass index, estimated glomerular filtration rate (eGFR), uric acid, smoking index, number of antihypertensive drugs, statin use, urinary protein levels, past cardiovascular event, glycated hemoglobin, and diabetes duration) as independent variables. The study population was composed of 70.3 % male subjects. Participants with diabetes accounted for 64.4 % of the total population. The mean follow-up duration was 2.2 +/- A 1.5 years. Alterations in IMT tended to be associated with systolic blood pressure (+10 mmHg) (beta = -0.0084, p = 0.09) and eGFR (+10 mL/min/1.73 m(2)) (beta = -0.0049, p = 0.06) in all participants. In participants without diabetes, alterations in IMT were associated with eGFR (+10 mL/min/1.73 m(2)) (beta = -0.0104, p = 0.03) and tended to be associated with systolic blood pressure (+10 mmHg) (beta = 0.0094, p = 0.06). No significant relationships were found in participants with diabetes. Low eGFR was associated with progression of carotid thickness independent of common cardiovascular risk factors in non-diabetic participants.	[Nakade, Yusuke; Miyajima, Yoshiyasu; Fukamachi, Mihiro; Oe, Hiroyasu; Nagahara, Mikio; Horita, Hiroshi; Sakai, Yoshio; Wada, Takashi] Kanazawa Univ Hosp, Clin Lab, Kanazawa, Ishikawa 9208641, Japan; [Nakade, Yusuke; Miyajima, Yoshiyasu; Iwata, Yasunori; Sakai, Yoshio; Wada, Takashi] Kanazawa Univ Hosp, Dept Lab Med, Kanazawa, Ishikawa 9208641, Japan; [Toyama, Tadashi; Furuichi, Kengo; Kitajima, Shinji; Sagara, Akihiro; Shinozaki, Yasuyuki; Hara, Akinori; Shimizu, Miho; Iwata, Yasunori; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa 9208641, Japan; [Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan	Furuichi, K (reprint author), Kanazawa Univ Hosp, Div Nephrol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	kfuruichi@m-kanazawa.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science, Sports and Culture, Japan	We wish to thank the staff of the Clinical Laboratory at Kanazawa University Hospital for their technical assistance in this study. This study was supported by Grants-in-Aid for Diabetic Nephropathy, Diabetic Nephropathy Research, and Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan and the Ministry of Education, Science, Sports and Culture, Japan.	Ono H, 2008, HYPERTENS RES, V31, P271, DOI 10.1291/hypres.31.271; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Wada T, 2012, CLIN EXP NEPHROL, V16, P96, DOI 10.1007/s10157-011-0508-z; Ishizaka N, 2007, HYPERTENS RES, V30, P1035, DOI 10.1291/hypres.30.1035; Zanchetti A, 1998, J HYPERTENS, V16, P949, DOI 10.1097/00004872-199816070-00008; Nakano T, 2010, AM J KIDNEY DIS, V55, P21, DOI 10.1053/j.ajkd.2009.06.034; Vaccaro O, 1998, INT J EPIDEMIOL, V27, P636, DOI 10.1093/ije/27.4.636; Polak JF, 1998, RADIOLOGY, V208, P649; Wagenknecht LE, 1998, DIABETES CARE, V21, P1812, DOI 10.2337/diacare.21.11.1812; Wagenknecht LE, 2003, ARTERIOSCL THROM VAS, V23, P1035, DOI 10.1161/01.ATV.0000072273.67342.6D; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Hirano M, 2010, ATHEROSCLEROSIS, V211, P451, DOI 10.1016/j.atherosclerosis.2010.03.003; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Bouchi R, 2010, HYPERTENS RES, V33, P1298, DOI 10.1038/hr.2010.170; Khaw KT, 2001, BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Zhang LX, 2007, AM J KIDNEY DIS, V49, P786, DOI 10.1053/j.ajkd.2007.03.011; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Mitsuhashi N, 2002, DIABETES CARE, V25, P1308, DOI 10.2337/diacare.25.8.1308; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; Taniwaki H, 1998, DIABETES CARE, V21, P1848, DOI 10.2337/diacare.21.11.1848; Wada T, 2014, CLIN EXP NEPHROL, V18, P613, DOI 10.1007/s10157-013-0879-4; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; OLEARY DH, 1992, STROKE, V23, P1752; HANDA N, 1995, STROKE, V26, P1781; Silvestrini M, 2010, ATHEROSCLEROSIS, V210, P452, DOI 10.1016/j.atherosclerosis.2009.12.033; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Yokoyama H, 2006, STROKE, V37, P2420, DOI 10.1161/01.STR.0000236632.58323.cd; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Mykkanen L, 1997, STROKE, V28, P1710; Selvin E, 2004, ANN INTERN MED, V141, P421; WOFFORD JL, 1991, ARTERIOSCLER THROMB, V11, P1786; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Kume S, 2010, NEUROSURG REV, V33, P419, DOI 10.1007/s10143-010-0270-9; Nakanishi S, 2005, DIABETOLOGIA, V48, P230, DOI 10.1007/s00125-004-1643-9; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kawamoto R, 2008, INTERNAL MED, V47, P391, DOI 10.2169/internalmedicine.47.0552; YAMASAKI Y, 1994, DIABETES, V43, P634, DOI 10.2337/diabetes.43.5.634; Atsunori K, 2012, J DIABETES INVEST, V3, P39; Ishizakaa Y, 2008, KIDNEY BLOOD PRESS R, V31, P164, DOI 10.1159/000131750; Nakade Y, 2014, CLIN EXP NEPHROL, V18, P763, DOI 10.1007/s10157-013-0920-7; Temelkova-Kurktschiev TS, 1999, DIABETES CARE, V22, P333, DOI 10.2337/diacare.22.2.333; Terminology and Diagnostic Criteria Committee, 2009, JPN J MED ULTRASON, V36, P501; Toyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071810	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					909	917		10.1007/s10157-015-1088-0		9	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700019		
J	Hoshino, Y; Kaga, T; Abe, Y; Endo, M; Wakai, S; Tsuchiya, K; Nitta, K				Hoshino, Yoshie; Kaga, Toshie; Abe, Yasutomo; Endo, Mariko; Wakai, Sachiko; Tsuchiya, Ken; Nitta, Kosaku			Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Hematuria without overt proteinuria; Renal biopsy; IgA nephropathy	ISOLATED MICROSCOPIC HEMATURIA; TERM-FOLLOW-UP; NATURAL-HISTORY; IGA NEPHROPATHY; AND/OR PROTEINURIA; PROGNOSIS; ADULTS; DISEASE	Whether to perform a renal biopsy for isolated hematuria remains a matter of controversy. We performed renal biopsy in hematuria without overt proteinuria patients and reported the proportion of glomerulonephritis, pathological activities, and statistical analysis of indicators associated with glomerulonephritis. Among 203 patients who underwent renal biopsy in Okubo Hospital, Japan, between January 2008 and October 2013, we identified 56 patients who fulfilled the criteria: (1) urine dipstick examination shows equal to or greater than +/- blood on three or more visits, (2) proteinuria < 0.3 g/day (g/g Cr), (3) eGFR a parts per thousand 60 ml/min/1.73 m(2), and (4) no current medication for renal disease. We investigated biopsy findings and compared the clinical indicators in the IgA nephropathy (IgAN) and non-IgAN group. The pathological diagnosis was IgAN in 35 cases (62 %), thin basement membrane disease (TBMD) in 7 (13 %), minor glomerular abnormality (MGA) in 6 (11 %), glomerular basement membrane (GBM) abnormality in 5 (9 %), and others in 3 (5 %). The histological grade of IgAN was I in 90 % and II in 10; 31 % of patients had some crescentic lesions. Comparisons between the IgAN and non-IgAN group revealed significant differences in age of onset (26 +/- A 13 vs. 34 +/- A 17 years, p = 0.04), serum IgA (340 +/- A 114 vs. 220 +/- A 101 mg/dl, p < 0.01), proteinuria (0.08 [0-0.25] vs. 0 [0-0.23] g/day [g/gCr], p < 0.01), and the presence of poikilocytes (40 vs. 10 %, p = 0.02). The proportion of IgAN in hematuria without overt proteinuria was high and the pathological activities were variable. Patients with hematuria without overt proteinuria should continue their medical follow-up and the best timing of biopsy may be controversial for these patients who have multiple risk factors of IgAN.	[Hoshino, Yoshie; Tsuchiya, Ken; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan; [Kaga, Toshie; Abe, Yasutomo; Endo, Mariko; Wakai, Sachiko] Tokyo Metropolitan Hlth & Med Treatment Corp, Okubo Hosp, Dept Nephrol, Tokyo, Japan	Hoshino, Y (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yhoshino@kc.twmu.ac.jp					SCHENA FP, 1990, AM J MED, V89, P209; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; TIEBOSCH ATMG, 1989, NEW ENGL J MED, V320, P14, DOI 10.1056/NEJM198901053200103; McGregor DO, 1998, CLIN NEPHROL, V49, P345; Tomson C, 2002, BJU INT, V90, P185, DOI 10.1046/j.1464-410X.2002.02841.x; Chow KM, 2004, QJM-INT J MED, V97, P739, DOI 10.1093/qjmed/hch125; Yamagata K, 2002, NEPHRON, V91, P34, DOI 10.1159/000057602; Ieiri N, 2012, CLIN EXP NEPHROL, V16, P122, DOI 10.1007/s10157-011-0530-1; Shen P, 2007, INT J CLIN PRACT, V61, P789, DOI 10.1111/j.1742-1241.2006.01159.x; Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Maeda A, 2003, J CLIN LAB ANAL, V17, P73, DOI 10.1002/jcla.10071; TOPHAM PS, 1994, Q J MED, V87, P329; Yamagata K, 1996, CLIN NEPHROL, V45, P281; Nieuwhof C, 1996, KIDNEY INT, V49, P222, DOI 10.1038/ki.1996.30; KOHLER H, 1991, KIDNEY INT, V40, P115, DOI 10.1038/ki.1991.188; Fuiano G, 2000, AM J KIDNEY DIS, V35, P448, DOI 10.1016/S0272-6386(00)70197-1; Feng CY, 2013, WORLD J PEDIATR, V9, P163, DOI 10.1007/s12519-013-0415-3; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Churg J, 1995, WHO MONOGRAPH RENAL; Hirakata Hideki, 2005, Nihon Jinzo Gakkai Shi, V47, P73; Imai E, 2012, NIHON JINZO GAKKAI S, V54, P1031; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Lee H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-94; Matsuo S, 2011, NIHON JINZO GAKKAI S, V53, P123; Miura Hideto, 2003, Rinsho Byori, V51, P740; Tomino Yasuhiko, 2003, Clin Exp Nephrol, V7, P93, DOI 10.1007/s10157-003-0232-4; Topham PS, 2004, FAM PRACT, V21, P18, DOI 10.1093/fampra/cmh105	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					918	924		10.1007/s10157-015-1090-6		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700020		
J	Hayashi, M; Uchida, S; Kawamura, T; Kuwahara, M; Nangaku, M; Iino, Y				Hayashi, Matsuhiko; Uchida, Shunya; Kawamura, Tetsuya; Kuwahara, Michio; Nangaku, Masaomi; Iino, Yasuhiko		The PROTECT-CKD Study Group	Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Chronic kidney disease; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; Calcium channel blocker; Diuretics	RENAL OUTCOMES; RISK; MULTICENTER; AMLODIPINE; DIURETICS; TRIAL	We conducted a randomized, open-label trial to determine which of the antihypertensive drugs was most beneficial for CKD patients with hypertension in spite of treatment with an angiotensin receptor blocker (ARB). Patients 20-75 years of age who had CKD according to the definition in the K/DOQI Guidelines and hypertension (systolic blood pressure a parts per thousand yen130 mmHg and/or diastolic blood pressure a parts per thousand yen80 mmHg) with the usual dose of an ARB were randomly assigned to receive losartan 50 mg plus 5 mg of the calcium channel blocker amlodipine (CCB group, n = 37), 5 mg of the angiotensin-converting enzyme inhibitor enalapril (ACEI group, n = 36), or 12.5 mg of the thiazide diuretic hydrochlorothiazide (HCTZ group, n = 36). The primary endpoints were changes in blood pressure (BP), ratio of urinary excretion of protein to creatinine (UPCR), tolerability, and eGFR during the 12-month treatment period compared with control period. There were no significant differences in BP and tolerability between the three groups. The percentage changes in UPCR at 12 months after start of the combination therapy were significantly different in the HCTZ group (-26.3 +/- A 11.1 %, mean +/- A SE) and CCB group (+46.7 +/- A 33.6 %, p < 0.05), while eGFR was significantly lower in the HCTZ group than in the ACEI group or CCB group at 4 months but not at 12 months. Addition of diuretics, CCB, or ACEI to ARB was equally effective for the control of hypertension in CKD, while, in terms of urinary excretion of protein, diuretics may be better than CCB.	[Hayashi, Matsuhiko] Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Uchida, Shunya] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Kawamura, Tetsuya] Jikei Univ, Sch Med, Tokyo, Japan; [Kuwahara, Michio] Shuwa Gen Hosp, Kasukabe, Japan; [Nangaku, Masaomi] Univ Tokyo, Sch Med, Tokyo 113, Japan; [Iino, Yasuhiko] Nippon Med Sch, Tokyo 113, Japan	Hayashi, M (reprint author), Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	matuhiko@z3.keio.jp			Kidney Foundation, Japan	The results presented in this paper have not been published previously in whole or part, but parts of this manuscript were presented in abstract form at Kidney Week 2013 of the American Society of Nephrology, Atlanta. This work was funded by a research grant from The Kidney Foundation, Japan.	Bakris GL, 2008, KIDNEY INT, V73, P1303, DOI 10.1038/ki.2008.102; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Iino Y, 2004, HYPERTENS RES, V27, P21, DOI 10.1291/hypres.27.21; Strippoli GFM, 2004, BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Shimosawa T, 2007, HYPERTENS RES, V30, P831, DOI 10.1291/hypres.30.831; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Matsui Y, 2011, AM J HYPERTENS, V24, P466, DOI 10.1038/ajh.2010.240; Sato N, 2013, J HYPERTENS, V31, P1245, DOI 10.1097/HJH.0b013e32835fdf60; Ernst ME, 2009, NEW ENGL J MED, V361, P2153, DOI 10.1056/NEJMra0907219; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Khosla N, 2006, CLIN J AM SOC NEPHRO, V1, P22; National Kidney Foundation, 2002, AM J KIDNEY DIS S1, V39, pS1	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					925	932		10.1007/s10157-015-1091-5		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700021		
J	Hattori, M; Sako, M; Kaneko, T; Ashida, A; Matsunaga, A; Igarashi, T; Itami, N; Ohta, T; Gotoh, Y; Satomura, K; Honda, M; Igarashi, T				Hattori, Motoshi; Sako, Mayumi; Kaneko, Tetsuji; Ashida, Akira; Matsunaga, Akira; Igarashi, Tohru; Itami, Noritomo; Ohta, Toshiyuki; Gotoh, Yoshimitsu; Satomura, Kenichi; Honda, Masataka; Igarashi, Takashi			End-stage renal disease in Japanese children: a nationwide survey during 2006-2011	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						End-stage renal disease; Children; Epidemiology; Renal replacement therapy; Japan	CHRONIC KIDNEY-DISEASE; REPLACEMENT THERAPY; REGISTRY; DIALYSIS; TRANSPLANTATION; SURVIVAL; OUTCOMES; QUALITY; SOCIETY; EUROPE	End-stage renal disease (ESRD) in children is considered a rare, but serious condition. Epidemiological and demographic information on pediatric ESRD patients around the world is important to better understand this disease and to improve patient care. The Japanese Society for Pediatric Nephrology (JSPN) reported epidemiological and demographic data in 1998. Since then, however, there has been no nationwide survey on Japanese children with ESRD. The JSPN conducted a cross-sectional nationwide survey in 2012 to update information on the incidence, primary renal disease, initial treatment modalities, and survival in pediatric Japanese patients with ESRD aged less than 20 years during the period 2006-2011. The average incidence of ESRD was 4.0 per million age-related population. Congenital anomalies of the kidney and urinary tract were the most common cause of ESRD, present in 39.8 % of these patients. In addition, 12.2 % had focal segmental glomerulosclerosis and 5.9 % had glomerulonephritis. Initial treatment modalities in patients who commenced renal replacement therapy (RRT) consisted of peritoneal dialysis, hemodialysis, and pre-emptive transplantation (Tx) in 61.7, 16.0, and 22.3 %, respectively. The Japanese RRT mortality rate was 18.2 deaths per 1000 person-years of observation. The incidence of ESRD is lower in Japanese children than in children of other high-income countries. Since 1998, notably, there has been a marked increase in pre-emptive Tx as an initial treatment modality for Japanese children with ESRD.	[Hattori, Motoshi] Tokyo Womens Med Univ, Sch Med, Dept Pediat Nephrol, Shinjuku Ku, Tokyo 1628666, Japan; [Sako, Mayumi] Natl Ctr Child Hlth & Dev, Ctr Social & Clin Res, Dept Dev Strategy, Div Clin Trials, Tokyo, Japan; [Kaneko, Tetsuji] Tokyo Metropolitan Childrens Med Ctr, Div Clin Res Support Ctr, Tokyo, Japan; [Ashida, Akira] Osaka Med Coll, Dept Pediat, Osaka, Japan; [Matsunaga, Akira] Matsunaga Kids Clin, Yamagata, Japan; [Igarashi, Tohru] Nippon Med Univ, Dept Pediat, Tokyo, Japan; [Itami, Noritomo] Nikko Mem Hosp, Kidney Ctr, Sapporo, Hokkaido, Japan; [Ohta, Toshiyuki] Hiroshima Prefectural Hosp, Dept Pediat Nephrol, Hiroshima, Japan; [Gotoh, Yoshimitsu] Nagoya Daini Red Cross Hosp, Dept Pediat, Aichi, Japan; [Satomura, Kenichi] Osaka Med Ctr, Dept Pediat Nephrol & Metab, Osaka, Japan; [Satomura, Kenichi] Res Inst Maternal & Child Hlth, Osaka, Japan; [Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan; [Igarashi, Takashi] Natl Ctr Child Hlth & Dev, Tokyo, Japan	Hattori, M (reprint author), Tokyo Womens Med Univ, Sch Med, Dept Pediat Nephrol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	hattori@kc.twmu.ac.jp			Japanese Society for Pediatric Nephrology (JSPN)	The JSPN ESRD Survey is funded by the Japanese Society for Pediatric Nephrology (JSPN). The authors thank all patients, families, physicians, and institutes who contributed to the JSPN ESRD Survey. The authors also thank Drs. Yuko Akioka, Kenji Ishikura, and Yuko Hamazaki for being members of the JSPN ESRD Survey Committee, and Drs. Shuich Ito, Osamu Uemura, Yoshihiko Ueda, Satoshi Sasaki, Ken Hatae, Hiroshi Hataya, Misako Hiramatsu, Mikiya Fujieda, and Hiroshi Yoshimura and the members of the JSPN, the Japanese Society for Dialysis Therapy (JSDT), and the Japanese Society for Clinical Renal Transplantation (JSCRT) for their contributions to data collection. The authors also thank Prof. Yasuo Ohashi, Mr. Masayuki Kurihara, and Ms. Chie Matsuda of the Japan Clinical Research Support Unit (Tokyo) for their help with data management.	van der Heijden BJ, 2004, PEDIATR NEPHROL, V19, P213, DOI 10.1007/s00467-003-1376-x; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; Yamada A, 2014, PEDIATR TRANSPLANT, V18, P453, DOI 10.1111/petr.12299; Orr NIT, 2009, PEDIATR NEPHROL, V24, P1719, DOI 10.1007/s00467-009-1181-2; van Stralen KJ, 2014, KIDNEY INT, V86, P168, DOI 10.1038/ki.2013.561; Tizard EJ, 2009, NEPHROL DIAL TRANSPL, V24, P2615, DOI 10.1093/ndt/gfp275; Schoenmaker NJ, 2013, NEPHROL DIAL TRANSPL, V28, P3052, DOI 10.1093/ndt/gft303; Andreoli SP, 2005, J AM SOC NEPHROL, V16, P2263, DOI 10.1681/ASN.2005020186; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Hattori S, 2002, PEDIATR NEPHROL, V17, P456; Warady BA, 2007, PEDIATR NEPHROL, V22, P1999, DOI 10.1007/s00467-006-0410-1; van Stralen KJ, 2010, PEDIATR NEPHROL, V25, P1379, DOI 10.1007/s00467-010-1472-7; Mitsnefes MM, 2013, JAMA-J AM MED ASSOC, V309, P1921, DOI 10.1001/jama.2013.4208; Bock ME, 2010, PEDIATR TRANSPLANT, V14, P561, DOI 10.1111/j.1399-3046.2010.01347.x; Borzych D, 2012, KIDNEY INT, V78, P1295; Schaefer F, 2012, PERITON DIALYSIS INT, V32, P399, DOI 10.3747/pdi.2012.00126; United States Renal Data System (USRDS), ANN DAT REP ATL CHRO	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					933	938		10.1007/s10157-014-1077-8		6	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700022		
J	Nagatoya, K; Nishimoto, K; Shibahara, N; Takahashi, T; Kanehara, H; Ueno, N; Yasuda, H; Okada, S; Ueda, H; Hirai, K; Inoue, T				Nagatoya, Katsuyuki; Nishimoto, Kazuhiko; Shibahara, Nobuhisa; Takahashi, Toshikazu; Kanehara, Hironori; Ueno, Nobuyuki; Yasuda, Hideaki; Okada, Shigeki; Ueda, Haruhiko; Hirai, Kei; Inoue, Toru		Hokusetsu Renal Osteodystrophy Stu	Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Postmenopausal woman; End-stage renal failure; Raloxifene; Bone metabolism; Vitamin D	CLINICAL-PRACTICE GUIDELINE; DIALYSIS PATIENTS; MINERAL DENSITY; MAINTENANCE HEMODIALYSIS; RENAL OSTEODYSTROPHY; BIOCHEMICAL MARKERS; HIP FRACTURE; RISK-FACTORS; OSTEOPOROSIS; PHOSPHATASE	Postmenopausal women with end-stage renal failure are at an increased risk of fracture because of the effects of secondary hyperparathyroidism and postmenopausal osteoporosis. In the present study, we investigated the feasibility of using raloxifene to prevent fractures in postmenopausal women with end-stage renal failure on hemodialysis. This study was conducted using a multicenter, single-arm, prospective design. Raloxifene was administered to postmenopausal women aged a parts per thousand yen50 years who were on maintenance hemodialysis and met any of the following criteria after a 24-week run-in period: an alkaline phosphatase level (bone formation marker) of a parts per thousand yen6.18 A mu kat/L (a parts per thousand yen370 U/L), a bone-specific alkaline phosphatase (BAP; bone formation marker) level of a parts per thousand yen0.59 A mu kat/L (a parts per thousand yen35.4 U/L), or a bone-derived tartrate-resistant acid phosphatase (TRACP-5b; bone resorption marker) level of a parts per thousand yen4.2 U/L. A total of 48 individuals were eligible for study inclusion. Of them, 30 individuals participated in this study. The BAP levels were significantly decreased at week 4, but returned to the baseline levels at week 24. Similarly, the TRACP-5b levels were significantly decreased at week 4, but returned to the baseline levels at week 24. The serum calcium value decreased consistently after the start of raloxifene therapy. The intact parathyroid hormone (iPTH) levels were likely increased at week 4. The ratio of BAP to iPTH levels and the ratio of TRACP-5b to iPTH levels both showed significant decreases over time. During the raloxifene therapy, no thrombosis or other drug-related adverse events developed. The study results indicated that raloxifene can transiently reduce the levels of bone metabolism markers and might be useful for preventing fractures in postmenopausal women with end-stage renal failure, although raloxifene use over the long term may not have adequate efficacy in the absence of appropriate concomitant active vitamin D therapy.	[Nagatoya, Katsuyuki] Osaka Med Coll Hosp, Blood Purificat Ctr, Takatsuki, Osaka, Japan; [Nagatoya, Katsuyuki] Osaka Rosai Hosp, Dept Lab Med, Sakai, Osaka 5918025, Japan; [Nishimoto, Kazuhiko] Nishimoto Clin, Hirakata, Osaka, Japan; [Shibahara, Nobuhisa] Arisawa Gen Hosp, Hirakata, Osaka, Japan; [Takahashi, Toshikazu] Takatsuki Gen Hosp, Dept Nephrol, Takatsuki, Osaka, Japan; [Kanehara, Hironori] Kanehara Clin, Takatsuki, Osaka, Japan; [Ueno, Nobuyuki] Sanko Clin, Ibaraki, Japan; [Yasuda, Hideaki] Sanko Fuzoku Clin, Takatsuki, Osaka, Japan; [Okada, Shigeki] Okada Clin, Osaka, Japan; [Ueda, Haruhiko] Kamo Hosp, Kyoto, Japan; [Hirai, Kei] Sanko Clin, Takatsuki, Osaka, Japan; [Inoue, Toru] Gen Hosp Higashikouri, Dept Internal Med, Hirakata, Osaka, Japan	Nagatoya, K (reprint author), Osaka Rosai Hosp, Dept Lab Med, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	katsuyuki@orh.go.jp			Chugai Pharmaceutical Co., Ltd.	Katsuyuki Nagatoya and Toru Inoue report receiving Grant support from Chugai Pharmaceutical Co., Ltd.	PAYNE RB, 1973, BRIT MED J, V4, P643; Hamano T, 2009, BONE, V45, pS19, DOI 10.1016/j.bone.2009.03.663; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Hernandez E, 2003, KIDNEY INT, V63, P2269, DOI 10.1046/j.1523-1755.2003.00005.x; Saito O, 2011, CLIN EXP NEPHROL, V15, P126, DOI 10.1007/s10157-010-0366-0; Tanaka M, 2011, THER APHER DIAL, V15, P62, DOI 10.1111/j.1744-9987.2011.00929.x; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Chu PL, 2003, AM J KIDNEY DIS, V41, P1052, DOI 10.1016/S0272-6386(03)00203-8; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Arneson TJ, 2013, AM J KIDNEY DIS, V62, P747, DOI 10.1053/j.ajkd.2013.02.368; Urena P, 2003, NEPHROL DIAL TRANSPL, V18, P2325, DOI 10.1093/ndt/gfg403; Eriguchi R, 2009, CLIN NEPHROL, V72, P423; Jadoul M, 2006, KIDNEY INT, V70, P1358, DOI 10.1038/sk.ki.5001754; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Fletcher S, 1997, NEPHRON, V75, P412; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, KIDNEY INT S, V113, pS1, DOI DOI 10.1038/KI.2009.188; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					939	946		10.1007/s10157-014-1065-z		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700023		
J	Tsutsui, H; Ohkubo, T; Tsuruta, Y; Kato, S; Yasuda, Y; Oshida, Y				Tsutsui, Hideyo; Ohkubo, Takayoshi; Tsuruta, Yoshinari; Kato, Sawako; Yasuda, Yoshinari; Oshida, Yoshiharu			Development and validation of a short-version checklist for patients undergoing hemodialysis based on the International Classification of Functioning, Disability and Health	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Short-version checklist; Hemodialysis; International Classification of Functioning, Disability and Health; Validity evaluation	QUALITY-OF-LIFE; KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS; DIALYSIS POPULATION; ASSOCIATION; AMYLOIDOSIS; INSTRUMENT; SECONDARY; SYMPTOMS; THERAPY	In 2009, we developed a "100-category checklist" for patients undergoing hemodialysis (HD) based on the International Classification of Functioning, Disability and Health, and we confirmed its validity. However, we found that for patients' daily assessment, 100 categories were too many. The purpose of the present study was to develop and validate a short version of the "100-category checklist." A total of 100 outpatients undergoing HD were recruited. They were interviewed using the "100-category checklist" and asked whether they had experienced problems after starting HD. From the "100-category checklist," we extracted categories that had greater than a 50 % rate of "yes" responses. Content validity was evaluated using the frequency of patients who had a problem in each category. Criterion validity was evaluated based on the correlation of the score from the "short-version checklist" categories with that from the Kidney Disease Quality of Life (KDQOL (TM)) questionnaire. Construct validity was evaluated using Spearman correlation coefficients between the number of problem categories and the presence of HD-related complications. Cronbach's coefficient alpha was calculated to evaluate internal consistency. Twenty-two categories were identified as problem categories. Criterion validity showed that 12 categories were significantly correlated with subscales of the KDQOL (TM). Construct validity showed that the presence of complications contributed to an increased number of problems associated with HD. Cronbach's coefficient alpha of this checklist was 0.79. The "short-version checklist" had a certain degree of validity, suggesting its usefulness in a simplified assessment of patients undergoing HD.	[Tsutsui, Hideyo; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, Tokyo 1738605, Japan; [Tsutsui, Hideyo; Oshida, Yoshiharu] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tsuruta, Yoshinari] Meiyo Clin, Toyohashi, Aichi 4418023, Japan; [Kato, Sawako] Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku, Nagoya, Aichi 4660064, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept Chron Kidney Dis Initiat, Showa Ku, Nagoya, Aichi 4660064, Japan	Tsutsui, H (reprint author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	htsutsui@med.teikyo-u.ac.jp			Kidney Foundation, Japan [JKF10-5]; Kidney Foundation, Aichi, Japan	This study was supported by a Grant from the Kidney Foundation, Japan (JKF10-5) and by a Grant from the Kidney Foundation, Aichi, Japan. The authors would like to thank M. Ogi, Y. Nagata, K. Kita, M. Natsume, F. Ito, and S. Ozaki; head nurse at Meiyo Clinic, for their support with respect to the interviews.	Chan R, 2012, QUAL LIFE RES, V21, P563, DOI 10.1007/s11136-011-9973-9; Farag YMK, 2011, CLIN NEPHROL, V75, P524, DOI 10.5414/CNP75524; Malindretos P, 2012, CLIN NEPHROL, V77, P196, DOI 10.5414/CN107030; [Anonymous], 2004, J REHABIL MED S; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Green J, 2001, QUAL LIFE RES, V10, P93, DOI 10.1023/A:1016630825992; Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; Carmichael P, 2000, QUAL LIFE RES, V9, P195, DOI 10.1023/A:1008933621829; Cofan F, 2002, RHEUMATOLOGY, V41, P701, DOI 10.1093/rheumatology/41.6.701-a; Gejyo F, 2003, NEPHROLOGY, V8, pS45, DOI 10.1046/j.1440-1797.8.s.10.x; Tsutsui H, 2009, THER APHER DIAL, V13, P186, DOI 10.1111/j.1744-9987.2009.00683.x; Wu YY, 2014, J INT MED RES, V42, P718, DOI 10.1177/0300060513509037; Chertow GM, 2012, HEMODIAL INT, V16, P188, DOI 10.1111/j.1542-4758.2011.00642.x; Kim JY, 2013, QUAL LIFE RES, V22, P753, DOI 10.1007/s11136-012-0203-x; BOSANAC PR, 1977, T AM SOC ART INT ORG, V23, P162; Otsubo S, 2009, NEPHROL DIAL TRANSPL, V24, P1593, DOI 10.1093/ndt/gfn706; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Moreira AC, 2013, NUTR HOSP, V28, P951, DOI 10.3305/nh.2013.28.3.6454; Cavalcante Milady Cutrim Vieira, 2013, J Bras Nefrol, V35, P79, DOI 10.5935/0101-2800.20130014; Tamura MK, 2012, NEUROLOGY, V79, P981, DOI 10.1212/WNL.0b013e31826845e9; Nakai S, 2014, NIHON TOSEKI IGAKKAI, V47, P1; Peter MF, 2009, QUALITY LIFE ASSESSM; Stucki A, 2004, J REHABIL MED S, V44, P107; Suwabe T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-179; Tsutsui H, 2014, THER APHER DIAL, V18, P473, DOI 10.1111/1744-9987.12163	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					953	960		10.1007/s10157-014-1075-x		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700025		
J	Yamahatsu, A; Hamada, C; Kaneko, K; Io, H; Nakata, J; Tomino, Y				Yamahatsu, Aya; Hamada, Chieko; Kaneko, Kayo; Io, Hiroaki; Nakata, Junichiro; Tomino, Yasuhiko			Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Encapsulating peritoneal sclerosis; Peritoneal dialysis; Long-term outcome; Enterolysis; Laparoscopy	DIALYSIS; DIAGNOSIS; MANAGEMENT; JAPAN	Encapsulating peritoneal sclerosis (EPS) is the most serious complication of peritoneal dialysis (PD) with a high mortality rate. The objective of the present study was to determine the clinical characteristics, the incidence rate, and the long-term outcome of EPS patients compared with control patients. Two hundred and seventy patients with end-stage kidney disease were started on PD from 1987 to 2013 in the Juntendo University Hospital. EPS was diagnosed by clinical findings, radiological findings, and macroscopic inspection at the time of laparoscopy or surgical operation. Patient medical records were analyzed retrospectively, including clinical characteristics, laboratory findings, treatment modality, and outcomes. Using a Kaplan-Meier analysis, we compared the survival rate between EPS patients and control PD patients, matched for age, gender, diabetes, and duration of PD. Among 270 PD patients, 13 patients (4.8 %) developed EPS. The mean duration of PD was 120.5 +/- A 42.8 months. There were no significant difference in demographic findings between EPS and control PD patients. Among the EPS patients, seven patients died, of which four deaths were directly attributed to EPS. All four patients that had had surgical enterolysis were doing well and had no recurrences. No significant difference in the survival rate between EPS and control PD patients was observed in the Kaplan-Meier analysis. There was no significant difference in the survival rate between EPS patients and control PD patients. It appears that an early diagnosis by laparoscopy and accurate treatment, including surgical enterolysis, might improve mortality.	[Yamahatsu, Aya; Hamada, Chieko; Kaneko, Kayo; Io, Hiroaki; Nakata, Junichiro; Tomino, Yasuhiko] Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med,Bunkyo Ku, Tokyo 1138421, Japan	Tomino, Y (reprint author), Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med,Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yasu@juntendo.ac.jp					Kropp J, 2009, SEMIN DIALYSIS, V22, P304, DOI 10.1111/j.1525-139X.2008.00546.x; Brown MC, 2009, CLIN J AM SOC NEPHRO, V4, P1222, DOI 10.2215/CJN.01260209; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Tarzi RM, 2008, CLIN J AM SOC NEPHRO, V3, P1702, DOI 10.2215/CJN.01820408; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS39; Kawaguchi Y, 2005, PERITON DIALYSIS INT, V25, pS83; Brown EA, 2009, PERITON DIALYSIS INT, V29, P595; Nomoto Y, 1996, AM J KIDNEY DIS, V28, P420, DOI 10.1016/S0272-6386(96)90501-6; Trigka K, 2011, INT UROL NEPHROL, V43, P519, DOI 10.1007/s11255-010-9848-y; Habib AM, 2010, NEPHROL DIAL TRANSPL, V25, P1633, DOI 10.1093/ndt/gfp677; Lindic J, 2009, THER APHER DIAL, V13, P282, DOI 10.1111/j.1744-9987.2009.00725.x; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Cho Y, 2013, KIDNEY INT, V84, P969, DOI 10.1038/ki.2013.190; Summers AM, 2005, KIDNEY INT, V68, P2381, DOI 10.1111/j.1523-1755.2005.00701.x; Ulmer C, 2013, SURGERY, V153, P219, DOI 10.1016/j.surg.2012.07.033; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Bansal Saurabh, 2010, Adv Perit Dial, V26, P75; Kawanishi Hideki, 2008, Adv Perit Dial, V24, P51; Lo WK, 2009, PERITON DIAL INT S2, V29, P211; Nakayama M, 2014, PERITON DIALYSIS INT, V34, P766, DOI 10.3747/pdi.2013.00074; Sonikian M, 2014, CLIN NEPHROL, V81, P283, DOI 10.5414/CN107542; Spence Robert, 2013, Ulster Med J, V82, P11	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					961	967		10.1007/s10157-015-1081-7		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700026		
J	Kawano, H; Muto, S; Ohmoto, Y; Iwata, F; Fujiki, H; Mori, T; Yan, L; Horie, S				Kawano, Haruna; Muto, Satoru; Ohmoto, Yasukazu; Iwata, Fusako; Fujiki, Hiroyuki; Mori, Toyoki; Yan, Lu; Horie, Shigeo			Exploring urinary biomarkers in autosomal dominant polycystic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Autosomal dominant polycystic kidney disease; Urinary biomarker; DBA/2FG-pcy mouse	MONOCYTE CHEMOATTRACTANT PROTEIN-1; GELATINASE-ASSOCIATED LIPOCALIN; NEUTROPHIL GELATINASE; EPITHELIAL-CELLS; RENAL INJURY; ENCODES; GENE; NGAL	Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disease, is a progressive disease characterized by a bilateral proliferation and enlargement of renal cysts. Recent reports have shown that tolvaptan, a vasopressin V2 receptor antagonist, has been effective in inhibiting renal cyst proliferation and enlargement in ADPKD patients, although no biomarker has identified to predict the effects of tolvaptan. We explored the effective urinary biomarkers in ADPKD in human and in an animal model. We measured 28 biomarkers in urine taken from ADPKD patients to compare with that of healthy subjects. Next, a gene expression analysis of the kidney from DBA/2FG-pcy mice (ADPKD model animals) was performed to identify prospective biomarkers. Additionally, we investigated the DBA/2FG-pcy mouse urine samples to determine the biomarkers' efficacy. There were statistically significant differences in 12 of the 28 prospective urinary biomarkers between urine from ADPKD patients and that from healthy subjects. Six of these matched with highly expressed gene products of DBA/sFG-pcy mouse kidneys. Among those 6 biomarkers, NGAL, M-CSF, and MCP-1 showed significantly higher values in the urine of DBA/2FG-pcy mice than that of wild type. This study suggests that NGAL, M-CSF, MCP-1 are potential candidates of urinary biomarkers in ADPKD.	[Kawano, Haruna; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Kawano, Haruna; Muto, Satoru; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Adv Therapeut Polycyst Kidney Dis, Tokyo, Japan; [Muto, Satoru; Yan, Lu; Horie, Shigeo] Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan; [Ohmoto, Yasukazu; Iwata, Fusako; Fujiki, Hiroyuki; Mori, Toyoki] Otsuka Pharmaceut Co Ltd, Res Inst Pharmacol Therapeut Dev, Tokushima 77101, Japan	Horie, S (reprint author), Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan.	shorie@juntendo.ac.jp			Ministry of Health, Labour and Welfare of Japan [Ippan-042]; Japan Society for the Promotion of Science (JSPS) [24592439]	The authors thank Dr. Okada Keiko and Dr. Muraguchi Masahiro for their technical assistance in our experiments. This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan (Grant No. Ippan-042) and a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (JSPS) (24592439).	Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; LeMeur Y, 1996, KIDNEY INT, V50, P1007; Zheng D, 2003, J AM SOC NEPHROL, V14, P2588, DOI 10.1097/01.ASN.0000088720.61783.19; Grantham JJ, 2010, CLIN J AM SOC NEPHRO, V5, P889, DOI 10.2215/CJN.00550110; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; Le Meur Y, 2004, NEPHROL DIAL TRANSPL, V19, P1862, DOI 10.1093/ndt/fgh257; Nagao S, 2012, EXP ANIM TOKYO, V61, P477; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; TAKAHASHI H, 1991, J AM SOC NEPHROL, V1, P980; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Qamar S, 2007, BIOCHEM SOC T, V35, P124; Chirag RP, 2012, KIDNEY INT, V81, P784; Gianluca A, 2013, AM J NEPHROL, V37, P175; Schiffl H, 2012, MOL DIAGN THER, V16, P199, DOI 10.2165/11634310-000000000-00000; WARD CJ, 1994, CELL, V77, P881	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					968	973		10.1007/s10157-014-1078-7		6	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700027		
J	Isotani, S; Shimoyama, H; Yokota, I; Noma, Y; Kitamura, K; China, T; Saito, K; Hisasue, S; Ide, H; Muto, S; Yamaguchi, R; Ukimura, O; Gill, IS; Horie, S				Isotani, Shuji; Shimoyama, Hirofumi; Yokota, Isao; Noma, Yasuhiro; Kitamura, Kousuke; China, Toshiyuki; Saito, Keisuke; Hisasue, Shin-ichi; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo; Ukimura, Osamu; Gill, Inderbir S.; Horie, Shigeo			Novel prediction model of renal function after nephrectomy from automated renal volumetry with preoperative multidetector computed tomography (MDCT)	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Chronic kidney disease; Volumetry; Multidetector computed tomography; Nephrectomy; Prediction model; Renal cortex; Renal function	CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; CT ANGIOGRAMS; DONORS	The predictive model of postoperative renal function may impact on planning nephrectomy. To develop the novel predictive model using combination of clinical indices with computer volumetry to measure the preserved renal cortex volume (RCV) using multidetector computed tomography (MDCT), and to prospectively validate performance of the model. Total 60 patients undergoing radical nephrectomy from 2011 to 2013 participated, including a development cohort of 39 patients and an external validation cohort of 21 patients. RCV was calculated by voxel count using software (Vincent, FUJIFILM). Renal function before and after radical nephrectomy was assessed via the estimated glomerular filtration rate (eGFR). Factors affecting postoperative eGFR were examined by regression analysis to develop the novel model for predicting postoperative eGFR with a backward elimination method. The predictive model was externally validated and the performance of the model was compared with that of the previously reported models. The postoperative eGFR value was associated with age, preoperative eGFR, preserved renal parenchymal volume (RPV), preserved RCV, % of RPV alteration, and % of RCV alteration (p < 0.01). The significant correlated variables for %eGFR alteration were %RCV preservation (r = 0.58, p < 0.01) and %RPV preservation (r = 0.54, p < 0.01). We developed our regression model as follows: postoperative eGFR = 57.87 - 0.55(age) - 15.01(body surface area) + 0.30(preoperative eGFR) + 52.92(%RCV preservation). Strong correlation was seen between postoperative eGFR and the calculated estimation model (r = 0.83; p < 0.001). The external validation cohort (n = 21) showed our model outperformed previously reported models. Combining MDCT renal volumetry and clinical indices might yield an important tool for predicting postoperative renal function.	[Isotani, Shuji; Shimoyama, Hirofumi; Noma, Yasuhiro; Kitamura, Kousuke; Saito, Keisuke; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo] Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, Tokyo 173, Japan; [Yokota, Isao] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo, Japan; [China, Toshiyuki; Hisasue, Shin-ichi; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Ukimura, Osamu; Gill, Inderbir S.] Univ So Calif, Inst Urol, Los Angeles, CA USA	Isotani, S (reprint author), Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, Kaga 2-11-1, Tokyo 173, Japan.	sisotan@med.teikyo-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Kato F, 2011, EUR J RADIOL, V79, P15, DOI 10.1016/j.ejrad.2009.11.013; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Yano M, 2012, RADIOLOGY, V265, P151, DOI 10.1148/radiol.12112338; Kang SK, 2013, AM J ROENTGENOL, V200, P1204, DOI 10.2214/AJR.12.10276; Breau RH, 2013, CUAJ-CAN UROL ASSOC, V7, P189, DOI 10.5489/cuaj.1338; Tsushima Y, 2001, J UROLOGY, V165, P382, DOI 10.1097/00005392-200102000-00007; Mir MC, 2013, UROLOGY, V82, P263, DOI 10.1016/j.urology.2013.03.068; Jeon HG, 2010, J UROLOGY, V184, P1057, DOI 10.1016/j.juro.2010.04.079; van den Dool SW, 2005, RADIOLOGY, V236, P189, DOI 10.1148/radiol.2361021463; Funahashi Y, 2009, UROLOGY, V74, P708, DOI 10.1016/j.urology.2008.11.008; Fowler JC, 2006, BRIT J RADIOL, V79, P935, DOI 10.1259/bjr/53140218; Herts BR, 2009, RADIOLOGY, V252, P109, DOI 10.1148/radiol.2521081873; Beland MD, 2010, AM J ROENTGENOL, V195, pW146, DOI 10.2214/AJR.09.4104; Summerlin AL, 2008, AM J ROENTGENOL, V191, P1552, DOI 10.2214/AJR.07.4023; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; DAWSON P, 1993, INVEST RADIOL, V28, P1039, DOI 10.1097/00004424-199311000-00014; Muto NS, 2011, EUR J RADIOL, V78, P151, DOI 10.1016/j.ejrad.2009.10.005; Muto NS, 2013, ADV COMPUT TOMOGR, V2, P55; Yokoyama M, 2013, INT J UROL, V21, P238	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					974	981		10.1007/s10157-015-1082-6		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700028		
J	Takeda, K; Minota, S				Takeda, Koichi; Minota, Seiji			Gross hematuria caused by the nutcracker syndrome	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Editorial Material						Hematuria; Nutcracker syndrome			[Takeda, Koichi; Minota, Seiji] Jichi Med Univ, Div Rheumatol & Clin Immunol, Dept Med, Shimotsuke, Tochigi 3290498, Japan	Takeda, K (reprint author), Jichi Med Univ, Div Rheumatol & Clin Immunol, Dept Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	r0734kt@jichi.ac.jp					Gulleroglu Kaan, 2014, World J Nephrol, V3, P277, DOI 10.5527/wjn.v3.i4.277	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					982	983		10.1007/s10157-015-1112-4		2	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700029		
J	Imashuku, Y; Kojima, A; Takahashi, K; Kitagawa, H				Imashuku, Yasuhiko; Kojima, Akiko; Takahashi, Kan; Kitagawa, Hirotoshi			Washing out potassium absorption filters with normal saline after use	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Letter						Potassium absorption filter; Hyperkalemia; Renal dysfunctions	ADSORPTION FILTER		[Imashuku, Yasuhiko; Kojima, Akiko; Takahashi, Kan; Kitagawa, Hirotoshi] Shiga Univ Med Sci, Dept Anesthesiol, Otsu, Shiga 5202192, Japan	Imashuku, Y (reprint author), Shiga Univ Med Sci, Dept Anesthesiol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	imashuku@belle.shiga-med.ac.jp					Nakagawa M, 2004, CAN J ANAESTH, V51, P639; Yamada C, 2010, TRANSFUSION, V50, P1926, DOI 10.1111/j.1537-2995.2010.02742.x; Cid J, 2008, TRANSFUSION, V48, P1966, DOI 10.1111/j.1537-2995.2008.01776.x; Kohno Yumiko, 2006, Masui, V55, P1490	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					984	984		10.1007/s10157-015-1093-3		1	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700030		
J	Asaga, S; Kinoshita, T; Hojo, T; Jimbo, K; Yoshida, M				Asaga, Sota; Kinoshita, Takayuki; Hojo, Takashi; Jimbo, Kenjiro; Yoshida, Masayuki			Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients With Clinically Node-Negative Ipsilateral Multiple Breast Cancer Treated With Total Mastectomy	CLINICAL BREAST CANCER			English	Article						Multiple breast cancer; Non-sentinel node metastasis; Predictive factor; Sentinel node metastasis; Total mastectomy	NUCLEIC-ACID AMPLIFICATION; AXILLARY DISSECTION; BLUE-DYE; BIOPSY; WOMEN; TRIAL; IDENTIFICATION; INVOLVEMENT; INJECTION; NOMOGRAM	We investigated the predictive factors for non-sentinel lymph node (SN) metastasis in ipsilateral multiple breast cancer and compared them with solitary breast cancer. The significant and potential factors in multiple breast cancer were pathologic invasion size and the number of positive SNs. These 2 could differentiate patients with positive non-SNs from those with negative non-SNs with high sensitivity. Background: Recent clinical trials have shown that axillary lymph node dissection can be omitted even with positive sentinel nodes (SN) unless the patient undergoes total mastectomy without irradiation. The aim of our study was to identify predictive factors for non-SN metastasis among patients with solitary or multiple breast cancer treated with total mastectomy. Patients and Methods: Clinically node-negative breast cancer patients with pathologically node-positive disease treated with total mastectomy and axillary dissection after SN biopsy were retrospectively analyzed. Significant pathologic predictive factors for positive non-SN metastasis were also examined. Results: There were 47 multiple and 143 solitary breast cancer patients. Pathologic diagnosis demonstrated that smaller invasion size but larger tumor size, including adjacent noninvasive cancer, was observed in multiple breast cancer. The number of involved SNs and the rate of non-SN metastasis were similar between the multiple and solitary groups. Regarding predictive factors for non-SN metastasis, lymphatic invasion and SN macrometastasis were significant factors in the solitary group, and pathologic invasion size > 2 cm was the only significant factor in the multiple group. Conclusion: Larger pathologic invasion size was important for predicting non-SN metastasis in multiple breast cancer.	[Asaga, Sota; Kinoshita, Takayuki; Hojo, Takashi; Jimbo, Kenjiro] Natl Canc Ctr, Dept Breast Surg, Tokyo 1040045, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan	Asaga, S (reprint author), Natl Canc Ctr, Dept Breast Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	soasaga@ncc.go.jp					Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Zhu LL, 2013, BREAST CANCER RES TR, V137, P783, DOI 10.1007/s10549-012-2360-6; Borgstein PJ, 1997, LANCET, V349, P1668, DOI 10.1016/S0140-6736(05)62634-7; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Jinno H, 2008, BREAST J, V14, P551, DOI 10.1111/j.1524-4741.2008.00646.x; Barranger E, 2005, BREAST CANCER RES TR, V91, P113, DOI 10.1007/s10549-004-5781-z; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Bolster MJ, 2007, ANN SURG ONCOL, V14, P181, DOI 10.1245/s10434-006-9065-1; Klimberg VS, 1999, ANN SURG, V229, P860, DOI 10.1097/00000658-199906000-00013; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goyal A, 2004, EJSO, V30, P475, DOI 10.1016/j.ejso.2004.02.009; Linehan DC, 1999, ANN SURG ONCOL, V6, P450, DOI 10.1007/s10434-999-0450-4; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Weiser MR, 2001, ANN SURG ONCOL, V8, P145, DOI 10.1245/aso.2001.8.2.145; Jimbo K, 2013, BREAST, V22, P1194, DOI 10.1016/j.breast.2013.08.003; Hilton JF, 2013, BREAST CANCER RES TR, V142, P143, DOI 10.1007/s10549-013-2714-8; Veronesi U, 2006, LANCET ONCOL, V7, P983, DOI 10.1016/S1470-2045(06)70947-0; Donker M, 2013, EUR J CANCER, V49, P2093, DOI 10.1016/j.ejca.2013.02.017; Saiz IB, 2014, REV ESP MED NUCL IMA, V33, P199, DOI 10.1016/j.remn.2013.10.010; Duraker N, 2014, BREAST J, V20, P61, DOI 10.1111/tbj.12205; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6	25	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	OCT	2015	15	5					362	369		10.1016/j.clbc.2015.01.009		8	Oncology	Oncology	CT6PF	WOS:000362934200009		
J	Shiohara, T; Ushigome, Y; Kano, Y; Takahashi, R				Shiohara, Tetsuo; Ushigome, Yukiko; Kano, Yoko; Takahashi, Ryo			Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review	CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY			English	Review						Regulatory T cells; Herpesviruses; Resident memory T cells; Fixed drug eruption; Drug-induced hypersensitivity syndrome; Immune reconstitution syndrome; Graft-versus-host disease	INDUCED HYPERSENSITIVITY SYNDROME; REGULATORY T-CELLS; VERSUS-HOST-DISEASE; RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RECONSTITUTION; TCR REPERTOIRE; LOCAL ANTIGEN; RM CELLS; IN-VIVO; INFECTION	A growing number of cells, mediators, and pathways have been implicated in severe drug eruptions. Fifteen years ago, we published landmark studies that sparked the current advances in our understanding of the role of viral reactivations in severe drug eruptions. Viral reactivations then became critically important as diagnostic tools, but how precisely they participated in the pathogenesis remained less well-defined. The question of whether viral reactivations are pathogenic or are instead as epiphenomenon of severe tissue damage has plagued the field of drug allergy for some decades. Recent evidence points to a crucial role for tissue-resident memory T (TRM) cells in immune protection against viral infections. Yet immune protection against viral infections is but one side of a coin, the other side of which comprises effector cells capable of mediating severe immunopathology: Once drug antigen is cross-recognized by these T cells, they could be activated to kill surrounding epidermal cells, resulting in drug-induced tissue damage. Such TRM cells could persistently reside in the skin lesions of fixed drug eruptions (FDE) and are most likely a major cell type responsible for the development of FDE. We also discuss the role of regulatory T (Treg) cells in the setting of drug allergy, in which herpesviruses are reactivated in sequence. Although many details of the complicated interactions among viruses, anti-viral immune responses, TRM cells, and Treg cells remain to be elucidated, we review the current status of this rapidly advancing field.	[Shiohara, Tetsuo; Ushigome, Yukiko; Kano, Yoko] Kyorin Univ, Sch Med, Dept Dermatol, Mitaka, Tokyo 1818611, Japan; [Shiohara, Tetsuo; Takahashi, Ryo] Kyorin Univ, Sch Med, Div Flow Cytometry, Mitaka, Tokyo 1818611, Japan	Takahashi, R (reprint author), Kyorin Univ, Sch Med, Div Flow Cytometry, Mitaka, Tokyo 1818611, Japan.	ryo@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (to T.S.) and the Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan (to T.S.).	SIGALNAHUM M, 1988, BRIT J DERMATOL, V118, P849, DOI 10.1111/j.1365-2133.1988.tb02604.x; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; LEVY M, 1984, MED HYPOTHESES, V14, P293, DOI 10.1016/0306-9877(87)90131-9; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Komatsu T, 1996, CLIN EXP IMMUNOL, V104, P343, DOI 10.1046/j.1365-2249.1996.30738.x; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Kano Y, 2006, BRIT J DERMATOL, V155, P301, DOI 10.1111/j.1365-2133.2006.07238.x; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Mizukawa Y, 2002, DERMATOLOGY, V205, P159, DOI 10.1159/000063892; Hirahara K, 2010, CLIN EXP DERMATOL, V35, P863, DOI 10.1111/j.1365-2230.2010.03820.x; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Arend SM, 2007, CLIN INFECT DIS, V45, P1470, DOI 10.1086/522993; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Mizukawa Y, 2002, AM J PATHOL, V161, P1337, DOI 10.1016/S0002-9440(10)64410-0; Legrand F, 2008, CLIN INFECT DIS, V46, P696, DOI 10.1086/527390; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Yu XL, 2008, J IMMUNOL, V181, P7356; Shiohara T, 2007, BRIT J DERMATOL, V156, P1083, DOI 10.1111/j.1365-2133.2007.07807.x; Shiohara T, 2007, CLIN REV ALLERG IMMU, V33, P124, DOI 10.1007/s12016-007-8010-9; Tohyama M, 2007, BRIT J DERMATOL, V157, P934, DOI 10.1111/j.1365-2133.2007.08167.x; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; Miceli MH, 2007, CANCER, V110, P112, DOI 10.1002/cncr.22738; Mizukawa Y, 2008, BRIT J DERMATOL, V158, P1230, DOI 10.1111/j.1365-2133.2008.08516.x; Belknap R, 2005, INT J TUBERC LUNG D, V9, P1057; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Aota N, 2009, DERMATOLOGY, V218, P275, DOI 10.1159/000187619; Senturk N, 2002, J EUR ACAD DERMATOL, V16, P414, DOI 10.1046/j.1468-3083.2002.00570_3.x; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; PULLEN H, 1967, LANCET, V2, P1176; Suzuki Y, 1998, ARCH DERMATOL, V134, P1108, DOI 10.1001/archderm.134.9.1108; Smith KJ, 1997, CLIN EXP DERMATOL, V22, P118, DOI 10.1046/j.1365-2230.1997.2130642.x; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Shiohara Tetsuo, 2010, Allergology International, V59, P333, DOI 10.2332/allergolint.10-RAI-0260; Ushigome Y, 2013, J AM ACAD DERMATOL, V68, P721, DOI 10.1016/j.jaad.2012.10.017; Aota N, 2009, AUTOIMMUN REV, V8, P488, DOI 10.1016/j.autrev.2009.02.029; Shiohara T, 2009, CURR OPIN ALLERGY CL, V9, P316, DOI 10.1097/ACI.0b013e32832cda4c; AGUT H, 1993, NEW ENGL J MED, V329, P203, DOI 10.1056/NEJM199307153290311; Kano Y, 2007, BRIT J DERMATOL, V156, P1061, DOI 10.1111/j.1365-2133.2007.07784.x; Shiohara T, 2012, CHEM IMMUNOL ALLERGY, V97, P106, DOI 10.1159/000335623; Asano Y, 2009, ARCH DERMATOL, V145, P1030, DOI 10.1001/archdermatol.2009.195; Garcia VC, 2005, CLIN INFECT DIS, V40, P756; Ishida T, 2014, ALLERGY IN PRESS; Koehn B, 2006, J IMMUNOL, V176; Kubota Y, 2005, JPN J DERMATOL, V116, P927; Marais Suzaan, 2009, Curr HIV/AIDS Rep, V6, P162, DOI 10.1007/s11904-009-0022-z; Picard DJB, 2010, SCI TRANSL MED, V2, DOI DOI 10.1126/SCITRANSLMED.3001116; Shiohara Tetsuo, 2007, P251, DOI 10.1159/000104205; Shiohara T, 2012, EXPERT REV DERMATOL, V7, P539; Tohyama H, 1998, ARCH DERMATOL, V134, P1113	57	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1080-0549	1559-0267		CLIN REV ALLERG IMMU	Clin. Rev. Allergy Immunol.	OCT	2015	49	2					192	202		10.1007/s12016-014-8421-3		11	Allergy; Immunology	Allergy; Immunology	CT6DS	WOS:000362902500006		
J	Suganuma, K				Suganuma, Keiko			Improvement of the standard method for assessing colour fastness to wet rubbing	COLORATION TECHNOLOGY			English	Article								Colour fastness to rubbing is evaluated by the degree of staining of a standard adjacent cotton cloth. However, some kinds of dye usually stain other textiles to a greater extent than cotton under wet conditions. In this work, rubbing fastness tests were carried out with various kinds of adjacent cloth in order to examine the factors affecting the wet rubbing fastness, and a more practical evaluation method using adjacent rubbing cloth was proposed. Dye transfer from the dyed fabric to the adjacent cloth depended on the affinity of the dyes for the fibre material of the dyed fabric and the adjacent cloth under wet conditions, in addition to the friction coefficient between the fabrics. A standard adjacent cloth should have a high staining property. The nylon staple cloth is preferred for fabrics dyed with vat, disperse, and acid dyes because it receives the most dye from rubbing with them.	Shohoku Coll, Sony Inst Higher Educ, Dept Creat Lifestyle Management, Atsugi, Kanagawa, Japan	Suganuma, K (reprint author), Shohoku Coll, Sony Inst Higher Educ, Dept Creat Lifestyle Management, Nurumizu 428, Atsugi, Kanagawa, Japan.	suganuma@shohoku.ac.jp					[Anonymous], 2009, 105F022009 ISO; [Anonymous], 2009, 105F092009 ISO; [Anonymous], 2001, 105F072001 ISO; [Anonymous], 2001, 105F052001 ISO; [Anonymous], 2001, 105F032001 ISO; [Anonymous], 2001, 105F012001 ISO; [Anonymous], 2000, 105F062000 ISO; [Anonymous], 2011, L0803 JIS JAP STAND; [Anonymous], 2015, TEXT HDB 2015, V2015, P26; [Anonymous], 2010, 105D012010 ISO; [Anonymous], 2005, L08052005 JIS JAP ST; [Anonymous], 1989, 105F101989 ISO; [Anonymous], 2004, L0849 JIS JAP STAND; [Anonymous], 2001, 105X122001 ISO; [Anonymous], 1989, 105C041989 ISO; Suganuma K, 2010, SEN-I GAKKAISHI, V66, P194; [Anonymous], 2001, 105F042001 ISO; [Anonymous], 2010, 1162010 AATCC; Consumer Product End-Use Research Institute Co. Ltd, 2011, DYEING REP, V264, P4; Nishikawa T, 2013, DYEING REP, V284, P7; Suganuma K, 2013, COLOR TECHNOL, V129, P443, DOI 10.1111/cote.12053; Suganuma K, 2013, ANN M 2013 JAP	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1472-3581	1478-4408		COLOR TECHNOL	Color. Technol.	OCT	2015	131	5					403	411		10.1111/cote.12170		9	Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles	Chemistry; Engineering; Materials Science	CT7EG	WOS:000362976000008		
J	Sun, ZY; Teng, HH; Xiao, F				Sun, Ziyao; Teng, Honghui; Xiao, Feng			A Slope Constrained 4th Order Multi-Moment Finite Volume Method with WENO Limiter	COMMUNICATIONS IN COMPUTATIONAL PHYSICS			English	Article						Multi-moment finite volume method; WENO; flux reconstruction; compressible flow; conservative method; oscillation-suppressing	ESSENTIALLY NONOSCILLATORY SCHEMES; NAVIER-STOKES EQUATIONS; OSCILLATION PREVENTING SCHEME; DISCONTINUOUS GALERKIN METHOD; HYPERBOLIC CONSERVATION-LAWS; SHOCK-CAPTURING SCHEMES; UNSTRUCTURED GRIDS; ELEMENT-METHOD; EFFICIENT IMPLEMENTATION; ADVECTION EQUATION	This paper presents a new and better suited formulation to implement the limiting projection to high-order schemes that make use of high-order local reconstructions for hyperbolic conservation laws. The scheme, so-called MCV-WENO4 (multimoment Constrained finite Volume with WENO limiter of 4th order) method, is an extension of the MCV method of Ii & Xiao (2009) by adding the 1st order derivative (gradient or slope) at the cell center as an additional constraint for the cell-wise local reconstruction. The gradient is computed from a limiting projection using the wrii7,No (weighted essentially non-oscillatory) reconstruction that is built from the nodal values at 5 solution points within 3 neighboring cells. Different from other existing methods where only the cell-average value is used in the WINO reconstruction, the present method takes account of the solution structure within each mesh cell, and thus minimizes the stencil for reconstruction. The resulting scheme has 4th-order accuracy and is of significant advantage in algorithmic simplicity and computational efficiency. Numerical results of one and two dimensional benchmark tests for scalar and Euler conservation laws are shown to verify the accuracy and oscillation-less property of the scheme.	[Sun, Ziyao; Xiao, Feng] Tokyo Inst Technol, Dept Energy Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Teng, Honghui] Chinese Acad Sci, Inst Mech, State Key Lab High Temp Gas Dynam, Beijing 100190, Peoples R China	Xiao, F (reprint author), Tokyo Inst Technol, Dept Energy Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	sun.z.ab@m.titech.ac.jp; hhteng@imech.ac.cn; xiao@es.titech.ac.jp			JSPS [24560187, 15H03916]	This work is supported in part by JSPS KAKENHI (24560187, 15H03916).	Li XL, 2013, MON WEATHER REV, V141, P1216, DOI 10.1175/MWR-D-12-00144.1; Hu CQ, 1999, J COMPUT PHYS, V150, P97, DOI 10.1006/jcph.1998.6165; Xiao F, 2001, J COMPUT PHYS, V170, P498, DOI 10.1006/jcph.2001.6746; Yee HC, 1999, J COMPUT PHYS, V150, P199, DOI 10.1006/jcph.1998.6177; Toro EF, 2006, J COMPUT PHYS, V212, P150, DOI 10.1016/j.jcp.2005.06.018; COCKBURN B, 1990, MATH COMPUT, V54, P545, DOI 10.2307/2008501; Shen YQ, 2014, COMPUT FLUIDS, V96, P1, DOI 10.1016/j.compfluid.2014.02.010; Zhong XH, 2013, J COMPUT PHYS, V232, P397, DOI 10.1016/j.jcp.2012.08.028; Chen CG, 2008, J COMPUT PHYS, V227, P5019, DOI 10.1016/j.jcp.2008.01.033; Borges R, 2008, J COMPUT PHYS, V227, P3191, DOI 10.1016/j.jcp.2007.11.038; Shu CW, 2009, SIAM REV, V51, P82, DOI 10.1137/070679065; Yabe T, 2001, J COMPUT PHYS, V169, P556, DOI 10.1006/jcph.2000.6625; Xiao F, 2013, APPL MATH MODEL, V37, P5092, DOI 10.1016/j.apm.2012.10.050; Xiao F, 1996, COMPUT PHYS COMMUN, V94, P103, DOI 10.1016/0010-4655(96)00008-2; Wang ZJ, 2002, J COMPUT PHYS, V179, P665, DOI 10.1006/jcph.2002.7082; Jiang GS, 1996, J COMPUT PHYS, V126, P202, DOI 10.1006/jcph.1996.0130; Wang ZJ, 2002, J COMPUT PHYS, V178, P210, DOI 10.1006/jcph.2002.7041; Kopriva DA, 1996, J COMPUT PHYS, V125, P244, DOI 10.1006/jcph.1996.0091; Xie B, 2014, J COMPUT PHYS, V277, P138, DOI 10.1016/j.jcp.2014.08.011; Qiu JX, 2005, SIAM J SCI COMPUT, V26, P907, DOI 10.1137/S1064827503425298; Titarev VA, 2002, J SCI COMPUT, V17, P609, DOI 10.1023/A:1015126814947; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; COCKBURN B, 1989, MATH COMPUT, V52, P411, DOI 10.2307/2008474; LIU XD, 1994, J COMPUT PHYS, V115, P200, DOI 10.1006/jcph.1994.1187; Qiu JX, 2004, J COMPUT PHYS, V193, P115, DOI 10.1016/j.jcp.2003.07.026; Chen CG, 2014, J COMPUT PHYS, V271, P191, DOI 10.1016/j.jcp.2013.10.026; Ii S, 2009, J COMPUT PHYS, V228, P3669, DOI 10.1016/j.jcp.2009.02.009; Henrick AK, 2005, J COMPUT PHYS, V207, P542, DOI 10.1016/j.jcp.2005.01.023; SHU CW, 1988, J COMPUT PHYS, V77, P439, DOI 10.1016/0021-9991(88)90177-5; Xiao F, 1996, COMPUT PHYS COMMUN, V93, P1, DOI 10.1016/0010-4655(95)00124-7; SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2; Wang ZJ, 2009, J COMPUT PHYS, V228, P8161, DOI 10.1016/j.jcp.2009.07.036; Ii S, 2007, J COMPUT PHYS, V222, P849, DOI 10.1016/j.jcp.2006.08.015; Sun YZ, 2007, COMMUN COMPUT PHYS, V2, P310; Spiteri RJ, 2002, SIAM J NUMER ANAL, V40, P469, DOI 10.1137/S0036142901389025; COCKBURN B, 1989, J COMPUT PHYS, V84, P90, DOI 10.1016/0021-9991(89)90183-6; Du J., 2014, APPL NUMERI IN PRESS; Huang CS, 2015, J SCI COMPUT, V64, P477, DOI 10.1007/s10915-014-9940-z; Huynh H.T., 2007, 40792007 AIAA, V4079, P2007; PATERA AT, 1984, J COMPUT PHYS, V54, P468, DOI 10.1016/0021-9991(84)90128-1; ROE PL, 1981, J COMPUT PHYS, V43, P357, DOI 10.1016/0021-9991(81)90128-5; Shen Y. Q., 2009, 19 AIAA COMP FLUID D, P2009; Toro E.F., 2009, RIEMANN SOLVERS NUME; Hesthaven JS, 2008, TEXTS APPL MATH, V54, P1; WOODWARD P, 1984, J COMPUT PHYS, V54, P115, DOI 10.1016/0021-9991(84)90142-6; Xiao F, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001532; Xie B, 2014, COMPUT FLUIDS, V104, P40, DOI 10.1016/j.compfluid.2014.08.002; YABE T, 1991, COMPUT PHYS COMMUN, V66, P219, DOI 10.1016/0010-4655(91)90071-R	48	0	0	GLOBAL SCIENCE PRESS	WANCHAI	ROOM 3208, CENTRAL PLAZA, 18 HARBOUR RD, WANCHAI, HONG KONG 00000, PEOPLES R CHINA	1815-2406	1991-7120		COMMUN COMPUT PHYS	Commun. Comput. Phys.	OCT	2015	18	4					901	930		10.4208/cicp.081214.250515s		30	Physics, Mathematical	Physics	CT7DQ	WOS:000362974400006		
J	Takahashi, T; Kadobayashi, Y				Takahashi, Takeshi; Kadobayashi, Youki			Reference Ontology for Cybersecurity Operational Information	COMPUTER JOURNAL			English	Article						cybersecurity; ontology design; information structure; knowledge model; information schema; knowledge base; information exchange		As our cyber society develops and expands, the importance of cybersecurity operations is growing in response to cybersecurity threats coming from beyond national borders. Efficient cybersecurity operations require information exchanges that go beyond organizational borders. Various industry specifications defining information schemata for such exchanges are thus emerging. These specifications, however, define their own schemata since their objectives and the types of information they deal with differ, and desirable schemata differ depending on the purposes. They need to be organized and orchestrated so that individual organizations can fully exchange information and collaborate with one another. To establish the foundations of such orchestration and facilitate information exchanges, this paper proposes a reference ontology for cybersecurity operational information. The ontology structures cybersecurity information and orchestrates industry specifications. We built it from the standpoint of cybersecurity operations in close collaboration with cybersecurity organizations including security operation centers handling actual cybersecurity operations in the USA, Japan and South Korea. This paper demonstrates its usability by discussing the coverage of industry specifications. It then defines an extensible information structure that collaborates with such specifications by using the ontology and describes a prototype cybersecurity knowledge base we constructed that facilitates cybersecurity information exchanges among various parties. Finally, it discusses the usage scenarios of the ontology and knowledge base in cybersecurity operations. Through this work, we wish to contribute to the advancement of cybersecurity information exchanges.	[Takahashi, Takeshi] Natl Inst Informat & Commun Technol, Network Secur Res Inst, Tokyo 1848795, Japan; [Kadobayashi, Youki] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 89165, Japan	Takahashi, T (reprint author), Natl Inst Informat & Commun Technol, Network Secur Res Inst, Tokyo 1848795, Japan.	takeshi_takahashi@ieee.org			JSPS KAKENHI [24700083]	This work was supported by JSPS KAKENHI [grant number 24700083]. Funding to pay the Open Access publication charges for this article was provided by JSPS KAKENHI [grant number 24700083].	[Anonymous], 2012, 270322012 ISOIEC; [Anonymous], 2009, 1977022009 ISOIEC; Rutkowski A, 2010, ACM SIGCOMM COMP COM, V40, P59, DOI 10.1145/1880153.1880163; [Anonymous], 2012, SPEC PUBL NAT I STAN, V800-61; [Anonymous], 2004, RES DESCR FRAM RDF C; Blanco C, 2011, COMPUT STAND INTER, V33, P372, DOI 10.1016/j.csi.2010.12.002; [Anonymous], 2012, COMM WEAKN EN; [Anonymous], 1992, C92188FINAL ORG EC C; [Anonymous], 2011, 7695 NIST; [Anonymous], 2014, COMM VULN EXP INT TE; [Anonymous], 2003, SPEC PUBL NAT I STAN, V800-35; Wang JA, 2012, INF SYST E-BUS MANAG, V10, P455, DOI 10.1007/s10257-011-0173-5; [Anonymous], 2011, 7692 NIST; [Anonymous], 2011, SPARQL QUER LANG RDF; [Anonymous], 2012, DSP0004 DISTR MAN TA; [Anonymous], 1995, SPEC PUBL NAT I STAN, V800-12; Lin RR, 2011, SIGMOD REC, V40, P5, DOI 10.1145/2007206.2007208; [Anonymous], 2008, SPEC PUBL NAT I STAN, V800-115; [Anonymous], 2011, 7694 NIST; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; [Anonymous], 2013, 181802013 ISOIEC; [Anonymous], 2014, LANG OP DEF VULN ASS; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; [Anonymous], 2014, MALW ATTR EN CHAR; [Anonymous], 2013, EXTENSIBLE ACC CONTR; [Anonymous], 2004, 1333511996 ISOIEC; [Anonymous], 2010, 7502 NIST; [Anonymous], 2006, SPEC PUBL NAT I STAN, V800-86; [Anonymous], 2012, OWL 2 WEB ONT LANG D; [Anonymous], 2013, COMM ATT PATT EN CLA; [Anonymous], 2011, OV CYB INF EXCH CYBE; [Anonymous], 2004, INC ORG SEC INC HAND; [Anonymous], GFDR192; [Anonymous], 2011, COMM VULN SCOR SYST; Baader F, 2003, LECT NOTES ARTIF INT, V2605, P228; Brownlee N., 1998, REQUEST COMMENTS 235; COBIT 5, 2012, 5 COBIT ISACA; Danyliw R., 2014, INCIDENT OBJECT DESC; Danyliw R., 2007, REQUEST COMMENTS 507; Decker S., 1999, P DS 8, P351; Denker G., 2005, Information Security Technical Report, V10, DOI 10.1016/j.istr.2004.11.002; Fenz S., 2009, P 4 INT S INF COMP C, P183, DOI DOI 10.1145/1533057.1533084; Guo L., 2003, P 2003 ACM SIGMOD IN, P16, DOI DOI 10.1145/872757.872762; IBM X-Force, 2013, IBM X FORC 2013 MID; IEEE ICSG Malware Metadata Exchange Format Working Group, 2014, MALW MET EXCH FORM V; Industry Consortium for Advancement of Security on the Internet, 2014, COMM VULN REP FRAM V; Jena Apache, 2014, SDB PERS TRIPL STOR; JPCERT/CC and IPA, 2014, JAP VULN NOT; Kesh S, 2007, COMMUN ACM, V50, P103, DOI 10.1145/1272516.1272521; Liu Z., 2007, P 33 INT C VER LARG, P1330; Martin R. A., 2009, CROSSTALK J DEF SOFT, V22, P26; Masoumzadeh A., 2013, P 8 ACM SIGSAC S INF, P149; Moreaus L, 2008, COMMUN ACM, V51, P52, DOI 10.1145/1330311.1330323; National Institute of Standards and Technology, 2014, NAT I STAND TECHN SP, V800; National Institute of Standards and Technology, 2014, FRAM IMPR CRIT INFR; National Institute of Standards and Technology, 2014, COMM CONF EN CCE; National Institute of Standards and Technology, 2014, NAT VULN DAT VERS 2; OECD, 2012, OECD DIG EC PAP, V211; Open Security Foundation, 2014, OP SOURC VULN DAT; Parkin S. E., 2009, P 2 INT C SEC INF NE, P46, DOI 10.1145/1626195.1626209; Red Hat Inc, 2014, SEC MEAS; Schmitt MN, 2013, TALLINN MANUAL INT L; Stanford Center for Biomedical Informatics Research, 2014, PROT ONT ED KNOWL AC; Symantec Corporation, 2014, INT SEC THREAT REP 2; The MITRE Corporation, 2014, MAK SEC MEAS; The MITRE Corporation, 2014, COMM RES FORM SPEC V; The MITRE Corporation, 2014, COMM EV EXPR; The MITRE Corporation, 2014, CYB OBS EXPRESSION; The MITRE Corporation, 2014, COMM WEAKN SCOR SYST; The White House, 2013, FED REG, V78; Tsoumas B., 2006, P 20 INT C ADV INF N, V1, P985; Wang JX, 2009, AUTOM TECHNOL, V10, P1	73	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	OCT	2015	58	10					2297	2312		10.1093/comjnl/bxu101		16	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CT6YG	WOS:000362959000008		
J	Attrapadung, N; Emura, K; Hanaoka, G; Sakai, Y				Attrapadung, Nuttapong; Emura, Keita; Hanaoka, Goichiro; Sakai, Yusuke			Revocable Group Signature with Constant-Size Revocation List	COMPUTER JOURNAL			English	Article						revocable group signature; identity-based revocation	VERIFIER-LOCAL REVOCATION; PUBLIC-KEY ENCRYPTION; BACKWARD UNLINKABILITY; RANDOM ORACLES; BILINEAR MAPS; BROADCAST ENCRYPTION; SCHEMES; CIPHERTEXTS; FOUNDATIONS; ASSUMPTIONS	It is essential that a multi-user cryptographic primitive be revocable since a legitimate user may quit the organization, or may act on malicious intent, or the relevant key may be leaked. In the group signature context, usually the group manager publishes the revocation list that contains revocation tokens. Since signers/verifiers need to obtain the revocation list in each revocation epoch to generate/verify a group signature, a small-size revocation list is really important in practice. However, all previous revocable group signatures require at least an Omicron(r)-size revocation list, where r is the number of revoked users. In this paper, we propose the first revocable group signature scheme with a constant-size revocation list using identity-based revocation (IBR) techniques. We use an IBR scheme proposed by Attrapadung-Libert-Panafieu (PKC 2011) as a building block. As in the Libert-Peters-Yung schemes (EUROCRYPT 2012/CRYPTO 2012), no signing key update is required. In addition, the verification cost does not depend on the number of revoked users r. Although the maximum number of revoked users needs to be fixed in the setup phase, the maximum number of group members is potentially unbounded as in IBR. This property has not been achieved in the recent scalable revocable group signature schemes and seems to be of independent interest.	[Attrapadung, Nuttapong; Hanaoka, Goichiro; Sakai, Yusuke] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Emura, Keita] Natl Inst Informat & Commun Technol NICT, Network Secur Res Inst, Secur Fundamentals Lab, Koganei, Tokyo 1848795, Japan	Emura, K (reprint author), Natl Inst Informat & Commun Technol NICT, Network Secur Res Inst, Secur Fundamentals Lab, 4-2-1 Nukui Kitamachi, Koganei, Tokyo 1848795, Japan.	k-emura@nict.go.jp					Abe M., 2010, IACR CRYPTOL EPRINT, V2010, P133; Acar T., 2013, LECT NOTES COMPUTER, V7859, P189; Ohtake G, 2009, LECT NOTES COMPUT SC, V5580, P149, DOI 10.1007/978-3-642-02384-2_10; Emura K, 2014, J APPL MATH, DOI 10.1155/2014/983040; Libert B, 2010, LECT NOTES COMPUT SC, V5978, P499, DOI 10.1007/978-3-642-11799-2_30; Boneh D, 2008, J CRYPTOL, V21, P149, DOI 10.1007/s00145-007-9005-7; Bellare M, 2005, LECT NOTES COMPUT SC, V3376, P136; Nakanishi T, 2005, LECT NOTES COMPUT SC, V3788, P533; Attrapadung N, 2011, LECT NOTES COMPUT SC, V6571, P90, DOI 10.1007/978-3-642-19379-8_6; Kiayias A, 2004, LECT NOTES COMPUT SC, V3027, P571; Abdalla M, 2004, LECT NOTES COMPUT SC, V3269, P1; Boneh D, 2004, LECT NOTES COMPUT SC, V3027, P223; Fan CI, 2011, LECT NOTES COMPUT SC, V7092, P214; Kiltz E, 2006, LECT NOTES COMPUT SC, V3876, P581; Choi SG, 2006, LECT NOTES COMPUT SC, V4266, P88; Groth J, 2006, LECT NOTES COMPUT SC, V4284, P444; Benjumea V, 2007, LECT NOTES COMPUT SC, V4856, P265; Attrapadung N, 2012, THEOR COMPUT SCI, V422, P15, DOI 10.1016/j.tcs.2011.12.004; Attrapadung N, 2010, LECT NOTES COMPUT SC, V6056, P384; Nguyen L, 2005, LECT NOTES COMPUT SC, V3376, P275; Abe M, 2010, LECT NOTES COMPUT SC, V6223, P209, DOI 10.1007/978-3-642-14623-7_12; Libert B, 2009, LECT NOTES COMPUT SC, V5888, P498, DOI 10.1007/978-3-642-10433-6_34; Furukawa J, 2006, IEICE T FUND ELECTR, VE89A, P1328, DOI 10.1093/ietfec/e89-a.5.1328; Naor M, 2002, LECT NOTES COMPUT SC, V2442, P481; Boneh D, 2005, LECT NOTES COMPUT SC, V3494, P440; Nakanishi T, 2006, LECT NOTES COMPUT SC, V4266, P17; Camenisch J, 2009, LECT NOTES COMPUT SC, V5443, P481; Groth J, 2007, LECT NOTES COMPUT SC, V4833, P164; Dodis Y, 2002, LECT NOTES COMPUT SC, V2696, P61; Nakanishi T, 2009, LECT NOTES COMPUT SC, V5443, P463; Boneh D, 2004, LECT NOTES COMPUT SC, V3152, P41; Wei LB, 2010, LECT NOTES COMPUT SC, V6487, P136; Kwon T, 2011, INFORM SCIENCES, V181, P2906, DOI 10.1016/j.ins.2011.02.016; Zhou SJ, 2006, LECT NOTES COMPUT SC, V4301, P126; Lewko A, 2010, P IEEE S SECUR PRIV, P273, DOI 10.1109/SP.2010.23; Benjumea V, 2004, LECT NOTES COMPUT SC, V2947, P402; Bellare M, 2003, LECT NOTES COMPUT SC, V2656, P614; Emura K, 2014, INT J INF SECUR, V13, P51, DOI 10.1007/s10207-013-0204-y; Ateniese G., 2005, IACR CRYPTOL EPRINT, V2005, P385; Attrapadung Nuttapong, 2012, Journal of Mathematical Cryptology, V5, DOI 10.1515/JMC.2011.009; Attrapadung N, 2014, LECT NOTES COMPUT SC, V8479, P419, DOI 10.1007/978-3-319-07536-5_25; Begum N., 2012, LNCS, V7839, P495; Boneh D, 2005, LECT NOTES COMPUT SC, V3621, P258; Boneh D, 2008, LECT NOTES COMPUT SC, V5350, P455, DOI 10.1007/978-3-540-89255-7_28; Boneh D., 2004, P 11 ACM C COMP COMM, P168, DOI 10.1145/1030083.1030106; Boyen X, 2006, LECT NOTES COMPUT SC, V4004, P427; Bringer J., 2012, SECRYPT, P215; Chaum D., 1991, P EUROCRYPT 91 BRIGH, P257; Chu C., 2012, 7 ACM S INF COMP COM, P26; Damgard I, 2008, LECT NOTES COMPUT SC, V4964, P239, DOI 10.1007/978-3-540-79263-5_15; Delerablee C, 2006, LECT NOTES COMPUT SC, V4341, P193; Diaz J, 2014, COMPUT SECUR, V46, P111, DOI 10.1016/j.cose.2014.06.009; Diaz J., 2012, PUBL KEY INFR SERV A, P112; Groth J, 2008, LECT NOTES COMPUT SC, V4965, P415; Kiayias A., 2006, International Journal of Security and Networks, V1, DOI 10.1504/IJSN.2006.010821; Kiayias A., 2004, IACR CRYPTOL EPRINT, V2004, P76; Libert B., 2012, LNCS, V7417, P571; Libert B., 2012, ADV CRYPT EUROCRYPT, V7237, P609; Nakanishi T., 2013, INF SEC CRYPT ICISC, P435; Naor D., 2001, ADV CRYPT CRYPTO 200, V2139, P41, DOI 10.1007/3-540-44647-8_3; Sakai Y., 2012, LNCS, V7293, P715; Yamada S., 2012, LECT NOTES COMPUT SC, V7293, P243	62	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	OCT	2015	58	10					2698	2715		10.1093/comjnl/bxv026		18	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CT6YG	WOS:000362959000035		
J	Pereira, M; Dowsley, R; Nascimento, ACA; Hanaoka, G				Pereira, Mayana; Dowsley, Rafael; Nascimento, Anderson C. A.; Hanaoka, Goichiro			Public-Key Encryption Schemes with Bounded CCA Security and Optimal Ciphertext Length Based on the CDH and HDH Assumptions	COMPUTER JOURNAL			English	Article						public-key encryption; bounded chosen ciphertext security; computational Diffie-Hellman assumption; hashed Diffie-Hellman assumption	COMPUTATIONAL DIFFIE-HELLMAN; STANDARD MODEL; ATTACK; CRYPTOSYSTEM; PARADIGM	In Cramer et al. (2007, Bounded CCA2-Secure Encryption. In Kurosawa, K. (ed.), Advances in Cryptology - ASIACRYPT 2007, Kuching, Malaysia, December 2-6, Lecture Notes in Computer Science, Vol. 4833, pp. 502-518. Springer, Berlin, Germany) proposed a public-key encryption scheme secure against adversaries with a bounded number of decryption queries based on the decisional Diffie-Hellman problem. In this paper, we show that the same result can be obtained based on weaker computational assumptions, namely: the computational Diffie-Hellman and the hashed Diffie-Hellman assumptions.	[Pereira, Mayana] Univ Brasilia, Dept Elect Engn, BR-70910900 Brasilia, DF, Brazil; [Dowsley, Rafael] Karlsruhe Inst Technol, Inst Theoret Informat, D-76131 Karlsruhe, Germany; [Nascimento, Anderson C. A.] Univ Washington, Inst Technol, Tacoma, WA 98402 USA; [Hanaoka, Goichiro] Natl Inst Adv Ind Sci & Technol, Chyioda Ku, Tokyo 1010021, Japan	Dowsley, R (reprint author), Karlsruhe Inst Technol, Inst Theoret Informat, Fasanengarten 5,Geb 50-34, D-76131 Karlsruhe, Germany.	rafael.dowsley@kit.edu					Hanaoka G, 2008, LECT NOTES COMPUT SC, V5350, P308, DOI 10.1007/978-3-540-89255-7_19; Cramer R, 2002, LECT NOTES COMPUT SC, V2332, P45; RACKOFF C, 1992, LECT NOTES COMPUT SC, V576, P433; Peikert C, 2008, ACM S THEORY COMPUT, P187; Cramer R, 1998, LECT NOTES COMPUT SC, V1462, P13; Lindell Y, 2006, J CRYPTOL, V19, P359, DOI 10.1007/s00145-005-0345-x; Hofheinz D, 2007, LECT NOTES COMPUT SC, V4622, P553; Cramer R, 2010, LECT NOTES COMPUT SC, V5978, P146; Haralambiev K, 2010, LECT NOTES COMPUT SC, V6056, P1; Cramer R, 2003, SIAM J COMPUT, V33, P167, DOI 10.1137/S0097539702403773; Dottling N, 2012, IEEE T INFORM THEORY, V58, P6672, DOI 10.1109/TIT.2012.2203582; Peikert C, 2009, ACM S THEORY COMPUT, P333; Cash D, 2009, J CRYPTOL, V22, P470, DOI 10.1007/s00145-009-9041-6; Herranz J, 2010, INFORM COMPUT, V208, P1243, DOI 10.1016/j.ic.2010.07.002; Rosen A, 2009, LECT NOTES COMPUT SC, V5444, P419; Hofheinz D, 2009, LECT NOTES COMPUT SC, V5479, P313, DOI 10.1007/978-3-642-01001-9_18; Cramer R, 2007, LECT NOTES COMPUT SC, V4833, P502; Dowsley R, 2009, LECT NOTES COMPUT SC, V5473, P240, DOI 10.1007/978-3-642-00862-7_16; Boneh D., 2001, LNCS, V2139, p[213, 27], DOI DOI 10.1007/3-540-44647-8_13; Boneh D., 2007, SIAM J COMPUT, V36, P1301, DOI 10.1137/S009753970544713X; Dolev D, 1991, 23 ANN ACM S THEOR C, P542; Goldreich O., 1989, 21 ACM S THEOR COMP, P25; Hanaoka G., 2006, 2006408 CRYPT EPRINT; Naor M, 1990, 22 ANN ACM S THEOR C, P427; Pereira M., 2010, LECT NOTES COMPUTER, V6531, P299; Sahai A., 1999, 40th Annual Symposium on Foundations of Computer Science (Cat. No.99CB37039), DOI 10.1109/SFFCS.1999.814628; Shoup V., 2004, 2004332 CRYPT EPRINT	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	OCT	2015	58	10					2738	2746		10.1093/comjnl/bxv040		9	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CT6YG	WOS:000362959000037		
J	Guidotti, LG; Isogawa, M; Chisari, FV				Guidotti, Luca G.; Isogawa, Masanori; Chisari, Francis V.			Host-virus interactions in hepatitis B virus infection	CURRENT OPINION IN IMMUNOLOGY			English	Review							TRANSGENIC MOUSE MODEL; REPLICATION IN-VIVO; T-CELLS; HEPATOCELLULAR-CARCINOMA; IMMUNE-RESPONSE; NATURAL-KILLER; VIRAL-HEPATITIS; HBV INFECTION; LIVER-DAMAGE; RECEPTOR	Hepatitis B virus (HBV) is a noncytopathic, hepatotropic, double-stranded DNA virus that causes acute and chronic hepatitis. Although HBV does not induce a measurable innate immune response in the infected liver, the outcome of infection is determined by the kinetics, breadth, vigor, trafficking, and effector functions of HBV-specific adaptive T cell responses, and the development of neutralizing antibodies. Dysregulation of one or more of these events leads to persistent HBV infection and a variably severe chronic necroinflammatory liver disease that fosters the development of hepatocellular carcinoma. Deeper understanding of the mechanisms responsible for immunological tolerance to HBV is needed in order to devise immunotherapeutic strategies to cure chronic HBV infection and prevent its life-threatening sequelae.	[Guidotti, Luca G.] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Isogawa, Masanori] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Chisari, Francis V.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Chisari, FV (reprint author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	fchisari@scripps.edu		Guidotti, Luca G./0000-0002-0205-2678	European Research Council (ERC) [250219]; JSPS [KAKENHI 26461015]; AMED; NIH [R01-AI-020001, R01-CA-040489]	This work was supported by grants: 250219 (LGG) from the European Research Council (ERC), KAKENHI 26461015 (MI) from JSPS, and Research Program on Hepatitis (MI) from AMED, and R01-AI-020001 and R01-CA-040489 (FVC) from the NIH.	Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Billerbeck E, 2007, WORLD J GASTROENTERO, V13, P4858; Di Bisceglie AM, 2009, HEPATOLOGY, V49, pS56, DOI 10.1002/hep.22962; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Krebs K, 2013, GASTROENTEROLOGY, V145, P456, DOI 10.1053/j.gastro.2013.04.047; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; REHERMANN B, 1995, J CLIN INVEST, V96, P1527, DOI 10.1172/JCI118191; Qasim W, 2015, J HEPATOL, V62, P486, DOI 10.1016/j.jhep.2014.10.001; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; Nakamoto Y, 2004, CANCER RES, V64, P3326, DOI 10.1158/0008-5472.CAN-03-3817; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Publicover J, 2013, J CLIN INVEST, V123, P3728, DOI 10.1172/JCI68182; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Kimura K, 2002, J IMMUNOL, V169, P5188; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Bottcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Burns GS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a024935; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Durantel D, 2015, COLD SPRING HARB PER, P5; Guidotti Luca G, 2015, Cell, V161, P486, DOI 10.1016/j.cell.2015.03.005; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Jo J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004210; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Lanford RE, 2013, GASTROENTEROLOGY, V144, pe1501; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; PURCELL RH, 1976, LANCET, V2, P757; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schurich A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003208	58	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0952-7915	1879-0372		CURR OPIN IMMUNOL	Curr. Opin. Immunol.	OCT	2015	36						61	66		10.1016/j.coi.2015.06.016		6	Immunology	Immunology	CT8MF	WOS:000363070000011		
J	Murakami, K; Yamamoto, K; Sugiura, T; Kawakami, M; Horita, S; Kirita, T				Murakami, Kazuhiro; Yamamoto, Kazuhiko; Sugiura, Tsutomu; Kawakami, Masayoshi; Horita, Satoshi; Kirita, Tadaaki			Biomechanical analysis of poly-L-lactic acid and titanium plates fixated for mandibular symphyseal fracture with a conservatively treated unilateral condylar fracture using the three-dimensional finite element method	DENTAL TRAUMATOLOGY			English	Article						mandibular fracture; condyle; symphysis; poly-L-lactic acid; titanium; finite element method	BITE FORCES; OSTEOSYNTHESIS; ANGLE	The purpose of this study was to investigate stress on poly-L-lactic acid (PLLA) plates with a thickness of 1.4 mm and titanium plates with a thickness of 1.0 and 1.4 mm placed for mandibular symphyseal fractures with or without conservatively treated, unilateral condylar fractures using finite element analysis. The symphyseal fracture region was defined by the following three conditions: the defect, the callus, and the contact condition. Stress on the plates was analyzed by an applying occlusal force of 478.1 N on the first molar of the non-condylar fracture side. In the model of isolated symphyseal fracture, the maximal stresses were below the material strength in all plate types and conditions. In the models with condylar fracture, the maximal stresses on these plates were much higher than those in the models of isolated symphyseal fracture, especially for the defect condition. Although the maximal stresses on all types of plates in the contact condition were below the material strengths, some of those in the defect condition were higher than these strengths. These results suggest that a PLLA plate can theoretically withstand stress under good reductions of symphyseal fractures, even for condylar fractures; however, both the PLLA plate and titanium miniplate may be at risk of fracture under poor reduction.	[Murakami, Kazuhiro; Yamamoto, Kazuhiko; Sugiura, Tsutomu; Kawakami, Masayoshi; Horita, Satoshi; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 6348522, Japan	Murakami, K (reprint author), Nara Med Univ, Dept Oral & Maxillofacial Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	murakami@naramed-u.ac.jp					TATE GS, 1994, J ORAL MAXIL SURG, V52, P734, DOI 10.1016/0278-2391(94)90489-8; Sawazaki R, 2010, J ORAL MAXIL SURG, V68, P1252, DOI 10.1016/j.joms.2009.03.064; Ellis E, 2013, J ORAL MAXIL SURG, V71, P726, DOI 10.1016/j.joms.2012.09.017; Lovald S, 2010, J ORAL MAXIL SURG, V68, P1833, DOI 10.1016/j.joms.2009.09.108; Ji BH, 2010, ORAL SURG ORAL MED O, V109, pE21, DOI 10.1016/j.tripleo.2009.11.003; Wagner A, 2002, ORAL SURG ORAL MED O, V94, P678, DOI 10.1067/moe.2002.126451; Vajgel A, 2013, J ORAL MAXIL SURG, V71, P335, DOI 10.1016/j.joms.2012.09.019; Ellis ED, 2001, J ORAL MAXIL SURG, V59, P389, DOI 10.1053/joms.2001.21873; Sugiura T, 2009, J ORAL MAXIL SURG, V67, P2397, DOI 10.1016/j.joms.2008.08.042; Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5; Murakami K, 2009, J ORAL MAXIL SURG, V67, P83, DOI 10.1016/j.joms.2008.08.002; Champy M, 1975, Zahn Mund Kieferheilkd Zentralbl, V63, P339; Keyak JH, 1998, J BIOMECH, V31, P125; Korioth Tom W. P., 1994, Journal of Orofacial Pain, V8, P178; Murakami K, 2014, J ORAL MAXILLOFAC SU, V72, pe1; Nishimura N., 1960, MECH PROPERTY IND MA, P141; Sugiura T, 2001, J ORAL MAXIL SURG, V59, P1161, DOI 10.1053/joms.2001.26718; Sugiura T., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P165	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2015	31	5					396	402		10.1111/edt.12179		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7HG	WOS:000362985000010		
J	Takagi, M; Babazono, T; Uchigata, Y				Takagi, M.; Babazono, T.; Uchigata, Y.			Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease	DIABETIC MEDICINE			English	Article							RENAL-INSUFFICIENCY; MICROALBUMINURIA; NEPHROPATHY; PROGRESSION; JAPAN; CHOLESTEROL; HEMOGLOBIN; IMPAIRMENT; PREVALENCE; PREDICTORS	Aims To determine differences in predictors of albuminuria and decreased estimated GFR in Japanese people with Type 2 diabetes mellitus without chronic kidney disease. Methods This single-centre observational cohort study involved 1802 Japanese people with Type 2 diabetes with normoalbuminuria and estimated GFR >= 60 ml/min/1.73 m(2) (740 women; mean +/- SD age 58 +/- 12 years). Two separate outcomes were evaluated: onset of albuminuria (>= 30 mg/g creatinine, albuminuria cohort; n = 1655) and decrease in estimated GFR (< 60 ml/min/1.73 m(2); estimated GFR cohort; n = 1777). A Cox proportional hazards model was used to identify significant predictors for each outcome. Results During a median follow-up period of 6.9 years for the albuminuria cohort and 8.0 years for the estimated GFR cohort, 181 and 316 individuals reached the respective outcome. The 5-year cumulative incidence of albuminuria was 8.3%, and that of decreased estimated GFR was 10.4%. In the multivariate Cox model, greater urinary albumin-to-creatinine ratio, presence of diabetic retinopathy and higher HbA(1c) levels were associated with both outcomes. Unique risk factors for onset of albuminuria were male gender and higher uric acid levels; those for decreased estimated GFR were older age, greater systolic blood pressure, and lower baseline estimated GFR and HDL cholesterol levels. Conclusions Identification of both common and distinct predictive factors for onset of albuminuria and decreased estimated GFR support the hypothesis that both common and distinct pathophysiological mechanisms are involved in the development of these two manifestations of chronic kidney disease in diabetes.	[Takagi, M.; Babazono, T.; Uchigata, Y.] Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Dept Med, Tokyo, Japan	Babazono, T (reprint author), Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Dept Med, Tokyo, Japan.	babazono@dmc.twmu.ac.jp					Park JY, 1998, DIABETES CARE, V21, P530, DOI 10.2337/diacare.21.4.530; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Forsblom CM, 1998, DIABETES CARE, V21, P1932, DOI 10.2337/diacare.21.11.1932; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Yokoyama H, 2009, NEPHROL DIAL TRANSPL, V24, P1212, DOI 10.1093/ndt/gfn603; Araki S, 2005, DIABETES, V54, P2983, DOI 10.2337/diabetes.54.10.2983; Tabaei BP, 2001, DIABETES CARE, V24, P1560, DOI 10.2337/diacare.24.9.1560; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Cederholm J, 2005, DIABETES RES CLIN PR, V67, P258, DOI 10.1016/j.diabres.2004.07.021; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Thomas MC, 2009, DIABETES CARE, V32, P1497, DOI 10.2337/dc08-2186; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Jardine MJ, 2012, AM J KIDNEY DIS, V60, P770, DOI 10.1053/j.ajkd.2012.04.025; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Mogensen CE, 1984, NEW ENGL J MED, V310, P356; Mongensen CE, 1983, DIABETES S2, V32, P64; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Toya K, 2014, J DIABETES INVEST, V5, P228, DOI 10.1111/jdi.12134; VIBERTI GC, 1982, LANCET, V1, P1430	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	OCT	2015	32	10					1354	1360		10.1111/dme.12793		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CT8DB	WOS:000363044100017		
J	Dirr, G; Ito, H; Rantzer, A; Ruffer, BS				Dirr, Gunther; Ito, Hiroshi; Rantzer, Anders; Rueffer, Bjoern S.			SEPARABLE LYAPUNOV FUNCTIONS FOR MONOTONE SYSTEMS: CONSTRUCTIONS AND LIMITATIONS	DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B			English	Article						Monotone systems; separable Lyapunov functions; converse Lyapunov theorems; explicit formulas; ordinary differential equations	TO-STATE STABILITY; LARGE-SCALE SYSTEMS; SMALL-GAIN THEOREM; DIFFERENTIAL-EQUATIONS; 3-DIMENSIONAL SYSTEMS; ISS SYSTEMS; IISS SYSTEMS; NETWORKS; CONVERGENCE	For monotone systems evolving on the positive orthant of R-+(n) two types of Lyapunov functions are considered: Sum- and max-separable Lyapunov functions. One can be written as a sum, the other as a maximum of functions of scalar arguments. Several constructive existence results for both types are given. Notably, one construction provides a max-separable Lyapunov function that is defined at least on an arbitrarily large compact set, based on little more than the knowledge about one trajectory. Another construction for a class of planar systems yields a global sum-separable Lyapunov function, provided the right hand side satisfies a small-gain type condition. A number of examples demonstrate these methods and shed light on the relation between the shape of sublevel sets and the right hand side of the system equation. Negative examples show that there are indeed globally asymptotically stable systems that do not admit either type of Lyapunov function.	[Dirr, Gunther] Univ Wurzburg, Inst Math, D-97074 Wurzburg, Germany; [Ito, Hiroshi] Kyushu Inst Technol, Dept Syst Design & Informat, Iizuka, Fukuoka 8208502, Japan; [Rantzer, Anders] Lund Univ, Automat Control LTH, SE-22100 Lund, Sweden; [Rueffer, Bjoern S.] Univ Newcastle UON, Fac Sci & IT, Sch Math & Phys Sci, Callaghan, NSW 2308, Australia	Dirr, G (reprint author), Univ Wurzburg, Inst Math, Campus Hubland Nord,Emil Fischer Str 40, D-97074 Wurzburg, Germany.	dirr@mathematik.uni-wuerzburg.de; hiroshi@ces.kyutech.ac.jp; rantzer@control.lth.se; bjoern@rueffer.info			JSPS KAKENHI [26420422]; LCCC Linnaeus Center; eLLIIT Excellence Center at Lund University	Hiroshi Ito has been supported by JSPS KAKENHI Grant Number 26420422.; Anders Rantzer is supported by the LCCC Linnaeus Center and the eLLIIT Excellence Center at Lund University.	HIRSCH MW, 1990, SIAM J MATH ANAL, V21, P1225, DOI 10.1137/0521067; Jiang ZP, 1996, AUTOMATICA, V32, P1211, DOI 10.1016/0005-1098(96)00051-9; Sontag ED, 1998, SYST CONTROL LETT, V34, P93, DOI 10.1016/S0167-6911(98)00003-6; [Anonymous], 2010, P 49 IEEE C DEC CONT; Angeli D, 2007, SYST CONTROL LETT, V56, P87, DOI 10.1016/j.sysconle.2006.08.003; Ito H, 2009, IEEE T AUTOMAT CONTR, V54, P2389, DOI 10.1109/TAC.2009.2028980; Hirsch MW, 2003, LECT NOTES CONTR INF, V294, P183; De Leenheer P, 2007, J MATH CHEM, V41, P295, DOI 10.1007/s10910-006-9075-z; Dashkovskiy SN, 2010, SIAM J CONTROL OPTIM, V48, P4089, DOI 10.1137/090746483; Rantzer A, 2013, IEEE DECIS CONTR P, P4590, DOI 10.1109/CDC.2013.6760604; Bacciotti A, 2000, SET-VALUED ANAL, V8, P299, DOI 10.1023/A:1008763931789; HIRSCH MW, 1985, SIAM J MATH ANAL, V16, P423, DOI 10.1137/0516030; Ito H, 2012, AUTOMATICA, V48, P1197, DOI 10.1016/j.automatica.2012.03.018; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1545, DOI 10.1109/TCBB.2012.88; Rantzer A, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P6608, DOI 10.1109/CDC.2011.6161293; Ito H, 2006, IEEE T AUTOMAT CONTR, V51, P1626, DOI 10.1109/TAC.2006.882930; Angeli D, 2000, IEEE T AUTOMAT CONTR, V45, P1082, DOI 10.1109/9.863594; HIRSCH MW, 1982, SIAM J MATH ANAL, V13, P167, DOI 10.1137/0513013; Ruffer BS, 2010, IEEE T AUTOMAT CONTR, V55, P1732, DOI 10.1109/TAC.2010.2048053; Ito H, 2013, IEEE T AUTOMAT CONTR, V58, P1192, DOI 10.1109/TAC.2012.2231552; Ruffer BS, 2010, POSITIVITY, V14, P257, DOI 10.1007/s11117-009-0016-5; SONTAG ED, 1989, IEEE T AUTOMAT CONTR, V34, P435, DOI 10.1109/9.28018; Hirsch MW, 1988, NONLINEARITY, V1, P51, DOI 10.1088/0951-7715/1/1/003; Ruffer BS, 2010, AUTOMATICA, V46, P1019, DOI 10.1016/j.automatica.2010.03.012; Ito H, 2010, IEEE T AUTOMAT CONTR, V55, P702, DOI 10.1109/TAC.2009.2037457; Rantzer A, 2012, IEEE DECIS CONTR P, P272, DOI 10.1109/CDC.2012.6426312; YORKE JA, 1968, B AM MATH SOC, V74, P322, DOI 10.1090/S0002-9904-1968-11940-8; Berman A., 1979, NONNEGATIVE MATRICES; Bhatia N. P., 1970, GRUNDLEHREN MATH WIS, V161; Clarke F. H., 1998, NONSMOOTH ANAL CONTR; Como G., 2014, IEEE T CONTR NETWORK, V2, P57; Hinrichsen D., 2005, MATH SYSTEMTHEORY, V1; Hirsch MW, 2005, HBK DIFF EQUAT ORDIN, V2, P239; HIRSCH MW, 1991, ERGOD THEOR DYN SYST, V11, P443; HIRSCH MW, 1989, J DIFFER EQUATIONS, V80, P94, DOI 10.1016/0022-0396(89)90097-1; Ito H., 2014, P 53 IEEE C DEC CONT, P2371; Khalil H.K., 2002, NONLINEAR SYSTEMS; Lakshmikantham V., 1969, DIFFERENTIAL INTEGRA, V1; Ruffer B. S., 2010, P 10 SICE ANN C CONT; Smith Hal L., 1995, MATH SURVEYS MONOGRA, V41; Sontag Eduardo D, 2007, Syst Synth Biol, V1, P59, DOI 10.1007/s11693-007-9005-9; Sontag E. D., 2010, CONTROL SYSTEMS HDB, P1034; SONTAG ED, 1995, SYST CONTROL LETT, V24, P351, DOI 10.1016/0167-6911(94)00050-6; Yoshizawa T., 1966, PUBLICATIONS MATH SO	44	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1531-3492	1553-524X		DISCRETE CONT DYN-B	Discrete Contin. Dyn. Syst.-Ser. B	OCT	2015	20	8					2497	2526		10.3934/dcdsb.2015.20.2497		30	Mathematics, Applied	Mathematics	CT4AD	WOS:000362747200009		
J	Okumura, T; Shimada, Y; Sakurai, T; Hori, R; Nagata, T; Sakai, Y; Tsukada, K				Okumura, T.; Shimada, Y.; Sakurai, T.; Hori, R.; Nagata, T.; Sakai, Y.; Tsukada, K.			Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis	DISEASES OF THE ESOPHAGUS			English	Article						basal layer; esophageal carcinogenesis; p75NTR; stem cell	NEUROTROPHIN RECEPTOR; TELOMERASE ACTIVITY; HTERT PROTEIN; IN-VITRO; CARCINOMA; P53; EXPRESSION; P63; DYSPLASIA; KERATINOCYTES	The low affinity neurotrophin receptor p75NTR is known to be expressed in the mitotically quiescent basal layer (BL) of the normal esophageal epithelium. The aim of the present study was to detect oncogenic changes in the p75NTR-positive BL during esophageal squamous carcinogenesis. The normal epithelium (NE), low-grade intraepithelial neoplasia (LGN), high-grade intraepithelial neoplasia (HGN), and esophageal squamous carcinoma (SCC), in which invasion was limited to the muscularis mucosa, were obtained from surgically removed esophagi. The expression of p75NTR, the proliferation marker ki67, hTERT, p53, and p63 was examined immunohistochemically. The expression of p75NTR was detected in these tissues with average staining indexes (number of stained cells/100 nucleated cells; SI) of 1.00, 0.99, 0.81, and 0.73, respectively. The expression of ki67 in the BL significantly increased with the progression from LGN to HGN. The expression of hTERT and p53 significantly increased with the progression from NE to LGN, and then increased in a stepwise manner in HGN and SCC, with SI (hTERT/p53) of 0.10/0.11, 0.32/0.45, 0.50/0.72, and 0.65/0.61, respectively. The expression of p63 showed no significant difference among NE, LGN, HGN, and SCC, with SI of 0.82, 0.77, 0.85, and 0.87, respectively. A correlation was observed between the expression of ki67 and p53 (P = 0.005), while a negative correlation was found between p75NTR and hTERT (P = 0.01). Our results demonstrated that phenotypic changes from quiescent to active proliferation in the p75NTR-positive BL occurred during the progression from LGN to HGN. The altered expression of hTERT and p53 in the BL was detected in LGN, which suggested that additional oncogenic events that disrupt mitotic regulation in the p75NTR-positive quiescent BL may play a crucial role in malignant transformation. Further investigations using the isolation and tracing of p75NTR-positive cells in precancerous epithelia may provide us with a better understanding of squamous carcinogenesis.	[Okumura, T.; Hori, R.; Nagata, T.; Tsukada, K.] Toyama Univ, Dept Surg & Sci, Grad Sch Med & Pharmaceut Sci, Toyama, Toyama 9300194, Japan; [Hori, R.] Toyama Univ, Dept Pathol 1, Grad Sch Med & Pharmaceut Sci, Toyama, Toyama 9300194, Japan; [Shimada, Y.] Kyoto Univ, Dept Nanobio Drug Discovery, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Sakai, Y.] Kyoto Univ, Grad Sch Med, Div Gastrointestinal Surg, Dept Surg, Kyoto, Japan; [Sakurai, T.] Kyoto Univ Hosp, Dept Clin Pathol, Kyoto 606, Japan	Okumura, T (reprint author), Toyama Univ, Dept Surg & Sci, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	okumura@med.u-toyama.ac.jp			MEXT KAKENHI [23591920]	The authors wish to thank Ms Sakiko Shimada for her technical assistance. This work was partly supported by a Grant-in-Aid for Scientific Research (C) MEXT KAKENHI Grant Number 23591920.	Irwin MS, 2001, APOPTOSIS, V6, P17, DOI 10.1023/A:1009663809458; Itakura Y, 1996, ANTICANCER RES, V16, P201; Okumura T, 2006, CLIN CANCER RES, V12, P5096, DOI 10.1158/1078-0432.CCR-05-2852; Kunimura C, 1998, ONCOGENE, V17, P187, DOI 10.1038/sj.onc.1201916; Tominaga T, 2002, J GASTROENTEROL, V37, P418, DOI 10.1007/s005350200061; Ramires M, 1997, J PATHOL, V182, P62; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Amioka T, 2004, ONCOL REP, V11, P51; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494; DAWSEY SM, 1994, CANCER, V74, P1686, DOI 10.1002/1097-0142(19940915)74:6<1686::AID-CNCR2820740608>3.0.CO;2-V; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Okumura T, 2014, INT J ONCOL, V44, P1923, DOI 10.3892/ijo.2014.2365; Harada H, 2003, MOL CANCER RES, V1, P729; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Kuwano H, 1998, INT J CANCER, V78, P149, DOI 10.1002/(SICI)1097-0215(19981005)78:2<149::AID-IJC4>3.0.CO;2-Z; Yan P, 2004, HISTOCHEM CELL BIOL, V121, P391, DOI 10.1007/s00418-004-0465-5; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Kawamura T, 1996, CANCER, V77, P843, DOI 10.1002/(SICI)1097-0142(19960301)77:5<843::AID-CNCR6>3.0.CO;2-F; Shimizu Y, 2010, J GASTROEN HEPATOL, V25, P314, DOI 10.1111/j.1440-1746.2009.06032.x; Schlemper RJ, 2000, CANCER, V88, P996, DOI 10.1002/(SICI)1097-0142(20000301)88:5<996::AID-CNCR8>3.0.CO;2-Q; Frost M, 2000, AM J CLIN PATHOL, V114, P726, DOI 10.1309/XWFE-ARMN-HG2D-AJYV; Gurgel CAS, 2008, J MOL HISTOL, V39, P311, DOI 10.1007/s10735-008-9167-0; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; HONG MK, 1995, CANCER, V75, P423, DOI 10.1002/1097-0142(19950115)75:2<423::AID-CNCR2820750202>3.0.CO;2-5; Gaur D, 1997, CLIN CANCER RES, V3, P2129; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Cheung PY, 2010, CANCER LETT, V293, P41, DOI 10.1016/j.canlet.2009.12.015; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Takubo K, 2007, HISTOPATHOLOGY, V51, P733, DOI 10.1111/j.1365-2559.2007.02766.x; Hamilton SR, 2000, WHO CLASSIFICATION T; Huang SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-9; Kuwano H, 2008, ESOPHAGUS, V5, P61, DOI [10.1007/s10388-008-0151-2, DOI 10.1007/S10388-008-0151-2]; Ratovitski EA, 2001, P NATL ACAD SCI USA, V98, P1817, DOI 10.1073/pnas.98.4.1817	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	OCT	2015	28	7					634	643		10.1111/dote.12245		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT5ZU	WOS:000362890600005		
J	Xue, L; Furusawa, Y; Yu, D				Xue, Lian; Furusawa, Yoshiya; Yu, Dong			ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam	DNA REPAIR			English	Article						Ionizing radiation; High LET; Early G2/M checkpoint; Low dose hyper-radiosensitivity; ATR	DOUBLE-STRAND BREAK; REPAIR PATHWAY CHOICE; DEPENDENT PROTEIN-KINASE; CELL-CYCLE ARREST; HYPER-RADIOSENSITIVITY; DNA-DAMAGE; V79 CELLS; MAMMALIAN-CELLS; AURORA-B; INCREASED RADIORESISTANCE	Little work has been done on the mechanism of low dose hyper-radiosensitivity (HRS) and later appeared radioresistance (termed induced radioresistance (IRR)) after irradiation with medium and high linear energy transfer (LET) particles. The aim of this study was to find out whether ATR pathway is involved in the mechanism of HRS induced by high LET radiation. GM0639 cells and two ATM deficient/mutant cells, AT5BIVA and AT2KY were irradiated by carbon ion beam. Thymidine block technique was developed to enrich the G2-phase population. Radiation induced early G2/M checkpoint was quantitatively assess with dual-parameter flow cytometry by detecting the cells positive for phospho-histone H3. The involvement of ATR pathway in HRS/IRR response was detected with pretreatment of specific inhibitors prior to carbon ion beam. The link between the early G2/M checkpoint and HRS/IRR under carbon ion beam was first confirmed in GM0639 cells, through the enrichment of cell population in G2-phase or with Aurora kinase inhibitor that attenuates the transition from G2 to M phase. Interestingly, the early G2/M arrest could still be observed in ATM deficient/mutant cells with an effect of ATR signaling, which was discovered to function in an LET-dependent manner, even as low as 0.2 Gy for carbon ion radiation. The involvement of ATR pathway in heavy particles induced HRS/IRR was determined with the specific ATR inhibitor in GM0639 cells, which affected the HRS/IRR occurrence similarly as ATM inhibitor. These data demonstrate that ATR pathway may cooperate with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam. (C) 2015 Elsevier B.V. All rights reserved.	[Xue, Lian] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou 215123, Peoples R China; [Xue, Lian] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Suzhou 215123, Peoples R China; [Furusawa, Yoshiya] Natl Inst Radiol Sci, Res Dev Support Ctr, Microbeam Dev Off, Chiba 260, Japan; [Yu, Dong] Soochow Univ, Coll Med, Sch Radiol Med & Protect, Suzhou 215123, Peoples R China	Yu, D (reprint author), Soochow Univ, Coll Med, Sch Radiol Med & Protect, 199 Renai Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	yudong@suda.edu.com			National Natural Scientific Foundation of China [81102076, 11475125]; Universities Natural Science Foundation of Jiangsu Province [BK20131165]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Scientific Research Foundation for Returned Scholars, Soochow University [Q412600711]	We give our thanks to Dr. Hirohiko Yajima, Dr. Ryuichi Okayasu, Dr. Masahiko Miura, Dr. Bing Wang, Dr. Yasuharu Ninomiya, Dr. Akira Fujimori, Dr. Xing Cui, Dr. Cuihua Liu, Dr. Ryoichi Hirayama, Dr. Yoshitaka Matsumoto, Dr. Hiroshi Fujisawa, Dr. Ayako Kariya and Dr. Huizi Li for their technical help. We thank Dr. Penny Jeggo for helping us with the preparation of the manuscript. This work was supported by 'National Natural Scientific Foundation of China (Nos. 81102076 and 11475125)', 'Universities Natural Science Foundation of Jiangsu Province (No. BK20131165)', 'Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)' and 'Scientific Research Foundation for Returned Scholars, Soochow University (No. Q412600711)'.	Krueger SA, 2007, INT J RADIAT ONCOL, V69, P1262, DOI 10.1016/j.ijrobp.2007.08.012; Bohrnsen G, 2002, RADIAT PROT DOSIM, V99, P255; Marples B, 2002, INT J RADIAT BIOL, V78, P1139, DOI 10.1080/09553000210166606; Fernet M, 2010, DNA REPAIR, V9, P48, DOI 10.1016/j.dnarep.2009.10.006; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; MARPLES B, 1993, RADIAT RES, V133, P41, DOI 10.2307/3578255; Tsoulou E, 2002, RADIAT PROT DOSIM, V99, P237; Marples B, 2003, RADIAT RES, V160, P38, DOI 10.1667/RR3013; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700; Tsoulou E, 2001, INT J RADIAT BIOL, V77, P1133, DOI 10.1080/09553000110073439; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Bower JJ, 2010, CELL CYCLE, V9, P1617, DOI 10.4161/cc.9.8.11470; Xue L, 2009, MUTAT RES-FUND MOL M, V670, P15, DOI 10.1016/j.mrfmmm.2009.06.016; Thomas C, 2008, INT J RADIAT BIOL, V84, P533, DOI 10.1080/09553000802195331; Marples B, 2008, INT J RADIAT ONCOL, V70, P1310, DOI 10.1016/j.ijrobp.2007.11.071; Okayasu R, 2006, RADIAT RES, V165, P59, DOI 10.1667/RR3489.1; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Xue L, 2009, INT J RADIAT ONCOL, V75, P235, DOI 10.1016/j.ijrobp.2009.04.088; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Vaganay-Juery S, 2000, BRIT J CANCER, V83, P514, DOI 10.1054/bjoc.2000.1258; Zhao YX, 2012, J RADIAT RES, V53, P686, DOI 10.1093/jrr/rrs024; Heuskin AC, 2013, RADIAT RES, V180, P491, DOI 10.1667/RR13358.1; Krueger SA, 2007, RADIAT RES, V167, P260, DOI 10.1667/RR0776.1; Marples B, 2004, RADIAT RES, V161, P247, DOI 10.1667/RR3130; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Krueger SA, 2010, INT J RADIAT ONCOL, V77, P1509, DOI 10.1016/j.ijrobp.2010.01.028; Grabarz A, 2013, CELL REP, V5, P21, DOI 10.1016/j.celrep.2013.08.034; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Crosio C, 2002, MOL CELL BIOL, V22, P874; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Gupta A., 2013, RADIAT RES, V181, P1; Heuskin AC, 2014, INT J RADIAT BIOL, V90, P81, DOI 10.3109/09553002.2013.835503; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Wera AC, 2013, RADIAT RES, V179, P273, DOI 10.1667/RR3008.1; Xue L, 2015, DNA REPAIR, V25, P72, DOI 10.1016/j.dnarep.2014.11.004	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	OCT	2015	34						1	8		10.1016/j.dnarep.2015.07.001		8	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CT8LO	WOS:000363068300001		
J	Watanabe, M; Watanabe, N; Maruyama, S; Kawashiro, T				Watanabe, Miyuki; Watanabe, Noriko; Maruyama, Sakiko; Kawashiro, Takashi			Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Toremifene; Tamoxifen; Metabolite kinetics; Bioactivation; CYP2D6; CYP3A4; CYP2C9; Pharmacogenomics; Polymorphisms	BREAST-CANCER PATIENTS; RECEIVING ADJUVANT TAMOXIFEN; CYTOCHROME-P450 ENZYMES; CLINICAL-OUTCOMES; CYP2D6; POLYMORPHISMS; 2D6; THERAPY; CYP2C19; IMPACT	Toremifene (TOR) and Tamoxifen (TAM) are widely used as endocrine therapy for estrogen receptor positive breast cancer. Poor metabolizers of TAM are likely to have worse clinical outcomes than patients who exhibit normal TAM metabolism due to lower plasma level of its active metabolite, 4-hydroxy-N-desmethyl (4OH-NDM) tamoxifen (endoxifen). In this study, we examined the role of individual cytochrome P450 (CYP) isoforms in the metabolism of TOR to N-desmethyl (NDM), 4-hydroxy (4OH) and 4OH-NDM metabolites in comparison with TAM using human liver microsomes (HLMs) with selective chemical inhibitors for each CYP isoform and recombinant CYP proteins. Similar levels of NDM metabolites were formed for both TOR and TAM, and N-demethylation of both compounds was primarily carried out by CYP3A4. We found that the formation of 4OH-NDM-TOR was catalyzed both by CYP2C9 and CYP2D6, whereas the formation of 4OH-TAM and endoxifen was specifically catalyzed by CYP2D6 in HLMs. Our results suggest that the potential contribution of CYP2D6 in the bioactivation pathway of TOR may be lower compared to TAM, and may have a different impact on clinical outcome than CYP2D6 polymorphisms. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Watanabe, Miyuki; Watanabe, Noriko; Maruyama, Sakiko; Kawashiro, Takashi] Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Kita Ku, Tokyo 1158588, Japan	Watanabe, N (reprint author), Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Kita Ku, 31-12 Shimo, Tokyo 1158588, Japan.	miyuki.watanabe@nipponkayaku.co.jp; noriko.watanabe@nipponkayaku.co.jp; sakiko.maruyama@nipponkayaku.co.jp; takashi.kawashiro@nipponkayaku.co.jp					Crewe HK, 2002, DRUG METAB DISPOS, V30, P869, DOI 10.1124/dmd.30.8.869; [Anonymous], 2010, BMC CANCER; Crewe HK, 1997, BIOCHEM PHARMACOL, V53, P171, DOI 10.1016/S0006-2952(96)00650-8; Garcia-Martin E, 2006, MOL DIAGN THER, V10, P29; Lu JH, 2011, ANALYST, V136, P467, DOI 10.1039/c0an00487a; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; COEZY E, 1982, CANCER RES, V42, P317; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Kim J, 2013, INT J CANCER, V132, P1475, DOI 10.1002/ijc.27794; Pyrhonen S, 1999, BREAST CANCER RES TR, V56, P133; Shimada T, 1999, DRUG METAB DISPOS, V27, P1274; Stearns V, 2003, J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Fujita K, 2006, CURR DRUG METAB, V7, P23, DOI 10.2174/138920006774832587; Jin Y, 2005, J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; BERTHOU F, 1994, BIOCHEM PHARMACOL, V47, P1883, DOI 10.1016/0006-2952(94)90319-0; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Arvanitidis K, 2007, FUND CLIN PHARMACOL, V21, P419, DOI 10.1111/j.1472-8206.2007.00510.x; Pyrhonen S, 1997, BRIT J CANCER, V76, P270, DOI 10.1038/bjc.1997.375; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Kitada M, 2003, INT J CLIN PHARM RES, V23, P31; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Rodrigues AD, 1999, BIOCHEM PHARMACOL, V57, P465; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Lim JSL, 2011, BRIT J CLIN PHARMACO, V71, P737, DOI 10.1111/j.1365-2125.2011.03905.x; Kelly CM, 2010, BMJ-BRIT MED J, V8, P340; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P1	32	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					325	333		10.1016/j.dmpk.2015.05.004		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900001		
J	Mikkaichi, T; Nakai, D; Yoshigae, Y; Imaoka, T; Okudaira, N; Izumi, T				Mikkaichi, Tsuyoshi; Nakai, Daisuke; Yoshigae, Yasushi; Imaoka, Tomoki; Okudaira, Noriko; Izumi, Takashi			Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Organic anion transporting polypeptide; Drug interaction; Hepatic uptake; Tissue distribution; Regulatory science	TISSUE DISTRIBUTION; TRANSPLANT RECIPIENTS; PRAVASTATIN; PHARMACOKINETICS; DISPOSITION; REPAGLINIDE; INHIBITOR; SINGLE; BASES	Organic anion transporting polypeptide (OATP) 1B1 and 1B3 are key molecules that are involved in hepatic uptake related to drug elimination, and OATP-mediated drug interactions are of clinical concern. In this study, with an aim to determine a cutoff value for the potential involvement of OATP, we collected data on the distribution of 12 human OATP and 24 non-OATP radiolabeled substrates in rats. The OATP substrates exhibited a higher tissue-to-plasma ratio (K-p) in the liver than that in the other tissues. As an index of liver-specific distribution, a hepatic Kp ratio (the ratio of Kp in the liver to that in other tissues) was introduced, and a hepatic Kp ratio <10 was proposed as a criterion for excluding the involvement of OATP in vivo. Approximately 20% of the non-OATP substrates as well as 100% of the OATP substrates exceeded the cutoff value of 10; therefore, further in vitro transport studies will be required to decide whether to conduct clinical drug interaction studies. Since distribution studies are usually conducted in rats during drug development, the use of a hepatic Kp ratio is practical and could refine the current decision tree for selecting OATP substrates in the drug interaction guidance/guidelines. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Mikkaichi, Tsuyoshi; Nakai, Daisuke; Yoshigae, Yasushi; Imaoka, Tomoki; Okudaira, Noriko; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1408710, Japan	Mikkaichi, T (reprint author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	mikkaichi.tsuyoshi.da@daiichisankyo.co.jp					Niemi M, 2005, CLIN PHARMACOL THER, V77, P468, DOI 10.1016/j.cplt.2005.01.018; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Smith DA, 2015, J MED CHEM, V58, P5691, DOI 10.1021/acs.jmedchem.5b00201; Niemi M, 2003, DIABETOLOGIA, V46, P347, DOI 10.1007/s00125-003-1034-7; Niemi M, 2004, PHARMACOGENETICS, V14, P429, DOI 10.1097/01.fpc.0000114750.08559.32; REGAZZI MB, 1993, TRANSPLANT P, V25, P2732; Muck W, 1999, CLIN PHARMACOL THER, V65, P251, DOI 10.1016/S0009-9236(99)70104-9; Murakami T, 2011, EXPERT OPIN DRUG MET, V7, P353, DOI 10.1517/17425255.2011.548805; Marciante KD, 2011, PHARMACOGENET GENOM, V21, P280, DOI 10.1097/FPC.0b013e328343dd7d; Watanabe T, 2010, DRUG METAB DISPOS, V38, P215, DOI 10.1124/dmd.109.030254; Nezasa K, 2002, XENOBIOTICA, V32, P715, DOI 10.1080/00498250210144820; Imaoka T, 2013, DRUG METAB DISPOS, V41, P1442, DOI 10.1124/dmd.113.051052; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Mwinyi J, 2004, CLIN PHARMACOL THER, V75, P415, DOI 10.1016/j.clpt.2003.12.016; Nakai D, 2001, J PHARMACOL EXP THER, V297, P861; Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502; KOMAI T, 1992, EUR J DRUG METAB PH, V17, P103; Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Tornio A, 2012, TRENDS PHARMACOL SCI, V33, P312, DOI 10.1016/j.tips.2012.03.001; Uchiyama N, 1990, YAKUBUTSUDOUTAI, V5, P133	21	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					334	340		10.1016/j.dmpk.2015.06.003		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900002		
J	Yamashiro, T; Ohta, K; Inoue, K; Furumiya, M; Hayashi, Y; Yuasa, H				Yamashiro, Takahiro; Ohta, Kinya; Inoue, Katsuhisa; Furumiya, Mai; Hayashi, Yayoi; Yuasa, Hiroaki			Kinetic and time-dependent features of sustained inhibitory effect of myricetin on folate transport by proton-coupled folate transporter	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Proton-coupled folate transporter; Folate; Flavonoid; Myricetin; Drug interaction; Sustained inhibition; Intestinal transport	GRAPEFRUIT JUICE; DRUG-INTERACTIONS; FUNCTIONAL-CHARACTERIZATION; CARRIER; MALABSORPTION; MODULATION; ABSORPTION; CELLS; RAT	Myricetin is a flavonoid that has recently been suggested to induce sustained inhibition of proton-coupled folate transporter (PCFT/SLC46A1), which operates for intestinal folate uptake. The present study was conducted to characterize the inhibitory effect in more detail, using human PCFT stably expressed in Madin-Darby canine kidney II cells, to gain information to cope with problems potentially arising from that. The kinetics of saturable folate transport was first assessed in the absence of myricetin in the cells pretreated with the flavonoid for 60 min. The pretreatment induced PCFT inhibition in a manner dependent on the concentration of myricetin, where the maximum transport rate was reduced by 35.5% and 83.1%, respectively, at its concentrations of 20 mu M and 50 mu M. The inhibitory effect was, however, less extensive at lower folate concentrations, because the Michaelis constant was also reduced similarly in a manner dependent on myricetin concentration. The inhibition was induced depending on the time of pretreatment and, after removal of myricetin (50 mM) upon the manifestation of an extensive inhibition at 60 min, reversed almost completely in 90 min. This rather short time required for recovery may suggest that the sustained inhibition of PCFT is of a reversible type. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Yamashiro, Takahiro; Ohta, Kinya; Yuasa, Hiroaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Inoue, Katsuhisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Hachioji, Tokyo 1920392, Japan; [Furumiya, Mai; Hayashi, Yayoi] Kinjo Gakuin Univ, Coll Pharm, Dept Biopharmaceut, Moriyama Ku, Nagoya, Aichi 4638521, Japan	Yuasa, H (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	yuasa@phar.nagoya-cu.ac.jp					Grimm SW, 2009, DRUG METAB DISPOS, V37, P1355, DOI 10.1124/dmd.109.026716; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Furumiya M, 2014, DRUG METAB PHARMACOK, V29, P312, DOI 10.2133/dmpk.DMPK-13-RG-107; Hamid A, 2007, FEBS J, V274, P6317, DOI 10.1111/j.1742-4658.2007.06150.x; Vuorinen H, 2000, J AGR FOOD CHEM, V48, P2675, DOI 10.1021/jf991388o; Huang SM, 2004, CLIN PHARMACOL THER, V75, P1, DOI 10.1016/j.clpt.2003.07.002; SchmiedlinRen P, 1997, DRUG METAB DISPOS, V25, P1228; Brantley SJ, 2014, DRUG METAB DISPOS, V42, P301, DOI 10.1124/dmd.113.055236; Lemos C, 2007, EUR J NUTR, V46, P329, DOI 10.1007/s00394-007-0670-y; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Greenblatt DJ, 2003, CLIN PHARMACOL THER, V74, P121, DOI 10.1016/S0009-9236(03)00118-8; Yuasa H, 2009, J PHARM SCI-US, V98, P1608, DOI 10.1002/jps.21515; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Guo LQ, 2000, DRUG METAB DISPOS, V28, P766; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Shitara Y, 2012, DRUG METAB PHARMACOK, V27, P368, DOI 10.2133/dmpk.DMPK-11-RG-096; Bailey DG, 1998, BRIT J CLIN PHARMACO, V46, P101, DOI 10.1046/j.1365-2125.1998.00764.x; Alvarez AI, 2010, J PHARM SCI-US, V99, P598, DOI 10.1002/jps.21851; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Lemos C, 2005, ALCOHOL CLIN EXP RES, V29, P664, DOI 10.1097/01.ALC.0000159114.86360.B5; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Furumiya M, 2015, DRUG METAB PHARMACOK, V30, P154, DOI 10.1016/j.dmpk.2014.11.001; Halsted CH, 2002, J NUTR, V132, p2367S; Shitara Y, 2013, J PHARM SCI-US, V102, P3427, DOI 10.1002/jps.23477	25	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					341	346		10.1016/j.dmpk.2015.06.002		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900003		
J	Akamine, Y; Miura, M; Komori, H; Tamai, I; Ieiri, I; Yasui-Furukori, N; Uno, T				Akamine, Yumiko; Miura, Masatomo; Komori, Hisakazu; Tamai, Ikumi; Ieiri, Ichiro; Yasui-Furukori, Norio; Uno, Tsukasa			The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Enantiomer; Fexofenadine; Grapefruit juice; OATP2B1; Pharmacokinetics	DRUG-INTERACTIONS; HEALTHY-SUBJECTS; P-GLYCOPROTEIN; PLASMA-CONCENTRATIONS; FRUIT JUICES; ORANGE; APPLE; TRANSPORTERS; INHIBITION; ITRACONAZOLE	The stereoselective pharmacokinetics of fexofenadine are associated with OATP2B1-mediated transport, and grapefruit juice (GFJ) is an inhibitor of OATP2B1. Therefore, in this study, we aimed to investigate whether and to what extent GFJ ingestion affected the pharmacokinetics of fexofenadine enantiomers in healthy subjects. In a randomized, two-phase, open-label, crossover study, 14 subjects received 60 mg of racemic fexofenadine simultaneously with water or GFJ. Ingestion of GFJ significantly decreased the areas under the plasma concentration-time curve (AUC(0-24)) for (R)- and (S)-fexofenadine by 39% and 52%, respectively. Subsequently, GFJ increased the mean R/S ratio of the AUC(0-24) from 1.58 to 1.96 (P < 0.05). Although GFJ greatly reduced the amounts of (R)- and (S)-fexofenadine excreted into the urine (Ae(0-24)) by 52% and 61%, respectively, the mean R/S ratios of Ae(0-24) and the renal clearances of both enantiomers were unchanged between the control and GFJ phases. GFJ, an OATP2B1 inhibitor, significantly reduced the plasma concentrations of fexofenadine enantiomers, exhibiting clinically moderate effects. The present results suggested that changes in OATP2B1 activity by GFJ may alter the stereoselective pharmacokinetics of fexofenadine and that reduced intestinal OATP2B1 activity may affect the stereo-selectivity of fexofenadine. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Akamine, Yumiko; Miura, Masatomo] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan; [Komori, Hisakazu; Tamai, Ikumi] Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan; [Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Uno, Tsukasa] Zikeikai Aoimori Hosp, Dept Pharm, Aomori, Japan	Miura, M (reprint author), Akita Univ Hosp, Akita 0108543, Japan.	m-miura@hos.akita-u.ac.jp					Akamine Y, 2015, J CLIN PHARM THER, V40, P98, DOI 10.1111/jcpt.12213; Shirasaka Y, 2011, DRUG METAB PHARMACOK, V26, P171, DOI 10.2133/dmpk.DMPK-10-RG-073; Neuhofel AL, 2002, J CLIN PHARMACOL, V42, P461, DOI 10.1177/0091270002424013; Tateishi T, 2008, BRIT J CLIN PHARMACO, V65, P693, DOI 10.1111/j.1365-2125.2008.03116.x; Seden K, 2010, DRUGS, V70, P2373, DOI 10.2165/11585250-000000000-00000; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI 10.1002/jps.23357; Shirasaka Y, 2011, J PHARM SCI-US, V100, P3843, DOI 10.1002/jps.22586; Kusuhara H, 2013, DRUG METAB DISPOS, V41, P206, DOI 10.1124/dmd.112.048330; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Miura M, 2007, CHIRALITY, V19, P223, DOI 10.1002/chir.20370; Lilja JJ, 2003, CLIN PHARMACOL THER, V73, P192, DOI 10.1067/mcp.2003.26; Akamine Y, 2010, XENOBIOTICA, V40, P782, DOI 10.3109/00498254.2010.515318; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Tapaninen T, 2011, BRIT J CLIN PHARMACO, V71, P718, DOI 10.1111/j.1365-2125.2010.03898.x; Sakugawa T, 2009, BRIT J CLIN PHARMACO, V67, P535, DOI 10.1111/j.1365-2125.2009.03396.x; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; Shitara Y, 2011, DRUG METAB PHARMACOK, V26, P220, DOI 10.2133/dmpk.DMPK-10-RV-094; Tamai I, 2012, ADV DRUG DELIVER REV, V64, P508, DOI 10.1016/j.addr.2011.07.007; Bailey DG, 2007, CLIN PHARMACOL THER, V81, P495, DOI 10.1038/sj.clpt.6100104; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664; Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189; Schwarz UI, 2005, CLIN PHARMACOL THER, V77, P291, DOI 10.1016/j.clpt.2004.11.111; Meier Y, 2007, DRUG METAB DISPOS, V35, P590, DOI 10.1124/dmd.106.013342; Miura M, 2007, J PHARMACEUT BIOMED, V43, P741, DOI 10.1016/j.jpba.2006.07.033; Prasad B, 2014, DRUG METAB DISPOS, V42, P78, DOI 10.1124/dmd.113.053819; Rebello S, 2012, EUR J CLIN PHARMACOL, V68, P697, DOI 10.1007/s00228-011-1167-4; Akamine Y, 2012, BRIT J CLIN PHARMACO, V73, P478, DOI 10.1111/j.1365-2125.2011.04106.x; Akamine Y, 2014, EUR J CLIN PHARMACOL, V70, P1087, DOI 10.1007/s00228-014-1705-y; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Shirasaka Y, 2014, PHARM RES-DORDR, V31, P2035, DOI 10.1007/s11095-014-1305-7; Robbins DK, 1998, BIOPHARM DRUG DISPOS, V19, P455, DOI 10.1002/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.3.CO;2-N; Bailey David G, 2004, Am J Cardiovasc Drugs, V4, P281, DOI 10.2165/00129784-200404050-00002; Rodriguez-Fragoso L., 2011, J FOOD SCI, V76, P112; Uno Tsukasa, 2006, Curr Clin Pharmacol, V1, P157, DOI 10.2174/157488406776872550	39	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					352	357		10.1016/j.dmpk.2015.06.005		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900005		
J	Tsukada, C; Saito, T; Maekawa, M; Mano, N; Oda, A; Hirasawa, N; Hiratsuka, M				Tsukada, Chiharu; Saito, Takahiro; Maekawa, Masamitsu; Mano, Nariyasu; Oda, Akifumi; Hirasawa, Noriyasu; Hiratsuka, Masahiro			Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6 alpha-hydroxylation and amodiaquine N-deethylation	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Cytochrome P450; CYP2C8; Genetic polymorphisms; Paclitaxel; Amodiaquine	IN-VITRO; JAPANESE POPULATION; DRUG-METABOLISM; OVARIAN-CANCER; POLYMORPHISMS; CYTOCHROME-P450; CYP2C8-ASTERISK-3; PHARMACOKINETICS; RHABDOMYOLYSIS; CERIVASTATIN	Cytochrome P450 2C8 (CYP2C8) is one of the enzymes primarily responsible for the metabolism of many drugs, including paclitaxel and amodiaquine. CYP2C8 genetic variants contribute to interindividual variations in the therapeutic efficacy and toxicity of paclitaxel. Although it is difficult to investigate the enzymatic function of most CYP2C8 variants in vivo, this can be investigated in vitro using recombinant CYP2C8 protein variants. The present study used paclitaxel to evaluate 6 alpha-hydroxylase activity and amodiaquine for the N-deethylase activity of wild-type and 11 CYP2C8 variants resulting in amino acid substitutions in vitro. The wild-type and variant CYP2C8 proteins were heterologously expressed in COS-7 cells. Paclitaxel 6 alpha-hydroxylation and amodiaquine N-deethylation activities were determined by measuring the concentrations of 6 alpha-hydroxypaclitaxel and N-desethylamodiaquine, respectively, and the kinetic parameters were calculated. Compared to the wild-type enzyme (CYP2C8.1), CYP2C8.11 and CYP2C8.14 showed little or no activity with either substrate. In addition, the intrinsic clearance values of CYP2C8.8 and CYP2C8.13 for paclitaxel were 68% and 67% that of CYP2C8.1, respectively. In contrast, the CLint values of CYP2C8.2 and CYP2C8.12 were 1.4 and 1.9 times higher than that of CYP2C8.1. These comprehensive findings could inform for further genotype-phenotype studies on interindividual differences in CYP2C8-mediated drug metabolism. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Tsukada, Chiharu; Saito, Takahiro; Hirasawa, Noriyasu; Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 9808578, Japan; [Maekawa, Masamitsu; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi 9808574, Japan; [Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Hiratsuka, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 9808578, Japan.	mhira@m.tohoku.ac.jp			Ministry of Health, Labour and Welfare (MHLW) of Japan; Smoking Research Foundation; Japan Research Foundation for Clinical Pharmacology	This study was supported in part by a grant from the Ministry of Health, Labour and Welfare (MHLW) of Japan ('Initiative to facilitate development of innovative drug, medical devices, and cellular & tissue-based product'), the Smoking Research Foundation, and the Japan Research Foundation for Clinical Pharmacology. We thank the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support.	Green H, 2009, BASIC CLIN PHARMACOL, V104, P130, DOI 10.1111/j.1742-7843.2008.00351.x; Soyama A, 2001, BIOL PHARM BULL, V24, P1427, DOI 10.1248/bpb.24.1427; Kaspera R, 2010, PHARMACOGENET GENOM, V20, P619, DOI 10.1097/FPC.0b013e32833ecace; Steed H, 2007, PHARMACOGENOMICS, V8, P803, DOI 10.2217/14622416.8.7.803; Ishikawa C, 2004, J HUM GENET, V49, P582, DOI 10.1007/s10038-004-0188-6; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; Soyama A, 2002, PHARMACOL TOXICOL, V91, P174, DOI 10.1034/j.1600-0773.2002.910404.x; SONNICHSEN DS, 1995, J PHARMACOL EXP THER, V275, P566; Hertz DL, 2014, BREAST CANCER RES TR, V145, P245, DOI 10.1007/s10549-014-2910-1; Bergmann TK, 2011, PHARMACOGENOMICS J, V11, P113, DOI 10.1038/tpj.2010.19; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Afzelius L, 2004, DRUG METAB DISPOS, V32, P1218; Parikh S, 2007, CLIN PHARMACOL THER, V82, P197, DOI 10.1038/sj.clpt.2007.6100122; Abraham JE, 2014, CLIN CANCER RES, V20, P2466, DOI 10.1158/1078-0432.CCR-13-3232; Leskela S, 2011, PHARMACOGENOMICS J, V11, P121, DOI 10.1038/tpj.2010.13; Gao YW, 2010, XENOBIOTICA, V40, P467, DOI 10.3109/00498254.2010.487163; Hanioka N, 2011, BASIC CLIN PHARMACOL, V108, P359, DOI 10.1111/j.1742-7843.2010.00669.x; Kaspera R, 2011, BIOCHEM PHARMACOL, V82, P681, DOI 10.1016/j.bcp.2011.06.027; Jiang HL, 2011, AMINO ACIDS, V40, P1195, DOI 10.1007/s00726-010-0743-8; Yeo CW, 2011, DRUG METAB DISPOS, V39, P711, DOI 10.1124/dmd.110.035899; Saito Y, 2007, PHARMACOGENET GENOM, V17, P461, DOI 10.1097/FPC.0b013e32805b72c1; Lai XS, 2009, CURR DRUG METAB, V10, P1009; Hanioka N, 2010, BASIC CLIN PHARMACOL, V107, P565, DOI 10.1111/j.1742-7843.2010.00543.x; Aquilante CL, 2013, PHARMACOGENET GENOM, V23, P721, DOI 10.1097/FPC.0b013e3283653b27; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Hichiya H, 2005, DRUG METAB DISPOS, V33, P630, DOI 10.1124/dmd.105.003830; Singh R, 2008, DRUG METAB PHARMACOK, V23, P165, DOI 10.2133/dmpk.23.165; Dravid PV, 2008, J CHROMATOGR B, V863, P129, DOI 10.1016/j.jchromb.2008.01.017; Aquilante CL, 2013, PHARMACOTHERAPY, V33, P1000, DOI 10.1002/phar.1292; Green H, 2011, J PHARM SCI-US, V100, P4205, DOI 10.1002/jps.22680; Lewis D. F. V., 2002, Xenobiotica, V32, P305, DOI 10.1080/00498250110112015; Soyama Akiko, 2002, Drug Metab Pharmacokinet, V17, P374, DOI 10.2133/dmpk.17.374; Taniguchi R, 2005, J PHARMACOL SCI, V97, P83, DOI 10.1254/jphs.FP0040603; Yu LS, 2013, BIOPHARM DRUG DISPOS, V34, P278, DOI 10.1002/bdd.1842	35	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					366	373		10.1016/j.dmpk.2015.07.003		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900007		
J	Sato, K; Ono, T; Yoshida, K; Ito, T; Kashiwagi, Y				Sato, Katsuhiko; Ono, Tetsuya; Yoshida, Kentaro; Ito, Toshinori; Kashiwagi, Yoshitomo			Electrochemical Determination of D-Glucose Using Nortropine-N-oxyl under Physiological Conditions	ELECTROANALYSIS			English	Article						Mediator; Nitroxyl radical; Electrocatalytic oxidation; Diabetes treatment	MODIFIED ELECTRODES; OXIDATION; ALCOHOLS; ACID; DIOL	Nortropine-N-oxyl (NNO) was synthesized in a single step from nortropine. The electrocatalytical activity of NNO was evaluated by cyclic voltammetry in pH7.0 phosphate buffer solution. The anodic peak current for ethanol, isopropanol and glucose was enhanced, showing these alcohols were oxidized by electrocatalytic effect of NNO. On the other hand, TEMPO derivative (4-hydroxy-2,2,6,6,-terramethylpiperidine N-oxyl free radical) could not oxidize the alcohols under the same condition. The electrochemical response of the NNO to glucose was investigated. The anodic peak current increased with an increase in the concentration of glucose. A linear response to the glucose concentration ranging from 0.1 to 10mM was obtained.	[Sato, Katsuhiko] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ono, Tetsuya; Yoshida, Kentaro; Ito, Toshinori; Kashiwagi, Yoshitomo] Ohu Univ, Sch Pharmaceut Sci, Koriyama, Fukushima 9638611, Japan	Kashiwagi, Y (reprint author), Ohu Univ, Sch Pharmaceut Sci, 31-1 Misumido, Koriyama, Fukushima 9638611, Japan.	y-kashiwagi@pha.ohu-u.ac.jp			JSPS KAKENHI [26670083, 26860111]; Foundation for Ohu University Joint Research Fund	This work was supported by JSPS KAKENHI Grant Numbers 26670083, 26860111. The Foundation for Ohu University Joint Research Fund is also acknowledged for financial support.	Demizu Y, 2008, TETRAHEDRON LETT, V49, P48, DOI 10.1016/j.tetlet.2007.11.016; Takahashi S, 2005, LANGMUIR, V21, P5102, DOI 10.1021/la050171n; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Shibuya M, 2009, J ORG CHEM, V74, P4619, DOI 10.1021/jo900486w; SEMMELHACK MF, 1986, TETRAHEDRON LETT, V27, P1119, DOI 10.1016/S0040-4039(00)84193-3; Takahashi S, 2011, J ENVIRON SCI-CHINA, V23, P1027, DOI 10.1016/S1001-0742(10)60509-8; Ibert M, 2010, ELECTROCHIM ACTA, V55, P3589, DOI 10.1016/j.electacta.2009.11.041; MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191; Arimori S, 2002, CHEM COMMUN, P2368, DOI 10.1039/b207643h; Kashiwagi Y, 1996, CHEM COMMUN, P2345; Murray R. W., 1992, TECHNIQUES CHEM 22, V22	11	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	OCT	2015	27	10					2272	2274		10.1002/elan.201500059		3	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CT6DU	WOS:000362902700003		
J	Zhang, ZP; Xiao, TF; Hao, J; Yu, P; Ohsaka, T; Mao, LQ				Zhang, Zipin; Xiao, Tongfang; Hao, Jie; Yu, Ping; Ohsaka, Takeo; Mao, Lanqun			An Online Electrochemical System for Continuous Measurement of Glutamate with Signal Amplification by Enzymatic Substrate Cycling	ELECTROANALYSIS			English	Article						OECS; In vivo microdialysis; Enzymatic substrate cycling; Glutamate	CAPILLARY-ELECTROPHORESIS; CARBON NANOTUBES; BRAIN MICRODIALYSIS; SENSITIVE DETECTION; MASS-SPECTROMETRY; DUAL-ENZYME; RAT-BRAIN; RELEASE; ISCHEMIA; NEUROTRANSMITTERS	This study demonstrates a new online electrochemical system (OECS) for continuous monitoring of glutamate by efficiently integrating in vivo microdialysis and selective electrochemical detection with an enhanced sensitivity through enzymatic substrate cycling. We find that the involvement of enzymatic substrate cycling in the biosensing scheme remarkably increases the sensitivity of the OECS toward the measurements of glutamate. Moreover, the OECS demonstrated here is stable, reproducible, and selective and could thus be potentially useful for continuous monitoring of glutamate release in central nervous system. This study essentially offers a new approach to the continuous measurements of cerebral glutamate release, which is believed to find interesting applications in understanding the molecular basis underlying brain functions.	[Zhang, Zipin; Xiao, Tongfang; Hao, Jie; Yu, Ping; Mao, Lanqun] Chinese Acad Sci, Key Lab Analyt Chem Living Biosyst, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China; [Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Mao, LQ (reprint author), Chinese Acad Sci, Key Lab Analyt Chem Living Biosyst, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.	lqmao@iccas.ac.cn			NSF of China [21321003, 21210007, 91213305, 21322503]; National Basic Research Program of China (973 programs) [2013CB933704]	This research was financially supported by the NSF of China (Grant Nos. 21321003, 21210007, and 91213305 for L. Mao; 21322503 for P. Yu), and the National Basic Research Program of China (973 programs, 2013CB933704).	Ahmed I., 2011, BRAIN; Zhang MN, 2012, ACCOUNTS CHEM RES, V45, P533, DOI 10.1021/ar200196h; Emre FB, 2014, ELECTROANAL, V26, P1354, DOI 10.1002/elan.201400048; Niwa O, 1998, ANAL CHEM, V70, P1126, DOI 10.1021/ac970257o; Liu K, 2009, BRAIN RES, V1253, P161, DOI 10.1016/j.brainres.2008.11.096; Yao T, 2001, ELECTROANAL, V13, P1361, DOI 10.1002/1521-4109(200111)13:16<1361::AID-ELAN1361>3.3.CO;2-4; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Yao T, 1998, TALANTA, V45, P917, DOI 10.1016/S0039-9140(97)00193-8; SZERB JC, 1991, BRAIN RES, V542, P259, DOI 10.1016/0006-8993(91)91576-M; Lin YQ, 2007, ANAL CHEM, V79, P9577, DOI 10.1021/ac070966u; Niwa O, 1998, ANAL CHEM, V70, P89, DOI 10.1021/ac970740z; Upadhyay S, 2006, SENSOR ACTUAT B-CHEM, V119, P570, DOI 10.1016/j.snb.2006.01.008; Lin YQ, 2009, ANAL CHEM, V81, P2067, DOI 10.1021/ac801946s; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Hogerton AL, 2013, ANAL CHEM, V85, P9070, DOI 10.1021/ac401631k; Gligor D, 2009, ELECTROANAL, V21, P360, DOI 10.1002/elan.200804397; Marsman A, 2013, SCHIZOPHRENIA BULL, V39, P120, DOI 10.1093/schbul/sbr069; ZHOU SY, 1995, ANAL CHEM, V67, P594, DOI 10.1021/ac00099a017; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Liu K, 2013, ANAL CHEM, V85, P9947, DOI 10.1021/ac402620c; Kaul S, 2011, ELECTROPHORESIS, V32, P284, DOI 10.1002/elps.201000463; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Gao Y, 2013, ANAL CHEM, V85, P11494, DOI 10.1021/ac402728d; Khampha W, 2004, ANAL CHIM ACTA, V518, P127, DOI 10.1016/j.aca.2004.05.048; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Lu XL, 2013, ANAL CHEM, V85, P4007, DOI 10.1021/ac303743a; Zhu KY, 2011, J CHROMATOGR B, V879, P737, DOI 10.1016/j.jchromb.2011.02.011; WANG AJ, 1992, ANAL CHEM, V64, P1051, DOI 10.1021/ac00033a016; Rossi DJ, 2000, NATURE, V403, P316; Lin YQ, 2014, ANAL CHEM, V86, P3895, DOI 10.1021/ac4042087; Lawrence NS, 2006, ELECTROCHEM COMMUN, V8, P71, DOI 10.1016/j.elecom.2005.10.026; Jiang BY, 2013, BIOSENS BIOELECTRON, V43, P289, DOI 10.1016/j.bios.2012.12.038; Zhuang XM, 2012, ANAL CHEM, V84, P1900, DOI 10.1021/ac202748s; Yang L, 2009, ELECTROPHORESIS, V30, P3527, DOI 10.1002/elps.200900195; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Yu P, 2015, ANAL CHEM, V87, P1373, DOI 10.1021/ac504249k; Cudjoe E, 2014, J CHROMATOGR A, V1341, P1, DOI 10.1016/j.chroma.2014.03.035; Lin Y., ANALYST IN PRESS, DOI [10.1039/C4AN02089H, DOI 10.1039/C4AN02089H]; Paquet M., 2013, MOL BRAIN, V6; Park H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0097-y	42	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	OCT	2015	27	10					2406	2411		10.1002/elan.201500122		6	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CT6DU	WOS:000362902700021		
J	Takahashi, M; Shigeto, J; Sakamoto, A; Izumi, S; Asada, K; Morikawa, H				Takahashi, Misa; Shigeto, Jun; Sakamoto, Atsushi; Izumi, Shunsuke; Asada, Kozi; Morikawa, Hiromichi			Dual selective nitration in Arabidopsis: Almost exclusive nitration of PsbO and PsbP, and highly susceptible nitration of four non-PSII proteins, including peroxiredoxin II E	ELECTROPHORESIS			English	Article						Arabidopsis; Peroxiredoxin II E; Protein tyrosine nitration; PsbO; PsbP	PHOTOSYSTEM-II; TYROSINE NITRATION; NITROGEN-DIOXIDE; NITRIC-OXIDE; THALIANA CHLOROPLASTS; THYLAKOID MEMBRANES; MASS-SPECTROMETRY; PROTEOME; PLANTS; LUMEN	Protein tyrosine nitration is a selective process, as revealed in studies of animals. However, evidence for selective protein nitration in plants is scarce. In this study, Arabidopsis plants were exposed to air with or without nitrogen dioxide at 40 ppm for 8 h in light. Proteins extracted from whole leaves or isolated chloroplasts were subjected to 2D PAGE followed by SYPRO Ruby staining and immunoblotting using an anti-3-nitrotyrosine antibody. We determined the relative intensity of a spot on an immunoblot (designated RISI), and relative intensity of the corresponding spot on SYPRO Ruby gel (designated RISS). Proteins that exhibited a high RISI value and/or a high RISI/RISS ratio were considered selectively nitrated. In whole leaf proteins from exposed plants, all immunopositive spots were identified as PsbO1, PsbO2 or PsbP1 by PMF. Thus, nitration was exclusive to PsbO and PsbP, extrinsic proteins of photosystem II (PSII). Their RISI/RISS ratio was <= 1.5. Non-exposed plants showed very faint nitration. In purified chloroplast proteins, PsbO and PsbP accounted for >80% of the total RISI values, while four non-PSII proteins, including peroxiredoxin II E, exhibited high RISI/RISS ratios (2.5 similar to 6.6). Tyr(9) of PsbO1 was identified as a nitration site. Thus, nitration is selective for two PSII and four non-PSII proteins in Arabidopsis.	[Takahashi, Misa; Shigeto, Jun; Sakamoto, Atsushi; Izumi, Shunsuke; Morikawa, Hiromichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima, Japan; [Asada, Kozi] Fukuyama Univ, Fac Engn, Fukuyama, Hiroshima 72902, Japan	Takahashi, M (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	mtakahas@sci.hiroshima-u.ac.jp		Sakamoto, Atsushi/0000-0001-5710-1900	Nippon Life Insurance Foundation; Nissan Science Foundation; Japan Science and Technology Agency [13GS0023]; Japan Society for the Promotion of Science [15710149]	This work was supported by a grant from the Nippon Life Insurance Foundation (to MT); by a grant from the Nissan Science Foundation (to MT); by a Grant-in-Aid for Creative Scientific Research from the Japan Science and Technology Agency no. 13GS0023 (to HM); and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science no. 15710149 (to MT).	Allahverdiyeva Y, 2009, BBA-BIOENERGETICS, V1787, P1230, DOI 10.1016/j.bbabio.2009.05.013; Takahashi M, 2005, NEW PHYTOL, V168, P149, DOI 10.1111/j.1469-8137.2005.01493.x; Wyman AJ, 2008, BIOCHEMISTRY-US, V47, P6490, DOI 10.1021/bi800225m; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; He XD, 2000, J BIOL CHEM, V275, P13250, DOI 10.1074/jbc.275.18.13250; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Cheng TL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00030; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Lozano-Juste J, 2011, J EXP BOT, V62, P3501, DOI 10.1093/jxb/err042; Dietz KJ, 2011, ANTIOXID REDOX SIGN, V15, P1129, DOI 10.1089/ars.2010.3657; Shapiro AD, 2005, VITAM HORM, V72, P339, DOI 10.1016/S0083-6729(05)72010-0; Morikawa H, 2004, PLANTA, V219, P14, DOI 10.1007/s00425-003-1200-7; Matsuo E, 2006, PROTEOMICS, V6, P2042, DOI 10.1002/pmic.200500575; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Cecconi D, 2009, ELECTROPHORESIS, V30, P2460, DOI 10.1002/elps.200800826; Signorelli S, 2011, ARCH BIOCHEM BIOPHYS, V512, P190, DOI 10.1016/j.abb.2011.06.003; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Chaki M, 2009, J EXP BOT, V60, P4221, DOI 10.1093/jxb/erp263; Takahashi M, 2001, PLANT PHYSIOL, V126, P731, DOI 10.1104/pp.126.2.731; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; TAKAHASHI M, 1985, PLANT CELL PHYSIOL, V26, P1093; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Anderson JM, 2008, PHOTOSYNTH RES, V98, P575, DOI 10.1007/s11120-008-9381-3; Rubbo H, 2008, BBA-GEN SUBJECTS, V1780, P1318, DOI 10.1016/j.bbagen.2008.03.007; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Galetskiy D, 2011, RAPID COMMUN MASS SP, V25, P184, DOI 10.1002/rcm.4855; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Takahashi M, 2014, NEW PHYTOL, V201, P1304, DOI 10.1111/nph.12609; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Beckman J. S., 1996, NITRIC OXIDE PRINCIP, P1, DOI 10.1016/B978-012435555-2/50002-4; GORG A, 1985, ELECTROPHORESIS, V6, P599, DOI 10.1002/elps.1150061206; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Takahashi M., 2014, PLANT SIG BEHAV, V9; Weigel D, 2002, ARABIDOPSIS LAB MANU	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	OCT	2015	36	20					2569	2578		10.1002/elps.201500145		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CT7VW	WOS:000363023600010		
J	Nicholas, A				Nicholas, Allan			A concept-based approach to teaching speech acts in the EFL classroom	ELT JOURNAL			English	Article							CONVERSATION ANALYSIS; PRAGMATICS	While concept-based instruction (CBI), grounded in sociocultural theory, has been the subject of increased attention in recent years, it is still a relatively unknown methodology in language teaching contexts. In this approach, the emphasis is on helping learners develop a deep, conceptual understanding of a skill or knowledge area, so that this knowledge can then be applied in a variety of situations. This article reports on a study in which elements of CBI were combined with findings from conversation analysis research to create a short course on speech acts and the act of requesting. By combining these two areas, the author addresses some of the challenges facing teachers wishing to teach pragmatics in the classroom. The article discusses key features of the course, and proposes a number of principles for effective concept-based speech act instruction.	Kanda Univ, External Language Consultancy Ctr, Chiba, Japan	Nicholas, A (reprint author), Kanda Univ, External Language Consultancy Ctr, Chiba, Japan.	allannicholas@me.com					McConachy T, 2013, ELT J, V67, P294, DOI 10.1093/elt/cct017; Barraja-Rohan AM, 2011, LANG TEACH RES, V15, P479, DOI 10.1177/1362168811412878; Kasper G, 2006, AILA REV, V19, P83, DOI 10.1075/aila.19.07kas; Huth T, 2006, LANG TEACH RES, V10, P53, DOI 10.1191/1362168806lr184oa; Austin J. L, 1962, DO THINGS WORDS; Barraja-Rohan A. M., 1997, TALK COURSE COMMUNIC; Brown P., 1987, POLITENESS SOME UNIV; Di Pietro R. J., 1987, STRATEGIC INTERACTIO; Fukushima S., 2000, REQUESTS AND CULTURE; Gal'perin P. Y., 1979, SOV PSYCHOL, V18, P19; Gibbs Jr R. W., 2005, EMBODIMENT COGNITIVE; LoCastro V., 2012, PRAGMATICS LANGUAGE; Mey J. L., 1993, PRAGMATICS INTRO; Negueruela E., 2008, SOCIOCULTURAL THEORY; Vygotsky L.S., 1978, MIND SOC DEV HIGHER	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0951-0893	1477-4526		ELT J	ELT J.	OCT	2015	69	4					383	394		10.1093/elt/ccv034		12	Education & Educational Research; Linguistics; Language & Linguistics	Education & Educational Research; Linguistics	CT7AA	WOS:000362964200004		
J	Das, J; Das, SK; Ahmed, S; Ferdous, F; Farzana, FD; Sarker, MHR; Ahmed, AMS; Chisti, MJ; Malek, MA; Rahman, A; Faruque, ASG; Mamun, AA				Das, J.; Das, S. K.; Ahmed, S.; Ferdous, F.; Farzana, F. D.; Sarker, M. H. R.; Ahmed, A. M. S.; Chisti, M. J.; Malek, M. A.; Rahman, A.; Faruque, A. S. G.; Mamun, A. A.			Determinants of percent expenditure of household income due to childhood diarrhoea in rural Bangladesh	EPIDEMIOLOGY AND INFECTION			English	Article						Bangladesh; diarrhoea; health economics; paediatrics; rotavirus; rural; Shigella	DISEASE; BURDEN; COST	There is limited information on percent expenditure of household income due to childhood diarrhoea especially in rural Bangladesh. A total of 4205 children aged < 5 years with acute diarrhoea were studied. Percent expenditure was calculated as total expenditure for the diarrhoeal episode divided by monthly family income, multiplied by 100. Overall median percent expenditure was 3.04 (range 0.01-94.35). For Vibrio cholerae it was 6.42 (range 0.52-82.85), for enterotoxigenic Escherichia coli 3.10 (range 0.22-91.87), for Shigella 3.17 (range 0.06-77.80), and for rotavirus 3.08 (range 0.06-48.00). In a multinomial logistic regression model, for the upper tertile of percent expenditure, significant higher odds were found for male sex, travelling a longer distance to reach hospital (>= median of 4 miles), seeking care elsewhere before attending hospital, vomiting, higher frequency of purging (>= 10 times/day), some or severe dehydration and stunting. V. cholerae was the highest and rotavirus was the least responsible pathogen for percent expenditure of household income due to childhood diarrhoea.	[Das, J.; Das, S. K.; Ahmed, S.; Ferdous, F.; Farzana, F. D.; Sarker, M. H. R.; Chisti, M. J.; Malek, M. A.; Rahman, A.; Faruque, A. S. G.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Das, S. K.; Ahmed, A. M. S.; Mamun, A. A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Ferdous, F.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki 305, Japan	Das, SK (reprint author), Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia.	sumon.das@uqconnect.edu.au			Government of Australia; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	icddr,b acknowledges with gratitude the commitment of Sida to its research efforts. icddr, b is also grateful to the Governments of Australia, Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. Our heartfelt thanks go to the Medical Director of Kumudini Women's Medical College and Hospital for his sincere support to the research team. We also acknowledge all the research personnel for their sincere efforts in data collection, and the laboratory personnel for their quality performance.	Alvis Guzman N, 2013, VACCINE, V31, pC58; Qadri F, 2005, EMERG INFECT DIS, V11, P1104; Aikins M, 2010, J INFECT DIS, V202, pS126, DOI 10.1086/653573; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Bhuiyan MU, 2014, AM J TROP MED HYG, V91, P165, DOI 10.4269/ajtmh.13-0484; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Ciccarelli Simona, 2013, Infect Drug Resist, V6, P133, DOI 10.2147/IDR.S12718; Das SK, 2013, J INFECT DEV COUNTR, V7, P900, DOI 10.3855/jidc.3003; Das SK, 2013, AM J TROP MED HYG, V89, P62, DOI 10.4269/ajtmh.13-0107; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69; Onyango AW, 2008, TRANING COURSE CHILD; Rheingans A, 2012, CLIN INFECT DIS S4, V55, P5327; Rheingans R, 2012, CLIN INFECT DIS, V55, P317; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; [孙立梅 Sun Limei], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P989; Walker C.L., 2013, LANCET, V38, P1405, DOI DOI 10.1016/S0140-6736(13)60222-6	17	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	OCT	2015	143	13					2700	2706		10.1017/S0950268814003781		7	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CT6XA	WOS:000362955200002		
J	Yahata, Y; Misaki, T; Ishida, Y; Nagira, M; Watahiki, M; Isobe, J; Terajima, J; Iyoda, S; Mitobe, J; Ohnishi, M; Sata, T; Taniguchi, K; Tada, Y; Okabe, N				Yahata, Y.; Misaki, T.; Ishida, Y.; Nagira, M.; Watahiki, M.; Isobe, J.; Terajima, J.; Iyoda, S.; Mitobe, J.; Ohnishi, M.; Sata, T.; Taniguchi, K.; Tada, Y.; Okabe, N.		E coli O111 Outbreak Invest Team	Epidemiological analysis of a large enterohaemorrhagic Escherichia coli O111 outbreak in Japan associated with haemolytic uraemic syndrome and acute encephalopathy	EPIDEMIOLOGY AND INFECTION			English	Article						Escherichia coli infection; foodborne diseases; infectious disease outbreaks	MULTISTATE OUTBREAK; O157-H7 INFECTIONS; UNITED-STATES; RISK-FACTORS; CONSUMPTION; DIVERSITY; FEATURES; STRAINS; DEATH; CHAIN	A large outbreak of enterohaemorrhagic Escherichia coli (EHEC) O111 and O157 occurred in Japan in April 2011. We conducted an unmatched case-control study and trace-back investigation to determine the source of EHEC O111 infection and risk factors for severe complications. Pulsed-field gel electrophoresis was performed to help define cases. A total of 86 individuals met the case definition. Of these, 40% experienced haemolytic uraemic syndrome (HUS), 24% acute encephalopathy, and 6% died. Illness was significantly associated with eating the raw beef dish yukhoe (odds ratio 19.64, 95% confidence interval 7.03-54.83), the likely food vehicle. EHEC O111 and its closely related stx-negative variants were found in the beef. HUS occurred most frequently in individuals aged 5-9 years, and this age group was significantly associated with acute encephalopathy. The prevalence of HUS and acute encephalopathy was higher than in previous non-O157-related outbreaks, indicating a high risk of severe complications.	[Yahata, Y.; Misaki, T.; Nagira, M.; Terajima, J.; Iyoda, S.; Mitobe, J.; Ohnishi, M.; Taniguchi, K.; Tada, Y.; Okabe, N.] Natl Inst Infect Dis, Tokyo, Japan; [Ishida, Y.] Toyama City Hosp, Toyama, Japan; [Watahiki, M.; Isobe, J.; Sata, T.] Toyama Inst Hlth, Toyama, Japan	Yahata, Y (reprint author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	yahata@nih.go.jp			Ministry of Health, Labour and Welfare of Japan [H23-TOKUBETU-SHITEI-004]	This work was supported by a Health Labour Sciences Research Grant for Special Research from the Ministry of Health, Labour and Welfare (grant number: H23-TOKUBETU-SHITEI-004) of Japan.	Chang HGH, 2004, EMERG INFECT DIS, V10, P928; Takanashi J, 2014, NEUROLOGY, V82, P564, DOI 10.1212/WNL.0000000000000120; Watahiki M, 2014, J CLIN MICROBIOL, V52, P2757, DOI 10.1128/JCM.00420-14; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Beutin L, 2007, J CLIN MICROBIOL, V45, P333, DOI 10.1128/JCM.01627-06; Nakano T, 1998, PEDIATR INFECT DIS J, V17, P534, DOI 10.1097/00006454-199806000-00026; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Rangel JM, 2005, EMERG INFECT DIS, V11, P603; Jay MT, 2004, CLIN INFECT DIS, V39, P1, DOI 10.1086/421088; Parry SM, 1998, LANCET, V351, P1019, DOI 10.1016/S0140-6736(97)08376-1; Piercefield EW, 2010, ARCH INTERN MED, V170, P1656, DOI 10.1001/archinternmed.2010.346; Sodha SV, 2011, EPIDEMIOL INFECT, V139, P309, DOI 10.1017/S0950268810000920; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Tserenpuntsag B, 2005, EMERG INFECT DIS, V11, P1955; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Bradley KK, 2012, EPIDEMIOL INFECT, V140, P1644, DOI 10.1017/S0950268811002329; Terajima J, 2002, JPN J INFECT DIS, V55, P19; BRANDT JR, 1994, J PEDIATR-US, V125, P519, DOI 10.1016/S0022-3476(94)70002-8; Centers for Disease Control and Prevention (CDC), 1996, MMWR-MORBID MORTAL W, V45, P249; Gould LH, 2000, CLIN INFECT DIS, V49, P1480, DOI DOI 10.1086/644621; Isobe J, 2014, J CLIN MICROBIOL, V52, P1112, DOI 10.1128/JCM.03469-13; National Institute of Infectious Diseases, 2010, IASR, V31, P151; National Institute of Infectious Diseases, 2007, INFECT AGENTS SURVEI, V28, P131; National Institute of Infectious Diseases, 2008, INFECT AGENTS SURVEI, V29, P117; National Institute of Infectious Diseases, 2009, INFECT AGENTS SURVEI, V30, P119; National Institute of Infectious Diseases, 2011, INFECT AGENTS SURVEI, V32, P125; National Institute of Infectious Diseases, 2013, IASR, V34, P123; Office of Public Health Science Office of Policy and Program Development Food Safety and Inspection Service United States Department of Agriculture, RISK PROF PATH NONO1; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Robert Koch-Institute, OUTBR CAS DEF EHEC H; Saitou T, 2012, IASR, V33, P128; Shefer AM, 1996, WESTERN J MED, V165, P15; Wendel A. M., 2006, CLIN INFECT DIS, V48, P1079, DOI [10.1086/597399, DOI 10.1086/597399]	34	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	OCT	2015	143	13					2721	2732		10.1017/S0950268814003641		12	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CT6XA	WOS:000362955200004		
J	Hoa, LNM; Bryant, JE; Choisy, M; Nguyet, LA; Bao, NT; Trang, NH; Chuc, NTK; Toan, TK; Saito, T; Takemae, N; Horby, P; Wertheim, H; Fox, A				Hoa, L. N. M.; Bryant, J. E.; Choisy, M.; Nguyet, L. A.; Bao, N. T.; Trang, N. H.; Chuc, N. T. K.; Toan, T. K.; Saito, T.; Takemae, N.; Horby, P.; Wertheim, H.; Fox, A.			Population susceptibility to a variant swine-origin influenza virus A(H3N2) in Vietnam, 2011-2012	EPIDEMIOLOGY AND INFECTION			English	Article						Influenza A; virology (human) and epidemiology; zoonoses	A VIRUS; EVOLUTION; VACCINE; H3N2V	A reassortant swine-origin A(H3N2) virus (A/swine/BinhDuong/03-9/2010) was detected through swine surveillance programmes in southern Vietnam in 2010. This virus contains haemagglutinin and neuraminidase genes from a human A(H3N2) virus circulating around 2004-2006, and the internal genes from triple-reassortant swine influenza A viruses (IAVs). To assess population susceptibility to this virus we measured haemagglutination inhibiting (HI) titres to A/swine/BinhDuong/03-9/2010 and to seasonal A/Perth/16/2009 for 947 sera collected from urban and rural Vietnamese people during 2011-2012. Seroprevalence (HI >= 40) was high and similar for both viruses, with 62.6% [95% confidence interval (CI) 59.4-65.7] against A/Perth/16/2009 and 54.6% (95% CI 51.4-57.8%) against A/swine/BinhDuong/03-9/2010, and no significant differences between urban and rural participants. Children aged <5 years lacked antibodies to the swine origin H3 virus despite high seroprevalence for A/Perth/16/2009. These results reveal vulnerability to infection to this contemporary swine IAV in children aged <5 years; however, cross-reactive immunity in adults would likely limit epidemic emergence potential.	[Hoa, L. N. M.; Bryant, J. E.; Choisy, M.; Nguyet, L. A.; Bao, N. T.; Trang, N. H.; Horby, P.; Wertheim, H.; Fox, A.] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Hoa, L. N. M.; Bryant, J. E.; Choisy, M.; Nguyet, L. A.; Bao, N. T.; Trang, N. H.; Horby, P.; Wertheim, H.; Fox, A.] Univ Oxford, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Bryant, J. E.; Horby, P.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Choisy, M.] Univ Montpellier I, MIVEGEC, UMR, Montpellier, France; [Choisy, M.] Univ Montpellier 2, CNRS 5290, IRD 224, Montpellier, France; [Chuc, N. T. K.; Toan, T. K.] Hanoi Med Univ, Hanoi, Vietnam; [Saito, T.; Takemae, N.] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Ibaraki, Japan; [Fox, A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Bryant, JE (reprint author), Univ Oxford, Clin Res Unit Vietnam, Natl Hosp Trop Dis, 78 Giai Phong St, Hanoi, Vietnam.	jbryant@oucru.org			'Biodiversity and Infectious Diseases in Southeast Asia' GDRI; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Wellcome Trust of Great Britain VIZIONS project [WT/093724]	M.C. is supported by the 'Biodiversity and Infectious Diseases in Southeast Asia' GDRI. T.S. and N.T. are supported by a programme of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors thank Dr Sabrina L. Swenson, National Veterinary Services Laboratories, Ames, IA, USA, for providing A/swine/Indiana/A00968373/2012 (H3N2v). Funding was obtained from the Wellcome Trust of Great Britain VIZIONS project (WT/093724).	Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Harder TC, 2013, J VIROL, V87, P10460, DOI 10.1128/JVI.00381-13; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Dao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091999; Fonville JM, SCIENCE IN PRESS; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Ngo LT, 2011, INFLUENZA OTHER RESP, V2, P1	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	OCT	2015	143	14					2959	2964		10.1017/S0950268815000187		6	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CT6XD	WOS:000362955500005		
J	Kagami, M; Kurosawa, K; Miyazaki, O; Ishino, F; Matsuoka, K; Ogata, T				Kagami, Masayo; Kurosawa, Kenji; Miyazaki, Osamu; Ishino, Fumitoshi; Matsuoka, Kentaro; Ogata, Tsutomu			Comprehensive clinical studies in 34 patients with molecularly defined UPD(14)pat and related conditions (Kagami-Ogata syndrome)	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article							PATERNAL UNIPARENTAL DISOMY; GENE-EXPRESSION; IMPRINTED GENE; NONCODING RNA; HYPOMETHYLATION; CHROMOSOME-14; ENDOCRINE; PHENOTYPE; COMPLEX; REGION	Paternal uniparental disomy 14 (UPD(14)pat) and epimutations and microdeletions affecting the maternally derived 14q32.2 imprinted region lead to a unique constellation of clinical features such as facial abnormalities, small bell-shaped thorax with a coat-hanger appearance of the ribs, abdominal wall defects, placentomegaly, and polyhydramnios. In this study, we performed comprehensive clinical studies in patients with UPD(14) pat (n=23), epimutations (n=5), and microdeletions (n=6), and revealed several notable findings. First, a unique facial appearance with full cheeks and a protruding philtrum and distinctive chest roentgenograms with increased coat-hanger angles to the ribs constituted the pathognomonic features from infancy through childhood. Second, birth size was well preserved, with a median birth length of +/- 0 SD (range, -1.7 to +3.0 SD) and a median birth weight of +2.3 SD (range, +0.1 to +8.8 SD). Third, developmental delay and/or intellectual disability was invariably present, with a median developmental/intellectual quotient of 55 (range, 29-70). Fourth, hepatoblastoma was identified in three infantile patients (8.8%), and histological examination in two patients showed a poorly differentiated embryonal hepatoblastoma with focal macrotrabecular lesions and well-differentiated hepatoblastoma, respectively. These findings suggest the necessity of an adequate support for developmental delay and periodical screening for hepatoblastoma in the affected patients, and some phenotypic overlap between UPD(14)pat and related conditions and Beckwith-Wiedemann syndrome. On the basis of our previous and present studies that have made a significant contribution to the clarification of underlying (epi)genetic factors and the definition of clinical findings, we propose the name 'Kagami-Ogata syndrome' for UPD(14)pat and related conditions.	[Kagami, Masayo; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; [Miyazaki, Osamu] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo, Japan; [Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo, Japan; [Matsuoka, Kentaro] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	Ogata, T (reprint author), Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan.	tomogata@hama-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [25253023, 23390083]; Grants for Health Research on Children, Youth, and Families [H25-001]; Ministry of Health, Labor and Welfare (MHLW) [H22-161]; National Center for Child Health and Development [23A-1, 25-10]; Takeda Science Foundation	We are grateful to all patients and their parents for their cooperation. We thank Drs Haruhiko Sago, Aiko Sasaki, Jun Shibasaki, Rika Kosaki, Michiko Hayashidani, Toshio Takeuchi, Shinya Tanaka, Mika Noguchi, Goro Sasaki, Kouji Matsumoto, Takeshi Utsunomiya, Yumiko Komatsu, Hirofumi Ohashi, Hiroshi Kishimoto, Maureen J O'Sullivan, Andrew J Green, Yoshiyuki Watabe, Tsuyako Iwai, Hitoshi Kawato, Akiko Yamamoto, Nobuhiro Suzumori, Hiroko Ueda, Makoto Kuwajima, Kiyoko Samejima, Hiroshi Yoshihashi, Yoriko Watanabe, Jin Nishimura, Shuku Ishikawa, Michiko Yamanaka, Machiko Nakagawa, Hiroharu Inoue, Takashi Imamura, Keiichi Motoyama and Ryoko Yoshinare for providing us with detailed clinical data and materials for molecular studies, Dr Gen Nishimura for interpretation of roentgengraphic findings, and Drs Tadayuki Ayabe, Keiko Matsubara, Yoichi Sekita and Maki Fukami for their support in molecular analyses. We also thank Ms. Emma Barber for her editorial assistance with the final draft of this paper. This work was supported by: Grants-in-Aid for Scientific Research (A) (25253023) and Research (B) (23390083) from the Japan Society for the Promotion of Science (JSPS), and by Grants for Health Research on Children, Youth, and Families (H25-001) and for Research on Intractable Diseases (H22-161) from the Ministry of Health, Labor and Welfare (MHLW), by Grants from the National Center for Child Health and Development (23A-1, 25-10), and by a Grant from Takeda Science Foundation.	Miyazaki O, 2011, PEDIATR RADIOL, V41, P1013, DOI 10.1007/s00247-011-2132-1; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Ioannides Y, 2014, J MED GENET, V51, P495, DOI 10.1136/jmedgenet-2014-102396; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Hurst LD, 1997, TRENDS GENET, V13, P436, DOI 10.1016/S0168-9525(97)01273-0; Yamazawa K, 2008, J HUM GENET, V53, P950, DOI 10.1007/s10038-008-0329-4; WANG JCC, 1991, AM J HUM GENET, V48, P1069; Horii M, 2012, CONGENIT ANOM, V52, P219, DOI 10.1111/j.1741-4520.2012.00364.x; Parveen Z, 2007, ARCH PATHOL LAB MED, V131, P131; Kagami M, 2005, AM J MED GENET A, V138A, P127, DOI 10.1002/ajmg.a.30941; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Berend SA, 2000, AM J HUM GENET, V66, P1787, DOI 10.1086/302916; Kurosawa K, 2002, AM J MED GENET, V110, P268, DOI 10.1002/ajmg.10404; Kagami M, 2012, EPIGENETICS-US, V7, P1142, DOI 10.4161/epi.21937; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Falix FA, 2012, PEDIATR BLOOD CANCER, V59, P743, DOI 10.1002/pbc.24024; Hoffmann K, 2011, BEST PRACT RES CL EN, V25, P77, DOI 10.1016/j.beem.2010.09.004; Kang ER, 2011, EPIGENETICS-US, V6, P937, DOI 10.4161/epi.6.7.16067; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.04.043; Kagami M, 2012, EUR J HUM GENET, V20, P928, DOI 10.1038/ejhg.2012.26; Kagami M, 2008, PLACENTA, V29, P760, DOI 10.1016/j.placenta.2008.06.001; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Beall MH, 2007, PLACENTA, V28, P816, DOI 10.1016/j.placenta.2006.11.009; Williams DH, 2005, PRENATAL DIAG, V25, P879, DOI 10.1002/pd.1155; Azzi S, 2014, HUM MUTAT, V35, P1211, DOI 10.1002/humu.22623; Beygo J, 2015, EUR J HUM GENET, V23, P180, DOI 10.1038/ejhg.2014.72; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Hosoki K, 2009, J PEDIATR-US, V155, P900, DOI 10.1016/j.jpeds.2009.06.045; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Modena Alberto Bacchi, 2004, Acta Biomed, V75 Suppl 1, P11; Riordan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003441	34	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	OCT	2015	23	11					1488	1498		10.1038/ejhg.2015.13		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CT6IH	WOS:000362916200012		
J	Chopin, N; Yanai, H; Iikawa, S; Pilet, G; Bouillon, JP; Medebielle, M				Chopin, Nicolas; Yanai, Hikaru; Iikawa, Shinya; Pilet, Guillaume; Bouillon, Jean-Philippe; Medebielle, Maurice			A Rapid Entry to Diverse gamma-Ylidenetetronate Derivatives through Regioselective Bromination of Tetronic Acid Derived gamma-Lactones and Metal-Catalyzed Postfunctionalization	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Halogenation; Cross-coupling; Cycloaddition; Lactones; Oxygen heterocycles	PULVINIC ACIDS; ANTIOXIDANT PROPERTIES; ORGANIC-SYNTHESIS; ENOL ETHERS; CYCLOADDITION; BIOSYNTHESIS; INHIBITORS; CHEMISTRY	The synthesis of a series of diverse methyl and benzyl gamma-ylidenetetronate derivatives was accomplished through the condensation of methyl and benzyl tetronates with (hetero)-aryl aldehydes in a new two- or three-step aldolisation/dehydration sequence. The bromination of methyl and benzyl gamma-ylidenetetronates occurred under mild conditions to provide the corresponding C-3-brominated gamma-unsaturated lactones. Di- and tribrominated gamma-lactones were prepared under slightly different conditions. Some brominated materials were employed in representative Stille, Suzuki-Miyaura, and Sonogashira cross-coupling reactions to yield functionalized methyl and benzyl gamma-ylidenetetronate derivatives. Compounds that resulted from the Sonogashira cross-coupling reactions were desilylated and converted into 1,2,3-triazole derivatives through a copper(I)-catalyzed 1,3-dipolar cycloaddition reaction with benzyl azide.	[Chopin, Nicolas; Iikawa, Shinya; Medebielle, Maurice] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol ICBMS, UMR CNRS UCBL INSA Lyon 5246, F-69622 Villeurbanne, France; [Yanai, Hikaru] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Pilet, Guillaume] Univ Lyon 1, Lab Multimat & Interfaces LMI, UMR CNRS UCBL 5615, F-69622 Villeurbanne, France; [Bouillon, Jean-Philippe] Univ Rouen, UMR CNRS Univ Rouen INSA Rouen 6014, Chim Organ Bioorgan Reactivite & Anal COBRA, IRCOF, F-76821 Mont St Aignan, France	Bouillon, JP (reprint author), Univ Rouen, UMR CNRS Univ Rouen INSA Rouen 6014, Chim Organ Bioorgan Reactivite & Anal COBRA, IRCOF, F-76821 Mont St Aignan, France.	yanai@toyaku.ac.jp; guillaume.pilet@univ-lyon1.fr; jean-philippe.bouillon@univ-rouen.fr; maurice.medebielle@univ-lyon1.fr			Agence Nationale de la Recherche (ANR) [ANR-11-EMMA-04-QUINOLAC]; Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique (CNRS); Universite Claude Bernard Lyon 1 (UCBL); PICS exchange program of CNRS [05871]	This work was supported by the Agence Nationale de la Recherche (ANR) (ANR-11-EMMA-04-QUINOLAC) and the Ministere de l'Enseignement Superieur et de la Recherche (Ph. D. fellowship to S. I.). Additional support was provided by the Centre National de la Recherche Scientifique (CNRS) and the Universite Claude Bernard Lyon 1 (UCBL). H. Y. and M. M. are grateful to the PICS exchange program of CNRS (grant number 05871) for fostering our international collaboration. The authors also thank Julien Bosson and Clement de Saint Jores for some materials syntheses and Florian Albrieux, Christian Duchet, Nathalie Enriques, and Reynald Helye from the Centre Commun de Spectrometrie de Masse (CCSM) of Universite Claude Bernard Lyon 1 for assistance and access to the mass spectrometry facility.	Nadal B, 2011, TETRAHEDRON, V67, P2605, DOI 10.1016/j.tet.2011.02.011; SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Uenishi J, 1997, J ORG CHEM, V62, P1691, DOI 10.1021/jo961993f; Weixler R, 2011, J ORG CHEM, V76, P5924, DOI 10.1021/jo201066d; Habrant D, 2009, J MED CHEM, V52, P2454, DOI 10.1021/jm801500h; Rouleau J, 2013, TETRAHEDRON, V69, P10842, DOI 10.1016/j.tet.2013.10.087; ROYLES BJL, 1995, CHEM REV, V95, P1981, DOI 10.1021/cr00038a009; POSS AJ, 1989, TETRAHEDRON LETT, V30, P2505, DOI 10.1016/S0040-4039(01)80436-6; [Anonymous], 2009, CRYSALISPRO V 1 171; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Hou JL, 2012, EXPERT OPIN DRUG DIS, V7, P489, DOI 10.1517/17460441.2012.682725; Chinchilla R, 2007, CHEM REV, V107, P874, DOI 10.1021/cr050992x; Bidon-Chanal A, 2013, EUR J MED CHEM, V60, P479, DOI 10.1016/j.ejmech.2012.12.014; Dubois S, 2012, ORG BIOMOL CHEM, V10, P4712, DOI 10.1039/c2ob25299f; Kotha S, 2002, TETRAHEDRON, V58, P9633, DOI 10.1016/S0040-4020(02)01188-2; Mansour TS, 2007, CHEMMEDCHEM, V2, P1414, DOI 10.1002/cmdc.200700094; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Selig R, 2011, TETRAHEDRON, V67, P9204, DOI 10.1016/j.tet.2011.09.053; Bourdreux Y, 2008, TETRAHEDRON, V64, P8930, DOI 10.1016/j.tet.2008.06.058; Antane S, 2006, BIOORG MED CHEM LETT, V16, P176, DOI 10.1016/j.bmcl.2005.09.021; Iikawa S, 2013, TETRAHEDRON LETT, V54, P4577, DOI 10.1016/j.tetlet.2013.06.106; Katakawa K, 2014, HETEROCYCLES, V88, P817, DOI 10.3987/COM-13-S(S)66; Albrecht D, 2008, J ORG CHEM, V73, P2345, DOI 10.1021/jo7027129; Kende AS, 2002, TETRAHEDRON, V58, P61, DOI 10.1016/S0040-4020(01)01138-3; Nadal B, 2010, BIOORGAN MED CHEM, V18, P7931, DOI 10.1016/j.bmc.2010.09.037; Schobert R, 2008, BIOORGAN MED CHEM, V16, P4203, DOI 10.1016/j.bmc.2008.02.069; Nadal B, 2009, TETRAHEDRON LETT, V50, P2430, DOI 10.1016/j.tetlet.2009.03.011; Chinchilla R, 2011, CHEM SOC REV, V40, P5084, DOI 10.1039/c1cs15071e; Gao HQ, 2013, BIOORG MED CHEM LETT, V23, P1776, DOI 10.1016/j.bmcl.2013.01.051; REHSE K, 1985, ARCH PHARM, V318, P11, DOI 10.1002/ardp.19853180104; Boschi A, 2000, J ORG CHEM, V65, P8470, DOI 10.1021/jo000799x; Boquet D., 2005, CHEMBIOCHEM, V6, P1234; CAMPBELL AC, 1985, J CHEM SOC PERK T 1, P1567, DOI 10.1039/p19850001567; Cascarano G., 1996, ACTA CRYSTALLOGR A, V52, pC; DEMEULEN.J, 1965, ACTA CRYSTALLOGR, V19, P1014, DOI 10.1107/S0365110X65004802; Fleck M., 2010, CHEM-EUR J, V167, P6015; Georgiadis D., 2013, NATURAL LACTONES LAC, P1; Zografos AL, 2006, SYNTHESIS-STUTTGART, P3157, DOI 10.1055/s-2006-950202; Ghobril C, 2011, EUR J ORG CHEM, P3416, DOI 10.1002/ejoc.201100491; Giordano C., 1992, J ORG CHEM, V57, P2766; Lacoske MH, 2015, J NAT PROD, V78, P562, DOI 10.1021/np500757w; PELTER A, 1987, J CHEM SOC PERK T 1, P717, DOI 10.1039/p19870000717; Rostovtsev V. V., 2002, ANGEW CHEM, V174, P2708, DOI DOI 10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0; Ruasse M.-F., 1993, ADV PHYS ORG CHEM, V28, P2072; Stachel H.-D., 1994, LIEBIGS ANN CHEM, V9, P961; Vieweg L, 2014, NAT PROD REP, V31, P1554, DOI 10.1039/c4np00015c; Watkin D. J., 1999, CRYSTALS ISSUE 11; Weixler R, 2014, SYNTHESIS-STUTTGART, V46, P2663, DOI 10.1055/s-0034-1378282; Yanai H., 2015, GREEN SYNTHETIC APPR, P257; Yang SH, 2009, SYNLETT, P1351, DOI 10.1055/s-0029-1216645; Yin X., 2010, DALTON T, V41, P9929	52	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	OCT	2015		28					6259	6269		10.1002/ejoc.201500663		11	Chemistry, Organic	Chemistry	CT4AK	WOS:000362747900016		
J	Ono, F; Hirata, O; Ichimaru, K; Saruhashi, K; Watanabe, H; Shinkai, S				Ono, Fumiyasu; Hirata, Osamu; Ichimaru, Keiko; Saruhashi, Koichiro; Watanabe, Hisayuki; Shinkai, Seiji			Mild One-Step Synthesis of 4,6-Benzylideneglycopyranosides from Aromatic Aldehydes and Gelation Abilities of the Glucose Derivatives	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Carbohydrates; Protecting groups; Self-assembly; Gels; Nanostructures	SUGAR-INTEGRATED GELATORS; GEL-PHASE MATERIALS; SUPRAMOLECULAR GELS; ORGANIC-SOLVENTS; OIL-SPILLS; ORGANOGELS; DIVERSITY; ACETALS; SCAFFOLDS; WATER	We report herein an efficient one-step synthesis of 4,6-benzylidene glycoside derivatives from aromatic aldehydes bearing electron-donating or -withdrawing groups as well as polymerisable monomer groups. Glucose, mannose and galactose derivatives could also be used successfully. Several of the glucose derivatives thus obtained acted as gelators for various solvents, including water. 4-(n-Butoxybenzylidene)glucose derivative 3a produced both a clear squalane gel and a hydrogel at 0.1 wt.-%. Furthermore, 3-(n-butoxybenzylidene)glucose derivative 3i produced a clear organogel and an opaque hydrogel. The critical gelation concentration (CGC) of 3i in squalane was determined to be 0.02 wt.-%, which is one of the lowest CGC values reported so far. The organogels, hydrogels and aqueous solution gels produced from 3a and 3d exhibited thixotropy. The strength and thixotropy of the organo- and hydrogel produced from 3a were estimated by a rheometer. The gel morphologies were observed by field-emission and wet-scanning electron microscopy, and the self-assembly modes were analysed by XRD. We have concluded that super-gelators can be created by this method.	[Ono, Fumiyasu; Ichimaru, Keiko; Watanabe, Hisayuki] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Collaborat Res Div, Adv Mat Res Lab,Nishi Ku, Fukuoka, Fukuoka 8190388, Japan; [Hirata, Osamu; Saruhashi, Koichiro; Watanabe, Hisayuki] Nissan Chem Ind Co Ltd, Funabashi, Chiba 2748507, Japan; [Shinkai, Seiji] Inst Syst Informat Technol & Nanotechnol ISIT, Nishi Ku, Fukuoka, Fukuoka 8190388, Japan	Ono, F (reprint author), Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Collaborat Res Div, Adv Mat Res Lab,Nishi Ku, 4-1 Kyudai Shinmachi, Fukuoka, Fukuoka 8190388, Japan.				Nissan Chemical Industries, Ltd.	The authors thank Ms. Makiko Fukuda for support with the rheological measurements. The authors thank Dr. Midori Watanabe, Center of Advanced Instrumental Analysis, Kyushu University, for support with the wet-SEM observations. The authors thank Mr. Taisuke Matsumoto, Evaluation Center of Materials Properties and Function, Institute for Materials Chemistry and Engineering, Kyushu University, for assistance with the XRD measurements and Mr. Yoshiaki Otani, Analytical Center in the Fukuoka Industry-Academia Symphonicity facility, for support with the NMR measurements. This work was financially supported by Nissan Chemical Industries, Ltd.	Alberts B., 2008, MOL BIOL CELL, P1505; Amanokura N., 1998, J CHEM SOC PERK T, V2, P2585; Yu GC, 2013, CHEM SOC REV, V42, P6697, DOI 10.1039/c3cs60080g; Yoza K, 1999, CHEM-EUR J, V5, P2722, DOI 10.1002/(SICI)1521-3765(19990903)5:9<2722::AID-CHEM2722>3.0.CO;2-N; Binatti I, 2002, J BRAZIL CHEM SOC, V13, P570, DOI 10.1590/S0103-50532002000500005; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Smith DK, 2009, CHEM SOC REV, V38, P684, DOI 10.1039/b800409a; Abreu MF, 2012, CARBOHYD RES, V353, P69, DOI 10.1016/j.carres.2012.03.021; Cipolla L, 2003, J CARBOHYD CHEM, V22, P631, DOI 10.1081/CAR-120026464; BAKER CW, 1974, CARBOHYD RES, V33, P372, DOI 10.1016/S0008-6215(00)82818-9; Cardona F, 2014, EUR J ORG CHEM, V2014, P2549, DOI 10.1002/ejoc.201400028; [Anonymous], 2008, ANGEW CHEM, P120; Chen Q, 2010, LANGMUIR, V26, P3165, DOI 10.1021/la903102z; BROWN MA, 1995, J ORGANOMET CHEM, V498, P275, DOI 10.1016/0022-328X(95)05529-X; Geng Y, 2013, EUR J ORG CHEM, V2013, P7035, DOI 10.1002/ejoc.201301116; Hoshizawa H, 2013, LANGMUIR, V29, P14666, DOI 10.1021/la402333h; Shundo A, 2011, CHEM COMMUN, V47, P8844, DOI 10.1039/c1cc12733k; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; Prathap A, 2012, CHEM COMMUN, V48, P5250, DOI 10.1039/c2cc31631e; Chen CT, 2005, ORG LETT, V7, P3343, DOI 10.1021/ol051178z; KIM S, 1989, TETRAHEDRON LETT, V30, P6279, DOI 10.1016/S0040-4039(01)93872-9; Gronwald O, 2001, CARBOHYD RES, V331, P307, DOI 10.1016/S0008-6215(01)00035-0; Gronwald O, 2002, CURR OPIN COLLOID IN, V7, P148, DOI 10.1016/S1359-0294(02)00016-X; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; Lobbel M, 2000, TETRAHEDRON-ASYMMETR, V11, P393, DOI 10.1016/S0957-4166(99)00504-2; Raeburn J, 2013, CHEM SOC REV, V42, P5143, DOI 10.1039/c3cs60030k; Piepenbrock MOM, 2010, CHEM REV, V110, P1960, DOI 10.1021/cr9003067; Gronwald O, 2001, CHEM-EUR J, V7, P4328, DOI 10.1002/1521-3765(20011015)7:20<4328::AID-CHEM4328>3.0.CO;2-S; BLOW DM, 1960, J AM CHEM SOC, V82, P3566, DOI 10.1021/ja01499a023; Lee SH, 2002, TETRAHEDRON LETT, V43, P2699, DOI 10.1016/S0040-4039(02)00387-8; Matsumoto K, 2015, PHYS CHEM CHEM PHYS, V17, P2192, DOI 10.1039/c4cp04395b; Tanaka A, 2015, J AM CHEM SOC, V137, P770, DOI 10.1021/ja510156v; Bourdreux Y, 2011, CHEM COMMUN, V47, P2146, DOI 10.1039/c0cc04398b; Brinksma J, 2000, LANGMUIR, V16, P9249, DOI 10.1021/la000839s; Buerkle LE, 2012, CHEM SOC REV, V41, P6089, DOI 10.1039/c2cs35106d; Ono F, 2014, RSC ADV, V4, P25940, DOI 10.1039/c4ra03096f; COLLINS PM, 1974, CARBOHYD RES, V33, P35, DOI 10.1016/S0008-6215(00)82938-9; Probert MA, 1997, TETRAHEDRON LETT, V38, P5861, DOI 10.1016/S0040-4039(97)01304-X; HODOSI G, 1994, TETRAHEDRON LETT, V35, P6129, DOI 10.1016/0040-4039(94)88095-6; Tanaka N, 2008, CARBOHYD RES, V343, P2675, DOI 10.1016/j.carres.2008.07.017; Mangan D, 2014, CARBOHYD RES, V395, P47, DOI 10.1016/j.carres.2014.05.002; Huang X, 2006, J AM CHEM SOC, V128, P15341, DOI 10.1021/ja0657206; Hou XY, 2011, LANGMUIR, V27, P12156, DOI 10.1021/la2022819; Sangeetha NM, 2005, CHEM SOC REV, V34, P821, DOI 10.1039/b417081b; CHITTENDEN GJF, 1988, RECL TRAV CHIM PAY B, V107, P607; EVANS ME, 1972, CARBOHYD RES, V21, P473, DOI 10.1016/S0008-6215(00)84931-9; Shirosaki T, 2006, J MATER RES, V21, P1274, DOI 10.1557/JMR.2006.0156; Luboradzki R, 2000, TETRAHEDRON, V56, P9595, DOI 10.1016/S0040-4020(00)00915-7; MILLER VP, 1989, J ORG CHEM, V54, P4175, DOI 10.1021/jo00278a035; Capozzi G, 2001, J ORG CHEM, V66, P8787, DOI 10.1021/jo010522c; Jadhav SR, 2010, ANGEW CHEM INT EDIT, V49, P7695, DOI 10.1002/anie.201002095; Dawn A, 2011, CHEM-ASIAN J, V6, P266, DOI 10.1002/asia.201000217; Liptak A, 2000, TETRAHEDRON LETT, V41, P4949, DOI 10.1016/S0040-4039(00)00735-8; Ajayaghosh A, 2008, CHEM SOC REV, V37, P109, DOI 10.1039/b704456a; Giri SK, 2008, J CARBOHYD CHEM, V27, P464, DOI 10.1080/07328300802458970; Cox D. J., 2014, EUR J ORG CHEM, V79, P4624; Gronwald O., 2001, J CHEM SOC P2, V10, P1933; Gronwald O, 2001, J CHEM SOC PERK T 2, P1933, DOI 10.1039/b104366h; Lescanne M, 2004, LANGMUIR, V20, P3032, DOI 10.1021/la035219g; Lindhorst T. K., 2007, ESSENTIAL CORBOHYDRA, P241; Luboradzki R, 2000, CHEM LETT, P1148, DOI 10.1246/cl.2000.1148; Munenobu K, 2014, ANAL CHEM, V86, P9924, DOI 10.1021/ac5026539; Neugebauer D, 2013, J POLYM SCI POL CHEM, V51, P2483, DOI 10.1002/pola.26642; Paquette LA, 2002, SYNTHESIS-STUTTGART, P2105; Richtmyer N. K., 1962, METHODS CARBOHYD CHE, V1, P107; Shirakawa M, 2005, J AM CHEM SOC, V127, P4164, DOI 10.1021/ja042869d; Yoza K, 1998, CHEM COMMUN, P907, DOI 10.1039/a800825f	67	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	OCT	2015		29					6439	6447		10.1002/ejoc.201500658		9	Chemistry, Organic	Chemistry	CT4AV	WOS:000362749100007		
J	Cacho, A; Ono, T; Kuboki, T; Martin, C				Cacho, Alberto; Ono, Tsuyoshi; Kuboki, Takuo; Martin, Conchita			Changes in joint space dimension after the correction of Class II division 1 malocclusion	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							CONDYLE-FOSSA RELATIONSHIP; FRANKEL APPLIANCE THERAPY; TEMPOROMANDIBULAR-JOINT; HERBST TREATMENT; ORTHODONTIC TREATMENT; ASYMPTOMATIC POPULATION; COMPUTED-TOMOGRAPHY; ACTIVATOR TREATMENT; MANDIBULAR CONDYLE; MIXED DENTITION	Objective: The aim of this prospective longitudinal investigation was to compare the relationship between the temporomandibular joint (TMJ) condyles and the temporal fossae by means of tomography before and after the orthodontic correction of Class II, division 1 malocclusion using the activator appliance. Materials and methods: The final sample consisted of 26 consecutively treated Class II, division 1 patients (19 boys and 7 girls with an average pre-treatment age of 11 years) who underwent orthodontic treatment by means of an activator appliance. Before treatment all patients were free of signs and symptoms associated to TMJ disorders. Bilateral tomographic records before and after treatment were taken and analyzed. Outlines of the condyle and temporal fossa were automatically determined by an edge-detection protocol, and the minimum joint space dimension was automatically measured every 2 degrees. For further analysis, the joint space was divided into anterior, superior, and posterior joint spaces. Results: The average treatment time with the activator appliance was 366 days. In all subjects, activator treatment resulted in a Class I dental arch relationship. After activator treatment, no differences were found in the joint space measurements in any direction. Comparisons between the right and left condyles were not significantly different. Conclusions: Joint space dimension in Class II division I children was similar before and after treatment in both TMJs.	[Cacho, Alberto; Martin, Conchita] Univ Complutense, Fac Odontol, Dept Prevent Dent Pedodont & Orthodont, E-28040 Madrid, Spain; [Ono, Tsuyoshi; Kuboki, Takuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Rehabil, Okayama 7008530, Japan	Martin, C (reprint author), Univ Complutense, Fac Odontol, Pl Ramon & Cajal S-N, E-28040 Madrid, Spain.	conchitamartin@odon.ucm.es	Martin, Conchita/G-3599-2015	Martin, Conchita/0000-0003-3997-6900			Katsavrias EG, 2004, ANGLE ORTHOD, V74, P79; Kuboki T, 1999, J OROFAC PAIN, V13, P38; Arat ZM, 2001, AM J ORTHOD DENTOFAC, V119, P316, DOI 10.1067/mod.2001.110245; Ruf S, 2000, ANGLE ORTHOD, V70, P183; KUNDINGER KK, 1991, AM J ORTHOD DENTOFAC, V100, P110, DOI 10.1016/S0889-5406(05)81517-3; Hansson LG, 1996, ORAL SURG ORAL MED O, V82, P698, DOI 10.1016/S1079-2104(96)80446-X; Pancherz H, 1999, AM J ORTHOD DENTOFAC, V116, P207, DOI 10.1016/S0889-5406(99)70219-2; PULLINGER A, 1986, ORAL SURG ORAL MED O, V62, P719, DOI 10.1016/0030-4220(86)90270-7; Voudouris JC, 2003, AM J ORTHOD DENTOFAC, V124, P13, DOI 10.1016/S0889-5406(03)00150-1; Ruf S, 1998, EUR J ORTHODONT, V20, P375, DOI 10.1093/ejo/20.4.375; Wadhawan N, 2008, ORTHOD CRANIOFAC RES, V11, P235, DOI 10.1111/j.1601-6343.2008.00436.x; Cohlmia JT, 1996, ANGLE ORTHOD, V66, P27; PULLINGER AG, 1985, J PROSTHET DENT, V53, P706, DOI 10.1016/0022-3913(85)90029-0; HAMILTON SD, 1987, AM J ORTHOD DENTOFAC, V92, P427, DOI 10.1016/0889-5406(87)90264-2; Croft RS, 1999, AM J ORTHOD DENTOFAC, V116, P435, DOI 10.1016/S0889-5406(99)70230-1; Pancherz H, 2004, AM J ORTHOD DENTOFAC, V126, P153, DOI 10.1016/j.ajodo.2003.07.015; Kinzinger GSM, 2006, DENTOMAXILLOFAC RAD, V35, P339, DOI 10.1259/dmfr/53048233; Kamelchuk LS, 1996, CRANIO, V14, P23; VARGERVIK K, 1985, AM J ORTHOD DENTOFAC, V88, P242, DOI 10.1016/S0002-9416(85)90219-2; Kinzinger G, 2007, J OROFAC ORTHOP, V68, P124, DOI 10.1007/s00056-007-0650-0; Vitral RWF, 2004, AM J ORTHOD DENTOFAC, V126, P48, DOI 10.1016/j.ajodo.2003.06.012; Ruf S, 1999, AM J ORTHOD DENTOFAC, V115, P607, DOI 10.1016/S0889-5406(99)70285-4; Ikeda K, 2009, AM J ORTHOD DENTOFAC, V135, P495, DOI 10.1016/j.ajodo.2007.05.021; PAULSEN HU, 1995, EUR J ORTHODONT, V17, P165; GIANELLY AA, 1983, ANGLE ORTHOD, V53, P131; Ruf S, 2002, ANGLE ORTHOD, V72, P527; Katsavrias EG, 2003, ANGLE ORTHOD, V73, P647; Chintakanon K, 2000, AM J ORTHOD DENTOFAC, V118, P494, DOI 10.1067/mod.2000.109839; ARTUN J, 1992, AM J ORTHOD DENTOFAC, V101, P48; PULLINGER AG, 1987, AM J ORTHOD DENTOFAC, V91, P200, DOI 10.1016/0889-5406(87)90447-1; GIANELLY AA, 1989, AM J ORTHOD DENTOFAC, V96, P428, DOI 10.1016/0889-5406(89)90328-4; MCNAMARA JA, 1982, AM J ORTHOD DENTOFAC, V82, P288, DOI 10.1016/0002-9416(82)90463-8; CREEKMORE TD, 1983, AM J ORTHOD DENTOFAC, V83, P89, DOI 10.1016/S0002-9416(83)90294-4; WOODSIDE DG, 1983, AM J ORTHOD DENTOFAC, V83, P460, DOI 10.1016/S0002-9416(83)90244-0; BACON W, 1992, European Journal of Orthodontics, V14, P224; LOGSDON LC, 1975, J DENT RES, V54, P184; Dalili Zahra, 2012, Dent Res J (Isfahan), V9, P607; Kuboki Takuo, 1997, Journal of Orofacial Pain, V11, P67; McNamara J, 2003, SEMIN ORTHOD, V9, P12, DOI 10.1053/sodo.2003.34021; McNamara J. A., 2003, SEMIN ORTHOD, V9, P26, DOI 10.1053/sodo.2003.34022; PANCHERZ H, 1985, AM J ORTHOD DENTOFAC, V88, P273, DOI 10.1016/0002-9416(85)90126-5; PANCHERZ H, 1979, AM J ORTHOD DENTOFAC, V76, P423, DOI 10.1016/0002-9416(79)90227-6; PANCHERZ H, 1982, AM J ORTHOD DENTOFAC, V82, P104, DOI 10.1016/0002-9416(82)90489-4; Prabhat K. C., 2012, ISRN DENT, V2012; Ronquillo H I, 1988, J Craniomandib Disord, V2, P137; Sarai T, 1994, T JAPAN SOC MECH ENG, V60, P285; WIESLANDER L, 1984, AM J ORTHOD DENTOFAC, V86, P1, DOI 10.1016/0002-9416(84)90271-9; Decrue A, 1990, Zahnarztl Prax, V41, P360	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	OCT	2015	37	5					467	473		10.1093/ejo/cju091		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7BD	WOS:000362967200004		
J	Cordova, L; Furuichi, N; Lederer, T				Cordova, L.; Furuichi, N.; Lederer, T.			Qualification of an ultrasonic flow meter as a transfer standard for measurements at Reynolds numbers up to 4 x 10(6) between NMIJ and PTB	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Inter laboratory comparison; Ultrasonic flow meter; Reynolds number dependence; Flow traceability; Transducer cavity	FLOWMETERS	The quality of any laboratory intercomparison depends to a large extent on the performance of the used flow meter. To find a flow meter that is capable of reaching a reproducibility better than 0.05% requires bounding all involved influence quantities down to the required level. The present paper describes the efforts performed while qualifying a time-of-flight ultrasonic flow meter as a transfer standard. It was determined that the most relevant influence quantity besides the flow profile within the bulk flow is the effect caused by the transducer pockets in the meter body. By taking advantage of a specially designed window chamber, it was possible to determine the magnitude of the errors introduced by the transducer pockets and to define, based on the findings, a procedure to perform a bilateral comparison between the hot water calibration facilities of the Physikalisch-Technische Bundesanstalt and the National Institute of Advanced Industrial Science and Technology. The results of the bilateral comparison are presented. (C) 2015 The Authors. Published by Elsevier Ltd.	[Cordova, L.; Lederer, T.] Phys Tech Bundesanstalt, Braunschweig, Germany; [Furuichi, N.] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan	Cordova, L (reprint author), Phys Tech Bundesanstalt, Braunschweig, Germany.	cordova.leopoldo@gmail.com					Alexandre Voser, 1999, THESIS ETH ZURICH; [Anonymous], 2011, 182011 PTC ASME; Zheng DD, 2011, FLOW MEAS INSTRUM, V22, P488, DOI 10.1016/j.flowmeasinst.2011.08.003; [Anonymous], 2003, 516722003 ISO; [Anonymous], 2012, 122422012 ISO; Tawackolian K, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/7/075304; [Anonymous], 1998, 9 AGA; YEH TT, 1994, FLOW MEAS INSTRUM, V5, P181, DOI 10.1016/0955-5986(94)90017-5; [Anonymous], 2009, 1434 EN; Brown GJ, 2013, P FLOMEKO 2013 PAR; Cousins T, 2004, N SEA FLOW MEAS WORK; Drenthen J, 2009, 7 INT S FLUID FLOW M; Furuichi N, 2009, FLOW MEAS INSTRUM, V20, P38, DOI 10.1016/j.flowmeasinst.2008.11.001; Furuichi N, 2014, P ASME 2014 POW C PO; Gersten K., 2005, FLUID MECH FLOW METE; Lunde P, 2000, GERG PROJECT ULTRASO; Mathies N., 2005, THESIS TU BERLIN; Mattingly GE, 1990, P 2 INT S FLUID FLOW, P271; Moore PI, 2000, MEAS SCI TECHNOL, V11, P1802, DOI 10.1088/0957-0233/11/12/321; Pannell CN, 1990, FLOW MEAS INSTRUM, V216, P224; Peter Lau, 1995, CALIBRATION INTERCOM, P77; Richard Paton, CCMFFK2; Shimada T, 2010, SYNTHESIOLOGY, V3; Takeda Y, 2012, ULTRASONIC DOPPLER V; Thorns J., 2010, THESIS TU BERLIN; Yeh TT, 1997, P ASME FEDSM 97	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	OCT	2015	45						28	42		10.1016/j.flowmeasinst.2015.04.006		15	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CT2AR	WOS:000362604900004		
J	Othman, NTA; Obara, H; Sapkota, A; Takei, M				Othman, Nur Tantiyani Ali; Obara, Hiromichi; Sapkota, Achyut; Takei, Masahiro			Measurement of particle migration in micro-channel by multi-capacitance sensing method	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Particle concentration; Micro-channel; Multi-layered sensor electrodes; Multi-capacitance sensing; Particle migration; Streamwise migration ratio; Cross-sectional migration ratio	PRESSURE-DRIVEN FLOW; BROWNIAN SUSPENSION	Study of particle migration is important to enhance and increase the efficiency of the positioning and sorting process in order to produce the high yield of desired product especially in microfluidic applications. In this study, in order to study particle migration, normalized particle concentration in a micro-channel has been calculated for high initial particle concentrations (xi=3.0, 5.0 and 10.0%) and the small particle diameters (d(p)=1.3, 1.5 and 2.1 mu m) by using capacitance data measured by a multi-capacitance sensing method. From the calculations, it has been observed that the particle concentration at the wall vicinity area is increased as xi and d(p) are increased while the particle concentration at the center area is decreased. To analyze the tendency of the particle migration, two quantitative indicators are introduced, viz., streamwise migration ratio (psi) which is the ratio of particle concentration at the downstream to the upstream cross-section position, and the cross-sectional migration ratio (phi) which is the ratio of the particle concentration at the wall to the center area at the same cross-sectional position. The result shows that the psi at the center area is decreased as the particles move along the channel irrespective of xi and d(p) while the psi at the wall vicinity area is increased. Based on psi and phi, it has been observed that the particle migrate from the center area towards the wall vicinity area in the case of low xi and small d(p) while the particles tend to concentrate on the center area in the case of high xi and the large d(p). As a result, the particle concentration at center is higher in the case of the lower xi and the smaller d(p) than that in the case of higher xi and the larger d(p). (C) 2015 Elsevier Ltd. All rights reserved.	[Othman, Nur Tantiyani Ali] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Ukm Bangi 46300, Selangor, Malaysia; [Obara, Hiromichi] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Mech Engn, Hachioji 1920397, Japan; [Sapkota, Achyut; Takei, Masahiro] Chiba Univ, Grad Sch Mech Engn, Div Artificial Syst Sci, Inage Ku, Chiba 2638522, Japan	Othman, NTA (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Ukm Bangi 46300, Selangor, Malaysia.	tantiyani@ukm.edu.my			Japan Science and Technology Agency [AS2311054B]	This study is supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-Step) of Japan Science and Technology Agency (#AS2311054B). Also, the authors express sincere thanks to Mr. M. Ichishima and Mr. H. Goto of Covalent Materials Corporation in Japan for the fabricating microchannel.	Othman NTA, 2013, FLOW MEAS INSTRUM, V31, P47, DOI 10.1016/j.flowmeasinst.2012.12.003; Liang LT, 2010, J COLLOID INTERF SCI, V347, P142, DOI 10.1016/j.jcis.2010.03.039; Semwogerere D, 2007, J FLUID MECH, V581, P437, DOI 10.1017/S0022112007006088; Butler JE, 1999, PHYS FLUIDS, V11, P2865, DOI 10.1063/1.870145; Chun B, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2176587; Matas JP, 2009, J FLUID MECH, V621, P59, DOI 10.1017/S0022112008004977; Oakey J, 2010, ANAL CHEM, V82, P3862, DOI 10.1021/ac100387b; Pasquino R, 2010, RHEOL ACTA, V49, P993, DOI 10.1007/s00397-010-0466-5; LOUGE M, 1990, POWDER TECHNOL, V62, P85, DOI 10.1016/0032-5910(90)80026-U; Yang WQ, 1996, MEAS SCI TECHNOL, V7, P1073, DOI 10.1088/0957-0233/7/7/012; Zheng X, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3237159; Allende M, 2000, J RHEOL, V44, P79, DOI 10.1122/1.551074; Frank M, 2003, J FLUID MECH, V493, P363, DOI 10.1017/S0022112003006001; Hampton RE, 1997, J RHEOL, V41, P621, DOI 10.1122/1.550863; Asgar A, 2008, LAB CHIP, P1906; Asgar A.B.S., 2008, PHYS FLUIDS, V20; Carlo D.D., 2007, P NATL ACAD SCI USA, V104, P18892; Semwogerere D, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2907378; Yong-Seok Choi, 2011, Lab on a Chip, V11, DOI 10.1039/c01c00212g	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	OCT	2015	45						162	169		10.1016/j.flowmeasinst.2015.06.015		8	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CT2AR	WOS:000362604900019		
J	Honma, M				Honma, Masamitsu			Evaluation of the in vivo genotoxicity of Allura Red AC (Food Red No. 40)	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Allura Red AC (Food Red No. 40); Comet assay; Micronucleus test; Transgenic gene mutation assay; OECD guidelines	COMET ASSAY; CHEMICAL-STRUCTURE; MUTAGENICITY; SALMONELLA; CARCINOGENICITY; DYES; MICE	Allura Red AC (Food Red No. 40) is a red azo dye that is used for food coloring in beverage and confectionary products. However, its genotoxic properties remain controversial. To clarify the in vivo gentoxicity, we treated mice with Allura Red AC and investigated the induction of DNA damage (liver, glandular stomach), clastogenicity/anuegenicity (bone marrow), and mutagenicity (liver, glandular stomach) using Comet assays, micronucleus tests, and transgenic gene mutation assays, respectively. All studies were conducted in accordance with the Organization for Economic Co-operation and Development (OECD) guideline. Although Allura Red AC was administered up to the maximum doses recommended by the OECD guideline, no genotoxic effect was observed in any of the genotoxic endpoints. These data clearly show no evidence of in vivo genotoxic potential of Allura Red AC administered up to the maximum doses in mice. (C) 2015 Elsevier Ltd. All rights reserved.	Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan	Honma, M (reprint author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	honma@nihs.go.jp			Standard and Evaluation Division of the Ministry of Health, Labor and Welfare, Japan	The in vivo genotoxicity tests in this study were conducted by the Food and Drug Safety Center, Hadano Institute, Kanagawa, Japan (Comet assay), the Safety Research Institute for Chemical Compounds, Hokkaido, Japan (micronucleus test), and the BioSafety Research Center, Shizuoka, Japan (TGR assay) under the direction of the Division of Genetics and Mutagenesis, National Institute of Health Sciences, Japan. This study was supported by the Standard and Evaluation Division of the Ministry of Health, Labor and Welfare, Japan.	Abramsson-Zetterberg L, 2013, FOOD CHEM TOXICOL, V59, P86, DOI 10.1016/j.fct.2013.05.047; TENNANT RW, 1991, MUTAT RES, V257, P209, DOI 10.1016/0165-1110(91)90002-D; Speit G, 2015, MUTAT RES-GEN TOX EN, V783, P6, DOI 10.1016/j.mrgentox.2014.09.006; BROWN JP, 1978, MUTAT RES, V56, P249, DOI 10.1016/0027-5107(78)90192-6; JUNG R, 1992, FOOD CHEM TOXICOL, V30, P635, DOI 10.1016/0278-6915(92)90199-U; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Tsuda S, 2001, TOXICOL SCI, V61, P92, DOI 10.1093/toxsci/61.1.92; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; ASHBY J, 1988, MUTAT RES, V204, P17, DOI 10.1016/0165-1218(88)90114-0; Sasaki YF, 2002, MUTAT RES-GEN TOX EN, V519, P103, DOI 10.1016/S1383-5718(02)00128-6; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; Zeiger E, 2000, REGUL TOXICOL PHARM, V32, P219, DOI 10.1006/rtph.2000.1422; EFSA (European Food Safety Authority) ECDC (European Centre for Disease Prevention and Control) EMEA (European Medicines Agency), 2009, EFSA J, V7; Fujita H., 1995, Annual Report of Tokyo Metropolitan Research Laboratory of Public Health, V46, P258; JECFA, 1980, WHO FOOD ADDITIVES S, V15; Matsumoto M, 2014, MUTAT RES-GEN TOX EN, V775, P94, DOI 10.1016/j.mrgentox.2014.10.009; MUZZALL JM, 1979, MUTAT RES, V67, P1, DOI 10.1016/0165-1218(79)90093-4; Nakajima M., 2012, GENES ENV, V34, P50; OECD, 2013, TG488 OECD GUID TEST; OECD, 1997, TG474 OECD GUID TEST; OECD, 2014, TG489 OECD GUID TEST; SFC, 1984, REP SCI COMM FOOD OP; SFC, 1989, REP SCI COMM FOOD OP	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	OCT	2015	84						270	275		10.1016/j.fct.2015.09.007		6	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CT5OR	WOS:000362860200027		
J	Ishiga, T; Kiso, F; Suetsugu, A; Utano, M; Yamashita, H; Ueki, Y; Yoshiie, R; Naruse, I				Ishiga, Takuya; Kiso, Fumihiko; Suetsugu, Akinori; Utano, Masakazu; Yamashita, Hiroshi; Ueki, Yasuaki; Yoshiie, Ryo; Naruse, Ichiro			Heating technique of slag-tapping hole in high-temperature coal gasifier	FUEL PROCESSING TECHNOLOGY			English	Article						IGCC; Coal gasification; Entrained bed; Ash fusing; Slag	ASH DEPOSITION	The integrated coal gasification combined cycle (IGCC) is expected to improve the thermal efficiency of coal-fired power generation more. In Japan, coal gasifiers will be required to handle various coals imported from many countries, just as existing pulverized coal-fired boilers do. In the coal gasifier, ash contained in coal is fused into liquid slag, and the fused slag flows through a slag-tapping hole separately from the syngas. The hole must be heated adequately to maintain the flow of the fused slag. In this study, a heating technique that works by supplying additional oxygen and nitrogen just below the slag-tapping hole was developed to handle coals with high ash fusing temperature. In gasification tests conducted in a 150 t/d coal gasifier, the fused slag was separated stably from coal at 1783 K which was the highest temperature handled without using flux or auxiliary fuel. This technique can expand the versatility of coal gasifiers as far as the coal types that can be used. (C) 2015 Elsevier B.V. All rights reserved.	[Ishiga, Takuya; Kiso, Fumihiko] Hitachi Ltd, Mat Res Ctr, Hitachi Res Lab, Hitachinaka, Ibaraki 3120034, Japan; [Suetsugu, Akinori] Mitsubishi Hitachi Power Syst Ltd, Boiler Prod Headquarters, Kure Shi, Hiroshima 7378508, Japan; [Utano, Masakazu; Yamashita, Hiroshi] Elect Power Dev Co Ltd, Wakamatsu Res Inst, Dept Res & Dev, Wakamatsu Ku, Kitakyushu, Fukuoka 8080111, Japan; [Ueki, Yasuaki; Naruse, Ichiro] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshiie, Ryo] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ishiga, T (reprint author), Hitachi Ltd, Mat Res Ctr, Hitachi Res Lab, 832-2 Horiguchi, Hitachinaka, Ibaraki 3120034, Japan.	takuya.ishiga.wm@hitachi.com					Naruse I, 2010, J CHEM ENG JPN, V43, P872; [Anonymous], 2012, Japanese Patent Publication, Patent No. 5139714; Wang J, 2013, FUEL PROCESS TECHNOL, V106, P704, DOI 10.1016/j.fuproc.2012.10.005; Naruse I, 2005, FUEL, V84, P405, DOI 10.1016/j.fuel.2004.09.007; Koyama S, 1996, FUEL, V75, P459, DOI 10.1016/0016-2361(95)00266-9; Kiso F, 2011, ENERGY, V36, P4032, DOI 10.1016/j.energy.2011.04.047; Akiyama T, 2008, KAGAKU KOGAKU RONBUN, V34, P477, DOI 10.1252/kakoronbunshu.34.477; Hashimoto T., 2009, MITSUBISHI HEAVY IND, V46, P5; Ishiga T., 2009, P 47 S JAP COMB 2009, P376; Ito O., 2008, HITACHI REV, V57, P166; JCOAL, JAP COAL PROD SUPPL; Jcoal, GEN AN STAND COAL SA; Kaneko S., 2010, ENERGY RESOURCES, V31, P92; Mahagaokar U., 1990, 90JPGCFACT16 ASME, P1; Miyadera H., 1995, J JAPAN I ENERGY, V74, P691; Nagasaki N., 2010, HITACHI REV, V59, P77; Naruse I., 2013, CLEAN COMBUST SUST W, P771; R. Clean Coal Power D Co. Ltd, TERM NAK IGCC DEM TE; Tominaga H., 2006, J JPN I ENERGY, V85, P36; Tominaga H., 2000, IFRF COMBUST J; Wasaka S., P INT C POW ENG; Watanabe T., GAS TECHN C	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						100	108		10.1016/j.fuproc.2015.05.017		9	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200012		
J	Uemura, Y; Matsumoto, R; Saadon, S; Matsumura, Y				Uemura, Yoshimitsu; Matsumoto, Ryunosuke; Saadon, Shazleen; Matsumura, Yukihiko			A study on torrefaction of Laminaria japonica	FUEL PROCESSING TECHNOLOGY			English	Article						Torrefaction; Laminaria japonica; Mass yield; Energy yield; Elementary analysis; Ash	SYNTHETIC INDICATOR; BIOFUEL PRODUCTION; KERNEL SHELL; MASS-LOSS; BIOMASS; MACROALGAE; RESIDUES; IMPACT; WOOD; DECOMPOSITION	Torrefaction of a macroalga Laminaria japonica, a representative macroalga, was carried out in a fixed-bed tubular reactor under nitrogen atmosphere at 423 to 573 K. Three useful findings were obtained for torrefaction of L japonica from this study. Firstly, the major reaction of the microalga may be decomposition of alginate, while the major reaction for torreterrestrial biomass is known to be decomposition of hemicellulose. Even so, H/C vs. O/C (so-called the van Krevelen plot) showed a similar trend between the macroalga and terrestrial biomass. Secondly, an extremely low temperature is effective to obtain a satisfactory energy yield of torrefied macroalga. Thirdly, the ash, nitrogen and sulfur can be considerably eliminated from the macroalga by torrefaction. (C) 2015 Elsevier B.V. All rights reserved.	[Uemura, Yoshimitsu; Saadon, Shazleen] Univ Teknol Petronas, Ctr Biofuel & Biochem Res, Tronoh 31750, Perak, Malaysia; [Matsumoto, Ryunosuke; Matsumura, Yukihiko] Hiroshima Univ, Dept Mech Engn, Hiroshima 724, Japan	Uemura, Y (reprint author), Univ Teknol Petronas, Ctr Biofuel & Biochem Res, Tronoh 31750, Perak, Malaysia.	yoshimitsu_uemura@petronas.com.my			International Collaboration Program, Graduate School of Engineering, Hiroshima University; Mitsubishi Corporation Education Trust Fund	This work was financially supported by two grants: the International Collaboration Program, Graduate School of Engineering, Hiroshima University and the Mitsubishi Corporation Education Trust Fund.	[Anonymous], 2014, INT J BIOMASS RENEWA; Repellin V, 2010, BIOMASS BIOENERG, V34, P602, DOI 10.1016/j.biombioe.2010.01.002; Uslu A, 2008, ENERGY, V33, P1206, DOI 10.1016/j.energy.2008.03.007; Bastianoni S, 2008, BIOMASS BIOENERG, V32, P619, DOI 10.1016/j.biombioe.2007.12.010; Prins MJ, 2006, ENERGY, V31, P3458, DOI 10.1016/j.energy.2006.03.008; Brachi P, 2015, FUEL PROCESS TECHNOL, V130, P147, DOI 10.1016/j.fuproc.2014.09.043; Sabil KM, 2013, BIOMASS BIOENERG, V56, P351, DOI 10.1016/j.biombioe.2013.05.015; Chen WH, 2010, ENERGY, V35, P2580, DOI 10.1016/j.energy.2010.02.054; Toscano G, 2015, FUEL, V143, P89, DOI 10.1016/j.fuel.2014.11.039; Deng J, 2009, J ANAL APPL PYROL, V86, P331, DOI 10.1016/j.jaap.2009.08.006; Sabil KM, 2013, APPL ENERG, V111, P821, DOI 10.1016/j.apenergy.2013.05.067; Uemura Y, 2015, FUEL, V144, P171, DOI 10.1016/j.fuel.2014.12.050; Arias B, 2008, FUEL PROCESS TECHNOL, V89, P169, DOI 10.1016/j.fuproc.2007.09.002; Jung KW, 2011, BIORESOURCE TECHNOL, V102, P2745, DOI 10.1016/j.biortech.2010.11.042; Uemura Y, 2013, FUEL, V103, P156, DOI 10.1016/j.fuel.2011.11.018; Couhert C, 2009, FUEL, V88, P2286, DOI 10.1016/j.fuel.2009.05.003; Basu P, 2010, BIOMASS GASIFICATION AND PYROLYSIS: PRACTICAL DESIGN AND THEORY, P65, DOI 10.1016/B978-0-12-374988-8.00003-9; Almeida G, 2010, BIORESOURCE TECHNOL, V101, P9778, DOI 10.1016/j.biortech.2010.07.026; Bridgeman TG, 2008, FUEL, V87, P844, DOI 10.1016/j.fuel.2007.05.041; Anastasakis K, 2011, FUEL, V90, P598, DOI 10.1016/j.fuel.2010.09.023; Phanphanich M, 2011, BIORESOURCE TECHNOL, V102, P1246, DOI 10.1016/j.biortech.2010.08.028; Adams JMM, 2011, BIORESOURCE TECHNOL, V102, P226, DOI 10.1016/j.biortech.2010.06.152; Uemura Y, 2011, FUEL, V90, P2585, DOI 10.1016/j.fuel.2011.03.021; Yazdani P, 2015, BIORESOURCE TECHNOL, V176, P196, DOI 10.1016/j.biortech.2014.10.141; Suzuki S, 2006, J EXP MAR BIOL ECOL, V339, P15, DOI 10.1016/j.jembe.2006.06.009; Prins MJ, 2006, J ANAL APPL PYROL, V77, P28, DOI 10.1016/j.jaap.2006.01.002; Aitken D, 2014, J CLEAN PROD, V75, P45, DOI 10.1016/j.jclepro.2014.03.080; Marquez GPB, 2014, RENEW SUST ENERG REV, V38, P1056, DOI 10.1016/j.rser.2014.07.056; Chen WH, 2014, BIORESOURCE TECHNOL, V169, P258, DOI 10.1016/j.biortech.2014.06.086; Kaewpanha M, 2014, FUEL PROCESS TECHNOL, V120, P106, DOI 10.1016/j.fuproc.2013.12.013; PENTANANUNT R, 1990, ENERGY, V15, P1175, DOI 10.1016/0360-5442(90)90109-F; Felfri FF, 2005, ENERGY SUSTAIN DEV, V9, P19; Imanishi H., 2006, P REN EN; Kiel J.H.A., 2008, P 16 EUR BIOM C EXH; Pahang H.K., 2014, P REG S CHEM ENG 201; Poudel J, 2015, FUEL, V140, P275, DOI 10.1016/j.fuel.2014.09.120; Prakobboon N., 2013, INT J BIOMASS RENEW, V2, P14; Prins MJ, 2006, J ANAL APPL PYROL, V77, P34; Rajab AH, 2013, INT J BIOMASS RENEW, V2, P13; Shibata K., 1992, BIOMASS PRODUCTION C, V1, P16; The Society of Chemical Engineers Japan, 2012, BIOM PROC HDB, P75; Uemura Y, 2010, Journal of Applied Sciences, V10	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						133	138		10.1016/j.fuproc.2015.05.016		6	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200016		
J	Jia, DN; Cathary, O; Peng, JH; Bi, XT; Lim, CJ; Sokhansanj, S; Liu, YP; Wang, RX; Tsutsumi, A				Jia, Dening; Cathary, Oceane; Peng, Jianghong; Bi, Xiaotao; Lim, C. Jim; Sokhansanj, Shahab; Liu, Yuping; Wang, Ruixu; Tsutsumi, Atsushi			Fluidization and drying of biomass particles in a vibrating fluidized bed with pulsed gas flow	FUEL PROCESSING TECHNOLOGY			English	Article						Fluidized bed; Gas-solid flow; Drying; Biomass; Vibration; Pulsation	DRYER; KINETICS; SAWDUST; QUALITY; SEEDS	Fluidization of biomass particles in the absence of inert bed materials has been tested in a pulsed fluidized bed with vibration, with the pulsation frequency ranging from 033 to 6.67 Hz. Intermittent fluidization at 033 Hz and apparently 'normal' fluidization at 6.67 Hz with regular bubble patterns were observed. Pulsation has proven to be effective in overcoming the bridging of irregular biomass particles induced by strong inter-particle forces. The vibration is only effective when the pulsation is inadequate, either at too low a frequency or too low in amplitude. Drying of biomass has been carried out to quantify the effectiveness of gas pulsation for fluidized bed dryers and torrefiers in terms of gas-solid contact efficiency and heat and mass transfer rates. The effects of gas flow rate, bed temperature, pulsation frequency and vibration intensity on drying performance have been systematically investigated. While higher temperature and gas flow rate are favored in drying, there exists an optimal range of pulsation frequency between 0.75 Hz and 1.5 Hz where gas-solid contact is enhanced in both the constant rate drying and falling rate drying periods. (C) 2015 Elsevier B.V. All rights reserved.	[Jia, Dening; Peng, Jianghong; Bi, Xiaotao; Lim, C. Jim; Sokhansanj, Shahab; Wang, Ruixu] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC V6T 1Z3, Canada; [Cathary, Oceane] Ecole Natl Super Tech Avancees, F-92120 Palaiseau, France; [Sokhansanj, Shahab] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Liu, Yuping; Tsutsumi, Atsushi] Univ Tokyo, Inst Ind Sci, Collaborat Res Ctr Energy Engn, Meguro Ku, Tokyo 1538505, Japan	Bi, XT (reprint author), Univ British Columbia, Dept Chem & Biol Engn, 2360 East Mall, Vancouver, BC V6T 1Z3, Canada.				Natural Sciences and Engineering Research Council of Canada (NSERC)	The authors are grateful to the Natural Sciences and Engineering Research Council of Canada (NSERC) for the financial support in the form of a Canada-Japan joint Strategic Project, Tolko Industries Ltd. for the generous donation of tested biomass samples, and Noram Engineering and Constructions for its in-kind contribution to the project.	Akhavan A., 2008, IND ENG CHEM RES, V48, P302; Bubnovich V, 2008, NUMER HEAT TR A-APPL, V54, P255, DOI 10.1080/10407780802084728; Bi HTT, 2007, CHEM ENG SCI, V62, P3473, DOI 10.1016/j.ces.2006.12.092; Liu YP, 2014, FUEL PROCESS TECHNOL, V122, P170, DOI 10.1016/j.fuproc.2014.01.036; Gawrzynski Z, 1996, DRY TECHNOL, V14, P1121, DOI 10.1080/07373939608917142; Hao BG, 2005, POWDER TECHNOL, V149, P51, DOI 10.1016/j.powtec.2004.10.004; Liu CP, 2012, POWDER TECHNOL, V221, P192, DOI 10.1016/j.powtec.2012.01.001; ECCLES ERA, 1992, DRY TECHNOL, V10, P139, DOI 10.1080/07373939208916418; Nitz M, 2007, J FOOD ENG, V80, P249, DOI 10.1016/j.jfoodeng.2006.05.025; Ciro-Velasquez HJ, 2010, DRY TECHNOL, V28, P389, DOI 10.1080/07373931003645116; Li ZY, 2004, J CHEM ENG JPN, V37, P1179, DOI 10.1252/jcej.37.1179; Meili L, 2010, DRY TECHNOL, V28, P402, DOI 10.1080/07373931003645298; ROY R, 1990, CHEM ENG SCI, V45, P3233, DOI 10.1016/0009-2509(90)80216-2; Stakic M, 2011, CHEM ENG PROCESS, V50, P428, DOI 10.1016/j.cep.2011.02.006; Coppens MO, 2003, CHEM ENG J, V96, P117, DOI [10.1016/j.cej.2003.08.007, 10.1016/j/cej.2003.08.007]; WAGNER W, 1993, J PHYS CHEM REF DATA, V22, P783; HASATANI M, 1991, DRY TECHNOL, V9, P349, DOI 10.1080/07373939108916670; LEGROS R, 1994, DRY TECHNOL, V12, P517, DOI 10.1080/07373939408959976; TURNBULL JH, 1993, BIOMASS BIOENERG, V4, P75, DOI 10.1016/0961-9534(93)90030-8; Reyes A, 2007, DRY TECHNOL, V25, P581, DOI 10.1080/07373930701227011; Zhao GB, 2003, AICHE J, V49, P869, DOI 10.1002/aic.690490407; van der Stelt MJC, 2011, BIOMASS BIOENERG, V35, P3748, DOI 10.1016/j.biombioe.2011.06.023; Wang XS, 2005, POWDER TECHNOL, V159, P142, DOI 10.1016/j.powtec.2005.08.007; Reyes A, 2006, DRY TECHNOL, V24, P1469, DOI 10.1080/07373930600952818; Renstrom R, 2002, DRY TECHNOL, V20, P449, DOI 10.1081/DRT-120002551; Kudra T, 2002, DRY TECHNOL, V20, P917, DOI 10.1081/DRT-120003769; GUPTA R, 1980, CAN J CHEM ENG, V58, P332; de Souza LFG, 2010, CHEM ENG TECHNOL, V33, P2015, DOI 10.1002/ceat.200900565; Moreno R, 2006, BIOSYST ENG, V94, P47, DOI 10.1016/j.biosystemseng.2006.01.011; KANTZAS A, 1994, AICHE J, V40, P1254, DOI 10.1002/aic.690400716; Seville JPK, 2000, POWDER TECHNOL, V113, P261, DOI 10.1016/S0032-5910(00)00309-0; Li H, 2012, BIORESOURCE TECHNOL, V103, P453, DOI 10.1016/j.biortech.2011.10.009; Cui HP, 2007, CHEM ENG SCI, V62, P45, DOI 10.1016/j.ces.2006.08.006; Daleffe R.V., 2005, DRYING TECHNOLOGY, V23, P1765, DOI 10.1080/07373930500209681; Drinkenburg A.A.H., 1967, P INT S FLUID JUN 6; Godoi FC, 2011, CHEM ENG PROCESS, V50, P623, DOI 10.1016/j.cep.2011.03.005; Harbaum K.L., 1962, J APPL CHEM-USSR, V12, P234; Harrison D, 1963, FLUIDISED PARTICLES; Mani S., 2006, APPL ENG AGR, V22; Massimilla G.V.L., 1966, CHEM ENG PROGR S SER, P63; Secretariat R., 2014, RENEWABLE GLOBAL STA; Tasirin SM, 2014, IND CROP PROD, V61, P193, DOI 10.1016/j.indcrop.2014.07.004; Wong H.W., 1971, CHEM ENG J, V2, P104, DOI 10.1016/0300-9467(71)80004-7; Zhang D., 2005, HYDRODYNAMICS HEAT T, P214	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						471	482		10.1016/j.fuproc.2015.06.023		12	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200055		
J	Li, CY; Appari, S; Zhang, LX; Huang, AN; Kuo, HP; Kudo, S; Hayashi, J; Norinaga, K				Li, Cheng-Yi; Appari, Srinivas; Zhang, Li-Xin; Huang, An-Ni; Kuo, Hsiu-Po; Kudo, Shinji; Hayashi, Jun-ichiro; Norinaga, Koyo			Modeling of gas/particle flow in coal conversion with a drop tube reactor using a lumped kinetic model accounting volatiles-char interaction	FUEL PROCESSING TECHNOLOGY			English	Article						Lumped kinetic model; Tar decomposition; Steam gasification; Volatiles-char interaction; CFD modeling	BIOMASS GASIFICATION PROCESSES; CIRCULATING FLUIDIZED-BED; VICTORIAN BROWN-COAL; VAPOR-PHASE CRACKING; GAS-SOLID FLOW; RAPID PYROLYSIS; STEAM GASIFICATION; TAR ELIMINATION; NASCENT CHAR; HEAVY OIL	Coal conversion including reforming of nascent tar over the char surface in a drop tube reactor (DTR) was studied both experimentally and numerically. Victorian brown coal and char prepared from the same coal were co-fed into an atmospheric DTR. The effects of reaction temperature (973-1173 K), solid hold-up (8.31 x 10(-6)-2.50 x 10(-4)), residence time (0-4.6 s for gas; 0-0.78 s for solid particles), and steam partial pressure (0-0.05 MPa) on the conversion characteristics were investigated. A 4-lump kinetic model consisting of tar, gases, char, and soot with 6 global reactions was developed based on the experimental results. The lumped kinetic model was integrated with a computational fluid dynamics (CFD) simulation using an Eulerian-Eulerian approach for mixed phase flow to simulate the coal conversion experiments in the DTR. The CFD results for product distribution during coal conversion in the DTR showed reasonable agreement with the experimental results. The CFD approach presented is suitable for use in designing and optimizing a pyrolyzer for a triple-bed combined circulating fluidized-bed coal gasifier, consisting of a downer (pyrolyzer), a bubbling fluidized bed (gasifier), and a riser (combustor). (C) 2015 Elsevier B.V. All rights reserved.	[Li, Cheng-Yi; Hayashi, Jun-ichiro; Norinaga, Koyo] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Appari, Srinivas; Kudo, Shinji; Hayashi, Jun-ichiro; Norinaga, Koyo] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [Zhang, Li-Xin] Xian Thermal Power Res Inst Co Ltd, Xian 710032, Peoples R China; [Huang, An-Ni; Kuo, Hsiu-Po] Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan; [Hayashi, Jun-ichiro] Kyushu Univ, Res & Educ Ctr Carbon Resources, Kasuga, Fukuoka 8168580, Japan	Norinaga, K (reprint author), Kyushu Univ, Inst Chem & Engn, Kasuga, Fukuoka 8168580, Japan.	norinaga@cm.kyushu-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan; MOST-JST, Strategic International Collaborative Research Program, SICORP; China Scholarship Council (CSC Program); Kyushu University Global COE program (G-COE Program)	This work was carried out as a part of the Energy Innovation Program: Strategic Technical Platform for Clean Coal Technology (STEP-CCT), and was in part supported financially by the New Energy and Industrial Technology Development Organization (NEDO), Japan and MOST-JST, Strategic International Collaborative Research Program, SICORP. In addition, Chengyi Li gratefully acknowledges the partial financial support given by the China Scholarship Council (CSC Program) and the Kyushu University Global COE program (G-COE Program).	Norinaga K, 2013, FUEL, V103, P141, DOI 10.1016/j.fuel.2011.07.045; Hayashi JI, 2006, PROCESS SAF ENVIRON, V84, P409, DOI 10.1205/psep06004; Shu Z, 2014, IND ENG CHEM RES, V53, P3378, DOI 10.1021/ie403496a; Hayashi J, 2000, FUEL, V79, P439, DOI 10.1016/S0016-2361(99)00179-9; Ropelato K, 2005, POWDER TECHNOL, V154, P179, DOI 10.1016/j.powtec.2005.05.005; Masek O, 2009, ENERG FUEL, V23, P4496, DOI 10.1021/ef900285e; Sathe C, 1999, ENERG FUEL, V13, P748, DOI 10.1021/ef980240o; Li CZ, 2013, FUEL, V112, P609, DOI 10.1016/j.fuel.2013.01.031; MOSBY JF, 1986, CHEM ENG SCI, V41, P989, DOI 10.1016/0009-2509(86)87184-6; Devi L, 2003, BIOMASS BIOENERG, V24, P125, DOI 10.1016/S0961-9534(02)00102-2; Balasubramanian P, 2008, FUEL, V87, P1660, DOI 10.1016/j.fuel.2007.08.009; Lussier MG, 1998, CARBON, V36, P1361, DOI 10.1016/S0008-6223(98)00123-7; Bayarsaikhan B, 2006, FUEL, V85, P340, DOI 10.1016/j.fuel.2005.06.001; UNGER PE, 1984, FUEL, V63, P606, DOI 10.1016/0016-2361(84)90154-6; Leckel D, 2006, ENERG FUEL, V20, P1761, DOI 10.1021/ef060034d; Zhang LX, 2013, FUEL PROCESS TECHNOL, V113, P1, DOI 10.1016/j.fuproc.2013.03.009; Guan GQ, 2011, CHEM ENG SCI, V66, P4212, DOI 10.1016/j.ces.2011.06.006; Vaishali S, 2008, CHEM ENG SCI, V63, P5107, DOI 10.1016/j.ces.2008.06.014; DAVE NC, 1993, FUEL, V72, P1331, DOI 10.1016/0016-2361(93)90133-M; Lee JG, 1996, FUEL, V75, P1035; Lan XY, 2009, CHEM ENG SCI, V64, P3847, DOI 10.1016/j.ces.2009.05.019; Kim YN, 2011, CHEM ENG SCI, V66, P5357, DOI 10.1016/j.ces.2011.07.036; Zhang L, 2013, FUEL, V112, P681, DOI 10.1016/j.fuel.2011.12.030; Hayashi J, 2014, ENERG FUEL, V28, P4, DOI 10.1021/ef401617k; Guan GQ, 2010, PARTICUOLOGY, V8, P602, DOI 10.1016/j.partic.2010.07.013; Jamil K, 2004, FUEL, V83, P833, DOI 10.1016/j.fuel.2003.09.017; Abu El-Rub Z, 2004, IND ENG CHEM RES, V43, P6911, DOI 10.1021/ie0498403; Zhang S, 2011, FUEL, V90, P1529, DOI 10.1016/j.fuel.2010.11.010; Matsuhara T, 2010, ENERG FUEL, V24, P76; Authayanun S, 2008, J IND ENG CHEM, V14, P771, DOI 10.1016/j.jiec.2008.05.007; Shi SP, 2006, J ENERGY INST, V79, P217, DOI 10.1179/174602206X148865; Li CZ, 2006, PROCESS SAF ENVIRON, V84, P407, DOI 10.1205/psep.ed.0606; [Anonymous], 2011, ANSYS FLUENT THEOR G; Vascellari M, 2014, FUEL, V118, P369, DOI 10.1016/j.fuel.2013.11.004; Hayashi JI, 2002, FUEL, V81, P1977, DOI 10.1016/S0016-2361(02)00128-X; Jeong HJ, 2014, APPL ENERG, V123, P29, DOI 10.1016/j.apenergy.2014.02.026; Guan GQ, 2010, CHEM ENG J, V164, P221, DOI 10.1016/j.cej.2010.08.005; THEOLOGOS KN, 1993, AICHE J, V39, P1007, DOI 10.1002/aic.690390610; Fushimi C, 2011, BIOMASS BIOENERG, V35, P179, DOI 10.1016/j.biombioe.2010.08.017; Elizalde I, 2009, APPL CATAL A-GEN, V365, P237, DOI 10.1016/j.apcata.2009.06.018; Masuda H., 2007, POWDER TECHNOLOGY FU; Norinaga K, 2014, BIOMASS BIOENERG, V69, P144, DOI 10.1016/j.biombioe.2014.07.008; Simell P., 1997, CATAL TODAY, V27, P3	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						588	594		10.1016/j.fuproc.2015.06.043		7	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200067		
J	Mochizuki, Y; Tsubouchi, N; Akiyama, T				Mochizuki, Yuuki; Tsubouchi, Naoto; Akiyama, Tomohiro			Reduction behavior and crushing strength of carbon-containing iron ore sinters prepared from tar recovered from coke oven gas	FUEL PROCESSING TECHNOLOGY			English	Article						Sinter; Carbon; COG tar; Reduction behavior; Crushing strength	COMBINED WATER-CONTENT; IRONMAKING APPLICATIONS; BLAST-FURNACE; COMPOSITE; TEMPERATURE; OXIDE; DECOMPOSITION; DEPOSITION; HEMATITE; ENHANCEMENT	The reduction behavior and crushing strength of carbon-containing iron ore sinters (SI-C) prepared from coke oven gas (COG) tar have been examined with a quartz-made fixed bed reactor and with a tensile and compression testing machine, respectively. When an as-received iron ore sinter (SI) is heated at 10 degrees C/min up to 600 degrees C in 55% H-2/He, the resulting sample (SI/600) gives a very small, broad pore size distribution profile, the surface area (S-BET) and pore volume (V-BJH) being 1.5 m(2)/g and 0.005 cm(3)/g, respectively. On the other hand, SI-pretreated in 55% H-2/He at 450 degrees C for 4 h (SI-450) provides the pore distribution profile peaking around 10 nm, and S-BET and V-BJH are 4 m(2)/g and 0.02 cm(3)/g, respectively. When carbon-containing iron ore sinters (SI/600-C and SI-450-C) are prepared by pyrolysis of the mixture of the pretreated SI and COG tar, no measurable amounts of S-BET and V-BJH are detectable in any case. The crushing strength of SI-450 is improved significantly by the deposition of tarderived carbonaceous materials into the pores formed during the pre-treatment. In a temperature-programed heat treatment in He, the evolution of CO, CO2 and H2O from the SI-450-C samples start after 600 degrees C, and each rate profile observed shows a large peak around 700-850 degrees C. The extent of reduction of SI-C, SI/600-C or SI450-C is 3, 19 or 55% on SI basis, respectively, and it depends on S-BET and/or V-BJH of the feed sample. (C) 2015 Elsevier B.V. All rights reserved.	[Mochizuki, Yuuki; Tsubouchi, Naoto; Akiyama, Tomohiro] Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan	Mochizuki, Y (reprint author), Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan.	mochi@eng.hokudai.ac.jp	Tsubouchi, Naoto/D-8112-2012	Tsubouchi, Naoto/0000-0001-8236-8252	CO<INF>2</INF> Ultimate Reduction in Steel-making process by innovative technology for cool Earth 50 (COURSE50) project - New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was supported by the CO<INF>2</INF> Ultimate Reduction in Steel-making process by innovative technology for cool Earth 50 (COURSE50) project sponsored by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Watakabe S, 2013, ISIJ INT, V53, P2065, DOI 10.2355/isijinternational.53.2065; Weiss B, 2011, IRONMAK STEELMAK, V38, P65, DOI 10.1179/030192310X12700328926065; Nogami H, 2014, TETSU TO HAGANE, V100, P227, DOI 10.2355/tetsutohagane.100.227; Murakami T, 2011, ISIJ INT, V51, P1220, DOI 10.2355/isijinternational.51.1220; Kawanari M, 2011, ISIJ INT, V51, P1227, DOI 10.2355/isijinternational.51.1227; Cahyono RB, 2014, FUEL PROCESS TECHNOL, V119, P272, DOI 10.1016/j.fuproc.2013.11.006; Pineau A, 2006, THERMOCHIM ACTA, V447, P89, DOI 10.1016/j.tca.2005.10.004; Konishi H, 2006, TETSU TO HAGANE, V92, P802; Rozhan AN, 2012, ENERG FUEL, V26, P7340, DOI 10.1021/ef301409f; Hata Y, 2009, ENERG FUEL, V23, P1128, DOI 10.1021/ef800967h; Cahyono RB, 2013, FUEL PROCESS TECHNOL, V113, P84, DOI 10.1016/j.fuproc.2013.03.012; Miura K, 2011, ISIJ INT, V51, P1234, DOI 10.2355/isijinternational.51.1234; Murakami T, 2009, ISIJ INT, V49, P1686; Kasai E, 1995, ISIJ INT, V35, P1444, DOI 10.2355/isijinternational.35.1444; Murakami T, 2011, ISIJ INT, V51, P9, DOI 10.2355/isijinternational.51.9; KASAOKA S, 1982, KAGAKU KOGAKU RONBUN, V8, P168; Cahyono RB, 2014, ENERG FUEL, V28, P2129, DOI 10.1021/ef500201m; Hosokai S, 2012, ENERG FUEL, V26, P7274, DOI 10.1021/ef3013272; Cahyono RB, 2013, ENERG FUEL, V27, P2687, DOI 10.1021/ef400322w; Kasai A, 2003, TETSU TO HAGANE, V89, P1212; Hata Y., 2008, CAMP ISIJ, V21, P212; Hata Y., 2007, CAMP ISIJ, V20, P923; Kosuge T., 1966, TETSU TO HAGANE, V3, P501; Kosuge T., 1966, TETSU TO HAGANE, V3, P498; Miwa T., 2010, J JPN I ENERGY, V89, P28; Shigaki I., 1982, TETSU TO HAGANE, V10, P1513; Sugahara K., 1969, TETSU TO HAGANE, V13, P1107; Takahashi R., 1986, B RES I MINER DRESSI, V41, P109; Takahashi R., 1980, TETSU TO HAGANE, V66, P1985; Yokoyama H., 2014, TETSU TO HAGANE, V100, P601	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						704	713		10.1016/j.fuproc.2015.07.012		10	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200081		
J	Hirooka, Y; Mazzitelli, G; Mirnov, S; Ono, M; Shimada, M; Tabares, FL				Hirooka, Y.; Mazzitelli, G.; Mirnov, S.; Ono, M.; Shimada, M.; Tabares, F. L.			A REVIEW OF THE PRESENT STATUS AND FUTURE PROSPECTS OF THE APPLICATION OF LIQUID METALS FOR PLASMA-FACING COMPONENTS IN MAGNETIC FUSION DEVICES	FUSION SCIENCE AND TECHNOLOGY			English	Article							LITHIUM DIVERTOR; TUNGSTEN; FIELDS	The application of liquid metals for plasma-facing components draws increasing interest as a potential means to resolve the technical issues assciated with exhaust power and particle handling in magnetic fusion devices beyond the International Thermonuclear Reactor Experiment (ITER). However, our knowledge is extremely limited at present about the physics as well as chemistry of the interactions between liquid metals and edge plasmas in a strong magnetic field. This paper is intended to provide a review of the present status and future propects of this subject.	[Hirooka, Y.] Grad Univ Adv Studies, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Mazzitelli, G.] Assoc EURATOM ENEA Fus, Ctr Ric Frascati, I-00044 Frascati, Italy; [Mirnov, S.] TRINITI, Troitsk 142190, Moscow Reg, Russia; [Ono, M.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Shimada, M.] JAEA Int Fus Res Ctr, IFERC Obuchi, Rokkasho, Aomori, Japan; [Tabares, F. L.] As EURATOM CIEMAT, Natl Inst Fus, Madrid 28040, Spain	Hirooka, Y (reprint author), Grad Univ Adv Studies, Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	hirooka.yoshihiko@nifs.ac.jp			Japanese Government JSPS [24360387, 26630475]	This research has been supported by the Japanese Government JSPS Grants # 24360387 and #26630475.	Doerner RP, 2001, J NUCL MATER, V290, P166, DOI 10.1016/S0022-3115(00)00568-7; Morley NB, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2930813; Davis JW, 1998, J NUCL MATER, V258, P308, DOI 10.1016/S0022-3115(98)00285-2; STRACHAN JD, 1994, NUCL FUSION, V34, P1017, DOI 10.1088/0029-5515/34/7/I07; Gilbert MR, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043005; Jaworski MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.094503; Narula M, 2006, FUSION ENG DES, V81, P1543, DOI 10.1016/j.fusengdes.2005.08.071; Sanchez J, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104018; Mirnov S, 2009, J NUCL MATER, V390-91, P876, DOI 10.1016/j.jnucmat.2009.01.228; Kugel HW, 2012, FUSION ENG DES, V87, P1724, DOI 10.1016/j.fusengdes.2011.07.010; Majeski R, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4802195; Abdou MA, 2001, FUSION ENG DES, V54, P181, DOI 10.1016/S0920-3796(00)00433-6; Tamura S, 2002, J NUCL MATER, V307, P735, DOI 10.1016/S0022-3115(02)01042-5; Ruzic DN, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/102002; Ying AY, 2004, FUSION ENG DES, V72, P35, DOI 10.1016/j.fusengdes.2004.07.004; Tamura S, 2005, J NUCL MATER, V337, P1043, DOI 10.1016/j.jnucmat.2004.10.103; Hirooka Y, 2006, NUCL FUSION, V46, pS56, DOI 10.1088/0029-5515/46/3/S08; Pitts RA, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014001; BADGER B., 1974, UWFDM68 U WISC, V68; BRAGINSKII SI, 1958, SOV PHYS JETP-USSR, V6, P358; HIROOKA Y., 2005, J NUCL MATER, V585, P337, DOI [http://dx.doi.org/10.1016/j.jnucmat.2004.09.065, DOI 10.1016/JJNUCMAT.2004.09.065]; HIROOKA Yoshi, 2014, NUCL FUSION, V54, DOI DOI 10.1088/0029-5515/54/12/122002; HIROOKA Yoshi, 2014, FUSION ENG DES, V89, P2833, DOI [http://dx.doi.org/10.1016/j.fusengdes.2014.04.014, DOI 10.1016/J.FUSENGDES.2014.04.014]; Kaita R, 2013, J NUCL MATER, V438, pS488, DOI 10.1016/j.jnucmat.2013.01.100; LOARTE A., 2014, PSI C KAN MAY 26 30; Mazzitelli G, 2011, FUSION ENG DES, V86, P580, DOI 10.1016/j.fusengdes.2010.11.007; SHIMADA Michiya, 2014, P 41 EPS C PLASM PHY; ZUI G. Z., 2014, FUSION ENG DES, V89, P2845, DOI DOI 10.1016/J.FUSENGDES.2014.05.020	28	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					477	483				7	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400003		
J	Iwai, Y; Kubo, H; Ohshima, Y; Noguchi, H; Edao, Y; Taniuchi, J				Iwai, Yasunori; Kubo, Hitoshi; Ohshima, Yusuke; Noguchi, Hiroshi; Edao, Yuki; Taniuchi, Junichi			HYDROPHOBIC PLATINUM HONEYCOMB CATALYST TO BE USED FOR TRITIUM OXIDATION REACTORS	FUSION SCIENCE AND TECHNOLOGY			English	Article							HYDROGEN	We have developed two types of hydrophobic platinum honeycomb catalyst to be used for tritium oxidation reactors. One is the hydrophobic platinum catalyst on a metal honeycomb. The other is the hydrophobic platinum catalyst on a ceramic honeycomb made of silicon carbide. The activity of these catalysts was evaluated with tritium. The effects of hydrogen concentration (0.02 to 1000 ppm) and water concentration (100 or 22000 ppm) in the gaseous feed on the activity were investigated. The fine platinum particles around a few nanometers significantly improve the catalytic activity for the oxidation tritium at a very small concentration. The hydrogen concentration in the gaseous feed slightly affects the overall reaction rate constant for hydrogen oxidation. Due to the competitive adsorption of hydrogen and water molecules on platinum surface, the overall reaction rate constant has the bottom value at the hydrogen concentration of 100 ppm with the dry feed gas. We have experimentally confirmed the activity of these honeycomb catalysts is as good as that of granular hydrophobic catalyst. The results support the hydrophobic honeycomb catalysts can be used for tritium oxidation reactors.	[Iwai, Yasunori; Edao, Yuki] Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan; [Kubo, Hitoshi; Ohshima, Yusuke; Noguchi, Hiroshi; Taniuchi, Junichi] Tanaka Kikinzoku Kogyo KK, Tsukuba, Ibaraki 3004247, Japan	Iwai, Y (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan.	iwai.yasunori@jaea.go.jp			JSPS KAKANHI [25420894]	Part of this work was supported by JSPS KAKANHI Grant-in-Aid for Scientific Research C (Grant Number 25420894). The authors wish to acknowledge this funding support.	Iwai Y, 2011, J NUCL SCI TECHNOL, V48, P1184, DOI 10.3327/jnst.48.1184; NARUSE Y, 1990, FUSION ENG DES, V12, P293, DOI 10.1016/0920-3796(90)90003-O; SCHIRA P, 1991, FUSION ENG DES, V18, P19, DOI 10.1016/0920-3796(91)90101-U; Iwai Y, 2014, FUSION SCI TECHNOL, V66, P214; Morfin F, 2004, APPL CATAL B-ENVIRON, V47, P47, DOI 10.1016/j.apcatb.2003.07.001; Popescu I, 2005, FUSION SCI TECHNOL, V48, P108	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					596	600				5	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400023		
J	Rinkwitz, S; Geng, FS; Manning, E; Suster, M; Kawakami, K; Becker, TS				Rinkwitz, Silke; Geng, Fan-Suo; Manning, Elizabeth; Suster, Maximiliano; Kawakami, Koichi; Becker, Thomas S.			BAC Transgenic Zebrafish Reveal Hypothalamic Enhancer Activity Around Obesity Associated SNP rs9939609 Within the Human FTO Gene	GENESIS			English	Article						mammal; organism; genetics; genomics; GWAS; tissue	GENOMIC REGULATORY BLOCKS; ADULT OBESITY; IDENTIFICATION; EXPRESSION; CHILDHOOD; MICE; IRX3	Single Nucleotide Polymorphisms in FTO intron 1 have been associated with obesity risk, leading to the hypothesis that FTO is the obesity-related gene. However, other studies have shown that the FTO gene is part of the regulatory domain of the neighboring IRX3 gene and that enhancers in FTO intron 1 regulate IRX3. While Irx3 activity was shown to be necessary in the hypothalamus for the metabolic function of Irx3 in mouse, no enhancers with hypothalamic activity have been demonstrated in the risk-associated region within FTO. In order to identify potential enhancers at the human FTO locus in vivo, we tested regulatory activity in FTO intron 1 using BAC transgenesis in zebrafish. A minimal gata2 promoter-GFP cassette was inserted 1.3 kb upstream of the obesity associated SNP rs9939609 in a human FTO BAC plasmid. In addition to the previously identified expression domains in notochord and kidney, human FTO BAC: GFP transgenic zebrafish larvae expressed GFP in the ventral posterior tuberculum, the posterior hypothalamus and the anterior brainstem, which are also expression domains of zebrafish irx3a. In contrast, an in-frame insertion of a GFP cassette at the FTO start codon resulted in weak ubiquitous GFP expression indicating that the promoter of FTO does likely not react to enhancers located in the obesity risk-associated region. (C) 2015 The Authors. genesis Published by Wiley Periodicals, Inc.	[Rinkwitz, Silke; Geng, Fan-Suo; Manning, Elizabeth; Becker, Thomas S.] Univ Sydney, Sch Med, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia; [Rinkwitz, Silke; Becker, Thomas S.] Univ Sydney, Sch Med, Dept Physiol, Sydney, NSW 2006, Australia; [Suster, Maximiliano] Uni Res AS, Neural Circuits & Behav Grp, Bergen, Norway; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan	Rinkwitz, S (reprint author), Univ Sydney, Sydney Med Sch, Brain & Mind Res Inst, Dept Physiol, Camperdown, NSW 2050, Australia.	silke.rinkwitz@sydney.edu.au			NHMRC [GNT1010713]; Medical Foundation of the University of Sydney; Norwegian Research Council [1753723/S 10]; EU ZF-HEALTH project, (EC) [HEALTH-F4-2010-242048]	Contract grant sponsor: NHMRC, Contract grant number: GNT1010713; Contract grant sponsor: Medical Foundation of the University of Sydney; Contract grant sponsor: Norwegian Research Council, Contract grant number: NFR Project 1753723/S 10; Contract grant sponsor: EU ZF-HEALTH project, (EC Grant Agreement HEALTH-F4-2010-242048)	Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; WILSON SW, 1990, DEVELOPMENT, V108, P121; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Ishibashi M, 2013, METHODS, V62, P216, DOI 10.1016/j.ymeth.2013.03.018; Kokubu C, 2009, NAT GENET, V41, P946, DOI 10.1038/ng.397; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Punnamoottil B, 2008, DEV DYNAM, V237, P2195, DOI 10.1002/dvdy.21618; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Flint J, 2013, CURR BIOL, V23, pR265, DOI 10.1016/j.cub.2013.01.040; Tung YCL, 2014, CELL METAB, V20, P710, DOI 10.1016/j.cmet.2014.09.010; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Suster ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-477; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Gestel van MA, 2014, PHYSL REP, V2; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Mueller T, 2005, ATLAS EARLY ZEBRAFIS, P183; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	OCT	2015	53	10					640	651		10.1002/dvg.22884		12	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	CT8HD	WOS:000363054800002		
J	Watanabe, T; Kanai, Y; Matsukawa, S; Michiue, T				Watanabe, Tomoko; Kanai, Yuna; Matsukawa, Shinya; Michiue, Tatsuo			Specific Induction of Cranial Placode Cells From Xenopus Ectoderm by Modulating the Levels of BMP, Wnt, and FGF Signaling	GENESIS			English	Article						Xenopus; cranial placode; prepracodal ectoderm; BMP; Wnt; FGF; patterning	NEURAL CREST INDUCTION; HOMEOBOX GENES; PLATE BORDER; STEM-CELLS; MESODERM; LAEVIS; FATE; DIFFERENTIATION; EXPRESSION; GRADIENT	The neural-epidermal boundary tissues include the neural crest and preplacodal ectoderm (PPE) as primordial constituents. The PPE region is essential for the development of various sensory and endocrine organs, such as the anterior lobe of the pituitary, olfactory epithelium, lens, trigeminal ganglion, and otic vesicles. During gastrulation, a neural region is induced in ectodermal cells that interacts with mesendodermal tissue and responds to several secreted factors. Among them, inhibition of bone morphogenetic protein (BMP) in the presumptive neuroectoderm is essential for the induction of neural regions, and formation of a Wnt and fibroblast growth factor (FGF) signaling gradient along the midline determines anterior-posterior patterning. In this study, we attempted to specifically induce PPE cells from undifferentiated Xenopus cells by regulating BMP, Wnt, and FGF signaling. We showed that the proper level of BMP inhibition with an injection of truncated BMP receptor or treatment with a chemical antagonist triggered the expression of PPE genes. In addition, by varying the amount of injected chordin, we optimized specific expression of the PPE genes. PPE gene expression is increased by adding an appropriate dose of an FGF receptor antagonist. Furthermore, co-injection with either wnt8 or the Wnt inhibitor dkk-1 altered the expression levels of several region-specific genes according to the injected dose. We specifically induced PPE cell differentiation in animal cap cells from early-stage Xenopus embryos by modulating BMP, Wnt, and FGF signaling. This is not the first research on placode induction, but our simple method could potentially be applied to mammalian stem cell systems. (C) 2015 Wiley Periodicals, Inc.	[Watanabe, Tomoko; Kanai, Yuna; Matsukawa, Shinya; Michiue, Tatsuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Tokyo 1538902, Japan; [Matsukawa, Shinya] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan	Michiue, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, 8-3-1 Komaba, Tokyo 1538902, Japan.	tmichiue@bio.c.u-tokyo.ac.jp			KAKENHI, Japan Society for the Promotion of Science [25127704, 22570200]	Contract grant sponsor: Grants-in-Aid for Scientific Research, KAKENHI, Japan Society for the Promotion of Science, Contract grant number: 25127704 and 22570200	LaBonne C, 1998, DEVELOPMENT, V125, P2403; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Glavic A, 2004, DEV BIOL, V272, P89, DOI 10.1016/j.ydbio.2004.04.020; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Hardcastle Z, 2000, CURR BIOL, V10, P1511, DOI 10.1016/S0960-9822(00)00825-3; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Christen B, 1997, DEV BIOL, V192, P455, DOI 10.1006/dbio.1997.8732; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev01516; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; MAYOR R, 1995, DEVELOPMENT, V121, P767; Heller N, 1999, DEV GENET, V24, P208, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<208::AID-DVG4>3.0.CO;2-J; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Leung AW, 2013, DEV BIOL, V379, P208, DOI 10.1016/j.ydbio.2013.04.023; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Morita M, 2013, INT J DEV BIOL, V57, P779, DOI 10.1387/ijdb.130161tm; Pandur PD, 2000, MECH DEVELOP, V96, P253, DOI 10.1016/S0925-4773(00)00396-8; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Dincer Z, 2013, CELL REP, V5, P1387, DOI 10.1016/j.celrep.2013.10.048; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Glinka A, 1998, NATURE, V391, P357; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Park BY, 2008, DEV BIOL, V324, P108, DOI 10.1016/j.ydbio.2008.09.009; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; Brivanlou PA. AH, 1995, NATURE, V376, P331; David R, 2001, MECH DEVELOP, V103, P189, DOI 10.1016/S0925-4773(01)00355-0; Matsukawa S, 2015, DEV BIOL, V399, P164, DOI 10.1016/j.ydbio.2014.12.028; Nieuwkoop P, 1994, NORMAL TABLE XENOPUS; Saint-Jeannet Jean-Pierre, 2014, Dev Biol, V389, P13, DOI 10.1016/j.ydbio.2014.02.011	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	OCT	2015	53	10					652	659		10.1002/dvg.22881		8	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	CT8HD	WOS:000363054800003		
J	Chen, ATY; Guo, CF; Itani, OA; Budaitis, BG; Williams, TW; Hopkins, CE; McEachin, RC; Pande, M; Grant, AR; Yoshina, S; Mitani, S; Hu, PJ				Chen, Albert Tzong-Yang; Guo, Chunfang; Itani, Omar A.; Budaitis, Breane G.; Williams, Travis W.; Hopkins, Christopher E.; McEachin, Richard C.; Pande, Manjusha; Grant, Ana R.; Yoshina, Sawako; Mitani, Shohei; Hu, Patrick J.			Longevity Genes Revealed by Integrative Analysis of Isoform-Specific daf-16/FoxO Mutants of Caenorhabditis elegans	GENETICS			English	Article						C. elegans; aging; longevity; insulin-like growth factor signaling; FoxO transcription factors	TRANSCRIPTION FACTOR FOXO1; LIFE-SPAN; C-ELEGANS; OXIDATIVE STRESS; INSULIN-RECEPTOR; REGULATES LONGEVITY; SIGNALING PATHWAY; INTERACTING GENES; RNA INTERFERENCE; GENOMICS VIEWER	FoxO transcription factors promote longevity across taxa. How they do so is poorly understood. In the nematode Caenorhabditis elegans, the A- and F-isoforms of the FoxO transcription factor DAF-16 extend life span in the context of reduced DAF-2 insulin-like growth factor receptor (IGFR) signaling. To elucidate the mechanistic basis for DAF-16/FoxO-dependent life span extension, we performed an integrative analysis of isoform-specific daf-16/FoxO mutants. In contrast to previous studies suggesting that DAF-16F plays a more prominent role in life span control than DAF-16A, isoform-specific daf-16/FoxO mutant phenotypes and whole transcriptome profiling revealed a predominant role for DAF-16A over DAF-16F in life span control, stress resistance, and target gene regulation. Integration of these datasets enabled the prioritization of a subset of 92 DAF-16/FoxO target genes for functional interrogation. Among 29 genes tested, two DAF-16A-specific target genes significantly influenced longevity. A loss-of-function mutation in the conserved gene gst-20, which is induced by DAF-16A, reduced life span extension in the context of daf-2/IGFR RNAi without influencing longevity in animals subjected to control RNAi. Therefore, gst-20 promotes DAF-16/FoxO-dependent longevity. Conversely, a loss-of-function mutation in srr-4, a gene encoding a seven-transmembrane-domain receptor family member that is repressed by DAF-16A, extended life span in control animals, indicating that DAF-16/FoxO may extend life span at least in part by reducing srr-4 expression. Our discovery of new longevity genes underscores the efficacy of our integrative strategy while providing a general framework for identifying specific downstream gene regulatory events that contribute substantially to transcription factor functions. As FoxO transcription factors have conserved functions in promoting longevity and may be dysregulated in aging-related diseases, these findings promise to illuminate fundamental principles underlying aging in animals.	[Chen, Albert Tzong-Yang; Guo, Chunfang; Itani, Omar A.; Budaitis, Breane G.; Williams, Travis W.; Hu, Patrick J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [McEachin, Richard C.; Pande, Manjusha; Grant, Ana R.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Hu, Patrick J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Hu, Patrick J.] Univ Michigan, Sch Med, Inst Gerontol, Ann Arbor, MI 48109 USA; [Hopkins, Christopher E.] Knudra Transgen, Murray, UT 84123 USA; [Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	Hu, PJ (reprint author), 3027 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	pathu@umich.edu			National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; Biology of Aging training grant by the National Institute on Aging [T32AG000114]; Functional Assessment Core of the UM Nathan Shock Center of Excellence in the Basic Biology of Aging from the American Cancer Society [DDC-119640]; R01 grant from the NIH [AG041177]	We thank Robert Lyons and Jeanne Geskes at the University of Michigan (UM) DNA Sequencing Core for their assistance with whole transcriptome profiling, the UM Bioinformatics Core and Mallory Freeberg for help with analysis of transcriptome profiling data, and John Kim and Colin Delaney for comments on the manuscript. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). This work was supported by the Biology of Aging training grant T32AG000114, awarded to the UM Geriatrics Center by the National Institute on Aging (A.T.-Y.C.), the Functional Assessment Core of the UM Nathan Shock Center of Excellence in the Basic Biology of Aging, research scholar grant DDC-119640 from the American Cancer Society (P.J.H.), and R01 grant AG041177 from the NIH (P.J.H.).	Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; FRIEDMAN DB, 1988, GENETICS, V118, P75; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Riesen M, 2014, AGING-US, V6, P98; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Yamamoto R, 2011, AGING CELL, V10, P729, DOI 10.1111/j.1474-9726.2011.00716.x; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Chen ATY, 2013, AGING CELL, V12, P932, DOI 10.1111/acel.12120; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; VOWELS JJ, 1992, GENETICS, V130, P105; Murakami S, 1996, GENETICS, V143, P1207; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Tsuchiya K, 2013, CIRC RES, V112, P992, DOI 10.1161/CIRCRESAHA.112.300749; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Honda Y, 1999, FASEB J, V13, P1385; Gems D, 1998, GENETICS, V150, P129; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.13.029; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741; Ashburner M, 2000, NAT GENET, V25, P25; Bansal Ankita, 2014, Longev Healthspan, V3, P5, DOI 10.1186/2046-2395-3-5; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; GOTTLIEB S, 1994, GENETICS, V137, P107; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Jünger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Langmead B., 2010, CURR PROTOC BIOINFOR, V11, P7, DOI DOI 10.1002/0471250953.BI1107S32; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Murphy C. T., 2013, WORMBOOK, V26, P1, DOI DOI 10.1895/WORMBOOK.1.164.1; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wood W. B., 1988, NEMATODE CAENORHABDI, P393	95	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2015	201	2					613	+		10.1534/genetics.115.177998		60	Genetics & Heredity	Genetics & Heredity	CT5HB	WOS:000362838500021		
J	Liu, GJ; Sanghavi, P; Bollinger, KE; Perry, L; Marshall, B; Roon, P; Tanaka, T; Nakamura, A; Gonsalvez, GB				Liu, Guojun; Sanghavi, Paulomi; Bollinger, Kathryn E.; Perry, Libby; Marshall, Brendan; Roon, Penny; Tanaka, Tsubasa; Nakamura, Akira; Gonsalvez, Graydon B.			Efficient Endocytic Uptake and Maturation in Drosophila Oocytes Requires Dynamitin/p50	GENETICS			English	Article						microtubule motors; endocytosis; cell polarity; kinesin; dynactin	OSKAR MESSENGER-RNA; EXOCYST COMPONENT SEC5; GROWTH-FACTOR RECEPTOR; CLATHRIN HEAVY-CHAIN; POSTERIOR LOCALIZATION; CYTOPLASMIC DYNEIN; CELL-FORMATION; GERM PLASM; TRANSPORT; PROTEIN	Dynactin is a multi-subunit complex that functions as a regulator of the Dynein motor. A central component of this complex is Dynamitin/p50 (Dmn). Dmn is required for endosome motility in mammalian cell lines. However, the extent to which Dmn participates in the sorting of cargo via the endosomal system is unknown. In this study, we examined the endocytic role of Dmn using the Drosophila melanogaster oocyte as a model. Yolk proteins are internalized into the oocyte via clathrin-mediated endocytosis, trafficked through the endocytic pathway, and stored in condensed yolk granules. Oocytes that were depleted of Dmn contained fewer yolk granules than controls. In addition, these oocytes accumulated numerous endocytic intermediate structures. Particularly prominent were enlarged endosomes that were relatively devoid of Yolk proteins. Ultrastructural and genetic analyses indicate that the endocytic intermediates are produced downstream of Rab5. Similar phenotypes were observed upon depleting Dynein heavy chain (Dhc) or Lis1. Dhc is the motor subunit of the Dynein complex and Lis1 is a regulator of Dynein activity. We therefore propose that Dmn performs its function in endocytosis via the Dynein motor. Consistent with a role for Dynein in endocytosis, the motor colocalized with the endocytic machinery at the oocyte cortex in an endocytosis-dependent manner. Our results suggest a model whereby endocytic activity recruits Dynein to the oocyte cortex. The motor along with its regulators, Dynactin and Lis1, functions to ensure efficient endocytic uptake and maturation.	[Liu, Guojun; Sanghavi, Paulomi; Perry, Libby; Marshall, Brendan; Roon, Penny; Gonsalvez, Graydon B.] Georgia Regents Univ, Cellular Biol & Anat, Augusta, GA 30912 USA; [Bollinger, Kathryn E.] Georgia Regents Univ, James & Jean Culver Vision Discovery Inst, Augusta, GA 30912 USA; [Tanaka, Tsubasa; Nakamura, Akira] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Germline Dev, Div Organogenesis, Kumamoto 8600811, Japan	Gonsalvez, GB (reprint author), Georgia Regents Univ, Cellular Biol & Anat, Augusta, GA 30912 USA.	ggonsalvez@gru.edu			National Institutes of Health [1R01GM100088-01]	We thank Simon Bullock, Anne Ephrussi, Vladimir Gelfand, Antoine Guichet, and Daniel St. Johnston for providing antibodies and fly strains that were essential for completing this work; Linton Traub for providing the GST-mRFP-RAP construct used in the endocytosis assays; Catherine Rabouille for advice on preparing Drosophila egg chambers for electron microscopy; Silvia Corvera for the TagRFP-T-EEA1 plasmid; the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for providing numerous fly strain and antibodies that were critical in completing this work; and Paul McNeil, Anna McNeil, and Tim Kurtz for assistance with various imaging experiments. This work was supported by a grant (1R01GM100088-01) from the National Institutes of Health (to G.B.G.).	EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Ramachandran R, 2011, SEMIN CELL DEV BIOL, V22, P10, DOI 10.1016/j.semcdb.2010.09.001; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Terenzio M, 2014, EMBO J, V33, P1582, DOI 10.15252/embj.201387579; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Compagnon J, 2009, J CELL SCI, V122, P25, DOI 10.1242/jcs.033027; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Vanzo N, 2007, DEV CELL, V12, P543, DOI 10.1016/j.devcel.2007.03.002; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; Jha A, 2012, MOL BIOL CELL, V23, P1742, DOI 10.1091/mbc.E11-11-0939; Sanghavi P, 2012, DEV BIOL, V367, P66, DOI 10.1016/j.ydbio.2012.04.024; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Yousefian J, 2013, J CELL SCI, V126, P1583, DOI 10.1242/jcs.114934; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; TSURUHARA T, 1990, CELL TISSUE RES, V259, P199, DOI 10.1007/BF00318441; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; Zhao TT, 2012, SCIENCE, V336, P999, DOI 10.1126/science.1219147; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Murthy M, 2004, DEVELOPMENT, V131, P377, DOI 10.1242/dev.00931; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Sommer B, 2005, J CELL BIOL, V169, P953, DOI 10.1083/jcb.200411053; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Valetti C, 1999, MOL BIOL CELL, V10, P4107; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/nmeth.1592, 10.1038/NMETH.1592]; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Girard E, 2014, TRAFFIC, V15, P309, DOI 10.1111/tra.12143; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; DIMARIO PJ, 1987, J CELL BIOL, V105, P199, DOI 10.1083/jcb.105.1.199; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Morais-de-Sa E, 2014, DEVELOPMENT, V141, P2984, DOI 10.1242/dev.109827; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; STENMARK H, 1994, EMBO J, V13, P1287; Zimyanin V, 2007, CURR BIOL, V17, P353, DOI 10.1016/j.cub.2006.12.044; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vazquez-Pianzola P, 2014, DEVELOPMENT, V141, P1915, DOI 10.1242/dev.099432; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Flores-Rodriguez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024479; Koch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004552; Long R. M., 2012, BIOL REP, V4, P16; Sanghavi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080605; Spradling A. C., 1994, DEV DROSOPHILA MELAN, P1; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Yu YXV, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-9	72	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2015	201	2					631	+		10.1534/genetics.115.180018		26	Genetics & Heredity	Genetics & Heredity	CT5HB	WOS:000362838500022		
J	Taguchi-Shiobara, F; Ota, T; Ebana, K; Ookawa, T; Yamasaki, M; Tanabata, T; Yamanouchi, U; Wu, JZ; Ono, N; Nonoue, Y; Nagata, K; Fukuoka, S; Hirabayashi, H; Yamamoto, T; Yano, M				Taguchi-Shiobara, Fumio; Ota, Tatsuya; Ebana, Kaworu; Ookawa, Taiichiro; Yamasaki, Masanori; Tanabata, Takanari; Yamanouchi, Utako; Wu, Jianzhong; Ono, Nozomi; Nonoue, Yasunori; Nagata, Kazufumi; Fukuoka, Shuichi; Hirabayashi, Hideyuki; Yamamoto, Toshio; Yano, Masahiro			Natural Variation in the Flag Leaf Morphology of Rice Due to a Mutation of the NARROW LEAF 1 Gene in Oryza sativa L.	GENETICS			English	Article						rice; flag leaf width; natural variation; Oryza sativa L.; NARROW LEAF 1	INCREASES YIELD; GRAIN-YIELD; GENOME; ASSOCIATION; REVEALS; NAL1; POPULATION; LANDRACE; MAP	We investigated the natural variations in the flag leaf morphology of rice. We conducted a principal component analysis based on nine flag leaf morphology traits using 103 accessions from the National Institute of Agrobiological Sciences Core Collection. The first component explained 39% of total variance, and the variable with highest loading was the width of the flag leaf (WFL). A genome-wide association analysis of 102 diverse Japanese accessions revealed that marker RM6992 on chromosome 4 was highly associated with WFL. In analyses of progenies derived from a cross between Takanari and Akenohoshi, the most significant quantitative trait locus (QTL) for WFL was in a 10.3-kb region containing the NARROW LEAF 1 (NAL1) gene, located 0.4 Mb downstream of RM6992. Analyses of chromosomal segment substitution lines indicated that a mutation (G1509A single-nucleotide mutation, causing an R233H amino acid substitution in NAL1) was present at the QTL. This explained 13 and 20% of total variability in WFL and the distance between small vascular bundles, respectively. The mutation apparently occurred during rice domestication and spread into japonica, tropical japonica, and indica subgroups. Notably, one accession, Phulba, had a NAL1 allele encoding only the N-terminal, or one-fourth, of the wild-type peptide. Given that the Phulba allele and the histidine-type allele showed essentially the same phenotype, the histidine-type allele was regarded as malfunctional. The phenotypes of transgenic plants varied depending on the ratio of histidine-type alleles to arginine-type alleles, raising the possibility that H-233-type products function differently from and compete with R-233-type products.	[Taguchi-Shiobara, Fumio; Ebana, Kaworu; Tanabata, Takanari; Yamanouchi, Utako; Wu, Jianzhong; Nonoue, Yasunori; Nagata, Kazufumi; Fukuoka, Shuichi; Yamamoto, Toshio; Yano, Masahiro] Agrogenom Res Ctr, Natl Inst Agrobiol Sci, Rice Appl Genom Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Ota, Tatsuya] Grad Univ Adv Studies, SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Ookawa, Taiichiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Yamasaki, Masanori] Kobe Univ, Grad Sch Agr Sci, Food Resources Educ & Res Ctr, Kasai, Hyogo 6752103, Japan; [Ono, Nozomi] Inst Soc Tech Innovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Hirabayashi, Hideyuki] NARO Inst Crop Sci, Rice Res Div, Tsukuba, Ibaraki 3058518, Japan	Taguchi-Shiobara, F (reprint author), Agrogenom Res Ctr, Natl Inst Agrobiol Sci, Rice Appl Genom Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	fstagu@affrc.go.jp			National Bioresource Project, Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Agrobiological Sciences technical support system; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR-0001, QTL-1002]; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [IVG-2003]	We thank Akemi Tagiri for thin sectioning and Haruko Onodera for production of transgenic plants. The wild rice accessions used in this study were obtained from the National Institute of Genetics, which is supported by the National Bioresource Project, Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was supported by the National Institute of Agrobiological Sciences technical support system and by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation NVR-0001 and QTL-1002 and Genomics-based Technology for Agricultural Improvement IVG-2003).	Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ebana K, 2011, THEOR APPL GENET, V122, P1199, DOI 10.1007/s00122-010-1524-1; CHURCHILL GA, 1994, GENETICS, V138, P963; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Chen ML, 2012, PLANT CELL REP, V31, P863, DOI 10.1007/s00299-011-1207-7; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; WATSON DJ, 1952, ADV AGRON, V4, P101, DOI 10.1016/S0065-2113(08)60307-7; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Yamasaki M, 2013, BREEDING SCI, V63, P49, DOI 10.1270/jsbbs.63.49; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; LANGDALE JA, 1989, DEV BIOL, V133, P128, DOI 10.1016/0012-1606(89)90304-7; Esau K., 1977, ANATOMY SEED PLANTS; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Hoshikawa K., 1989, GROWING RICE PLANT A; INOSAKA MASAYUKI, 1962, BULL FAC AGRIC UNIV MIYAZAKI, V7, P15; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Jiang D., 2015, PLOS ONE, V10; MATSUO T., 1952, BULL NATL INST AGRIC SCI [JAPAN] SER D PLANT PHYSIOL, V3, P1; Nagata K, 2015, BREEDING SCI, V65, P308, DOI 10.1270/jsbbs.65.308; Sinclair TR, 1999, SCIENCE, V283, P1455, DOI DOI 10.1126/SCIENCE.283.5407.1455C; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Tanaka A., 1958, J SCI SOIL MANURE, V29, P327; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	33	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2015	201	2					795	+		10.1534/genetics.115.181040		30	Genetics & Heredity	Genetics & Heredity	CT5HB	WOS:000362838500033		
J	Watanabe, T; Tani, M; Ishibashi, Y; Endo, I; Okino, N; Ito, M				Watanabe, Takashi; Tani, Motohiro; Ishibashi, Yohei; Endo, Ikumi; Okino, Nozomu; Ito, Makoto			Ergosteryl-beta-glucosidase (Egh1) involved in sterylglucoside catabolism and vacuole formation in Saccharomyces cerevisiae	GLYCOBIOLOGY			English	Article						ergosteryl-beta-glucosidase; glycolipid; Saccharomyces cerevisiae; sterylglucoside	CHOLESTEROL GLUCOSYLATION; CRYPTOCOCCUS-NEOFORMANS; PICHIA-PASTORIS; HEAT-SHOCK; FUSION; PROTEINS; STEROL; FUNGI; ENDOGLYCOCERAMIDASE; STRESS	Sterylglucosides (SGs) are composed of a glucose and sterol derivatives, and are distributed in fungi, plants and mammals. We recently identified EGCrP1 and EGCrP2 (endoglycoceramidase-related proteins 1 and 2) as a beta-glucocerebrosidase and steryl-beta-glucosidase, respectively, in Cryptococcus neoformans. We herein describe an EGCrP2 homologue (Egh1; ORF name, Yir007w) involved in SG catabolism in Saccharomyces cerevisiae. The purified recombinant Egh1 hydrolyzed various beta-glucosides including ergosteryl beta-glucoside (EG), cholesteryl beta-glucoside, sitosteryl beta-glucoside, para-nitrophenyl beta-glucoside, 4-methylumberifellyl beta-glucoside and glucosylceramide. The disruption of EGH1 in S. cerevisiae BY4741 (egh1 Delta) resulted in the accumulation of EG and fragmentation of vacuoles. The expression of EGH1 in egh1 Delta (revertant) reduced the accumulation of EG, and restored the morphology of vacuoles. The accumulation of EG was not detected in EGH1 and UGT51(ATG26) double-disrupted mutants (ugt51 Delta egh1 Delta), indicating that EG was synthesized by Ugt51(Atg26) and degraded by Egh1 in vivo. These results clearly demonstrated that Egh1 is an ergosteryl-beta-glucosidase that is functionally involved in the EG catabolic pathway and vacuole formation in S. cerevisiae.	[Watanabe, Takashi; Ishibashi, Yohei; Endo, Ikumi; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fac Sci,Higashi Ku, Fukuoka 8128581, Japan; [Tani, Motohiro] Kyushu Univ, Fac Sci, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan	Ito, M (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fac Sci,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24380058, 15H04488]; Japan Foundation for Applied Enzymology	This work was supported in part by the Grant-in-Aid for Scientific Research B (# 24380058, # 15H04488) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Foundation for Applied Enzymology (to M.I.).	Oku M, 2003, EMBO J, V22, P3231, DOI 10.1093/emboj/cdg331; Mayer A, 2000, MOL BIOL CELL, V11, P807; Cao Y, 2007, AUTOPHAGY, V3, P17; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; ITO M, 1989, J BIOL CHEM, V264, P9510; Kunimoto S, 2000, CELL STRESS CHAPERON, V5, P3, DOI 10.1379/1466-1268(2000)005<0003:EOCGBH>2.0.CO;2; Kunimoto S, 2002, CELL STRUCT FUNCT, V27, P157, DOI 10.1247/csf.27.157; Brachmann CB, 1998, YEAST, V14, P115; Nakagawa T, 1999, J BIOCHEM-TOKYO, V126, P604; ITO M, 1986, J BIOL CHEM, V261, P14278; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Hayashi Y, 2008, ANAL BIOCHEM, V383, P122, DOI 10.1016/j.ab.2008.07.024; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Watanabe T, 2015, J BIOL CHEM, V290, P1005, DOI 10.1074/jbc.M114.616300; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; NAEWBANIJ M, 1984, CEREAL CHEM, V61, P385; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Kunimoto S, 2003, CELL STRUCT FUNCT, V28, P179; Akiyama H, 2013, BIOCHEM BIOPH RES CO, V441, P838, DOI 10.1016/j.bbrc.2013.10.145; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MurakamiMurofushi K, 1997, J BIOL CHEM, V272, P486; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899	35	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT	2015	25	10					1079	1089		10.1093/glycob/cwv045		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7JL	WOS:000362990900005		
J	Wang, N; Seko, A; Takeda, Y; Kikuma, T; Ito, Y				Wang, Ning; Seko, Akira; Takeda, Yoichi; Kikuma, Takashi; Ito, Yukishige			Cooperative role of calnexin and TigA in Aspergillus oryzae glycoprotein folding	GLYCOBIOLOGY			English	Article						Aspergillus oryzae; calnexin; N-linked glycoprotein; protein disulfide isomerase; ribonuclease	BETA-N-ACETYLGLUCOSAMINIDASE; MANNOSE-TYPE OLIGOSACCHARIDE; DOWN CHEMOENZYMATIC APPROACH; PROTEIN-DISULFIDE-ISOMERASE; QUALITY-CONTROL; HOMOGENEOUS GLYCOPROTEINS; ENDOPLASMIC-RETICULUM; RIBONUCLEASE B; MOLECULAR CHAPERONE; EFFICIENT SYNTHESIS	Calnexin (CNX), known as a lectin chaperone located in the endoplasmic reticulum (ER), specifically recognizes G(1)M(9)GN(2)-proteins and facilitates their proper folding with the assistance of ERp57 in mammalian cells. However, it has been left unidentified how CNX works in Aspergillus oryzae, which is a filamentous fungus widely exploited in biotechnology. In this study, we found that a protein disulfide isomerase homolog TigA can bind with A. oryzae CNX (AoCNX), which was revealed to specifically recognize monoglucosylated glycans, similarly to CNX derived from other species, and accelerate the folding of G(1)M(9)GN(2)-ribonuclease (RNase) in vitro. For refolding experiments, a homogeneous monoglucosylated high-mannose-type glycoprotein G(1)M(9)GN(2)-RNase was chemoenzymatically synthesized from G(1)M(9)GN-oxazoline and GN-RNase. Denatured G(1)M(9)GN(2)-RNase was refolded with highest efficiency in the presence of both soluble form of AoCNX and TigA. TigA contains two thioredoxin domains with CGHC motif, mutation analysis of which revealed that the one in N-terminal regions is involved in binding to AoCNX, while the other in catalyzing protein refolding. The results suggested that in glycoprotein folding process of A. oryzae, TigA plays a similar role as ERp57 in mammalian cells, as a partner protein of AoCNX.	[Wang, Ning; Seko, Akira; Takeda, Yoichi; Ito, Yukishige] Japan Sci & Technol Agcy JST, ERATO, Ito Glycotril Project, Wako, Saitama 3510198, Japan; [Wang, Ning; Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Kikuma, Takashi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Ito, Y (reprint author), Japan Sci & Technol Agcy JST, ERATO, Ito Glycotril Project, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yukito@riken.jp	Ito, Yukishige/M-5119-2014; 	Ito, Yukishige/0000-0001-6251-7249; Takeda, Yoichi/0000-0002-7146-3585			Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Sakono M, 2014, BBA-GEN SUBJECTS, V1840, P2904, DOI 10.1016/j.bbagen.2014.04.012; Sakamoto I, 2012, J AM CHEM SOC, V134, P5428, DOI 10.1021/ja2109079; OHTA M, 1991, GLYCOCONJUGATE J, V8, P400, DOI 10.1007/BF00731292; Fujikawa K, 2015, CHEM-EUR J, V21, P3224, DOI 10.1002/chem.201405781; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; Jeenes DJ, 1997, GENE, V193, P151, DOI 10.1016/S0378-1119(97)00098-X; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Dedola S, 2014, ANGEW CHEM INT EDIT, V53, P2883, DOI 10.1002/anie.201309665; Park C, 2001, METHOD ENZYMOL, V341, P81; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Watanabe T, 2007, BIOSCI BIOTECH BIOCH, V71, P2688, DOI 10.1271/bbb.70289; Matsuo I, 2003, J AM CHEM SOC, V125, P3402, DOI 10.1021/ja021288q; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/nchembio.314, 10.1038/NCHEMBIO.314]; Yamamoto K, 2001, J BIOSCI BIOENG, V92, P493, DOI 10.1263/jbb.92.493; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; MINOBE S, 1979, J BIOCHEM-TOKYO, V86, P1851; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Arai MA, 2005, CHEMBIOCHEM, V6, P2281, DOI 10.1002/cbic.200500143; Aikawa J, 2012, GLYCOCONJUGATE J, V29, P35, DOI 10.1007/s10719-011-9362-1; Archer DB, 2000, CURR OPIN BIOTECH, V11, P478, DOI 10.1016/S0958-1669(00)00129-4; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Yuan Y, 2010, BIOPOLYMERS, V94, P373, DOI 10.1002/bip.21374; Whitley P, 1996, J BIOL CHEM, V271, P6241; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Koizumi A, 2013, ANGEW CHEM INT EDIT, V52, P7426, DOI 10.1002/anie.201301613; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; Sims AH, 2004, MYCOL RES, V108, P853, DOI 10.1017/S09537562040067X; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Takeda Y, 2013, CARBOHYD RES, V375, P112, DOI 10.1016/j.carres.2013.04.032; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Makimura Y, 2012, CARBOHYD RES, V364, P41, DOI 10.1016/j.carres.2012.10.011; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; NAKAO Y, 1987, J BIOCHEM-TOKYO, V102, P171; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang N, 2015, CARBOHYD RES, V411, P37, DOI 10.1016/j.carres.2015.04.011; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658	54	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT	2015	25	10					1090	1099		10.1093/glycob/cwv043		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7JL	WOS:000362990900006		
J	Hane, M; Matsuoka, S; Ono, S; Miyata, S; Kitajima, K; Sato, C				Hane, Masaya; Matsuoka, Shuhei; Ono, Sayaka; Miyata, Shinji; Kitajima, Ken; Sato, Chihiro			Protective effects of polysialic acid on proteolytic cleavage of FGF2 and proBDNF/BDNF	GLYCOBIOLOGY			English	Article						BDNF; FGF2; NCAM; plasmin; polysialic acid; polysialyltransferase; proBDNF; SPR; ST8SIA2/STX; Trypsin	CELL-ADHESION MOLECULE; FIBROBLAST-GROWTH-FACTOR; NEUROTROPHIC FACTOR; MUTATED POLYSIALYLTRANSFERASE; FUNCTIONAL IMPAIRMENTS; MAMMALIAN BRAIN; SCHIZOPHRENIA; EXPRESSION; PLASTICITY; MICE	Polysialic acid (polySia) is a linear polymer of sialic acid that modifies neural cell adhesion molecule (NCAM) in the vertebrate brain. PolySia is a large and exclusive molecule that functions as a negative regulator of cell-cell interactions. Recently, we demonstrated that polySia can specifically bind fibroblast growth factor 2 (FGF2) and BDNF; however, the protective effects of polySia on the proteolytic cleavage of these proteins remain unknown, although heparin/heparan sulfate has been shown to impair the cleavage of FGF2 by trypsin. Here, we analyzed the protective effects of polySia on the proteolytic cleavage of FGF2 and proBDNF/BDNF. We found that polySia protected intact FGF2 from tryptic activity via the specific binding of extended polySia chains on NCAM to FGF2. Oligo/polySia also functioned to impair the processing of proBDNF by plasmin via binding of oligo/polySia chains on NCAM. In addition, the polySia structure synthesized by mutated polysialyltransferase, ST8SIA2/STX(SNP7), which was previously identified from a schizophrenia patient, was impaired for these functions compared with polySia produced by normal ST8SIA2. Taken together, these data suggest that the protective effects of polySia toward FGF2 and proBDNF may be involved in the regulation of the concentrations of these neurologically active molecules.	[Hane, Masaya; Matsuoka, Shuhei; Ono, Sayaka; Miyata, Shinji; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Hane, Masaya; Matsuoka, Shuhei] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Sato, C (reprint author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014		Ministry of Education, Science, Sports and Culture [15K06995, 23110002, 26110708]	This research was supported in part by Grants-in-Aid for Scientific Research (C) (15K06995) and Scientific Research on Innovative Areas (No. 23110002, Deciphering sugar chain-based signals regulating integrative neural functions) (26110708) from the Ministry of Education, Science, Sports and Culture.	Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005-08.016; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5; Turner CA, 2009, PHARMACOL BIOCHEM BE, V92, P100, DOI 10.1016/j.pbb.2008.10.018; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Hildebrandt H, 2010, ADV EXP MED BIOL, V663, P95, DOI 10.1007/978-1-4419-1170-4_6; BARDE YA, 1982, EMBO J, V1, P549; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; TARDIEU M, 1994, GROWTH FACTORS, V11, P291, DOI 10.3109/08977199409011002; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; YANG PF, 1994, J BIOL CHEM, V269, P23039; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Fumagalli F, 2005, NEUROBIOL DIS, V20, P731, DOI 10.1016/j.nbd.2005.05.005; Weltrowski A, 2012, MACROMOL BIOSCI, V12, P740, DOI 10.1002/mabi.201100518; Graham BM, 2010, NEUROPSYCHOPHARMACOL, V35, P1348, DOI 10.1038/npp.2010.3; Bush MA, 2001, J CLIN PHARMACOL, V41, P378, DOI 10.1177/00912700122010230; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Krocher T, 2015, BRAIN STRUCT FUNCT, V220, P71, DOI 10.1007/s00429-013-0638-z; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Nagae M, 2013, J BIOL CHEM, V288, P33784, DOI 10.1074/jbc.M113.496224; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Eckhardt M, 2000, J NEUROSCI, V20, P5234; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SATO C, 1993, J BIOL CHEM, V268, P23675; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556	51	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT	2015	25	10					1112	1124		10.1093/glycob/cwv049		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7JL	WOS:000362990900008		
J	Kanie, O				Kanie, Osamu			Introduction to the special issue on chemical glycobiology: all the aspects are important	GLYCOCONJUGATE JOURNAL			English	Editorial Material									Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan	Kanie, O (reprint author), Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan.	kanie@tokai-u.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					421	423		10.1007/s10719-015-9623-5		3	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600001		
J	Toshima, K; Takahashi, D				Toshima, Kazunobu; Takahashi, Daisuke			Chemical approach for target-selective degradation of oligosaccharides using photoactivatable organic molecules	GLYCOCONJUGATE JOURNAL			English	Review						Photodegradation; Lectin; Boronic acid; Kemp's acid; Anthraquinone; Anthracene	CONVERGENT FUNCTIONAL-GROUPS; CELL-WALL; MYCOBACTERIUM-TUBERCULOSIS; ACID; RECOGNITION; BINDING; LECTIN; COMPLEXES; DNA; PHOTOCLEAVAGE	Molecular design, chemical synthesis, and biological evaluation of several organic molecules, which can target-selectively photodegrade oligosaccharides by irradiation with a specific wavelength of light under mild conditions without any additives, are introduced. These novel class of photochemical agents promise bright prospects for finding not only molecular-targeted bioprobes for understanding of the structure-activity relationships of oligosaccharides but also novel therapeutic drugs targeting biologically important oligosaccharides.	[Toshima, Kazunobu; Takahashi, Daisuke] Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Toshima, K (reprint author), Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	toshima@applc.keio.ac.jp	Takahashi, Daisuke /F-7647-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23310153, 26282212, 24102528, 26102738, 22710220]	The authors wish to sincerely thank all of the co-authors of the references cited in this review article. This research was supported in part by Scientific Research (B) (No. 23310153 and 26282212), Scientific Research on Innovative Areas "Chemical Biology of Natural Products" (No. 24102528 and 26102738), and Grants-in-Aid for Young Scientists (B) (No. 22710220) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Nishibu M, 2012, ORG BIOMOL CHEM, V10, P8393, DOI 10.1039/c2ob26417j; Hayashi N, 2004, BIOSCI BIOTECH BIOCH, V68, P2512, DOI 10.1271/bbb.68.2512; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; AQUINO AM, 1990, J AM CHEM SOC, V112, P5819, DOI 10.1021/ja00171a022; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; WILLIAMS K, 1989, J AM CHEM SOC, V111, P1090, DOI 10.1021/ja00185a045; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SIMKOVIC I, 1990, CARBOHYD RES, V201, P346, DOI 10.1016/0008-6215(90)84251-O; Takahashi D, 2010, ANGEW CHEM INT EDIT, V49, P10096, DOI 10.1002/anie.201005161; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174; Hirose K, 2001, J INCL PHENOM MACRO, V39, P193, DOI 10.1023/A:1011117412693; Djanashvili K, 2005, CHEM-EUR J, V11, P4010, DOI 10.1002/chem.200401335; Springsteen G, 2001, CHEM COMMUN, P1608, DOI 10.1039/b104895n; Toshima K, 2000, BIOORG MED CHEM LETT, V10, P2163, DOI 10.1016/S0960-894X(00)00410-8; KOCH T, 1993, PHOTOCHEM PHOTOBIOL, V58, P554, DOI 10.1111/j.1751-1097.1993.tb04931.x; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Toshima K, 2004, ARKIVOC, P28; KEMP DS, 1981, J ORG CHEM, V46, P5140, DOI 10.1021/jo00338a014; NORRILD JC, 1995, J AM CHEM SOC, V117, P1479, DOI 10.1021/ja00110a003; Scherman MS, 2003, ANTIMICROB AGENTS CH, V47, P378, DOI 10.1128/AAC.47.1.378-382.2003; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; Ishii M, 2007, ANGEW CHEM INT EDIT, V46, P8396, DOI 10.1002/anie.200702127; ASKEW B, 1989, J AM CHEM SOC, V111, P1082, DOI 10.1021/ja00185a044; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Hamachi I, 2000, J AM CHEM SOC, V122, P12065, DOI 10.1021/ja002044d; Bender M. L., 1978, CYCLODEXTRIN CHEM; Bycroft B.W., 1988, DICT ANTIBIOTICS REL; Ernst B., 2000, CARBOHYDRATE CHEM BI; Gibson A.R., 1974, CAN J CHEM, V52, P3095; James T.D, 2006, BORONIC ACIDS PREPAR, P441; Kamerling J.P., 2007, COMPREHENSIVE GLYCOS	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					475	482		10.1007/s10719-015-9591-9		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600006		
J	Taichi, M; Kitazume, S; Vong, K; Imamaki, R; Kurbangalieva, A; Taniguchi, N; Tanaka, K				Taichi, Misako; Kitazume, Shinobu; Vong, Kenward; Imamaki, Rie; Kurbangalieva, Almira; Taniguchi, Naoyuki; Tanaka, Katsunori			Cell surface and in vivo interaction of dendrimeric N-glycoclusters	GLYCOCONJUGATE JOURNAL			English	Article						Asparagine-linked glycans (N-Glycan); Dendrimer; Platelet endothelial cell adhesion molecule (PECAM); Glycocluster; In vivo imaging; Lectin	ADHESION MOLECULE PECAM; ASIALOGLYCOPROTEIN RECEPTOR; INNATE IMMUNITY; DRUG-DELIVERY; NEOGLYCOPROTEINS; BIODISTRIBUTION; INFLAMMATION; GLYCANS; BINDING; VITRO	While many examples have been reported that glycoclusters interact with target lectins more strongly than single molecules of glycans, through multivalency effects, literature examples to support lectin interactions/modulations on cell surface and in live animals is quite rare. Our N-glycoclusters, which were efficiently prepared by immobilizing 16 molecules of the asparagine-linked glycans (N-glycans) onto a lysine-based dendron template through histidine-mediated Huisgen cycloaddition, were shown to efficiently detect platelet endothelial cell adhesion molecule (PECAM) on human umbilical vein endothelial cells (HUVEC) as a alpha(2-6)-sialylated oligosaccharides recognizing lectin. Furthermore, the identity of the N-glycans on our N-glycoclusters allowed control over organ-selective accumulation and serum clearance properties when intravenously injected into mice.	[Taichi, Misako; Vong, Kenward; Tanaka, Katsunori] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan; [Kitazume, Shinobu; Imamaki, Rie; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, RIKEN Global Res Cluster, Wako, Saitama 3510198, Japan; [Kurbangalieva, Almira; Tanaka, Katsunori] Kazan Fed Univ, Biofunct Chem Lab, A Butlerov Inst Chem, Kazan 420008, Russia; [Tanaka, Katsunori] JST PRESTO, Wako, Saitama 3510198, Japan	Tanaka, K (reprint author), RIKEN, Biofunct Synthet Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kotzenori@riken.jp			Japan Society for the Promotion of Science [23681047, 25560410, 26560438, 26870859]; Mizutani Foundation for Glycoscience; MEXT [25430122, 26102743]	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, No. 23681047, 25560410, 26560438, and 26870859; by a Research Grant from the Mizutani Foundation for Glycoscience; and by a MEXT Grant-in-Aid for Scientific Research (C) (No. 25430122) and on Innovative Areas "Chemical Biology of Natural Products: Target ID and Regulation of Bioactivity" (No. 26102743). This work was also performed under the Russian Government Program of Competitive Growth of Kazan Federal University.	Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; van Kasteren SI, 2009, P NATL ACAD SCI USA, V106, P18, DOI 10.1073/pnas.0806787106; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Ikehara Y, 2006, CANCER RES, V66, P8740, DOI 10.1158/0008-5472.CAN-06-0470; Tanaka K, 2008, ORG BIOMOL CHEM, V6, P815, DOI 10.1039/b718157b; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Wong CWY, 2000, MOL BIOL CELL, V11, P3109; Bird IN, 1999, J CELL SCI, V112, P1989; Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237; MORELL AG, 1968, J BIOL CHEM, V243, P155; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; Davicino RC, 2011, INT IMMUNOPHARMACOL, V11, P1457, DOI 10.1016/j.intimp.2011.05.002; Chabre YM, 2010, ADV CARBOHYD CHEM BI, V63, P165, DOI 10.1016/S0065-2318(10)63006-5; Leeuwenburgh MA, 2003, CURR OPIN CHEM BIOL, V7, P757, DOI 10.1016/j.cbpa.2003.10.009; Andre S, 1997, BIOCONJUGATE CHEM, V8, P845, DOI 10.1021/bc970164d; Fukase K, 2012, CURR OPIN CHEM BIOL, V16, P614, DOI 10.1016/j.cbpa.2012.09.005; Tanaka K, 2008, ANGEW CHEM INT EDIT, V47, P102, DOI 10.1002/anie.200702989; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Serres S, 2009, J NEUROSCI, V29, P4820, DOI 10.1523/JNEUROSCI.0406-09.2009; Chabre YM, 2008, CURR TOP MED CHEM, V8, P1237, DOI 10.2174/156802608785848987; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Nieda M, 2001, IMMUNOLOGY, V102, P137, DOI 10.1046/j.1365-2567.2001.01175.x; Chen WC, 2010, BLOOD, V115, P4778, DOI 10.1182/blood-2009-12-257386; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Renaudet O, 2008, MINI-REV ORG CHEM, V5, P274, DOI 10.2174/157019308786242142; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Ogura A, 2014, GLYCOCONJUGATE J, V31, P273, DOI 10.1007/s10719-014-9520-3; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Tanaka K, 2007, TETRAHEDRON LETT, V48, P6475, DOI 10.1016/j.tetlet.2007.07.055; Kikkeri R, 2009, J AM CHEM SOC, V131, P2110, DOI 10.1021/ja807711w; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS, VIII; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS, VII; Kitazume S, 2014, J BIOL CHEM, V289, P27604, DOI 10.1074/jbc.M114.563585; Ogura A, 2014, MINI-REV MED CHEM, V14, P1072; Roy R., 2002, REV MOL BIOTECHNOL, V90, P291; Vyas SP, 2001, CRIT REV THER DRUG, V18, P1; Willis M, 1998, ADV DRUG DELIV REV, V29, P249, DOI DOI 10.1016/S0169-409X(97)00083-5	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					497	503		10.1007/s10719-015-9594-6		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600008		
J	Kato, K; Yamaguchi, T				Kato, Koichi; Yamaguchi, Takumi			Paramagnetic NMR probes for characterization of the dynamic conformations and interactions of oligosaccharides	GLYCOCONJUGATE JOURNAL			English	Review						Nuclear magnetic resonance spectroscopy; Paramagnetic effect; Conformational dynamics; Oligosaccharide; Lanthanide ion; Spin label	RESIDUAL DIPOLAR COUPLINGS; NUCLEAR-MAGNETIC-RESONANCE; N-LINKED OLIGOSACCHARIDES; METHYL-D-GLUCOPYRANOSIDE; SPIN-LABEL ANTIBODY; CONCANAVALIN-A; PSEUDOCONTACT SHIFTS; STRUCTURAL BIOLOGY; ADHESION DOMAIN; HUMAN CD2	Paramagnetism-assisted nuclear magnetic resonance (NMR) techniques have recently been applied to a wide variety of biomolecular systems, using sophisticated immobilization methods to attach paramagnetic probes, such as spin labels and lanthanide-chelating groups, at specific sites of the target biomolecules. This is also true in the field of carbohydrate NMR spectroscopy. NMR analysis of oligosaccharides is often precluded by peak overlap resulting from the lack of variability of local chemical structures, by the insufficiency of conformational restraints from nuclear Overhauser effect (NOE) data due to low proton density, and moreover, by the inherently flexible nature of carbohydrate chains. Paramagnetic probes attached to the reducing ends of oligosaccharides cause paramagnetic relaxation enhancements (PREs) and/or pseudocontact shifts (PCSs) resolve the peak overlap problem. These spectral perturbations can be sources of long-range atomic distance information, which complements the local conformational information derived from J couplings and NOEs. Furthermore, paramagnetic NMR approaches, in conjunction with computational methods, have opened up possibilities for the description of dynamic conformational ensembles of oligosaccharides in solution. Several applications of paramagnetic NMR techniques are presented to demonstrate their utility for characterizing the conformational dynamics of oligosaccharides and for probing the carbohydrate-recognition modes of proteins. These techniques can be applied to the characterization of transient, non-stoichiometric interactions and will contribute to the visualization of dynamic biomolecular processes involving sugar chains.	[Kato, Koichi; Yamaguchi, Takumi] Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi; Yamaguchi, Takumi] Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi; Yamaguchi, Takumi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	Kato, K (reprint author), Inst Mol Sci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	kkatonmr@ims.ac.jp			Okazaki ORION project; JSPS/MEXT [25102008, 24249002, 26560451, 24750170, 15 K17889]; Nanotechnology Platform Program	This study was partly supported by the Okazaki ORION project, JSPS/MEXT Grants-in-Aid for Scientific Research (25102008, 24249002, 26560451, 24750170 and 15 K17889) and the Nanotechnology Platform Program (Molecule and Material Synthesis).	DeMarco ML, 2010, J AM CHEM SOC, V132, P1334, DOI 10.1021/ja907518x; Bertini I, 2001, J AM CHEM SOC, V123, P4181, DOI 10.1021/ja0028626; Jones DH, 2010, J BIOMOL NMR, V46, P89, DOI 10.1007/s10858-009-9365-4; Erdelyi M, 2011, CHEM-EUR J, V17, P9368, DOI 10.1002/chem.201100854; Su XC, 2010, J BIOMOL NMR, V46, P101, DOI 10.1007/s10858-009-9331-1; Jain NU, 2001, PROTEIN SCI, V10, P2393, DOI 10.1110/ps.17401; Mallagaray A, 2011, CHEM COMMUN, V47, P7179, DOI 10.1039/c1cc11860a; Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b; Yamaguchi T, 2013, CHEM LETT, V42, P544, DOI 10.1246/cl.130040; Yamamoto S, 2011, CHEM-EUR J, V17, P9280, DOI 10.1002/chem.201100856; Tolman JR, 2001, J AM CHEM SOC, V123, P1416, DOI 10.1021/ja002500y; Otting G, 2008, J BIOMOL NMR, V42, P1, DOI 10.1007/s10858-008-9256-0; Zhuang TD, 2008, PROTEIN SCI, V17, P1220, DOI 10.1110/ps.034561.108; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Kamiya Y, 2011, J BIOMOL NMR, V50, P397, DOI 10.1007/s10858-011-9525-1; BARRY CD, 1971, NATURE, V232, P236, DOI 10.1038/232236a0; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; MARTINEZYAMOUT M, 1994, J MOL BIOL, V244, P301, DOI 10.1006/jmbi.1994.1731; HOMANS SW, 1987, BIOCHEMISTRY-US, V26, P6649, DOI 10.1021/bi00395a014; ANGLISTER J, 1984, BIOCHEMISTRY-US, V23, P1138, DOI 10.1021/bi00301a016; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Shishmarev D, 2013, J BIOMOL NMR, V56, P203, DOI 10.1007/s10858-013-9738-6; HOMANS SW, 1986, BIOCHEMISTRY-US, V25, P6342, DOI 10.1021/bi00368a076; WOODS RJ, 1995, CURR OPIN STRUC BIOL, V5, P591, DOI 10.1016/0959-440X(95)80049-2; Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f; GRIMALDI JJ, 1975, J BIOL CHEM, V250, P1618; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Canales A, 2012, MAGN RESON CHEM, V50, pS80, DOI 10.1002/mrc.3888; BREWER CF, 1973, P NATL ACAD SCI USA, V70, P1007, DOI 10.1073/pnas.70.4.1007; Sato S, 2004, CARBOHYD RES, V339, P2425, DOI 10.1016/j.carres.2004.07.014; Zhang Y, 2013, CHEM LETT, V42, P1455, DOI 10.1246/cl.130789; LEAHY DJ, 1988, P NATL ACAD SCI USA, V85, P3661, DOI 10.1073/pnas.85.11.3661; Saio T, 2009, J BIOMOL NMR, V44, P157, DOI 10.1007/s10858-009-9325-z; KOENIG SH, 1973, P NATL ACAD SCI USA, V70, P475, DOI 10.1073/pnas.70.2.475; Enoki S, 2015, ANAL CHEM, V87, P2079, DOI 10.1021/ac502408c; Doi T, 2014, CHEM SCI, V5, P1860, DOI 10.1039/c3sc53237b; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; WYSS DF, 1995, BIOCHEMISTRY-US, V34, P1622, DOI 10.1021/bi00005a019; Lebel P, 2014, NAT METHODS, V11, P456, DOI 10.1038/nmeth.2854; Torizawa T, 2000, NUCLEIC ACIDS RES, V28, P944, DOI 10.1093/nar/28.4.944; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Zhang Y, 2012, MOLECULES, V17, P6658, DOI 10.3390/molecules17066658; Bini D, 2012, CARBOHYD RES, V354, P21, DOI 10.1016/j.carres.2012.03.002; Kamiya Y, 2014, CURR OPIN STRUC BIOL, V26, P44, DOI 10.1016/j.sbi.2014.03.008; Peters T, 1996, CURR OPIN STRUC BIOL, V6, P710, DOI 10.1016/S0959-440X(96)80039-X; WOOTEN EW, 1990, EUR BIOPHYS J, V18, P139, DOI 10.1007/BF02427373; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Canales A, 2013, ANGEW CHEM INT EDIT, V52, P13789, DOI 10.1002/anie.201307845; Satoh T, 2015, MOLECULES, V20, P2475, DOI 10.3390/molecules20022475; Bertini I, 2002, PROG NUCL MAG RES SP, V40, P249, DOI 10.1016/S0079-6565(02)00002-X; Su XC, 2008, J AM CHEM SOC, V130, P1681, DOI [10.1021/ja076564l, 10.1021/ja0765641]; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Canales A, 2014, J AM CHEM SOC, V136, P8011, DOI 10.1021/ja502406x; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Yamamoto S, 2012, CHEM COMMUN, V48, P4752, DOI 10.1039/c2cc30353a; Liu S, 2009, BIOCHEMISTRY-US, V48, P11211, DOI 10.1021/bi9015154; MCDONALD CC, 1969, BIOCHEM BIOPH RES CO, V35, P43, DOI 10.1016/0006-291X(69)90480-X; Wohnert J, 2003, J AM CHEM SOC, V125, P13338, DOI 10.1021/ja036022d; Henry B, 1999, CARBOHYD RES, V315, P48, DOI 10.1016/S0008-6215(98)00301-2; Keizers PHJ, 2008, J AM CHEM SOC, V130, P14802, DOI 10.1021/ja8054832; BYRD JC, 1982, J BIOL CHEM, V257, P4657; Dwek R.A, 1973, NUCL MAGNETIC RESONA; Hansel R, 2014, ANGEW CHEM INT EDIT, V53, P10300, DOI 10.1002/anie.201311320; Kamiya Yukiko, 2013, Biomolecules, V3, P108, DOI 10.3390/biom3010108; Luchinat C., 2010, ENCY NMR, V6, P3317, DOI [10.1002/9780470034590.emrstm1088, DOI 10.1002/9780470034590.EMRSTM1088]; Rodriguez-Castaneda F, 2006, MAGN RESON CHEM, V44, pS10, DOI 10.1002/mrc.1811; Satoh T, 2014, FEBS LETT, V588, P4422, DOI 10.1016/j.febslet.2014.10.013; Sharp R.R., 2003, NUCL MAGN RESON SPEC, V32, P473, DOI 10.1039/9781847553881-00473; VILLAFRA.JJ, 1974, ARCH BIOCHEM BIOPHYS, V160, P465, DOI 10.1016/0003-9861(74)90422-6; Vliegenthart J F, 1980, Adv Exp Med Biol, V125, P77; Wuthrich K., 1976, NMR BIOL RES PEPTIDE; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Yamaguchi T, 2014, ANGEW CHEM INT EDIT, V53, P10941, DOI 10.1002/anie.201406145; Yamaguchi T., 2014, GLYCOSCI BIOL MED, V1, P137, DOI [10.1007/978-4-431-54841-6101, DOI 10.1007/978-4-431-54841-6101]; Yamaguchi Yoshiki, 2014, Adv Neurobiol, V9, P165, DOI 10.1007/978-1-4939-1154-7_8; Zhang Y, 2015, ADV EXP MED BIOL, V842, P217, DOI 10.1007/978-3-319-11280-0_14	79	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					505	513		10.1007/s10719-015-9599-1		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600009		
J	Miyagawa-Yamaguchi, A; Kotani, N; Honke, K				Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi			Each GPI-anchored protein species forms a specific lipid raft depending on its GPI attachment signal	GLYCOCONJUGATE JOURNAL			English	Article						EMARS; HRP; Fluorescein tyramide; Visualization of co-clustering molecules; N-glycosylation	ENZYME-MEDIATED ACTIVATION; DECAY-ACCELERATING FACTOR; HORSERADISH-PEROXIDASE; LIVING CELLS; EMARS METHOD; SITE; AMPLIFICATION; TRANSDUCTION; COMPLEXES; THY-1	We previously reported a method, termed enzyme-mediated activation of radical sources (EMARS) for analysis of co-clustered molecules with horseradish peroxidase (HRP) fusion proteins expressed in living cells. This method is featured by radical formation of labeling reagents by HRP. In the current study, we have employed another labeling reagent, fluorescein-conjugated tyramide (FT) instead of the original arylazide compounds. Although hydrogen peroxide is required for the activation of FT, the labeling efficiency by HRP and the nonspecific reactions by endogenous enzyme(s) have been dramatically improved compared with the original fluorescein arylazide. This revised EMARS method has enabled visualization of co-clustered molecules in the endoplasmic reticulum and Golgi membranes with confocal microscopy. By using this method, we have found that GPI-anchored proteins, decay accelerating factor (DAF) and Thy-1 are exclusively co-clustered with HRP-DAFGPI and HRP-Thy1GPI, in which GPI attachment signals of DAF and Thy-1 have been connected to HRP, respectively. Furthermore, the N-glycosylation types of DAF and Thy-1 have been found to correspond to those of HRP-DAFGPI and HRP-Thy1GPI, respectively. These results indicate that each GPI-anchored protein species forms a specific lipid raft depending on its GPI attachment signal, and that the EMARS method can segregate individual lipid rafts.	[Miyagawa-Yamaguchi, Arisa; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi 7838505, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan	Honke, K (reprint author), Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi 7838505, Japan.	khonke@kochi-u.ac.jp					ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457; Honke K, 2011, J NEUROCHEM, V116, P690, DOI 10.1111/j.1471-4159.2010.07027.x; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Schikorski T, 2010, METHODS MOL BIOL, V657, P315, DOI 10.1007/978-1-60761-783-9_25; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; PAREKH RB, 1987, EMBO J, V6, P1233; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Matsui T, 2003, APPL MICROBIOL BIOT, V62, P517, DOI 10.1007/s00253-003-1273-z; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Honke K, 2012, SENSORS-BASEL, V12, P16037, DOI 10.3390/s121216037; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Brodbeck WG, 2000, IMMUNOLOGY, V101, P104, DOI 10.1046/j.1365-2567.2000.00086.x; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Devasahayam M, 1999, GLYCOBIOLOGY, V9, P1381, DOI 10.1093/glycob/9.12.1381; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Bendayan M, 2001, SCIENCE, V291, P1363, DOI 10.1126/science.291.5507.1363; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Miyagawa-Yamaguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093054; Miyagawa-Yamaguchi A, 2014, TRENDS GLYCOSCI GLYC, V26, P59	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					531	540		10.1007/s10719-015-9595-5		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600011		
J	Sakamoto, Y; Ohta, T; Ito, Y				Sakamoto, Yasuharu; Ohta, Tsuyoshi; Ito, Yukishige			Stereoselective synthesis of UDP-2-(2-ketopropyl)galactose aided by di-tert-butylsilylene protecting group	GLYCOCONJUGATE JOURNAL			English	Article						Stereoselective synthesis; Galactose derivative; Di-tert-butylsilylene; Iodination; Radical methallylation	BETA-N-ACETYLGLUCOSAMINE; O-LINKED GLCNAC; DYNAMIC INTERPLAY; HISTONE H3; PROTEINS; GLYCOSYLATION; GLCNACYLATION; IDENTIFICATION; PHOSPHATE; RESIDUES	UDP-2-(2-ketopropyl)galactose (1) has been utilized as a valuable probe for profiling proteins modified by O-GlcNAc. In this work, we developed a protocol for efficient synthesis of 1. Thus, 2-methallylgalactose derivative 11, a synthetic intermediate for the compound 1, was prepared by stereoselective iodination and methallylation at C-2 position, through exploitation of 4,6-O-di-tert-butylsilylene protecting group.	[Sakamoto, Yasuharu; Ohta, Tsuyoshi; Ito, Yukishige] RIKEN, Synthet Cellular Chem, Wako, Saitama 3510198, Japan; [Ito, Yukishige] Japan Sci & Technol Agcy JST, ERATO Glycotril Project, Wako, Saitama 3510198, Japan	Sakamoto, Y (reprint author), RIKEN, Synthet Cellular Chem, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ysakamot@riken.jp; yukito@riken.jp	Ito, Yukishige/M-5119-2014	Ito, Yukishige/0000-0001-6251-7249	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation, Osaka, Japan (NIBIO) [09-01]	We thank Dr. Yayoi Hongo and Dr. Takemichi Nakamura for ESI mass measurements. We also thank Ms. Akemi Takahashi and Ms. Satoko Shirahata for technical assistance. This research was supported by the Advanced Research for Medical Products Mining Program (09-01) of the National Institute of Biomedical Innovation, Osaka, Japan (NIBIO).	Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; CHOU CF, 1992, J BIOL CHEM, V267, P3901; KECK GE, 1985, TETRAHEDRON, V41, P4079, DOI 10.1016/S0040-4020(01)97185-6; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/nchembio.412, 10.1038/NCHEMBIO.412]; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Dulcey AE, 2011, TETRAHEDRON, V67, P2013, DOI 10.1016/j.tet.2011.01.081; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Hang HC, 2001, J AM CHEM SOC, V123, P1242, DOI 10.1021/ja002962b; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Imamura A, 2003, TETRAHEDRON LETT, V44, P6725, DOI 10.1016/S0040-4039(03)01647-2; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Imamura A, 2005, ORG LETT, V7, P4415, DOI 10.1021/ol051592z; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Imamura A, 2006, CHEM-EUR J, V12, P8862, DOI 10.1002/chem.200600832; Kesrse K.P., 1991, P NATL ACAD SCI USA, V88, P1701	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					541	548		10.1007/s10719-015-9581-y		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600012		
J	Han, XT; Ping, B; Morita, M; Ebi, R; Inoue, J; Tanaka, Y; Chen, Y; Wan, XC; Yang, WT; Chang, B; Wu, XH				Han, Xiaotian; Ping, Bo; Morita, Masakatsu; Ebi, Ryuichiro; Inoue, Junya; Tanaka, Yosuke; Chen, Ying; Wan, Xiaochun; Yang, Wentao; Chang, Bin; Wu, Xiaohua			A novel highly sensitive and specific flow cytometry system for cervical cancer screening	GYNECOLOGIC ONCOLOGY			English	Article						Cervical cancer; Flow cytometry; Human papillomavirus	HUMAN-PAPILLOMAVIRUS DNA; HISTOLOGICAL SUBTYPES; TUMOR-CELLS; CYTOLOGY; HPV; ADENOCARCINOMA; LESIONS; RISK; IDENTIFICATION; PREVALENCE	Purpose. This study assessed the performance of a novel flow cytometry (FCM) cervical cancer screening system compared with human papillomavirus (HPV) Hybrid Capture 2 (HC2). Methods. Chinese women aged 20 years or older were enrolled in this study at Fudan University Shanghai Cancer Center. All participants underwent cytology/pathology testing (gold standard), HPV HC2 testing and FCM testing involving analysis of cell proliferation index (CPIx). Results. Among 437 women enrolled in this study, 185 women (42.3%) were diagnosed as "gold standard positive" by pathology with diseases including cervical intraepithelial neoplasia (CIN) grade 2 (n = 11), CIN3 (n = 41), squamous cell carcinoma (SCC; n = 115), adenocarcinoma in situ (n = 2) and adenocarcinoma (n = 16). The remaining 252 cases were deemed "gold standard negative". The sensitivity was 87.6% (95% Cl, 82.8-923) for FCM testing and 89.7% (95% CI, 85.4-94.1; p = 0.5121) for HPV HC2 testing. The specificity of FCM testing was 90.5% (95% CI, 86.2-94.7), which was superior to the specificity of HPV HC2 testing (84.5%, 95% CI, 79.3-89.7; p = 0.04). In the 20-29 years old group, the sensitivity and the specificity of FCM testing were 90.0% (95% Cl, 71.4-100.0) and 92.9% (95% CI, 76.9-100.0), respectively. The FCM testing CPIx statistically increased with the transition from normal cervical specimens to SCC specimens. Conclusions. Our results showed that the FCM screening system had high sensitivity and specificity for women of various ages. The FCM CPIx was able to evaluate the severity of disease quantitatively. (C) 2015 Elsevier Inc. All rights reserved.	[Han, Xiaotian; Wu, Xiaohua] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Han, Xiaotian; Ping, Bo; Chen, Ying; Wan, Xiaochun; Yang, Wentao; Chang, Bin; Wu, Xiaohua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Ping, Bo; Chen, Ying; Wan, Xiaochun; Yang, Wentao; Chang, Bin] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China; [Morita, Masakatsu; Ebi, Ryuichiro; Inoue, Junya; Tanaka, Yosuke] Sysmex Corp, HU Business Unit, UB Prod Engn, Prod Dev, Kobe, Hyogo, Japan	Wu, XH (reprint author), Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, 270 DongAn Rd, Shanghai 200032, Peoples R China.	docwuxh@hotmail.com			"Clinical study of cervical cancer FCM screening system" project of Sysmex Corporation UB Product Engineering through Fudan University Shanghai Cancer Center [2012-66-625]	We are grateful to the staff of the Department of Gynecologic Oncology of Fudan University Shanghai Cancer Center for specimen collection and the staff of the Department of Pathology for specimen identification. This research is sponsored by the "Clinical study of cervical cancer FCM screening system" project of Sysmex Corporation UB Product Engineering through Fudan University Shanghai Cancer Center (Num. 2012-66-625).	An HJ, 2005, MODERN PATHOL, V18, P528, DOI 10.1038/modpathol.3800316; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; KIMMIG R, 1995, J CANCER RES CLIN, V121, P107, DOI 10.1007/BF01202222; Melsheimer P, 2001, CYTOMETRY, V46, P166, DOI 10.1002/cyto.1101; Bulk S, 2006, BRIT J CANCER, V94, P171, DOI 10.1038/sj.bjc.6602915; Lorenzato M, 2002, AM J CLIN PATHOL, V118, P708; de Cremoux P, 2003, AM J CLIN PATHOL, V120, P492, DOI 10.1309/XFUCPP6M5XUA94B8; Guo M, 2004, AM J CLIN PATHOL, V122, P894, DOI 10.1309/0DGGQAMJCJBXB; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Bollmann R, 2001, CANCER CYTOPATHOL, V93, P222, DOI 10.1002/cncr.9033; Leinonen M, 2009, J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; PEREZ DJ, 1981, BRIT J CANCER, V43, P526, DOI 10.1038/bjc.1981.75; Tong H, 2009, CLIN CANCER RES, V15, P6438, DOI 10.1158/1078-0432.CCR-09-1689; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Clavel C, 2001, BRIT J CANCER, V84, P1616, DOI 10.1054/bjoc.2001.1845; Steinbeck RG, 1997, ACTA ONCOL, V36, P3; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Guillaud M, 2006, CANCER, V107, P309, DOI 10.1002/cncr.21993; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Arbyn M, 2013, COCHRANE DB SYST REV, V3, P8054, DOI DOI 10.1002/14651858.CD008054.PUB2; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Ebi R., 2013, US Patent Application, Publication, Patent No. [US20130217110 A12013, 20130217110A1]; Ebi R., 2014, US Patent Application, Publication, Patent No. [US20140199702 A12014, 20140199702A1]; Fukuda M., 2009, US Patent Application, Publication, Patent No. [US2009/0091746 A12009, 20090091746A1]; Jastania R, 2006, AM J CLIN PATHOL, V125, P223, DOI 10.1309/QEJBY77YMTEVJ66; Morisaki H., 2014, CYTOMETRY RES, V24, P41; Moyer A.V., 2012, ANN INTERN MED, V156, P880; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI 10.1309/AJCPTGD94EVRSJCG; Shirasuna K., 2015, K SHIRASUNA, P1, Patent No. EP2860263A1; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh M., 2008, J CANC EPIDEMIOL, V2008; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wright TC, 2015, GYNECOL ONCOL, V136, P189, DOI 10.1016/j.ygyno.2014.11.076	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	OCT	2015	139	1					52	58		10.1016/j.ygyno.2015.07.102		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CT6ND	WOS:000362928800009		
J	Todo, Y; Yamazaki, H; Takeshita, S; Ohba, Y; Sudo, S; Minobe, S; Okamoto, K; Kato, H				Todo, Yukiharu; Yamazaki, Hiroyuki; Takeshita, Sho; Ohba, Yoko; Sudo, Satoko; Minobe, Shinichiro; Okamoto, Kazuhira; Kato, Hidenori			Close relationship between removal of circumflex iliac nodes to distal external iliac nodes and postoperative lower-extremity lymphedema in uterine corpus malignant tumors	GYNECOLOGIC ONCOLOGY			English	Article						Cancer survivor; Lymphadenectomy; Leg edema; Circumflex iliac node; Endometrial cancer	ENDOMETRIAL CANCER; METASTASIS; LYMPHADENECTOMY; COMPLICATIONS; STATISTICS; CARCINOMA	Objective. The aim of this study was to confirm a causal relationship between removal of circumflex iliac nodes to the distal external iliac nodes (CINDEIN) and lower-extremity lymphedema after systematic lymphadenectomy in patients with uterine corpus malignancies. Methods. A retrospective chart review was carried out for all patients with uterine corpus malignant tumor managed at Hokkaido Cancer Center between 1991 and 2013. All 318 patients underwent CINDEIN dissection as a part of initial surgery and 217 patients did not. Patients had undergone hysterectomy, bilateral salpingooophorectomy and lymphadenectomy and their medical records were reviewed. The type of lymphadenectomy gradually shifted from pelvic lymphadenectomy with removal of CINDEIN to full lymphadenectomy without CINDEIN dissection during this period. We identified patients with postoperative lower-extremity lymphedema (POLEL). Logistic regression analysis was used to select the risk factors for POLEL Results. Of 535 patients evaluated, POLEL was noted in the medical records of 126 patients (23.6%), with median follow-up of 71 months. The occurrence of POLEL was significantly higher in the CINDEIN-dissection group than in the CINDEIN-sparing group (34.3% vs. 7.8%, P < 0.0001). Multivariate analysis confirmed that adjuvant radiation therapy [odds ratio (OR) = 6.3, 95% confidence interval (CI) = 2.6-14.9], resection of more than 31 lymph nodes (OR = 2.0, 95% CI = 1.2-3.5), and removal of CINDEIN (OR = 5.4,95% Cl = 3.1-93) were independent risk factors for POLEL. Conclusions. Elimination of CINDEIN dissection can be helpful in reducing the incidence of POLEL. (C) 2015 Elsevier Inc. All rights reserved.	[Todo, Yukiharu; Yamazaki, Hiroyuki; Takeshita, Sho; Ohba, Yoko; Sudo, Satoko; Minobe, Shinichiro; Okamoto, Kazuhira; Kato, Hidenori] Natl Hosp Org, Hokkaido Canc Ctr, Div Gynecol Oncol, Sapporo, Hokkaido 0030804, Japan	Todo, Y (reprint author), Natl Hosp Org, Hokkaido Canc Ctr, Div Gynecol Oncol, Shiroishi Ku, 4-2 Kikusui, Sapporo, Hokkaido 0030804, Japan.	yukiharu@sap-cc.go.jp					Yin YJ, 2014, INT J GYNECOL CANCER, V24, P935, DOI 10.1097/IGC.0000000000000138; Hareyama H, 2012, ANN SURG ONCOL, V19, P268, DOI 10.1245/s10434-011-1863-4; Konno Y, 2011, INT J GYNECOL CANCER, V21, P385, DOI 10.1097/IGC.0b013e3182094e09; Todo Y, 2011, GYNECOL ONCOL, V122, P55, DOI 10.1016/j.ygyno.2011.03.031; Matsumoto K, 2002, CANCER LETT, V180, P83, DOI 10.1016/S0304-3835(01)00803-5; Ohba Y, 2011, INT J CLIN ONCOL, V16, P238, DOI 10.1007/s10147-010-0171-5; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Abu-Rustum NR, 2007, GYNECOL ONCOL, V106, P4, DOI 10.1016/j.ygyno.2007.03.026; Kodama J, 2006, EUR J OBSTET GYN R B, V124, P222, DOI 10.1016/j.ejogrb.2005.06.027; Ohba Y, 2012, GYNECOL ONCOL, V126, P387, DOI 10.1016/j.ygyno.2012.05.031; Hoffman MS, 1999, OBSTET GYNECOL, V94, P391, DOI 10.1016/S0029-7844(99)00310-5; Niikura H, 2004, GYNECOL ONCOL, V92, P669, DOI 10.1016/j.ygyno.2003.10.039; Todo Y, 2010, GYNECOL ONCOL, V119, P60, DOI 10.1016/j.ygyno.2010.06.018; International Society of Lymphology, 2003, LYMPHOLOGY, V36, P84; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	OCT	2015	139	1					160	164		10.1016/j.ygyno.2015.07.003		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CT6ND	WOS:000362928800025		
J	Kaneko, Y; Kato, R; Nakahara, S; Tobiume, T; Morishima, I; Tanaka, K; Nakajima, T; Irie, T; Kusano, KF; Kamakura, S; Nagase, T; Takayanagi, K; Matsumoto, K; Kurabayashi, M				Kaneko, Yoshiaki; Kato, Ritsushi; Nakahara, Shiro; Tobiume, Takeshi; Morishima, Itsuro; Tanaka, Kazuhiko; Nakajima, Tadashi; Irie, Tadanobu; Kusano, Kengo Fukushima; Kamakura, Shiro; Nagase, Takahiko; Takayanagi, Kan; Matsumoto, Kazuo; Kurabayashi, Masahiko			Characteristics and Catheter Ablation of Focal Atrial Tachycardia Originating From the Interatrial Septum	HEART LUNG AND CIRCULATION			English	Article						Ectopic atrial tachycardia; Electrical catheter ablation; Cardiac electrophysiology; Atrial septum; Electrocardiogram	LEFT-HEART CATHETERIZATION; INTRACARDIAC ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHIC CHARACTERISTICS; ELECTROPHYSIOLOGIC CHARACTERIZATION; RADIOFREQUENCY ABLATION; CORONARY-SINUS; FIBRILLATION; CONDUCTION; SITE; MECHANISMS	Background Ablation of focal atrial tachycardia (AT) originating from the interatrial septum (IAS) is challenging because of its complex anatomy. Methods We studied the electrocardiographic and electrophysiologic characteristics of focal, septal AT in seven patients who underwent successful ablation. Results The site of successful ablation was at the site of earliest activation on the right side of the IAS in three patients and on the left side in four patients, >1 cm away from the centre of the fossa ovalis in the septum secundum. A negative or +/-versus a positive or -/+P wave in lead V-1 during AT accurately predicted a right-versus left-sided origin of the AT, respectively. In the four left septal AT cases, right atrial activation mapping opposite the site of successful ablation revealed the presence of a small, low-frequency potential followed by a larger, high-frequency potential. In contrast, a high-frequency potential was not preceded by a low-frequency potential in the three right septal AT cases. Conclusions Septal AT may originate from either side of the septum secundum. The P wave polarity in lead V1 accurately predicted the side of the IAS that the AT originated from. Left septal AT is characterised by the recording of double potentials reflecting far-field activation of the left-sided IAS, followed by near-field activation of the right-sided IAS, when recording from its right side, opposite the AT origin. These observations are particularly relevant when mapping an apparent right septal AT.	[Kaneko, Yoshiaki; Nakajima, Tadashi; Irie, Tadanobu; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 3718511, Japan; [Kato, Ritsushi; Nagase, Takahiko; Matsumoto, Kazuo] Saitama Med Univ, Div Cardiol, Int Med Ctr, Hidaka, Saitama, Japan; [Nakahara, Shiro; Takayanagi, Kan] Dokkyo Med Univ, Koshigaya Hosp, Dept Cardiol, Koshigaya, Saitama, Japan; [Tobiume, Takeshi] Univ Tokushima, Dept Cardiol, Tokushima 770, Japan; [Morishima, Itsuro] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Gifu, Japan; [Tanaka, Kazuhiko] Kasukabe Chuo Gen Hosp, Heart Ctr Arrhythmia Unit, Kazukabe, Saitama, Japan; [Kusano, Kengo Fukushima; Kamakura, Shiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan	Kaneko, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	kanekoy@gunma-u.ac.jp			 [25461043]	This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 25461043).	Saoudi N, 2001, EUR HEART J, V22, P1162, DOI 10.1053/euhj.2001.2658; Tung S, 2003, J AM COLL CARDIOL, V42, P110, DOI 10.1016/S0735-1097(03)00563-1; Kalman JM, 1998, J AM COLL CARDIOL, V31, P451, DOI 10.1016/S0735-1097(97)00492-0; Lemery R, 2004, CIRCULATION, V110, P2083, DOI 10.1161/01.CIR.0000144461.83835.A1; Hachiya H, 2005, CIRC J, V69, P205, DOI 10.1253/circj.69.205; Marrouche NF, 2002, J AM COLL CARDIOL, V40, P1133, DOI 10.1016/S0735-1097(02)02071-5; Chen CC, 2000, J CARDIOVASC ELECTR, V11, P744, DOI 10.1111/j.1540-8167.2000.tb00045.x; Yamaguchi T, 2010, EUROPACE, V12, P1698, DOI 10.1093/europace/euq326; Tada H, 1998, PACE, V21, P2431, DOI 10.1111/j.1540-8159.1998.tb01196.x; Morton JB, 2001, J CARDIOVASC ELECTR, V12, P653, DOI 10.1046/j.1540-8167.2001.00653.x; Chae S, 2007, J AM COLL CARDIOL, V50, P1781, DOI 10.1016/j.jacc.2007.07.044; Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058; Wong MCG, 2013, J CARDIOVASC ELECTR, V24, P413, DOI 10.1111/jce.12049; Ren JF, 2007, ECHOCARDIOGR-J CARD, V24, P533, DOI 10.1111/j.1540-8175.2007.00426.x; Roberts-Thomson KC, 2006, PACE, V29, P643, DOI 10.1111/j.1540-8159.2006.00413.x; Daoud EG, 1999, J CARDIOVASC ELECTR, V10, P358, DOI 10.1111/j.1540-8167.1999.tb00683.x; Kistler PM, 2005, J AM COLL CARDIOL, V45, P1488, DOI 10.1016/j.jacc.2005.01.042; Akiyama M, 2004, J CARDIOVASC ELECTR, V15, P1371, DOI 10.1046/j.1540-8167.2004.04422.x; Kumagai K, 2006, J CARDIOVASC ELECTR, V17, P907, DOI 10.1111/j.1540-8167.2006.00518.x; Anderson RH, 1996, ANAT REC, V246, P1, DOI 10.1002/(SICI)1097-0185(199609)246:1<1::AID-AR1>3.0.CO;2-Y; Hanaoka T, 2003, JPN HEART J, V44, P673, DOI 10.1536/jhj.44.673; Dong J, 2005, HEART RHYTHM, V2, P578, DOI 10.1016/j.hrthm.2005.03.014; Kistler PM, 2003, J AM COLL CARDIOL, V41, P2212, DOI 10.1016/S0735-1097(03)00484-4; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Anderson RH, 1999, CLIN ANAT, V12, P362, DOI 10.1002/(SICI)1098-2353(1999)12:5<362::AID-CA6>3.0.CO;2-F; TANG CW, 1995, J AM COLL CARDIOL, V26, P1315, DOI 10.1016/0735-1097(95)00307-X; Schernthaner C, 2013, ECHOCARDIOGR-J CARD, V30, P402, DOI 10.1111/echo.12067; Kistler PM, 2003, CIRCULATION, V108, P1968, DOI 10.1161/01.CIR.0000095269.36984.75	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1443-9506	1444-2892		HEART LUNG CIRC	Heart Lung Circ.	OCT	2015	24	10					988	995		10.1016/j.hlc.2015.03.009		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT6FJ	WOS:000362907800011		
J	Kobayashi, K; Kuroda, M; Shigemura, Y				Kobayashi, Kazuhiro; Kuroda, Minami; Shigemura, Yuuho			Synthesis of 1,3-Dihydro-3-oxo-2-benzofuran-1-carboxylates via Intramolecular Cyclization of 2-[2-(Dimethoxymethyl)phenyl]-2-hydroxyalkanoates Followed by Oxidation	HELVETICA CHIMICA ACTA			English	Article						1; 3-Dihydro-3-oxo-2-benzofuran-1-carboxylates; [2-(Dimethoxymethyl)phenyl]lithiums; 2-[2-(Dimethoxymethyl)phenyl]-2-hydroxyalkanoates; Pyridinium chlorochromate oxidation; Phthalides	3-SUBSTITUTED PHTHALIDES	A novel and efficient method for the preparation of 1,3-dihydro-3-oxo-2-benzofuran-1-carboxylates 4 under mild conditions has been developed. Thus, the reaction of [2-(dimethoxymethyl)phenyl]lithiums, generated easily from 1-bromo-2-(dimethoxymethyl)benzenes 1, with -keto esters gives the corresponding 2-[2-(dimethoxymethyl)phenyl]-2-hydroxyalkanoates 2. The TsOH-catalyzed cyclization of these hydroxy acetals is followed by the oxidation of the resulting cyclic acetals 3 with PCC to give the desired products in satisfactory yields. The reaction of [2-(dimethoxymethyl)-4,5-dimethoxyphenyl]lithium with (MeOCO)(2), followed by treatment with NaBH4 or organolithiums, affords 2-[2-(dimethoxymethyl)-4,5-dimethoxyphenyl]-2-hydroxyalkanoates 6, which can similarly be transformed into the corresponding 1,3-dihydro-3-oxo-2-benzofuran-1-carboxylates 7 in reasonable yields.	[Kobayashi, Kazuhiro; Kuroda, Minami; Shigemura, Yuuho] Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp					Youn SW, 2014, ORG BIOMOL CHEM, V12, P2388, DOI 10.1039/c3ob42546k; Martin C, 2001, J ORG CHEM, V66, P3797, DOI 10.1021/jo0100188; HARRIS TM, 1988, J AM CHEM SOC, V110, P6186, DOI 10.1021/ja00226a038; GRIBBLE GW, 1980, TETRAHEDRON LETT, V21, P4137, DOI 10.1016/S0040-4039(00)93671-2; Kobayashi K, 2013, HELV CHIM ACTA, V96, P1894, DOI 10.1002/hlca.201300112; Yue D, 2006, J ORG CHEM, V71, P3381, DOI 10.1021/jo0524573; Mizutani Y, 2012, TETRAHEDRON LETT, V53, P5903, DOI 10.1016/j.tetlet.2012.08.091; KEAY BA, 1983, CAN J CHEM, V61, P1987, DOI 10.1139/v83-343; Pfeiffer P, 1941, J PRAKTISCHE CHEMIE, V159, P241, DOI 10.1002/prac.19411590803; Hoshimoto Y, 2012, ANGEW CHEM INT EDIT, V51, P10812, DOI 10.1002/anie.201206186; Kobayashi K, 2014, HELV CHIM ACTA, V97, P1055; Shi XY, 2012, ADV SYNTH CATAL, V354, P2933, DOI 10.1002/adsc.201200690; Hubschwerlen C., 2014, PCT Int. Appl, Patent No. [WO 2014181266, 2014181266]; Ishibashi M., 2009, Kokai Tokkyo Koho, Patent No. [JP 20098178052, 20098178052]; Ishibashi M., 2012, Kokai Tokkyo Koho, Patent No. [JP 2012171907, 2012171907]; Kuroda M, 2015, HELV CHIM ACTA, V98, P279, DOI 10.1002/hlca.201400333	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	OCT	2015	98	10					1364	1371		10.1002/hlca.201500175		8	Chemistry, Multidisciplinary	Chemistry	CT6XY	WOS:000362958200003		
J	Mao, TL; Ayhan, A; Kuo, KT; Lin, MC; Tseng, LH; Ogawa, H				Mao, Tsui-Lien; Ayhan, Ayse; Kuo, Kuang-Ting; Lin, Ming-Chieh; Tseng, Li-Hui; Ogawa, Hiroshi			Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: implications for pathogenetic and survival differences	HISTOPATHOLOGY			English	Article						ARID1A; endometrioid carcinoma; high-grade; immunohistochemistry	NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; ARID1A EXPRESSION; P53 EXPRESSION; DEFICIENCY; DIAGNOSIS; MUTATION; OUTCOMES; UTILITY	Aims: To compare the clinical and pathogenetic differences between high-grade (HG) endometrioid carcinomas with and without concurrent low-grade (LG) components. Methods and results: The expression of ARID1A, PTEN, p53 and mismatch repair (MMR) proteins in HG endometrioid carcinomas without (n = 19) or with (n = 22) concurrent LG endometrioid carcinomas was studied by immunohistochemistry. Microsatellite instability (MSI) was also tested in 31 cases. The frequencies of ARID1A loss, PTEN loss, MMR deficiency or MSI and aberrant p53 expression were 58%, 37%, 37% and 47% in pure HG tumours, and 77%, 45%, 55% and 32% in HG tumours with concurrent LG components (P = 0.07 for ARID1A; P > 0.1 for other proteins). Pure HG tumours had a higher frequency of the type II phenotype (positive for ARID1A, PTEN and MMR proteins; aberrant p53 expression) than HG tumours with concurrent LG components (21% versus 5%) (P = 0.2). The 5-year overall survival rate was worse for pure HG tumours (61.7%) than for HG tumours with concurrent LG components (93.3%) (P = 0.07). Conclusions: HG endometrioid carcinomas are heterogeneous in pathogenesis: some arise from LG endometrioid carcinomas via the type I pathway, whereas others may arise de novo through either the type I pathway or the type II pathway, and have a different prognosis. Thus, HG endometrioid carcinomas should be subclassified properly and treated accordingly.	[Mao, Tsui-Lien; Kuo, Kuang-Ting; Lin, Ming-Chieh] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Mao, Tsui-Lien; Kuo, Kuang-Ting; Lin, Ming-Chieh] Coll Med, Taipei, Taiwan; [Ayhan, Ayse; Ogawa, Hiroshi] Seirei Mikatahara Gen Hosp, Hamamatsu, Shizuoka, Japan; [Tseng, Li-Hui] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan	Mao, TL (reprint author), 7 Chung Shan South Rd, Taipei 100, Taiwan.	tlmao@ntu.edu.tw		TSENG, LI-HUI/0000-0002-8308-6772	NSC [100-2320-B-002-081]	This work was supported by NSC 100-2320-B-002-081. We thank Ms. Jenny Chen for her help in producing the tables and figures.	Modica I, 2007, AM J SURG PATHOL, V31, P744, DOI 10.1097/01.pas.0000213428.61374.06; Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Brinton LA, 2013, GYNECOL ONCOL, V129, P277, DOI 10.1016/j.ygyno.2013.02.023; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Watson N, 2007, J MOL DIAGN, V9, P472, DOI 10.2353/jmoldx.2007.060162; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Llobet D, 2009, J CLIN PATHOL, V62, P777, DOI 10.1136/jcp.2008.056101; Mutter GL, 2000, J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Allo G, 2014, MODERN PATHOL, V27, P255, DOI 10.1038/modpathol.2013.144; Zannoni GF, 2010, VIRCHOWS ARCH, V457, P27, DOI 10.1007/s00428-010-0939-z; Voss MA, 2012, GYNECOL ONCOL, V124, P15, DOI 10.1016/j.ygyno.2011.07.030; Alkushi A, 2010, INT J GYNECOL PATHOL, V29, P343, DOI 10.1097/PGP.0b013e3181cd6552; Le Gallo M, 2014, CLIN CHEM, V60, P98, DOI 10.1373/clinchem.2013.205740; Shia J, 2013, MODERN PATHOL, V26, P131, DOI 10.1038/modpathol.2012.138; Werner HMJ, 2013, MODERN PATHOL, V26, P428, DOI 10.1038/modpathol.2012.174; Bosse T, 2013, MODERN PATHOL, V26, P1525, DOI 10.1038/modpathol.2013.96; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Alvarez T, 2012, AM J SURG PATHOL, V36, P753, DOI 10.1097/PAS.0b013e318247b7bb; Garg K, 2012, INT J GYNECOL PATHOL, V31, P48, DOI 10.1097/PGP.0b013e3182230d00; Soslow RA, 2010, SEMIN DIAGN PATHOL, V27, P261, DOI 10.1053/j.semdp.2010.09.003; Gilks CB, 2013, AM J SURG PATHOL, V37, P874, DOI 10.1097/PAS.0b013e31827f576a; Reid-Nicholson M, 2006, MODERN PATHOL, V19, P1091, DOI 10.1038/modpathol.3800620; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Hoang LN, 2013, AM J SURG PATHOL, V37, P1421, DOI 10.1097/PAS.0b013e31828c63ed; Joost P, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-126; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; Samarnthai N, 2010, OBSTET GYNECOL INT, V2010, DOI DOI 10.1155/2010/162363; Zaino R, 2014, WHO CLASSIFICATION T, P121	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	OCT	2015	67	4					474	482		10.1111/his.12664		9	Cell Biology; Pathology	Cell Biology; Pathology	CT3TS	WOS:000362730400006		
J	Nishiyama, H; Togashi, K; Kawamoto, Y; Kato, N				Nishiyama, Hiroki; Togashi, Ko; Kawamoto, Yuichi; Kato, Nei			A Cooperative ONU Sleep Method for Reducing Latency and Energy Consumption of STA in Smart-FiWi Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Passive optical network (PON); wireless local area network (WLAN); fiber wireless (FiWi) network; Optical network unit (ONU) sleep; power saving mode (PSM); adaptive PSM (APSM); and energy efficiency	POWER SAVING MECHANISM; OPTICAL NETWORKS; EFFICIENT; CAPACITY	Fiber-Wireless (FiWi) network is a classification of network that combines the massive bandwidth of the optical network and the reach of the wireless network. FiWi networks are usually composed of an optical and a wireless component. Since both components are designed to work independently, some mechanisms, such as the different power saving methods in both components, may not cooperate with each other and this may result in an undesirable performance. In this paper, we identify that the conflicting power saving mechanisms cause unnecessary energy consumption and introduce additional delay to the overall FiWi network. To cope with this problem, we propose a novel ONU sleep method, which dynamically control the ONU sleep period based on the STAs energy control mechanism. Finally, we demonstrate that our proposed method has shorter latency and is more efficient in term of energy consumption than the existing method.	[Nishiyama, Hiroki; Togashi, Ko; Kawamoto, Yuichi; Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Nishiyama, H (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	bigtree@it.ecei.tohoku.ac.jp; Togashi@it.ecei.tohoku.ac.jp; youpsan@it.ecei.tohoku.ac.jp; Kato@it.ecei.tohoku.ac.jp			JSPS KAKENHI	This work was supported by JSPS KAKENHI.	Kubo R, 2010, J OPT COMMUN NETW, V2, P716, DOI 10.1364/JOCN.2.000716; Ding N, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P2821; He Y, 2008, IEEE WCNC, P1362; Togashi K, 2013, IEEE ICC, P6225, DOI 10.1109/ICC.2013.6655603; Fadlullah ZM, 2013, IEEE INTELL SYST, V28, P86, DOI 10.1109/MIS.2013.46; Tucker RS, 2011, IEEE J SEL TOP QUANT, V17, P261, DOI 10.1109/JSTQE.2010.2051217; Manweiler J, 2012, IEEE T MOBILE COMPUT, V11, P739, DOI [10.1109/TMC.2011.269, 10.1109/TMC.2011.268]; Shumate PW, 2008, J LIGHTWAVE TECHNOL, V26, P1093, DOI 10.1109/JLT.2008.923601; He S, 2013, 2013 IEEE MILITARY COMMUNICATIONS CONFERENCE (MILCOM 2013), P928, DOI 10.1109/MILCOM.2013.161; Aurzada F, 2011, IEEE T COMMUN, V59, P1378, DOI 10.1109/TCOMM.2011.030411.100418; Nag A, 2012, J OPT COMMUN NETW, V4, P1018, DOI 10.1364/JOCN.4.001018; Pack S, 2005, J COMMUN NETW-S KOR, V7, P126; IEEE Computer Society, 2007, WIR LAN MED ACC CONT; IEEE Computer Society LAN MAN Standards Committee, 1999, 80211 IEEE COMP SOC; Jardosh A. P., 2007, P 8 IEEE WORKSH MOB, V15, P85; Kubo R., 2009, P IEEE GLOBECOM, P1; Rozner E., 2010, P 8 INT C MOB SYST A, P91, DOI DOI 10.1145/1814433.1814445; Yi X., 2013, P 10 IEEE INT C SENS, P568; Yong H., 2008, P IEEE WIR COMM NETW, P1362	19	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	OCT	2015	26	10					2621	2629		10.1109/TPDS.2014.2360405		9	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CT4QJ	WOS:000362791400001		
J	Nishiyama, H; Takahashi, A; Kato, N; Nakahira, K; Sugiyama, T				Nishiyama, Hiroki; Takahashi, Asato; Kato, Nei; Nakahira, Katsuya; Sugiyama, Takatoshi			Dynamic Replication and Forwarding Control Based on Node Surroundings in Cooperative Delay-Tolerant Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Delay-tolerant networks (DTNs); routing; replication control; forwarding control	MESSAGE DISSEMINATION	Delay-tolerant networks (DTNs) are a promising network architecture which can provide reliable multi-hop message transmission between participating mobile nodes in an unfavorable environment that is prone to link disruption and disconnection by replicating and relaying messages without any need of physical infrastructure. Additionally, DTNs can also operate as cooperative DTNs to extend the coverage of other type of networks by carrying the messages that originate from farther away base station in a multi-hop fashion to the base station. In this paper, we focus on these cooperative DTNs and propose a novel routing scheme, ring distribution routing (RDR), that controls the replication and forwarding based on the source node surroundings. This paper also analyzes the reliability and buffer efficiency in RDR. Furthermore, we show that RDR provides the reliable and immediate message delivery in any environment through extensive computer simulations.	[Nishiyama, Hiroki; Takahashi, Asato; Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Nakahira, Katsuya; Sugiyama, Takatoshi] Nippon Telegraph & Tel Corp, Access Network Serv Syst Labs, Yokosuka, Kanagawa, Japan	Nishiyama, H (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	bigtree@it.ecei.tohoku.ac.jp; asato@it.ecei.tohoku.ac.jp; kato@it.ecei.tohoku.ac.jp; nakahira.katsuya@lab.ntt.co.jp; sugiyama.takatoshi@lab.ntt.co.jp					[Anonymous], 2015, THE ONE; Pereira PR, 2012, IEEE COMMUN SURV TUT, V14, P1166, DOI 10.1109/SURV.2011.081611.00102; Izumikawa H, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P2196; Tseng YC, 2013, AD HOC NETW, V11, P1150, DOI 10.1016/j.adhoc.2013.01.001; He SB, 2013, IEEE J SEL AREA COMM, V31, P75, DOI 10.1109/JSAC.2013.SUP.0513007; Zhu HJ, 2014, IEEE T PARALL DISTR, V25, P22, DOI 10.1109/TPDS.2013.36; Bujari A, 2012, 2012 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P344, DOI 10.1109/WCNCW.2012.6215519; Luiz DF, 2012, 2012 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATIONS (ISCC), P394, DOI 10.1109/ISCC.2012.6249328; Feng ZX, 2012, IEEE SYM PARA DISTR, P1484, DOI 10.1109/IPDPSW.2012.187; Mei HB, 2011, 2011 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P516; Caini C, 2011, P IEEE, V99, P1980, DOI 10.1109/JPROC.2011.2158378; Ehsan S, 2012, IEEE T WIREL COMMUN, V11, P1220, DOI 10.1109/TWC.2012.012412.111405; Wang TY, 2013, IEEE J SEL AREA COMM, V31, P538, DOI 10.1109/JSAC.2013.SUP.0513048; Liang H, 2012, IEEE T COMMUN, V60, P2644, DOI 10.1109/TCOMM.2012.082812.110813; Zhuang YY, 2011, IEEE J SEL AREA COMM, V29, P187, DOI 10.1109/JSAC.2011.110118; Ochiai H, 2011, IEEE SENS J, V11, P2861, DOI 10.1109/JSEN.2011.2170562; Fall K, 2003, ACM SIGCOMM COMP COM, V33, P27; Cerf V., 2007, 4838 RFC; El Gamal A., IEEE T INF THEORY, V52, P2568; Keranen A., 2009, P 2 INT C SIM TOOLS, P55; Kim S.-E., 2012, P VLSI TECHN SYST AP, P1, DOI 10.1109/IPIN.2012.6418947; Spyropoulos T., 2005, P ACM SIGCOMM WORKSH, P252, DOI [10.1145/1080139.1080143, DOI 10.1145/1080139.1080143]; Spyropoulos T., 2004, P 1 ANN IEEE COMM SO, P235; Takahashi A., 2013, P INT C COMP NETW CO, P890; Takahashi A, 2014, IEEE T VEH TECHNOL, V63, P3223, DOI 10.1109/TVT.2014.2299288	25	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	OCT	2015	26	10					2711	2719		10.1109/TPDS.2014.2359889		9	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CT4QJ	WOS:000362791400008		
J	Anderson, DF; Koyama, M				Anderson, David F.; Koyama, Masanori			An asymptotic relationship between coupling methods for stochastically modeled population processes	IMA JOURNAL OF NUMERICAL ANALYSIS			English	Article						stochastic modeling; biochemical network; continuous time Markov chain; couplings; random time change; stochastic simulation	MULTILEVEL MONTE-CARLO; TIME MARKOV-CHAINS; CHEMICAL-REACTIONS; SIMULATION	This paper is concerned with elucidating a relationship between two common coupling methods for the continuous time Markov chain models utilized in the cell biology literature. The couplings considered here are primarily used in a computational framework by providing reductions in variance for different Monte Carlo estimators, thereby allowing for significantly more accurate results for a fixed amount of computational time. Common applications of the couplings include the estimation of parametric sensitivities via finite difference methods and the estimation of expectations via multi-level Monte Carlo algorithms. While a number of coupling strategies have been proposed for the models considered here, and a number of articles have experimentally compared the different strategies, to date there has been no mathematical analysis describing the connections between them. Such analyses are critical in order to determine the best use for each. In the current paper, we show a connection between the common reaction path (CRP) method and the split coupling (SC) method, which is termed coupled finite differences in the parametric sensitivities literature. In particular, we show that the two couplings are both limits of a third coupling strategy we call the 'local-CRP' coupling, with the SC method arising as a key parameter goes to infinity, and the CRP coupling arising as the same parameter goes to zero. The analysis helps explain why the SC method often provides a lower variance than does the CRP method, a fact previously shown experimentally.	[Anderson, David F.] Univ Wisconsin, Dept Math, Madison, WI 53706 USA; [Koyama, Masanori] Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Integrated Syst Biol Lab, Kyoto, Japan	Koyama, M (reprint author), Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Integrated Syst Biol Lab, Kyoto, Japan.	anderson@math.wisc.edu; koyama.masanori@gmail.com			NSF [DMS-1009275, DMS-1318832, DMS-0805793]; Army Research Office [W911NF-14-1-0401]	D.F.A. was supported by NSF grants DMS-1009275 and DMS-1318832 and Army Research Office grant W911NF-14-1-0401. M.K. was supported by NSF grants DMS-1009275, DMS-1318832 and DMS-0805793.	Anderson D. F., 2012, J CHEM PHYS, V137; Anderson D. F., 2014, ARXIV13102676; Anderson DF, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P3, DOI 10.1007/978-1-4419-6766-4_1; Rathinam M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3280166; Anderson DF, 2012, MULTISCALE MODEL SIM, V10, P146, DOI 10.1137/110840546; Anderson DF, 2012, SIAM J NUMER ANAL, V50, P2237, DOI 10.1137/110849079; Anderson DF, 2011, ANN APPL PROBAB, V21, P2226, DOI 10.1214/10-AAP756; Diaconis P, 2013, BERNOULLI, V19, P1294, DOI 10.3150/12-BEJSP09; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Arampatzis G, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4868649; Giles MB, 2008, OPER RES, V56, P607, DOI 10.1287/opre.1070.0496; Srivastava R, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790650; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Ethier S., 1986, MARKOV PROCESSES CHA; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Koyama M., 2013, THESIS U WISCONSIN M; Kurtz T. G., 1981, CBMS NSF REGIONAL C, V36; Kurtz T.G., 1982, LECT NOTES CONTROL I, V42, P177	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0272-4979	1464-3642		IMA J NUMER ANAL	IMA J. Numer. Anal.	OCT	2015	35	4					1757	1778		10.1093/imanum/dru044		22	Mathematics, Applied	Mathematics	CT5CV	WOS:000362826000010		
J	Takano, M; Ohkusa, M; Otani, M; Min, KS; Kadoyama, K; Minami, K; Sano, K; Matsuyama, S				Takano, Masaoki; Ohkusa, Mami; Otani, Mieko; Min, Kyong-Son; Kadoyama, Keiichi; Minami, Katori; Sano, Keiji; Matsuyama, Shogo			Lipid A-activated inducible nitric oxide synthase expression via nuclear factor-kappa B in mouse choroid plexus cells	IMMUNOLOGY LETTERS			English	Article						Choroid plexus; iNOS; Lipid A; NF kappa B; I kappa B; RNAi	EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; INNATE IMMUNE-RESPONSE; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTOR-4; BACTERIAL-MENINGITIS; IN-VITRO; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; BRAIN; RAT	Choroid plexus (CP) which is responsible for the inflammatory mediators including nitric oxide (NO) are thought to play a crucial role in the process of bacterial meningitis. The present study investigated the mechanisms regulating inducible nitric oxide synthase (iNOS) expression in the choroid plexus epithelium (CPe) in mice. Initially, the expression of iNOS in mouse CPe was strengthened by intracerebroventriclar (i.c.v.) administration of lipid A, which is part of a Gram-negative bacterial endotoxin located at one end of the lipopolysaccharide (LPS) molecule. Next, the expression of iNOS in the CP epithelial cell line ECPC-4 cells was increased from 24 to 48 h after lipid A treatment, although mRNA and proteins of toll-like receptor (TLR)-2 and -4 expressed in ECPC-4 cells were not changed by lipid A. The expression of total nuclear factor kappa B (NF kappa B), an inflammatory transcriptional factor, in ECPC-4 cells was not changed for 72 h after lipid A treatment, while cytoplasmic NF kappa B was decreased and nuclear NF kappa B was increased from 1 to 2 h. In addition, the phosphorylation of inhibitor kappa B (I kappa B) was peaked at 10 min, and the level of I kappa B was attenuated from 10 to 45 min after lipid A treatment. Moreover, the RNA interference (RNAi) of NF kappa B suppressed the expression of iNOS induced by lipid A. We demonstrated that lipid A-induced iNOS expression in ECPC-4 cells was mainly regulated by the activation of NF kappa B-I kappa B intracellular signaling pathway. Thus, we propose that the CPe plays a pivotal role in innate immunity responses of the brain, that is, the signal pathway TLRs on the CPe following inflammatory stimulation such as meningitis is activated, leading to iNOS expression through NF kappa B. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Takano, Masaoki; Ohkusa, Mami; Otani, Mieko; Minami, Katori; Sano, Keiji] Kobe Gakuin Univ, Mol Cell Biol Lab, Sch Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Min, Kyong-Son] Osaka Ohtani Univ, Toxicol Lab, Fac Pharm, Tondabayashi, Osaka 5848540, Japan; [Kadoyama, Keiichi; Matsuyama, Shogo] Himeji Dokkyo Univ, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan	Takano, M (reprint author), Kobe Gakuin Univ, Mol Cell Biol Lab, Sch Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	takano@pharm.kobegakuin.ac.jp			Smoking Research Foundation; Kobe Gakuin University; Ministry of Education, Culture, Sports, Science and Technology of Japan [18023033, 21500352, 21390271, 20023027]	This work was supported by grants from the Smoking Research Foundation, Kobe Gakuin University for Collaborative Research B, and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 18023033, 21500352, 21390271, 20023027).	Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Milhavet O, 2003, PHARMACOL REV, V55, P629, DOI 10.1124/pr.55.4.1; PFISTER HW, 1995, J NEUROL NEUROSUR PS, V58, P384, DOI 10.1136/jnnp.58.3.384; Balyasnikova IV, 2000, J CEREBR BLOOD F MET, V20, P688; Boje KMK, 1996, BRAIN RES, V720, P75, DOI 10.1016/0006-8993(96)00142-4; TUNKEL AR, 1993, ANNU REV MED, V44, P103, DOI 10.1146/annurev.med.44.1.103; Liu SB, 2000, SHOCK, V14, P361, DOI 10.1097/00024382-200014030-00021; CAMPBELL IL, 1994, J IMMUNOL, V153, P3622; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Korytko PJ, 1996, NEUROPHARMACOLOGY, V35, P231, DOI 10.1016/0028-3908(95)00162-X; Speake T, 2001, MICROSC RES TECHNIQ, V52, P49, DOI 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C; Enjoji M, 1996, JPN J CANCER RES, V87, P893; BUSTER BL, 1995, INFECT IMMUN, V63, P3835; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; ENJOJI M, 1995, J NEUROCHEM, V64, P961; Olin MR, 2008, J INFECT DIS, V198, P886, DOI 10.1086/591097; Leitner DF, 2012, BBA-GEN SUBJECTS, V1820, P393, DOI 10.1016/j.bbagen.2011.10.016; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; VISSER JJ, 1994, ANN INTERN MED, V120, P345; Koedel U, 1997, NEUROSCI LETT, V225, P33, DOI 10.1016/S0304-3940(97)00177-8; Shenep JL, 1998, J INFECT DIS, V177, P766; Stridh L, 2013, TRANSL STROKE RES, V4, P220, DOI 10.1007/s12975-012-0248-8; Braun J, 2009, INT J NEUROSCI, V119, P455, DOI 10.1080/00207450802479970; Takano M, 2008, NEUROSCI LETT, V434, P310, DOI 10.1016/j.neulet.2008.01.072; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Schwerk C, 2011, MICROBES INFECT, V13, P953, DOI 10.1016/j.micinf.2011.05.012; Leib SL, 1998, J INFECT DIS, V177, P692; Adam RA, 2004, INFECT IMMUN, V72, P3084, DOI 10.1128/IAI.72.5.3084-3087.2004; LU J, 1995, BRAIN RES, V699, P275, DOI 10.1016/0006-8993(95)00919-H; HABERL RL, 1994, NEUROL RES, V16, P108; Faure E, 2001, J IMMUNOL, V166, P2018; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; XIE QW, 1994, J BIOL CHEM, V269, P4705	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					57	62		10.1016/j.imlet.2015.07.007		6	Immunology	Immunology	CT2JQ	WOS:000362628200001		
J	Nakagawa, Y; Negishi, Y; Shimizu, M; Takahashi, M; Ichikawa, M; Takahashi, H				Nakagawa, Yohko; Negishi, Yasuyuki; Shimizu, Masumi; Takahashi, Megumi; Ichikawa, Masao; Takahashi, Hidemi			Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes	IMMUNOLOGY LETTERS			English	Article						Cytotoxic T lymphocytes; Hypoxia; Extracellular pH; Low pH	HEMATOPOIETIC STEM-CELLS; INDUCIBLE FACTOR-I; MHC MOLECULE; OXYGEN LEVELS; LACTIC-ACID; CANCER; INDUCTION; MICROENVIRONMENT; REQUIREMENTS; METABOLISM	The major effector cells for cellular adaptive immunity are CD8(+) cytotoxic T lymphocytes (CTLs), which can recognize and kill virus-infected cells and tumor cells. Although CTLs exhibit strong cytolytic activity against target cells in vitro, a number of studies have demonstrated that their function is often impaired within tumors. Nevertheless, CTLs can regain their cytotoxic ability after escaping from the tumor environment, suggesting that the milieu created by tumors may affect the function of CTLs. As for the tumor environment, the patho-physiological situation present in vivo has been shown to differ from in vitro experimental conditions. In particular, low pH and hypoxia are the most important microenvironmental factors within growing tumors. In the present study, to determine the effect of these factors on CTL function in vivo, we examined the cytolytic activity of CTLs against their targets using murine CTL lines and the induction of these cells from memory cells under low pH or hypoxic conditions using antigen-primed spleen cells. The results indicated that both cytotoxic activity and the induction of functional CTLs were markedly inhibited under low pH. In contrast, in hypoxic conditions, although cytotoxic activity was almost unchanged, the induction of CTLs in vitro showed a slight enhancement, which was completely abrogated in low pH conditions. Therefore, antigen-specific CTL functions may be more vulnerable to low pH than to the oxygen concentration in vivo. The findings shown here provide new therapeutic approaches for controlling tumor growth by retaining CM cytotoxicity through the maintenance of higher pH conditions. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.	[Nakagawa, Yohko; Negishi, Yasuyuki; Shimizu, Masumi; Takahashi, Megumi; Takahashi, Hidemi] Nippon Med Sch, Dept Microbiol & Immunol, Tokyo 1138602, Japan; [Ichikawa, Masao] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 1138602, Japan	Nakagawa, Y (reprint author), Nippon Med Sch, Dept Microbiol & Immunol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	tanuki@nms.ac.jp			Ministry of Education, Science, Sport, and Culture from the Ministry of Health and Labor and Welfare, Japan [25461715]; Japanese Health Sciences Foundation; Promotion and Mutual Aid Corporation for Private Schools of Japan; MEXT-supported Program for the Strategic Research Foundation at Private Universities, Japan	This study was supported in part by grants from the Ministry of Education, Science, Sport, and Culture from the Ministry of Health and Labor and Welfare, Japan (25461715 to H.T.); from the Japanese Health Sciences Foundation; from the Promotion and Mutual Aid Corporation for Private Schools of Japan; and from a MEXT-supported Program for the Strategic Research Foundation at Private Universities, Japan.	Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Warburg O, 1925, SCIENCE, V61, P575, DOI 10.1126/science.61.1588.575; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; ROTSTEIN OD, 1988, J SURG RES, V45, P298, DOI 10.1016/0022-4804(88)90079-0; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Mendler AN, 2012, INT J CANCER, V131, P633, DOI 10.1002/ijc.26410; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; Neumann AK, 2005, P NATL ACAD SCI USA, V102, P17071, DOI 10.1073/pnas.0506070102; TAKESHITA T, 1995, J IMMUNOL, V154, P1973; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Warburg O, 1923, BIOCHEM Z, V142, P317; Yokosuka T, 2002, J EXP MED, V195, P991, DOI 10.1084/jem.20010809; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; LOEFFLER DA, 1992, BRIT J CANCER, V66, P619, DOI 10.1038/bjc.1992.326; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Harimoto H, 2013, IMMUNOL CELL BIOL, V91, P545, DOI 10.1038/icb.2013.38; Nakagawa Y, 2013, INT IMMUNOL, V25, P11, DOI 10.1093/intimm/dxs086; SIMCHOWITZ L, 1986, J BIOL CHEM, V261, P6492; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Caldwell CC, 2001, J IMMUNOL, V167, P6140; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi SB, 2011, INT J MOL MED, V28, P449, DOI 10.3892/ijmm.2011.719; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Choi SYC, 2013, J PATHOL, V230, P350, DOI 10.1002/path.4218; Kaida A, 2012, BIOCHEM BIOPH RES CO, V421, P855, DOI 10.1016/j.bbrc.2012.04.102; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Kraus M, 1996, TUMOR BIOL, V17, P133; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCl200421086; Andrikopoulou E, 2011, CURR MOL MED, V11, P218; REDEGELD F, 1991, J IMMUNOL, V147, P3638; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Itoi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047512; Semenza GL, 2011, NEW ENGL J MED, V365, P537, DOI 10.1056/NEJMra1011165; VAUPEL P, 1989, CANCER RES, V49, P6449	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					72	86		10.1016/j.imlet.2015.07.003		15	Immunology	Immunology	CT2JQ	WOS:000362628200004		
J	Takenouchi, T; Tsukimoto, M; Iwamaru, Y; Sugama, S; Sekiyama, K; Sato, M; Kojima, S; Hashimoto, M; Kitani, H				Takenouchi, Takato; Tsukimoto, Mitsutoshi; Iwamaru, Yoshifumi; Sugama, Shuei; Sekiyama, Kazunari; Sato, Mitsuru; Kojima, Shuji; Hashimoto, Makoto; Kitani, Hiroshi			Extracellular ATP induces unconventional release of glyceraldehyde-3-phosphate dehydrogenase from microglial cells	IMMUNOLOGY LETTERS			English	Article						Glyceraldehyde-3-phosphate dehydrogenase; Microglial cells; P2X7 receptor; Unconventional release	TRANSFERRIN RECEPTOR; ANTIMICROBIAL PEPTIDE; IL-1-BETA SECRETION; P2X(7) RECEPTOR; ACTIVATION; GAPDH; PROTEIN; MATURATION; INTERLEUKIN-1-BETA; MECHANISMS	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key glycolytic enzyme that is predominantly localized in the cytoplasm. However, recent studies have suggested that GAPDH is released by various cells and that extracellular GAPDH is involved in the regulation of neuritogenesis in neuronal cells. It has also been reported that GAPDH is expressed on the surfaces of macrophages and functions as a transferrin receptor. However, since GAPDH is a leaderless protein the mechanisms by which it reaches the extracellular environment remain unclear. Here, we examined the role of P2X7 receptor (P2X7R), an ATP-gated cation channel, in the unconventional release of GAPDH from microglial cells, the resident macrophages in the brain. The activation of P2X7R by ATP triggered GAPDH release from lipopolysaccharide (LPS)-primed microglial cells. ATP-induced microvesicle formation, exosome release, and K+ efflux followed by caspase-1 activation are likely involved in the GAPDH release, but ATP-induced dilatation of membrane pores and lysosome exocytosis are not. It was also demonstrated that exogenous GAPDH facilitated LPS-induced phosphorylation of p38 MAP kinase in microglial cells. These findings suggest that P2X7R plays an important role in the unconventional release of GAPDH from microglial cells, and the GAPDH released into the extracellular space might be involved in the regulation of the neuroinflammatory response in the brain. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.	[Takenouchi, Takato; Sato, Mitsuru; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Div Anim Sci, Tsukuba, Ibaraki 3058634, Japan; [Tsukimoto, Mitsutoshi; Kojima, Shuji] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Iwamaru, Yoshifumi] Natl Inst Anim Hlth, Pr Dis Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Sugama, Shuei] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan; [Sekiyama, Kazunari; Hashimoto, Makoto] Tokyo Metropolitan Inst Med Sci, Div Sensory & Motor Syst, Tokyo 1560057, Japan	Takenouchi, T (reprint author), Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Div Anim Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	ttakenou@affrc.go.jp; kitani@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [25450521]; NIAS Strategic Research Fund from National Institute of Agrobiological Sciences; Ministry of Agriculture, Forestry and Fisheries of Japan [AGB-1002]	This study was supported by a Grant-in-Aid for Scientific Research (Category C: Grant #25450521) from the Japan Society for the Promotion of Science (JSPS), the NIAS Strategic Research Fund from National Institute of Agrobiological Sciences, and a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomic-based Technology for Agricultural Improvement, AGB-1002).	Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Takenouchi T, 2011, J NEUROCHEM, V117, P712, DOI 10.1111/j.1471-4159.2011.07240.x; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Takenouchi T, 2008, J IMMUNOL, V180, P7827; Qu Y, 2007, J IMMUNOL, V179, P1913; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Aguilera L, 2012, INT J BIOCHEM CELL B, V44, P955, DOI 10.1016/j.biocel.2012.03.002; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Madureira P, 2007, J IMMUNOL, V178, P1379; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Yanagitai M, 2012, BIOCHEM BIOPH RES CO, V418, P22, DOI 10.1016/j.bbrc.2011.12.087; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Takenouchi T, 2009, J IMMUNOL, V182, P2051, DOI 10.4049/jimmunol.0802577; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Seo JK, 2014, FISH SHELLFISH IMMUN, V36, P571, DOI 10.1016/j.fsi.2014.01.003; Yang Y, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/352371; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Seo JM, 2012, FISH SHELLFISH IMMUN, V33, P743, DOI 10.1016/j.fsi.2012.06.023; Rawat P, 2012, BIOCHEM CELL BIOL, V90, P329, DOI [10.1139/o11-058, 10.1139/O11-058]; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Sahoo S, 2013, PARASITE IMMUNOL, V35, P457, DOI 10.1111/pim.12058; Seidler NW, 2013, ADV EXP MED BIOL, V985, P149, DOI 10.1007/978-94-007-4716-6_5; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; Wagener J, 2013, J INVEST DERMATOL, V133, P144, DOI 10.1038/jid.2012.254; Kawada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119415; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; VEDIA LM, 1992, J BIOL CHEM, V267, P24929	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					116	124		10.1016/j.imlet.2015.08.002		9	Immunology	Immunology	CT2JQ	WOS:000362628200008		
J	Matsui, T; Joo, HD; Lee, JM; Ju, SM; Tao, WH; Higashimoto, Y; Fukami, K; Yamagishi, SI				Matsui, Takanori; Joo, Hoo Don; Lee, Jae Min; Ju, Sung Mi; Tao, Wang Hong; Higashimoto, Yuichiro; Fukami, Kei; Yamagishi, Sho-ichi			Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products	IMMUNOLOGY LETTERS			English	Article						AGEs; Monoclonal antibody; Endothelial cells; Diabetes; ELISA	INDUCED DIABETIC-RATS; ENDOTHELIAL-CELLS; IMMUNOLOGICAL DETECTION; SERUM-LEVELS; EXPRESSION; AGES; PROTEIN; ASSAY; RAGE	We have previously found that glyceraldehyde-derived advanced glycation end products (glycer-AGEs) elicit oxidative stress generation and evoke inflammatory and thrombotic reactions through their higher binding affinity to RAGE (receptor for AGEs), thereby playing a role in vascular complications in diabetes. Furthermore, circulating levels of glycer-AGEs are elevated in diabetes. We characterized a monoclonal antibody (mAb) raised against glycer-AGEs and prepared its specific ELISA system in human serum. We developed here mAb reacted specifically with glycer-AGEs or glyceraldehyde-derived pyridinium, but not other structurally identified AGEs or AGE precursors. The mAb not only completely neutralized the deleterious effects of glycer-AGEs on endothelial cells, but also detected glycer-AGEs in the aorta of type 2 diabetic rats. Intra and inter-assay coefficient variations of the ELISA were 6 and 2.6%, respectively. ELISA linearity was shown intact within 5-fold dilution, and recovery ratio of added glycer-AGEs was 88-117%. Results of serum and plasma were comparable, and repeated freeze-thawing of samples did not affect the results (90.1-112.4%). Serum glycer-AGEs levels in 30 healthy subjects evaluated by the ELISA were strongly correlated with those by polyclonal Ab-based one (r=0.82). Our present study suggests the clinical utility of mAb for evaluating glycer-AGE levels in both tissue and serum. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Matsui, Takanori; Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Joo, Hoo Don; Lee, Jae Min; Ju, Sung Mi; Tao, Wang Hong] Boditech Med Inc, Chunchon, South Korea; [Higashimoto, Yuichiro] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka 830, Japan; [Fukami, Kei] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 830, Japan	Yamagishi, SI (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390111]	This work was supported in part by Grants-in-Aid for Scientific Research (B) 22390111 (SY) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Matsui T, 2011, PHARMACOL RES, V63, P383, DOI 10.1016/j.phrs.2011.02.003; Ahn JS, 2003, CLIN CHIM ACTA, V332, P51, DOI 10.1016/S0009-8981(03)00113-X; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094; Ahmed N, 2005, MOL NUTR FOOD RES, V49, P691, DOI 10.1002/mnfr.200500008; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2006.04943.x; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P442, DOI 10.1271/bbb.60497; Higashimoto Y, 2013, MICROVASC RES, V90, P64, DOI 10.1016/j.mvr.2013.08.010; Ueda S, 2012, CARDIOVASC THER, V30, P249, DOI 10.1111/j.1755-5922.2011.00264.x; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Vlassara H, 1996, DIABETES, V45, pS65; Rahbar S, 2007, CELL BIOCHEM BIOPHYS, V48, P147, DOI 10.1007/s12013-07-0021-x; Jinnouchi Y, 2006, CLIN EXP MED, V6, P191, DOI 10.1007/s10238-006-0115-6; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Takeuchi M, 2010, LAB INVEST, V90, P1117, DOI 10.1038/labinvest.2010.62; Takeuchi M, 2001, MOL MED, V7, P783; Yamamoto Y, 2007, DIABETES RES CLIN PR, V77, pS30, DOI 10.1016/j.diabres.2007.01.030; Ha S.G., 1999, HYBRIDOMA, V18, P37; Ishibashi Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-60; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Matsui T, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0162-3; Ojima A., 2014, LAB INVEST, V94, P42; Ojima A, 2013, AM J PATHOL, V182, P132, DOI 10.1016/j.ajpath.2012.09.016	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					141	146		10.1016/j.imlet.2015.08.008		6	Immunology	Immunology	CT2JQ	WOS:000362628200011		
J	Azuma, K; Ikeda, K; Kagi, N; Yanagi, U; Osawa, H				Azuma, K.; Ikeda, K.; Kagi, N.; Yanagi, U.; Osawa, H.			Prevalence and risk factors associated with nonspecific building-related symptoms in office employees in Japan: relationships between work environment, Indoor Air Quality, and occupational stress	INDOOR AIR			English	Article						Epidemiology; Building-related symptoms; Indoor Air Quality; Sick Building Syndrome; Work environment; Occupational stress	PRINTER TONER PARTICLES; US-EPA BASE; SWEDISH WORKFORCE; ORGANIC-COMPOUNDS; OXIDATIVE STRESS; ROOM-TEMPERATURE; SYNDROME SBS; SICK; HEALTH; DAMPNESS	A nationwide cross-sectional study of 3335 employees was conducted in 320 offices in Japan to estimate the prevalence of building-related symptoms (BRSs) and determine the risk factors related to work environment, Indoor Air Quality, and occupational stress. Data were collected through self-administered questionnaires. The prevalences of general symptoms, eye irritation, and upper respiratory symptoms were 14.4%, 12.1%, and 8.9%, respectively. Multiple logistic regression analyses revealed that eye irritation was significantly associated with carpeting [odds ratio (OR), 1.73; 95% confidence interval (CI), 1.24-2.41], coldness perception (OR, 1.28; 95% CI, 1.13-1.45), and air dryness perception (OR, 1.61; 95% CI, 1.42-1.82). General symptoms were significantly associated with unpleasant odors (OR, 1.37; 95% CI, 1.13-1.65), amount of work (OR, 1.24; 95% CI, 1.06-1.45), and interpersonal conflicts (OR, 1.44; 95% CI, 1.23-1.69). Upper respiratory symptoms were significantly associated with crowded workspaces (OR, 1.36; 95% CI, 1.13-1.63), air dryness perception (OR, 2.07; 95% CI, 1.79-2.38), and reported dustiness on the floor (OR, 1.39; 95% CI, 1.16-1.67). Although psychosocial support is important to reduce and control BRSs, maintaining appropriate air-conditioning and a clean and uncrowded workspace is of equal importance.	[Azuma, K.] Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka 5898511, Japan; [Ikeda, K.] Nihon Univ, Dept Architecture, Coll Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Kagi, N.] Tokyo Inst Technol, Dept Mech & Environm Informat, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan; [Yanagi, U.] Kogakuin Univ, Dept Architecture, Sch Architecture, Shinjuku Ku, Tokyo, Japan; [Osawa, H.] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan	Azuma, K (reprint author), Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, 377-2 Ohnohigashi, Osaka 5898511, Japan.	kenazuma@med.kindai.ac.jp			Japanese Ministry of Health, Labour and Welfare [H23-health/crisis-009]	This study was financially supported by a Grant-in-Aid for Health and Labour Sciences Research Grant (H23-health/crisis-009) provided by the Japanese Ministry of Health, Labour and Welfare. We would like to extend our sincere thanks to Takayuki Nakamura, Tomoko Shimodaira, and the staff of the Japan Building Maintenance Association for their help in conducting the survey. We thank Daichi Takano and Yuma Nakagawa (formerly of the Department of Architecture, College of Science and Technology, Nihon University) for their assistance in the laboratory. We also thank all participants for their collaboration.	Wolkoff P, 2008, ENVIRON INT, V34, P1204, DOI 10.1016/j.envint.2008.04.005; Apte MG, 2000, INDOOR AIR, V10, P246, DOI 10.1034/j.1600-0668.2000.010004246.x; Chao HJ, 2003, ENVIRON HEALTH PERSP, V111, P1242, DOI 10.1289/ehp.5697; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Niven RM, 2000, OCCUP ENVIRON MED, V57, P627, DOI 10.1136/oem.57.9.627; Zhang X, 2012, SCI TOTAL ENVIRON, V430, P75, DOI 10.1016/j.scitotenv.2012.04.040; Konczol M, 2013, TOXICOL LETT, V216, P171, DOI 10.1016/j.toxlet.2012.11.018; Fisk WJ, 2009, INDOOR AIR, V19, P159, DOI 10.1111/j.1600-0668.2008.00575.x; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Runeson R, 2004, INDOOR AIR, V14, P394, DOI 10.1111/j.1600-0668.2004.00261.x; Mendell MJ, 2008, INDOOR AIR, V18, P301, DOI 10.1111/j.1600-0668.2008.00531.x; Hansen AM, 2008, INDOOR AIR, V18, P440, DOI 10.1111/j.1600-0668.2008.00571.x; Khatri M, 2013, NANOTOXICOLOGY, V7, P1014, DOI 10.3109/17435390.2012.691998; JAAKKOLA JJK, 1989, ENVIRON INT, V15, P163, DOI 10.1016/0160-4120(89)90022-6; Hosmer DW, 1997, STAT MED, V16, P965; Wolkoff P, 2010, TOXICOL LETT, V199, P203, DOI 10.1016/j.toxlet.2010.09.001; Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x; Erdmann CA, 2004, INDOOR AIR, V14, P127, DOI 10.1111/j.1600-0668.2004.00298.x; Burge PS, 2004, OCCUP ENVIRON MED, V61, P185, DOI 10.1136/oem.2003.008813; Marmot AF, 2006, OCCUP ENVIRON MED, V63, P283, DOI 10.1136/oem.2005.022889; Ozaki K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-253; Reijula K, 2004, OCCUP ENVIRON MED, V61, P33; Ooi PL, 1998, OCCUP ENVIRON MED, V55, P188; Nafiu OO, 2014, J PERIANESTH NURS, V29, P84, DOI 10.1016/j.jopan.2013.03.010; Allermann L, 2007, INDOOR AIR, V17, P458, DOI 10.1111/j.1600-0668.2007.00493.x; TEEUW KB, 1994, ARCH INTERN MED, V154, P2339, DOI 10.1001/archinte.154.20.2339; Bai R, 2010, TOXICOL LETT, V199, P288, DOI 10.1016/j.toxlet.2010.09.011; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Brightman HS, 2008, INDOOR AIR, V18, P335, DOI 10.1111/j.1600-0668.2008.00557.x; Wada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056319; Nakazawa H, 2005, IND HEALTH, V43, P341, DOI 10.2486/indhealth.43.341; [Anonymous], 1998, INDOOR AIR S; Ogasawara K, 2011, J AFFECT DISORDERS, V128, P33, DOI 10.1016/j.jad.2010.06.015; FINNEGAN MJ, 1984, BRIT MED J, V289, P1573; Norback D, 2008, INT ARCH OCC ENV HEA, V82, P21, DOI 10.1007/s00420-008-0301-9; RUOTSALAINEN R, 1995, INT ARCH OCC ENV HEA, V66, P369, DOI 10.1007/BF00383142; Runeson R, 2006, INDOOR AIR, V16, P445, DOI 10.1111/j.1600-0668.2006.00438.x; Azuma K., 2012, T SOC HEAT AIR COND, V179, P19; Azuma K., 2011, P 12 INT C IND AIR Q; BMEC, 2007, LAW MAINT SAN BUILD; MHLW, 2002, REP COMM MAINT SAN B; Mizoue T, 2001, AM J EPIDEMIOL, V154, P803, DOI 10.1093/aje/154.9.803; NORBACK D, 1990, BRIT J IND MED, V47, P733; Runeson-Broberg R, 2013, INT ARCH OCC ENV HEA, V86, P915, DOI 10.1007/s00420-012-0827-8; Santos IS, 2014, EUR J PAIN, V18, P1290, DOI 10.1002/j.1532-2149.2014.489.x; Shimomitsu T, 2000, INVESTIGATION RES RE, P101; USEPA, 2003, STAND EPA PROT CHAR; WHO, 2009, GUID IND QUAL DAMPN; Zweers T, 1992, INDOOR AIR, V2, P127, DOI 10.1111/j.1600-0668.1992.00001.x	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-6947	1600-0668		INDOOR AIR	Indoor Air	OCT	2015	25	5					499	511		10.1111/ina.12158		13	Construction & Building Technology; Engineering, Environmental; Public, Environmental & Occupational Health	Construction & Building Technology; Engineering; Public, Environmental & Occupational Health	CT5KH	WOS:000362848000005		
J	Takaki, S; Shehabi, Y; Pickering, JW; Endre, Z; Miyashita, T; Goto, T				Takaki, Shunsuke; Shehabi, Yahya; Pickering, John W.; Endre, Zoltan; Miyashita, Tetsuya; Goto, Takahisa			Perioperative change in creatinine following cardiac surgery with cardiopulmonary bypass is useful in predicting acute kidney injury: a single-centre retrospective cohort study	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Dilution of creatinine; Cardiopulmonary bypass; Acute kidney injury	ACUTE-RENAL-FAILURE; SURGICAL-PATIENTS; SERUM CREATININE; ASSOCIATION; KINETICS; RISK; CLEARANCE; BIOMARKER; PROGNOSIS; MORTALITY	OBJECTIVES: Acute kidney injury is common following cardiac surgery. Experimental models of acute kidney injury suggest that successful therapy should be implemented within 24-48 h of renal injury. However, it is difficult to detect acute kidney injury shortly after cardiac surgery, because creatinine concentration is diluted by cardiopulmonary bypass. We hypothesized that, following cardiopulmonary bypass, creatinine reduction ratios would correlate with haematocrit reduction ratios and would be associated with the incidence of acute kidney injury. METHODS: We collected demographic and blood test data from consecutive patients (n = 1137) who had undergone cardiac surgery with cardiopulmonary bypass. The creatinine reduction ratio was calculated as follows: (preoperative creatinine-postoperative creatinine)/preoperative creatinine. Patients were assigned to either of two groups. The first group (Group 1) was used to determine the threshold for acute kidney injury, and the second group (Group 2) was used to assess diagnostic performance. Acute kidney injury was defined as an increase in serum creatinine level >0.3 mg/dl or >150% from baseline. RESULTS: The incidence of acute kidney injury was 14.5% (79/545) in Group 1 and 15.5% (92/592) in Group 2. Postoperatively, creatinine concentration correlated strongly with haematocrit concentration (Pearson's r(2): 0.91). In Group 1, the area under the receiver operating characteristic curve, sensitivity and specificity were 0.71, 64.1 and 66.4%, respectively, for creatinine reduction ratios of <20%. In Group 2, the odds ratio, positive predictive value, negative predictive value and relative risk for creatinine reduction ratio performance were 4.3 (95% confidence interval 2.6-7.0), 0.27 (0.21-0.32), 0.92 (0.89-0.95) and 3.42 (2.22-5.27), respectively. CONCLUSIONS: The creatinine reduction ratio may be associated with perioperative renal injury. Therefore, it is a good diagnostic indicator with high performance, and may be useful in detecting acute kidney injury at an earlier stage relative to conventional means. In addition, using creatinine reduction ratios in this manner is financially feasible.	[Takaki, Shunsuke; Miyashita, Tetsuya; Goto, Takahisa] Yokohama City Univ Med, Dept Anesthesiol, Yokohama, Kanagawa, Japan; [Takaki, Shunsuke; Miyashita, Tetsuya; Goto, Takahisa] Yokohama City Univ Med, Intens Care Unit, Yokohama, Kanagawa, Japan; [Shehabi, Yahya] Prince Wales Hosp, Dept Intens Care, Sydney, NSW, Australia; [Pickering, John W.] Univ Otago, Christchurch Hosp, Christchurch & Emergency Dept, Christchurch, New Zealand; [Endre, Zoltan] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia	Takaki, S (reprint author), 3-9 Fukuura, Yokohama, Kanagawa, Japan.	shunty5323@gmail.com	Endre, Zoltan/A-3331-2009	Endre, Zoltan/0000-0002-4782-8695			Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Rivers EP, 2006, CHEST, V129, P217, DOI 10.1378/chest.129.2.217; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Huybregts RAJM, 2009, ANESTH ANALG, V109, P331, DOI 10.1213/ane.0b013e3181ac52b2; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Bloor GK, 1996, J CARDIOTHOR VASC AN, V10, P899, DOI 10.1016/S1053-0770(96)80053-X; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Loef BG, 2005, J AM SOC NEPHROL, V16, P195; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Chertow GM, 1997, CIRCULATION, V95, P878; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Pickering JW, 2013, CRIT CARE, V17, DOI 10.1186/cc11931; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008	24	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2015	21	4					465	469		10.1093/icvts/ivv184		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT8HU	WOS:000363056800014		
J	Mizuno, Y; Uchinaka, A; Horii, Y; Mori, S; Hamada, Y; Miyagawa, S; Saito, A; Sawa, Y; Matsuura, N; Kawaguchi, N				Mizuno, Yoko; Uchinaka, Ayako; Horii, Yoshihito; Mori, Seiji; Hamada, Yoshinosuke; Miyagawa, Shigeru; Saito, Atsuhiro; Sawa, Yoshiki; Matsuura, Nariaki; Kawaguchi, Naomasa			Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Smooth muscle actin; Collagen type III; Osteopontin-derived peptide SVVYGLR; Dilated cardiomyopathic hearts	SMOOTH MUSCLE ACTIN; CONTRACTILE ACTIVITY; COLLAGEN; MYOFIBROBLAST; DISEASE; J2N-K; HEART; RATIO	OBJECTIVES: Osteopontin is a multifunctional cytokine that can modulate a variety of cellular activities, such as fibrotic response and inflammation. Osteopontin-derived peptide Ser-Val-Val-Tyr-Gly-Leu-Arg (SVVYGLR; SV) induces angiogenesis and the expression of smooth muscle actin (SMA) in fibroblasts. In this study, we determined the effects of SV peptide on dilated cardiomyopathy (DCM). METHODS: Gels containing SV peptide (SV group), a random SV peptide (GYRVLSV) (random group) or a simple phosphate-buffered saline solution (PBS group) were transplanted on to the left ventricular (LV) anterior wall of a DCM hamster model. A control group simply underwent chest opening and closing. We used echocardiography to measure cardiac function before gel implantation (week 0) and 2, 4, 6 and 8 weeks after gel implantation. Changes in histology and myocardial remodelling were evaluated 8 weeks after the gel implantation. RESULTS: At 8 weeks post-treatment, the SV group had significantly better maintained cardiac function compared with the other groups. Histological analysis showed that LV chamber dilatation and cardiomyocyte hypertrophy were significantly attenuated, and the distribution of SMA-positive cells in the LV anterior wall area was greater in the SV group. The capillary density in the epicardial aspect of the anterior wall in the SV group was also significantly increased, indicating that the SV peptide released from the implanted gel had promoted angiogenesis. Furthermore, Western blotting and histological analyses showed that the level of expression of collagen type III at the gelimplanted anterior wall in the SV group was significantly increased, and the type III/type I collagen ratio was higher in the SV group than in the control or PBS groups. CONCLUSIONS: SV peptide treatment improved cardiac function, and inhibited the dilatation of the LV chamber and cardiomyocyte hypertrophy. By inducing the differentiation of fibroblasts to SMA-positive muscle-like cells and increasing type III collagen, SV peptide conferred a contractile property on the gel-implanted wall. We believe that the SVVYGLR peptide treatment could be used as a bridge to a left ventricular assist device and heart transplantation and for cardiac regeneration therapy without cell transplantation in the future.	[Mizuno, Yoko; Uchinaka, Ayako; Horii, Yoshihito; Kawaguchi, Naomasa] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Cardiovasc Pathol, Suita, Osaka 5650871, Japan; [Mori, Seiji; Hamada, Yoshinosuke; Matsuura, Nariaki] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Saito, Atsuhiro] Osaka Univ, Grad Sch Med, Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan	Kawaguchi, N (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Cardiovasc Pathol, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	kawaguch@sahs.med.osaka-u.ac.jp					Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; YOSHIKANE H, 1992, JPN CIRC J, V56, P899; Uchinaka A, 2013, CARDIOVASC RES, V99, P102, DOI 10.1093/cvr/cvt088; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Pauschinger M, 1999, CIRCULATION, V99, P2750; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637; Hamada Y, 2004, DENT MATER J, V23, P650; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hamada Y, 2007, DENT MATER J, V26, P487; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Mitsuhashi S, 2003, J BIOCHEM, V134, P269, DOI 10.1093/jb/mvg140; LAPIERE CM, 1977, CONNECT TISSUE RES, V5, P21, DOI 10.3109/03008207709152608; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Takeda N, 2003, INT J MOL MED, V11, P13; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7; BISHOP JE, 1990, J MOL CELL CARDIOL, V22, P1157, DOI 10.1016/0022-2828(90)90079-H; Babick AP, 2004, AM J PHYSIOL-CELL PH, V287, pC1202, DOI 10.1152/ajpcell.00155.2004; Kis K, 2011, EXPERT REV MOL MED, V13, pe27; Uchinaka A, 2014, TISSUE ENG PT A, V20, P3073, DOI [10.1089/ten.TEA.2013.0763, 10.1089/ten.tea.2013.0763]	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2015	21	4					506	514		10.1093/icvts/ivv197		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT8HU	WOS:000363056800025		
